Citrus Sinensis ID: 013081
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 450 | 2.2.26 [Sep-21-2011] | |||||||
| Q8RWC9 | 444 | CBL-interacting serine/th | yes | no | 0.964 | 0.977 | 0.696 | 1e-175 | |
| Q94C40 | 432 | CBL-interacting serine/th | no | no | 0.953 | 0.993 | 0.674 | 1e-172 | |
| Q9LGV5 | 461 | CBL-interacting protein k | yes | no | 0.971 | 0.947 | 0.650 | 1e-168 | |
| Q0D4B2 | 525 | CBL-interacting protein k | no | no | 0.946 | 0.811 | 0.665 | 1e-167 | |
| Q75L42 | 454 | CBL-interacting protein k | no | no | 0.944 | 0.936 | 0.638 | 1e-163 | |
| Q6ZLP5 | 450 | CBL-interacting protein k | no | no | 0.951 | 0.951 | 0.523 | 1e-132 | |
| Q93VD3 | 482 | CBL-interacting serine/th | no | no | 0.886 | 0.827 | 0.540 | 1e-129 | |
| Q2V452 | 441 | CBL-interacting serine/th | no | no | 0.922 | 0.941 | 0.514 | 1e-128 | |
| Q84VQ3 | 439 | CBL-interacting serine/th | no | no | 0.9 | 0.922 | 0.514 | 1e-127 | |
| Q2QY53 | 438 | CBL-interacting protein k | no | no | 0.873 | 0.897 | 0.535 | 1e-127 |
| >sp|Q8RWC9|CIPK1_ARATH CBL-interacting serine/threonine-protein kinase 1 OS=Arabidopsis thaliana GN=CIPK1 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 616 bits (1588), Expect = e-175, Method: Compositional matrix adjust.
Identities = 310/445 (69%), Positives = 369/445 (82%), Gaps = 11/445 (2%)
Query: 5 EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE 64
+K ++GMRLG+YELGRTLGEGNFGKVKFA+D SG FAVKI++K+RI L + QIKRE
Sbjct: 9 KKAEKGMRLGKYELGRTLGEGNFGKVKFAKDTVSGHSFAVKIIDKSRIADLNFSLQIKRE 68
Query: 65 IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
I TLK+LKHP++VRLHEVLASK+KI MV+E VTGGELFD+I S G+L E +GRK+FQQLI
Sbjct: 69 IRTLKMLKHPHIVRLHEVLASKTKINMVMELVTGGELFDRIVSNGKLTETDGRKMFQQLI 128
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
DG+SYCH+KGVFHRDLKLEN+LLD+KG+IKI+DFGLSALPQHFRDDGLLHTTCGSPNYVA
Sbjct: 129 DGISYCHSKGVFHRDLKLENVLLDAKGHIKITDFGLSALPQHFRDDGLLHTTCGSPNYVA 188
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244
PEVLANRGYDGA SDIWSCGVILYVILTG LPFDDRNLAVLYQKI +GD +P+WLSPGA
Sbjct: 189 PEVLANRGYDGAASDIWSCGVILYVILTGCLPFDDRNLAVLYQKICKGDPPIPRWLSPGA 248
Query: 245 QNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP-DDDEEDIFVDNEAFSMHEVPSDG 303
+ +++++L+PNPV RIT+ GIKA EWF+ +Y P+ P DDDEE++ D++AFS+ E+ S+
Sbjct: 249 RTMIKRMLDPNPVTRITVVGIKASEWFKLEYIPSIPDDDDEEEVDTDDDAFSIQELGSEE 308
Query: 304 GRTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEM 363
G+ SP +INAFQLIGMSS LDLSGFFE+E+VSER+IRFTSN SAKDLLE+IE VTEM
Sbjct: 309 GKGSDSPTIINAFQLIGMSSFLDLSGFFEQENVSERRIRFTSNSSAKDLLEKIETAVTEM 368
Query: 364 GFRVQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQIKTS 423
GF VQKK+ KL+ QE + QK LSV AEVFEI PSL VVELRKSYGD +YR
Sbjct: 369 GFSVQKKHAKLRVKQEERNQKGQVGLSVTAEVFEIKPSLNVVELRKSYGDSCLYR----- 423
Query: 424 IVFVQLCNKLSSDLGL-PPSQELLA 447
QL +L D+G P QE++
Sbjct: 424 ----QLYERLLKDVGTSSPEQEIVT 444
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q94C40|CIPKH_ARATH CBL-interacting serine/threonine-protein kinase 17 OS=Arabidopsis thaliana GN=CIPK17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 604 bits (1557), Expect = e-172, Method: Compositional matrix adjust.
Identities = 296/439 (67%), Positives = 357/439 (81%), Gaps = 10/439 (2%)
Query: 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL 68
+GMR+G+YELGRTLGEGN KVKFA D +G FA+KI+EK+ I L ++ QIKREI TL
Sbjct: 4 KGMRVGKYELGRTLGEGNSAKVKFAIDTLTGESFAIKIIEKSCITRLNVSFQIKREIRTL 63
Query: 69 KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
K+LKHPN+VRLHEVLASK+KIYMVLE VTGG+LFD+I SKG+L E +GRK+FQQLIDGVS
Sbjct: 64 KVLKHPNIVRLHEVLASKTKIYMVLECVTGGDLFDRIVSKGKLSETQGRKMFQQLIDGVS 123
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
YCHNKGVFHRDLKLEN+LLD+KG+IKI+DFGLSAL QH+R+DGLLHTTCGSPNYVAPEVL
Sbjct: 124 YCHNKGVFHRDLKLENVLLDAKGHIKITDFGLSALSQHYREDGLLHTTCGSPNYVAPEVL 183
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL 248
AN GYDGA SDIWSCGVILYVILTG LPFDD NLAV+ +KIF+GD +P+W+S GA+ ++
Sbjct: 184 ANEGYDGAASDIWSCGVILYVILTGCLPFDDANLAVICRKIFKGDPPIPRWISLGAKTMI 243
Query: 249 RKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPG 308
+++L+PNPV R+TIAGIKA +WF+ DYTP+N DDD++ + + F M E + ++P
Sbjct: 244 KRMLDPNPVTRVTIAGIKAHDWFKHDYTPSNYDDDDDVYLIQEDVFMMKEYEEE--KSPD 301
Query: 309 SPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQ 368
SP +INAFQLIGMSS LDLSGFFE E +SER+IRFTSN AKDLLE IE I TEMGF +Q
Sbjct: 302 SPTIINAFQLIGMSSFLDLSGFFETEKLSERQIRFTSNSLAKDLLENIETIFTEMGFCLQ 361
Query: 369 KKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQIKTSIVFVQ 428
KK+ KLKA +E QK LSV AEVFEISPSL VVELRKS+GD ++Y+Q+ + +
Sbjct: 362 KKHAKLKAIKEESTQKRQCGLSVTAEVFEISPSLNVVELRKSHGDSSLYKQL-----YER 416
Query: 429 LCNKLSSDLGLPPSQELLA 447
L N+L S QELLA
Sbjct: 417 LLNELGSS---SQVQELLA 432
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LGV5|CIPK1_ORYSJ CBL-interacting protein kinase 1 OS=Oryza sativa subsp. japonica GN=CIPK1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 592 bits (1526), Expect = e-168, Method: Compositional matrix adjust.
Identities = 296/455 (65%), Positives = 360/455 (79%), Gaps = 18/455 (3%)
Query: 1 MVIAEKKQEGMR---LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKI 57
MV E + E R LGRYE+GRTLGEGNFGKVK+A+ L +G FA+KIL++N+I+ L+
Sbjct: 1 MVNGEAEAECTRASLLGRYEIGRTLGEGNFGKVKYARHLATGAHFAIKILDRNKILSLRF 60
Query: 58 TDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR 117
DQI+REI TLKLLKHPNVVRLHEV ASK+KIYMVLEYV GGELFDKIA KG+L E EGR
Sbjct: 61 DDQIRREIGTLKLLKHPNVVRLHEVAASKTKIYMVLEYVNGGELFDKIAVKGKLSEHEGR 120
Query: 118 KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC 177
+LFQQLID VSYCH+KGV+HRDLK EN+L+D +GNIKISDFGLSALPQH +DGLLHTTC
Sbjct: 121 RLFQQLIDAVSYCHDKGVYHRDLKPENVLVDRRGNIKISDFGLSALPQHLGNDGLLHTTC 180
Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP 237
GSPNY+APEVL NRGYDG+ SDIWSCGVILYV+L GYLPFDDRNL VLYQKIF+GD ++P
Sbjct: 181 GSPNYIAPEVLQNRGYDGSLSDIWSCGVILYVMLVGYLPFDDRNLVVLYQKIFKGDTQIP 240
Query: 238 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMH 297
KWLSP A++LLR+ILEPNP+KRI IAGIK EWF++DYTP P DD++D ++D+ +
Sbjct: 241 KWLSPSARDLLRRILEPNPMKRINIAGIKEHEWFQKDYTPVVPYDDDDDNYLDS-VLPIK 299
Query: 298 EVPSDGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIE 357
E + + P INAFQLIGM+S LDLSGFFE+ED S+RKIRFTS HS KDL ++IE
Sbjct: 300 EQIDEAKQE--KPTHINAFQLIGMASALDLSGFFEEEDASQRKIRFTSTHSPKDLFDKIE 357
Query: 358 DIVTEMGFRVQKKNGKLKATQEHKPQKSL---GSLSVAAEVFEISPSLYVVELRKSYGDP 414
++VTEMGF+VQ+ N KLK + + K+L S V EV E+ PSLYVVEL+KS+GDP
Sbjct: 358 NVVTEMGFQVQRGNSKLKVMKNGRGSKNLRNPSSFLVCTEVVELGPSLYVVELKKSHGDP 417
Query: 415 TVYRQIKTSIVFVQLCNKLSSDLGLPPSQELLATE 449
+YR QLC +LS +LG+ ++++ TE
Sbjct: 418 ILYR---------QLCERLSDELGVCKTEQIQRTE 443
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0D4B2|CIPKL_ORYSJ CBL-interacting protein kinase 21 OS=Oryza sativa subsp. japonica GN=CIPK21 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 587 bits (1514), Expect = e-167, Method: Compositional matrix adjust.
Identities = 293/440 (66%), Positives = 348/440 (79%), Gaps = 14/440 (3%)
Query: 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
MR+G+YE+GR LGEG+FGKVK A+ D+G FA+KIL++ RI+ +KI +QIKREIATLK
Sbjct: 81 AMRMGKYEMGRALGEGHFGKVKLARHADTGAAFAIKILDRQRILAMKIDEQIKREIATLK 140
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
LLKHPNVVRLHEV ASK+KIYMVLEYV GGELFDKIA KG+L E EGRKLFQQL+D VSY
Sbjct: 141 LLKHPNVVRLHEVSASKTKIYMVLEYVNGGELFDKIALKGKLSEKEGRKLFQQLMDAVSY 200
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
CH KGV+HRDLK EN+L+D+KGNIK+SDFGLSALPQ+ R DGLLHTTCGSPNY+APEVL
Sbjct: 201 CHEKGVYHRDLKPENVLVDAKGNIKVSDFGLSALPQNQRKDGLLHTTCGSPNYIAPEVLL 260
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLR 249
NRGYDG+ SDIWSCGVILYV+LTG LPFDD+N VLYQKI +GD ++PKWLSPGAQ++LR
Sbjct: 261 NRGYDGSLSDIWSCGVILYVMLTGNLPFDDQNTVVLYQKILKGDARIPKWLSPGAQDILR 320
Query: 250 KILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGS 309
KIL+PNP+ R+ I GI+A EWF QDYTPA P DD++D + + M E + T +
Sbjct: 321 KILDPNPITRLDITGIRAHEWFRQDYTPAMPFDDDDDNNISDGNLHMTE--NQDIETSPA 378
Query: 310 PPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQK 369
INAFQLIGMSSCLDLSGFFEKEDVSERKIRF SN+S L E+IE VTE GF+VQK
Sbjct: 379 ISQINAFQLIGMSSCLDLSGFFEKEDVSERKIRFVSNYSPTSLFEKIESTVTEKGFQVQK 438
Query: 370 KNGKLKATQ---EHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQIKTSIVF 426
+GKLK Q E + G+L ++AEVFEI+ SLYVVEL++S GD ++YR
Sbjct: 439 NSGKLKVIQVCKEPANPRGHGNLLISAEVFEINESLYVVELKRSSGDCSLYR-------- 490
Query: 427 VQLCNKLSSDLGLPPSQELL 446
QLC LS DLG+ Q+LL
Sbjct: 491 -QLCASLSEDLGICKRQQLL 509
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q75L42|CIPKH_ORYSJ CBL-interacting protein kinase 17 OS=Oryza sativa subsp. japonica GN=CIPK17 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 575 bits (1481), Expect = e-163, Method: Compositional matrix adjust.
Identities = 279/437 (63%), Positives = 347/437 (79%), Gaps = 12/437 (2%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
LG YE+GRTLGEGNFGKVK+A+ L +G FAVKIL++ R++ L+ DQI+REIATLKLL+
Sbjct: 10 LGGYEMGRTLGEGNFGKVKYARHLATGGHFAVKILDRGRVVSLRAGDQIRREIATLKLLR 69
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
HP+VVRLHEV ASK+KIYMVLE+V GGELF++IA KG+L E EGR+LFQQLIDGVSYCH+
Sbjct: 70 HPHVVRLHEVAASKTKIYMVLEFVNGGELFERIAVKGKLSEKEGRRLFQQLIDGVSYCHD 129
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
+GV+HRDLK EN+L+D KGNIKISDFGLSALPQH +DGLLHTTCGSPNY+APEVL N+G
Sbjct: 130 RGVYHRDLKPENVLVDQKGNIKISDFGLSALPQHLGNDGLLHTTCGSPNYIAPEVLQNKG 189
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKIL 252
YDG+ SDIWSCGVILYV+L GYLPFDDRN+ VLYQKIF+GD ++PKWLS AQNLLR+IL
Sbjct: 190 YDGSLSDIWSCGVILYVMLIGYLPFDDRNIVVLYQKIFKGDTQIPKWLSHSAQNLLRRIL 249
Query: 253 EPNPVKRITIAGIKADEWFEQDYTPANP-DDDEEDIFVDNEAFSMHEVPSDGGRTPGSPP 311
EPNP+KRI +AGIK+ EWF++DY P P DDD+ED+ + ++ + G +
Sbjct: 250 EPNPMKRIDMAGIKSHEWFQKDYIPVLPYDDDDEDVQFGARLPAKEQINDEPGDK--NSH 307
Query: 312 LINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKN 371
INAFQLIGM+S LDLSGFFE E+VS+R+IRFTS H KD ++IE TE+GF+VQ+ +
Sbjct: 308 QINAFQLIGMASSLDLSGFFEDEEVSQRRIRFTSTHPPKDAFDKIESSATELGFQVQRGH 367
Query: 372 GKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQIKTSIVFVQLCN 431
KLK + K K+ S V+AEVFE+ PS+ VVELRKS GDP +YR QLC
Sbjct: 368 SKLKLMRNCKGSKNPESFMVSAEVFELGPSVNVVELRKSNGDPALYR---------QLCE 418
Query: 432 KLSSDLGLPPSQELLAT 448
++SSD+G ++++ AT
Sbjct: 419 RISSDMGARNTEQIFAT 435
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6ZLP5|CIPKN_ORYSJ CBL-interacting protein kinase 23 OS=Oryza sativa subsp. japonica GN=CIPK23 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 472 bits (1214), Expect = e-132, Method: Compositional matrix adjust.
Identities = 234/447 (52%), Positives = 317/447 (70%), Gaps = 19/447 (4%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
R+GRYELGRTLGEG F KVKFA++ DSG A+KIL+K++++ K+ QIKREI+T+KL+
Sbjct: 9 RVGRYELGRTLGEGTFAKVKFARNADSGENVAIKILDKDKVLKHKMIAQIKREISTMKLI 68
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
+HPNV+R+HEV+ASK+KIY+V+E VTGGELFDKIAS+GRL+E + RK FQQLI+ V YCH
Sbjct: 69 RHPNVIRMHEVMASKTKIYIVMELVTGGELFDKIASRGRLKEDDARKYFQQLINAVDYCH 128
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
++GV+HRDLK EN+LLD+ G +K+SDFGLSAL Q R+DGLLHTTCG+PNYVAPEV+ N+
Sbjct: 129 SRGVYHRDLKPENLLLDASGTLKVSDFGLSALSQQVREDGLLHTTCGTPNYVAPEVINNK 188
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 251
GYDGA +D+WSCGVIL+V++ GYLPF+D NL LY+KIF+ DF P W S A+ L++KI
Sbjct: 189 GYDGAKADLWSCGVILFVLMAGYLPFEDSNLMSLYKKIFKADFSCPSWFSTSAKKLIKKI 248
Query: 252 LEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVD------NEAFSMHEVPSDGGR 305
L+PNP RITIA + +EWF++ Y P P + D+ +D NE+ ++ + R
Sbjct: 249 LDPNPSTRITIAELINNEWFKKGYQP--PRFETADVNLDDINSIFNESGDQTQLVVE--R 304
Query: 306 TPGSPPLINAFQLIGMSSCLDLSGFFEKEDVS--ERKIRFTSNHSAKDLLERIEDIVTEM 363
P ++NAF+LI S L+L FEK+ +R+ RF S A ++L +IE M
Sbjct: 305 REERPSVMNAFELISTSQGLNLGTLFEKQSQGSVKRETRFASRLPANEILSKIEAAAGPM 364
Query: 364 GFRVQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQIKTS 423
GF VQK+N KLK E+ +K G L++A EVFE++PSLY+VELRKS GD + +
Sbjct: 365 GFNVQKRNYKLKLQGENPGRK--GQLAIATEVFEVTPSLYMVELRKSNGDTLEFHKF--- 419
Query: 424 IVFVQLCNKLSSDLGLPPSQELLATEV 450
+ + N L + P S + E+
Sbjct: 420 --YHNISNGLKDVMWKPESSIIAGDEI 444
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q93VD3|CIPKN_ARATH CBL-interacting serine/threonine-protein kinase 23 OS=Arabidopsis thaliana GN=CIPK23 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 462 bits (1189), Expect = e-129, Method: Compositional matrix adjust.
Identities = 220/407 (54%), Positives = 299/407 (73%), Gaps = 8/407 (1%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+G+YELGRTLGEG F KVKFA+++++G A+K+++K +++ K+ QIKREI+T+KL+K
Sbjct: 28 VGKYELGRTLGEGTFAKVKFARNVENGDNVAIKVIDKEKVLKNKMIAQIKREISTMKLIK 87
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
HPNV+R+ EV+ASK+KIY VLE+VTGGELFDKI+S GRL+E E RK FQQLI+ V YCH+
Sbjct: 88 HPNVIRMFEVMASKTKIYFVLEFVTGGELFDKISSNGRLKEDEARKYFQQLINAVDYCHS 147
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
+GV+HRDLK EN+LLD+ G +K+SDFGLSALPQ R+DGLLHTTCG+PNYVAPEV+ N+G
Sbjct: 148 RGVYHRDLKPENLLLDANGALKVSDFGLSALPQQVREDGLLHTTCGTPNYVAPEVINNKG 207
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKIL 252
YDGA +D+WSCGVIL+V++ GYLPF+D NL LY+KIF+ +F P W S A+ L+++IL
Sbjct: 208 YDGAKADLWSCGVILFVLMAGYLPFEDSNLTSLYKKIFKAEFTCPPWFSASAKKLIKRIL 267
Query: 253 EPNPVKRITIAGIKADEWFEQDYTP-----ANPDDDEEDIFVDNEAFSMHEVPSDGGRTP 307
+PNP RIT A + +EWF++ Y A+ D+ D D+ S + V
Sbjct: 268 DPNPATRITFAEVIENEWFKKGYKAPKFENADVSLDDVDAIFDDSGESKNLVVERREEGL 327
Query: 308 GSPPLINAFQLIGMSSCLDLSGFFEKE-DVSERKIRFTSNHSAKDLLERIEDIVTEMGFR 366
+P +NAF+LI S L+L FEK+ + +RK RFTS SA +++ +IE MGF
Sbjct: 328 KTPVTMNAFELISTSQGLNLGSLFEKQMGLVKRKTRFTSKSSANEIVTKIEAAAAPMGFD 387
Query: 367 VQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGD 413
V+ N K+K T E +K G L+VA EVF+++PSLY+VE+RKS GD
Sbjct: 388 VKTNNYKMKLTGEKSGRK--GQLAVATEVFQVAPSLYMVEMRKSGGD 432
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein leads to activation of the kinase in a calcium-dependent manner. Downstream of CBL1, CBL2, CBL3 and CBL9, regulates by phosphorylation the K(+) conductance and uptake of AKT1 in low K(+) condition, in response to calcium signaling and during the stomatal opening regulation by monitoring the turgor pressure in guard cells. In response to low nitrate concentration, phosphorylates NRT1.1, switching it from a low-affinity nitrate transporter to a high-affinity transporter. Confers tolerance to low potassium conditions. Involved in drought sensitivity and leaf transpiration. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2V452|CIPK3_ARATH CBL-interacting serine/threonine-protein kinase 3 OS=Arabidopsis thaliana GN=CIPK3 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 460 bits (1183), Expect = e-128, Method: Compositional matrix adjust.
Identities = 226/439 (51%), Positives = 314/439 (71%), Gaps = 24/439 (5%)
Query: 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
++Q R+G+YE+GRT+GEG F KVKFA++ ++G P A+KIL+K +++ K+ +QI+REI
Sbjct: 4 RQQVKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIRREI 63
Query: 66 ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID 125
AT+KL+KHPNVV+L+EV+ASK+KI+++LEYVTGGELFDKI + GR++E E R+ FQQLI
Sbjct: 64 ATMKLIKHPNVVQLYEVMASKTKIFIILEYVTGGELFDKIVNDGRMKEDEARRYFQQLIH 123
Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 185
V YCH++GV+HRDLK EN+LLDS GN+KISDFGLSAL Q RDDGLLHT+CG+PNYVAP
Sbjct: 124 AVDYCHSRGVYHRDLKPENLLLDSYGNLKISDFGLSALSQQVRDDGLLHTSCGTPNYVAP 183
Query: 186 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQ 245
EVL +RGYDGAT+D+WSCGV+LYV+L GYLPFDD NL LY+KI G+F P WLS GA
Sbjct: 184 EVLNDRGYDGATADMWSCGVVLYVLLAGYLPFDDSNLMNLYKKISSGEFNCPPWLSLGAM 243
Query: 246 NLLRKILEPNPVKRITIAGIKADEWFEQDYTPA-------NPDDDEEDIFVDNEAFSMHE 298
L+ +IL+PNP+ R+T + DEWF++DY P + DD + +F D+E + E
Sbjct: 244 KLITRILDPNPMTRVTPQEVFEDEWFKKDYKPPVFEERDDSNMDDIDAVFKDSEEHLVTE 303
Query: 299 VPSDGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIED 358
+ P INAF++I MS L+L F+ E +R+ R T A +++E+IE+
Sbjct: 304 ------KREEQPAAINAFEIISMSRGLNLENLFDPEQEFKRETRITLRGGANEIIEKIEE 357
Query: 359 IVTEMGFRVQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYR 418
+GF VQKKN K++ +K G+L+VA E+F+++PSL++V++ KS GD
Sbjct: 358 AAKPLGFDVQKKNYKMRLENVKAGRK--GNLNVATEIFQVAPSLHMVQVSKSKGD----- 410
Query: 419 QIKTSIVFVQLCNKLSSDL 437
++ F + KLS+ L
Sbjct: 411 ----TLEFHKFYKKLSNSL 425
|
Involved in the resistance to some abiotic stresses (e.g. high salt, hyperosmotic stress) in young seedlings, by regulating the expression of several stress-inducible genes (cold-and salt-induced genes but not drought-responsive genes). Required for the ABA response during germination. CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q84VQ3|CIPKQ_ARATH CBL-interacting serine/threonine-protein kinase 26 OS=Arabidopsis thaliana GN=CIPK26 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 455 bits (1171), Expect = e-127, Method: Compositional matrix adjust.
Identities = 218/424 (51%), Positives = 308/424 (72%), Gaps = 19/424 (4%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
R+G+YE+G+TLG+G F KV+ A + ++G A+KIL+K +++ K+ +QI+REI T+KL+
Sbjct: 9 RVGKYEVGKTLGQGTFAKVRCAVNTETGERVALKILDKEKVLKHKMAEQIRREICTMKLI 68
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
HPNVVRL+EVLASK+KIY+VLE+ TGGELFDKI GRL+E RK FQQLI+ V YCH
Sbjct: 69 NHPNVVRLYEVLASKTKIYIVLEFGTGGELFDKIVHDGRLKEENARKYFQQLINAVDYCH 128
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
++GV+HRDLK EN+LLD++GN+K+SDFGLSAL + R DGLLHT CG+PNY APEVL ++
Sbjct: 129 SRGVYHRDLKPENLLLDAQGNLKVSDFGLSALSRQVRGDGLLHTACGTPNYAAPEVLNDQ 188
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 251
GYDGAT+D+WSCGVIL+V+L GYLPF+D NL LY+KI G++ P WLSPGA+NL+ +I
Sbjct: 189 GYDGATADLWSCGVILFVLLAGYLPFEDSNLMTLYKKIIAGEYHCPPWLSPGAKNLIVRI 248
Query: 252 LEPNPVKRITIAGIKADEWFEQDYTPANPD-------DDEEDIFVDNEAFSMHEVPSDGG 304
L+PNP+ RITI + D WF+++Y PA + DD + +F D+E + E +
Sbjct: 249 LDPNPMTRITIPEVLGDAWFKKNYKPAVFEEKEEANLDDVDAVFKDSEEHHVTEKKEE-- 306
Query: 305 RTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMG 364
P +NAF+LI MS LDL FE+E+ +R+ RF + +A DL+++IE+ +G
Sbjct: 307 ----QPTSMNAFELISMSRALDLGNLFEEEEGFKRETRFAAKGAANDLVQKIEEASKPLG 362
Query: 365 FRVQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDP----TVYRQI 420
F +QKKN K++ +K G+L VA E+F++SPSL+++E+RK+ GD Y+++
Sbjct: 363 FDIQKKNYKMRLENVTAGRK--GNLRVATEIFQVSPSLHMIEVRKTKGDTLEFHKFYKKL 420
Query: 421 KTSI 424
TS+
Sbjct: 421 STSL 424
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2QY53|CIPKW_ORYSJ CBL-interacting protein kinase 32 OS=Oryza sativa subsp. japonica GN=CIPK32 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 454 bits (1167), Expect = e-127, Method: Compositional matrix adjust.
Identities = 219/409 (53%), Positives = 299/409 (73%), Gaps = 16/409 (3%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
R+G+YELGRT+GEG F KVKFA+D ++G P A+KIL+K +++ K+ +QIKREI+T+KL+
Sbjct: 9 RVGKYELGRTIGEGTFAKVKFARDTETGDPVAIKILDKEKVLKHKMVEQIKREISTMKLI 68
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
KHPNVVR++EV+ SK+KIY+VLEYVTGGELFD I + GR++E E R+ FQQLI+ V YCH
Sbjct: 69 KHPNVVRIYEVMGSKTKIYIVLEYVTGGELFDTIVNHGRMREDEARRYFQQLINAVDYCH 128
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
++GV+HRDLK EN+LLDS GN+K+SDFGLSAL Q +DDGLLHTTCG+PNYVAPEVL ++
Sbjct: 129 SRGVYHRDLKPENLLLDSYGNLKVSDFGLSALSQQIKDDGLLHTTCGTPNYVAPEVLEDQ 188
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 251
GYDGA +D+WSCGVIL+V+L GYLPF+D NL LY+KI +F P W S A+ LL +I
Sbjct: 189 GYDGAMADLWSCGVILFVLLAGYLPFEDSNLMTLYKKISNAEFTFPPWTSFPAKRLLTRI 248
Query: 252 LEPNPVKRITIAGIKADEWFEQDYTPANPD-------DDEEDIFVDNEAFSMHEVPSDGG 304
L+PNP+ R+TI I DEWF++ Y D DD +F D+E + E +
Sbjct: 249 LDPNPMTRVTIPEILEDEWFKKGYKRPEFDEKYDTTLDDVYAVFNDSEEHHVTEKKEE-- 306
Query: 305 RTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMG 364
P +NAF+LI MS+ L+L F+ E +R+ RFTS K+++ +IE+ +G
Sbjct: 307 -----PEALNAFELISMSAGLNLGNLFDSEQEFKRETRFTSKCPPKEIVRKIEEAAKPLG 361
Query: 365 FRVQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGD 413
F VQKKN KL+ + +K G+L+VA E+ +++PSL++VE+RK+ GD
Sbjct: 362 FDVQKKNYKLRLEKVKAGRK--GNLNVATEILQVAPSLHMVEVRKAKGD 408
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 450 | ||||||
| 255556588 | 436 | CBL-interacting serine/threonine-protein | 0.957 | 0.988 | 0.795 | 0.0 | |
| 224110276 | 474 | predicted protein [Populus trichocarpa] | 0.955 | 0.907 | 0.793 | 0.0 | |
| 356548027 | 446 | PREDICTED: CBL-interacting serine/threon | 0.957 | 0.966 | 0.758 | 0.0 | |
| 356530499 | 447 | PREDICTED: CBL-interacting serine/threon | 0.975 | 0.982 | 0.730 | 0.0 | |
| 363807952 | 448 | uncharacterized protein LOC100805710 [Gl | 0.957 | 0.962 | 0.740 | 0.0 | |
| 357450323 | 465 | CBL-interacting protein kinase [Medicago | 0.946 | 0.916 | 0.759 | 0.0 | |
| 359477295 | 392 | PREDICTED: CBL-interacting serine/threon | 0.837 | 0.961 | 0.831 | 0.0 | |
| 297736814 | 391 | unnamed protein product [Vitis vinifera] | 0.835 | 0.961 | 0.829 | 0.0 | |
| 356558505 | 437 | PREDICTED: CBL-interacting serine/threon | 0.935 | 0.963 | 0.747 | 0.0 | |
| 357479181 | 446 | CBL-interacting protein kinase [Medicago | 0.94 | 0.948 | 0.720 | 1e-180 |
| >gi|255556588|ref|XP_002519328.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis] gi|223541643|gb|EEF43192.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 735 bits (1897), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 354/445 (79%), Positives = 393/445 (88%), Gaps = 14/445 (3%)
Query: 2 VIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI 61
++ + GMRLG YELGRTLGEGNFGKVK A+++DSGLPFAVKILEKNRIIHL I+DQI
Sbjct: 1 MVTHQHHNGMRLGNYELGRTLGEGNFGKVKLAKNIDSGLPFAVKILEKNRIIHLNISDQI 60
Query: 62 KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ 121
KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYV GGELFD+IASKG+L EA+GRKLFQ
Sbjct: 61 KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVNGGELFDRIASKGKLPEAQGRKLFQ 120
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
QL+DGVSYCHNKGVFHRDLKLEN+L+D+KGNIKISDFGLSALPQHFRDDGLLHTTCGSPN
Sbjct: 121 QLVDGVSYCHNKGVFHRDLKLENVLVDAKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 180
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLS 241
YVAPE+L+NRGYDGATSD WSCGVILYVILTGYLPFDDRNLAVLYQKIF+GD ++PKWLS
Sbjct: 181 YVAPEILSNRGYDGATSDTWSCGVILYVILTGYLPFDDRNLAVLYQKIFKGDAQIPKWLS 240
Query: 242 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPS 301
GAQN++R+IL+PNPV RIT+A IK+DEWF+QDYTPA EEDI +DNE FSMHE+P
Sbjct: 241 SGAQNMIRRILDPNPVTRITMADIKSDEWFKQDYTPA-----EEDIHIDNEGFSMHELPP 295
Query: 302 DGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVT 361
+G SP LINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSN S KDLL++IE+ T
Sbjct: 296 EGESILRSPTLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNRSMKDLLQKIEETAT 355
Query: 362 EMGFRVQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQIK 421
EMGFR+QKKNGKLK QE K Q+SLGSLSVAAEVFEISPSL+VVEL+KS GDP+VYR
Sbjct: 356 EMGFRIQKKNGKLKVVQERKEQRSLGSLSVAAEVFEISPSLHVVELQKSNGDPSVYR--- 412
Query: 422 TSIVFVQLCNKLSSDLGLPPSQELL 446
QLC KLS+DL LP + LL
Sbjct: 413 ------QLCKKLSNDLRLPSDEGLL 431
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224110276|ref|XP_002315469.1| predicted protein [Populus trichocarpa] gi|116265922|gb|ABJ91209.1| CBL-interacting protein kinase 1 [Populus trichocarpa] gi|222864509|gb|EEF01640.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 731 bits (1888), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 349/440 (79%), Positives = 396/440 (90%), Gaps = 10/440 (2%)
Query: 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
GM+LG+YELGRTLGEGNFGKVK A+++++G PFAVKILEKNRII LKITDQIKREIATLK
Sbjct: 14 GMQLGKYELGRTLGEGNFGKVKLAKNIETGQPFAVKILEKNRIIDLKITDQIKREIATLK 73
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFD+IASKG+L EAEGRK+FQQLIDGVSY
Sbjct: 74 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDRIASKGKLPEAEGRKMFQQLIDGVSY 133
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
CH+KGVFHRDLKLEN+L+D+KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE+L+
Sbjct: 134 CHSKGVFHRDLKLENVLVDAKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEILS 193
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLR 249
NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF+GD ++PKWLSPGA+N+++
Sbjct: 194 NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFKGDAQVPKWLSPGAKNMIK 253
Query: 250 KILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGS 309
+IL+PNPV RIT A IKADEWF+ DYTP + ++++D+++D+ AFS+ E PS+ G +P S
Sbjct: 254 RILDPNPVTRITTADIKADEWFKLDYTPMDSAEEQDDVYIDDAAFSIQEAPSEDG-SPKS 312
Query: 310 PPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQK 369
P LINAFQLIGMSSCLDLSG FEKEDVSERKIRFTSNHS DLLE+IEDIVTEMGFRVQK
Sbjct: 313 PNLINAFQLIGMSSCLDLSGLFEKEDVSERKIRFTSNHSMSDLLEKIEDIVTEMGFRVQK 372
Query: 370 KNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQIKTSIVFVQL 429
+NG+ + QEH+ +KS GSLSVA EVFEISPSLYVVELRKSYGD + YR QL
Sbjct: 373 RNGRFQVIQEHRGKKSSGSLSVATEVFEISPSLYVVELRKSYGDSSAYR---------QL 423
Query: 430 CNKLSSDLGLPPSQELLATE 449
C KLS+DLG+P S LL TE
Sbjct: 424 CTKLSNDLGVPSSPGLLTTE 443
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356548027|ref|XP_003542405.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 692 bits (1787), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 336/443 (75%), Positives = 382/443 (86%), Gaps = 12/443 (2%)
Query: 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
++EGMRLG+YELGRTLGEGNFGKVKFA++ DSG FAVKI+EKN+I+ L IT+QIKREIA
Sbjct: 12 EREGMRLGKYELGRTLGEGNFGKVKFARNTDSGQAFAVKIIEKNKIVDLNITNQIKREIA 71
Query: 67 TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
TLKLL+HPNVVRL+EVLASK+KIYMVLEYV GGELFD IASKG+L E E RKLFQQLIDG
Sbjct: 72 TLKLLRHPNVVRLYEVLASKTKIYMVLEYVNGGELFDIIASKGKLTEGECRKLFQQLIDG 131
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
VSYCH KGVFHRDLKLEN+L+D+KGNIK++DFGLSALPQH R+DGLLHTTCGSPNYVAPE
Sbjct: 132 VSYCHTKGVFHRDLKLENVLVDNKGNIKVTDFGLSALPQHLREDGLLHTTCGSPNYVAPE 191
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN 246
VLAN+GYDGATSD WSCGVILYV LTGYLPFDDRNL VLYQKIF+GD ++PKWLSPGAQN
Sbjct: 192 VLANKGYDGATSDTWSCGVILYVSLTGYLPFDDRNLVVLYQKIFKGDAQIPKWLSPGAQN 251
Query: 247 LLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDG-GR 305
++R+IL+PNP RIT+AGIK D WF++ Y PANP+D ED+ VDNEAFS HE P++ R
Sbjct: 252 MIRRILDPNPETRITMAGIKEDPWFKKGYIPANPED--EDVHVDNEAFSSHEEPNEAEQR 309
Query: 306 TPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGF 365
GSP LINAFQLIGMSSCLDLSGFFEKEDVSERKIRF S S KDL++RIED VTEM F
Sbjct: 310 NSGSPTLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFASILSVKDLIDRIEDTVTEMEF 369
Query: 366 RVQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQIKTSIV 425
RV+KKNGKLK +E+K K+LG LSV EVFEISPSLYVVELRKSYGD +VY+
Sbjct: 370 RVEKKNGKLKVMRENKVHKTLGCLSVVVEVFEISPSLYVVELRKSYGDGSVYK------- 422
Query: 426 FVQLCNKLSSDLGLPPSQELLAT 448
QLC KL +DLG+PP Q L+ +
Sbjct: 423 --QLCKKLLNDLGVPPKQGLVRS 443
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356530499|ref|XP_003533818.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 680 bits (1754), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 328/449 (73%), Positives = 387/449 (86%), Gaps = 10/449 (2%)
Query: 3 IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
+ K+++G+RLG+YELG+TLGEGNFGKVK A+D SG FAVKIL+K++II L DQIK
Sbjct: 6 LGRKEEQGVRLGKYELGKTLGEGNFGKVKLARDTHSGKLFAVKILDKSKIIDLNNIDQIK 65
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
REI+TLKLLKHPNVVRL+EVLASK+KIYMVLEYV GGELFDKIASKG+L+EAEGRK+FQQ
Sbjct: 66 REISTLKLLKHPNVVRLYEVLASKTKIYMVLEYVNGGELFDKIASKGKLKEAEGRKIFQQ 125
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
LID VS+CHNKGVFHRDLKLEN+L+D+KGNIKI+DF LSALPQHFR+DGLLHTTCGSPNY
Sbjct: 126 LIDCVSFCHNKGVFHRDLKLENVLVDAKGNIKITDFNLSALPQHFREDGLLHTTCGSPNY 185
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSP 242
VAPE+LAN+GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF+G+ ++P+WLSP
Sbjct: 186 VAPEILANKGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFKGEVQIPRWLSP 245
Query: 243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSD 302
G+QN+++++L+ NP RIT+A IK DEWF++ YTPANP+D+EE +++D+E FS+H+V +
Sbjct: 246 GSQNIIKRMLDANPKTRITMAMIKEDEWFKEGYTPANPEDEEESVYIDDEDFSIHDVSHE 305
Query: 303 GGR-TPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVT 361
+ P SP LINAFQLI MSS LDLSG FE+EDVSERKIRFTS HS KDL+ERIEDIVT
Sbjct: 306 ADQGCPRSPTLINAFQLISMSSSLDLSGLFEQEDVSERKIRFTSIHSPKDLVERIEDIVT 365
Query: 362 EMGFRVQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQIK 421
EMGFRVQKKNG LK QE K QK GS SV AEVFEISPSLYVVEL KS GD ++YR
Sbjct: 366 EMGFRVQKKNGMLKVIQEIKVQKCPGSFSVEAEVFEISPSLYVVELSKSCGDASLYR--- 422
Query: 422 TSIVFVQLCNKLSSDLGLPPSQELLATEV 450
QLC KLS+DLG+ Q+L ++EV
Sbjct: 423 ------QLCKKLSNDLGVHTRQQLGSSEV 445
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|363807952|ref|NP_001242199.1| uncharacterized protein LOC100805710 [Glycine max] gi|255644530|gb|ACU22768.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 679 bits (1753), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 328/443 (74%), Positives = 379/443 (85%), Gaps = 12/443 (2%)
Query: 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
++EGMRLG+Y+LGRTLGEGNFGKVKFA++ DSG FAVKI++KN I+ + IT+QI REIA
Sbjct: 14 EREGMRLGKYDLGRTLGEGNFGKVKFARNTDSGQAFAVKIIDKNTIVDINITNQIIREIA 73
Query: 67 TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
TLKLL+HPNVVRL+EVLASK+KIYMVLEYV GGELFD IASKG+ E EGRKLFQQLIDG
Sbjct: 74 TLKLLRHPNVVRLYEVLASKTKIYMVLEYVNGGELFDIIASKGKHIEGEGRKLFQQLIDG 133
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
VSYCH KGVFHRDLKLEN+L+D+KGNIKI+DFGLSALPQH R+DGLLHTTCGSPNYVAPE
Sbjct: 134 VSYCHTKGVFHRDLKLENVLVDNKGNIKITDFGLSALPQHLREDGLLHTTCGSPNYVAPE 193
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN 246
VLAN+GYDGATSD WSCGVILYVIL G+LPFDDRNL VLYQKIF+GD ++PKWL+PGA+N
Sbjct: 194 VLANKGYDGATSDTWSCGVILYVILPGHLPFDDRNLVVLYQKIFKGDVQIPKWLTPGARN 253
Query: 247 LLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDG-GR 305
++R+IL+PNP RIT+AGIK D WF++ Y P NP+D ED++VD EAFS+HE P++ R
Sbjct: 254 MIRRILDPNPETRITMAGIKEDPWFKKGYIPVNPED--EDVYVDQEAFSIHEQPNEAEQR 311
Query: 306 TPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGF 365
GSP LINAFQLIGMSSCLDLSGFFEKEDVSERKIRF SN S KDL+ERIED TEM F
Sbjct: 312 NSGSPSLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFASNLSVKDLIERIEDTATEMEF 371
Query: 366 RVQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQIKTSIV 425
RV+KKNGKLK +E+K K+LG LSV EVF IS SLYVVELRKSYGD +VY+
Sbjct: 372 RVEKKNGKLKVIRENKVHKTLGCLSVVVEVFGISSSLYVVELRKSYGDGSVYK------- 424
Query: 426 FVQLCNKLSSDLGLPPSQELLAT 448
QLCNKL +DLG+PP Q L+ +
Sbjct: 425 --QLCNKLLNDLGIPPKQPLVRS 445
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357450323|ref|XP_003595438.1| CBL-interacting protein kinase [Medicago truncatula] gi|355484486|gb|AES65689.1| CBL-interacting protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 672 bits (1733), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 332/437 (75%), Positives = 379/437 (86%), Gaps = 11/437 (2%)
Query: 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
+RLG+YELG+TLGEGNFGKVK A+D D G FAVKILEKN+I+ L TDQIKREI+TLKL
Sbjct: 15 VRLGKYELGKTLGEGNFGKVKLARDTDCGQFFAVKILEKNKIVDLNNTDQIKREISTLKL 74
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
LKHPNVVRL+EVLASK+KIYMVLEYV GGELFDKI+SKG+L EA GRK+FQQLIDGVSYC
Sbjct: 75 LKHPNVVRLYEVLASKTKIYMVLEYVNGGELFDKISSKGKLTEAHGRKMFQQLIDGVSYC 134
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
HNKGVFHRDLKLEN+L+D+KGNIKI+DF LSALPQH R DGLLHTTCGSPNYVAPE+LAN
Sbjct: 135 HNKGVFHRDLKLENVLVDAKGNIKITDFNLSALPQHCRADGLLHTTCGSPNYVAPEILAN 194
Query: 191 RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 250
RGYDGA SDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF+ D ++P+WLSPGAQN+++K
Sbjct: 195 RGYDGAKSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFKADVQIPRWLSPGAQNIIKK 254
Query: 251 ILEPNPVKRITIAGIKADEWFEQDYTPAN--PDDDEEDIFVDNEAFSMHEVPSDGGRTPG 308
IL+PNP R+T+ IK DEWF++ Y PAN +++EED+F+D+EAFS+HEV DG ++P
Sbjct: 255 ILDPNPKTRVTMDMIKEDEWFKEGYNPANLEDEEEEEDVFIDDEAFSIHEVSLDGDQSPK 314
Query: 309 SPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQ 368
SP LINAFQLIGMSSCLDLSGFFE+EDVSERKIRFTSNHS KDL E+IEDIV EMGF+V
Sbjct: 315 SPALINAFQLIGMSSCLDLSGFFEQEDVSERKIRFTSNHSPKDLTEKIEDIVIEMGFKVH 374
Query: 369 KKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQIKTSIVFVQ 428
KKNGKLK QE K KSL SLSVAAEVFE+ PSLYVVELRKSYGD +VYR Q
Sbjct: 375 KKNGKLKVIQEDKAHKSLDSLSVAAEVFEVGPSLYVVELRKSYGDASVYR---------Q 425
Query: 429 LCNKLSSDLGLPPSQEL 445
LC +LS+DLG+ E+
Sbjct: 426 LCKRLSNDLGIAEVAEV 442
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359477295|ref|XP_002275061.2| PREDICTED: CBL-interacting serine/threonine-protein kinase 1-like [Vitis vinifera] gi|229609839|gb|ACQ83535.1| CBL-interacting protein kinase 19 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 672 bits (1733), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 321/386 (83%), Positives = 353/386 (91%), Gaps = 9/386 (2%)
Query: 61 IKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
IKREIATLKLLKHPNVVRLHEVLASK+KIYMVLEYVTGGELFD+IAS G+L EAEGRKLF
Sbjct: 14 IKREIATLKLLKHPNVVRLHEVLASKTKIYMVLEYVTGGELFDRIASNGKLSEAEGRKLF 73
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
QQLID VSYCHNKGVFHRDLKLEN+L+DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP
Sbjct: 74 QQLIDAVSYCHNKGVFHRDLKLENVLVDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 133
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWL 240
NYVAPE+LANRGYDG+TSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF+GD ++PKWL
Sbjct: 134 NYVAPEILANRGYDGSTSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFKGDAQMPKWL 193
Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVP 300
S GA+N++++IL+P P RIT+AGIKADEWF+Q YTPA P+++EEDI VD+EAFS++EVP
Sbjct: 194 SSGAKNIIKRILDPKPETRITMAGIKADEWFKQQYTPAYPEEEEEDIHVDDEAFSIYEVP 253
Query: 301 SDGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIV 360
+ ++PGSP LINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNH KDLLE+IEDIV
Sbjct: 254 MEAKKSPGSPNLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHCPKDLLEKIEDIV 313
Query: 361 TEMGFRVQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQI 420
TEMGFRV+KKNG+LK QEHK QKS GSLSVAAEVFEISPSLYVVELRKSYGD +VYR
Sbjct: 314 TEMGFRVEKKNGRLKVMQEHKCQKSFGSLSVAAEVFEISPSLYVVELRKSYGDSSVYR-- 371
Query: 421 KTSIVFVQLCNKLSSDLGLPPSQELL 446
QLC KLSSDLG+P SQELL
Sbjct: 372 -------QLCKKLSSDLGVPTSQELL 390
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297736814|emb|CBI26015.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 665 bits (1715), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 320/386 (82%), Positives = 352/386 (91%), Gaps = 10/386 (2%)
Query: 61 IKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
IKREIATLKLLKHPNVVRLHEVLASK+KIYMVLEYVTGGELFD+IAS G+L EAEGRKLF
Sbjct: 14 IKREIATLKLLKHPNVVRLHEVLASKTKIYMVLEYVTGGELFDRIASNGKLSEAEGRKLF 73
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
QQLID VSYCHNKGVFHRDLKLEN+L+DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP
Sbjct: 74 QQLIDAVSYCHNKGVFHRDLKLENVLVDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 133
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWL 240
NYVAPE+LANRGYDG+TSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF+GD ++PKWL
Sbjct: 134 NYVAPEILANRGYDGSTSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFKGDAQMPKWL 193
Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVP 300
S GA+N++++IL+P P RIT+AGIKADEWF+Q YTPA P+++EEDI VD+EAFS++E P
Sbjct: 194 SSGAKNIIKRILDPKPETRITMAGIKADEWFKQQYTPAYPEEEEEDIHVDDEAFSIYE-P 252
Query: 301 SDGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIV 360
+ ++PGSP LINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNH KDLLE+IEDIV
Sbjct: 253 MEAKKSPGSPNLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHCPKDLLEKIEDIV 312
Query: 361 TEMGFRVQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQI 420
TEMGFRV+KKNG+LK QEHK QKS GSLSVAAEVFEISPSLYVVELRKSYGD +VYR
Sbjct: 313 TEMGFRVEKKNGRLKVMQEHKCQKSFGSLSVAAEVFEISPSLYVVELRKSYGDSSVYR-- 370
Query: 421 KTSIVFVQLCNKLSSDLGLPPSQELL 446
QLC KLSSDLG+P SQELL
Sbjct: 371 -------QLCKKLSSDLGVPTSQELL 389
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356558505|ref|XP_003547546.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 663 bits (1711), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 323/432 (74%), Positives = 375/432 (86%), Gaps = 11/432 (2%)
Query: 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL 68
+GMRLG+YELG+TLGEGNFGKVK A+D SG FAVKIL+K++II L TDQIKREI TL
Sbjct: 12 QGMRLGKYELGKTLGEGNFGKVKLARDTHSGKLFAVKILDKSKIIDLNNTDQIKREIFTL 71
Query: 69 KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
KLLKHPNVVRL+EVLASK+KIYMVLEYV GGELFDKIASKG+L+EA GRK+FQQLID VS
Sbjct: 72 KLLKHPNVVRLYEVLASKTKIYMVLEYVNGGELFDKIASKGKLKEAVGRKIFQQLIDCVS 131
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
+CHNKGVFHRDLKLEN+L+D+KGNIKI+DF LSALPQHFR DGLLHTTCGSPNYVAPE+L
Sbjct: 132 FCHNKGVFHRDLKLENVLVDAKGNIKITDFNLSALPQHFRADGLLHTTCGSPNYVAPEIL 191
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL 248
AN+GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI +G+ ++P+WLSPG+QN++
Sbjct: 192 ANKGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKILKGEVQIPRWLSPGSQNII 251
Query: 249 RKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGR-TP 307
+++L+ N RIT+A IK DEWF++ Y+PANP+D+EE +++D E FS+H+V + + +P
Sbjct: 252 KRMLDVNLKTRITMAMIKEDEWFKEGYSPANPEDEEESVYID-EDFSIHDVSLEADQGSP 310
Query: 308 GSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRV 367
SP LINAFQLI MSS LDLSG FE+EDVSERKIRFTS HS KDL+ER+EDIVTEMGFRV
Sbjct: 311 RSPTLINAFQLISMSSSLDLSGLFEQEDVSERKIRFTSIHSPKDLVERLEDIVTEMGFRV 370
Query: 368 QKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQIKTSIVFV 427
QKKNG LK QE K QK LG+LSVAAEVFEISPSLYVVEL KS GD +VYR
Sbjct: 371 QKKNGMLKVVQEIKTQKCLGNLSVAAEVFEISPSLYVVELSKSCGDASVYR--------- 421
Query: 428 QLCNKLSSDLGL 439
QLC KLS+DLG+
Sbjct: 422 QLCKKLSNDLGV 433
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357479181|ref|XP_003609876.1| CBL-interacting protein kinase [Medicago truncatula] gi|355510931|gb|AES92073.1| CBL-interacting protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 639 bits (1648), Expect = e-180, Method: Compositional matrix adjust.
Identities = 312/433 (72%), Positives = 373/433 (86%), Gaps = 10/433 (2%)
Query: 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL 68
EG+RLG+YELGR LGEGNFGKVKFA++ DSG P+A+KI++KN+II L IT+QIKREI L
Sbjct: 19 EGVRLGKYELGRILGEGNFGKVKFARNTDSGQPYAIKIIDKNKIIDLNITNQIKREICAL 78
Query: 69 KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
KLL+HPNVV+L+EVLASK+KIYMVLEYVTG ELFDKIASKG+L E EGRKLFQQLIDGVS
Sbjct: 79 KLLRHPNVVKLYEVLASKTKIYMVLEYVTGEELFDKIASKGKLPEGEGRKLFQQLIDGVS 138
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
YCH+KGVFHRDLKLEN+L+D+KGN+KI+DFGLSALPQ FR DGLLHTTCGS NYVAPE+L
Sbjct: 139 YCHSKGVFHRDLKLENVLVDAKGNLKITDFGLSALPQQFRADGLLHTTCGSANYVAPEIL 198
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL 248
ANRGY+GA+SD+WSCGVILYV+LTG+LPFDDRNLAVLYQK+ +GDF+ PKWLS GAQN++
Sbjct: 199 ANRGYNGASSDVWSCGVILYVVLTGFLPFDDRNLAVLYQKVLKGDFQKPKWLSAGAQNII 258
Query: 249 RKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPG 308
++IL+PNP RIT+A IK D WF++ Y A +D+E+ ++VD++AF++HE+ + ++
Sbjct: 259 KRILDPNPKTRITMAEIKEDLWFKEGYNQAYHEDEEDGVYVDDQAFNIHELSHEEEKSSS 318
Query: 309 SPPL-INAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRV 367
P+ INAFQLIGMSSCLDLSGFFEKEDVSERKIRFT+N SAK L+E+IED VTEM FRV
Sbjct: 319 QSPIRINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTANLSAKVLMEKIEDSVTEMEFRV 378
Query: 368 QKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQIKTSIVFV 427
QKKNGK+K QE+K K+LGSLSV EVFEIS SLYVVELRK YGD +VYR
Sbjct: 379 QKKNGKMKVMQENKDHKTLGSLSVIIEVFEISSSLYVVELRKCYGDASVYR--------- 429
Query: 428 QLCNKLSSDLGLP 440
QLC KL +DLG+P
Sbjct: 430 QLCKKLLNDLGVP 442
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 450 | ||||||
| TAIR|locus:2090537 | 444 | CIPK1 "CBL-interacting protein | 0.962 | 0.975 | 0.703 | 1.2e-163 | |
| TAIR|locus:2007685 | 432 | CIPK17 "CBL-interacting protei | 0.953 | 0.993 | 0.674 | 5.6e-155 | |
| TAIR|locus:2009812 | 482 | CIPK23 "CBL-interacting protei | 0.882 | 0.823 | 0.552 | 1.1e-117 | |
| TAIR|locus:2059279 | 451 | CIPK3 "CBL-interacting protein | 0.902 | 0.900 | 0.535 | 2.3e-117 | |
| TAIR|locus:1005716172 | 439 | CIPK26 "calcineurin B-like pro | 0.913 | 0.936 | 0.521 | 4.4e-116 | |
| TAIR|locus:2155233 | 446 | SOS2 "SALT OVERLY SENSITIVE 2" | 0.948 | 0.957 | 0.478 | 8.1e-108 | |
| TAIR|locus:2135962 | 445 | CIPK8 "CBL-interacting protein | 0.942 | 0.952 | 0.485 | 1.3e-107 | |
| TAIR|locus:2181047 | 421 | CIPK15 "CBL-interacting protei | 0.904 | 0.966 | 0.484 | 6.2e-101 | |
| TAIR|locus:2152380 | 439 | CIPK20 "CBL-interacting protei | 0.862 | 0.883 | 0.472 | 6.4e-99 | |
| TAIR|locus:2126749 | 441 | SIP3 "SOS3-interacting protein | 0.882 | 0.900 | 0.464 | 1.3e-98 |
| TAIR|locus:2090537 CIPK1 "CBL-interacting protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1593 (565.8 bits), Expect = 1.2e-163, P = 1.2e-163
Identities = 313/445 (70%), Positives = 369/445 (82%)
Query: 5 EKKQE-GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR 63
EKK E GMRLG+YELGRTLGEGNFGKVKFA+D SG FAVKI++K+RI L + QIKR
Sbjct: 8 EKKAEKGMRLGKYELGRTLGEGNFGKVKFAKDTVSGHSFAVKIIDKSRIADLNFSLQIKR 67
Query: 64 EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL 123
EI TLK+LKHP++VRLHEVLASK+KI MV+E VTGGELFD+I S G+L E +GRK+FQQL
Sbjct: 68 EIRTLKMLKHPHIVRLHEVLASKTKINMVMELVTGGELFDRIVSNGKLTETDGRKMFQQL 127
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
IDG+SYCH+KGVFHRDLKLEN+LLD+KG+IKI+DFGLSALPQHFRDDGLLHTTCGSPNYV
Sbjct: 128 IDGISYCHSKGVFHRDLKLENVLLDAKGHIKITDFGLSALPQHFRDDGLLHTTCGSPNYV 187
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPG 243
APEVLANRGYDGA SDIWSCGVILYVILTG LPFDDRNLAVLYQKI +GD +P+WLSPG
Sbjct: 188 APEVLANRGYDGAASDIWSCGVILYVILTGCLPFDDRNLAVLYQKICKGDPPIPRWLSPG 247
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDD-EEDIFVDNEAFSMHEVPSD 302
A+ +++++L+PNPV RIT+ GIKA EWF+ +Y P+ PDDD EE++ D++AFS+ E+ S+
Sbjct: 248 ARTMIKRMLDPNPVTRITVVGIKASEWFKLEYIPSIPDDDDEEEVDTDDDAFSIQELGSE 307
Query: 303 GGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTE 362
G+ SP +INAFQLIGMSS LDLSGFFE+E+VSER+IRFTSN SAKDLLE+IE VTE
Sbjct: 308 EGKGSDSPTIINAFQLIGMSSFLDLSGFFEQENVSERRIRFTSNSSAKDLLEKIETAVTE 367
Query: 363 MGFRVQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQIKT 422
MGF VQKK+ KL+ QE + QK LSV AEVFEI PSL VVELRKSYGD +YRQ
Sbjct: 368 MGFSVQKKHAKLRVKQEERNQKGQVGLSVTAEVFEIKPSLNVVELRKSYGDSCLYRQ--- 424
Query: 423 SIVFVQLCNKLSSDLGLP-PSQELL 446
L +L D+G P QE++
Sbjct: 425 ------LYERLLKDVGTSSPEQEIV 443
|
|
| TAIR|locus:2007685 CIPK17 "CBL-interacting protein kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1511 (537.0 bits), Expect = 5.6e-155, P = 5.6e-155
Identities = 296/439 (67%), Positives = 358/439 (81%)
Query: 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL 68
+GMR+G+YELGRTLGEGN KVKFA D +G FA+KI+EK+ I L ++ QIKREI TL
Sbjct: 4 KGMRVGKYELGRTLGEGNSAKVKFAIDTLTGESFAIKIIEKSCITRLNVSFQIKREIRTL 63
Query: 69 KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
K+LKHPN+VRLHEVLASK+KIYMVLE VTGG+LFD+I SKG+L E +GRK+FQQLIDGVS
Sbjct: 64 KVLKHPNIVRLHEVLASKTKIYMVLECVTGGDLFDRIVSKGKLSETQGRKMFQQLIDGVS 123
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
YCHNKGVFHRDLKLEN+LLD+KG+IKI+DFGLSAL QH+R+DGLLHTTCGSPNYVAPEVL
Sbjct: 124 YCHNKGVFHRDLKLENVLLDAKGHIKITDFGLSALSQHYREDGLLHTTCGSPNYVAPEVL 183
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL 248
AN GYDGA SDIWSCGVILYVILTG LPFDD NLAV+ +KIF+GD +P+W+S GA+ ++
Sbjct: 184 ANEGYDGAASDIWSCGVILYVILTGCLPFDDANLAVICRKIFKGDPPIPRWISLGAKTMI 243
Query: 249 RKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPG 308
+++L+PNPV R+TIAGIKA +WF+ DYTP+N DDD++ + + F M E + ++P
Sbjct: 244 KRMLDPNPVTRVTIAGIKAHDWFKHDYTPSNYDDDDDVYLIQEDVFMMKEYEEE--KSPD 301
Query: 309 SPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQ 368
SP +INAFQLIGMSS LDLSGFFE E +SER+IRFTSN AKDLLE IE I TEMGF +Q
Sbjct: 302 SPTIINAFQLIGMSSFLDLSGFFETEKLSERQIRFTSNSLAKDLLENIETIFTEMGFCLQ 361
Query: 369 KKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQIKTSIVFVQ 428
KK+ KLKA +E QK LSV AEVFEISPSL VVELRKS+GD ++Y+Q+ + +
Sbjct: 362 KKHAKLKAIKEESTQKRQCGLSVTAEVFEISPSLNVVELRKSHGDSSLYKQL-----YER 416
Query: 429 LCNKLSSDLGLPPSQELLA 447
L N+L S + QELLA
Sbjct: 417 LLNELGSSSQV---QELLA 432
|
|
| TAIR|locus:2009812 CIPK23 "CBL-interacting protein kinase 23" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1159 (413.0 bits), Expect = 1.1e-117, P = 1.1e-117
Identities = 227/411 (55%), Positives = 309/411 (75%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
R+G+YELGRTLGEG F KVKFA+++++G A+K+++K +++ K+ QIKREI+T+KL+
Sbjct: 27 RVGKYELGRTLGEGTFAKVKFARNVENGDNVAIKVIDKEKVLKNKMIAQIKREISTMKLI 86
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
KHPNV+R+ EV+ASK+KIY VLE+VTGGELFDKI+S GRL+E E RK FQQLI+ V YCH
Sbjct: 87 KHPNVIRMFEVMASKTKIYFVLEFVTGGELFDKISSNGRLKEDEARKYFQQLINAVDYCH 146
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
++GV+HRDLK EN+LLD+ G +K+SDFGLSALPQ R+DGLLHTTCG+PNYVAPEV+ N+
Sbjct: 147 SRGVYHRDLKPENLLLDANGALKVSDFGLSALPQQVREDGLLHTTCGTPNYVAPEVINNK 206
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 251
GYDGA +D+WSCGVIL+V++ GYLPF+D NL LY+KIF+ +F P W S A+ L+++I
Sbjct: 207 GYDGAKADLWSCGVILFVLMAGYLPFEDSNLTSLYKKIFKAEFTCPPWFSASAKKLIKRI 266
Query: 252 LEPNPVKRITIAGIKADEWFEQDY-TPA--NPD---DDEEDIFVDN-EAFSMH-EVPSDG 303
L+PNP RIT A + +EWF++ Y P N D DD + IF D+ E+ ++ E +G
Sbjct: 267 LDPNPATRITFAEVIENEWFKKGYKAPKFENADVSLDDVDAIFDDSGESKNLVVERREEG 326
Query: 304 GRTPGSPPLINAFQLIGMSSCLDLSGFFEKE-DVSERKIRFTSNHSAKDLLERIEDIVTE 362
+TP + +NAF+LI S L+L FEK+ + +RK RFTS SA +++ +IE
Sbjct: 327 LKTPVT---MNAFELISTSQGLNLGSLFEKQMGLVKRKTRFTSKSSANEIVTKIEAAAAP 383
Query: 363 MGFRVQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGD 413
MGF V+ N K+K T E +K G L+VA EVF+++PSLY+VE+RKS GD
Sbjct: 384 MGFDVKTNNYKMKLTGEKSGRK--GQLAVATEVFQVAPSLYMVEMRKSGGD 432
|
|
| TAIR|locus:2059279 CIPK3 "CBL-interacting protein kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1156 (412.0 bits), Expect = 2.3e-117, P = 2.3e-117
Identities = 219/409 (53%), Positives = 303/409 (74%)
Query: 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
++Q R+G+YE+GRT+GEG F KVKFA++ ++G P A+KIL+K +++ K+ +QI+REI
Sbjct: 14 RQQVKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIRREI 73
Query: 66 ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID 125
AT+KL+KHPNVV+L+EV+ASK+KI+++LEYVTGGELFDKI + GR++E E R+ FQQLI
Sbjct: 74 ATMKLIKHPNVVQLYEVMASKTKIFIILEYVTGGELFDKIVNDGRMKEDEARRYFQQLIH 133
Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 185
V YCH++GV+HRDLK EN+LLDS GN+KISDFGLSAL Q RDDGLLHT+CG+PNYVAP
Sbjct: 134 AVDYCHSRGVYHRDLKPENLLLDSYGNLKISDFGLSALSQQVRDDGLLHTSCGTPNYVAP 193
Query: 186 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQ 245
EVL +RGYDGAT+D+WSCGV+LYV+L GYLPFDD NL LY+KI G+F P WLS GA
Sbjct: 194 EVLNDRGYDGATADMWSCGVVLYVLLAGYLPFDDSNLMNLYKKISSGEFNCPPWLSLGAM 253
Query: 246 NLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEA-FSMHEVPSDGG 304
L+ +IL+PNP+ R+T + DEWF++DY P ++ ++ D +A F E
Sbjct: 254 KLITRILDPNPMTRVTPQEVFEDEWFKKDYKPPVFEERDDSNMDDIDAVFKDSEEHLVTE 313
Query: 305 RTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMG 364
+ P INAF++I MS L+L F+ E +R+ R T A +++E+IE+ +G
Sbjct: 314 KREEQPAAINAFEIISMSRGLNLENLFDPEQEFKRETRITLRGGANEIIEKIEEAAKPLG 373
Query: 365 FRVQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGD 413
F VQKKN K++ +K G+L+VA E+F+++PSL++V++ KS GD
Sbjct: 374 FDVQKKNYKMRLENVKAGRK--GNLNVATEIFQVAPSLHMVQVSKSKGD 420
|
|
| TAIR|locus:1005716172 CIPK26 "calcineurin B-like protein (CBL)-interacting protein kinase 26" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1144 (407.8 bits), Expect = 4.4e-116, P = 4.4e-116
Identities = 218/418 (52%), Positives = 306/418 (73%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
R+G+YE+G+TLG+G F KV+ A + ++G A+KIL+K +++ K+ +QI+REI T+KL+
Sbjct: 9 RVGKYEVGKTLGQGTFAKVRCAVNTETGERVALKILDKEKVLKHKMAEQIRREICTMKLI 68
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
HPNVVRL+EVLASK+KIY+VLE+ TGGELFDKI GRL+E RK FQQLI+ V YCH
Sbjct: 69 NHPNVVRLYEVLASKTKIYIVLEFGTGGELFDKIVHDGRLKEENARKYFQQLINAVDYCH 128
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
++GV+HRDLK EN+LLD++GN+K+SDFGLSAL + R DGLLHT CG+PNY APEVL ++
Sbjct: 129 SRGVYHRDLKPENLLLDAQGNLKVSDFGLSALSRQVRGDGLLHTACGTPNYAAPEVLNDQ 188
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 251
GYDGAT+D+WSCGVIL+V+L GYLPF+D NL LY+KI G++ P WLSPGA+NL+ +I
Sbjct: 189 GYDGATADLWSCGVILFVLLAGYLPFEDSNLMTLYKKIIAGEYHCPPWLSPGAKNLIVRI 248
Query: 252 LEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEA-FSMHEVPSDGGRTPGSP 310
L+PNP+ RITI + D WF+++Y PA ++ EE D +A F E + P
Sbjct: 249 LDPNPMTRITIPEVLGDAWFKKNYKPAVFEEKEEANLDDVDAVFKDSEEHHVTEKKEEQP 308
Query: 311 PLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKK 370
+NAF+LI MS LDL FE+E+ +R+ RF + +A DL+++IE+ +GF +QKK
Sbjct: 309 TSMNAFELISMSRALDLGNLFEEEEGFKRETRFAAKGAANDLVQKIEEASKPLGFDIQKK 368
Query: 371 NGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPT----VYRQIKTSI 424
N K++ +K G+L VA E+F++SPSL+++E+RK+ GD Y+++ TS+
Sbjct: 369 NYKMRLENVTAGRK--GNLRVATEIFQVSPSLHMIEVRKTKGDTLEFHKFYKKLSTSL 424
|
|
| TAIR|locus:2155233 SOS2 "SALT OVERLY SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1066 (380.3 bits), Expect = 8.1e-108, P = 8.1e-108
Identities = 214/447 (47%), Positives = 304/447 (68%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
R+G+YE+GRT+GEG F KVKFA++ D+G A+KI+ K+ I+ ++ DQIKREI+ +K++
Sbjct: 7 RVGKYEVGRTIGEGTFAKVKFARNTDTGDNVAIKIMAKSTILKNRMVDQIKREISIMKIV 66
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
+HPN+VRL+EVLAS SKIY+VLE+VTGGELFD+I KGRL+E+E RK FQQL+D V++CH
Sbjct: 67 RHPNIVRLYEVLASPSKIYIVLEFVTGGELFDRIVHKGRLEESESRKYFQQLVDAVAHCH 126
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
KGV+HRDLK EN+LLD+ GN+K+SDFGLSALPQ + LL TTCG+PNYVAPEVL+ +
Sbjct: 127 CKGVYHRDLKPENLLLDTNGNLKVSDFGLSALPQEGVE--LLRTTCGTPNYVAPEVLSGQ 184
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 251
GYDG+ +DIWSCGVIL+VIL GYLPF + +L LY+KI +F P W S + L+ +I
Sbjct: 185 GYDGSAADIWSCGVILFVILAGYLPFSETDLPGLYRKINAAEFSCPPWFSAEVKFLIHRI 244
Query: 252 LEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE----DIFVDNEAFSMHEVPSDGGRTP 307
L+PNP RI I GIK D WF +Y P ++EE DI + V + R
Sbjct: 245 LDPNPKTRIQIQGIKKDPWFRLNYVPIRAREEEEVNLDDIRAVFDGIEGSYVAENVERND 304
Query: 308 GSPPLINAFQLIGMSSCLDLSGFFEK-EDVSERKIRFTSNHSAKDLLERIEDIVTEMGFR 366
P ++NAF++I +S L+LS F++ +D +R+ RF S +++ IE + MGF+
Sbjct: 305 EGPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFK 364
Query: 367 VQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQIKTSIVF 426
+N K + E G L+V E++E++PSL++V++RK+ G+ Y + +
Sbjct: 365 SHTRNFKTRL--EGLSSIKAGQLAVVIEIYEVAPSLFMVDVRKAAGETLEYHKF-----Y 417
Query: 427 VQLCNKLSSDL-----GLPPSQELLAT 448
+LC+KL + + G+P S E+L T
Sbjct: 418 KKLCSKLENIIWRATEGIPKS-EILRT 443
|
|
| TAIR|locus:2135962 CIPK8 "CBL-interacting protein kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1064 (379.6 bits), Expect = 1.3e-107, P = 1.3e-107
Identities = 213/439 (48%), Positives = 301/439 (68%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
++G+YELGRT+GEG F KVKFAQ+ ++G A+KI++++ II K+ DQIKREI+ +KL+
Sbjct: 5 KVGKYELGRTIGEGTFAKVKFAQNTETGESVAMKIVDRSTIIKRKMVDQIKREISIMKLV 64
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
+HP VVRL+EVLAS++KIY++LEY+TGGELFDKI GRL E+E RK F QLIDGV YCH
Sbjct: 65 RHPCVVRLYEVLASRTKIYIILEYITGGELFDKIVRNGRLSESEARKYFHQLIDGVDYCH 124
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
+KGV+HRDLK EN+LLDS+GN+KISDFGLSALP+ + +L TTCG+PNYVAPEVL+++
Sbjct: 125 SKGVYHRDLKPENLLLDSQGNLKISDFGLSALPE--QGVTILKTTCGTPNYVAPEVLSHK 182
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 251
GY+GA +DIWSCGVILYV++ GYLPFD+ +L LY KI + +F P + + GA++L+ +I
Sbjct: 183 GYNGAVADIWSCGVILYVLMAGYLPFDEMDLPTLYSKIDKAEFSCPSYFALGAKSLINRI 242
Query: 252 LEPNPVKRITIAGIKADEWFEQDYTPANPDDDE----EDIFVDNEAFSMHEVPSDGGRTP 307
L+PNP RITIA I+ DEWF +DYTP D E +D++ + DG R
Sbjct: 243 LDPNPETRITIAEIRKDEWFLKDYTPVQLIDYEHVNLDDVYAAFDDPEEQTYAQDGTRDT 302
Query: 308 GSPPLINAFQLIGMSSCLDLSGFFEK-EDVSERKIRFTSNHSAKDLLERIEDIVTEMGFR 366
G P +NAF LI +S L+L+ F++ +D + + RF S+ A +L +E + MGF+
Sbjct: 303 G-PLTLNAFDLIILSQGLNLATLFDRGKDSMKHQTRFISHKPANVVLSSMEVVSQSMGFK 361
Query: 367 VQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQIKTSIVF 426
+N K++ E SV EVF+++PS+ +V+++ + GD Y + +
Sbjct: 362 THIRNYKMRV--EGLSANKTSHFSVILEVFKVAPSILMVDIQNAAGDAEEYLKF-----Y 414
Query: 427 VQLCNKLSSDLGLPPSQEL 445
C+KL + PP +
Sbjct: 415 KTFCSKLDDIIWKPPDASM 433
|
|
| TAIR|locus:2181047 CIPK15 "CBL-interacting protein kinase 15" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1001 (357.4 bits), Expect = 6.2e-101, P = 6.2e-101
Identities = 204/421 (48%), Positives = 285/421 (67%)
Query: 5 EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE 64
EKK + L RYE+G+ LG+G F KV A+ L +G A+K+++K RI+ + +T+QIKRE
Sbjct: 2 EKKGSVLML-RYEVGKFLGQGTFAKVYHARHLKTGDSVAIKVIDKERILKVGMTEQIKRE 60
Query: 65 IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
I+ ++LL+HPN+V LHEV+A+KSKIY V+E+V GGELF+K+ S G+L+E RK FQQL+
Sbjct: 61 ISAMRLLRHPNIVELHEVMATKSKIYFVMEHVKGGELFNKV-STGKLREDVARKYFQQLV 119
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
V +CH++GV HRDLK EN+LLD GN+KISDFGLSAL R DGLLHTTCG+P YVA
Sbjct: 120 RAVDFCHSRGVCHRDLKPENLLLDEHGNLKISDFGLSALSDSRRQDGLLHTTCGTPAYVA 179
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244
PEV++ GYDG +D+WSCGVIL+V+L GYLPF D NL LY+KI + + K P WL+PGA
Sbjct: 180 PEVISRNGYDGFKADVWSCGVILFVLLAGYLPFRDSNLMELYKKIGKAEVKFPNWLAPGA 239
Query: 245 QNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGG 304
+ LL++IL+PNP R++ I WF + + EE+ VD EA +
Sbjct: 240 KRLLKRILDPNPNTRVSTEKIMKSSWFRKGLQEEVKESVEEETEVDAEAEGNASAEKEKK 299
Query: 305 RTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMG 364
R +NAF++I +S+ DLSG FEK + E ++RFTSN A ++ E++ +I ++
Sbjct: 300 RCIN----LNAFEIISLSTGFDLSGLFEKGEEKE-EMRFTSNREASEITEKLVEIGKDLK 354
Query: 365 FRVQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQI-KTS 423
+V+KK E + + S + V AEVFEI+PS ++V L+KS GD Y+++ K S
Sbjct: 355 MKVRKKE------HEWRVKMSAEATVVEAEVFEIAPSYHMVVLKKSGGDTAEYKRVMKES 408
Query: 424 I 424
I
Sbjct: 409 I 409
|
|
| TAIR|locus:2152380 CIPK20 "CBL-interacting protein kinase 20" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 982 (350.7 bits), Expect = 6.4e-99, P = 6.4e-99
Identities = 195/413 (47%), Positives = 280/413 (67%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+YELGR LG+G F KV A+++ +G A+K+++K ++ + + DQIKREI+ ++L++HP
Sbjct: 11 KYELGRLLGQGTFAKVYHARNIKTGESVAIKVIDKQKVAKVGLIDQIKREISVMRLVRHP 70
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
+VV LHEV+ASK+KIY +EYV GGELFDK+ SKG+L+E RK FQQLI + YCH++G
Sbjct: 71 HVVFLHEVMASKTKIYFAMEYVKGGELFDKV-SKGKLKENIARKYFQQLIGAIDYCHSRG 129
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
V+HRDLK EN+LLD G++KISDFGLSAL + + DGLLHTTCG+P YVAPEV+ +GYD
Sbjct: 130 VYHRDLKPENLLLDENGDLKISDFGLSALRESKQQDGLLHTTCGTPAYVAPEVIGKKGYD 189
Query: 195 GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEP 254
GA +D+WSCGV+LYV+L G+LPF ++NL +Y+KI +G+FK P W P + LL +IL+P
Sbjct: 190 GAKADVWSCGVVLYVLLAGFLPFHEQNLVEMYRKITKGEFKCPNWFPPEVKKLLSRILDP 249
Query: 255 NPVKRITIAGIKADEWFEQDY----TPANPDDDEEDIFVDN--EAFSMHEVPSDGGRTPG 308
NP RI I I + WF++ + TP +P+ + D + + AFS+
Sbjct: 250 NPNSRIKIEKIMENSWFQKGFKKIETPKSPESHQIDSLISDVHAAFSV------------ 297
Query: 309 SPPLINAFQLIG-MSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMG-FR 366
P NAF LI +S DLSG FEKE+ SE K FT+ AK+++ + E+I T F
Sbjct: 298 KPMSYNAFDLISSLSQGFDLSGLFEKEERSESK--FTTKKDAKEIVSKFEEIATSSERFN 355
Query: 367 VQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQ 419
+ K + +K + + +K G L++ E+FE++ S ++VE +KS GD Y+Q
Sbjct: 356 LTKSDVGVKMEDKREGRK--GHLAIDVEIFEVTNSFHMVEFKKSGGDTMEYKQ 406
|
|
| TAIR|locus:2126749 SIP3 "SOS3-interacting protein 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 979 (349.7 bits), Expect = 1.3e-98, P = 1.3e-98
Identities = 192/413 (46%), Positives = 275/413 (66%)
Query: 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
G+ GRYELGR LG G F KV A+++ +G A+K++ K +++ + + DQIKREI+ ++
Sbjct: 18 GLLHGRYELGRLLGHGTFAKVYHARNIQTGKSVAMKVVGKEKVVKVGMVDQIKREISVMR 77
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
++KHPN+V LHEV+ASKSKIY +E V GGELF K+A KGRL+E R FQQLI V +
Sbjct: 78 MVKHPNIVELHEVMASKSKIYFAMELVRGGELFAKVA-KGRLREDVARVYFQQLISAVDF 136
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
CH++GV+HRDLK EN+LLD +GN+K++DFGLSA +H + DGLLHTTCG+P YVAPEV+
Sbjct: 137 CHSRGVYHRDLKPENLLLDEEGNLKVTDFGLSAFTEHLKQDGLLHTTCGTPAYVAPEVIL 196
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLR 249
+GYDGA +D+WSCGVIL+V+L GYLPF D NL +Y+KI+RGDFK P WLS A+ L+
Sbjct: 197 KKGYDGAKADLWSCGVILFVLLAGYLPFQDDNLVNMYRKIYRGDFKCPGWLSSDARRLVT 256
Query: 250 KILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEA--FSMHEVPSDGGRTP 307
K+L+PNP RITI + WF++ T + + I E F +H+ +
Sbjct: 257 KLLDPNPNTRITIEKVMDSPWFKKQATRSRNEPVAATITTTEEDVDFLVHKSKEE----- 311
Query: 308 GSPPLINAFQLIGMSSCLDLSGFFEKEDVSE-RKIRFTSNHSAKDLLERIEDIVTEMG-- 364
+NAF +I +S DLS FE++ E R++RF ++ A ++ +E+ +G
Sbjct: 312 --TETLNAFHIIALSEGFDLSPLFEEKKKEEKREMRFATSRPASSVISSLEE-AARVGNK 368
Query: 365 FRVQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVY 417
F V+K +++ + +K G L+V AE+F ++PS VVE++K +GD Y
Sbjct: 369 FDVRKSESRVRIEGKQNGRK--GKLAVEAEIFAVAPSFVVVEVKKDHGDTLEY 419
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q8RWC9 | CIPK1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6966 | 0.9644 | 0.9774 | yes | no |
| Q9LGV5 | CIPK1_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.6505 | 0.9711 | 0.9479 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | CIPK1 | SubName- Full=CBL-interacting protein kinase 1; (474 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
 | CBL10 | hypothetical protein (264 aa) | • | 0.510 | |||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 450 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-107 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-91 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-77 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-75 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-69 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-68 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-65 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-63 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-63 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-59 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-56 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-55 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-51 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 9e-51 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-50 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-50 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-48 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-48 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-48 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 9e-48 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-47 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-47 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-46 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-46 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-46 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-46 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-46 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-45 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-45 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-45 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 8e-45 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-44 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-44 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-44 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-44 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-44 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-44 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-44 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-44 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-42 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-42 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-42 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-42 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-42 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-42 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-42 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-41 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 8e-41 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-40 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-40 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-40 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-39 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-39 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-39 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-39 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-39 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 9e-39 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-38 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-38 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 7e-38 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-37 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-37 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-37 | |
| cd12195 | 116 | cd12195, CIPK_C, C-terminal regulatory domain of C | 5e-37 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-36 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-36 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-36 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-36 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-36 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-35 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-35 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-35 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-35 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-35 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-35 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-35 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-35 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-34 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-34 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-34 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 8e-34 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-33 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-33 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-33 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-32 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-32 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-32 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-32 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-32 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-32 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-31 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-31 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-31 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-31 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-30 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-30 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-30 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-30 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-30 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-30 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-30 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 7e-30 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-30 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 9e-30 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-29 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-29 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-29 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-29 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-29 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-29 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-29 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-29 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-28 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-28 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-28 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-28 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-28 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-28 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-27 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-27 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-27 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-27 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-27 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-27 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-27 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-27 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-26 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-26 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-26 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-26 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-26 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-26 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-26 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-26 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 9e-26 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 9e-26 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-25 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-25 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-25 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-25 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-25 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-25 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-25 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-25 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-25 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 9e-25 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-24 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-24 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-24 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-24 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-24 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-24 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-24 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-24 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-23 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-23 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-23 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-23 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-23 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-23 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-23 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-23 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 9e-23 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-22 | |
| pfam03822 | 58 | pfam03822, NAF, NAF domain | 1e-22 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-22 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-22 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-22 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-22 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-22 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-22 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-21 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-21 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-21 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-21 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-21 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-21 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-21 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-21 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-21 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 8e-21 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-21 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-20 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-20 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-20 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-20 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-20 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-20 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-20 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-20 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 8e-20 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 8e-20 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-19 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-19 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-19 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-19 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-19 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-19 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-19 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-19 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-19 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-19 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-19 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 7e-19 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-19 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-19 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 8e-19 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-19 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-18 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-18 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-18 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-18 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-18 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-18 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-18 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 8e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 9e-18 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-17 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-17 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-17 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-17 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-16 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-16 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 7e-16 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 9e-16 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-15 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-15 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-15 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-15 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-15 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-15 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-15 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-15 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-15 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 7e-15 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 8e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-14 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-14 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-14 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-13 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-13 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-13 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-13 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-13 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-13 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-13 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-12 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-12 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-12 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-12 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-12 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 9e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-11 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-11 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-10 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 8e-10 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 9e-10 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-09 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-09 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 3e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 9e-09 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 9e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-07 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 6e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 7e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-04 | |
| cd12120 | 95 | cd12120, AMPKA_C_like, C-terminal regulatory domai | 3e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 4e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 5e-04 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 0.001 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.002 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 316 bits (812), Expect = e-107
Identities = 115/260 (44%), Positives = 162/260 (62%), Gaps = 10/260 (3%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
YE+ LGEG+FGKV A+D +G A+K+++K +I K ++I REI LK LKHPN
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIK--KDRERILREIKILKKLKHPN 58
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
+VRL++V + K+Y+V+EY GG+LFD + +GRL E E R +Q++ + Y H+KG+
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
HRDLK ENILLD G++K++DFGL+ L T G+P Y+APEVL +GY
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLAR---QLDPGEKLTTFVGTPEYMAPEVLLGKGYGK 175
Query: 196 ATSDIWSCGVILYVILTGYLPFDDR-NLAVLYQKIFRGDFKLPKW---LSPGAQNLLRKI 251
A DIWS GVILY +LTG PF L L++KI + P +SP A++L+RK+
Sbjct: 176 A-VDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKL 234
Query: 252 LEPNPVKRITIAGIKADEWF 271
L +P KR+T +F
Sbjct: 235 LVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 276 bits (709), Expect = 4e-91
Identities = 107/263 (40%), Positives = 147/263 (55%), Gaps = 10/263 (3%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
YEL R LG G+FG V A+ +G AVKIL+K K +REI L+ L HPN
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKK-DQTARREIRILRRLSHPN 59
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
+VRL + K +Y+V+EY GG+LFD ++ G L E E +K+ Q++ G+ Y H+ G+
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
HRDLK ENILLD G +KI+DFGL+ + + L T G+P Y+APEVL G
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAK--KLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLA---VLYQKIFRGDFKLPKW----LSPGAQNLL 248
D+WS GVILY +LTG PF N+ L ++I + + S A++L+
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237
Query: 249 RKILEPNPVKRITIAGIKADEWF 271
+K L +P KR T I WF
Sbjct: 238 KKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 240 bits (615), Expect = 3e-77
Identities = 101/253 (39%), Positives = 156/253 (61%), Gaps = 6/253 (2%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
LG+G+FGKV + D+G +A+K+L+K +II K + E L + HP +V+LH
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
++ K+Y+VLEY GGELF ++ +GR E R +++ + Y H+ G+ +RDLK
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
ENILLD+ G+IK++DFGL+ + + +T CG+P Y+APEVL +GY G D W
Sbjct: 121 PENILLDADGHIKLTDFGLAK--ELSSEGSRTNTFCGTPEYLAPEVLLGKGY-GKAVDWW 177
Query: 202 SCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT 261
S GV+LY +LTG PF + +Y+KI + + P++LSP A++L+ +L+ +P KR+
Sbjct: 178 SLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLG 237
Query: 262 IAG---IKADEWF 271
G IKA +F
Sbjct: 238 SGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 236 bits (604), Expect = 6e-75
Identities = 100/262 (38%), Positives = 153/262 (58%), Gaps = 11/262 (4%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E +TLG G+FG+V + SG +A+KIL K +I+ LK + + E L+ ++HP
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
+V L+ S +Y+V+EYV GGELF + GR E R Q++ + Y H+ +
Sbjct: 63 LVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDI 122
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
+RDLK EN+LLDS G IKI+DFG + R G +T CG+P Y+APE++ ++GY
Sbjct: 123 VYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTLCGTPEYLAPEIILSKGYGK 177
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
A D W+ G+++Y +L GY PF D N +Y+KI G + P + SP A++L+R +L+ +
Sbjct: 178 A-VDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVD 236
Query: 256 PVKRI-----TIAGIKADEWFE 272
KR+ + IK WF
Sbjct: 237 LTKRLGNLKNGVNDIKNHPWFA 258
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 220 bits (562), Expect = 7e-69
Identities = 91/279 (32%), Positives = 148/279 (53%), Gaps = 24/279 (8%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHP 74
++ G+ +GEG+F V A++ ++ +A+KIL+K ++I K +K E L +L HP
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
+++L+ + +Y VLEY GEL I G L E R +++ + Y H+KG
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG 122
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLS------ALPQHFRDDGLLHTT------------ 176
+ HRDLK ENILLD +IKI+DFG + + P+ + D +
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASF 182
Query: 177 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL 236
G+ YV+PE+L N G +SD+W+ G I+Y +LTG PF N + +QKI + ++
Sbjct: 183 VGTAEYVSPELL-NEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSF 241
Query: 237 PKWLSPGAQNLLRKILEPNPVKRITIAG----IKADEWF 271
P P A++L+ K+L +P R+ + +KA +F
Sbjct: 242 PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 215 bits (551), Expect = 4e-68
Identities = 96/247 (38%), Positives = 136/247 (55%), Gaps = 37/247 (14%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
LGEG FG V A+D +G A+KI++K L +++ REI LK L HPN+V+L+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLL--EELLREIEILKKLNHPNIVKLYG 58
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL 140
V ++ +Y+V+EY GG L D + G+L E E ++ Q+++G+ Y H+ G+ HRDL
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 141 KLENILLDSK-GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 199
K ENILLDS G +K++DFGLS D LL T G+P Y+APEVL +GY SD
Sbjct: 119 KPENILLDSDNGKVKLADFGLSK--LLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 200 IWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 259
IWS GVILY + P ++L+RK+L+ +P KR
Sbjct: 177 IWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKR 205
Query: 260 ITIAGIK 266
+ I
Sbjct: 206 PSAKEIL 212
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 210 bits (537), Expect = 2e-65
Identities = 89/254 (35%), Positives = 140/254 (55%), Gaps = 7/254 (2%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+ G LG G+FG V A D D+G AVK +E + ++ + ++REI L L+HP
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEEL-EALEREIRILSSLQHP 59
Query: 75 NVVRL--HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
N+VR E K+ + + LEYV+GG L + G+L E RK +Q+++G++Y H+
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
G+ HRD+K NIL+DS G +K++DFG + + G+P ++APEV+
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI-RGE 178
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRN--LAVLYQKIFRGDF-KLPKWLSPGAQNLLR 249
G +DIWS G + + TG P+ + +A LY+ G+ ++P+ LS A++ LR
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238
Query: 250 KILEPNPVKRITIA 263
K L +P KR T
Sbjct: 239 KCLRRDPKKRPTAD 252
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 206 bits (526), Expect = 1e-63
Identities = 93/260 (35%), Positives = 144/260 (55%), Gaps = 13/260 (5%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
LG G FG+V+ + FA+K ++K I+ + I E L+ HP +V+L+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
K IYM++EY GGEL+ + +G E R ++ Y HN+G+ +RDLK
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
EN+LLDS G +K+ DFG + + + T CG+P YVAPE++ N+GYD + D W
Sbjct: 121 PENLLLDSNGYVKLVDFGFA---KKLKSGQKTWTFCGTPEYVAPEIILNKGYDFS-VDYW 176
Query: 202 SCGVILYVILTGYLPF--DDRNLAVLYQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPV 257
S G++LY +LTG PF DD + +Y I +G+ KL P ++ A++L++++L NP
Sbjct: 177 SLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE 236
Query: 258 KRI-----TIAGIKADEWFE 272
+R+ I IK +WF
Sbjct: 237 ERLGNLKGGIKDIKKHKWFN 256
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 205 bits (523), Expect = 3e-63
Identities = 87/262 (33%), Positives = 139/262 (53%), Gaps = 21/262 (8%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL------EKNRIIHLKITDQIKREIATL 68
+YE+ + +G+G+FGKV + G + +K + EK R + E+ L
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKER-------EDALNEVKIL 53
Query: 69 KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR----LQEAEGRKLFQQLI 124
K L HPN+++ +E K K+ +V+EY GG+L KI + + E + F QL
Sbjct: 54 KKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLC 113
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
+ Y H++ + HRD+K +NI L S G +K+ DFG+S + L T G+P Y++
Sbjct: 114 LALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS--TVDLAKTVVGTPYYLS 171
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPG 243
PE+ N+ Y+ SDIWS G +LY + T PF+ NL L KI +G + +P S
Sbjct: 172 PELCQNKPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSE 230
Query: 244 AQNLLRKILEPNPVKRITIAGI 265
+NL+ +L+ +P +R +IA I
Sbjct: 231 LRNLVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 195 bits (498), Expect = 8e-59
Identities = 88/258 (34%), Positives = 147/258 (56%), Gaps = 6/258 (2%)
Query: 3 IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
+ +L +E+G TLG G+FG+V+ A+ +G +A+K L+K I+ +K +
Sbjct: 7 FTKPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVA 66
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
+E + L L HP +V + ++++Y +LE+V GGELF + GR + +
Sbjct: 67 QEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAE 126
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
L+ Y H+K + +RDLK EN+LLD+KG++K++DFG + + T CG+P Y
Sbjct: 127 LVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEY 181
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSP 242
+APEV+ ++G+ A D W+ GV+LY + GY PF D +Y+KI G K P W
Sbjct: 182 LAPEVIQSKGHGKAV-DWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDG 240
Query: 243 GAQNLLRKILEPNPVKRI 260
A++L++ +L+ + KR+
Sbjct: 241 RARDLVKGLLQTDHTKRL 258
|
Length = 329 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 2e-56
Identities = 91/262 (34%), Positives = 150/262 (57%), Gaps = 11/262 (4%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
E +T+G G FG+V +D S +A+K++ +I LK + E LK + HP
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
++RL + +YM++EYV GGELF + + GR + G +++ + Y H+K +
Sbjct: 63 IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEI 122
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
+RDLK ENILLD +G+IK++DFG + + RD T CG+P Y+APEV+ ++G++
Sbjct: 123 VYRDLKPENILLDKEGHIKLTDFGFA---KKLRDR--TWTLCGTPEYLAPEVIQSKGHNK 177
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
A D W+ G+++Y +L GY PF D N +Y+KI G + P+ L A++L++K+L +
Sbjct: 178 AV-DWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVD 236
Query: 256 PVKRI-----TIAGIKADEWFE 272
+R+ +K WF+
Sbjct: 237 RTRRLGNMKNGADDVKNHRWFK 258
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 185 bits (471), Expect = 1e-55
Identities = 88/259 (33%), Positives = 142/259 (54%), Gaps = 12/259 (4%)
Query: 25 GNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA 84
G +G+V A+ +G +A+K+++K +I DQ+ E L + P VV+L+
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63
Query: 85 SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLEN 144
K +Y+V+EY+ GG+L + + G L E R +++ + Y H+ G+ HRDLK +N
Sbjct: 64 GKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDN 123
Query: 145 ILLDSKGNIKISDFGLSAL----PQHFRDDGLLHT--TCGSPNYVAPEVLANRGYDGATS 198
IL+DS G++K++DFGLS + Q +D G+P+Y+APEV+ +G+ T
Sbjct: 124 ILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH-SKTV 182
Query: 199 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK--WLSPGAQNLLRKILEPNP 256
D WS G ILY L G PF ++Q I G + P+ +S A +L+ K+L P+P
Sbjct: 183 DWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDP 242
Query: 257 VKRI---TIAGIKADEWFE 272
KR+ +I IK +F+
Sbjct: 243 EKRLGAKSIEEIKNHPFFK 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 177 bits (448), Expect = 4e-51
Identities = 98/292 (33%), Positives = 149/292 (51%), Gaps = 27/292 (9%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP- 74
Y + R LGEG+FG+V A+D A+K+L K K ++ REI L L HP
Sbjct: 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFD---KIASKGRLQEAEGRKLFQQLIDGVSYCH 131
N+V+L++ + +Y+V+EYV GG L D KI KG L E+E + Q++ + Y H
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 132 NKGVFHRDLKLENILLDSKGN-IKISDFGLSAL----PQHFRDDGLLHTTCGSPNYVAPE 186
+KG+ HRD+K ENILLD G +K+ DFGL+ L L T+ G+P Y+APE
Sbjct: 119 SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178
Query: 187 VL--ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------ 232
VL + Y ++SDIWS G+ LY +LTG PF+ + + +
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238
Query: 233 -DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDD 283
P+ +S A +LL+K+L +P R++ + + + + D
Sbjct: 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSD 290
|
Length = 384 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 9e-51
Identities = 82/253 (32%), Positives = 139/253 (54%), Gaps = 13/253 (5%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E+ +G+G FG+V A+ +G A+K+++ + ++I EI LK KHPN
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLES---KEKKEKIINEIQILKKCKHPN 58
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKG 134
+V+ + K ++++V+E+ +GG L D + S + L E++ + ++L+ G+ Y H+ G
Sbjct: 59 IVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG 118
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
+ HRD+K NILL S G +K+ DFGLSA D +T G+P ++APEV+ + YD
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSA---QLSDTKARNTMVGTPYWMAPEVINGKPYD 175
Query: 195 GATSDIWSCGVILYVILTGYLPF-DDRNLAVLYQKIFRGD---FKLPKWLSPGAQNLLRK 250
+DIWS G+ + G P+ + + L+ KI + P+ S ++ L+K
Sbjct: 176 YK-ADIWSLGITAIELAEGKPPYSELPPMKALF-KIATNGPPGLRNPEKWSDEFKDFLKK 233
Query: 251 ILEPNPVKRITIA 263
L+ NP KR T
Sbjct: 234 CLQKNPEKRPTAE 246
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 6e-50
Identities = 91/245 (37%), Positives = 145/245 (59%), Gaps = 7/245 (2%)
Query: 20 RTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRII-HLKITDQIKREIATLKLLKHPN 75
+ LG+G +GKV + + D+G FA+K+L+K I+ + K T K E L+ +KHP
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
+V L + K+Y++LEY++GGELF + +G E ++ + + H +G+
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
+RDLK ENILLD++G++K++DFGL + + + HT CG+ Y+APE+L G+ G
Sbjct: 122 IYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHTFCGTIEYMAPEILMRSGH-G 178
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
D WS G ++Y +LTG PF N KI +G LP +L+P A++LL+K+L+ N
Sbjct: 179 KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRN 238
Query: 256 PVKRI 260
P R+
Sbjct: 239 PSSRL 243
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 6e-50
Identities = 83/259 (32%), Positives = 132/259 (50%), Gaps = 7/259 (2%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y+LG +G G FG V +L++G A+K + +I + I +EI LK LKHP
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKS-IMQEIDLLKNLKHP 59
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N+V+ + + +Y++LEY G L I G E+ Q++ G++Y H +G
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC-GSPNYVAPEVLANRGY 193
V HRD+K NIL G +K++DFG++ D + G+P ++APEV+ G
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVA---TKLNDVSKDDASVVGTPYWMAPEVIEMSGA 176
Query: 194 DGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGDFKLPKWLSPGAQNLLRKIL 252
A SDIWS G + +LTG P+ D N +A L++ + LP+ +SP ++ L +
Sbjct: 177 STA-SDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCF 235
Query: 253 EPNPVKRITIAGIKADEWF 271
+ +P R T + W
Sbjct: 236 QKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 168 bits (426), Expect = 2e-48
Identities = 107/324 (33%), Positives = 177/324 (54%), Gaps = 39/324 (12%)
Query: 20 RTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQI--KREIATLKLLKHP 74
+ LG+G+FGKV + + D+G +A+K+L+K LK+ D++ K E L + HP
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKAT---LKVRDRVRTKMERDILAEVNHP 58
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
+V+LH ++ K+Y++L+++ GG+LF +++ + E + + +L + + H+ G
Sbjct: 59 FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG 118
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
+ +RDLK ENILLD +G+IK++DFGLS + ++ CG+ Y+APEV+ RG+
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSKESID--HEKKAYSFCGTVEYMAPEVVNRRGHT 176
Query: 195 GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEP 254
+ +D WS GV+++ +LTG LPF ++ I + +P++LSP AQ+LLR + +
Sbjct: 177 QS-ADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKR 235
Query: 255 NPVKRI-----TIAGIKADEWF-------------EQDYTPA--NPDDDEEDIFVDNEAF 294
NP R+ + IK +F + + PA PDD + D E
Sbjct: 236 NPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKPPFKPAVGRPDD---TFYFDPEFT 292
Query: 295 SMHEVPSDGGRTPGSPPLINAFQL 318
S P D +PG PP NA QL
Sbjct: 293 S--RTPKD---SPGIPPSANAHQL 311
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 167 bits (426), Expect = 2e-48
Identities = 90/242 (37%), Positives = 144/242 (59%), Gaps = 4/242 (1%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVR 78
+ LG+G+FGKV A+ + +AVK+L+K+ I+ + E L L KHP + +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
LH +K +++ V+EYV GG+L I GR E R +++ G+ + H +G+ +R
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
DLKL+N+LLDS+G+IKI+DFG+ + T CG+P+Y+APE+L+ + Y G
Sbjct: 121 DLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTFCGTPDYIAPEILSYQPY-GPAV 177
Query: 199 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258
D W+ GV+LY +L G PF+ + L+Q I + + P+WLS A+++L+ L NP K
Sbjct: 178 DWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEK 237
Query: 259 RI 260
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 5e-48
Identities = 79/248 (31%), Positives = 128/248 (51%), Gaps = 7/248 (2%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+EL R +G+G FGKV Q D+ FA+K + K + + + E L+ L HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
+V L + +Y+V++ + GG+L ++ K + E + + +++ + Y H+KG+
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
HRD+K +NILLD +G++ I+DF ++ D L +T G+P Y+APEVL +GY
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIAT---KVTPDTLTTSTSGTPGYMAPEVLCRQGY-S 177
Query: 196 ATSDIWSCGVILYVILTGYLPFD--DRNLAVLYQKIF-RGDFKLPKWLSPGAQNLLRKIL 252
D WS GV Y L G P+ R + + D P S A + + K+L
Sbjct: 178 VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLL 237
Query: 253 EPNPVKRI 260
E +P KR+
Sbjct: 238 ERDPQKRL 245
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 9e-48
Identities = 85/262 (32%), Positives = 132/262 (50%), Gaps = 16/262 (6%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
YE+ T+G+G+FG V+ + G K ++ + K Q+ E+ L+ LKHPN
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTE-KEKQQLVSEVNILRELKHPN 60
Query: 76 VVRL--HEVLASKSKIYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGVSY 129
+VR + S +Y+V+EY GG+L I + ++E ++ QL+ +
Sbjct: 61 IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120
Query: 130 CHNKG-----VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
CHN+ V HRDLK NI LD+ N+K+ DFGL+ + H D T G+P Y++
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH--DSSFAKTYVGTPYYMS 178
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPG 243
PE L + YD SDIWS G ++Y + PF RN L KI G F ++P S
Sbjct: 179 PEQLNHMSYD-EKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSE 237
Query: 244 AQNLLRKILEPNPVKRITIAGI 265
+++ +L +P KR + +
Sbjct: 238 LNEVIKSMLNVDPDKRPSTEEL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 3e-47
Identities = 94/297 (31%), Positives = 138/297 (46%), Gaps = 76/297 (25%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIATLKLL 71
YE LGEG +G V A+D +G A+K +I + I REI+ LK L
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALK-----KIRLDNEEEGIPSTALREISLLKEL 55
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGE-----LFDKIASKGRLQEAEGRKLFQQLIDG 126
KHPN+V+L +V+ ++ K+Y+V EY + DK L + + QL+ G
Sbjct: 56 KHPNIVKLLDVIHTERKLYLVFEYC---DMDLKKYLDKRPGP--LSPNLIKSIMYQLLRG 110
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----- 181
++YCH+ + HRDLK +NIL++ G +K++DFGL+ G P
Sbjct: 111 LAYCHSHRILHRDLKPQNILINRDGVLKLADFGLA-------------RAFGIPLRTYTH 157
Query: 182 ------YVAPEVL-ANRGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAVLYQKIFR-- 231
Y APE+L ++ Y A DIWS G I ++TG F D + L+ KIF+
Sbjct: 158 EVVTLWYRAPEILLGSKHYSTAV-DIWSVGCIFAEMITGKPLFPGDSEIDQLF-KIFQIL 215
Query: 232 --------------GDFK--LPKW-----------LSPGAQNLLRKILEPNPVKRIT 261
D+K PK+ L P +LL K+L+ NP KRI+
Sbjct: 216 GTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRIS 272
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 164 bits (416), Expect = 6e-47
Identities = 84/241 (34%), Positives = 136/241 (56%), Gaps = 3/241 (1%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+ LG+G FGKV ++ +G +A+KIL+K II E L+ +HP + L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
+ ++ V+EY GGELF ++ + E R +++ + Y H+ V +RD
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 199
LKLEN++LD G+IKI+DFGL + D + T CG+P Y+APEVL + Y G D
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177
Query: 200 IWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 259
W GV++Y ++ G LPF +++ L++ I + + P+ LSP A++LL +L+ +P +R
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237
Query: 260 I 260
+
Sbjct: 238 L 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 1e-46
Identities = 86/266 (32%), Positives = 136/266 (51%), Gaps = 13/266 (4%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLKLLK 72
R++ G +G G FGKV A +LD+G AVK ++ N K +I E+ L+LLK
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND---PKTIKEIADEMKVLELLK 57
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
HPN+V+ + V + K+Y+ +EY +GG L + + L E R QL++G++Y H+
Sbjct: 58 HPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHS 117
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSAL--PQHFRDDGLLHTTCGSPNYVAPEVLAN 190
G+ HRD+K NI LD G IK+ DFG + + + G+P Y+APEV+
Sbjct: 118 HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177
Query: 191 RGYDG--ATSDIWSCGVILYVILTGYLPFD--DRNLAVLYQKIFRGDFKLPK--WLSPGA 244
G +DIWS G ++ + TG P+ D +++ +P LSP
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEG 237
Query: 245 QNLLRKILEPNPVKRITIAGIKADEW 270
++ L + LE +P KR T + + +
Sbjct: 238 KDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 163 bits (413), Expect = 2e-46
Identities = 85/240 (35%), Positives = 139/240 (57%), Gaps = 4/240 (1%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN-VVRLH 80
LG+G+FGKV A+ + +A+KIL+K+ II + E L L P + +LH
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLH 67
Query: 81 EVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL 140
+ ++Y V+EYV GG+L I G+ +E ++ G+ + H+KG+ +RDL
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127
Query: 141 KLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDI 200
KL+N++LD++G+IKI+DFG+ ++ T CG+P+Y+APE++A + Y G + D
Sbjct: 128 KLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGTPDYIAPEIIAYQPY-GKSVDW 184
Query: 201 WSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI 260
W+ GV+LY +L G PFD + L+Q I + PK LS A ++ + +L +P KR+
Sbjct: 185 WAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKRL 244
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 2e-46
Identities = 97/267 (36%), Positives = 145/267 (54%), Gaps = 10/267 (3%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVR 78
+ +G+G+FGKV A+ G +AVK+L+K I+ K + I E L K LKHP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
LH + K+Y VL+YV GGELF + + E R ++ + Y H+ + +R
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
DLK ENILLDS+G++ ++DFGL + + T CG+P Y+APEVL YD T
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKEPYD-RTV 177
Query: 199 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258
D W G +LY +L G PF R+++ +Y I +LP + A +LL +L + +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRR 237
Query: 259 RITIAGIKADEWFEQD---YTPANPDD 282
R+ G KAD ++ ++P N DD
Sbjct: 238 RL---GAKADFLEIKNHVFFSPINWDD 261
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 161 bits (408), Expect = 3e-46
Identities = 91/274 (33%), Positives = 158/274 (57%), Gaps = 22/274 (8%)
Query: 16 YELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIH-LKITDQIKREIATLKLL 71
+EL R LG G +GKV + + D+G +A+K+L+K I+ K + + E L+ +
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 72 KH-PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
+ P +V LH + +K++++L+YV GGELF + + E+E R +++ + +
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHL 121
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSAL---PQHFRDDGLLHTTCGSPNYVAPEV 187
H G+ +RD+KLENILLDS+G++ ++DFGLS + R ++ CG+ Y+APEV
Sbjct: 122 HQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEER----AYSFCGTIEYMAPEV 177
Query: 188 L--ANRGYDGATSDIWSCGVILYVILTGYLPF---DDRNL-AVLYQKIFRGDFKLPKWLS 241
+ + G+D A D WS GV+ + +LTG PF ++N + + ++I + PK +S
Sbjct: 178 IRGGSGGHDKAV-DWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMS 236
Query: 242 PGAQNLLRKILEPNPVKRITIAG---IKADEWFE 272
A++ ++K+LE +P KR+ G IK +F+
Sbjct: 237 AEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQ 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 6e-46
Identities = 85/251 (33%), Positives = 138/251 (54%), Gaps = 4/251 (1%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL-LKHPNVVR 78
+ LG+G+FGKV A+ + +A+K+L+K+ I+ D E L L KHP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
LH +K +++ V+EYV GG+L +I + E R ++ + + H GV +R
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
DLKL+NILLD++G+ K++DFG+ + + T CG+P+Y+APE+L Y G +
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEILQELEY-GPSV 177
Query: 199 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258
D W+ GV++Y ++ G PF+ N L++ I D P WLS A ++L+ + NP K
Sbjct: 178 DWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNK 237
Query: 259 RITIAGIKADE 269
R+ + E
Sbjct: 238 RLGCVASQGGE 248
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 1e-45
Identities = 93/250 (37%), Positives = 136/250 (54%), Gaps = 7/250 (2%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVR 78
+ +G+G+FGKV A+ G +AVK+L+K I+ K I E L K +KHP +V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
LH + K+Y VL+YV GGELF + + E R ++ + Y H+ + +R
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
DLK ENILLDS+G++ ++DFGL + T CG+P Y+APEVL + YD T
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLRKQPYD-RTV 177
Query: 199 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258
D W G +LY +L G PF R+ A +Y I +L +S A++LL +L+ + K
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTK 237
Query: 259 RITIAGIKAD 268
R+ G K D
Sbjct: 238 RL---GAKDD 244
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 160 bits (405), Expect = 2e-45
Identities = 87/255 (34%), Positives = 144/255 (56%), Gaps = 7/255 (2%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVR 78
R LG+G+FGKV A+ +SG +AVK+L+K+ I+ + E L L + HP + +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
L+ + +++ V+E+V GG+L I R EA R ++ + + H+KG+ +R
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
DLKL+N+LLD +G+ K++DFG+ + + T CG+P+Y+APE+L Y G +
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQEMLY-GPSV 177
Query: 199 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258
D W+ GV+LY +L G+ PF+ N L++ I + P WLS A ++L+ + NP
Sbjct: 178 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTM 237
Query: 259 R---ITIAGIKADEW 270
R +T+ G +A
Sbjct: 238 RLGSLTLGGEEAILR 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 4e-45
Identities = 82/258 (31%), Positives = 134/258 (51%), Gaps = 21/258 (8%)
Query: 25 GNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH-PNVVRLHEVL 83
G FG V A+ +G FA+K+L+K+ +I +K E A + + P V +L+
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 84 ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLE 143
SK +Y+V+EY+ GG+ I + G L E ++ +++ GV H +G+ HRD+K E
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPE 126
Query: 144 NILLDSKGNIKISDFGLSA---LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDI 200
N+L+D G++K++DFGLS + F G+P+Y+APE + G D SD
Sbjct: 127 NLLIDQTGHLKLTDFGLSRNGLENKKF---------VGTPDYLAPETILGVGDDKM-SDW 176
Query: 201 WSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK----WLSPGAQNLLRKILEPNP 256
WS G +++ L GY PF ++ I P+ + SP A +L+ ++L +P
Sbjct: 177 WSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDP 236
Query: 257 VKRITIAG---IKADEWF 271
KR+ G IK+ +F
Sbjct: 237 AKRLGANGYQEIKSHPFF 254
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 8e-45
Identities = 90/253 (35%), Positives = 142/253 (56%), Gaps = 4/253 (1%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL-LKHPNVVR 78
+ LG+G+FGKV A+ + FA+K L+K+ ++ + E L L +HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
L +K ++ V+EY+ GG+L I S GR EA R ++I G+ + H KG+ +R
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
DLKL+N+LLD G+IKI+DFG+ ++ +G T CG+P+Y+APE+L + Y+ +
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGMCK--ENMNGEGKASTFCGTPDYIAPEILKGQKYNESV- 177
Query: 199 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258
D WS GV+LY +L G PF + L+ I P+W+S A++ L K+ E +P K
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTK 237
Query: 259 RITIAGIKADEWF 271
R+ + G F
Sbjct: 238 RLGVDGDIRQHPF 250
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 158 bits (400), Expect = 1e-44
Identities = 103/306 (33%), Positives = 158/306 (51%), Gaps = 19/306 (6%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI-ATLKLLKHPNVVR 78
+ +G+G+FGKV A+ +AVK+L+K I+ K I E LK +KHP +V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
LH + K+Y VL+Y+ GGELF + + E R ++ + Y H+ + +R
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
DLK ENILLDS+G+I ++DFGL ++ +G T CG+P Y+APEVL + YD T
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQPYD-RTV 177
Query: 199 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258
D W G +LY +L G PF RN A +Y I +L ++ A++LL +L+ + K
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTK 237
Query: 259 RIT-------------IAGIKADEWFEQDYTPA-NPD-DDEEDIFVDNEAFSMHEVPSDG 303
R+ + I D+ + TP NP+ D+ + F+ VP+
Sbjct: 238 RLGAKDDFMEIKNHIFFSPINWDDLINKKITPPFNPNVSGPNDLRHFDPEFTEEPVPNSI 297
Query: 304 GRTPGS 309
G++P S
Sbjct: 298 GQSPDS 303
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 1e-44
Identities = 83/241 (34%), Positives = 136/241 (56%), Gaps = 3/241 (1%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+ LG+G FGKV ++ +G +A+KIL K II E L+ +HP + L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
+ ++ V+EY GGELF ++ + E R +++ + Y H++ V +RD
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 199
+KLEN++LD G+IKI+DFGL + D + T CG+P Y+APEVL + Y G D
Sbjct: 121 IKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177
Query: 200 IWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 259
W GV++Y ++ G LPF +++ L++ I + + P+ LSP A++LL +L+ +P +R
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237
Query: 260 I 260
+
Sbjct: 238 L 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 2e-44
Identities = 87/242 (35%), Positives = 144/242 (59%), Gaps = 8/242 (3%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH---LKITDQIKREIATLKLLKHPNVVR 78
LG+G+FGKV A+ + +A+KIL+K+ +I ++ T KR +A K P + +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD--KPPFLTQ 65
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
LH + ++Y V+EYV GG+L I G+ +E + ++ G+ + H +G+ +R
Sbjct: 66 LHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYR 125
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
DLKL+N++LDS+G+IKI+DFG+ +H D T CG+P+Y+APE++A + Y G +
Sbjct: 126 DLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEIIAYQPY-GKSV 182
Query: 199 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258
D W+ GV+LY +L G PFD + L+Q I + PK LS A ++ + ++ +P K
Sbjct: 183 DWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSK 242
Query: 259 RI 260
R+
Sbjct: 243 RL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 3e-44
Identities = 90/255 (35%), Positives = 136/255 (53%), Gaps = 7/255 (2%)
Query: 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLP-FAVKILEKNRIIHLKITDQIKRE 64
K++ M+ + RTLG G+FG+V A + P A+K EK++II K D + E
Sbjct: 22 KRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSE 81
Query: 65 IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
L + HP V L+ +S +Y+VLE+V GGE F + R G Q++
Sbjct: 82 RKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIV 141
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
Y + + +RDLK EN+LLD G IK++DFG + + D +T CG+P Y+A
Sbjct: 142 LIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLCGTPEYIA 196
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244
PE+L N G+ G +D W+ G+ +Y IL G PF ++YQKI G PK+L
Sbjct: 197 PEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNC 255
Query: 245 QNLLRKILEPNPVKR 259
++L++K+L + KR
Sbjct: 256 KHLMKKLLSHDLTKR 270
|
Length = 340 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 3e-44
Identities = 86/282 (30%), Positives = 137/282 (48%), Gaps = 38/282 (13%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
RY++ +GEG G V A+D ++G A+K + R + I +Q REI L+ +HP
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVA-LRRLEGGIPNQALREIKALQACQHP 59
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNK 133
VV+L +V S +V+EY+ L + + + R L EA+ + + L+ GV+Y H
Sbjct: 60 YVVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN 118
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHT-TCGSPNYVAPEVL-ANR 191
G+ HRDLK N+L+ + G +KI+DFGL+ L ++ L++ + Y APE+L R
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARL--FSEEEPRLYSHQVATRWYRAPELLYGAR 176
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRN--------LAVL---YQKIFRGDFKLPKW- 239
YD D+W+ G I +L G F N L ++ + G LP +
Sbjct: 177 KYDPGV-DLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN 235
Query: 240 ------------------LSPGAQNLLRKILEPNPVKRITIA 263
SP A +LL+ +L +P KR++ A
Sbjct: 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAA 277
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 157 bits (397), Expect = 3e-44
Identities = 89/241 (36%), Positives = 136/241 (56%), Gaps = 3/241 (1%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+ LG+G FGKV ++ SG +A+KIL+K II E LK +HP + L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
+K ++ V+EYV GGELF ++ + E R +++ + Y H+ + +RD
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 199
LKLEN++LD G+IKI+DFGL + D + T CG+P Y+APEVL + Y G D
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177
Query: 200 IWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 259
W GV++Y ++ G LPF +++ L++ I D K P+ LS A++LL +L +P KR
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKR 237
Query: 260 I 260
+
Sbjct: 238 L 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 3e-44
Identities = 91/255 (35%), Positives = 137/255 (53%), Gaps = 6/255 (2%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
+G+G+FGKV + D+ +A+K + K I+ E L + P +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
S K+Y+VL ++ GGELF + +GR + R +L+ + H V +RDLK
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
ENILLD +G+I + DFGL L + +DD +T CG+P Y+APE+L GY A D W
Sbjct: 121 PENILLDYQGHIALCDFGLCKL--NMKDDDKTNTFCGTPEYLAPELLLGHGYTKAV-DWW 177
Query: 202 SCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT 261
+ GV+LY +LTG PF D N+ +Y+KI + + P A++LL +L +P +R+
Sbjct: 178 TLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLG 237
Query: 262 IAG---IKADEWFEQ 273
G IK +F Q
Sbjct: 238 YNGAQEIKNHPFFSQ 252
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 157 bits (397), Expect = 4e-44
Identities = 98/332 (29%), Positives = 174/332 (52%), Gaps = 31/332 (9%)
Query: 16 YELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIH-LKITDQIKREIATLKLL 71
+EL + LG G +GKV + + D+G +A+K+L+K ++ K + + E L+ +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 72 KH-PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
+ P +V LH +++K++++L+YV+GGE+F + + E E R ++I + +
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHL 121
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF--RDDGLLHTTCGSPNYVAPEVL 188
H G+ +RD+KLENILLDS+G++ ++DFGLS + F + ++ CG+ Y+APE++
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVVLTDFGLS---KEFLSEEKERTYSFCGTIEYMAPEII 178
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPFD---DRNL-AVLYQKIFRGDFKLPKWLSPGA 244
+G G D WS G++++ +LTG PF +RN + + ++I + D P ++ P A
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEA 238
Query: 245 QNLLRKILEPNPVKRITIAGIKADEWFEQDY---------------TPANPD-DDEEDIF 288
Q+LL K+L +P KR+ A E E + P P +E D+
Sbjct: 239 QDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPSIRNELDVG 298
Query: 289 VDNEAFS-MHEVPSDGGRTPGSPPLINAFQLI 319
E F+ + V S G P + + +
Sbjct: 299 NFAEEFTNLEPVYSPAGTPPSGARVFQGYSFV 330
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 1e-42
Identities = 84/243 (34%), Positives = 144/243 (59%), Gaps = 10/243 (4%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL----KHPNVV 77
LG+G+FGKV A+ + +A+KIL+K+ +I D ++ + ++L K P +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ---DDDVECTMVEKRVLALSGKPPFLT 64
Query: 78 RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
+LH + ++Y V+EYV GG+L +I GR +E ++ G+ + H+KG+ +
Sbjct: 65 QLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIY 124
Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT 197
RDLKL+N++LDS+G+IKI+DFG+ ++ D T CG+P+Y+APE++A + Y G +
Sbjct: 125 RDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDYIAPEIIAYQPY-GKS 181
Query: 198 SDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPV 257
D W+ GV+LY +L G PF+ + L+Q I + PK +S A + + ++ +P
Sbjct: 182 VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPG 241
Query: 258 KRI 260
KR+
Sbjct: 242 KRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 2e-42
Identities = 84/256 (32%), Positives = 132/256 (51%), Gaps = 13/256 (5%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVK--ILEKNRIIHLKITDQIKREIATLKLLK 72
R+ G LG G+FG V +LD G FAVK L + + Q+++EIA L L+
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
HPN+V+ + +Y+ LE V GG L + G E R +Q++ G+ Y H+
Sbjct: 61 HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD 120
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
+ HRD+K NIL+D+ G +K++DFG++ + + + GSP ++APEV+A +G
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMA---KQVVEFSFAKSFKGSPYWMAPEVIAQQG 177
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR-GDFK----LPKWLSPGAQNL 247
G +DIWS G + + TG P+ +F+ G K +P LS A++
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPWSQLE---GVAAVFKIGRSKELPPIPDHLSDEAKDF 234
Query: 248 LRKILEPNPVKRITIA 263
+ K L+ +P R T A
Sbjct: 235 ILKCLQRDPSLRPTAA 250
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 2e-42
Identities = 76/258 (29%), Positives = 124/258 (48%), Gaps = 25/258 (9%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD----QIKREIATLKLLK 72
E + LG+G+ G V + +G +A+K IH+ + Q+ RE+ TL+ +
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKK------IHVDGDEEFRKQLLRELKTLRSCE 57
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
P VV+ + + +I +VLEY+ GG L D + G++ E + +Q++ G+ Y H
Sbjct: 58 SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT 117
Query: 133 K-GVFHRDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
K + HRD+K N+L++SKG +KI+DFG+S L +T G+ Y++PE +
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLEN---TLDQCNTFVGTVTYMSPERIQG 174
Query: 191 RGYDGATSDIWSCGVILYVILTGYLPFDDRN---LAVLYQKIFRGDFKLPKW----LSPG 243
+DIWS G+ L G PF L Q I G P SP
Sbjct: 175 E-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGP--PPSLPAEEFSPE 231
Query: 244 AQNLLRKILEPNPVKRIT 261
++ + L+ +P KR +
Sbjct: 232 FRDFISACLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 152 bits (384), Expect = 2e-42
Identities = 84/242 (34%), Positives = 138/242 (57%), Gaps = 4/242 (1%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+ LG+G FGKV ++ +G +A+KIL+K I+ E L+ +HP + L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHR 138
+ ++ V+EY GGELF ++ + E R +++ + Y H+ K V +R
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
DLKLEN++LD G+IKI+DFGL + +D + T CG+P Y+APEVL + Y G
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAV 177
Query: 199 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258
D W GV++Y ++ G LPF +++ L++ I + + P+ LSP A++LL +L+ +P +
Sbjct: 178 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQ 237
Query: 259 RI 260
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 3e-42
Identities = 84/250 (33%), Positives = 138/250 (55%), Gaps = 8/250 (3%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI-IHL-KITDQIKREIATLKLLKH 73
+ G+ LG+G FG+V D+D+G AVK + + K + ++ EI LK L+H
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH 63
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
+V+ + L + + +EY+ GG + D++ + G L E RK +Q+++GV Y H+
Sbjct: 64 ERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN 123
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG-LLHTTCGSPNYVAPEVLANRG 192
+ HRD+K NIL DS GN+K+ DFG S Q G + + G+P +++PEV++ G
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG 183
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFR--GDFKLPKWLSPGAQNLLR 249
Y G +D+WS G + +LT P+ + +A ++ KI + +LP +SP A+N LR
Sbjct: 184 Y-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF-KIATQPTNPQLPSHVSPDARNFLR 241
Query: 250 KILEPNPVKR 259
+ N KR
Sbjct: 242 RTFVENAKKR 251
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 3e-42
Identities = 83/249 (33%), Positives = 143/249 (57%), Gaps = 10/249 (4%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL----KHPN 75
+ LG+G+FGKV A+ + FA+K L+K+ ++ + D ++ + ++L +HP
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVL---MDDDVECTMVEKRVLSLAWEHPF 57
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
+ L+ +K ++ V+EY+ GG+L I S + ++I G+ + H+KG+
Sbjct: 58 LTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGI 117
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
+RDLKL+NILLD+ G+IKI+DFG+ ++ D T CG+P+Y+APE+L + Y
Sbjct: 118 VYRDLKLDNILLDTDGHIKIADFGMCK--ENMLGDAKTCTFCGTPDYIAPEILLGQKY-N 174
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
+ D WS GV+LY +L G PF + L+Q I + P+WL+ A+++L K+
Sbjct: 175 TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVRE 234
Query: 256 PVKRITIAG 264
P +R+ + G
Sbjct: 235 PERRLGVKG 243
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 7e-42
Identities = 97/300 (32%), Positives = 142/300 (47%), Gaps = 57/300 (19%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK----ITDQIKREIATLKLL 71
YE +GEG +G+V A++ +G A+K K R+ + K IT REI L+ L
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALK---KIRMENEKEGFPIT--AIREIKLLQKL 55
Query: 72 KHPNVVRLHEVLASKSK--IYMVLEYV----TGGELFDKIASKG-RLQEAEGRKLFQQLI 124
+HPN+VRL E++ SK K IYMV EY+ TG + S + E++ + +QL+
Sbjct: 56 RHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTG-----LLDSPEVKFTESQIKCYMKQLL 110
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
+G+ Y H+ G+ HRD+K NIL+++ G +K++DFGL A P R+ + Y
Sbjct: 111 EGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGL-ARPYTKRNSADYTNRVITLWYRP 169
Query: 185 PEVL--ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR----------- 231
PE+L A R Y D+WS G IL + G F +KIF
Sbjct: 170 PELLLGATR-YGPE-VDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWP 227
Query: 232 GDFKLP--------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271
G KLP + P A +LL K+L +P KRI+ E+F
Sbjct: 228 GVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 149 bits (377), Expect = 1e-41
Identities = 87/267 (32%), Positives = 161/267 (60%), Gaps = 17/267 (6%)
Query: 16 YELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIH-LKITDQIKREIATLKLL 71
+EL + LG G +GKV + + DSG +A+K+L+K I+ K T+ + E L+ +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 72 KH-PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
+ P +V LH + +K++++L+Y+ GGELF ++ + R +E E + +++ + +
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHL 121
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL--LHTTCGSPNYVAPEVL 188
H G+ +RD+KLENILLDS G++ ++DFGLS + F +D + ++ CG+ Y+AP+++
Sbjct: 122 HKLGIIYRDIKLENILLDSNGHVVLTDFGLS---KEFHEDEVERAYSFCGTIEYMAPDIV 178
Query: 189 A--NRGYDGATSDIWSCGVILYVILTGYLPF----DDRNLAVLYQKIFRGDFKLPKWLSP 242
+ G+D A D WS GV++Y +LTG PF + + A + ++I + + P+ +S
Sbjct: 179 RGGDGGHDKAV-DWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 237
Query: 243 GAQNLLRKILEPNPVKRITIAGIKADE 269
A+++++++L +P KR+ ADE
Sbjct: 238 LAKDIIQRLLMKDPKKRLGCGPSDADE 264
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 8e-41
Identities = 85/268 (31%), Positives = 131/268 (48%), Gaps = 31/268 (11%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD-----QIKR-----E 64
+++ + LG+G++G V + VK L N+ LK D Q +R E
Sbjct: 1 DFKVLKKLGKGSYGSV-----------YKVKRLSDNQFYALKEVDLGSMSQKEREDAVNE 49
Query: 65 IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLF 120
I L + HPN++ E +K+ +V+EY G+L I + + E E ++F
Sbjct: 50 IRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIF 109
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
QL+ G+ H + + HRDLK NILL + +KI D G+S + + + T G+P
Sbjct: 110 IQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLK----KNMAKTQIGTP 165
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKW 239
+Y+APEV R Y SDIWS G +LY + T PF+ R++ L K+ RG + +P
Sbjct: 166 HYMAPEVWKGRPYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPI 224
Query: 240 LSPGAQNLLRKILEPNPVKRITIAGIKA 267
S QN +R +L+ P R I A
Sbjct: 225 YSQDLQNFIRSMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 1e-40
Identities = 83/258 (32%), Positives = 148/258 (57%), Gaps = 11/258 (4%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL----KHPN 75
+ LG+G+FGKV A+ G FAVK L+K+ ++ I D ++ + ++L ++P
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL---IDDDVECTMVEKRVLALAWENPF 57
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
+ L+ +K ++ V+E++ GG+L I KGR +++ G+ + H+KG+
Sbjct: 58 LTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGI 117
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
+RDLKL+N++LD G+IKI+DFG+ ++ D T CG+P+Y+APE+L Y
Sbjct: 118 IYRDLKLDNVMLDRDGHIKIADFGMCK--ENVFGDNRASTFCGTPDYIAPEILQGLKYTF 175
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
+ D WS GV+LY +L G PF + L++ I P+W++ ++++L K+ E +
Sbjct: 176 SV-DWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERD 234
Query: 256 PVKRITIAG-IKADEWFE 272
P +R+ + G I+ +F+
Sbjct: 235 PTRRLGVVGNIRGHPFFK 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 1e-40
Identities = 88/291 (30%), Positives = 143/291 (49%), Gaps = 34/291 (11%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
+E+ + +G G FG+V +D D+G +A+K+L K+ +I ++ E L
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
P +V+L+ + +Y+V+EY+ GG+L + + K E R +L+ + H
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSA---------------LPQHFRDDGLLH---- 174
G HRD+K +NIL+D+ G+IK++DFGL FRD+ L+
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180
Query: 175 --------TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY 226
+T G+P+Y+APEVL Y D WS GVILY +L G+ PF L Y
Sbjct: 181 KQRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPFYSDTLQETY 239
Query: 227 QKI--FRGDFKLP--KWLSPGAQNLLRKILEPNPVKRITIA-GIKADEWFE 272
KI ++ + P +SP A +L+ ++L P R+ IK+ +F+
Sbjct: 240 NKIINWKESLRFPPDPPVSPEAIDLICRLLCD-PEDRLGSFEEIKSHPFFK 289
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 147 bits (371), Expect = 2e-40
Identities = 101/312 (32%), Positives = 158/312 (50%), Gaps = 20/312 (6%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI-ATLKLLKHPNVVR 78
+ +G+G+FGKV A+ G +AVK+L+K +++ K I E LK +KHP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
LH + K+Y VL++V GGELF + + E R ++ + Y H+ + +R
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
DLK ENILLDS+G++ ++DFGL D T CG+P Y+APEV+ + YD T
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTT--TFCGTPEYLAPEVIRKQPYDN-TV 177
Query: 199 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258
D W G +LY +L G PF R++A +Y I L S A ++L ++LE + +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQR 237
Query: 259 RI----TIAGIKADEWFEQ-DYT---------PANPD-DDEEDIFVDNEAFSMHEVPSDG 303
R+ I+ +FE +T P NP+ + +DI + F+ VP
Sbjct: 238 RLGAKEDFLEIQEHPFFESLSWTDLEQKKIPPPFNPNVEGPDDISNFDAVFTEETVPYSV 297
Query: 304 GRTPGSPPLINA 315
+ ++NA
Sbjct: 298 CFSSD-YSIVNA 308
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 1e-39
Identities = 72/228 (31%), Positives = 116/228 (50%), Gaps = 14/228 (6%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
+G+G +G+V A+ D+G A+K ++K+ + L + E L K +V+L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
+Y+ +EYV GG+ + + G L E R ++ + V H G HRDLK
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLK 128
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLL---HTTCGSPNYVAPEVLANRGYDGATS 198
EN L+D+ G+IK++DFGLS G++ ++ GSP+Y+APEVL +GYD T
Sbjct: 129 PENFLIDASGHIKLTDFGLSK--------GIVTYANSVVGSPDYMAPEVLRGKGYD-FTV 179
Query: 199 DIWSCGVILYVILTGYLPFDDRNLAVLYQKI--FRGDFKLPKWLSPGA 244
D WS G +LY L G+ PF ++ + ++ + P + P
Sbjct: 180 DYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRF 227
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 2e-39
Identities = 81/242 (33%), Positives = 127/242 (52%), Gaps = 7/242 (2%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI---KREIATLKLLKHPNVVR 78
LG G+FGKV A+ +G +A+K L+K II + + KR T +HP +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
L ++ + V+EY GG+L I E ++ G+ Y H + +R
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHENKIVYR 125
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
DLKL+N+LLD++G +KI+DFGL F D T CG+P ++APEVL Y A
Sbjct: 126 DLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR--TSTFCGTPEFLAPEVLTETSYTRAV- 182
Query: 199 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258
D W GV++Y +L G PF + ++ I + + P++LS A +++R++L NP +
Sbjct: 183 DWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRNPER 242
Query: 259 RI 260
R+
Sbjct: 243 RL 244
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 141 bits (359), Expect = 3e-39
Identities = 73/257 (28%), Positives = 115/257 (44%), Gaps = 25/257 (9%)
Query: 17 ELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
LG+ LGEG FG+V + + AVK L+++ ++ RE ++ L
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQI--EEFLREARIMRKLD 59
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID------- 125
HPNVV+L V + +Y+V+EY+ GG+L L++ + L+
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDL------LSYLRKNRPKLSLSDLLSFALQIAR 113
Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVA 184
G+ Y +K HRDL N L+ +KISDFGLS + DD P ++A
Sbjct: 114 GMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSR--DLYDDDYYRKRGGKLPIRWMA 171
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDF-KLPKWLSP 242
PE L + SD+WS GV+L+ I T G P+ + + + + G P P
Sbjct: 172 PESLKEGKFTSK-SDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPP 230
Query: 243 GAQNLLRKILEPNPVKR 259
+L+ + +P R
Sbjct: 231 ELYDLMLQCWAEDPEDR 247
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 141 bits (359), Expect = 3e-39
Identities = 75/261 (28%), Positives = 117/261 (44%), Gaps = 32/261 (12%)
Query: 17 ELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIK---REIATLK 69
LG+ LGEG FG+V + AVK L+++ QI+ RE ++
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKED-----ASEQQIEEFLREARIMR 56
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID--- 125
L HPN+V+L V + + +V+EY+ GG+L L++ ++L L+
Sbjct: 57 KLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDL------LDYLRKNRPKELSLSDLLSFAL 110
Query: 126 ----GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP- 180
G+ Y +K HRDL N L+ +KISDFGLS + DD P
Sbjct: 111 QIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSR--DLYDDDYYKVKGGKLPI 168
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDF-KLPK 238
++APE L + SD+WS GV+L+ I T G P+ + A + + + +G P
Sbjct: 169 RWMAPESLKEGKFTSK-SDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPP 227
Query: 239 WLSPGAQNLLRKILEPNPVKR 259
P L+ + +P R
Sbjct: 228 NCPPELYKLMLQCWAEDPEDR 248
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 141 bits (359), Expect = 3e-39
Identities = 71/224 (31%), Positives = 106/224 (47%), Gaps = 13/224 (5%)
Query: 17 ELGRTLGEGNFGKVK----FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
ELG+ LGEG FG+V + AVK L K + + E + +K L
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL-KEGASEEEREE-FLEEASIMKKLS 59
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCH 131
HPN+VRL V +Y+V EY+ GG+L D + +L + ++ Q+ G+ Y
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG--SPNYVAPEVLA 189
+K HRDL N L+ +KISDFGLS + DD G ++APE L
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLS--RDIYEDDYYRKRGGGKLPIKWMAPESLK 177
Query: 190 NRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG 232
+ + SD+WS GV+L+ I T G P+ + + + + G
Sbjct: 178 DGKFTSK-SDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDG 220
|
Length = 258 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 9e-39
Identities = 97/317 (30%), Positives = 138/317 (43%), Gaps = 70/317 (22%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT-DQIK----REIATLK 69
RYE G+ LGEG + V A+D ++G A+K K ++ K D I REI L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIK---KIKLGERKEAKDGINFTALREIKLLQ 57
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVS 128
LKHPN++ L +V KS I +V E++ +L I K L A+ + + G+
Sbjct: 58 ELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLE 116
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN------- 181
Y H+ + HRDLK N+L+ S G +K++DFGL+ + GSPN
Sbjct: 117 YLHSNWILHRDLKPNNLLIASDGVLKLADFGLA-------------RSFGSPNRKMTHQV 163
Query: 182 ----YVAPEVLANRGYDGATSDIWSCGVILYVILTG--YLPFDD--RNLAVLYQKIFR-- 231
Y APE+L + G D+WS G I +L +LP D L KIF
Sbjct: 164 VTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLG----KIFEAL 219
Query: 232 ---------GDFKLPKWL----SPG-------------AQNLLRKILEPNPVKRITIAGI 265
G LP ++ P A +LL+++L NP KRIT
Sbjct: 220 GTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQA 279
Query: 266 KADEWFEQDYTPANPDD 282
+F D P P
Sbjct: 280 LEHPYFSNDPAPTPPSQ 296
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 1e-38
Identities = 79/254 (31%), Positives = 139/254 (54%), Gaps = 7/254 (2%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+Y + +GEG+FGK + + G + +K + +++ K ++ ++E+A L +KHP
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-KEREESRKEVAVLSNMKHP 59
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRL-QEAEGRKLFQQLIDGVSYCHN 132
N+V+ E +Y+V++Y GG+L+ KI A +G L E + F Q+ + + H+
Sbjct: 60 NIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
+ + HRD+K +NI L G IK+ DFG++ + + L T G+P Y++PE+ NR
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--LARTCIGTPYYLSPEICENRP 177
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKI 251
Y+ SDIW+ G +LY + T F+ N+ L KI RG + + S +NL+ ++
Sbjct: 178 YNN-KSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQL 236
Query: 252 LEPNPVKRITIAGI 265
+ NP R ++ I
Sbjct: 237 FKRNPRDRPSVNSI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 2e-38
Identities = 90/263 (34%), Positives = 131/263 (49%), Gaps = 26/263 (9%)
Query: 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILE------KNRIIHLKITDQIKREIATLKLLK 72
G +G G+FG V + SG AVK +E ++ + D + REIA LK L+
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
H N+V+ + + LEYV GG + + + G +E R +Q++ G++Y HN
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC--------GSPNYVA 184
+G+ HRD+K NIL+D+KG IKISDFG+S + L T GS ++A
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFGISKKLEA----NSLSTKTNGARPSLQGSVFWMA 180
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR-GDFKLPKW---L 240
PEV+ Y DIWS G ++ +LTG PF D Q IF+ G+ P+ +
Sbjct: 181 PEVVKQTSYTRKA-DIWSLGCLVVEMLTGKHPFPDCT---QLQAIFKIGENASPEIPSNI 236
Query: 241 SPGAQNLLRKILEPNPVKRITIA 263
S A + L K E + KR T A
Sbjct: 237 SSEAIDFLEKTFEIDHNKRPTAA 259
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 7e-38
Identities = 79/263 (30%), Positives = 146/263 (55%), Gaps = 18/263 (6%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVR 78
R +G G++ KV + + +A+K+++K + + D ++ E + HP +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
LH ++S+++ V+E+V+GG+L + + +L E R ++ +++ H +G+ +R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD-GAT 197
DLKL+N+LLD++G+IK++D+G+ + R T CG+PNY+APE+L RG D G +
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPEIL--RGEDYGFS 176
Query: 198 SDIWSCGVILYVILTGYLPFD--------DRNLA-VLYQKIFRGDFKLPKWLSPGAQNLL 248
D W+ GV+++ ++ G PFD D+N L+Q I ++P+ LS A ++L
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVL 236
Query: 249 RKILEPNPVKRITIAGIKADEWF 271
+ L +P +R+ G F
Sbjct: 237 KGFLNKDPKERL---GCHPQTGF 256
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 2e-37
Identities = 80/287 (27%), Positives = 131/287 (45%), Gaps = 36/287 (12%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+ LG+G+ G+V + +G FA+K+L+K +I ++ E L L HP + L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 80 HEVLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
+ +++ + +V++Y GGELF + L E R +++ + Y H G+ +
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVY 126
Query: 138 RDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCGSPN------------- 181
RDLK ENILL G+I +SDF LS + L + S
Sbjct: 127 RDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPS 186
Query: 182 -----------YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF 230
Y+APEV++ G+ A D W+ G++LY +L G PF N + I
Sbjct: 187 FRSNSFVGTEEYIAPEVISGDGHGSAV-DWWTLGILLYEMLYGTTPFKGSNRDETFSNIL 245
Query: 231 RGDFKLPK--WLSPGAQNLLRKILEPNPVKRITIAG----IKADEWF 271
+ + P +S A++L+RK+L +P KR+ IK +F
Sbjct: 246 KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF 292
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 3e-37
Identities = 83/259 (32%), Positives = 134/259 (51%), Gaps = 18/259 (6%)
Query: 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-------HLKITDQIKREIATLKLL 71
G +G+G +G+V A ++ +G AVK +E I + ++ EI TLK L
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
H N+V+ ++ + + LEYV GG + + + GR +E R +Q+++G++Y H
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN- 190
+KG+ HRDLK +N+L+D+ G KISDFG+S D+ + GS ++APEV+ +
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY 185
Query: 191 -RGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAVLYQKIFRGDFKLP------KWLSP 242
+GY A DIWS G ++ + G P+ D+ +A ++ K+ P LSP
Sbjct: 186 SQGYS-AKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMF-KLGNKRSAPPIPPDVSMNLSP 243
Query: 243 GAQNLLRKILEPNPVKRIT 261
A + L NP R T
Sbjct: 244 VALDFLNACFTINPDNRPT 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 4e-37
Identities = 84/279 (30%), Positives = 138/279 (49%), Gaps = 28/279 (10%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E + + G +G V + ++ FA+K + K +I Q+ E L ++P
Sbjct: 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF 62
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
VV + +K + MV+EYV GG+ + + G L R F + + + Y HN G+
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGI 122
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSAL-----------------PQHFRDDGLLHTTCG 178
HRDLK +N+L+ S G+IK++DFGLS + + F D + CG
Sbjct: 123 VHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQV----CG 178
Query: 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK 238
+P Y+APEV+ +GY G D W+ G+ILY L G +PF L+ ++ D + P+
Sbjct: 179 TPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 237
Query: 239 W---LSPGAQNLLRKILEPNPVKRITIAG---IKADEWF 271
L AQ+L+ ++L NP++R+ G +K +F
Sbjct: 238 GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFF 276
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|213380 cd12195, CIPK_C, C-terminal regulatory domain of Calcineurin B-Like (CBL)-interacting protein kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 5e-37
Identities = 51/108 (47%), Positives = 74/108 (68%), Gaps = 3/108 (2%)
Query: 314 NAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKN-G 372
NAF LI +SS LDLSG FE+ED +R+ RFTS A++++E++E+ ++GFRV+KK G
Sbjct: 1 NAFDLISLSSGLDLSGLFEEEDEVKRETRFTSRKPAEEIIEKLEEAAKKLGFRVRKKKEG 60
Query: 373 KLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQI 420
+K E + G L+V+ EVFE++PSL VVE++KS GD Y +
Sbjct: 61 GVK--LEGQKGGRKGRLAVSVEVFEVTPSLVVVEVKKSAGDTLEYHKF 106
|
CIPKs are serine/threonine protein kinases (STKs), catalyzing the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. They comprise a unique family in higher plants of proteins that interact with the calcineurin B-like (CBL) calcium sensors to form a signaling network that decode specific calcium signals triggered by a variety of environmental stimuli including salinity, drought, cold, light, and mechanical perturbation, among others. The specificity of the response relies on differences in expression and localization of both CBLs and CIPKs, as well as on the interaction specificity of CBL-CIPK combinations. There are 25, 30, and 43 CIPK genes identified in the Arabidopsis thaliana, Oryza sativa, and Zea mays genomes, respectively. The founding member of the CIPK family is Arabidopsis thaliana CIPK24, also called SOS2 (Salt Overlay Sensitive 2). CIPKs contain an N-terminal catalytic kinase domain and a C-terminal regulatory domain that contains the FISL (also called NAF for Asn-Ala-Phe) and PPI-binding motifs, which are involved in the interaction with CBLs and PP2C-type protein phosphatases, respectively. Studies using SOS2, SOS3, and ABI2 phosphatase show that the binding of CBL and PP2C-type protein phosphatase to CIPK is mutually exclusive. The binding of CBL to CIPK is inhibitory to kinase activity. Length = 116 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 135 bits (340), Expect = 1e-36
Identities = 83/248 (33%), Positives = 129/248 (52%), Gaps = 8/248 (3%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+Y + R +GEG+FG+ Q ++S +A+K + + + ++E L +KHP
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSS--AVEDSRKEAVLLAKMKHP 58
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIA-SKGRL-QEAEGRKLFQQLIDGVSYCHN 132
N+V E + +Y+V+EY GG+L KI +G+L E + F Q+ GV + H
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
K V HRD+K +NI L G +K+ DFG + L T G+P YV PE+ N
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS--PGAYACTYVGTPYYVPPEIWENMP 176
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRKI 251
Y+ SDIWS G ILY + T PF + L K+ +G +K LP S ++L++++
Sbjct: 177 YNN-KSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQM 235
Query: 252 LEPNPVKR 259
+ NP R
Sbjct: 236 FKRNPRSR 243
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (341), Expect = 1e-36
Identities = 78/263 (29%), Positives = 121/263 (46%), Gaps = 23/263 (8%)
Query: 20 RTLGEGNFGKVKFA---QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+ LGEG FG+V AVK L K + D +E +K L HPNV
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL-KEDASEEERKD-FLKEARVMKKLGHPNV 58
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLID-------GV 127
VRL V + +Y+VLEY+ GG+L D + + + + + L+ G+
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG-SPN-YVAP 185
Y +K HRDL N L+ +KISDFGLS + DD T G P ++AP
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLS--RDVYDDDYYRKKTGGKLPIRWMAP 176
Query: 186 EVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSP 242
E L + + SD+WS GV+L+ I T G P+ + + + + +G ++L P++
Sbjct: 177 ESLKDGIFTSK-SDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG-YRLPKPEYCPD 234
Query: 243 GAQNLLRKILEPNPVKRITIAGI 265
L+ + +P R T + +
Sbjct: 235 ELYELMLSCWQLDPEDRPTFSEL 257
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 2e-36
Identities = 78/251 (31%), Positives = 141/251 (56%), Gaps = 13/251 (5%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVR 78
R +G G++ KV + + +A+K+++K + + D ++ E + HP +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
LH ++S+++ V+EYV GG+L + + +L E R ++ ++Y H +G+ +R
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
DLKL+N+LLDS+G+IK++D+G+ + R T CG+PNY+APE+L Y G +
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSV 177
Query: 199 DIWSCGVILYVILTGYLPFD--------DRNLA-VLYQKIFRGDFKLPKWLSPGAQNLLR 249
D W+ GV+++ ++ G PFD D+N L+Q I ++P+ LS A ++L+
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 237
Query: 250 KILEPNPVKRI 260
L +P +R+
Sbjct: 238 SFLNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 7e-36
Identities = 77/283 (27%), Positives = 118/283 (41%), Gaps = 40/283 (14%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVK---ILEKNRIIHLKITDQIKREIATLKL 70
+YE+ +GEG +G V ++ +G A+K E + + RE+ L+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTAL----REVKVLRQ 56
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
L+H N+V L E K ++Y+V EYV L AS G L R QL+ ++YC
Sbjct: 57 LRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYC 116
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
H+ + HRD+K ENIL+ G +K+ DFG A R L + Y APE+L
Sbjct: 117 HSHNIIHRDIKPENILVSESGVLKLCDFGF-ARALRARPASPLTDYVATRWYRAPELLVG 175
Query: 191 RGYDGATSDIWSCGVI-------------------LYVILTGYLPFDDRNLAVLYQ-KIF 230
G D+W+ G I LY+I P + + F
Sbjct: 176 DTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235
Query: 231 RG------------DFKLPKWLSPGAQNLLRKILEPNPVKRIT 261
G + + P +S A + L+ L +P +R+T
Sbjct: 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLT 278
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 7e-36
Identities = 76/248 (30%), Positives = 129/248 (52%), Gaps = 19/248 (7%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVK--ILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+GEG G+V A D +G A+K L K + I EI +K KHPN+V
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNK------ELIINEILIMKDCKHPNIVDY 80
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
++ ++++V+EY+ GG L D I + R+ E + + ++++ G+ Y H++ V HR
Sbjct: 81 YDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHR 140
Query: 139 DLKLENILLDSKGNIKISDFGLSAL--PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 196
D+K +NILL G++K++DFG +A + + ++ G+P ++APEV+ + Y
Sbjct: 141 DIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR----NSVVGTPYWMAPEVIKRKDYGPK 196
Query: 197 TSDIWSCGVILYVILTGYLP-FDDRNLAVLYQKIFRG--DFKLPKWLSPGAQNLLRKILE 253
DIWS G++ + G P + L L+ +G K P+ SP ++ L K L
Sbjct: 197 V-DIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLV 255
Query: 254 PNPVKRIT 261
+P KR +
Sbjct: 256 KDPEKRPS 263
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 1e-35
Identities = 72/248 (29%), Positives = 127/248 (51%), Gaps = 9/248 (3%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E+ +G+G+FG V +A+K ++ +++ + + I E L L
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAI-DEARVLAKLDSSY 60
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNK 133
++R +E K K+ +V+EY G+L + L E + + F Q++ G+++ H+K
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL-HTTCGSPNYVAPEVLANRG 192
+ HRD+K N+ LD+ N+KI D G++ L D+ +T G+P Y++PE+ ++
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKL---LSDNTNFANTIVGTPYYLSPELCEDKP 177
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRKI 251
Y+ SD+W+ GV+LY TG PFD N L KI RG F + + S L+ +
Sbjct: 178 YN-EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQC 236
Query: 252 LEPNPVKR 259
L + +R
Sbjct: 237 LTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 1e-35
Identities = 81/254 (31%), Positives = 126/254 (49%), Gaps = 10/254 (3%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
LG+G FG+V Q +G +A K L+K R+ K E L+ + +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGVSYCHNKGVFHRD 139
+K + +V+ + GG+L I + G E R +F Q+I G+ + H + + +RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 199
LK EN+LLD GN++ISD GL+ + + G+P Y+APEVL YD + D
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAV---ELKGGKKIKGRAGTPGYMAPEVLQGEVYD-FSVD 176
Query: 200 IWSCGVILYVILTGYLPFDDRNLAV----LYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
++ G LY ++ G PF R V L ++ + P SP A++L +L+ +
Sbjct: 177 WFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236
Query: 256 PVKRITIAGIKADE 269
P KR+ G ADE
Sbjct: 237 PEKRLGCRGGSADE 250
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 1e-35
Identities = 82/244 (33%), Positives = 133/244 (54%), Gaps = 8/244 (3%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-ITDQI-KREIATLKLLKH-PNVVR 78
+G+G FG+V + D+ +A+K+L K I+ K + I +R I LL P +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
L + S +Y+V +Y++GGELF + +GR E + +L+ + + H + +R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN-RGYDGAT 197
DLK ENILLD+ G+I + DFGLS + D+ +T CG+ Y+APEVL + +GY
Sbjct: 121 DLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLDEKGY-TKH 177
Query: 198 SDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK-WLSPGAQNLLRKILEPNP 256
D WS GV+++ + G+ PF + +Y+ I G + PK LS + ++ +L NP
Sbjct: 178 VDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNP 237
Query: 257 VKRI 260
R+
Sbjct: 238 QHRL 241
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 4e-35
Identities = 74/249 (29%), Positives = 139/249 (55%), Gaps = 11/249 (4%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVR 78
R +G G++ KV + + +A+K+++K + + D ++ E + +P +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
LH + S++++V+EYV GG+L + + +L E R ++ +++ H +G+ +R
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
DLKL+N+LLD+ G+IK++D+G+ + T CG+PNY+APE+L Y G +
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSV 177
Query: 199 DIWSCGVILYVILTGYLPFD------DRNLA-VLYQKIFRGDFKLPKWLSPGAQNLLRKI 251
D W+ GV+++ ++ G PFD D N L+Q I ++P++LS A ++L+
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF 237
Query: 252 LEPNPVKRI 260
L +P +R+
Sbjct: 238 LNKDPKERL 246
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 4e-35
Identities = 78/258 (30%), Positives = 122/258 (47%), Gaps = 9/258 (3%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+YE R +G G FG V + +K + ++ + E LKLL HP
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHP 59
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHN 132
N++ +E + +V+EY GG L + I + L E F Q++ + + H
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT 119
Query: 133 KGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
K + HRDLK +NILLD + KI DFG+S + +T G+P Y++PE+ +
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKI---LSSKSKAYTVVGTPCYISPELCEGK 176
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRK 250
Y+ SDIW+ G +LY + + F+ NL L KI G F + SP + L+
Sbjct: 177 PYN-QKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILS 235
Query: 251 ILEPNPVKRITIAGIKAD 268
+L +P KR ++ I A
Sbjct: 236 MLNLDPSKRPQLSQIMAQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 5e-35
Identities = 85/300 (28%), Positives = 127/300 (42%), Gaps = 50/300 (16%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+T+G G FG+V + +D+ +A+K L K ++ +K E L + VV+L
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
+ K +Y V++Y+ GG++ + G +E R +L + H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRD 126
Query: 140 LKLENILLDSKGNIKISDFGLSA------------LPQHFRDDG---------------- 171
+K +NIL+D G+IK++DFGL H R D
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLK 186
Query: 172 -------------LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD 218
L H+ G+PNY+APEVL GY D WS GVILY +L G PF
Sbjct: 187 PLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQPPFL 245
Query: 219 DRNLAVLYQKI--FRGDFKLPKW--LSPGAQNLLRKILEPNPVKRI---TIAGIKADEWF 271
A K+ + +P LS A +L+ + L R+ IKA +F
Sbjct: 246 ADTPAETQLKVINWETTLHIPSQAKLSREASDLILR-LCCGAEDRLGKNGADEIKAHPFF 304
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 6e-35
Identities = 82/285 (28%), Positives = 125/285 (43%), Gaps = 51/285 (17%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLLKH 73
Y+ +GEG +G V A+D +G A+K K ++ REI LK L H
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIK---KIKLRFESEGIPKTALREIKLLKELNH 57
Query: 74 PNVVRLHEVLASKSKIYMVLEYV-TGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
PN+++L +V K +Y+V E++ T K +G L E+ + QL+ G+++CH+
Sbjct: 58 PNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRG-LPESLIKSYLYQLLQGLAFCHS 116
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV------APE 186
G+ HRDLK EN+L++++G +K++DFGL+ F +T +YV APE
Sbjct: 117 HGILHRDLKPENLLINTEGVLKLADFGLARS---FGSPVRPYT-----HYVVTRWYRAPE 168
Query: 187 VLANRGYDGATSDIWSCGVILYVILTG--YLPFDD-----------------RNLAVLYQ 227
+L DIWS G I +L+ P
Sbjct: 169 LLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS 228
Query: 228 KIFRGDFKLPKW-----------LSPGAQNLLRKILEPNPVKRIT 261
F PK SP A +LL ++L +P KRIT
Sbjct: 229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRIT 273
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 9e-35
Identities = 71/252 (28%), Positives = 124/252 (49%), Gaps = 12/252 (4%)
Query: 19 GRTLGEGNFGKVKFAQDLDSGLPFAVK---ILEKNRIIHLKITDQIKREIATLKLLKHPN 75
G+ LG G F A+D+ +G AVK + ++ + +++EI + L HP+
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
++R+ S + +E++ GG + ++ G +EA +QL+ G+SY H +
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQI 124
Query: 136 FHRDLKLENILLDSKGN-IKISDFGLSA-LPQHFRDDGLLH-TTCGSPNYVAPEVLANRG 192
HRD+K N+L+DS G ++I+DFG +A L G G+ ++APEVL
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ 184
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR-----GDFKLPKWLSPGAQNL 247
Y G + D+WS G ++ + T P++ + IF+ +P+ LSPG +++
Sbjct: 185 Y-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDV 243
Query: 248 LRKILEPNPVKR 259
+ LE P R
Sbjct: 244 TLRCLELQPEDR 255
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 91/300 (30%), Positives = 149/300 (49%), Gaps = 45/300 (15%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E + +G G FG+V+ Q D+G +A+K L K+ ++ + ++ E L +P
Sbjct: 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW 62
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
VV+L+ ++ +Y+++EY+ GG++ + K E E R + I + H G
Sbjct: 63 VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGY 122
Query: 136 FHRDLKLENILLDSKGNIKISDFGLS-----------------ALPQHFRDD-------- 170
HRD+K +N+LLD+KG+IK+SDFGL ALP +F D
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182
Query: 171 -----------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD 219
L ++T G+P+Y+APEV GY D WS GVI+Y +L GY PF
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPFCS 241
Query: 220 RNLAVLYQKI--FRGDFKLPK--WLSPGAQNLLRKILEPNPVKRITIAG---IKADEWFE 272
N Y+KI ++ + P LSP A++L++++ +R+ G IK+ +F+
Sbjct: 242 DNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLC-CEAERRLGNNGVNEIKSHPFFK 300
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 2e-34
Identities = 73/250 (29%), Positives = 125/250 (50%), Gaps = 16/250 (6%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+++ LGEG++G V A ++G A+K++ + +I +EI+ LK P
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQ-----EIIKEISILKQCDSPY 59
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
+V+ + + +++V+EY G + D KI +K L E E + Q + G+ Y H+
Sbjct: 60 IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLHSN 118
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 193
HRD+K NILL+ +G K++DFG+S Q +T G+P ++APEV+ GY
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSG--QLTDTMAKRNTVIGTPFWMAPEVIQEIGY 176
Query: 194 DGATSDIWSCGVILYVILTGYLPFDD----RNLAVLYQKIFRGDFKLPKWLSPGAQNLLR 249
+ DIWS G+ + G P+ D R + ++ K P+ SP + ++
Sbjct: 177 NNKA-DIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPT-LSDPEKWSPEFNDFVK 234
Query: 250 KILEPNPVKR 259
K L +P +R
Sbjct: 235 KCLVKDPEER 244
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 4e-34
Identities = 83/259 (32%), Positives = 142/259 (54%), Gaps = 16/259 (6%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
RYE+ + +GEG+FGK+ A+ +K ++ ++ +K + K+E+ L +KHP
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMKHP 59
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL--FQQLIDGVSYCHN 132
N+V ++++V+EY GG+L +I + + +E + L F Q+ G+ + H+
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 133 KGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTC-GSPNYVAPEVLAN 190
+ + HRD+K +NI L G + K+ DFG++ + D L TC G+P Y++PE+ N
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIA---RQLNDSMELAYTCVGTPYYLSPEICQN 176
Query: 191 RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPG----AQN 246
R Y+ T DIWS G +LY + T PF+ NL L KI +G F P +SP ++
Sbjct: 177 RPYNNKT-DIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA-P--ISPNFSRDLRS 232
Query: 247 LLRKILEPNPVKRITIAGI 265
L+ ++ + +P R +I I
Sbjct: 233 LISQLFKVSPRDRPSITSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 8e-34
Identities = 91/318 (28%), Positives = 134/318 (42%), Gaps = 70/318 (22%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKL 70
+L YE+ LGEG FG+V A+ + +G A+K IL N IT REI LK
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITAL--REIKILKK 63
Query: 71 LKHPNVVRLHEVLASKSK--------IYMVLEYVT---GGELFDKIASKGRLQEAEGRKL 119
LKHPNVV L ++ + +YMV Y+ G L + +L E++ +
Sbjct: 64 LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENP---SVKLTESQIKCY 120
Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179
QL++G++Y H + HRD+K NIL+D++G +KI+DFGL+ + + G
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLA---RPYDGPPPNPKGGGG 177
Query: 180 PN------------YVAPE-VLANRGYDGATSDIWSCGVILYVILTG--YLP-FDDRNLA 223
Y PE +L R Y A DIW G + + T L D +
Sbjct: 178 GGTRKYTNLVVTRWYRPPELLLGERRYTTAV-DIWGIGCVFAEMFTRRPILQGKSDIDQL 236
Query: 224 VLYQKIFR-----GDFKLPKWLS-PGAQN------------------------LLRKILE 253
IF+ + P W S PG + LL K+L
Sbjct: 237 ---HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLS 293
Query: 254 PNPVKRITIAGIKADEWF 271
+P KR+T + +F
Sbjct: 294 LDPYKRLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 3e-33
Identities = 81/262 (30%), Positives = 134/262 (51%), Gaps = 21/262 (8%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR---EIATLKLLKHPNVVR 78
LG+G FGKV AQ ++GL A KI I ++ ++++ EI L KHPN+V
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKI------IQIESEEELEDFMVEIDILSECKHPNIVG 66
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKGVFH 137
L+E ++K+++++E+ GG L + R L E + R + +Q+++ +++ H+ V H
Sbjct: 67 LYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIH 126
Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA-----NRG 192
RDLK NILL G++K++DFG+SA + T G+P ++APEV+A +
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKS--TLQKRDTFIGTPYWMAPEVVACETFKDNP 184
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGAQNLLR 249
YD +DIWS G+ L + P + N + KI + + P S + L+
Sbjct: 185 YD-YKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLK 243
Query: 250 KILEPNPVKRITIAGIKADEWF 271
L +P R T A + +
Sbjct: 244 SCLVKDPDDRPTAAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 3e-33
Identities = 88/266 (33%), Positives = 134/266 (50%), Gaps = 31/266 (11%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL--------EKNRIIHLKITDQIKREIA 66
+Y + R LG G G V A+ + G PFAVK++ +KNR + E+
Sbjct: 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRA---------QAEVC 83
Query: 67 TLKLLKHPNVVRLHEVLASK--------SKIYMVLEYVTGGELFDKIASKGR----LQEA 114
L ++V+ HE A K I +VL+Y G+L +I S+ + +E
Sbjct: 84 CLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREH 143
Query: 115 EGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH 174
E LF Q++ V + H+K + HRD+K NILL S G +K+ DFG S + D +
Sbjct: 144 EAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGR 203
Query: 175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF 234
T CG+P YVAPE+ + Y +D++S GV+LY +LT PFD N+ + K G +
Sbjct: 204 TFCGTPYYVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY 262
Query: 235 K-LPKWLSPGAQNLLRKILEPNPVKR 259
LP +SP Q ++ +L +P +R
Sbjct: 263 DPLPPSISPEMQEIVTALLSSDPKRR 288
|
Length = 496 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 4e-33
Identities = 80/262 (30%), Positives = 130/262 (49%), Gaps = 13/262 (4%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
LG +++ + +G+G F V A L G A+K ++ ++ K +EI LK L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGEL---FDKIASKGRL-QEAEGRKLFQQLIDGVS 128
HPNV++ +++ +VLE G+L + RL E K F QL +
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL-LHTTCGSPNYVAPEV 187
+ H+K + HRD+K N+ + + G +K+ D GL + F H+ G+P Y++PE
Sbjct: 121 HMHSKRIMHRDIKPANVFITATGVVKLGDLGLG---RFFSSKTTAAHSLVGTPYYMSPER 177
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPF--DDRNLAVLYQKIFRGDFK-LPK-WLSPG 243
+ GY+ SDIWS G +LY + PF D NL L +KI + D+ LP S
Sbjct: 178 IHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEE 236
Query: 244 AQNLLRKILEPNPVKRITIAGI 265
++L+ + + P+P KR I+ +
Sbjct: 237 LRDLVSRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-32
Identities = 85/263 (32%), Positives = 135/263 (51%), Gaps = 29/263 (11%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ-----IKREIATLK 69
YEL + +G G +G V A+D+ +G A+K++ K+ I++EI+ LK
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVI--------KLEPGDDFEIIQQEISMLK 55
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVS 128
+HPN+V + K+++V+EY GG L D ++G L E + + ++ + G++
Sbjct: 56 ECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLA 115
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
Y H G HRD+K NILL G++K++DFG+SA Q + G+P ++APEV
Sbjct: 116 YLHETGKIHRDIKGANILLTEDGDVKLADFGVSA--QLTATIAKRKSFIGTPYWMAPEVA 173
Query: 189 ANR---GYDGATSDIWSCGVILYVILTGYLP-FDDRNLAVLYQKIFRGDFKLP------K 238
A GYDG DIW+ G+ + P FD + L+ I + +F P K
Sbjct: 174 AVERKGGYDGK-CDIWALGITAIELAELQPPMFDLHPMRALFL-ISKSNFPPPKLKDKEK 231
Query: 239 WLSPGAQNLLRKILEPNPVKRIT 261
W SP + ++K L +P KR T
Sbjct: 232 W-SPVFHDFIKKCLTKDPKKRPT 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 87/301 (28%), Positives = 131/301 (43%), Gaps = 75/301 (24%)
Query: 24 EGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK-------REIATLKLLKHPNV 76
EG +G V A+D +G A+K LK+ + + REI L L+HPN+
Sbjct: 15 EGTYGVVYRARDKKTGEIVALK--------KLKMEKEKEGFPITSLREINILLKLQHPNI 66
Query: 77 VRLHEVLASKS--KIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNK 133
V + EV+ + KIYMV+EYV +L + + K ++E + L QL+ GV++ H+
Sbjct: 67 VTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN 125
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN-----------Y 182
+ HRDLK N+LL+++G +KI DFGL+ R+ GSP Y
Sbjct: 126 WILHRDLKTSNLLLNNRGILKICDFGLA------RE-------YGSPLKPYTQLVVTLWY 172
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR----------- 231
APE+L D+WS G I +LT F ++ KIF+
Sbjct: 173 RAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWP 232
Query: 232 GDFKLPKW---------------------LSPGAQNLLRKILEPNPVKRITIAGIKADEW 270
G +LP LS +LL ++L +P KRI+ +
Sbjct: 233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292
Query: 271 F 271
F
Sbjct: 293 F 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 4e-32
Identities = 89/291 (30%), Positives = 138/291 (47%), Gaps = 55/291 (18%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIATLKLLKHPNVV 77
LGEG + V ++ +G A+K IHL + REI+ +K LKH N+V
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKE------IHLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 78 RLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
RLH+V+ +++K+ +V EY+ + D +G L + QL+ G+++CH V
Sbjct: 62 RLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRV 121
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----YVAPEVL-AN 190
HRDLK +N+L++ +G +K++DFGL+ R G+ T + Y AP+VL +
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLA------RAFGIPVNTFSNEVVTLWYRAPDVLLGS 175
Query: 191 RGYDGATS-DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR-----------GDFKLPK 238
R Y +TS DIWS G I+ ++TG F N KIFR G +LP+
Sbjct: 176 RTY--STSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233
Query: 239 W------------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271
+ P +LL ++L+ NP RI+ WF
Sbjct: 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 4e-32
Identities = 90/283 (31%), Positives = 134/283 (47%), Gaps = 59/283 (20%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ------IKREIATLKLLKHPN 75
+GEG +G V A+D +G A+K I L+ D+ I REI+ LK L HPN
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKK------IRLETEDEGVPSTAI-REISLLKELNHPN 59
Query: 76 VVRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
+VRL +V+ S++K+Y+V E++ + D G L + QL+ G++YCH+
Sbjct: 60 IVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTG-LDPPLIKSYLYQLLQGIAYCHSH 118
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL-----LHTTCGSPNYVAPEVL 188
V HRDLK +N+L+D +G +K++DFGL+ R G+ H + Y APE+L
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLA------RAFGVPVRTYTHEVV-TLWYRAPEIL 171
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAVLYQKIFR---------------- 231
DIWS G I ++ F D + L+ +IFR
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLF-RIFRTLGTPDEDVWPGVTSL 230
Query: 232 GDFK--LPKW-----------LSPGAQNLLRKILEPNPVKRIT 261
D+K PKW L +LL K+L +P KRI+
Sbjct: 231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRIS 273
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 5e-32
Identities = 66/210 (31%), Positives = 110/210 (52%), Gaps = 16/210 (7%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-----ITDQIKREIATLK 69
+ L +G+G+FG+V A D + A+K+ I L+ I D I++EI L
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKV------IDLEEAEDEIED-IQQEIQFLS 54
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
+ P + + + SK+++++EY GG D + G+L E + ++++ G+ Y
Sbjct: 55 QCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP-GKLDETYIAFILREVLLGLEY 113
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
H +G HRD+K NILL +G++K++DFG+S Q +T G+P ++APEV+
Sbjct: 114 LHEEGKIHRDIKAANILLSEEGDVKLADFGVSG--QLTSTMSKRNTFVGTPFWMAPEVIK 171
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFDD 219
GYD +DIWS G+ + G P D
Sbjct: 172 QSGYDEK-ADIWSLGITAIELAKGEPPLSD 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 5e-32
Identities = 79/244 (32%), Positives = 130/244 (53%), Gaps = 8/244 (3%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL--EKNRIIHLKITDQIKREIATLKLLKH 73
+ LG+ LG G FG+V D D+G AVK + + + K + ++ EI LK L+H
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 74 PNVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
+V+ + L + K+ + +EY+ GG + D++ + G L E R+ +Q++ GVSY H
Sbjct: 64 DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH 123
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL-LHTTCGSPNYVAPEVLAN 190
+ + HRD+K NIL DS GN+K+ DFG S Q G + + G+P +++PEV++
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG 183
Query: 191 RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK--LPKWLSPGAQNLL 248
GY G +D+WS + +LT P+ + KI K LP +S ++ L
Sbjct: 184 EGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFL 242
Query: 249 RKIL 252
++I
Sbjct: 243 KQIF 246
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 1e-31
Identities = 77/241 (31%), Positives = 131/241 (54%), Gaps = 8/241 (3%)
Query: 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILE--KNRIIHLKITDQIKREIATLKLLKHPNV 76
G+ LG+G FG+V D+D+G A K ++ K ++ EI LK L+H +
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 77 VRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
V+ + L +++ + + +EY+ GG + D++ + G L E+ RK +Q+++G+SY H+
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM 126
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL-LHTTCGSPNYVAPEVLANRGY 193
+ HRD+K NIL DS GN+K+ DFG S Q G + + G+P +++PEV++ GY
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGY 186
Query: 194 DGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR--GDFKLPKWLSPGAQNLLRKI 251
G +D+WS G + +LT P+ + KI + +LP +S A++ L I
Sbjct: 187 -GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFLGCI 245
Query: 252 L 252
Sbjct: 246 F 246
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 2e-31
Identities = 79/244 (32%), Positives = 135/244 (55%), Gaps = 8/244 (3%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKN--RIIHLKITDQIKREIATLKLLKH 73
+ LG+ LG+G FG+V D D+G AVK ++ + K + ++ EI LK L H
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 74 PNVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
+V+ + L + + + +E++ GG + D++ S G L E RK +Q+++GVSY H
Sbjct: 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH 123
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL-LHTTCGSPNYVAPEVLAN 190
+ + HRD+K NIL DS GN+K+ DFG S Q G + + G+P +++PEV++
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183
Query: 191 RGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFR-GDFKLPKWLSPGAQNLL 248
GY G +DIWS G + +LT P+ + +A +++ + + LP +S ++ L
Sbjct: 184 EGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFL 242
Query: 249 RKIL 252
++I
Sbjct: 243 KRIF 246
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 7e-31
Identities = 83/284 (29%), Positives = 137/284 (48%), Gaps = 41/284 (14%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
+GEG +G V A++ +G A+K + + + I REI+ LK L HPN+V+L +
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 66
Query: 82 VLASKSKIYMVLEYVTGG-ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL 140
V+ +++K+Y+V E++ + F + + + QL+ G+++CH+ V HRDL
Sbjct: 67 VIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 126
Query: 141 KLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----YVAPEVLANRGYDGA 196
K +N+L++++G IK++DFGL+ R G+ T Y APE+L Y
Sbjct: 127 KPQNLLINTEGAIKLADFGLA------RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 180
Query: 197 TSDIWSCGVILYVILT--GYLPFDD---------RNLAVLYQKIFRG-----DFK--LPK 238
DIWS G I ++T P D R L + ++ G D+K PK
Sbjct: 181 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPK 240
Query: 239 W-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271
W L ++LL ++L +P KRI+ A +F
Sbjct: 241 WARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 8e-31
Identities = 81/263 (30%), Positives = 129/263 (49%), Gaps = 25/263 (9%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLKLLKH 73
YEL +G G V A L + A+K LEK + D++++E+ + H
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTS----VDELRKEVQAMSQCNH 58
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK---GRLQEAEGRKLFQQLIDGVSYC 130
PNVV+ + ++++V+ Y++GG L D + S G L EA + ++++ G+ Y
Sbjct: 59 PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG-----LLHTTCGSPNYVAP 185
H+ G HRD+K NILL G++KI+DFG+SA D G + T G+P ++AP
Sbjct: 119 HSNGQIHRDIKAGNILLGEDGSVKIADFGVSAS---LADGGDRTRKVRKTFVGTPCWMAP 175
Query: 186 EVLAN-RGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGDFKLP-----K 238
EV+ GYD +DIWS G+ + TG P+ + VL + L K
Sbjct: 176 EVMEQVHGYD-FKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYK 234
Query: 239 WLSPGAQNLLRKILEPNPVKRIT 261
S + ++ L+ +P KR T
Sbjct: 235 KYSKSFRKMISLCLQKDPSKRPT 257
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 2e-30
Identities = 65/204 (31%), Positives = 107/204 (52%), Gaps = 27/204 (13%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK-REI-ATLKLLKH 73
Y++ + LG+G FG V A++ ++G A+K + K + + + + RE+ + KL +H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKM-KKKFYSWE--ECMNLREVKSLRKLNEH 57
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGR-LQEAEGRKLFQQLIDGVSYCH 131
PN+V+L EV ++Y V EY+ G L+ + KG+ E+ R + Q++ G+++ H
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYV------ 183
G FHRDLK EN+L+ +KI+DFGL+ R P +YV
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFGLA------R-----EIRSRPPYTDYVSTRWYR 165
Query: 184 APEVLANRGYDGATSDIWSCGVIL 207
APE+L + DIW+ G I+
Sbjct: 166 APEILLRSTSYSSPVDIWALGCIM 189
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 85/282 (30%), Positives = 144/282 (51%), Gaps = 29/282 (10%)
Query: 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI----KREIA 66
M+ +++ + +G G FG+V+ + S +A+K+L K +I K +D +R+I
Sbjct: 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI--KRSDSAFFWEERDI- 96
Query: 67 TLKLLKHPN---VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL 123
+ H N +V+LH +YMV+EY+ GG+L + + S + E R ++
Sbjct: 97 ----MAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTAEV 151
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH--TTCGSPN 181
+ + H+ G HRD+K +N+LLD G++K++DFG +G++ T G+P+
Sbjct: 152 VLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM---KMDANGMVRCDTAVGTPD 208
Query: 182 YVAPEVLANRGYD---GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF--RGDFKL 236
Y++PEVL ++G D G D WS GV LY +L G PF +L Y KI +
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTF 268
Query: 237 PK--WLSPGAQNLLRKILEPNPVK--RITIAGIKADEWFEQD 274
P +S A++L+ L V+ R + IK+ +F+ D
Sbjct: 269 PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-30
Identities = 68/257 (26%), Positives = 124/257 (48%), Gaps = 15/257 (5%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+ L R LG G FG+V + + A+KIL+ + ++ ++E+ LK L+H +
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNR-VRVAIKILKSDDLLKQ---QDFQKEVQALKRLRHKH 63
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGR-LQEAEGRKLFQQLIDGVSYCHNK 133
++ L V + +Y++ E + G L + S +G+ L A + Q+ +G++Y +
Sbjct: 64 LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRG 192
HRDL NIL+ K++DFGL+ L ++D L + P + APE A+ G
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARL---IKEDVYLSSDKKIPYKWTAPEA-ASHG 179
Query: 193 YDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKWLS--PGAQNLLR 249
SD+WS G++LY + T G +P+ N +Y +I G +++P ++
Sbjct: 180 TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG-YRMPCPAKCPQEIYKIML 238
Query: 250 KILEPNPVKRITIAGIK 266
+ P R + ++
Sbjct: 239 ECWAAEPEDRPSFKALR 255
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 95/312 (30%), Positives = 132/312 (42%), Gaps = 68/312 (21%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+TLG G FG+V A+ +D+ +A+K L K ++ +K E L + VVRL
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
+ K +Y V++Y+ GG++ + G E R +L V H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRD 126
Query: 140 LKLENILLDSKGNIKISDFGL---------SALPQ---HFRDDG---------------- 171
+K +NIL+D G+IK++DFGL S Q H R D
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCG 186
Query: 172 -----------------LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 214
L H+ G+PNY+APEVL GY D WS GVILY +L G
Sbjct: 187 DRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQ 245
Query: 215 LPFDDRNLAVLYQKIFRGDFKLPKW-----------LSPGAQNLLRKILEPNPVKRITIA 263
PF L Q K+ W LSP A +L+ K+ P R+
Sbjct: 246 PPF-------LAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCR-GPEDRLGKN 297
Query: 264 G---IKADEWFE 272
G IKA +F+
Sbjct: 298 GADEIKAHPFFK 309
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 2e-30
Identities = 86/259 (33%), Positives = 132/259 (50%), Gaps = 13/259 (5%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKI--TDQIKREIATLKLLK 72
RY L + LG+G+FG V +D + +K+L++ + L T Q +E L L
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIA----SKGRLQEAEGRKLFQQLIDGVS 128
HP +V+ H + ++ EY G +L K+ + L E + + F QL+ GV
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 129 YCHNKGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
Y H + + HRDLK +NI L K N+ KI DFG+S L D L T G+P Y++PE
Sbjct: 121 YMHQRRILHRDLKAKNIFL--KNNLLKIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEA 176
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQN 246
L ++GYD + SDIWS G ILY + F+ +N + +I G LP+ S +
Sbjct: 177 LKHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNS 235
Query: 247 LLRKILEPNPVKRITIAGI 265
+++ +L +P R + A I
Sbjct: 236 IMQSMLNKDPSLRPSAAEI 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 3e-30
Identities = 97/324 (29%), Positives = 132/324 (40%), Gaps = 90/324 (27%)
Query: 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--------REIATLK 69
L R +GEG +G V A+D SG A+K K R D + REI L
Sbjct: 12 LNR-IGEGTYGIVYRARDTTSGEIVALK---KVR------MDNERDGIPISSLREITLLL 61
Query: 70 LLKHPNVVRLHEVLASKS--KIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLID 125
L+HPN+V L EV+ K I++V+EY L D + + E++ + L QL+
Sbjct: 62 NLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSESQVKCLMLQLLR 119
Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCGSPN- 181
G+ Y H + HRDLK+ N+LL KG +KI+DFGL+ LP +P
Sbjct: 120 GLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM----------TPKV 169
Query: 182 ----YVAPEVL-ANRGYDGATSDIWSCGVILYVILTG--YLP------------------ 216
Y APE+L Y A D+W+ G IL +L LP
Sbjct: 170 VTLWYRAPELLLGCTTYTTAI-DMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTP 228
Query: 217 -------FDDRNLAVLYQKIFRGDFKLPK-----------WLSPGAQNLLRKILEPNPVK 258
F D L G F LPK WLS LL +L +P K
Sbjct: 229 NESIWPGFSDLPLV--------GKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKK 280
Query: 259 RITIAGIKADEWFEQDYTPANPDD 282
R T +F++ P P+
Sbjct: 281 RATAEEALESSYFKEKPLPCEPEM 304
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 3e-30
Identities = 86/293 (29%), Positives = 134/293 (45%), Gaps = 56/293 (19%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLLKH 73
+++ +GEG +G+V A+D D+G A+K K R+ + K I REI L+ L H
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALK---KVRLDNEKEGFPITAIREIKILRQLNH 65
Query: 74 PNVVRLHEVLASKSK----------IYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQ 122
N+V L E++ K Y+V EY+ +L + S E + +Q
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQ 124
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT-CGSPN 181
L++G++YCH K HRD+K NILL++KG IK++DFGL+ L + ++ +T +
Sbjct: 125 LLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARL--YNSEESRPYTNKVITLW 182
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD-DRNLAVL--------------- 225
Y PE+L G D+WSCG IL + T F ++ LA L
Sbjct: 183 YRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW 242
Query: 226 -----------------YQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT 261
Y++ R +F + A +LL +L +P KR T
Sbjct: 243 PDVIKLPYFNTMKPKKQYRRRLREEFSF---IPTPALDLLDHMLTLDPSKRCT 292
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 7e-30
Identities = 75/247 (30%), Positives = 118/247 (47%), Gaps = 34/247 (13%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E + +G G FG+V+ Q D+G +A+KIL K ++ + I+ E L
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
VV++ K +Y+++E++ GG++ + K L E E + + + + H G
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122
Query: 136 FHRDLKLENILLDSKGNIKISDFGLS-----------------ALPQHFRDDG------- 171
HRD+K +N+LLDSKG++K+SDFGL +LP F
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182
Query: 172 ---------LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL 222
L +T G+P+Y+APEV GY+ D WS GVI+Y +L GY PF
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 223 AVLYQKI 229
Y+K+
Sbjct: 242 QETYKKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 7e-30
Identities = 76/259 (29%), Positives = 135/259 (52%), Gaps = 26/259 (10%)
Query: 15 RYELGR--TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE-----IAT 67
R L +GEG+ G V A D +G AVK ++ + Q +RE +
Sbjct: 18 RSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMD--------LRKQQRRELLFNEVVI 69
Query: 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
++ +HPN+V ++ ++++V+E++ GG L D I + R+ E + + ++ +
Sbjct: 70 MRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKAL 128
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
S+ H +GV HRD+K ++ILL S G +K+SDFG A Q ++ + G+P ++APEV
Sbjct: 129 SFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPEV 186
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLP-FDDRNLAVLYQKIFRGD----FKLPKWLSP 242
++ Y G DIWS G+++ ++ G P F++ L + K R + K +SP
Sbjct: 187 ISRLPY-GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM--KRIRDNLPPKLKNLHKVSP 243
Query: 243 GAQNLLRKILEPNPVKRIT 261
++ L ++L +P +R T
Sbjct: 244 RLRSFLDRMLVRDPAQRAT 262
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 9e-30
Identities = 72/247 (29%), Positives = 119/247 (48%), Gaps = 34/247 (13%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E + +G G FG+V+ Q D+G +A+KIL K ++ + I+ E L
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
VV++ K +Y+++E++ GG++ + K L E + + + + H G
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF 122
Query: 136 FHRDLKLENILLDSKGNIKISDFGL-SALPQHFRDD------------------------ 170
HRD+K +N+LLD+KG++K+SDFGL + L + R +
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182
Query: 171 --------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL 222
L ++T G+P+Y+APEV GY+ D WS GVI+Y +L GY PF
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 223 AVLYQKI 229
Y+K+
Sbjct: 242 QETYRKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 1e-29
Identities = 76/235 (32%), Positives = 117/235 (49%), Gaps = 14/235 (5%)
Query: 37 DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL-HEVLASKSKIYMVLEY 95
+G A+K+L + + +RE A L HPN+V L A ++ V EY
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 96 VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---N 152
V G L + +A+ G L E +L Q++D ++ HN+G+ HRDLK +NI++ G +
Sbjct: 61 VPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120
Query: 153 IKISDFGLSALPQHFRDDGLLHTT-----CGSPNYVAPEVLANRGYDGATSDIWSCGVIL 207
K+ DFG+ L RD + T G+P Y APE L SD+++ G+I
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVT-PNSDLYAWGLIF 179
Query: 208 YVILTGYLPFDDRNLA-VLYQKIFRGDFKLPKWLS--PGAQNLLRKILEPNPVKR 259
LTG ++A +LYQ++ D LP W++ P Q +LRK L +P +R
Sbjct: 180 LECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQ-VLRKALNKDPRQR 233
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 71/268 (26%), Positives = 134/268 (50%), Gaps = 16/268 (5%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+++ +G G+FG+V+ ++ +G +A+K+++K+ ++ + + E L + P
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
+ +L K +Y+V+EY GG+L + + + E + +L+ + H G
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG 122
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT--CGSPNYVAPEVL-ANR 191
HRD+K EN+L+D G+IK++DFG +A + ++++ G+P+Y+APEVL
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSAA---RLTANKMVNSKLPVGTPDYIAPEVLTTMN 179
Query: 192 GYDGATSDI----WSCGVILYVILTGYLPFDDRNLAVLYQKI--FRGDFKLPKWL--SPG 243
G T + WS GVI Y ++ G PF + A Y I F+ K P+ S
Sbjct: 180 GDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSD 239
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWF 271
+L++ +L +R+ G+ +F
Sbjct: 240 FLDLIQSLL-CGQKERLGYEGLCCHPFF 266
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 86/258 (33%), Positives = 130/258 (50%), Gaps = 23/258 (8%)
Query: 15 RYELGRTLGEGNFGK-VKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR-----EIATL 68
Y R LG+G FG+ + + D L V E ++L + +R EI L
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSL---VVWKE----VNLTRLSEKERRDALNEIVIL 53
Query: 69 KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIA-SKGRLQEAE--GRKLFQQLID 125
LL+HPN++ + + + + +EY GG L+DKI KG+L E E LFQ ++
Sbjct: 54 SLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQ-IVS 112
Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC-GSPNYVA 184
VSY H G+ HRD+K NI L G IK+ DFG+S + + + T G+P Y++
Sbjct: 113 AVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGIS---KILGSEYSMAETVVGTPYYMS 169
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPG 243
PE+ Y+ SDIW+ G +LY +LT FD N L KI +G++ + S
Sbjct: 170 PELCQGVKYN-FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSE 228
Query: 244 AQNLLRKILEPNPVKRIT 261
+L+ +L+ +P KR T
Sbjct: 229 LISLVHSLLQQDPEKRPT 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 3e-29
Identities = 71/208 (34%), Positives = 111/208 (53%), Gaps = 23/208 (11%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLK 72
G +EL +GEG +GKV A+ +G A+KI++ II + + IK E L K
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD---IIEDEEEE-IKEEYNILRKYSN 61
Query: 73 HPNVVRLHEVLASKS------KIYMVLEYVTGG---ELFDKIASKG-RLQEAEGRKLFQQ 122
HPN+ + K+ ++++V+E GG +L + KG RL+E + ++
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
+ G++Y H V HRD+K +NILL +K+ DFG+SA Q G +T G+P +
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA--QLDSTLGRRNTFIGTPYW 179
Query: 183 VAPEVLA-----NRGYDGATSDIWSCGV 205
+APEV+A + YD A SD+WS G+
Sbjct: 180 MAPEVIACDEQPDASYD-ARSDVWSLGI 206
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 81/284 (28%), Positives = 143/284 (50%), Gaps = 15/284 (5%)
Query: 2 VIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI 61
++ + ++ M+ Y++ + +G G FG+V+ + S +A+K+L K +I +
Sbjct: 31 IVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFF 90
Query: 62 KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ 121
E + P VV+L +YMV+EY+ GG+L + + S + E +
Sbjct: 91 WEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTA 149
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH--TTCGS 179
+++ + H+ G+ HRD+K +N+LLD G++K++DFG + G++ T G+
Sbjct: 150 EVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC---MKMDETGMVRCDTAVGT 206
Query: 180 PNYVAPEVLANR---GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF--RGDF 234
P+Y++PEVL ++ GY G D WS GV L+ +L G PF +L Y KI +
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSL 266
Query: 235 KLPK--WLSPGAQNLLRKILEPNPVK--RITIAGIKADEWFEQD 274
P+ +S A+NL+ L V+ R + IK +F+ D
Sbjct: 267 NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 89/329 (27%), Positives = 133/329 (40%), Gaps = 67/329 (20%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-HLKITDQIKREIATLKLLKH 73
RYEL + +G G +G V A D +G A+K + + + L +I REI L+ L+H
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKI--SNVFDDLIDAKRILREIKLLRHLRH 58
Query: 74 PNVVRLHEVLASKSK-----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
N++ L ++L S +Y+V E + +L I S L + + Q++ G+
Sbjct: 59 ENIIGLLDILRPPSPEDFNDVYIVTELM-ETDLHKVIKSPQPLTDDHIQYFLYQILRGLK 117
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYV--- 183
Y H+ V HRDLK NIL++S ++KI DFGL+ P L YV
Sbjct: 118 YLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE-------YVVTR 170
Query: 184 ---APEV-LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF--------- 230
APE+ L++ Y A DIWS G I +LT F R+ I
Sbjct: 171 WYRAPELLLSSSRYTKAI-DIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEE 229
Query: 231 ----------------RGDFKLPKW------LSPGAQNLLRKILEPNPVKRITIAGIKAD 268
SP A +LL K+L +P KRIT A
Sbjct: 230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289
Query: 269 EWFEQDYTPA----------NPDDDEEDI 287
+ Q + P D++++
Sbjct: 290 PYLAQLHDPEDEPVAKPPFDFDFFDDDEL 318
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 4e-29
Identities = 81/264 (30%), Positives = 125/264 (47%), Gaps = 18/264 (6%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
LG GN G V +G AVK + I+ I QI RE+ L P +V
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLE--INEAIQKQILRELDILHKCNSPYIVGF 64
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKI--ASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVF 136
+ + I + +EY+ GG L DKI +GR+ E K+ ++ G++Y H K +
Sbjct: 65 YGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKII 123
Query: 137 HRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 196
HRD+K NIL++S+G IK+ DFG+S + L T G+ +Y+APE + Y
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVSG----QLVNSLAKTFVGTSSYMAPERIQGNDY-SV 178
Query: 197 TSDIWSCGVILYVILTGYLPF---DDRNLAV--LYQKIFRGDF-KLPK-WLSPGAQNLLR 249
SDIWS G+ L + TG P+ +D + L Q I +LP SP Q+ +
Sbjct: 179 KSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVN 238
Query: 250 KILEPNPVKRITIAGIKADEWFEQ 273
L +P +R + + + ++
Sbjct: 239 LCLIKDPRERPSYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 6e-29
Identities = 86/293 (29%), Positives = 137/293 (46%), Gaps = 65/293 (22%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK-------REIAT 67
+YE +GEG +G V A++ ++ A+K +++ D + REI
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALK--------RVRLDDDDEGVPSSALREICL 52
Query: 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLID 125
LK LKH N+VRL++VL S K+ +V EY + FD + G + + QL+
Sbjct: 53 LKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFD--SCNGDIDPEIVKSFMFQLLK 110
Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN---- 181
G+++CH+ V HRDLK +N+L++ G +K++DFGL+ R G + C S
Sbjct: 111 GLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLA------RAFG-IPVRCYSAEVVTL 163
Query: 182 -YVAPEVL-ANRGYDGATS-DIWSCGVILYVILTGYLP-FDDRNLAVLYQKIFR------ 231
Y P+VL + Y TS D+WS G I + P F ++ ++IFR
Sbjct: 164 WYRPPDVLFGAKLYS--TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT 221
Query: 232 -----GDFKLPKW------------------LSPGAQNLLRKILEPNPVKRIT 261
G KLP + L+ ++LL+ +L NPV+RI+
Sbjct: 222 EESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRIS 274
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 67/206 (32%), Positives = 111/206 (53%), Gaps = 14/206 (6%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
E +G G G V +G +A+K++ N ++ QI REI L+ + HPNV
Sbjct: 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRR--QICREIEILRDVNHPNV 134
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFD-KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
V+ H++ +I ++LE++ GG L IA + L + + +Q++ G++Y H + +
Sbjct: 135 VKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLAD-----VARQILSGIAYLHRRHI 189
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL---ANRG 192
HRD+K N+L++S N+KI+DFG+S + D +++ G+ Y++PE + N G
Sbjct: 190 VHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP--CNSSVGTIAYMSPERINTDLNHG 247
Query: 193 -YDGATSDIWSCGVILYVILTGYLPF 217
YDG DIWS GV + G PF
Sbjct: 248 AYDGYAGDIWSLGVSILEFYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 2e-28
Identities = 73/243 (30%), Positives = 107/243 (44%), Gaps = 46/243 (18%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+TLG G FG+V A +D+ +A+K L K +++ +K E L + VV+L
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
+ K +Y V++Y+ GG++ + E R +L + H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRD 126
Query: 140 LKLENILLDSKGNIKISDFGL----------------------SALPQHFRDD------- 170
+K +NIL+D G+IK++DFGL S P DD
Sbjct: 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCG 186
Query: 171 ----------------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 214
L H+ G+PNY+APEVL +GY D WS GVIL+ +L G
Sbjct: 187 DRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFEMLVGQ 245
Query: 215 LPF 217
PF
Sbjct: 246 PPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 3e-28
Identities = 82/244 (33%), Positives = 124/244 (50%), Gaps = 12/244 (4%)
Query: 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILE---KNRIIHLKITDQIKREIATLKLLKHPN 75
G LG+G +G V + + G AVK +E N + K ++++ E+ LK LKH N
Sbjct: 5 GEVLGKGAYGTV-YCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
+V+ + I + +E+V GG + + G L E K +Q++DGV+Y HN V
Sbjct: 64 IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCV 123
Query: 136 FHRDLKLENILLDSKGNIKISDFG----LSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
HRD+K N++L G IK+ DFG L+ + H +L + G+P ++APEV+
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES 183
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFD--DRNLAVLYQKIFRGDF-KLPKWLSPGAQNLL 248
GY G SDIWS G ++ + TG P DR A+ Y RG +LP S A + +
Sbjct: 184 GY-GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFV 242
Query: 249 RKIL 252
L
Sbjct: 243 TSCL 246
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 4e-28
Identities = 82/256 (32%), Positives = 126/256 (49%), Gaps = 10/256 (3%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
R LG+G FG+V Q +G +A K LEK RI K E L+ + VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGVSYCHNKGVFH 137
+K + +VL + GG+L I G EGR +F ++ G+ H + + +
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVY 125
Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT 197
RDLK ENILLD G+I+ISD GL+ H + + G+ Y+APEV+ N Y +
Sbjct: 126 RDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGRVGTVGYMAPEVVKNERYT-FS 181
Query: 198 SDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR----GDFKLPKWLSPGAQNLLRKILE 253
D W+ G +LY ++ G PF R + +++ R + + SP A++L + +L
Sbjct: 182 PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLC 241
Query: 254 PNPVKRITIAGIKADE 269
+P +R+ G A E
Sbjct: 242 KDPKERLGCQGGGARE 257
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 5e-28
Identities = 94/269 (34%), Positives = 144/269 (53%), Gaps = 37/269 (13%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLH 80
LG+G +G V A+DL + + A+K I E++ + + EIA LKH N+V+
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDS----RYVQPLHEEIALHSYLKHRNIVQY- 70
Query: 81 EVLASKS-----KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLF--QQLIDGVSYCHN 132
L S S KI+M E V GG L + SK G L++ E +F +Q+++G+ Y H+
Sbjct: 71 --LGSDSENGFFKIFM--EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD 126
Query: 133 KGVFHRDLKLENILLDS-KGNIKISDFGLSALPQHFRDDGL---LHTTCGSPNYVAPEVL 188
+ HRD+K +N+L+++ G +KISDFG S R G+ T G+ Y+APEV+
Sbjct: 127 NQIVHRDIKGDNVLVNTYSGVVKISDFGTSK-----RLAGINPCTETFTGTLQYMAPEVI 181
Query: 189 --ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR-GDFK----LPKWLS 241
RGY GA +DIWS G + + TG PF + L +F+ G FK +P+ LS
Sbjct: 182 DKGPRGY-GAPADIWSLGCTIVEMATGKPPFIE--LGEPQAAMFKVGMFKIHPEIPESLS 238
Query: 242 PGAQNLLRKILEPNPVKRITIAGIKADEW 270
A+N + + EP+P KR + + D +
Sbjct: 239 AEAKNFILRCFEPDPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 83/275 (30%), Positives = 136/275 (49%), Gaps = 15/275 (5%)
Query: 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
M+ YE+ + +G G FG+V+ + + +A+K+L K +I + E +
Sbjct: 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 99
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
P VV+L +YMV+EY+ GG+L + + S + E R +++ +
Sbjct: 100 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAI 158
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH--TTCGSPNYVAPEVL 188
H+ G HRD+K +N+LLD G++K++DFG +G++ T G+P+Y++PEVL
Sbjct: 159 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTC---MKMNKEGMVRCDTAVGTPDYISPEVL 215
Query: 189 ANR---GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF--RGDFKLP--KWLS 241
++ GY G D WS GV LY +L G PF +L Y KI + P +S
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 275
Query: 242 PGAQNLLRKILEPNPVK--RITIAGIKADEWFEQD 274
A+NL+ L V+ R + IK +F+ D
Sbjct: 276 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 1e-27
Identities = 79/256 (30%), Positives = 124/256 (48%), Gaps = 10/256 (3%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
R LG+G FG+V Q +G +A K LEK RI K E L+ + VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 65
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGVSYCHNKGVFH 137
+K + +VL + GG+L I + G E R +F ++ G+ H + + +
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVY 125
Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT 197
RDLK ENILLD G+I+ISD GL+ + + G+ Y+APEV+ N Y +
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAV---EIPEGETIRGRVGTVGYMAPEVVKNERY-TFS 181
Query: 198 SDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR----GDFKLPKWLSPGAQNLLRKILE 253
D W G ++Y ++ G PF R V +++ R + + S A+++ R++L
Sbjct: 182 PDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLT 241
Query: 254 PNPVKRITIAGIKADE 269
+P R+ G A+E
Sbjct: 242 KDPGFRLGCRGEGAEE 257
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 86/290 (29%), Positives = 137/290 (47%), Gaps = 57/290 (19%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ-----IKREIATLKL 70
YE +GEG +G V A+DL++G A+K + + ++++ REIA LK
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKK------VRVPLSEEGIPLSTLREIALLKQ 54
Query: 71 LK---HPNVVRLHEVLA-----SKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLF 120
L+ HPN+VRL +V + K+ +V E+V K G L + L
Sbjct: 55 LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG-LPPETIKDLM 113
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
+QL+ GV + H+ + HRDLK +NIL+ S G +KI+DFGL+ + + + L + +
Sbjct: 114 RQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI---YSFEMALTSVVVTL 170
Query: 181 NYVAPEVLANRGYDGATS-DIWSCGVILYVI---------------------LTGYLPFD 218
Y APEVL Y AT D+WS G I + + G +
Sbjct: 171 WYRAPEVLLQSSY--ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEE 228
Query: 219 D--RNLAVL---YQKIFRGDFK--LPKWLSPGAQNLLRKILEPNPVKRIT 261
+ RN+++ + FK +P+ + +LL+K+L NP KRI+
Sbjct: 229 EWPRNVSLPRSSFPSYTPRSFKSFVPE-ICEEGLDLLKKMLTFNPHKRIS 277
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 75/282 (26%), Positives = 124/282 (43%), Gaps = 50/282 (17%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+ +G+G FG+V+ Q D+G +A+K L K+ + +K E L P VV L
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
+ +Y+++E++ GG+L + E R + + + H G HRD
Sbjct: 67 YYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRD 126
Query: 140 LKLENILLDSKGNIKISDFGL--------------------SALPQHFRDDGLL------ 173
+K +NIL+D G+IK+SDFGL S + + +
Sbjct: 127 IKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINL 186
Query: 174 -------------------HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 214
++T G+P+Y+APE+ +GY G D WS G I++ L G+
Sbjct: 187 TMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMFECLIGW 245
Query: 215 LPFDDRNLAVLYQKI--FRGDFKLPK--WLSPGAQNLLRKIL 252
PF N Y+KI +R P LS A++L+R+++
Sbjct: 246 PPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLI 287
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 91/322 (28%), Positives = 137/322 (42%), Gaps = 71/322 (22%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDS--GLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+YE+ +G G +G+V A+ + G +A+K + ++ + I+ REIA L+ LK
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 73 HPNVVRLHEVLASKS--KIYMVLEYVTGGELFDKI-----ASKGRLQEAEGRKLFQQLID 125
H NVV L EV + +Y++ +Y +L+ I A + + + + L Q+++
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILN 119
Query: 126 GVSYCHNKGVFHRDLKLENILL----DSKGNIKISDFGL-----SALPQHFRDDGLLHTT 176
GV Y H+ V HRDLK NIL+ +G +KI D GL + L D ++ T
Sbjct: 120 GVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTI 179
Query: 177 CGSPNYVAPEV-LANRGYDGATSDIWSCGVILYVILTGYLPF----DDRNLAVLYQ---- 227
Y APE+ L R Y A DIW+ G I +LT F + +Q
Sbjct: 180 W----YRAPELLLGARHYTKAI-DIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQL 234
Query: 228 -KIFR-----------------------GDFK--------LPKW------LSPGAQNLLR 249
+IF DFK L KW +LLR
Sbjct: 235 ERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLR 294
Query: 250 KILEPNPVKRITIAGIKADEWF 271
K+LE +P KRIT +F
Sbjct: 295 KLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 3e-27
Identities = 71/209 (33%), Positives = 110/209 (52%), Gaps = 18/209 (8%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL--EKNRIIHLKITDQIKREIATLKLLKHP 74
EL R LGEG G V + ++G+ FA+K + + N + QI RE+ K K P
Sbjct: 5 ELSR-LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQ----KQILRELEINKSCKSP 59
Query: 75 NVVRLHE--VLASKSKIYMVLEYVTGGEL---FDKIASKG-RLQEAEGRKLFQQLIDGVS 128
+V+ + + S S I + +EY GG L + K+ +G R+ E K+ + ++ G+S
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
Y H++ + HRD+K NILL KG +K+ DFG+S + L T G+ Y+APE +
Sbjct: 120 YLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV----NSLAGTFTGTSFYMAPERI 175
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPF 217
+ Y TSD+WS G+ L + PF
Sbjct: 176 QGKPYS-ITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 4e-27
Identities = 81/275 (29%), Positives = 133/275 (48%), Gaps = 40/275 (14%)
Query: 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
L R LG G FG+V + + AVK L+ + + +E +K L+H +V
Sbjct: 10 LERKLGAGQFGEV-WMGTWNGTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLV 64
Query: 78 RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVSY 129
+L+ V + + IY+V EY++ G L D L+ EG+KL QL+D G++Y
Sbjct: 65 QLYAVCSEEEPIYIVTEYMSKGSLLD------FLKSGEGKKLRLPQLVDMAAQIAEGMAY 118
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY----VAP 185
++ HRDL NIL+ KI+DFGL+ L DD +T + AP
Sbjct: 119 LESRNYIHRDLAARNILVGENLVCKIADFGLARL---IEDD--EYTAREGAKFPIKWTAP 173
Query: 186 EVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244
E AN G SD+WS G++L I+T G +P+ + +++ RG +++P+ P
Sbjct: 174 EA-ANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG-YRMPR--PPNC 229
Query: 245 ----QNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
+L+ + + +P +R T ++ F +DY
Sbjct: 230 PEELYDLMLQCWDKDPEERPTFEYLQ---SFLEDY 261
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 89/324 (27%), Positives = 142/324 (43%), Gaps = 50/324 (15%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
RY+ +G G +G+V A D +G A+K L + IH K T RE+ LK +
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRT---YRELRLLKHMD 72
Query: 73 HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
H NV+ L +V L +Y+V + G +L + + + +L + + L Q++ G
Sbjct: 73 HENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQ-KLSDDHIQFLVYQILRG 130
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
+ Y H+ G+ HRDLK NI ++ +KI DFGL+ D + + Y APE
Sbjct: 131 LKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT-----DDEMTGYVATRWYRAPE 185
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF----------------------------- 217
++ N + T DIWS G I+ +LTG F
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245
Query: 218 -DDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
RN ++ + DFK + +P A +LL K+L +P KRIT A A + + +
Sbjct: 246 ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305
Query: 276 TPAN-PDDDEEDIFVDNEAFSMHE 298
P + P D ++ ++ E
Sbjct: 306 DPEDEPVAPPYDQSFESRDLTVDE 329
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 5e-27
Identities = 84/282 (29%), Positives = 133/282 (47%), Gaps = 56/282 (19%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ-----IKREIATLKLLKHPNV 76
+GEG +G V ++ +G A+K I L+ ++ REI+ LK L+HPN+
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKK------IRLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 77 VRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
V L +VL +S++Y++ E+++ + D + + + Q++ G+ +CH++
Sbjct: 62 VCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR 121
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL-----LHTTCGSPNYVAPEVLA 189
V HRDLK +N+L+D+KG IK++DFGL+ R G+ H + Y APEVL
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLA------RAFGIPVRVYTHEVV-TLWYRAPEVLL 174
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFD-DRNLAVLYQKIFR----------------G 232
DIWS G I + T F D + L+ +IFR
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLF-RIFRILGTPTEDVWPGVTSLP 233
Query: 233 DFK--LPKW-----------LSPGAQNLLRKILEPNPVKRIT 261
D+K PKW L +LL K+L +P KRI+
Sbjct: 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRIS 275
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 85/285 (29%), Positives = 131/285 (45%), Gaps = 48/285 (16%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL---EKNRIIHLKITDQIKREIATLKLL 71
+YE +GEG++G V ++ ++G A+K E + +I KI REI LK L
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIK-KIA---LREIRMLKQL 57
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
KHPN+V L EV K K+++V EY L + + + E +K+ Q + V++CH
Sbjct: 58 KHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH 117
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN-YVAPEVLAN 190
HRD+K ENIL+ +G IK+ DFG + + DD +T + Y APE+L
Sbjct: 118 KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD---YTDYVATRWYRAPELLVG 174
Query: 191 RGYDGATSDIWSCGVILYVILTG-------------YLPFDDRNLAVLY---QKIFR-GD 233
G D+W+ G + +LTG YL + L L Q+IF
Sbjct: 175 DTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLI--RKTLGDLIPRHQQIFSTNQ 232
Query: 234 F-----------------KLPKWLSPGAQNLLRKILEPNPVKRIT 261
F K P +S A + L+ L+ +P +R++
Sbjct: 233 FFKGLSIPEPETREPLESKFPN-ISSPALSFLKGCLQMDPTERLS 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 73/249 (29%), Positives = 130/249 (52%), Gaps = 15/249 (6%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E+ + +G G FG+V + ++ FA+KIL K ++ T + E L +
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
+ LH ++ +Y+V++Y GG+L ++ + RL E R +++ + H
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT--CGSPNYVAPEVLA--- 189
HRD+K +NIL+D G+I+++DFG S L +DG + ++ G+P+Y++PE+L
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFG-SCL--KLMEDGTVQSSVAVGTPDYISPEILQAME 179
Query: 190 -NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF--RGDFKLPKW---LSPG 243
+G G D WS GV +Y +L G PF +L Y KI + F+ P +S
Sbjct: 180 DGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSED 239
Query: 244 AQNLLRKIL 252
A++L+R+++
Sbjct: 240 AKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 78/257 (30%), Positives = 124/257 (48%), Gaps = 15/257 (5%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
L + + + +G G F +V A L G+P A+K ++ ++ K +EI LK L
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGVS 128
HPNV++ + +++ +VLE G+L I K + E K F QL +
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
+ H++ V HRD+K N+ + + G +K+ D GL H+ G+P Y++PE +
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPERI 178
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPF--DDRNLAVLYQKIFRGDFKLPKWLSPGAQN 246
GY+ SDIWS G +LY + PF D NL L +KI + D+ P S
Sbjct: 179 HENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY--PPLPSDHYSE 235
Query: 247 LLRKILE----PNPVKR 259
LR+++ P+P KR
Sbjct: 236 ELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 75/259 (28%), Positives = 133/259 (51%), Gaps = 18/259 (6%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT-----LKL 70
Y R +G+G++G+V + G + +K L +L+ + +R+ A L
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKL------NLRNASRRERKAAEQEAQLLSQ 55
Query: 71 LKHPNVVRLHEVLASKS-KIYMVLEYVTGGELFDKIA-SKGRL-QEAEGRKLFQQLIDGV 127
LKHPN+V E + +Y+V+ + GG+L+ K+ KG+L E + + F Q+ +
Sbjct: 56 LKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL 115
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
Y H K + HRDLK +N+ L IK+ D G++ + ++ D + T G+P Y++PE+
Sbjct: 116 QYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLIGTPYYMSPEL 173
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQN 246
+N+ Y+ SD+W+ G +Y + T F+ +++ L +I G +PK SP
Sbjct: 174 FSNKPYN-YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGE 232
Query: 247 LLRKILEPNPVKRITIAGI 265
L+ +L P KR ++ I
Sbjct: 233 LIATMLSKRPEKRPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 5e-26
Identities = 87/260 (33%), Positives = 134/260 (51%), Gaps = 26/260 (10%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ---IKREIATLKLLK 72
YEL + +G G +G V A++L +G AVKI I L+ D I++EI +K K
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKI------IKLEPGDDFSLIQQEIFMVKECK 64
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
H N+V S+ K+++ +EY GG L D G L E + + ++ + G++Y H+
Sbjct: 65 HCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHS 124
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA--- 189
KG HRD+K NILL G++K++DFG++A + + G+P ++APEV A
Sbjct: 125 KGKMHRDIKGANILLTDNGDVKLADFGVAA--KITATIAKRKSFIGTPYWMAPEVAAVEK 182
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLP--FDDRNLAVLYQKIFRGDFKLP------KWLS 241
N GY+ DIW+ G I + L P FD + L+ + + +F+ P KW S
Sbjct: 183 NGGYN-QLCDIWAVG-ITAIELAELQPPMFDLHPMRALFL-MSKSNFQPPKLKDKTKW-S 238
Query: 242 PGAQNLLRKILEPNPVKRIT 261
N ++ L NP KR T
Sbjct: 239 STFHNFVKISLTKNPKKRPT 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 6e-26
Identities = 77/248 (31%), Positives = 132/248 (53%), Gaps = 13/248 (5%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
RYE +G+G G V A D+ +G A+K + + ++ I EI +K LK+P
Sbjct: 23 RYE---KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL---IINEILVMKELKNP 76
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N+V + ++++V+EY+ GG L D + ++ + EA+ + ++ + + + H
Sbjct: 77 NIVNFLDSFLVGDELFVVMEYLAGGSLTD-VVTETCMDEAQIAAVCRECLQALEFLHANQ 135
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
V HRD+K +N+LL G++K++DFG A Q + T G+P ++APEV+ + Y
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAY- 192
Query: 195 GATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGDFKL--PKWLSPGAQNLLRKI 251
G DIWS G++ ++ G P+ + N L LY G +L P+ LSP ++ L +
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRC 252
Query: 252 LEPNPVKR 259
LE + KR
Sbjct: 253 LEMDVEKR 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 8e-26
Identities = 85/295 (28%), Positives = 135/295 (45%), Gaps = 48/295 (16%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL---EKNRIIHLKITDQIKREIATLKLL 71
+YE +GEG++G V + ++G A+K E ++++ KI REI LK L
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVK-KIA---MREIRMLKQL 57
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
+H N+V L EV K ++Y+V E+V L D L E+ RK Q++ G+ +CH
Sbjct: 58 RHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH 117
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCGSPNYVAPEVL 188
+ + HRD+K ENIL+ G +K+ DFG + A P D + + Y APE+L
Sbjct: 118 SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV-----ATRWYRAPELL 172
Query: 189 ANRGYDGATSDIWSCGVILYVILTG--YLPFDDR------------NLAVLYQKIFRG-- 232
G DIW+ G ++ +LTG P D NL +Q+IF+
Sbjct: 173 VGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232
Query: 233 ----------------DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271
+ + PK S +L ++ L +P R + + + E+F
Sbjct: 233 LFAGMRLPEVKEIEPLEKRFPKL-SGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 8e-26
Identities = 73/253 (28%), Positives = 129/253 (50%), Gaps = 20/253 (7%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE-----IATLK 69
+Y +G+G G V A D+ +G A+K + + Q K+E I ++
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIK--------QMNLQQQPKKELIINEILVMR 71
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
KHPN+V + ++++V+EY+ GG L D + ++ + E + + ++ + + +
Sbjct: 72 ENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEF 130
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
H+ V HRD+K +NILL G++K++DFG A Q + T G+P ++APEV+
Sbjct: 131 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVT 188
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRG--DFKLPKWLSPGAQN 246
+ Y G DIWS G++ ++ G P+ + N L LY G + + P+ LS ++
Sbjct: 189 RKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 247
Query: 247 LLRKILEPNPVKR 259
L + LE + KR
Sbjct: 248 FLNRCLEMDVEKR 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 9e-26
Identities = 82/269 (30%), Positives = 124/269 (46%), Gaps = 39/269 (14%)
Query: 22 LGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVR 78
LG+G+FG V+ + SG +P AVK L+ +++ I D +E A + L H N++R
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL--SDIMDDFLKEAAIMHSLDHENLIR 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ---QLIDGVSYCHNKGV 135
L+ V+ + + MV E G L D++ K L L Q+ +G+ Y +K
Sbjct: 61 LYGVVLTHP-LMMVTELAPLGSLLDRL-RKDALGHFLISTLCDYAVQIANGMRYLESKRF 118
Query: 136 FHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYV----------- 183
HRDL NILL S +KI DFGL ALPQ +YV
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQ------------NEDHYVMEEHLKVPFAW 166
Query: 184 -APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKW 239
APE L R + A SD+W GV L+ + T G P+ + + + +KI + +L P+
Sbjct: 167 CAPESLRTRTFSHA-SDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEA 225
Query: 240 LSPGAQNLLRKILEPNPVKRITIAGIKAD 268
N++ + NP R T A ++
Sbjct: 226 CPQDIYNVMLQCWAHNPADRPTFAALREF 254
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 9e-26
Identities = 88/322 (27%), Positives = 137/322 (42%), Gaps = 57/322 (17%)
Query: 15 RYE-LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----------- 62
RY G LGEG +GKV+ A D +G A+K ++ I + D+
Sbjct: 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTL 68
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
RE+ + +KH N++ L +V I +V++ + +L + K RL E++ + + Q
Sbjct: 69 RELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQ 127
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCGS 179
+++G++ H HRDL NI ++SKG KI+DFGL+ P + T
Sbjct: 128 ILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187
Query: 180 PN---------YVAPEVL--ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQK 228
Y APE+L A + Y A D+WS G I +LTG F N +
Sbjct: 188 EEMTSKVVTLWYRAPELLMGAEK-YHFAV-DMWSVGCIFAELLTGKPLFPGENEIDQLGR 245
Query: 229 IF--RG-------------------DFKLPKWLSPGAQN-------LLRKILEPNPVKRI 260
IF G + PK L N LL+ +L+ NP++RI
Sbjct: 246 IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERI 305
Query: 261 TIAGIKADEWFEQDYTPANPDD 282
+ E+F+ D P +P
Sbjct: 306 SAKEALKHEYFKSDPLPCDPSQ 327
|
Length = 335 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 79/259 (30%), Positives = 124/259 (47%), Gaps = 11/259 (4%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
L +++ + +G G F +V A L P A+K ++ ++ K +EI LK L
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGVS 128
HPNV++ + +++ +VLE G+L I K + E K F QL V
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
+ H++ V HRD+K N+ + + G +K+ D GL H+ G+P Y++PE +
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPERI 178
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPF--DDRNLAVLYQKIFRGDF-KLPK-WLSPGA 244
GY+ SDIWS G +LY + PF D NL L QKI + D+ LP S
Sbjct: 179 HENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKL 237
Query: 245 QNLLRKILEPNPVKRITIA 263
+ L+ + P+P +R I
Sbjct: 238 RELVSMCIYPDPDQRPDIG 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 17/204 (8%)
Query: 20 RTLGEGNFGKVKFA----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+ LGEG+FGKV+ ++G AVK L + +D +REI L+ L H N
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL-NHSGEEQHRSD-FEREIEILRTLDHEN 67
Query: 76 VVRLHEVL--ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF----QQLIDGVSY 129
+V+ V + +++EY+ G L D + R ++ K Q+ G+ Y
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQ---RHRDQINLKRLLLFSSQICKGMDY 124
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVL 188
++ HRDL NIL++S+ +KISDFGL+ + +D + SP + APE L
Sbjct: 125 LGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECL 184
Query: 189 ANRGYDGATSDIWSCGVILYVILT 212
+ A SD+WS GV LY + T
Sbjct: 185 RTSKFSSA-SDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 4e-25
Identities = 77/251 (30%), Positives = 135/251 (53%), Gaps = 26/251 (10%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE-----IATLKLLKHPNV 76
+GEG+ G V A++ SG AVK+++ + Q +RE + ++ +H NV
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMD--------LRKQQRRELLFNEVVIMRDYQHQNV 80
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVF 136
V +++ ++++++E++ GG L D I S+ RL E + + + ++ + Y H++GV
Sbjct: 81 VEMYKSYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVI 139
Query: 137 HRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 196
HRD+K ++ILL G +K+SDFG A Q +D + G+P ++APEV++ Y G
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCA--QISKDVPKRKSLVGTPYWMAPEVISRTPY-GT 196
Query: 197 TSDIWSCGVILYVILTGYLP-FDDRNLAVLYQKIFRGDFKLPKW-----LSPGAQNLLRK 250
DIWS G+++ ++ G P F D + + K R D PK +SP ++ L +
Sbjct: 197 EVDIWSLGIMVIEMVDGEPPYFSDSPVQAM--KRLR-DSPPPKLKNAHKISPVLRDFLER 253
Query: 251 ILEPNPVKRIT 261
+L P +R T
Sbjct: 254 MLTREPQERAT 264
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 4e-25
Identities = 71/210 (33%), Positives = 109/210 (51%), Gaps = 16/210 (7%)
Query: 62 KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRL------QEAE 115
+ E+ L H +V+ + S K+ +++EY +GG+L +I K RL QE E
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI--KQRLKEHLPFQEYE 170
Query: 116 GRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL-- 173
LF Q++ + H++ + HRDLK NI L G IK+ DFG S + + D L
Sbjct: 171 VGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFS---KQYSDSVSLDV 227
Query: 174 -HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG 232
+ CG+P Y+APE+ + Y +D+WS GVILY +LT + PF + + Q++ G
Sbjct: 228 ASSFCGTPYYLAPELWERKRYS-KKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG 286
Query: 233 DFK-LPKWLSPGAQNLLRKILEPNPVKRIT 261
+ P +S G + LL +L NP R T
Sbjct: 287 KYDPFPCPVSSGMKALLDPLLSKNPALRPT 316
|
Length = 478 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 4e-25
Identities = 78/261 (29%), Positives = 132/261 (50%), Gaps = 12/261 (4%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH---PNVVR 78
+G G FG+V + D+G +A+K L+K RI + E L L+ P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
+ + K+ +L+ + GG+L ++ G EAE R ++I G+ + HN+ V +R
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYR 121
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN-RGYDGAT 197
DLK NILLD G+++ISD GL+ + H + G+ Y+APEVL YD ++
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGVAYD-SS 176
Query: 198 SDIWSCGVILYVILTGYLPF---DDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEP 254
+D +S G +L+ +L G+ PF ++ + + +LP SP ++LL +L+
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 236
Query: 255 NPVKRITIAGIKADEWFEQDY 275
+ +R+ G A E E +
Sbjct: 237 DVNRRLGCLGRGAQEVKEHPF 257
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 4e-25
Identities = 84/292 (28%), Positives = 130/292 (44%), Gaps = 66/292 (22%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLLK- 72
Y++ +GEG F +V AQ +G +A+K ++K H K +Q+ REI L+ L
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKK----HFKSLEQVNNLREIQALRRLSP 56
Query: 73 HPNVVRLHEVLASKS--KIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGV 127
HPN++RL EVL + ++ +V E + L++ I KGR L E + QL+ +
Sbjct: 57 HPNILRLIEVLFDRKTGRLALVFELMDM-NLYELI--KGRKRPLPEKRVKSYMYQLLKSL 113
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV---- 183
+ H G+FHRD+K ENIL+ +K++DFG S P Y
Sbjct: 114 DHMHRNGIFHRDIKPENILIK-DDILKLADFG-SC-----------RGIYSKPPYTEYIS 160
Query: 184 -----APEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN----------------- 221
APE L GY G DIW+ G + + IL+ + F N
Sbjct: 161 TRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDA 220
Query: 222 -LAVLYQKIFRGDFKLPK-------WL----SPGAQNLLRKILEPNPVKRIT 261
+ ++K ++ P L S +LL+K+L +P +RIT
Sbjct: 221 EVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERIT 272
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 6e-25
Identities = 76/260 (29%), Positives = 130/260 (50%), Gaps = 10/260 (3%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH---PNVVR 78
+G G FG+V + D+G +A+K L+K RI + E L L+ P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
+ + K+ +L+ + GG+L ++ G E E R ++I G+ + HN+ V +R
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
DLK NILLD G+++ISD GL+ + H + G+ Y+APEVL +++
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGTAYDSSA 177
Query: 199 DIWSCGVILYVILTGYLPF---DDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
D +S G +L+ +L G+ PF ++ + + + +LP SP ++LL +L+ +
Sbjct: 178 DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRD 237
Query: 256 PVKRITIAGIKADEWFEQDY 275
KR+ G A E E +
Sbjct: 238 VSKRLGCLGRGAQEVKEHVF 257
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 6e-25
Identities = 59/202 (29%), Positives = 103/202 (50%), Gaps = 26/202 (12%)
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
+PN ++L+ + + ++++Y+ G+LFD + +G+L EAE +K+ +QL++ ++ H
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLH 126
Query: 132 NKGVFHRDLKLENILLD-SKGNIKISDFGLS---ALPQHFRDDGLLHTTCGSPNYVAPEV 187
+ H D+KLEN+L D +K I + D+GL P + DG L +Y +PE
Sbjct: 127 KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY--DGTL-------DYFSPEK 177
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN--------LAVLYQKIFRGDFKLPKW 239
+ YD + D W+ GV+ Y +LTG PF + L QK K
Sbjct: 178 IKGHNYD-VSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK----KLPFIKN 232
Query: 240 LSPGAQNLLRKILEPNPVKRIT 261
+S A + ++ +L+ N R+T
Sbjct: 233 VSKNANDFVQSMLKYNINYRLT 254
|
Length = 267 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 9e-25
Identities = 74/255 (29%), Positives = 131/255 (51%), Gaps = 16/255 (6%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+EL + +G G +G V A+++++G A+K++ ++ + +++EI +K KH N
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVI---KLEPGEDFAVVQQEIIMMKDCKHSN 67
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
+V + K+++ +E+ GG L D G L E++ + ++ + G+ Y H+KG
Sbjct: 68 IVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK 127
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA--NRGY 193
HRD+K NILL G++K++DFG+SA Q + G+P ++APEV A +G
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSA--QITATIAKRKSFIGTPYWMAPEVAAVERKGG 185
Query: 194 DGATSDIWSCGVILYVILTGYLP-FDDRNLAVLYQKIFRGDFKLP------KWLSPGAQN 246
DIW+ G+ + P FD + L+ + + +F+ P KW S +
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL-MTKSNFQPPKLKDKMKW-SNSFHH 243
Query: 247 LLRKILEPNPVKRIT 261
++ L NP KR T
Sbjct: 244 FVKMALTKNPKKRPT 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 9e-25
Identities = 76/258 (29%), Positives = 133/258 (51%), Gaps = 21/258 (8%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR---EIATLKLLK 72
+E+ LG+G FGKV AQ+ ++G +L ++I K ++++ EI L
Sbjct: 7 WEIIGELGDGAFGKVYKAQNKETG------VLAAAKVIDTKSEEELEDYMVEIDILASCD 60
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCH 131
HPN+V+L + ++ +++++E+ GG + + R L E + R + +Q ++ ++Y H
Sbjct: 61 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH 120
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL--- 188
+ HRDLK NIL G+IK++DFG+SA ++ R + G+P ++APEV+
Sbjct: 121 ENKIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCE 178
Query: 189 --ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPG 243
+R YD +D+WS G+ L + P + N + KI + + P S
Sbjct: 179 TSKDRPYD-YKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSE 237
Query: 244 AQNLLRKILEPNPVKRIT 261
++ L+K LE N R T
Sbjct: 238 FKDFLKKCLEKNVDARWT 255
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 95/306 (31%), Positives = 139/306 (45%), Gaps = 62/306 (20%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ-----IKREIATLKL 70
YE +GEG +GKV A+D ++G A+K K R L++ ++ REI+ L++
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALK---KTR---LEMDEEGIPPTALREISLLQM 56
Query: 71 LKH-PNVVRLHEVLASKSK-----IYMVLEYVTGGELFDKIASKGR-----LQEAEGRKL 119
L +VRL +V + K +Y+V EY+ +L + S GR L +
Sbjct: 57 LSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSF 115
Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLS---ALPQHFRDDGLLHT 175
QL+ GV++CH GV HRDLK +N+L+D KG +KI+D GL ++P H
Sbjct: 116 MYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPV----KSYTHE 171
Query: 176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAVLYQKIFR--- 231
+ Y APEVL + DIWS G I + F D L L IF+
Sbjct: 172 IV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLL-HIFKLLG 229
Query: 232 --------GDFKL------PKW-----------LSPGAQNLLRKILEPNPVKRITIAGIK 266
G KL P+W LSP +LL+K+L +P KRI+
Sbjct: 230 TPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAAL 289
Query: 267 ADEWFE 272
+F+
Sbjct: 290 THPYFD 295
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 80/272 (29%), Positives = 137/272 (50%), Gaps = 19/272 (6%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E+ + +G G FG+V + ++G +A+KIL K ++ T + E L
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW 62
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKG 134
+ LH ++ +Y+V++Y GG+L ++ RL E R +++ + H G
Sbjct: 63 ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG 122
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT--CGSPNYVAPEVLA--- 189
HRD+K +N+LLD G+I+++DFG S L DG + + G+P+Y++PE+L
Sbjct: 123 YVHRDIKPDNVLLDKNGHIRLADFG-SCL--RLLADGTVQSNVAVGTPDYISPEILQAME 179
Query: 190 -NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI--FRGDFKLP---KWLSPG 243
+G G D WS GV +Y +L G PF +L Y KI + F+ P +S
Sbjct: 180 DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEE 239
Query: 244 AQNLLRKILEPNPVKRITIAGI---KADEWFE 272
A++L+R+++ P R+ G+ K +FE
Sbjct: 240 AKDLIRRLICS-PETRLGRNGLQDFKDHPFFE 270
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-24
Identities = 66/213 (30%), Positives = 111/213 (52%), Gaps = 21/213 (9%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD----QIKREIATLKL 70
R EL +G G +G V + + +G A+KI I+L D I+RE+A L
Sbjct: 5 RLEL---IGRGAYGAVYRGKHVPTGRVVALKI------INLDTPDDDVSDIQREVALLSQ 55
Query: 71 LKH---PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
L+ PN+ + + ++++++EY GG + + G + E + ++++ +
Sbjct: 56 LRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVAL 114
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
Y H GV HRD+K NIL+ + GN+K+ DFG++AL T G+P ++APEV
Sbjct: 115 KYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--SKRSTFVGTPYWMAPEV 172
Query: 188 LAN-RGYDGATSDIWSCGVILYVILTGYLPFDD 219
+ + YD +DIWS G+ +Y + TG P+ D
Sbjct: 173 ITEGKYYD-TKADIWSLGITIYEMATGNPPYSD 204
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 73/215 (33%), Positives = 108/215 (50%), Gaps = 8/215 (3%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
R LG+G FG+V Q +G +A K LEK RI K E L+ + VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGVSYCHNKGVFH 137
+K + +VL + GG+L I + G E R LF +++ G+ H + +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVY 125
Query: 138 RDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 196
RDLK ENILLD G+I+ISD GL+ +P+ + G+ Y+APEVL N+ Y
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAVKIPE----GESIRGRVGTVGYMAPEVLNNQRY-TL 180
Query: 197 TSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR 231
+ D W G ++Y ++ G PF R V +++ R
Sbjct: 181 SPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDR 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-24
Identities = 67/202 (33%), Positives = 94/202 (46%), Gaps = 19/202 (9%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+G+GNFG V + L AVK LK + +E LK HPN+V+L
Sbjct: 1 EKIGKGNFGDV-YKGVLKGNTEVAVKTCRSTLPPDLKR--KFLQEAEILKQYDHPNIVKL 57
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLID---GVSYCHNKGV 135
V K IY+V+E V GG L + K RL +KL Q +D G+ Y +K
Sbjct: 58 IGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTV---KKLLQMSLDAAAGMEYLESKNC 114
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----YVAPEVLANR 191
HRDL N L+ +KISDFG+S + G+ + G + APE L N
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMS----REEEGGIYTVSDGLKQIPIKWTAPEAL-NY 169
Query: 192 GYDGATSDIWSCGVILYVILTG 213
G + SD+WS G++L+ +
Sbjct: 170 GRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 3e-24
Identities = 74/259 (28%), Positives = 129/259 (49%), Gaps = 19/259 (7%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E+ LG+G FGKV A++ ++G A K++E L + EI L HP
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL---EDYMVEIEILATCNHPY 70
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKG 134
+V+L K+++++E+ GG + + R L E + + + +Q+++ + Y H+
Sbjct: 71 IVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK 130
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSA--LPQHFRDDGLLHTTCGSPNYVAPEV----- 187
+ HRDLK N+LL G+IK++DFG+SA + R D + G+P ++APEV
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI----GTPYWMAPEVVMCET 186
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGA 244
+ + YD +DIWS G+ L + P + N + KI + + P S
Sbjct: 187 MKDTPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEF 245
Query: 245 QNLLRKILEPNPVKRITIA 263
++ L+ L+ +P R + A
Sbjct: 246 RDFLKTALDKHPETRPSAA 264
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 4e-24
Identities = 81/257 (31%), Positives = 125/257 (48%), Gaps = 12/257 (4%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
R LG+G FG+V Q +G +A K LEK RI K E L+ + VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGVSYCHNKGVFH 137
+K + +VL + GG+L I + G E R +F +L G+ + + +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVY 125
Query: 138 RDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 196
RDLK ENILLD +G+I+ISD GL+ +P+ G + G+ Y+APEV+ N Y
Sbjct: 126 RDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV----GTVGYMAPEVINNEKY-TF 180
Query: 197 TSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR----GDFKLPKWLSPGAQNLLRKIL 252
+ D W G ++Y ++ G PF R V +++ R + + S A+++ R +L
Sbjct: 181 SPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLL 240
Query: 253 EPNPVKRITIAGIKADE 269
NP +R+ G A
Sbjct: 241 TKNPKERLGCRGNGAAG 257
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 7e-24
Identities = 71/249 (28%), Positives = 127/249 (51%), Gaps = 15/249 (6%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E+ + +G G FG+V + + +A+KIL K ++ T + E L
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
+ LH ++ +Y+V++Y GG+L ++ + RL E R +++ + H
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT--CGSPNYVAPEVLA--- 189
HRD+K +N+LLD G+I+++DFG S L + DG + ++ G+P+Y++PE+L
Sbjct: 123 YVHRDIKPDNVLLDMNGHIRLADFG-SCLKMN--QDGTVQSSVAVGTPDYISPEILQAME 179
Query: 190 -NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLPKWL---SPG 243
G G D WS GV +Y +L G PF +L Y KI + F+ P + S
Sbjct: 180 DGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE 239
Query: 244 AQNLLRKIL 252
A++L+++++
Sbjct: 240 AKDLIQRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 1e-23
Identities = 78/254 (30%), Positives = 124/254 (48%), Gaps = 14/254 (5%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
+G GNFG+V + P AVK + LK + +E LK HPN+VRL
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLK--AKFLQEARILKQYSHPNIVRLIG 60
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL 140
V K IY+V+E V GG+ + ++G RL+ E ++ + G+ Y +K HRDL
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 141 KLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----YVAPEVLANRGYDGA 196
N L+ K +KISDFG+S +DG+ +T G + APE L N G +
Sbjct: 121 AARNCLVTEKNVLKISDFGMS----REEEDGVYASTGGMKQIPVKWTAPEAL-NYGRYSS 175
Query: 197 TSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA-QNLLRKILEP 254
SD+WS G++L+ + G +P+ + + + I +G L P A L+ + E
Sbjct: 176 ESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEY 235
Query: 255 NPVKRITIAGIKAD 268
+P +R + + + +
Sbjct: 236 DPGQRPSFSTVHQE 249
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 1e-23
Identities = 70/251 (27%), Positives = 119/251 (47%), Gaps = 20/251 (7%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+LG T+G+G FG V G AVK L+ E + + L+HPN+
Sbjct: 9 KLGATIGKGEFGDVM--LGDYRGQKVAVKCLKD----DSTAAQAFLAEASVMTTLRHPNL 62
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQ-QLIDGVSYCHNKG 134
V+L V+ + +Y+V EY+ G L D + S+GR + + F + +G+ Y K
Sbjct: 63 VQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN 122
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGY 193
HRDL N+L+ K+SDFGL+ ++ + P + APE L + +
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLA------KEASQGQDSGKLPVKWTAPEALREKKF 176
Query: 194 DGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGAQNLLRK 250
SD+WS G++L+ I + G +P+ L + + +G +++ P+ P +++
Sbjct: 177 S-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG-YRMEAPEGCPPEVYKVMKD 234
Query: 251 ILEPNPVKRIT 261
E +P KR T
Sbjct: 235 CWELDPAKRPT 245
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-23
Identities = 47/137 (34%), Positives = 81/137 (59%)
Query: 25 GNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA 84
G FGKV + ++ +AVK+++K +I+ + Q++ E L L K P +V L+ L
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74
Query: 85 SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLEN 144
S + +Y+V+EY+ GG++ + G E K ++ + Y H G+ HRDLK +N
Sbjct: 75 SANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDN 134
Query: 145 ILLDSKGNIKISDFGLS 161
+L+ ++G+IK++DFGLS
Sbjct: 135 MLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 2e-23
Identities = 93/302 (30%), Positives = 142/302 (47%), Gaps = 60/302 (19%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ-----IKREIATLK 69
+YE +GEG +G V A+D + A+K I L+ D+ REI+ LK
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKK------IRLEQEDEGVPSTAIREISLLK 56
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ----QLID 125
++H N+VRL +V+ S+ ++Y+V EY+ +L K A+ +L + Q++
Sbjct: 57 EMQHGNIVRLQDVVHSEKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLYQILR 113
Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGN-IKISDFGLSALPQHFRDDGLLHTTCGSPN--- 181
G++YCH+ V HRDLK +N+L+D + N +K++DFGL+ R G+ T
Sbjct: 114 GIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLA------RAFGIPVRTFTHEVVTL 167
Query: 182 -YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAVLYQKIFR-------- 231
Y APE+L + DIWS G I ++ F D + L+ KIFR
Sbjct: 168 WYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF-KIFRILGTPNEE 226
Query: 232 --------GDFK--LPKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEW 270
D+K PKW L P +LL K+L +P KRIT E+
Sbjct: 227 TWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEY 286
Query: 271 FE 272
F+
Sbjct: 287 FK 288
|
Length = 294 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 2e-23
Identities = 66/209 (31%), Positives = 102/209 (48%), Gaps = 21/209 (10%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLK 72
+YE +G+G FG+V A+ + A+K +L +N IT REI L+LLK
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITAL--REIKILQLLK 69
Query: 73 HPNVVRLHEVLASKSK--------IYMVLEYVT---GGELFDKIASKGRLQEAEGRKLFQ 121
H NVV L E+ +K+ Y+V E+ G L +K + +E +K+ +
Sbjct: 70 HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNK---NVKFTLSEIKKVMK 126
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTT-CGS 179
L++G+ Y H + HRD+K NIL+ G +K++DFGL+ A +T +
Sbjct: 127 MLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVT 186
Query: 180 PNYVAPEVLAN-RGYDGATSDIWSCGVIL 207
Y PE+L R Y G D+W G I+
Sbjct: 187 LWYRPPELLLGERDY-GPPIDMWGAGCIM 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 3e-23
Identities = 62/196 (31%), Positives = 110/196 (56%), Gaps = 7/196 (3%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
+GEG+ G V A + +G AVK ++ + + + + E+ ++ H NVV ++
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYN 86
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
++++V+E++ GG L D I + R+ E + + ++ +SY HN+GV HRD+K
Sbjct: 87 SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIK 145
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
++ILL S G IK+SDFG A Q ++ + G+P ++APEV++ Y G DIW
Sbjct: 146 SDSILLTSDGRIKLSDFGFCA--QVSKEVPKRKSLVGTPYWMAPEVISRLPY-GTEVDIW 202
Query: 202 SCGVILYVILTGYLPF 217
S G+++ ++ G P+
Sbjct: 203 SLGIMVIEMIDGEPPY 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 3e-23
Identities = 72/253 (28%), Positives = 130/253 (51%), Gaps = 20/253 (7%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL--- 71
+Y +G+G G V A D+ +G A+K + + Q K+E+ ++L
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIK--------QMNLQQQPKKELIINEILVMR 71
Query: 72 --KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
K+PN+V + ++++V+EY+ GG L D + ++ + E + + ++ + + +
Sbjct: 72 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALDF 130
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
H+ V HRD+K +NILL G++K++DFG A Q + T G+P ++APEV+
Sbjct: 131 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVT 188
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGDFKL--PKWLSPGAQN 246
+ Y G DIWS G++ ++ G P+ + N L LY G +L P+ LS ++
Sbjct: 189 RKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRD 247
Query: 247 LLRKILEPNPVKR 259
L + LE + +R
Sbjct: 248 FLNRCLEMDVDRR 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 8e-23
Identities = 77/268 (28%), Positives = 126/268 (47%), Gaps = 20/268 (7%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPF-AVK-------ILEKNRIIHLKITDQIKREIAT 67
Y + LG G FG V + ++G A+K K++ K I E+
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 68 LK-LLKHPNVVRLHEVLASKSKIYMVLEYVTG---GELFDKIASKG-RLQEAEGRKLFQQ 122
+K L+HPN+VR ++ ++Y+V++ + G GE F+ + K R E +F Q
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 123 LIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
++ + Y H K + HRDL NI+L + I+DFGL+ Q + L + G+
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQ---PESKLTSVVGTIL 178
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWL 240
Y PE++ N Y G +D+W+ G ILY + T PF N+ L KI ++ LP+ +
Sbjct: 179 YSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM 237
Query: 241 -SPGAQNLLRKILEPNPVKRITIAGIKA 267
S +++ L P+ R I + A
Sbjct: 238 YSEDVTDVITSCLTPDAEARPDIIQVSA 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 9e-23
Identities = 84/296 (28%), Positives = 127/296 (42%), Gaps = 55/296 (18%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
RY R LG G+ G V A D D AVK + +K REI ++ L H
Sbjct: 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVK---HALREIKIIRRLDH 61
Query: 74 PNVVRLHEVLASKSK--------------IYMVLEYVTGGELFDKIASKGRLQEAEGRKL 119
N+V+++EVL +Y+V EY+ + +G L E R
Sbjct: 62 DNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGPLSEEHARLF 119
Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLS-ALPQHFRDDGLLHTTC 177
QL+ G+ Y H+ V HRDLK N+ ++++ + KI DFGL+ + H+ G L
Sbjct: 120 MYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGL 179
Query: 178 GSPNYVAPE-VLANRGYDGATSDIWSCGVILYVILTGYLPF------------------- 217
+ Y +P +L+ Y A D+W+ G I +LTG F
Sbjct: 180 VTKWYRSPRLLLSPNNYTKAI-DMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238
Query: 218 --DDRN--LAVLYQKIFRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRIT 261
+DRN L V+ + R D P+ ++P A + L +IL NP+ R+T
Sbjct: 239 REEDRNELLNVIPSFV-RNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLT 293
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 1e-22
Identities = 84/270 (31%), Positives = 135/270 (50%), Gaps = 29/270 (10%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HP 74
+E+ T+G+G +GKV + +G AVKIL+ IH I ++I+ E LK L HP
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDP---IH-DIDEEIEAEYNILKALSDHP 75
Query: 75 NVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRK------LFQQL 123
NVV+ + + K ++++VLE GG + D + KG L+ E + + +
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLV--KGFLKRGERMEEPIIAYILHEA 133
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
+ G+ + H HRD+K NILL ++G +K+ DFG+SA R +T+ G+P ++
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWM 191
Query: 184 APEVLA-----NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---DFK 235
APEV+A + YD A D+WS G+ + G P D + KI R
Sbjct: 192 APEVIACEQQLDSTYD-ARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLH 250
Query: 236 LPKWLSPGAQNLLRKILEPNPVKRITIAGI 265
P+ S + +RK L + KR T++ +
Sbjct: 251 QPELWSNEFNDFIRKCLTKDYEKRPTVSDL 280
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|217748 pfam03822, NAF, NAF domain | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 1e-22
Identities = 29/58 (50%), Positives = 43/58 (74%), Gaps = 1/58 (1%)
Query: 313 INAFQLIGMSSCLDLSGFFEKEDVSERK-IRFTSNHSAKDLLERIEDIVTEMGFRVQK 369
+NAF LI +SS LDLSG FE+E S++K RFTS A +++ ++E+I E+GF+V+K
Sbjct: 1 LNAFDLISLSSGLDLSGLFEEEKKSKKKETRFTSRKPASEIISKLEEIAKELGFKVKK 58
|
Length = 58 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 97.1 bits (241), Expect = 1e-22
Identities = 70/255 (27%), Positives = 132/255 (51%), Gaps = 24/255 (9%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL--- 71
+Y +G+G G V A D+ +G A++ + + Q K+E+ ++L
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIR--------QMNLQQQPKKELIINEILVMR 72
Query: 72 --KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
K+PN+V + ++++V+EY+ GG L D + ++ + E + + ++ + + +
Sbjct: 73 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEF 131
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSA--LPQHFRDDGLLHTTCGSPNYVAPEV 187
H+ V HRD+K +NILL G++K++DFG A P+ + ++ G+P ++APEV
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV----GTPYWMAPEV 187
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGDFKL--PKWLSPGA 244
+ + Y G DIWS G++ ++ G P+ + N L LY G +L P+ LS
Sbjct: 188 VTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246
Query: 245 QNLLRKILEPNPVKR 259
++ L + L+ + KR
Sbjct: 247 RDFLNRCLDMDVEKR 261
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 1e-22
Identities = 79/264 (29%), Positives = 126/264 (47%), Gaps = 23/264 (8%)
Query: 16 YELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL 68
+E+ RT LG G +G+V L AVK L+++ + ++ +E A +
Sbjct: 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVM 56
Query: 69 KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ---QLID 125
K +KHPN+V+L V + Y++ E++T G L D + R QE L Q+
Sbjct: 57 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISS 115
Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVA 184
+ Y K HRDL N L+ +K++DFGLS L D H P + A
Sbjct: 116 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTA 173
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLS 241
PE LA + SD+W+ GV+L+ I T G P+ +L+ +Y+ + +G +++ P+
Sbjct: 174 PESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG-YRMERPEGCP 231
Query: 242 PGAQNLLRKILEPNPVKRITIAGI 265
P L+R + NP R + A I
Sbjct: 232 PKVYELMRACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 1e-22
Identities = 77/245 (31%), Positives = 121/245 (49%), Gaps = 31/245 (12%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-K 72
+E+ T+G+G +GKV + G AVKIL+ + ++I+ E L+ L
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPN 77
Query: 73 HPNVVRLHEVL-----ASKSKIYMVLEYVTGG---ELFDKIASKG-RLQEAEGRKLFQQL 123
HPNVV+ + + ++++VLE GG EL + G RL EA +
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
+ G+ + HN + HRD+K NILL ++G +K+ DFG+SA R +T+ G+P ++
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWM 195
Query: 184 APEVLA-----NRGYDGATSDIWSCGVILYVILTGYLP-FDDRNLAVLYQKIFRGDFKLP 237
APEV+A + YD A D+WS G+ + G P FD + L FK+P
Sbjct: 196 APEVIACEQQYDYSYD-ARCDVWSLGITAIELGDGDPPLFDMHPVKTL--------FKIP 246
Query: 238 KWLSP 242
+ P
Sbjct: 247 RNPPP 251
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 2e-22
Identities = 88/304 (28%), Positives = 132/304 (43%), Gaps = 56/304 (18%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
RY++ +G+G++G V A D +G A+K + + H+ +I REI L+LL+HP
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI-NDVFEHVSDATRILREIKLLRLLRHP 59
Query: 75 NVVRLHEVLASKSK-----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
++V + ++ S+ IY+V E + +L I + L + QL+ + Y
Sbjct: 60 DIVEIKHIMLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHHQFFLYQLLRALKY 118
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV------ 183
H VFHRDLK +NIL ++ +KI DFGL+ + F D T +YV
Sbjct: 119 IHTANVFHRDLKPKNILANADCKLKICDFGLARV--AFNDTP---TAIFWTDYVATRWYR 173
Query: 184 APEVLANRGYDGATS--DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF------- 234
APE L + T DIWS G I +LTG F +N V++Q D
Sbjct: 174 APE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN--VVHQLDLITDLLGTPSPE 230
Query: 235 -------------------KLPKWLS-------PGAQNLLRKILEPNPVKRITIAGIKAD 268
K P S P A LL ++L +P R T AD
Sbjct: 231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290
Query: 269 EWFE 272
+F+
Sbjct: 291 PYFK 294
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 2e-22
Identities = 79/267 (29%), Positives = 125/267 (46%), Gaps = 20/267 (7%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
LG+G FG+V Q +G +A K L K R+ K + E L + +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEA--EGRKLF--QQLIDGVSYCHNKGVFH 137
+K+ + +V+ + GG+L I + E R F Q+I G+ + H + + +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT--CGSPNYVAPEVLANRGYDG 195
RDLK EN+LLD+ GN++ISD GL+ + DG T G+P ++APE+L YD
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELK----DGQSKTKGYAGTPGFMAPELLQGEEYDF 176
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAV----LYQKIFRGDFKLPKWLSPGAQNLLRKI 251
+ D ++ GV LY ++ PF R V L Q+I P SP +++ +
Sbjct: 177 SV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEAL 235
Query: 252 LEPNPVKRI-----TIAGIKADEWFEQ 273
L +P KR+ G++ F
Sbjct: 236 LAKDPEKRLGFRDGNCDGLRTHPLFRD 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 4e-22
Identities = 95/310 (30%), Positives = 143/310 (46%), Gaps = 52/310 (16%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
RY+ +G G +G V A D +GL AVK L + IIH K T RE+ LK +K
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 74
Query: 73 HPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
H NV+ L +V +Y+V ++ G +L + I +L + + L Q++ G
Sbjct: 75 HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 132
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
+ Y H+ + HRDLK N+ ++ +KI DFGL+ +H D+ + + Y APE
Sbjct: 133 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 187
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKIFR 231
++ N + T DIWS G I+ +LTG F D L A L +KI
Sbjct: 188 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 247
Query: 232 GDFK--------LPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
+ +PK +P A +LL K+L + KRIT A A +F Q +
Sbjct: 248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 307
Query: 276 TPANPDDDEE 285
+PDD+
Sbjct: 308 ---DPDDEPV 314
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 7e-22
Identities = 59/199 (29%), Positives = 106/199 (53%), Gaps = 8/199 (4%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
+G+G+FG+V D + A+KI++ +I D I++EI L P + R +
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIED-IQQEITVLSQCDSPYITRYYG 69
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
+K+++++EY+ GG D + G L+E + ++++ G+ Y H++ HRD+K
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDIK 128
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT-CGSPNYVAPEVLANRGYDGATSDI 200
N+LL +G++K++DFG++ D + T G+P ++APEV+ YD +DI
Sbjct: 129 AANVLLSEQGDVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-FKADI 184
Query: 201 WSCGVILYVILTGYLPFDD 219
WS G+ + G P D
Sbjct: 185 WSLGITAIELAKGEPPNSD 203
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 67/201 (33%), Positives = 103/201 (51%), Gaps = 11/201 (5%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
RY + +G G FG V A+D +G A+K + K + + + RE+ LK L+H
Sbjct: 11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPV-LAKRTYRELKLLKHLRHE 69
Query: 75 NVVRLHEVLASKSK-IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
N++ L ++ S + IY V E + G ++ + L++ + Q++ G+ Y H+
Sbjct: 70 NIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSA 127
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV-LANRG 192
GV HRDLK NIL++ ++KI DFGL A Q + G + T Y APE+ L +
Sbjct: 128 GVVHRDLKPSNILINENCDLKICDFGL-ARIQDPQMTGYVSTR----YYRAPEIMLTWQK 182
Query: 193 YDGATSDIWSCGVILYVILTG 213
YD DIWS G I +L G
Sbjct: 183 YDVEV-DIWSAGCIFAEMLEG 202
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 2e-21
Identities = 68/204 (33%), Positives = 106/204 (51%), Gaps = 19/204 (9%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
LG+GNFG+V F L P AVK +++ LKI + E LK HPN+V+L
Sbjct: 3 LGKGNFGEV-FKGTLKDKTPVAVKTCKEDLPQELKI--KFLSEARILKQYDHPNIVKLIG 59
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---GVSYCHNKGVFHR 138
V + IY+V+E V GG+ + K E + ++L + +D G++Y +K HR
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRKKK--DELKTKQLVKFALDAAAGMAYLESKNCIHR 117
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----YVAPEVLANRGYD 194
DL N L+ +KISDFG+S ++D ++++ G + APE L N G
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR-----QEDDGIYSSSGLKQIPIKWTAPEAL-NYGRY 171
Query: 195 GATSDIWSCGVILYVILT-GYLPF 217
+ SD+WS G++L+ + G P+
Sbjct: 172 SSESDVWSYGILLWETFSLGVCPY 195
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 2e-21
Identities = 90/314 (28%), Positives = 135/314 (42%), Gaps = 50/314 (15%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
RY + +G G +G V A D +G A+K L + L + RE+ LK +KH
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSEL-FAKRAYRELRLLKHMKHE 74
Query: 75 NVVRLHEVLASKSKI------YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
NV+ L +V + Y+V+ ++ G K+ +L E + L Q++ G+
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLK 132
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
Y H G+ HRDLK N+ ++ +KI DFGL+ + D + + Y APEV+
Sbjct: 133 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVTRWYRAPEVI 187
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPF------------------------------D 218
N + T DIWS G I+ +LTG F D
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSED 247
Query: 219 DRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ---- 273
+N + + DF+ L +P A N+L K+L + RIT A A +FE+
Sbjct: 248 AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307
Query: 274 -DYTPANPDDDEED 286
D T A P DD D
Sbjct: 308 EDETEAPPYDDSFD 321
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 95/329 (28%), Positives = 144/329 (43%), Gaps = 65/329 (19%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
RY+ +GEG +G V A +G+ A+K + H + REI L+ KH
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISP--FEHQTFCQRTLREIKILRRFKHE 63
Query: 75 NVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
N++ + +++ S +Y+V E + +L+ I ++ L + Q++ G+ Y
Sbjct: 64 NIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQ-HLSNDHIQYFLYQILRGLKY 121
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGL--SALPQHFRDDGLLHTTCGSPNYVAPEV 187
H+ V HRDLK N+LL++ ++KI DFGL A P+H G L + Y APE+
Sbjct: 122 IHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH-DHTGFLTEYVATRWYRAPEI 180
Query: 188 -LANRGYDGATSDIWSCGVILYVILTG--------Y------------------------ 214
L ++GY A DIWS G IL +L+ Y
Sbjct: 181 MLNSKGYTKAI-DIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS 239
Query: 215 ---------LPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI 265
LPF + V + K+F P P A +LL K+L NP KRIT+
Sbjct: 240 LRARNYIKSLPFKPK---VPWNKLF------PN-ADPKALDLLDKMLTFNPHKRITVEEA 289
Query: 266 KADEWFEQDYTPANPDDDEEDIFVDNEAF 294
A + EQ + P++ EE D E F
Sbjct: 290 LAHPYLEQYHDPSDEPVAEEPFPFDFELF 318
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 4e-21
Identities = 75/204 (36%), Positives = 109/204 (53%), Gaps = 22/204 (10%)
Query: 22 LGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
LG+GNFG V+ QD ++G AVK L+ + HL+ +REI LK L+H N+
Sbjct: 12 LGKGNFGSVELCRYDPLQD-NTGEVVAVKKLQHSTAEHLR---DFEREIEILKSLQHDNI 67
Query: 77 VRLHEVLASKSK--IYMVLEYVTGGELFDK-IASKGRLQEAEGRKLFQ---QLIDGVSYC 130
V+ V S + + +V+EY+ G L D + RL + RKL Q+ G+ Y
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERL---DHRKLLLYASQICKGMEYL 124
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNY-VAPEVL 188
+K HRDL NIL++S+ +KI DFGL+ LPQ ++ + SP + APE L
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD-KEYYKVREPGESPIFWYAPESL 183
Query: 189 ANRGYDGATSDIWSCGVILYVILT 212
+ A SD+WS GV+LY + T
Sbjct: 184 TESKFSVA-SDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 5e-21
Identities = 57/173 (32%), Positives = 94/173 (54%), Gaps = 10/173 (5%)
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ- 121
RE++ LK LKH N+V LH+++ ++ + +V EY+ +L + + G L K+F
Sbjct: 52 REVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMF 110
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCG 178
QL+ G+SYCH + + HRDLK +N+L++ KG +K++DFGL+ ++P + ++
Sbjct: 111 QLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV----- 165
Query: 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR 231
+ Y P+VL D+W G ILY + TG F + IFR
Sbjct: 166 TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFR 218
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 6e-21
Identities = 75/207 (36%), Positives = 108/207 (52%), Gaps = 25/207 (12%)
Query: 20 RTLGEGNFGKVKF-----AQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
R LGEG+FGKV A D +G AVK L++ T K+EI LK L H
Sbjct: 10 RVLGEGHFGKVSLYCYDPAND-GTGEMVAVKTLKRECGQQN--TSGWKKEINILKTLYHE 66
Query: 75 NVVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
N+V+ + + + +++EYV G L D + K +L A+ QQ+ +G++Y H+
Sbjct: 67 NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNLAQLLLFAQQICEGMAYLHS 125
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQ-----HFRDDGLLHTTCGSPNY-VAP 185
+ HRDL N+LLD+ +KI DFGL+ A+P+ R+DG SP + A
Sbjct: 126 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG------DSPVFWYAV 179
Query: 186 EVLANRGYDGATSDIWSCGVILYVILT 212
E L + A SD+WS GV LY +LT
Sbjct: 180 ECLKENKFSYA-SDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 6e-21
Identities = 65/205 (31%), Positives = 99/205 (48%), Gaps = 13/205 (6%)
Query: 20 RTLGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+ LG GNFG V L + AVK L++ I K + RE + + L HP +
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGK--KEFLREASVMAQLDHPCI 58
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVF 136
VRL V + + +V+E G L + + + ++ ++L Q+ G++Y +K
Sbjct: 59 VRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117
Query: 137 HRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGS-P-NYVAPEVLANRGY 193
HRDL N+LL ++ KISDFG+S AL D TT G P + APE + +
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRAL--GAGSDYYRATTAGRWPLKWYAPECINYGKF 175
Query: 194 DGATSDIWSCGVILYVILT-GYLPF 217
SD+WS GV L+ + G P+
Sbjct: 176 SSK-SDVWSYGVTLWEAFSYGAKPY 199
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 7e-21
Identities = 105/346 (30%), Positives = 146/346 (42%), Gaps = 83/346 (23%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK---------R 63
L +YE+ + LG+G +G V A D + A+K KI D + R
Sbjct: 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALK----------KIFDAFRNATDAQRTFR 55
Query: 64 EIATLK-LLKHPNVVRLHEVL-ASKSK-IYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
EI L+ L HPN+V+L V+ A K IY+V EY+ +L I L++ R +
Sbjct: 56 EIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVI-RANILEDVHKRYIM 113
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGS 179
QL+ + Y H+ V HRDLK NILL+S +K++DFGL+ +L + + T
Sbjct: 114 YQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLT--- 170
Query: 180 PNYVA------PEVL-ANRGYDGATSDIWSCGVILYVILTG------------------- 213
+YVA PE+L + Y D+WS G IL +L G
Sbjct: 171 -DYVATRWYRAPEILLGSTRYTKGV-DMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEV 228
Query: 214 ------------YLPFDDRNLAVLYQ-KIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI 260
PF L L D LPK S A +LL+K+L NP KR+
Sbjct: 229 IGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPK-ASDDALDLLKKLLVFNPNKRL 287
Query: 261 TIAGIKADEWFEQDYTPA--NPDDDE---EDI---FVDNEAFSMHE 298
T A+E E Y NP D+ I DN S+ E
Sbjct: 288 T-----AEEALEHPYVAQFHNPSDEPVLPYPITIPLDDNVKLSVAE 328
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 8e-21
Identities = 88/287 (30%), Positives = 130/287 (45%), Gaps = 49/287 (17%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILE-KNRIIHLKITDQIKREIATLKLLK- 72
+YE +G G +G V A+D SG A+K + + L ++ RE+A LK L+
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLS--TVREVALLKRLEA 58
Query: 73 --HPNVVRLHEVLAS-----KSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQL 123
HPN+VRL +V A+ ++K+ +V E+V DK+ G L + L +Q
Sbjct: 59 FDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG-LPAETIKDLMRQF 117
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ-HFRDDGLLHTTCGSPNY 182
+ G+ + H + HRDLK ENIL+ S G +K++DFGL+ + ++ T Y
Sbjct: 118 LRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLW----Y 173
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF------------ 230
APEVL Y D+WS G I + F + A KIF
Sbjct: 174 RAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 232
Query: 231 ------RGDFK----------LPKWLSPGAQNLLRKILEPNPVKRIT 261
RG F +P+ GAQ LL ++L NP KRI+
Sbjct: 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQ-LLLEMLTFNPHKRIS 278
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 9e-21
Identities = 72/248 (29%), Positives = 131/248 (52%), Gaps = 16/248 (6%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
+GEG+ G V A SG AVK ++ + + + + E+ ++ +H NVV ++
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
++++V+E++ GG L D I + R+ E + + ++ +S H +GV HRD+K
Sbjct: 85 SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIK 143
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
++ILL G +K+SDFG A Q ++ + G+P ++APE+++ Y G DIW
Sbjct: 144 SDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPELISRLPY-GPEVDIW 200
Query: 202 SCGVILYVILTGYLP-FDDRNLAVLYQKIFRGDFKLPKW-----LSPGAQNLLRKILEPN 255
S G+++ ++ G P F++ L + K+ R + PK +SP + L ++L +
Sbjct: 201 SLGIMVIEMVDGEPPYFNEPPLKAM--KMIRDNLP-PKLKNLHKVSPSLKGFLDRLLVRD 257
Query: 256 PVKRITIA 263
P +R T A
Sbjct: 258 PAQRATAA 265
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 2e-20
Identities = 75/254 (29%), Positives = 127/254 (50%), Gaps = 38/254 (14%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
RL YE+ + +G G FG+V + + F K + R + + Q+ E+ ++ L
Sbjct: 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISY-RGLKEREKSQLVIEVNVMREL 69
Query: 72 KHPNVVRLHEVLASKS--KIYMVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLID 125
KH N+VR + +K+ K+Y+++E+ G+L I G+++E + +QL+
Sbjct: 70 KHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLH 129
Query: 126 GVSYCHN-------KGVFHRDLKLENILLDSK----GNI-------------KISDFGLS 161
++YCHN + V HRDLK +NI L + G I KI DFGLS
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS 189
Query: 162 ALPQHFRDDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDD 219
++ + + H+ G+P Y +PE+L + + YD SD+W+ G I+Y + +G PF
Sbjct: 190 ---KNIGIESMAHSCVGTPYYWSPELLLHETKSYDD-KSDMWALGCIIYELCSGKTPFHK 245
Query: 220 -RNLAVLYQKIFRG 232
N + L ++ RG
Sbjct: 246 ANNFSQLISELKRG 259
|
Length = 1021 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 2e-20
Identities = 74/281 (26%), Positives = 124/281 (44%), Gaps = 34/281 (12%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD----QIKREIATLKLLKHPNVV 77
LG+GN+G V +G+ A+K I L++ + QI E+ L P +V
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKE------IRLELDESKFNQIIMELDILHKAVSPYIV 62
Query: 78 RLHEVLASKSKIYMVLEYVTGG---ELFDKIASKGRLQEAEGRKLFQQLIDGVSYC---H 131
+ + +YM +EY+ G +L+ + + E R++ ++ G+ + H
Sbjct: 63 DFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH 122
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
N + HRD+K N+L++ G +K+ DFG+S L T G +Y+APE + +
Sbjct: 123 N--IIHRDVKPTNVLVNGNGQVKLCDFGVSGN----LVASLAKTNIGCQSYMAPERIKSG 176
Query: 192 GYDGA-----TSDIWSCGVILYVILTGYLPFDDRNLAVLY---QKIFRGD-FKLPKWLSP 242
G + SD+WS G+ + + G P+ A ++ I GD LP S
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSD 236
Query: 243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDD 283
AQ+ + K L P +R T A + W + N D D
Sbjct: 237 DAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY---KNADVD 274
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 3e-20
Identities = 62/250 (24%), Positives = 113/250 (45%), Gaps = 20/250 (8%)
Query: 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
+ LG G FG V + + A+K++ + + D E + L HPN+V
Sbjct: 8 FLKELGSGQFGVVHLGKWRGK-IDVAIKMIREGAMSE----DDFIEEAKVMMKLSHPNLV 62
Query: 78 RLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVF 136
+L+ V + I++V EY+ G L + + KG+L + + + + Y + G
Sbjct: 63 QLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFI 122
Query: 137 HRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGY 193
HRDL N L+ +K+SDFGL+ ++ DD + G+ + PEV +
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLA---RYVLDDQYTSSQ-GTKFPVKWAPPEVF-DYSR 177
Query: 194 DGATSDIWSCGVILYVILT-GYLPFDDR-NLAVLYQKIFRGDFKL--PKWLSPGAQNLLR 249
+ SD+WS GV+++ + + G +P++ N V+ + + G ++L PK ++
Sbjct: 178 FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV-ESVSAG-YRLYRPKLAPTEVYTIMY 235
Query: 250 KILEPNPVKR 259
P R
Sbjct: 236 SCWHEKPEDR 245
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 3e-20
Identities = 66/230 (28%), Positives = 109/230 (47%), Gaps = 28/230 (12%)
Query: 13 LGRYELGRTLGEGNFGKV---------------KFAQDLDSGLPFAVKILEKNRIIHLKI 57
L + + L G FGK+ + + G P +++ K +
Sbjct: 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRA 206
Query: 58 TDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV---LEYVTGGELFDK-IASKGRLQE 113
Q++ EI L L H N++++ E+L S++ YM+ ++ ++D+ K R
Sbjct: 207 AIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLL 266
Query: 114 AEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL---PQHFRDD 170
+ R + +QL+ V Y H+K + HRD+KLENI L+ G I + DFG + + D
Sbjct: 267 KQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDY 326
Query: 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDD 219
G + T + +PE+LA GY T DIWSCG+IL +L+ + P D
Sbjct: 327 GWVGTVATN----SPEILAGDGYCEIT-DIWSCGLILLDMLSHDFCPIGD 371
|
Length = 501 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 5e-20
Identities = 62/218 (28%), Positives = 117/218 (53%), Gaps = 15/218 (6%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+ LG G FG VK+ + A+K++++ + D+ E + L H +V+L
Sbjct: 10 KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMKLSHEKLVQL 64
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
+ V + IY+V EY++ G L + + G R Q ++ ++ + + +G++Y +K HR
Sbjct: 65 YGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHR 124
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDG 195
DL N L+D +G +K+SDFGLS ++ DD ++ GS + PEVL +
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLS---RYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFS- 179
Query: 196 ATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG 232
+ SD+W+ GV+++ + + G +P++ N + +K+ +G
Sbjct: 180 SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQG 217
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 5e-20
Identities = 72/254 (28%), Positives = 121/254 (47%), Gaps = 20/254 (7%)
Query: 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ-IKREIATLK 69
+ L + LG +GEG FG V + G AVK I +T Q E A +
Sbjct: 3 LNLQKLTLGEIIGEGEFGAVLQGEYT--GQKVAVKN------IKCDVTAQAFLEETAVMT 54
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGV 127
L H N+VRL V+ +Y+V+E ++ G L + + ++GR + + + + +G+
Sbjct: 55 KLHHKNLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGM 113
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
Y +K + HRDL NIL+ G K+SDFGL+ + D+ L + APE
Sbjct: 114 EYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV-----KWTAPEA 168
Query: 188 LANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQ 245
L ++ + + SD+WS GV+L+ + + G P+ +L + + + +G + P+
Sbjct: 169 LKHKKFS-SKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVY 227
Query: 246 NLLRKILEPNPVKR 259
L+ E P KR
Sbjct: 228 VLMTSCWETEPKKR 241
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 6e-20
Identities = 73/274 (26%), Positives = 124/274 (45%), Gaps = 33/274 (12%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL----KITDQIKREIATLKLLKHPN 75
LG GN G V + + +G A K+ +H+ + QI RE+ + + P
Sbjct: 11 SDLGAGNGGSVSKVKHIPTGTVMAKKV------VHIGAKSSVRKQILRELQIMHECRSPY 64
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNK- 133
+V + +++ I M +E++ G L D+I K G + K+ +++G++Y +N
Sbjct: 65 IVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH 123
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
+ HRD+K NIL++S+G IK+ DFG+S L D T G+ Y++PE +
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD-----TFVGTSTYMSPERIQGGK 178
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRN------------LAVLYQKIFRGDFKLPK-W 239
Y SD+WS G+ + + G PF N L +L Q + +LP
Sbjct: 179 YT-VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSD 237
Query: 240 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273
++ + L +P +R T + A F Q
Sbjct: 238 FPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 6e-20
Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 33/224 (14%)
Query: 17 ELGRTLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
L R LG+G+FG V K + A+K + +N + +I + E + +K
Sbjct: 9 TLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI--EFLNEASVMKEF 66
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR--------KLFQ-- 121
+VVRL V+++ +V+E + G+L + S+ R + K Q
Sbjct: 67 NCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSR-RPEAENNPGLGPPTLQKFIQMA 125
Query: 122 -QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL---PQHFRDDG--LLHT 175
++ DG++Y K HRDL N ++ +KI DFG++ ++R G LL
Sbjct: 126 AEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL-- 183
Query: 176 TCGSP-NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 217
P ++APE L + G SD+WS GV+L+ + T P+
Sbjct: 184 ----PVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPY 222
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 7e-20
Identities = 66/219 (30%), Positives = 113/219 (51%), Gaps = 19/219 (8%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
G +EL +G G +G+V + + +G A+K+++ + ++IK EI LK H
Sbjct: 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKLEINMLKKYSH 71
Query: 74 -PNVVRLHEVLASKS------KIYMVLEYVTGGELFDKIA-SKGR-LQEAEGRKLFQQLI 124
N+ + KS ++++V+E+ G + D + +KG L+E + ++++
Sbjct: 72 HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREIL 131
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
G+++ H V HRD+K +N+LL +K+ DFG+SA Q R G +T G+P ++A
Sbjct: 132 RGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMA 189
Query: 185 PEVLANRGYDGAT----SDIWSCGVILYVILTGYLPFDD 219
PEV+A AT SDIWS G+ + G P D
Sbjct: 190 PEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 7e-20
Identities = 64/223 (28%), Positives = 116/223 (52%), Gaps = 17/223 (7%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
+G+G+FG+V D + A+KI++ +I D I++EI L P V + +
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIED-IQQEITVLSQCDSPYVTKYYG 69
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
+K+++++EY+ GG D + + G E + + ++++ G+ Y H++ HRD+K
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIK 128
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT-CGSPNYVAPEVLANRGYDGATSDI 200
N+LL +G++K++DFG++ D + T G+P ++APEV+ YD + +DI
Sbjct: 129 AANVLLSEQGDVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIQQSAYD-SKADI 184
Query: 201 WSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGDFKLPKWLSP 242
WS G+ + G P D + + VL F +PK P
Sbjct: 185 WSLGITAIELAKGEPPNSDMHPMRVL--------FLIPKNNPP 219
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 8e-20
Identities = 86/313 (27%), Positives = 136/313 (43%), Gaps = 51/313 (16%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-- 72
RYEL + LG+G +G V A++ ++ V I + + KI KR + LKLL+
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKIL--AKRALRELKLLRHF 58
Query: 73 --HPNVVRLHE---VLASK-SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
H N+ L++ V +++Y+ E + +L I S L +A + Q++ G
Sbjct: 59 RGHKNITCLYDMDIVFPGNFNELYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQILCG 117
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA--LPQHFRDDGLLHTTCGSPNYVA 184
+ Y H+ V HRDLK N+L+++ +KI DFGL+ + G + + Y A
Sbjct: 118 LKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRA 177
Query: 185 PEV-LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN--------LAVL---------- 225
PE+ L+ + Y A D+WS G IL +L F ++ L VL
Sbjct: 178 PEIMLSFQSYTKAI-DVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236
Query: 226 ------YQKIFRGDFKLPK---WLSPGAQ----NLLRKILEPNPVKRITIAGIKADEWFE 272
I K + P A +LL K+L +P KRI++ +E E
Sbjct: 237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISV-----EEALE 291
Query: 273 QDYTPANPDDDEE 285
Y D D+E
Sbjct: 292 HPYLAIWHDPDDE 304
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 8e-20
Identities = 60/208 (28%), Positives = 94/208 (45%), Gaps = 26/208 (12%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH----LKITDQIKREIATLKL 70
RY+ +G G +G V A D SG A+K +I H + + RE+ L+
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIK-----KIPHAFDVPTLAKRTLRELKILRH 60
Query: 71 LKHPNVVRLHEVLASKSK----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
KH N++ + ++L +Y+V++ + +L I S L E R QL+ G
Sbjct: 61 FKHDNIIAIRDILRPPGADFKDVYVVMD-LMESDLHHIIHSDQPLTEEHIRYFLYQLLRG 119
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV--- 183
+ Y H+ V HRDLK N+L++ ++I DFG++ + T YV
Sbjct: 120 LKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMT----EYVATR 175
Query: 184 ---APEVL-ANRGYDGATSDIWSCGVIL 207
APE+L + Y A D+WS G I
Sbjct: 176 WYRAPELLLSLPEYTTAI-DMWSVGCIF 202
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 1e-19
Identities = 68/201 (33%), Positives = 103/201 (51%), Gaps = 18/201 (8%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT----DQIKREIATLKLLKHPNVV 77
LG GN G V SGL A K+ IHL+I +QI RE+ L P +V
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKL------IHLEIKPAIRNQIIRELKVLHECNSPYIV 62
Query: 78 RLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNK-GV 135
+ S +I + +E++ GG L D++ K GR+ E K+ ++ G++Y K +
Sbjct: 63 GFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPENILGKISIAVLRGLTYLREKHKI 121
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
HRD+K NIL++S+G IK+ DFG+S D + ++ G+ +Y++PE L Y
Sbjct: 122 MHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQGTHY-T 176
Query: 196 ATSDIWSCGVILYVILTGYLP 216
SDIWS G+ L + G P
Sbjct: 177 VQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 1e-19
Identities = 60/190 (31%), Positives = 98/190 (51%), Gaps = 12/190 (6%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILE-KNRIIHLKITDQIKREIATLKLLKHPNVVR 78
R +G G+FG V FA+D+ + A+K + + + K D IK E+ L+ L+HPN ++
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIK-EVRFLQKLRHPNTIQ 79
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
+ ++V+EY G K LQE E + + G++Y H+ + HR
Sbjct: 80 YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL--ANRG-YDG 195
D+K NILL G +K+ DFG +++ + G+P ++APEV+ + G YDG
Sbjct: 140 DVKAGNILLSEPGLVKLGDFGSASIMAP------ANXFVGTPYWMAPEVILAMDEGQYDG 193
Query: 196 ATSDIWSCGV 205
D+WS G+
Sbjct: 194 KV-DVWSLGI 202
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 2e-19
Identities = 58/199 (29%), Positives = 105/199 (52%), Gaps = 8/199 (4%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
+G+G+FG+V D + A+KI++ +I D I++EI L P V + +
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIED-IQQEITVLSQCDSPYVTKYYG 69
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
+K+++++EY+ GG D + G L E + + ++++ G+ Y H++ HRD+K
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 128
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT-CGSPNYVAPEVLANRGYDGATSDI 200
N+LL G +K++DFG++ D + T G+P ++APEV+ YD + +DI
Sbjct: 129 AANVLLSEHGEVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-SKADI 184
Query: 201 WSCGVILYVILTGYLPFDD 219
WS G+ + G P +
Sbjct: 185 WSLGITAIELAKGEPPHSE 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 2e-19
Identities = 70/207 (33%), Positives = 104/207 (50%), Gaps = 23/207 (11%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFA----VKILEKNRIIHLKITDQIKREIATLKL 70
+YE +GEG +GKV A+DL +G F V++ + L RE+A L+
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI----REVAVLRH 57
Query: 71 LK---HPNVVRLHEVLA-----SKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLF 120
L+ HPNVVRL +V ++K+ +V E+V DK+ G E + +
Sbjct: 58 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI-KDMM 116
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
QL+ G+ + H+ V HRDLK +NIL+ S G IK++DFGL+ + + L + +
Sbjct: 117 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTL 173
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVIL 207
Y APEVL Y D+WS G I
Sbjct: 174 WYRAPEVLLQSSY-ATPVDLWSVGCIF 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 64/199 (32%), Positives = 105/199 (52%), Gaps = 20/199 (10%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKN-RIIHLKITDQIKREIATLKLLKH 73
+ R +G G+FG V FA+D+ + A+K + + + + K D IK E+ L+ L+H
Sbjct: 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIK-EVRFLQQLRH 74
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
PN + + ++V+EY G ++ + K LQE E + + G++Y H
Sbjct: 75 PNTIEYKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAAICHGALQGLAYLH 132
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSAL--PQHFRDDGLLHTTCGSPNYVAPEV-L 188
+ HRD+K NILL G +K++DFG ++L P ++ G+P ++APEV L
Sbjct: 133 SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--------NSFVGTPYWMAPEVIL 184
Query: 189 A-NRG-YDGATSDIWSCGV 205
A + G YDG D+WS G+
Sbjct: 185 AMDEGQYDGKV-DVWSLGI 202
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 2e-19
Identities = 90/331 (27%), Positives = 147/331 (44%), Gaps = 64/331 (19%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
RY+ +G G +G V A D AVK L + +IH + T RE+ LK +K
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRT---YRELRLLKHMK 72
Query: 73 HPNVVRLHEVLASK------SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
H NV+ L +V +++Y+V + G +L + I +L + + L QL+ G
Sbjct: 73 HENVIGLLDVFTPATSIENFNEVYLVTN-LMGADL-NNIVKCQKLSDEHVQFLIYQLLRG 130
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
+ Y H+ G+ HRDLK N+ ++ ++I DFGL+ + D + + Y APE
Sbjct: 131 LKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTGYVATRWYRAPE 185
Query: 187 VLANRGYDGATSDIWSCGVILYVILTG--YLPFDD------RNLAVL------------- 225
++ N + T DIWS G I+ +L G P +D R + V+
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245
Query: 226 -----------------YQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268
+KIFRG +P A +LL K+L + KRI+ + A
Sbjct: 246 EHARKYIQSLPHMPQQDLKKIFRG-------ANPLAIDLLEKMLVLDSDKRISASEALAH 298
Query: 269 EWFEQDYTPAN-PDDDEEDIFVDNEAFSMHE 298
+F Q + P + P+ + D +N+ ++ E
Sbjct: 299 PYFSQYHDPEDEPEAEPYDESPENKERTIEE 329
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-19
Identities = 64/226 (28%), Positives = 113/226 (50%), Gaps = 13/226 (5%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+L + LG G FG+V ++ AVK L+ + E +K L+H +
Sbjct: 9 KLVKKLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKL 63
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKG 134
VRL+ V+ + IY++ EY+ G L D + S G++ + Q+ +G++Y K
Sbjct: 64 VRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 123
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGY 193
HRDL+ N+L+ KI+DFGL+ + + ++ P + APE + N G
Sbjct: 124 YIHRDLRAANVLVSESLMCKIADFGLARVIED--NEYTAREGAKFPIKWTAPEAI-NFGS 180
Query: 194 DGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
SD+WS G++LY I+T G +P+ + + + + RG +++P+
Sbjct: 181 FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG-YRMPR 225
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 3e-19
Identities = 97/328 (29%), Positives = 144/328 (43%), Gaps = 59/328 (17%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKI-TDQIKREIATLKLLKH 73
RY + +G G +G V A D +G A+K L +R +I + RE+ LK ++H
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKL--SRPFQSEIFAKRAYRELTLLKHMQH 73
Query: 74 PNVVRLHEVLASKS------KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
NV+ L +V S Y+V+ Y+ KI L E + + L Q++ G+
Sbjct: 74 ENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGH-PLSEDKVQYLVYQMLCGL 130
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
Y H+ G+ HRDLK N+ ++ +KI DFGL+ +H D + + Y APEV
Sbjct: 131 KYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLA---RH--ADAEMTGYVVTRWYRAPEV 185
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQ------------------- 227
+ N + T DIWS G I+ +LTG F ++ L L Q
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK 245
Query: 228 ----------KIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ-- 273
K R DF PK SP A +LL K+LE + KR+T +F+
Sbjct: 246 AAKSYIKSLPKYPRKDFSTLFPK-ASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304
Query: 274 ---DYTPANPDDDEEDIFVDNEAFSMHE 298
+ T P DD ++NE S+ E
Sbjct: 305 DADEETEQQPYDDS----LENEKLSVDE 328
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 3e-19
Identities = 71/220 (32%), Positives = 108/220 (49%), Gaps = 19/220 (8%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT----DQIKREIATLKLLKHPNVV 77
LG GN G V SGL A K+ IHL+I +QI RE+ L P +V
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKL------IHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 78 RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVF 136
+ S +I + +E++ GG L + GR+ E K+ +I G++Y K +
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIM 126
Query: 137 HRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 196
HRD+K NIL++S+G IK+ DFG+S D + ++ G+ +Y++PE L Y
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQ----LIDSMANSFVGTRSYMSPERLQGTHYS-V 181
Query: 197 TSDIWSCGVILYVILTGYLPF---DDRNLAVLYQKIFRGD 233
SDIWS G+ L + G P D + L +++ GD
Sbjct: 182 QSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGD 221
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 3e-19
Identities = 67/239 (28%), Positives = 113/239 (47%), Gaps = 27/239 (11%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLK 69
E + LG G FG V + G +P A+K+L + K +I E +
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMA 64
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELF-------DKIASKGRLQEAEGRKLFQQ 122
+ HP+VVRL + S S++ ++ + + G L D I S+ L Q
Sbjct: 65 SVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCV------Q 117
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS-P- 180
+ G+SY K + HRDL N+L+ + ++KI+DFGL+ L D+ H G P
Sbjct: 118 IAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD--VDEKEYHAEGGKVPI 175
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
++A E + +R Y SD+WS GV ++ ++T G P++ + + +G+ +LP+
Sbjct: 176 KWMALESILHRIYT-HKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE-RLPQ 232
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 87.1 bits (215), Expect = 3e-19
Identities = 66/219 (30%), Positives = 114/219 (52%), Gaps = 19/219 (8%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
G +EL +G G +G+V + + +G A+K+++ + ++IK+EI LK H
Sbjct: 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 61
Query: 74 -PNVVRLHEVLASKS------KIYMVLEYVTGGELFDKIA-SKGR-LQEAEGRKLFQQLI 124
N+ + K+ ++++V+E+ G + D I +KG L+E + ++++
Sbjct: 62 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 121
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
G+S+ H V HRD+K +N+LL +K+ DFG+SA Q R G +T G+P ++A
Sbjct: 122 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMA 179
Query: 185 PEVLANRGYDGAT----SDIWSCGVILYVILTGYLPFDD 219
PEV+A AT SD+WS G+ + G P D
Sbjct: 180 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 218
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 5e-19
Identities = 54/173 (31%), Positives = 91/173 (52%), Gaps = 10/173 (5%)
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ- 121
RE++ LK LKH N+V LH+++ ++ + +V EY+ +L + G KLF
Sbjct: 53 REVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLF 111
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCG 178
QL+ G++YCH + V HRDLK +N+L++ +G +K++DFGL+ ++P + ++
Sbjct: 112 QLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV----- 166
Query: 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR 231
+ Y P++L D+W G I Y + TG F + IFR
Sbjct: 167 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFR 219
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 87.1 bits (215), Expect = 5e-19
Identities = 57/189 (30%), Positives = 97/189 (51%), Gaps = 10/189 (5%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
R +G G+FG V FA+D+ + A+K + + + I +E+ L+ +KHPN +
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
+ ++V+EY G K LQE E + + G++Y H+ + HRD
Sbjct: 91 KGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 150
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL--ANRG-YDGA 196
+K NILL G +K++DFG +++ ++ G+P ++APEV+ + G YDG
Sbjct: 151 IKAGNILLTEPGQVKLADFGSASIASP------ANSFVGTPYWMAPEVILAMDEGQYDGK 204
Query: 197 TSDIWSCGV 205
D+WS G+
Sbjct: 205 V-DVWSLGI 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 7e-19
Identities = 65/256 (25%), Positives = 116/256 (45%), Gaps = 48/256 (18%)
Query: 29 KVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88
KV D + F +K L K + + RE T+ PN+V LH+ + S+
Sbjct: 8 KVLLVMDTRTQQTFILKGLRK--------SSEYSRERLTIIPHCVPNMVCLHKYIVSEDS 59
Query: 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 148
+++VL++ GG+L+ I+ + E ++ +++ + H +G+ RDL NILLD
Sbjct: 60 VFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLD 119
Query: 149 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----YVAPEVLANRGYDGATS------ 198
+G+I+++ F + + + +C Y APEV G S
Sbjct: 120 DRGHIQLTYFS------RWSE---VEDSCDGEAVENMYCAPEV-------GGISEETEAC 163
Query: 199 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-----DFKLPKWLSPGAQNLLRKILE 253
D WS G IL+ +LTG L + G +P+W+S A++LL+++L+
Sbjct: 164 DWWSLGAILFELLTG---------KTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQ 214
Query: 254 PNPVKRITIAGIKADE 269
NP +R+ ++
Sbjct: 215 FNPTERLGAGVAGVED 230
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 7e-19
Identities = 78/275 (28%), Positives = 130/275 (47%), Gaps = 38/275 (13%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+L R LG G FG+V + ++ P AVK L+ + D + E +K L+HP +
Sbjct: 9 QLLRKLGAGQFGEV-WEGLWNNTTPVAVKTLKPGT---MDPKDFL-AEAQIMKKLRHPKL 63
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVS 128
++L+ V + IY+V E + G L + LQ GR L QLID G++
Sbjct: 64 IQLYAVCTLEEPIYIVTELMKYGSLLE------YLQGGAGRALKLPQLIDMAAQVASGMA 117
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAP 185
Y + HRDL N+L+ K++DFGL+ + ++D + G+ + AP
Sbjct: 118 YLEAQNYIHRDLAARNVLVGENNICKVADFGLARV---IKED-IYEAREGAKFPIKWTAP 173
Query: 186 EVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244
E A SD+WS G++L I+T G +P+ A + Q++ +G +++P PG
Sbjct: 174 EA-ALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG-YRMPC--PPGC 229
Query: 245 QNLLRKIL----EPNPVKRITIAGIKADEWFEQDY 275
L I+ + +P R T ++ W +D+
Sbjct: 230 PKELYDIMLDCWKEDPDDRPTFETLQ---WKLEDF 261
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 7e-19
Identities = 61/212 (28%), Positives = 104/212 (49%), Gaps = 6/212 (2%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
LG+G FG+V Q ++G +A K L+K R+ E L+ + P +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGVSYCHNKGVFHRD 139
SK+ + +V+ + GG+L I + G R + Q+ G+ + H+ + +RD
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 199
+K EN+LLD +GN ++SD GL+ +D + G+ Y+APE+L Y D
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLAV---ELKDGKTITQRAGTNGYMAPEILKEEPYSYPV-D 176
Query: 200 IWSCGVILYVILTGYLPFDDRNLAVLYQKIFR 231
++ G +Y ++ G PF D V +++ R
Sbjct: 177 WFAMGCSIYEMVAGRTPFKDHKEKVAKEELKR 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 7e-19
Identities = 60/188 (31%), Positives = 95/188 (50%), Gaps = 12/188 (6%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILE-KNRIIHLKITDQIKREIATLKLLKHPNVVRLH 80
+G G+FG V FA + + AVK + + + K D IK E+ L+ LKHPN +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIK-EVKFLQQLKHPNTIEYK 87
Query: 81 EVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL 140
+ ++V+EY G K LQE E + + G++Y H+ + HRD+
Sbjct: 88 GCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDI 147
Query: 141 KLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL--ANRG-YDGAT 197
K NILL G +K++DFG ++ ++ G+P ++APEV+ + G YDG
Sbjct: 148 KAGNILLTEPGQVKLADFGSASKSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKV 201
Query: 198 SDIWSCGV 205
D+WS G+
Sbjct: 202 -DVWSLGI 208
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 8e-19
Identities = 73/230 (31%), Positives = 113/230 (49%), Gaps = 20/230 (8%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT----DQIKREIATLKLLKHPNVV 77
LG GN G V Q SGL A K+ IHL+I +QI RE+ L P +V
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKL------IHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 78 RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVF 136
+ S +I + +E++ GG L + R+ E K+ ++ G++Y K +
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIM 126
Query: 137 HRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 196
HRD+K NIL++S+G IK+ DFG+S D + ++ G+ +Y++PE L Y
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQ----LIDSMANSFVGTRSYMSPERLQGTHYS-V 181
Query: 197 TSDIWSCGVILYVILTGYLPF---DDRNL-AVLYQKIFRGDFKLPKWLSP 242
SDIWS G+ L + G P D + L A+ + + G+ P +SP
Sbjct: 182 QSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISP 231
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 9e-19
Identities = 71/239 (29%), Positives = 115/239 (48%), Gaps = 39/239 (16%)
Query: 20 RTLGEGNFGKVKFAQDLDSG---LPFAVKIL-----EKNRIIHLKITDQIKREIATLKLL 71
+ +G G FG+V + G + A+K L +K R+ L E + +
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFL-------TEASIMGQF 62
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID------ 125
HPN++RL V+ + ++ EY+ G L DK L+E +G+ QL+
Sbjct: 63 DHPNIIRLEGVVTKSRPVMIITEYMENGSL-DKF-----LRENDGKFTVGQLVGMLRGIA 116
Query: 126 -GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG--SP-N 181
G+ Y HRDL NIL++S K+SDFGLS + D +TT G P
Sbjct: 117 SGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLS---RRLEDSEATYTTKGGKIPIR 173
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDD-RNLAVLYQKIFRGDFKLPK 238
+ APE +A R + A SD+WS G++++ +++ G P+ D N V+ + + G ++LP
Sbjct: 174 WTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSYGERPYWDMSNQDVI-KAVEDG-YRLPP 229
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 1e-18
Identities = 73/260 (28%), Positives = 125/260 (48%), Gaps = 17/260 (6%)
Query: 17 ELGRTLGEGNFGKVK---FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
LGR +GEG FG V + + + AVK + + ++ +E ++ H
Sbjct: 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC--TSPSVREKFLQEAYIMRQFDH 66
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHN 132
P++V+L V+ +++ +++V+E GEL + +K L A QL ++Y +
Sbjct: 67 PHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES 125
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS-P-NYVAPEVLAN 190
K HRD+ N+L+ S +K+ DFGLS ++ D+ + G P ++APE +
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLS---RYLEDESYYKASKGKLPIKWMAPESINF 182
Query: 191 RGYDGATSDIWSCGVILYVILT-GYLPFDD-RNLAVLYQKIFRGD-FKLPKWLSPGAQNL 247
R + A SD+W GV ++ IL G PF +N V+ +I G+ +P P +L
Sbjct: 183 RRFTSA-SDVWMFGVCMWEILMLGVKPFQGVKNNDVI-GRIENGERLPMPPNCPPTLYSL 240
Query: 248 LRKILEPNPVKRITIAGIKA 267
+ K +P KR +KA
Sbjct: 241 MTKCWAYDPSKRPRFTELKA 260
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 1e-18
Identities = 56/167 (33%), Positives = 86/167 (51%), Gaps = 34/167 (20%)
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ- 121
RE + LK LKH N+V LH+++ +K + +V EY+ +L + G +LF
Sbjct: 52 REASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLF 110
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQH----------FR 168
QL+ G++YCH + V HRDLK +N+L+ +G +K++DFGL+ ++P +R
Sbjct: 111 QLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYR 170
Query: 169 -DDGLLHTTCGSPNYVAPEVLANRGYDGATS-DIWSCGVILYVILTG 213
D LL GS Y +TS D+W G I Y + TG
Sbjct: 171 PPDVLL----GSTEY-------------STSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
YE LGEG++ V + +G A+K++ T RE + LK LKH N
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFT--AIREASLLKGLKHAN 64
Query: 76 VVRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
+V LH+++ +K + +V EYV + DK G L + QL+ G+SY H +
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHTDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQR 122
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
+ HRDLK +N+L+ G +K++DFGL+ ++P H + ++ + Y P+VL
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-----TLWYRPPDVLLG 177
Query: 191 RGYDGATSDIWSCGVILYVILTGYLPF 217
D+W G I ++ G F
Sbjct: 178 STEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 2e-18
Identities = 63/233 (27%), Positives = 109/233 (46%), Gaps = 30/233 (12%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ RY++ R +G+G G+V A D A+K + ++ + + + RE L
Sbjct: 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI 60
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGEL-------FDKIASKGRLQEAEGRK----LFQ 121
HP +V ++ + + +Y + Y+ G L + K + L E +F
Sbjct: 61 HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD---------GL 172
++ + Y H+KGV HRDLK +NILL G + I D+G + + +D +
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 173 LHTT-------CGSPNYVAPEVLANRGYDGATS-DIWSCGVILYVILTGYLPF 217
+++ G+P+Y+APE L G + S DI++ GVILY +LT P+
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERL--LGVPASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 4e-18
Identities = 82/287 (28%), Positives = 126/287 (43%), Gaps = 44/287 (15%)
Query: 18 LGRTLGEGNFGKV--KFAQDLDSGLP----FAVKILEKNRIIHLKITDQIKREIATLKLL 71
LG+TLGEG FGKV A L G AVK+L++N ++ D + E LK +
Sbjct: 4 LGKTLGEGEFGKVVKATAFRL-KGRAGYTTVAVKMLKENAS-SSELRDLLS-EFNLLKQV 60
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGEL--FDKIASK------GRLQEAEGRKLFQ-- 121
HP+V++L+ + + +++EY G L F + + K G L
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 122 --------------QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167
Q+ G+ Y + HRDL N+L+ +KISDFGLS +
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSR--DVY 178
Query: 168 RDDGLLHTTCGS--PNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDD---RN 221
+D + + G ++A E L + Y SD+WS GV+L+ I+T G P+
Sbjct: 179 EEDSYVKRSKGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237
Query: 222 LAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268
L L + +R + P+ S NL+ + P KR T A I +
Sbjct: 238 LFNLLKTGYRME--RPENCSEEMYNLMLTCWKQEPDKRPTFADISKE 282
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 5e-18
Identities = 74/238 (31%), Positives = 116/238 (48%), Gaps = 26/238 (10%)
Query: 16 YELGRTLGEGNFGKVKFAQ---DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ LGR LG+G FG V+ AQ + S AVK+L K I ++ RE A +K
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFD 59
Query: 73 HPNVVRLHEV-LASKSK----IYMV-LEYVTGGELFDKIASKGRLQE----AEGRKLFQQ 122
HPNV++L V L S++K I MV L ++ G+L + R+ E + L +
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMS-RIGEEPFTLPLQTLVRF 118
Query: 123 LID---GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179
+ID G+ Y +K HRDL N +L+ + ++DFGLS + C S
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS---KKIYSGDYYRQGCAS 175
Query: 180 P---NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD 233
++A E LA+ Y SD+W+ GV ++ I+T G P+ + +Y + +G+
Sbjct: 176 KLPVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN 232
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 5e-18
Identities = 51/173 (29%), Positives = 91/173 (52%), Gaps = 10/173 (5%)
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF-Q 121
RE++ LK LKH N+V LH+++ + + +V EY+ +L + G + K+F
Sbjct: 53 REVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLY 111
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCG 178
Q++ G++YCH + V HRDLK +N+L++ +G +K++DFGL+ ++P + ++
Sbjct: 112 QILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV----- 166
Query: 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR 231
+ Y P+VL D+W G I + + +G F + IFR
Sbjct: 167 TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFR 219
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 8e-18
Identities = 71/226 (31%), Positives = 109/226 (48%), Gaps = 37/226 (16%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLP-----FAVKILEKNRIIHLKITDQIKREIATLK 69
R LG+ LGEG FG+V A+ + P AVK+L+ + ++D + E+ +K
Sbjct: 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEK-DLSDLVS-EMEMMK 70
Query: 70 LL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAE--------GRKLF 120
++ KH N++ L V + +Y+V+EY G L D + ++ E L
Sbjct: 71 MIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT 130
Query: 121 Q--------QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--- 169
Q Q+ G+ + +K HRDL N+L+ +KI+DFGL+ RD
Sbjct: 131 QKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLA------RDIHH 184
Query: 170 -DGLLHTTCGS-P-NYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
D TT G P ++APE L +R Y SD+WS GV+L+ I T
Sbjct: 185 IDYYRKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 9e-18
Identities = 79/278 (28%), Positives = 133/278 (47%), Gaps = 35/278 (12%)
Query: 20 RTLGEGNFGKVKFA----QDLDSGLPFAVKILE-KNRIIHLKITDQIKREIATLKLLKHP 74
R LGEG+FGKV+ + ++G AVK L+ ++ H+ +K+EI L+ L H
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI---ADLKKEIEILRNLYHE 66
Query: 75 NVVRLHEVLASK--SKIYMVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCH 131
N+V+ + + I +++E++ G L + + +K ++ + K Q+ G+ Y
Sbjct: 67 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG 126
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY-VAPEVLAN 190
++ HRDL N+L++S+ +KI DFGL+ + ++ + SP + APE L
Sbjct: 127 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186
Query: 191 RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI--FRGDF---KLPKWLSPGAQ 245
+ A SD+WS GV LY +LT Y + + + + I G +L + L G +
Sbjct: 187 SKFYIA-SDVWSFGVTLYELLT-YCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKR 244
Query: 246 ------------NLLRKILEPNPVKRIT----IAGIKA 267
L+RK E P KR T I G +A
Sbjct: 245 LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 1e-17
Identities = 77/281 (27%), Positives = 118/281 (41%), Gaps = 53/281 (18%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIATLKLLKHPNVV 77
LGEG++ V +G A+K+ I +K + + RE + LK LKH N+V
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKV------ISMKTEEGVPFTAIREASLLKGLKHANIV 66
Query: 78 RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
LH+++ +K + V EY+ I G L R QL+ G++Y H + + H
Sbjct: 67 LLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILH 126
Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----YVAPEVLANRGY 193
RDLK +N+L+ G +K++DFGL+ R + T S Y P+VL
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLA------RAKSIPSQTYSSEVVTLWYRPPDVLLGATD 180
Query: 194 DGATSDIWSCGVILYVILTGYLPFDDRN------------LAVLYQKIFRGDFKLPKW-- 239
+ DIW G I +L G F + L V + + G KLP +
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKP 240
Query: 240 -----------------LS--PGAQNLLRKILEPNPVKRIT 261
LS P A++L ++L P RI+
Sbjct: 241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRIS 281
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 1e-17
Identities = 73/272 (26%), Positives = 121/272 (44%), Gaps = 27/272 (9%)
Query: 18 LGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
LG+ LGEG FG V + +QD S L AVK ++ + + +I + + E A +K HP
Sbjct: 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFL-SEAACMKDFDHP 61
Query: 75 NVVRLHEV---LASKSKI---YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID--- 125
NV++L V +S KI ++L ++ G+L + RL + Q L+
Sbjct: 62 NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYS-RLGGLPEKLPLQTLLKFMV 120
Query: 126 ----GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP- 180
G+ Y N+ HRDL N +L + ++DFGLS + +
Sbjct: 121 DIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS---KKIYSGDYYRQGRIAKM 177
Query: 181 --NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKL 236
++A E LA+R Y + SD+W+ GV ++ I T G P+ +Y + G+ K
Sbjct: 178 PVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQ 236
Query: 237 PKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268
P+ +L+ +P R T ++
Sbjct: 237 PEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 1e-17
Identities = 69/270 (25%), Positives = 123/270 (45%), Gaps = 24/270 (8%)
Query: 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
+ + +L +T+G+G FG V G AVK ++ + + E + +
Sbjct: 3 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLA-----EASVMTQ 55
Query: 71 LKHPNVVRLHEVLAS-KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---G 126
L+H N+V+L V+ K +Y+V EY+ G L D + S+GR G L + +D
Sbjct: 56 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEA 114
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
+ Y HRDL N+L+ K+SDFGL+ +D G L + APE
Sbjct: 115 MEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPE 169
Query: 187 VLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPG 243
L + + SD+WS G++L+ I + G +P+ L + ++ +G +K+ P P
Sbjct: 170 ALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPDGCPPV 227
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQ 273
+++++ + R + ++ E E
Sbjct: 228 VYDVMKQCWHLDAATRPSFLQLR--EQLEH 255
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 1e-17
Identities = 56/198 (28%), Positives = 98/198 (49%), Gaps = 17/198 (8%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
Y + +TL G+ G+V A P +KI +K + E L+ + HP+
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTL---------IEAMLLQNVNHPS 118
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKG 134
V+R+ + L S + MVL + + +L+ + + L + + +Q+++G+ Y H +
Sbjct: 119 VIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR 177
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD-GLLHTTCGSPNYVAPEVLANRGY 193
+ HRD+K ENI ++ + I D G + P GL G+ APEVLA Y
Sbjct: 178 IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGL----AGTVETNAPEVLARDKY 233
Query: 194 DGATSDIWSCGVILYVIL 211
+ + +DIWS G++L+ +L
Sbjct: 234 N-SKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 2e-17
Identities = 70/259 (27%), Positives = 113/259 (43%), Gaps = 27/259 (10%)
Query: 21 TLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
TLG G FG+V K ++ VK L+K + +L+ + +RE+ + L H N
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQS--EFRRELDMFRKLSHKN 69
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGEL--FDKIASKGR-------LQEAEGRKLFQQLIDG 126
VVRL + YM+LEY G+L F + L + L Q+ G
Sbjct: 70 VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAP 185
+ + N HRDL N L+ S+ +K+S LS + + P ++AP
Sbjct: 130 MDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDV--YNSEYYKLRNALIPLRWLAP 187
Query: 186 EVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244
E + + SD+WS GV+++ + T G LPF + + ++ G +LP + G
Sbjct: 188 EAVQEDDFS-TKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP--VPEGC 244
Query: 245 QNLLRKILE----PNPVKR 259
+ L K++ NP R
Sbjct: 245 PSRLYKLMTRCWAVNPKDR 263
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 5e-17
Identities = 70/232 (30%), Positives = 115/232 (49%), Gaps = 26/232 (11%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+L + LG G FG+V + A+K L++ + + E +K L+HP +
Sbjct: 9 KLVKKLGAGQFGEVWMGY-YNGHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRL 63
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVS 128
VRL+ V+ ++ IY++ EY+ G L D L+ EG KL +LID G++
Sbjct: 64 VRLYAVV-TQEPIYIITEYMENGSLVD------FLKTPEGIKLTINKLIDMAAQIAEGMA 116
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEV 187
+ K HRDL+ NIL+ KI+DFGL+ L + ++ P + APE
Sbjct: 117 FIERKNYIHRDLRAANILVSETLCCKIADFGLARLIED--NEYTAREGAKFPIKWTAPEA 174
Query: 188 LANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
+ N G SD+WS G++L I+T G +P+ + Q + RG +++P+
Sbjct: 175 I-NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG-YRMPR 224
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 9e-17
Identities = 60/220 (27%), Positives = 109/220 (49%), Gaps = 17/220 (7%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+ LG G FG V + + + A+K + + + + E + L HP +V+L
Sbjct: 10 KELGSGQFGVVHLGK-WRAQIKVAIKAINEGAMSE----EDFIEEAKVMMKLSHPKLVQL 64
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
+ V + +Y+V E++ G L + + + G+L + + Q + +G+ Y HR
Sbjct: 65 YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHR 124
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDG 195
DL N L+ S G +K+SDFG++ ++ DD ++ G+ + PEV Y
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMT---RYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYS- 179
Query: 196 ATSDIWSCGVILYVILT-GYLPFDDR-NLAVLYQKIFRGD 233
+ SD+WS GV+++ + T G +PF+ + N V+ + I RG
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVV-EMISRGF 218
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 1e-16
Identities = 56/201 (27%), Positives = 100/201 (49%), Gaps = 19/201 (9%)
Query: 21 TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLH 80
LG GN G V A L + AVK++ + I +++ QI E+ L P ++ +
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLD--ITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 81 EVLASKSKIYMVLEYVTGGEL--FDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVF 136
+++I + E++ GG L + KI GR+ A ++ G++Y + +
Sbjct: 66 GAFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVA--------VVKGLTYLWSLKIL 117
Query: 137 HRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 196
HRD+K N+L++++G +K+ DFG+S + + T G+ Y+APE ++ Y G
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVSTQLV----NSIAKTYVGTNAYMAPERISGEQY-GI 172
Query: 197 TSDIWSCGVILYVILTGYLPF 217
SD+WS G+ + G P+
Sbjct: 173 HSDVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 2e-16
Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 25/217 (11%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSG---LPFAVKIL-----EKNRIIHLKITDQIKREIA 66
++ + +G G FG+V + G +P A+K L EK R L E +
Sbjct: 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFL-------SEAS 57
Query: 67 TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLI 124
+ HPN++ L V+ + +V EY+ G L D K G+ + + + +
Sbjct: 58 IMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRGIA 116
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---N 181
G+ Y + G HRDL NIL++S K+SDFGLS + + D +TT G
Sbjct: 117 SGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIR 174
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 217
+ APE +A R + A SD+WS G++++ +++ G P+
Sbjct: 175 WTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPY 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 4e-16
Identities = 59/222 (26%), Positives = 110/222 (49%), Gaps = 16/222 (7%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
+G G FG V L+ A+K + + + + E + L HP +V+L+
Sbjct: 12 IGSGQFGLVWLGYWLEKR-KVAIKTIREGAMSE----EDFIEEAQVMMKLSHPKLVQLYG 66
Query: 82 VLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL 140
V +S I +V E++ G L D + A +G+ + + + +G++Y + V HRDL
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDL 126
Query: 141 KLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGAT 197
N L+ +K+SDFG++ F D ++ G+ + +PEV + Y +
Sbjct: 127 AARNCLVGENQVVKVSDFGMT----RFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYS-SK 181
Query: 198 SDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
SD+WS GV+++ + + G P+++R+ + + + I G F+L K
Sbjct: 182 SDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAG-FRLYK 222
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 7e-16
Identities = 57/195 (29%), Positives = 96/195 (49%), Gaps = 7/195 (3%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
++E+ +GEG +G V + ++ A+K K+ + ++ + RE+ L+ LK
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKF-KDSEENEEVKETTLRELKMLRTLKQE 60
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
N+V L E + K+Y+V EYV EL +++ + G E + R QLI + +CH
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPN-GVPPE-KVRSYIYQLIKAIHWCHK 118
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
+ HRD+K EN+L+ +K+ DFG + + + Y +PE+L
Sbjct: 119 NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYV-ATRWYRSPELLLGAP 177
Query: 193 YDGATSDIWSCGVIL 207
Y G D+WS G IL
Sbjct: 178 Y-GKAVDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 7e-16
Identities = 61/226 (26%), Positives = 112/226 (49%), Gaps = 14/226 (6%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+L + LG G FG+V A + AVK ++ + E +K L+H +
Sbjct: 9 KLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSVEAFLA----EANVMKTLQHDKL 63
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKG 134
V+LH V+ +K IY++ E++ G L D + S + + Q+ +G+++ +
Sbjct: 64 VKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 122
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGY 193
HRDL+ NIL+ + KI+DFGL+ + + ++ P + APE + N G
Sbjct: 123 YIHRDLRAANILVSASLVCKIADFGLARVIED--NEYTAREGAKFPIKWTAPEAI-NFGS 179
Query: 194 DGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
SD+WS G++L I+T G +P+ + + + + RG +++P+
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMPR 224
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 9e-16
Identities = 70/250 (28%), Positives = 113/250 (45%), Gaps = 8/250 (3%)
Query: 22 LGEGNFGKVK--FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
LG GNFG VK + S AVKIL KN + D++ RE ++ L +P +VR+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKIL-KNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
+ ++S + +V+E G L + + E +L Q+ G+ Y HRD
Sbjct: 62 IGICEAESWM-LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRD 120
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATS 198
L N+LL ++ KISDFGLS + T P + APE + N + S
Sbjct: 121 LAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM-NYYKFSSKS 179
Query: 199 DIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNP 256
D+WS GV+++ + G P+ + Q I G+ + P+ P +L++
Sbjct: 180 DVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGV 239
Query: 257 VKRITIAGIK 266
+R A ++
Sbjct: 240 DERPGFAVVE 249
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 64/213 (30%), Positives = 99/213 (46%), Gaps = 18/213 (8%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
L RY+ + +G G G V A D G+ AVK L + H K + RE+ LK
Sbjct: 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAK---RAYRELVLLKC 76
Query: 71 LKHPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
+ H N++ L V + +Y+V+E + L I + L L Q++
Sbjct: 77 VNHKNIISLLNVFTPQKSLEEFQDVYLVME-LMDANLCQVIHME--LDHERMSYLLYQML 133
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
G+ + H+ G+ HRDLK NI++ S +KI DFGL+ + ++ + Y A
Sbjct: 134 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC---TNFMMTPYVVTRYYRA 190
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPF 217
PEV+ GY DIWS G I+ ++ G + F
Sbjct: 191 PEVILGMGYK-ENVDIWSVGCIMGELVKGSVIF 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 69/224 (30%), Positives = 108/224 (48%), Gaps = 31/224 (13%)
Query: 15 RYELGRTLGEGNFGKVKFAQ--DLDSGLP-----FAVKILEKNRIIHLKITDQIKREIAT 67
R LG+ LGEG FG+V A+ LD P AVK+L K+ ++D I E+
Sbjct: 19 RLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKML-KSDATEKDLSDLIS-EMEM 76
Query: 68 LKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-------------GRLQE 113
+K++ KH N++ L +Y+++EY + G L + + ++ ++
Sbjct: 77 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQ 136
Query: 114 AEGRKLFQ---QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170
+ L Q+ G+ Y +K HRDL N+L+ +KI+DFGL+ H D
Sbjct: 137 LSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI--D 194
Query: 171 GLLHTTCGS--PNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
TT G ++APE L +R Y SD+WS GV+L+ I T
Sbjct: 195 YYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 77/293 (26%), Positives = 123/293 (41%), Gaps = 72/293 (24%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEK---NRIIHLKITDQIKREIATLKLLKHPNVVR 78
+G G +G V A++ ++ A+K + NRI + REI L+ L H NV+
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTL----REIKLLRHLDHENVIA 68
Query: 79 LHEVLASKSK-----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
+ +++ + +Y+V E + +L I S L + + QL+ G+ Y H+
Sbjct: 69 IKDIMPPPHREAFNDVYIVYE-LMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSA 127
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----------YV 183
V HRDLK N+LL++ ++KI DFGL+ TT + Y
Sbjct: 128 NVLHRDLKPSNLLLNANCDLKICDFGLA------------RTTSEKGDFMTEYVVTRWYR 175
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILTG--------YL------------PFDD---- 219
APE+L N D+WS G I +L Y+ P ++
Sbjct: 176 APELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF 235
Query: 220 ----------RNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITI 262
R+L ++ F F P +P A +LL K+L +P KRIT+
Sbjct: 236 IRNEKARRYIRSLPYTPRQSFARLF--PH-ANPLAIDLLEKMLVFDPSKRITV 285
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 71/255 (27%), Positives = 115/255 (45%), Gaps = 30/255 (11%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK--LLKH--PNVV 77
+G G G+V + +G AVK + + ++ KR + L L H P +V
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRT-----GNKEENKRILMDLDVVLKSHDCPYIV 77
Query: 78 RLHEVLASKSKIYMVLEYVTGGELFDKIA--SKGRLQEAEGRKLFQQLIDGVSYCHNK-G 134
+ + + S +++ +E + DK+ +G + E K+ ++ + Y K G
Sbjct: 78 KCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG 135
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHT-TCGSPNYVAPEVL----A 189
V HRD+K NILLD+ GN+K+ DFG+S D T + G Y+APE +
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISG----RLVDSKAKTRSAGCAAYMAPERIDPPDP 191
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFD--DRNLAVLYQKIFRGDF-KLP--KWLSPGA 244
N YD +D+WS G+ L + TG P+ VL KI + + LP + SP
Sbjct: 192 NPKYD-IRADVWSLGISLVELATGQFPYKNCKTEFEVL-TKILQEEPPSLPPNEGFSPDF 249
Query: 245 QNLLRKILEPNPVKR 259
+ + L + KR
Sbjct: 250 CSFVDLCLTKDHRKR 264
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 3e-15
Identities = 75/262 (28%), Positives = 121/262 (46%), Gaps = 26/262 (9%)
Query: 18 LGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
LG+TLGEG FG V + QD DS L AVK ++ ++ D + E +K HP
Sbjct: 3 LGKTLGEGEFGSVMEGQLNQD-DSILKVAVKTMKIAICTRSEMEDFL-SEAVCMKEFDHP 60
Query: 75 NVVRLHEVL--ASKSKIY----MVLEYVTGGEL-----FDKIASKGRLQEAEGR-KLFQQ 122
NV+RL V +S+ Y ++L ++ G+L + ++ + + K
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL---PQHFRDDGLLHTTCGS 179
+ G+ Y +K HRDL N +L+ N+ ++DFGLS ++R +
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV-- 178
Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLP 237
++A E LA+R Y SD+WS GV ++ I T G P+ + +Y + +G+ K P
Sbjct: 179 -KWIAIESLADRVYT-TKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQP 236
Query: 238 KWLSPGAQNLLRKILEPNPVKR 259
G +L+ NP R
Sbjct: 237 PDCLDGLYSLMSSCWLLNPKDR 258
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 3e-15
Identities = 77/272 (28%), Positives = 128/272 (47%), Gaps = 33/272 (12%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+L + LG G FG+V + + AVK L+ + + E +K L+H +
Sbjct: 9 QLIKKLGNGQFGEV-WMGTWNGNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKL 63
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVS 128
V+L+ V+ S+ IY+V EY++ G L D L++ EGR L L+D G++
Sbjct: 64 VQLYAVV-SEEPIYIVTEYMSKGSLLD------FLKDGEGRALKLPNLVDMAAQVAAGMA 116
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAP 185
Y HRDL+ NIL+ KI+DFGL+ L + D G+ + AP
Sbjct: 117 YIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIE----DNEYTARQGAKFPIKWTAP 172
Query: 186 EVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPG 243
E A G SD+WS G++L ++T G +P+ N + +++ RG P+
Sbjct: 173 EA-ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPIS 231
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
L+ + + +P +R T +++ F +DY
Sbjct: 232 LHELMLQCWKKDPEERPTFEYLQS---FLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-15
Identities = 49/162 (30%), Positives = 78/162 (48%), Gaps = 16/162 (9%)
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
REI LK + H ++ L KS + MV+ +LF + G L + + ++
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRR 193
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA-------LPQHFRDDGLLHT 175
L++ ++Y H +G+ HRD+K ENI LD N + DFG + PQ + G L T
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLET 253
Query: 176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 217
+PE+LA Y A +DIWS G++L+ + +
Sbjct: 254 N-------SPELLALDPY-CAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 4e-15
Identities = 74/279 (26%), Positives = 118/279 (42%), Gaps = 44/279 (15%)
Query: 18 LGRTLGEGNFGKVKFAQDLDSGLP------FAVKILEKNRIIHLKITDQIKREIATLKLL 71
L R LGEG FGKV F + P AVK L++ + +RE L
Sbjct: 9 LKRELGEGAFGKV-FLGECYHLEPENDKELVAVKTLKETASNDAR--KDFEREAELLTNF 65
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS--------------KGRLQEAEGR 117
+H N+V+ + V MV EY+ G+L + S G L ++
Sbjct: 66 QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125
Query: 118 KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT- 176
++ Q+ G+ Y ++ HRDL N L+ +KI DFG+S RD ++TT
Sbjct: 126 QIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMS------RD---VYTTD 176
Query: 177 ----CGSP----NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQ 227
G ++ PE + R + SD+WS GV+L+ I T G P+ + + +
Sbjct: 177 YYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE 235
Query: 228 KIFRGDFKL-PKWLSPGAQNLLRKILEPNPVKRITIAGI 265
I +G P+ +++ + +P +RI I I
Sbjct: 236 CITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 4e-15
Identities = 72/275 (26%), Positives = 121/275 (44%), Gaps = 40/275 (14%)
Query: 15 RYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
G+TLG G FGKV A D+ + AVK+L+ H + + E+ +
Sbjct: 36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPT--AHSSEREALMSELKIMS 93
Query: 70 LL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ---QLID 125
L H N+V L I ++ EY G+L + + K R L Q+
Sbjct: 94 HLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAK 152
Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV-- 183
G+++ +K HRDL N+LL +KI DFGL+ RD +++ + NYV
Sbjct: 153 GMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA------RD--IMNDS----NYVVK 200
Query: 184 ----------APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG 232
APE + N Y SD+WS G++L+ I + G P+ + + K+ +
Sbjct: 201 GNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE 259
Query: 233 DFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGI 265
+++ P+ ++++ + +P+KR T I
Sbjct: 260 GYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 5e-15
Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
E R +G G FG V D G A+K + N +L ++ RE+ L KH NV
Sbjct: 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKM-PNVFQNLVSCKRVFRELKMLCFFKHDNV 61
Query: 77 VRLHEVLASK-----SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF-QQLIDGVSYC 130
+ ++L +IY+V E + +L I S L ++ K+F Q++ G+ Y
Sbjct: 62 LSALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLS-SDHVKVFLYQILRGLKYL 119
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL-A 189
H+ G+ HRD+K N+L++S +KI DFGL+ + + + + + Y APE+L
Sbjct: 120 HSAGILHRDIKPGNLLVNSNCVLKICDFGLARV-EEPDESKHMTQEVVTQYYRAPEILMG 178
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPF 217
+R Y A DIWS G I +L + F
Sbjct: 179 SRHYTSAV-DIWSVGCIFAELLGRRILF 205
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 6e-15
Identities = 70/218 (32%), Positives = 105/218 (48%), Gaps = 25/218 (11%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLD--SGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
L YE G +G G +G V A+ D +A+K +E I+ REIA L+
Sbjct: 1 LFEYE-GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT-----GISMSACREIALLRE 54
Query: 71 LKHPNVVRLHEVLASKS--KIYMVLEYVTGGELFDKI-------ASKGRLQEAEG--RKL 119
LKHPNV+ L +V S + K++++ +Y +L+ I A+K +Q G + L
Sbjct: 55 LKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSL 113
Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILL----DSKGNIKISDFGLSAL-PQHFRDDGLLH 174
Q++DG+ Y H V HRDLK NIL+ +G +KI+D G + L + L
Sbjct: 114 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
+ Y APE+L + DIW+ G I +LT
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 7e-15
Identities = 66/233 (28%), Positives = 104/233 (44%), Gaps = 19/233 (8%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFA-VKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLH 80
+G G FGKV + G+ A V + E +E+ + L HPNV++
Sbjct: 3 IGNGWFGKV-LLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 81 EVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ-----LIDGVSYCHNKGV 135
+VLE+ G+L + + S + +K Q + G+ + H
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADF 121
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS-P-NYVAPEVLANRGY 193
H DL L N L + ++KI D+GL AL Q + +D + C + P ++APE++ RG
Sbjct: 122 IHSDLALRNCQLTADLSVKIGDYGL-ALEQ-YPEDYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 194 DGAT------SDIWSCGVILYVILT-GYLPFDD-RNLAVLYQKIFRGDFKLPK 238
D S+IWS GV ++ + T P+ D + VL Q + D KLPK
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPK 232
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 7e-15
Identities = 75/273 (27%), Positives = 111/273 (40%), Gaps = 35/273 (12%)
Query: 20 RTLGEGNFGKVKFAQDLD-----SG-LPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
LG G FG+V D SG + AVK L K K + +E + H
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK--EFLKEAHLMSNFNH 58
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEG-----RKLFQQLID--- 125
PN+V+L V Y+++E + GG+L + R++ ++L +D
Sbjct: 59 PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYL-RDARVERFGPPLLTLKELLDICLDVAK 117
Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGN-----IKISDFGL-----SALPQHFRDDGLLHT 175
G Y HRDL N L+ KG +KI DFGL + +GLL
Sbjct: 118 GCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDR-NLAVLYQKIFRGD 233
++APE L + G SD+WS GV+++ ILT G P+ N VL G
Sbjct: 178 -----RWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGR 231
Query: 234 FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIK 266
+ P+ L+ +P +R T I+
Sbjct: 232 LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQ 264
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 7e-15
Identities = 71/218 (32%), Positives = 105/218 (48%), Gaps = 25/218 (11%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSG--LPFAVKILEKNRIIHLKITDQIKREIATLKL 70
L YE G +G G +G V A+ D +A+K +E I+ REIA L+
Sbjct: 1 LFEYE-GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT-----GISMSACREIALLRE 54
Query: 71 LKHPNVVRLHEVLASKS--KIYMVLEYVTGGELFDKI----ASKG-----RLQEAEGRKL 119
LKHPNV+ L +V S S K++++ +Y +L+ I ASK +L + + L
Sbjct: 55 LKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSL 113
Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILL----DSKGNIKISDFGLSAL-PQHFRDDGLLH 174
Q++DG+ Y H V HRDLK NIL+ +G +KI+D G + L + L
Sbjct: 114 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
+ Y APE+L + DIW+ G I +LT
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 8e-15
Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 31/221 (14%)
Query: 22 LGEGNFGKVKFAQ-----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
LGEG FGKV + + S A+K L++N K+ + ++E + L+HPN+
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP--KVQQEFRQEAELMSDLQHPNI 70
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIAS----------------KGRLQEAEGRKLF 120
V L V + M+ EY+ G+L + + K L ++ +
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL---PQHFRDDGLLHTTC 177
Q+ G+ Y + HRDL N L+ +KISDFGLS ++R + +
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYR---VQSKSL 187
Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 217
++ PE + G SDIWS GV+L+ I + G P+
Sbjct: 188 LPVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 8e-15
Identities = 68/234 (29%), Positives = 107/234 (45%), Gaps = 51/234 (21%)
Query: 15 RYELGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
R LG+ LGEG FG+V A+ D + AVK+L+ N + D I E+
Sbjct: 13 RLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT-DKDLADLIS-EMEL 70
Query: 68 LKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQE------------- 113
+KL+ KH N++ L V + +Y+++EY A+KG L+E
Sbjct: 71 MKLIGKHKNIINLLGVCTQEGPLYVIVEY----------AAKGNLREFLRARRPPGPDYT 120
Query: 114 ------AEGRKLFQQLID-------GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGL 160
E + F+ L+ G+ Y ++ HRDL N+L+ +KI+DFGL
Sbjct: 121 FDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGL 180
Query: 161 SALPQHFRDDGLLHTTCGS--PNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
+ D T+ G ++APE L +R Y SD+WS G++++ I T
Sbjct: 181 ARGVHDI--DYYKKTSNGRLPVKWMAPEALFDRVYT-HQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 76/270 (28%), Positives = 123/270 (45%), Gaps = 37/270 (13%)
Query: 22 LGEGNFGKVKFAQDLDSGLPF--AVKILEK--NRIIHLKITDQIKREIATLKLLKHPNVV 77
+GEGNFG+V A GL A+K+L++ + H +++ KL HPN++
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELE---VLCKLGHHPNII 66
Query: 78 RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAE--------------GRKLFQQL 123
L ++ +Y+ +EY G L D + K R+ E + ++L Q
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFL-RKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 124 ID---GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS- 179
D G+ Y K HRDL N+L+ KI+DFGLS + + + T G
Sbjct: 126 SDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVY-----VKKTMGRL 180
Query: 180 -PNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL- 236
++A E L Y SD+WS GV+L+ I++ G P+ A LY+K+ +G +++
Sbjct: 181 PVRWMAIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRME 238
Query: 237 -PKWLSPGAQNLLRKILEPNPVKRITIAGI 265
P+ L+R+ P +R A I
Sbjct: 239 KPRNCDDEVYELMRQCWRDRPYERPPFAQI 268
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 68/237 (28%), Positives = 110/237 (46%), Gaps = 36/237 (15%)
Query: 20 RTLGEGNFGKVKFAQDLDSG---LPFAVKIL-----EKNRIIHLKITDQIKREIATLKLL 71
+ +G G FG+V G + A+K L EK R L E + +
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLS-------EASIMGQF 63
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID------ 125
H N++RL V+ ++ EY+ G L DK L++ +G QL+
Sbjct: 64 SHHNIIRLEGVVTKFKPAMIITEYMENGAL-DKY-----LRDHDGEFSSYQLVGMLRGIA 117
Query: 126 -GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---N 181
G+ Y + HRDL NIL++S K+SDFGLS + + + +TT G
Sbjct: 118 AGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG--TYTTSGGKIPIR 175
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLP 237
+ APE +A R + A SD+WS G++++ +++ G P+ D + + + I G F+LP
Sbjct: 176 WTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG-FRLP 230
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 86/330 (26%), Positives = 145/330 (43%), Gaps = 59/330 (17%)
Query: 15 RYELGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
R LG+ LGEG FG+V A+ + + + AVK+L K+ ++D + E+
Sbjct: 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKML-KDDATDKDLSDLVS-EMEM 70
Query: 68 LKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK---------GRLQEAEGR 117
+K++ KH N++ L +Y+++EY + G L + + ++ + E +
Sbjct: 71 MKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQ 130
Query: 118 KLFQQLID-------GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD- 169
F+ L+ G+ Y ++ HRDL N+L+ +KI+DFGL+ RD
Sbjct: 131 LTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLA------RDV 184
Query: 170 ---DGLLHTTCGS--PNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLA 223
D TT G ++APE L +R Y SD+WS GV+L+ I T G P+ +
Sbjct: 185 HNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243
Query: 224 VLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGI-----------KADEW- 270
L++ + G P + ++R+ P +R T + DE+
Sbjct: 244 ELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTSTDEYL 303
Query: 271 -----FEQDYTPANPDDDEEDIFVDNEAFS 295
FEQ Y+P PD D+ F+
Sbjct: 304 DLSVPFEQ-YSPGCPDSPSSCSSGDDSVFA 332
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 3e-14
Identities = 75/269 (27%), Positives = 121/269 (44%), Gaps = 35/269 (13%)
Query: 22 LGEGNFGKVKFAQDLDSGLPF--AVKILEK--NRIIHLKITDQIKREIATLKLLKHPNVV 77
+GEGNFG+V A+ GL A+K +++ ++ H +++ KL HPN++
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELE---VLCKLGHHPNII 59
Query: 78 RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAE--------------GRKLFQQL 123
L + +Y+ +EY G L D + K R+ E + ++L
Sbjct: 60 NLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLHFA 118
Query: 124 ID---GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS- 179
D G+ Y K HRDL NIL+ KI+DFGLS + + + T G
Sbjct: 119 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-----VKKTMGRL 173
Query: 180 -PNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKL 236
++A E L Y SD+WS GV+L+ I++ G P+ A LY+K+ +G +
Sbjct: 174 PVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 232
Query: 237 PKWLSPGAQNLLRKILEPNPVKRITIAGI 265
P +L+R+ P +R + A I
Sbjct: 233 PLNCDDEVYDLMRQCWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 3e-14
Identities = 62/235 (26%), Positives = 108/235 (45%), Gaps = 34/235 (14%)
Query: 22 LGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKR----EIATLKLLKHP 74
+G G FG+V + G + A+K L+ T++ +R E + + HP
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG------YTEKQRRDFLSEASIMGQFDHP 65
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI-------DGV 127
N++ L V+ + ++ E++ G L L++ +G+ QL+ G+
Sbjct: 66 NIIHLEGVVTKSRPVMIITEFMENGAL------DSFLRQNDGQFTVIQLVGMLRGIAAGM 119
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVA 184
Y HRDL NIL++S K+SDFGLS + D ++ G + A
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA 179
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILT-GYLPF-DDRNLAVLYQKIFRGDFKLP 237
PE +A R + A SD+WS G++++ +++ G P+ D N V+ D++LP
Sbjct: 180 PEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVI--NAIEQDYRLP 231
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 4e-14
Identities = 66/225 (29%), Positives = 109/225 (48%), Gaps = 39/225 (17%)
Query: 18 LGRTLGEGNFGKVKFAQDL--DSGLP-----FAVKILEKNRIIHLKITDQIKREIATLKL 70
LG+ LGEG FG+V A+ L D P AVK+L K+ ++D + E+ +K+
Sbjct: 19 LGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVS-EMEMMKM 76
Query: 71 L-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRL---------QEAEGRKLF 120
+ KH N++ L +Y+++EY + G L + + ++ + + + F
Sbjct: 77 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTF 136
Query: 121 QQLID-------GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD---- 169
+ L+ G+ Y ++ HRDL N+L+ +KI+DFGL+ RD
Sbjct: 137 KDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA------RDVNNI 190
Query: 170 DGLLHTTCGS--PNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
D TT G ++APE L +R Y SD+WS GV+++ I T
Sbjct: 191 DYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 5e-14
Identities = 78/267 (29%), Positives = 118/267 (44%), Gaps = 31/267 (11%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVRLH 80
+GEGNFG+V A+ GL I E+ L KL HPN++ L
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 81 EVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF----------QQLID----- 125
+ +Y+ +EY G L D + K R+ E + QQL+
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 126 --GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS--PN 181
G+ Y K HRDL NIL+ KI+DFGLS + + + T G
Sbjct: 134 ARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-----VKKTMGRLPVR 188
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKWL 240
++A E L Y SD+WS GV+L+ I++ G P+ A LY+K+ +G ++L K L
Sbjct: 189 WMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRLEKPL 246
Query: 241 SPGAQ--NLLRKILEPNPVKRITIAGI 265
+ + +L+R+ P +R + A I
Sbjct: 247 NCDDEVYDLMRQCWREKPYERPSFAQI 273
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 7e-14
Identities = 64/219 (29%), Positives = 96/219 (43%), Gaps = 31/219 (14%)
Query: 18 LGRTLGEGNFGKVKFAQ-----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
L R LGEG FGKV A+ + AVK L+ L +RE L L+
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQ 65
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELF----------------DKIASKGRLQEAEG 116
H ++V+ + V + MV EY+ G+L +KG L ++
Sbjct: 66 HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 125
Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---LPQHFRDDGLL 173
+ Q+ G+ Y ++ HRDL N L+ + +KI DFG+S ++R G
Sbjct: 126 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG-- 183
Query: 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
HT ++ PE + R + SD+WS GVIL+ I T
Sbjct: 184 HTML-PIRWMPPESIMYRKFT-TESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 8e-14
Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
L RY+ + +G G G V A D +G A+K L + + H K + RE+ +KL
Sbjct: 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAK---RAYRELVLMKL 71
Query: 71 LKHPNVVRLHEV------LASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQ 122
+ H N++ L V L +Y+V+E + ++ R+ L Q
Sbjct: 72 VNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS-----YLLYQ 126
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN- 181
++ G+ + H+ G+ HRDLK NI++ S +KI DFGL+ R G + +P
Sbjct: 127 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAG--TSFMMTPYV 178
Query: 182 ----YVAPEVLANRGYDGATSDIWSCGVIL 207
Y APEV+ GY DIWS G I+
Sbjct: 179 VTRYYRAPEVILGMGYK-ENVDIWSVGCIM 207
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 17/210 (8%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REI-ATLKLLKHPNVVR 78
+G G FG V SG AVK + R + +Q + ++ ++ P +V+
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVK---RIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVK 67
Query: 79 LHEVLASKSKIYMVLEYV-TGGELFDKIA---SKGRLQEAEGRKLFQQLIDGVSYCHNK- 133
+ L + ++ +E + + F K K + E K+ + ++Y +
Sbjct: 68 FYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL 127
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 193
+ HRD+K NILLD GNIK+ DFG+S D G Y+APE +
Sbjct: 128 KIIHRDVKPSNILLDRNGNIKLCDFGISG---QLVDSIAKTRDAGCRPYMAPERIDPSAR 184
Query: 194 DG--ATSDIWSCGVILYVILTGYLPFDDRN 221
DG SD+WS G+ LY + TG P+ N
Sbjct: 185 DGYDVRSDVWSLGITLYEVATGKFPYPKWN 214
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 40/152 (26%), Positives = 76/152 (50%), Gaps = 5/152 (3%)
Query: 64 EIATLKLLKHPNVVRLHEVLASKSKIYMVL-EYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
E L+ + HP++++L ++L Y T +L+ +A+K + + + +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT--DLYCYLAAKRNIAICDILAIERS 190
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
++ + Y H + HRD+K ENI ++ G++ + DFG + P + + G+
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK-YYGWAGTIAT 249
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGY 214
APE+LA Y G DIWS G++L+ + T +
Sbjct: 250 NAPELLARDPY-GPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 2e-13
Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 24/214 (11%)
Query: 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK---REIATLKLLKHP 74
L R LGEG FGKV F + + P KIL + + + K RE L L+H
Sbjct: 9 LKRELGEGAFGKV-FLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHE 67
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-------------RLQEAEGRKLFQ 121
++V+ + V + MV EY+ G+L + + G L +++ + Q
Sbjct: 68 HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---LPQHFRDDGLLHTTCG 178
Q+ G+ Y ++ HRDL N L+ +KI DFG+S ++R G HT
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG--HTML- 184
Query: 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
++ PE + R + SD+WS GV+L+ I T
Sbjct: 185 PIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 2e-13
Identities = 75/267 (28%), Positives = 127/267 (47%), Gaps = 33/267 (12%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
LG+G FG+V + + A+K L+ ++ + +E +K L+H +V L+
Sbjct: 14 LGQGCFGEV-WMGTWNGTTKVAIKTLKPGTMM----PEAFLQEAQIMKKLRHDKLVPLYA 68
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR--KLFQ------QLIDGVSYCHNK 133
V+ S+ IY+V E++ G L D L+E +G+ KL Q Q+ DG++Y
Sbjct: 69 VV-SEEPIYIVTEFMGKGSLLD------FLKEGDGKYLKLPQLVDMAAQIADGMAYIERM 121
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLAN 190
HRDL+ NIL+ KI+DFGL+ L + D G+ + APE A
Sbjct: 122 NYIHRDLRAANILVGDNLVCKIADFGLARLIE----DNEYTARQGAKFPIKWTAPEA-AL 176
Query: 191 RGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLL 248
G SD+WS G++L ++T G +P+ + +++ RG P+ L+
Sbjct: 177 YGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELM 236
Query: 249 RKILEPNPVKRITIAGIKADEWFEQDY 275
+ + +P +R T I++ F +DY
Sbjct: 237 KLCWKKDPDERPTFEYIQS---FLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 75/272 (27%), Positives = 117/272 (43%), Gaps = 34/272 (12%)
Query: 22 LGEGNFGKVKFAQ------DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
LGEG FGKV A+ + D L AVK L++ +RE L +L+H +
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKML-VAVKALKE---ASESARQDFQREAELLTVLQHQH 68
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR----LQEAEGRKLFQ---------- 121
+VR + V + MV EY+ G+L + S G L E Q
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 122 -QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---LPQHFRDDGLLHTTC 177
Q+ G+ Y + HRDL N L+ +KI DFG+S ++R G T
Sbjct: 129 SQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG---RTM 185
Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFK 235
++ PE + R + SDIWS GV+L+ I T G P+ + + I +G + +
Sbjct: 186 LPIRWMPPESILYRKFT-TESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELE 244
Query: 236 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267
P+ P +++ + P +R+ I I +
Sbjct: 245 RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 2e-13
Identities = 58/194 (29%), Positives = 95/194 (48%), Gaps = 14/194 (7%)
Query: 22 LGEGNFGKVK--FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
LG GNFG VK + + A+K+L+ + D++ RE + L +P +VR+
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRM 60
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
V +++ + +V+E +GG L ++ K + + +L Q+ G+ Y K HR
Sbjct: 61 IGVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHR 119
Query: 139 DLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYD 194
DL N+LL ++ KISDFGLS AL DD + APE + R +
Sbjct: 120 DLAARNVLLVNQHYAKISDFGLSKALGA---DDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 195 GATSDIWSCGVILY 208
+ SD+WS G+ ++
Sbjct: 177 -SRSDVWSYGITMW 189
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 44/147 (29%), Positives = 78/147 (53%), Gaps = 5/147 (3%)
Query: 64 EIATLKLLKHPNVVRLHEVLASKSKIYMVL-EYVTGGELFDKIASKGR-LQEAEGRKLFQ 121
E L+ L HP V+ L +V +VL +Y + +L+ + ++ R L A+ + +
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRS--DLYTYLGARLRPLGLAQVTAVAR 267
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
QL+ + Y H +G+ HRD+K EN+L++ +I + DFG + + + G+ +
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVD 327
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILY 208
APEVLA Y + DIWS G++++
Sbjct: 328 TNAPEVLAGDPYT-PSVDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 4e-13
Identities = 59/236 (25%), Positives = 88/236 (37%), Gaps = 50/236 (21%)
Query: 14 GRYELGRTLGEGNFGKVKFA-----QDLDSGLP-----------FAVKILEKNRIIHLKI 57
LGEG FG+V QD AVK+L + + +
Sbjct: 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARE 64
Query: 58 TDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL---------FDKIASK 108
D +K E+ L L PN+ RL V + M++EY+ G+L +
Sbjct: 65 -DFLK-EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLAC 122
Query: 109 GRLQEAEGRKLFQ--QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---L 163
+ L+ Q+ G+ Y + HRDL N L+ IKI+DFG+S
Sbjct: 123 NSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182
Query: 164 PQHFRDDGLLHTTCGSPNYVAP-------EVLANRGYDGATSDIWSCGVILYVILT 212
++R G P VL + + SD+W+ GV L+ ILT
Sbjct: 183 SDYYRVQG---------RAPLPIRWMAWESVLLGK-FTTK-SDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 5e-13
Identities = 77/259 (29%), Positives = 123/259 (47%), Gaps = 28/259 (10%)
Query: 20 RTLGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
R +G+G+FG V +DS + AVK L NRI L+ +Q +E +K HPNV
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSL--NRITDLEEVEQFLKEGIIMKDFSHPNV 58
Query: 77 VRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCHN 132
+ L + L S+ +VL Y+ G+L + I S+ +++ G L Q+ G+ Y +
Sbjct: 59 LSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL--QVAKGMEYLAS 116
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-------DGLLHTTCGSP-NYVA 184
K HRDL N +LD +K++DFGL+ RD HT P ++A
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLA------RDIYDKEYYSVHNHTGAKLPVKWMA 170
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL-PKWLSP 242
E L + + SD+WS GV+L+ ++T G P+ D + + + +G L P++
Sbjct: 171 LESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPD 229
Query: 243 GAQNLLRKILEPNPVKRIT 261
++ P P R T
Sbjct: 230 PLYEVMLSCWHPKPEMRPT 248
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-12
Identities = 62/234 (26%), Positives = 93/234 (39%), Gaps = 47/234 (20%)
Query: 17 ELGRTLGEGNFGKVKFAQ-----DLDSGLPFAVKIL-----EKNRIIHLKITDQIKREIA 66
L R LG G FG+V L AVK L E++ L E
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLM-------EAL 61
Query: 67 TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR--------- 117
+ H N+VRL V + +++LE + GG+L K L+E R
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDL------KSFLRENRPRPERPSSLTM 115
Query: 118 ----KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSA---LPQHF 167
+ + G Y HRD+ N LL KG KI+DFG++ ++
Sbjct: 116 KDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYY 175
Query: 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDR 220
R G ++ PE + G + +D+WS GV+L+ I + GY+P+ R
Sbjct: 176 RKGG---RAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPYPGR 225
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 69/269 (25%), Positives = 120/269 (44%), Gaps = 24/269 (8%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI----ATLKLLKHPN 75
LG G +G V + + +G AVK + + +Q KR + +++ + P
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRAT----VNSQEQ-KRLLMDLDISMRSVDCPY 61
Query: 76 VVRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHN 132
V + L + +++ +E + + + K+ KG + E K+ ++ + Y H+
Sbjct: 62 TVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS 121
Query: 133 K-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE----V 187
K V HRD+K N+L++ G +K+ DFG+S + D G Y+APE
Sbjct: 122 KLSVIHRDVKPSNVLINRNGQVKLCDFGISG---YLVDSVAKTIDAGCKPYMAPERINPE 178
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN--LAVLYQKIFRGDFKLPK-WLSPGA 244
L +GYD SD+WS G+ + + TG P+D L Q + +LP SP
Sbjct: 179 LNQKGYD-VKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEF 237
Query: 245 QNLLRKILEPNPVKRITIAGIKADEWFEQ 273
Q+ + K L+ N +R + +FE
Sbjct: 238 QDFVNKCLKKNYKERPNYPELLQHPFFEL 266
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 55/231 (23%), Positives = 99/231 (42%), Gaps = 21/231 (9%)
Query: 17 ELGRTLGEGNFGK--VKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
EL +G+ V A+ + AVK + + + +++EI T + L+HP
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLK-LLQQEIITSRQLQHP 59
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHN 132
N++ S++Y+V + G D + + L E + + +++ + Y H+
Sbjct: 60 NILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS 119
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--------NYVA 184
KG HR +K +ILL G + +S GL G +++
Sbjct: 120 KGFIHRSVKASHILLSGDGKVVLS--GLRYS-VSMIKHGKRQRVVHDFPKSSVKNLPWLS 176
Query: 185 PEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY-QKIFRG 232
PEVL +GY+ SDI+S G+ + G++PF D + +K+ RG
Sbjct: 177 PEVLQQNLQGYN-EKSDIYSVGITACELANGHVPFKDMPATQMLLEKV-RG 225
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-12
Identities = 65/238 (27%), Positives = 102/238 (42%), Gaps = 47/238 (19%)
Query: 15 RYELGRTLGEGNFGKV--KFAQDLDSGLPF---AVKILEKNRIIHLKITDQIKREIATLK 69
Y R +G+G FG+V A L PF AVK+L++ ++ Q RE A +
Sbjct: 8 EYV--RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ--REAALMA 63
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS---------------------- 107
HPN+V+L V A + ++ EY+ G+L + +
Sbjct: 64 EFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLN 123
Query: 108 KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167
L E + +Q+ G++Y + HRDL N L+ +KI+DFGLS
Sbjct: 124 PLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS------ 177
Query: 168 RDDGLLHTTCGSPN------YVAPE-VLANRGYDGATSDIWSCGVILYVILT-GYLPF 217
R+ S N ++ PE + NR Y SD+W+ GV+L+ I + G P+
Sbjct: 178 RNIYSADYYKASENDAIPIRWMPPESIFYNR-YT-TESDVWAYGVVLWEIFSYGMQPY 233
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 4e-12
Identities = 74/284 (26%), Positives = 123/284 (43%), Gaps = 30/284 (10%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
L RY+ + +G G G V A D A+K L + H K + RE+ +K
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 72
Query: 71 LKHPNVVRLHEVLASK------SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
+ H N++ L V + +Y+V+E + L I + L L Q++
Sbjct: 73 VNHKNIISLLNVFTPQKSLEEFQDVYLVME-LMDANLCQVIQME--LDHERMSYLLYQML 129
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPN 181
G+ + H+ G+ HRDLK NI++ S +KI DFGL+ R G ++ +
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRY 183
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-DFKLPKWL 240
Y APEV+ GY DIWS G I+ ++ + F R+ + K+ P+++
Sbjct: 184 YRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242
Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDE 284
Q +R +E P AG+ + F PA+ + ++
Sbjct: 243 KK-LQPTVRNYVENRP----KYAGLTFPKLFPDSLFPADSEHNK 281
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 5e-12
Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 20 RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+ LG G FG V + G +P A+K+L +N K +I E + + P
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN--TSPKANKEILDEAYVMAGVGSPY 70
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
V RL + + S + +V + + G L D + +K R+ + Q+ G+SY
Sbjct: 71 VCRLLGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR 129
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
+ HRDL N+L+ S ++KI+DFGL+ L D+ H G ++A E + +R
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLD--IDETEYHADGGKVPIKWMALESILHRR 187
Query: 193 YDGATSDIWSCGVILYVILT-GYLPFD 218
+ SD+WS GV ++ ++T G P+D
Sbjct: 188 FT-HQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-12
Identities = 62/225 (27%), Positives = 100/225 (44%), Gaps = 18/225 (8%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
L RY+ + +G G G V A D A+K L + H K + RE+ +K
Sbjct: 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 79
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRK---LFQQLIDGV 127
+ H N++ L V + + + EL D + E + + L Q++ G+
Sbjct: 80 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPNYVA 184
+ H+ G+ HRDLK NI++ S +KI DFGL+ R G ++ + Y A
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRYYRA 193
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI 229
PEV+ GY DIWS G I+ ++ G + F + + K+
Sbjct: 194 PEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 237
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 9e-12
Identities = 60/225 (26%), Positives = 97/225 (43%), Gaps = 39/225 (17%)
Query: 22 LGEGNFGKVKFAQDLDSGLP------FAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
LGE FGKV + L P A+K L+ + ++ K E L+HPN
Sbjct: 13 LGEDRFGKV-YKGHLFGTAPGEQTQAVAIKTLKDK--AEGPLREEFKHEAMMRSRLQHPN 69
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELF----------------DKIASKGRLQEAEGRKL 119
+V L V+ + + M+ Y + +L D K L+ A+ +
Sbjct: 70 IVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHI 129
Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD------DGLL 173
Q+ G+ + + V H+DL N+L+ K N+KISD GL FR+ L+
Sbjct: 130 VTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGL------FREVYAADYYKLM 183
Query: 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 217
+ +++PE + G SDIWS GV+L+ + + G P+
Sbjct: 184 GNSLLPIRWMSPEAIM-YGKFSIDSDIWSYGVVLWEVFSYGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 65/237 (27%), Positives = 111/237 (46%), Gaps = 34/237 (14%)
Query: 18 LGRTLGEGNFGKV-KFAQDLDSG--LPFAVKILEKNRIIHLKITDQIKR----EIATLKL 70
+ R LG G FG++ + L S LP A+ L +D+ +R E TL
Sbjct: 9 IERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAG------CSDKQRRGFLAEALTLGQ 62
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID----- 125
H N+VRL V+ + + +V EY++ G L L++ EG+ + QL+
Sbjct: 63 FDHSNIVRLEGVITRGNTMMIVTEYMSNGAL------DSFLRKHEGQLVAGQLMGMLPGL 116
Query: 126 --GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG-SPN- 181
G+ Y G H+ L +L++S KIS F L + + + + T G SP
Sbjct: 117 ASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFR--RLQED-KSEAIYTTMSGKSPVL 173
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLP 237
+ APE + + A SD+WS G++++ +++ G P+ D + + + + G F+LP
Sbjct: 174 WAAPEAIQYHHFSSA-SDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG-FRLP 228
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 60/225 (26%), Positives = 99/225 (44%), Gaps = 29/225 (12%)
Query: 15 RYELGRTLGEGNFGKVKFA----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
R L L EG FG++ + + VK + K+ +++T ++ E L
Sbjct: 7 RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTV-KDHASEIQVTLLLQ-ESCLLYG 64
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEG------RKLFQ--- 121
L H N++ + V + VL + RL EA ++L
Sbjct: 65 LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAI 124
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
Q+ G+SY H +GV H+D+ N ++D + +KI+D LS RD + C N
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALS------RDLFPMDYHCLGDN 178
Query: 182 ------YVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDD 219
++A E L N+ Y A SD+WS GV+L+ ++T G P+ +
Sbjct: 179 ENRPVKWMALESLVNKEYSSA-SDVWSFGVLLWELMTLGQTPYVE 222
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 75/284 (26%), Positives = 127/284 (44%), Gaps = 32/284 (11%)
Query: 20 RTLGEGNFGKV--KFAQDLDSGLP---FAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
R LG+G+FG V A+D+ G AVK + ++ + +I + E + +K
Sbjct: 12 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFTCH 69
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGR---------KLFQQLI 124
+VVRL V++ +V+E + G+L + S + + GR ++ ++
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---LPQHFRD--DGLLHTTCGS 179
DG++Y + K HRDL N ++ +KI DFG++ ++R GLL
Sbjct: 130 DGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV---- 185
Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDD-RNLAVLYQKIFRGDFKLP 237
++APE L + G +SD+WS GV+L+ I + P+ N VL + G P
Sbjct: 186 -RWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQP 243
Query: 238 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPD 281
+L+R + NP R T I + D P+ P+
Sbjct: 244 DNCPERVTDLMRMCWQFNPKMRPTFLEIV--NLLKDDLHPSFPE 285
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 56/207 (27%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 20 RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+ LG G FG V + G +P A+K L + K +I E + + +P+
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE--ATSPKANKEILDEAYVMASVDNPH 70
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
V RL + + S + ++ + + G L D + K + Q+ G++Y +
Sbjct: 71 VCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR 129
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
+ HRDL N+L+ + ++KI+DFGL+ L D+ H G ++A E + +R
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLAKLLG--ADEKEYHAEGGKVPIKWMALESILHRI 187
Query: 193 YDGATSDIWSCGVILYVILT-GYLPFD 218
Y SD+WS GV ++ ++T G P+D
Sbjct: 188 YT-HQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 5e-11
Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 17/202 (8%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
LG+G FG+V + + A+K L+ + + +E +K L+H +V+L+
Sbjct: 14 LGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 68
Query: 82 VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
V+ S+ IY+V EY++ G L D K L+ + + Q+ G++Y HRD
Sbjct: 69 VV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 127
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGA 196
L+ NIL+ K++DFGL+ L + D G+ + APE A G
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIE----DNEYTARQGAKFPIKWTAPEA-ALYGRFTI 182
Query: 197 TSDIWSCGVILYVILT-GYLPF 217
SD+WS G++L + T G +P+
Sbjct: 183 KSDVWSFGILLTELTTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 26/213 (12%)
Query: 20 RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+ LG G FG V + G +P A+KIL N K + E + + HP+
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKIL--NETTGPKANVEFMDEALIMASMDHPH 70
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ----QLIDGVSYCH 131
+VRL V S + I +V + + G L D + ++ G +L Q+ G+ Y
Sbjct: 71 LVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLE 126
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSAL-----PQHFRDDGLLHTTCGSPNYVAPE 186
+ + HRDL N+L+ S ++KI+DFGL+ L ++ D G + ++A E
Sbjct: 127 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPI-----KWMALE 181
Query: 187 VLANRGYDGATSDIWSCGVILYVILT-GYLPFD 218
+ R + SD+WS GV ++ ++T G P+D
Sbjct: 182 CIHYRKFT-HQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 63/266 (23%), Positives = 116/266 (43%), Gaps = 36/266 (13%)
Query: 22 LGEGNFGKVK----FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
LGE FGK+ + +D A+K L+ I + + + ++E + + L HPN+V
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKD--INNPQQWGEFQQEASLMAELHHPNIV 70
Query: 78 RLHEVLASKSKIYMVLEYVTGGELFDKI-----------------ASKGRLQEAEGRKLF 120
L V+ + + M+ EY+ G+L + + K L + +
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---LPQHFRDDGLLHTTC 177
Q+ G+ Y + H+DL NIL+ + ++KISD GLS ++R + +
Sbjct: 131 IQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYR---VQPKSL 187
Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVI----LTGYLPFDDRNLAVLYQKIFRGD 233
++ PE + + + SDIWS GV+L+ I L Y F ++ + + +K R
Sbjct: 188 LPIRWMPPEAIMYGKFS-SDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK--RQL 244
Query: 234 FKLPKWLSPGAQNLLRKILEPNPVKR 259
+ P +L+ + + P +R
Sbjct: 245 LPCSEDCPPRMYSLMTECWQEGPSRR 270
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 48/173 (27%), Positives = 72/173 (41%), Gaps = 28/173 (16%)
Query: 15 RYELGRTLGEGNFGKVKF------AQDLDSGLP--------FAVKILEKNRIIHLKITDQ 60
+ L LGEG FG+V A+ L G P AVK+L + + +
Sbjct: 6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD--VTKTARND 63
Query: 61 IKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG---------ELFDKIASKGRL 111
+EI + LK+PN++RL V S + M+ EY+ G E+ +
Sbjct: 64 FLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNI 123
Query: 112 QEAEGRKLFQ---QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS 161
L Q+ G+ Y + HRDL N L+ + IKI+DFG+S
Sbjct: 124 PSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 6e-10
Identities = 64/231 (27%), Positives = 96/231 (41%), Gaps = 56/231 (24%)
Query: 22 LGEGNFGKV---------KFAQD-------LDSGLPFAVKILEKNRIIHLKITDQIKREI 65
LGEG FG+V KF + + AVK+L ++ + + D +K EI
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNAR-NDFLK-EI 70
Query: 66 ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEG--------- 116
+ LK PN++RL V + + M+ EY+ G+L ++ S+ QEA
Sbjct: 71 KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL-NQFLSRHEPQEAAEKADVVTISY 129
Query: 117 ---RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---LPQHFRDD 170
+ Q+ G+ Y + HRDL N L+ IKI+DFG+S ++R
Sbjct: 130 STLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 171 GLLHTTCGSPNYVAPEVLANR---------GYDGATSDIWSCGVILYVILT 212
G VL R G SD+W+ GV L+ ILT
Sbjct: 190 G-------------RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 8e-10
Identities = 57/236 (24%), Positives = 103/236 (43%), Gaps = 26/236 (11%)
Query: 22 LGEGNFGKVKFAQ-DLDSGLPFA-VKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+G G FGKV ++ D+G+ VK L+ N K ++ ++ ++L+HPN+++
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKAN--ASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
+V EY G+L ++ + Q +++ ++ GV++ H
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNF 120
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL--HTTCGSPNYVAPEVLANRGY 193
H DL L N L S +K+ D+G+ P +++D + C ++APE++ +
Sbjct: 121 LHSDLALRNCFLTSDLTVKVGDYGIG--PSRYKEDYIETEDDKCVPLRWLAPELVGEF-H 177
Query: 194 DGAT-------SDIWSCGVILYVILTG----YLPFDDRNLAVLYQKIFRGDFKLPK 238
G S++W+ GV L+ + Y DR VL I KL K
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE--VLNHVIKDQQVKLFK 231
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 9e-10
Identities = 58/217 (26%), Positives = 97/217 (44%), Gaps = 23/217 (10%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLKLLKHP 74
E+GR G N V A+ +G V+I LE HLK ++ E+ +HP
Sbjct: 5 EIGR--GFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKA---LQNEVVLSHFFRHP 59
Query: 75 NVVRLHEVLASKSKIYMV---LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
N++ V + S ++++ + Y + L +G + EA + + G++Y H
Sbjct: 60 NIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEG-MSEALIGNILFGALRGLNYLH 118
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY-------VA 184
G HR++K +IL+ G + +S GLS L R+ P + ++
Sbjct: 119 QNGYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLS 176
Query: 185 PEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDD 219
PE+L GY+ SDI+S G+ + TG +PF D
Sbjct: 177 PELLRQDLYGYN-VKSDIYSVGITACELATGRVPFQD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 65/229 (28%), Positives = 98/229 (42%), Gaps = 46/229 (20%)
Query: 22 LGEGNFGKVKFA-----QDLDS-GLPF----------AVKILEKNRIIHLKITDQIKREI 65
LGEG FG+V QDL + PF AVKIL + + + D +K E+
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNAR-NDFLK-EV 70
Query: 66 ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR-------- 117
L LK PN++RL V + + M+ EY+ G+L ++ S L + E
Sbjct: 71 KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL-NQFLSSHHLDDKEENGNDAVPPA 129
Query: 118 ------------KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA--- 162
+ Q+ G+ Y + HRDL N L+ IKI+DFG+S
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 163 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 211
++R G ++A E + + A SD+W+ GV L+ IL
Sbjct: 190 AGDYYRIQG---RAVLPIRWMAWECILMGKFTTA-SDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 54/204 (26%), Positives = 92/204 (45%), Gaps = 19/204 (9%)
Query: 19 GRTLGEGNFGKVK---FAQDLDS-GLPFAVKILE--KNRIIHLKITDQIKREIATLKLLK 72
+ LG G FG V + + DS +P A+K ++ R +ITD + + L
Sbjct: 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHM----LAMGSLD 67
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCH 131
H +VRL + S + +V + G L D + + L Q+ G+ Y
Sbjct: 68 HAYIVRLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE 126
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSAL--PQHFRDDGLLHTTCGSP-NYVAPEVL 188
+ HR+L NILL S ++I+DFG++ L P D ++ +P ++A E +
Sbjct: 127 EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD---DKKYFYSEHKTPIKWMALESI 183
Query: 189 ANRGYDGATSDIWSCGVILYVILT 212
Y SD+WS GV ++ +++
Sbjct: 184 LFGRYT-HQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 77/303 (25%), Positives = 125/303 (41%), Gaps = 51/303 (16%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
Y+LG +G G+FG V A +D+ A+K + L+ RE+ +K L H N
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV-------LQDPQYKNRELLIMKNLNHIN 120
Query: 76 VVRLHEVLASKS------KIYM--VLEYV--TGGELFDKIASKGRLQEAEGRKLFQ-QLI 124
++ L + ++ I++ V+E++ T + A KL+ QL
Sbjct: 121 IIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLC 180
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGN-IKISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
++Y H+K + HRDLK +N+L+D + +K+ DFG + + C S Y
Sbjct: 181 RALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG--SAKNLLAGQRSVSYIC-SRFYR 237
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD--------RNLAVL---------- 225
APE++ D+WS G I+ ++ GY F R + VL
Sbjct: 238 APELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKE 297
Query: 226 ----YQKIFRGDFK-------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274
Y I D K PK A N + + L+ P+KR+ AD +F+
Sbjct: 298 MNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357
Query: 275 YTP 277
P
Sbjct: 358 RDP 360
|
Length = 440 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 3e-09
Identities = 45/167 (26%), Positives = 76/167 (45%), Gaps = 14/167 (8%)
Query: 64 EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQ 121
E+ KL HPN+V + +++++V ++ G D I + + E + Q
Sbjct: 49 ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQ 108
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
++ + Y H+ G HR +K +IL+ G + +S GL + L P
Sbjct: 109 GVLKALDYIHHMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPK 166
Query: 182 Y-------VAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDD 219
Y ++PEVL +GYD A SDI+S G+ + G++PF D
Sbjct: 167 YSVKVLPWLSPEVLQQNLQGYD-AKSDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 5e-09
Identities = 37/119 (31%), Positives = 56/119 (47%), Gaps = 14/119 (11%)
Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP 237
G+P+Y+APE+L + + A D W+ GV L+ LTG PF+D ++Q I D P
Sbjct: 542 GTPDYLAPELLLGKPHGPAV-DWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600
Query: 238 ---KWLSPGAQNLLRKILEPNPVKRITIAGIKAD------EWFEQDYTP----ANPDDD 283
+ LS AQN + +L +P KR + +K +W PDD+
Sbjct: 601 EGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLFHGVDWENLQNQTMPFIPQPDDE 659
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 9e-09
Identities = 56/215 (26%), Positives = 102/215 (47%), Gaps = 28/215 (13%)
Query: 18 LGRTLGEGNFGKV--KFAQDLDSGLP---FAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ R LG+G+FG V A+ + P A+K + + + +I + E + +K
Sbjct: 10 MSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMKEFN 67
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEG------RKLFQ---Q 122
+VVRL V++ +++E +T G+L + S + ++ +K+ Q +
Sbjct: 68 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGE 127
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRD--DGLLHTTC 177
+ DG++Y + HRDL N ++ +KI DFG++ ++R GLL
Sbjct: 128 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV-- 185
Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
+++PE L + G SD+WS GV+L+ I T
Sbjct: 186 ---RWMSPESLKD-GVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 9e-08
Identities = 65/228 (28%), Positives = 98/228 (42%), Gaps = 36/228 (15%)
Query: 55 LKITDQIKREIA-----TLKLLK---HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI- 105
LK+ D R+IA T L+ H ++ +H V S+ MV E+V G L D
Sbjct: 49 LKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL-DVCL 107
Query: 106 -ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-------NIKISD 157
KGR+ A + QQL +SY +K + H ++ +NILL G IK+SD
Sbjct: 108 RKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSD 167
Query: 158 FGLS--ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI-LTGY 214
G+S AL + R + + ++APE + +D WS G L I G
Sbjct: 168 PGVSFTALSREERVERI--------PWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGE 219
Query: 215 LPFDDRNLAV---LYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 259
+P +R + Y+K R LP+ L+ + L P +R
Sbjct: 220 VPLKERTPSEKERFYEKKHR----LPEPSCKELATLISQCLTYEPTQR 263
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 70/279 (25%), Positives = 101/279 (36%), Gaps = 97/279 (34%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILE--------KNRIIHLKITDQI 61
R +LG+ LG G FGKV A S AVK+L+ K + LKI I
Sbjct: 8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHI 67
Query: 62 KREIATLKLL-----------------KHPNVVRLHEVLASKSKIYMV--LEYVTGGELF 102
+ + LL K N L L SK + + + E+
Sbjct: 68 GHHLNVVNLLGACTKPGGPLMVIVEYCKFGN---LSNYLRSKRECFSPYRNKSTRKREMK 124
Query: 103 DKIASKGRL------------------------QEAEGRKLFQ-------------QLID 125
K K RL ++ EG +L++ Q+
Sbjct: 125 QKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVAR 184
Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV-- 183
G+ + ++ HRDL NILL +KI DFGL+ RD P+YV
Sbjct: 185 GMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA------RD------IYKDPDYVRK 232
Query: 184 ----------APEVLANRGYDGATSDIWSCGVILYVILT 212
APE + ++ Y SD+WS GV+L+ I +
Sbjct: 233 GDARLPLKWMAPESIFDKVYT-TQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 5e-07
Identities = 54/216 (25%), Positives = 90/216 (41%), Gaps = 36/216 (16%)
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF-- 120
+ + L H ++V+L+ V I MV EYV G L D + + + KL
Sbjct: 50 ETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPL-DVFLHREKNNVSLHWKLDVA 107
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILL----DSKGN---IKISDFG--LSALPQHFRDDG 171
+QL + Y +K + H ++ +NIL+ ++G IK+SD G ++ L + R +
Sbjct: 108 KQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE- 166
Query: 172 LLHTTCGSPNYVAPEVLANRGYDGATSDI----WSCGVILYVILT-GYLPFDDRNLA--- 223
P ++APE + N A+ I WS G L I + G P + +
Sbjct: 167 ------RIP-WIAPECIRN---GQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE 216
Query: 224 VLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 259
YQ + +P NL+ + +P KR
Sbjct: 217 RFYQD--QHRLPMPDC--AELANLINQCWTYDPTKR 248
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 6e-07
Identities = 57/228 (25%), Positives = 95/228 (41%), Gaps = 33/228 (14%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
R+++ LGEG FGKV A D AVKI+ K T K EI ++ ++
Sbjct: 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQ 184
Query: 74 PNV------VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
+ +++ +++ ++ G L D I G ++ Q +
Sbjct: 185 ADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVAL 244
Query: 128 SYCHNK-GVFHRDLKLENILLDSKGN----------------IKISDFGLSALPQHFRDD 170
Y H + + H DLK ENIL+++ ++I D G +H R
Sbjct: 245 DYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSRT- 303
Query: 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD 218
+ +Y +PEV+ G+ +T D+WS G I+Y + TG L +D
Sbjct: 304 ----AIVSTRHYRSPEVVLGLGWMYST-DMWSMGCIIYELYTGKLLYD 346
|
Length = 467 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 35/102 (34%), Positives = 52/102 (50%), Gaps = 12/102 (11%)
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS----ALPQHFRD-DGLLHTT 176
Q+ G+ + ++ HRDL NILL +KI DFGL+ P + R D L
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL- 245
Query: 177 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 217
++APE + +R Y SD+WS GV+L+ I + G P+
Sbjct: 246 ----KWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPY 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 28/159 (17%)
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
Q+ G+S+ +K HRDL NILL KI DFGL+ + R+D N
Sbjct: 222 QVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLA---RDIRNDS---------N 269
Query: 182 YV------------APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQK 228
YV APE + N Y SD+WS G++L+ I + G P+ + + K
Sbjct: 270 YVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYK 328
Query: 229 IFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGI 265
+ + +++ P+ ++++ + +P+KR T I
Sbjct: 329 MIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQI 367
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 37/115 (32%), Positives = 58/115 (50%), Gaps = 7/115 (6%)
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH--TTCGS 179
Q+ +G+ + +K HRDL N+L+ +KI DFGL+ RD + +T
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLAR--DIMRDSNYISKGSTFLP 304
Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNL-AVLYQKIFRG 232
++APE + N Y SD+WS G++L+ I T G P+ + + Y I RG
Sbjct: 305 LKWMAPESIFNNLYT-TLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRG 358
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 4e-06
Identities = 58/243 (23%), Positives = 107/243 (44%), Gaps = 35/243 (14%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLLKHPNVV 77
+ +G G FGKV +++SG A +++ K + + +Q+K E + L+H N++
Sbjct: 1 KEIGNGWFGKV-ILGEVNSGYTPA-QVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLL 58
Query: 78 RLHEVLASKSKIYMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLID---GVSYCHN 132
+ + +V+E+ G+L + S K L + L + + G+ + H
Sbjct: 59 QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN-------YVAP 185
H DL L N LL + +KI D+GLS +++D + +P+ ++AP
Sbjct: 119 NNFIHSDLALRNCLLTADLTVKIGDYGLSHN--KYKEDYYV-----TPDQLWVPLRWIAP 171
Query: 186 EVLANRGYD------GATSDIWSCGVILYVILT-GYLPF---DDRNLAVLYQKIFRGDFK 235
E++ + S++WS GV ++ + G P+ D VL + K
Sbjct: 172 ELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ--VLTYTVREQQLK 229
Query: 236 LPK 238
LPK
Sbjct: 230 LPK 232
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 6e-06
Identities = 40/153 (26%), Positives = 66/153 (43%), Gaps = 20/153 (13%)
Query: 99 GELFDKIASKGRLQEAEGRKLFQ-----------------QLIDGVSYCHNKGVFHRDLK 141
+D+ AS ++E + L Q+ G+ + +K HRDL
Sbjct: 205 RSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLA 264
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
N+LL +KI DFGL+ H + +T ++APE + + Y SD+W
Sbjct: 265 ARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYT-TLSDVW 323
Query: 202 SCGVILYVILT-GYLPFDDRNL-AVLYQKIFRG 232
S G++L+ I + G P+ + + Y KI G
Sbjct: 324 SYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSG 356
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 7e-06
Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 6/99 (6%)
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-DGLLHTTCGSP 180
Q+ G+ + ++ HRDL NILL +KI DFGL+ ++D D + + P
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR--DIYKDPDYVRKGSARLP 239
Query: 181 -NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 217
++APE + ++ Y SD+WS GV+L+ I + G P+
Sbjct: 240 LKWMAPESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPY 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 52/196 (26%), Positives = 88/196 (44%), Gaps = 29/196 (14%)
Query: 48 EKNRIIHLKITDQIKREIA--------TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG 99
EK + LK+ D R+I+ ++ + H ++V L+ V + MV E+V G
Sbjct: 30 EKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFG 89
Query: 100 --ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL-----DSKGN 152
+LF S L K+ +QL +SY +K + H ++ +NILL D +
Sbjct: 90 PLDLFMHRKSD-VLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECG 148
Query: 153 --IKISDFG--LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 208
IK+SD G ++ L + + + ++APE + + +D WS G L+
Sbjct: 149 PFIKLSDPGIPITVLSRQECVERI--------PWIAPECVEDSKNLSIAADKWSFGTTLW 200
Query: 209 VI-LTGYLPFDDRNLA 223
I G +P D+ LA
Sbjct: 201 EICYNGEIPLKDKTLA 216
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 33/120 (27%), Positives = 53/120 (44%), Gaps = 26/120 (21%)
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR---KLFQQLIDGVSYCHNKGV 135
L +++ SK Y V Y L K+ + E E + + +Q++ + H+ G+
Sbjct: 222 LADLMQSKEFPYNVEPY-----LLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGI 276
Query: 136 FHRDLKLENILLD-SKGNIKISDFGLSA--------LPQHFRDDGLLHTTCGSPNYVAPE 186
HRD+K +NI+ G+ KI D G +A +P+ F D P Y APE
Sbjct: 277 VHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLD---------PRYAAPE 327
|
Length = 566 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 44/241 (18%), Positives = 89/241 (36%), Gaps = 29/241 (12%)
Query: 41 PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLH----EVLASKSKIYMVLEYV 96
++ +K H + D + EI L+ + N+++++ +++ ++ ++LEY
Sbjct: 45 EVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104
Query: 97 TGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKI 155
T G L + + + L + G+ + +++L + L+ +KI
Sbjct: 105 TRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKI 164
Query: 156 SDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT---------SDIWSCGVI 206
GL SP + + Y DI+S GV+
Sbjct: 165 ICHGL-------------EKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVV 211
Query: 207 LYVILTGYLPFDDRNLAVLYQKIFR--GDFKLPKWLSPGAQNLLRKILEPNPVKRITIAG 264
L+ I TG +PF++ +Y I KLP + ++ + +KR I
Sbjct: 212 LWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKE 271
Query: 265 I 265
I
Sbjct: 272 I 272
|
Length = 283 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 45/158 (28%), Positives = 71/158 (44%), Gaps = 14/158 (8%)
Query: 64 EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL 123
EIA + L+HPN+V+L + S+ Y++ EY+ G L + + + L RK+ +
Sbjct: 733 EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN---LSWERRRKIAIGI 789
Query: 124 IDGVSYCH---NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
+ + H + V +L E I++D K + +LP D S
Sbjct: 790 AKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL----RLSLPGLLCTD---TKCFISS 842
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD 218
YVAPE + SDI+ G+IL +LTG P D
Sbjct: 843 AYVAPETRETKDIT-EKSDIYGFGLILIELLTGKSPAD 879
|
Length = 968 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 40/139 (28%), Positives = 59/139 (42%), Gaps = 37/139 (26%)
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
Q+ G+ + +K HRD+ N+LL KI DFGL+ RD N
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLA------RD------IMNDSN 267
Query: 182 YV------------APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAV---L 225
YV APE + + Y SD+WS G++L+ I + G P+ + V
Sbjct: 268 YVVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGKSPYP--GILVNSKF 324
Query: 226 YQKIFRG------DFKLPK 238
Y+ + RG DF P+
Sbjct: 325 YKMVKRGYQMSRPDFAPPE 343
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|213376 cd12120, AMPKA_C_like, C-terminal regulatory domain of 5'-AMP-activated protein kinase (AMPK) alpha subunit and similar domains | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 3e-04
Identities = 19/101 (18%), Positives = 38/101 (37%), Gaps = 11/101 (10%)
Query: 339 RKIRFTSNHSAKDLLERIEDIVTEMGFR--VQKKNGKLKATQEHKPQKSLGSLSVAAEVF 396
++ S ++ E I ++ G + N + + L S EV+
Sbjct: 4 WELEIHSRIDPSEIYEGIHKVLEGWGKNLVFRITNFIITGKLVNDHILFLRSTLFEIEVY 63
Query: 397 EISPSLYVVELRKSYGDPTVYRQIKTSIVFVQLCNKLSSDL 437
E+ P L++V+ +K G ++ F +L K+ L
Sbjct: 64 EVGPGLFMVDFKKKTG---------STKTFTKLATKIQIKL 95
|
This family is composed of AMPKs, microtubule-associated protein/microtubule affinity regulating kinases (MARKs), yeast Kcc4p-like proteins, plant calcineurin B-Like (CBL)-interacting protein kinases (CIPKs), and similar proteins. They are serine/threonine protein kinases (STKs) that catalyze the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. AMPKs act as sensors for the energy status of the cell and are activated by cellular stresses that lead to ATP depletion such as hypoxia, heat shock, and glucose deprivation, among others. MARKs phosphorylate the tau protein and related microtubule-associated proteins (MAPs) on tubulin binding sites to induce detachment from microtubules, and are involved in the regulation of cell shape and polarity, cell cycle control, transport, and the cytoskeleton. Kcc4p and related proteins are septin-associated proteins that are involved in septin organization and in the yeast morphogenesis checkpoint coordinating the cell cycle with bud formation. CIPKs interact with the calcineurin B-like (CBL) calcium sensors to form a signaling network that decode specific calcium signals triggered by a variety of environmental stimuli including salinity, drought, cold, light, and mechanical perturbation, among others. All members of this family contain an N-terminal catalytic kinase domain and a C-terminal regulatory domain which is also called kinase associated domain 1 (KA1) in some cases. The C-terminal regulatory domain serves as a protein interaction domain in AMPKs and CIPKs. In MARKs and Kcc4p-like proteins, this domain binds phospholipids and may be involved in membrane localization. Length = 95 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 4e-04
Identities = 17/43 (39%), Positives = 28/43 (65%)
Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFG 159
+ + +Q++ G+ H G+ HRD+K EN+L+ G +KI DFG
Sbjct: 312 KGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFG 354
|
Length = 507 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 5e-04
Identities = 28/132 (21%), Positives = 52/132 (39%), Gaps = 17/132 (12%)
Query: 37 DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVV-RLHEVLASKSKIYMVLE 94
+ +KI +RE+A L+LL + V ++ S Y+++E
Sbjct: 19 TKDEDYVLKINPSREKGA-----DREREVAILQLLARKGLPVPKVLASGESDGWSYLLME 73
Query: 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN---KGVFHRDLKLENILLDSKG 151
++ G L + E E + +QL + ++ H + H DL NIL+D
Sbjct: 74 WIEGETL-------DEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK 126
Query: 152 NIKISDFGLSAL 163
+ I D+ +
Sbjct: 127 ILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 53/217 (24%), Positives = 91/217 (41%), Gaps = 41/217 (18%)
Query: 21 TLGEGNFGKVKFAQDLDSG-------LPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
+LG+G F K+ + G +K+L+K+ H ++ + + L H
Sbjct: 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSH 58
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGEL-------FDKIASKGRLQEAEGRKLFQQLIDG 126
++V + V + MV EYV G L + I +L+ A +QL
Sbjct: 59 KHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVA------KQLAWA 112
Query: 127 VSYCHNKGVFHRDLKLENILL-----DSKGN---IKISDFGLS--ALPQHFRDDGLLHTT 176
+ + +KG+ H ++ +N+LL GN IK+SD G+S LP+ + +
Sbjct: 113 LHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERI---- 168
Query: 177 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 213
+V PE + N +D WS G L+ I +G
Sbjct: 169 ----PWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.7 bits (91), Expect = 0.002
Identities = 29/87 (33%), Positives = 43/87 (49%), Gaps = 7/87 (8%)
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
NV ++ V I V+EY+ G L D I S G + R++ + V H+ G
Sbjct: 62 NVPAVYFVDPENFII--VMEYIEGEPLKDLINSNGMEELELSREIGRL----VGKLHSAG 115
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLS 161
+ H DL N++L S G I + DFGL+
Sbjct: 116 IIHGDLTTSNMIL-SGGKIYLIDFGLA 141
|
Length = 211 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 450 | |||
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.92 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.91 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.9 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.9 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.87 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.86 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.84 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.84 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.81 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.79 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.79 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.78 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.77 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.74 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.72 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.71 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.61 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.58 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.55 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.55 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.55 | |
| PF03822 | 63 | NAF: NAF domain; InterPro: IPR004041 The NAF domai | 99.5 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.48 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.46 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.44 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.33 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.27 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.27 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.14 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.12 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.11 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.09 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.07 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.06 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.82 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.77 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.69 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.67 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.65 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.57 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.56 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.44 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.42 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.4 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.3 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.22 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.17 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 98.14 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.14 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.13 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.0 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.93 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.89 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.89 | |
| PF02149 | 47 | KA1: Kinase associated domain 1; InterPro: IPR0017 | 97.86 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.83 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.82 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.79 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.75 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.75 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.73 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.53 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.39 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.33 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.29 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.25 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.19 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.06 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.93 | |
| PLN02236 | 344 | choline kinase | 96.89 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.78 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.57 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.39 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.34 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.16 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.08 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.69 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.48 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.37 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.21 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 93.55 |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-63 Score=496.49 Aligned_cols=265 Identities=54% Similarity=1.008 Sum_probs=248.3
Q ss_pred CcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccc--hhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeC
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH--LKITDQIKREIATLKLLK-HPNVVRLHEVLASK 86 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~ 86 (450)
....|+|.+++.||+|+||+|++|.+..+|+.||+|++++..... ....+.+.+|+.++++++ ||||+++++++...
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 467899999999999999999999999999999999887753321 134678889999999999 99999999999999
Q ss_pred CEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccC-CCeEEeecCCCCCCC
Q 013081 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGLSALPQ 165 (450)
Q Consensus 87 ~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~-g~lkl~DFGla~~~~ 165 (450)
..+|+|||||.||+|++++.+.++++|.+++.+|+||++|++|||++||+||||||||||++.+ +++||+|||++....
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 9999999999999999999999999999999999999999999999999999999999999999 999999999999754
Q ss_pred cccCCCccccccCCCCccchhhhccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCC-CHH
Q 013081 166 HFRDDGLLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWL-SPG 243 (450)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~-s~~ 243 (450)
.....+.+.||||.|+|||++.+.+ |.+.++|||||||+||.|++|+.||++.+...++.++.++.+.+|.|+ |++
T Consensus 173 --~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~ 250 (370)
T KOG0583|consen 173 --GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPE 250 (370)
T ss_pred --CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHH
Confidence 3556889999999999999999988 999999999999999999999999999999999999999999999999 999
Q ss_pred HHHHHHHccccCcCCCCCHHHHHhcccccc-CCC
Q 013081 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQ-DYT 276 (450)
Q Consensus 244 ~~~Li~~~L~~dP~~R~t~~~il~h~~~~~-~~~ 276 (450)
+.+|+++||.+||.+|+|+.+|+.||||+. +..
T Consensus 251 ~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~~~~ 284 (370)
T KOG0583|consen 251 ARSLIEKMLVPDPSTRITLLEILEHPWFQKENPL 284 (370)
T ss_pred HHHHHHHHcCCCcccCCCHHHHhhChhhccCCCC
Confidence 999999999999999999999999999998 443
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-63 Score=499.94 Aligned_cols=265 Identities=48% Similarity=0.840 Sum_probs=251.3
Q ss_pred cCCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013081 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (450)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (450)
.....+|-|++++.||.|+-|.|.+|++..||+.+|||++.+...........+.+||-+|+.+.|||++++|+++++..
T Consensus 6 ~~~~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~ 85 (786)
T KOG0588|consen 6 SHKNTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQ 85 (786)
T ss_pred cccccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCc
Confidence 34567899999999999999999999999999999999998774444444678999999999999999999999999999
Q ss_pred EEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcc
Q 013081 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 167 (450)
.+|+|+||++||+||+++.++|++++.++.++|+||+.|+.|||..+|+||||||+|+|+|..+++||+|||+|.+-
T Consensus 86 ~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe--- 162 (786)
T KOG0588|consen 86 HLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLE--- 162 (786)
T ss_pred eEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecc---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999863
Q ss_pred cCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 013081 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247 (450)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~L 247 (450)
..+.++.+.||+|+|.|||++.+.+|+|.++||||||||||.||||++||++.|...++.++.+|.+.+|..+|+++++|
T Consensus 163 ~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdL 242 (786)
T KOG0588|consen 163 VPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDL 242 (786)
T ss_pred cCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHH
Confidence 35678999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHccccCcCCCCCHHHHHhccccccCC
Q 013081 248 LRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 248 i~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
|++||+.||++|+|.++|++|||+....
T Consensus 243 Lr~ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 243 LRRMLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred HHHHhccCccccccHHHHhhCchhhcCC
Confidence 9999999999999999999999997654
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-63 Score=479.24 Aligned_cols=262 Identities=39% Similarity=0.717 Sum_probs=235.4
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchh----HHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK----ITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~----~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (450)
...+.|.+.+.||+|+||.|.+|.++.||+.||||++++....... -...+.+|+++|++|+|||||+++++++..
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 3456899999999999999999999999999999999887654321 234578999999999999999999999999
Q ss_pred CEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccC---CCeEEeecCCCCC
Q 013081 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK---GNIKISDFGLSAL 163 (450)
Q Consensus 87 ~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~---g~lkl~DFGla~~ 163 (450)
...|+||||++||+|++.+..++.+.+...+.+++||+.||.|||++||+||||||+|||+..+ ..+||+|||+|+.
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 9999999999999999999999999999999999999999999999999999999999999776 6799999999997
Q ss_pred CCcccCCCccccccCCCCccchhhhccCCC--CCccchhhhHHHHHHHHHhCCCCCCCCcHHH-HHHHHHhCCCCC--CC
Q 013081 164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGY--DGATSDIWSCGVILYVILTGYLPFDDRNLAV-LYQKIFRGDFKL--PK 238 (450)
Q Consensus 164 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~--~~~~~DiwSlGvil~elltG~~Pf~~~~~~~-~~~~i~~~~~~~--p~ 238 (450)
.. ....+.+.||||.|+|||++.+.++ ++.++|+||+||+||.+|+|++||.+..... +.++|.++.+.+ |.
T Consensus 329 ~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~ 405 (475)
T KOG0615|consen 329 SG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQ 405 (475)
T ss_pred cc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChh
Confidence 43 5678899999999999999987654 3457899999999999999999999876655 899999998765 34
Q ss_pred C--CCHHHHHHHHHccccCcCCCCCHHHHHhccccccCC
Q 013081 239 W--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 239 ~--~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
| +|.++++||.+||..||++|||++++|+||||+...
T Consensus 406 w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 406 WDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred hhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 4 899999999999999999999999999999998643
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-62 Score=488.76 Aligned_cols=264 Identities=37% Similarity=0.698 Sum_probs=251.7
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
.+|..++.||+|||+.||.+++..+|+.||+|++.+.........+.+.+||+|++.|+|||||+++++|++.+.+|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 56999999999999999999999999999999999988888888999999999999999999999999999999999999
Q ss_pred ccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCcc
Q 013081 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (450)
Q Consensus 94 E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 173 (450)
|+|..++|..+++++++++|.+|+.|++||+.||.|||+++|+|||||..|++++++-+|||+|||||+..+. ++...
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~--~~Erk 175 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY--DGERK 175 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecC--ccccc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999997653 34567
Q ss_pred ccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccc
Q 013081 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE 253 (450)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~ 253 (450)
.+.||||.|.|||++...++ +..+||||+||+||.||.|++||+..+..+.+.+|...++.+|..+|.++++||++||+
T Consensus 176 ~TlCGTPNYIAPEVl~k~gH-sfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~ 254 (592)
T KOG0575|consen 176 KTLCGTPNYIAPEVLNKSGH-SFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLR 254 (592)
T ss_pred ceecCCCcccChhHhccCCC-CCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhc
Confidence 88999999999999997777 69999999999999999999999999999999999999999999999999999999999
Q ss_pred cCcCCCCCHHHHHhccccccCCCCCCC
Q 013081 254 PNPVKRITIAGIKADEWFEQDYTPANP 280 (450)
Q Consensus 254 ~dP~~R~t~~~il~h~~~~~~~~~~~~ 280 (450)
+||.+|||+++||.|+||..++.|...
T Consensus 255 ~~P~~Rpsl~~vL~h~Ff~~g~~p~~l 281 (592)
T KOG0575|consen 255 PNPSERPSLDEVLDHPFFKSGFTPARL 281 (592)
T ss_pred CCcccCCCHHHHhcCHhhhCCCcCCCC
Confidence 999999999999999999888877554
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-59 Score=445.68 Aligned_cols=261 Identities=38% Similarity=0.716 Sum_probs=243.9
Q ss_pred CcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (450)
......|++++.||+|+||+|+.++.+.+++.+|+|+++|..+......+....|..||..++||.||+++..|++...+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 45578999999999999999999999999999999999998888777789999999999999999999999999999999
Q ss_pred EEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC
Q 013081 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 169 (450)
|+|+||+.||+|+..|++.+.++|..|+.|+..|+.||.|||+.||+||||||||||+|.+|+++|+||||++... ..
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~--~~ 178 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL--KD 178 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcc--cC
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999998532 24
Q ss_pred CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCC-CCCCCCHHHHHHH
Q 013081 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLL 248 (450)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~Li 248 (450)
+....+.|||+.|||||++.+.+|+ ..+|+||||+++|+|++|.+||.+.+...++++|.+++.. .|..+++++++|+
T Consensus 179 ~~~t~tfcGT~eYmAPEil~~~gy~-~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll 257 (357)
T KOG0598|consen 179 GDATRTFCGTPEYMAPEILLGKGYD-KAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLL 257 (357)
T ss_pred CCccccccCCccccChHHHhcCCCC-cccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHH
Confidence 4466778999999999999999885 8899999999999999999999999999999999999844 4555999999999
Q ss_pred HHccccCcCCCC----CHHHHHhcccccc
Q 013081 249 RKILEPNPVKRI----TIAGIKADEWFEQ 273 (450)
Q Consensus 249 ~~~L~~dP~~R~----t~~~il~h~~~~~ 273 (450)
+++|..||.+|. ++.+|.+||||..
T Consensus 258 ~~LL~rdp~~RLg~~~d~~~ik~HpfF~~ 286 (357)
T KOG0598|consen 258 KKLLKRDPRQRLGGPGDAEEIKRHPFFKG 286 (357)
T ss_pred HHHhccCHHHhcCCCCChHHhhcCccccc
Confidence 999999999995 6899999999964
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-59 Score=429.94 Aligned_cols=257 Identities=39% Similarity=0.753 Sum_probs=245.4
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (450)
..+.+|+++++||.|+||.|-+++++.+|..+|+|+++++........++..+|.++|+.+.||.++++++.+.+.+.+|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 56789999999999999999999999999999999999999888888899999999999999999999999999999999
Q ss_pred EEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCC
Q 013081 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (450)
Q Consensus 91 lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 170 (450)
+||||++||+|++++++.+++++..|+.|+.||+.||+|||+++|++|||||||||+|.+|.+||+|||+|+.. .
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v-----~ 195 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRV-----S 195 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEe-----c
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999843 2
Q ss_pred CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 013081 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 250 (450)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~ 250 (450)
+...+.||||.|+|||++...+|. .++|.|||||++|||++|.+||.+.+...+|++|..++..+|+.+++++++||++
T Consensus 196 ~rT~TlCGTPeYLAPEii~sk~yn-kavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~ 274 (355)
T KOG0616|consen 196 GRTWTLCGTPEYLAPEIIQSKGYN-KAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKK 274 (355)
T ss_pred CcEEEecCCccccChHHhhcCCCC-cchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHH
Confidence 347789999999999999999985 8899999999999999999999999999999999999999999999999999999
Q ss_pred ccccCcCCCC-----CHHHHHhcccccc
Q 013081 251 ILEPNPVKRI-----TIAGIKADEWFEQ 273 (450)
Q Consensus 251 ~L~~dP~~R~-----t~~~il~h~~~~~ 273 (450)
+|+.|-.+|. ...+|..||||+.
T Consensus 275 LL~vD~t~R~gnlknG~~dIk~H~wF~~ 302 (355)
T KOG0616|consen 275 LLQVDLTKRFGNLKNGVEDIKNHPWFKG 302 (355)
T ss_pred HHhhhhHhhhcCcCCCccccccCccccc
Confidence 9999999994 4678999999984
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-57 Score=452.34 Aligned_cols=263 Identities=35% Similarity=0.642 Sum_probs=244.4
Q ss_pred CcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSK 88 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 88 (450)
.....+|.+++.||+|+|++|++|+++.+++.||||++.+..+..+...+-+.+|-.+|.+| .||+|++|+-.|.++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 45567999999999999999999999999999999999998887777788899999999999 79999999999999999
Q ss_pred EEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc
Q 013081 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 168 (450)
+|+|+||+++|+|.++|.+.|.|++..++.|+.||+.||+|||++|||||||||||||+|.|+++||+|||-|+......
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999998754321
Q ss_pred CC---------C--ccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCC
Q 013081 169 DD---------G--LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP 237 (450)
Q Consensus 169 ~~---------~--~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p 237 (450)
.. . ...+.+||..|++||++..... ++.+|+|+||||||.|++|.+||.+.+...++++|....+.+|
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~-~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp 307 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPA-GPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFP 307 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCCC-CcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCC
Confidence 11 1 1245799999999999877654 6999999999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHHHccccCcCCCCCHHHHHhcccccc
Q 013081 238 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 238 ~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
+.+++.+++||+++|..||.+|+|+.||.+||||..
T Consensus 308 ~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~ 343 (604)
T KOG0592|consen 308 EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG 343 (604)
T ss_pred CCCCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence 999999999999999999999999999999999974
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-57 Score=433.53 Aligned_cols=261 Identities=39% Similarity=0.654 Sum_probs=239.5
Q ss_pred CcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (450)
...+|+|.+.+.||+|+||+||+|+++.++..||||.+.+... ..+..+.+..||.+|+.++|||||+++++...++.+
T Consensus 6 ~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i 84 (429)
T KOG0595|consen 6 MRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFI 84 (429)
T ss_pred ccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeE
Confidence 4567999999999999999999999999999999999988765 455678899999999999999999999999999999
Q ss_pred EEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccC------CCeEEeecCCCCC
Q 013081 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK------GNIKISDFGLSAL 163 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~------g~lkl~DFGla~~ 163 (450)
|+|||||.||+|.++|++.+.+++..++.++.||+.||++||+++|+||||||+|||++.. -.+||+|||+|+.
T Consensus 85 ~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 85 YLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 9999999999999999999999999999999999999999999999999999999999875 3589999999996
Q ss_pred CCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCC---CCCCCC
Q 013081 164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---KLPKWL 240 (450)
Q Consensus 164 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~ 240 (450)
.. ...+..+.||+|.|||||++....|+ .|+|+||+|+|+|+|++|+.||+..+..+++..+.++.. .+|.++
T Consensus 165 L~---~~~~a~tlcGSplYMAPEV~~~~~Yd-AKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~ 240 (429)
T KOG0595|consen 165 LQ---PGSMAETLCGSPLYMAPEVIMSQQYD-AKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAEL 240 (429)
T ss_pred CC---chhHHHHhhCCccccCHHHHHhcccc-chhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhc
Confidence 53 56678899999999999999888886 899999999999999999999999999999988887753 345668
Q ss_pred CHHHHHHHHHccccCcCCCCCHHHHHhccccccCC
Q 013081 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 241 s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
++...+|+...|+.+|..|.+..+-+.|+++....
T Consensus 241 s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 241 SNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred cCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 88899999999999999999999999999987654
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-57 Score=431.12 Aligned_cols=259 Identities=44% Similarity=0.787 Sum_probs=247.0
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
-||++.++||+|+||+|.+|.+...|+.||||.|+++.+.+....-.++|||+||..|+||||+.+|++|+..+.+.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 48999999999999999999999999999999999999998888899999999999999999999999999999999999
Q ss_pred ccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCcc
Q 013081 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (450)
Q Consensus 94 E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 173 (450)
||..+|+|+|++..++.+++.+++++|+||.+|+.|||.++++|||||.+|||+|.|+++||+|||++..+ .+...+
T Consensus 133 EYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly---~~~kfL 209 (668)
T KOG0611|consen 133 EYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLY---ADKKFL 209 (668)
T ss_pred EecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhh---ccccHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999864 356689
Q ss_pred ccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccc
Q 013081 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE 253 (450)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~ 253 (450)
.++||+|.|.+||++.+.+|.|+.+|-|||||+||.|..|..||++.+...+..+|.++.+.-|.. +..+.-||++||.
T Consensus 210 qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~-PSdA~gLIRwmLm 288 (668)
T KOG0611|consen 210 QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPET-PSDASGLIRWMLM 288 (668)
T ss_pred HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCC-CchHHHHHHHHHh
Confidence 999999999999999999999999999999999999999999999999999999999998877764 6688999999999
Q ss_pred cCcCCCCCHHHHHhccccccCCC
Q 013081 254 PNPVKRITIAGIKADEWFEQDYT 276 (450)
Q Consensus 254 ~dP~~R~t~~~il~h~~~~~~~~ 276 (450)
.||.+|.|+.+|-.|=|.+.++.
T Consensus 289 VNP~RRATieDiAsHWWvNwgy~ 311 (668)
T KOG0611|consen 289 VNPERRATIEDIASHWWVNWGYN 311 (668)
T ss_pred cCcccchhHHHHhhhheeecccc
Confidence 99999999999999999987664
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-56 Score=422.89 Aligned_cols=259 Identities=29% Similarity=0.506 Sum_probs=235.4
Q ss_pred CcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE-
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK- 88 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~- 88 (450)
+..+++.+.+..||+|+.|+||+++|+.|++.+|+|++..+ .+....+++.+|+++++.++|||||++|+.|..+..
T Consensus 75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~ 152 (364)
T KOG0581|consen 75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE 152 (364)
T ss_pred ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence 34456788999999999999999999999999999999543 255667999999999999999999999999999995
Q ss_pred EEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhh-cCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcc
Q 013081 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~-~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 167 (450)
++|+||||+||+|.+.+...++++|.....++.|+++||.|||+ ++|+||||||+|||++..|.+||||||.+....
T Consensus 153 isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv-- 230 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILV-- 230 (364)
T ss_pred EEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhh--
Confidence 99999999999999999988999999999999999999999995 899999999999999999999999999998542
Q ss_pred cCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCC-----cHHHHHHHHHhC-CCCCCCC-C
Q 013081 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR-----NLAVLYQKIFRG-DFKLPKW-L 240 (450)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~-----~~~~~~~~i~~~-~~~~p~~-~ 240 (450)
++...+..||..|||||.+.+..| +.++||||||+.++||.+|+.||... +..+++..|..+ .+.+|.. +
T Consensus 231 --nS~a~tfvGT~~YMsPERi~g~~Y-s~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~f 307 (364)
T KOG0581|consen 231 --NSIANTFVGTSAYMSPERISGESY-SVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEF 307 (364)
T ss_pred --hhhcccccccccccChhhhcCCcC-CcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccC
Confidence 236788999999999999998877 58899999999999999999999874 667888889886 4567776 9
Q ss_pred CHHHHHHHHHccccCcCCCCCHHHHHhccccccCC
Q 013081 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 241 s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
|+++++||..||++||.+|||+.|+++|||+.+..
T Consensus 308 S~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 308 SPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 99999999999999999999999999999998653
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-55 Score=432.45 Aligned_cols=262 Identities=35% Similarity=0.634 Sum_probs=238.3
Q ss_pred CcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (450)
...+++|+++..||+|+||.||+|+.+.||+.+|+|++++......+.++.++.|-.+|...++|+||+++-.|.+...+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 45678999999999999999999999999999999999998888888889999999999999999999999999999999
Q ss_pred EEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCc---
Q 013081 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH--- 166 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~--- 166 (450)
|+||||++||++..+|.+.+.|++..++.|+.+++.|++-+|+.|++||||||+|+|||..|++||+||||++....
T Consensus 217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999863211
Q ss_pred -----------------ccCC-------------------------CccccccCCCCccchhhhccCCCCCccchhhhHH
Q 013081 167 -----------------FRDD-------------------------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCG 204 (450)
Q Consensus 167 -----------------~~~~-------------------------~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlG 204 (450)
...+ ......+|||.|+|||++.+.+| +..+|+||||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY-~~~cDwWSLG 375 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGY-GKECDWWSLG 375 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCC-CccccHHHHH
Confidence 0000 01123479999999999999997 5899999999
Q ss_pred HHHHHHHhCCCCCCCCcHHHHHHHHHhCC--CCCCCC--CCHHHHHHHHHccccCcCCCCC---HHHHHhcccccc
Q 013081 205 VILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLPKW--LSPGAQNLLRKILEPNPVKRIT---IAGIKADEWFEQ 273 (450)
Q Consensus 205 vil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~--~s~~~~~Li~~~L~~dP~~R~t---~~~il~h~~~~~ 273 (450)
||+||||.|++||.+.++.+.+.+|.... +.+|.. +++++++||.+||. ||.+|.- ++||.+||||..
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~ 450 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKG 450 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCcccc
Confidence 99999999999999999999999998875 666754 78999999999999 9999985 999999999974
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-56 Score=404.04 Aligned_cols=256 Identities=39% Similarity=0.759 Sum_probs=234.5
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
+.|++.+.||+|.|+.||++.+..+|+.+|+|+++....... ..+.+.+|++|-+.|+||||+++++.+.+....|+|+
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 689999999999999999999999999999999987665443 3578999999999999999999999999999999999
Q ss_pred ccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccC---CCeEEeecCCCCCCCcccCC
Q 013081 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDD 170 (450)
Q Consensus 94 E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~---g~lkl~DFGla~~~~~~~~~ 170 (450)
|++.|++|+.-|..+..++|..+-.+++||++||+|||.+||+|||+||+|+|+-.. .-+||+|||+|.... +.
T Consensus 90 e~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~---~g 166 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN---DG 166 (355)
T ss_pred ecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC---Cc
Confidence 999999998888777789999999999999999999999999999999999999643 359999999998543 55
Q ss_pred CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCC--C--CCHHHHH
Q 013081 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK--W--LSPGAQN 246 (450)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~--~s~~~~~ 246 (450)
.......|||.|||||++...+| +.++|||+||||||.||.|++||.+.+...+|++|..+.+.+|+ | +++++++
T Consensus 167 ~~~~G~~GtP~fmaPEvvrkdpy-~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~ 245 (355)
T KOG0033|consen 167 EAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKS 245 (355)
T ss_pred cccccccCCCcccCHHHhhcCCC-CCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHH
Confidence 67788899999999999988887 58899999999999999999999999999999999999777654 4 8999999
Q ss_pred HHHHccccCcCCCCCHHHHHhccccccC
Q 013081 247 LLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 247 Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
|+++||..||.+|+|+.|+|+|||+.+.
T Consensus 246 LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 246 LIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred HHHHHhccChhhhccHHHHhCCchhcch
Confidence 9999999999999999999999999764
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-55 Score=403.80 Aligned_cols=250 Identities=32% Similarity=0.535 Sum_probs=224.9
Q ss_pred CCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEE-EE-EeC
Q 013081 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE-VL-ASK 86 (450)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~-~~-~~~ 86 (450)
....+..|++++.||+|+||+||++.+..+|..||.|.++-... +......+..||.+|++|+|||||++++ .+ ++.
T Consensus 14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ 92 (375)
T KOG0591|consen 14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN 92 (375)
T ss_pred CcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence 45566789999999999999999999999999999999974433 4555788999999999999999999998 34 444
Q ss_pred CEEEEEEccCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHhhhhh--cC--eeeccCCCCcEEEccCCCeEEeec
Q 013081 87 SKIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHN--KG--VFHRDLKLENILLDSKGNIKISDF 158 (450)
Q Consensus 87 ~~~~lv~E~~~gg~L~~~i~~----~~~l~~~~~~~i~~ql~~aL~~LH~--~g--ivHrDlKp~NILl~~~g~lkl~DF 158 (450)
..++||||||.+|+|...|+. ...++|..+++++.||+.||.+||+ .+ |+||||||.||+++.+|.+||+||
T Consensus 93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf 172 (375)
T KOG0591|consen 93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF 172 (375)
T ss_pred hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence 458999999999999998864 4569999999999999999999999 45 999999999999999999999999
Q ss_pred CCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCC-CC
Q 013081 159 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LP 237 (450)
Q Consensus 159 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-~p 237 (450)
||++.++. .....++.+|||.||+||++...+|+ +++||||+||++|||++-++||.+.+...+.++|.+++++ +|
T Consensus 173 GL~r~l~s--~~tfA~S~VGTPyYMSPE~i~~~~Y~-~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p 249 (375)
T KOG0591|consen 173 GLGRFLSS--KTTFAHSLVGTPYYMSPERIHESGYN-FKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLP 249 (375)
T ss_pred hhHhHhcc--hhHHHHhhcCCCcccCHHHHhcCCCC-cchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCc
Confidence 99998755 44567788999999999999999996 9999999999999999999999999999999999999876 77
Q ss_pred -CCCCHHHHHHHHHccccCcCCCCCH
Q 013081 238 -KWLSPGAQNLLRKILEPNPVKRITI 262 (450)
Q Consensus 238 -~~~s~~~~~Li~~~L~~dP~~R~t~ 262 (450)
..+|.++..||..|+.+||.+||+.
T Consensus 250 ~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 250 DEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHhhhHHHHHHHHHccCCcccCCCc
Confidence 5689999999999999999999986
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-54 Score=391.00 Aligned_cols=262 Identities=35% Similarity=0.688 Sum_probs=246.7
Q ss_pred ccCCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013081 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (450)
Q Consensus 7 ~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (450)
....-.+++|++++.||+|.||.||+|+.+.++-.||+|++-++.+...+...++.||++|...|+||||+++|++|.+.
T Consensus 15 ~~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~ 94 (281)
T KOG0580|consen 15 ATKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS 94 (281)
T ss_pred cccccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc
Confidence 34456688999999999999999999999999999999999988887777789999999999999999999999999999
Q ss_pred CEEEEEEccCCCCChHHHHH--hcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCC
Q 013081 87 SKIYMVLEYVTGGELFDKIA--SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP 164 (450)
Q Consensus 87 ~~~~lv~E~~~gg~L~~~i~--~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~ 164 (450)
..+|+++||+.+|+|+..+. +..++++..+..|++|++.||.|||..+|+||||||+|+|++.+|.+|++|||-+...
T Consensus 95 ~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 95 KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 99999999999999999998 6678999999999999999999999999999999999999999999999999998753
Q ss_pred CcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHH
Q 013081 165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244 (450)
Q Consensus 165 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~ 244 (450)
+.....+.|||..|.+||...+.+++ ..+|+|++|++.||++.|.+||...+..+.|++|.+.+..+|..++.++
T Consensus 175 ----p~~kR~tlcgt~dyl~pEmv~~~~hd-~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a 249 (281)
T KOG0580|consen 175 ----PSNKRKTLCGTLDYLPPEMVEGRGHD-KFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGA 249 (281)
T ss_pred ----CCCCceeeecccccCCHhhcCCCCcc-chhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhH
Confidence 24456789999999999999998886 8899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHccccCcCCCCCHHHHHhcccccc
Q 013081 245 QNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
.+||.+||.++|.+|.+..|++.|||...
T Consensus 250 ~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 250 ADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 99999999999999999999999999864
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-54 Score=417.88 Aligned_cols=271 Identities=39% Similarity=0.663 Sum_probs=236.7
Q ss_pred ccCCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccch-----------hHHHHHHHHHHHHHhCCCCC
Q 013081 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL-----------KITDQIKREIATLKLLKHPN 75 (450)
Q Consensus 7 ~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~-----------~~~~~~~~Ei~il~~l~hpn 75 (450)
......+++|++++.||+|.||+|.+|++..+++.||||++.+...... .-.+++.+||.+|++|+|||
T Consensus 90 ~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~n 169 (576)
T KOG0585|consen 90 DQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPN 169 (576)
T ss_pred cccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcC
Confidence 3455778999999999999999999999999999999999987543211 11368999999999999999
Q ss_pred cceEEEEEEe--CCEEEEEEccCCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCC
Q 013081 76 VVRLHEVLAS--KSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN 152 (450)
Q Consensus 76 Iv~l~~~~~~--~~~~~lv~E~~~gg~L~~~i~~~~~-l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~ 152 (450)
||+|+++..+ .+.+|+|+|||..|.+...-. ..+ +++.+|+.|++.++.||+|||.+||+||||||.|+||+++|+
T Consensus 170 VV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~-d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 170 VVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPP-DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred eeEEEEeecCcccCceEEEEEeccCCccccCCC-CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCc
Confidence 9999999965 468999999999998865433 344 999999999999999999999999999999999999999999
Q ss_pred eEEeecCCCCCCCccc---CCCccccccCCCCccchhhhcc---CCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHH
Q 013081 153 IKISDFGLSALPQHFR---DDGLLHTTCGSPNYVAPEVLAN---RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY 226 (450)
Q Consensus 153 lkl~DFGla~~~~~~~---~~~~~~~~~gt~~y~APE~l~~---~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~ 226 (450)
+||+|||.+....... .+..+....|||.|+|||.+.. ..+.+.+.||||+||+||.|+.|++||-+....+++
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~ 328 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELF 328 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHH
Confidence 9999999987653221 1223455789999999999876 557789999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCC--CCHHHHHHHHHccccCcCCCCCHHHHHhccccccCCCCC
Q 013081 227 QKIFRGDFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA 278 (450)
Q Consensus 227 ~~i~~~~~~~p~~--~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~~~~ 278 (450)
.+|....+.+|.. +.+.+++||.+||++||.+|+++.+|..|||........
T Consensus 329 ~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~ 382 (576)
T KOG0585|consen 329 DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSP 382 (576)
T ss_pred HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCC
Confidence 9999999988876 799999999999999999999999999999998775443
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-52 Score=415.73 Aligned_cols=263 Identities=35% Similarity=0.711 Sum_probs=239.5
Q ss_pred ccccCCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 013081 5 EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA 84 (450)
Q Consensus 5 ~~~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 84 (450)
........+++|++.+.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.++++++||||+++++++.
T Consensus 9 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 88 (329)
T PTZ00263 9 KPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ 88 (329)
T ss_pred ccccCCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 33455667899999999999999999999999999999999998665444444678899999999999999999999999
Q ss_pred eCCEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCC
Q 013081 85 SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP 164 (450)
Q Consensus 85 ~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~ 164 (450)
+.+..|+||||+.||+|.+.+.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 89 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 168 (329)
T PTZ00263 89 DENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV 168 (329)
T ss_pred cCCEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEc
Confidence 99999999999999999999998889999999999999999999999999999999999999999999999999998753
Q ss_pred CcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHH
Q 013081 165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244 (450)
Q Consensus 165 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~ 244 (450)
.. .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+.++..+...+|.++++.+
T Consensus 169 ~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 242 (329)
T PTZ00263 169 PD-----RTFTLCGTPEYLAPEVIQSKGH-GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRA 242 (329)
T ss_pred CC-----CcceecCChhhcCHHHHcCCCC-CCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHH
Confidence 22 2335689999999999987776 58999999999999999999999998888888999999999999999999
Q ss_pred HHHHHHccccCcCCCCC-----HHHHHhcccccc
Q 013081 245 QNLLRKILEPNPVKRIT-----IAGIKADEWFEQ 273 (450)
Q Consensus 245 ~~Li~~~L~~dP~~R~t-----~~~il~h~~~~~ 273 (450)
.+||.+||+.||.+|++ +++++.||||..
T Consensus 243 ~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 243 RDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred HHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 99999999999999997 799999999975
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-54 Score=398.91 Aligned_cols=257 Identities=28% Similarity=0.425 Sum_probs=221.0
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 92 (450)
|++|+.+..+|+|+||.||+++++.||+.||||.+... ..+....+-..|||++|++|+|||+|.++++|......++|
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es-edd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVES-EDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccC-CccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence 57899999999999999999999999999999998543 33455567788999999999999999999999999999999
Q ss_pred EccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCc
Q 013081 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 172 (450)
+|||+..-|.++-....+++++.++.|+.|++.|+.|||+++++||||||||||++.+|.+||||||+|+.... .+..
T Consensus 80 FE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pgd~ 157 (396)
T KOG0593|consen 80 FEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--PGDN 157 (396)
T ss_pred eeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC--Ccch
Confidence 99998744444433456799999999999999999999999999999999999999999999999999997643 4445
Q ss_pred cccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHh--------------CC-----
Q 013081 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR--------------GD----- 233 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~--------------~~----- 233 (450)
...++.|.+|+|||.+.+...+|.++||||+||++.||++|.+.|.+.+..+....|.+ ..
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G 237 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG 237 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence 67789999999999999866668999999999999999999999999877665544432 11
Q ss_pred --CCCC----------CCCCHHHHHHHHHccccCcCCCCCHHHHHhccccc
Q 013081 234 --FKLP----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 272 (450)
Q Consensus 234 --~~~p----------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~ 272 (450)
++-| +.++.-+.+|+++||+.||.+|++.+|++.|++|.
T Consensus 238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 1111 12567889999999999999999999999999993
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-53 Score=423.19 Aligned_cols=258 Identities=31% Similarity=0.590 Sum_probs=241.5
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 92 (450)
|++|-+.+.||+|+||.||+|+.+.+.+.||+|.+.|..... ...+.+.+|++|++.++||||+.++++|++...+|+|
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~-k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNE-KELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCch-HHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence 578999999999999999999999999999999998876543 3468899999999999999999999999999999999
Q ss_pred EccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCc
Q 013081 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 172 (450)
+|||.| +|+.+++.++.++|+.++.++.|+++||.|||+++|.|||+||.|||++..|.+|+||||+|+.... +..+
T Consensus 80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t~v 156 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NTSV 156 (808)
T ss_pred ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc--Ccee
Confidence 999987 9999999999999999999999999999999999999999999999999999999999999997654 4456
Q ss_pred cccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcc
Q 013081 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKIL 252 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L 252 (450)
.....|||.|||||++.+.+|+ ..+|+||+|||+|||++|++||...+...+.+.|.......|...+..+.+|+..+|
T Consensus 157 ltsikGtPlYmAPElv~e~pyd-~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL 235 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYD-HTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLL 235 (808)
T ss_pred eeeccCcccccCHHHHcCCCcc-chhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHh
Confidence 6777899999999999988885 889999999999999999999999999999999999999999999999999999999
Q ss_pred ccCcCCCCCHHHHHhccccccCC
Q 013081 253 EPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 253 ~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
.+||.+|.|..+++.|||.+...
T Consensus 236 ~kdP~~RltW~~Ll~HpF~k~~~ 258 (808)
T KOG0597|consen 236 IKDPAQRLTWTDLLGHPFWKGKI 258 (808)
T ss_pred hcChhhcccHHHHhcChHHhhhh
Confidence 99999999999999999987543
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-53 Score=407.62 Aligned_cols=261 Identities=34% Similarity=0.542 Sum_probs=224.3
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--EEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS--KIY 90 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--~~~ 90 (450)
..+|..++.||+|+||.||++.+..+|...|||.+....... .+.+.+|+.+|++++|||||+.++...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~---~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT---SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh---HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 456999999999999999999999999999999987663222 678999999999999999999999754444 699
Q ss_pred EEEccCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEcc-CCCeEEeecCCCCCCCcc-
Q 013081 91 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-KGNIKISDFGLSALPQHF- 167 (450)
Q Consensus 91 lv~E~~~gg~L~~~i~~~~-~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~-~g~lkl~DFGla~~~~~~- 167 (450)
++|||++||+|.+++.+.+ ++++..+++|.+||++||+|||++||+||||||+|||++. +|.+||+|||++......
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999999999877 7999999999999999999999999999999999999999 799999999999865431
Q ss_pred cCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCC-CcHHHHHHHHHhC--CCCCCCCCCHHH
Q 013081 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRG--DFKLPKWLSPGA 244 (450)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~--~~~~p~~~s~~~ 244 (450)
..........|||.|||||++.+....+.++||||+||++.||+||+.||.+ .........+... .+.+|.++|+++
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a 252 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEA 252 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHH
Confidence 1122344678999999999998643444589999999999999999999997 4444444444433 367889999999
Q ss_pred HHHHHHccccCcCCCCCHHHHHhccccccCCC
Q 013081 245 QNLLRKILEPNPVKRITIAGIKADEWFEQDYT 276 (450)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~~ 276 (450)
++||.+|+..||++|||+.++|.|||..+...
T Consensus 253 ~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 253 KDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred HHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 99999999999999999999999999987544
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-52 Score=411.83 Aligned_cols=263 Identities=33% Similarity=0.530 Sum_probs=229.9
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SK 88 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~ 88 (450)
.....|+.++.||+|+||.||+|++..+|+.||+|.++.+.. ..++.....|||.||++|+||||++|.++..+. ..
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS 192 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence 345679999999999999999999999999999999987653 345677888999999999999999999998776 78
Q ss_pred EEEEEccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcc
Q 013081 89 IYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 167 (450)
+|+|+|||+. +|.-++.. .-.|++.+++.|++||+.||+|||++||+|||||..|||||.+|++||+|||||+++...
T Consensus 193 iYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 193 IYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 9999999976 88887776 347999999999999999999999999999999999999999999999999999976543
Q ss_pred cCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC--C--------CCCC
Q 013081 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--D--------FKLP 237 (450)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~--------~~~p 237 (450)
........+-|.+|+|||.+.+..-++.+.|+||+||||.||++|++.|.+.+..+...+|++- . ..+|
T Consensus 272 -~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP 350 (560)
T KOG0600|consen 272 -GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP 350 (560)
T ss_pred -CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence 2234667788999999999999888899999999999999999999999999998888888641 1 0111
Q ss_pred -------------------CCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCCC
Q 013081 238 -------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 276 (450)
Q Consensus 238 -------------------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~~ 276 (450)
..+++.+.+|+..||..||.+|.|+.++|.++||.....
T Consensus 351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~ 408 (560)
T KOG0600|consen 351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPL 408 (560)
T ss_pred cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCC
Confidence 125789999999999999999999999999999954433
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-52 Score=423.94 Aligned_cols=260 Identities=32% Similarity=0.627 Sum_probs=242.0
Q ss_pred CcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCE
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSK 88 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~ 88 (450)
...+.+|.+++.||+|+||+|++|..+.+++.+|||+++|..+...+.++....|-+|+...+ ||.+++++..|.+.++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 456789999999999999999999999999999999999998888888899999999999885 9999999999999999
Q ss_pred EEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc
Q 013081 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 168 (450)
+|+||||+.||++. .+...+.|++..|+.|+..++.||.|||++||+|||||.+|||+|.+|++||+|||+++.. ..
T Consensus 444 l~fvmey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~--m~ 520 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG--MG 520 (694)
T ss_pred EEEEEEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccccccc--CC
Confidence 99999999999944 4455678999999999999999999999999999999999999999999999999999843 22
Q ss_pred CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 013081 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL 248 (450)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li 248 (450)
.+....+.||||.|+|||++....| +..+|+|||||+|||||.|..||.+.+.++++..|...+..+|.|+|.++.+++
T Consensus 521 ~g~~TsTfCGTpey~aPEil~e~~Y-t~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il 599 (694)
T KOG0694|consen 521 QGDRTSTFCGTPEFLAPEVLTEQSY-TRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIM 599 (694)
T ss_pred CCCccccccCChhhcChhhhccCcc-cchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHH
Confidence 3456789999999999999998888 599999999999999999999999999999999999999999999999999999
Q ss_pred HHccccCcCCCCC-----HHHHHhcccccc
Q 013081 249 RKILEPNPVKRIT-----IAGIKADEWFEQ 273 (450)
Q Consensus 249 ~~~L~~dP~~R~t-----~~~il~h~~~~~ 273 (450)
+++|.+||.+|.- +.+|.+||||..
T Consensus 600 ~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~ 629 (694)
T KOG0694|consen 600 RRLLRKNPEKRLGSGERDAEDIKKHPFFRS 629 (694)
T ss_pred HHHhccCcccccCCCCCCchhhhhCCcccc
Confidence 9999999999985 578999999964
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-52 Score=411.71 Aligned_cols=265 Identities=37% Similarity=0.679 Sum_probs=246.0
Q ss_pred CcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (450)
+..-|=|++.+.||+|-|+.|.+|++.-||+.||||++++.+..... ..++.+|++.|+.+.|||||++|++..+...+
T Consensus 14 gkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~s-t~hlfqEVRCMKLVQHpNiVRLYEViDTQTKl 92 (864)
T KOG4717|consen 14 GKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLS-TGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKL 92 (864)
T ss_pred cceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhh-hhHHHHHHHHHHHhcCcCeeeeeehhcccceE
Confidence 45567899999999999999999999999999999999998765543 46788999999999999999999999999999
Q ss_pred EEEEccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEc-cCCCeEEeecCCCCCCCcc
Q 013081 90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHF 167 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~-~~g~lkl~DFGla~~~~~~ 167 (450)
|+|+|+-.||+|+|+|.+ ..++.|+.+++||.||+.|+.|||+..++||||||+|+.+. .-|-+||+|||++..+.
T Consensus 93 yLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~-- 170 (864)
T KOG4717|consen 93 YLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ-- 170 (864)
T ss_pred EEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCC--
Confidence 999999999999999865 45799999999999999999999999999999999998775 56899999999998643
Q ss_pred cCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 013081 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247 (450)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~L 247 (450)
....+.+.||+..|.|||++.+..|+.+++||||||||||.|.+|++||+..+..+....|..+.+..|..++.++++|
T Consensus 171 -PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdL 249 (864)
T KOG4717|consen 171 -PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDL 249 (864)
T ss_pred -CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHH
Confidence 4567889999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHccccCcCCCCCHHHHHhccccccCCCCC
Q 013081 248 LRKILEPNPVKRITIAGIKADEWFEQDYTPA 278 (450)
Q Consensus 248 i~~~L~~dP~~R~t~~~il~h~~~~~~~~~~ 278 (450)
|..||..||.+|.|.++|..++|++....+.
T Consensus 250 I~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~ 280 (864)
T KOG4717|consen 250 IQSMLVRDPKKRASLEEIVSTSWLQAGDRGL 280 (864)
T ss_pred HHHHHhcCchhhccHHHHhccccccCCCCCc
Confidence 9999999999999999999999999765543
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-51 Score=403.34 Aligned_cols=254 Identities=35% Similarity=0.661 Sum_probs=232.5
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999997654433344577889999999999999999999999999999999
Q ss_pred ccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCcc
Q 013081 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (450)
Q Consensus 94 E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 173 (450)
||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... ..
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~-----~~ 155 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-----RT 155 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC-----Cc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999875321 22
Q ss_pred ccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccc
Q 013081 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE 253 (450)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~ 253 (450)
...+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+..+...+|..+++.+.+||++||+
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 234 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGH-NKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLV 234 (291)
T ss_pred ccccCChhhcCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcC
Confidence 34679999999999887766 58999999999999999999999999988999999999999999999999999999999
Q ss_pred cCcCCCCC-----HHHHHhcccccc
Q 013081 254 PNPVKRIT-----IAGIKADEWFEQ 273 (450)
Q Consensus 254 ~dP~~R~t-----~~~il~h~~~~~ 273 (450)
.||.+|++ +++++.||||..
T Consensus 235 ~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 235 VDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred CCHHHccCCccCCHHHHhcCccccC
Confidence 99999995 999999999974
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-52 Score=379.14 Aligned_cols=261 Identities=33% Similarity=0.465 Sum_probs=227.6
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
.+|...+.||+|+||.||+|++..||+.||||.+...... .+......|||..|+.++||||+.++++|.+.+.+.+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~k-dGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAK-DGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccc-cCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 5899999999999999999999999999999999766443 334567889999999999999999999999999999999
Q ss_pred ccCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCc
Q 013081 94 EYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (450)
Q Consensus 94 E~~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 172 (450)
||++. +|...|+.. ..++..+++.|+.|++.||+|||++.|+||||||.|+|++++|.+||+|||+|+.+... +..
T Consensus 81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p--~~~ 157 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP--NRI 157 (318)
T ss_pred Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCC--Ccc
Confidence 99964 999988754 47999999999999999999999999999999999999999999999999999987542 233
Q ss_pred cccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC--C----------------
Q 013081 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--F---------------- 234 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~---------------- 234 (450)
....+-|.+|+|||.+.+...++...||||.|||+.||+-|.+-|.+.+..+....|++.- +
T Consensus 158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~ 237 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK 237 (318)
T ss_pred cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence 3344889999999999988878899999999999999999999999998888777776421 1
Q ss_pred ----CCC------CCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCCCCC
Q 013081 235 ----KLP------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA 278 (450)
Q Consensus 235 ----~~p------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~~~~ 278 (450)
+.| +..++++.+|+.+||..||.+|+|+.|+++|+||.....|.
T Consensus 238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt 291 (318)
T KOG0659|consen 238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPT 291 (318)
T ss_pred HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCC
Confidence 011 11467889999999999999999999999999999755443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-53 Score=411.68 Aligned_cols=260 Identities=30% Similarity=0.495 Sum_probs=225.6
Q ss_pred CcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCC-
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKS- 87 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~- 87 (450)
...+.||.+++.||.|+||.||+|+.+.+|..||||.+++.... .+.. .=.||+..|++|+ |||||++.+++.+..
T Consensus 6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~-~nLREvksL~kln~hpniikL~Evi~d~~~ 83 (538)
T KOG0661|consen 6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEEC-MNLREVKSLRKLNPHPNIIKLKEVIRDNDR 83 (538)
T ss_pred hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHH-HHHHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence 34578999999999999999999999999999999999764432 2222 2348999999998 999999999998777
Q ss_pred EEEEEEccCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCc
Q 013081 88 KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 166 (450)
.+|+|||||+ ..|+++++.+ ..|++..++.|+.||++||+|+|.+|++|||+||||||+..+..+||+|||+|+...
T Consensus 84 ~L~fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~- 161 (538)
T KOG0661|consen 84 ILYFVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR- 161 (538)
T ss_pred eEeeeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc-
Confidence 9999999995 6999999764 469999999999999999999999999999999999999999999999999999543
Q ss_pred ccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHh---------------
Q 013081 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR--------------- 231 (450)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~--------------- 231 (450)
.......++.|.+|+|||++.+.++++.+.|+|++|||++|+.+-++.|.|.+..+...+|..
T Consensus 162 --SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 162 --SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred --cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 334566789999999999999999999999999999999999999999999888777666642
Q ss_pred ----CCCCCC-----------CCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCC
Q 013081 232 ----GDFKLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 232 ----~~~~~p-----------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
-.+.+| +.+++++.+||.+||.+||++|||+.|+|+||||+...
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 012222 12688999999999999999999999999999998654
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-51 Score=410.38 Aligned_cols=257 Identities=41% Similarity=0.771 Sum_probs=235.9
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~l 91 (450)
-..|++++.||+|.||.||.++++.+|+.+|+|++.+...........+.+|+++|+++. ||||+.+++++++...+|+
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 358999999999999999999999999999999999887765555678999999999998 9999999999999999999
Q ss_pred EEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccC----CCeEEeecCCCCCCCcc
Q 013081 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK----GNIKISDFGLSALPQHF 167 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~----g~lkl~DFGla~~~~~~ 167 (450)
|||+|.||+|++.+... .+++.++..+++|++.|+.|||+.||+||||||+|+|+... +.+|++|||+|.....
T Consensus 114 vmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~- 191 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP- 191 (382)
T ss_pred EEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC-
Confidence 99999999999999877 49999999999999999999999999999999999999643 4799999999986543
Q ss_pred cCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCC--CC--CCHH
Q 013081 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP--KW--LSPG 243 (450)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p--~~--~s~~ 243 (450)
.......||||.|+|||++...+| +..+||||+||++|.|++|.+||.+.+....+.++..+.+.++ .| ++..
T Consensus 192 --~~~~~~~~Gtp~y~APEvl~~~~y-~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~ 268 (382)
T KOG0032|consen 192 --GERLHTIVGTPEYVAPEVLGGRPY-GDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISES 268 (382)
T ss_pred --CceEeeecCCccccCchhhcCCCC-CcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHH
Confidence 457889999999999999987777 5899999999999999999999999999999999999977554 44 7999
Q ss_pred HHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 244 ~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
+++||++||..||.+|+|+.++|+|||+...
T Consensus 269 akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 269 AKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred HHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 9999999999999999999999999998764
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-53 Score=385.69 Aligned_cols=259 Identities=36% Similarity=0.666 Sum_probs=232.5
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeeccccc-----chhHHHHHHHHHHHHHhCC-CCCcceEEEEEEe
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-----HLKITDQIKREIATLKLLK-HPNVVRLHEVLAS 85 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~ 85 (450)
-+.+|+-.+.||.|..+.|.++.++.+|+.+|+|++...... ..++.+.-.+|+.||+++. ||||+++.+++++
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 356889999999999999999999999999999999643211 2334567778999999995 9999999999999
Q ss_pred CCEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCC
Q 013081 86 KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (450)
Q Consensus 86 ~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 165 (450)
+...++|+|.|+.|+|+|++.....+++.+++++++||++|++|||.++|+||||||+|||++++-++||+|||+|+..+
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999998543
Q ss_pred cccCCCccccccCCCCccchhhhcc-----CCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCC--CC
Q 013081 166 HFRDDGLLHTTCGSPNYVAPEVLAN-----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL--PK 238 (450)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~-----~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~--p~ 238 (450)
.+..+...||||+|.|||.+.. .+-++...|+|+||||||.||+|.+||-.....-+...|..|++++ |+
T Consensus 175 ---~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~spe 251 (411)
T KOG0599|consen 175 ---PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPE 251 (411)
T ss_pred ---CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcc
Confidence 4556788999999999999853 2223578999999999999999999999988889999999997655 66
Q ss_pred C--CCHHHHHHHHHccccCcCCCCCHHHHHhcccccc
Q 013081 239 W--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 239 ~--~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
| +|..+++||++||+.||.+|+|+.|+|+||||++
T Consensus 252 Wadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 252 WADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred hhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 7 8899999999999999999999999999999964
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-51 Score=405.09 Aligned_cols=251 Identities=34% Similarity=0.641 Sum_probs=227.8
Q ss_pred eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEccCCCC
Q 013081 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG 99 (450)
Q Consensus 20 ~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 99 (450)
+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+..|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998655444444567889999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccccccCC
Q 013081 100 ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179 (450)
Q Consensus 100 ~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt 179 (450)
+|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+||
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~--~~~~~~~~~gt 158 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc--CCCcccceecC
Confidence 9999999888999999999999999999999999999999999999999999999999999874221 22234567899
Q ss_pred CCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccccCcCCC
Q 013081 180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 259 (450)
Q Consensus 180 ~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R 259 (450)
+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.......+..+...+|..+++++.+||++||++||++|
T Consensus 159 ~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05571 159 PEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred ccccChhhhcCCCC-CccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHc
Confidence 99999999887766 58999999999999999999999998888888888888888999999999999999999999999
Q ss_pred C-----CHHHHHhcccccc
Q 013081 260 I-----TIAGIKADEWFEQ 273 (450)
Q Consensus 260 ~-----t~~~il~h~~~~~ 273 (450)
| ++.++++||||..
T Consensus 238 ~~~~~~~~~~ll~h~~f~~ 256 (323)
T cd05571 238 LGGGPEDAKEIMEHRFFAS 256 (323)
T ss_pred CCCCCCCHHHHHcCCCcCC
Confidence 9 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-51 Score=407.31 Aligned_cols=260 Identities=35% Similarity=0.627 Sum_probs=235.7
Q ss_pred cCCcccCCeEEeeeecccCceEEEEEEECCCC-ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013081 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSG-LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (450)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~-~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (450)
.....+++|++.+.||+|+||.||+|.+..++ ..||+|.+.+...........+.+|+.+++.++||||+++++++.+.
T Consensus 24 ~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~ 103 (340)
T PTZ00426 24 KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE 103 (340)
T ss_pred CCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC
Confidence 45567789999999999999999999876654 78999999766544444567788999999999999999999999999
Q ss_pred CEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCc
Q 013081 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (450)
Q Consensus 87 ~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 166 (450)
+..|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999999999999999888999999999999999999999999999999999999999999999999999975322
Q ss_pred ccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHH
Q 013081 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN 246 (450)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 246 (450)
...+.+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+....+.++..+...+|..+++.+.+
T Consensus 184 -----~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 257 (340)
T PTZ00426 184 -----RTYTLCGTPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKH 257 (340)
T ss_pred -----CcceecCChhhcCHHHHhCCCC-CccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence 2345689999999999887666 5899999999999999999999999998888999999988899999999999
Q ss_pred HHHHccccCcCCCC-----CHHHHHhcccccc
Q 013081 247 LLRKILEPNPVKRI-----TIAGIKADEWFEQ 273 (450)
Q Consensus 247 Li~~~L~~dP~~R~-----t~~~il~h~~~~~ 273 (450)
+|++||+.||.+|+ |++++++||||..
T Consensus 258 li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 258 LMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred HHHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 99999999999996 8999999999975
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-50 Score=398.06 Aligned_cols=250 Identities=36% Similarity=0.629 Sum_probs=226.6
Q ss_pred ecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEccCCCCCh
Q 013081 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL 101 (450)
Q Consensus 22 LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 101 (450)
||+|+||.||+|++..+++.||+|++.+...........+.+|+.++++++||||+++++++.+.+..|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999999765444444467788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccccccCCCC
Q 013081 102 FDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181 (450)
Q Consensus 102 ~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~ 181 (450)
.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+||+.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~ 158 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK--DDDKTNTFCGTPE 158 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCcc--CCCccccccCCcc
Confidence 99998888999999999999999999999999999999999999999999999999999875322 2223445689999
Q ss_pred ccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccccCcCCCC-
Q 013081 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI- 260 (450)
Q Consensus 182 y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~- 260 (450)
|+|||++.+..+ +.++||||+||++|+|++|+.||.+.+....+.++......+|..+++.+.+||.+||++||.+||
T Consensus 159 y~aPE~~~~~~~-~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~ 237 (312)
T cd05585 159 YLAPELLLGHGY-TKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLG 237 (312)
T ss_pred cCCHHHHcCCCC-CCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCC
Confidence 999999987766 588999999999999999999999998888899999988899999999999999999999999997
Q ss_pred --CHHHHHhccccccC
Q 013081 261 --TIAGIKADEWFEQD 274 (450)
Q Consensus 261 --t~~~il~h~~~~~~ 274 (450)
++.+++.||||.+.
T Consensus 238 ~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 238 YNGAQEIKNHPFFSQL 253 (312)
T ss_pred CCCHHHHHcCCCcCCC
Confidence 57999999999763
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-51 Score=412.56 Aligned_cols=266 Identities=42% Similarity=0.796 Sum_probs=250.3
Q ss_pred cCCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013081 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (450)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (450)
.....+|-|.+.++||+|.|++|.+|++..++..||||++++....... ...+.+|+++|+.|+|||||+++.+.....
T Consensus 50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~-~~k~~rev~imk~l~HPnIvkl~~v~~t~~ 128 (596)
T KOG0586|consen 50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSK-RQKLGREVDIMKSLNHPNIVKLFSVIETEA 128 (596)
T ss_pred cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHH-HHHHHHHHHHHHhcCCcceeeeeeeeeecc
Confidence 4567789999999999999999999999999999999999987664443 455899999999999999999999999999
Q ss_pred EEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcc
Q 013081 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 167 (450)
.+|+||||+.+|++++++.+.+++.+..++.+|.|+.+|++|||+++|+|||||++||||+.+-++||+|||++..+.
T Consensus 129 ~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-- 206 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD-- 206 (596)
T ss_pred eeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999999764
Q ss_pred cCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 013081 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247 (450)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~L 247 (450)
....+.+.||+|.|.|||++.+..|+++.+|+||+|++||.|++|.+||++.+...+..+...+.+.+|-.++-++.+|
T Consensus 207 -~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~l 285 (596)
T KOG0586|consen 207 -YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDL 285 (596)
T ss_pred -ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHH
Confidence 4567899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHccccCcCCCCCHHHHHhccccccCCCC
Q 013081 248 LRKILEPNPVKRITIAGIKADEWFEQDYTP 277 (450)
Q Consensus 248 i~~~L~~dP~~R~t~~~il~h~~~~~~~~~ 277 (450)
|+++|.++|.+|++.++|+.|.|.+.....
T Consensus 286 Lrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 286 LRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred HHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 999999999999999999999999765443
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-50 Score=398.52 Aligned_cols=251 Identities=36% Similarity=0.639 Sum_probs=227.0
Q ss_pred eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEccCCCC
Q 013081 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG 99 (450)
Q Consensus 20 ~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 99 (450)
+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765444445677889999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccccccCC
Q 013081 100 ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179 (450)
Q Consensus 100 ~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt 179 (450)
+|.+.+...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+||
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~~gt 158 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT--DAATMKTFCGT 158 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCC--cccccccccCC
Confidence 9999998888899999999999999999999999999999999999999999999999999874221 12233456899
Q ss_pred CCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccccCcCCC
Q 013081 180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 259 (450)
Q Consensus 180 ~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R 259 (450)
+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......+|..+++++.+||++||++||.+|
T Consensus 159 ~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (328)
T cd05593 159 PEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKR 237 (328)
T ss_pred cCccChhhhcCCCC-CccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHc
Confidence 99999999887766 58999999999999999999999988888888888888888999999999999999999999999
Q ss_pred C-----CHHHHHhcccccc
Q 013081 260 I-----TIAGIKADEWFEQ 273 (450)
Q Consensus 260 ~-----t~~~il~h~~~~~ 273 (450)
+ ++.++++||||..
T Consensus 238 ~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 238 LGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred CCCCCCCHHHHhcCCCcCC
Confidence 7 8999999999965
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=401.74 Aligned_cols=259 Identities=31% Similarity=0.561 Sum_probs=224.3
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
++|++++.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998755444445678889999999999999999999999999999999
Q ss_pred ccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC----
Q 013081 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD---- 169 (450)
Q Consensus 94 E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~---- 169 (450)
||++||+|.+++.+.+++++..++.++.|++.||+|||++||+||||||+|||++.+|++||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999875321100
Q ss_pred -----------------------------CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCC
Q 013081 170 -----------------------------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR 220 (450)
Q Consensus 170 -----------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~ 220 (450)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCC-CCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 001234689999999999987776 48999999999999999999999998
Q ss_pred cHHHHHHHHHhC--CCCCCCC--CCHHHHHHHHHcccc--CcCCCCCHHHHHhcccccc
Q 013081 221 NLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEP--NPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 221 ~~~~~~~~i~~~--~~~~p~~--~s~~~~~Li~~~L~~--dP~~R~t~~~il~h~~~~~ 273 (450)
+....+.++... ...+|+. +++++.+||.+|+.. ++..||++++|++||||+.
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~ 298 (363)
T cd05628 240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEG 298 (363)
T ss_pred CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCC
Confidence 888888888764 3445543 789999999997652 2335689999999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-50 Score=384.73 Aligned_cols=262 Identities=31% Similarity=0.474 Sum_probs=224.6
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-----CCE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-----KSK 88 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----~~~ 88 (450)
.+|..++.||+|+||.|+.|.++.+|+.||||.+... ..+.-..++..||+.+|+.++|+||+.+.+++.. -..
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 4566689999999999999999999999999988532 3345557899999999999999999999999855 457
Q ss_pred EEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc
Q 013081 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 168 (450)
+|+|+|++ +.+|...|+.++.+++..++.++.||+.||.|+|+.+|+||||||.|+|++.+..+||||||+|+..+...
T Consensus 101 vYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~ 179 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF 179 (359)
T ss_pred eEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccC
Confidence 99999999 56999999888889999999999999999999999999999999999999999999999999999765433
Q ss_pred CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHh-----------------
Q 013081 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR----------------- 231 (450)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~----------------- 231 (450)
....+...+.|.+|+|||++.+..-++.+.||||+|||+.||++|++.|.+.+.....+.|..
T Consensus 180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ 259 (359)
T KOG0660|consen 180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK 259 (359)
T ss_pred cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence 455667788999999999987766667999999999999999999999988766555444421
Q ss_pred ------CCCCCC--------CCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCCCC
Q 013081 232 ------GDFKLP--------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277 (450)
Q Consensus 232 ------~~~~~p--------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~~~ 277 (450)
.....| +..++.+.+|+.+||..||.+|+|++|+|+|||+..-..+
T Consensus 260 ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp 319 (359)
T KOG0660|consen 260 ARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDP 319 (359)
T ss_pred HHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCC
Confidence 111112 2478999999999999999999999999999999865443
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-50 Score=389.25 Aligned_cols=265 Identities=31% Similarity=0.504 Sum_probs=238.5
Q ss_pred cCCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013081 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (450)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (450)
.....+..|++++.||.|.-|+||+|....++..+|+|+++++.....+...++..|-.||+.++||.+..||..++++.
T Consensus 71 ~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~ 150 (459)
T KOG0610|consen 71 DGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDK 150 (459)
T ss_pred CCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccc
Confidence 35566779999999999999999999999999999999999988877777888999999999999999999999999999
Q ss_pred EEEEEEccCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCC
Q 013081 88 KIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 165 (450)
..|++||||+||+|+.+.+++ +.+++..++.|+..++.||+|||-.|||+||||||||||.++|++-|+||.|+....
T Consensus 151 ~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 999999999999999988764 469999999999999999999999999999999999999999999999999875310
Q ss_pred c-----------------------------c-----c--------------------CCCccccccCCCCccchhhhccC
Q 013081 166 H-----------------------------F-----R--------------------DDGLLHTTCGSPNYVAPEVLANR 191 (450)
Q Consensus 166 ~-----------------------------~-----~--------------------~~~~~~~~~gt~~y~APE~l~~~ 191 (450)
. . . .+......+||-.|+|||++.+.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 0 0 0 00122345799999999999998
Q ss_pred CCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCC--CCHHHHHHHHHccccCcCCCCC----HHHH
Q 013081 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKW--LSPGAQNLLRKILEPNPVKRIT----IAGI 265 (450)
Q Consensus 192 ~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~--~s~~~~~Li~~~L~~dP~~R~t----~~~i 265 (450)
+. +.++|+|+|||.+||||.|..||.+.+..+.+.++......+|.. ++..+++||+++|.+||.+|.. ++||
T Consensus 311 GH-gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eI 389 (459)
T KOG0610|consen 311 GH-GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEI 389 (459)
T ss_pred CC-CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHh
Confidence 88 589999999999999999999999999999999999998888864 7899999999999999999998 9999
Q ss_pred Hhcccccc
Q 013081 266 KADEWFEQ 273 (450)
Q Consensus 266 l~h~~~~~ 273 (450)
.+||||+.
T Consensus 390 K~HpFF~g 397 (459)
T KOG0610|consen 390 KRHPFFEG 397 (459)
T ss_pred hcCccccC
Confidence 99999985
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-50 Score=396.21 Aligned_cols=251 Identities=33% Similarity=0.642 Sum_probs=226.6
Q ss_pred eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEccCCCC
Q 013081 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG 99 (450)
Q Consensus 20 ~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 99 (450)
+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++.+......|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998654444444567888999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccccccCC
Q 013081 100 ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179 (450)
Q Consensus 100 ~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt 179 (450)
+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+||
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~gt 158 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccC--CCCccccccCC
Confidence 9999998888899999999999999999999999999999999999999999999999999874211 12223456899
Q ss_pred CCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccccCcCCC
Q 013081 180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 259 (450)
Q Consensus 180 ~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R 259 (450)
+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+.......+......+|..+++.+.+||.+||++||.+|
T Consensus 159 ~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05595 159 PEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred cCcCCcccccCCCC-CchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHh
Confidence 99999999877766 58999999999999999999999998888888888888888999999999999999999999999
Q ss_pred C-----CHHHHHhcccccc
Q 013081 260 I-----TIAGIKADEWFEQ 273 (450)
Q Consensus 260 ~-----t~~~il~h~~~~~ 273 (450)
+ ++.++++|+||..
T Consensus 238 ~~~~~~~~~~~l~h~~~~~ 256 (323)
T cd05595 238 LGGGPSDAKEVMEHRFFLS 256 (323)
T ss_pred CCCCCCCHHHHHcCCCcCC
Confidence 8 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=386.73 Aligned_cols=262 Identities=29% Similarity=0.495 Sum_probs=231.1
Q ss_pred CcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (450)
-...+.|++...||.|..+.||+|+...+++.||||+++.+++.+. .+.+.+|+..|+.++||||++.+..|..+..+
T Consensus 22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~L 99 (516)
T KOG0582|consen 22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVDSEL 99 (516)
T ss_pred CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEeccee
Confidence 3456799999999999999999999999999999999998887654 68999999999999999999999999999999
Q ss_pred EEEEccCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcc
Q 013081 90 YMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 167 (450)
|+||.|+.+|++++++... .+++|..+..++++++.||.|||++|-+|||||+.||||+.+|.|||+|||.+...-..
T Consensus 100 WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 100 WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 9999999999999999763 35999999999999999999999999999999999999999999999999987654322
Q ss_pred cCC-C-ccccccCCCCccchhhh-cc-CCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCC-----
Q 013081 168 RDD-G-LLHTTCGSPNYVAPEVL-AN-RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK----- 238 (450)
Q Consensus 168 ~~~-~-~~~~~~gt~~y~APE~l-~~-~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~----- 238 (450)
... . ...+..|||+|||||++ .. .+| +.|+||||||++..||.+|..||....+..+...-+++.++.+.
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GY-dfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~ 258 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGY-DFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLD 258 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCc-cchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCC
Confidence 111 1 12667999999999994 33 455 59999999999999999999999999888887777777765432
Q ss_pred -----CCCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 239 -----WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 239 -----~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
.++..++.+|..||++||.+|||++++|+|+||++.
T Consensus 259 ~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~ 299 (516)
T KOG0582|consen 259 KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA 299 (516)
T ss_pred hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence 267789999999999999999999999999999754
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=394.80 Aligned_cols=251 Identities=34% Similarity=0.649 Sum_probs=225.8
Q ss_pred eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEccCCC
Q 013081 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTG 98 (450)
Q Consensus 20 ~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 98 (450)
+.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.++..+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999865443334456777888888877 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccccccC
Q 013081 99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 178 (450)
Q Consensus 99 g~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 178 (450)
|+|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF--NGKTTSTFCG 158 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc--CCCccccccc
Confidence 99999998888999999999999999999999999999999999999999999999999999874221 2223445689
Q ss_pred CCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccccCcCC
Q 013081 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258 (450)
Q Consensus 179 t~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~ 258 (450)
|+.|+|||++.+..+ +.++||||+||++|+|++|+.||.+.+....+..+..+....|.++++++.+||++||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 237 (320)
T cd05590 159 TPDYIAPEILQEMLY-GPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTM 237 (320)
T ss_pred CccccCHHHHcCCCC-CCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHH
Confidence 999999999887666 5889999999999999999999999999899999999888999999999999999999999999
Q ss_pred CCCH------HHHHhcccccc
Q 013081 259 RITI------AGIKADEWFEQ 273 (450)
Q Consensus 259 R~t~------~~il~h~~~~~ 273 (450)
||++ .+++.||||..
T Consensus 238 R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 238 RLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred CCCCCCCCCHHHHHcCCCcCC
Confidence 9998 89999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-49 Score=393.25 Aligned_cols=256 Identities=34% Similarity=0.630 Sum_probs=229.7
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCC-CcceEEEEEEeCCEEEEEE
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP-NVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~lv~ 93 (450)
+|++++.||+|+||.||+|.+..+++.||+|++.+.........+.+..|+.+++.++|+ +|+++++++.+.+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 589999999999999999999999999999999875443344456788899999999765 5888999999999999999
Q ss_pred ccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCcc
Q 013081 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (450)
Q Consensus 94 E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 173 (450)
||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... .....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~ 158 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF--GGKTT 158 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC--CCCce
Confidence 9999999999998888899999999999999999999999999999999999999999999999999864211 22234
Q ss_pred ccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccc
Q 013081 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE 253 (450)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~ 253 (450)
...+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.+.+....+..+......+|..+++.+.+++++||+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 237 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLT 237 (324)
T ss_pred eeecCCccccChhhhcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence 45689999999999987766 58899999999999999999999999988899999988888999999999999999999
Q ss_pred cCcCCCCCH-----HHHHhcccccc
Q 013081 254 PNPVKRITI-----AGIKADEWFEQ 273 (450)
Q Consensus 254 ~dP~~R~t~-----~~il~h~~~~~ 273 (450)
+||.+|++. +++++||||..
T Consensus 238 ~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 238 KHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred cCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 999999986 89999999975
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-49 Score=395.72 Aligned_cols=254 Identities=30% Similarity=0.530 Sum_probs=226.4
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
++|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++......|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999998765444444677889999999999999999999999999999999
Q ss_pred ccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCcc
Q 013081 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (450)
Q Consensus 94 E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 173 (450)
||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~ 155 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YA 155 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----cc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999975322 34
Q ss_pred ccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC--CCCCC------CCCHHHH
Q 013081 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLPK------WLSPGAQ 245 (450)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~------~~s~~~~ 245 (450)
...+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+....+..+.... ...|. .+++++.
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~ 234 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGY-DFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234 (333)
T ss_pred CCcccCccccChhHhcCCCC-CCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence 55689999999999987766 589999999999999999999999988877776665432 22232 3589999
Q ss_pred HHHHHccccCcCCCCCHHHHHhcccccc
Q 013081 246 NLLRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 246 ~Li~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
+||.+||..+|.+|||+.++++||||..
T Consensus 235 ~li~~~l~~~~~rr~s~~~ll~h~~~~~ 262 (333)
T cd05600 235 DLITKLINDPSRRFGSLEDIKNHPFFKE 262 (333)
T ss_pred HHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence 9999999999999999999999999985
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=400.40 Aligned_cols=258 Identities=33% Similarity=0.613 Sum_probs=225.6
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
++|++++.||+|+||.||+|++..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998655444445677889999999999999999999999999999999
Q ss_pred ccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCC---
Q 013081 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD--- 170 (450)
Q Consensus 94 E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~--- 170 (450)
||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 99999999999988889999999999999999999999999999999999999999999999999998643211000
Q ss_pred ---------------------------------CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCC
Q 013081 171 ---------------------------------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 217 (450)
Q Consensus 171 ---------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf 217 (450)
......+||+.|+|||++.+.++ +.++|||||||++|+|++|..||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCC-CCeeeeecchhHHHHhhcCCCCC
Confidence 01123579999999999887776 58999999999999999999999
Q ss_pred CCCcHHHHHHHHHhCC--CCCCC--CCCHHHHHHHHHccccCcCCCCC---HHHHHhcccccc
Q 013081 218 DDRNLAVLYQKIFRGD--FKLPK--WLSPGAQNLLRKILEPNPVKRIT---IAGIKADEWFEQ 273 (450)
Q Consensus 218 ~~~~~~~~~~~i~~~~--~~~p~--~~s~~~~~Li~~~L~~dP~~R~t---~~~il~h~~~~~ 273 (450)
.+.+....+.++.... ..+|. .+++.+.+||++||. +|.+|++ +.++++||||..
T Consensus 240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~ 301 (364)
T cd05599 240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKG 301 (364)
T ss_pred CCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 9988887777776543 34444 368999999999996 9999998 999999999975
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-49 Score=401.31 Aligned_cols=259 Identities=32% Similarity=0.531 Sum_probs=223.4
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
+.|++++.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 46999999999999999999999999999999998765555555678999999999999999999999999999999999
Q ss_pred ccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC----
Q 013081 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD---- 169 (450)
Q Consensus 94 E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~---- 169 (450)
||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 9999999999998888899999999999999999999999999999999999999999999999999764211000
Q ss_pred -----------------------------------------CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHH
Q 013081 170 -----------------------------------------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 208 (450)
Q Consensus 170 -----------------------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ 208 (450)
.....+.+||+.|+|||++.+..+ +.++||||+||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DiwSlG~il~ 239 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGY-TQLCDWWSVGVILF 239 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCC-CCccceeehhhHHH
Confidence 001134579999999999987776 58999999999999
Q ss_pred HHHhCCCCCCCCcHHHHHHHHHh--CCCCCCC--CCCHHHHHHHHHcc--ccCcCCCCCHHHHHhcccccc
Q 013081 209 VILTGYLPFDDRNLAVLYQKIFR--GDFKLPK--WLSPGAQNLLRKIL--EPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 209 elltG~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~Li~~~L--~~dP~~R~t~~~il~h~~~~~ 273 (450)
+|++|..||...+......++.. .....|. .+++++.+||.+|+ ..+|..|+++.++++||||..
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~ 310 (381)
T cd05626 240 EMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSE 310 (381)
T ss_pred HHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCC
Confidence 99999999998877666666653 2344554 47999999999955 556666999999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-51 Score=383.06 Aligned_cols=263 Identities=33% Similarity=0.640 Sum_probs=246.6
Q ss_pred cCCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013081 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (450)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (450)
...+.++.|+.++.||+|+||+|-+++.+.+|+.+|+|+++++-+...+.+..-..|-++|+..+||.+..+.-.|.+.+
T Consensus 162 ~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d 241 (516)
T KOG0690|consen 162 KNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD 241 (516)
T ss_pred cceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc
Confidence 44568999999999999999999999999999999999999988877777788889999999999999999999999999
Q ss_pred EEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcc
Q 013081 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 167 (450)
++++||||+.||+|+-.+.+...+++..++.|...|++||.|||+++|++||||.+|+|+|.||++||+|||+++. ..
T Consensus 242 rlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE--~I 319 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKE--EI 319 (516)
T ss_pred eEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchh--cc
Confidence 9999999999999999999989999999999999999999999999999999999999999999999999999984 23
Q ss_pred cCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 013081 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247 (450)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~L 247 (450)
.......+.||||.|.|||++....| +.++|.|.+||++|||++|++||...+...++..|..+...+|..++++++.|
T Consensus 320 ~~g~t~kTFCGTPEYLAPEVleDnDY-graVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktL 398 (516)
T KOG0690|consen 320 KYGDTTKTFCGTPEYLAPEVLEDNDY-GRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTL 398 (516)
T ss_pred cccceeccccCChhhcCchhhccccc-cceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHH
Confidence 34456788999999999999998888 69999999999999999999999999999999999999999999999999999
Q ss_pred HHHccccCcCCCC-----CHHHHHhcccccc
Q 013081 248 LRKILEPNPVKRI-----TIAGIKADEWFEQ 273 (450)
Q Consensus 248 i~~~L~~dP~~R~-----t~~~il~h~~~~~ 273 (450)
+..+|.+||.+|. .+.+|++|+||..
T Consensus 399 LsGLL~kdP~kRLGgGpdDakEi~~h~FF~~ 429 (516)
T KOG0690|consen 399 LSGLLKKDPKKRLGGGPDDAKEIMRHRFFAS 429 (516)
T ss_pred HHHHhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence 9999999999997 4889999999964
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-49 Score=388.96 Aligned_cols=254 Identities=31% Similarity=0.578 Sum_probs=225.5
Q ss_pred eEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHH---HhCCCCCcceEEEEEEeCCEEEEE
Q 013081 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL---KLLKHPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 16 y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il---~~l~hpnIv~l~~~~~~~~~~~lv 92 (450)
|++.+.||+|+||.||+|.+..+|+.||||++.+.........+.+.+|+.++ +.++||||+++++++.+....|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78999999999999999999999999999999865443334456777777765 456799999999999999999999
Q ss_pred EccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCc
Q 013081 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 172 (450)
|||++|++|...+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ....
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~ 157 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG--FGDR 157 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC--CCCc
Confidence 999999999988754 6799999999999999999999999999999999999999999999999999874221 1223
Q ss_pred cccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcc
Q 013081 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKIL 252 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L 252 (450)
....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+.......|..+++.+.+||.+||
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L 236 (324)
T cd05589 158 TSTFCGTPEFLAPEVLTETSY-TRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLL 236 (324)
T ss_pred ccccccCccccCHhHhcCCCC-CcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHh
Confidence 446789999999999887666 5889999999999999999999999988888888888888889999999999999999
Q ss_pred ccCcCCCC-----CHHHHHhcccccc
Q 013081 253 EPNPVKRI-----TIAGIKADEWFEQ 273 (450)
Q Consensus 253 ~~dP~~R~-----t~~~il~h~~~~~ 273 (450)
+.||.+|| ++.++++||||..
T Consensus 237 ~~dP~~R~~~~~~~~~~l~~~~~f~~ 262 (324)
T cd05589 237 RRNPERRLGSGEKDAEDVKKQPFFRD 262 (324)
T ss_pred hcCHhHcCCCCCCCHHHHhhCCCcCC
Confidence 99999999 7999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-49 Score=392.94 Aligned_cols=251 Identities=35% Similarity=0.642 Sum_probs=226.3
Q ss_pred eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEccCCC
Q 013081 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTG 98 (450)
Q Consensus 20 ~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 98 (450)
+.||+|+||.||+|.+..+++.||+|++.+...........+..|..+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999999875444444456777899999876 799999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccccccC
Q 013081 99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 178 (450)
Q Consensus 99 g~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 178 (450)
++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g 158 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL--NGVTTTTFCG 158 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceeccc--CCcccccccc
Confidence 99999998888999999999999999999999999999999999999999999999999999874321 2223445689
Q ss_pred CCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccccCcCC
Q 013081 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258 (450)
Q Consensus 179 t~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~ 258 (450)
|+.|+|||++.+..+ +.++||||+||++|+|++|+.||...+....+..+.......|.++++++.+||.+||++||++
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~ 237 (321)
T cd05591 159 TPDYIAPEILQELEY-GPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNK 237 (321)
T ss_pred CccccCHHHHcCCCC-CCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHH
Confidence 999999999887766 5899999999999999999999999999999999999988899999999999999999999999
Q ss_pred CC-------CHHHHHhcccccc
Q 013081 259 RI-------TIAGIKADEWFEQ 273 (450)
Q Consensus 259 R~-------t~~~il~h~~~~~ 273 (450)
|+ ++.++++||||..
T Consensus 238 R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 238 RLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred cCCCCCCCCCHHHHhcCCccCC
Confidence 99 9999999999964
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-49 Score=388.80 Aligned_cols=251 Identities=33% Similarity=0.630 Sum_probs=222.7
Q ss_pred eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEccCCC
Q 013081 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTG 98 (450)
Q Consensus 20 ~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 98 (450)
+.||+|+||.||+|.+..+|+.||+|++.+..............|..++..+ +||||+++++++.+.+..|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4799999999999999999999999999765432223345677788888765 899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccccccC
Q 013081 99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 178 (450)
Q Consensus 99 g~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 178 (450)
|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF--GDNRASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc--CCCceeccCC
Confidence 99999998888899999999999999999999999999999999999999999999999999874221 1223456789
Q ss_pred CCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccccCcCC
Q 013081 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258 (450)
Q Consensus 179 t~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~ 258 (450)
|+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.......+......+|.++++++.+||.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (316)
T cd05620 159 TPDYIAPEILQGLKY-TFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTR 237 (316)
T ss_pred CcCccCHHHHcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 999999999987766 5899999999999999999999999888888888888888889999999999999999999999
Q ss_pred CCCH-HHHHhcccccc
Q 013081 259 RITI-AGIKADEWFEQ 273 (450)
Q Consensus 259 R~t~-~~il~h~~~~~ 273 (450)
||++ +++++||||..
T Consensus 238 R~~~~~~~~~h~~f~~ 253 (316)
T cd05620 238 RLGVVGNIRGHPFFKT 253 (316)
T ss_pred cCCChHHHHcCCCcCC
Confidence 9998 58999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-49 Score=384.83 Aligned_cols=255 Identities=27% Similarity=0.437 Sum_probs=215.2
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
.+++|++.+.||.|+||.||+|.+..+++.||+|.++..... .....+.+|+.+++.++||||+++++++.+....|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 80 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTL 80 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC--CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 478899999999999999999999999999999998754322 223567899999999999999999999999999999
Q ss_pred EEccCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCC
Q 013081 92 VLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~~-~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 170 (450)
||||+.| +|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 81 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~--~~ 157 (288)
T cd07871 81 VFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV--PT 157 (288)
T ss_pred EEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccC--CC
Confidence 9999975 8999887644 579999999999999999999999999999999999999999999999999875322 12
Q ss_pred CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC-----------------
Q 013081 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD----------------- 233 (450)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~----------------- 233 (450)
.......|++.|+|||++.+....+.++||||+||++|+|++|+.||.+.+..+....+....
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 223456789999999998765545689999999999999999999998877655544432210
Q ss_pred --CCCC-----------CCCCHHHHHHHHHccccCcCCCCCHHHHHhcccc
Q 013081 234 --FKLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 234 --~~~p-----------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~ 271 (450)
..+| ..+++++.+||++||++||.+|||++|+++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 0111 2367899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=394.77 Aligned_cols=251 Identities=34% Similarity=0.647 Sum_probs=226.3
Q ss_pred eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEccCCCC
Q 013081 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG 99 (450)
Q Consensus 20 ~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 99 (450)
+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++......|+||||++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765444444567788999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhh-cCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccccccC
Q 013081 100 ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 178 (450)
Q Consensus 100 ~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~-~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 178 (450)
+|.+++...+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||++..... ........+|
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g 158 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCG 158 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCC--CCcccccccC
Confidence 999999888889999999999999999999997 7999999999999999999999999999874211 2223345689
Q ss_pred CCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccccCcCC
Q 013081 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258 (450)
Q Consensus 179 t~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~ 258 (450)
|+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.......+......+|..+++++.+||.+||++||++
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~ 237 (325)
T cd05594 159 TPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQ 237 (325)
T ss_pred CcccCCHHHHccCCC-CCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHH
Confidence 999999999987766 5899999999999999999999999888888888888888899999999999999999999999
Q ss_pred CC-----CHHHHHhcccccc
Q 013081 259 RI-----TIAGIKADEWFEQ 273 (450)
Q Consensus 259 R~-----t~~~il~h~~~~~ 273 (450)
|+ ++.++++||||..
T Consensus 238 R~~~~~~~~~~il~h~~~~~ 257 (325)
T cd05594 238 RLGGGPDDAKEIMQHKFFAG 257 (325)
T ss_pred hCCCCCCCHHHHhcCCCcCC
Confidence 97 9999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-50 Score=377.71 Aligned_cols=265 Identities=31% Similarity=0.409 Sum_probs=228.1
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE--eCCEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA--SKSKI 89 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~~~ 89 (450)
.++.|+.+..|++|+||.||+|+|+.|++.||+|.++.+. ...++.-.-.|||.+|.+++|||||.+-++.. +-+.+
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek-ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc-ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 4568999999999999999999999999999999997655 33445556779999999999999999999875 44679
Q ss_pred EEEEccCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc
Q 013081 90 YMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~-~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 168 (450)
|+|||||+. +|..++.+.+ +|...+++.++.|+++|++|||.+.|+||||||+|+|++..|.+||+|||+|+.++..
T Consensus 153 y~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp- 230 (419)
T KOG0663|consen 153 YIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP- 230 (419)
T ss_pred eeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC-
Confidence 999999975 9999998755 8999999999999999999999999999999999999999999999999999976542
Q ss_pred CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC---------------
Q 013081 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--------------- 233 (450)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--------------- 233 (450)
-......+-|.+|+|||.+.+...++.+.|+||+|||+.||+++++.|.+.+..+...+|++-.
T Consensus 231 -~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 231 -LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred -cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 2334556789999999999988878899999999999999999999999998888887776410
Q ss_pred ----CCCCC-----------C--CCHHHHHHHHHccccCcCCCCCHHHHHhccccccCCCCCCC
Q 013081 234 ----FKLPK-----------W--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280 (450)
Q Consensus 234 ----~~~p~-----------~--~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~~~~~~ 280 (450)
..+++ + ++....+|++++|..||.+|.|+.|.|+|+||.....|..|
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P 373 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDP 373 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCCh
Confidence 11111 1 45788999999999999999999999999999986665444
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=389.39 Aligned_cols=259 Identities=33% Similarity=0.617 Sum_probs=223.7
Q ss_pred CeEEeeeecccCceEEEEEEEC---CCCceEEEEEeeccccc-chhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEE
Q 013081 15 RYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRII-HLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKI 89 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 89 (450)
+|++++.||+|+||.||+|++. .+++.||+|++.+.... .....+.+.+|+.+++.++ ||||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999864 47899999999764332 2233567889999999994 99999999999999999
Q ss_pred EEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC
Q 013081 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 169 (450)
|+||||++||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++...... .
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~-~ 159 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE-E 159 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc-C
Confidence 999999999999999988888999999999999999999999999999999999999999999999999998754221 1
Q ss_pred CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCC----cHHHHHHHHHhCCCCCCCCCCHHHH
Q 013081 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR----NLAVLYQKIFRGDFKLPKWLSPGAQ 245 (450)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s~~~~ 245 (450)
.......+||+.|+|||++.+....+.++|||||||++|+|++|..||... ........+......+|..+++.+.
T Consensus 160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (332)
T cd05614 160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQ 239 (332)
T ss_pred CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHH
Confidence 122345689999999999876655568999999999999999999999643 3344555666677788888999999
Q ss_pred HHHHHccccCcCCCC-----CHHHHHhccccccC
Q 013081 246 NLLRKILEPNPVKRI-----TIAGIKADEWFEQD 274 (450)
Q Consensus 246 ~Li~~~L~~dP~~R~-----t~~~il~h~~~~~~ 274 (450)
+|+.+||+.||++|| +++++++||||+..
T Consensus 240 ~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 240 DLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred HHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 999999999999999 88899999999763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-49 Score=384.11 Aligned_cols=255 Identities=30% Similarity=0.445 Sum_probs=220.2
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEc
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 94 (450)
.|++.+.||+|+||.||+|.+..+|+.||+|.+.+...........+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 38899999999999999999999999999999976554433334567899999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCc
Q 013081 95 YVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (450)
Q Consensus 95 ~~~gg~L~~~i~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 172 (450)
|++||+|.+.+... .++++..+..++.|++.||+|||++||+||||||+|||+++++.+||+|||++..... ...
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~---~~~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE---GET 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC---CCe
Confidence 99999998887543 3689999999999999999999999999999999999999999999999999875321 122
Q ss_pred cccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHH----HHHHHHHhCCCCCCCCCCHHHHHHH
Q 013081 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA----VLYQKIFRGDFKLPKWLSPGAQNLL 248 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~----~~~~~i~~~~~~~p~~~s~~~~~Li 248 (450)
....+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||...+.. .....+......++..+++.+.+|+
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 236 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKY-TFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSIC 236 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCC-CcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHH
Confidence 345679999999999987766 58899999999999999999999875432 2333344445667778999999999
Q ss_pred HHccccCcCCCCC-----HHHHHhcccccc
Q 013081 249 RKILEPNPVKRIT-----IAGIKADEWFEQ 273 (450)
Q Consensus 249 ~~~L~~dP~~R~t-----~~~il~h~~~~~ 273 (450)
++||+.||.+||| ++++++||||..
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~ 266 (285)
T cd05631 237 RMLLTKNPKERLGCRGNGAAGVKQHPIFKN 266 (285)
T ss_pred HHHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence 9999999999997 899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-49 Score=399.68 Aligned_cols=258 Identities=34% Similarity=0.556 Sum_probs=223.7
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
++|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+...+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 46999999999999999999999999999999998755444455678899999999999999999999999999999999
Q ss_pred ccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc-----
Q 013081 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR----- 168 (450)
Q Consensus 94 E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~----- 168 (450)
||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999975321100
Q ss_pred ----------------------------------------CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHH
Q 013081 169 ----------------------------------------DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 208 (450)
Q Consensus 169 ----------------------------------------~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ 208 (450)
........+||+.|+|||++.+.++ +.++||||+||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DiwSlGvil~ 239 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILY 239 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCC-CCeeeEEechHHHH
Confidence 0001123579999999999988777 48999999999999
Q ss_pred HHHhCCCCCCCCcHHHHHHHHHhC--CCCCC--CCCCHHHHHHHHHccccCcCCCCC---HHHHHhcccccc
Q 013081 209 VILTGYLPFDDRNLAVLYQKIFRG--DFKLP--KWLSPGAQNLLRKILEPNPVKRIT---IAGIKADEWFEQ 273 (450)
Q Consensus 209 elltG~~Pf~~~~~~~~~~~i~~~--~~~~p--~~~s~~~~~Li~~~L~~dP~~R~t---~~~il~h~~~~~ 273 (450)
+|++|++||.+.+......++... ....| ..+++++.+||.+|+ .+|.+|++ +.++++||||..
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~ 310 (382)
T cd05625 240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKT 310 (382)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCC
Confidence 999999999988877776666653 33344 348999999999986 59999997 999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-49 Score=399.84 Aligned_cols=258 Identities=31% Similarity=0.553 Sum_probs=223.0
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
++|++++.||+|+||.||+|.+..+++.||||++.+...........+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999997654444445678899999999999999999999999999999999
Q ss_pred ccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCC---
Q 013081 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD--- 170 (450)
Q Consensus 94 E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~--- 170 (450)
||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 99999999999988889999999999999999999999999999999999999999999999999998632110000
Q ss_pred ------------------------------------------CccccccCCCCccchhhhccCCCCCccchhhhHHHHHH
Q 013081 171 ------------------------------------------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 208 (450)
Q Consensus 171 ------------------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ 208 (450)
......+||+.|+|||++.+..+ +.++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ 239 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMF 239 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCC-CCceeeEecchhhh
Confidence 00113579999999999987766 58999999999999
Q ss_pred HHHhCCCCCCCCcHHHHHHHHHhC--CCCCCC--CCCHHHHHHHHHccccCcCCC---CCHHHHHhcccccc
Q 013081 209 VILTGYLPFDDRNLAVLYQKIFRG--DFKLPK--WLSPGAQNLLRKILEPNPVKR---ITIAGIKADEWFEQ 273 (450)
Q Consensus 209 elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~Li~~~L~~dP~~R---~t~~~il~h~~~~~ 273 (450)
+|++|.+||.+.+....+.++... ...+|. .+++++.+||.+||. +|.+| +|+.+++.||||..
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred hhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 999999999988887777777653 345555 378999999999998 66665 59999999999974
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=388.45 Aligned_cols=252 Identities=37% Similarity=0.681 Sum_probs=224.8
Q ss_pred eeeecccCceEEEEEEEC---CCCceEEEEEeeccccc-chhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEc
Q 013081 19 GRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRII-HLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (450)
Q Consensus 19 ~~~LG~G~~g~Vy~a~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 94 (450)
++.||+|+||.||+|++. .+++.||+|++.+.... .......+.+|+.+++.++||||+++++++..++..|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999864 47889999999764432 22334567899999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccc
Q 013081 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH 174 (450)
Q Consensus 95 ~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 174 (450)
|++|++|.+.+.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... ......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~ 158 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH--EGTVTH 158 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc--CCCccc
Confidence 999999999999888899999999999999999999999999999999999999999999999999874221 223344
Q ss_pred cccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcccc
Q 013081 175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEP 254 (450)
Q Consensus 175 ~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~ 254 (450)
..+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+......++..+...+|..+++.+.+||.+||++
T Consensus 159 ~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 237 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGH-GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKR 237 (323)
T ss_pred ccCCCccccChhhccCCCC-CCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccc
Confidence 5689999999999887666 589999999999999999999999998888888898898899999999999999999999
Q ss_pred CcCCCC-----CHHHHHhcccccc
Q 013081 255 NPVKRI-----TIAGIKADEWFEQ 273 (450)
Q Consensus 255 dP~~R~-----t~~~il~h~~~~~ 273 (450)
||++|| ++.++++||||..
T Consensus 238 ~p~~R~~~~~~~~~~l~~h~~~~~ 261 (323)
T cd05584 238 NPSSRLGAGPGDAAEVQSHPFFRH 261 (323)
T ss_pred CHhHcCCCCCCCHHHHhcCCCcCC
Confidence 999999 8999999999975
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-49 Score=389.33 Aligned_cols=256 Identities=34% Similarity=0.624 Sum_probs=229.5
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEE
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
+|++++.||+|+||.||+|.+..+++.||+|++.+...........+..|..++..+ .||+|+++++++.+.+..|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 589999999999999999999999999999999875443334456677888888877 5899999999999999999999
Q ss_pred ccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCcc
Q 013081 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (450)
Q Consensus 94 E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 173 (450)
||++||+|.+.+...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~--~~~~~ 158 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW--DGVTT 158 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCC--CCCcc
Confidence 9999999999998888999999999999999999999999999999999999999999999999999874321 12234
Q ss_pred ccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccc
Q 013081 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE 253 (450)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~ 253 (450)
...+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.+.+.......+......+|..+++++.+|+.+||+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~ 237 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMT 237 (323)
T ss_pred ccCCCChhhcCHHHhcCCCC-CCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcc
Confidence 45689999999999987776 58999999999999999999999999988999999988888999999999999999999
Q ss_pred cCcCCCCC-----HHHHHhcccccc
Q 013081 254 PNPVKRIT-----IAGIKADEWFEQ 273 (450)
Q Consensus 254 ~dP~~R~t-----~~~il~h~~~~~ 273 (450)
.||.+|++ ..++++||||..
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 238 KHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred cCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 99999998 489999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-50 Score=399.91 Aligned_cols=259 Identities=27% Similarity=0.511 Sum_probs=230.9
Q ss_pred CCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013081 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (450)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (450)
.+....+|.....||+|+.|.||.|....+++.||||.++...... .+-+.+|+.+|+..+|+|||++++.|--.+.
T Consensus 268 ~~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~de 344 (550)
T KOG0578|consen 268 QGDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDE 344 (550)
T ss_pred CCChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhcccce
Confidence 3455678999999999999999999999999999999998776544 4678899999999999999999999988899
Q ss_pred EEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc
Q 013081 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 168 (450)
+|+||||++||+|.|.+.. ..++|.++..+.++++.||+|||.+||+|||||.+|||++.+|.+||+|||++......
T Consensus 345 LWVVMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~- 422 (550)
T KOG0578|consen 345 LWVVMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE- 422 (550)
T ss_pred eEEEEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccc-
Confidence 9999999999999998875 45999999999999999999999999999999999999999999999999999865442
Q ss_pred CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHh-C--CCCCCCCCCHHHH
Q 013081 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR-G--DFKLPKWLSPGAQ 245 (450)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~-~--~~~~p~~~s~~~~ 245 (450)
.....+.+|||+|||||++....| |++.||||||++.+||+-|.+||-.+++......|.. + .+..|+.+|+.++
T Consensus 423 -~~KR~TmVGTPYWMAPEVvtrk~Y-G~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~k 500 (550)
T KOG0578|consen 423 -QSKRSTMVGTPYWMAPEVVTRKPY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELK 500 (550)
T ss_pred -cCccccccCCCCccchhhhhhccc-CccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHH
Confidence 224567899999999999998887 6999999999999999999999998777665555554 3 3455777999999
Q ss_pred HHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 246 NLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 246 ~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
+|+.+||+.||.+|+|+.++|+||||+..
T Consensus 501 dFL~~cL~~dv~~RasA~eLL~HpFl~~a 529 (550)
T KOG0578|consen 501 DFLDRCLVVDVEQRASAKELLEHPFLKMA 529 (550)
T ss_pred HHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence 99999999999999999999999999643
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-49 Score=390.53 Aligned_cols=251 Identities=30% Similarity=0.611 Sum_probs=221.0
Q ss_pred eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEccCCC
Q 013081 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTG 98 (450)
Q Consensus 20 ~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 98 (450)
+.||+|+||.||+|.+..+++.||+|++++...........+.+|+.+++.+ +||||+++++++.+...+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876554444567788999999998 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccccccC
Q 013081 99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 178 (450)
Q Consensus 99 g~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 178 (450)
|+|.+++.+.+++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.... .........+|
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~--~~~~~~~~~~g 158 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI--RPGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccc--cCCCccccccC
Confidence 9999999888899999999999999999999999999999999999999999999999999987321 12223456789
Q ss_pred CCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCC---------cHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q 013081 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR---------NLAVLYQKIFRGDFKLPKWLSPGAQNLLR 249 (450)
Q Consensus 179 t~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~---------~~~~~~~~i~~~~~~~p~~~s~~~~~Li~ 249 (450)
|+.|+|||++.+..+ +.++|+||+||++|+|++|+.||+.. ......+.+......+|..+++.+.+||+
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~ 237 (329)
T cd05588 159 TPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK 237 (329)
T ss_pred CccccCHHHHcCCCC-CCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 999999999987766 58999999999999999999999631 22335566677778889999999999999
Q ss_pred HccccCcCCCCC------HHHHHhcccccc
Q 013081 250 KILEPNPVKRIT------IAGIKADEWFEQ 273 (450)
Q Consensus 250 ~~L~~dP~~R~t------~~~il~h~~~~~ 273 (450)
+||++||.+|+| ++++++||||..
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 238 GFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 999999999997 789999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-49 Score=395.35 Aligned_cols=258 Identities=33% Similarity=0.618 Sum_probs=228.4
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
++|++++.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999998765444345678899999999999999999999999999999999
Q ss_pred ccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc-----
Q 013081 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR----- 168 (450)
Q Consensus 94 E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~----- 168 (450)
||++|++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 999999999999888899999999999999999999999999999999999999999999999999997543321
Q ss_pred ----------------------CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHH
Q 013081 169 ----------------------DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY 226 (450)
Q Consensus 169 ----------------------~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~ 226 (450)
.........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY-GLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCC-CCceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 0012345679999999999988766 58999999999999999999999998888777
Q ss_pred HHHHh--CCCCCCCC--CCHHHHHHHHHccccCcCCCCC-HHHHHhcccccc
Q 013081 227 QKIFR--GDFKLPKW--LSPGAQNLLRKILEPNPVKRIT-IAGIKADEWFEQ 273 (450)
Q Consensus 227 ~~i~~--~~~~~p~~--~s~~~~~Li~~~L~~dP~~R~t-~~~il~h~~~~~ 273 (450)
.++.. ....+|.. +++.+.+||.+||. ||.+||+ +.++++||||..
T Consensus 240 ~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 240 NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred HHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence 77776 44455544 59999999999997 9999999 999999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-48 Score=385.18 Aligned_cols=251 Identities=36% Similarity=0.683 Sum_probs=222.0
Q ss_pred eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEccCCC
Q 013081 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTG 98 (450)
Q Consensus 20 ~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 98 (450)
+.||+|+||.||+|.+..+++.||+|++.+...........+..|..++..+ +||||+++++++......|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999865433333345566777777654 799999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccccccC
Q 013081 99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 178 (450)
Q Consensus 99 g~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 178 (450)
|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~--~~~~~~~~~g 158 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN--GEGKASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCC--CCCccccccC
Confidence 99999998888999999999999999999999999999999999999999999999999999874322 1233456689
Q ss_pred CCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccccCcCC
Q 013081 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258 (450)
Q Consensus 179 t~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~ 258 (450)
|+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+....+..+......+|.++++++.+||.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~ 237 (316)
T cd05592 159 TPDYIAPEILKGQKY-NESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTK 237 (316)
T ss_pred CccccCHHHHcCCCC-CCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 999999999887766 5889999999999999999999999988888888888888889999999999999999999999
Q ss_pred CCCHH-HHHhcccccc
Q 013081 259 RITIA-GIKADEWFEQ 273 (450)
Q Consensus 259 R~t~~-~il~h~~~~~ 273 (450)
||++. +++.||||..
T Consensus 238 R~~~~~~l~~h~~~~~ 253 (316)
T cd05592 238 RLGVDGDIRQHPFFRG 253 (316)
T ss_pred cCCChHHHHcCcccCC
Confidence 99864 8899999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-49 Score=398.82 Aligned_cols=258 Identities=32% Similarity=0.533 Sum_probs=222.7
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
++|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.++++++||||+++++.+.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999997654433344577889999999999999999999999999999999
Q ss_pred ccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC----
Q 013081 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD---- 169 (450)
Q Consensus 94 E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~---- 169 (450)
||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|........
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 9999999999999888899999999999999999999999999999999999999999999999999853211000
Q ss_pred -------------------------------------CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh
Q 013081 170 -------------------------------------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212 (450)
Q Consensus 170 -------------------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt 212 (450)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvilyell~ 239 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILYEMLV 239 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCC-Ccceeeeeccceeeehhh
Confidence 001123579999999999987776 589999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHhC--CCCCCC--CCCHHHHHHHHHccccCcCCCC---CHHHHHhcccccc
Q 013081 213 GYLPFDDRNLAVLYQKIFRG--DFKLPK--WLSPGAQNLLRKILEPNPVKRI---TIAGIKADEWFEQ 273 (450)
Q Consensus 213 G~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~Li~~~L~~dP~~R~---t~~~il~h~~~~~ 273 (450)
|+.||.+.+......++... ....|. .+++.+.+||.+|+ .+|.+|+ |+.++++||||..
T Consensus 240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence 99999998877766666543 233333 48999999999976 5999999 9999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=395.79 Aligned_cols=264 Identities=29% Similarity=0.514 Sum_probs=228.8
Q ss_pred cCCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013081 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (450)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (450)
......++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+..
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~ 116 (370)
T cd05596 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK 116 (370)
T ss_pred cCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 34456789999999999999999999999999999999997654433334566889999999999999999999999999
Q ss_pred EEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcc
Q 013081 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 167 (450)
..|+||||++||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 99999999999999998865 56899999999999999999999999999999999999999999999999998754221
Q ss_pred cCCCccccccCCCCccchhhhccCC---CCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC--CCCCC--CC
Q 013081 168 RDDGLLHTTCGSPNYVAPEVLANRG---YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLPK--WL 240 (450)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~---~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~ 240 (450)
........+||+.|+|||++.+.. ..+.++|||||||++|+|++|+.||.+.+....+.++.... ..+|. .+
T Consensus 196 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 274 (370)
T cd05596 196 -GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEI 274 (370)
T ss_pred -CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCC
Confidence 111234568999999999986532 34689999999999999999999999998888888887643 45555 47
Q ss_pred CHHHHHHHHHccccCcCC--CCCHHHHHhcccccc
Q 013081 241 SPGAQNLLRKILEPNPVK--RITIAGIKADEWFEQ 273 (450)
Q Consensus 241 s~~~~~Li~~~L~~dP~~--R~t~~~il~h~~~~~ 273 (450)
|.++.+||++||+.+|.+ |+|+.++++||||..
T Consensus 275 s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 275 SKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred CHHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 999999999999999988 999999999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-48 Score=385.18 Aligned_cols=251 Identities=37% Similarity=0.706 Sum_probs=226.1
Q ss_pred eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEccCCC
Q 013081 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTG 98 (450)
Q Consensus 20 ~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 98 (450)
+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.+...+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999876544444456778899999888 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccccccC
Q 013081 99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 178 (450)
Q Consensus 99 g~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 178 (450)
|+|.+.+.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL--GGVTTSTFCG 158 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCc--CCCcccceec
Confidence 99999998888999999999999999999999999999999999999999999999999999864211 2223445689
Q ss_pred CCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccccCcCC
Q 013081 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258 (450)
Q Consensus 179 t~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~ 258 (450)
|+.|+|||++.+..+ +.++||||+||++|+|++|+.||.+.+.......+......+|..+++.+.+||++||+.||.+
T Consensus 159 ~~~y~aPE~~~~~~~-~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (318)
T cd05570 159 TPDYIAPEILSYQPY-GPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEK 237 (318)
T ss_pred CccccCHHHhcCCCC-CcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHH
Confidence 999999999987776 5899999999999999999999999888888888888888889999999999999999999999
Q ss_pred CCCH-----HHHHhcccccc
Q 013081 259 RITI-----AGIKADEWFEQ 273 (450)
Q Consensus 259 R~t~-----~~il~h~~~~~ 273 (450)
|||+ .++++||||..
T Consensus 238 R~s~~~~~~~~ll~~~~~~~ 257 (318)
T cd05570 238 RLGCLPTGEQDIKGHPFFRE 257 (318)
T ss_pred cCCCCCCCHHHHhcCCCcCC
Confidence 9999 99999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=380.11 Aligned_cols=255 Identities=25% Similarity=0.407 Sum_probs=214.0
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
++|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 479999999999999999999999999999999976433 2233567889999999999999999999999999999999
Q ss_pred ccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCcc
Q 013081 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (450)
Q Consensus 94 E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 173 (450)
||++++.+..+......+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++...... .....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~ 158 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG-SNANY 158 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccc-ccccc
Confidence 99998877666555567999999999999999999999999999999999999999999999999999854321 11123
Q ss_pred ccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC-------------------C
Q 013081 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-------------------F 234 (450)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-------------------~ 234 (450)
....||+.|+|||++.+..+ +.++||||+||++|+|++|++||.+.+.......+.... .
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPY-GKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred cccccccccCCcHHHcCCCC-CCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 34579999999999987776 589999999999999999999998766543332221110 0
Q ss_pred CCC-------------CCCCHHHHHHHHHccccCcCCCCCHHHHHhcccc
Q 013081 235 KLP-------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 235 ~~p-------------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~ 271 (450)
..| ..+|+.+.+||++||++||++|||++++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 011 1267889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=383.68 Aligned_cols=257 Identities=28% Similarity=0.432 Sum_probs=211.1
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 92 (450)
.++|++.+.||+|+||.||+|.+..+++.||+|++....... ....+.+|+.+++.++||||+++++++.+....|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG--TPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc--cchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 468999999999999999999999999999999987543221 234677899999999999999999999999999999
Q ss_pred EccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCC
Q 013081 93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 171 (450)
|||+. ++|.+.+.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~ 158 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV--PSH 158 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccC--CCc
Confidence 99995 688887765 35799999999999999999999999999999999999999999999999999874322 112
Q ss_pred ccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcH-HHHHHHHHh--CCC---------C----
Q 013081 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL-AVLYQKIFR--GDF---------K---- 235 (450)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~--~~~---------~---- 235 (450)
.....+||+.|+|||++.+....+.++||||+||++|+|++|..||.+... ......+.. +.. .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF 238 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence 234567899999999987665556889999999999999999999987532 222222211 000 0
Q ss_pred --------CCC---------CCCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 236 --------LPK---------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 236 --------~p~---------~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
.|. ..++.+.+|+.+||++||.+|||+.++++||||.+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 010 135688999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-48 Score=385.03 Aligned_cols=256 Identities=34% Similarity=0.627 Sum_probs=228.3
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEE
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv~ 93 (450)
.|++.+.||+|+||.||+|.++.+|+.||+|++.+.........+.+..|..+++.+. ||+|+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788999999999999999999999999999998654433334567788999998886 577889999999999999999
Q ss_pred ccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCcc
Q 013081 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (450)
Q Consensus 94 E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 173 (450)
||++||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~--~~~~~ 158 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV--DGVTT 158 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCC--CCccc
Confidence 9999999999998888999999999999999999999999999999999999999999999999999874321 12233
Q ss_pred ccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccc
Q 013081 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE 253 (450)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~ 253 (450)
...+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.....+.+.......|..+++.+.+|+.+||+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~ 237 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPY-GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMT 237 (323)
T ss_pred cCccCCccccCHHHHcCCCC-CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcc
Confidence 45679999999999887766 58999999999999999999999999888889999988888999999999999999999
Q ss_pred cCcCCCCC-----HHHHHhcccccc
Q 013081 254 PNPVKRIT-----IAGIKADEWFEQ 273 (450)
Q Consensus 254 ~dP~~R~t-----~~~il~h~~~~~ 273 (450)
+||.+|++ ..++++||||..
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h~~f~~ 262 (323)
T cd05615 238 KHPSKRLGCGPEGERDIREHAFFRR 262 (323)
T ss_pred cCHhhCCCCCCCCHHHHhcCcccCC
Confidence 99999997 578999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=387.41 Aligned_cols=251 Identities=37% Similarity=0.625 Sum_probs=221.7
Q ss_pred eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEEEEEEccCCC
Q 013081 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA-TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG 98 (450)
Q Consensus 20 ~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 98 (450)
+.||+|+||+||+|.+..+|+.||+|++.+...........+.+|.. +++.++||||+++++.+.+....|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999999999999999997654333333445555554 56889999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccccccC
Q 013081 99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 178 (450)
Q Consensus 99 g~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 178 (450)
|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... ........+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE--HSKTTSTFCG 158 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc--CCCccccccC
Confidence 99999999888999999999999999999999999999999999999999999999999999874221 2223445689
Q ss_pred CCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccccCcCC
Q 013081 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258 (450)
Q Consensus 179 t~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~ 258 (450)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+.++.......+..+++.+.+||++||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (323)
T cd05575 159 TPEYLAPEVLRKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTK 237 (323)
T ss_pred ChhhcChhhhcCCCC-CccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHh
Confidence 999999999887766 5889999999999999999999999988888899988888888889999999999999999999
Q ss_pred CCCH----HHHHhcccccc
Q 013081 259 RITI----AGIKADEWFEQ 273 (450)
Q Consensus 259 R~t~----~~il~h~~~~~ 273 (450)
||++ .++++||||..
T Consensus 238 R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 238 RLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred CCCCCCCHHHHHcCCCcCC
Confidence 9987 69999999965
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-48 Score=387.12 Aligned_cols=251 Identities=31% Similarity=0.617 Sum_probs=220.4
Q ss_pred eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEccCCC
Q 013081 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTG 98 (450)
Q Consensus 20 ~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 98 (450)
+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.++.++ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876554545567788999998877 799999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccccccC
Q 013081 99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 178 (450)
Q Consensus 99 g~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 178 (450)
|+|.+++...+++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC--CCCccccccC
Confidence 99999998888999999999999999999999999999999999999999999999999999874221 1223345689
Q ss_pred CCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCC---------CcHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q 013081 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD---------RNLAVLYQKIFRGDFKLPKWLSPGAQNLLR 249 (450)
Q Consensus 179 t~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~---------~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~ 249 (450)
|+.|+|||++.+..+ +.++||||+||++|+|++|..||.. .........+......+|..++..+.+||+
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~ 237 (329)
T cd05618 159 TPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 237 (329)
T ss_pred CccccCHHHHcCCCC-CCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 999999999987766 5899999999999999999999952 122345566677788889999999999999
Q ss_pred HccccCcCCCCC------HHHHHhcccccc
Q 013081 250 KILEPNPVKRIT------IAGIKADEWFEQ 273 (450)
Q Consensus 250 ~~L~~dP~~R~t------~~~il~h~~~~~ 273 (450)
+||+.||.+||| +.++++||||..
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 238 SFLNKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred HHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 999999999998 589999999965
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-48 Score=385.18 Aligned_cols=252 Identities=34% Similarity=0.610 Sum_probs=222.4
Q ss_pred eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEccCCC
Q 013081 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTG 98 (450)
Q Consensus 20 ~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 98 (450)
+.||+|+||+||+|.+..+++.||+|++.+..............|..++..+ +||||+++++++.+....|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999865432223345667788888764 899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccccccC
Q 013081 99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 178 (450)
Q Consensus 99 g~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 178 (450)
|+|.+.+.....+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML--GDAKTCTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC--CCCceeeecC
Confidence 99999998888899999999999999999999999999999999999999999999999999874211 1223445689
Q ss_pred CCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccccCcCC
Q 013081 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258 (450)
Q Consensus 179 t~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~ 258 (450)
|+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.......+......+|.+++.++.+||.+||+.||++
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 237 (316)
T cd05619 159 TPDYIAPEILLGQKY-NTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPER 237 (316)
T ss_pred CccccCHHHHcCCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhh
Confidence 999999999887766 5899999999999999999999999888888888877777888999999999999999999999
Q ss_pred CCCHH-HHHhccccccC
Q 013081 259 RITIA-GIKADEWFEQD 274 (450)
Q Consensus 259 R~t~~-~il~h~~~~~~ 274 (450)
||++. ++++||||...
T Consensus 238 R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 238 RLGVKGDIRQHPFFREI 254 (316)
T ss_pred cCCChHHHHcCcccCCC
Confidence 99996 89999999763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=393.98 Aligned_cols=264 Identities=30% Similarity=0.530 Sum_probs=226.8
Q ss_pred CCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013081 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (450)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (450)
.....++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.++..
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 34556899999999999999999999999999999999976544333345678899999999999999999999999999
Q ss_pred EEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc
Q 013081 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 168 (450)
.|+||||++||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|......
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~- 195 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET- 195 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccC-
Confidence 9999999999999998865 46899999999999999999999999999999999999999999999999999754321
Q ss_pred CCCccccccCCCCccchhhhccCC---CCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC--CCCCC--CCC
Q 013081 169 DDGLLHTTCGSPNYVAPEVLANRG---YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLPK--WLS 241 (450)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~---~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s 241 (450)
......+.+||+.|+|||++.+.+ +.+.++||||+||++|+|++|..||.+.+....+.++.... ..+|. .++
T Consensus 196 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s 275 (370)
T cd05621 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEIS 275 (370)
T ss_pred CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCC
Confidence 111234678999999999987543 34689999999999999999999999988888888887643 45555 369
Q ss_pred HHHHHHHHHccccCcCC--CCCHHHHHhccccccC
Q 013081 242 PGAQNLLRKILEPNPVK--RITIAGIKADEWFEQD 274 (450)
Q Consensus 242 ~~~~~Li~~~L~~dP~~--R~t~~~il~h~~~~~~ 274 (450)
+.+++++.+||..+|.+ |+|+.++++||||+..
T Consensus 276 ~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 276 KHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred HHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 99999999999866654 8999999999999763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=392.95 Aligned_cols=258 Identities=31% Similarity=0.576 Sum_probs=225.1
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
+.|++++.||+|+||.||+|.+..+++.||+|++++...........+.+|+.++..++||||+++++.+.+...+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998654444445678889999999999999999999999999999999
Q ss_pred ccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC----
Q 013081 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD---- 169 (450)
Q Consensus 94 E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~---- 169 (450)
||++||+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999874321100
Q ss_pred -----------------------------CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCC
Q 013081 170 -----------------------------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR 220 (450)
Q Consensus 170 -----------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~ 220 (450)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-~~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCC-CCcceeccccceeeecccCCCCCCCC
Confidence 011224589999999999988777 48999999999999999999999998
Q ss_pred cHHHHHHHHHhC--CCCCCCC--CCHHHHHHHHHccccCcCCCC---CHHHHHhcccccc
Q 013081 221 NLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRI---TIAGIKADEWFEQ 273 (450)
Q Consensus 221 ~~~~~~~~i~~~--~~~~p~~--~s~~~~~Li~~~L~~dP~~R~---t~~~il~h~~~~~ 273 (450)
+....+.++... ...+|+. +++.+.+||.+|+ .||.+|+ ++.++++||||..
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~ 298 (360)
T cd05627 240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEG 298 (360)
T ss_pred CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCC
Confidence 888888877753 3444543 7899999999987 4999998 4899999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-49 Score=374.21 Aligned_cols=260 Identities=32% Similarity=0.484 Sum_probs=224.2
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC-cceEEEEEEeCC----
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN-VVRLHEVLASKS---- 87 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~---- 87 (450)
+..|+.++.||+|+||+||+|+++.+|+.||+|.++.+... +.......||+.+++.|+|+| |+.+++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 56788899999999999999999999999999999866432 334567889999999999999 999999998877
Q ss_pred --EEEEEEccCCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCC
Q 013081 88 --KIYMVLEYVTGGELFDKIASKG----RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS 161 (450)
Q Consensus 88 --~~~lv~E~~~gg~L~~~i~~~~----~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla 161 (450)
..|+|+||++ .+|..++.... .++...++.+++||+.||+|||++||+||||||+||||+++|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 8999999995 59999998654 5888999999999999999999999999999999999999999999999999
Q ss_pred CCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC---------
Q 013081 162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--------- 232 (450)
Q Consensus 162 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--------- 232 (450)
+.... .........+|.+|+|||++.+...++...||||+|||++||++++.-|.+.+.......|.+-
T Consensus 168 ra~~i--p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 168 RAFSI--PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHhcC--CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 96442 2233556789999999999998877789999999999999999999999999887777777531
Q ss_pred ---------CCCCCCC------------CCHHHHHHHHHccccCcCCCCCHHHHHhccccccCCC
Q 013081 233 ---------DFKLPKW------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 276 (450)
Q Consensus 233 ---------~~~~p~~------------~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~~ 276 (450)
...+|.| .+++..+++.+||+.+|.+|.|+..++.||||.....
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 1122222 2358899999999999999999999999999987543
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-48 Score=384.45 Aligned_cols=251 Identities=34% Similarity=0.651 Sum_probs=223.8
Q ss_pred eeeecccCceEEEEEEEC---CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEcc
Q 013081 19 GRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY 95 (450)
Q Consensus 19 ~~~LG~G~~g~Vy~a~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 95 (450)
++.||+|+||.||++++. .+|+.||+|++.+..... .....+.+|+.++++++||||+++++++.+.+..|+||||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence 368999999999999863 578999999997654322 2245677899999999999999999999999999999999
Q ss_pred CCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCcccc
Q 013081 96 VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHT 175 (450)
Q Consensus 96 ~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~ 175 (450)
++||+|.+++.+...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... .......
T Consensus 80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~--~~~~~~~ 157 (318)
T cd05582 80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID--HEKKAYS 157 (318)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCC--CCCceec
Confidence 99999999998888899999999999999999999999999999999999999999999999999875322 1223445
Q ss_pred ccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccccC
Q 013081 176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255 (450)
Q Consensus 176 ~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~d 255 (450)
.+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+.......+......+|..+++.+.+||++||++|
T Consensus 158 ~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~ 236 (318)
T cd05582 158 FCGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRN 236 (318)
T ss_pred ccCChhhcCHHHHcCCCC-CCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcC
Confidence 689999999999887666 5899999999999999999999999888888888888888899999999999999999999
Q ss_pred cCCCCC-----HHHHHhcccccc
Q 013081 256 PVKRIT-----IAGIKADEWFEQ 273 (450)
Q Consensus 256 P~~R~t-----~~~il~h~~~~~ 273 (450)
|.+||| +.+++.||||..
T Consensus 237 P~~R~~a~~~~~~~~~~~~~~~~ 259 (318)
T cd05582 237 PANRLGAGPDGVEEIKRHPFFST 259 (318)
T ss_pred HhHcCCCCCCCHHHHhCCCCcCC
Confidence 999999 788999999975
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=387.66 Aligned_cols=258 Identities=28% Similarity=0.529 Sum_probs=224.2
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
++|++.+.||+|+||.||+|.+..+|+.||+|++++...........+.+|+.+++.++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765434445677889999999999999999999999999999999
Q ss_pred ccCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCc
Q 013081 94 EYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (450)
Q Consensus 94 E~~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 172 (450)
||++||+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....... ...
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~-~~~ 159 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK-MVN 159 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCC-cee
Confidence 999999999999875 689999999999999999999999999999999999999999999999999997543211 112
Q ss_pred cccccCCCCccchhhhcc-----CCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC--CCCC--CCCCHH
Q 013081 173 LHTTCGSPNYVAPEVLAN-----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLP--KWLSPG 243 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~~-----~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p--~~~s~~ 243 (450)
....+||+.|+|||++.. ....+.++|||||||++|+|++|..||...+....+.++.... ..+| ..+++.
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSD 239 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHH
Confidence 334579999999999863 2334688999999999999999999999888877777776542 3334 357999
Q ss_pred HHHHHHHccccCcCCCCCHHHHHhcccccc
Q 013081 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 244 ~~~Li~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
+.+||.+||. ||.+|||+.++++||||..
T Consensus 240 ~~~li~~ll~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 240 FLDLIQSLLC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred HHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence 9999999998 9999999999999999975
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-48 Score=385.80 Aligned_cols=249 Identities=31% Similarity=0.507 Sum_probs=216.1
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCce-EEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-EEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLP-FAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-KIY 90 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~-vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-~~~ 90 (450)
.....+.+.||+|+||+||+|.+ .|+. ||+|++......... .+.+.+|+.+|++++|||||++++++.... ...
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~ 116 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLC 116 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceE
Confidence 44566777899999999999998 4556 999999876554444 789999999999999999999999998887 799
Q ss_pred EEEccCCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHhhhhhcC-eeeccCCCCcEEEccCC-CeEEeecCCCCCCCc
Q 013081 91 MVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKG-VFHRDLKLENILLDSKG-NIKISDFGLSALPQH 166 (450)
Q Consensus 91 lv~E~~~gg~L~~~i~~--~~~l~~~~~~~i~~ql~~aL~~LH~~g-ivHrDlKp~NILl~~~g-~lkl~DFGla~~~~~ 166 (450)
+||||+++|+|.+++.. ...++...+..++.||+.|++|||+++ |+||||||+|||++.++ ++||||||+++....
T Consensus 117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 99999999999999987 678999999999999999999999999 99999999999999998 999999999986433
Q ss_pred ccCCCccccccCCCCccchhhhc--cCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHH-hC-CCCCCCCCCH
Q 013081 167 FRDDGLLHTTCGSPNYVAPEVLA--NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF-RG-DFKLPKWLSP 242 (450)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~--~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~-~~-~~~~p~~~s~ 242 (450)
.. .......||+.|||||++. ...| +.++||||||++||||+||..||.+.........+. .+ ...+|..+++
T Consensus 197 ~~--~~~~~~~GT~~wMAPEv~~~~~~~~-~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~ 273 (362)
T KOG0192|consen 197 SK--TSMTSVAGTYRWMAPEVLRGEKSPY-TEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPP 273 (362)
T ss_pred cc--ccccCCCCCccccChhhhcCCCCcC-CccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCH
Confidence 11 2233368999999999998 4466 599999999999999999999999988765555544 33 5667888999
Q ss_pred HHHHHHHHccccCcCCCCCHHHHHh
Q 013081 243 GAQNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
.+..|+.+||+.||.+||++.+|+.
T Consensus 274 ~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 274 HLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 9999999999999999999999865
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=388.16 Aligned_cols=250 Identities=32% Similarity=0.562 Sum_probs=219.9
Q ss_pred ecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC---CCCCcceEEEEEEeCCEEEEEEccCCC
Q 013081 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL---KHPNVVRLHEVLASKSKIYMVLEYVTG 98 (450)
Q Consensus 22 LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~~~~lv~E~~~g 98 (450)
||+|+||+||+|++..+++.||+|++.+.............+|..++..+ .||||+++++++.+....|+||||++|
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999765443333344556677777665 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccccccC
Q 013081 99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 178 (450)
Q Consensus 99 g~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 178 (450)
|+|.+.+.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~g 158 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLT--DNKTTNTFCG 158 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC--CCCCccCccC
Confidence 99999999888999999999999999999999999999999999999999999999999999874321 2233456789
Q ss_pred CCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHccccCcC
Q 013081 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKW-LSPGAQNLLRKILEPNPV 257 (450)
Q Consensus 179 t~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~-~s~~~~~Li~~~L~~dP~ 257 (450)
|+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+....+.++..+...+|.. +++.+.+||++||++||.
T Consensus 159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~ 238 (330)
T cd05586 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQ 238 (330)
T ss_pred CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHH
Confidence 9999999998765545689999999999999999999999998888888888887777754 799999999999999999
Q ss_pred CCC----CHHHHHhcccccc
Q 013081 258 KRI----TIAGIKADEWFEQ 273 (450)
Q Consensus 258 ~R~----t~~~il~h~~~~~ 273 (450)
+|| ++.++++||||..
T Consensus 239 ~R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 239 HRLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred HCCCCCCCHHHHhcCccccC
Confidence 998 7999999999975
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-48 Score=384.97 Aligned_cols=251 Identities=35% Similarity=0.597 Sum_probs=221.4
Q ss_pred eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEEEEEEccCCC
Q 013081 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA-TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG 98 (450)
Q Consensus 20 ~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 98 (450)
+.||+|+||+||+|.+..+|+.||+|++.+...........+.+|.. +++.++||||+++++++...+..|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999999999999999997654433333455566655 56789999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccccccC
Q 013081 99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 178 (450)
Q Consensus 99 g~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 178 (450)
|+|...+...+++++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTTTTFCG 158 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC--CCCCcccccC
Confidence 99999998888999999999999999999999999999999999999999999999999999874221 1223345689
Q ss_pred CCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccccCcCC
Q 013081 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258 (450)
Q Consensus 179 t~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~ 258 (450)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||...+....+.++.......++..+..+.++|++||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~ 237 (325)
T cd05604 159 TPEYLAPEVIRKQPY-DNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQR 237 (325)
T ss_pred ChhhCCHHHHcCCCC-CCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHh
Confidence 999999999987776 4889999999999999999999999888888888888887777789999999999999999999
Q ss_pred CCCH----HHHHhcccccc
Q 013081 259 RITI----AGIKADEWFEQ 273 (450)
Q Consensus 259 R~t~----~~il~h~~~~~ 273 (450)
||++ .++++||||..
T Consensus 238 R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 238 RLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred cCCCCCCHHHHhcCCCcCC
Confidence 9976 58999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-48 Score=382.78 Aligned_cols=251 Identities=36% Similarity=0.620 Sum_probs=221.3
Q ss_pred eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEEEEEEccCCC
Q 013081 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA-TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG 98 (450)
Q Consensus 20 ~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 98 (450)
+.||+|+||.||+|++..+|+.||+|++.+...........+.+|.. +++.++||||+++++++.+.+..|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999997654433333445556654 67889999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccccccC
Q 013081 99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 178 (450)
Q Consensus 99 g~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 178 (450)
++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE--PEETTSTFCG 158 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC--CCCccccccC
Confidence 99999998888899999999999999999999999999999999999999999999999999874211 2223445689
Q ss_pred CCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccccCcCC
Q 013081 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258 (450)
Q Consensus 179 t~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~ 258 (450)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+......+|...+..+.++|.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (321)
T cd05603 159 TPEYLAPEVLRKEPY-DRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRR 237 (321)
T ss_pred CcccCCHHHhcCCCC-CCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhh
Confidence 999999999887766 4889999999999999999999999988888888888888888889999999999999999999
Q ss_pred CCCH----HHHHhcccccc
Q 013081 259 RITI----AGIKADEWFEQ 273 (450)
Q Consensus 259 R~t~----~~il~h~~~~~ 273 (450)
|+++ .++++|+||..
T Consensus 238 R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 238 RLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred cCCCCCCHHHHhCCCCcCC
Confidence 9975 59999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=382.45 Aligned_cols=257 Identities=30% Similarity=0.459 Sum_probs=209.8
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----CEE
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-----SKI 89 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~~~ 89 (450)
+|++.+.||+|+||.||+|.+..+|+.||||.+..... ......++.+|+.+++.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 69999999999999999999999999999999864322 222245788999999999999999999987543 358
Q ss_pred EEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC
Q 013081 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 169 (450)
|+||||+. ++|.+.+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 99999994 69999998888899999999999999999999999999999999999999999999999999975322111
Q ss_pred -CCccccccCCCCccchhhhccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHh----------------
Q 013081 170 -DGLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR---------------- 231 (450)
Q Consensus 170 -~~~~~~~~gt~~y~APE~l~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~---------------- 231 (450)
.......+||+.|+|||++.+. ...+.++|||||||++|+|++|++||.+.+.......+..
T Consensus 159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 238 (338)
T cd07859 159 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE 238 (338)
T ss_pred ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 1122456799999999998652 3346899999999999999999999987654332211110
Q ss_pred ----------CCCCC--C---CCCCHHHHHHHHHccccCcCCCCCHHHHHhcccccc
Q 013081 232 ----------GDFKL--P---KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 232 ----------~~~~~--p---~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
...+. + +.+++.+.++|.+||+.||++|||++++++||||+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~ 295 (338)
T cd07859 239 KARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKG 295 (338)
T ss_pred hHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhh
Confidence 00011 0 236788999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=381.70 Aligned_cols=251 Identities=30% Similarity=0.611 Sum_probs=221.0
Q ss_pred eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEccCCC
Q 013081 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTG 98 (450)
Q Consensus 20 ~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 98 (450)
+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.++.++ +||||+++++++.+...+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876554445567788999999888 599999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccccccC
Q 013081 99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 178 (450)
Q Consensus 99 g~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 178 (450)
|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG--PGDTTSTFCG 158 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccC--CCCceecccC
Confidence 99999998888999999999999999999999999999999999999999999999999999874211 1223456789
Q ss_pred CCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCC-------CcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q 013081 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD-------RNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 251 (450)
Q Consensus 179 t~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~-------~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~ 251 (450)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||.. ......++.+......+|..+++.+.++|.+|
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~ 237 (327)
T cd05617 159 TPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF 237 (327)
T ss_pred CcccCCHHHHCCCCC-CchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence 999999999987766 5899999999999999999999953 22334566666777788888999999999999
Q ss_pred cccCcCCCCC------HHHHHhcccccc
Q 013081 252 LEPNPVKRIT------IAGIKADEWFEQ 273 (450)
Q Consensus 252 L~~dP~~R~t------~~~il~h~~~~~ 273 (450)
|+.||.+|++ +.++++||||..
T Consensus 238 L~~dP~~R~~~~~~~~~~~i~~h~~f~~ 265 (327)
T cd05617 238 LNKDPKERLGCQPQTGFSDIKSHTFFRS 265 (327)
T ss_pred hccCHHHcCCCCCCCCHHHHHcCCCCCC
Confidence 9999999998 579999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=387.79 Aligned_cols=265 Identities=31% Similarity=0.526 Sum_probs=226.7
Q ss_pred cCCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013081 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (450)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (450)
......++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+..
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34556689999999999999999999999999999999997644433344566889999999999999999999999999
Q ss_pred EEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcc
Q 013081 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 167 (450)
..|+||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence 99999999999999998865 46899999999999999999999999999999999999999999999999998754221
Q ss_pred cCCCccccccCCCCccchhhhccCC---CCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC--CCCCC--CC
Q 013081 168 RDDGLLHTTCGSPNYVAPEVLANRG---YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLPK--WL 240 (450)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~---~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~ 240 (450)
........+||+.|+|||++.... ..+.++|||||||++|+|++|..||.+.+....+.++.... ..+|. .+
T Consensus 196 -~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 274 (371)
T cd05622 196 -GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDI 274 (371)
T ss_pred -CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCC
Confidence 111234568999999999987543 34689999999999999999999999999888888887643 44443 58
Q ss_pred CHHHHHHHHHccccCcCC--CCCHHHHHhccccccC
Q 013081 241 SPGAQNLLRKILEPNPVK--RITIAGIKADEWFEQD 274 (450)
Q Consensus 241 s~~~~~Li~~~L~~dP~~--R~t~~~il~h~~~~~~ 274 (450)
++.+.+||.+||..+|.+ |+++.++++|+||...
T Consensus 275 s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 275 SKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred CHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 999999999999854443 7899999999999763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=381.64 Aligned_cols=251 Identities=37% Similarity=0.625 Sum_probs=219.9
Q ss_pred eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHH-HHHHhCCCCCcceEEEEEEeCCEEEEEEccCCC
Q 013081 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI-ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG 98 (450)
Q Consensus 20 ~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei-~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 98 (450)
+.||+|+||.||+|++..+++.||+|++.+...........+.+|. .+++.++||||+++++++...+..|+||||++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4799999999999999999999999999765433222233444444 456889999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccccccC
Q 013081 99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 178 (450)
Q Consensus 99 g~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 178 (450)
++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~--~~~~~~~~~g 158 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNGTTSTFCG 158 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccccc--CCCCcccccC
Confidence 99999999888899999999999999999999999999999999999999999999999999874321 2233456789
Q ss_pred CCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccccCcCC
Q 013081 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258 (450)
Q Consensus 179 t~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~ 258 (450)
|+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+....+..+.......++.+++.+.++|.+||++||.+
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (325)
T cd05602 159 TPEYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTK 237 (325)
T ss_pred CccccCHHHHcCCCC-CCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHH
Confidence 999999999987766 4889999999999999999999999888888888888877888889999999999999999999
Q ss_pred CCCHH----HHHhcccccc
Q 013081 259 RITIA----GIKADEWFEQ 273 (450)
Q Consensus 259 R~t~~----~il~h~~~~~ 273 (450)
|+++. ++++|+||..
T Consensus 238 R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 238 RLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred CCCCCCCHHHHhcCcccCC
Confidence 99876 8999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=371.82 Aligned_cols=249 Identities=29% Similarity=0.483 Sum_probs=214.4
Q ss_pred ecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEccCCCCCh
Q 013081 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL 101 (450)
Q Consensus 22 LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 101 (450)
||+|+||+||++.+..+++.||+|.+.+.........+.+..|+.+++.++||||+++++++......|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999999999999999999765444333446778899999999999999999999999999999999999999
Q ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCcccccc
Q 013081 102 FDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC 177 (450)
Q Consensus 102 ~~~i~~----~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~ 177 (450)
.+.+.. ...+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++..... .........
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKD--GQSKTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCC--CCccccccC
Confidence 887742 35699999999999999999999999999999999999999999999999999875432 112234467
Q ss_pred CCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcH----HHHHHHHHhCCCCCCCCCCHHHHHHHHHccc
Q 013081 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL----AVLYQKIFRGDFKLPKWLSPGAQNLLRKILE 253 (450)
Q Consensus 178 gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~ 253 (450)
||+.|+|||++.+..+ +.++||||+||++|+|++|+.||..... ......+.......|..+++.+.+++.+||+
T Consensus 159 g~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 237 (280)
T cd05608 159 GTPGFMAPELLQGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLA 237 (280)
T ss_pred CCcCccCHHHhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhc
Confidence 9999999999987776 4889999999999999999999976432 2334444555566777899999999999999
Q ss_pred cCcCCCC-----CHHHHHhcccccc
Q 013081 254 PNPVKRI-----TIAGIKADEWFEQ 273 (450)
Q Consensus 254 ~dP~~R~-----t~~~il~h~~~~~ 273 (450)
.||++|| |++++++||||+.
T Consensus 238 ~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 238 KDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred CCHHHhcCCCCCCHHHHhcChhhhc
Confidence 9999999 8899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=386.95 Aligned_cols=255 Identities=27% Similarity=0.450 Sum_probs=228.5
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
..|...+.||+|+||.||+|.+..+++.||+|+++.+...+ ..+.+.+|+.++..++++||.+.|+.+-.+..+|++|
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~d--eIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAED--EIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcch--hhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 46888899999999999999999999999999998776543 3688999999999999999999999999999999999
Q ss_pred ccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCcc
Q 013081 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (450)
Q Consensus 94 E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 173 (450)
|||.||++.+.++....+++.++.-++++++.||.|||.++.+|||||+.|||+..+|++||+|||.+...... ....
T Consensus 91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~--~~rr 168 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT--VKRR 168 (467)
T ss_pred HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeech--hhcc
Confidence 99999999999999888899999999999999999999999999999999999999999999999999865432 2234
Q ss_pred ccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHcc
Q 013081 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKIL 252 (450)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~~L 252 (450)
.+.+|||.|||||++...+|+ .++||||||++.+||++|.+||.+.+++.....|-+..+ .+...+|+.+++|+..||
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~-~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL 247 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYD-TKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACL 247 (467)
T ss_pred ccccccccccchhhhcccccc-chhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHh
Confidence 789999999999999987886 899999999999999999999999888655544544433 233458999999999999
Q ss_pred ccCcCCCCCHHHHHhcccccc
Q 013081 253 EPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 253 ~~dP~~R~t~~~il~h~~~~~ 273 (450)
++||+.|||+.++|+|+|.+.
T Consensus 248 ~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 248 DKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred hcCcccCcCHHHHhhhHHHHh
Confidence 999999999999999999976
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-47 Score=375.84 Aligned_cols=256 Identities=29% Similarity=0.437 Sum_probs=219.1
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
..++|++++.||+|+||.||+|.+..+|..||+|++.... .......+.+|+.+++.++||||+++++++...+..|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 4578999999999999999999999999999999987542 23345789999999999999999999999999999999
Q ss_pred EEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhc-CeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCC
Q 013081 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~-givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 170 (450)
||||++|++|.+++.....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~---- 156 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---- 156 (331)
T ss_pred EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc----
Confidence 999999999999998888899999999999999999999986 699999999999999999999999999874322
Q ss_pred CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHH--------------------
Q 013081 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF-------------------- 230 (450)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~-------------------- 230 (450)
.......||+.|+|||++.+..+ +.++||||+||++|+|++|+.||...+...+...+.
T Consensus 157 ~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (331)
T cd06649 157 SMANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRP 235 (331)
T ss_pred cccccCCCCcCcCCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccc
Confidence 23345679999999999887766 589999999999999999999997765443322111
Q ss_pred --------------------------hCC-CCCC-CCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 231 --------------------------RGD-FKLP-KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 231 --------------------------~~~-~~~p-~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
... ...+ ..+++++.+||.+||++||++|||+.++++||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 000 1111 1367899999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-47 Score=377.11 Aligned_cols=259 Identities=29% Similarity=0.534 Sum_probs=220.2
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
++|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999997654434444567889999999999999999999999999999999
Q ss_pred ccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCc
Q 013081 94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (450)
Q Consensus 94 E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 172 (450)
||++||+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~ 159 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG-TVQ 159 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC-Ccc
Confidence 99999999999976 4579999999999999999999999999999999999999999999999999986432211 111
Q ss_pred cccccCCCCccchhhhcc----CCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC--CCCC---CCCCHH
Q 013081 173 LHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLP---KWLSPG 243 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~~----~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p---~~~s~~ 243 (450)
....+||+.|+|||++.. ....+.++||||+||++|+|++|+.||.+.+....+.++.... ..+| ..+++.
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 239 (331)
T cd05597 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEE 239 (331)
T ss_pred ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHH
Confidence 233579999999999863 3344688999999999999999999999888777777776532 3333 347999
Q ss_pred HHHHHHHccccCcCC--CCCHHHHHhcccccc
Q 013081 244 AQNLLRKILEPNPVK--RITIAGIKADEWFEQ 273 (450)
Q Consensus 244 ~~~Li~~~L~~dP~~--R~t~~~il~h~~~~~ 273 (450)
+++||++||..++.+ |+++.++++||||..
T Consensus 240 ~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~ 271 (331)
T cd05597 240 AKDLIRRLICSPETRLGRNGLQDFKDHPFFEG 271 (331)
T ss_pred HHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence 999999998664443 889999999999975
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-47 Score=369.18 Aligned_cols=255 Identities=29% Similarity=0.442 Sum_probs=219.8
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEc
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 94 (450)
.|++.+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++.++||||+++++.+..++..|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48999999999999999999999999999999976544333334567889999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCc
Q 013081 95 YVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (450)
Q Consensus 95 ~~~gg~L~~~i~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 172 (450)
|+.||+|.+.+... ..+++..+..++.|++.||.|||+.|++||||||+||++++++.++|+|||++..... ...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~---~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE---GET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC---CCc
Confidence 99999999888653 4699999999999999999999999999999999999999999999999999875322 122
Q ss_pred cccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHH----HHHHHHhCCCCCCCCCCHHHHHHH
Q 013081 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV----LYQKIFRGDFKLPKWLSPGAQNLL 248 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~----~~~~i~~~~~~~p~~~s~~~~~Li 248 (450)
....+|++.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+... ....+......+|..+++.+.+|+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~-~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERY-TFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC 236 (285)
T ss_pred cccccCCCCccCcHHhcCCCC-CccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence 344589999999999877665 588999999999999999999998765432 223334445566677999999999
Q ss_pred HHccccCcCCCC-----CHHHHHhcccccc
Q 013081 249 RKILEPNPVKRI-----TIAGIKADEWFEQ 273 (450)
Q Consensus 249 ~~~L~~dP~~R~-----t~~~il~h~~~~~ 273 (450)
.+||+.||.+|| ++.++++||||..
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred HHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 999999999999 8999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=371.02 Aligned_cols=258 Identities=25% Similarity=0.427 Sum_probs=215.6
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
.+++|.+.+.||+|+||.||+|++..+++.||+|.++...... ....+.+|+.++++++||||+++++++..++..|+
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 81 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTL 81 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC--cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEE
Confidence 4678999999999999999999999999999999987543222 23467789999999999999999999999999999
Q ss_pred EEccCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCC
Q 013081 92 VLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 170 (450)
||||+.+ +|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~ 158 (309)
T cd07872 82 VFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSV--PT 158 (309)
T ss_pred EEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCC--Cc
Confidence 9999975 888887654 4589999999999999999999999999999999999999999999999999874322 11
Q ss_pred CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC------------------
Q 013081 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------------ 232 (450)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------------ 232 (450)
.......+|+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+..+....+.+.
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 22334578999999999876555568999999999999999999999887655444333211
Q ss_pred -CCCCC-----------CCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 233 -DFKLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 233 -~~~~p-----------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
....| ..+++++.+||.+||+.||.+|||+.++++||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 01111 2368899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-47 Score=384.65 Aligned_cols=254 Identities=21% Similarity=0.348 Sum_probs=210.1
Q ss_pred CcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (450)
+...++|++++.||+|+||.||+|.+..+++.||+|... ...+.+|+.++++++||||+++++++......
T Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 158 (391)
T PHA03212 88 GIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---------RGGTATEAHILRAINHPSIIQLKGTFTYNKFT 158 (391)
T ss_pred ccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCee
Confidence 455678999999999999999999999999999999653 23467899999999999999999999999999
Q ss_pred EEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC
Q 013081 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 169 (450)
++++|++. ++|.+++.....+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|...... .
T Consensus 159 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~-~ 236 (391)
T PHA03212 159 CLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI-N 236 (391)
T ss_pred EEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc-c
Confidence 99999995 689999988888999999999999999999999999999999999999999999999999999753221 1
Q ss_pred CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCc-------HHHHHHHH-------------
Q 013081 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-------LAVLYQKI------------- 229 (450)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~-------~~~~~~~i------------- 229 (450)
.......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||-... .......+
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred ccccccccCccCCCChhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 123345689999999999887766 589999999999999999998764321 01111111
Q ss_pred -------------HhCCC----CCCCC-----CCHHHHHHHHHccccCcCCCCCHHHHHhccccccCC
Q 013081 230 -------------FRGDF----KLPKW-----LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 230 -------------~~~~~----~~p~~-----~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
..... ..|.| ++.++.+||.+||++||.+|||+.|+|+||||+...
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 383 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP 383 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence 11100 11111 466899999999999999999999999999998643
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-47 Score=392.39 Aligned_cols=251 Identities=26% Similarity=0.378 Sum_probs=207.4
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC------
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK------ 86 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------ 86 (450)
-++|++++.||+|+||.||+|.+..+++.||||.+.... ....+|+.+++.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 468999999999999999999999999999999885432 2345799999999999999999887432
Q ss_pred --CEEEEEEccCCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCC-CeEEeecC
Q 013081 87 --SKIYMVLEYVTGGELFDKIA----SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFG 159 (450)
Q Consensus 87 --~~~~lv~E~~~gg~L~~~i~----~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g-~lkl~DFG 159 (450)
..+++||||+++ +|.+.+. ....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 247799999975 7776664 346799999999999999999999999999999999999999765 69999999
Q ss_pred CCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC-------
Q 013081 160 LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------- 232 (450)
Q Consensus 160 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------- 232 (450)
+|+.... .......+||+.|+|||++.+...++.++||||+||++|+|++|.+||.+.+......++...
T Consensus 217 la~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 217 SAKNLLA---GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred cchhccC---CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 9985432 222345678999999999876655578999999999999999999999987665544444321
Q ss_pred ----------CC------------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 233 ----------DF------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 233 ----------~~------------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
.. .+|...++++.+||.+||++||.+|||+.|+++||||...
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 01 1234467899999999999999999999999999999754
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=366.08 Aligned_cols=254 Identities=39% Similarity=0.746 Sum_probs=231.8
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
++|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.++++++||||+++++++......|++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999997665544455678999999999999999999999999999999999
Q ss_pred ccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCcc
Q 013081 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (450)
Q Consensus 94 E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 173 (450)
||+++++|.+++...+.+++..+..++.||+.||.|||++|++||||+|.|||++.++.+||+|||++...... .
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~ 155 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----T 155 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----C
Confidence 99999999999998889999999999999999999999999999999999999999999999999998854321 3
Q ss_pred ccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccc
Q 013081 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE 253 (450)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~ 253 (450)
...+|++.|+|||.+.+..+ +.++||||+|+++|+|++|..||...+......++..+...+|..+++.+.++|.+||+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 234 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQ 234 (290)
T ss_pred CCCCCCccccChhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHcc
Confidence 45578999999999876655 58899999999999999999999988877788888888888899999999999999999
Q ss_pred cCcCCCC-----CHHHHHhcccccc
Q 013081 254 PNPVKRI-----TIAGIKADEWFEQ 273 (450)
Q Consensus 254 ~dP~~R~-----t~~~il~h~~~~~ 273 (450)
.||.+|+ +++++++||||..
T Consensus 235 ~~p~~R~~~~~~~~~~l~~~~~~~~ 259 (290)
T cd05580 235 VDLTKRLGNLKNGVNDIKNHPWFAG 259 (290)
T ss_pred CCHHHccCcccCCHHHHHcCccccc
Confidence 9999999 9999999999965
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=393.62 Aligned_cols=261 Identities=33% Similarity=0.531 Sum_probs=227.3
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS--- 87 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--- 87 (450)
..-++|++.+.||+|+||.||+|.+..+|+.||||++...... ......+.+|+.++..++|+||+++++.+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 4457999999999999999999999999999999999765443 334567889999999999999999988764332
Q ss_pred -----EEEEEEccCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeec
Q 013081 88 -----KIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDF 158 (450)
Q Consensus 88 -----~~~lv~E~~~gg~L~~~i~~----~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DF 158 (450)
.+++||||+++|+|.+.+.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence 47899999999999998864 346899999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCC-CCC
Q 013081 159 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLP 237 (450)
Q Consensus 159 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p 237 (450)
|+++..............+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+......++..+.. +.|
T Consensus 188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 266 (496)
T PTZ00283 188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPY-SKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLP 266 (496)
T ss_pred ccCeeccccccccccccccCCcceeCHHHhCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCC
Confidence 99986543222334456789999999999987766 5899999999999999999999999888888877776643 567
Q ss_pred CCCCHHHHHHHHHccccCcCCCCCHHHHHhcccccc
Q 013081 238 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 238 ~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
..+++.+.+|+.+||+.||.+|||+.++++|||++.
T Consensus 267 ~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 267 PSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred CCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 789999999999999999999999999999999864
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-48 Score=360.69 Aligned_cols=253 Identities=34% Similarity=0.646 Sum_probs=221.2
Q ss_pred cccCCeEE-eeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEe---
Q 013081 11 MRLGRYEL-GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLAS--- 85 (450)
Q Consensus 11 ~~~~~y~i-~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~--- 85 (450)
...++|.+ -+.||-|-.|+|-.+.++.||+.+|+|++.. ....+||++..=+.+ |||||.++++|++
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D--------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~ 129 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD--------SPKARREVELHWMASGHPHIVSIIDVYENSYQ 129 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc--------CHHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence 34567877 4679999999999999999999999999853 256788998877664 9999999999853
Q ss_pred -CCEEEEEEccCCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccC---CCeEEeecC
Q 013081 86 -KSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK---GNIKISDFG 159 (450)
Q Consensus 86 -~~~~~lv~E~~~gg~L~~~i~~~~~--l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~---g~lkl~DFG 159 (450)
...+.+|||.++||+||+.|+.++. ++|.+|..+++||..|+.|||+.+|.||||||||+|...+ ..+||+|||
T Consensus 130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccc
Confidence 4678899999999999999998765 9999999999999999999999999999999999999754 469999999
Q ss_pred CCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCc----HHHHHHHHHhCCCC
Q 013081 160 LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN----LAVLYQKIFRGDFK 235 (450)
Q Consensus 160 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~----~~~~~~~i~~~~~~ 235 (450)
+|+.... ...+.+.|.||.|+|||++....|+ ..+|+||+||++|.||+|++||.... ...+..+|..+.+.
T Consensus 210 FAK~t~~---~~~L~TPc~TPyYvaPevlg~eKyd-kscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~ 285 (400)
T KOG0604|consen 210 FAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYE 285 (400)
T ss_pred cccccCC---CccccCCcccccccCHHHhCchhcC-CCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCcc
Confidence 9986432 4567899999999999999887775 88999999999999999999997644 34678889999777
Q ss_pred CC--CC--CCHHHHHHHHHccccCcCCCCCHHHHHhccccccCC
Q 013081 236 LP--KW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 236 ~p--~~--~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
+| +| +|..++++|+++|..+|.+|.|+.++++|||..+..
T Consensus 286 FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 286 FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 76 45 899999999999999999999999999999998653
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-47 Score=379.77 Aligned_cols=258 Identities=28% Similarity=0.444 Sum_probs=215.9
Q ss_pred CcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (450)
...+++|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++||||+++++++...+..
T Consensus 70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 147 (353)
T PLN00034 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEI 147 (353)
T ss_pred CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeE
Confidence 345678999999999999999999999999999999986543 233457789999999999999999999999999999
Q ss_pred EEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC
Q 013081 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 169 (450)
|+||||+++++|.+. ...++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 148 ~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~-- 221 (353)
T PLN00034 148 QVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT-- 221 (353)
T ss_pred EEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccc--
Confidence 999999999998653 34678888999999999999999999999999999999999999999999999854321
Q ss_pred CCccccccCCCCccchhhhcc----CCCCCccchhhhHHHHHHHHHhCCCCCCCCcHH---HHHHHHH-hCCCCCCCCCC
Q 013081 170 DGLLHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLA---VLYQKIF-RGDFKLPKWLS 241 (450)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~----~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---~~~~~i~-~~~~~~p~~~s 241 (450)
........||+.|+|||++.. ..+.+.++|||||||++|+|++|+.||...... .....+. ......+..++
T Consensus 222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (353)
T PLN00034 222 MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATAS 301 (353)
T ss_pred cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccC
Confidence 112345679999999998743 345567899999999999999999999743322 2222222 22344566789
Q ss_pred HHHHHHHHHccccCcCCCCCHHHHHhccccccCC
Q 013081 242 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 242 ~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
+++.+||.+||+.||++|||+.|+++||||....
T Consensus 302 ~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 302 REFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 9999999999999999999999999999998753
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=390.76 Aligned_cols=257 Identities=28% Similarity=0.439 Sum_probs=224.8
Q ss_pred cCCeEEeeeecccCceEEEEEEECCC-CceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDS-GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~-~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
...|.+.+.||+|+||.||+|.+..+ ++.||+|.+... .......+.+|+.+++.++||||+++++++...+..|+
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence 44599999999999999999998877 788999977543 23334677889999999999999999999999999999
Q ss_pred EEccCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcc
Q 013081 92 VLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~----~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 167 (450)
||||++||+|.+.+.. ..++++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 9999999999987753 457999999999999999999999999999999999999999999999999999864332
Q ss_pred cCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCC-CCCCCCCHHHHH
Q 013081 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQN 246 (450)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~ 246 (450)
.........+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.+.+......++..+.. +.|..+++++.+
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 301 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRY-SKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKA 301 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHH
Confidence 22223456789999999999887766 5899999999999999999999999888888888776654 456678999999
Q ss_pred HHHHccccCcCCCCCHHHHHhcccccc
Q 013081 247 LLRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 247 Li~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
||.+||++||++|||+.+++.|+|++.
T Consensus 302 li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 302 LLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 999999999999999999999999864
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-48 Score=382.06 Aligned_cols=258 Identities=30% Similarity=0.518 Sum_probs=238.2
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE-EE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK-IY 90 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~-~~ 90 (450)
.+++|..++.+|+|+||.+++++++..++.+++|.++........ .....+|+.+++++.|||||.+.+.+..++. .+
T Consensus 2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~ 80 (426)
T KOG0589|consen 2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLC 80 (426)
T ss_pred ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEE
Confidence 478999999999999999999999999999999999877655433 4578899999999999999999999988888 99
Q ss_pred EEEccCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc
Q 013081 91 MVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 91 lv~E~~~gg~L~~~i~~~~--~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 168 (450)
|||+||+||+|.+.|.+.+ -++++.+..||.|++.|+.|||+++|+|||||+.||+++.++.+||+|||+|+....
T Consensus 81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~-- 158 (426)
T KOG0589|consen 81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP-- 158 (426)
T ss_pred EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCC--
Confidence 9999999999999997643 589999999999999999999999999999999999999999999999999997644
Q ss_pred CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHH
Q 013081 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNL 247 (450)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~L 247 (450)
..+...+..|||.|+.||++.+.+|. .|+|||||||++|||++-+++|...+...+..+|.++. .+.|..++.+++.|
T Consensus 159 ~~~~a~tvvGTp~YmcPEil~d~pYn-~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~l 237 (426)
T KOG0589|consen 159 EDSLASTVVGTPYYMCPEILSDIPYN-EKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSL 237 (426)
T ss_pred chhhhheecCCCcccCHHHhCCCCCC-ccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHH
Confidence 33477889999999999999999985 99999999999999999999999999999999999986 77889999999999
Q ss_pred HHHccccCcCCCCCHHHHHhcccccc
Q 013081 248 LRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 248 i~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
|+.||..+|..||++.++|.+|.+..
T Consensus 238 v~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 238 VKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred HHHHhhcCCccCCCHHHHhhChhhhh
Confidence 99999999999999999999988763
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=373.64 Aligned_cols=259 Identities=28% Similarity=0.507 Sum_probs=220.9
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
++|++.+.||+|+||.||++.+..+++.||+|++.+...........+.+|+.++..++||||+++++.+.+....|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999997644333334556888999999999999999999999999999999
Q ss_pred ccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCc
Q 013081 94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (450)
Q Consensus 94 E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 172 (450)
||++||+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~-~~~~ 159 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-GTVQ 159 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC-Ccce
Confidence 99999999999976 467999999999999999999999999999999999999999999999999998643211 1112
Q ss_pred cccccCCCCccchhhhcc----CCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC--CCCCC---CCCHH
Q 013081 173 LHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLPK---WLSPG 243 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~~----~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~---~~s~~ 243 (450)
....+||+.|+|||++.. ....+.++|||||||++|+|++|+.||...+....+.++.... ..+|. .+++.
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~ 239 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSED 239 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHH
Confidence 234689999999999863 3334689999999999999999999999988888888887653 33343 47999
Q ss_pred HHHHHHHccccCcCC--CCCHHHHHhcccccc
Q 013081 244 AQNLLRKILEPNPVK--RITIAGIKADEWFEQ 273 (450)
Q Consensus 244 ~~~Li~~~L~~dP~~--R~t~~~il~h~~~~~ 273 (450)
+.+|+++||..+|.+ |++++++++||||..
T Consensus 240 ~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 240 AKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred HHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 999999999765544 789999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=380.76 Aligned_cols=258 Identities=28% Similarity=0.417 Sum_probs=216.7
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----EE
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-----KI 89 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~ 89 (450)
+|++++.||+|+||.||+|.+..+|+.||+|.+.... .+.....++.+|+.+++.++||||+++++++.... ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 4789999999999999999999999999999986432 22233567889999999999999999999998776 78
Q ss_pred EEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC
Q 013081 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 169 (450)
|+||||+. ++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~-~ 157 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD-E 157 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC-c
Confidence 99999996 689998888888999999999999999999999999999999999999999999999999999754321 1
Q ss_pred CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHh------------------
Q 013081 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR------------------ 231 (450)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~------------------ 231 (450)
........+|+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+..
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 237 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR 237 (372)
T ss_pred cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence 12233457899999999988766557899999999999999999999988765544433321
Q ss_pred -----CCC---------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCC
Q 013081 232 -----GDF---------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 232 -----~~~---------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
... ..+...++++.+||.+||+.||.+|||+.++++||||....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 111 12234678999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=373.63 Aligned_cols=259 Identities=27% Similarity=0.494 Sum_probs=221.1
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
++|++.+.||+|+||.||++++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999997644333344566888999999999999999999999999999999
Q ss_pred ccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCc
Q 013081 94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (450)
Q Consensus 94 E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 172 (450)
||++||+|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~~~~ 159 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD-GTVQ 159 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC-Ccee
Confidence 99999999999986 467999999999999999999999999999999999999999999999999998753221 1112
Q ss_pred cccccCCCCccchhhhccC----CCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC--CCCCC---CCCHH
Q 013081 173 LHTTCGSPNYVAPEVLANR----GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLPK---WLSPG 243 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~----~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~---~~s~~ 243 (450)
....+||+.|+|||++.+. +..+.++||||+||++|+|++|+.||...+....+.++.... .++|. .+++.
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~ 239 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE 239 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHH
Confidence 2345799999999998652 233688999999999999999999999888887777776643 34443 36899
Q ss_pred HHHHHHHccccCcCC--CCCHHHHHhcccccc
Q 013081 244 AQNLLRKILEPNPVK--RITIAGIKADEWFEQ 273 (450)
Q Consensus 244 ~~~Li~~~L~~dP~~--R~t~~~il~h~~~~~ 273 (450)
+.+||.+||..++.+ |++++++++|+||..
T Consensus 240 ~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 240 AKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred HHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 999999999876655 579999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=363.94 Aligned_cols=252 Identities=31% Similarity=0.435 Sum_probs=208.3
Q ss_pred CCeEEeeeecccCceEEEEEEECC-CCceEEEEEeecccccchhHHHHHHHHHHHHHhC---CCCCcceEEEEEE-----
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLD-SGLPFAVKILEKNRIIHLKITDQIKREIATLKLL---KHPNVVRLHEVLA----- 84 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~----- 84 (450)
.+|++.+.||+|+||.||+|.+.. +++.||+|.++...... .....+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 479999999999999999999865 57889999987543322 2234566788877766 5999999999985
Q ss_pred eCCEEEEEEccCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCC
Q 013081 85 SKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA 162 (450)
Q Consensus 85 ~~~~~~lv~E~~~gg~L~~~i~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~ 162 (450)
....+++||||+. ++|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 3456899999996 5899988653 458999999999999999999999999999999999999999999999999997
Q ss_pred CCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCC-C------
Q 013081 163 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-K------ 235 (450)
Q Consensus 163 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~------ 235 (450)
.... ........||+.|+|||++.+..+ +.++||||+||++|+|++|++||.+.+......++..... +
T Consensus 159 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 159 IYSF---QMALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred eccC---CcccccccccccccChHHHhCCCC-CCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 5432 223445679999999999877666 5889999999999999999999998877666666543210 0
Q ss_pred --------------------CCCCCCHHHHHHHHHccccCcCCCCCHHHHHhcccc
Q 013081 236 --------------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 236 --------------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~ 271 (450)
..+.+++.+.+|+.+||+.||++|||+.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 112367888999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-46 Score=375.02 Aligned_cols=258 Identities=29% Similarity=0.447 Sum_probs=211.1
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS--- 87 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--- 87 (450)
..+++|++.+.||+|+||.||+|.+..+|+.||+|.+.+... .......+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence 456899999999999999999999999999999999865432 2333567889999999999999999999986443
Q ss_pred ---EEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCC
Q 013081 88 ---KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP 164 (450)
Q Consensus 88 ---~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~ 164 (450)
..|+||||+.+ +|.+.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 97 EFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred ccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 57999999965 6666654 35889999999999999999999999999999999999999999999999999743
Q ss_pred CcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHH--------------
Q 013081 165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF-------------- 230 (450)
Q Consensus 165 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~-------------- 230 (450)
. .........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+....+..+.
T Consensus 174 ~---~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 174 C---TNFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred c---cCccCCCCcccCCCCCchhccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 2 2223345678999999999987776 488999999999999999999998765433222211
Q ss_pred --------hCCCC---------CCC-----------CCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCCC
Q 013081 231 --------RGDFK---------LPK-----------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 276 (450)
Q Consensus 231 --------~~~~~---------~p~-----------~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~~ 276 (450)
..... +|. ..++.+.+||.+||++||++|||+.|+++||||...+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~ 323 (359)
T cd07876 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYD 323 (359)
T ss_pred HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcC
Confidence 11111 111 13578899999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-46 Score=356.46 Aligned_cols=257 Identities=32% Similarity=0.546 Sum_probs=221.9
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccc--hhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH--LKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
+.|++.+.||+|++|.||.|.+..+++.||+|.+....... ......+.+|+.++++++||||+++++++.+....|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46999999999999999999999999999999987543221 2234678899999999999999999999999999999
Q ss_pred EEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCC
Q 013081 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 171 (450)
++||++|++|.+.+...+.+++..++.++.|++.||.|||+.|++||||+|+||+++++++++|+|||++..........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999987543211111
Q ss_pred -ccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC--CCCCCCCCCHHHHHHH
Q 013081 172 -LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQNLL 248 (450)
Q Consensus 172 -~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li 248 (450)
......|++.|+|||++.+..+ +.++||||+|+++|+|++|+.||...+......++... ....|..+++.+.++|
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 240 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEGY-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFL 240 (263)
T ss_pred ccccCCCcCccccCcceeccCCC-CchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHH
Confidence 1134568899999999887665 58999999999999999999999887665555444433 4456777899999999
Q ss_pred HHccccCcCCCCCHHHHHhcccc
Q 013081 249 RKILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 249 ~~~L~~dP~~R~t~~~il~h~~~ 271 (450)
++||..+|.+|||+.++++|+||
T Consensus 241 ~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 241 RRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHhhcCcccCCCHHHHhhCCCC
Confidence 99999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=360.19 Aligned_cols=253 Identities=37% Similarity=0.649 Sum_probs=215.5
Q ss_pred eEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEcc
Q 013081 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY 95 (450)
Q Consensus 16 y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 95 (450)
|++++.||+|+||.||+|.+..+++.||+|++......... .....+|+.++++++||||+++++++......+++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence 89999999999999999999999999999999876543322 23445699999999999999999999999999999999
Q ss_pred CCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCcccc
Q 013081 96 VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHT 175 (450)
Q Consensus 96 ~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~ 175 (450)
+.+++|.+++...+.+++..+..++.||+.||++||++|++||||||+||+++.++.++|+|||.+.... ........
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~~~~~~ 157 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENNENFNP 157 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEEST--STTSEBSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccc
Confidence 9999999999988899999999999999999999999999999999999999999999999999987431 12334556
Q ss_pred ccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCc---HHHHHHHHHhCCCCCC----CCCCHHHHHHH
Q 013081 176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN---LAVLYQKIFRGDFKLP----KWLSPGAQNLL 248 (450)
Q Consensus 176 ~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~~p----~~~s~~~~~Li 248 (450)
.++++.|+|||++......+.++||||||+++|+|++|..||...+ ......+........+ ...++.+.++|
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 237 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLI 237 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHH
Confidence 7889999999998734455699999999999999999999999873 3333333333222111 11248999999
Q ss_pred HHccccCcCCCCCHHHHHhcccc
Q 013081 249 RKILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 249 ~~~L~~dP~~R~t~~~il~h~~~ 271 (450)
.+||+.||++|||+.++++||||
T Consensus 238 ~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 238 KKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHccCChhHCcCHHHHhcCCCC
Confidence 99999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-46 Score=369.56 Aligned_cols=257 Identities=29% Similarity=0.439 Sum_probs=217.4
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
.-++|++.+.||+|+||.||+|.+..++..+|+|++.... .......+.+|+++++.++||||+++++++.+.+..|+
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 3478999999999999999999999999999999987542 23345678999999999999999999999999999999
Q ss_pred EEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhc-CeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCC
Q 013081 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~-givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 170 (450)
||||++|++|.+++...+.+++..+..++.|++.||.|||+. +|+||||||+|||++.+|.+||+|||++.....
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~---- 156 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---- 156 (333)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh----
Confidence 999999999999999888899999999999999999999975 799999999999999999999999999874321
Q ss_pred CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHH----------------------
Q 013081 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQK---------------------- 228 (450)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~---------------------- 228 (450)
......+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||...........
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (333)
T cd06650 157 SMANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPG 235 (333)
T ss_pred hccccCCCCccccCHHHhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCcc
Confidence 22344579999999999877655 5889999999999999999999986544322111
Q ss_pred ----------------------HHhC-CCCCC-CCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCC
Q 013081 229 ----------------------IFRG-DFKLP-KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 229 ----------------------i~~~-~~~~p-~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
+... ....+ ..+++++.+||.+||++||++|||+.+++.||||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 1111 11111 13678899999999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-47 Score=361.41 Aligned_cols=252 Identities=31% Similarity=0.477 Sum_probs=213.9
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----EE
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-----KI 89 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~ 89 (450)
.|.-.+.+|.|+||.||.|....+++.||||.+-.+.. --.+|..+|++++|||||++.-+|.... ..
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 58999999999999999999999999999998754432 2237999999999999999998885432 23
Q ss_pred EEEEccCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccC-CCeEEeecCCCCCC
Q 013081 90 YMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGLSALP 164 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~----~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~-g~lkl~DFGla~~~ 164 (450)
.+||||++ .+|.+.++. +.+++.-.++-|..||++||+|||+.||+||||||+|||+|.+ |.+||||||.|+..
T Consensus 98 nlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 98 NLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 57999996 599988874 5789999999999999999999999999999999999999977 89999999999975
Q ss_pred CcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC------------
Q 013081 165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------ 232 (450)
Q Consensus 165 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------ 232 (450)
.. +....+...|..|+|||.+.+...++.+.||||+|||+.||+-|++.|.+.+.......|.+-
T Consensus 177 ~~---~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 177 VK---GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred cc---CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 43 334467788999999999998887789999999999999999999999998877666555421
Q ss_pred -----CCCC------------CCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCCCC
Q 013081 233 -----DFKL------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277 (450)
Q Consensus 233 -----~~~~------------p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~~~ 277 (450)
...+ ....++++.+|+.++|..+|.+|.++.|++.||||..-..+
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 1111 12368999999999999999999999999999999875544
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=360.39 Aligned_cols=255 Identities=30% Similarity=0.451 Sum_probs=216.6
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEc
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 94 (450)
.|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+.++++++|+||+.+++.+.+.+..|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 47889999999999999999999999999999876554444445667889999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCc
Q 013081 95 YVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (450)
Q Consensus 95 ~~~gg~L~~~i~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 172 (450)
|++|++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..... ...
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~---~~~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE---GQT 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCC---Ccc
Confidence 99999999988643 3589999999999999999999999999999999999999999999999999874322 112
Q ss_pred cccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHH---HHHHHHH-hCCCCCCCCCCHHHHHHH
Q 013081 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA---VLYQKIF-RGDFKLPKWLSPGAQNLL 248 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---~~~~~i~-~~~~~~p~~~s~~~~~Li 248 (450)
.....|++.|+|||++.+..+ +.++||||+||++|+|++|..||...... ....... ......+..+++++.+|+
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLC 236 (285)
T ss_pred ccCCCCCccccChHHHcCCCC-CCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHH
Confidence 234579999999999987766 58899999999999999999999864321 1122221 223345667899999999
Q ss_pred HHccccCcCCCCC-----HHHHHhcccccc
Q 013081 249 RKILEPNPVKRIT-----IAGIKADEWFEQ 273 (450)
Q Consensus 249 ~~~L~~dP~~R~t-----~~~il~h~~~~~ 273 (450)
++||+.||.+||| +.++++||||..
T Consensus 237 ~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 237 KMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred HHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 9999999999999 999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-47 Score=355.98 Aligned_cols=256 Identities=32% Similarity=0.622 Sum_probs=223.8
Q ss_pred eEE-eeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEE
Q 013081 16 YEL-GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 16 y~i-~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv~ 93 (450)
|.+ .+.||+|+||.|-.+.+..+|..+|||++++.. .....++.||++++..++ |+||++++++|+++.++|+||
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVf 155 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVF 155 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEE
Confidence 444 568999999999999999999999999998873 233688999999999995 999999999999999999999
Q ss_pred ccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCC---eEEeecCCCCCCCcccC-
Q 013081 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRD- 169 (450)
Q Consensus 94 E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~---lkl~DFGla~~~~~~~~- 169 (450)
|-+.||+|...|.++..|++.+|.++.+.|++||+|||.+||.|||+||+|||...-+. +|||||.+..-.....+
T Consensus 156 EKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 156 EKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred ecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 99999999999999999999999999999999999999999999999999999976554 79999999864332221
Q ss_pred ----CCccccccCCCCccchhhhc----cCCCCCccchhhhHHHHHHHHHhCCCCCCCC---------------cHHHHH
Q 013081 170 ----DGLLHTTCGSPNYVAPEVLA----NRGYDGATSDIWSCGVILYVILTGYLPFDDR---------------NLAVLY 226 (450)
Q Consensus 170 ----~~~~~~~~gt~~y~APE~l~----~~~~~~~~~DiwSlGvil~elltG~~Pf~~~---------------~~~~~~ 226 (450)
...+.++||+..|||||++. ...++..++|.||||||||.||+|++||.+. -...++
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LF 315 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLF 315 (463)
T ss_pred CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHH
Confidence 22455789999999999863 3445568999999999999999999999652 134677
Q ss_pred HHHHhCCCCCCC--C--CCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 227 QKIFRGDFKLPK--W--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 227 ~~i~~~~~~~p~--~--~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
..|..+.+++|+ | +|.++++||+.+|..||.+|.++.++++|||++..
T Consensus 316 esIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~ 367 (463)
T KOG0607|consen 316 ESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRC 367 (463)
T ss_pred HHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccccc
Confidence 888899999995 4 89999999999999999999999999999999764
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=361.67 Aligned_cols=258 Identities=26% Similarity=0.434 Sum_probs=216.0
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
.+++|++.+.||+|+||.||+|.+..+++.||+|.+....... ....+.+|+.+++.++||||+++++++......|+
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 81 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 81 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC--chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence 5788999999999999999999999999999999987543222 23567789999999999999999999999999999
Q ss_pred EEccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCC
Q 013081 92 VLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 170 (450)
||||+. ++|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 82 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~--~~ 158 (301)
T cd07873 82 VFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSI--PT 158 (301)
T ss_pred EEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCC--CC
Confidence 999997 589888865 35689999999999999999999999999999999999999999999999999875322 11
Q ss_pred CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC------------------
Q 013081 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------------ 232 (450)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------------ 232 (450)
.......+++.|+|||++.+....+.++||||+||++|+|++|++||...+.......+...
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence 22334567899999999876655578999999999999999999999887765444333211
Q ss_pred -CCCCC-----------CCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 233 -DFKLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 233 -~~~~p-----------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
....| ..+++.+.+||.+||++||.+|||+.++++||||+.-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~ 292 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 01111 2368889999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=372.03 Aligned_cols=257 Identities=28% Similarity=0.405 Sum_probs=212.1
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK----- 86 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 86 (450)
.+++|++.+.||+|+||.||.|.+..+++.||||.+.+... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 46899999999999999999999999999999999875432 223356788999999999999999999987543
Q ss_pred -CEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCC
Q 013081 87 -SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (450)
Q Consensus 87 -~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 165 (450)
...|+||||+.+ +|.+.+.. .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 457999999965 77777653 58899999999999999999999999999999999999999999999999997532
Q ss_pred cccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC------------
Q 013081 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD------------ 233 (450)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------ 233 (450)
. ........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+....+.++....
T Consensus 178 ~---~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (364)
T cd07875 178 T---SFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253 (364)
T ss_pred C---CCcccCCcccCCcCCHHHHhCCCC-CchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence 2 223345679999999999987766 589999999999999999999998877655544443210
Q ss_pred ----------CC--------------------CCCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCCC
Q 013081 234 ----------FK--------------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 276 (450)
Q Consensus 234 ----------~~--------------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~~ 276 (450)
.. .+...+..+++||.+||+.||.+|||+.++++||||...+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~ 326 (364)
T cd07875 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD 326 (364)
T ss_pred HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccC
Confidence 00 00113467899999999999999999999999999975443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=359.43 Aligned_cols=251 Identities=31% Similarity=0.434 Sum_probs=206.5
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC---CCCCcceEEEEEEe-----C
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL---KHPNVVRLHEVLAS-----K 86 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~-----~ 86 (450)
+|++.+.||+|+||.||+|.+..+|+.||+|.+....... .....+.+|+.+++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 6999999999999999999999999999999987543222 2234556777777766 69999999998754 3
Q ss_pred CEEEEEEccCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCC
Q 013081 87 SKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP 164 (450)
Q Consensus 87 ~~~~lv~E~~~gg~L~~~i~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~ 164 (450)
...+++|||+.+ +|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 568999999974 898888653 35899999999999999999999999999999999999999999999999999854
Q ss_pred CcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC-----------
Q 013081 165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD----------- 233 (450)
Q Consensus 165 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~----------- 233 (450)
.. ........||+.|+|||++.+..+ +.++||||+||++|+|++|.+||.+........++....
T Consensus 159 ~~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 159 SC---QMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cC---cccCCCccccccccCchHhhCCCC-CCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 32 122344578999999999887665 589999999999999999999998876655554443210
Q ss_pred C----------------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhcccc
Q 013081 234 F----------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 234 ~----------------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~ 271 (450)
. ...+.++..+.+||.+||++||.+|||+.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 0112367788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-46 Score=386.18 Aligned_cols=253 Identities=25% Similarity=0.365 Sum_probs=205.1
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCC------CCcceEEEEEEeC
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH------PNVVRLHEVLASK 86 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~h------pnIv~l~~~~~~~ 86 (450)
.++|++++.||+|+||.||+|.+..+++.||||+++... ........|+.+++.++| ++++++++++...
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 478999999999999999999999999999999996432 123456678888777765 4588899988754
Q ss_pred -CEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhh-cCeeeccCCCCcEEEccCC-------------
Q 013081 87 -SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKG------------- 151 (450)
Q Consensus 87 -~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~-~givHrDlKp~NILl~~~g------------- 151 (450)
..+|+|||++ |++|.+++.+.+.+++..++.++.||+.||+|||+ .||+||||||+|||++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence 5789999988 78999999888899999999999999999999998 5999999999999998766
Q ss_pred ---CeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHH
Q 013081 152 ---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQK 228 (450)
Q Consensus 152 ---~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~ 228 (450)
.+||+|||++.... ......+||+.|+|||++.+..| +.++|||||||++|+|++|++||.+.+.......
T Consensus 283 ~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~-~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 283 DPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGW-MYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred CCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 49999999886321 22345689999999999988777 5889999999999999999999988665443332
Q ss_pred HHhCCCCCC----------------------------C--------------CCCHHHHHHHHHccccCcCCCCCHHHHH
Q 013081 229 IFRGDFKLP----------------------------K--------------WLSPGAQNLLRKILEPNPVKRITIAGIK 266 (450)
Q Consensus 229 i~~~~~~~p----------------------------~--------------~~s~~~~~Li~~~L~~dP~~R~t~~~il 266 (450)
+......+| . ..++.+.+||.+||++||.+|||+.|+|
T Consensus 357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L 436 (467)
T PTZ00284 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT 436 (467)
T ss_pred HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence 221100000 0 0145677999999999999999999999
Q ss_pred hccccccCCC
Q 013081 267 ADEWFEQDYT 276 (450)
Q Consensus 267 ~h~~~~~~~~ 276 (450)
+||||.+.+.
T Consensus 437 ~Hp~~~~~~~ 446 (467)
T PTZ00284 437 THPYVLKYYP 446 (467)
T ss_pred cCccccccCC
Confidence 9999987543
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=371.37 Aligned_cols=258 Identities=28% Similarity=0.427 Sum_probs=211.3
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK---- 86 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 86 (450)
..+++|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 356899999999999999999999999999999999865432 233356788999999999999999999988543
Q ss_pred --CEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCC
Q 013081 87 --SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP 164 (450)
Q Consensus 87 --~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~ 164 (450)
...|++|||+++ +|.+.+.. .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 93 EFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred ccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 357999999965 67776653 5889999999999999999999999999999999999999999999999999753
Q ss_pred CcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC------------
Q 013081 165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------ 232 (450)
Q Consensus 165 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------ 232 (450)
. .........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 170 ~---~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 170 G---TSFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred C---CccccCCccccCCccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 2 2223345689999999999987776 48899999999999999999999887654333222110
Q ss_pred ----------C-----CC---------------CCCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCCC
Q 013081 233 ----------D-----FK---------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 276 (450)
Q Consensus 233 ----------~-----~~---------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~~ 276 (450)
. .. .+...+..+.+||.+||+.||++|||+.|+++||||...+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~ 319 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYD 319 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccC
Confidence 0 00 01113567899999999999999999999999999975543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-46 Score=369.92 Aligned_cols=252 Identities=26% Similarity=0.402 Sum_probs=205.8
Q ss_pred cCCeEEeeeecccCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK 86 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 86 (450)
-++|++++.||+|+||.||+|.+. .+++.||+|++.... .......+.+|+.+++.+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 468999999999999999999752 356789999986432 223356788999999999 899999999988654
Q ss_pred -CEEEEEEccCCCCChHHHHHhc---------------------------------------------------------
Q 013081 87 -SKIYMVLEYVTGGELFDKIASK--------------------------------------------------------- 108 (450)
Q Consensus 87 -~~~~lv~E~~~gg~L~~~i~~~--------------------------------------------------------- 108 (450)
..+|++|||++||+|.+++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4689999999999999998642
Q ss_pred -----CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccccccCCCCcc
Q 013081 109 -----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 183 (450)
Q Consensus 109 -----~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~ 183 (450)
.++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...............+++.|+
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 247788899999999999999999999999999999999999999999999997542211111222345668899
Q ss_pred chhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHH-HHHHHHhC-CCCCCCCCCHHHHHHHHHccccCcCCCC
Q 013081 184 APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAV-LYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRI 260 (450)
Q Consensus 184 APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~-~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~ 260 (450)
|||++.+..+ +.++|||||||++|+|++ |..||.+..... ....+..+ ....|..+++.+.+|+.+||+.||.+||
T Consensus 244 aPE~~~~~~~-~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP 322 (338)
T cd05102 244 APESIFDKVY-TTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERP 322 (338)
T ss_pred CcHHhhcCCC-CcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCc
Confidence 9999887766 589999999999999997 999998765433 33333333 3455677899999999999999999999
Q ss_pred CHHHHHh
Q 013081 261 TIAGIKA 267 (450)
Q Consensus 261 t~~~il~ 267 (450)
|+.++++
T Consensus 323 s~~el~~ 329 (338)
T cd05102 323 TFSALVE 329 (338)
T ss_pred CHHHHHH
Confidence 9999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-46 Score=371.22 Aligned_cols=255 Identities=29% Similarity=0.431 Sum_probs=211.4
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC------
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK------ 86 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------ 86 (450)
.++|++++.||+|+||.||+|.+..+++.||+|.+.+... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4789999999999999999999999999999999865432 222345677999999999999999999987533
Q ss_pred CEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCc
Q 013081 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (450)
Q Consensus 87 ~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 166 (450)
...|+++|++ |++|.+.+. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~ 170 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD 170 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence 4579999998 789987765 46799999999999999999999999999999999999999999999999999985322
Q ss_pred ccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC-------------
Q 013081 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD------------- 233 (450)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------- 233 (450)
.....+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 171 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07878 171 -----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245 (343)
T ss_pred -----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcch
Confidence 23456799999999998775555789999999999999999999998766544443332110
Q ss_pred ----------CCCC--------CCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCC
Q 013081 234 ----------FKLP--------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 234 ----------~~~p--------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
...| ...++.+.+||.+||++||.+|||+.++++||||.+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~ 305 (343)
T cd07878 246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305 (343)
T ss_pred hhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence 0011 13567789999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=357.81 Aligned_cols=248 Identities=27% Similarity=0.449 Sum_probs=208.8
Q ss_pred ecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEccCCCCCh
Q 013081 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL 101 (450)
Q Consensus 22 LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 101 (450)
||+|+||.||++.+..+|+.||+|.+.............+..|+.++++++||||+++++++.++...|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999999764433322345566799999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccccccCC
Q 013081 102 FDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179 (450)
Q Consensus 102 ~~~i~~~~--~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt 179 (450)
.+.+...+ .+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++..... ........|+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~---~~~~~~~~~~ 157 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD---GKTITQRAGT 157 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCC---CceeeccCCC
Confidence 98886533 588999999999999999999999999999999999999999999999999875432 1223345799
Q ss_pred CCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcH----HHHHHHHHhCCCCCC-CCCCHHHHHHHHHcccc
Q 013081 180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL----AVLYQKIFRGDFKLP-KWLSPGAQNLLRKILEP 254 (450)
Q Consensus 180 ~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~~p-~~~s~~~~~Li~~~L~~ 254 (450)
+.|+|||++.+..+ +.++||||+||++|+|++|+.||..... ..............+ ..+++++.+|+++||++
T Consensus 158 ~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 236 (277)
T cd05607 158 NGYMAPEILKEEPY-SYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAK 236 (277)
T ss_pred CCccCHHHHccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhcc
Confidence 99999999887775 5899999999999999999999976432 233344444443333 35899999999999999
Q ss_pred CcCCCCCH----HHHHhcccccc
Q 013081 255 NPVKRITI----AGIKADEWFEQ 273 (450)
Q Consensus 255 dP~~R~t~----~~il~h~~~~~ 273 (450)
||.+||++ .+++.|+||+.
T Consensus 237 ~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 237 KPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred CHhhCCCCccchhhhhcChhhcC
Confidence 99999999 67889999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=351.97 Aligned_cols=256 Identities=34% Similarity=0.520 Sum_probs=220.8
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccc------hhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH------LKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~------~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (450)
+|.++..||+|++|.||+|.+..+++.||+|.+....... ....+.+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 5889999999999999999999899999999886543322 2334678899999999999999999999999999
Q ss_pred EEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc
Q 013081 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 168 (450)
.+++|||+++++|.+++...+.+++..++.++.|++.||+|||++|++||||+|+||++++++.++|+|||++.......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999988553211
Q ss_pred C----CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHH
Q 013081 169 D----DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPG 243 (450)
Q Consensus 169 ~----~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 243 (450)
. ........|++.|+|||.+.+..+ +.++|+||+||++|+|++|+.||.+.+......++... ....|..++..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSY-TRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE 239 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccCCC-CchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHH
Confidence 1 111223468899999999887666 58899999999999999999999887665544444443 44566778999
Q ss_pred HHHHHHHccccCcCCCCCHHHHHhcccc
Q 013081 244 AQNLLRKILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 244 ~~~Li~~~L~~dP~~R~t~~~il~h~~~ 271 (450)
+.++|++||++||.+||++.++++||||
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 240 AIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=348.52 Aligned_cols=253 Identities=28% Similarity=0.540 Sum_probs=219.4
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCEEEEEE
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-KSKIYMVL 93 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~lv~ 93 (450)
+|++++.||+|++|.||+|.+..+++.||+|.+...... ....+.+.+|+.++++++|||++++++.+.. +...|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 599999999999999999999999999999998654332 2335678899999999999999999998764 45689999
Q ss_pred ccCCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCC
Q 013081 94 EYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (450)
Q Consensus 94 E~~~gg~L~~~i~~--~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 171 (450)
||+++++|.+.+.. ...+++.+++.++.|++.||++||++|++||||||+||+++.++.++|+|||++..... ...
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~--~~~ 157 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN--QCD 157 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecc--cCC
Confidence 99999999999875 34689999999999999999999999999999999999999999999999999875432 122
Q ss_pred ccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCC-CCCCCCCHHHHHHHHH
Q 013081 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRK 250 (450)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~ 250 (450)
......+++.|+|||++.+..+ +.++|+||+|+++|+|++|+.||...+.......+..+.. ..+..+++.+.+++.+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd08223 158 MASTLIGTPYYMSPELFSNKPY-NYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIAT 236 (257)
T ss_pred ccccccCCcCccChhHhcCCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence 3445678999999999887666 4889999999999999999999998777766666666544 4566789999999999
Q ss_pred ccccCcCCCCCHHHHHhcccc
Q 013081 251 ILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 251 ~L~~dP~~R~t~~~il~h~~~ 271 (450)
||++||.+|||+.++++||||
T Consensus 237 ~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 237 MLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HhccCcccCCCHHHHhcCCCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=356.51 Aligned_cols=256 Identities=29% Similarity=0.442 Sum_probs=219.7
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEc
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 94 (450)
.|+..+.||+|+||+||+|.+..+++.||+|.+.+...........+.+|+.+++.++|+||+.+++.+..++..|++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 47889999999999999999999999999999976554444445667889999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCc
Q 013081 95 YVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (450)
Q Consensus 95 ~~~gg~L~~~i~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 172 (450)
|+.+++|.+.+... .++++..+..++.|++.||.|||++||+||||||+||++++++.+||+|||++..... ...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~---~~~ 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE---GES 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCC---CCc
Confidence 99999999888643 3699999999999999999999999999999999999999999999999999864321 122
Q ss_pred cccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHH----HHHHHhCCCCCCCCCCHHHHHHH
Q 013081 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVL----YQKIFRGDFKLPKWLSPGAQNLL 248 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~----~~~i~~~~~~~p~~~s~~~~~Li 248 (450)
.....|++.|+|||++.+..+ +.++|+||+||++|+|++|..||.+...... ..++.......+..+++.+.+|+
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRY-TLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC 236 (285)
T ss_pred ccCCCCCcCccChHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence 234579999999999877666 5889999999999999999999987655432 23333444556667899999999
Q ss_pred HHccccCcCCCCC-----HHHHHhccccccC
Q 013081 249 RKILEPNPVKRIT-----IAGIKADEWFEQD 274 (450)
Q Consensus 249 ~~~L~~dP~~R~t-----~~~il~h~~~~~~ 274 (450)
.+||+.||++||| +.+++.|+||..-
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 237 KMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred HHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 9999999999999 8999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=357.19 Aligned_cols=254 Identities=30% Similarity=0.447 Sum_probs=215.8
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
++|++.+.||+|+||.||+|.+..++..+|+|.+.... ......++.+|++++++++||||+++++.+.+++..|++|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 46999999999999999999999999999999986532 2334567889999999999999999999999999999999
Q ss_pred ccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhh-cCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCc
Q 013081 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (450)
Q Consensus 94 E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~-~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 172 (450)
||++|++|.+++...+++++..+..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||++.... ...
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~----~~~ 154 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSM 154 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccc----ccc
Confidence 999999999999888889999999999999999999997 599999999999999999999999999987432 223
Q ss_pred cccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC--------------------
Q 013081 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-------------------- 232 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-------------------- 232 (450)
....+|++.|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+...
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHY-TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred cccCCCCcCccChhHhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 345689999999999876655 58899999999999999999999765543332222110
Q ss_pred -----------------CCCCCC-CCCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 233 -----------------DFKLPK-WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 233 -----------------~~~~p~-~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
....|. .+++++.+|+.+||..||++|||+.++++||||...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 011111 267889999999999999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-45 Score=358.23 Aligned_cols=260 Identities=31% Similarity=0.528 Sum_probs=226.5
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
.+|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+.+++.++||||+++++.+.+....|++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 37999999999999999999999999999999998765544345678899999999999999999999999999999999
Q ss_pred ccCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC--
Q 013081 94 EYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-- 169 (450)
Q Consensus 94 E~~~gg~L~~~i~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~-- 169 (450)
||+.|++|.+++... ..+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||++........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999998753 5699999999999999999999999999999999999999999999999999875322110
Q ss_pred -------------------------CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHH
Q 013081 170 -------------------------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV 224 (450)
Q Consensus 170 -------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~ 224 (450)
........||..|+|||++.+..+ +.++||||||+++|+|++|..||.+.+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC-CchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 001123468899999999887665 589999999999999999999999888877
Q ss_pred HHHHHHhCCCCCCCC--CCHHHHHHHHHccccCcCCCCC----HHHHHhccccccC
Q 013081 225 LYQKIFRGDFKLPKW--LSPGAQNLLRKILEPNPVKRIT----IAGIKADEWFEQD 274 (450)
Q Consensus 225 ~~~~i~~~~~~~p~~--~s~~~~~Li~~~L~~dP~~R~t----~~~il~h~~~~~~ 274 (450)
.+.++......+|.. +++.+.++|.+||..||++||| +.+++.||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~ 295 (316)
T cd05574 240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV 295 (316)
T ss_pred HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence 777777666655554 6999999999999999999999 9999999999763
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-46 Score=376.35 Aligned_cols=250 Identities=32% Similarity=0.445 Sum_probs=215.4
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-C-----CCcceEEEEEEeCC
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-H-----PNVVRLHEVLASKS 87 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h-----pnIv~l~~~~~~~~ 87 (450)
.+|++.+.||+|+||.|-+|.|..|++.||||+++.. ..+..+...|+.+|..|+ | -|+|+++++|...+
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~ 261 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN 261 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence 4899999999999999999999999999999999764 345678888999999997 4 48999999999999
Q ss_pred EEEEEEccCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCC--CeEEeecCCCCC
Q 013081 88 KIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG--NIKISDFGLSAL 163 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~~--~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g--~lkl~DFGla~~ 163 (450)
+.|||+|.+ +.+|.++++.+. +++...++.+++||+.||.+||+.||||+|||||||||.+-+ .+||+|||.|..
T Consensus 262 HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 262 HLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred ceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccc
Confidence 999999999 579999998754 699999999999999999999999999999999999997654 699999999985
Q ss_pred CCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHh------------
Q 013081 164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR------------ 231 (450)
Q Consensus 164 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~------------ 231 (450)
.. ....+.+-+..|+|||++.+.+|+ .+.||||||||++||++|.+.|.+.+..+.+..|..
T Consensus 341 ~~-----q~vytYiQSRfYRAPEVILGlpY~-~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~ 414 (586)
T KOG0667|consen 341 ES-----QRVYTYIQSRFYRAPEVILGLPYD-TAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT 414 (586)
T ss_pred cC-----CcceeeeeccccccchhhccCCCC-CccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 32 234488899999999999999996 889999999999999999999999887766655521
Q ss_pred ---------C-------------------------------CCCCCCC-----------CCHHHHHHHHHccccCcCCCC
Q 013081 232 ---------G-------------------------------DFKLPKW-----------LSPGAQNLLRKILEPNPVKRI 260 (450)
Q Consensus 232 ---------~-------------------------------~~~~p~~-----------~s~~~~~Li~~~L~~dP~~R~ 260 (450)
. ....|.. -...+.+||.+||++||.+|+
T Consensus 415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~ 494 (586)
T KOG0667|consen 415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI 494 (586)
T ss_pred ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence 0 0001200 124578999999999999999
Q ss_pred CHHHHHhccccccC
Q 013081 261 TIAGIKADEWFEQD 274 (450)
Q Consensus 261 t~~~il~h~~~~~~ 274 (450)
|+.|+|+|||+...
T Consensus 495 tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 495 TPAQALNHPFLTGT 508 (586)
T ss_pred CHHHHhcCcccccc
Confidence 99999999999843
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-45 Score=352.56 Aligned_cols=253 Identities=30% Similarity=0.451 Sum_probs=209.7
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEc
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 94 (450)
+|++.+.||+|++|.||+|.+..+++.||+|.+..... .......+.+|+.++++++||||+++++++.++...|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 58999999999999999999999999999999865432 22234678899999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCC
Q 013081 95 YVTGGELFDKIASK---GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (450)
Q Consensus 95 ~~~gg~L~~~i~~~---~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 171 (450)
|++ ++|.+++... ..+++..++.++.||+.||+|||++|++||||||+|||++.+|.+||+|||++..... ...
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--~~~ 156 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI--PVR 156 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCC--Ccc
Confidence 997 5888887642 5689999999999999999999999999999999999999999999999999874322 112
Q ss_pred ccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC-------------------
Q 013081 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------------- 232 (450)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------------- 232 (450)
......+++.|+|||++.+....+.++|||||||++|+|++|++||.+.+.......+...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence 2234467899999999876555568899999999999999999999876543322221110
Q ss_pred -C---------CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhcccc
Q 013081 233 -D---------FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 233 -~---------~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~ 271 (450)
. ......+++++.+||++||+.||.+|||+.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 0 00122368899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=344.57 Aligned_cols=253 Identities=28% Similarity=0.483 Sum_probs=222.5
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEc
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 94 (450)
.|++.+.||+|++|.||+|.+..+++.|++|.+...... ......+.+|+.+++.++||||+++++.+.+....|++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 488999999999999999999999999999998754433 3345778899999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCc
Q 013081 95 YVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (450)
Q Consensus 95 ~~~gg~L~~~i~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 172 (450)
|++|++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..... ....
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~--~~~~ 157 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD--NTNF 157 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccC--ccch
Confidence 99999999998764 5789999999999999999999999999999999999999999999999999875432 1222
Q ss_pred cccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHc
Q 013081 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKI 251 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~~ 251 (450)
....+|++.|+|||++.+..+ +.++|+|||||++|+|++|+.||...+......++..+.. +.+..+++.+.+++.+|
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKPY-NEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQC 236 (256)
T ss_pred hhccccCccccCHHHhcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence 344578999999999887765 5889999999999999999999998887777777776644 34556889999999999
Q ss_pred cccCcCCCCCHHHHHhcccc
Q 013081 252 LEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 252 L~~dP~~R~t~~~il~h~~~ 271 (450)
|+.+|++||++.+++.|||+
T Consensus 237 l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 237 LTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred ccCCcccCcCHHHHhhCCCC
Confidence 99999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-47 Score=399.98 Aligned_cols=263 Identities=29% Similarity=0.512 Sum_probs=234.2
Q ss_pred CCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013081 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (450)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (450)
-.+.-.+|++++.||+|+||.|.+++++.+++.||+|++++-.........-|..|-.+|..-+.+.|++++-.|.++.+
T Consensus 70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~ 149 (1317)
T KOG0612|consen 70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERY 149 (1317)
T ss_pred HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence 34555789999999999999999999999999999999987444434445778889999999999999999999999999
Q ss_pred EEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc
Q 013081 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 168 (450)
+|+||||++||+|..++.+..++|+..|+.|+..|+.||+-+|+.|+|||||||+|||+|..|++||+|||.+-.... .
T Consensus 150 LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~-d 228 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA-D 228 (1317)
T ss_pred eEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCC-C
Confidence 999999999999999999888999999999999999999999999999999999999999999999999998765432 1
Q ss_pred CCCccccccCCCCccchhhhcc----CCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC--CCCCC--CCC
Q 013081 169 DDGLLHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLP--KWL 240 (450)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~----~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p--~~~ 240 (450)
..-.....+|||.|.+||++.. .+.+|+.+|+||+||++|||+.|..||...+..+.|.+|... .+.+| ..+
T Consensus 229 G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~V 308 (1317)
T KOG0612|consen 229 GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDV 308 (1317)
T ss_pred CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCccccc
Confidence 1224556799999999999863 256689999999999999999999999999999999999887 67888 449
Q ss_pred CHHHHHHHHHccccCcCCCCC---HHHHHhcccccc
Q 013081 241 SPGAQNLLRKILEPNPVKRIT---IAGIKADEWFEQ 273 (450)
Q Consensus 241 s~~~~~Li~~~L~~dP~~R~t---~~~il~h~~~~~ 273 (450)
|+++++||++++ -+|+.|.. ++++..||||..
T Consensus 309 SeeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g 343 (1317)
T KOG0612|consen 309 SEEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEG 343 (1317)
T ss_pred CHHHHHHHHHHh-cChhhhcccccHHHHHhCccccC
Confidence 999999999988 46888888 999999999974
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=354.10 Aligned_cols=261 Identities=25% Similarity=0.441 Sum_probs=222.8
Q ss_pred ccCCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013081 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (450)
Q Consensus 7 ~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (450)
...+....+|++.+.||+|+||.||+|.+..+++.||+|.+...... ..+.+.+|+.+++.++||||+++++.+...
T Consensus 13 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~ 89 (296)
T cd06654 13 VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVG 89 (296)
T ss_pred cccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeC
Confidence 34566678999999999999999999999999999999998765432 246788999999999999999999999999
Q ss_pred CEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCc
Q 013081 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (450)
Q Consensus 87 ~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 166 (450)
...|+||||++|++|.+++.. ..+++.++..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 90 DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred CEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence 999999999999999998864 5689999999999999999999999999999999999999999999999999875332
Q ss_pred ccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC---CCCCCCCCCHH
Q 013081 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---DFKLPKWLSPG 243 (450)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~ 243 (450)
. ........|++.|+|||.+.+..+ +.++||||+||++|+|++|+.||...+.......+... ....|..+++.
T Consensus 169 ~--~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (296)
T cd06654 169 E--QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 245 (296)
T ss_pred c--ccccCcccCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHH
Confidence 1 112234578999999999877655 58999999999999999999999887654433333222 22345568899
Q ss_pred HHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 244 ~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
+.+|+.+||++||.+|||+.+++.||||...
T Consensus 246 l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 246 FRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred HHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 9999999999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=360.02 Aligned_cols=247 Identities=32% Similarity=0.469 Sum_probs=195.0
Q ss_pred eeeecccCceEEEEEEEC--CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEEEEEc
Q 013081 19 GRTLGEGNFGKVKFAQDL--DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--KSKIYMVLE 94 (450)
Q Consensus 19 ~~~LG~G~~g~Vy~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~lv~E 94 (450)
++.||+|+||.||+|.+. .+++.||+|.+..... ...+.+|+.++++++||||+++++++.. ....|++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 578999999999999975 4678999999865432 3457789999999999999999999854 467899999
Q ss_pred cCCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEE----ccCCCeEEeecCCC
Q 013081 95 YVTGGELFDKIASK---------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL----DSKGNIKISDFGLS 161 (450)
Q Consensus 95 ~~~gg~L~~~i~~~---------~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl----~~~g~lkl~DFGla 161 (450)
|+. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 995 5888877532 258999999999999999999999999999999999999 45678999999999
Q ss_pred CCCCccc-CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHH---------HHHHHHHh
Q 013081 162 ALPQHFR-DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA---------VLYQKIFR 231 (450)
Q Consensus 162 ~~~~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---------~~~~~i~~ 231 (450)
....... ........+||+.|+|||++.+....+.++||||+||++|+|++|++||...... ....++..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence 8643211 1122345688999999999887665578999999999999999999999653211 11111111
Q ss_pred C----------------------------CCCC----------CCCCCHHHHHHHHHccccCcCCCCCHHHHHhcccc
Q 013081 232 G----------------------------DFKL----------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 232 ~----------------------------~~~~----------p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~ 271 (450)
. .... ....+..+.+||++||++||.+|||++|+++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 0000 01135678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=350.08 Aligned_cols=253 Identities=32% Similarity=0.560 Sum_probs=224.2
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEc
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 94 (450)
+|++.+.||.|+||.||+|.+..+++.||+|++.+.........+.+.+|+.++++++||||+++++.+.+....|+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 59999999999999999999999999999999987655454556889999999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccc
Q 013081 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH 174 (450)
Q Consensus 95 ~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 174 (450)
|+.|++|.+.+....++++..+..++.||++||.|||++|++|+||+|+||++++++.++|+|||++..... .....
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~---~~~~~ 157 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP---DTLTT 157 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCC---Ccccc
Confidence 999999999998877899999999999999999999999999999999999999999999999999875432 22334
Q ss_pred cccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcH---HHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q 013081 175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL---AVLYQKIFRGDFKLPKWLSPGAQNLLRKI 251 (450)
Q Consensus 175 ~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~p~~~s~~~~~Li~~~ 251 (450)
...|+..|+|||++.+..+ +.++|+||+|+++|+|++|..||...+. ..............|..++..+.++|.+|
T Consensus 158 ~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (258)
T cd05578 158 STSGTPGYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKL 236 (258)
T ss_pred ccCCChhhcCHHHHcccCC-CCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHH
Confidence 5678899999999877665 5899999999999999999999987763 33333333356677778899999999999
Q ss_pred cccCcCCCCCH--HHHHhcccc
Q 013081 252 LEPNPVKRITI--AGIKADEWF 271 (450)
Q Consensus 252 L~~dP~~R~t~--~~il~h~~~ 271 (450)
|+.||.+||++ .++++||||
T Consensus 237 l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 237 LERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ccCChhHcCCccHHHHhcCCCC
Confidence 99999999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=353.29 Aligned_cols=257 Identities=30% Similarity=0.447 Sum_probs=221.7
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 92 (450)
.++|++.+.||.|+||.||+|.+..+++.||+|.+... .....+.+.+|+.++++++||||+++++.+......|+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 35799999999999999999999889999999998643 233456788999999999999999999999999999999
Q ss_pred EccCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCC
Q 013081 93 LEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 171 (450)
|||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++..... ...
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~--~~~ 158 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS--TLQ 158 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcc--ccc
Confidence 9999999999998764 5799999999999999999999999999999999999999999999999999875322 112
Q ss_pred ccccccCCCCccchhhhccC----CCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCC---CCCCCCCHHH
Q 013081 172 LLHTTCGSPNYVAPEVLANR----GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---KLPKWLSPGA 244 (450)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~----~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~ 244 (450)
......|++.|+|||++... ...+.++|+||+||++|+|++|++||...+......++..+.. ..|..++..+
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSF 238 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHH
Confidence 23345789999999997532 2235789999999999999999999998877766666666532 3456689999
Q ss_pred HHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 245 QNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
.++|.+||+.+|.+|||+.++++||||...
T Consensus 239 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 239 NDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 999999999999999999999999999754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=351.42 Aligned_cols=255 Identities=27% Similarity=0.423 Sum_probs=214.7
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (450)
...++|++.+.||+|+||.||+|.+..+++.||+|+++.... .....+.+|+.+++.++||||+++++.+......|
T Consensus 6 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~ 82 (267)
T cd06645 6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG---EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLW 82 (267)
T ss_pred CcHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Confidence 344689999999999999999999999999999999865432 22456788999999999999999999999999999
Q ss_pred EEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCC
Q 013081 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (450)
Q Consensus 91 lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 170 (450)
++|||+++++|.+++...+.+++.+++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++..... ..
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~--~~ 160 (267)
T cd06645 83 ICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA--TI 160 (267)
T ss_pred EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccC--cc
Confidence 9999999999999998888999999999999999999999999999999999999999999999999999874322 11
Q ss_pred CccccccCCCCccchhhhc--cCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCC-----CCCCHH
Q 013081 171 GLLHTTCGSPNYVAPEVLA--NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP-----KWLSPG 243 (450)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~--~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p-----~~~s~~ 243 (450)
.......|++.|+|||++. .....+.++|+||+||++|+|++|..||...................+ ..++..
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNS 240 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHH
Confidence 2223457899999999974 222335789999999999999999999976554433333333332222 136788
Q ss_pred HHHHHHHccccCcCCCCCHHHHHhccc
Q 013081 244 AQNLLRKILEPNPVKRITIAGIKADEW 270 (450)
Q Consensus 244 ~~~Li~~~L~~dP~~R~t~~~il~h~~ 270 (450)
+.++|.+||+.||++|||+.++++|||
T Consensus 241 ~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 241 FHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-45 Score=350.14 Aligned_cols=254 Identities=30% Similarity=0.429 Sum_probs=213.3
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
..++|++++.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.++++++||||+++++++......|+
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc---chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence 34689999999999999999999999999999999865432 224568899999999999999999999999999999
Q ss_pred EEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCC
Q 013081 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 171 (450)
||||+++++|.+.+...+++++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..... ...
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~--~~~ 161 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITA--TIA 161 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecc--ccc
Confidence 999999999999998888899999999999999999999999999999999999999999999999999875422 111
Q ss_pred ccccccCCCCccchhhhcc--CCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCC-----CCCCHHH
Q 013081 172 LLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP-----KWLSPGA 244 (450)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~--~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p-----~~~s~~~ 244 (450)
......|++.|+|||.+.. ....+.++|+||+||++|+|++|..||...........+....+..+ ..++..+
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTF 241 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHH
Confidence 2234578999999999742 22235789999999999999999999976554433333323322222 2368899
Q ss_pred HHHHHHccccCcCCCCCHHHHHhccc
Q 013081 245 QNLLRKILEPNPVKRITIAGIKADEW 270 (450)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~~il~h~~ 270 (450)
.+|+++||+.||++|||++++++|+|
T Consensus 242 ~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 242 HNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 99999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=354.70 Aligned_cols=259 Identities=32% Similarity=0.581 Sum_probs=224.0
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
+.|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+.+++.++||||+++++.+.+++..|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46999999999999999999999999999999987664433444567889999999999999999999999999999999
Q ss_pred ccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc-----
Q 013081 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR----- 168 (450)
Q Consensus 94 E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~----- 168 (450)
||++|++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999986311000
Q ss_pred --------CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCC--
Q 013081 169 --------DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK-- 238 (450)
Q Consensus 169 --------~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~-- 238 (450)
.........|++.|+|||.+....+ +.++|+|||||++|+|++|..||.+.+.......+..+....|.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD 239 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence 0001123467889999999877665 68999999999999999999999988887777777766544443
Q ss_pred -CCCHHHHHHHHHccccCcCCCCC---HHHHHhcccccc
Q 013081 239 -WLSPGAQNLLRKILEPNPVKRIT---IAGIKADEWFEQ 273 (450)
Q Consensus 239 -~~s~~~~~Li~~~L~~dP~~R~t---~~~il~h~~~~~ 273 (450)
.+++.+.++|.+||++||++||| +.++++||||..
T Consensus 240 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 240 EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence 47899999999999999999998 799999999965
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=353.97 Aligned_cols=263 Identities=32% Similarity=0.438 Sum_probs=220.4
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeeccccc--chhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII--HLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 92 (450)
+|++.+.||+|+||.||+|.+..+|+.||+|.+...... .......+.+|+.++++++||||+++++++.+....|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 589999999999999999999999999999999765433 123346678899999999999999999999999999999
Q ss_pred EccCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCC
Q 013081 93 LEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~~~-~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 171 (450)
|||+ +++|.+++.... .+++..++.++.||++||.|||++|++||||||+||+++.++.++|+|||++...... ..
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~--~~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP--NR 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC--Cc
Confidence 9999 899999998766 7999999999999999999999999999999999999999999999999999754321 12
Q ss_pred ccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC-C----------------
Q 013081 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-F---------------- 234 (450)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~---------------- 234 (450)
......+++.|+|||.+.+....+.++|+||+||++|+|++|.+||.+.+......++.... .
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 22334578899999998665555789999999999999999999998776655444443210 0
Q ss_pred ------C-----CCCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCCCCCCC
Q 013081 235 ------K-----LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280 (450)
Q Consensus 235 ------~-----~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~~~~~~ 280 (450)
. .....+..+.++|.+||++||++|||+.+++.|+||.....+..+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~~ 294 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTPP 294 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCCC
Confidence 0 012246789999999999999999999999999999987766543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=349.98 Aligned_cols=255 Identities=28% Similarity=0.441 Sum_probs=213.2
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
++|++.+.||+|+||.||+|.+..+|+.||+|.+..... .....+.+.+|+.+++.++||||+++++++......|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 579999999999999999999999999999999865432 1223456789999999999999999999999999999999
Q ss_pred ccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCcc
Q 013081 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (450)
Q Consensus 94 E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 173 (450)
||++++.|...+.....+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++....... ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--~~~ 157 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG--DDY 157 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCc--ccc
Confidence 999998888877776789999999999999999999999999999999999999999999999999998543311 122
Q ss_pred ccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC-------------------CC
Q 013081 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-------------------DF 234 (450)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-------------------~~ 234 (450)
....++..|+|||++.+....+.++||||+|+++|+|++|..||.+.+..+....+... ..
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 34467889999999876555568999999999999999999999876654333222110 00
Q ss_pred CCC------------CCCCHHHHHHHHHccccCcCCCCCHHHHHhcccc
Q 013081 235 KLP------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 235 ~~p------------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~ 271 (450)
..| +.++..+.+|+.+||++||++|||+.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 001 2357889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-45 Score=370.22 Aligned_cols=252 Identities=25% Similarity=0.386 Sum_probs=207.8
Q ss_pred cCCeEEeeeecccCceEEEEEEEC--CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDL--DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (450)
-.+|++++.||+|+||.||+|... .++..||+|.+... ....+|+.+++.++||||+++++++......|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 457999999999999999999764 35688999987543 23468999999999999999999999999999
Q ss_pred EEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCC
Q 013081 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (450)
Q Consensus 91 lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 170 (450)
++||++. ++|.+++...+++++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 163 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~ 241 (392)
T PHA03207 163 MVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241 (392)
T ss_pred EEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence 9999995 689999987788999999999999999999999999999999999999999999999999999754332222
Q ss_pred CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcH---HHHHHHHHh----------------
Q 013081 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL---AVLYQKIFR---------------- 231 (450)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~---~~~~~~i~~---------------- 231 (450)
.......||+.|+|||++....+ +.++||||+||++|+|++|..||.+... ...+..+.+
T Consensus 242 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 320 (392)
T PHA03207 242 PQCYGWSGTLETNSPELLALDPY-CAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN 320 (392)
T ss_pred ccccccccccCccCHhHhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence 22335679999999999987776 5889999999999999999999965431 111111111
Q ss_pred -------------CCCCCCC-----CCCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 232 -------------GDFKLPK-----WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 232 -------------~~~~~p~-----~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
..+..|. .++.++.+||++||..||.+|||+.+++.||||.+.
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 0111121 246788999999999999999999999999999764
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=355.14 Aligned_cols=253 Identities=29% Similarity=0.476 Sum_probs=209.4
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEc
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 94 (450)
+|++.+.||+|+||.||+|.+..+|+.||+|.+..... .......+.+|+.++++++||||+++++++.+....|+++|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 69999999999999999999999999999999875432 22234567889999999999999999999999999999999
Q ss_pred cCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCcc
Q 013081 95 YVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (450)
Q Consensus 95 ~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 173 (450)
|+. ++|.+.+.. .+.+++..++.++.||+.||.|||++|++||||||+||+++.++++||+|||++..... .....
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~--~~~~~ 156 (284)
T cd07839 80 YCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGI--PVRCY 156 (284)
T ss_pred cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCC--CCCCc
Confidence 996 578887764 56799999999999999999999999999999999999999999999999999875432 11222
Q ss_pred ccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCC-CCCcHHHHHHHHHhCC-------------------
Q 013081 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAVLYQKIFRGD------------------- 233 (450)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf-~~~~~~~~~~~i~~~~------------------- 233 (450)
....+++.|+|||++.+....+.++||||+||++|+|++|..|| .+.+....+..+.+..
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP 236 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence 34567899999999877665578999999999999999988885 4444444433332110
Q ss_pred C----------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhcccc
Q 013081 234 F----------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 234 ~----------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~ 271 (450)
. ...+.+++.+.+||.+||+.||.+|||+++++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0 0112367899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=345.95 Aligned_cols=256 Identities=29% Similarity=0.476 Sum_probs=220.4
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
++|++++.||.|+||.||+|.+..++..+|+|++....... ....+.+|+.+++.++||||+++++.+......|++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 47999999999999999999998899999999987554332 4578999999999999999999999999999999999
Q ss_pred ccCCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCC
Q 013081 94 EYVTGGELFDKIASK---GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (450)
Q Consensus 94 E~~~gg~L~~~i~~~---~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 170 (450)
||++|++|.+++... ..+++..++.++.||+.||+|||++|++||||+|+||++++++.++|+|||++.........
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 999999999999764 45899999999999999999999999999999999999999999999999998754432221
Q ss_pred --CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCC-CC-----CCCCH
Q 013081 171 --GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LP-----KWLSP 242 (450)
Q Consensus 171 --~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-~p-----~~~s~ 242 (450)
......+|++.|+|||++......+.++|+||+||++|+|++|+.||...+....+.+......+ .+ ..+++
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK 238 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccH
Confidence 12344578999999999877644568999999999999999999999887776666665554322 21 24678
Q ss_pred HHHHHHHHccccCcCCCCCHHHHHhcccc
Q 013081 243 GAQNLLRKILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t~~~il~h~~~ 271 (450)
.+.+++.+||+.||++|||+.+++.||||
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 239 SFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 99999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=353.69 Aligned_cols=260 Identities=27% Similarity=0.470 Sum_probs=222.7
Q ss_pred cCCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013081 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (450)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (450)
..+....+|++.+.||.|+||.||+|.+..+|+.||+|.+..... ...+.+.+|+.+++.++||||+++++++....
T Consensus 13 ~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 89 (296)
T cd06655 13 SIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGD 89 (296)
T ss_pred hcCCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCc
Confidence 344455679999999999999999999999999999999865432 22467889999999999999999999999999
Q ss_pred EEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcc
Q 013081 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 167 (450)
..|+|+||++|++|.+.+.. ..+++.++..++.|++.||+|||++|++||||||+||+++.++.+||+|||++......
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 90 ELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred eEEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 99999999999999998865 46899999999999999999999999999999999999999999999999998754321
Q ss_pred cCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC---CCCCCCCCCHHH
Q 013081 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---DFKLPKWLSPGA 244 (450)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~ 244 (450)
.......++++.|+|||.+.+..+ +.++|+|||||++|+|++|+.||.+.+.......+... ....|..+++.+
T Consensus 169 --~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (296)
T cd06655 169 --QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIF 245 (296)
T ss_pred --cccCCCcCCCccccCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHH
Confidence 112234578999999999877665 58899999999999999999999887765544444433 223455689999
Q ss_pred HHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 245 QNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
.+||++||..||.+|||+.+++.||||+..
T Consensus 246 ~~li~~~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 246 RDFLNRCLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred HHHHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence 999999999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=376.39 Aligned_cols=255 Identities=28% Similarity=0.449 Sum_probs=227.8
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
+-|+|+..||.|+||+||+|.++.++-..|-|+|... ..+..+.+.-||.||..++||+||++++.|..++.+||..
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 4688999999999999999999999999999998643 3445788899999999999999999999999999999999
Q ss_pred ccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCc
Q 013081 94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (450)
Q Consensus 94 E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 172 (450)
|||.||-....+.. ..++++.+++.+.+|++.||.|||+++|+|||||..|||++-+|.++|+|||.+..... ....
T Consensus 109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~qk 186 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQK 186 (1187)
T ss_pred eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh--HHhh
Confidence 99999999887755 55799999999999999999999999999999999999999999999999999875332 2234
Q ss_pred cccccCCCCccchhhhc-----cCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCC---CCCCCCHHH
Q 013081 173 LHTTCGSPNYVAPEVLA-----NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK---LPKWLSPGA 244 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~-----~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~ 244 (450)
..++.|||+|||||++. ..+|+ .++||||||++|.+|..+.+|....++.....++.+..++ -|+.++..+
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYD-ykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F 265 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSF 265 (1187)
T ss_pred hccccCCcccccchheeeccccCCCch-hhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHH
Confidence 56789999999999975 35664 8999999999999999999999999999999999887654 367789999
Q ss_pred HHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 245 QNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
.+++.+||.+||..||+++++++|||++..
T Consensus 266 ~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 266 SDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred HHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 999999999999999999999999999853
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=351.13 Aligned_cols=255 Identities=25% Similarity=0.376 Sum_probs=218.6
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCC-----ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSG-----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 85 (450)
..+++|++.+.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.++++++||||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~ 79 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK 79 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence 45678999999999999999999976555 689999986443 23345678999999999999999999999999
Q ss_pred CCEEEEEEccCCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEcc
Q 013081 86 KSKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 149 (450)
Q Consensus 86 ~~~~~lv~E~~~gg~L~~~i~~~----------------~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~ 149 (450)
....|++|||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||++++
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE 159 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence 89999999999999999999764 45788999999999999999999999999999999999999
Q ss_pred CCCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHH
Q 013081 150 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQK 228 (450)
Q Consensus 150 ~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~ 228 (450)
++.+||+|||++................+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+.......
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKF-TTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM 238 (283)
T ss_pred CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcC-chhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 99999999999875322111122334567889999999877666 589999999999999998 9999998888887777
Q ss_pred HHhCC-CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 229 IFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 229 i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
+..+. ...|..+++++.+|+.+||+.||.+|||+.+++++
T Consensus 239 i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 239 IRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 76653 45567799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=346.54 Aligned_cols=257 Identities=31% Similarity=0.501 Sum_probs=216.1
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeeccccc-------chhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-------HLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~-------~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (450)
+|.+.+.||+|+||.||+|.+..+|+.||+|.++..... .....+.+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 689999999999999999999989999999988643211 1123457889999999999999999999999999
Q ss_pred EEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcc
Q 013081 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 167 (450)
..++||||++|++|.+++...+++++..++.++.|++.||.|||++|++||||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999988888999999999999999999999999999999999999999999999999998754332
Q ss_pred cCCCccccccCCCCccchhhhccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC--CCCCCC----CC
Q 013081 168 RDDGLLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPK----WL 240 (450)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~----~~ 240 (450)
..........|+..|+|||.+.... ..+.++|+||||+++|+|++|..||..........++... ...++. .+
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence 2222233457889999999987654 3468899999999999999999999766554433333222 223333 35
Q ss_pred CHHHHHHHHHccccCcCCCCCHHHHHhcccc
Q 013081 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 241 s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~ 271 (450)
+..+.++|.+||+++|.+|||+.++++||||
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 242 SPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 8899999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=346.20 Aligned_cols=255 Identities=29% Similarity=0.469 Sum_probs=216.9
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeeccccc---chhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
+|++++.||+|+||.||+|.+ .+++.+|+|.+...... .......+.+|+.+++.++||||+++++++.+....|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 589999999999999999986 47889999998654321 22334678999999999999999999999999999999
Q ss_pred EEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcc----
Q 013081 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF---- 167 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~---- 167 (450)
++||++|++|.+++.+.+++++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 9999999999999988888999999999999999999999999999999999999999999999999998743211
Q ss_pred cCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC---CCCCCCCCCHHH
Q 013081 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---DFKLPKWLSPGA 244 (450)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~ 244 (450)
..........|++.|+|||++.+..+ +.++|+|||||++|+|++|..||...+.......+... ....|..++..+
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESGY-GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238 (265)
T ss_pred cccccccccCCCccccChhhhcCCCC-cchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence 11122334568999999999877665 58899999999999999999999876654444333332 234566689999
Q ss_pred HHHHHHccccCcCCCCCHHHHHhcccc
Q 013081 245 QNLLRKILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~~il~h~~~ 271 (450)
.++|++||+++|.+|||+.+++.||||
T Consensus 239 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 239 IDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=345.79 Aligned_cols=248 Identities=35% Similarity=0.688 Sum_probs=221.0
Q ss_pred ecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEccCCCCCh
Q 013081 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL 101 (450)
Q Consensus 22 LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 101 (450)
||.|++|.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++.+.++...|+++||++|++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 79999999999999989999999999876655445567899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccccccCCCC
Q 013081 102 FDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181 (450)
Q Consensus 102 ~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~ 181 (450)
.+.+.+...+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++...... ......+|++.
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~ 157 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG---QKTWTFCGTPE 157 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc---cccccccCCcC
Confidence 999988888999999999999999999999999999999999999999999999999998854321 12334578999
Q ss_pred ccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCc--HHHHHHHHH--hCCCCCCCCCCHHHHHHHHHccccCcC
Q 013081 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN--LAVLYQKIF--RGDFKLPKWLSPGAQNLLRKILEPNPV 257 (450)
Q Consensus 182 y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~--~~~~~~~i~--~~~~~~p~~~s~~~~~Li~~~L~~dP~ 257 (450)
|+|||.+....+ +.++|+||+|+++|+|++|..||.... ....+.++. ......|...++++.++|.+||+.||+
T Consensus 158 ~~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 236 (262)
T cd05572 158 YVAPEIILNKGY-DFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE 236 (262)
T ss_pred ccChhHhcCCCC-CChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChh
Confidence 999999877666 588999999999999999999998776 666677776 345667777899999999999999999
Q ss_pred CCCC-----HHHHHhcccccc
Q 013081 258 KRIT-----IAGIKADEWFEQ 273 (450)
Q Consensus 258 ~R~t-----~~~il~h~~~~~ 273 (450)
+||| +.|+++||||+.
T Consensus 237 ~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 237 ERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred hCcCCcccCHHHHhcChhhhC
Confidence 9999 999999999974
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=349.03 Aligned_cols=255 Identities=27% Similarity=0.444 Sum_probs=218.0
Q ss_pred eEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEcc
Q 013081 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY 95 (450)
Q Consensus 16 y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 95 (450)
|++.+.||+|+||.||+|.+..++..+|+|.+.... ....+.+.+|+.+++.++||||+++++.+......|+|+||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 788999999999999999999999999999986432 23356788999999999999999999999999999999999
Q ss_pred CCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccc
Q 013081 96 VTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH 174 (450)
Q Consensus 96 ~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 174 (450)
+++++|.+.+.+ ..++++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||++..... ......
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~--~~~~~~ 161 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TIQRRD 161 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccc--cccccc
Confidence 999999888764 56799999999999999999999999999999999999999999999999999875322 112234
Q ss_pred cccCCCCccchhhhcc----CCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC---CCCCCCCCHHHHHH
Q 013081 175 TTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGAQNL 247 (450)
Q Consensus 175 ~~~gt~~y~APE~l~~----~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~L 247 (450)
...+++.|+|||++.. ....+.++||||+||++|+|++|.+||...+......++.... ...|..++..+.+|
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDF 241 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHH
Confidence 4578999999999742 2223478999999999999999999998877666655555442 23455688999999
Q ss_pred HHHccccCcCCCCCHHHHHhccccccCC
Q 013081 248 LRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 248 i~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
|.+||++||.+|||+.++++||||....
T Consensus 242 i~~~l~~~p~~Rp~~~~il~~~~~~~~~ 269 (282)
T cd06643 242 LKKCLEKNVDARWTTTQLLQHPFVTVNS 269 (282)
T ss_pred HHHHccCChhhCcCHHHHhcCCCEeccC
Confidence 9999999999999999999999998653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=349.97 Aligned_cols=249 Identities=30% Similarity=0.466 Sum_probs=207.0
Q ss_pred eecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHh---CCCCCcceEEEEEEeCCEEEEEEccCC
Q 013081 21 TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL---LKHPNVVRLHEVLASKSKIYMVLEYVT 97 (450)
Q Consensus 21 ~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~---l~hpnIv~l~~~~~~~~~~~lv~E~~~ 97 (450)
.||+|+||.||+|.+..+++.+|+|.+.+.............+|..+++. .+||||+.+++.+...+..|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999999999999999999999976544322222334455544443 479999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCcccccc
Q 013081 98 GGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC 177 (450)
Q Consensus 98 gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~ 177 (450)
|++|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||+++++.++|+|||++..... .......
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~----~~~~~~~ 156 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK----KKPHASV 156 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccc----cCccCcC
Confidence 999999998888899999999999999999999999999999999999999999999999999874322 1223457
Q ss_pred CCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCc---HHHHHHHHHhCCCCCCCCCCHHHHHHHHHcccc
Q 013081 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN---LAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEP 254 (450)
Q Consensus 178 gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~ 254 (450)
||+.|+|||.+......+.++||||+||++|+|++|..||.... ..............+|..+++++.++|++||..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 236 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQR 236 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcC
Confidence 99999999998654444688999999999999999999997532 222223333445567778999999999999999
Q ss_pred CcCCCC-----CHHHHHhcccccc
Q 013081 255 NPVKRI-----TIAGIKADEWFEQ 273 (450)
Q Consensus 255 dP~~R~-----t~~~il~h~~~~~ 273 (450)
||++|+ |+.++++||||+.
T Consensus 237 ~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 237 DVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred CHHHhcCCCCCCHHHHHhCccccC
Confidence 999999 6999999999976
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=365.43 Aligned_cols=244 Identities=29% Similarity=0.458 Sum_probs=213.1
Q ss_pred eEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEcc
Q 013081 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY 95 (450)
Q Consensus 16 y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 95 (450)
+.+++.||+|-||+||+|.... ...||+|.+...... .+.+.+|+++|++|+|+|||++++++..+..+||||||
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~ 282 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY 282 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence 4567889999999999999743 347999999754332 35677999999999999999999999998899999999
Q ss_pred CCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCcc
Q 013081 96 VTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (450)
Q Consensus 96 ~~gg~L~~~i~~--~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 173 (450)
++.|+|.++++. ...+...+...++.|||+|++||+++++|||||-..||||++++.+||+|||||+..... .....
T Consensus 283 m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~-~Y~~~ 361 (468)
T KOG0197|consen 283 MPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD-EYTAS 361 (468)
T ss_pred cccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCC-ceeec
Confidence 999999999987 456899999999999999999999999999999999999999999999999999943221 11111
Q ss_pred ccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHc
Q 013081 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKI 251 (450)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~ 251 (450)
....-..-|+|||.+....+ +.+||||||||+||||+| |+.||.+.+..+....+.+| +++.|..+|+.+.+++..|
T Consensus 362 ~~~kfPIkWtAPEa~~~~~F-S~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~C 440 (468)
T KOG0197|consen 362 EGGKFPIKWTAPEALNYGKF-SSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKSC 440 (468)
T ss_pred CCCCCCceecCHHHHhhCCc-ccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHH
Confidence 22233457999999988887 589999999999999999 99999999999999999988 7899999999999999999
Q ss_pred cccCcCCCCCHHHHH
Q 013081 252 LEPNPVKRITIAGIK 266 (450)
Q Consensus 252 L~~dP~~R~t~~~il 266 (450)
|..+|++|||++.+.
T Consensus 441 W~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 441 WHEDPEDRPTFETLR 455 (468)
T ss_pred hhCCcccCCCHHHHH
Confidence 999999999998664
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=342.60 Aligned_cols=253 Identities=30% Similarity=0.592 Sum_probs=221.7
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEc
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 94 (450)
+|++.+.||+|+||.||.+.+..+|+.||+|.+...... ......+.+|+.+++.++||||+++++++...+..|+|+|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 699999999999999999999999999999998754332 2235678999999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCc
Q 013081 95 YVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (450)
Q Consensus 95 ~~~gg~L~~~i~~~~--~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 172 (450)
|+.+++|.+.+.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~--~~~ 157 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST--VEL 157 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc--hhh
Confidence 999999999987543 5899999999999999999999999999999999999999999999999998754321 112
Q ss_pred cccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHc
Q 013081 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKI 251 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~~ 251 (450)
.....|++.|+|||++.+..+ +.++|+|||||++|+|++|..||...+......++..+.. +.|..++.++.++|.+|
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 236 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRPY-NNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQL 236 (256)
T ss_pred hhhccCCccccCHHHhCCCCC-CCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHH
Confidence 234468899999999877655 5889999999999999999999998888777777776654 45667899999999999
Q ss_pred cccCcCCCCCHHHHHhcccc
Q 013081 252 LEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 252 L~~dP~~R~t~~~il~h~~~ 271 (450)
|+.+|++||++.++++||||
T Consensus 237 l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 237 FKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred hhCChhhCcCHHHHhhCcCC
Confidence 99999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=388.58 Aligned_cols=267 Identities=28% Similarity=0.458 Sum_probs=220.1
Q ss_pred ccCCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-
Q 013081 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS- 85 (450)
Q Consensus 7 ~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~- 85 (450)
......+++|++++.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.+++.++||||+++++++..
T Consensus 6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~-e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de 84 (1021)
T PTZ00266 6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKNIVRYIDRFLNK 84 (1021)
T ss_pred cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence 34567789999999999999999999999999999999999765432 3345778999999999999999999998854
Q ss_pred -CCEEEEEEccCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHhhhhhc-------CeeeccCCCCcEEEccC---
Q 013081 86 -KSKIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNK-------GVFHRDLKLENILLDSK--- 150 (450)
Q Consensus 86 -~~~~~lv~E~~~gg~L~~~i~~----~~~l~~~~~~~i~~ql~~aL~~LH~~-------givHrDlKp~NILl~~~--- 150 (450)
...+|+||||+++++|.++|.. .+.+++..++.|+.||+.||.|||+. +|+||||||+||||+.+
T Consensus 85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 4679999999999999998865 35799999999999999999999985 49999999999999642
Q ss_pred --------------CCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccC-CCCCccchhhhHHHHHHHHHhCCC
Q 013081 151 --------------GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILTGYL 215 (450)
Q Consensus 151 --------------g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~~DiwSlGvil~elltG~~ 215 (450)
+.+||+|||++..... .......+||+.|+|||++... ...+.++||||||||||+|++|..
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~---~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~ 241 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGI---ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241 (1021)
T ss_pred cccccccccccCCCCceEEccCCccccccc---cccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCC
Confidence 3489999999985422 2233456899999999998643 334689999999999999999999
Q ss_pred CCCCCcHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCCCC
Q 013081 216 PFDDRNLAVLYQKIFRGDFKLP-KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277 (450)
Q Consensus 216 Pf~~~~~~~~~~~i~~~~~~~p-~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~~~ 277 (450)
||...+..............+| ...++++.+||.+||+.+|.+|||+.|+|.|+|+.....+
T Consensus 242 PF~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~p 304 (1021)
T PTZ00266 242 PFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGPP 304 (1021)
T ss_pred CCCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCCC
Confidence 9986654433333333333333 3478999999999999999999999999999999865443
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=348.37 Aligned_cols=255 Identities=25% Similarity=0.456 Sum_probs=221.9
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
++|++.+.||.|++|.||+|.+..+++.||+|.+..... ......+.+|+.+++.++||||+++++.+.++...|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA--EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc--chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 479999999999999999999999999999999875432 223467889999999999999999999999999999999
Q ss_pred ccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCcc
Q 013081 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (450)
Q Consensus 94 E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 173 (450)
||+++++|.+++... ++++..++.++.|++.||.|||+.|++||||+|+||++++++.++|+|||+++...... ...
T Consensus 79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~ 155 (274)
T cd06609 79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SKR 155 (274)
T ss_pred EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--ccc
Confidence 999999999998764 89999999999999999999999999999999999999999999999999998654321 123
Q ss_pred ccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC-CCCCCC-CCHHHHHHHHHc
Q 013081 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FKLPKW-LSPGAQNLLRKI 251 (450)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~-~s~~~~~Li~~~ 251 (450)
....+++.|+|||.+.+..+ +.++||||+||++|+|++|..||...+.......+.... ...+.. +++.+.+++.+|
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~-~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 234 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGY-DEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLC 234 (274)
T ss_pred ccccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHH
Confidence 34578899999999887665 589999999999999999999998877666555555443 334444 789999999999
Q ss_pred cccCcCCCCCHHHHHhccccccC
Q 013081 252 LEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 252 L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
|..||++|||++++++||||...
T Consensus 235 l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 235 LNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred hhCChhhCcCHHHHhhChhhcCC
Confidence 99999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=348.35 Aligned_cols=255 Identities=32% Similarity=0.483 Sum_probs=215.8
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEc
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 94 (450)
+|++++.||+|+||.||+|.+..+|+.||+|.+...... ......+.+|+.++++++||||+++++++......|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 699999999999999999999999999999998765432 2335778999999999999999999999999999999999
Q ss_pred cCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCcc
Q 013081 95 YVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (450)
Q Consensus 95 ~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 173 (450)
|+ |++|.+++.. ..++++.+++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++....... ....
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~~ 157 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE-PRLY 157 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC-CCcc
Confidence 99 9999999865 4579999999999999999999999999999999999999999999999999988643321 1223
Q ss_pred ccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC-------------------C
Q 013081 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-------------------F 234 (450)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-------------------~ 234 (450)
....|+..|+|||++.+....+.++||||+||++|+|++|.+||.+.+.......+.... .
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 456789999999998766655789999999999999999999998776554444333210 0
Q ss_pred CC-----------CCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccc
Q 013081 235 KL-----------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 272 (450)
Q Consensus 235 ~~-----------p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~ 272 (450)
.. .+..+..+.+||.+||++||.+|||+++++.||||.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 00 123578899999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=358.87 Aligned_cols=256 Identities=21% Similarity=0.363 Sum_probs=207.7
Q ss_pred EEeeeeccc--CceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEc
Q 013081 17 ELGRTLGEG--NFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (450)
Q Consensus 17 ~i~~~LG~G--~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 94 (450)
+++++||+| +|++||++.+..+|+.||+|.++..... ......+.+|+.+++.++||||+++++++..++..|+|||
T Consensus 1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 79 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS 79 (327)
T ss_pred ChhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEe
Confidence 357889999 7899999999999999999999765432 3345678899999999999999999999999999999999
Q ss_pred cCCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC---
Q 013081 95 YVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--- 169 (450)
Q Consensus 95 ~~~gg~L~~~i~~--~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~--- 169 (450)
|+++|+|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++.++++|||.+........
T Consensus 80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 9999999999865 34589999999999999999999999999999999999999999999999986543211100
Q ss_pred --CCccccccCCCCccchhhhccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCC-----------
Q 013081 170 --DGLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK----------- 235 (450)
Q Consensus 170 --~~~~~~~~gt~~y~APE~l~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~----------- 235 (450)
........++..|+|||++.+. ...+.++||||+||++|+|++|+.||..............+..+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE 239 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence 0111234577889999998753 22368999999999999999999999875544333222221110
Q ss_pred -----------------------------------CCCCCCHHHHHHHHHccccCcCCCCCHHHHHhcccccc
Q 013081 236 -----------------------------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 236 -----------------------------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
....+++.+.+||++||+.||++|||++++++||||++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 11125678999999999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=350.87 Aligned_cols=241 Identities=19% Similarity=0.258 Sum_probs=211.0
Q ss_pred eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe----CCEEEEEEcc
Q 013081 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS----KSKIYMVLEY 95 (450)
Q Consensus 20 ~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~~~lv~E~ 95 (450)
..||+|+++.||+|.. +|+.||||.+.+.........+.+.+|+.+|++++||||+++++++.+ ....++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 6799999999999997 789999999987655454556788999999999999999999999866 4578999999
Q ss_pred CCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhc-CeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccc
Q 013081 96 VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH 174 (450)
Q Consensus 96 ~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~-givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 174 (450)
++||+|.+++...+.+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||++..... ...
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~-----~~~ 178 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSS-----PPF 178 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcc-----ccc
Confidence 99999999999888899999999999999999999985 999999999999999999999999999875322 123
Q ss_pred cccCCCCccchhhhcc--CCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC--CCCCCCCCCHHHHHHHHH
Q 013081 175 TTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQNLLRK 250 (450)
Q Consensus 175 ~~~gt~~y~APE~l~~--~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~ 250 (450)
...|++.|+|||++.+ ..+ +.++|||||||++|+|++|..||.+.+....+..+... ..+.|..+++.+.+|+.+
T Consensus 179 ~~~~~~~y~aPE~~~~~~~~~-~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 257 (283)
T PHA02988 179 KNVNFMVYFSYKMLNDIFSEY-TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEA 257 (283)
T ss_pred cccCcccccCHHHhhhccccc-cchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHH
Confidence 4578999999999875 344 68999999999999999999999998888877777544 455566789999999999
Q ss_pred ccccCcCCCCCHHHHHhc
Q 013081 251 ILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 251 ~L~~dP~~R~t~~~il~h 268 (450)
||+.||++|||+.++++.
T Consensus 258 cl~~dp~~Rps~~ell~~ 275 (283)
T PHA02988 258 CTSHDSIKRPNIKEILYN 275 (283)
T ss_pred HhcCCcccCcCHHHHHHH
Confidence 999999999999999863
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=347.09 Aligned_cols=253 Identities=27% Similarity=0.404 Sum_probs=211.8
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEe------
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS------ 85 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~------ 85 (450)
-|+|++.+.||+|+||.||+|.+..+++.||+|.+..... ....+.+|+.+++++ +||||+++++.+..
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 4789999999999999999999999999999999865431 235788999999998 69999999999864
Q ss_pred CCEEEEEEccCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCC
Q 013081 86 KSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL 163 (450)
Q Consensus 86 ~~~~~lv~E~~~gg~L~~~i~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~ 163 (450)
...+|++|||+.+++|.+++... ..+++..+..++.|++.||+|||++||+||||||+||++++++.+||+|||++..
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 34689999999999999998763 4689999999999999999999999999999999999999999999999999875
Q ss_pred CCcccCCCccccccCCCCccchhhhccC----CCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCC--CCC
Q 013081 164 PQHFRDDGLLHTTCGSPNYVAPEVLANR----GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF--KLP 237 (450)
Q Consensus 164 ~~~~~~~~~~~~~~gt~~y~APE~l~~~----~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--~~p 237 (450)
... .........|++.|+|||++... ...+.++||||+||++|+|++|..||................. ..+
T Consensus 161 ~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd06637 161 LDR--TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKS 238 (272)
T ss_pred ccc--ccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCC
Confidence 432 11233456799999999998632 2235789999999999999999999987665544444333221 123
Q ss_pred CCCCHHHHHHHHHccccCcCCCCCHHHHHhcccc
Q 013081 238 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 238 ~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~ 271 (450)
..++..+.+|+.+||..||.+|||+.+++.||||
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 239 KKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 4478899999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=352.96 Aligned_cols=262 Identities=26% Similarity=0.437 Sum_probs=222.0
Q ss_pred ccCCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013081 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (450)
Q Consensus 7 ~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (450)
...+...++|++++.||+|+||.||+|.+..+++.||+|.+...... ..+.+.+|+.+++.++||||+++++.+...
T Consensus 12 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 88 (297)
T cd06656 12 VSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVG 88 (297)
T ss_pred cccCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 34455668999999999999999999999999999999998754332 246788999999999999999999999999
Q ss_pred CEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCc
Q 013081 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (450)
Q Consensus 87 ~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 166 (450)
...|+||||++|++|.+++.+ ..+++.++..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++.....
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 89 DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (297)
T ss_pred CEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence 999999999999999998865 5689999999999999999999999999999999999999999999999999875332
Q ss_pred ccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC---CCCCCCCCCHH
Q 013081 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---DFKLPKWLSPG 243 (450)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~ 243 (450)
. ........+++.|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+... ....|..+++.
T Consensus 168 ~--~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (297)
T cd06656 168 E--QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAV 244 (297)
T ss_pred C--ccCcCcccCCccccCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHH
Confidence 1 122334578999999999887665 58999999999999999999999876654332222222 22345568899
Q ss_pred HHHHHHHccccCcCCCCCHHHHHhccccccCC
Q 013081 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 244 ~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
+.+|+.+||+.||++|||+.+++.||||+...
T Consensus 245 ~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 245 FRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence 99999999999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=350.00 Aligned_cols=256 Identities=27% Similarity=0.414 Sum_probs=218.5
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 92 (450)
-+.|++++.||+|+||.||+|.+..+++.||+|.+... .......+.+|+.+++.++||||+++++.+..+...|+|
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 46799999999999999999999999999999998654 334467788999999999999999999999999999999
Q ss_pred EccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCC
Q 013081 93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 171 (450)
|||++|++|...+.+ ...+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++..... ...
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~--~~~ 165 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK--TLQ 165 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccc--ccc
Confidence 999999999887754 45789999999999999999999999999999999999999999999999999874322 111
Q ss_pred ccccccCCCCccchhhhccC----CCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCC---CCCCCCCHHH
Q 013081 172 LLHTTCGSPNYVAPEVLANR----GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---KLPKWLSPGA 244 (450)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~----~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~ 244 (450)
......+++.|+|||++... ...+.++|+|||||++|+|++|..||...+......++..... ..+..++.++
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEF 245 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHH
Confidence 22345688999999997532 2225789999999999999999999988776666655554432 3345678999
Q ss_pred HHHHHHccccCcCCCCCHHHHHhcccccc
Q 013081 245 QNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
.++|.+||..||++||++.++++||||..
T Consensus 246 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 274 (292)
T cd06644 246 RDFLKTALDKHPETRPSAAQLLEHPFVSS 274 (292)
T ss_pred HHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 99999999999999999999999999964
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=351.44 Aligned_cols=255 Identities=29% Similarity=0.431 Sum_probs=214.7
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
++|++.+.||+|+||.||+|.+..+++.||+|.+.+..... ...+.+.+|+.+++.++||||+++++++......|+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 47999999999999999999999899999999986543322 34567889999999999999999999999999999999
Q ss_pred ccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCcc
Q 013081 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (450)
Q Consensus 94 E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 173 (450)
||++++.|.+.......+++..++.++.|++.||+|||+.|++||||+|+||++++++.++|+|||++...... ....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~--~~~~ 157 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP--GEVY 157 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC--cccc
Confidence 99999999887776667999999999999999999999999999999999999999999999999998754321 1223
Q ss_pred ccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC-------------------CC
Q 013081 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-------------------DF 234 (450)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-------------------~~ 234 (450)
....++..|+|||++.+....+.++||||+||++|+|++|++||...........+... ..
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 34568899999999876555568899999999999999999999876544333222210 00
Q ss_pred C------------CCCCCCHHHHHHHHHccccCcCCCCCHHHHHhcccc
Q 013081 235 K------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 235 ~------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~ 271 (450)
. .++.++..+.+|+.+||+.+|.+|||+.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0 123467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=343.73 Aligned_cols=256 Identities=30% Similarity=0.508 Sum_probs=215.2
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeeccccc--chhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEE
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII--HLKITDQIKREIATLKLLKHPNVVRLHEVLAS--KSKIY 90 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~ 90 (450)
.|++.+.||+|+||.||+|.+..++..||+|.+...... .......+.+|+.+++.++||||+++++++.. ....|
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 589999999999999999999999999999998654322 22345678999999999999999999998865 46789
Q ss_pred EEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc-C
Q 013081 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR-D 169 (450)
Q Consensus 91 lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~-~ 169 (450)
+++||+++++|.+.+...+.+++...+.++.|++.||+|||++||+||||||+||+++.++.+||+|||++....... .
T Consensus 83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS 162 (266)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccccc
Confidence 999999999999999888889999999999999999999999999999999999999999999999999987543211 1
Q ss_pred CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC--CCCCCCCCCHHHHHH
Q 013081 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQNL 247 (450)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~L 247 (450)
........++..|+|||.+.+..+ +.++||||+||++|+|++|+.||..........+.... ...+|..+++.+.++
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (266)
T cd06651 163 GTGIRSVTGTPYWMSPEVISGEGY-GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDF 241 (266)
T ss_pred CCccccCCccccccCHHHhCCCCC-CchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHH
Confidence 112233568899999999877665 58899999999999999999999876554444333322 345567788999999
Q ss_pred HHHccccCcCCCCCHHHHHhccccc
Q 013081 248 LRKILEPNPVKRITIAGIKADEWFE 272 (450)
Q Consensus 248 i~~~L~~dP~~R~t~~~il~h~~~~ 272 (450)
+ +||..+|++|||+.++++||||+
T Consensus 242 i-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 242 L-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred H-HHhcCChhhCcCHHHHhcCcccc
Confidence 9 57778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=348.15 Aligned_cols=257 Identities=34% Similarity=0.638 Sum_probs=229.2
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv 92 (450)
++|++.+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.++++++ ||||+++++++.+....|++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999998755544444578889999999998 99999999999999999999
Q ss_pred EccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC---
Q 013081 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--- 169 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~--- 169 (450)
|||+++++|.+.+.+.+.+++..++.++.|++.||.|||++|++|+||+|+||+++.+++++|+|||++........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 99999999999999888999999999999999999999999999999999999999999999999999885433211
Q ss_pred ---------------CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCC
Q 013081 170 ---------------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF 234 (450)
Q Consensus 170 ---------------~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~ 234 (450)
........++..|+|||++....+ +.++|+||+|++++++++|..||...+....++.+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 239 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY 239 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCCCC-ChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCC
Confidence 012233467899999999876654 5889999999999999999999998887777777777788
Q ss_pred CCCCCCCHHHHHHHHHccccCcCCCCCH----HHHHhcccc
Q 013081 235 KLPKWLSPGAQNLLRKILEPNPVKRITI----AGIKADEWF 271 (450)
Q Consensus 235 ~~p~~~s~~~~~Li~~~L~~dP~~R~t~----~~il~h~~~ 271 (450)
.+|..+++.+.+||.+||+.||.+|||+ .++++||||
T Consensus 240 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 240 SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 8888899999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=347.82 Aligned_cols=250 Identities=29% Similarity=0.454 Sum_probs=210.5
Q ss_pred eecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHH---HHHHHhCCCCCcceEEEEEEeCCEEEEEEccCC
Q 013081 21 TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE---IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT 97 (450)
Q Consensus 21 ~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E---i~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 97 (450)
.||+|+||.||+|.+..+++.||+|.+.+..............| +..++...||||+++++.+.+....|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999999999999999999976544322222223334 344555679999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCcccccc
Q 013081 98 GGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC 177 (450)
Q Consensus 98 gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~ 177 (450)
|++|.+++.+.+.+++..++.++.|++.||.|||+++++||||||+||+++.++.+||+|||++..... ......+
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~----~~~~~~~ 156 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK----KKPHASV 156 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCc----cCCcCcC
Confidence 999999998888899999999999999999999999999999999999999999999999999874322 1234567
Q ss_pred CCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCC---cHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcccc
Q 013081 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR---NLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEP 254 (450)
Q Consensus 178 gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~---~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~ 254 (450)
|++.|+|||++.+....+.++||||+||++|+|++|+.||.+. ................|..+++.+.+++.+||..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~ 236 (278)
T cd05606 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 236 (278)
T ss_pred CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhc
Confidence 9999999999875544468899999999999999999999876 3334444444556677777899999999999999
Q ss_pred CcCCCC-----CHHHHHhccccccC
Q 013081 255 NPVKRI-----TIAGIKADEWFEQD 274 (450)
Q Consensus 255 dP~~R~-----t~~~il~h~~~~~~ 274 (450)
+|.+|| ++.++++||||...
T Consensus 237 ~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 237 DVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred CHHhccCCCCCCHHHHHhCccccCC
Confidence 999999 99999999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=339.44 Aligned_cols=252 Identities=31% Similarity=0.509 Sum_probs=220.6
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEc
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 94 (450)
+|++.+.||+|+||.||+|.+..+++.+|+|.+....... .....+.+|+.++++++||||+++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 6999999999999999999999999999999997654433 335789999999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCC-CeEEeecCCCCCCCcccCCC
Q 013081 95 YVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLSALPQHFRDDG 171 (450)
Q Consensus 95 ~~~gg~L~~~i~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g-~lkl~DFGla~~~~~~~~~~ 171 (450)
|++|++|.+++... ..+++..+..++.|++.||+|||++|++||||+|+||++++++ .+||+|||++..... ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~---~~ 156 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS---KS 156 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC---Cc
Confidence 99999999999763 3589999999999999999999999999999999999998665 579999999985432 12
Q ss_pred ccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHH
Q 013081 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRK 250 (450)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~ 250 (450)
......|++.|+|||.+.+..+ +.++||||+|+++|+|++|+.||...+.......+.... .+.+..+++.+.+++.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 235 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPY-NQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILS 235 (256)
T ss_pred cccccccCCcccCchhccCCCC-CcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHH
Confidence 2334578999999999876655 588999999999999999999999888777776666553 45667789999999999
Q ss_pred ccccCcCCCCCHHHHHhcccc
Q 013081 251 ILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 251 ~L~~dP~~R~t~~~il~h~~~ 271 (450)
||++||++|||+.++++||||
T Consensus 236 ~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 236 MLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HccCChhhCCCHHHHhhCCCC
Confidence 999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=345.45 Aligned_cols=257 Identities=27% Similarity=0.479 Sum_probs=217.0
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeeccccc---chhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
+|+.++.||+|+||.||.|.+..+++.||+|++...... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 588999999999999999999999999999998754321 12345789999999999999999999999999999999
Q ss_pred EEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCC-CeEEeecCCCCCCCcccC-
Q 013081 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLSALPQHFRD- 169 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g-~lkl~DFGla~~~~~~~~- 169 (450)
|+||++|++|.+.+.+.+++++..+..++.||+.||.|||++|++||||+|+||+++.++ .+||+|||++........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 999999999999998888899999999999999999999999999999999999998876 599999999875432211
Q ss_pred -CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHH---H--hCCCCCCCCCCHH
Q 013081 170 -DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI---F--RGDFKLPKWLSPG 243 (450)
Q Consensus 170 -~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i---~--~~~~~~p~~~s~~ 243 (450)
........|+..|+|||++.+..+ +.++|+||+|+++|+|++|..||...........+ . ......|..++++
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGEQY-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG 239 (268)
T ss_pred CCccccccccccceeCHhHhccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHH
Confidence 111234568899999999876665 58899999999999999999999754432222222 1 1234566678999
Q ss_pred HHHHHHHccccCcCCCCCHHHHHhccccc
Q 013081 244 AQNLLRKILEPNPVKRITIAGIKADEWFE 272 (450)
Q Consensus 244 ~~~Li~~~L~~dP~~R~t~~~il~h~~~~ 272 (450)
+.+++.+||+.||++|||+.++++||||.
T Consensus 240 ~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 240 LRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 99999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=339.13 Aligned_cols=253 Identities=30% Similarity=0.503 Sum_probs=222.8
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEc
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 94 (450)
+|++++.||.|+||.||.+++..+++.+++|.+....... .....+.+|+.++++++||||+++++++.+....+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 6999999999999999999999999999999987654332 335678899999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCc
Q 013081 95 YVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (450)
Q Consensus 95 ~~~gg~L~~~i~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 172 (450)
|++|++|.+.+... ..+++..+..++.|++.||.|||+.|++||||+|+||++++++.+||+|||++....... ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~--~~ 157 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY--SM 157 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc--cc
Confidence 99999999999764 468999999999999999999999999999999999999999999999999987543311 13
Q ss_pred cccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCC-CCCCCCHHHHHHHHHc
Q 013081 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRKI 251 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~Li~~~ 251 (450)
.....|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.......+..+.+. .+..++..+.+++.+|
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKY-NFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSL 236 (256)
T ss_pred ccccCCCccccCHhhcCCCCC-CCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence 345678999999999877665 57899999999999999999999988887777777766443 3455899999999999
Q ss_pred cccCcCCCCCHHHHHhcccc
Q 013081 252 LEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 252 L~~dP~~R~t~~~il~h~~~ 271 (450)
|.++|.+|||+.++++|+|+
T Consensus 237 l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 237 LQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred cccCcccCCCHHHHhhCcCC
Confidence 99999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=351.24 Aligned_cols=262 Identities=31% Similarity=0.454 Sum_probs=217.0
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SKI 89 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~ 89 (450)
.+++|++.+.||+|+||.||+|.+..+|+.||+|.+....... .....+.+|+.++++++||||+++++++... +..
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 5689999999999999999999999999999999987543222 2234567899999999999999999998654 568
Q ss_pred EEEEccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc
Q 013081 90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 168 (450)
|+||||+.+ +|.+.+.. ...+++.+++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 999999964 88888765 4679999999999999999999999999999999999999999999999999988543211
Q ss_pred CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC----------------
Q 013081 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---------------- 232 (450)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---------------- 232 (450)
.......+++.|+|||++.+....+.++||||+||++|+|++|.+||.+.+....+..+...
T Consensus 163 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 163 --KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred --CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 12223346788999999876555568999999999999999999999988877666555431
Q ss_pred ---CCCCC-----------CCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCCCC
Q 013081 233 ---DFKLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277 (450)
Q Consensus 233 ---~~~~p-----------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~~~ 277 (450)
.+..+ .+.++.+.+||.+||++||++|||+.+++.||||.....+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~ 299 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP 299 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence 11111 2358899999999999999999999999999999876554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=348.63 Aligned_cols=256 Identities=27% Similarity=0.442 Sum_probs=217.8
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
++|++++.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.++++++||||+++++.+...+..|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 47999999999999999999999999999999886532 2233467889999999999999999999999999999999
Q ss_pred ccCCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHhhhhh-cCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC
Q 013081 94 EYVTGGELFDKIASK---GRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (450)
Q Consensus 94 E~~~gg~L~~~i~~~---~~l~~~~~~~i~~ql~~aL~~LH~-~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 169 (450)
||++|++|..++... ..+++..++.++.||+.||.|||+ .|++||||||+||+++.++.+||+|||++....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~---- 154 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV---- 154 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccccc----
Confidence 999999998888763 379999999999999999999996 599999999999999999999999999987432
Q ss_pred CCccccccCCCCccchhhhccCCC-----CCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHH---HHhC-CCCCCCCC
Q 013081 170 DGLLHTTCGSPNYVAPEVLANRGY-----DGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQK---IFRG-DFKLPKWL 240 (450)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~-----~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~---i~~~-~~~~p~~~ 240 (450)
........+++.|+|||.+.+... .+.++|+||+||++|+|++|..||........... +..+ ....|..+
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd06622 155 ASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGY 234 (286)
T ss_pred CCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCccc
Confidence 223345678899999999854332 35789999999999999999999977655443332 3333 34566678
Q ss_pred CHHHHHHHHHccccCcCCCCCHHHHHhccccccCC
Q 013081 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 241 s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
++++.+||.+||+.+|++||++.+++.||||....
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 99999999999999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-44 Score=345.43 Aligned_cols=250 Identities=24% Similarity=0.396 Sum_probs=210.8
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
.+|++.+.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.++++++||||+++++.+......+++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 36889999999999999999999999999999987543 2333567889999999999999999999999999999999
Q ss_pred ccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCcc
Q 013081 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (450)
Q Consensus 94 E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 173 (450)
||+++++|..+ ..+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++..... ...
T Consensus 79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~----~~~ 150 (279)
T cd06619 79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN----SIA 150 (279)
T ss_pred ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc----ccc
Confidence 99999998654 4578999999999999999999999999999999999999999999999999874322 223
Q ss_pred ccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcH-------HHHHHHHHhCC-CCC-CCCCCHHH
Q 013081 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL-------AVLYQKIFRGD-FKL-PKWLSPGA 244 (450)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-------~~~~~~i~~~~-~~~-p~~~s~~~ 244 (450)
...+||+.|+|||++.+..+ +.++|+||+||++|+|++|+.||..... ......+.... ... ....++++
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQY-GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKF 229 (279)
T ss_pred cCCCCChhhcCceeecCCCC-CCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHH
Confidence 45689999999999887665 5899999999999999999999965321 12222222222 122 23478899
Q ss_pred HHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 245 QNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
.+++.+||+.||.+||++.+++.||||...
T Consensus 230 ~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 230 VHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred HHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=339.91 Aligned_cols=251 Identities=30% Similarity=0.477 Sum_probs=216.4
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
++|++.+.||.|+||.||+|.+..+++.+|+|++...... ..+.+.+|+.+++.++||||+++++.+......|++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD---DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh---hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 6899999999999999999999999999999999755322 3578899999999999999999999999999999999
Q ss_pred ccCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCc
Q 013081 94 EYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (450)
Q Consensus 94 E~~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 172 (450)
||+++++|.+++... .++++..++.++.|++.||.|||++|++||||+|+||+++.++.+||+|||++...... ...
T Consensus 80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~--~~~ 157 (262)
T cd06613 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT--IAK 157 (262)
T ss_pred eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh--hhc
Confidence 999999999998775 78999999999999999999999999999999999999999999999999998754321 112
Q ss_pred cccccCCCCccchhhhccC---CCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCC-----CCCCCCHHH
Q 013081 173 LHTTCGSPNYVAPEVLANR---GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-----LPKWLSPGA 244 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~---~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-----~p~~~s~~~ 244 (450)
.....++..|+|||.+... .+ +.++|+||||+++|+|++|..||.+.+.......+....+. .+..++.++
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~-~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGY-DGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVF 236 (262)
T ss_pred cccccCCccccCchhhcccccCCc-CchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHH
Confidence 2345788999999998765 45 47899999999999999999999887655544444444222 123357889
Q ss_pred HHHHHHccccCcCCCCCHHHHHhccc
Q 013081 245 QNLLRKILEPNPVKRITIAGIKADEW 270 (450)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~~il~h~~ 270 (450)
.+++++||.++|..|||+.+++.|+|
T Consensus 237 ~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 237 HDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 99999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-44 Score=339.23 Aligned_cols=254 Identities=33% Similarity=0.506 Sum_probs=219.5
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeeccccc--chhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII--HLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 92 (450)
+|+..+.||+|+||.||+|.+..+++.||+|.+...... ..+....+.+|+.+++.++||||+++++++......|++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 688899999999999999999889999999998654321 233457889999999999999999999999999999999
Q ss_pred EccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCc
Q 013081 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 172 (450)
+||++|++|.+++.+.+.+++..+..++.||+.||+|||++|++|+||+|+||+++.++.+||+|||++...... ..
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~---~~ 157 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF---SF 157 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccc---cc
Confidence 999999999999988888999999999999999999999999999999999999999999999999998754321 12
Q ss_pred cccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHh--CCCCCCCCCCHHHHHHHHH
Q 013081 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR--GDFKLPKWLSPGAQNLLRK 250 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~Li~~ 250 (450)
.....|++.|+|||.+......+.++|+||+||++|+|++|..||..........++.. ....+|..+++.+.+++++
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHH
Confidence 34567899999999987655346889999999999999999999987664444444333 2344567789999999999
Q ss_pred ccccCcCCCCCHHHHHhcccc
Q 013081 251 ILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 251 ~L~~dP~~R~t~~~il~h~~~ 271 (450)
||+.+|.+|||+.+++.|||+
T Consensus 238 ~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 238 CLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HhhcCcccCcCHHHHhcCCCC
Confidence 999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=350.30 Aligned_cols=253 Identities=25% Similarity=0.349 Sum_probs=205.9
Q ss_pred ccCCeEEeeeecccCceEEEEEEECC----------------CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLD----------------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~----------------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn 75 (450)
.-++|++.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.++++++|||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCC
Confidence 35789999999999999999998532 34579999987543 2333567899999999999999
Q ss_pred cceEEEEEEeCCEEEEEEccCCCCChHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHhhhhhcCee
Q 013081 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-------------------RLQEAEGRKLFQQLIDGVSYCHNKGVF 136 (450)
Q Consensus 76 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~-------------------~l~~~~~~~i~~ql~~aL~~LH~~giv 136 (450)
|+++++++.+.+..|++|||+++|+|.+++.... .+++..+..++.||+.||.|||++||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 9999999999999999999999999999886532 367788999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh--CC
Q 013081 137 HRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT--GY 214 (450)
Q Consensus 137 HrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt--G~ 214 (450)
||||||+|||++.++.+||+|||++................+++.|+|||++....+ +.++|||||||++|+|++ +.
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF-TTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCC-CchhhhHHHHHHHHHHHHccCC
Confidence 999999999999999999999999975432111112233456789999999877665 589999999999999987 67
Q ss_pred CCCCCCcHHHHHHHHHh---C-----CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHh
Q 013081 215 LPFDDRNLAVLYQKIFR---G-----DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 215 ~Pf~~~~~~~~~~~i~~---~-----~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
.||.+.+.......... . ....|+.+++.+.+|+.+||+.||.+|||+.+|.+
T Consensus 240 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 240 QPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred CCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 88987665554433321 1 12335568899999999999999999999999953
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=364.02 Aligned_cols=253 Identities=25% Similarity=0.402 Sum_probs=208.1
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCC-----CceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEe
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDS-----GLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS 85 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 85 (450)
..++|++++.||+|+||.||+|++..+ +..||+|.+..... ......+.+|+.+++.+ +||||+++++.+..
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 345799999999999999999986443 45799999975432 23356788999999999 89999999999999
Q ss_pred CCEEEEEEccCCCCChHHHHHhc---------------------------------------------------------
Q 013081 86 KSKIYMVLEYVTGGELFDKIASK--------------------------------------------------------- 108 (450)
Q Consensus 86 ~~~~~lv~E~~~gg~L~~~i~~~--------------------------------------------------------- 108 (450)
....|+||||+++|+|.+++...
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 99999999999999999988542
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCcccc
Q 013081 109 -------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHT 175 (450)
Q Consensus 109 -------------~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~ 175 (450)
.++++.++++++.||+.||.|||++||+||||||+|||+++++.+||+|||+++.............
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 2478889999999999999999999999999999999999999999999999875432111111222
Q ss_pred ccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHcc
Q 013081 176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQNLLRKIL 252 (450)
Q Consensus 176 ~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~~L 252 (450)
..+++.|+|||++.+..+ +.++||||+||++|+|++ |+.||..........+.... ....|..+++++.+++.+||
T Consensus 274 ~~~~~~y~aPE~~~~~~~-~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 352 (374)
T cd05106 274 ARLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCW 352 (374)
T ss_pred CCCccceeCHHHhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHc
Confidence 345668999999877665 589999999999999997 99999876544433333333 44566778999999999999
Q ss_pred ccCcCCCCCHHHHHh
Q 013081 253 EPNPVKRITIAGIKA 267 (450)
Q Consensus 253 ~~dP~~R~t~~~il~ 267 (450)
+.||.+|||+.++++
T Consensus 353 ~~dp~~RPs~~~l~~ 367 (374)
T cd05106 353 NLEPTERPTFSQISQ 367 (374)
T ss_pred CCChhhCcCHHHHHH
Confidence 999999999999876
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=345.62 Aligned_cols=260 Identities=28% Similarity=0.422 Sum_probs=216.0
Q ss_pred ccCCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEe
Q 013081 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS 85 (450)
Q Consensus 7 ~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 85 (450)
...+...++|++.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++++ +|||++++++++..
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 344456789999999999999999999999999999999986432 1245678899999999 79999999999864
Q ss_pred C-----CEEEEEEccCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEe
Q 013081 86 K-----SKIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKIS 156 (450)
Q Consensus 86 ~-----~~~~lv~E~~~gg~L~~~i~~----~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~ 156 (450)
. ...|+||||++|++|.+++.. ...+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~ 170 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLV 170 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEe
Confidence 3 468999999999999998753 4578999999999999999999999999999999999999999999999
Q ss_pred ecCCCCCCCcccCCCccccccCCCCccchhhhccCC----CCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC
Q 013081 157 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG----YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG 232 (450)
Q Consensus 157 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~----~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~ 232 (450)
|||++....... .......|++.|+|||++.... ..+.++||||+||++|+|++|+.||...+.......+.+.
T Consensus 171 dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~ 248 (291)
T cd06639 171 DFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN 248 (291)
T ss_pred ecccchhccccc--ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC
Confidence 999987543211 1123457899999999976433 1358899999999999999999999887665555455443
Q ss_pred C---CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccc
Q 013081 233 D---FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 272 (450)
Q Consensus 233 ~---~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~ 272 (450)
. ...+..++..+.+||.+||++||++|||+.++++||||+
T Consensus 249 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 249 PPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 2 223445778999999999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=338.94 Aligned_cols=253 Identities=32% Similarity=0.560 Sum_probs=220.4
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE--eCCEEEEE
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA--SKSKIYMV 92 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~~~~lv 92 (450)
+|++.+.||.|+||.||+|.+..+++.||+|.+...... ....+++.+|+.+++.++||||+++++.+. .....|++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 589999999999999999999999999999998765432 333577889999999999999999999775 34678999
Q ss_pred EccCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHhhhh-----hcCeeeccCCCCcEEEccCCCeEEeecCCCCC
Q 013081 93 LEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCH-----NKGVFHRDLKLENILLDSKGNIKISDFGLSAL 163 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~----~~~l~~~~~~~i~~ql~~aL~~LH-----~~givHrDlKp~NILl~~~g~lkl~DFGla~~ 163 (450)
|||+++++|.+++.+ ..++++..++.++.||+.||+||| +.+++||||||+||+++.++.+||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999999865 467999999999999999999999 89999999999999999999999999999986
Q ss_pred CCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCC-CCCCCCCH
Q 013081 164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSP 242 (450)
Q Consensus 164 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~ 242 (450)
.... ........|++.|+|||++....+ +.++|+||||+++|+|++|..||...+.......+..+.. ..|..++.
T Consensus 160 ~~~~--~~~~~~~~~~~~~~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (265)
T cd08217 160 LGHD--SSFAKTYVGTPYYMSPEQLNHMSY-DEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSS 236 (265)
T ss_pred ccCC--cccccccccCCCccChhhhcCCCC-CchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCH
Confidence 5432 112344578999999999877665 5889999999999999999999998887777777766643 45667899
Q ss_pred HHHHHHHHccccCcCCCCCHHHHHhcccc
Q 013081 243 GAQNLLRKILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t~~~il~h~~~ 271 (450)
.+.+++.+||+.+|++|||+.++++|||+
T Consensus 237 ~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 237 ELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 99999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=369.27 Aligned_cols=250 Identities=24% Similarity=0.340 Sum_probs=204.4
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 92 (450)
.++|.+.+.||+|+||.||+|.+..+++.||||... ...+.+|++++++++||||+++++++...+..|++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 458999999999999999999999999999999542 23456899999999999999999999999999999
Q ss_pred EccCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCC
Q 013081 93 LEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 171 (450)
||++. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 99995 6888888654 469999999999999999999999999999999999999999999999999997543322222
Q ss_pred ccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCC--------CcHHHHHHHHHhCCC---------
Q 013081 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD--------RNLAVLYQKIFRGDF--------- 234 (450)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~--------~~~~~~~~~i~~~~~--------- 234 (450)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|..|+-. .....+.+.+.....
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~-~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPY-TPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCC-CchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 2334679999999999987776 5899999999999999998765421 111222222221111
Q ss_pred --------------------CCCCC-----CCHHHHHHHHHccccCcCCCCCHHHHHhcccccc
Q 013081 235 --------------------KLPKW-----LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 235 --------------------~~p~~-----~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
..+.| +++.+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 11112 4568999999999999999999999999999974
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=340.18 Aligned_cols=257 Identities=31% Similarity=0.502 Sum_probs=216.1
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeeccccc--chhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII--HLKITDQIKREIATLKLLKHPNVVRLHEVLAS--KSKI 89 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~ 89 (450)
..|++++.||+|+||.||.|.+..+|..||+|.+...... .....+.+.+|+.++++++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4699999999999999999999999999999998643221 22345788999999999999999999998865 3578
Q ss_pred EEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC
Q 013081 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 169 (450)
|++|||++|++|.+++.+...+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 89999999999999998878899999999999999999999999999999999999999999999999999875432111
Q ss_pred -CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC--CCCCCCCCCHHHHH
Q 013081 170 -DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQN 246 (450)
Q Consensus 170 -~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~ 246 (450)
........|+..|+|||++.+..+ +.++|||||||++|+|++|+.||..........+.... ....|..++..+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD 240 (265)
T ss_pred cccccccCCCCccccChhhhcCCCC-CcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence 112234568999999999877665 58899999999999999999999876555444444332 23456667889999
Q ss_pred HHHHccccCcCCCCCHHHHHhccccc
Q 013081 247 LLRKILEPNPVKRITIAGIKADEWFE 272 (450)
Q Consensus 247 Li~~~L~~dP~~R~t~~~il~h~~~~ 272 (450)
+|++||. +|++|||++++++|||+.
T Consensus 241 ~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 241 FLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 9999995 999999999999999973
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=354.69 Aligned_cols=261 Identities=35% Similarity=0.622 Sum_probs=237.9
Q ss_pred CcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSK 88 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 88 (450)
.....+|..+..||+|+||+|-+|..+.+.+.+|||+++++-+......+--..|-++|... +-|.+++++..|.+-++
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 45667899999999999999999999999999999999988766555455555677888877 47889999999999999
Q ss_pred EEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc
Q 013081 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 168 (450)
+|+||||+.||+|-..|++-+++.|..|..|+..|+-||-+||++||++||||.+||++|.+|++||+|||+++. ...
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE--ni~ 502 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE--NIF 502 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccc--ccc
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999984 233
Q ss_pred CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 013081 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL 248 (450)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li 248 (450)
......+.||||.|+|||++...+| +..+|+||+||+|||||+|++||++.+..++++.|......+|..+|.++.++.
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~YqPY-gksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ic 581 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAIC 581 (683)
T ss_pred CCcceeeecCCCcccccceEEeccc-ccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHH
Confidence 4556778999999999999988877 689999999999999999999999999999999999999999999999999999
Q ss_pred HHccccCcCCCCC-----HHHHHhcccccc
Q 013081 249 RKILEPNPVKRIT-----IAGIKADEWFEQ 273 (450)
Q Consensus 249 ~~~L~~dP~~R~t-----~~~il~h~~~~~ 273 (450)
...|.+.|.+|.. -.+|..||||..
T Consensus 582 kg~ltK~P~kRLGcg~~ge~di~~H~FFR~ 611 (683)
T KOG0696|consen 582 KGLLTKHPGKRLGCGPEGERDIREHPFFRR 611 (683)
T ss_pred HHHhhcCCccccCCCCccccchhhCcchhh
Confidence 9999999999975 467999999964
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=345.93 Aligned_cols=255 Identities=30% Similarity=0.487 Sum_probs=207.9
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
.+++|++.+.||+|++|.||+|.+..+++.||+|.+....... ....+.+|+.+++.++||||+++++++.+....|+
T Consensus 3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (291)
T cd07844 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTL 80 (291)
T ss_pred CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEE
Confidence 4688999999999999999999999899999999987543221 12456789999999999999999999999999999
Q ss_pred EEccCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCC
Q 013081 92 VLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 170 (450)
||||+.+ +|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++..... ..
T Consensus 81 v~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~--~~ 157 (291)
T cd07844 81 VFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSV--PS 157 (291)
T ss_pred EEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCC--CC
Confidence 9999975 999988653 4689999999999999999999999999999999999999999999999999874321 11
Q ss_pred CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCc-HHHHHHHHHhC-----------------
Q 013081 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRG----------------- 232 (450)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~~----------------- 232 (450)
.......+++.|+|||++.+....+.++||||+||++|+|++|+.||.+.. .......+.+.
T Consensus 158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 112234578899999998765544688999999999999999999997655 22222222110
Q ss_pred ----CCCC---------CCCCC--HHHHHHHHHccccCcCCCCCHHHHHhcccc
Q 013081 233 ----DFKL---------PKWLS--PGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 233 ----~~~~---------p~~~s--~~~~~Li~~~L~~dP~~R~t~~~il~h~~~ 271 (450)
.... ...++ ..+.+++.+||++||.+|||+.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0000 01234 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-44 Score=342.43 Aligned_cols=254 Identities=30% Similarity=0.447 Sum_probs=213.6
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC---
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKS--- 87 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~--- 87 (450)
..++|++.+.||+|++|.||+|.+..+++.+|+|++..... ..+.+.+|+.+++++ .||||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 35899999999999999999999998999999999875432 246788999999999 6999999999986544
Q ss_pred ---EEEEEEccCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCC
Q 013081 88 ---KIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGL 160 (450)
Q Consensus 88 ---~~~lv~E~~~gg~L~~~i~~----~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGl 160 (450)
.+|++|||+++++|.+++.. ...+++..++.++.|++.||.|||++|++||||+|+||+++.++.+||+|||+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 48999999999999998865 35799999999999999999999999999999999999999999999999999
Q ss_pred CCCCCcccCCCccccccCCCCccchhhhccC----CCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCC--
Q 013081 161 SALPQHFRDDGLLHTTCGSPNYVAPEVLANR----GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-- 234 (450)
Q Consensus 161 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~----~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-- 234 (450)
+..... .........|++.|+|||++... ...+.++|||||||++|+|++|+.||...+......++.....
T Consensus 160 ~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 237 (275)
T cd06608 160 SAQLDS--TLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPT 237 (275)
T ss_pred ceeccc--chhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCC
Confidence 875322 11223445789999999997542 2235789999999999999999999987665555555554422
Q ss_pred -CCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhcccc
Q 013081 235 -KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 235 -~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~ 271 (450)
..+..++..+.+||.+||..||++|||+.++++|||+
T Consensus 238 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 238 LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 2233367899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=338.52 Aligned_cols=249 Identities=33% Similarity=0.569 Sum_probs=217.5
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEc
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 94 (450)
+|++.+.||+|+||.||++.+..+++.||+|.++.... ....+.+.+|+.+++.++||||+++++.+.+.+..|++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 58999999999999999999999999999999865432 2335778899999999999999999999999999999999
Q ss_pred cCCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCc
Q 013081 95 YVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (450)
Q Consensus 95 ~~~gg~L~~~i~~--~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 172 (450)
|+++++|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+||++++++.++++|||++..... ....
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~--~~~~ 156 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS--PGAY 156 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecc--cccc
Confidence 9999999998864 34589999999999999999999999999999999999999999999999999875432 1122
Q ss_pred cccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHc
Q 013081 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKI 251 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~~ 251 (450)
.....|++.|+|||++.+..+ +.++|+||+|+++|+|++|..||...+.......+..+.. +.|..++..+.+||.+|
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 235 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPY-NNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQM 235 (255)
T ss_pred cccccCCccccCHHHHccCCc-CchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHH
Confidence 334578999999999877665 5889999999999999999999998887777777766643 45667899999999999
Q ss_pred cccCcCCCCCHHHHHhc
Q 013081 252 LEPNPVKRITIAGIKAD 268 (450)
Q Consensus 252 L~~dP~~R~t~~~il~h 268 (450)
|+.||++|||+.+++..
T Consensus 236 l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 236 FKRNPRSRPSATTILSR 252 (255)
T ss_pred HhCCcccCCCHHHHhhc
Confidence 99999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=345.75 Aligned_cols=248 Identities=30% Similarity=0.490 Sum_probs=213.0
Q ss_pred ecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEccCCCCCh
Q 013081 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL 101 (450)
Q Consensus 22 LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 101 (450)
||+|+||+||+|.+..+|+.||+|.+.+...........+.+|+.++++++||||+++++++...+..|+||||++|++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999999765443333345677899999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccccccCC
Q 013081 102 FDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179 (450)
Q Consensus 102 ~~~i~~~~--~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt 179 (450)
.+++.+.+ .+++.+++.++.|++.||.|||++|++||||+|+||++++++.++|+|||++..... ........++
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~ 157 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGT 157 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccccCC
Confidence 99997755 799999999999999999999999999999999999999999999999999875432 2223345678
Q ss_pred CCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcH----HHHHHHHHhCCCCCCCCCCHHHHHHHHHccccC
Q 013081 180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL----AVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255 (450)
Q Consensus 180 ~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~d 255 (450)
..|+|||++.+..+ +.++|+||+||++|+|++|+.||..... ......+.......|..+++.+.++|.+||+.|
T Consensus 158 ~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 236 (277)
T cd05577 158 PGYMAPEVLQGEVY-DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236 (277)
T ss_pred CCcCCHHHhcCCCC-CchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence 89999999877665 5889999999999999999999977543 233333444455667778999999999999999
Q ss_pred cCCCC-----CHHHHHhcccccc
Q 013081 256 PVKRI-----TIAGIKADEWFEQ 273 (450)
Q Consensus 256 P~~R~-----t~~~il~h~~~~~ 273 (450)
|.+|| ++.+++.||||..
T Consensus 237 p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 237 PEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred hhHccCCCcccHHHHHhChhhhc
Confidence 99999 8889999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=341.41 Aligned_cols=251 Identities=22% Similarity=0.322 Sum_probs=212.6
Q ss_pred cCCeEEeeeecccCceEEEEEEEC---CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (450)
..+|++.+.||+|+||.||+|.+. ..+..||+|.++... .......+.+|+.++++++||||+++++++......
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 467999999999999999999865 356799999987543 223356788999999999999999999999999999
Q ss_pred EEEEccCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc
Q 013081 90 YMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 168 (450)
|+||||+++|+|.+++... +.+++..++.++.||+.||+|||++|++||||||+|||++.++.+|++|||.+......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~- 160 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE- 160 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc-
Confidence 9999999999999998764 57899999999999999999999999999999999999999999999999987643211
Q ss_pred CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 013081 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 246 (450)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 246 (450)
.........+++.|+|||++.+..+ +.++||||+||++|++++ |..||.+.+.......+..+ ..+.|..++..+.+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHF-SSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQ 239 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCc-cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence 0011112345678999999877666 589999999999999775 99999988877777766655 34567778999999
Q ss_pred HHHHccccCcCCCCCHHHHHh
Q 013081 247 LLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 247 Li~~~L~~dP~~R~t~~~il~ 267 (450)
++.+||+++|.+|||+.+|++
T Consensus 240 li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 240 LMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHcCCCchhCCCHHHHHH
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=362.50 Aligned_cols=253 Identities=28% Similarity=0.424 Sum_probs=207.7
Q ss_pred cCCeEEeeeecccCceEEEEEEE-----CCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQD-----LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK 86 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 86 (450)
.++|++++.||+|+||.||+|.+ ..++..||+|+++.... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 45899999999999999999974 34677899999864432 22356788999999999 899999999999999
Q ss_pred CEEEEEEccCCCCChHHHHHhcC---------------------------------------------------------
Q 013081 87 SKIYMVLEYVTGGELFDKIASKG--------------------------------------------------------- 109 (450)
Q Consensus 87 ~~~~lv~E~~~gg~L~~~i~~~~--------------------------------------------------------- 109 (450)
...|+||||++||+|.+++....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 99999999999999999886421
Q ss_pred ------------------CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCC
Q 013081 110 ------------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (450)
Q Consensus 110 ------------------~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 171 (450)
.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 47788899999999999999999999999999999999999999999999997543221111
Q ss_pred ccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHH-HHHHHhC-CCCCCCCCCHHHHHHH
Q 013081 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVL-YQKIFRG-DFKLPKWLSPGAQNLL 248 (450)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~-~~~i~~~-~~~~p~~~s~~~~~Li 248 (450)
......+++.|+|||++.+..+ +.++|||||||++|+|++ |..||........ .+.+..+ ....|...+.++.+|+
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~-~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 350 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIM 350 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCC-CCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHH
Confidence 1222345678999999887666 589999999999999998 9999987654433 3333333 2344666789999999
Q ss_pred HHccccCcCCCCCHHHHHhc
Q 013081 249 RKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 249 ~~~L~~dP~~R~t~~~il~h 268 (450)
.+||++||++|||+.++++.
T Consensus 351 ~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 351 KSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHccCChhHCcCHHHHHHH
Confidence 99999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=347.71 Aligned_cols=261 Identities=28% Similarity=0.416 Sum_probs=209.8
Q ss_pred CCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-
Q 013081 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS- 87 (450)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~- 87 (450)
....+++|++.+.||+|+||.||+|.+..+++.||+|.+...... ......+.+|+.++++++||||+++++++....
T Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 85 (310)
T cd07865 7 FCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKAT 85 (310)
T ss_pred ccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc-CCchhHHHHHHHHHHhCCCCCccceEEEEecccc
Confidence 345678999999999999999999999999999999998654322 222345678999999999999999999986543
Q ss_pred -------EEEEEEccCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecC
Q 013081 88 -------KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFG 159 (450)
Q Consensus 88 -------~~~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFG 159 (450)
..|+||||+. ++|.+.+... ..+++.+++.++.||+.||+|||++|++||||||+||+++.++.+||+|||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 86 PYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred cccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCC
Confidence 4599999996 5888877654 378999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCcccCC--CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHh--CC--
Q 013081 160 LSALPQHFRDD--GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR--GD-- 233 (450)
Q Consensus 160 la~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~--~~-- 233 (450)
++......... .......++..|+|||.+.+....+.++||||+|+++|+|++|..||.+.+.......+.. +.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99754322111 1223456788999999987655446889999999999999999999987765433322221 00
Q ss_pred ---------------CCCC-------------CCCCHHHHHHHHHccccCcCCCCCHHHHHhcccc
Q 013081 234 ---------------FKLP-------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 234 ---------------~~~p-------------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~ 271 (450)
...| ...++.+.+||.+||..||.+|||++++++||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 0011 1135678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=344.97 Aligned_cols=256 Identities=29% Similarity=0.468 Sum_probs=215.8
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
++|++.+.||+|+||.||+|.+..+++.||+|.++.... .....+.+.+|+++++.++||||+++++++...+..|++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 589999999999999999999999999999999865432 2334578899999999999999999999999999999999
Q ss_pred ccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCcc
Q 013081 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (450)
Q Consensus 94 E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 173 (450)
||++++.+..+..+...+++.++..++.||+.||.|||++|++||||+|+||++++++.+||+|||++........ ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~~ 158 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SPL 158 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-ccc
Confidence 9999877777666667799999999999999999999999999999999999999999999999999886543211 123
Q ss_pred ccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC---------------------
Q 013081 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--------------------- 232 (450)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--------------------- 232 (450)
....+++.|+|||++......+.++|+||+|+++|+|++|.+||.+.+.......+...
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 44678899999999887745568999999999999999999999876554333222110
Q ss_pred CC-----------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhcccc
Q 013081 233 DF-----------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 233 ~~-----------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~ 271 (450)
.. ..|..+++.+.+||++||..+|++|||++++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 00 1233458899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=337.41 Aligned_cols=256 Identities=33% Similarity=0.545 Sum_probs=217.8
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEc
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 94 (450)
||++.+.||+|+||.||+|.+..+++.||+|.+...... ......+.+|+.+++.++||||+++++...+.+..++++|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 699999999999999999999989999999999766443 3456889999999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCC-c-
Q 013081 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG-L- 172 (450)
Q Consensus 95 ~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~-~- 172 (450)
|+++++|.+++.+...+++..++.++.|++.||.|||++|++||||+|+||++++++.+||+|||++.......... .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 159 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence 99999999999887789999999999999999999999999999999999999999999999999988643321111 1
Q ss_pred cccccCCCCccchhhhccCC--CCCccchhhhHHHHHHHHHhCCCCCCCCc-HHHHHHHHHh-CCCCCCCCC--CHHHHH
Q 013081 173 LHTTCGSPNYVAPEVLANRG--YDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFR-GDFKLPKWL--SPGAQN 246 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~--~~~~~~DiwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~-~~~~~p~~~--s~~~~~ 246 (450)
.....+++.|+|||++.... ..+.++||||+|+++|+|++|..||.... .......+.. ....+|.+. ++.+.+
T Consensus 160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (264)
T cd06626 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKD 239 (264)
T ss_pred ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHH
Confidence 22457889999999987654 23588999999999999999999997653 2222222222 234456554 899999
Q ss_pred HHHHccccCcCCCCCHHHHHhcccc
Q 013081 247 LLRKILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 247 Li~~~L~~dP~~R~t~~~il~h~~~ 271 (450)
+|.+||+.+|.+|||+.+++.|||+
T Consensus 240 li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 240 FLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHccCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=340.55 Aligned_cols=251 Identities=34% Similarity=0.630 Sum_probs=221.5
Q ss_pred ecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEccCCCCCh
Q 013081 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL 101 (450)
Q Consensus 22 LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 101 (450)
||.|+||.||+|.+..+|+.+|+|++.............+.+|+.++++++||||+++++.+.+....|+++||++|++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999989999999999765544444567899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC------CCcccc
Q 013081 102 FDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD------DGLLHT 175 (450)
Q Consensus 102 ~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~------~~~~~~ 175 (450)
.+++.+.+.+++..+..++.||+.||+|||++|++||||+|+||++++++.++|+|||++........ ......
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 99998878899999999999999999999999999999999999999999999999999875322111 112234
Q ss_pred ccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHccc
Q 013081 176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWL--SPGAQNLLRKILE 253 (450)
Q Consensus 176 ~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~--s~~~~~Li~~~L~ 253 (450)
..+++.|+|||.+....+ +.++|+||||+++|+|++|..||........+..+..+....|... ++.+.+++.+||+
T Consensus 161 ~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 239 (265)
T cd05579 161 IVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239 (265)
T ss_pred cccCccccCHHHhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhc
Confidence 568889999999877664 5889999999999999999999998888888888877777766665 9999999999999
Q ss_pred cCcCCCCCH---HHHHhcccccc
Q 013081 254 PNPVKRITI---AGIKADEWFEQ 273 (450)
Q Consensus 254 ~dP~~R~t~---~~il~h~~~~~ 273 (450)
.+|.+|||+ .++++||||+.
T Consensus 240 ~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 240 PDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred CCHhhcCCCccHHHHhcCccccC
Confidence 999999999 99999999974
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=345.60 Aligned_cols=253 Identities=29% Similarity=0.451 Sum_probs=210.6
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEc
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 94 (450)
.|++.+.||.|++|.||+|.+..+|+.||||.+..... .......+.+|++++++++||||+++++++.+....|++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 48999999999999999999999999999999865432 22234678899999999999999999999999999999999
Q ss_pred cCCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCc
Q 013081 95 YVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (450)
Q Consensus 95 ~~~gg~L~~~i~~--~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 172 (450)
|+. ++|.+++.. ...+++..++.++.|++.||+|||++|++||||+|+||+++.++.+||+|||++...... ...
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~--~~~ 156 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRT 156 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC--ccc
Confidence 996 589888865 356899999999999999999999999999999999999999999999999998754321 122
Q ss_pred cccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC------------------C
Q 013081 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD------------------F 234 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------------~ 234 (450)
.....+++.|+|||++.+....+.++|||||||++|+|+||+.||.+.+......++.... .
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP 236 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence 2344678899999998766655688999999999999999999998766543333322110 0
Q ss_pred CC-----------CCCCCHHHHHHHHHccccCcCCCCCHHHHHhcccc
Q 013081 235 KL-----------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 235 ~~-----------p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~ 271 (450)
.+ ...+++.++++|.+||+.||++|||+.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred hcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 11 12367889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=338.56 Aligned_cols=250 Identities=27% Similarity=0.457 Sum_probs=215.9
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
++|++.+.||+|+||.||+|.+..+++.+|+|.+..... ...+.+|+.+++.++||||+++++.+.+....|+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 579999999999999999999988899999999865421 578999999999999999999999999999999999
Q ss_pred ccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCc
Q 013081 94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (450)
Q Consensus 94 E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 172 (450)
||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++...... ...
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~--~~~ 155 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT--MAK 155 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccC--ccc
Confidence 99999999999875 457899999999999999999999999999999999999999999999999998854331 112
Q ss_pred cccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC---CCCCCCCCCHHHHHHHH
Q 013081 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---DFKLPKWLSPGAQNLLR 249 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~Li~ 249 (450)
.....|+..|+|||++.+..+ +.++||||+|+++|+|++|+.||...........+... ....+..++..+.++|.
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~-~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 234 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGY-NNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVK 234 (256)
T ss_pred cccccCCccccCHHHHhcCCC-CchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHH
Confidence 234558899999999877765 58899999999999999999999876655443333222 22334457889999999
Q ss_pred HccccCcCCCCCHHHHHhcccc
Q 013081 250 KILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 250 ~~L~~dP~~R~t~~~il~h~~~ 271 (450)
+||+.||++|||+.+++.||||
T Consensus 235 ~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 235 KCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHhcChhhCcCHHHHhcCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=366.29 Aligned_cols=260 Identities=32% Similarity=0.618 Sum_probs=243.5
Q ss_pred CcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (450)
.+.+...+++.+||-|+||.|-++........+|+|++++..+.+....+.+..|-+||-.++.|.||++|..|.+...+
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv 495 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV 495 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence 46678889999999999999999987655556999999998888888889999999999999999999999999999999
Q ss_pred EEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC
Q 013081 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 169 (450)
|+.||-|-||+|+..++.++.|++..++.|..-+++|++|||++||++|||||+|++++.+|.+||.|||+|+... .
T Consensus 496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~---~ 572 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG---S 572 (732)
T ss_pred hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhc---c
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999643 4
Q ss_pred CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC--CCCCCCCCCHHHHHH
Q 013081 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQNL 247 (450)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~L 247 (450)
.+..-+.||||.|+|||++.+++.+ .++|.||||+++||||+|.+||.+.++...|..|+++ .+.+|..++..+.+|
T Consensus 573 g~KTwTFcGTpEYVAPEIILnKGHD-~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~L 651 (732)
T KOG0614|consen 573 GRKTWTFCGTPEYVAPEIILNKGHD-RAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDL 651 (732)
T ss_pred CCceeeecCCcccccchhhhccCcc-hhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHH
Confidence 4567789999999999999999986 8899999999999999999999999999999999998 578999999999999
Q ss_pred HHHccccCcCCCCC-----HHHHHhcccccc
Q 013081 248 LRKILEPNPVKRIT-----IAGIKADEWFEQ 273 (450)
Q Consensus 248 i~~~L~~dP~~R~t-----~~~il~h~~~~~ 273 (450)
|+++...+|.+|.. +.+|.+|.||..
T Consensus 652 ik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 652 IKKLCRDNPTERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred HHHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence 99999999999986 899999999974
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=343.74 Aligned_cols=254 Identities=27% Similarity=0.390 Sum_probs=205.7
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 92 (450)
.++|.+.+.||+|+||.||+|.+..+|+.||+|.+....... ....+.+|+.+++.++|+||+++++++.++...|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG--VPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC--CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 367999999999999999999999999999999986543222 234677899999999999999999999999999999
Q ss_pred EccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCC
Q 013081 93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 171 (450)
|||+. ++|.+.+.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++++||+|||++...... ..
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--~~ 158 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP--SQ 158 (291)
T ss_pred Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCC--CC
Confidence 99995 677776654 456889999999999999999999999999999999999999999999999998753321 12
Q ss_pred ccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHH-HHHHHHHhC--------------C---
Q 013081 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKIFRG--------------D--- 233 (450)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~--------------~--- 233 (450)
......+++.|+|||++.+....+.++||||+||++|+|++|..||.+.+.. +...++... .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07870 159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNY 238 (291)
T ss_pred CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccc
Confidence 2334567899999999876544457899999999999999999999865432 111111100 0
Q ss_pred ------CCCCC---------CCCHHHHHHHHHccccCcCCCCCHHHHHhcccc
Q 013081 234 ------FKLPK---------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 234 ------~~~p~---------~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~ 271 (450)
...+. ..++.+.+++.+||+.||.+|||+.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 00000 125688999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=346.56 Aligned_cols=256 Identities=32% Similarity=0.438 Sum_probs=214.3
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SKI 89 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~ 89 (450)
.+++|++.+.||+|+||.||+|.+..+++.+|+|.++..... ......+.+|+.++++++||||+++++++... ...
T Consensus 3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (293)
T cd07843 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKI 81 (293)
T ss_pred chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcE
Confidence 356899999999999999999999999999999999754332 23345677899999999999999999998777 899
Q ss_pred EEEEccCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc
Q 013081 90 YMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~-~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 168 (450)
|++|||+.+ +|.+.+.... .+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||++......
T Consensus 82 ~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~- 159 (293)
T cd07843 82 YMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP- 159 (293)
T ss_pred EEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC-
Confidence 999999974 9988887643 5899999999999999999999999999999999999999999999999998854331
Q ss_pred CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC---------------
Q 013081 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--------------- 233 (450)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--------------- 233 (450)
........+++.|+|||.+.+....+.++|+||+|+++|+|++|..||...+......++....
T Consensus 160 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 160 -LKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred -ccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 1223345678999999998766555688999999999999999999998877655554433210
Q ss_pred ----------------CCCCCC-CCHHHHHHHHHccccCcCCCCCHHHHHhcccc
Q 013081 234 ----------------FKLPKW-LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 234 ----------------~~~p~~-~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~ 271 (450)
..++.. +++.+.+||++||+.||++|||+.|++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 112222 58889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-44 Score=341.38 Aligned_cols=253 Identities=30% Similarity=0.474 Sum_probs=217.9
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+.++++++||||+++++.+......|+++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 468899999999999999999999999999999876532 234577889999999999999999999999999999999
Q ss_pred ccCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhh-cCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCC
Q 013081 94 EYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (450)
Q Consensus 94 E~~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~-~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 171 (450)
||++|++|.+++... ..+++..+..++.|++.||+|||+ .|++||||||+||++++++.++|+|||.+..... .
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~----~ 154 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN----S 154 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHH----H
Confidence 999999999999875 789999999999999999999999 9999999999999999999999999999874322 1
Q ss_pred ccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCC-----cHHHHHHHHHhC-CCCCCCC-CCHHH
Q 013081 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR-----NLAVLYQKIFRG-DFKLPKW-LSPGA 244 (450)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~-----~~~~~~~~i~~~-~~~~p~~-~s~~~ 244 (450)
......++..|+|||.+.+..+ +.++||||+|+++|+|++|..||... ......+.+... ....+.. +++.+
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd06605 155 LAKTFVGTSSYMAPERIQGNDY-SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDF 233 (265)
T ss_pred HhhcccCChhccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence 1222678899999999877655 58999999999999999999999754 233344444443 2334444 88999
Q ss_pred HHHHHHccccCcCCCCCHHHHHhcccccc
Q 013081 245 QNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
.++|.+||..||++|||+.+++.||||+.
T Consensus 234 ~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 234 QDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred HHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 99999999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-44 Score=350.88 Aligned_cols=247 Identities=32% Similarity=0.468 Sum_probs=193.6
Q ss_pred eeeecccCceEEEEEEECC--CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE--eCCEEEEEEc
Q 013081 19 GRTLGEGNFGKVKFAQDLD--SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA--SKSKIYMVLE 94 (450)
Q Consensus 19 ~~~LG~G~~g~Vy~a~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~~~~lv~E 94 (450)
+..||+|+||.||+|.+.. ++..||+|.+..... ...+.+|+.+++.++||||+++++++. .....|++||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 4689999999999999654 668999999865432 345778999999999999999999884 4567899999
Q ss_pred cCCCCChHHHHHh---------cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEE----ccCCCeEEeecCCC
Q 013081 95 YVTGGELFDKIAS---------KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL----DSKGNIKISDFGLS 161 (450)
Q Consensus 95 ~~~gg~L~~~i~~---------~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl----~~~g~lkl~DFGla 161 (450)
|+. ++|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 81 YAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred eeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 996 588777742 1248899999999999999999999999999999999999 45678999999999
Q ss_pred CCCCcccC-CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHH---------HHHHHHHh
Q 013081 162 ALPQHFRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA---------VLYQKIFR 231 (450)
Q Consensus 162 ~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---------~~~~~i~~ 231 (450)
+....... ........||+.|+|||++.+....+.++||||+||++|+|+||.+||...... ....++..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence 86432111 112344578999999999877665578999999999999999999999753211 00101000
Q ss_pred ----------------------------CCC----------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhcccc
Q 013081 232 ----------------------------GDF----------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 232 ----------------------------~~~----------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~ 271 (450)
... ......+..+.+|+.+||+.||.+|||++|+++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000 0011135678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=338.45 Aligned_cols=247 Identities=32% Similarity=0.586 Sum_probs=210.9
Q ss_pred eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHH-HhCCCCCcceEEEEEEeCCEEEEEEccCCC
Q 013081 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVRLHEVLASKSKIYMVLEYVTG 98 (450)
Q Consensus 20 ~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 98 (450)
+.||+|+||.||+|.+..+|+.||+|++.+...........+..|..++ ...+|||++++++++...+..|+++||++|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999999999999999998765433222233445555544 455899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccccccC
Q 013081 99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 178 (450)
Q Consensus 99 g~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 178 (450)
++|.+++...+++++..+..++.|++.||.|||+.|++||||+|+||++++++.+||+|||++..... .....|
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~ 155 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVG 155 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cccCCC
Confidence 99999998888899999999999999999999999999999999999999999999999999874321 234568
Q ss_pred CCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCC----CCCCCHHHHHHHHHcccc
Q 013081 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL----PKWLSPGAQNLLRKILEP 254 (450)
Q Consensus 179 t~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~----p~~~s~~~~~Li~~~L~~ 254 (450)
++.|+|||.+.+..+ +.++||||+|+++|+|++|..||...+....+..+..+.... +..+++.+.+++.+||+.
T Consensus 156 ~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 234 (260)
T cd05611 156 TPDYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCM 234 (260)
T ss_pred CcCccChhhhcCCCC-cchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccC
Confidence 899999999877664 689999999999999999999999888877777766554333 335789999999999999
Q ss_pred CcCCCC---CHHHHHhcccccc
Q 013081 255 NPVKRI---TIAGIKADEWFEQ 273 (450)
Q Consensus 255 dP~~R~---t~~~il~h~~~~~ 273 (450)
||++|| +++|++.||||..
T Consensus 235 ~p~~R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 235 DPAKRLGANGYQEIKSHPFFKS 256 (260)
T ss_pred CHHHccCCCcHHHHHcChHhhc
Confidence 999999 5589999999964
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=358.36 Aligned_cols=247 Identities=27% Similarity=0.400 Sum_probs=200.4
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 92 (450)
-.+|++++.||+|+||.||+|.+..+++.||+|+..+. ....|+.++++++||||+++++++......|+|
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 35799999999999999999999999999999985432 234699999999999999999999999999999
Q ss_pred EccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCC
Q 013081 93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 171 (450)
|||+. ++|.+++.. ..++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~---~~ 211 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV---AP 211 (357)
T ss_pred EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc---Cc
Confidence 99995 588888765 45799999999999999999999999999999999999999999999999999874321 12
Q ss_pred ccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhC-CCCCCCCcHH---------HHHHHHHhC----CCCCC
Q 013081 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG-YLPFDDRNLA---------VLYQKIFRG----DFKLP 237 (450)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG-~~Pf~~~~~~---------~~~~~i~~~----~~~~p 237 (450)
......||+.|+|||++.+..+ +.++||||+||++|+|+++ ..+|...... ....++... ...+|
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 290 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKY-NSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290 (357)
T ss_pred ccccccccccccCCeecCCCCC-CchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence 2334679999999999887766 5899999999999999985 4444432110 011111110 00011
Q ss_pred ------------------------------CCCCHHHHHHHHHccccCcCCCCCHHHHHhcccccc
Q 013081 238 ------------------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 238 ------------------------------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
..++..+.+||.+||+.||.+|||+.|+++||||++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 124667788999999999999999999999999975
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=343.10 Aligned_cols=255 Identities=32% Similarity=0.441 Sum_probs=209.3
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCE----
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSK---- 88 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~---- 88 (450)
++|++.+.||+|+||.||+|.+..+|+.||+|.+..... .......+.+|+.+++.++ ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 479999999999999999999999999999999865432 2223467888999999995 6999999999876665
Q ss_pred -EEEEEccCCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEcc-CCCeEEeecCCC
Q 013081 89 -IYMVLEYVTGGELFDKIASK-----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-KGNIKISDFGLS 161 (450)
Q Consensus 89 -~~lv~E~~~gg~L~~~i~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~-~g~lkl~DFGla 161 (450)
.|++|||+++ +|.+++... ..+++..++.++.||+.||.|||++|++||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999986 888887642 35899999999999999999999999999999999999998 889999999998
Q ss_pred CCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCC-------
Q 013081 162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF------- 234 (450)
Q Consensus 162 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~------- 234 (450)
...... ........+++.|+|||++.+....+.++|+||+|+++|+|++|..||.+.+......++.....
T Consensus 159 ~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 159 RAFSIP--VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred eecCCC--ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 743221 11223346788999999987655556899999999999999999999988766554444432100
Q ss_pred ----------CCC-----------CCCCHHHHHHHHHccccCcCCCCCHHHHHhccccc
Q 013081 235 ----------KLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 272 (450)
Q Consensus 235 ----------~~p-----------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~ 272 (450)
..| +.+++.+.+||.+||++||.+|||+.+++.||||+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 001 23688999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=341.55 Aligned_cols=252 Identities=31% Similarity=0.486 Sum_probs=211.6
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEc
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 94 (450)
+|++.+.||.|++|.||+|.+..+|+.||+|.+...... .....+.+|+.++++++||||+++++.+.+.+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE--GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc--cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 589999999999999999999999999999998755322 124567789999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCC
Q 013081 95 YVTGGELFDKIASK---GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (450)
Q Consensus 95 ~~~gg~L~~~i~~~---~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 171 (450)
|+++ +|.+.+... .++++..+..++.|++.||+|||+.|++||||||+||++++++.++|+|||++...... ..
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~--~~ 155 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP--VN 155 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC--cc
Confidence 9975 888887653 36899999999999999999999999999999999999999999999999998754321 11
Q ss_pred ccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC------------------
Q 013081 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD------------------ 233 (450)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------------ 233 (450)
......+++.|+|||.+.+....+.++|+|||||++|+|++|+.||.+.+......++....
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 22345678999999998765555689999999999999999999998877655544433210
Q ss_pred CC-----------CCCCCCHHHHHHHHHccccCcCCCCCHHHHHhcccc
Q 013081 234 FK-----------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 234 ~~-----------~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~ 271 (450)
.. ..+.+++.+.+++.+||+.||.+|||+.++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00 112357889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=341.54 Aligned_cols=256 Identities=26% Similarity=0.489 Sum_probs=217.7
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEE
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK---HPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~l 91 (450)
.|++.+.||+|+||.||+|.+..+++.||+|.++.... ......+.+|+.++++++ |||++++++++......|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP--DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 58889999999999999999999999999999865432 223567889999999997 9999999999999999999
Q ss_pred EEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCC
Q 013081 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 171 (450)
+|||++|++|.+++.. +.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++...... ..
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~--~~ 156 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN--SS 156 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC--cc
Confidence 9999999999998865 57999999999999999999999999999999999999999999999999998754331 12
Q ss_pred ccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC-CCCCCC-CCHHHHHHHH
Q 013081 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FKLPKW-LSPGAQNLLR 249 (450)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~-~s~~~~~Li~ 249 (450)
......|++.|+|||.+.+....+.++|+||+||++|+|++|..||...+.......+.... ..++.. ++.++.+++.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVA 236 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHH
Confidence 23345789999999998765555689999999999999999999998876655443333322 223332 7889999999
Q ss_pred HccccCcCCCCCHHHHHhccccccCC
Q 013081 250 KILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 250 ~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
+||+.||++|||+.+++.|+||+...
T Consensus 237 ~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 237 ACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred HHcCCCcccCcCHHHHhhChHhhccc
Confidence 99999999999999999999997654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=343.13 Aligned_cols=258 Identities=27% Similarity=0.426 Sum_probs=219.6
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
..++|++++.||+|+||.||+|.+..+|+.||+|++.... .......+.+|+.+++.++||||+++++.+......|+
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 4568999999999999999999999999999999986543 23345788999999999999999999999999999999
Q ss_pred EEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhh-cCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCC
Q 013081 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~-~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 170 (450)
||||+++++|.+++...+++++..++.++.|++.||.|||+ .|++||||||+||+++.++.++|+|||++.....
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~---- 156 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN---- 156 (284)
T ss_pred EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhh----
Confidence 99999999999999888889999999999999999999997 5999999999999999999999999999864321
Q ss_pred CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHH-----------HHHHHHHhCC-CCCCC
Q 013081 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-----------VLYQKIFRGD-FKLPK 238 (450)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-----------~~~~~i~~~~-~~~p~ 238 (450)
......+|+..|+|||++.+..+ +.++|+||+||++|+|++|..||...... .....+.... ..++.
T Consensus 157 ~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd06620 157 SIADTFVGTSTYMSPERIQGGKY-TVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPS 235 (284)
T ss_pred hccCccccCcccCCHHHHccCCC-CccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCc
Confidence 12234679999999999876655 58899999999999999999999865431 2233333332 22333
Q ss_pred C-CCHHHHHHHHHccccCcCCCCCHHHHHhccccccCCC
Q 013081 239 W-LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 276 (450)
Q Consensus 239 ~-~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~~ 276 (450)
. ++..+.+|+.+||++||++|||+.++++|+||.+...
T Consensus 236 ~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~ 274 (284)
T cd06620 236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALR 274 (284)
T ss_pred hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 3 7889999999999999999999999999999977543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=342.17 Aligned_cols=253 Identities=27% Similarity=0.377 Sum_probs=215.3
Q ss_pred ccCCeEEeeeecccCceEEEEEEECC-----CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (450)
..++|.+.+.||+|+||.||+|.+.. +++.||+|.+..... .+..+.+.+|+++++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 35679999999999999999998743 467899999865432 22357899999999999999999999999999
Q ss_pred CEEEEEEccCCCCChHHHHHhcC--------------CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCC
Q 013081 87 SKIYMVLEYVTGGELFDKIASKG--------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN 152 (450)
Q Consensus 87 ~~~~lv~E~~~gg~L~~~i~~~~--------------~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~ 152 (450)
...|++|||++|++|.+++...+ .+++..+..++.|++.||.|||++|++||||||+||+++.++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 99999999999999999997543 4788999999999999999999999999999999999999999
Q ss_pred eEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHh
Q 013081 153 IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFR 231 (450)
Q Consensus 153 lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~ 231 (450)
+||+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ 239 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCc-chhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 99999999874322111112234456789999999887766 588999999999999999 9999988887777777776
Q ss_pred CCCC-CCCCCCHHHHHHHHHccccCcCCCCCHHHHHh
Q 013081 232 GDFK-LPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 232 ~~~~-~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
+... .|..++..+.+++.+||+.||++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 240 GRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 6543 45668999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=341.14 Aligned_cols=249 Identities=31% Similarity=0.486 Sum_probs=206.4
Q ss_pred eEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeC--CEEEEE
Q 013081 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASK--SKIYMV 92 (450)
Q Consensus 16 y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~--~~~~lv 92 (450)
|++.+.||+|+||.||+|.+..+++.||+|.+.+...... .....+|+.+++++. ||||+++++++.+. +..|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~--~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE--QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch--hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 7889999999999999999999999999999865432221 223457889998885 99999999999887 889999
Q ss_pred EccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCC
Q 013081 93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 171 (450)
|||+. ++|.+.+.. ...+++..++.++.|++.||.|||+.|++||||+|+||+++. +.+||+|||++..... ..
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~---~~ 153 (282)
T cd07831 79 FELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYS---KP 153 (282)
T ss_pred EecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEeccccccccc---CC
Confidence 99997 588888765 357899999999999999999999999999999999999999 9999999999975432 12
Q ss_pred ccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC------------------C
Q 013081 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------------D 233 (450)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------------~ 233 (450)
......+++.|+|||++......+.++||||+||++|+|++|..||.+.+..+....+... .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07831 154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233 (282)
T ss_pred CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence 2233568899999998766666678999999999999999999999887765544433211 1
Q ss_pred CCCC-----------CCCCHHHHHHHHHccccCcCCCCCHHHHHhcccc
Q 013081 234 FKLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 234 ~~~p-----------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~ 271 (450)
+.+| ..++..+.+||.+||++||++|||+.++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1111 2367899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=342.46 Aligned_cols=255 Identities=24% Similarity=0.427 Sum_probs=219.4
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
+.|+..+.||.|+||.||.|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++.+.+....|+||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 468899999999999999999999999999999875432 233578899999999999999999999999999999999
Q ss_pred ccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCcc
Q 013081 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (450)
Q Consensus 94 E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 173 (450)
||++|++|.+++.. +++++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++...... ....
T Consensus 82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~ 158 (277)
T cd06640 82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT--QIKR 158 (277)
T ss_pred ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCC--cccc
Confidence 99999999998865 67899999999999999999999999999999999999999999999999998754321 1122
Q ss_pred ccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHcc
Q 013081 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKIL 252 (450)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L 252 (450)
....++..|+|||++.+..+ +.++|+||+||++|+|++|..||...+.......+... ....+..++..+.+++.+||
T Consensus 159 ~~~~~~~~y~apE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAY-DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACL 237 (277)
T ss_pred ccccCcccccCHhHhccCCC-ccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHc
Confidence 33568889999999876665 58999999999999999999999887766555444333 23344557889999999999
Q ss_pred ccCcCCCCCHHHHHhccccccC
Q 013081 253 EPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 253 ~~dP~~R~t~~~il~h~~~~~~ 274 (450)
+.+|++|||+.+++.|+||...
T Consensus 238 ~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 238 NKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred ccCcccCcCHHHHHhChHhhhc
Confidence 9999999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=342.43 Aligned_cols=256 Identities=30% Similarity=0.445 Sum_probs=211.6
Q ss_pred CcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEE----
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA---- 84 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~---- 84 (450)
....++|++.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 345679999999999999999999999999999999875432 1235678899999999 6999999999873
Q ss_pred -eCCEEEEEEccCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecC
Q 013081 85 -SKSKIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFG 159 (450)
Q Consensus 85 -~~~~~~lv~E~~~gg~L~~~i~~----~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFG 159 (450)
.....|++|||++|++|.+.+.. ...+++..++.++.|++.||.|||+++++||||||+||+++.++.+||+|||
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg 169 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG 169 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCC
Confidence 44678999999999999988752 3568999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCcccCCCccccccCCCCccchhhhccC----CCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC--
Q 013081 160 LSALPQHFRDDGLLHTTCGSPNYVAPEVLANR----GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-- 233 (450)
Q Consensus 160 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~----~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-- 233 (450)
++..... .........|++.|+|||++... ...+.++||||+||++|+|++|..||...+......++....
T Consensus 170 ~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (286)
T cd06638 170 VSAQLTS--TRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPP 247 (286)
T ss_pred ceeeccc--CCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCC
Confidence 9875432 11123345789999999997532 223578999999999999999999998776544443333221
Q ss_pred -CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhcccc
Q 013081 234 -FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 234 -~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~ 271 (450)
...|..++..+.+|+.+||+.||++|||+.++++|+||
T Consensus 248 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 248 TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 22345578899999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-45 Score=354.25 Aligned_cols=260 Identities=30% Similarity=0.466 Sum_probs=231.3
Q ss_pred CcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (450)
.+..+.|..-+.||+|+||.||-++.+.||+.+|+|.+.+.++....-.....+|-.+|.+++.|.||.+--.|++.+.+
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L 260 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL 260 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence 35567889999999999999999999999999999999887766555556778899999999999999999999999999
Q ss_pred EEEEccCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcc
Q 013081 90 YMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~--~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 167 (450)
++||..|+||+|.-.|.+.+ .+++..++.|+.+|+.||++||+.+|++||+||+|||+|+.|++.|+|+|||....
T Consensus 261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~-- 338 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP-- 338 (591)
T ss_pred EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC--
Confidence 99999999999998887766 79999999999999999999999999999999999999999999999999998543
Q ss_pred cCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcH----HHHHHHHHhCCCCCCCCCCHH
Q 013081 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL----AVLYQKIFRGDFKLPKWLSPG 243 (450)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~~p~~~s~~ 243 (450)
........+||.+|||||++.+..| +...|.||+||++|+|+.|+.||..... +++-+.+......+|+.+|++
T Consensus 339 -~g~~~~~rvGT~GYMAPEvl~ne~Y-~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~e 416 (591)
T KOG0986|consen 339 -EGKPIRGRVGTVGYMAPEVLQNEVY-DFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEE 416 (591)
T ss_pred -CCCccccccCcccccCHHHHcCCcc-cCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHH
Confidence 3344556699999999999998886 5889999999999999999999976432 244556666677889999999
Q ss_pred HHHHHHHccccCcCCCC-----CHHHHHhcccccc
Q 013081 244 AQNLLRKILEPNPVKRI-----TIAGIKADEWFEQ 273 (450)
Q Consensus 244 ~~~Li~~~L~~dP~~R~-----t~~~il~h~~~~~ 273 (450)
+++|.+.+|++||++|. .++++.+||+|+.
T Consensus 417 akslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ 451 (591)
T KOG0986|consen 417 AKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD 451 (591)
T ss_pred HHHHHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence 99999999999999997 4679999999986
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=336.83 Aligned_cols=253 Identities=30% Similarity=0.497 Sum_probs=214.1
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 92 (450)
+++|++.+.||+|+||.||+|++..+++.||+|.+.............+.+|+.+++.++||||+++++++.+.+..|++
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 47899999999999999999999999999999988765444555567788999999999999999999999999999999
Q ss_pred EccCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc
Q 013081 93 LEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~----~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 168 (450)
+||+++++|.+++.. ...+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~- 159 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK- 159 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch-
Confidence 999999999988753 345899999999999999999999999999999999999999999999999998754321
Q ss_pred CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCc--HHHHHHHHHhCCC-CCC-CCCCHHH
Q 013081 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN--LAVLYQKIFRGDF-KLP-KWLSPGA 244 (450)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~--~~~~~~~i~~~~~-~~p-~~~s~~~ 244 (450)
........|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||.... .......+..... +.+ ..++..+
T Consensus 160 -~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08228 160 -TTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKL 237 (267)
T ss_pred -hHHHhcCCCCccccChhhhccCCC-CchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence 112334578899999999877666 588999999999999999999996543 2344444443322 222 3578899
Q ss_pred HHHHHHccccCcCCCCCHHHHHhc
Q 013081 245 QNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
.+++.+||+.+|++|||+.++++.
T Consensus 238 ~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 238 RELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHHCCCCcccCcCHHHHHHH
Confidence 999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=342.44 Aligned_cols=253 Identities=26% Similarity=0.413 Sum_probs=210.6
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEE------
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA------ 84 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~------ 84 (450)
..|.|++.+.||.|+||.||+|.+..+++.||+|++.... .....+.+|+.+++++ +||||+++++++.
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 4589999999999999999999999999999999986542 2245688899999998 6999999999984
Q ss_pred eCCEEEEEEccCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCC
Q 013081 85 SKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA 162 (450)
Q Consensus 85 ~~~~~~lv~E~~~gg~L~~~i~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~ 162 (450)
.....|++|||+.+|+|.+++... ..+++..+..++.||+.||+|||++|++||||||+||++++++.++|+|||++.
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 346789999999999999988653 458899999999999999999999999999999999999999999999999987
Q ss_pred CCCcccCCCccccccCCCCccchhhhcc-----CCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC-CC-
Q 013081 163 LPQHFRDDGLLHTTCGSPNYVAPEVLAN-----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FK- 235 (450)
Q Consensus 163 ~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~- 235 (450)
.... .........|++.|+|||++.. ..+ +.++|+|||||++|+|++|..||...........+.... ..
T Consensus 170 ~~~~--~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~-~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 246 (282)
T cd06636 170 QLDR--TVGRRNTFIGTPYWMAPEVIACDENPDATY-DYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL 246 (282)
T ss_pred hhhc--cccCCCcccccccccCHhhcCcccCcCcCC-CcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCC
Confidence 5322 1122345678999999999753 233 578999999999999999999997765544333333322 11
Q ss_pred CCCCCCHHHHHHHHHccccCcCCCCCHHHHHhcccc
Q 013081 236 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 236 ~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~ 271 (450)
.+..+++.+.+||++||+.||.+|||+.++++||||
T Consensus 247 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 247 KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred cccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 123478999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=340.32 Aligned_cols=255 Identities=23% Similarity=0.364 Sum_probs=213.8
Q ss_pred cccCCeEEeeeecccCceEEEEEEEC----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDL----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (450)
..+..|++.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 79 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE 79 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence 45678999999999999999999853 456789999986432 233356788999999999999999999999999
Q ss_pred CEEEEEEccCCCCChHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEcc
Q 013081 87 SKIYMVLEYVTGGELFDKIASK-----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 149 (450)
Q Consensus 87 ~~~~lv~E~~~gg~L~~~i~~~-----------------~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~ 149 (450)
...|++|||+++++|.+++... ..+++.++..++.|++.||+|||++|++||||||+|||+++
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~ 159 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE 159 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC
Confidence 9999999999999999998532 24788899999999999999999999999999999999999
Q ss_pred CCCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHH
Q 013081 150 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQK 228 (450)
Q Consensus 150 ~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~ 228 (450)
++.+||+|||+++...............++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKF-SSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM 238 (283)
T ss_pred CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 99999999999975432111122233456778999999876665 589999999999999998 9999988776666665
Q ss_pred HHhC-CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 229 IFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 229 i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
+... ..+.|..+++.+.+++.+||++||.+||++.+|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 239 VRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 5544 355677789999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=344.53 Aligned_cols=261 Identities=25% Similarity=0.387 Sum_probs=219.4
Q ss_pred cCCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013081 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (450)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (450)
.....-.+|++.+.||+|+||.||+|.+..+|+.||+|.+........+....+.+|+.+++.++||||+++++++....
T Consensus 9 ~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~ 88 (307)
T cd06607 9 SKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH 88 (307)
T ss_pred cCCCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC
Confidence 33445567999999999999999999999999999999987554444445577899999999999999999999999999
Q ss_pred EEEEEEccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCc
Q 013081 88 KIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 166 (450)
..|+||||+. |+|.+.+.. .+++++..+..++.||+.||.|||++|++||||+|+||+++.++.+||+|||++.....
T Consensus 89 ~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 89 TAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred eEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 9999999997 577776653 56799999999999999999999999999999999999999999999999999874322
Q ss_pred ccCCCccccccCCCCccchhhhcc--CCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC-CCC-CCCCCH
Q 013081 167 FRDDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FKL-PKWLSP 242 (450)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~-p~~~s~ 242 (450)
.....+++.|+|||++.+ ....+.++||||+|+++|+|++|+.||.+.+.......+.... ... +..++.
T Consensus 168 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (307)
T cd06607 168 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSD 241 (307)
T ss_pred ------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCH
Confidence 234568899999998742 2334588999999999999999999998877665544444332 222 234688
Q ss_pred HHHHHHHHccccCcCCCCCHHHHHhccccccCC
Q 013081 243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
.+.++|.+||..||++|||+.+++.||||....
T Consensus 242 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 242 YFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 999999999999999999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=334.37 Aligned_cols=255 Identities=29% Similarity=0.493 Sum_probs=221.7
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
..|++.+.||+|++|.||+|.+..+++.||+|.+...... .....+.+|+..+++++||||+++++++......|++|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 3689999999999999999999999999999998765432 34578999999999999999999999999999999999
Q ss_pred ccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhh-cCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCc
Q 013081 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (450)
Q Consensus 94 E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~-~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 172 (450)
||+++++|.+++....++++..+..++.|++.||+|||+ .|++||||+|+||+++.++.++|+|||++...... ...
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~ 156 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENT--LDQ 156 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccC--CCc
Confidence 999999999999888889999999999999999999999 99999999999999999999999999998854321 122
Q ss_pred cccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCC---cHHHHHHHHHhC-CCCCCCC-CCHHHHHH
Q 013081 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR---NLAVLYQKIFRG-DFKLPKW-LSPGAQNL 247 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~---~~~~~~~~i~~~-~~~~p~~-~s~~~~~L 247 (450)
.....++..|+|||.+....+ +.++|+||||+++|+|++|..||... ........+... ....+.. ++..+.++
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 235 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESY-SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDF 235 (264)
T ss_pred ccceeecccccCHhhhCCCCC-CchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence 235578899999999877654 58999999999999999999999876 344445554443 3444555 88999999
Q ss_pred HHHccccCcCCCCCHHHHHhcccccc
Q 013081 248 LRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 248 i~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
|.+||.++|++|||+.++++|||++.
T Consensus 236 i~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 236 ISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred HHHHccCChhhCCCHHHHHhCHHHHh
Confidence 99999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=351.91 Aligned_cols=257 Identities=29% Similarity=0.452 Sum_probs=211.1
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK----- 86 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 86 (450)
..++|++.+.||+|+||.||+|.+..+|+.||+|.+.+... .......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 45789999999999999999999999999999999865432 233346778899999999999999999988543
Q ss_pred -CEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCC
Q 013081 87 -SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (450)
Q Consensus 87 -~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 165 (450)
...|+||||+. ++|.+.+... +++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++....
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 35799999996 5888887653 8999999999999999999999999999999999999999999999999997532
Q ss_pred cccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC-------------
Q 013081 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------- 232 (450)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------- 232 (450)
. ........+++.|+|||++.+..+ +.++|||||||++|+|++|+.||...+....+.++...
T Consensus 170 ~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 170 T---SFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred C---CCCCCCCcccccccCHHHHhCCCC-CCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 2 222344578999999999987776 58899999999999999999999876654433333210
Q ss_pred ---------CC-----C---------C-------CCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCCC
Q 013081 233 ---------DF-----K---------L-------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 276 (450)
Q Consensus 233 ---------~~-----~---------~-------p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~~ 276 (450)
.. + . +...++.+.+||.+||+.||++|||+.++|.||||...+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~ 319 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD 319 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccC
Confidence 00 0 0 1123567899999999999999999999999999986554
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=334.38 Aligned_cols=253 Identities=30% Similarity=0.568 Sum_probs=217.8
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEc
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 94 (450)
+|++.+.||+|+||.||+|.+..+|..||+|.+....... ...+.+.+|+.+++.++||||+++++.+.+....|+++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 6899999999999999999999999999999987653322 234678899999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCC-eEEeecCCCCCCCcccCCC
Q 013081 95 YVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN-IKISDFGLSALPQHFRDDG 171 (450)
Q Consensus 95 ~~~gg~L~~~i~~~~--~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~-lkl~DFGla~~~~~~~~~~ 171 (450)
|+++++|.+++.... .+++..+..++.|++.||.|||+++++||||||+||++++++. +||+|||.+..... ...
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~--~~~ 157 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND--SME 157 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccC--Ccc
Confidence 999999999987643 4799999999999999999999999999999999999998864 69999999875432 112
Q ss_pred ccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCC-CCCCCCCHHHHHHHHH
Q 013081 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRK 250 (450)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~ 250 (450)
......|++.|+|||++.+..+ +.++|+||+|+++|+|++|..||...+.......+..... +.+..++..+.+++.+
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 236 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPY-NNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQ 236 (257)
T ss_pred cccccCCCccccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHH
Confidence 2234568999999999877665 5889999999999999999999988777666666555433 3445678999999999
Q ss_pred ccccCcCCCCCHHHHHhcccc
Q 013081 251 ILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 251 ~L~~dP~~R~t~~~il~h~~~ 271 (450)
||+.+|++|||+.++++||||
T Consensus 237 ~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 237 LFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HhccChhhCcCHHHHhhCCCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=349.53 Aligned_cols=259 Identities=31% Similarity=0.477 Sum_probs=209.9
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----CE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-----SK 88 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~~ 88 (450)
++|++.+.||+|+||.||+|.+..+|+.||+|.+.... .......+.+|+.++++++||||+++++++... ..
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 68999999999999999999999999999999986422 223356788899999999999999999987543 35
Q ss_pred EEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc
Q 013081 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 168 (450)
.|+++||+. ++|.+.+.. +++++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~lv~e~~~-~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 83 VYIVQELME-TDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred EEEEehhcc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 899999996 588877754 679999999999999999999999999999999999999999999999999987543211
Q ss_pred C-CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHh----------------
Q 013081 169 D-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR---------------- 231 (450)
Q Consensus 169 ~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~---------------- 231 (450)
. .......+||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+..
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (336)
T cd07849 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL 240 (336)
T ss_pred cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhch
Confidence 1 11223457899999999876654456899999999999999999999987654332221110
Q ss_pred -------C---CCC-----CCCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCCC
Q 013081 232 -------G---DFK-----LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 276 (450)
Q Consensus 232 -------~---~~~-----~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~~ 276 (450)
. ... ..+..++.+.+|+.+||++||.+|||+.++++||||+....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 0 000 01235788999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=345.75 Aligned_cols=256 Identities=32% Similarity=0.477 Sum_probs=207.4
Q ss_pred CeEEeeeecccCceEEEEEEECC--CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEE
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLD--SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SKIY 90 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~ 90 (450)
+|++.+.||+|+||.||+|.+.. +++.||+|.+.............+.+|+.+++.++||||+++++++.+. ...|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 69999999999999999999988 8999999999764433333456788999999999999999999999887 8899
Q ss_pred EEEccCCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEcc----CCCeEEeecCCC
Q 013081 91 MVLEYVTGGELFDKIAS-----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS----KGNIKISDFGLS 161 (450)
Q Consensus 91 lv~E~~~gg~L~~~i~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~----~g~lkl~DFGla 161 (450)
+||||+.+ +|.+.+.. ...+++..++.++.|++.||+|||++||+||||||+||+++. ++.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999964 77776642 136899999999999999999999999999999999999999 899999999999
Q ss_pred CCCCcccC-CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHH---------HHHHHH-
Q 013081 162 ALPQHFRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV---------LYQKIF- 230 (450)
Q Consensus 162 ~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~---------~~~~i~- 230 (450)
........ .......++++.|+|||++.+....+.++|||||||++|+|++|++||.+..... ....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 86433221 1123345789999999998765545688999999999999999999997644321 000000
Q ss_pred -------------------------hCCCCCC-----------CCCCHHHHHHHHHccccCcCCCCCHHHHHhcccc
Q 013081 231 -------------------------RGDFKLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 231 -------------------------~~~~~~p-----------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~ 271 (450)
......+ ...+..+.+++.+||++||++|||+.+++.||||
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 0001111 1456789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=333.73 Aligned_cols=245 Identities=28% Similarity=0.451 Sum_probs=205.5
Q ss_pred eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEccCCCC
Q 013081 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG 99 (450)
Q Consensus 20 ~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 99 (450)
+.||+|+||.||+|.+..+++.||+|.+.... ..+....+.+|+.++++++||||+++++++......|+||||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 46999999999999999999999999876432 3344578999999999999999999999999999999999999999
Q ss_pred ChHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccccccC
Q 013081 100 ELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 178 (450)
Q Consensus 100 ~L~~~i~~~~-~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 178 (450)
+|.+++...+ .+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++................+
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence 9999987644 689999999999999999999999999999999999999999999999999874322110000111123
Q ss_pred CCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccccCc
Q 013081 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNP 256 (450)
Q Consensus 179 t~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP 256 (450)
+..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+.......+... ....|..++..+.+|+.+||++||
T Consensus 159 ~~~y~aPE~~~~~~~-~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 237 (252)
T cd05084 159 PVKWTAPEALNYGRY-SSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDP 237 (252)
T ss_pred ceeecCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCCh
Confidence 456999999877665 588999999999999998 99999877666555555443 455667789999999999999999
Q ss_pred CCCCCHHHHHh
Q 013081 257 VKRITIAGIKA 267 (450)
Q Consensus 257 ~~R~t~~~il~ 267 (450)
++|||+.++++
T Consensus 238 ~~Rps~~~~~~ 248 (252)
T cd05084 238 GQRPSFSTVHQ 248 (252)
T ss_pred hhCcCHHHHHH
Confidence 99999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=357.32 Aligned_cols=251 Identities=33% Similarity=0.664 Sum_probs=220.4
Q ss_pred eEE--eeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 16 YEL--GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 16 y~i--~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
|++ -+.||.|-||+||-|+++.+|+.||||+|++.+..... ..++++|+.||+.+.||+||.+--.+++.+++++||
T Consensus 564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVM 642 (888)
T KOG4236|consen 564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVM 642 (888)
T ss_pred HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEe
Confidence 454 47899999999999999999999999999988776543 488999999999999999999999999999999999
Q ss_pred ccCCCCChHHHHH--hcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCC---CeEEeecCCCCCCCccc
Q 013081 94 EYVTGGELFDKIA--SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQHFR 168 (450)
Q Consensus 94 E~~~gg~L~~~i~--~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g---~lkl~DFGla~~~~~~~ 168 (450)
|-+.| +..+.|- ..+++++...+.++.||+.||.|||-++|+|+||||||||+.... .+||||||+|++..
T Consensus 643 EKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg--- 718 (888)
T KOG4236|consen 643 EKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIG--- 718 (888)
T ss_pred hhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecc---
Confidence 99955 6666663 467899999999999999999999999999999999999997654 69999999999754
Q ss_pred CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCC--CC--CCHHH
Q 013081 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP--KW--LSPGA 244 (450)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p--~~--~s~~~ 244 (450)
..+...+.+|||.|.|||++.+++|+ ..-|+||.|||+|.-|+|..||.... ++..+|.+..+-+| +| +++.+
T Consensus 719 EksFRrsVVGTPAYLaPEVLrnkGyN-rSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~PW~eis~~A 795 (888)
T KOG4236|consen 719 EKSFRRSVVGTPAYLAPEVLRNKGYN-RSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNPWSEISPEA 795 (888)
T ss_pred hhhhhhhhcCCccccCHHHHhhcccc-ccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCchhhcCHHH
Confidence 34556788999999999999999997 78899999999999999999997543 44556666655444 44 89999
Q ss_pred HHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 245 QNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
.+||..+|+..-.+|+|+++.+.|||++..
T Consensus 796 idlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 796 IDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred HHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 999999999999999999999999999864
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=340.41 Aligned_cols=258 Identities=30% Similarity=0.455 Sum_probs=212.2
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 92 (450)
+++|++.+.||+|++|.||+|.+..+|+.||+|.+..... .......+.+|+.++++++||||+++++++.+....|+|
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence 5789999999999999999999999999999999865432 223346788999999999999999999999999999999
Q ss_pred EccCCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEcc-CCCeEEeecCCCCCCCcccC
Q 013081 93 LEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-KGNIKISDFGLSALPQHFRD 169 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~~~~--l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~-~g~lkl~DFGla~~~~~~~~ 169 (450)
|||++ ++|.+.+..... +++..++.++.||+.||+|||++|++||||+|+||+++. ++.+||+|||++......
T Consensus 80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~-- 156 (294)
T PLN00009 80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP-- 156 (294)
T ss_pred Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC--
Confidence 99995 588888765443 578899999999999999999999999999999999985 457999999999753221
Q ss_pred CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC----------------
Q 013081 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---------------- 233 (450)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---------------- 233 (450)
........+++.|+|||.+.+....+.++||||+||++|+|++|..||...+......++....
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 1122344678999999998765555689999999999999999999998776655544433210
Q ss_pred ----C---C------CCCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 234 ----F---K------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 234 ----~---~------~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
. . ..+.+++.+.+++.+||+.||++||++.++++||||...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 0 0 112367889999999999999999999999999999753
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=345.54 Aligned_cols=257 Identities=27% Similarity=0.451 Sum_probs=218.0
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
..|.....||+|+||.||++.+..++..||||.+.... ....+.+.+|+.+++.++||||+++++.+...+..|++|
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~ 98 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence 45666788999999999999999999999999986432 233567889999999999999999999999999999999
Q ss_pred ccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCcc
Q 013081 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (450)
Q Consensus 94 E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 173 (450)
||++|++|.+++.. +.+++.++..++.||+.||+|||++||+||||||+||++++++.++|+|||++..... .....
T Consensus 99 e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~--~~~~~ 175 (292)
T cd06658 99 EFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK--EVPKR 175 (292)
T ss_pred eCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccc--ccccC
Confidence 99999999998754 5789999999999999999999999999999999999999999999999999874322 12223
Q ss_pred ccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC---CCCCCCCCHHHHHHHHH
Q 013081 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGAQNLLRK 250 (450)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~Li~~ 250 (450)
....|++.|+|||.+.+..+ +.++|+||+|+++|+|++|+.||...+.......+.... ...+..+++.+.+++.+
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 254 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDL 254 (292)
T ss_pred ceeecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHH
Confidence 44678999999999877666 588999999999999999999998877665555444332 22223478899999999
Q ss_pred ccccCcCCCCCHHHHHhccccccCCCC
Q 013081 251 ILEPNPVKRITIAGIKADEWFEQDYTP 277 (450)
Q Consensus 251 ~L~~dP~~R~t~~~il~h~~~~~~~~~ 277 (450)
||..||.+|||+.++++||||.....|
T Consensus 255 ~l~~~P~~Rpt~~~il~~~~~~~~~~~ 281 (292)
T cd06658 255 MLVREPSQRATAQELLQHPFLKLAGPP 281 (292)
T ss_pred HccCChhHCcCHHHHhhChhhhccCCc
Confidence 999999999999999999999865544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=338.46 Aligned_cols=253 Identities=22% Similarity=0.307 Sum_probs=210.9
Q ss_pred cCCeEEeeeecccCceEEEEEEECC-----CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (450)
-++|++.+.||+|+||.||.|.+.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 4679999999999999999998642 45689999885432 2223456889999999999999999999999999
Q ss_pred EEEEEEccCCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEee
Q 013081 88 KIYMVLEYVTGGELFDKIASKG----------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISD 157 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~~----------~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~D 157 (450)
..++||||+++++|.+++.+.. .++...+..++.|++.||+|||++|++||||||+|||+++++.++|+|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~d 162 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 162 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECC
Confidence 9999999999999999986532 356788899999999999999999999999999999999999999999
Q ss_pred cCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCC-CC
Q 013081 158 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FK 235 (450)
Q Consensus 158 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~ 235 (450)
||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+.... ..
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~ 241 (277)
T cd05062 163 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLD 241 (277)
T ss_pred CCCccccCCcceeecCCCCccCHhhcChhHhhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 999874322111111123456788999999876655 589999999999999999 799999888777766665553 45
Q ss_pred CCCCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 236 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 236 ~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
.|..+++.+.+++.+||+.||++|||+.+++++
T Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 242 KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 667789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=343.65 Aligned_cols=254 Identities=24% Similarity=0.423 Sum_probs=216.8
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
..|+..+.||+|+||.||+|.+..+++.||+|.+..... ....+.+.+|+.+++.++||||+++++.+......|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 457788999999999999999999999999999865432 233568899999999999999999999999999999999
Q ss_pred ccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCcc
Q 013081 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (450)
Q Consensus 94 E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 173 (450)
||++|++|.+++.. +++++..++.++.|++.||.|||++|++|+||+|+||++++++.++|+|||++...... ....
T Consensus 82 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~--~~~~ 158 (277)
T cd06642 82 EYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT--QIKR 158 (277)
T ss_pred EccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCc--chhh
Confidence 99999999998864 67899999999999999999999999999999999999999999999999998754321 1122
Q ss_pred ccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHcc
Q 013081 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKIL 252 (450)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L 252 (450)
....|+..|+|||++.+..+ +.++|+||+||++|+|++|..||...........+... ....+..++..+.+++.+||
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAY-DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACL 237 (277)
T ss_pred hcccCcccccCHHHhCcCCC-chhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHc
Confidence 33468899999999887665 58899999999999999999999876655544444333 23344557889999999999
Q ss_pred ccCcCCCCCHHHHHhcccccc
Q 013081 253 EPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 253 ~~dP~~R~t~~~il~h~~~~~ 273 (450)
+.+|++|||+.++++||||..
T Consensus 238 ~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 238 NKDPRFRPTAKELLKHKFITR 258 (277)
T ss_pred cCCcccCcCHHHHHHhHHHHH
Confidence 999999999999999999975
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=339.28 Aligned_cols=258 Identities=24% Similarity=0.323 Sum_probs=213.4
Q ss_pred cCCeEEeeeecccCceEEEEEEECC-----CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (450)
-++|++.+.||+|+||.||+|.++. .+..||+|.+..... ......+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 4689999999999999999997542 355899998864432 222456788999999999999999999999999
Q ss_pred EEEEEEccCCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEee
Q 013081 88 KIYMVLEYVTGGELFDKIASKG----------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISD 157 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~~----------~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~D 157 (450)
..|++|||+++|+|.+++...+ .++...+..++.||+.||.|||++||+||||||+|||++.++.++|+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~D 162 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGD 162 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECc
Confidence 9999999999999999997532 346678899999999999999999999999999999999999999999
Q ss_pred cCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCC
Q 013081 158 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFK 235 (450)
Q Consensus 158 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~ 235 (450)
||+++...............++..|+|||.+.+..+ +.++|+||+||++|+|++ |..||.+.+.......+..+ ...
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~ 241 (288)
T cd05061 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLD 241 (288)
T ss_pred CCccccccccccccccCCCcccccccCHHHhccCCC-ChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 999875322111111122345678999999877665 589999999999999999 89999988877777666655 345
Q ss_pred CCCCCCHHHHHHHHHccccCcCCCCCHHHHHh------cccccc
Q 013081 236 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKA------DEWFEQ 273 (450)
Q Consensus 236 ~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~------h~~~~~ 273 (450)
.+..+++.+.+++.+||+.||++|||+.++++ ||||..
T Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 242 QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 66778899999999999999999999999987 777754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=339.29 Aligned_cols=250 Identities=28% Similarity=0.406 Sum_probs=212.6
Q ss_pred CCeEEeeeecccCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (450)
.+|.+.+.||+|+||.||++.+. .++..+|+|.+.... ......+.+|+.++++++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 81 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 47999999999999999999853 345679999886432 3345678999999999999999999999999999
Q ss_pred EEEEEccCCCCChHHHHHhcC-------------CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEE
Q 013081 89 IYMVLEYVTGGELFDKIASKG-------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKI 155 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~~i~~~~-------------~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl 155 (450)
.|++|||+++++|.+++...+ .+++..+..++.||+.||+|||++|++||||||+|||+++++.+||
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEe
Confidence 999999999999999987543 4899999999999999999999999999999999999999999999
Q ss_pred eecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCC-
Q 013081 156 SDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD- 233 (450)
Q Consensus 156 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~- 233 (450)
+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+..+.
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~ 240 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV 240 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCc
Confidence 99999875432111112233456788999999876655 589999999999999998 999999888777777777765
Q ss_pred CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHh
Q 013081 234 FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 234 ~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
...+..+++++.+|+.+||++||.+|||+.++++
T Consensus 241 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 241 LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 3456678999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=345.59 Aligned_cols=253 Identities=21% Similarity=0.324 Sum_probs=210.4
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCce----EEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLP----FAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~----vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (450)
...+|++.+.||+|+||.||+|.+..+++. ||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~- 81 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 81 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence 346799999999999999999998766654 8999986432 233457788999999999999999999998764
Q ss_pred EEEEEEccCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCc
Q 013081 88 KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 166 (450)
..++++||+++|+|.+.+... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence 578999999999999999764 4688999999999999999999999999999999999999999999999999986433
Q ss_pred ccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHH
Q 013081 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGA 244 (450)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~ 244 (450)
...........++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+............+ ..+.|..++..+
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 240 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHH
Confidence 211111222345678999999887766 589999999999999998 99999887766554444333 345567789999
Q ss_pred HHHHHHccccCcCCCCCHHHHHhc
Q 013081 245 QNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
.+++.+||..||.+|||+.+++.+
T Consensus 241 ~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 241 YMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=330.12 Aligned_cols=253 Identities=34% Similarity=0.587 Sum_probs=223.4
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEc
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 94 (450)
+|++.+.||.|+||.||+|.+..+++.||+|.+..... .......+.+|+++++.++|||++++++.+......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 69999999999999999999998999999999876443 22345778899999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCC
Q 013081 95 YVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (450)
Q Consensus 95 ~~~gg~L~~~i~~~----~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 170 (450)
|++|++|.+.+.+. ..+++..+..++.|++.||+|||++|++|+||+|+||+++.+++++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 157 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-- 157 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence 99999999999764 679999999999999999999999999999999999999999999999999998643321
Q ss_pred CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHH
Q 013081 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLR 249 (450)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~ 249 (450)
......+|++.|+|||.+....+ +.++|+||+|+++|+|++|..||...+........... ..+.|..++..+.+++.
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKPY-NYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVS 236 (258)
T ss_pred ceecceeeeecccChhHhccCCC-CccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 23445678999999999877665 58899999999999999999999988777777666655 34556678999999999
Q ss_pred HccccCcCCCCCHHHHHhcccc
Q 013081 250 KILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 250 ~~L~~dP~~R~t~~~il~h~~~ 271 (450)
+||..+|++|||+.++++||||
T Consensus 237 ~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 237 SLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHcCCChhhCcCHHHHhcCCCC
Confidence 9999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=329.01 Aligned_cols=253 Identities=32% Similarity=0.537 Sum_probs=222.0
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEc
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 94 (450)
+|++.+.||+|++|.||+|.+..+++.||+|.+...... ......+.+|+.++++++|||++++++++.+....|++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 589999999999999999999999999999999765432 2345789999999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccc
Q 013081 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH 174 (450)
Q Consensus 95 ~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 174 (450)
|+++++|.+++...+.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++....... ....
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~--~~~~ 157 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS--KDDA 157 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCc--cccc
Confidence 99999999999888899999999999999999999999999999999999999999999999999998654321 1234
Q ss_pred cccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHH-hCCCCCCCCCCHHHHHHHHHccc
Q 013081 175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF-RGDFKLPKWLSPGAQNLLRKILE 253 (450)
Q Consensus 175 ~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~-~~~~~~p~~~s~~~~~Li~~~L~ 253 (450)
...++..|+|||.+.... .+.++|+||+|+++|+|++|..||...+......+.. ......|..+++.+.+++.+||.
T Consensus 158 ~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 236 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQ 236 (254)
T ss_pred ccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHh
Confidence 457899999999987666 4688999999999999999999998766554444443 33455667789999999999999
Q ss_pred cCcCCCCCHHHHHhcccc
Q 013081 254 PNPVKRITIAGIKADEWF 271 (450)
Q Consensus 254 ~dP~~R~t~~~il~h~~~ 271 (450)
.+|++|||+.+++.||||
T Consensus 237 ~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 237 KDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred CChhhCcCHHHHhcCCCC
Confidence 999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=337.50 Aligned_cols=255 Identities=24% Similarity=0.420 Sum_probs=219.3
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEc
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 94 (450)
-|++.+.||.|+||.||+|.+..+++.||+|.+..... ......+.+|+.++++++||||+++++.+..+...|+|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 37788999999999999999988999999999864432 2335678899999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccc
Q 013081 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH 174 (450)
Q Consensus 95 ~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 174 (450)
|+++++|.+++.+ +.+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++...... .....
T Consensus 83 ~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~--~~~~~ 159 (277)
T cd06641 83 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT--QIKRN 159 (277)
T ss_pred eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccc--hhhhc
Confidence 9999999998865 57899999999999999999999999999999999999999999999999998754321 11123
Q ss_pred cccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccc
Q 013081 175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILE 253 (450)
Q Consensus 175 ~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~ 253 (450)
...++..|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+... ....+..++.++.+++.+||+
T Consensus 160 ~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 238 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLN 238 (277)
T ss_pred cccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcc
Confidence 3568899999999876655 48899999999999999999999887766555555444 334566789999999999999
Q ss_pred cCcCCCCCHHHHHhccccccCC
Q 013081 254 PNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 254 ~dP~~R~t~~~il~h~~~~~~~ 275 (450)
.+|.+||++.++++||||....
T Consensus 239 ~~p~~Rp~~~~~l~~~~~~~~~ 260 (277)
T cd06641 239 KEPSFRPTAKELLKHKFIVRFA 260 (277)
T ss_pred CChhhCcCHHHHHhCHHHhhhh
Confidence 9999999999999999998753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=339.65 Aligned_cols=252 Identities=31% Similarity=0.459 Sum_probs=210.8
Q ss_pred eEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEcc
Q 013081 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY 95 (450)
Q Consensus 16 y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 95 (450)
|++.+.||.|++|.||+|.+..+|..||+|++..... .......+.+|+.+++.++|||++++++++.+....|++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 7889999999999999999999999999999875532 222345678899999999999999999999999999999999
Q ss_pred CCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCcc
Q 013081 96 VTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (450)
Q Consensus 96 ~~gg~L~~~i~~~~--~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 173 (450)
+. ++|.+++.... .+++..+..++.|++.||+|||+++++||||+|+||+++.++.++|+|||++...... ....
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~--~~~~ 156 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP--VRTY 156 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC--cccc
Confidence 95 68999887655 6899999999999999999999999999999999999999999999999998754321 1122
Q ss_pred ccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC--------------------
Q 013081 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-------------------- 233 (450)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-------------------- 233 (450)
....+++.|+|||++.+....+.++|+||+|+++|+|++|++||...+......++.+..
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence 334578899999988765545688999999999999999999998776554433332210
Q ss_pred ---------CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhcccc
Q 013081 234 ---------FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 234 ---------~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~ 271 (450)
......+++.+.++|.+||++||.+|||+.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 01123467899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=331.93 Aligned_cols=252 Identities=31% Similarity=0.501 Sum_probs=214.5
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 92 (450)
.++|++.+.||+|+||.||+|.+..+|+.||+|.++............+.+|+.++++++|+||+++++.+...+..+++
T Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CCceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 36899999999999999999999989999999998754444444467899999999999999999999999999999999
Q ss_pred EccCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc
Q 013081 93 LEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~----~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 168 (450)
|||++|++|.+++.. ...+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~-- 158 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS-- 158 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccC--
Confidence 999999999998864 34589999999999999999999999999999999999999999999999999875432
Q ss_pred CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCc--HHHHHHHHHhCC-CCCCC-CCCHHH
Q 013081 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN--LAVLYQKIFRGD-FKLPK-WLSPGA 244 (450)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~--~~~~~~~i~~~~-~~~p~-~~s~~~ 244 (450)
.........+++.|+|||.+.+..+ +.++|+||+||++|+|++|..||.... .......+..+. .+.|. .++..+
T Consensus 159 ~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08224 159 KTTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEEL 237 (267)
T ss_pred CCcccceecCCccccCHHHhccCCC-CchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHH
Confidence 1122344578999999999887766 488999999999999999999996543 334444444443 23444 688899
Q ss_pred HHHHHHccccCcCCCCCHHHHHh
Q 013081 245 QNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
.++|.+||.++|++|||+.++++
T Consensus 238 ~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 238 RDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHHcCCCcccCCCHHHHHH
Confidence 99999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=343.71 Aligned_cols=252 Identities=27% Similarity=0.422 Sum_probs=210.5
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCce--EEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLP--FAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKS 87 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~--vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 87 (450)
..+++|++.+.||+|+||.||+|.+..++.. +|+|.+... ........+.+|+.++.++ +||||+++++++...+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 81 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence 4578999999999999999999998877765 466665432 2333456788999999999 8999999999999999
Q ss_pred EEEEEEccCCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCC
Q 013081 88 KIYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG 151 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~~----------------~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g 151 (450)
.+|++|||+++++|.+++...+ .+++..++.++.||+.||+|||++|++||||||+|||++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 161 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence 9999999999999999987542 478999999999999999999999999999999999999999
Q ss_pred CeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHH
Q 013081 152 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIF 230 (450)
Q Consensus 152 ~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~ 230 (450)
.+||+|||++....... ......++..|+|||++....+ +.++|||||||++|+|+| |..||.+.+.......+.
T Consensus 162 ~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 237 (303)
T cd05088 162 VAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 237 (303)
T ss_pred cEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCC-cccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh
Confidence 99999999986322110 1111234567999999876654 589999999999999998 999998887777666665
Q ss_pred hC-CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 231 RG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 231 ~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
.+ ....|..+++.+.+|+.+||+.+|++|||+.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 238 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 44 334555688999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=337.55 Aligned_cols=253 Identities=24% Similarity=0.344 Sum_probs=212.1
Q ss_pred cCCeEEeeeecccCceEEEEEEECC-----CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (450)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 4679999999999999999999977 77899999886432 2223466889999999999999999999999888
Q ss_pred EEEEEEccCCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCC---CeEEee
Q 013081 88 KIYMVLEYVTGGELFDKIASKG-------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---NIKISD 157 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~~-------~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g---~lkl~D 157 (450)
..|++|||++|++|.+++...+ .+++..+..++.||+.||+|||++|++||||||+|||++.++ .+||+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence 9999999999999999997643 489999999999999999999999999999999999998765 599999
Q ss_pred cCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCC
Q 013081 158 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFK 235 (450)
Q Consensus 158 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~ 235 (450)
||+++...............+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+... ...
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~ 241 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIF-TSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLD 241 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHHhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 999985421111111112233568999999877666 589999999999999997 99999988777666655543 455
Q ss_pred CCCCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 236 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 236 ~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
.|..+++.+.+++.+||+.||++|||+.++++|
T Consensus 242 ~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 242 PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 677789999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=337.54 Aligned_cols=255 Identities=26% Similarity=0.457 Sum_probs=218.3
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEc
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 94 (450)
.|.-.+.||+|++|.||+|.+..+++.+|+|.++... ....+.+.+|+.+++.++||||+++++++...+..|+++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 4555679999999999999999999999999886432 2224668899999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccc
Q 013081 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH 174 (450)
Q Consensus 95 ~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 174 (450)
|++|++|.+++.. +++++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++...... .....
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~--~~~~~ 173 (285)
T cd06648 97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE--VPRRK 173 (285)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccC--Ccccc
Confidence 9999999999877 67999999999999999999999999999999999999999999999999988743221 11223
Q ss_pred cccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCC---CCCCCHHHHHHHHHc
Q 013081 175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL---PKWLSPGAQNLLRKI 251 (450)
Q Consensus 175 ~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~---p~~~s~~~~~Li~~~ 251 (450)
...|++.|+|||.+.+..+ +.++|+||+||++|+|++|..||...+......++.....+. +..+++.+.+++++|
T Consensus 174 ~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 252 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRM 252 (285)
T ss_pred cccCCccccCHHHhcCCCC-CCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHH
Confidence 4578999999999877665 588999999999999999999998877766666665553222 233788999999999
Q ss_pred cccCcCCCCCHHHHHhccccccCCC
Q 013081 252 LEPNPVKRITIAGIKADEWFEQDYT 276 (450)
Q Consensus 252 L~~dP~~R~t~~~il~h~~~~~~~~ 276 (450)
|+.+|++|||+.++++||||.....
T Consensus 253 l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 253 LVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred cccChhhCcCHHHHccCcccccCCC
Confidence 9999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=337.64 Aligned_cols=245 Identities=27% Similarity=0.485 Sum_probs=205.5
Q ss_pred cCCeEEeeee--cccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 013081 13 LGRYELGRTL--GEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKI 89 (450)
Q Consensus 13 ~~~y~i~~~L--G~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 89 (450)
.++|++.+.+ |+|+||.||++.++.++..+|+|++....... .|+.....+ +||||+++++.+...+..
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 4678887777 99999999999999999999999987543211 122222223 699999999999999999
Q ss_pred EEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCC-CeEEeecCCCCCCCccc
Q 013081 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLSALPQHFR 168 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g-~lkl~DFGla~~~~~~~ 168 (450)
|+||||++|++|.+++....++++.+++.++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++.....
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~-- 162 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT-- 162 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC--
Confidence 99999999999999998878999999999999999999999999999999999999999998 999999999874321
Q ss_pred CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHH----HHHHHhCCCCCCCCCCHHH
Q 013081 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVL----YQKIFRGDFKLPKWLSPGA 244 (450)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~----~~~i~~~~~~~p~~~s~~~ 244 (450)
.....|++.|+|||++.+..+ +.++||||+|+++|+|++|..||........ .........+.++.+++.+
T Consensus 163 ----~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T PHA03390 163 ----PSCYDGTLDYFSPEKIKGHNY-DVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNA 237 (267)
T ss_pred ----CccCCCCCcccChhhhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHH
Confidence 223468999999999987776 5889999999999999999999986543221 1122233445566789999
Q ss_pred HHHHHHccccCcCCCCC-HHHHHhccccc
Q 013081 245 QNLLRKILEPNPVKRIT-IAGIKADEWFE 272 (450)
Q Consensus 245 ~~Li~~~L~~dP~~R~t-~~~il~h~~~~ 272 (450)
.+||.+||++||.+||+ ++++++||||+
T Consensus 238 ~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 238 NDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred HHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 99999999999999996 69999999996
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=331.43 Aligned_cols=246 Identities=29% Similarity=0.416 Sum_probs=215.4
Q ss_pred eeecccCceEEEEEEECCC---CceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEccC
Q 013081 20 RTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYV 96 (450)
Q Consensus 20 ~~LG~G~~g~Vy~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 96 (450)
+.||+|+||.||+|.+... +..||+|.+....... ....+.+|+..++.++||||+++++++......+++|||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4799999999999999865 8999999987654322 3578999999999999999999999999999999999999
Q ss_pred CCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcc
Q 013081 97 TGGELFDKIASK---------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (450)
Q Consensus 97 ~gg~L~~~i~~~---------~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 167 (450)
++++|.+++... ..+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999999875 78999999999999999999999999999999999999999999999999999865432
Q ss_pred cCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHH
Q 013081 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQ 245 (450)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 245 (450)
..........+++.|+|||.+....+ +.++||||||+++|+|++ |..||...........+..+ ....|..+++++.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIF-TSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY 237 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCc-chhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHH
Confidence 21122344567889999999877655 589999999999999999 69999998887777777754 4566788899999
Q ss_pred HHHHHccccCcCCCCCHHHHHhc
Q 013081 246 NLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 246 ~Li~~~L~~dP~~R~t~~~il~h 268 (450)
+++.+||..||++|||+.+++++
T Consensus 238 ~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 238 ELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHHccCCcccCcCHHHHHHh
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=340.47 Aligned_cols=254 Identities=24% Similarity=0.365 Sum_probs=215.9
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCC-----CceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDS-----GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (450)
.+.+|++.+.||+|+||.||+|.+..+ ++.||+|.+.... .......+.+|+.+++.++||||+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 456799999999999999999987543 5789999987443 233457788999999999999999999999999
Q ss_pred CEEEEEEccCCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccC
Q 013081 87 SKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 150 (450)
Q Consensus 87 ~~~~lv~E~~~gg~L~~~i~~~----------------~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~ 150 (450)
...++++||+.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++++
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 9999999999999999998532 347888999999999999999999999999999999999999
Q ss_pred CCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHH
Q 013081 151 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKI 229 (450)
Q Consensus 151 g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i 229 (450)
+.+||+|||+++...............+++.|+|||++....+ +.++||||+||++|+|++ |..||.+.+.......+
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI 239 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999875432222222334456789999999876665 588999999999999998 99999988888787777
Q ss_pred HhCC-CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 230 FRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 230 ~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
.... .+.|..++..+.+|+.+||+.+|.+||++.+|+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 240 RNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 7664 35577799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=328.91 Aligned_cols=255 Identities=34% Similarity=0.539 Sum_probs=220.1
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEEEE
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SKIYMV 92 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~lv 92 (450)
+|++.+.||+|++|.||+|.+..+++.|++|++...... ....+.+.+|+.++++++||||+++++.+... ...|++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 588999999999999999999989999999998765432 33467899999999999999999999999888 899999
Q ss_pred EccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCc
Q 013081 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 172 (450)
+||+++++|.+++.+...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 99999999999998877999999999999999999999999999999999999999999999999999886543221112
Q ss_pred cccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCc-HHHHHHHHH--hCCCCCCCCCCHHHHHHHH
Q 013081 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIF--RGDFKLPKWLSPGAQNLLR 249 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~-~~~~~~~i~--~~~~~~p~~~s~~~~~Li~ 249 (450)
.....++..|+|||.+....+ +.++||||+|+++|+|++|..||.... .......+. ......|..++..+.+++.
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~ 238 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRGEEY-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238 (260)
T ss_pred ccCCCCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHH
Confidence 345678999999999876654 589999999999999999999998765 222333333 2344567778999999999
Q ss_pred HccccCcCCCCCHHHHHhcccc
Q 013081 250 KILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 250 ~~L~~dP~~R~t~~~il~h~~~ 271 (450)
+||+.||++|||+.+++.||||
T Consensus 239 ~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 239 KCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HhCcCChhhCCCHHHHhhCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=361.94 Aligned_cols=250 Identities=29% Similarity=0.501 Sum_probs=217.5
Q ss_pred eecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEccCCCCC
Q 013081 21 TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGE 100 (450)
Q Consensus 21 ~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~ 100 (450)
.||+|+||+||-|+|..|...+|||-+.... .....-+..||.+.++|+|.|||++++.+..++.+-|+||-++||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 6999999999999999999999999986442 3346789999999999999999999999999999999999999999
Q ss_pred hHHHHHh-cCCC--CHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEc-cCCCeEEeecCCCCCCCcccCCCccccc
Q 013081 101 LFDKIAS-KGRL--QEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTT 176 (450)
Q Consensus 101 L~~~i~~-~~~l--~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~-~~g~lkl~DFGla~~~~~~~~~~~~~~~ 176 (450)
|.++++. -|++ .|...-.|.+||++||.|||++.|+|||||-+|+||+ -.|.+||+|||-++.... -+....+.
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TETF 736 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTETF 736 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhcc--CCcccccc
Confidence 9999986 4677 7888999999999999999999999999999999996 468999999998875433 34466788
Q ss_pred cCCCCccchhhhccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCc--HHHHHH-HHHhCCCCCCCCCCHHHHHHHHHcc
Q 013081 177 CGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILTGYLPFDDRN--LAVLYQ-KIFRGDFKLPKWLSPGAQNLLRKIL 252 (450)
Q Consensus 177 ~gt~~y~APE~l~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~--~~~~~~-~i~~~~~~~p~~~s~~~~~Li~~~L 252 (450)
-||.-|||||++..+ .-+|.++|||||||++.||.||++||-... ...+++ -.++..+++|..++.+++++|.+|+
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcF 816 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCF 816 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHc
Confidence 999999999998642 233799999999999999999999996532 233433 2345567889999999999999999
Q ss_pred ccCcCCCCCHHHHHhccccccCC
Q 013081 253 EPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 253 ~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
.+||..||++.++|.+||++.+.
T Consensus 817 epd~~~R~sA~~LL~DpFlq~~~ 839 (1226)
T KOG4279|consen 817 EPDPCDRPSAKDLLQDPFLQHNN 839 (1226)
T ss_pred CCCcccCccHHHhccCcccccCC
Confidence 99999999999999999998763
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=336.43 Aligned_cols=256 Identities=23% Similarity=0.378 Sum_probs=207.3
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHH-HHhCCCCCcceEEEEEEeCCEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT-LKLLKHPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~i-l~~l~hpnIv~l~~~~~~~~~~~lv 92 (450)
++|++.+.||+|+||.||+|.+..+|+.||+|.++....... ...+..|+.+ ++.++||||+++++++......|++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE--QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH--HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 479999999999999999999999999999999876533222 3455556664 6777899999999999999999999
Q ss_pred EccCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHhhhhhc-CeeeccCCCCcEEEccCCCeEEeecCCCCCCCcc
Q 013081 93 LEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~----~~~l~~~~~~~i~~ql~~aL~~LH~~-givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 167 (450)
|||++ |+|.+.+.. ...+++..++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||++.....
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~- 156 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD- 156 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccc-
Confidence 99996 578777653 34689999999999999999999997 999999999999999999999999999875322
Q ss_pred cCCCccccccCCCCccchhhhccC---CCCCccchhhhHHHHHHHHHhCCCCCCCC-cHHHHHHHHHhC-CCCCC-CCCC
Q 013081 168 RDDGLLHTTCGSPNYVAPEVLANR---GYDGATSDIWSCGVILYVILTGYLPFDDR-NLAVLYQKIFRG-DFKLP-KWLS 241 (450)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~---~~~~~~~DiwSlGvil~elltG~~Pf~~~-~~~~~~~~i~~~-~~~~p-~~~s 241 (450)
........|+..|+|||++.+. ...+.++|+||+||++|+|++|+.||... +..........+ ....| ..+|
T Consensus 157 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd06617 157 --SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFS 234 (283)
T ss_pred --ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccC
Confidence 1112235688999999987542 22357899999999999999999999753 222223333333 33344 3478
Q ss_pred HHHHHHHHHccccCcCCCCCHHHHHhccccccCC
Q 013081 242 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 242 ~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
.++.++|.+||..+|.+|||+.++++||||....
T Consensus 235 ~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 235 PEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 9999999999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=350.03 Aligned_cols=262 Identities=27% Similarity=0.409 Sum_probs=214.7
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE----eCCEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA----SKSKI 89 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~----~~~~~ 89 (450)
++|++.+.||+|+||.||+|.+..+|+.||+|.+..... .......+.+|+.++++++||||+++++++. .....
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 689999999999999999999999999999999875432 2233567888999999999999999999875 34578
Q ss_pred EEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC
Q 013081 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 169 (450)
|+||||+. ++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++........
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 99999995 68999998878899999999999999999999999999999999999999999999999999875432111
Q ss_pred --CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHh----------------
Q 013081 170 --DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR---------------- 231 (450)
Q Consensus 170 --~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~---------------- 231 (450)
........|+..|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+..
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~ 242 (334)
T cd07855 163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD 242 (334)
T ss_pred CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh
Confidence 11223457899999999987654456899999999999999999999987654332222111
Q ss_pred ----------CCCCC-----CCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCCCC
Q 013081 232 ----------GDFKL-----PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277 (450)
Q Consensus 232 ----------~~~~~-----p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~~~ 277 (450)
..... .+..++.+.++|++||+.+|.+|||+.+++.||||.+...+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~ 303 (334)
T cd07855 243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP 303 (334)
T ss_pred hHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCC
Confidence 00011 12368899999999999999999999999999999865433
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=377.20 Aligned_cols=255 Identities=25% Similarity=0.395 Sum_probs=210.0
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 92 (450)
+|+|++++.||+|+||.||+|.+..+|+.||+|.+..+........+++.+|+++++.++||||+++++++.+.+..|++
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 58999999999999999999999999999999999765444455567899999999999999999999999999999999
Q ss_pred EccCCCCChHHHHHhc-----------CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCC
Q 013081 93 LEYVTGGELFDKIASK-----------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS 161 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~~-----------~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla 161 (450)
|||++|++|.+++.+. .+++...+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 9999999999988641 23556778899999999999999999999999999999999999999999999
Q ss_pred CCCCcccC----------------CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHH
Q 013081 162 ALPQHFRD----------------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVL 225 (450)
Q Consensus 162 ~~~~~~~~----------------~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~ 225 (450)
........ .......+||+.|+|||++.+..+ +.++||||+||++|+|+||..||........
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~-S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA-SESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 75421100 011123579999999999887766 5899999999999999999999987554433
Q ss_pred HHHH-HhCCCCC--CCCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 226 YQKI-FRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 226 ~~~i-~~~~~~~--p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
.... ....... ...+++.+.+++.+||++||++||+..+.+.+
T Consensus 240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2221 1111111 13478999999999999999999987665544
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=333.41 Aligned_cols=253 Identities=23% Similarity=0.356 Sum_probs=214.1
Q ss_pred cCCeEEeeeecccCceEEEEEEECCC---CceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (450)
.++|++.+.||+|+||.||+|.+..+ ...||+|.++... .......+.+|+.+++.++||||+++++.+......
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 36799999999999999999998654 4589999986543 233356788999999999999999999999999999
Q ss_pred EEEEccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc
Q 013081 90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 168 (450)
|++|||+++++|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||+++++.++|+|||++.......
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 999999999999999876 3478999999999999999999999999999999999999999999999999998653211
Q ss_pred CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 013081 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 246 (450)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 246 (450)
.........+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+... ..+.+...++.+.+
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQ 239 (266)
T ss_pred cceeccCCCCCccccChhhhccCCC-ccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 1111122345678999999877665 589999999999999998 99999887777666666654 34556678999999
Q ss_pred HHHHccccCcCCCCCHHHHHhc
Q 013081 247 LLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 247 Li~~~L~~dP~~R~t~~~il~h 268 (450)
|+.+||+.+|++||++.+++++
T Consensus 240 li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 240 LMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=333.87 Aligned_cols=249 Identities=31% Similarity=0.484 Sum_probs=207.9
Q ss_pred EeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEccCC
Q 013081 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT 97 (450)
Q Consensus 18 i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 97 (450)
....||+|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.++||||+++++++...+..|+++||++
T Consensus 12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 88 (268)
T cd06624 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVP 88 (268)
T ss_pred ceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCC
Confidence 3468999999999999999999999999886543 2235678999999999999999999999999999999999999
Q ss_pred CCChHHHHHhc-CCC--CHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEcc-CCCeEEeecCCCCCCCcccCCCcc
Q 013081 98 GGELFDKIASK-GRL--QEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-KGNIKISDFGLSALPQHFRDDGLL 173 (450)
Q Consensus 98 gg~L~~~i~~~-~~l--~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~-~g~lkl~DFGla~~~~~~~~~~~~ 173 (450)
|++|.+.+... .++ ++..+..++.||+.||+|||++||+||||||+||+++. ++.++|+|||++..... .....
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~--~~~~~ 166 (268)
T cd06624 89 GGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCT 166 (268)
T ss_pred CCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheeccc--CCCcc
Confidence 99999998764 456 88899999999999999999999999999999999986 67999999999875432 11223
Q ss_pred ccccCCCCccchhhhccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCcHH--HHHHH-HHhCCCCCCCCCCHHHHHHHH
Q 013081 174 HTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYVILTGYLPFDDRNLA--VLYQK-IFRGDFKLPKWLSPGAQNLLR 249 (450)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--~~~~~-i~~~~~~~p~~~s~~~~~Li~ 249 (450)
....|++.|+|||++.... ..+.++|+||+|+++|+|++|..||...... ..... .......+|..+++.+.+|+.
T Consensus 167 ~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 246 (268)
T cd06624 167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFIL 246 (268)
T ss_pred ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHH
Confidence 3446889999999986543 2468899999999999999999999754322 22221 223345567778999999999
Q ss_pred HccccCcCCCCCHHHHHhcccc
Q 013081 250 KILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 250 ~~L~~dP~~R~t~~~il~h~~~ 271 (450)
+||+.+|.+|||+.+++.||||
T Consensus 247 ~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 247 RCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHcCCCchhCCCHHHHHhCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=335.17 Aligned_cols=251 Identities=27% Similarity=0.372 Sum_probs=209.2
Q ss_pred eEEeeeecccCceEEEEEEECC---CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE----
Q 013081 16 YELGRTLGEGNFGKVKFAQDLD---SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK---- 88 (450)
Q Consensus 16 y~i~~~LG~G~~g~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~---- 88 (450)
|++++.||+|+||.||.|.... ++..||+|.+..+... ......+.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 6789999999999999998764 3478999998754332 2335678999999999999999999998765443
Q ss_pred --EEEEEccCCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCC
Q 013081 89 --IYMVLEYVTGGELFDKIASK------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGL 160 (450)
Q Consensus 89 --~~lv~E~~~gg~L~~~i~~~------~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGl 160 (450)
.+++|||+++++|..++... ..+++..+..++.|++.||+|||++|++||||||+||++++++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 79999999999999888432 3589999999999999999999999999999999999999999999999999
Q ss_pred CCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCC
Q 013081 161 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPK 238 (450)
Q Consensus 161 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~ 238 (450)
++...............++..|+|||.+....+ +.++||||+||++|+|++ |..||.+.+.......+..+ ....|.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPE 238 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 875432111111222345678999999876655 589999999999999999 99999888777777666655 455677
Q ss_pred CCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 239 WLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 239 ~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
.+++.+.+++.+||+.||++|||+.+++++
T Consensus 239 ~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 239 DCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=333.07 Aligned_cols=251 Identities=27% Similarity=0.419 Sum_probs=215.1
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
....|++.+.||+|+||.||+|.+..+++.||+|.+..+. .....+.+|+.+++.++||||+++++++..+...++
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (263)
T cd05052 4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 79 (263)
T ss_pred chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEE
Confidence 3467999999999999999999999999999999986432 124678899999999999999999999999999999
Q ss_pred EEccCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC
Q 013081 92 VLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 169 (450)
+|||+++++|.+++... ..+++..++.++.|++.||+|||++|++||||||+|||+++++.+||+|||++........
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 99999999999998753 3589999999999999999999999999999999999999999999999999875432111
Q ss_pred CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 013081 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 247 (450)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 247 (450)
.......+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+ ....|..+++.+.++
T Consensus 160 -~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (263)
T cd05052 160 -TAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYEL 237 (263)
T ss_pred -eccCCCCCccccCCHHHhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHH
Confidence 11112234567999999877666 588999999999999998 99999988887777777654 456677789999999
Q ss_pred HHHccccCcCCCCCHHHHHhc
Q 013081 248 LRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 248 i~~~L~~dP~~R~t~~~il~h 268 (450)
+.+||+.||++|||+.++++.
T Consensus 238 i~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 238 MRACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred HHHHccCCcccCCCHHHHHHH
Confidence 999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=342.37 Aligned_cols=258 Identities=26% Similarity=0.464 Sum_probs=218.6
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 92 (450)
..-|+....||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.++||||+++++.+......|++
T Consensus 20 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv 96 (297)
T cd06659 20 RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVL 96 (297)
T ss_pred hhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEE
Confidence 3446667789999999999999998999999999865432 2246788999999999999999999999999999999
Q ss_pred EccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCc
Q 013081 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 172 (450)
+||+++++|.+.+.. ..+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++...... ...
T Consensus 97 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~--~~~ 173 (297)
T cd06659 97 MEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPK 173 (297)
T ss_pred EecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccc--ccc
Confidence 999999999887754 67899999999999999999999999999999999999999999999999998743221 112
Q ss_pred cccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCC---CCCCCCCHHHHHHHH
Q 013081 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---KLPKWLSPGAQNLLR 249 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~Li~ 249 (450)
....+|++.|+|||++.+..+ +.++||||+||++|+|++|+.||...+.......+..... ..+..+++.+.++|+
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~ 252 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPY-GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLE 252 (297)
T ss_pred ccceecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHH
Confidence 334678999999999877665 5899999999999999999999987776655555443322 223457889999999
Q ss_pred HccccCcCCCCCHHHHHhccccccCCCC
Q 013081 250 KILEPNPVKRITIAGIKADEWFEQDYTP 277 (450)
Q Consensus 250 ~~L~~dP~~R~t~~~il~h~~~~~~~~~ 277 (450)
+||+.+|.+|||+.++++||||.+...+
T Consensus 253 ~~l~~~P~~Rps~~~ll~~~~~~~~~~~ 280 (297)
T cd06659 253 RMLTREPQERATAQELLDHPFLLQTGLP 280 (297)
T ss_pred HHhcCCcccCcCHHHHhhChhhccCCCc
Confidence 9999999999999999999999876544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=346.26 Aligned_cols=256 Identities=30% Similarity=0.407 Sum_probs=213.8
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS---- 87 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---- 87 (450)
..++|++++.||+|+||.||+|.+..+|+.||+|.+.+... .......+.+|+.+++.++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 45789999999999999999999999999999999865322 2333467889999999999999999999986543
Q ss_pred --EEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCC
Q 013081 88 --KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (450)
Q Consensus 88 --~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 165 (450)
.+|+||||+ |++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++....
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 468999999 7799887764 679999999999999999999999999999999999999999999999999987532
Q ss_pred cccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCC-----------
Q 013081 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF----------- 234 (450)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~----------- 234 (450)
. ......+++.|+|||.+.+....+.++|+||+||++|+|++|..||.+.+....+.++.....
T Consensus 170 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07880 170 S-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ 244 (343)
T ss_pred c-----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence 2 223456789999999987644456899999999999999999999987765544444332111
Q ss_pred --------------------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCC
Q 013081 235 --------------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 235 --------------------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
...+.+++.+.++|.+||+.||.+|||+.+++.||||+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 245 SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred chhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 01234688899999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=330.70 Aligned_cols=247 Identities=40% Similarity=0.753 Sum_probs=222.7
Q ss_pred ecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEccCCCCCh
Q 013081 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL 101 (450)
Q Consensus 22 LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 101 (450)
||+|+||.||.+.+..+++.+|+|++.+...........+.+|+.+++.++||||+++++.+.++...|++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999889999999999876655544567899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccccccCCCC
Q 013081 102 FDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181 (450)
Q Consensus 102 ~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~ 181 (450)
.+++.....+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++....... .......++..
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 158 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPE 158 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcCCcc
Confidence 9999988889999999999999999999999999999999999999999999999999987543211 22345678899
Q ss_pred ccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccccCcCCCCC
Q 013081 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT 261 (450)
Q Consensus 182 y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t 261 (450)
|+|||.+.+... +.++|+||||+++|+|++|..||...+.......+.....++|..++..+.+++++||..||++|||
T Consensus 159 ~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~ 237 (250)
T cd05123 159 YLAPEVLLGKGY-GKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLG 237 (250)
T ss_pred ccChHHhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCC
Confidence 999999876654 5889999999999999999999988887777888877888888889999999999999999999999
Q ss_pred H---HHHHhcccc
Q 013081 262 I---AGIKADEWF 271 (450)
Q Consensus 262 ~---~~il~h~~~ 271 (450)
+ .++++||||
T Consensus 238 ~~~~~~l~~~~~f 250 (250)
T cd05123 238 SGGAEEIKAHPFF 250 (250)
T ss_pred cccHHHHHhCCCC
Confidence 9 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=335.23 Aligned_cols=253 Identities=24% Similarity=0.326 Sum_probs=214.1
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCC-----CceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDS-----GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (450)
..++|++.+.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG 81 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence 456899999999999999999987643 4789999986432 223346788999999999999999999999999
Q ss_pred CEEEEEEccCCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEe
Q 013081 87 SKIYMVLEYVTGGELFDKIASKG----------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKIS 156 (450)
Q Consensus 87 ~~~~lv~E~~~gg~L~~~i~~~~----------~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~ 156 (450)
...|++|||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEEC
Confidence 99999999999999999986432 36788999999999999999999999999999999999999999999
Q ss_pred ecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CC
Q 013081 157 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DF 234 (450)
Q Consensus 157 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~ 234 (450)
|||+++...............++..|+|||.+....+ +.++|||||||++|+|++ |..||.+.+.......+..+ ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHL 240 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCC-CcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCC
Confidence 9999875432211122334567789999999876665 588999999999999998 99999888777776666654 45
Q ss_pred CCCCCCCHHHHHHHHHccccCcCCCCCHHHHHh
Q 013081 235 KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 235 ~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
..|..++..+.+++.+||+.+|++|||+.++++
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 241 DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 567778999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=337.90 Aligned_cols=259 Identities=32% Similarity=0.595 Sum_probs=219.6
Q ss_pred CeEEeeeecccCceEEEEEEEC---CCCceEEEEEeeccccc-chhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 013081 15 RYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRII-HLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKI 89 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 89 (450)
.|++.+.||+|+||.||.|.+. .+|+.||+|++...... .....+.+.+|+.+++++ +||||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4899999999999999999875 47899999998754332 222346788999999999 599999999999999999
Q ss_pred EEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC
Q 013081 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 169 (450)
|+||||+++++|.+++....++++..+..++.|++.||.|||++|++||||+|+|||++.++.+||+|||++...... .
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-~ 159 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED-E 159 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc-c
Confidence 999999999999999988888999999999999999999999999999999999999999999999999998754321 1
Q ss_pred CCccccccCCCCccchhhhccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCc----HHHHHHHHHhCCCCCCCCCCHHH
Q 013081 170 DGLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILTGYLPFDDRN----LAVLYQKIFRGDFKLPKWLSPGA 244 (450)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~----~~~~~~~i~~~~~~~p~~~s~~~ 244 (450)
.......+|+..|+|||.+... ...+.++||||+|+++|+|++|..||...+ .......+.....+.|..+++.+
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (290)
T cd05613 160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 239 (290)
T ss_pred ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHH
Confidence 1223356789999999997653 234578999999999999999999997432 33444555556667777899999
Q ss_pred HHHHHHccccCcCCCC-----CHHHHHhccccccC
Q 013081 245 QNLLRKILEPNPVKRI-----TIAGIKADEWFEQD 274 (450)
Q Consensus 245 ~~Li~~~L~~dP~~R~-----t~~~il~h~~~~~~ 274 (450)
.+++++||+.||++|| ++.+++.||||+..
T Consensus 240 ~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 274 (290)
T cd05613 240 KDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274 (290)
T ss_pred HHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence 9999999999999997 89999999999764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=330.68 Aligned_cols=256 Identities=31% Similarity=0.499 Sum_probs=216.8
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccc--cchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI--IHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SKI 89 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~ 89 (450)
.+|++.+.||+|+||.||+|.+..+++.||+|.+..... ........+.+|+.++++++||||+++++.+.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 369999999999999999999999999999998854321 1233457899999999999999999999998653 568
Q ss_pred EEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC
Q 013081 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 169 (450)
++++||++|++|.+++.+.+.+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 99999999999999998878899999999999999999999999999999999999999999999999999975432111
Q ss_pred -CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC--CCCCCCCCCHHHHH
Q 013081 170 -DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQN 246 (450)
Q Consensus 170 -~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~ 246 (450)
........|+..|+|||.+.+..+ +.++|+|||||++|+|++|+.||..........++... ...+|..+++.+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 240 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGEGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRD 240 (264)
T ss_pred cCccccccCCcccccCHhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHH
Confidence 111234568999999999877665 58899999999999999999999887655555554433 34567789999999
Q ss_pred HHHHccccCcCCCCCHHHHHhcccc
Q 013081 247 LLRKILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 247 Li~~~L~~dP~~R~t~~~il~h~~~ 271 (450)
++.+||+ +|.+|||+.+++.|||.
T Consensus 241 ~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 241 FLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHhc-CcccCccHHHHhcCCCC
Confidence 9999999 57999999999999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=348.27 Aligned_cols=258 Identities=27% Similarity=0.408 Sum_probs=213.0
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----C
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-----S 87 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~ 87 (450)
..+|.+.+.||+|+||.||+|.+..+++.||||.+...... ......+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDN-RIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 35899999999999999999999999999999998754322 22245677899999999999999999987543 3
Q ss_pred EEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcc
Q 013081 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 167 (450)
..|+++||+. ++|.+.+...+++++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~- 160 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE- 160 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC-
Confidence 5899999995 68999998888899999999999999999999999999999999999999999999999999985432
Q ss_pred cCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHh----------------
Q 013081 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR---------------- 231 (450)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~---------------- 231 (450)
.........++..|+|||.+.+....+.++||||+||++|+|++|+.||.+.+.......+..
T Consensus 161 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07858 161 -KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE 239 (337)
T ss_pred -CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence 112334557899999999987644456899999999999999999999987654332222211
Q ss_pred -------C-----CC---CCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 232 -------G-----DF---KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 232 -------~-----~~---~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
. .. ...+.+++.+.+||++||++||++|||+.++++||||...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0 00 0123478899999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=341.47 Aligned_cols=260 Identities=27% Similarity=0.444 Sum_probs=219.5
Q ss_pred CCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013081 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (450)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (450)
.+...++|++.+.||+|+||.||++.+..+++.||+|.+..... ...+.+.+|+.+++.++||||+++++.+.....
T Consensus 14 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~ 90 (293)
T cd06647 14 VGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKHPNIVNYLDSYLVGDE 90 (293)
T ss_pred ccCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc---hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCc
Confidence 45556899999999999999999999988999999999864322 224678899999999999999999999999999
Q ss_pred EEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc
Q 013081 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 168 (450)
.|+|+||++|++|.+++.+ ..+++.++..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 91 ~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~- 168 (293)
T cd06647 91 LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE- 168 (293)
T ss_pred EEEEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc-
Confidence 9999999999999998865 46889999999999999999999999999999999999999999999999988754321
Q ss_pred CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC-C--CCCCCCCCHHHH
Q 013081 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-D--FKLPKWLSPGAQ 245 (450)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-~--~~~p~~~s~~~~ 245 (450)
........|++.|+|||.+....+ +.++|+||+||++|++++|+.||...+.......+... . ...+..++..+.
T Consensus 169 -~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 246 (293)
T cd06647 169 -QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 246 (293)
T ss_pred -ccccccccCChhhcCchhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHH
Confidence 122234568899999999877665 58899999999999999999999876654433322222 2 223344788999
Q ss_pred HHHHHccccCcCCCCCHHHHHhccccccCC
Q 013081 246 NLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 246 ~Li~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
+++++||+.+|.+||++.+++.|+||....
T Consensus 247 ~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 247 DFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=334.46 Aligned_cols=252 Identities=30% Similarity=0.501 Sum_probs=213.3
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 92 (450)
+++|++.+.||+|+||.||+|.+..+++.+|||.+......+......+.+|+.+++.++||||+++++++..++..|++
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence 47899999999999999999999999999999988765444444457888999999999999999999999999999999
Q ss_pred EccCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc
Q 013081 93 LEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~----~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 168 (450)
|||++|++|.+++.. ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~- 159 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK- 159 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC-
Confidence 999999999998863 356899999999999999999999999999999999999999999999999998754321
Q ss_pred CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcH--HHHHHHHHhCCC-CC-CCCCCHHH
Q 013081 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL--AVLYQKIFRGDF-KL-PKWLSPGA 244 (450)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~--~~~~~~i~~~~~-~~-p~~~s~~~ 244 (450)
.......+|++.|+|||.+.+..+ +.++|+||||+++|+|++|..||.+... ......+..... +. +..+++.+
T Consensus 160 -~~~~~~~~~~~~~~ape~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08229 160 -TTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 237 (267)
T ss_pred -CcccccccCCcCccCHHHhcCCCc-cchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHH
Confidence 122345678999999999877666 4889999999999999999999976543 233444433322 22 24588999
Q ss_pred HHHHHHccccCcCCCCCHHHHHh
Q 013081 245 QNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
.+++.+||+.||++|||+.+|++
T Consensus 238 ~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 238 RQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHhcCCCcccCCCHHHHHH
Confidence 99999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=339.05 Aligned_cols=255 Identities=29% Similarity=0.459 Sum_probs=214.5
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCC-----CceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDS-----GLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA 84 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 84 (450)
...++|++.+.||+|+||.||+|.+... ...+|+|.+..... ......+.+|+.+++++ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 4457899999999999999999987643 37899999875432 23346788999999999 7999999999999
Q ss_pred eCCEEEEEEccCCCCChHHHHHh----------------cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEc
Q 013081 85 SKSKIYMVLEYVTGGELFDKIAS----------------KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 148 (450)
Q Consensus 85 ~~~~~~lv~E~~~gg~L~~~i~~----------------~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~ 148 (450)
..+..|++|||+++|+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT 166 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc
Confidence 99999999999999999999864 24588999999999999999999999999999999999999
Q ss_pred cCCCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHH
Q 013081 149 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQ 227 (450)
Q Consensus 149 ~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~ 227 (450)
.++.+||+|||++................++..|+|||++.+..+ +.++||||+||++|+|++ |..||.+......+.
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 245 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 245 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCc-CcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence 999999999999986433211111222335678999999876665 588999999999999998 999999888777777
Q ss_pred HHHhC-CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 228 KIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 228 ~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
.+..+ ....|..++..+.+|+.+||.+||++|||+.+++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 246 LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 66655 345666789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=346.73 Aligned_cols=257 Identities=30% Similarity=0.424 Sum_probs=209.4
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC------
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK------ 86 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------ 86 (450)
-++|++.+.||.|+||.||+|.+..+|+.||+|.+..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence 3799999999999999999999999999999999865443 2356788999999999999999999876543
Q ss_pred --------CEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEcc-CCCeEEee
Q 013081 87 --------SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-KGNIKISD 157 (450)
Q Consensus 87 --------~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~-~g~lkl~D 157 (450)
...|++|||++ ++|.+.+.. +++++..++.++.||++||.|||++|++||||||+||+++. ++.+||+|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 81 DVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 35799999996 588887754 57999999999999999999999999999999999999985 55789999
Q ss_pred cCCCCCCCcccC-CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC---
Q 013081 158 FGLSALPQHFRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--- 233 (450)
Q Consensus 158 FGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--- 233 (450)
||++........ ........++..|+|||++......+.++||||+||++|+|++|..||.+.+.......+....
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999875422111 1122334678999999987665555689999999999999999999998776555444433210
Q ss_pred ----------------------CC-----CCCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 234 ----------------------FK-----LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 234 ----------------------~~-----~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
.. +...++.++.+||.+||++||.+|||+.+++.||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 00 112467889999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=308.49 Aligned_cols=257 Identities=31% Similarity=0.514 Sum_probs=220.8
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
.+|.-.++||+|+||+|++|++.++++.||+|.++.+.. +++......|||.+++.++|.|||+++++..++....+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 467778999999999999999999999999999976543 3445678899999999999999999999999999999999
Q ss_pred ccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCc
Q 013081 94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (450)
Q Consensus 94 E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 172 (450)
|||. .+|..+... ++.++.+.++.++.|++.||.|||++++.|||+||+|+|++.+|.+|++|||+|+.+.. .-..
T Consensus 81 e~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgi--pvrc 157 (292)
T KOG0662|consen 81 EFCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGI--PVRC 157 (292)
T ss_pred HHhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCC--ceEe
Confidence 9994 588877765 57799999999999999999999999999999999999999999999999999996543 2223
Q ss_pred cccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC--CCC---------CCC--
Q 013081 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG--DFK---------LPK-- 238 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~--~~~---------~p~-- 238 (450)
....+-|.+|++|.++.+...++...|+||.|||+.|+.. |++.|.+.+..+...+|++. .+. +|.
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence 3445678999999999998888889999999999999987 99999999988888888652 110 111
Q ss_pred ----------C------CCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 239 ----------W------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 239 ----------~------~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
| ++..-++|++++|.-+|.+|++++.+++||||.+.
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 1 23345899999999999999999999999999754
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=330.68 Aligned_cols=248 Identities=25% Similarity=0.431 Sum_probs=210.5
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 92 (450)
.++|++.+.||+|+||.||+|... .+..+|+|.+...... ...+.+|+.++++++||||+++++++......|++
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence 467999999999999999999874 4567999988644321 35688899999999999999999999999999999
Q ss_pred EccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCC
Q 013081 93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 171 (450)
|||++||+|.+++.. .+.+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||+++...... ..
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~-~~ 156 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE-YT 156 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCc-ee
Confidence 999999999999875 3568999999999999999999999999999999999999999999999999987432111 01
Q ss_pred ccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHH
Q 013081 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLR 249 (450)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~ 249 (450)
......++..|+|||++....+ +.++|+||+|+++|+|++ |+.||...+.......+..+. ...|...+..+.+++.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKY-SSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMY 235 (256)
T ss_pred ccCCCCCchhhCChhhcccCcc-chhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence 1112234568999999876665 589999999999999999 999999988887777777653 3456668899999999
Q ss_pred HccccCcCCCCCHHHHHh
Q 013081 250 KILEPNPVKRITIAGIKA 267 (450)
Q Consensus 250 ~~L~~dP~~R~t~~~il~ 267 (450)
+||+.||.+|||+.++++
T Consensus 236 ~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 236 SCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHccCCcccCcCHHHHHH
Confidence 999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=337.94 Aligned_cols=253 Identities=23% Similarity=0.293 Sum_probs=211.6
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCC----------------ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSG----------------LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~----------------~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn 75 (450)
..++|++++.||+|+||.||+|.+..++ ..||+|.+..... ....+.+.+|++++++++|||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCC
Confidence 4579999999999999999999876544 4589999875432 234678899999999999999
Q ss_pred cceEEEEEEeCCEEEEEEccCCCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCc
Q 013081 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-----------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLEN 144 (450)
Q Consensus 76 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~-----------~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~N 144 (450)
|+++++++..+...+++|||+.+++|.+++.... .+++..++.++.|++.||+|||++|++||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 9999999999999999999999999999997755 68999999999999999999999999999999999
Q ss_pred EEEccCCCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh--CCCCCCCCcH
Q 013081 145 ILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT--GYLPFDDRNL 222 (450)
Q Consensus 145 ILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt--G~~Pf~~~~~ 222 (450)
|+++.++.++|+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKF-TTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCC-CccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 9999999999999999875332211122334566789999999876555 589999999999999998 7889987766
Q ss_pred HHHHHHHHhC--------CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHh
Q 013081 223 AVLYQKIFRG--------DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 223 ~~~~~~i~~~--------~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
.......... ..+.|..+++++.+|+.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 240 QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 6555544322 12344557899999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=337.65 Aligned_cols=253 Identities=27% Similarity=0.403 Sum_probs=213.0
Q ss_pred cccCCeEEeeeecccCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 85 (450)
...++|.+.+.||+|+||.||+|.+. .++..+|+|.+.... ....+.+.+|+.++++++||||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (291)
T cd05094 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGD 78 (291)
T ss_pred CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEcc
Confidence 34678999999999999999999854 345679999875432 2234678899999999999999999999999
Q ss_pred CCEEEEEEccCCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEcc
Q 013081 86 KSKIYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 149 (450)
Q Consensus 86 ~~~~~lv~E~~~gg~L~~~i~~~~----------------~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~ 149 (450)
....++||||+++++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA 158 (291)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc
Confidence 999999999999999999997543 3889999999999999999999999999999999999999
Q ss_pred CCCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHH
Q 013081 150 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQK 228 (450)
Q Consensus 150 ~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~ 228 (450)
++.++|+|||++................+++.|+|||++.+..+ +.++||||+||++|+|++ |..||...+.......
T Consensus 159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 237 (291)
T cd05094 159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237 (291)
T ss_pred CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999975432111122234456789999999877665 588999999999999999 9999988777777766
Q ss_pred HHhCCC-CCCCCCCHHHHHHHHHccccCcCCCCCHHHHHh
Q 013081 229 IFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 229 i~~~~~-~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
+..+.. ..+..++..+.+++.+||++||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 238 ITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 666543 345568899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=333.63 Aligned_cols=251 Identities=27% Similarity=0.380 Sum_probs=207.1
Q ss_pred eEEeeeecccCceEEEEEEECCCCc--eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe------CC
Q 013081 16 YELGRTLGEGNFGKVKFAQDLDSGL--PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS------KS 87 (450)
Q Consensus 16 y~i~~~LG~G~~g~Vy~a~~~~~~~--~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------~~ 87 (450)
|.+++.||+|+||.||+|.+..++. .||+|.+..... .....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 4578999999999999999877765 699998865432 33345788899999999999999999998632 23
Q ss_pred EEEEEEccCCCCChHHHHHh------cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCC
Q 013081 88 KIYMVLEYVTGGELFDKIAS------KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS 161 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~------~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla 161 (450)
..+++|||+.+|+|.+.+.. ...+++..+..++.|++.||+|||++||+||||||+|||+++++.+||+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 57899999999999988742 234889999999999999999999999999999999999999999999999999
Q ss_pred CCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCC-CCCCCC
Q 013081 162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKW 239 (450)
Q Consensus 162 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~ 239 (450)
................+++.|+|||.+.+..+ +.++||||+||++|+|++ |..||.+......+..+..+. .+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVY-TTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPD 238 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCc-ChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 86432111111123356778999999877665 589999999999999999 899998877777777776653 355667
Q ss_pred CCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 240 LSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 240 ~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
++..+.++|.+||++||++|||+.+++++
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 239 CLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 88999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=353.05 Aligned_cols=254 Identities=26% Similarity=0.401 Sum_probs=207.7
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCC-----CceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDS-----GLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLA 84 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~ 84 (450)
..-++|++++.||+|+||.||+|.+... +..||||++.... .....+.+.+|+.+++++. ||||+++++++.
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 3456889999999999999999987533 3479999986543 2233567899999999996 999999999999
Q ss_pred eCCEEEEEEccCCCCChHHHHHhc--------------------------------------------------------
Q 013081 85 SKSKIYMVLEYVTGGELFDKIASK-------------------------------------------------------- 108 (450)
Q Consensus 85 ~~~~~~lv~E~~~gg~L~~~i~~~-------------------------------------------------------- 108 (450)
+....|+|||||++|+|.+++..+
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 999999999999999999887542
Q ss_pred ----------------------------------------CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEc
Q 013081 109 ----------------------------------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 148 (450)
Q Consensus 109 ----------------------------------------~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~ 148 (450)
..+++..+..++.||+.||+|||+.||+||||||+|||++
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~ 271 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe
Confidence 2377888899999999999999999999999999999999
Q ss_pred cCCCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHH-HH
Q 013081 149 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAV-LY 226 (450)
Q Consensus 149 ~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~-~~ 226 (450)
.++.+||+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||....... .+
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~ 350 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLY-TTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY 350 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence 999999999999875432211112233457788999999877666 589999999999999997 999998765443 33
Q ss_pred HHHHhC-CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHh
Q 013081 227 QKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 227 ~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
..+..+ ..+.+..+++.+.+++.+||+.||++|||+.++.+
T Consensus 351 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 351 NKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 333333 34456678999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=344.53 Aligned_cols=265 Identities=30% Similarity=0.385 Sum_probs=216.8
Q ss_pred ccCCeEE-eeeecccCceEEEEEEECCCCceEEEEEeecccccchh-----------HHHHHHHHHHHHHhCCCCCcceE
Q 013081 12 RLGRYEL-GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-----------ITDQIKREIATLKLLKHPNVVRL 79 (450)
Q Consensus 12 ~~~~y~i-~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~-----------~~~~~~~Ei~il~~l~hpnIv~l 79 (450)
.-++|.. .+.||+|+||.||+|.+..+++.||+|.+......... ....+.+|+.+++.++||||+++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 3468875 57799999999999999999999999998654322100 11357799999999999999999
Q ss_pred EEEEEeCCEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecC
Q 013081 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFG 159 (450)
Q Consensus 80 ~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFG 159 (450)
++++......|++|||+. ++|.+.+.....+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||
T Consensus 86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 86 VDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred eEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence 999999999999999996 5999999888889999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCcc------------cCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHH
Q 013081 160 LSALPQHF------------RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQ 227 (450)
Q Consensus 160 la~~~~~~------------~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~ 227 (450)
++...... ..........+++.|+|||.+.+....+.++|+||+||++|+|++|.+||.+.+......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~ 244 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG 244 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 98754310 001122334578899999998765555789999999999999999999999877665554
Q ss_pred HHHhCC--C--------------------------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCCCC
Q 013081 228 KIFRGD--F--------------------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277 (450)
Q Consensus 228 ~i~~~~--~--------------------------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~~~ 277 (450)
.+.... . ......+..+.++|.+||+++|++|||+++++.||||+....+
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~ 322 (335)
T PTZ00024 245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLP 322 (335)
T ss_pred HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCC
Confidence 443210 0 0012357889999999999999999999999999999865433
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=339.27 Aligned_cols=255 Identities=27% Similarity=0.445 Sum_probs=212.7
Q ss_pred cccCCeEEeeeecccCceEEEEEEECC-------CCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLD-------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEV 82 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~ 82 (450)
...++|.+++.||+|+||.||+|.+.. ++..+|+|.+..+. .......+.+|+.+++.+ +||||++++++
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGA 92 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 445789999999999999999998643 23579999987542 222346788899999999 79999999999
Q ss_pred EEeCCEEEEEEccCCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEE
Q 013081 83 LASKSKIYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENIL 146 (450)
Q Consensus 83 ~~~~~~~~lv~E~~~gg~L~~~i~~~~----------------~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NIL 146 (450)
+...+..|+||||+++|+|.+++.... .++..++..++.|++.||+|||++|++||||||+|||
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil 172 (307)
T cd05098 93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 172 (307)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheE
Confidence 999999999999999999999997542 4788999999999999999999999999999999999
Q ss_pred EccCCCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHH
Q 013081 147 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVL 225 (450)
Q Consensus 147 l~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~ 225 (450)
++.++.+||+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+....
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~ 251 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 251 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCC-CcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence 99999999999999875432111111122234578999999877665 589999999999999998 9999988877777
Q ss_pred HHHHHhCC-CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 226 YQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 226 ~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
...+.... .+.|..++.++.+|+.+||..+|.+|||+.+++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 252 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 66665553 46677789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=333.51 Aligned_cols=254 Identities=30% Similarity=0.455 Sum_probs=210.8
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--KSKIYM 91 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~l 91 (450)
++|+..+.||.|++|.||+|.+..+++.+|+|.+..... ......+.+|++++++++||||+++++++.. ...+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 579999999999999999999999999999999875432 2345778999999999999999999998854 447899
Q ss_pred EEccCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcc
Q 013081 92 VLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~----~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 167 (450)
||||++|++|.+++.. ...+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~- 157 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN- 157 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccc-
Confidence 9999999999887653 34689999999999999999999999999999999999999999999999999874322
Q ss_pred cCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCC-----cHHHHHHHHHhCC-CCCC----
Q 013081 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR-----NLAVLYQKIFRGD-FKLP---- 237 (450)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~-----~~~~~~~~i~~~~-~~~p---- 237 (450)
.......++..|+|||.+.+..+ +.++|||||||++|+|++|..||... ........+.... ...+
T Consensus 158 ---~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd06621 158 ---SLAGTFTGTSFYMAPERIQGKPY-SITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG 233 (287)
T ss_pred ---cccccccCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence 12234567889999999877666 58899999999999999999999865 2233333333321 1111
Q ss_pred --CCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 238 --KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 238 --~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
..+++.+.+++.+||.+||++|||+.|++.||||...
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 1246789999999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=367.57 Aligned_cols=250 Identities=32% Similarity=0.535 Sum_probs=209.5
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEE-EE---eC---
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEV-LA---SK--- 86 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~-~~---~~--- 86 (450)
+++|.+.|.+|||+.||+|.+...|..||+|.+-.. ++...+.+++||++|++|+ |||||.+++. .. ..
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 567899999999999999999888899999987543 5566789999999999997 9999999993 21 11
Q ss_pred CEEEEEEccCCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHhhhhhcC--eeeccCCCCcEEEccCCCeEEeecCCCC
Q 013081 87 SKIYMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLDSKGNIKISDFGLSA 162 (450)
Q Consensus 87 ~~~~lv~E~~~gg~L~~~i~~--~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlKp~NILl~~~g~lkl~DFGla~ 162 (450)
-.+++.||||.||.|-|++.. ..+|++.++.+||.|+++||++||.++ |||||||-|||||+.+|+.||||||-|+
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 246789999999999999974 356999999999999999999999997 9999999999999999999999999987
Q ss_pred CCCcccC--CC--cc---ccccCCCCccchhhh--ccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC
Q 013081 163 LPQHFRD--DG--LL---HTTCGSPNYVAPEVL--ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD 233 (450)
Q Consensus 163 ~~~~~~~--~~--~~---~~~~gt~~y~APE~l--~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~ 233 (450)
..-.... .+ .. -....|+-|+|||++ .++...+.|+|||+|||+||-|+....||++... ..|..+.
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----laIlng~ 270 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----LAILNGN 270 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----eeEEecc
Confidence 4322110 00 00 123578999999995 3445567999999999999999999999988643 2567788
Q ss_pred CCCCC--CCCHHHHHHHHHccccCcCCCCCHHHHHhcccc
Q 013081 234 FKLPK--WLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 234 ~~~p~--~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~ 271 (450)
+.+|+ .++..+.+||+.||++||.+||++.|++.+-+.
T Consensus 271 Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~ 310 (738)
T KOG1989|consen 271 YSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE 310 (738)
T ss_pred ccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence 88876 589999999999999999999999999887543
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=342.24 Aligned_cols=251 Identities=28% Similarity=0.460 Sum_probs=220.7
Q ss_pred eEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEcc
Q 013081 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY 95 (450)
Q Consensus 16 y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 95 (450)
|+++++||+|+||.||+|.++.+|+.+|||.+..+. ....+.+||.+|++++.|++|++|+.+.....+|+||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 788999999999999999999999999999886442 257788999999999999999999999999999999999
Q ss_pred CCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccc
Q 013081 96 VTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH 174 (450)
Q Consensus 96 ~~gg~L~~~i~-~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 174 (450)
|..|++.|.++ ++.++++.++..+++.-+.||+|||...-+|||||..|||++.+|..||+|||.|..... .-....
T Consensus 110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMAKRN 187 (502)
T KOG0574|consen 110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMAKRN 187 (502)
T ss_pred cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhh--hHHhhC
Confidence 99999999987 456899999999999999999999999999999999999999999999999999874322 112345
Q ss_pred cccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC---CCCCCCCCHHHHHHHHHc
Q 013081 175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGAQNLLRKI 251 (450)
Q Consensus 175 ~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~Li~~~ 251 (450)
+..|||.|||||++..-+|+ .++||||||++..||..|++||.+-.+....-.|-... +.-|+.+|.++.+++++|
T Consensus 188 TVIGTPFWMAPEVI~EIGY~-~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~C 266 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGYD-TKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSC 266 (502)
T ss_pred ccccCcccccHHHHHHhccc-hhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHH
Confidence 78999999999999999997 78999999999999999999999877664433333322 234566899999999999
Q ss_pred cccCcCCCCCHHHHHhccccccC
Q 013081 252 LEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 252 L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
|.++|++|.|+.++++|||.+..
T Consensus 267 LiK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 267 LIKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred hcCCHHHHHHHHHHhhhhhhcCC
Confidence 99999999999999999998753
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=339.45 Aligned_cols=258 Identities=30% Similarity=0.455 Sum_probs=208.6
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK----- 86 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 86 (450)
.+++|++.+.||+|+||.||+|.+..+++.||+|.+....... .....+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence 4789999999999999999999999999999999986543222 1234567899999999999999999887433
Q ss_pred ---CEEEEEEccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCC
Q 013081 87 ---SKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA 162 (450)
Q Consensus 87 ---~~~~lv~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~ 162 (450)
..+|++|||+.+ +|.+.+.. ...+++..++.++.||++||+|||++|++||||||+||++++++.++|+|||++.
T Consensus 85 ~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 85 RKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred ccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccch
Confidence 357999999965 67776654 4579999999999999999999999999999999999999999999999999997
Q ss_pred CCCcccCC---------CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC
Q 013081 163 LPQHFRDD---------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD 233 (450)
Q Consensus 163 ~~~~~~~~---------~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~ 233 (450)
........ .......+++.|+|||.+.+....+.++||||+||++|+|++|++||.+.+.......+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 54321111 111233578899999998765545688999999999999999999999877765555443210
Q ss_pred C-----------------------CCC-------CCCCHHHHHHHHHccccCcCCCCCHHHHHhcccc
Q 013081 234 F-----------------------KLP-------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 234 ~-----------------------~~p-------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~ 271 (450)
. ..+ ..+++.+.++|.+||+.||.+|||+.+++.||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 0 000 1244678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=337.12 Aligned_cols=250 Identities=28% Similarity=0.424 Sum_probs=209.9
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCc--eEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGL--PFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKI 89 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~--~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 89 (450)
.++|++.+.||+|+||.||+|.+..++. .+|+|.+.... .....+.+.+|+.+++++ +||||+++++++...+..
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 78 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYL 78 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcc
Confidence 3689999999999999999999877765 46888775322 223356788999999999 799999999999999999
Q ss_pred EEEEccCCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCe
Q 013081 90 YMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNI 153 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~----------------~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~l 153 (450)
|++|||+++++|.+++.... .+++..++.++.|++.||+|||++|++||||||+|||+++++.+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeE
Confidence 99999999999999996532 48889999999999999999999999999999999999999999
Q ss_pred EEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC
Q 013081 154 KISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG 232 (450)
Q Consensus 154 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~ 232 (450)
||+|||++....... .......+..|+|||++....+ +.++|||||||++|+|++ |..||.+.+......++..+
T Consensus 159 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~ 234 (297)
T cd05089 159 KIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVY-TTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 234 (297)
T ss_pred EECCcCCCcccccee---ccCCCCcCccccCchhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Confidence 999999986422110 0111223457999999877665 589999999999999998 99999998888777777665
Q ss_pred -CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 233 -DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 233 -~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
....|..+++.+.+|+.+||+.||.+|||++++++.
T Consensus 235 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 235 YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 345566789999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=334.44 Aligned_cols=253 Identities=32% Similarity=0.500 Sum_probs=212.3
Q ss_pred eEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEEEEE
Q 013081 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SKIYMVL 93 (450)
Q Consensus 16 y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~lv~ 93 (450)
|++.+.||+|+||.||+|.+..+++.+|+|.+.... ........+.+|+.+++.++|||++++++++... ...|+|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 789999999999999999999999999999998654 2333456788999999999999999999999887 8999999
Q ss_pred ccCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCc
Q 013081 94 EYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (450)
Q Consensus 94 E~~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 172 (450)
||+++ +|.+.+.+. ..+++..++.++.||+.||+|||+.|++|+||||+||++++++.+||+|||++........ ..
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-~~ 157 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-AD 157 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-cc
Confidence 99975 898888765 5799999999999999999999999999999999999999999999999999885533211 12
Q ss_pred cccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCC------------------
Q 013081 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF------------------ 234 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~------------------ 234 (450)
.....++..|+|||.+.+....+.++||||+|+++|+|++|+.||...+......++.....
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 23446788999999876654456899999999999999999999988776655544433100
Q ss_pred -----C--------CCCCCCHHHHHHHHHccccCcCCCCCHHHHHhcccc
Q 013081 235 -----K--------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 235 -----~--------~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~ 271 (450)
. +...+++.+.+++++||..||.+|||+.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 0 001137889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=347.17 Aligned_cols=253 Identities=27% Similarity=0.405 Sum_probs=205.4
Q ss_pred cCCeEEeeeecccCceEEEEEEECC-----CCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEe-
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS- 85 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~- 85 (450)
-++|++.+.||+|+||.||+|.+.. +++.||+|+++... .....+.+.+|+.+++++ +||||+++++++..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 3589999999999999999997533 45789999986433 222346788999999999 79999999998754
Q ss_pred CCEEEEEEccCCCCChHHHHHhc---------------------------------------------------------
Q 013081 86 KSKIYMVLEYVTGGELFDKIASK--------------------------------------------------------- 108 (450)
Q Consensus 86 ~~~~~lv~E~~~gg~L~~~i~~~--------------------------------------------------------- 108 (450)
+..+|++|||+++++|.+++...
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 46789999999999999988542
Q ss_pred ----CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccccccCCCCccc
Q 013081 109 ----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184 (450)
Q Consensus 109 ----~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~A 184 (450)
.++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++................++..|+|
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 2678999999999999999999999999999999999999999999999999985432111111223455678999
Q ss_pred hhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHH-HHHhC-CCCCCCCCCHHHHHHHHHccccCcCCCCC
Q 013081 185 PEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQ-KIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRIT 261 (450)
Q Consensus 185 PE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~-~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t 261 (450)
||++.+..+ +.++||||+||++|+|++ |..||.+....+... .+..+ ....|...++++.+++.+||+.+|++|||
T Consensus 244 PE~~~~~~~-~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs 322 (337)
T cd05054 244 PESIFDKVY-TTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPT 322 (337)
T ss_pred cHHhcCCCC-CccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcC
Confidence 999888776 488999999999999998 999998754433332 33222 33445668899999999999999999999
Q ss_pred HHHHHhc
Q 013081 262 IAGIKAD 268 (450)
Q Consensus 262 ~~~il~h 268 (450)
+.++++|
T Consensus 323 ~~ell~~ 329 (337)
T cd05054 323 FSELVEI 329 (337)
T ss_pred HHHHHHH
Confidence 9999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=359.21 Aligned_cols=244 Identities=36% Similarity=0.596 Sum_probs=214.6
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIY 90 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 90 (450)
....|++...+|.|+|+.|..+.+..+++..++|++.+.. ....+|+.++.+. +||||+++++++.+....|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCceee
Confidence 3568999999999999999999999999999999998762 2334577666666 6999999999999999999
Q ss_pred EEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEE-ccCCCeEEeecCCCCCCCcccC
Q 013081 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL-DSKGNIKISDFGLSALPQHFRD 169 (450)
Q Consensus 91 lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl-~~~g~lkl~DFGla~~~~~~~~ 169 (450)
+|||++.|+.+.+.+.....+. .++..|++||+.|+.|||++||+||||||+|||+ ++.|+++|+|||.++....
T Consensus 393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~--- 468 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER--- 468 (612)
T ss_pred eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCch---
Confidence 9999999999999998766555 8888999999999999999999999999999999 6889999999999985332
Q ss_pred CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCc-HHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 013081 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGDFKLPKWLSPGAQNLL 248 (450)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~~~~~~p~~~s~~~~~Li 248 (450)
...+.|-|..|+|||++...+|+ +++||||||++||+||+|+.||.... ..++..++..+.+. .++|..+++||
T Consensus 469 --~~~tp~~t~~y~APEvl~~~~yt-~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s--~~vS~~AKdLl 543 (612)
T KOG0603|consen 469 --SCDTPALTLQYVAPEVLAIQEYT-EACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS--ECVSDEAKDLL 543 (612)
T ss_pred --hhcccchhhcccChhhhccCCCC-cchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc--cccCHHHHHHH
Confidence 15677889999999999988874 99999999999999999999997644 34666666555444 88999999999
Q ss_pred HHccccCcCCCCCHHHHHhcccc
Q 013081 249 RKILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 249 ~~~L~~dP~~R~t~~~il~h~~~ 271 (450)
++||+.||.+|+++.+++.||||
T Consensus 544 ~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 544 QQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHhccCChhhCcChhhhccCcch
Confidence 99999999999999999999999
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=345.71 Aligned_cols=256 Identities=30% Similarity=0.415 Sum_probs=214.7
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE---
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK--- 88 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~--- 88 (450)
.-++|++.+.||+|++|.||+|.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++++.....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 45789999999999999999999999999999999865422 22335678889999999999999999988765544
Q ss_pred ---EEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCC
Q 013081 89 ---IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (450)
Q Consensus 89 ---~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 165 (450)
.|+|+||+ |++|.+++.. .++++..++.++.|++.||.|||+.||+||||||+||++++++.+||+|||++....
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 89999999 6799998875 579999999999999999999999999999999999999999999999999988542
Q ss_pred cccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCC----------
Q 013081 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK---------- 235 (450)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------- 235 (450)
. ......+++.|+|||.+.+....+.++||||+||++|+|++|+.||.+.+....+..+......
T Consensus 170 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (343)
T cd07851 170 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS 244 (343)
T ss_pred c-----cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence 2 1344578899999999876445568999999999999999999999887766555444332100
Q ss_pred ---------------------CCCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCC
Q 013081 236 ---------------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 236 ---------------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
....+++.+.+||++||++||.+|||+.++++||||.+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence 0123588999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=370.53 Aligned_cols=151 Identities=31% Similarity=0.588 Sum_probs=142.2
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
.+++|.+++.||+|+||.||+|.+..+++.||||++.+...........+.+|+.+++.++||||+++++++.....+|+
T Consensus 2 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 81 (669)
T cd05610 2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL 81 (669)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence 36899999999999999999999999999999999987665556667889999999999999999999999999999999
Q ss_pred EEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCC
Q 013081 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA 162 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~ 162 (450)
||||+.|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 82 VmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 82 VMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=332.06 Aligned_cols=248 Identities=25% Similarity=0.423 Sum_probs=213.8
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 92 (450)
-++|++++.||.|+||.||+|.+.. ++.+|+|++..... .....+.+|+.+++.++||||+++++++.+....|++
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 3579999999999999999999877 88999999875532 2246788999999999999999999999999999999
Q ss_pred EccCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCC
Q 013081 93 LEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 170 (450)
|||+++++|.+++... ..+++..++.++.||+.||.|||++|++||||||+||++++++.+||+|||++...... .
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~--~ 158 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED--V 158 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCc--c
Confidence 9999999999999753 46899999999999999999999999999999999999999999999999998754221 1
Q ss_pred CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHH
Q 013081 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLL 248 (450)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li 248 (450)
.......++..|+|||++....+ +.++||||||+++|+|++ |+.||...+....+..+..+ ..+.|..+++.+.+++
T Consensus 159 ~~~~~~~~~~~~~~PE~~~~~~~-~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 237 (261)
T cd05148 159 YLSSDKKIPYKWTAPEAASHGTF-STKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIM 237 (261)
T ss_pred ccccCCCCceEecCHHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHH
Confidence 11223345678999999877665 588999999999999998 89999988877777776654 4456677899999999
Q ss_pred HHccccCcCCCCCHHHHHh
Q 013081 249 RKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 249 ~~~L~~dP~~R~t~~~il~ 267 (450)
.+||+.||.+|||+.++++
T Consensus 238 ~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 238 LECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHcCCCchhCcCHHHHHH
Confidence 9999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=328.73 Aligned_cols=245 Identities=26% Similarity=0.370 Sum_probs=206.2
Q ss_pred eeecccCceEEEEEEE--CCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEccCC
Q 013081 20 RTLGEGNFGKVKFAQD--LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT 97 (450)
Q Consensus 20 ~~LG~G~~g~Vy~a~~--~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 97 (450)
+.||+|+||.||+|.+ ..++..+|+|++.... .+....+.+.+|+.+++.++||||+++++++. ....+++|||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~ 78 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAE 78 (257)
T ss_pred CcCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCC
Confidence 3689999999999964 4578899999986443 23445678999999999999999999999875 456789999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCC-Cccccc
Q 013081 98 GGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD-GLLHTT 176 (450)
Q Consensus 98 gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~-~~~~~~ 176 (450)
+++|.+++.....+++..+..++.|++.||+|||++|++||||||.||+++.++.+||+|||++......... ......
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05116 79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG 158 (257)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCC
Confidence 9999999988788999999999999999999999999999999999999999999999999999754321111 011223
Q ss_pred cCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHcccc
Q 013081 177 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEP 254 (450)
Q Consensus 177 ~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~ 254 (450)
.+++.|+|||.+....+ +.++|+|||||++|+|++ |..||.+.+.......+..+ ..+.|..+++++.++|.+||++
T Consensus 159 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~ 237 (257)
T cd05116 159 KWPVKWYAPECMNYYKF-SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTY 237 (257)
T ss_pred CCCccccCHhHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhcc
Confidence 44678999999876555 588999999999999998 99999988777777766665 4567778999999999999999
Q ss_pred CcCCCCCHHHHHh
Q 013081 255 NPVKRITIAGIKA 267 (450)
Q Consensus 255 dP~~R~t~~~il~ 267 (450)
||++||++++|..
T Consensus 238 ~p~~Rp~~~~i~~ 250 (257)
T cd05116 238 GVDERPGFAVVEL 250 (257)
T ss_pred CchhCcCHHHHHH
Confidence 9999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=337.67 Aligned_cols=259 Identities=30% Similarity=0.491 Sum_probs=211.7
Q ss_pred CcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-- 87 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-- 87 (450)
....++|++.+.||+|+||.||+|.+..+|+.||+|.++..... ......+.+|+.++++++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA 81 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc-cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence 34568999999999999999999999999999999998754322 222456788999999999999999999986654
Q ss_pred --------EEEEEEccCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeec
Q 013081 88 --------KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDF 158 (450)
Q Consensus 88 --------~~~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DF 158 (450)
..|+++||+++ ++.+.+... ..+++..++.++.|++.||.|||+.||+||||||+||++++++.+||+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred hhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcc
Confidence 79999999976 777776653 46999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC---CC-
Q 013081 159 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---DF- 234 (450)
Q Consensus 159 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~~- 234 (450)
|++........ .......+++.|+|||.+.+....+.++||||+||++|+|++|++||...+.......+... ..
T Consensus 161 g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (302)
T cd07864 161 GLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239 (302)
T ss_pred cccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 99885432111 11223356788999999876554568999999999999999999999877665544443321 00
Q ss_pred --------------------------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhcccc
Q 013081 235 --------------------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 235 --------------------------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~ 271 (450)
.....+++.+.+++.+||+.||.+|||+.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 0012368899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=336.67 Aligned_cols=254 Identities=26% Similarity=0.401 Sum_probs=214.8
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
+.|...+.||+|+||.||+|.+..+|+.||+|.+.............+.+|+.+++.++|||++++++++.+....|++|
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 35777889999999999999999999999999997655444444567889999999999999999999999999999999
Q ss_pred ccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCc
Q 013081 94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (450)
Q Consensus 94 E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 172 (450)
||+. ++|.+.+.. ..++++..+..++.||+.||.|||++|++||||+|+||+++.++.+||+|||++.... .
T Consensus 101 e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~------~ 173 (313)
T cd06633 101 EYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS------P 173 (313)
T ss_pred ecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC------C
Confidence 9996 577777754 4578999999999999999999999999999999999999999999999999986321 2
Q ss_pred cccccCCCCccchhhhcc--CCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCC-C-CCCCCHHHHHHH
Q 013081 173 LHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-L-PKWLSPGAQNLL 248 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~~--~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-~-p~~~s~~~~~Li 248 (450)
.....|+..|+|||++.. ....+.++||||+||++|+|++|..||...+......++.....+ . ...++..+.+|+
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 253 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFV 253 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHH
Confidence 234578999999999742 233457899999999999999999999887765555555443322 1 234678899999
Q ss_pred HHccccCcCCCCCHHHHHhccccccC
Q 013081 249 RKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 249 ~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
.+||+++|.+||++.+++.||||...
T Consensus 254 ~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 254 DYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred HHHccCChhhCcCHHHHhcCcccCCC
Confidence 99999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=331.71 Aligned_cols=253 Identities=24% Similarity=0.348 Sum_probs=210.1
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCc----eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGL----PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (450)
...+|++.+.||+|+||.||+|.+..+++ .||+|++.... .......+.+|+.+++.++||||+++++++.. .
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~ 81 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-S 81 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-C
Confidence 34689999999999999999999877776 48999986443 23335678899999999999999999999865 4
Q ss_pred EEEEEEccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCc
Q 013081 88 KIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 166 (450)
..++++||+++|+|.+.+.. .+.+++..+..++.|++.||+|||++||+||||||+|||+++++.+||+|||+++....
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 57899999999999999876 45699999999999999999999999999999999999999999999999999985432
Q ss_pred ccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHH
Q 013081 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGA 244 (450)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~ 244 (450)
...........+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||...........+..+ ..+.+..+++.+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRF-THQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDV 240 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHH
Confidence 111111122335678999999877666 589999999999999998 99999887766665555544 345566789999
Q ss_pred HHHHHHccccCcCCCCCHHHHHhc
Q 013081 245 QNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
.+++.+||+.||++|||+.+++..
T Consensus 241 ~~li~~~l~~dp~~Rp~~~~l~~~ 264 (279)
T cd05109 241 YMIMVKCWMIDSECRPRFRELVDE 264 (279)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=333.34 Aligned_cols=252 Identities=28% Similarity=0.408 Sum_probs=211.8
Q ss_pred ccCCeEEeeeecccCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (450)
...+|++.+.||+|+||.||+|... .++..+|+|.+... .......+.+|+++++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 3467899999999999999999743 35678999987643 233457899999999999999999999999999
Q ss_pred CEEEEEEccCCCCChHHHHHhcC---------------CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCC
Q 013081 87 SKIYMVLEYVTGGELFDKIASKG---------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG 151 (450)
Q Consensus 87 ~~~~lv~E~~~gg~L~~~i~~~~---------------~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g 151 (450)
...|++|||+++++|.+++...+ .+++..+..++.||+.||+|||++|++||||||+|||+++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence 99999999999999999987643 478999999999999999999999999999999999999999
Q ss_pred CeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHH
Q 013081 152 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIF 230 (450)
Q Consensus 152 ~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~ 230 (450)
.+||+|||++................+++.|+|||.+.+..+ +.++|||||||++|+|++ |.+||...........+.
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 238 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF-TTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT 238 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence 999999999874322111111223345688999999877666 588999999999999998 999998877776666665
Q ss_pred hC-CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHh
Q 013081 231 RG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 231 ~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
.+ ....|..+++.+.+|+.+||+.||.+||++.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 239 QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 55 44556778999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=343.90 Aligned_cols=260 Identities=33% Similarity=0.431 Sum_probs=218.6
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----EE
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-----KI 89 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~ 89 (450)
+|++.+.||.|++|.||+|.+..+++.||+|.+..... .....+.+.+|+.+++.++||||+++++++.... ..
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 69999999999999999999999999999999875432 2334578899999999999999999999987765 78
Q ss_pred EEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC
Q 013081 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 169 (450)
|++|||+. ++|.+.+.+..++++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++........
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 99999997 58999998878999999999999999999999999999999999999999999999999999986433211
Q ss_pred -CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCC-------------
Q 013081 170 -DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK------------- 235 (450)
Q Consensus 170 -~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~------------- 235 (450)
........+++.|+|||++.+....+.++|+||+|+++|+|++|.+||.+.+....+..+......
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 238 (330)
T cd07834 159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK 238 (330)
T ss_pred ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence 012344568899999999887744568999999999999999999999988776655554431100
Q ss_pred ------------------CCCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCCC
Q 013081 236 ------------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 276 (450)
Q Consensus 236 ------------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~~ 276 (450)
..+.+++.+.+||.+||++||.+|||+.+++.||||+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 11236788999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=348.89 Aligned_cols=257 Identities=26% Similarity=0.395 Sum_probs=211.3
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~l 91 (450)
-..|++++.||.||.++||++.....+- +|+|.+... ..+......+.+||..|.+|+ |.+||+++++=..++.+|+
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~i-yalkkv~~~-~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQI-YALKKVVLL-EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcc-hhhhHHHHh-hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 3579999999999999999999755554 555544322 235566889999999999996 9999999999999999999
Q ss_pred EEccCCCCChHHHHHhcCCCC-HHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCC
Q 013081 92 VLEYVTGGELFDKIASKGRLQ-EAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~~~l~-~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 170 (450)
||||= ..+|...+.+..... ....+.|..|++.|+.++|++||||.||||.|.|+ -.|.+||+|||+|.........
T Consensus 438 vmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTTs 515 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTTS 515 (677)
T ss_pred Eeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCccccc
Confidence 99986 469999998766544 36889999999999999999999999999999998 6789999999999876554444
Q ss_pred CccccccCCCCccchhhhccCCC----------CCccchhhhHHHHHHHHHhCCCCCCCC-cHHHHHHHHHhC--CCCCC
Q 013081 171 GLLHTTCGSPNYVAPEVLANRGY----------DGATSDIWSCGVILYVILTGYLPFDDR-NLAVLYQKIFRG--DFKLP 237 (450)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~----------~~~~~DiwSlGvil~elltG~~Pf~~~-~~~~~~~~i~~~--~~~~p 237 (450)
-...+.+||+.||+||.+....+ .+.++||||||||||+|+.|++||..- +...-+..|... ..++|
T Consensus 516 I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp 595 (677)
T KOG0596|consen 516 IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFP 595 (677)
T ss_pred eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcccccc
Confidence 45677899999999999865433 267899999999999999999999753 344444555554 34666
Q ss_pred CCCCHH-HHHHHHHccccCcCCCCCHHHHHhcccccc
Q 013081 238 KWLSPG-AQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 238 ~~~s~~-~~~Li~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
..-+.. +.++++.||..||++|||+.++|+|||++.
T Consensus 596 ~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 596 DIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred CCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 654444 999999999999999999999999999875
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=336.83 Aligned_cols=257 Identities=26% Similarity=0.436 Sum_probs=215.1
Q ss_pred CCcccCCeEEeeeecccCceEEEEEEEC-------CCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEE
Q 013081 9 EGMRLGRYELGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLH 80 (450)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~ 80 (450)
......+|++++.||+|+||.||+|.+. ..+..||+|.+.... .......+.+|+.+++.+ +||||++++
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 87 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL 87 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchhee
Confidence 3455679999999999999999999753 234579999986432 223356789999999999 799999999
Q ss_pred EEEEeCCEEEEEEccCCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCc
Q 013081 81 EVLASKSKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLEN 144 (450)
Q Consensus 81 ~~~~~~~~~~lv~E~~~gg~L~~~i~~~----------------~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~N 144 (450)
+++......|++|||+++|+|.+++... ..++...+..++.||+.||.|||++|++||||||+|
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 167 (304)
T cd05101 88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN 167 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence 9999999999999999999999999753 246788899999999999999999999999999999
Q ss_pred EEEccCCCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHH
Q 013081 145 ILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLA 223 (450)
Q Consensus 145 ILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~ 223 (450)
||++.++.+||+|||++................+++.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+..
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 246 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVE 246 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCC-CchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 9999999999999999985433222222233456778999999877666 588999999999999998 89999988887
Q ss_pred HHHHHHHhC-CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 224 VLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 224 ~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
.....+..+ ....|..++..+.+|+.+||.++|.+|||+.++++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 247 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 777776654 344566789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=336.98 Aligned_cols=255 Identities=27% Similarity=0.437 Sum_probs=212.4
Q ss_pred cccCCeEEeeeecccCceEEEEEEECC-------CCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLD-------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEV 82 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~ 82 (450)
..-++|.+++.||+|+||.||+|.+.. ....+|+|.+.... .......+.+|+.+++++ +||||++++++
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGV 86 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence 345789999999999999999998632 34579999986432 223356788999999999 69999999999
Q ss_pred EEeCCEEEEEEccCCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEE
Q 013081 83 LASKSKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENIL 146 (450)
Q Consensus 83 ~~~~~~~~lv~E~~~gg~L~~~i~~~----------------~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NIL 146 (450)
+......|++|||+++|+|.+++... ..++...+..++.||+.||.|||++|++||||||+|||
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil 166 (314)
T cd05099 87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVL 166 (314)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEE
Confidence 99999999999999999999999653 24788999999999999999999999999999999999
Q ss_pred EccCCCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHH
Q 013081 147 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVL 225 (450)
Q Consensus 147 l~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~ 225 (450)
++.++.+||+|||+++...............+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+....
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~ 245 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVY-THQSDVWSFGILMWEIFTLGGSPYPGIPVEEL 245 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCc-CccchhhHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999999985432111111222334568999999877655 589999999999999999 9999998887777
Q ss_pred HHHHHhCC-CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 226 YQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 226 ~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
+..+..+. ...|..++.++.+|+.+||+.||++|||+.++++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 289 (314)
T cd05099 246 FKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEA 289 (314)
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 77666553 45567788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=328.27 Aligned_cols=249 Identities=24% Similarity=0.418 Sum_probs=209.7
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 92 (450)
.++|++++.||+|+||.||+|.+.. +..+|+|.+...... .+.+.+|+.++++++||||+++++++......|++
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 4679999999999999999998754 456999988644321 35688999999999999999999999988899999
Q ss_pred EccCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCC
Q 013081 93 LEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 171 (450)
|||+.+++|.+++... ..+++..++.++.|++.||+|||++|++||||||.||+++.++.+||+|||++....... ..
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~-~~ 156 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE-YT 156 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCc-ee
Confidence 9999999999998763 468999999999999999999999999999999999999999999999999987432211 00
Q ss_pred ccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHH
Q 013081 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLR 249 (450)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~ 249 (450)
......++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+.......+..+. ...+...++.+.+++.
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKF-SSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMY 235 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcc-cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 1111234567999999876665 588999999999999999 999999887777777776653 3345667899999999
Q ss_pred HccccCcCCCCCHHHHHhc
Q 013081 250 KILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 250 ~~L~~dP~~R~t~~~il~h 268 (450)
+||++||.+|||+.+++.+
T Consensus 236 ~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 236 SCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHcCCCcccCCCHHHHHHh
Confidence 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=333.84 Aligned_cols=250 Identities=29% Similarity=0.389 Sum_probs=209.4
Q ss_pred CeEEeeeecccCceEEEEEEECC-----CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (450)
+|++.+.||+|+||.||+|.+.. ....+|+|.+..... ......+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 58899999999999999998753 235799998865432 22356788999999999999999999999999999
Q ss_pred EEEEccCCCCChHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcE
Q 013081 90 YMVLEYVTGGELFDKIASK------------------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENI 145 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~------------------------~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NI 145 (450)
|+++||+.+++|.+++... .++++..+..++.|++.||.|||++|++||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 9999999999999988642 2478899999999999999999999999999999999
Q ss_pred EEccCCCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHH
Q 013081 146 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAV 224 (450)
Q Consensus 146 Ll~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~ 224 (450)
|+++++.+||+|||++...............+++..|+|||.+.+..+ +.++||||||+++|+|++ |..||.+.....
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCc-chHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999875422211111233456778999999876655 588999999999999999 999999888777
Q ss_pred HHHHHHhC-CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHh
Q 013081 225 LYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 225 ~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
........ ..+.|..++..+.+++.+||++||++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 238 LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 66655543 44556778999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=336.81 Aligned_cols=256 Identities=25% Similarity=0.402 Sum_probs=218.0
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
..|+..+.||+|+||.||+|.+..++..||+|.+........+....+.+|+.+++.++|||++++++++..+...|+||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34889999999999999999999999999999997655444455678999999999999999999999999999999999
Q ss_pred ccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCc
Q 013081 94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (450)
Q Consensus 94 E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 172 (450)
||+.| +|.+.+.. ..++++..+..++.|++.||.|||++||+||||+|+||+++.++.+||+|||++.....
T Consensus 105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------ 177 (317)
T cd06635 105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP------ 177 (317)
T ss_pred eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC------
Confidence 99975 77777654 56799999999999999999999999999999999999999999999999999874321
Q ss_pred cccccCCCCccchhhhcc--CCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCC-C-CCCCCHHHHHHH
Q 013081 173 LHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-L-PKWLSPGAQNLL 248 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~~--~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-~-p~~~s~~~~~Li 248 (450)
.....|++.|+|||++.. .+..+.++||||+||++|+|++|..||...+.......+...... . +..+++.+.+|+
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 257 (317)
T cd06635 178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV 257 (317)
T ss_pred cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHH
Confidence 234578999999999742 233468899999999999999999999887766666666554332 2 234788999999
Q ss_pred HHccccCcCCCCCHHHHHhccccccCCC
Q 013081 249 RKILEPNPVKRITIAGIKADEWFEQDYT 276 (450)
Q Consensus 249 ~~~L~~dP~~R~t~~~il~h~~~~~~~~ 276 (450)
.+||+.+|.+|||+.++++|+|+.....
T Consensus 258 ~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 258 DSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred HHHccCCcccCcCHHHHHhChhhhccCc
Confidence 9999999999999999999999976443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=387.90 Aligned_cols=259 Identities=32% Similarity=0.520 Sum_probs=225.0
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEc
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 94 (450)
||+-+..||.|.||.||.|.+..+|+..|+|-+.-.... ....+.+.+|..++..++|||+|+.|++=.++...||.||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 688899999999999999999999999999988765544 3446789999999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc--CCCc
Q 013081 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR--DDGL 172 (450)
Q Consensus 95 ~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~--~~~~ 172 (450)
||+||+|.+.++..+-.++...+.|..|++.|++|||++|||||||||+|||++.+|.+|++|||.|....... -.+.
T Consensus 1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHH
Confidence 99999999999987778888999999999999999999999999999999999999999999999998644321 1234
Q ss_pred cccccCCCCccchhhhccCC--CCCccchhhhHHHHHHHHHhCCCCCCCCcHH--HHHHHHHhCCCCCCCCCCHHHHHHH
Q 013081 173 LHTTCGSPNYVAPEVLANRG--YDGATSDIWSCGVILYVILTGYLPFDDRNLA--VLYQKIFRGDFKLPKWLSPGAQNLL 248 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~--~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--~~~~~i~~~~~~~p~~~s~~~~~Li 248 (450)
++...|||.|||||++.+.. -.+-++||||||||..||+||+.||...+.. -+|.--.-..+++|..+|++.++||
T Consensus 1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFl 1474 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFL 1474 (1509)
T ss_pred HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHH
Confidence 56678999999999997643 2356799999999999999999999765433 3333333447889999999999999
Q ss_pred HHccccCcCCCCCHHHHHhccccccC
Q 013081 249 RKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 249 ~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
.+||+.||++|+++.|+++|.|-+..
T Consensus 1475 e~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1475 EHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred HHHHhcCchhhhHHHHHHHhhccccc
Confidence 99999999999999999999876543
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=333.04 Aligned_cols=266 Identities=32% Similarity=0.478 Sum_probs=215.2
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCC----ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-CC
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-KS 87 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~ 87 (450)
+..|++...||+|+||.||+|..++++ ..+|||.+.-+.. ..+......||+.++|.++|||++.+..++-+ +.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD-GTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 457999999999999999999655543 3799999865432 23446788899999999999999999999866 88
Q ss_pred EEEEEEccCCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccC----CCeEEeec
Q 013081 88 KIYMVLEYVTGGELFDKIAS-----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK----GNIKISDF 158 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~----g~lkl~DF 158 (450)
.+|+++||++. +|...|.- ...++...++.++.||+.|+.|||++-|+||||||.|||+..+ |.|||+||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999999976 89888853 2368999999999999999999999999999999999999888 89999999
Q ss_pred CCCCCCCcccC-CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcH---------HHHHHH
Q 013081 159 GLSALPQHFRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL---------AVLYQK 228 (450)
Q Consensus 159 Gla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~---------~~~~~~ 228 (450)
|+|+++...-. -......+-|.+|+|||.+.+...++++.|||+.|||+.||+|-.+.|.+... .+...+
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 99997643211 11334567899999999999988889999999999999999999998865321 122333
Q ss_pred HHhC--CC---------CCCCC--------------------------CCHHHHHHHHHccccCcCCCCCHHHHHhcccc
Q 013081 229 IFRG--DF---------KLPKW--------------------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 229 i~~~--~~---------~~p~~--------------------------~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~ 271 (450)
|+.- .+ .+|++ -++.+.+|+.+||+.||.+|+|++|+|+|+||
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF 340 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF 340 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence 3220 00 11211 25678999999999999999999999999999
Q ss_pred ccCCCCCCC
Q 013081 272 EQDYTPANP 280 (450)
Q Consensus 272 ~~~~~~~~~ 280 (450)
..+..|..+
T Consensus 341 ~~d~lpp~p 349 (438)
T KOG0666|consen 341 TEDPLPPLP 349 (438)
T ss_pred ccCCCCCCc
Confidence 988766443
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=320.72 Aligned_cols=249 Identities=32% Similarity=0.530 Sum_probs=214.6
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEc
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 94 (450)
.|++.+.||+|++|.||+|.+..+++.+++|.+..... .....+.+|+.+++.++|||++++++++......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 48899999999999999999988999999999876543 235789999999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCcc
Q 013081 95 YVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (450)
Q Consensus 95 ~~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 173 (450)
|++|++|.+.+... ..+++..+..++.|++.||.+||++|++||||+|+||++++++.++|+|||.+........ .
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~ 154 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R 154 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence 99999999998775 5899999999999999999999999999999999999999999999999999875433211 3
Q ss_pred ccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC-CCCCC--CCCCHHHHHHHHH
Q 013081 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-DFKLP--KWLSPGAQNLLRK 250 (450)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-~~~~p--~~~s~~~~~Li~~ 250 (450)
....++..|+|||.+....+ +.++|+||+|+++|+|++|..||...+........... ....+ ..++..+.++|.+
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 233 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPY-DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKK 233 (253)
T ss_pred cceecCCcccCHHHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHH
Confidence 45678999999999876654 58899999999999999999999887544433333322 22222 2248999999999
Q ss_pred ccccCcCCCCCHHHHHhccc
Q 013081 251 ILEPNPVKRITIAGIKADEW 270 (450)
Q Consensus 251 ~L~~dP~~R~t~~~il~h~~ 270 (450)
||+.||++|||+.+++.|||
T Consensus 234 ~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 234 CLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HccCChhhCCCHHHHhcCCC
Confidence 99999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=342.78 Aligned_cols=256 Identities=31% Similarity=0.442 Sum_probs=210.2
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC------
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK------ 86 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------ 86 (450)
-++|++.+.||+|+||.||+|.+..+|+.||+|.+.+... .....+.+.+|+.++++++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 4799999999999999999999999999999999865422 222346788999999999999999999988543
Q ss_pred CEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCc
Q 013081 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (450)
Q Consensus 87 ~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 166 (450)
...|++++++ |++|.+.+.. ..+++..++.++.|++.||.|||++||+||||||+||++++++.+||+|||++.....
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~ 172 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 172 (345)
T ss_pred ccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc
Confidence 3478888887 7899887764 5699999999999999999999999999999999999999999999999999874321
Q ss_pred ccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC-------------
Q 013081 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD------------- 233 (450)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------- 233 (450)
......+++.|+|||++.+....+.++||||+||++|+|++|+.||...+.......+....
T Consensus 173 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (345)
T cd07877 173 -----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 247 (345)
T ss_pred -----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhccc
Confidence 23345789999999998764445688999999999999999999998765544333322210
Q ss_pred ----------CCCC--------CCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCCC
Q 013081 234 ----------FKLP--------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 276 (450)
Q Consensus 234 ----------~~~p--------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~~ 276 (450)
...| ...++.+.+||.+||++||.+|||+.+++.||||.+...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~ 308 (345)
T cd07877 248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 308 (345)
T ss_pred HhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence 0011 125788999999999999999999999999999986443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=335.62 Aligned_cols=255 Identities=26% Similarity=0.410 Sum_probs=211.0
Q ss_pred CcccCCeEEeeeecccCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEE
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVL 83 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~ 83 (450)
....++|++.+.||+|+||.||+|.+. .++..||+|.+.... .....+.+.+|+.+++++ +||||+++++.+
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 344568999999999999999999752 345689999986543 223356789999999999 799999999999
Q ss_pred EeCCEEEEEEccCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCC
Q 013081 84 ASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS 161 (450)
Q Consensus 84 ~~~~~~~lv~E~~~gg~L~~~i~~~~--~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla 161 (450)
...+..|++|||+.+|+|.+++.... .+++.++..++.|++.||.|||++|++||||||+|||++.++.++|+|||++
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccc
Confidence 99999999999999999999997543 3899999999999999999999999999999999999999999999999998
Q ss_pred CCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC--CCCCCC
Q 013081 162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG--DFKLPK 238 (450)
Q Consensus 162 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~--~~~~p~ 238 (450)
................+++.|+|||.+....+ +.++||||+||++|+|++ |..||........+.+.... ....+.
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 267 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPE 267 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCC-CcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCC
Confidence 75432211111223346788999999877665 589999999999999998 99999887665544444433 234456
Q ss_pred CCCHHHHHHHHHccccCcCCCCCHHHHHh
Q 013081 239 WLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 239 ~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
..++.+.+++.+||+++|++|||+.++++
T Consensus 268 ~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 268 HAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 68999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=332.33 Aligned_cols=256 Identities=29% Similarity=0.473 Sum_probs=220.6
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (450)
..-..|++.+.||+|++|.||.|.+..+++.||+|++..... ....+.+|+.+++.++||||+++++.+......|
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 91 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELW 91 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEE
Confidence 445679999999999999999999988899999999975432 3567889999999999999999999999999999
Q ss_pred EEEccCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC
Q 013081 91 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (450)
Q Consensus 91 lv~E~~~gg~L~~~i~~~~-~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 169 (450)
+++||++|++|.+++.... .+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~-- 169 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE-- 169 (286)
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccc--
Confidence 9999999999999998876 8999999999999999999999999999999999999999999999999988643321
Q ss_pred CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC-CCC--CCCCCHHHHH
Q 013081 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FKL--PKWLSPGAQN 246 (450)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~--p~~~s~~~~~ 246 (450)
........+++.|+|||++.+..+ +.++|+||+||++|+|++|+.||...+.......+.... ... +..++..+.+
T Consensus 170 ~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 248 (286)
T cd06614 170 KSKRNSVVGTPYWMAPEVIKRKDY-GPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKD 248 (286)
T ss_pred hhhhccccCCcccCCHhHhcCCCC-CCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHH
Confidence 112234468899999999877665 588999999999999999999998877655554444332 222 2337889999
Q ss_pred HHHHccccCcCCCCCHHHHHhcccccc
Q 013081 247 LLRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 247 Li~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
+|.+||+.+|.+|||+.+++.|+||..
T Consensus 249 li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 249 FLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred HHHHHhccChhhCcCHHHHhhChHhhc
Confidence 999999999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=327.92 Aligned_cols=248 Identities=23% Similarity=0.426 Sum_probs=208.8
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
.+|++.+.||+|+||.||+|.+. ++..+|+|++.+.... ...+.+|+.+++.++||||+++++++...+..|++|
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 46899999999999999999875 4668999998654321 346778999999999999999999999999999999
Q ss_pred ccCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCc
Q 013081 94 EYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (450)
Q Consensus 94 E~~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 172 (450)
||++|++|.+++... +.+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||+++...... ...
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~-~~~ 157 (256)
T cd05059 79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ-YTS 157 (256)
T ss_pred ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccc-ccc
Confidence 999999999998753 468999999999999999999999999999999999999999999999999987432110 000
Q ss_pred cccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHH
Q 013081 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRK 250 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~ 250 (450)
.....++..|+|||.+.+..+ +.++|+||||+++|+|++ |..||...+.......+... ....|..+++.+.+++.+
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRF-SSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYS 236 (256)
T ss_pred cCCCCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence 111123457999999887666 588999999999999999 89999887776666666554 445667789999999999
Q ss_pred ccccCcCCCCCHHHHHhc
Q 013081 251 ILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 251 ~L~~dP~~R~t~~~il~h 268 (450)
||..+|++|||+.++++.
T Consensus 237 cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 237 CWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HhcCChhhCcCHHHHHHH
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=324.88 Aligned_cols=251 Identities=32% Similarity=0.535 Sum_probs=220.6
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEc
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 94 (450)
+|++.+.||+|+||.||++.+..+++.+|+|.+....... .....+.+|+.+++.++||||+++++++.+....|+++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 5899999999999999999999999999999987654332 335677889999999999999999999999999999999
Q ss_pred cCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCC
Q 013081 95 YVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (450)
Q Consensus 95 ~~~gg~L~~~i~~----~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 170 (450)
|+++++|.+++.+ ...+++..+..++.|++.||+|||+.|++||||+|+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 9999999998866 356899999999999999999999999999999999999999999999999999764332
Q ss_pred CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCC-CCCCCCCHHHHHHHH
Q 013081 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLR 249 (450)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~ 249 (450)
......+++.|+|||.+.+..+ +.++|+||+|+++|+|++|+.||...+.......+..+.. ..+..++.++.+++.
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKGRPY-SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIR 234 (256)
T ss_pred -CcccccCCccccCHHHHCCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHH
Confidence 3344678999999999877666 5789999999999999999999998887777666666543 355568899999999
Q ss_pred HccccCcCCCCCHHHHHhcccc
Q 013081 250 KILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 250 ~~L~~dP~~R~t~~~il~h~~~ 271 (450)
+||..+|++|||+.++++||++
T Consensus 235 ~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 235 SMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHcCCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999964
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=352.58 Aligned_cols=254 Identities=26% Similarity=0.412 Sum_probs=224.8
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEc
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 94 (450)
.|.=++.||.|+||.||.|++..+.+.||||.+........+....+.+|++.|++++|||+|.+.++|-.+...|+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 46678899999999999999999999999999987776666667889999999999999999999999999999999999
Q ss_pred cCCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCcc
Q 013081 95 YVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (450)
Q Consensus 95 ~~~gg~L~~~i~-~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 173 (450)
||- |+-.|++. ...++-+.++..+..+.+.||+|||+.+.||||||..|||+++.|.|||+|||.|.+.. ..
T Consensus 107 YCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~------PA 179 (948)
T KOG0577|consen 107 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA------PA 179 (948)
T ss_pred HHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC------ch
Confidence 995 58888875 35689999999999999999999999999999999999999999999999999998643 35
Q ss_pred ccccCCCCccchhhhc---cCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCC-CCCC-CCCHHHHHHH
Q 013081 174 HTTCGSPNYVAPEVLA---NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPK-WLSPGAQNLL 248 (450)
Q Consensus 174 ~~~~gt~~y~APE~l~---~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~-~~s~~~~~Li 248 (450)
.+++|||+|||||++. .+.|+ -++|||||||+..||...++|+-..|......-|..+.. .+++ .+|..+++|+
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYd-gkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fv 258 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV 258 (948)
T ss_pred hcccCCccccchhHheeccccccC-CccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHH
Confidence 6789999999999974 34554 689999999999999999999988888877777776643 3332 3789999999
Q ss_pred HHccccCcCCCCCHHHHHhccccccCCC
Q 013081 249 RKILEPNPVKRITIAGIKADEWFEQDYT 276 (450)
Q Consensus 249 ~~~L~~dP~~R~t~~~il~h~~~~~~~~ 276 (450)
..||++-|..|||.++++.|+|......
T Consensus 259 d~CLqKipqeRptse~ll~H~fv~R~Rp 286 (948)
T KOG0577|consen 259 DSCLQKIPQERPTSEELLKHRFVLRERP 286 (948)
T ss_pred HHHHhhCcccCCcHHHHhhcchhccCCC
Confidence 9999999999999999999999875443
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=330.59 Aligned_cols=253 Identities=21% Similarity=0.312 Sum_probs=208.1
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCce----EEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLP----FAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~----vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (450)
..++|++++.||+|+||.||+|.+..+++. +|+|.+.... .......+..|+.+++.++||||+++++++. ..
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~ 81 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GA 81 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CC
Confidence 457899999999999999999998877764 6777664321 2223467888999999999999999999875 45
Q ss_pred EEEEEEccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCc
Q 013081 88 KIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 166 (450)
..++++||+++|+|.+++.. .+.+++..+..++.||+.||+|||++|++||||||+|||+++++.+||+|||+++....
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 57889999999999999975 45789999999999999999999999999999999999999999999999999975432
Q ss_pred ccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHH
Q 013081 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGA 244 (450)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~ 244 (450)
...........++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.........+..+. .+.|..++..+
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRY-THQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDV 240 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHH
Confidence 111112233457778999999877666 589999999999999998 999998877666555555443 34455678899
Q ss_pred HHHHHHccccCcCCCCCHHHHHhc
Q 013081 245 QNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
.+++.+||..||++|||+.++++.
T Consensus 241 ~~li~~c~~~~p~~Rps~~el~~~ 264 (279)
T cd05111 241 YMVMVKCWMIDENVRPTFKELANE 264 (279)
T ss_pred HHHHHHHcCCCcccCcCHHHHHHH
Confidence 999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=342.14 Aligned_cols=256 Identities=21% Similarity=0.343 Sum_probs=205.2
Q ss_pred eeeccc--CceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEccCC
Q 013081 20 RTLGEG--NFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT 97 (450)
Q Consensus 20 ~~LG~G--~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 97 (450)
..||+| +||.||+|.+..+|+.||+|++...... .+..+.+.+|+.+++.++||||+++++++......|+++||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT-EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 456666 9999999999999999999998765433 2345789999999999999999999999999999999999999
Q ss_pred CCChHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCC-C---
Q 013081 98 GGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD-G--- 171 (450)
Q Consensus 98 gg~L~~~i~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~-~--- 171 (450)
+++|.+++.+. ..+++..+..++.||+.||+|||++|++||||||+|||++.++.++++|||.+......... .
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 99999998764 35899999999999999999999999999999999999999999999999865422111000 0
Q ss_pred -ccccccCCCCccchhhhccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCC---------------
Q 013081 172 -LLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF--------------- 234 (450)
Q Consensus 172 -~~~~~~gt~~y~APE~l~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--------------- 234 (450)
......++..|+|||++.+.. ..+.++||||+||++|+|++|..||.+...............
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR 242 (328)
T ss_pred cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence 011123567799999987542 236889999999999999999999987654444333322211
Q ss_pred --------------------------------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCCC
Q 013081 235 --------------------------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 276 (450)
Q Consensus 235 --------------------------------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~~ 276 (450)
+.+..+++.+.+|+++||+.||++|||+.++++||||.....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 011225678999999999999999999999999999976543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=327.92 Aligned_cols=254 Identities=22% Similarity=0.363 Sum_probs=212.3
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCc---eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGL---PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (450)
.++.|++.+.||+|+||.||+|.+..+++ .||+|.+.... .......+.+|+.+++.++||||+++++++.+...
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 79 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRP 79 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCc
Confidence 35679999999999999999999877665 69999986532 33345789999999999999999999999999999
Q ss_pred EEEEEccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcc
Q 013081 89 IYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 167 (450)
.+++|||+++++|.+++.. .+.+++.+++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++......
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 80 VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred eEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 9999999999999999875 356899999999999999999999999999999999999999999999999998754321
Q ss_pred cCCCcccccc---CCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCH
Q 013081 168 RDDGLLHTTC---GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSP 242 (450)
Q Consensus 168 ~~~~~~~~~~---gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~ 242 (450)
.......... .+..|+|||.+....+ +.++||||+||++|+|++ |..||...+.......+... ..+.+..++.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 238 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPT 238 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcc-cchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCH
Confidence 1111111111 2357999999887766 588999999999999887 99999887777666666543 3445566889
Q ss_pred HHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 243 GAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
.+.+++.+||+++|++||++.+++..
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~i~~~ 264 (269)
T cd05065 239 ALHQLMLDCWQKDRNARPKFGQIVST 264 (269)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=327.74 Aligned_cols=248 Identities=25% Similarity=0.388 Sum_probs=207.7
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
..++|++.+.||+|+||.||+|.+..++ .||+|.+...... .+.+.+|+.+++.++||||+++++.+. ....|+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l 77 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYI 77 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEE
Confidence 3578999999999999999999986554 5999998753321 356889999999999999999999875 456899
Q ss_pred EEccCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC
Q 013081 92 VLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 169 (450)
+|||+++|+|.+++... ..+++..+..++.|++.||+|||+.|++||||||+||++++++.+||+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~- 156 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE- 156 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc-
Confidence 99999999999999753 358899999999999999999999999999999999999999999999999997543211
Q ss_pred CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 013081 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 247 (450)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 247 (450)
........++..|+|||++.+..+ +.++||||+||++|+|++ |..||.+.........+..+ ..+.+..++..+.++
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 235 (262)
T cd05071 157 YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL 235 (262)
T ss_pred cccccCCcccceecCHhHhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHH
Confidence 111223446678999999876666 589999999999999999 99999887777666666554 344556689999999
Q ss_pred HHHccccCcCCCCCHHHHHh
Q 013081 248 LRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 248 i~~~L~~dP~~R~t~~~il~ 267 (450)
+.+||++||++|||+.++++
T Consensus 236 i~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 236 MCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHccCCcccCCCHHHHHH
Confidence 99999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=334.39 Aligned_cols=256 Identities=24% Similarity=0.334 Sum_probs=207.6
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~l 91 (450)
..+|+..+.||+|+||.||++.+..+++.||+|.+...... .....+.+|+.++.++. ||||+++++++..+...|+
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~ 80 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI 80 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence 35677889999999999999999999999999998754332 33567889999999996 9999999999999999999
Q ss_pred EEccCCCCChHHHH---H--hcCCCCHHHHHHHHHHHHHHHhhhhhc-CeeeccCCCCcEEEccCCCeEEeecCCCCCCC
Q 013081 92 VLEYVTGGELFDKI---A--SKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (450)
Q Consensus 92 v~E~~~gg~L~~~i---~--~~~~l~~~~~~~i~~ql~~aL~~LH~~-givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 165 (450)
+|||+. +++.++. . ..+.+++..+..++.|++.||+|||+. |++||||||+||+++.++.+||+|||++....
T Consensus 81 ~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 81 CMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred EEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 999985 4554432 2 246799999999999999999999975 99999999999999999999999999987432
Q ss_pred cccCCCccccccCCCCccchhhhccC--CCCCccchhhhHHHHHHHHHhCCCCCCCCcH-HHHHHHHHhCC-CCCC----
Q 013081 166 HFRDDGLLHTTCGSPNYVAPEVLANR--GYDGATSDIWSCGVILYVILTGYLPFDDRNL-AVLYQKIFRGD-FKLP---- 237 (450)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~-~~~p---- 237 (450)
. ........|++.|+|||++.+. ...+.++||||+||++|+|++|+.||..... .....++..+. ...+
T Consensus 160 ~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd06616 160 D---SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEE 236 (288)
T ss_pred c---CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCC
Confidence 1 1122344689999999998766 2446899999999999999999999976542 12222322222 1222
Q ss_pred CCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 238 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 238 ~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
..+++.+.+|+.+||++||++|||+.++++||||...
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 237 REFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred CccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 2378899999999999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=326.75 Aligned_cols=249 Identities=25% Similarity=0.403 Sum_probs=209.7
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
..++|++++.||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.+++.++||||+++++.+......|+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYI 78 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence 4568999999999999999999964 566799998764322 24678899999999999999999999999999999
Q ss_pred EEccCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC
Q 013081 92 VLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 169 (450)
+|||+++++|.+++... ..++......++.|++.||+|||++|++||||||+||+++.++.+||+|||++........
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 99999999999998653 4688999999999999999999999999999999999999999999999999985432111
Q ss_pred CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 013081 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 247 (450)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 247 (450)
.......++..|+|||.+....+ +.++|||||||++|+|++ |..||...+.......+... ..+.+..++.++.++
T Consensus 159 -~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (261)
T cd05072 159 -TAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDI 236 (261)
T ss_pred -eccCCCccceecCCHHHhccCCC-ChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 11122345678999999876665 588999999999999998 99999887777666666544 334445688999999
Q ss_pred HHHccccCcCCCCCHHHHHh
Q 013081 248 LRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 248 i~~~L~~dP~~R~t~~~il~ 267 (450)
+.+||..+|++|||++++.+
T Consensus 237 i~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 237 MKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHccCCcccCcCHHHHHH
Confidence 99999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=330.41 Aligned_cols=263 Identities=30% Similarity=0.606 Sum_probs=238.8
Q ss_pred ccCCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEe
Q 013081 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS 85 (450)
Q Consensus 7 ~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 85 (450)
.+.++-+..|++++.||+|+|++|-+++.+.|.+.+|+|+++++-..+.+..+.+..|-.+..+. +||.+|.++..|.+
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt 322 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT 322 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence 34456678999999999999999999999999999999999998877777788888898888877 69999999999999
Q ss_pred CCEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCC
Q 013081 86 KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (450)
Q Consensus 86 ~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 165 (450)
+.++++|.||++||+|.-.+++...++++.|+.|...|+.||.|||++||++||||.+|+|+|..|++||+|+|+++.
T Consensus 323 esrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke-- 400 (593)
T KOG0695|consen 323 ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE-- 400 (593)
T ss_pred cceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhc--
Confidence 999999999999999988888889999999999999999999999999999999999999999999999999999874
Q ss_pred cccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCC--------CcHHHHHHHHHhCCCCCC
Q 013081 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD--------RNLAVLYQKIFRGDFKLP 237 (450)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~--------~~~~~~~~~i~~~~~~~p 237 (450)
...+.....+.||||.|.|||++.+..| +..+|.|+|||+++||++|+.||+- .+..-+++-|+.....+|
T Consensus 401 ~l~~gd~tstfcgtpnyiapeilrgeey-gfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqirip 479 (593)
T KOG0695|consen 401 GLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIP 479 (593)
T ss_pred CCCCCcccccccCCCcccchhhhccccc-CceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccccc
Confidence 3445567788999999999999998887 6999999999999999999999952 234457788888899999
Q ss_pred CCCCHHHHHHHHHccccCcCCCC------CHHHHHhccccc
Q 013081 238 KWLSPGAQNLLRKILEPNPVKRI------TIAGIKADEWFE 272 (450)
Q Consensus 238 ~~~s~~~~~Li~~~L~~dP~~R~------t~~~il~h~~~~ 272 (450)
..+|-.+..+++..|++||.+|. ..+++..|+||.
T Consensus 480 rslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr 520 (593)
T KOG0695|consen 480 RSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFR 520 (593)
T ss_pred ceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhh
Confidence 99999999999999999999996 378999999996
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=328.38 Aligned_cols=252 Identities=25% Similarity=0.359 Sum_probs=213.4
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCc----eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGL----PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (450)
..++|++++.||+|+||.||+|.+..+|+ .||+|.+..... ......+.+|+.++++++||||+++++++.+ .
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 81 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-S 81 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence 45789999999999999999999876665 589998865532 3345778899999999999999999999887 7
Q ss_pred EEEEEEccCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCc
Q 013081 88 KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 166 (450)
..+++|||+++|+|.+++... ..+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 889999999999999998764 4699999999999999999999999999999999999999999999999999986432
Q ss_pred ccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHH
Q 013081 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGA 244 (450)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~ 244 (450)
...........++..|+|||.+....+ +.++|+||+||++|++++ |..||.+.......+.+..+ ..+.|...+..+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIY-THKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDV 240 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCc-CchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHH
Confidence 211111122234568999999876665 588999999999999999 99999998887777777665 356677788999
Q ss_pred HHHHHHccccCcCCCCCHHHHHh
Q 013081 245 QNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
.+++.+||..||..|||+.++++
T Consensus 241 ~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 241 YMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHHHcCCChhhCCCHHHHHH
Confidence 99999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=331.27 Aligned_cols=248 Identities=34% Similarity=0.526 Sum_probs=205.9
Q ss_pred EEeeeecccCceEEEEEEEC----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013081 17 ELGRTLGEGNFGKVKFAQDL----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 17 ~i~~~LG~G~~g~Vy~a~~~----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 92 (450)
.+.+.||.|+||.||+|... ..+..|+||.+... ......+.+.+|++.+++++||||+++++++......++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence 56789999999999999987 45678999999542 2333468899999999999999999999999988889999
Q ss_pred EccCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCC
Q 013081 93 LEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 170 (450)
+||+++|+|.+++... ..+++.....++.||+.||.|||+++++||||+|.|||++.++.+||+|||++.........
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999886 67999999999999999999999999999999999999999999999999999854211111
Q ss_pred CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHH
Q 013081 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLL 248 (450)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li 248 (450)
.......+...|+|||.+....+ +.++||||||+++||+++ |+.||.+.+......++..+ ..+.|..++..+.++|
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~-~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEY-TKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLI 238 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEE-SHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHH
T ss_pred ccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHH
Confidence 12233456778999999887765 589999999999999999 78999998888877777665 3456677899999999
Q ss_pred HHccccCcCCCCCHHHHHh
Q 013081 249 RKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 249 ~~~L~~dP~~R~t~~~il~ 267 (450)
.+||..||.+|||+.++++
T Consensus 239 ~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 239 QQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHT-SSGGGS--HHHHHH
T ss_pred HHHcCCChhhCcCHHHHHh
Confidence 9999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=341.72 Aligned_cols=260 Identities=32% Similarity=0.432 Sum_probs=212.8
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC--CE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK--SK 88 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~--~~ 88 (450)
..++|++.+.||+|+||.||+|.+..+|+.+|+|.+.+... .......+.+|+.+++++ +||||+++++++... ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 45789999999999999999999998999999998864322 222245677899999999 999999999988643 46
Q ss_pred EEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc
Q 013081 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 168 (450)
.|+||||+. ++|.+.+... .+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161 (337)
T ss_pred EEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence 899999997 5999988765 78999999999999999999999999999999999999999999999999998543322
Q ss_pred CC---CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC------------
Q 013081 169 DD---GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD------------ 233 (450)
Q Consensus 169 ~~---~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------ 233 (450)
.. .......||+.|+|||++.+....+.++|+||||+++|+|++|+.||.+........++....
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07852 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK 241 (337)
T ss_pred ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHH
Confidence 11 223345789999999988765555689999999999999999999998765443333221110
Q ss_pred ----------------C---CCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 234 ----------------F---KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 234 ----------------~---~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
. ...+.++..+.++|.+||+.||++|||+.++++|||+++-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 0 0112268899999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=325.99 Aligned_cols=248 Identities=25% Similarity=0.368 Sum_probs=209.3
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 92 (450)
.++|++.+.||+|++|.||+|.+. +++.||+|.+..... ..+.+.+|+.++++++||||+++++++...+..|++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV 79 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeee
Confidence 467999999999999999999974 457899999865432 145688999999999999999999999999999999
Q ss_pred EccCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCC
Q 013081 93 LEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~~~--~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 170 (450)
|||++|++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 158 (261)
T cd05068 80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY- 158 (261)
T ss_pred eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-
Confidence 99999999999997644 689999999999999999999999999999999999999999999999999875432110
Q ss_pred CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHH
Q 013081 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLL 248 (450)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li 248 (450)
........+..|+|||++.+..+ +.++||||||+++|+|++ |+.||.+.+.......+... ..+.+..++..+.+++
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 237 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRF-SIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIM 237 (261)
T ss_pred cccCCCcCceeccCccccccCCC-CchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence 00111123457999999876655 588999999999999999 99999988877777666554 3445666899999999
Q ss_pred HHccccCcCCCCCHHHHHh
Q 013081 249 RKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 249 ~~~L~~dP~~R~t~~~il~ 267 (450)
.+||+.+|.+||++.+++.
T Consensus 238 ~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 238 LDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHhhcCcccCCCHHHHHH
Confidence 9999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=343.03 Aligned_cols=254 Identities=26% Similarity=0.388 Sum_probs=205.6
Q ss_pred ccCCeEEeeeecccCceEEEEEEE-----CCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEe
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQD-----LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS 85 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 85 (450)
.-++|++++.||+|+||.||+|.+ ..+++.||||+++.... ......+.+|+.++.++ +||||+++++++..
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTK 82 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence 356899999999999999999984 34678999999965432 22356788999999999 68999999998754
Q ss_pred -CCEEEEEEccCCCCChHHHHHhc--------------------------------------------------------
Q 013081 86 -KSKIYMVLEYVTGGELFDKIASK-------------------------------------------------------- 108 (450)
Q Consensus 86 -~~~~~lv~E~~~gg~L~~~i~~~-------------------------------------------------------- 108 (450)
....+++|||+++|+|.+++...
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 45689999999999999998642
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCcccccc
Q 013081 109 -----------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC 177 (450)
Q Consensus 109 -----------~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~ 177 (450)
..++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++................
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 136778889999999999999999999999999999999999999999999987542211111122334
Q ss_pred CCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHH-HHHHHHhC-CCCCCCCCCHHHHHHHHHcccc
Q 013081 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAV-LYQKIFRG-DFKLPKWLSPGAQNLLRKILEP 254 (450)
Q Consensus 178 gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~-~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~ 254 (450)
+++.|+|||++.+..+ +.++||||||+++|+|++ |..||....... ....+..+ ....|.+.++.+.+++.+||+.
T Consensus 243 ~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~ 321 (343)
T cd05103 243 LPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHG 321 (343)
T ss_pred CCcceECcHHhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccC
Confidence 5678999999877666 589999999999999997 999998754332 22333333 4456777899999999999999
Q ss_pred CcCCCCCHHHHHhc
Q 013081 255 NPVKRITIAGIKAD 268 (450)
Q Consensus 255 dP~~R~t~~~il~h 268 (450)
||++|||+.++++|
T Consensus 322 ~p~~Rps~~eil~~ 335 (343)
T cd05103 322 EPSQRPTFSELVEH 335 (343)
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=324.38 Aligned_cols=244 Identities=26% Similarity=0.389 Sum_probs=204.9
Q ss_pred eeecccCceEEEEEEECCCC---ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEccC
Q 013081 20 RTLGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYV 96 (450)
Q Consensus 20 ~~LG~G~~g~Vy~a~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 96 (450)
+.||+|+||.||+|.+..++ ..+|+|.+...... ...+.+.+|+.+++.++||||+++++++. ....+++|||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 47999999999999876554 78999998765432 33567889999999999999999999876 45689999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCC-cccc
Q 013081 97 TGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG-LLHT 175 (450)
Q Consensus 97 ~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~-~~~~ 175 (450)
++++|.+++.....+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++.......... ....
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 999999999887889999999999999999999999999999999999999999999999999988543211110 0111
Q ss_pred ccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccc
Q 013081 176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILE 253 (450)
Q Consensus 176 ~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~ 253 (450)
..++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+.......+... ..+.|..+++.+.+++.+||.
T Consensus 158 ~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 236 (257)
T cd05060 158 GRWPLKWYAPECINYGKF-SSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWK 236 (257)
T ss_pred ccccccccCHHHhcCCCC-CccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhc
Confidence 123467999999876665 589999999999999998 99999888777666666554 345677789999999999999
Q ss_pred cCcCCCCCHHHHHh
Q 013081 254 PNPVKRITIAGIKA 267 (450)
Q Consensus 254 ~dP~~R~t~~~il~ 267 (450)
+||++|||+.++++
T Consensus 237 ~~p~~Rp~~~~l~~ 250 (257)
T cd05060 237 YRPEDRPTFSELES 250 (257)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=331.06 Aligned_cols=259 Identities=33% Similarity=0.592 Sum_probs=217.3
Q ss_pred CeEEeeeecccCceEEEEEEEC---CCCceEEEEEeeccccc-chhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 013081 15 RYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRII-HLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKI 89 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 89 (450)
.|++.+.||+|++|.||+|.+. .+++.||+|++.+.... .......+.+|+.+++++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4899999999999999999864 46789999998754332 223346788999999999 599999999999999999
Q ss_pred EEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC
Q 013081 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 169 (450)
|+||||+.|++|.+.+.....+++..++.++.|++.||.|||+.|++||||||.||+++.++.++|+|||++...... .
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~ 159 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE-E 159 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc-c
Confidence 999999999999999988788999999999999999999999999999999999999999999999999998754321 1
Q ss_pred CCccccccCCCCccchhhhccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCc----HHHHHHHHHhCCCCCCCCCCHHH
Q 013081 170 DGLLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYVILTGYLPFDDRN----LAVLYQKIFRGDFKLPKWLSPGA 244 (450)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~----~~~~~~~i~~~~~~~p~~~s~~~ 244 (450)
.......+|++.|+|||.+.+.. ..+.++|+||+|+++|+|++|..||.... .......+.....+.|..+++.+
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 239 (288)
T cd05583 160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEA 239 (288)
T ss_pred ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHH
Confidence 11223456899999999986543 24578999999999999999999996432 23444555566677788899999
Q ss_pred HHHHHHccccCcCCCCC---HHHHHhccccccC
Q 013081 245 QNLLRKILEPNPVKRIT---IAGIKADEWFEQD 274 (450)
Q Consensus 245 ~~Li~~~L~~dP~~R~t---~~~il~h~~~~~~ 274 (450)
.+++.+||+.||++||| +.++++||||+..
T Consensus 240 ~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 240 RDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred HHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence 99999999999999998 5678999999753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=331.15 Aligned_cols=253 Identities=26% Similarity=0.382 Sum_probs=212.3
Q ss_pred ccCCeEEeeeecccCceEEEEEEECC-----CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (450)
..++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 35689999999999999999998753 67899999986543 223356788999999999999999999999999
Q ss_pred CEEEEEEccCCCCChHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCc
Q 013081 87 SKIYMVLEYVTGGELFDKIASKG----------------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLEN 144 (450)
Q Consensus 87 ~~~~lv~E~~~gg~L~~~i~~~~----------------------~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~N 144 (450)
...|++|||+++++|.+++.... .+++..+..++.||+.||+|||++|++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 99999999999999999986432 37888899999999999999999999999999999
Q ss_pred EEEccCCCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHH
Q 013081 145 ILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLA 223 (450)
Q Consensus 145 ILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~ 223 (450)
|+++.++.++|+|||++................+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+..
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999874322111111222345678999999877666 589999999999999998 88999887777
Q ss_pred HHHHHHHhCC-CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHh
Q 013081 224 VLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 224 ~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
+....+..+. .+.|..++..+.+|+.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 240 EVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 7777766654 3456778999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=326.38 Aligned_cols=252 Identities=23% Similarity=0.394 Sum_probs=210.7
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCc---eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGL---PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (450)
.++|++++.||+|+||.||+|.+..++. .+|+|.+..... ......+.+|+.++++++||||+++++++.+.+..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 4689999999999999999999865543 799998865432 23356889999999999999999999999999999
Q ss_pred EEEEccCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc
Q 013081 90 YMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 168 (450)
|++|||++|++|.+++... +.+++.++..++.|++.||+|||++|++||||||+|||++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999999764 468999999999999999999999999999999999999999999999999998643321
Q ss_pred CCCc-cccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHH
Q 013081 169 DDGL-LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQ 245 (450)
Q Consensus 169 ~~~~-~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 245 (450)
.... .....++..|+|||.+.+..+ +.++|+|||||++|++++ |..||.+.........+..+ ..+.+..+++.+.
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALH 239 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCcc-CchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHH
Confidence 1110 111223568999999877665 589999999999999887 99999887766666666554 3344556789999
Q ss_pred HHHHHccccCcCCCCCHHHHHh
Q 013081 246 NLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 246 ~Li~~~L~~dP~~R~t~~~il~ 267 (450)
+++.+||+++|.+|||+.++++
T Consensus 240 ~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 240 QLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHHcccCchhCCCHHHHHH
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=335.09 Aligned_cols=256 Identities=25% Similarity=0.387 Sum_probs=215.1
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
.-..|+..+.||+|+||.||+|++..+++.+|+|.+............++.+|+.+++.++|||++++++++......|+
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence 34568889999999999999999999999999999875433333445678899999999999999999999999999999
Q ss_pred EEccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCC
Q 013081 92 VLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 170 (450)
||||+. |+|.+.+.. ..++++..+..++.|++.||.|||++|++||||+|+|||++.++.++|+|||++.....
T Consensus 93 v~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~---- 167 (308)
T cd06634 93 VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167 (308)
T ss_pred EEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC----
Confidence 999996 578776653 45689999999999999999999999999999999999999999999999999874322
Q ss_pred CccccccCCCCccchhhhcc--CCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCC-C-CCCCCHHHHH
Q 013081 171 GLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-L-PKWLSPGAQN 246 (450)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~--~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-~-p~~~s~~~~~ 246 (450)
.....|++.|+|||.+.+ ....+.++|||||||++|+|++|..||...+.......+.....+ . +..++..+.+
T Consensus 168 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (308)
T cd06634 168 --ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN 245 (308)
T ss_pred --cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHH
Confidence 234568899999999753 223357899999999999999999999876655544444444322 2 3357889999
Q ss_pred HHHHccccCcCCCCCHHHHHhccccccC
Q 013081 247 LLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 247 Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
||++||+++|.+||++.++++|||+...
T Consensus 246 li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 246 FVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred HHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 9999999999999999999999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=347.36 Aligned_cols=257 Identities=27% Similarity=0.362 Sum_probs=210.7
Q ss_pred CCcccCCeEEeeeecccCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEE
Q 013081 9 EGMRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEV 82 (450)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~ 82 (450)
-....++|.+++.||+|+||.||+|++. .+++.||+|+++.... ......+.+|+.++.++. ||||+++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~~H~niv~~~~~ 109 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR--SSEKQALMSELKIMSHLGPHLNIVNLLGA 109 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC--hhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence 3455678999999999999999999864 3556899999975432 223457889999999997 9999999999
Q ss_pred EEeCCEEEEEEccCCCCChHHHHHhcC-----------------------------------------------------
Q 013081 83 LASKSKIYMVLEYVTGGELFDKIASKG----------------------------------------------------- 109 (450)
Q Consensus 83 ~~~~~~~~lv~E~~~gg~L~~~i~~~~----------------------------------------------------- 109 (450)
+...+..|+||||+++|+|.+++...+
T Consensus 110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 999999999999999999999986432
Q ss_pred ---------------------------------------------CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCc
Q 013081 110 ---------------------------------------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLEN 144 (450)
Q Consensus 110 ---------------------------------------------~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~N 144 (450)
.++...++.++.||+.||+|||+.|++||||||+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N 269 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN 269 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence 25677788999999999999999999999999999
Q ss_pred EEEccCCCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHH
Q 013081 145 ILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLA 223 (450)
Q Consensus 145 ILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~ 223 (450)
||+++++.+||+|||+++...............+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||......
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY-TTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCC-CcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 9999999999999999975422111111223467889999999877665 588999999999999998 89999876544
Q ss_pred HHHHHH-HhC-CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 224 VLYQKI-FRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 224 ~~~~~i-~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
...... ..+ ..+.|..++..+.+|+.+||.++|.+||++.+|+..
T Consensus 349 ~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 349 EQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 443333 333 345677789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=323.80 Aligned_cols=244 Identities=25% Similarity=0.469 Sum_probs=208.3
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEE-EeCCEE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVL-ASKSKI 89 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-~~~~~~ 89 (450)
..+.+|++.+.||+|+||.||+|.. .|..||+|.+.... ..+.+.+|+.++++++|||++++++++ ......
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 75 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence 3567899999999999999999986 47889999985432 246788999999999999999999975 455678
Q ss_pred EEEEccCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcc
Q 013081 90 YMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~--~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 167 (450)
|++|||+++++|.+++...+ .+++..+..++.|++.||+|||++|++||||||+||++++++.+||+|||++.....
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~- 154 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS- 154 (256)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc-
Confidence 99999999999999987644 488999999999999999999999999999999999999999999999999874322
Q ss_pred cCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHH
Q 013081 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQ 245 (450)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 245 (450)
......++..|+|||++....+ +.++|||||||++|+|++ |+.||...+.......+..+ ....++.+++.+.
T Consensus 155 ----~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (256)
T cd05082 155 ----TQDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVY 229 (256)
T ss_pred ----cCCCCccceeecCHHHHccCCC-CchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 1223445678999999876665 588999999999999998 99999988777776666554 3455667899999
Q ss_pred HHHHHccccCcCCCCCHHHHHh
Q 013081 246 NLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 246 ~Li~~~L~~dP~~R~t~~~il~ 267 (450)
+++.+||+.+|++|||+.++++
T Consensus 230 ~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 230 DVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHHhcCChhhCcCHHHHHH
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=338.12 Aligned_cols=254 Identities=27% Similarity=0.438 Sum_probs=211.8
Q ss_pred cCCeEEeeeecccCceEEEEEEECCC-------CceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDS-------GLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA 84 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~-------~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 84 (450)
-.+|++++.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.+++++ +||||+++++++.
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 35799999999999999999986432 2369999886432 223357889999999999 7999999999999
Q ss_pred eCCEEEEEEccCCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEc
Q 013081 85 SKSKIYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 148 (450)
Q Consensus 85 ~~~~~~lv~E~~~gg~L~~~i~~~~----------------~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~ 148 (450)
.....|++|||+++|+|.+++.... .++...+..++.|++.||+|||++|++||||||+|||++
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~ 168 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT 168 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc
Confidence 9999999999999999999987532 367788899999999999999999999999999999999
Q ss_pred cCCCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHH
Q 013081 149 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQ 227 (450)
Q Consensus 149 ~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~ 227 (450)
.++.+||+|||+++...............++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+......
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 247 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 247 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCc-CchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 999999999999875432211111222334567999999877666 488999999999999998 999999888877777
Q ss_pred HHHhC-CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhcc
Q 013081 228 KIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADE 269 (450)
Q Consensus 228 ~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~ 269 (450)
.+... ..+.|..++..+.+|+.+||+.+|.+|||+.+++++-
T Consensus 248 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 248 LLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 76654 3456667889999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=325.87 Aligned_cols=248 Identities=26% Similarity=0.395 Sum_probs=208.3
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
..++|++.+.||+|+||.||+|.+. .+..||+|.+...... .+.+.+|+.++++++|||++++++++. ....|+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l 77 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYI 77 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEE
Confidence 4568999999999999999999865 5667999998754331 356889999999999999999999875 456899
Q ss_pred EEccCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC
Q 013081 92 VLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 169 (450)
+|||+++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||++++++.++|+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~- 156 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE- 156 (260)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc-
Confidence 99999999999998753 358999999999999999999999999999999999999999999999999997543211
Q ss_pred CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 013081 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 247 (450)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 247 (450)
........++..|+|||.+....+ +.++|+||||+++|+|++ |.+||.+.+.......+..+ ..+.|...+..+.+|
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (260)
T cd05070 157 YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHEL 235 (260)
T ss_pred cccccCCCCCccccChHHHhcCCC-cchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHH
Confidence 111122235567999999876655 589999999999999999 99999888777777766654 455677789999999
Q ss_pred HHHccccCcCCCCCHHHHHh
Q 013081 248 LRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 248 i~~~L~~dP~~R~t~~~il~ 267 (450)
+.+||++||++|||++++.+
T Consensus 236 i~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 236 MLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHcccCcccCcCHHHHHH
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=332.75 Aligned_cols=254 Identities=26% Similarity=0.457 Sum_probs=214.4
Q ss_pred EEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEccC
Q 013081 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYV 96 (450)
Q Consensus 17 ~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 96 (450)
+....||+|+||.||+|.+..+|+.||+|.+.... ......+.+|+.+++.++||||+++++.+...+..|++|||+
T Consensus 23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (292)
T cd06657 23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 99 (292)
T ss_pred hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence 33467999999999999999999999999875332 223567889999999999999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccccc
Q 013081 97 TGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT 176 (450)
Q Consensus 97 ~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~ 176 (450)
++++|.+++.. +++++..++.++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++..... ........
T Consensus 100 ~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~--~~~~~~~~ 176 (292)
T cd06657 100 EGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKSL 176 (292)
T ss_pred CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccc--cccccccc
Confidence 99999987754 5789999999999999999999999999999999999999999999999998864322 11122345
Q ss_pred cCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC---CCCCCCCCCHHHHHHHHHccc
Q 013081 177 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---DFKLPKWLSPGAQNLLRKILE 253 (450)
Q Consensus 177 ~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~Li~~~L~ 253 (450)
.|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||.+.........+... .......+++.+.+++.+||+
T Consensus 177 ~~~~~y~~pE~~~~~~~-~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 255 (292)
T cd06657 177 VGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLV 255 (292)
T ss_pred ccCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHh
Confidence 78999999999876655 58999999999999999999999887665554444332 222334578999999999999
Q ss_pred cCcCCCCCHHHHHhccccccCCCC
Q 013081 254 PNPVKRITIAGIKADEWFEQDYTP 277 (450)
Q Consensus 254 ~dP~~R~t~~~il~h~~~~~~~~~ 277 (450)
.||.+||++.+++.||||.....+
T Consensus 256 ~~P~~R~~~~~ll~~~~~~~~~~~ 279 (292)
T cd06657 256 RDPAQRATAAELLKHPFLAKAGPP 279 (292)
T ss_pred CCcccCcCHHHHhcChHHhccCCC
Confidence 999999999999999999887643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=349.41 Aligned_cols=240 Identities=26% Similarity=0.426 Sum_probs=209.3
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 92 (450)
|....-++-||.|+.|.||+|+. .++.||||.++. .-..+|.-|++|+||||+.+.++|.....++||
T Consensus 123 Fe~IsELeWlGSGaQGAVF~Grl--~netVAVKKV~e----------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIi 190 (904)
T KOG4721|consen 123 FEEISELEWLGSGAQGAVFLGRL--HNETVAVKKVRE----------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCII 190 (904)
T ss_pred HHHhhhhhhhccCcccceeeeec--cCceehhHHHhh----------hhhhhHHHHHhccCcceeeEeeeecCCceeEEe
Confidence 34444567799999999999986 677899997642 223578999999999999999999999999999
Q ss_pred EccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCc
Q 013081 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 172 (450)
||||..|.|...++...+++......|..+|+.|+.|||.+.|||||||.-||||..+..|||+|||-++... +...
T Consensus 191 MEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~---~~ST 267 (904)
T KOG4721|consen 191 MEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELS---DKST 267 (904)
T ss_pred eeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhh---hhhh
Confidence 9999999999999999999999999999999999999999999999999999999999999999999987432 2234
Q ss_pred cccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC--CCCCCCCCCHHHHHHHHH
Q 013081 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQNLLRK 250 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~ 250 (450)
.-.++||..|||||++.+.+- +.|+|||||||||||||||..||.+-+...+..-+-.. .++.|+.++..++=||+.
T Consensus 268 kMSFaGTVaWMAPEvIrnePc-sEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kq 346 (904)
T KOG4721|consen 268 KMSFAGTVAWMAPEVIRNEPC-SEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQ 346 (904)
T ss_pred hhhhhhhHhhhCHHHhhcCCc-ccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHH
Confidence 456899999999999987766 59999999999999999999999876655443322222 467789999999999999
Q ss_pred ccccCcCCCCCHHHHHhc
Q 013081 251 ILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 251 ~L~~dP~~R~t~~~il~h 268 (450)
||+-.|..||++.+|+.|
T Consensus 347 cw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 347 CWNSKPRNRPSFRQILLH 364 (904)
T ss_pred HHhcCCCCCccHHHHHHH
Confidence 999999999999999998
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=332.72 Aligned_cols=252 Identities=23% Similarity=0.324 Sum_probs=205.4
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCC--------------ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcce
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSG--------------LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVR 78 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~--------------~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~ 78 (450)
.++|++.+.||+|+||.||+|++..++ ..||+|.++... .......+.+|++++++++|||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 468999999999999999999875432 359999987542 2334567899999999999999999
Q ss_pred EEEEEEeCCEEEEEEccCCCCChHHHHHhcC------------CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEE
Q 013081 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKG------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENIL 146 (450)
Q Consensus 79 l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~------------~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NIL 146 (450)
+++++......|+||||+.+++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 9999999999999999999999999886432 3678889999999999999999999999999999999
Q ss_pred EccCCCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh--CCCCCCCCcHHH
Q 013081 147 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT--GYLPFDDRNLAV 224 (450)
Q Consensus 147 l~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt--G~~Pf~~~~~~~ 224 (450)
++.++.+||+|||++................+++.|+|||++....+ +.++|||||||++|+|++ |..||...+...
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCc-CchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 99999999999999875322111112223345678999999877665 689999999999999988 778998766555
Q ss_pred HHHHHHh-----C---CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHh
Q 013081 225 LYQKIFR-----G---DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 225 ~~~~i~~-----~---~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
....+.. . ....++.+++.+.+|+.+||+.||++|||+++|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 4443321 1 12334557899999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=359.51 Aligned_cols=260 Identities=28% Similarity=0.400 Sum_probs=196.6
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCC-CceEEEEEe--------------ecccccchhHHHHHHHHHHHHHhCCCCCc
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDS-GLPFAVKIL--------------EKNRIIHLKITDQIKREIATLKLLKHPNV 76 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~-~~~vAvK~i--------------~~~~~~~~~~~~~~~~Ei~il~~l~hpnI 76 (450)
..++|++++.||+|+||+||+|..+.. +...+.|.+ .+...........+.+|+.++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 457899999999999999999876432 333333311 11111122234678899999999999999
Q ss_pred ceEEEEEEeCCEEEEEEccCCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCC
Q 013081 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASK-----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG 151 (450)
Q Consensus 77 v~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g 151 (450)
+++++++...+..|++++++. ++|.+++... .......++.++.||+.||.|||++||+||||||+|||++.+|
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 999999999999999999994 5787776532 2345677889999999999999999999999999999999999
Q ss_pred CeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCC-CCCCC--cHHHHHHH
Q 013081 152 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYL-PFDDR--NLAVLYQK 228 (450)
Q Consensus 152 ~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~-Pf~~~--~~~~~~~~ 228 (450)
.+||+|||++...... ........+||+.|+|||++.+..+ +.++|||||||++|+|++|.. ||.+. +......+
T Consensus 305 ~vkL~DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~ 382 (501)
T PHA03210 305 KIVLGDFGTAMPFEKE-REAFDYGWVGTVATNSPEILAGDGY-CEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK 382 (501)
T ss_pred CEEEEeCCCceecCcc-cccccccccCCcCCCCchhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence 9999999999754321 1122334689999999999988776 588999999999999999875 44332 12122222
Q ss_pred HHhC----CCCC-----------------------C-----CCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 229 IFRG----DFKL-----------------------P-----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 229 i~~~----~~~~-----------------------p-----~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
+... ...+ + ..++.++.++|.+||++||.+|||+.|+|.||||...
T Consensus 383 ~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 383 IIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 1110 0000 0 1145678889999999999999999999999999764
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=336.46 Aligned_cols=259 Identities=26% Similarity=0.378 Sum_probs=209.1
Q ss_pred CeEEeeeecccCceEEEEEEECCC--CceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEe----CC
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDS--GLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS----KS 87 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~----~~ 87 (450)
+|++.+.||+|+||.||+|.+..+ +..||+|.+..... .......+.+|+.+++++ .||||+++++.... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS-KKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 589999999999999999999888 99999999864322 222356788899999999 59999999987532 24
Q ss_pred EEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcc
Q 013081 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 167 (450)
.+|+++||+. ++|.+.+....++++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 5789999985 699999988888999999999999999999999999999999999999999999999999999754321
Q ss_pred cC--CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC-------------
Q 013081 168 RD--DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------- 232 (450)
Q Consensus 168 ~~--~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------- 232 (450)
.. ........||+.|+|||++.+....+.++||||+||++|+|++|.+||...+.......+...
T Consensus 159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd07857 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238 (332)
T ss_pred cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence 11 112234578999999998766444468999999999999999999999876644333222210
Q ss_pred ---------------CCCC---CCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCC
Q 013081 233 ---------------DFKL---PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 233 ---------------~~~~---p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
...+ ....+..+.+|+.+||++||.+|||+.+++.|||+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH 299 (332)
T ss_pred hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence 0011 122578999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=329.64 Aligned_cols=252 Identities=34% Similarity=0.513 Sum_probs=212.5
Q ss_pred eEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEcc
Q 013081 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY 95 (450)
Q Consensus 16 y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 95 (450)
|++.+.||+|++|.||+|.+..+++.||+|++.... ......+.+.+|+.++++++||||+++++++.+....|+|+||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 678899999999999999999999999999997654 2233356778899999999999999999999999999999999
Q ss_pred CCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccc
Q 013081 96 VTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH 174 (450)
Q Consensus 96 ~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 174 (450)
+. ++|.+.+.+. ..+++..+..++.|++.||+|||++||+||||+|+||++++++.++|+|||++...... .....
T Consensus 80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~--~~~~~ 156 (282)
T cd07829 80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIP--LRTYT 156 (282)
T ss_pred cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCC--ccccC
Confidence 97 5999999876 57999999999999999999999999999999999999999999999999998754321 11223
Q ss_pred cccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC------------------CCCC
Q 013081 175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------------DFKL 236 (450)
Q Consensus 175 ~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------------~~~~ 236 (450)
...++..|+|||.+.+....+.++|+||+||++|+|++|..||...+......++... ...+
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07829 157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF 236 (282)
T ss_pred ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence 4456788999999876645568999999999999999999999887765554443321 0011
Q ss_pred C-----------CCCCHHHHHHHHHccccCcCCCCCHHHHHhcccc
Q 013081 237 P-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 237 p-----------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~ 271 (450)
+ +.++..+.++|++||+.||++||++.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 1 1247789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=322.55 Aligned_cols=244 Identities=28% Similarity=0.503 Sum_probs=211.8
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
..+.|++.+.||.|+||.||+|.+ .|+.||+|.+..... ..+++.+|+.+++.++||||+++++++.+....|+
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 77 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI 77 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence 456899999999999999999987 478999999865432 35788999999999999999999999998999999
Q ss_pred EEccCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC
Q 013081 92 VLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~~--~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 169 (450)
||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~-- 155 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG-- 155 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccc--
Confidence 999999999999997755 6999999999999999999999999999999999999999999999999999854211
Q ss_pred CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 013081 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 247 (450)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 247 (450)
.....++..|+|||.+....+ +.++||||||+++|+|++ |..||...+.......+..+ ....|..+++.+.++
T Consensus 156 ---~~~~~~~~~~~ape~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 231 (256)
T cd05039 156 ---QDSGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKV 231 (256)
T ss_pred ---cccCCCcccccCchhhcCCcC-CcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHH
Confidence 112344567999999876655 588999999999999998 99999888777666655544 445567789999999
Q ss_pred HHHccccCcCCCCCHHHHHh
Q 013081 248 LRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 248 i~~~L~~dP~~R~t~~~il~ 267 (450)
|.+||..+|++|||+.++++
T Consensus 232 i~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 232 MKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHhccChhhCcCHHHHHH
Confidence 99999999999999999976
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=331.09 Aligned_cols=252 Identities=23% Similarity=0.338 Sum_probs=205.1
Q ss_pred cCCeEEeeeecccCceEEEEEEECC----------------CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLD----------------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~----------------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI 76 (450)
-++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence 4689999999999999999986432 34579999986542 23345788999999999999999
Q ss_pred ceEEEEEEeCCEEEEEEccCCCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcE
Q 013081 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-----------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENI 145 (450)
Q Consensus 77 v~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~-----------~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NI 145 (450)
+++++++......|++|||+++++|.+++.... .+++..+..++.|++.||+|||++|++||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 999999999999999999999999999987532 366778999999999999999999999999999999
Q ss_pred EEccCCCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh--CCCCCCCCcHH
Q 013081 146 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT--GYLPFDDRNLA 223 (450)
Q Consensus 146 Ll~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt--G~~Pf~~~~~~ 223 (450)
|++.++.++|+|||++................+++.|+|||......+ +.++|||||||++|+|++ |..||...+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKF-TTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCc-cchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 999999999999999875422111112223345678999998776665 589999999999999998 78999876655
Q ss_pred HHHHHHH--------hCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHh
Q 013081 224 VLYQKIF--------RGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 224 ~~~~~i~--------~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
....... ....+.|..+++.+.+|+.+||+.||.+|||+.++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 241 QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 4433221 1123445668899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=327.80 Aligned_cols=250 Identities=33% Similarity=0.463 Sum_probs=207.6
Q ss_pred eEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC---CCCCcceEEEEEEeCCE----
Q 013081 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL---KHPNVVRLHEVLASKSK---- 88 (450)
Q Consensus 16 y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~~---- 88 (450)
|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++++ +|||++++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 7899999999999999999988899999999975433 222345566788877766 59999999999987776
Q ss_pred -EEEEEccCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCC
Q 013081 89 -IYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (450)
Q Consensus 89 -~~lv~E~~~gg~L~~~i~~~~--~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 165 (450)
.|++|||+.+ +|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++....
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999999974 8988887643 58999999999999999999999999999999999999999999999999987543
Q ss_pred cccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC-----CC-----
Q 013081 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-----FK----- 235 (450)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-----~~----- 235 (450)
. ........+++.|+|||++.+..+ +.++|+||+||++|+|++|.+||.+.+..+...++.... ..
T Consensus 159 ~---~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 159 F---EMALTSVVVTLWYRAPEVLLQSSY-ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred C---CcccccccccccccChHHhccCCC-CCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 2 122234457899999999887665 588999999999999999999999887766665554310 00
Q ss_pred ------C-----------CCCCCHHHHHHHHHccccCcCCCCCHHHHHhcccc
Q 013081 236 ------L-----------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 236 ------~-----------p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~ 271 (450)
+ .+.+++.+.++|.+||+.||++||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0 01245788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=323.57 Aligned_cols=248 Identities=25% Similarity=0.398 Sum_probs=207.1
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
..++|++.+.||+|++|.||+|.+..+ ..+|+|.+..... ..+.+.+|+.+++.++|||++++++++. ....|+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYI 77 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEE
Confidence 457899999999999999999997655 4699998765432 2356888999999999999999999875 456899
Q ss_pred EEccCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC
Q 013081 92 VLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~~--~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 169 (450)
+|||+.+++|.+++.... .+++..+..++.|++.||+|||++|++||||||+||++++++.++|+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~- 156 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE- 156 (260)
T ss_pred EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc-
Confidence 999999999999997533 47899999999999999999999999999999999999999999999999997543211
Q ss_pred CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 013081 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 247 (450)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 247 (450)
........++..|+|||.+.+..+ +.++||||+|+++|+|++ |..||.+.........+... ..+.|..++..+.++
T Consensus 157 ~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (260)
T cd05069 157 YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHEL 235 (260)
T ss_pred ccccCCCccchhhCCHHHhccCCc-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHH
Confidence 111122345678999999876655 589999999999999999 99999988777776666554 345566789999999
Q ss_pred HHHccccCcCCCCCHHHHHh
Q 013081 248 LRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 248 i~~~L~~dP~~R~t~~~il~ 267 (450)
+++||.+||++|||++++++
T Consensus 236 i~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 236 MKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHccCCcccCcCHHHHHH
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=339.11 Aligned_cols=253 Identities=31% Similarity=0.438 Sum_probs=208.2
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC------
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK------ 86 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------ 86 (450)
.++|.+.+.||+|+||.||+|.+..+|+.||+|.+.+... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 4799999999999999999999999999999999875432 222346688999999999999999999998654
Q ss_pred CEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCc
Q 013081 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (450)
Q Consensus 87 ~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 166 (450)
..+|+++||+. .+|.+.+ ...+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++.....
T Consensus 93 ~~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 93 QDFYLVMPYMQ-TDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred ceEEEEecccc-cCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 35699999996 4776654 34689999999999999999999999999999999999999999999999999874321
Q ss_pred ccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC--------------
Q 013081 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-------------- 232 (450)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-------------- 232 (450)
......+++.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+...
T Consensus 170 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 170 -----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred -----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 2234567899999999876444568999999999999999999999987655444333221
Q ss_pred ---------CCCCC--------CCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 233 ---------DFKLP--------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 233 ---------~~~~p--------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
....+ +..++.+.+||.+||++||.+|||+.+++.||||+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 00011 2367789999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=326.48 Aligned_cols=253 Identities=32% Similarity=0.523 Sum_probs=214.1
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeeccccc--chhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII--HLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 92 (450)
||.+.+.||+|+||.||+|.+..++..+++|+++..... ......++.+|+.+++.++||||+++++.+.+....+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 699999999999999999999888888888887543321 122245677899999999999999999999988999999
Q ss_pred EccCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc
Q 013081 93 LEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~----~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 168 (450)
+||+++++|.+.+.. ...+++..++.++.|++.||.|||++|++|+||+|+||+++. +.++|+|||++.....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~-- 157 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG-- 157 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCC--
Confidence 999999999988753 456999999999999999999999999999999999999975 6799999999875422
Q ss_pred CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHH
Q 013081 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNL 247 (450)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~L 247 (450)
.........|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+......++..+. ...|..++.++.++
T Consensus 158 ~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (260)
T cd08222 158 SCDLATTFTGTPYYMSPEALKHQGY-DSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSI 236 (260)
T ss_pred CcccccCCCCCcCccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHH
Confidence 2223344568899999999876666 478999999999999999999998877766666665553 34456688999999
Q ss_pred HHHccccCcCCCCCHHHHHhcccc
Q 013081 248 LRKILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 248 i~~~L~~dP~~R~t~~~il~h~~~ 271 (450)
|.+||..||++||++.++++||||
T Consensus 237 i~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 237 MQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHhcCChhhCcCHHHHhhCCCC
Confidence 999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=334.86 Aligned_cols=257 Identities=31% Similarity=0.461 Sum_probs=210.8
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCEEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-KSKIYM 91 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~l 91 (450)
-++|++.+.||.|+||.||+|.+..+++.||+|.+.+... .......+.+|+.+++.++||||+++++++.. ....|+
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 4689999999999999999999999999999998865432 22335678899999999999999999999865 567899
Q ss_pred EEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCC
Q 013081 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 171 (450)
++||+ +++|.+.+.. .++++..+..++.||++||+|||++||+||||+|.||++++++.++|+|||++.....
T Consensus 88 v~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~----- 160 (328)
T cd07856 88 VTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP----- 160 (328)
T ss_pred Eeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC-----
Confidence 99999 5688877754 5689999999999999999999999999999999999999999999999999874321
Q ss_pred ccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHh--------------------
Q 013081 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR-------------------- 231 (450)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~-------------------- 231 (450)
......+++.|+|||++.+....+.++||||+||++|+|++|+.||...+.......+.+
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd07856 161 QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLR 240 (328)
T ss_pred CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHH
Confidence 223456788999999876644456899999999999999999999987654322211110
Q ss_pred ------CCCCCC-----CCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCCCC
Q 013081 232 ------GDFKLP-----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277 (450)
Q Consensus 232 ------~~~~~p-----~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~~~ 277 (450)
.....| +.+++.+.++|++||+.+|++|||+++++.||||.....+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~ 297 (328)
T cd07856 241 FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297 (328)
T ss_pred HHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence 001111 2467899999999999999999999999999999765544
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=322.90 Aligned_cols=243 Identities=26% Similarity=0.389 Sum_probs=202.5
Q ss_pred eecccCceEEEEEEEC--CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEccCCC
Q 013081 21 TLGEGNFGKVKFAQDL--DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG 98 (450)
Q Consensus 21 ~LG~G~~g~Vy~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 98 (450)
.||+|+||.||+|.+. ..+..||+|++.... .....+.+.+|+.++++++||||+++++++. ....|+||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence 4899999999999765 346679999986542 2334567999999999999999999999885 4578999999999
Q ss_pred CChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCc-cccc
Q 013081 99 GELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL-LHTT 176 (450)
Q Consensus 99 g~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~-~~~~ 176 (450)
++|.+++.. ...+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||++........... ....
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 999999874 45799999999999999999999999999999999999999999999999999875432111100 1112
Q ss_pred cCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHcccc
Q 013081 177 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEP 254 (450)
Q Consensus 177 ~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~ 254 (450)
.+++.|+|||++....+ +.++|||||||++|+|++ |..||.+.........+..+ ....|...++++.+++.+||..
T Consensus 159 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~ 237 (257)
T cd05115 159 KWPLKWYAPECINFRKF-SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIY 237 (257)
T ss_pred CCCcccCCHHHHccCCC-CchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 33578999999876665 588999999999999996 99999988777776666654 4567778899999999999999
Q ss_pred CcCCCCCHHHHHh
Q 013081 255 NPVKRITIAGIKA 267 (450)
Q Consensus 255 dP~~R~t~~~il~ 267 (450)
||++||++.++.+
T Consensus 238 ~~~~Rp~~~~i~~ 250 (257)
T cd05115 238 KWEDRPNFAKVEE 250 (257)
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=347.99 Aligned_cols=258 Identities=33% Similarity=0.535 Sum_probs=224.8
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
+-|..++.||-|+||+|.++....|...+|+|.+++........+..++.|-.||...+.+.||+||-.|.+++.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 45788999999999999999999999999999999888777777889999999999999999999999999999999999
Q ss_pred ccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC----
Q 013081 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD---- 169 (450)
Q Consensus 94 E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~---- 169 (450)
+|++||++-.++-+.+-|+|..|+.|+..|..|+++.|..|+|||||||+|||||.+|++||+||||++-+.+..+
T Consensus 709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYY 788 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 788 (1034)
T ss_pred eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999975422110
Q ss_pred --------C----------------------------CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhC
Q 013081 170 --------D----------------------------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 213 (450)
Q Consensus 170 --------~----------------------------~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG 213 (450)
+ -..+..+||+.|+|||++...+|. ..||+||.|||||||+.|
T Consensus 789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~-q~cdwws~gvil~em~~g 867 (1034)
T KOG0608|consen 789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT-QLCDWWSVGVILYEMLVG 867 (1034)
T ss_pred cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc-ccchhhHhhHHHHHHhhC
Confidence 0 012334699999999999999985 889999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhC--CCCCC--CCCCHHHHHHHHHccccCcCCCCC---HHHHHhcccccc
Q 013081 214 YLPFDDRNLAVLYQKIFRG--DFKLP--KWLSPGAQNLLRKILEPNPVKRIT---IAGIKADEWFEQ 273 (450)
Q Consensus 214 ~~Pf~~~~~~~~~~~i~~~--~~~~p--~~~s~~~~~Li~~~L~~dP~~R~t---~~~il~h~~~~~ 273 (450)
++||...+..+...++.+. .+.+| ..+|+++.+||.++. -+++.|.. ++|+..||||+.
T Consensus 868 ~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkg 933 (1034)
T KOG0608|consen 868 QPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKG 933 (1034)
T ss_pred CCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccc
Confidence 9999988777666555543 23444 448999999998865 56777874 678999999974
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=325.94 Aligned_cols=253 Identities=22% Similarity=0.308 Sum_probs=210.5
Q ss_pred ccCCeEEeeeecccCceEEEEEEECC----CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-C
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLD----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-K 86 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~ 86 (450)
.-++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++.. .
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 34689999999999999999999876 36889999886432 33446778999999999999999999998765 5
Q ss_pred CEEEEEEccCCCCChHHHHHhc--------CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeec
Q 013081 87 SKIYMVLEYVTGGELFDKIASK--------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDF 158 (450)
Q Consensus 87 ~~~~lv~E~~~gg~L~~~i~~~--------~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DF 158 (450)
...++++||+++++|.+++... ..+++..+..++.|++.||+|||++|++||||||+||++++++.+||+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCC
Confidence 7789999999999999998653 45899999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCC
Q 013081 159 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKL 236 (450)
Q Consensus 159 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~ 236 (450)
|+++...............++..|+|||++.+..+ +.++|||||||++|++++ |+.||...+.......+..+ ....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 240 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEY-SSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQ 240 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCC-CchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCC
Confidence 99975322111111122345678999999877665 588999999999999999 99999988777766655554 3344
Q ss_pred CCCCCHHHHHHHHHccccCcCCCCCHHHHHh
Q 013081 237 PKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 237 p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
+..+++++.+++.+||..||++|||+.++++
T Consensus 241 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 241 PINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 5567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=321.67 Aligned_cols=249 Identities=27% Similarity=0.407 Sum_probs=211.7
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
..++|++.+.||+|+||.||+|.+. .++.||+|.+...... .+.+.+|+.++++++||||+++++++......|+
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI 78 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccC----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence 4578999999999999999999975 4578999998754321 3578899999999999999999999998899999
Q ss_pred EEccCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC
Q 013081 92 VLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~~--~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 169 (450)
+|||+++++|.+++.... .++...+..++.|++.||.|||++|++||||||+||++++++.+||+|||++.......
T Consensus 79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~- 157 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE- 157 (261)
T ss_pred EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh-
Confidence 999999999999997643 68999999999999999999999999999999999999999999999999987543210
Q ss_pred CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 013081 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 247 (450)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 247 (450)
........++..|+|||.+.+..+ +.++|+||+|+++|+|++ |+.||.+.+......++..+ ..+.|...+..+.++
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRF-TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDL 236 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 011112234568999999876655 689999999999999999 99999988877777777655 345566688999999
Q ss_pred HHHccccCcCCCCCHHHHHh
Q 013081 248 LRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 248 i~~~L~~dP~~R~t~~~il~ 267 (450)
+.+||+.+|++|||+.++.+
T Consensus 237 i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 237 MLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHcccCcccCCCHHHHHH
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=322.21 Aligned_cols=247 Identities=27% Similarity=0.423 Sum_probs=207.6
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 92 (450)
-.+|++++.||+|+||.||+|.+. +++.||+|.+...... ...+.+|+.++++++||||+++++++. ....|++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYII 78 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEE
Confidence 467999999999999999999864 5778999998754322 357889999999999999999999874 5678999
Q ss_pred EccCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCC
Q 013081 93 LEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 170 (450)
|||+.+++|.+++... ..+++.++..++.|++.||+|||+.|++||||||+||++++++.++|+|||++...... ..
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~-~~ 157 (260)
T cd05067 79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN-EY 157 (260)
T ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCC-Cc
Confidence 9999999999998653 46899999999999999999999999999999999999999999999999998754321 11
Q ss_pred CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHH
Q 013081 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLL 248 (450)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li 248 (450)
.......++..|+|||++....+ +.++||||+|+++|+|++ |++||.+.+.......+... ..+.+...+.++.+++
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELM 236 (260)
T ss_pred ccccCCcccccccCHHHhccCCc-CcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 11122345678999999876655 589999999999999999 99999988777666666554 3455667889999999
Q ss_pred HHccccCcCCCCCHHHHHh
Q 013081 249 RKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 249 ~~~L~~dP~~R~t~~~il~ 267 (450)
.+||+.+|++|||+++++.
T Consensus 237 ~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 237 RLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHccCChhhCCCHHHHHH
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=322.25 Aligned_cols=252 Identities=23% Similarity=0.362 Sum_probs=210.6
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCc---eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGL---PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (450)
...|+..+.||+|+||.||+|.+..++. .+|+|.+.... .......+.+|+++++.++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA 81 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence 3578999999999999999999876654 79999886442 223356788999999999999999999999999999
Q ss_pred EEEEccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc
Q 013081 90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 168 (450)
|++|||+++++|.+++.. .+.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 999999999999999875 3578999999999999999999999999999999999999999999999999987543221
Q ss_pred CCCcc-ccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHH
Q 013081 169 DDGLL-HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQ 245 (450)
Q Consensus 169 ~~~~~-~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 245 (450)
..... .....++.|+|||++....+ +.++||||+||++|+|++ |+.||...+.......+..+ ..+.+..++..+.
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 240 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVY 240 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCCc-ChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 11111 11123457999999877666 589999999999999998 99999887777776666554 3344455789999
Q ss_pred HHHHHccccCcCCCCCHHHHHh
Q 013081 246 NLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 246 ~Li~~~L~~dP~~R~t~~~il~ 267 (450)
+++.+||+.+|++||++.++++
T Consensus 241 ~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 241 QLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHHcCCCcccCcCHHHHHH
Confidence 9999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=328.17 Aligned_cols=252 Identities=33% Similarity=0.498 Sum_probs=211.4
Q ss_pred eEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEcc
Q 013081 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY 95 (450)
Q Consensus 16 y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 95 (450)
|++.+.||+|++|.||+|.+..+|+.+|+|.+...... ......+.+|+.++++++||||+++++++......|+++||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 67889999999999999999989999999998754432 23457788999999999999999999999999999999999
Q ss_pred CCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccc
Q 013081 96 VTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH 174 (450)
Q Consensus 96 ~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 174 (450)
+++ +|.+.+.. ...+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+....... ....
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~ 156 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYT 156 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cccc
Confidence 975 88888766 4589999999999999999999999999999999999999999999999999987543321 1223
Q ss_pred cccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC-------------------CCC
Q 013081 175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-------------------DFK 235 (450)
Q Consensus 175 ~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-------------------~~~ 235 (450)
...++..|+|||.+.+....+.++|+||+|+++|+|++|+.||...+..+...++... ...
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS 236 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhh
Confidence 3467889999999877644568999999999999999999999887765544443221 000
Q ss_pred -----------CCCCCCHHHHHHHHHccccCcCCCCCHHHHHhcccc
Q 013081 236 -----------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 236 -----------~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~ 271 (450)
..+.++..+.++|.+||++||.+||++.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 112367889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=327.97 Aligned_cols=250 Identities=30% Similarity=0.482 Sum_probs=208.1
Q ss_pred eEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEc
Q 013081 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMVLE 94 (450)
Q Consensus 16 y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv~E 94 (450)
|++.+.||+|++|.||+|.+..+++.||+|.+....... ......+|+..+++++ ||||+++++++...+..|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW--EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch--hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 788999999999999999999899999999986543211 1234557999999999 9999999999999999999999
Q ss_pred cCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCc
Q 013081 95 YVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (450)
Q Consensus 95 ~~~gg~L~~~i~~~~--~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 172 (450)
|+ +|+|.+.+.... .+++..+..++.|++.||.|||++|++|+||+|+||++++++.++|+|||++..... ...
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~---~~~ 154 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS---RPP 154 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccC---CCC
Confidence 99 789999887754 789999999999999999999999999999999999999999999999999875432 112
Q ss_pred cccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC-------------------C
Q 013081 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-------------------D 233 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-------------------~ 233 (450)
.....++..|+|||++......+.++|+||||+++|+|++|++||...+......++... .
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 234568899999999865554568999999999999999999999877655444333211 0
Q ss_pred CCC-----------CCCCCHHHHHHHHHccccCcCCCCCHHHHHhcccc
Q 013081 234 FKL-----------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 234 ~~~-----------p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~ 271 (450)
... ....++.+.++|++||+.||++|||+.|++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 000 11236789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=326.85 Aligned_cols=239 Identities=23% Similarity=0.299 Sum_probs=199.8
Q ss_pred eeecccCceEEEEEEECCCCc-------eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013081 20 RTLGEGNFGKVKFAQDLDSGL-------PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 20 ~~LG~G~~g~Vy~a~~~~~~~-------~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 92 (450)
+.||+|+||.||+|.+..++. .||+|.+.... ....+.+.+|+.+++.++||||+++++++......++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 469999999999999865544 48888875432 33456788899999999999999999999998999999
Q ss_pred EccCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCC--------eEEeecCCCCC
Q 013081 93 LEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN--------IKISDFGLSAL 163 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~~~-~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~--------lkl~DFGla~~ 163 (450)
|||+++|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++. ++++|||++..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999999997644 5899999999999999999999999999999999999988765 69999998864
Q ss_pred CCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhC-CCCCCCCcHHHHHHHHHhCCCCCCCCCCH
Q 013081 164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG-YLPFDDRNLAVLYQKIFRGDFKLPKWLSP 242 (450)
Q Consensus 164 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG-~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~ 242 (450)
.. ......+++.|+|||++.+....+.++||||+||++|+|++| ..||...+..... ........+|...+.
T Consensus 158 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 230 (258)
T cd05078 158 VL------PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-QFYEDRHQLPAPKWT 230 (258)
T ss_pred cC------CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-HHHHccccCCCCCcH
Confidence 32 123456889999999988755556899999999999999998 5777665544332 334445667777788
Q ss_pred HHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 243 GAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
.+.+|+.+||+.||++|||++++++.
T Consensus 231 ~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 231 ELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHHHHHHhccChhhCCCHHHHHHh
Confidence 99999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=319.37 Aligned_cols=248 Identities=28% Similarity=0.434 Sum_probs=212.0
Q ss_pred eEEeeeecccCceEEEEEEECCCC----ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 16 YELGRTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 16 y~i~~~LG~G~~g~Vy~a~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
+++.+.||.|+||.||+|.+..++ ..||+|.+..... ......+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 367899999999999999998766 8999999865432 2245789999999999999999999999999999999
Q ss_pred EEccCCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC
Q 013081 92 VLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~~~--l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 169 (450)
+|||+++++|.+.+..... +++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 9999999999999976544 99999999999999999999999999999999999999999999999999875433211
Q ss_pred CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 013081 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 247 (450)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 247 (450)
.. .....+++.|+|||.+....+ +.++|+||+|+++|+|++ |.+||...+.......+... ....+...+..+.++
T Consensus 159 ~~-~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (258)
T smart00219 159 YK-KKGGKLPIRWMAPESLKDGKF-TSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKL 236 (258)
T ss_pred cc-cccCCCcccccChHHhccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHH
Confidence 11 111236789999999865554 689999999999999998 89999988877777777665 345566789999999
Q ss_pred HHHccccCcCCCCCHHHHHh
Q 013081 248 LRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 248 i~~~L~~dP~~R~t~~~il~ 267 (450)
+.+||..||++|||+.++++
T Consensus 237 i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 237 MLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHCcCChhhCcCHHHHHh
Confidence 99999999999999999976
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=319.05 Aligned_cols=245 Identities=27% Similarity=0.384 Sum_probs=207.1
Q ss_pred eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEccCCCC
Q 013081 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG 99 (450)
Q Consensus 20 ~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 99 (450)
+.||+|+||.||+|.+.. ++.||+|.+...... .....+.+|+.++++++||||+++++++.+....|++|||+.|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 479999999999999877 999999998654332 34578899999999999999999999999999999999999999
Q ss_pred ChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccccccC
Q 013081 100 ELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 178 (450)
Q Consensus 100 ~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 178 (450)
+|.+++.. ...+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++................+
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 99999865 35689999999999999999999999999999999999999999999999999875432111111122334
Q ss_pred CCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccccCc
Q 013081 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNP 256 (450)
Q Consensus 179 t~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP 256 (450)
+..|+|||.+.+..+ +.++|+|||||++|+|++ |..||...........+... ....|..++..+.+++.+||..+|
T Consensus 158 ~~~y~~PE~~~~~~~-~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 236 (251)
T cd05041 158 PIKWTAPEALNYGRY-TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDP 236 (251)
T ss_pred eeccCChHhhccCCC-CcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccCh
Confidence 567999999876655 589999999999999999 89999887776666666544 345566789999999999999999
Q ss_pred CCCCCHHHHHhc
Q 013081 257 VKRITIAGIKAD 268 (450)
Q Consensus 257 ~~R~t~~~il~h 268 (450)
++|||+.++++.
T Consensus 237 ~~Rp~~~ell~~ 248 (251)
T cd05041 237 ENRPSFSEIYNE 248 (251)
T ss_pred hhCcCHHHHHHH
Confidence 999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=323.59 Aligned_cols=243 Identities=28% Similarity=0.431 Sum_probs=202.6
Q ss_pred eeecccCceEEEEEEECCCCc--eEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEccC
Q 013081 20 RTLGEGNFGKVKFAQDLDSGL--PFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYV 96 (450)
Q Consensus 20 ~~LG~G~~g~Vy~a~~~~~~~--~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~ 96 (450)
+.||+|+||.||+|.+..++. .+|+|.+.... .......+.+|+.+++++ +||||+++++++...+..|++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 468999999999999988775 46888775322 223356788999999999 7999999999999999999999999
Q ss_pred CCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCC
Q 013081 97 TGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGL 160 (450)
Q Consensus 97 ~gg~L~~~i~~~~----------------~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGl 160 (450)
++++|.+++.... .+++..++.++.|++.||+|||++|++||||||+|||+++++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999999987533 478899999999999999999999999999999999999999999999999
Q ss_pred CCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCC
Q 013081 161 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPK 238 (450)
Q Consensus 161 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~ 238 (450)
+...... ........++.|+|||++....+ +.++|||||||++|+|++ |..||.+.+.......+... ..+.+.
T Consensus 159 ~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 234 (270)
T cd05047 159 SRGQEVY---VKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 234 (270)
T ss_pred ccccchh---hhccCCCCccccCChHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCC
Confidence 8632211 01112234567999999876655 589999999999999997 99999888777777666554 344566
Q ss_pred CCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 239 WLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 239 ~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
.++.++.+|+.+||..||.+|||+.+++..
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 264 (270)
T cd05047 235 NCDDEVYDLMRQCWREKPYERPSFAQILVS 264 (270)
T ss_pred cCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 688999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=319.99 Aligned_cols=244 Identities=29% Similarity=0.457 Sum_probs=206.3
Q ss_pred eeecccCceEEEEEEECC-CCc--eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEccC
Q 013081 20 RTLGEGNFGKVKFAQDLD-SGL--PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYV 96 (450)
Q Consensus 20 ~~LG~G~~g~Vy~a~~~~-~~~--~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 96 (450)
+.||+|++|.||+|.+.. +++ .||+|.+...... ...+.+.+|+.++++++||||+++++++.. ...+++|||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999999765 333 6999999765543 456889999999999999999999999988 8899999999
Q ss_pred CCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCC-Ccc
Q 013081 97 TGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD-GLL 173 (450)
Q Consensus 97 ~gg~L~~~i~~~~--~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~-~~~ 173 (450)
++++|.+.+.+.. .+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++......... ...
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 9999999997754 6899999999999999999999999999999999999999999999999999864331111 111
Q ss_pred ccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC--CCCCCCCCCHHHHHHHHH
Q 013081 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQNLLRK 250 (450)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~ 250 (450)
....++..|+|||.+....+ +.++|||||||++|+|++ |..||...+.......+... ....|..++..+.+++.+
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTF-SHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ 236 (257)
T ss_pred cCCCCCceecCHHHhcccCc-CchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHH
Confidence 23457789999999877665 588999999999999999 99999887777766666542 334456688999999999
Q ss_pred ccccCcCCCCCHHHHHh
Q 013081 251 ILEPNPVKRITIAGIKA 267 (450)
Q Consensus 251 ~L~~dP~~R~t~~~il~ 267 (450)
||+.+|++|||+.++++
T Consensus 237 ~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 237 CWAHNPADRPTFAALRE 253 (257)
T ss_pred HCCCCcccCCCHHHHHH
Confidence 99999999999999976
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=315.35 Aligned_cols=254 Identities=27% Similarity=0.420 Sum_probs=207.9
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEE-----EeC
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVL-----ASK 86 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-----~~~ 86 (450)
.-.||++.+.||+|||+-||++.+..+++.+|+|.+.... .+..+...+||...++++|||+++++++. ...
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 3469999999999999999999999999999999986554 34468899999999999999999988765 234
Q ss_pred CEEEEEEccCCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHhhhhhcC--eeeccCCCCcEEEccCCCeEEeecCC
Q 013081 87 SKIYMVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLDSKGNIKISDFGL 160 (450)
Q Consensus 87 ~~~~lv~E~~~gg~L~~~i~~~----~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlKp~NILl~~~g~lkl~DFGl 160 (450)
...|++++|...|+|.+.++.. ..+++.++..|+.+|++||.+||+.. .+||||||.|||+.+.+.+++.|||.
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccC
Confidence 5699999999999999998752 26999999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCcccCCC-------ccccccCCCCccchhhhccCC--CCCccchhhhHHHHHHHHHhCCCCCCCCcH--HHHHHHH
Q 013081 161 SALPQHFRDDG-------LLHTTCGSPNYVAPEVLANRG--YDGATSDIWSCGVILYVILTGYLPFDDRNL--AVLYQKI 229 (450)
Q Consensus 161 a~~~~~~~~~~-------~~~~~~gt~~y~APE~l~~~~--~~~~~~DiwSlGvil~elltG~~Pf~~~~~--~~~~~~i 229 (450)
++.....-.++ .......|..|+|||.+.-.. ..+.++|||||||+||+|+.|..||+..-. ..+...+
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv 255 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAV 255 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEee
Confidence 87543211111 111235789999999975432 346899999999999999999999964211 1122233
Q ss_pred HhCCCCCCC--CCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 230 FRGDFKLPK--WLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 230 ~~~~~~~p~--~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
..+.+.+|. .+|..+.+||+.||++||.+||++.+++.+
T Consensus 256 ~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 256 QNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred eccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 444555554 389999999999999999999999999875
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=323.70 Aligned_cols=252 Identities=26% Similarity=0.393 Sum_probs=212.8
Q ss_pred cCCeEEeeeecccCceEEEEEEECC-----CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (450)
.++|++.+.||+|+||.||+|+... +.+.||+|.+.... .......+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 4689999999999999999999754 35679999886533 2234578999999999999999999999999989
Q ss_pred EEEEEEccCCCCChHHHHHhcC---------CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeec
Q 013081 88 KIYMVLEYVTGGELFDKIASKG---------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDF 158 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~~---------~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DF 158 (450)
..|+||||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++++||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999999997655 6899999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCC--C
Q 013081 159 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDF--K 235 (450)
Q Consensus 159 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~--~ 235 (450)
|++...... .........+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||.+.........+..+.. +
T Consensus 162 ~~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 239 (275)
T cd05046 162 SLSKDVYNS-EYYKLRNALIPLRWLAPEAVQEDDF-STKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP 239 (275)
T ss_pred ccccccCcc-cccccCCceeEEeecChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCC
Confidence 998643211 1112233456778999999876665 588999999999999999 8999987776666666665543 3
Q ss_pred CCCCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 236 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 236 ~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
.+..++..+.+++.+||+.||.+|||+.+++.+
T Consensus 240 ~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 240 VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 455688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=347.43 Aligned_cols=252 Identities=25% Similarity=0.393 Sum_probs=216.1
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (450)
...+...++..||+|.||+||+|.+-. .||||+++...... +..+.|++|+.++++-+|.||+-+.+++..... .
T Consensus 389 Ip~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~-~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-A 463 (678)
T KOG0193|consen 389 IPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTP-EQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-A 463 (678)
T ss_pred cCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCH-HHHHHHHHHHHHHhhcchhhheeeehhhcCCce-e
Confidence 345667889999999999999999855 49999998766544 468999999999999999999999999988776 9
Q ss_pred EEEccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC
Q 013081 91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (450)
Q Consensus 91 lv~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 169 (450)
||+.+|+|-+|+.++.- ...|.....+.|++|++.|+.|||.++|+|||||..||++.+++.|||+||||+........
T Consensus 464 IiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g 543 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG 543 (678)
T ss_pred eeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence 99999999999998864 35688999999999999999999999999999999999999999999999999997665555
Q ss_pred CCccccccCCCCccchhhhcc--CCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCC-----CCCCCCH
Q 013081 170 DGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-----LPKWLSP 242 (450)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~--~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-----~p~~~s~ 242 (450)
.......-|...|||||++.. ...+++.+|||||||++|||+||.+||...+.+.+.-.+-+|... .-..++.
T Consensus 544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk 623 (678)
T KOG0193|consen 544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPK 623 (678)
T ss_pred ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHH
Confidence 555667778999999999863 223368999999999999999999999987777666555555221 1234677
Q ss_pred HHHHHHHHccccCcCCCCCHHHHHh
Q 013081 243 GAQNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
++++|+..||.++|++||++.+||.
T Consensus 624 ~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 624 AMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHHHHHHhcCcccCccHHHHHH
Confidence 9999999999999999999999987
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=324.06 Aligned_cols=250 Identities=30% Similarity=0.396 Sum_probs=200.6
Q ss_pred CCe-EEeeeecccCceEEEEEE----ECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--C
Q 013081 14 GRY-ELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--K 86 (450)
Q Consensus 14 ~~y-~i~~~LG~G~~g~Vy~a~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~ 86 (450)
+|| ++.+.||+|+||+||++. ...+++.||+|++..... ......+.+|+.+++.++||||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 567 999999999999998765 345788999999865432 2234678899999999999999999998765 3
Q ss_pred CEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCc
Q 013081 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (450)
Q Consensus 87 ~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 166 (450)
...|++|||+++++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||+++++.+||+|||++.....
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 468999999999999999876 4699999999999999999999999999999999999999999999999999885432
Q ss_pred ccCC-CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHH--H-------------HHHHHH
Q 013081 167 FRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA--V-------------LYQKIF 230 (450)
Q Consensus 167 ~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--~-------------~~~~i~ 230 (450)
.... .......++..|+|||.+....+ +.++||||||+++|+|++|..||...... . ......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKF-SYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCC-CcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence 1111 11222345678999999876665 58999999999999999999998653211 0 001111
Q ss_pred hC-CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHh
Q 013081 231 RG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 231 ~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
.. ..+.|..++..+.+++.+||++||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 11 23345668899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=325.49 Aligned_cols=238 Identities=25% Similarity=0.320 Sum_probs=195.6
Q ss_pred eecccCceEEEEEEECC------------------------CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc
Q 013081 21 TLGEGNFGKVKFAQDLD------------------------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76 (450)
Q Consensus 21 ~LG~G~~g~Vy~a~~~~------------------------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI 76 (450)
.||+|+||.||+|.... ....||+|++.... ......+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 69999999999997432 12458899886432 2334678889999999999999
Q ss_pred ceEEEEEEeCCEEEEEEccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCC----
Q 013081 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---- 151 (450)
Q Consensus 77 v~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g---- 151 (450)
+++++++......|+||||+++|+|...+.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999998865 56789999999999999999999999999999999999998654
Q ss_pred ---CeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHH-hCCCCCCCCcHHHHHH
Q 013081 152 ---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL-TGYLPFDDRNLAVLYQ 227 (450)
Q Consensus 152 ---~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ell-tG~~Pf~~~~~~~~~~ 227 (450)
.+|++|||++..... .....+++.|+|||.+.+....+.++|||||||++|+|+ +|..||.........
T Consensus 159 ~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~- 231 (274)
T cd05076 159 TSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE- 231 (274)
T ss_pred ccceeeecCCcccccccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH-
Confidence 389999998763211 123457889999999876554568999999999999985 699999876654432
Q ss_pred HHHhCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 228 KIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 228 ~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
.........|...++.+.++|.+||+.+|++|||+.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 232 RFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHHHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 23334445566667899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=318.11 Aligned_cols=249 Identities=24% Similarity=0.419 Sum_probs=210.7
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 92 (450)
.++|++.+.||+|+||.||+|.+. ++..+|+|.+...... ...+.+|+.++++++||||+++++++......|++
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence 457999999999999999999875 4678999988654332 35688999999999999999999999999999999
Q ss_pred EccCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCC
Q 013081 93 LEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 171 (450)
|||+.+++|.+++... +.+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++....... ..
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~ 156 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YT 156 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCc-cc
Confidence 9999999999998753 568999999999999999999999999999999999999999999999999987432210 11
Q ss_pred ccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHH
Q 013081 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLR 249 (450)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~ 249 (450)
......++..|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+..+ ....|...+..+.+|+.
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKY-SSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQ 235 (256)
T ss_pred ccCCCccchhhcCHhHhccCCc-ChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHH
Confidence 1122335578999999876665 588999999999999998 99999988877777776655 33446668899999999
Q ss_pred HccccCcCCCCCHHHHHhc
Q 013081 250 KILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 250 ~~L~~dP~~R~t~~~il~h 268 (450)
+||+.+|++|||+.++++.
T Consensus 236 ~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 236 HCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHcccChhhCCCHHHHHHh
Confidence 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=326.54 Aligned_cols=260 Identities=23% Similarity=0.361 Sum_probs=211.3
Q ss_pred CCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCC
Q 013081 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKS 87 (450)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~ 87 (450)
....++.|++.+.||+|+||.||+|.+..+++.||||.+.+.... .....+.+|+.++.++. ||||+++++++.+..
T Consensus 10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 87 (296)
T cd06618 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFITDS 87 (296)
T ss_pred ccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeecCC
Confidence 345678999999999999999999999988999999999754322 22455667787776664 999999999999999
Q ss_pred EEEEEEccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhh-cCeeeccCCCCcEEEccCCCeEEeecCCCCCCC
Q 013081 88 KIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~-~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 165 (450)
..|++|||+. +.|.+.+.. .+++++..+..++.|++.||+|||+ .||+||||+|+||++++++.+||+|||++....
T Consensus 88 ~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 88 DVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 9999999985 577776655 4579999999999999999999997 599999999999999999999999999987532
Q ss_pred cccCCCccccccCCCCccchhhhccCC---CCCccchhhhHHHHHHHHHhCCCCCCCCcH-HHHHHHHHhCC-CCCC--C
Q 013081 166 HFRDDGLLHTTCGSPNYVAPEVLANRG---YDGATSDIWSCGVILYVILTGYLPFDDRNL-AVLYQKIFRGD-FKLP--K 238 (450)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~---~~~~~~DiwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~-~~~p--~ 238 (450)
. ........+++.|+|||.+.+.. ..+.++||||||+++|+|++|+.||..... ......+.... ...+ .
T Consensus 167 ~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (296)
T cd06618 167 D---SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNE 243 (296)
T ss_pred C---CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCC
Confidence 2 11123345788999999986542 235789999999999999999999976433 33444444443 2222 2
Q ss_pred CCCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 239 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 239 ~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
.++.++.+|+.+||+.||.+|||+.+++.||||...
T Consensus 244 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 244 GFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred CCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 378899999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=331.17 Aligned_cols=255 Identities=21% Similarity=0.346 Sum_probs=200.7
Q ss_pred EeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEccCC
Q 013081 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT 97 (450)
Q Consensus 18 i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 97 (450)
+++.+| ++|.||.+++..+++.||+|.+..... .......+.+|+.+++.++||||+++++++......|++|||++
T Consensus 6 i~~~~~--~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 6 IGKCFE--DLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred hhHhhc--CCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 334444 445566666667999999999976532 23346789999999999999999999999999999999999999
Q ss_pred CCChHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC-----C
Q 013081 98 GGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-----D 170 (450)
Q Consensus 98 gg~L~~~i~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~-----~ 170 (450)
+++|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.+|.+||+|||.+........ .
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 99999998753 4689999999999999999999999999999999999999999999999998864321111 1
Q ss_pred CccccccCCCCccchhhhccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCC---------------
Q 013081 171 GLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF--------------- 234 (450)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--------------- 234 (450)
.......++..|+|||++... ...+.++|+||+||++|+|++|..||..............+..
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDS 242 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCC
Confidence 112334577899999998653 2235889999999999999999999987554333222111110
Q ss_pred -------------------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCC
Q 013081 235 -------------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 235 -------------------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
..+..++..+.+|+.+||+.||++|||+.++++||||+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 243 MSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred cCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 00112356788999999999999999999999999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=315.31 Aligned_cols=244 Identities=26% Similarity=0.423 Sum_probs=204.6
Q ss_pred eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEccCCCC
Q 013081 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG 99 (450)
Q Consensus 20 ~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 99 (450)
+.||+|+||.||+|... ++..+|+|.+.... .......+.+|+.+++.++||||+++++++......++||||++++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 46899999999999864 68899999986543 2233457889999999999999999999999999999999999999
Q ss_pred ChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccccccC
Q 013081 100 ELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 178 (450)
Q Consensus 100 ~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 178 (450)
+|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....... ........+
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~ 156 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI-YSSSGLKQI 156 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccc-cccCCCCCC
Confidence 999988753 468999999999999999999999999999999999999999999999999987432110 111112344
Q ss_pred CCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccccCc
Q 013081 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNP 256 (450)
Q Consensus 179 t~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP 256 (450)
++.|+|||++....+ +.++||||+|+++|++++ |..||.+.+.......+..+ ....|..++..+.+++.+||+.+|
T Consensus 157 ~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (250)
T cd05085 157 PIKWTAPEALNYGRY-SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKP 235 (250)
T ss_pred cccccCHHHhccCCC-CchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCc
Confidence 677999999876655 588999999999999999 99999888777666666554 345567789999999999999999
Q ss_pred CCCCCHHHHHhc
Q 013081 257 VKRITIAGIKAD 268 (450)
Q Consensus 257 ~~R~t~~~il~h 268 (450)
++|||+.++++.
T Consensus 236 ~~Rp~~~~l~~~ 247 (250)
T cd05085 236 ENRPKFSELQKE 247 (250)
T ss_pred ccCCCHHHHHHH
Confidence 999999999764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=320.70 Aligned_cols=251 Identities=26% Similarity=0.403 Sum_probs=208.7
Q ss_pred cCCeEEeeeecccCceEEEEEEECCC---CceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (450)
-.+|.+.+.||+|+||.||+|.+... ...||+|...... .....+.+.+|+.+++.++||||+++++++.+ ...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~ 81 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV 81 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence 45799999999999999999987544 4579999875432 23345788999999999999999999999875 457
Q ss_pred EEEEccCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc
Q 013081 90 YMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~-~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 168 (450)
|++|||+++++|.+++.+.. .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 89999999999999997644 58999999999999999999999999999999999999999999999999987543211
Q ss_pred CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 013081 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 246 (450)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 246 (450)
. .......+++.|+|||.+....+ +.++||||||+++|+|++ |..||.+.+.......+..+ ..+.|..+++.+.+
T Consensus 162 ~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (270)
T cd05056 162 Y-YKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 239 (270)
T ss_pred c-eecCCCCccccccChhhhccCCC-CchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHH
Confidence 0 01112234568999999876655 588999999999999996 99999888777666666555 45567778999999
Q ss_pred HHHHccccCcCCCCCHHHHHhc
Q 013081 247 LLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 247 Li~~~L~~dP~~R~t~~~il~h 268 (450)
++.+||.++|++|||+.+++..
T Consensus 240 li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 240 LMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=321.18 Aligned_cols=239 Identities=23% Similarity=0.301 Sum_probs=195.8
Q ss_pred eeecccCceEEEEEEECC------------CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013081 20 RTLGEGNFGKVKFAQDLD------------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (450)
Q Consensus 20 ~~LG~G~~g~Vy~a~~~~------------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (450)
+.||+|+||.||+|.... ....||+|++.... ......+.+|+.+++.++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 468999999999998532 23368999876432 334567888999999999999999999999999
Q ss_pred EEEEEEccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCC-------eEEeecC
Q 013081 88 KIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN-------IKISDFG 159 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~-------lkl~DFG 159 (450)
..+++|||+++++|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++. ++++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 99999999999999888865 456999999999999999999999999999999999999987764 8999999
Q ss_pred CCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHH-hCCCCCCCCcHHHHHHHHHhCCCCCCC
Q 013081 160 LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL-TGYLPFDDRNLAVLYQKIFRGDFKLPK 238 (450)
Q Consensus 160 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ell-tG~~Pf~~~~~~~~~~~i~~~~~~~p~ 238 (450)
++..... .....++..|+|||.+......+.++||||+||++|+|+ +|..||......... ...........
T Consensus 158 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~~~~ 230 (262)
T cd05077 158 IPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCMLVT 230 (262)
T ss_pred CCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCccCCC
Confidence 9864321 223467889999999875555568999999999999998 599999876544332 33334444444
Q ss_pred CCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 239 WLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 239 ~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
..++++.+|+.+||+.||.+||++.+|+.+
T Consensus 231 ~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 231 PSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred CChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=320.28 Aligned_cols=229 Identities=28% Similarity=0.446 Sum_probs=194.7
Q ss_pred cCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEccCCCCChHHH
Q 013081 25 GNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDK 104 (450)
Q Consensus 25 G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~ 104 (450)
|.+|.||+|++..+++.||+|.+.+.. ...+|...+....||||+++++++.+....|++|||++||+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 899999999999999999999987542 223445555566799999999999999999999999999999999
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccccccCCCCccc
Q 013081 105 IASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184 (450)
Q Consensus 105 i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~A 184 (450)
+.+..++++..+..++.|+++||+|||++|++||||||+||+++.++.++++|||.+..... ......++..|+|
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~-----~~~~~~~~~~y~a 150 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED-----SCDGEAVENMYCA 150 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccc-----ccccCCcCccccC
Confidence 98878899999999999999999999999999999999999999999999999998764322 1233456788999
Q ss_pred hhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccccCcCCCCCH--
Q 013081 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITI-- 262 (450)
Q Consensus 185 PE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~-- 262 (450)
||.+....+ +.++|+||+|+++|+|++|+.||....... .......+|.++++.+.+||.+||+.||++|||+
T Consensus 151 PE~~~~~~~-~~~~DvwslG~il~el~~g~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 151 PEVGGISEE-TEACDWWSLGAILFELLTGKTLVECHPSGI----NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred CcccCCCCC-CchhhHHHHHHHHHHHHHCcchhhcCchhc----ccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCc
Confidence 999876655 588999999999999999999886432210 0112345788899999999999999999999985
Q ss_pred ---HHHHhcccc
Q 013081 263 ---AGIKADEWF 271 (450)
Q Consensus 263 ---~~il~h~~~ 271 (450)
+++++||||
T Consensus 226 ~~~~~~~~h~~~ 237 (237)
T cd05576 226 AGVEDIKSHPFF 237 (237)
T ss_pred cchHHHHcCCCC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=320.18 Aligned_cols=245 Identities=23% Similarity=0.306 Sum_probs=193.7
Q ss_pred eeecccCceEEEEEEECC--CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEccCC
Q 013081 20 RTLGEGNFGKVKFAQDLD--SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT 97 (450)
Q Consensus 20 ~~LG~G~~g~Vy~a~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 97 (450)
+.||+|+||.||+|.... ....+|+|.+.... .......+.+|+.+++.++||||+++++.+......|+||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 469999999999996432 44578888775432 23334678899999999999999999999999999999999999
Q ss_pred CCChHHHHHhcC-----CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCc
Q 013081 98 GGELFDKIASKG-----RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (450)
Q Consensus 98 gg~L~~~i~~~~-----~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 172 (450)
+|+|.+++.... ..++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 999999987643 246788899999999999999999999999999999999999999999999864321111111
Q ss_pred cccccCCCCccchhhhccC------CCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCC-----CCCC
Q 013081 173 LHTTCGSPNYVAPEVLANR------GYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFK-----LPKW 239 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~------~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~-----~p~~ 239 (450)
.....+++.|+|||++... ...+.++||||+||++|+|++ |..||..........+.... ... .+..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK 238 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence 1233456789999997532 233678999999999999999 89999887665555444332 222 2335
Q ss_pred CCHHHHHHHHHccccCcCCCCCHHHHHh
Q 013081 240 LSPGAQNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 240 ~s~~~~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
+++.+.+++..|+ .||++|||++++++
T Consensus 239 ~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 239 YSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred CCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 7888999999998 59999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=317.92 Aligned_cols=242 Identities=27% Similarity=0.489 Sum_probs=205.7
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
.+++|++.+.||+|+||.||.+.. +++.||+|.+.... ....+.+|+.++++++||||+++++++... ..|+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred cHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence 457899999999999999999864 78889999985432 235788999999999999999999998654 4799
Q ss_pred EEccCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC
Q 013081 92 VLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~~--~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 169 (450)
+|||+.+++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~--- 152 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSM--- 152 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccc---
Confidence 999999999999997643 588999999999999999999999999999999999999999999999999874321
Q ss_pred CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 013081 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 247 (450)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 247 (450)
.......+..|+|||.+.+..+ +.++|+||+||++|+|++ |+.||...+.......+.++ ....+..+++.+.++
T Consensus 153 --~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (254)
T cd05083 153 --GVDNSKLPVKWTAPEALKHKKF-SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVL 229 (254)
T ss_pred --cCCCCCCCceecCHHHhccCCc-CchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHH
Confidence 1122334568999999876655 588999999999999998 99999988877776666555 334456688999999
Q ss_pred HHHccccCcCCCCCHHHHHh
Q 013081 248 LRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 248 i~~~L~~dP~~R~t~~~il~ 267 (450)
+.+||+.+|.+|||+++++.
T Consensus 230 i~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 230 MTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=326.00 Aligned_cols=253 Identities=24% Similarity=0.342 Sum_probs=207.8
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCc----eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGL----PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (450)
..++|+..+.||+|+||.||+|.+..+|+ .||+|.+..... ......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~- 81 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLSP- 81 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence 34688999999999999999999887776 468888764332 22345688999999999999999999998654
Q ss_pred EEEEEEccCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCc
Q 013081 88 KIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~~-~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 166 (450)
..++++||+++|+|.+.+.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence 4678999999999999987644 689999999999999999999999999999999999999999999999999985432
Q ss_pred ccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHH
Q 013081 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGA 244 (450)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~ 244 (450)
...........++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.........+..+ ..+.+...+..+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKF-THQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDV 240 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCC-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHH
Confidence 211111223456778999999876665 588999999999999998 99999887655554444433 344456688999
Q ss_pred HHHHHHccccCcCCCCCHHHHHhc
Q 013081 245 QNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
.+++.+||..+|++||++.++++.
T Consensus 241 ~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 241 YMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=321.51 Aligned_cols=245 Identities=27% Similarity=0.393 Sum_probs=203.7
Q ss_pred eeecccCceEEEEEEECCCC------ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 20 RTLGEGNFGKVKFAQDLDSG------LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 20 ~~LG~G~~g~Vy~a~~~~~~------~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
+.||+|+||.||+|.+.... +.+|+|.+.+... ......+.+|+.+++.++||||+++++++......|++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc--hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 46999999999999976543 6899998864321 123467889999999999999999999999999999999
Q ss_pred ccCCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCC-----CeEEeecCCC
Q 013081 94 EYVTGGELFDKIASK-------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-----NIKISDFGLS 161 (450)
Q Consensus 94 E~~~gg~L~~~i~~~-------~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g-----~lkl~DFGla 161 (450)
||++|++|.+++... ..+++..+..++.|++.||+|||+.+++|+||||+||+++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999998642 3478899999999999999999999999999999999999888 8999999998
Q ss_pred CCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCC
Q 013081 162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKW 239 (450)
Q Consensus 162 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~ 239 (450)
................++..|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+..+ .+..+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKF-TTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPEN 237 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCc-ccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCccc
Confidence 74322111112223456788999999877665 689999999999999998 99999887766666655543 4556677
Q ss_pred CCHHHHHHHHHccccCcCCCCCHHHHHh
Q 013081 240 LSPGAQNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 240 ~s~~~~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
+++.+.+++.+||.++|.+|||+.++++
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 238 CPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred chHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 8999999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=313.97 Aligned_cols=259 Identities=24% Similarity=0.387 Sum_probs=215.2
Q ss_pred CCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCC
Q 013081 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKS 87 (450)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~ 87 (450)
....++..+.+..||.|+.|.||+++.+.+|...|||.+.+.. +.+..+++.+.+.++.... +|+||+.+++|..+.
T Consensus 87 ~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~ 164 (391)
T KOG0983|consen 87 YQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT 164 (391)
T ss_pred cccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc
Confidence 3344556778889999999999999999999999999998664 4555788999999888775 899999999999999
Q ss_pred EEEEEEccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhc-CeeeccCCCCcEEEccCCCeEEeecCCCCCCC
Q 013081 88 KIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~-givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 165 (450)
.+++.||.+. ..+..++.+ .++++|..+-++...+++||.||.++ ||+|||+||+|||+|+.|++||||||++...-
T Consensus 165 dV~IcMelMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlv 243 (391)
T KOG0983|consen 165 DVFICMELMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV 243 (391)
T ss_pred hHHHHHHHHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceee
Confidence 9999999984 333333333 56899999999999999999999865 99999999999999999999999999987432
Q ss_pred cccCCCccccccCCCCccchhhhcc---CCCCCccchhhhHHHHHHHHHhCCCCCCCCc-HHHHHHHHHhCCCCC-C--C
Q 013081 166 HFRDDGLLHTTCGSPNYVAPEVLAN---RGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGDFKL-P--K 238 (450)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~---~~~~~~~~DiwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~~~~~~-p--~ 238 (450)
+........|.+.|||||.+.- ..| ...+||||||+.++||.||..||.+.+ ..++..++.+..++. | .
T Consensus 244 ---dSkAhtrsAGC~~YMaPERidp~~~~kY-DiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~ 319 (391)
T KOG0983|consen 244 ---DSKAHTRSAGCAAYMAPERIDPPDKPKY-DIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHM 319 (391)
T ss_pred ---cccccccccCCccccCccccCCCCCCcc-chhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCccc
Confidence 2222334578999999999753 234 478999999999999999999999854 456777888765543 2 2
Q ss_pred CCCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 239 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 239 ~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
.+|+.+.+|+..||++|+.+||...++|+|||....
T Consensus 320 gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 320 GFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred CcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence 389999999999999999999999999999998753
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=345.60 Aligned_cols=257 Identities=27% Similarity=0.504 Sum_probs=222.9
Q ss_pred cccCCeE-EeeeecccCceEEEEEEECCCCceEEEEEeecccc-cchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013081 11 MRLGRYE-LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI-IHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (450)
Q Consensus 11 ~~~~~y~-i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (450)
..-|||- ....||+|+|-+||+|.|..+|..||.-.+..... ...+..+++..|+.+|+.|+||||+++|+.+.+...
T Consensus 36 ~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n 115 (632)
T KOG0584|consen 36 DPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN 115 (632)
T ss_pred CCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC
Confidence 3345663 45789999999999999999999999876654333 244557899999999999999999999999977655
Q ss_pred --EEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhc--CeeeccCCCCcEEEccC-CCeEEeecCCCCC
Q 013081 89 --IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK--GVFHRDLKLENILLDSK-GNIKISDFGLSAL 163 (450)
Q Consensus 89 --~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~--givHrDlKp~NILl~~~-g~lkl~DFGla~~ 163 (450)
+.+|+|.+.+|+|+.|+.+.+.++...++.|++||+.||.|||++ -|+|||||-+||+|+.+ |.|||+|+|||++
T Consensus 116 ~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl 195 (632)
T KOG0584|consen 116 KTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL 195 (632)
T ss_pred ceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHH
Confidence 889999999999999999999999999999999999999999998 49999999999999865 8999999999996
Q ss_pred CCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCC-CcHHHHHHHHHhCCCC--CCCCC
Q 013081 164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGDFK--LPKWL 240 (450)
Q Consensus 164 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~ 240 (450)
... .......|||.|||||++. ..|+ ..+||||||.++.||.|+..||.. .+...+|+++..|..+ +..--
T Consensus 196 ~r~----s~aksvIGTPEFMAPEmYE-E~Yn-E~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~ 269 (632)
T KOG0584|consen 196 LRK----SHAKSVIGTPEFMAPEMYE-ENYN-ELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVK 269 (632)
T ss_pred hhc----cccceeccCccccChHHHh-hhcc-hhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccC
Confidence 432 3345579999999999976 5675 899999999999999999999975 6788999999988543 33445
Q ss_pred CHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 241 s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
+|++++||.+||.. .+.|+|+.++|.||||..+
T Consensus 270 dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 270 DPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred CHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 89999999999999 9999999999999999875
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=322.35 Aligned_cols=250 Identities=27% Similarity=0.409 Sum_probs=201.5
Q ss_pred eEEeeeecccCceEEEEEEE----CCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEE
Q 013081 16 YELGRTLGEGNFGKVKFAQD----LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SKI 89 (450)
Q Consensus 16 y~i~~~LG~G~~g~Vy~a~~----~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~ 89 (450)
|++++.||+|+||.||+|.. ..++..||+|.+.... .......+.+|+.+++.++||||+++++++... ...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 68899999999999999974 4578899999986442 233457899999999999999999999998765 678
Q ss_pred EEEEccCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc
Q 013081 90 YMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 168 (450)
|++|||++|++|.+++.+. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCc
Confidence 9999999999999998764 358999999999999999999999999999999999999999999999999988543211
Q ss_pred CC-CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCc---------------HHHHHHHHHhC
Q 013081 169 DD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN---------------LAVLYQKIFRG 232 (450)
Q Consensus 169 ~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~---------------~~~~~~~i~~~ 232 (450)
.. .......++..|+|||++.+..+ +.++||||+||++|+|+++..|+.... .......+..+
T Consensus 164 ~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd05079 164 EYYTVKDDLDSPVFWYAPECLIQSKF-YIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG 242 (284)
T ss_pred cceeecCCCCCCccccCHHHhccCCC-CccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcC
Confidence 11 11224456778999999877665 588999999999999999877653211 01111111112
Q ss_pred -CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 233 -DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 233 -~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
..+.+..+++.+.+|+.+||++||.+|||+.+++++
T Consensus 243 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 243 KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 234456689999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=316.09 Aligned_cols=249 Identities=25% Similarity=0.412 Sum_probs=207.4
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (450)
...++|++.+.||+|+||.||+|.+. .+..+|+|.+.... .....+.+|+.+++.++|+||+++++.+.. ...|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 35689999999999999999999854 55679999886432 224678899999999999999999999877 7789
Q ss_pred EEEccCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc
Q 013081 91 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 91 lv~E~~~gg~L~~~i~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 168 (450)
++|||+++++|.+++... ..++...+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 999999999999999763 357888999999999999999999999999999999999999999999999987543211
Q ss_pred CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 013081 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 246 (450)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 246 (450)
........++..|+|||++....+ +.++|+|||||++|++++ |..||.+.+.......+..+ ..+.+...+.++.+
T Consensus 157 -~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (260)
T cd05073 157 -YTAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYN 234 (260)
T ss_pred -cccccCCcccccccCHhHhccCCc-CccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHH
Confidence 111112335567999999876554 588999999999999999 99999987777666665554 33455668899999
Q ss_pred HHHHccccCcCCCCCHHHHHh
Q 013081 247 LLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 247 Li~~~L~~dP~~R~t~~~il~ 267 (450)
++.+||++||++||++.++++
T Consensus 235 ~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 235 IMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHHcccCcccCcCHHHHHH
Confidence 999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=318.86 Aligned_cols=245 Identities=21% Similarity=0.277 Sum_probs=193.9
Q ss_pred eeecccCceEEEEEEEC--CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEccCC
Q 013081 20 RTLGEGNFGKVKFAQDL--DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT 97 (450)
Q Consensus 20 ~~LG~G~~g~Vy~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 97 (450)
+.||+|+||.||+|... .++..+|+|.++.... ......+.+|+.++++++||||+++++.+.+....|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 46899999999999854 3567899998865432 2224578899999999999999999999999999999999999
Q ss_pred CCChHHHHHhcC-----CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCc
Q 013081 98 GGELFDKIASKG-----RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (450)
Q Consensus 98 gg~L~~~i~~~~-----~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 172 (450)
+|+|.+++.... ..++..++.++.|++.||+|||++|++||||||+||+++.++++||+|||++...........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 999999986432 356778889999999999999999999999999999999999999999999874322111111
Q ss_pred cccccCCCCccchhhhccCC------CCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCC--C---CC
Q 013081 173 LHTTCGSPNYVAPEVLANRG------YDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKL--P---KW 239 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~------~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~--p---~~ 239 (450)
.....+++.|+|||++.+.. ..+.++||||+|+++|+|++ |..||............... .... | ..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP 238 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence 22346788999999986432 12578999999999999996 99999876655544332222 2222 2 23
Q ss_pred CCHHHHHHHHHccccCcCCCCCHHHHHh
Q 013081 240 LSPGAQNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 240 ~s~~~~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
.++.+.+++.+|+ .+|++|||+++++.
T Consensus 239 ~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 239 LSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 6788999999999 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=316.32 Aligned_cols=246 Identities=26% Similarity=0.374 Sum_probs=200.0
Q ss_pred eeecccCceEEEEEEECC---CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE-eCCEEEEEEcc
Q 013081 20 RTLGEGNFGKVKFAQDLD---SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA-SKSKIYMVLEY 95 (450)
Q Consensus 20 ~~LG~G~~g~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~~~~~lv~E~ 95 (450)
+.||+|+||.||+|.+.. .+..||+|.+.... .......+.+|+.+++.++||||+++++++. .++..|++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 468999999999998654 34579999875322 2334578889999999999999999999765 45678999999
Q ss_pred CCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC--CCc
Q 013081 96 VTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--DGL 172 (450)
Q Consensus 96 ~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~--~~~ 172 (450)
+.+++|.+++.+. ..+++..+..++.|++.||+|||+.|++||||||+|||+++++.+||+|||+++....... ...
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence 9999999998764 3467788899999999999999999999999999999999999999999999874322110 011
Q ss_pred cccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHH
Q 013081 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRK 250 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~ 250 (450)
.....+++.|+|||.+....+ +.++|||||||++|+|++ |.+||...+..........+. ...|..+++.+.+++.+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (262)
T cd05058 159 HTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLS 237 (262)
T ss_pred cccCcCCccccChhHhccCcc-chHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH
Confidence 123345678999999877665 589999999999999999 677888777766666665553 44466688999999999
Q ss_pred ccccCcCCCCCHHHHHhc
Q 013081 251 ILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 251 ~L~~dP~~R~t~~~il~h 268 (450)
||+++|++||++.+++..
T Consensus 238 cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 238 CWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HcCCChhhCCCHHHHHHH
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=318.57 Aligned_cols=251 Identities=26% Similarity=0.392 Sum_probs=205.9
Q ss_pred eEEeeeecccCceEEEEEEEC---CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----
Q 013081 16 YELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS----- 87 (450)
Q Consensus 16 y~i~~~LG~G~~g~Vy~a~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----- 87 (450)
|.+.+.||+|+||.||+|.+. .+++.||||++..+.. .....+.+.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 678899999999999999864 3578999999865433 3334577889999999999999999999875432
Q ss_pred -EEEEEEccCCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCC
Q 013081 88 -KIYMVLEYVTGGELFDKIASK------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGL 160 (450)
Q Consensus 88 -~~~lv~E~~~gg~L~~~i~~~------~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGl 160 (450)
..++++||+.+|+|.+++... ..++...++.++.|++.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 347889999999998877432 2478999999999999999999999999999999999999999999999999
Q ss_pred CCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCC
Q 013081 161 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPK 238 (450)
Q Consensus 161 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~ 238 (450)
++...............+++.|++||.+....+ +.++|||||||++|+|++ |++||.+.+....+..+... ....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVY-TTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPP 238 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCcc-chhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence 885432111111223345678999999877665 578999999999999999 99999888777777666554 345566
Q ss_pred CCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 239 WLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 239 ~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
.+++.+.+++.+||+.+|+.|||+.+++.+
T Consensus 239 ~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 239 DCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=353.21 Aligned_cols=251 Identities=27% Similarity=0.396 Sum_probs=217.7
Q ss_pred ccCCeEEeeeecccCceEEEEEEECC-----CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (450)
..+.-++.+.||+|+||+||+|+-.. ..+.||||.++... +.....+|+||++++..++|||||++++++..+
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 34567788999999999999998532 34689999996543 334578999999999999999999999999999
Q ss_pred CEEEEEEccCCCCChHHHHHhcC--------------CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCC
Q 013081 87 SKIYMVLEYVTGGELFDKIASKG--------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN 152 (450)
Q Consensus 87 ~~~~lv~E~~~gg~L~~~i~~~~--------------~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~ 152 (450)
+.+|+|+|||..|||.+++.... +++..+...++.||+.|++||-++.++||||-..|+||.++-.
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLV 641 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceE
Confidence 99999999999999999986432 2788999999999999999999999999999999999999999
Q ss_pred eEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHh
Q 013081 153 IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFR 231 (450)
Q Consensus 153 lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~ 231 (450)
|||+|||+++..-............-...|||||.+..+.| +.+|||||+||+|||+++ |+.||.+.+.++..+.+..
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kF-TteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~ 720 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKF-TTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRA 720 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcc-cchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHc
Confidence 99999999985432211222222334568999999998888 488999999999999999 9999999999999998888
Q ss_pred C-CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHH
Q 013081 232 G-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI 265 (450)
Q Consensus 232 ~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~i 265 (450)
+ .++.|+.+|.++.+|+..||+.+|++||++.||
T Consensus 721 g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 721 GQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred CCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 7 478899999999999999999999999999997
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=339.57 Aligned_cols=250 Identities=28% Similarity=0.445 Sum_probs=215.1
Q ss_pred CCeEEeeeecccCceEEEEEEECCCC----ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (450)
++-.+.+.||+|+||+||+|..+..+ ..||+|..........+....+.+|+++|+.++|||||++||+......+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 34556799999999999999865432 23899998754444556678899999999999999999999999999999
Q ss_pred EEEEccCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc
Q 013081 90 YMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~-~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 168 (450)
|+|||+|+||+|.+++++.+ .++..+...++.+.+.||+|||+++++||||-..|+|++.++.+||+|||+++.-..
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~-- 314 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ-- 314 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcc--
Confidence 99999999999999999877 499999999999999999999999999999999999999999999999999985321
Q ss_pred CCCcccccc-CCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC--CCCCCCCCCHHH
Q 013081 169 DDGLLHTTC-GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGA 244 (450)
Q Consensus 169 ~~~~~~~~~-gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~ 244 (450)
.......+ -...|+|||.+....| +.++||||+||++||+.+ |..||.+........++... ..+.|...+..+
T Consensus 315 -~~~~~~~~klPirWLAPEtl~~~~~-s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~ 392 (474)
T KOG0194|consen 315 -YVMKKFLKKLPIRWLAPETLNTGIF-SFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKEL 392 (474)
T ss_pred -eeeccccccCcceecChhhhccCcc-ccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHH
Confidence 11112122 4468999999988755 699999999999999999 89999999999999999554 455667788899
Q ss_pred HHHHHHccccCcCCCCCHHHHHh
Q 013081 245 QNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
..++.+|+..||++|||+.++.+
T Consensus 393 ~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 393 AKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHHhccCChhhccCHHHHHH
Confidence 99999999999999999999865
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=315.62 Aligned_cols=237 Identities=22% Similarity=0.254 Sum_probs=195.0
Q ss_pred eeecccCceEEEEEEECCCC----------ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013081 20 RTLGEGNFGKVKFAQDLDSG----------LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (450)
Q Consensus 20 ~~LG~G~~g~Vy~a~~~~~~----------~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (450)
+.||+|+||.||+|.+..++ ..+++|++..... ....+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 47999999999999998776 3588887654321 14678899999999999999999999887 778
Q ss_pred EEEEccCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCC-------CeEEeecCCC
Q 013081 90 YMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-------NIKISDFGLS 161 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~-~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g-------~lkl~DFGla 161 (450)
|+||||+++|+|.+++.... .++...+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999999998766 799999999999999999999999999999999999999888 7999999998
Q ss_pred CCCCcccCCCccccccCCCCccchhhhccC-CCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCC
Q 013081 162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKW 239 (450)
Q Consensus 162 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~ 239 (450)
..... .....++..|+|||++... ...+.++||||+||++|+|++ |..||...+......... .....|..
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~ 228 (259)
T cd05037 156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPMP 228 (259)
T ss_pred ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCCC
Confidence 74322 2334577889999998765 344689999999999999999 688887765433322222 22223332
Q ss_pred CCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 240 LSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 240 ~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
....+.+++.+||+.+|.+|||+.++++.
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 257 (259)
T cd05037 229 DCAELANLINQCWTYDPTKRPSFRAILRD 257 (259)
T ss_pred CchHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 34899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=317.96 Aligned_cols=265 Identities=28% Similarity=0.435 Sum_probs=218.8
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-----
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS----- 85 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----- 85 (450)
...+.|+-+.+||+|.||+|++|+.+++|+.||+|.+-.+. ...++.....+|+.+|..|+|+|++.++++|.+
T Consensus 14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen-eKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~ 92 (376)
T KOG0669|consen 14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIEICRTKATPT 92 (376)
T ss_pred ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc-cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCc
Confidence 45688999999999999999999999999999998754322 123445677899999999999999999988743
Q ss_pred ---CCEEEEEEccCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCC
Q 013081 86 ---KSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS 161 (450)
Q Consensus 86 ---~~~~~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla 161 (450)
...+|+|+.+|+. +|+-++.+. .+++..+++.+++++++||.|+|+..|+|||+||+|+||+.+|.+||+|||++
T Consensus 93 ~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 93 NRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence 3458999999975 898888765 68999999999999999999999999999999999999999999999999999
Q ss_pred CCCCcccCCC--ccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHh--CCC---
Q 013081 162 ALPQHFRDDG--LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR--GDF--- 234 (450)
Q Consensus 162 ~~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~--~~~--- 234 (450)
+.+....+.. .....+-|.+|++||.+.+..-+|++.|||+.|||+.+|+||.+.+++.+.......|.. +..
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 8655432221 223456799999999998877778999999999999999999999998776655544421 110
Q ss_pred -----------------CCCCC-------------CCHHHHHHHHHccccCcCCCCCHHHHHhccccccCCCC
Q 013081 235 -----------------KLPKW-------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277 (450)
Q Consensus 235 -----------------~~p~~-------------~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~~~ 277 (450)
++|.. -++++.+|+.++|..||.+|++++++++|.||..+..|
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 11111 25688999999999999999999999999999887655
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=317.67 Aligned_cols=251 Identities=26% Similarity=0.410 Sum_probs=200.1
Q ss_pred CCeEEeeeecccCceEEEEEE----ECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CC
Q 013081 14 GRYELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--KS 87 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~ 87 (450)
.+|++.+.||+|+||.||.|. +..+++.||+|.+.... ......+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 378999999999999999997 44678899999986442 3335678999999999999999999998643 45
Q ss_pred EEEEEEccCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCc
Q 013081 88 KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 166 (450)
..|+||||+++++|.+++... ..+++..+..++.|++.||+|||++|++||||||+||++++++.+||+|||++.....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 689999999999999998754 4689999999999999999999999999999999999999999999999999986432
Q ss_pred ccCCC-ccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHH---------------HHHHHH
Q 013081 167 FRDDG-LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV---------------LYQKIF 230 (450)
Q Consensus 167 ~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~---------------~~~~i~ 230 (450)
..... ......++..|+|||++.+..+ +.++||||+||++|+|++|..|+....... ......
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCc-ChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 11110 0111223456999999877665 589999999999999999887765432110 011112
Q ss_pred hC--CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 231 RG--DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 231 ~~--~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
.. ..+.+..++..+.+|+.+||+++|++|||+.++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05081 240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ 279 (284)
T ss_pred hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 21 234456688999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=312.95 Aligned_cols=250 Identities=30% Similarity=0.501 Sum_probs=210.3
Q ss_pred CeEEeeeecccCceEEEEEEECC-CCceEEEEEeecccc-------cchhHHHHHHHHHHHHHh-CCCCCcceEEEEEEe
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLD-SGLPFAVKILEKNRI-------IHLKITDQIKREIATLKL-LKHPNVVRLHEVLAS 85 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~-~~~~vAvK~i~~~~~-------~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~ 85 (450)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+..... ........+.+|+.++++ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999987 788999998864321 122334567789988875 799999999999999
Q ss_pred CCEEEEEEccCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHhhhhh-cCeeeccCCCCcEEEccCCCeEEeecCC
Q 013081 86 KSKIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGL 160 (450)
Q Consensus 86 ~~~~~lv~E~~~gg~L~~~i~~----~~~l~~~~~~~i~~ql~~aL~~LH~-~givHrDlKp~NILl~~~g~lkl~DFGl 160 (450)
.+..|++|||++|++|.+++.. ...+++..++.++.|++.||.|||+ .|++||||+|+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999988743 3568999999999999999999996 6899999999999999999999999999
Q ss_pred CCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCC-CCC-
Q 013081 161 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPK- 238 (450)
Q Consensus 161 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-~p~- 238 (450)
+...... .......|+..|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+...... .+.
T Consensus 161 ~~~~~~~---~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd08528 161 AKQKQPE---SKLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEG 236 (269)
T ss_pred eeecccc---cccccccCcccCcChhhhcCCCC-chHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcc
Confidence 9754321 13345678999999999887655 68999999999999999999999887777666666555433 222
Q ss_pred CCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 239 WLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 239 ~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
.+++.+.+++.+||+.||++|||+.++.++
T Consensus 237 ~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 237 MYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred cCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 578999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=358.73 Aligned_cols=255 Identities=32% Similarity=0.533 Sum_probs=207.8
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-------
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS------- 85 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------- 85 (450)
+.+|+.++.||+||||.||+++++-+|+.||||.|.... .......+.+|+..+.+|+|||||+++..+.+
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 456788999999999999999999999999999997654 34456889999999999999999998832100
Q ss_pred --------------------------------------------------------------------------------
Q 013081 86 -------------------------------------------------------------------------------- 85 (450)
Q Consensus 86 -------------------------------------------------------------------------------- 85 (450)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ------------------------C--------CEEEEEEccCCCCChHHHHHhcCCC-CHHHHHHHHHHHHHHHhhhhh
Q 013081 86 ------------------------K--------SKIYMVLEYVTGGELFDKIASKGRL-QEAEGRKLFQQLIDGVSYCHN 132 (450)
Q Consensus 86 ------------------------~--------~~~~lv~E~~~gg~L~~~i~~~~~l-~~~~~~~i~~ql~~aL~~LH~ 132 (450)
+ ..+||-||||+...|.+++.++... ....++++|+||++||.|+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence 0 1368999999987777777765544 478899999999999999999
Q ss_pred cCeeeccCCCCcEEEccCCCeEEeecCCCCCCC----------------cccCCCccccccCCCCccchhhhccCC--CC
Q 013081 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQ----------------HFRDDGLLHTTCGSPNYVAPEVLANRG--YD 194 (450)
Q Consensus 133 ~givHrDlKp~NILl~~~g~lkl~DFGla~~~~----------------~~~~~~~~~~~~gt~~y~APE~l~~~~--~~ 194 (450)
+||+||||||.||+++++++|||+|||+|+... ...+.+.....+||..|+|||++.+.. .+
T Consensus 716 ~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y 795 (1351)
T KOG1035|consen 716 QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY 795 (1351)
T ss_pred CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence 999999999999999999999999999998611 001122345568999999999998766 34
Q ss_pred CccchhhhHHHHHHHHHhCCCCCCC-CcHHHHHHHHHhCCCCCCCCC----CHHHHHHHHHccccCcCCCCCHHHHHhcc
Q 013081 195 GATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGDFKLPKWL----SPGAQNLLRKILEPNPVKRITIAGIKADE 269 (450)
Q Consensus 195 ~~~~DiwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~p~~~----s~~~~~Li~~~L~~dP~~R~t~~~il~h~ 269 (450)
..|+|+||||||+|||+ .||.- ........+..++.++.|..+ -+.-..+|++||+.||++|||+.|+|++.
T Consensus 796 n~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~ 872 (1351)
T KOG1035|consen 796 NSKIDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSE 872 (1351)
T ss_pred cchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhcc
Confidence 59999999999999999 45754 344456666667777766332 24567899999999999999999999999
Q ss_pred ccc
Q 013081 270 WFE 272 (450)
Q Consensus 270 ~~~ 272 (450)
||.
T Consensus 873 llp 875 (1351)
T KOG1035|consen 873 LLP 875 (1351)
T ss_pred CCC
Confidence 986
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=311.98 Aligned_cols=245 Identities=21% Similarity=0.318 Sum_probs=193.4
Q ss_pred eeecccCceEEEEEEECCC--CceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEccCC
Q 013081 20 RTLGEGNFGKVKFAQDLDS--GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT 97 (450)
Q Consensus 20 ~~LG~G~~g~Vy~a~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 97 (450)
+.||+|+||.||+|..... ...+++|.+.... .....+.+.+|+.+++.++||||+++++.+......|+||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 4699999999999975433 3356677665432 22335788999999999999999999999999999999999999
Q ss_pred CCChHHHHHhc----CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCcc
Q 013081 98 GGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (450)
Q Consensus 98 gg~L~~~i~~~----~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 173 (450)
+|+|.+++.+. ..+++..++.++.||+.||+|||+++++||||||+|||++.++.+||+|||++............
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99999998753 24567788899999999999999999999999999999999999999999998632111111122
Q ss_pred ccccCCCCccchhhhccCC------CCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCC-C-----CCCCCC
Q 013081 174 HTTCGSPNYVAPEVLANRG------YDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-F-----KLPKWL 240 (450)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~------~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~-----~~p~~~ 240 (450)
...++++.|+|||++.... ..+.++|||||||++|+|++ |..||...+....+..+..+. . ..+..+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY 238 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence 3467889999999975321 12578999999999999997 688998777666665554332 1 223347
Q ss_pred CHHHHHHHHHccccCcCCCCCHHHHHh
Q 013081 241 SPGAQNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 241 s~~~~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
++.+.+++..|| .+|.+|||+.++++
T Consensus 239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 239 SERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred cHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 889999999999 67999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=315.16 Aligned_cols=252 Identities=27% Similarity=0.408 Sum_probs=204.5
Q ss_pred cCCeEEeeeecccCceEEEEEEEC----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--C
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDL----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--K 86 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~ 86 (450)
...|++.+.||+|+||.||+|... .+++.||+|++...... .....+.+|+.+++.++||||+++++++.. .
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 357889999999999999999864 35889999999755432 345789999999999999999999999877 5
Q ss_pred CEEEEEEccCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCC
Q 013081 87 SKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (450)
Q Consensus 87 ~~~~lv~E~~~gg~L~~~i~~~~-~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 165 (450)
...|++|||+++++|.+++.... .+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++....
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 67899999999999999997644 58999999999999999999999999999999999999999999999999998643
Q ss_pred cccCC-CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHH---------------HHHHH
Q 013081 166 HFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV---------------LYQKI 229 (450)
Q Consensus 166 ~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~---------------~~~~i 229 (450)
..... .......++..|+|||.+....+ +.++||||+|+++|+|++|..||....... ....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKF-SSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCC-CcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence 21111 11112344567999999877665 588999999999999999999987543211 11111
Q ss_pred HhC-CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHh
Q 013081 230 FRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 230 ~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
... ..+.+..++..+.+|+.+||+++|++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 240 KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 221 23445567889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=315.86 Aligned_cols=252 Identities=13% Similarity=0.146 Sum_probs=192.5
Q ss_pred cCCeEEeeeecccCceEEEEEEECCC---CceEEEEEeecccccc--hhH------HHHHHHHHHHHHhCCCCCcceEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIH--LKI------TDQIKREIATLKLLKHPNVVRLHE 81 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~---~~~vAvK~i~~~~~~~--~~~------~~~~~~Ei~il~~l~hpnIv~l~~ 81 (450)
-++|++.+.||+|+||.||+|.+..+ +..+|+|+........ +.. ......+...++.+.|+||+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 36899999999999999999998777 6778888654322110 000 011223445566778999999998
Q ss_pred EEEeCC----EEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEee
Q 013081 82 VLASKS----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISD 157 (450)
Q Consensus 82 ~~~~~~----~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~D 157 (450)
.+.... ..++++|++. .++.+.+......++..++.++.|++.||+|||++||+||||||+|||++.++.++|+|
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~D 169 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIID 169 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEE
Confidence 765443 4578888874 47777776655678999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCcccC-----CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcH-HH-------
Q 013081 158 FGLSALPQHFRD-----DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL-AV------- 224 (450)
Q Consensus 158 FGla~~~~~~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-~~------- 224 (450)
||+|+....... ........||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+. ..
T Consensus 170 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~-~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~ 248 (294)
T PHA02882 170 YGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACV-TRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC 248 (294)
T ss_pred cCCceeeccCCcccccccccccccCCCccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHH
Confidence 999975432110 111233479999999999887766 6899999999999999999999987632 11
Q ss_pred -HHHHHHhCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHh
Q 013081 225 -LYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 225 -~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
...++..+....+ ..++.+.+++..|+..+|++||+++++++
T Consensus 249 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 249 DFIKRLHEGKIKIK-NANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHHHhhhhhhccC-CCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 2233333333333 46889999999999999999999999875
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=324.61 Aligned_cols=247 Identities=30% Similarity=0.413 Sum_probs=195.4
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-EEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-KIYMV 92 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-~~~lv 92 (450)
+.|.-.+.||+|+||.||+|.-. +|..||||.+....... ...|.+|+.++.+++|||+|+|+++|.+.+ ..++|
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LV 150 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLV 150 (361)
T ss_pred hCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEE
Confidence 45666789999999999999964 45899999776543321 345999999999999999999999999988 59999
Q ss_pred EccCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhhcC---eeeccCCCCcEEEccCCCeEEeecCCCCCCCcc
Q 013081 93 LEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKG---VFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~~~--~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 167 (450)
+||++.|+|.+.+.... ++++....+|+.+++.||+|||... |+||||||.|||+|++.+.||+|||+|......
T Consensus 151 YEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~ 230 (361)
T KOG1187|consen 151 YEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG 230 (361)
T ss_pred EEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc
Confidence 99999999999997654 8999999999999999999999853 999999999999999999999999999753221
Q ss_pred cCCCccccc-cCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCc------HHHHH-HHHHhCC------
Q 013081 168 RDDGLLHTT-CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN------LAVLY-QKIFRGD------ 233 (450)
Q Consensus 168 ~~~~~~~~~-~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~------~~~~~-~~i~~~~------ 233 (450)
.....+. .||..|+|||.+..... +.++|||||||+|.||+||+.|.+... ..... ..+..+.
T Consensus 231 --~~~~~~~~~gt~gY~~PEy~~~g~l-t~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD 307 (361)
T KOG1187|consen 231 --DTSVSTTVMGTFGYLAPEYASTGKL-TEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVD 307 (361)
T ss_pred --ccceeeecCCCCccCChhhhccCCc-CcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeC
Confidence 2222223 89999999999876544 689999999999999999999887532 11211 1222211
Q ss_pred CCCC-CCCC--H---HHHHHHHHccccCcCCCCCHHHHHh
Q 013081 234 FKLP-KWLS--P---GAQNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 234 ~~~p-~~~s--~---~~~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
..+. ...+ . .+..+..+|++.+|..||++.|+++
T Consensus 308 ~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 308 PRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred CCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 1111 1222 2 2456778999999999999999754
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=319.78 Aligned_cols=251 Identities=30% Similarity=0.475 Sum_probs=205.9
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC--CCC----cceEEEEEEeC
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK--HPN----VVRLHEVLASK 86 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~--hpn----Iv~l~~~~~~~ 86 (450)
-+||.++.++|+|+||.|-.+.|..++..||||+++.- ....+...-|+.+++++. .|+ ++.+.++|+-.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 57999999999999999999999999999999998642 223456677999999994 232 67888999999
Q ss_pred CEEEEEEccCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEcc---------------
Q 013081 87 SKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS--------------- 149 (450)
Q Consensus 87 ~~~~lv~E~~~gg~L~~~i~~~~--~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~--------------- 149 (450)
++++||+|.+ |.++++.+.+++ +++..+++.+.+||+++++|||+.+++|-||||||||+.+
T Consensus 164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccce
Confidence 9999999998 779999998755 6899999999999999999999999999999999999943
Q ss_pred -----CCCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHH-
Q 013081 150 -----KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA- 223 (450)
Q Consensus 150 -----~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~- 223 (450)
+..++|+|||.|+... ..-.+.+.|..|+|||++.+-++. .++||||+||||+||.+|...|+..+..
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~-----e~hs~iVsTRHYRAPEViLgLGwS-~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDH-----EHHSTIVSTRHYRAPEVILGLGWS-QPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred eccCCCcceEEEecCCcceec-----cCcceeeeccccCCchheeccCcC-CccCceeeeeEEEEeeccceecccCCcHH
Confidence 2348999999998532 223567889999999999999995 8899999999999999999999764422
Q ss_pred --HHHHHHHh------------------CCCCCCCC-------------------------CCHHHHHHHHHccccCcCC
Q 013081 224 --VLYQKIFR------------------GDFKLPKW-------------------------LSPGAQNLLRKILEPNPVK 258 (450)
Q Consensus 224 --~~~~~i~~------------------~~~~~p~~-------------------------~s~~~~~Li~~~L~~dP~~ 258 (450)
.+.++++. +.+..|.. ....+.+||++||..||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 23333321 11111110 1135789999999999999
Q ss_pred CCCHHHHHhccccccC
Q 013081 259 RITIAGIKADEWFEQD 274 (450)
Q Consensus 259 R~t~~~il~h~~~~~~ 274 (450)
|+|+.|+|.||||...
T Consensus 397 RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 397 RITLREALSHPFFARL 412 (415)
T ss_pred cccHHHHhcCHHhhcC
Confidence 9999999999999754
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=348.35 Aligned_cols=251 Identities=26% Similarity=0.393 Sum_probs=213.5
Q ss_pred CCeEEeeeecccCceEEEEEEECCC-Cc----eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDS-GL----PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~-~~----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (450)
..-++++.||+|+||.||.|.-... |. .||+|.+.+. .+.+....|.+|..+|+.++|||||++++++-+...
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~ 769 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP 769 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence 4667899999999999999986543 32 4888887654 345567899999999999999999999999999999
Q ss_pred EEEEEccCCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCC
Q 013081 89 IYMVLEYVTGGELFDKIASK-------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS 161 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~~i~~~-------~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla 161 (450)
.+|++|||+||+|..+|++. ..++..+...++.||+.|+.||+++++|||||...|+||+....+||+|||+|
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchh
Confidence 99999999999999999875 24889999999999999999999999999999999999999999999999999
Q ss_pred CCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHH-hCCCCCCCC
Q 013081 162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIF-RGDFKLPKW 239 (450)
Q Consensus 162 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~-~~~~~~p~~ 239 (450)
+........+......-...|||||.+....+ +.++|||||||+|||++| |..||.+.+..++..-.. .++++.|+.
T Consensus 850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iF-tskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~ 928 (1025)
T KOG1095|consen 850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIF-TSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPSY 928 (1025)
T ss_pred HhhhhchheeccCccccceecCCHHHHhhccc-ccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCCC
Confidence 93211111111111122357999999998666 689999999999999999 999999988777776444 458889999
Q ss_pred CCHHHHHHHHHccccCcCCCCCHHHHHh
Q 013081 240 LSPGAQNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 240 ~s~~~~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
++..+.+++..||+.+|++||++..|++
T Consensus 929 CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 929 CPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CChHHHHHHHHHccCChhhCccHHHHHh
Confidence 9999999999999999999999999987
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=336.56 Aligned_cols=242 Identities=35% Similarity=0.543 Sum_probs=197.8
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC------
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS------ 87 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~------ 87 (450)
+-|..-+.||+||||.||+++++.+|+.||||.+++... ..-.+..-+|+++|++|+|||||+++++=++..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~--~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS--LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcc--cchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 678889999999999999999999999999999986542 233678889999999999999999999865433
Q ss_pred EEEEEEccCCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEc--cCCC--eEEeecCC
Q 013081 88 KIYMVLEYVTGGELFDKIAS---KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD--SKGN--IKISDFGL 160 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~---~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~--~~g~--lkl~DFGl 160 (450)
...+|||||.||+|+..+++ ..++++.+.+.++..+..||.|||++||+||||||.||++- ++|. .||+|||.
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 46899999999999999964 45799999999999999999999999999999999999984 4454 69999999
Q ss_pred CCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCC-----cHHHHHHHHHh----
Q 013081 161 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR-----NLAVLYQKIFR---- 231 (450)
Q Consensus 161 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~-----~~~~~~~~i~~---- 231 (450)
|+..+ ++....+..||+.|.+||.+.+..+++..+|.||+||++|++.||..||... +...++..+.+
T Consensus 171 Arel~---d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 171 ARELD---DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG 247 (732)
T ss_pred cccCC---CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence 99643 4557888999999999999986566689999999999999999999999532 12223322221
Q ss_pred ----------------CCCCCCCCCCHHH----HHHHHHccccCcCCCC
Q 013081 232 ----------------GDFKLPKWLSPGA----QNLLRKILEPNPVKRI 260 (450)
Q Consensus 232 ----------------~~~~~p~~~s~~~----~~Li~~~L~~dP~~R~ 260 (450)
..++.|..+++.+ -..+..+|..+|.+|.
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 1123344445443 4567788999999998
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=318.17 Aligned_cols=262 Identities=30% Similarity=0.435 Sum_probs=219.1
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccch----hHHHHHHHHHHHHHhCCCCCcceEEEEEEe-C
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL----KITDQIKREIATLKLLKHPNVVRLHEVLAS-K 86 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~ 86 (450)
.-.||-++.+||+|+|+.||+|.|...++.||+|+-..+..+.. ...+...||.+|.+.|+||.||++|+++.- .
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 34689999999999999999999999999999999876655433 345678899999999999999999999964 4
Q ss_pred CEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhc--CeeeccCCCCcEEEcc---CCCeEEeecCCC
Q 013081 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK--GVFHRDLKLENILLDS---KGNIKISDFGLS 161 (450)
Q Consensus 87 ~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~--givHrDlKp~NILl~~---~g~lkl~DFGla 161 (450)
+.++-|+|||+|.+|.-++....-+++.+|+.|+.||+.||.||... .|+|-||||.|||+-. -|.+||+||||+
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 66889999999999999999999999999999999999999999986 5999999999999954 367999999999
Q ss_pred CCCCcccCCC-----ccccccCCCCccchhhhcc---CCCCCccchhhhHHHHHHHHHhCCCCCCCCcH-HHHHH--HHH
Q 013081 162 ALPQHFRDDG-----LLHTTCGSPNYVAPEVLAN---RGYDGATSDIWSCGVILYVILTGYLPFDDRNL-AVLYQ--KIF 230 (450)
Q Consensus 162 ~~~~~~~~~~-----~~~~~~gt~~y~APE~l~~---~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-~~~~~--~i~ 230 (450)
++++....+. +.....||.+|++||.+.- .+-.+.++||||.|||+|.++.|+.||...-. ..+.+ -|+
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIl 700 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTIL 700 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchh
Confidence 9876433221 3344579999999998643 34457899999999999999999999986532 23322 233
Q ss_pred hC-CCCCC--CCCCHHHHHHHHHccccCcCCCCCHHHHHhcccccc
Q 013081 231 RG-DFKLP--KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 231 ~~-~~~~p--~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
+. +..+| +.+++++++||++||+..-+.|....++-.||+|..
T Consensus 701 kAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 701 KATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred cceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 32 44555 458999999999999999999999999999999865
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=335.03 Aligned_cols=258 Identities=21% Similarity=0.272 Sum_probs=181.1
Q ss_pred CCcccCCeEEeeeecccCceEEEEEEECCC----CceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEE--
Q 013081 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDS----GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEV-- 82 (450)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~----~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~-- 82 (450)
.....++|++.+.||+|+||.||+|.+..+ +..||+|.+...... +....| .++...+.++..+...
T Consensus 127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~e--~l~~~~~~~~~~~~~~~~ 199 (566)
T PLN03225 127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMNE--RVRRACPNSCADFVYGFL 199 (566)
T ss_pred CCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHHH--HHHhhchhhHHHHHHhhh
Confidence 344678999999999999999999999888 999999987543211 111111 1122222222222111
Q ss_pred ----EEeCCEEEEEEccCCCCChHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHhhhhhcCeeec
Q 013081 83 ----LASKSKIYMVLEYVTGGELFDKIASKGR--------------------LQEAEGRKLFQQLIDGVSYCHNKGVFHR 138 (450)
Q Consensus 83 ----~~~~~~~~lv~E~~~gg~L~~~i~~~~~--------------------l~~~~~~~i~~ql~~aL~~LH~~givHr 138 (450)
.......|+|+||+.+++|.+++..... .....++.++.||+.||.|||++||+||
T Consensus 200 ~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHR 279 (566)
T PLN03225 200 EPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHR 279 (566)
T ss_pred cccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence 2456789999999999999998865321 1234567899999999999999999999
Q ss_pred cCCCCcEEEcc-CCCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCC---------------------CCc
Q 013081 139 DLKLENILLDS-KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY---------------------DGA 196 (450)
Q Consensus 139 DlKp~NILl~~-~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~---------------------~~~ 196 (450)
||||+|||++. ++.+||+|||+|+..... ........++|+.|+|||++..... .+.
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~-~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~ 358 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD 358 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCccccccc-cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCC
Confidence 99999999986 579999999999754321 1223456789999999997643221 124
Q ss_pred cchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCC---------------------CCCCCCHHHHHHHHHccccC
Q 013081 197 TSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK---------------------LPKWLSPGAQNLLRKILEPN 255 (450)
Q Consensus 197 ~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------------~p~~~s~~~~~Li~~~L~~d 255 (450)
++||||+||+||+|+++..|++... ......+...... .....+....+||.+||++|
T Consensus 359 k~DVwSlGviL~el~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 359 RFDIYSAGLIFLQMAFPNLRSDSNL-IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred CcccHHHHHHHHHHHhCcCCCchHH-HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 5699999999999999887765421 1111111111111 01112334568999999999
Q ss_pred cCCCCCHHHHHhccccccCC
Q 013081 256 PVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 256 P~~R~t~~~il~h~~~~~~~ 275 (450)
|.+|||+.++|+||||....
T Consensus 438 P~kR~ta~e~L~Hpff~~~~ 457 (566)
T PLN03225 438 GRQRISAKAALAHPYFDREG 457 (566)
T ss_pred cccCCCHHHHhCCcCcCCCC
Confidence 99999999999999997643
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=291.24 Aligned_cols=240 Identities=45% Similarity=0.786 Sum_probs=208.3
Q ss_pred CceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEccCCCCChHHHH
Q 013081 26 NFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI 105 (450)
Q Consensus 26 ~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i 105 (450)
+||.||+|.+..+|+.+|+|++........ .+.+.+|+..+++++|+||+++++.+......++++||+.+++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 589999999998999999999876543322 578999999999999999999999999999999999999999999999
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccccccCCCCccch
Q 013081 106 ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 185 (450)
Q Consensus 106 ~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP 185 (450)
.....++...+..++.|++.++.|||+.|++|+||+|.||+++.++.++|+|||.+...... .......++..|+||
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~~~~~p 155 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPG---GLLTTFVGTPEYMAP 155 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccc---cccccccCCcCCCCH
Confidence 87666999999999999999999999999999999999999999999999999998854321 134456788999999
Q ss_pred hhhccCCCCCccchhhhHHHHHHHHHhCCCCCCC-CcHHHHHHHHHhCCCCCCCC---CCHHHHHHHHHccccCcCCCCC
Q 013081 186 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGDFKLPKW---LSPGAQNLLRKILEPNPVKRIT 261 (450)
Q Consensus 186 E~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~p~~---~s~~~~~Li~~~L~~dP~~R~t 261 (450)
|.+....+ +.++||||+|+++|++++|..||.. .+...............+.. ++..+.+++.+||..+|++||+
T Consensus 156 E~~~~~~~-~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~ 234 (244)
T smart00220 156 EVLLGKGY-GKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT 234 (244)
T ss_pred HHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccC
Confidence 99876666 4799999999999999999999987 55555555555554443322 8899999999999999999999
Q ss_pred HHHHHhcccc
Q 013081 262 IAGIKADEWF 271 (450)
Q Consensus 262 ~~~il~h~~~ 271 (450)
+.++++||||
T Consensus 235 ~~~~~~~~~~ 244 (244)
T smart00220 235 AEEALQHPFF 244 (244)
T ss_pred HHHHhhCCCC
Confidence 9999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=318.39 Aligned_cols=244 Identities=27% Similarity=0.441 Sum_probs=207.5
Q ss_pred eEEeeeecccCceEEEEEEECC--C--CceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 16 YELGRTLGEGNFGKVKFAQDLD--S--GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 16 y~i~~~LG~G~~g~Vy~a~~~~--~--~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
..+.+.||.|-||.||.|.... . .-.||||..+.+... +..+.|..|..+|+.++||||+++++++.+ ...||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~--d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi 467 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP--DDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI 467 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh--hhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence 3456789999999999998543 2 336899988765433 337889999999999999999999999965 56899
Q ss_pred EEccCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCC
Q 013081 92 VLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~~-~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 170 (450)
|||.++-|+|..+++.+. .++......|..||+.||+|||+.+++||||-..|||+....-+||+|||+++-.+. +
T Consensus 468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed---~ 544 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLED---D 544 (974)
T ss_pred EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccc---c
Confidence 999999999999998654 699999999999999999999999999999999999999999999999999996543 2
Q ss_pred CccccccC--CCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 013081 171 GLLHTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 246 (450)
Q Consensus 171 ~~~~~~~g--t~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 246 (450)
.......| ..-|||||.+.-+.+ +.++|||.|||.+||++. |..||.+-...+....+.+| ++++|+.+++.+..
T Consensus 545 ~yYkaS~~kLPIKWmaPESINfRrF-TtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYs 623 (974)
T KOG4257|consen 545 AYYKASRGKLPIKWMAPESINFRRF-TTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYS 623 (974)
T ss_pred chhhccccccceeecCccccchhcc-cchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHH
Confidence 22333333 346999999877777 578999999999999988 99999987666666666666 68999999999999
Q ss_pred HHHHccccCcCCCCCHHHHH
Q 013081 247 LLRKILEPNPVKRITIAGIK 266 (450)
Q Consensus 247 Li~~~L~~dP~~R~t~~~il 266 (450)
|+.+||+.+|.+||++.+|.
T Consensus 624 lmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 624 LMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred HHHHHhccCcccCCcHHHHH
Confidence 99999999999999988764
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=326.60 Aligned_cols=257 Identities=26% Similarity=0.424 Sum_probs=223.2
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEE-----
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA----- 84 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~----- 84 (450)
..-+.|++.+.||.|.+|.||+++++.+++.+|+|+++.... ..+.++.|.++++.+ .|||++.+++++.
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d----~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED----EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc----ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 345689999999999999999999999999999999876532 246788899999988 5999999999985
Q ss_pred eCCEEEEEEccCCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCC
Q 013081 85 SKSKIYMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA 162 (450)
Q Consensus 85 ~~~~~~lv~E~~~gg~L~~~i~~--~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~ 162 (450)
.++.+|+|||||.||+..|++++ ..++.|+.+..+++.++.|+.+||++.++|||||-.|||++.+|.|||+|||+++
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSa 171 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSA 171 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeee
Confidence 35789999999999999999975 4579999999999999999999999999999999999999999999999999998
Q ss_pred CCCcccCCCccccccCCCCccchhhhccC-----CCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCC--
Q 013081 163 LPQHFRDDGLLHTTCGSPNYVAPEVLANR-----GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-- 235 (450)
Q Consensus 163 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~-----~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-- 235 (450)
..+. ..+...+..|||.|||||++... .| ...+|+||||++..||-.|.+|+-+..+....-+|-+...+
T Consensus 172 Qlds--T~grRnT~iGtP~WMAPEViac~e~~d~ty-d~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkL 248 (953)
T KOG0587|consen 172 QLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATY-DYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL 248 (953)
T ss_pred eeec--ccccccCcCCCcccccceeeecccCCCCCc-ccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccc
Confidence 6544 23456788999999999998643 23 46799999999999999999999999988776666655332
Q ss_pred -CCCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 236 -LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 236 -~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
-|+.++.++.++|..||.+|..+||+..+++.|||....
T Consensus 249 krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 249 KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred cchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence 245588999999999999999999999999999999743
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=286.07 Aligned_cols=251 Identities=25% Similarity=0.461 Sum_probs=205.7
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeC--CE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASK--SK 88 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~--~~ 88 (450)
..++|++.+.+|+|.|++|+.|.+..+++.++||+++.-+ .+.++||+.||+.|+ ||||++++++..+. ..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 3468999999999999999999999999999999986432 478999999999997 99999999998654 45
Q ss_pred EEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCC-CeEEeecCCCCCCCcc
Q 013081 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLSALPQHF 167 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g-~lkl~DFGla~~~~~~ 167 (450)
..+|+||+++.+...+- ..++.-+++.|+.||+.||+|||+.||+|||+||.|+++|... .++|+|+|+|.+...
T Consensus 110 paLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp- 185 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP- 185 (338)
T ss_pred chhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCC-
Confidence 77999999887765543 4588899999999999999999999999999999999999764 699999999987543
Q ss_pred cCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCC-CCcHHHHHHHHH-------------hCC
Q 013081 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD-DRNLAVLYQKIF-------------RGD 233 (450)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~-~~~~~~~~~~i~-------------~~~ 233 (450)
.......+.+..|--||.+..-+.+...-|+|||||+|..|+..+-||- +.+..+...+|. +-.
T Consensus 186 --~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~ 263 (338)
T KOG0668|consen 186 --GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ 263 (338)
T ss_pred --CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence 2334556778899999999887777789999999999999999999983 322222222221 101
Q ss_pred CCC-------------CCC-----------CCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 234 FKL-------------PKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 234 ~~~-------------p~~-----------~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
..+ -+| .++++.+|+.++|..|-.+|+|+.|++.||||...
T Consensus 264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~ 328 (338)
T KOG0668|consen 264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV 328 (338)
T ss_pred cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence 111 111 57999999999999999999999999999999754
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=311.43 Aligned_cols=246 Identities=27% Similarity=0.424 Sum_probs=215.0
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEc
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 94 (450)
+..+..+||-|-||.||.|.++.-.-.||||.++.+.. .++.|.+|..+|+.++|||+|+++++|..+..+|||+|
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM----eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE 343 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE 343 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcch----hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence 34567789999999999999999888999999865432 25789999999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCc
Q 013081 95 YVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (450)
Q Consensus 95 ~~~gg~L~~~i~~~~--~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 172 (450)
||..|+|.+++++.. .++.-...+++.||.+|++||..+++|||||-..|+|+.++..+|++||||++++...... .
T Consensus 344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT-A 422 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT-A 422 (1157)
T ss_pred cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCcee-c
Confidence 999999999998754 4777788899999999999999999999999999999999999999999999976432111 0
Q ss_pred cccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHH
Q 013081 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRK 250 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~ 250 (450)
........-|.|||-+..+.+ +.++|||+|||+|||+.| |-.||.+-+....|....++ ++.-|+.+++.+.+|++.
T Consensus 423 HAGAKFPIKWTAPEsLAyNtF-SiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMra 501 (1157)
T KOG4278|consen 423 HAGAKFPIKWTAPESLAYNTF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMRA 501 (1157)
T ss_pred ccCccCcccccCccccccccc-ccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHHHH
Confidence 111223467999999987777 489999999999999999 99999999998888887776 678899999999999999
Q ss_pred ccccCcCCCCCHHHHH
Q 013081 251 ILEPNPVKRITIAGIK 266 (450)
Q Consensus 251 ~L~~dP~~R~t~~~il 266 (450)
||+++|..||++++|-
T Consensus 502 CW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 502 CWNWSPSDRPSFAEIH 517 (1157)
T ss_pred HhcCCcccCccHHHHH
Confidence 9999999999999873
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=316.61 Aligned_cols=254 Identities=30% Similarity=0.434 Sum_probs=218.9
Q ss_pred CCeEEeeeecccCceEEEEEEECC-CC--ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLD-SG--LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~-~~--~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (450)
++..+.++||+|.||.|+.|.++. +| -.||||.++...... ....|.+|+.+|.+|+|||+++||++..+ ...-
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~m 186 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAM 186 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chhh
Confidence 567788999999999999998875 33 379999997655432 46899999999999999999999999877 6788
Q ss_pred EEEccCCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc
Q 013081 91 MVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 91 lv~E~~~gg~L~~~i~~--~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 168 (450)
+|||++++|+|.+.+.+ ...|.......|+.||+.|+.||.++++|||||-..|||+-....||||||||.+......
T Consensus 187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 99999999999999986 3468888999999999999999999999999999999999999999999999999765433
Q ss_pred CCCccc-cccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHH
Q 013081 169 DDGLLH-TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQ 245 (450)
Q Consensus 169 ~~~~~~-~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 245 (450)
+.-.+. ...-...|+|||.+....+ +.++|||++||++|||++ |..||.+.+...+.+++-.+ .++.|+.++.++.
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kF-ShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY 345 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKF-SHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIY 345 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccc-cccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHH
Confidence 222111 1223457999999998888 589999999999999999 99999999999999888765 6788999999999
Q ss_pred HHHHHccccCcCCCCCHHHHHhcccc
Q 013081 246 NLLRKILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 246 ~Li~~~L~~dP~~R~t~~~il~h~~~ 271 (450)
+++..||..+|.+|||+..|.++-+.
T Consensus 346 ~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 346 QIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred HHHHHhccCCccccccHHHHHHhHHH
Confidence 99999999999999999999765444
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=312.34 Aligned_cols=263 Identities=19% Similarity=0.237 Sum_probs=190.2
Q ss_pred cccCCeEEeeeecccCceEEEEEEEC----------------CCCceEEEEEeecccccch-h----------HHHHHHH
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDL----------------DSGLPFAVKILEKNRIIHL-K----------ITDQIKR 63 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~----------------~~~~~vAvK~i~~~~~~~~-~----------~~~~~~~ 63 (450)
...++|++.++||+|+||.||+|... ..++.||||.+........ + ..+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 45679999999999999999999752 2456799999864321110 0 0122334
Q ss_pred HHHHHHhCCCCCc-----ceEEEEEEe--------CCEEEEEEccCCCCChHHHHHhcC---------------------
Q 013081 64 EIATLKLLKHPNV-----VRLHEVLAS--------KSKIYMVLEYVTGGELFDKIASKG--------------------- 109 (450)
Q Consensus 64 Ei~il~~l~hpnI-----v~l~~~~~~--------~~~~~lv~E~~~gg~L~~~i~~~~--------------------- 109 (450)
|+.++.+++|.++ +++++++.. .+..|+||||+++++|.+++....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 7777777776554 566666542 356899999999999999886421
Q ss_pred ---CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccccccCCCCccchh
Q 013081 110 ---RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186 (450)
Q Consensus 110 ---~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE 186 (450)
.+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||++........ .......+|+.|+|||
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeChh
Confidence 235677889999999999999999999999999999999999999999999974322111 1111234589999999
Q ss_pred hhccCCC--------------------C-CccchhhhHHHHHHHHHhCCC-CCCCCcHH-----------HHHHHHHhCC
Q 013081 187 VLANRGY--------------------D-GATSDIWSCGVILYVILTGYL-PFDDRNLA-----------VLYQKIFRGD 233 (450)
Q Consensus 187 ~l~~~~~--------------------~-~~~~DiwSlGvil~elltG~~-Pf~~~~~~-----------~~~~~i~~~~ 233 (450)
++..... . ..+.||||+||++|+|++|.+ ||.+.... ..+..+....
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~ 460 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK 460 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence 9754321 1 124799999999999999986 77542211 1112222233
Q ss_pred CCCC--CCCCHHHHHHHHHccccCc---CCCCCHHHHHhccccccC
Q 013081 234 FKLP--KWLSPGAQNLLRKILEPNP---VKRITIAGIKADEWFEQD 274 (450)
Q Consensus 234 ~~~p--~~~s~~~~~Li~~~L~~dP---~~R~t~~~il~h~~~~~~ 274 (450)
+.++ ...++.+.+|+.+||..+| .+|+|+.|+|+||||...
T Consensus 461 ~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~~ 506 (507)
T PLN03224 461 YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLPE 506 (507)
T ss_pred CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCCC
Confidence 3343 3478999999999999866 689999999999999653
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=291.64 Aligned_cols=252 Identities=28% Similarity=0.446 Sum_probs=210.9
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC------
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK------ 86 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------ 86 (450)
-.||.-++.+|.|+- .|..|.|..++++||+|.+... ..+....++..+|..++..+.|+||++++.++...
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 468999999999999 8889999999999999988665 33344468899999999999999999999998644
Q ss_pred CEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCc
Q 013081 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (450)
Q Consensus 87 ~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 166 (450)
...|+||||+. .+|...+. -.++-.....++.|++.|+.|||+.||+||||||+||++..++.+||.|||+|+...
T Consensus 94 ~e~y~v~e~m~-~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~- 169 (369)
T KOG0665|consen 94 QEVYLVMELMD-ANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED- 169 (369)
T ss_pred HhHHHHHHhhh-hHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccC-
Confidence 35799999995 58888776 347788999999999999999999999999999999999999999999999998532
Q ss_pred ccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC--------------
Q 013081 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-------------- 232 (450)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-------------- 232 (450)
.+-.....+.|..|.|||++.+.+| .+.+||||+||++.||++|+..|.+.+..+.+.++...
T Consensus 170 --~~~~mtpyVvtRyyrapevil~~~~-ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~ 246 (369)
T KOG0665|consen 170 --TDFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP 246 (369)
T ss_pred --cccccCchhheeeccCchheeccCC-cccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence 2235667789999999999999886 58999999999999999999999887665555444210
Q ss_pred --------C-----CC----CCCC-----------CCHHHHHHHHHccccCcCCCCCHHHHHhcccccc
Q 013081 233 --------D-----FK----LPKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 233 --------~-----~~----~p~~-----------~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
. .. +|.+ -+..+++|+.+||..||++|.|++++|.|||++-
T Consensus 247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~v 315 (369)
T KOG0665|consen 247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKV 315 (369)
T ss_pred HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeee
Confidence 0 11 1211 1346899999999999999999999999999983
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=309.21 Aligned_cols=250 Identities=28% Similarity=0.414 Sum_probs=210.8
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCC------CCcceEEEEEEeCC
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH------PNVVRLHEVLASKS 87 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~h------pnIv~l~~~~~~~~ 87 (450)
++|.+....|+|-|++|..|.+...|+.||||+|+.+. -+.+.=.+|+++|++|+. -|+++++-.|...+
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE----~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn 507 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE----VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN 507 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch----HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence 68999999999999999999999999999999998653 344566789999999973 48999999999999
Q ss_pred EEEEEEccCCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCC-CeEEeecCCCCC
Q 013081 88 KIYMVLEYVTGGELFDKIASKG---RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLSAL 163 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~~---~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g-~lkl~DFGla~~ 163 (450)
++|+|+|-+ ...|.+.+.+.| +|....++.|++||.-||..|-.+||+|.||||+||||++.. .+||||||.|..
T Consensus 508 HLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~ 586 (752)
T KOG0670|consen 508 HLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASF 586 (752)
T ss_pred eeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccccc
Confidence 999999988 579999998754 688999999999999999999999999999999999999875 589999999875
Q ss_pred CCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCC----
Q 013081 164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKW---- 239 (450)
Q Consensus 164 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~---- 239 (450)
.. ......+.-+..|.|||++.+.+|+ ...|+||.||+||||.||+..|.+.+...+........-++|..
T Consensus 587 ~~----eneitPYLVSRFYRaPEIiLG~~yd-~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRK 661 (752)
T KOG0670|consen 587 AS----ENEITPYLVSRFYRAPEIILGLPYD-YPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRK 661 (752)
T ss_pred cc----cccccHHHHHHhccCcceeecCccc-CCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhh
Confidence 32 2334556667789999999999996 88999999999999999999999977666654443211111100
Q ss_pred --------------------------------------------------------CCHHHHHHHHHccccCcCCCCCHH
Q 013081 240 --------------------------------------------------------LSPGAQNLLRKILEPNPVKRITIA 263 (450)
Q Consensus 240 --------------------------------------------------------~s~~~~~Li~~~L~~dP~~R~t~~ 263 (450)
+-..+++|+.+||..||++|.|+.
T Consensus 662 gqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~n 741 (752)
T KOG0670|consen 662 GQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVN 741 (752)
T ss_pred cchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHH
Confidence 013578999999999999999999
Q ss_pred HHHhcccccc
Q 013081 264 GIKADEWFEQ 273 (450)
Q Consensus 264 ~il~h~~~~~ 273 (450)
|+|+||||+.
T Consensus 742 qAL~HpFi~~ 751 (752)
T KOG0670|consen 742 QALKHPFITE 751 (752)
T ss_pred HHhcCCcccC
Confidence 9999999974
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=291.33 Aligned_cols=257 Identities=28% Similarity=0.423 Sum_probs=212.4
Q ss_pred eEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----EEE
Q 013081 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-----KIY 90 (450)
Q Consensus 16 y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~~ 90 (450)
.+--+.||.|+||.||.+.|..+|+.||+|.+.. -..+....+++.+|+.+|...+|.|++..+++..... .+|
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pn-vfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPN-VFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcch-HHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 4556899999999999999999999999998743 2223334578999999999999999999999875443 468
Q ss_pred EEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCC
Q 013081 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (450)
Q Consensus 91 lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 170 (450)
+++|.+. .+|...|..-+.++.+.++-+..||+.||.|||+.||.||||||.|+|++.|..+||||||+|+.-+.. +.
T Consensus 134 V~TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d-~~ 211 (449)
T KOG0664|consen 134 VLTELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR-DR 211 (449)
T ss_pred HHHHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchh-hh
Confidence 8899885 488888888889999999999999999999999999999999999999999999999999999975442 22
Q ss_pred CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHH--------------------
Q 013081 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF-------------------- 230 (450)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~-------------------- 230 (450)
..+...+-|.+|+|||++.+...++.+.||||.|||+.|||-.+..|+..++....+.|.
T Consensus 212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~ 291 (449)
T KOG0664|consen 212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN 291 (449)
T ss_pred hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence 334445678999999999988877899999999999999999999998877665554442
Q ss_pred ---hCCCCCCC-----------CCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCC
Q 013081 231 ---RGDFKLPK-----------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 231 ---~~~~~~p~-----------~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
++....|+ .-..+...++..+|.+||++|++.++.+.|++.....
T Consensus 292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R 350 (449)
T KOG0664|consen 292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR 350 (449)
T ss_pred HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence 22222222 1234778999999999999999999999999987654
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=305.11 Aligned_cols=250 Identities=25% Similarity=0.383 Sum_probs=208.2
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
++..++++||+|-||.|.++.- ..+..||+|.++.....+ ....|.+||++|.+|+||||++++++|..++.+++++
T Consensus 538 s~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~--~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKN--ARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred hheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchh--HHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 4567899999999999999984 447899999998665444 3688999999999999999999999999999999999
Q ss_pred ccCCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCC
Q 013081 94 EYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (450)
Q Consensus 94 E~~~gg~L~~~i~~~~~--l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 171 (450)
||++.|+|.+++..... .......+++.||++|++||.+.+++||||.|.|+|++.++++||+|||+++-.-......
T Consensus 615 EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred HHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCcee
Confidence 99999999999987643 3455667799999999999999999999999999999999999999999998432211112
Q ss_pred ccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh--CCCCCCCCcHHHHHHHHH---hC-----CCCCCCCCC
Q 013081 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT--GYLPFDDRNLAVLYQKIF---RG-----DFKLPKWLS 241 (450)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt--G~~Pf~~~~~~~~~~~i~---~~-----~~~~p~~~s 241 (450)
.-...+-...|||||.+..+++ +.++|+|++|+++||+++ ...||...+.+....+.. .. -+..|.-++
T Consensus 695 vqgr~vlpiRwmawEsillgkF-ttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp 773 (807)
T KOG1094|consen 695 VQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACP 773 (807)
T ss_pred eecceeeeeeehhHHHHHhccc-cchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCc
Confidence 2223345678999999888887 588999999999999765 899998877765554432 21 235577799
Q ss_pred HHHHHHHHHccccCcCCCCCHHHHHh
Q 013081 242 PGAQNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 242 ~~~~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
..+.+|+.+||..+.++|||++++-.
T Consensus 774 ~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 774 QGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred HHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 99999999999999999999999844
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=286.90 Aligned_cols=253 Identities=26% Similarity=0.394 Sum_probs=204.3
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHh-CCCCCcceEEEEEEeCCEEEEEE
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL-LKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
..+-+..||.|+||+|++-.++.+|+..|||.++.... .....++..|.....+ -+.||||++|+....++..|+.|
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM 142 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM 142 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence 33446789999999999999999999999999987654 3335788888875544 46999999999999999999999
Q ss_pred ccCCCCChHHHH-----HhcCCCCHHHHHHHHHHHHHHHhhhhhc-CeeeccCCCCcEEEccCCCeEEeecCCCCCCCcc
Q 013081 94 EYVTGGELFDKI-----ASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (450)
Q Consensus 94 E~~~gg~L~~~i-----~~~~~l~~~~~~~i~~ql~~aL~~LH~~-givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 167 (450)
|+++ .+|..+- ..+..++|...-.+....+.||+||... .|+|||+||+|||++..|.+||||||++....
T Consensus 143 ELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv-- 219 (361)
T KOG1006|consen 143 ELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV-- 219 (361)
T ss_pred HHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHH--
Confidence 9994 3553221 2345799999999999999999999865 89999999999999999999999999986321
Q ss_pred cCCCccccccCCCCccchhhhcc--CCCCCccchhhhHHHHHHHHHhCCCCCCCCcH-HHHHHHHHhCCCCC---CCC--
Q 013081 168 RDDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNL-AVLYQKIFRGDFKL---PKW-- 239 (450)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~~~---p~~-- 239 (450)
+.-....-.|..+|||||.+.. .+|+ -++||||||++|||+.||..|+.+-+. .+...++..+.++. +..
T Consensus 220 -~SiAkT~daGCrpYmAPERi~p~~~gyD-iRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~ 297 (361)
T KOG1006|consen 220 -DSIAKTVDAGCRPYMAPERIDPSDKGYD-IRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECV 297 (361)
T ss_pred -HHHHhhhccCCccccChhccCCccCCcc-hhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCccccc
Confidence 1111223468889999999864 3454 889999999999999999999987543 34555566665543 222
Q ss_pred -CCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 240 -LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 240 -~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
++..+..+|.-||.+|-+.||...+++++||+...
T Consensus 298 ~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 298 HYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred ccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 78999999999999999999999999999998754
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=307.38 Aligned_cols=207 Identities=33% Similarity=0.602 Sum_probs=187.8
Q ss_pred cCCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHH-----HHHHHHHHHHHhCC---CCCcceE
Q 013081 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT-----DQIKREIATLKLLK---HPNVVRL 79 (450)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~-----~~~~~Ei~il~~l~---hpnIv~l 79 (450)
.+-..+..|..++.||.|+||.|++|.++.+...|+||.|.|+++.-.... -.+-.||+||..|+ |+||+++
T Consensus 555 ~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKl 634 (772)
T KOG1152|consen 555 KEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKL 634 (772)
T ss_pred eeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhh
Confidence 344567889999999999999999999999999999999988776432222 24567999999998 9999999
Q ss_pred EEEEEeCCEEEEEEccC-CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeec
Q 013081 80 HEVLASKSKIYMVLEYV-TGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDF 158 (450)
Q Consensus 80 ~~~~~~~~~~~lv~E~~-~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DF 158 (450)
+++|++++.+|++||-. +|-+||++|+....++|.+++.+|+|++.|+++||+.||+|||||-||+.++.+|-+||+||
T Consensus 635 LdfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 635 LDFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred hheeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeec
Confidence 99999999999999976 57799999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCC
Q 013081 159 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD 218 (450)
Q Consensus 159 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~ 218 (450)
|.|.. ...+......||..|.|||++.+.+|-|..-|||++|++||.++....||.
T Consensus 715 gsaa~----~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAY----TKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhh----hcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99884 345678899999999999999999999999999999999999999888875
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=311.97 Aligned_cols=252 Identities=24% Similarity=0.411 Sum_probs=220.9
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCC---ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (450)
.+...|.+.||.|.||+|++|+-+..| ..||||.++... .+.....|..|+.||-+.+||||++|.++......+
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~Pv 705 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPV 705 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCcee
Confidence 345678899999999999999987666 479999996443 344568899999999999999999999999999999
Q ss_pred EEEEccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc
Q 013081 90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 168 (450)
.||+|||++|+|..+++. ++.|+..+...+++-|++|+.||-+.|.+||||...||||+.+-..|++|||+++..+...
T Consensus 706 MIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred EEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 999999999999999875 5789999999999999999999999999999999999999999999999999999765432
Q ss_pred CCCccccccC--CCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHH
Q 013081 169 DDGLLHTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGA 244 (450)
Q Consensus 169 ~~~~~~~~~g--t~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~ 244 (450)
.....+.-| ...|.|||.+..+.+ +.++||||+||+|||.++ |..||-+.+.++..+.|..+ +++.|-.+|..+
T Consensus 786 -~~~ytt~GGKIPiRWTAPEAIa~RKF-TsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL 863 (996)
T KOG0196|consen 786 -EAAYTTLGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAAL 863 (996)
T ss_pred -CccccccCCccceeecChhHhhhccc-CchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHH
Confidence 122222223 257999999998888 488999999999999888 99999999888898888887 778888899999
Q ss_pred HHHHHHccccCcCCCCCHHHHHhc
Q 013081 245 QNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
.+|+..||++|-.+||++.||+.+
T Consensus 864 ~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 864 YQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHHHHHHHHHhhcCCCHHHHHHH
Confidence 999999999999999999999875
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=290.87 Aligned_cols=130 Identities=31% Similarity=0.483 Sum_probs=115.2
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-----C---CCcceEEEEEEe
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-----H---PNVVRLHEVLAS 85 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----h---pnIv~l~~~~~~ 85 (450)
|||.+.++||.|-|++||+|+|..+.+.||+|+.+.. ....+....||.+|++++ | .+||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 7999999999999999999999999999999998643 344677889999999985 2 369999999854
Q ss_pred ----CCEEEEEEccCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhhc-CeeeccCCCCcEEEc
Q 013081 86 ----KSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLD 148 (450)
Q Consensus 86 ----~~~~~lv~E~~~gg~L~~~i~~~--~~l~~~~~~~i~~ql~~aL~~LH~~-givHrDlKp~NILl~ 148 (450)
+.++++|+|++ |..|..+|... ++++...+++|++|++.||.|||.. ||+|-||||+|||+.
T Consensus 154 sGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred cCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 56899999999 88999998763 5799999999999999999999975 999999999999994
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=334.48 Aligned_cols=237 Identities=23% Similarity=0.333 Sum_probs=187.7
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
+.|...+.||+|+||.||+|.+..++..||+|.+..... ...+|++++++++||||+++++++.+....|+||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 346667889999999999999989999999998864321 1234688999999999999999999999999999
Q ss_pred ccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhh---hcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCC
Q 013081 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH---NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (450)
Q Consensus 94 E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 170 (450)
||++||+|.+++.. +++..+..++.|++.||+||| +.+|+||||||+||+++.++..++. ||.+.....
T Consensus 763 Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---- 834 (968)
T PLN00113 763 EYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---- 834 (968)
T ss_pred eCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----
Confidence 99999999999863 889999999999999999999 6699999999999999999888876 666543211
Q ss_pred CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCc-----HHHHHHHHHhC-------CCCC--
Q 013081 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-----LAVLYQKIFRG-------DFKL-- 236 (450)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~-----~~~~~~~i~~~-------~~~~-- 236 (450)
.....||+.|+|||++.+..+ +.++||||+||++|||+||+.||+... ........... +...
T Consensus 835 --~~~~~~t~~y~aPE~~~~~~~-~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 835 --DTKCFISSAYVAPETRETKDI-TEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred --CCCccccccccCcccccCCCC-CcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC
Confidence 123368899999999887766 589999999999999999999996421 11111111100 0001
Q ss_pred ----CCCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 237 ----PKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 237 ----p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
+.....++.+++.+||+.||++|||+.++++.
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 01112356789999999999999999999875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=305.50 Aligned_cols=257 Identities=30% Similarity=0.442 Sum_probs=224.4
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (450)
-.-.+|++++.+|.|+||.||+|+|+.+++..|+|+++.+...+ ..-+.+||-+++.++||||+.+++.+-.....|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd---~~~iqqei~~~~dc~h~nivay~gsylr~dklw 88 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD---FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLW 88 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc---ccccccceeeeecCCCcChHHHHhhhhhhcCcE
Confidence 44578999999999999999999999999999999998765433 567889999999999999999999999999999
Q ss_pred EEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCC
Q 013081 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (450)
Q Consensus 91 lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 170 (450)
+.||||.||+|.+.-.-.+++++.++.+..+.-+.||+|||+.|-+|||||-.|||+++.|.+|++|||.+...... -
T Consensus 89 icMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitat--i 166 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT--I 166 (829)
T ss_pred EEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhh--h
Confidence 99999999999998777889999999999999999999999999999999999999999999999999998743321 1
Q ss_pred CccccccCCCCccchhhhc---cCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCC-----CCCH
Q 013081 171 GLLHTTCGSPNYVAPEVLA---NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK-----WLSP 242 (450)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~---~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~-----~~s~ 242 (450)
.......|||.|||||+-. ..+| ...+|||++|+...|+---++|--+..+........+..+..|. .+++
T Consensus 167 ~KrksfiGtpywmapEvaaverkggy-nqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~ 245 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGY-NQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSE 245 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccc-cccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchH
Confidence 2345678999999999842 3445 58999999999999999999997777777666666666555543 3789
Q ss_pred HHHHHHHHccccCcCCCCCHHHHHhcccccc
Q 013081 243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
.+.+|++.+|.++|++|||++.+|.|||..+
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 9999999999999999999999999999854
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=307.90 Aligned_cols=243 Identities=31% Similarity=0.434 Sum_probs=195.8
Q ss_pred eeeecccCceE-EEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEccC
Q 013081 19 GRTLGEGNFGK-VKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMVLEYV 96 (450)
Q Consensus 19 ~~~LG~G~~g~-Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv~E~~ 96 (450)
-+.+|.|+-|+ ||+|.. .|+.||||.+-. +....+.|||..|+.-+ |||||++|+.=.++...||..|.|
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY--EGREVAVKRLLE------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred HHHcccCCCCcEEEEEee--CCceehHHHHhh------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 46789999986 789987 788999997743 23567889999999994 999999999999999999999999
Q ss_pred CCCChHHHHHhcCC----CCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEcc---CC--CeEEeecCCCCCCCcc
Q 013081 97 TGGELFDKIASKGR----LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS---KG--NIKISDFGLSALPQHF 167 (450)
Q Consensus 97 ~gg~L~~~i~~~~~----l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~---~g--~lkl~DFGla~~~~~~ 167 (450)
. .+|.++++..+. ......+....|+++||++||+.+|+||||||+||||+. ++ +++|+|||+++.....
T Consensus 586 ~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 586 A-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred h-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 5 699999987421 111456889999999999999999999999999999976 44 5899999999865432
Q ss_pred cC-CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhC-CCCCCCCcHHHHHHHHHhCCCCCCCC---CCH
Q 013081 168 RD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG-YLPFDDRNLAVLYQKIFRGDFKLPKW---LSP 242 (450)
Q Consensus 168 ~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG-~~Pf~~~~~~~~~~~i~~~~~~~p~~---~s~ 242 (450)
.. -+...+..||-+|+|||++..... ..++||||+||++|..++| ..||.+.-.. ..+|.++...+..- -+.
T Consensus 665 ~sS~~r~s~~sGt~GW~APE~L~~~~~-~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~~L~~L~~~~d~ 741 (903)
T KOG1027|consen 665 KSSFSRLSGGSGTSGWQAPEQLREDRK-TQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNYTLVHLEPLPDC 741 (903)
T ss_pred cchhhcccCCCCcccccCHHHHhcccc-CcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCccceeeeccCchH
Confidence 21 123456689999999999987655 4689999999999999995 9999865332 23566665443211 122
Q ss_pred HHHHHHHHccccCcCCCCCHHHHHhcccccc
Q 013081 243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
++.+||.+|++++|..||++.++|.||+|=.
T Consensus 742 eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~ 772 (903)
T KOG1027|consen 742 EAKDLISRMLNPDPQLRPSATDVLNHPLFWD 772 (903)
T ss_pred HHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence 8999999999999999999999999999953
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=275.73 Aligned_cols=245 Identities=27% Similarity=0.439 Sum_probs=191.9
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHH--hCCCCCcceEEEEEEe----CC
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK--LLKHPNVVRLHEVLAS----KS 87 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~--~l~hpnIv~l~~~~~~----~~ 87 (450)
.+.++.+.||+|.||+||+|.+ .|+.||||++.... .....||.+|.+ .|+|+||+.+++.-.. -.
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred heeEEEEEecCccccceeeccc--cCCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 5788999999999999999998 78899999995432 355667776665 5599999999976422 24
Q ss_pred EEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhh-----c---CeeeccCCCCcEEEccCCCeEEeecC
Q 013081 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-----K---GVFHRDLKLENILLDSKGNIKISDFG 159 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~-----~---givHrDlKp~NILl~~~g~lkl~DFG 159 (450)
.+|+|++|.+.|+|+|++.+ ..++.+.+.+++.-+++||+|||. + .|.|||||..||||..+|..-|+|+|
T Consensus 283 QLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 68999999999999999987 779999999999999999999994 2 49999999999999999999999999
Q ss_pred CCCCCCcccC--CCccccccCCCCccchhhhccC----CCCC-ccchhhhHHHHHHHHHhC----------CCCCCC---
Q 013081 160 LSALPQHFRD--DGLLHTTCGSPNYVAPEVLANR----GYDG-ATSDIWSCGVILYVILTG----------YLPFDD--- 219 (450)
Q Consensus 160 la~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~----~~~~-~~~DiwSlGvil~elltG----------~~Pf~~--- 219 (450)
||....+..+ +-..+..+||..|||||++... .+.+ ..+||||||.|+||+... ++||.+
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 9986544322 2245667999999999998542 1222 348999999999999863 678854
Q ss_pred --CcHHHHHHHHHhC--CCCCCC-CCCH----HHHHHHHHccccCcCCCCCHHHHHh
Q 013081 220 --RNLAVLYQKIFRG--DFKLPK-WLSP----GAQNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 220 --~~~~~~~~~i~~~--~~~~p~-~~s~----~~~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
++.+++.+-+... .+.+|. |-+. .+..|++.||..||.-|.|+--|.+
T Consensus 442 ~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 442 SDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred CCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 4455555443322 344443 4332 3457899999999999999877754
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=297.50 Aligned_cols=247 Identities=29% Similarity=0.468 Sum_probs=206.9
Q ss_pred EEeeeecccCceEEEEEEEC----C---CCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 013081 17 ELGRTLGEGNFGKVKFAQDL----D---SGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSK 88 (450)
Q Consensus 17 ~i~~~LG~G~~g~Vy~a~~~----~---~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 88 (450)
.+.+.||+|+||.|++|.-. . ....||||.+...... ...+.+..|+.+|+.+ .||||+.+.+.+...+.
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~ 376 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP 376 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence 56679999999999999632 1 1457999998655433 4468899999999999 59999999999999999
Q ss_pred EEEEEccCCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCC
Q 013081 89 IYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN 152 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~~i~~~~----------------~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~ 152 (450)
.++|+||+..|+|.++++..+ .++..+...++.||+.|++||++.+++||||-..|||+..+..
T Consensus 377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~ 456 (609)
T KOG0200|consen 377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKV 456 (609)
T ss_pred eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCE
Confidence 999999999999999998755 3888999999999999999999999999999999999999999
Q ss_pred eEEeecCCCCCCCcccCCCccccccCCC--CccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCc-HHHHHHH
Q 013081 153 IKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRN-LAVLYQK 228 (450)
Q Consensus 153 lkl~DFGla~~~~~~~~~~~~~~~~gt~--~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~-~~~~~~~ 228 (450)
+||+|||+|+........ ......|+. .|||||.+....| +.++||||+||+|||+.+ |..||.+-. ..++++.
T Consensus 457 ~kIaDFGlar~~~~~~~y-~~~~~~~~LP~kWmApEsl~~~~f-t~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~ 534 (609)
T KOG0200|consen 457 IKIADFGLARDHYNKDYY-RTKSSAGTLPVKWMAPESLFDRVF-TSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEF 534 (609)
T ss_pred EEEccccceeccCCCCce-EecCCCCccceeecCHHHhccCcc-cccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHH
Confidence 999999999853221111 111122223 4999999988655 689999999999999999 999998844 5556666
Q ss_pred HHhC-CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHh
Q 013081 229 IFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 229 i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
+..| +...|..+++++.++++.||+.+|.+||++.++.+
T Consensus 535 l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 535 LKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 6666 56889999999999999999999999999999865
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=290.68 Aligned_cols=247 Identities=24% Similarity=0.357 Sum_probs=211.2
Q ss_pred EEeeeecccCceEEEEEEECCCCc----eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013081 17 ELGRTLGEGNFGKVKFAQDLDSGL----PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 17 ~i~~~LG~G~~g~Vy~a~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 92 (450)
...+.||+|+||+||+|.+.-.|+ +||+|++...... +....+.+|+-+|..|+|||++++++++.... +-||
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~--~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP--KASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc--hhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 446789999999999998765444 7899998765433 23578899999999999999999999997665 7789
Q ss_pred EccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCC
Q 013081 93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 171 (450)
++|+++|.|.|+++. +..+-......|..||++|+.|||.++++||||-..|+||..-..+|++|||+|+........-
T Consensus 776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey 855 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY 855 (1177)
T ss_pred HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence 999999999999975 4578899999999999999999999999999999999999999999999999999866533322
Q ss_pred ccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHH
Q 013081 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLR 249 (450)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~ 249 (450)
......-.+.|||=|.+....| +.++||||+||++||++| |..|+++....++-..+..+ +++.|+.++-++..++.
T Consensus 856 ~~~~gK~pikwmale~i~~~~~-thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~mv 934 (1177)
T KOG1025|consen 856 SAPGGKVPIKWMALESIRIRKY-THQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVMV 934 (1177)
T ss_pred cccccccCcHHHHHHHhhccCC-CchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHHH
Confidence 2222233567999999888777 599999999999999999 99999998888877777666 57889999999999999
Q ss_pred HccccCcCCCCCHHHHHh
Q 013081 250 KILEPNPVKRITIAGIKA 267 (450)
Q Consensus 250 ~~L~~dP~~R~t~~~il~ 267 (450)
+||..|+..||++.++-.
T Consensus 935 kCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 935 KCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHhccCcccCccHHHHHH
Confidence 999999999999988643
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=263.08 Aligned_cols=253 Identities=28% Similarity=0.449 Sum_probs=202.5
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEE-EEeCCEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEV-LASKSKI 89 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~-~~~~~~~ 89 (450)
..+.|.+.+.||+|.||++.+|+++.+++.+++|.+.+... ....+.+|..---.| .|.||+.-|++ |++.+.+
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y 97 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY 97 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence 34789999999999999999999999999999999976543 256788888765556 49999999887 5677788
Q ss_pred EEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEcc--CCCeEEeecCCCCCCCcc
Q 013081 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS--KGNIKISDFGLSALPQHF 167 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~--~g~lkl~DFGla~~~~~~ 167 (450)
.+++||++-|+|.+-+.. .++.|...+.++.|+++|++|+|+.+++|||||.+||||-. ..++||||||+.+..+
T Consensus 98 vF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g-- 174 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG-- 174 (378)
T ss_pred EEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccC--
Confidence 899999999999988876 55889999999999999999999999999999999999943 3479999999987432
Q ss_pred cCCCccccccCCCCccchhhhccCC---C-CCccchhhhHHHHHHHHHhCCCCCCCCcH----HHHHHHHHhC-CCCCCC
Q 013081 168 RDDGLLHTTCGSPNYVAPEVLANRG---Y-DGATSDIWSCGVILYVILTGYLPFDDRNL----AVLYQKIFRG-DFKLPK 238 (450)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~---~-~~~~~DiwSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~-~~~~p~ 238 (450)
......--+..|.|||.+.... + ..+.+|+|.||+++|.+|||.+||+.... ...+.++..+ ....|.
T Consensus 175 ---~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~ 251 (378)
T KOG1345|consen 175 ---TTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPK 251 (378)
T ss_pred ---ceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCch
Confidence 2233344567899999864321 1 13568999999999999999999985432 2344455544 345554
Q ss_pred C---CCHHHHHHHHHccccCcCCC---CCHHHHHhccccccC
Q 013081 239 W---LSPGAQNLLRKILEPNPVKR---ITIAGIKADEWFEQD 274 (450)
Q Consensus 239 ~---~s~~~~~Li~~~L~~dP~~R---~t~~~il~h~~~~~~ 274 (450)
. +++.+..+.++-|.++|++| .++..-....|.+..
T Consensus 252 ~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~ 293 (378)
T KOG1345|consen 252 KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKL 293 (378)
T ss_pred hhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhh
Confidence 4 78999999999999999999 566667777887643
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=276.91 Aligned_cols=247 Identities=24% Similarity=0.352 Sum_probs=196.4
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHh--CCCCCcceEEEEEEeCC--
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL--LKHPNVVRLHEVLASKS-- 87 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~~~-- 87 (450)
.+...++.+.||+|.||.||+|.- +++.||||++.... ...+..|-.|.+. ++|+||+++++.-...+
T Consensus 208 ~l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~ 279 (534)
T KOG3653|consen 208 ELDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQE------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD 279 (534)
T ss_pred cCCchhhHHHhhcCccceeehhhc--cCceeEEEecCHHH------HHHHHhHHHHHhccCccchhHHHhhchhccCCcc
Confidence 355678899999999999999986 66999999996542 4556666666654 47999999998754433
Q ss_pred --EEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhh---------cCeeeccCCCCcEEEccCCCeEEe
Q 013081 88 --KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN---------KGVFHRDLKLENILLDSKGNIKIS 156 (450)
Q Consensus 88 --~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~---------~givHrDlKp~NILl~~~g~lkl~ 156 (450)
.+++|+||.+.|+|.+++.. ..+++....+++.-+++||+|||+ -.|+|||||..||||..|++.-|+
T Consensus 280 ~~eywLVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa 358 (534)
T KOG3653|consen 280 RMEYWLVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA 358 (534)
T ss_pred ccceeEEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence 79999999999999999986 568999999999999999999996 259999999999999999999999
Q ss_pred ecCCCCCCCcccCCCccccccCCCCccchhhhccCCCC-----CccchhhhHHHHHHHHHhCC------------CCCC-
Q 013081 157 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD-----GATSDIWSCGVILYVILTGY------------LPFD- 218 (450)
Q Consensus 157 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-----~~~~DiwSlGvil~elltG~------------~Pf~- 218 (450)
|||+|..+......+.....+||..|||||++.+.--- -...||||+|.||||+++.- +||+
T Consensus 359 DFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ 438 (534)
T KOG3653|consen 359 DFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA 438 (534)
T ss_pred ccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence 99999987766566667778999999999998653211 13589999999999999852 3443
Q ss_pred ----CCcHHHHHHHHHhC--CCCCCCC-----CCHHHHHHHHHccccCcCCCCCHHHHHh
Q 013081 219 ----DRNLAVLYQKIFRG--DFKLPKW-----LSPGAQNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 219 ----~~~~~~~~~~i~~~--~~~~p~~-----~s~~~~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
.++.+++.....+. ++.+|+. --..+.+.+..||+.||+-|.|+.=+.+
T Consensus 439 evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~e 498 (534)
T KOG3653|consen 439 EVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEE 498 (534)
T ss_pred HhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHH
Confidence 24455555554433 4555543 2346789999999999999999865443
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=247.81 Aligned_cols=213 Identities=45% Similarity=0.786 Sum_probs=187.1
Q ss_pred ecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEccCCCCCh
Q 013081 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL 101 (450)
Q Consensus 22 LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 101 (450)
||+|++|.||++.+..+++.+++|++....... ....+.+|+..++.++|++|+++++++......++++||+.|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999987654321 346799999999999999999999999999999999999999999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEcc-CCCeEEeecCCCCCCCcccCCCccccccCC
Q 013081 102 FDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-KGNIKISDFGLSALPQHFRDDGLLHTTCGS 179 (450)
Q Consensus 102 ~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~-~g~lkl~DFGla~~~~~~~~~~~~~~~~gt 179 (450)
.+++... ..++...++.++.|++.++.+||+.|++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~ 156 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGT 156 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCC
Confidence 9998875 57899999999999999999999999999999999999999 89999999999875432110 23445688
Q ss_pred CCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccccCcCCC
Q 013081 180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 259 (450)
Q Consensus 180 ~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R 259 (450)
..|++||.+......+.++|+|++|+++++| ..+.+++.+|++.||++|
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~l~~~l~~~p~~R 205 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKR 205 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------HHHHHHHHHHhhCCcccC
Confidence 8999999987653446889999999999999 788999999999999999
Q ss_pred CCHHHHHhcc
Q 013081 260 ITIAGIKADE 269 (450)
Q Consensus 260 ~t~~~il~h~ 269 (450)
|++.++++++
T Consensus 206 ~~~~~l~~~~ 215 (215)
T cd00180 206 PSAKEILEHL 215 (215)
T ss_pred cCHHHHhhCC
Confidence 9999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-32 Score=251.93 Aligned_cols=220 Identities=45% Similarity=0.752 Sum_probs=187.6
Q ss_pred eEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEcc
Q 013081 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY 95 (450)
Q Consensus 16 y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 95 (450)
|.+.+.||.|++|.||+|.+..+++.+|+|.+...... ...+.+.+|+..+++++|+|++++++.+......++++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 67889999999999999999888999999999765432 2467899999999999999999999999999999999999
Q ss_pred CCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccc
Q 013081 96 VTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH 174 (450)
Q Consensus 96 ~~gg~L~~~i~~~~~-l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 174 (450)
+++++|.+.+..... +++..+..++.|++.++.+||++|++|+||+|.||+++.++.++|+|||++....... .....
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~-~~~~~ 157 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL-AALLK 157 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc-ccccc
Confidence 999999999987666 8999999999999999999999999999999999999999999999999988643321 01234
Q ss_pred cccCCCCccchhhh-ccCCCCCccchhhhHHHHHHHHHhCCCCCCC--CcHHHHHHHHHhCCCCCCCC
Q 013081 175 TTCGSPNYVAPEVL-ANRGYDGATSDIWSCGVILYVILTGYLPFDD--RNLAVLYQKIFRGDFKLPKW 239 (450)
Q Consensus 175 ~~~gt~~y~APE~l-~~~~~~~~~~DiwSlGvil~elltG~~Pf~~--~~~~~~~~~i~~~~~~~p~~ 239 (450)
...++..|++||.+ ....+ +.++|+||||+++++|++|+.||.. .+...+.+.+..+.....+|
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~-~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 224 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGY-GEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPLLWEW 224 (225)
T ss_pred ceeccCCcCCHhHhcCCCCC-CchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCcccccc
Confidence 56788899999998 44444 4689999999999999999999987 34447777777776544443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=272.88 Aligned_cols=253 Identities=28% Similarity=0.415 Sum_probs=202.3
Q ss_pred cCCeEEeeeecccCceEEEEEEECC---CCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLD---SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSK 88 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~ 88 (450)
...|.++++||+|+|+.||+|.+.. .++.||+|.+..... ..++..|+++|..+. +.||+++.+.+...+.
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-----p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-----PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-----chHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 4578999999999999999999877 788999998865432 467999999999995 9999999999999999
Q ss_pred EEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccC-CCeEEeecCCCCCCCcc
Q 013081 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGLSALPQHF 167 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~-g~lkl~DFGla~~~~~~ 167 (450)
..+|+||.+..+..++... ++..+++.|++.++.||.++|.+||+||||||.|+|.+.. +.-.|+|||+|...+..
T Consensus 110 v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~ 186 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY 186 (418)
T ss_pred eEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhh
Confidence 9999999999888887654 7789999999999999999999999999999999999854 67899999999721000
Q ss_pred c-------------------------------CCC-----------ccccccCCCCccchhhhccCCCCCccchhhhHHH
Q 013081 168 R-------------------------------DDG-----------LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGV 205 (450)
Q Consensus 168 ~-------------------------------~~~-----------~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGv 205 (450)
. ..+ ......|||+|+|||++...+-.++++||||.||
T Consensus 187 ~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GV 266 (418)
T KOG1167|consen 187 QQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGV 266 (418)
T ss_pred hhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccc
Confidence 0 000 0112359999999999988887789999999999
Q ss_pred HHHHHHhCCCCCCCCcH-----HH---------HHH------H------------------HH--------hCCC-----
Q 013081 206 ILYVILTGYLPFDDRNL-----AV---------LYQ------K------------------IF--------RGDF----- 234 (450)
Q Consensus 206 il~elltG~~Pf~~~~~-----~~---------~~~------~------------------i~--------~~~~----- 234 (450)
|+..++++..||-.... .+ +.+ + .. +...
T Consensus 267 I~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~ 346 (418)
T KOG1167|consen 267 ILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTER 346 (418)
T ss_pred eeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceee
Confidence 99999999999932110 00 000 0 00 0000
Q ss_pred -CCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhcccccc
Q 013081 235 -KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 235 -~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
...+.++..+.+|+.+||+.||.+|+|++++|.||||..
T Consensus 347 ~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 347 EIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred ccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 001125668999999999999999999999999999973
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=244.33 Aligned_cols=210 Identities=24% Similarity=0.439 Sum_probs=172.2
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEE
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
...-+..||+|+||.|-+.++..+|+..|+|.+... . +....+++.+|+.+..+. .+|.+|.+|+.+..+..+|+.|
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~t-v-n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRAT-V-NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhh-c-ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 445577899999999999999999999999998643 2 233457788899877665 6999999999999999999999
Q ss_pred ccCCCCChHH----HHHhcCCCCHHHHHHHHHHHHHHHhhhhhc-CeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc
Q 013081 94 EYVTGGELFD----KIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 94 E~~~gg~L~~----~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~-givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 168 (450)
|.+. .+|.. .+...+.++|...-+++..++.||.|||++ .++|||+||.|||++.+|++|+||||++-..
T Consensus 125 E~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L---- 199 (282)
T KOG0984|consen 125 ELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYL---- 199 (282)
T ss_pred HHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceee----
Confidence 9995 46633 344567899999999999999999999987 8999999999999999999999999998743
Q ss_pred CCCcccc-ccCCCCccchhhhc----cCCCCCccchhhhHHHHHHHHHhCCCCCCC-CcHHHHHHHHHhC
Q 013081 169 DDGLLHT-TCGSPNYVAPEVLA----NRGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRG 232 (450)
Q Consensus 169 ~~~~~~~-~~gt~~y~APE~l~----~~~~~~~~~DiwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~ 232 (450)
.++...+ ..|...|||||.+. ..+| +-++||||||+.++||.+++.||+. .++.+..+++...
T Consensus 200 ~dSiAkt~daGCkpYmaPEri~~e~n~~gY-~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 200 VDSIAKTMDAGCKPYMAPERINPELNQKGY-SVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred hhhhHHHHhcCCCccCChhhcCcccCcccc-eeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 2233333 56888999999874 3455 4899999999999999999999975 3455666666554
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-33 Score=294.71 Aligned_cols=260 Identities=32% Similarity=0.541 Sum_probs=212.4
Q ss_pred CCe-EEeeeecccCceEEEEEEECCCCceEEEEEeec---ccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013081 14 GRY-ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK---NRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (450)
Q Consensus 14 ~~y-~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~---~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (450)
..| ...+.+|.|++|.|+.+......+.++.|.... ...........+..|..+-..++|||++.....+.+....
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~ 396 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI 396 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc
Confidence 456 467899999999999888877777777776542 1122222334477899999999999998877777666666
Q ss_pred EEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC
Q 013081 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 169 (450)
+-+||||++ +|+..+...+.++..++..+++||+.||+|+|+.||.|||+||+|+++..+|.+||+|||.+..+.....
T Consensus 397 ~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 397 LQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 666999999 9999999888999999999999999999999999999999999999999999999999999987654444
Q ss_pred C--CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHH--HHH-------HhCCCCCCC
Q 013081 170 D--GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY--QKI-------FRGDFKLPK 238 (450)
Q Consensus 170 ~--~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~--~~i-------~~~~~~~p~ 238 (450)
. ......+|+.+|+|||++.+..|+....||||+|++++.|.+|+.||......+.. ... ..+...+..
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLS 555 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHH
Confidence 3 45667899999999999999999999999999999999999999999765443221 111 111122223
Q ss_pred CCCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 239 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 239 ~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
.++...+.+|.+||++||.+|.|+++|++++||+..
T Consensus 556 ~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 556 LLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred hchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 478889999999999999999999999999999864
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=295.88 Aligned_cols=201 Identities=16% Similarity=0.205 Sum_probs=147.6
Q ss_pred hCCC-CCcceEEEEE-------EeCCEEEEEEccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccC
Q 013081 70 LLKH-PNVVRLHEVL-------ASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL 140 (450)
Q Consensus 70 ~l~h-pnIv~l~~~~-------~~~~~~~lv~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDl 140 (450)
.++| +||.++++++ .....++.++||+ +++|.+++.. ..++++.+++.+++||+.||+|||++||+||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 3455 5777777776 2334577888987 6699999965 456999999999999999999999999999999
Q ss_pred CCCcEEEccC-------------------CCeEEeecCCCCCCCcccCC--------------CccccccCCCCccchhh
Q 013081 141 KLENILLDSK-------------------GNIKISDFGLSALPQHFRDD--------------GLLHTTCGSPNYVAPEV 187 (450)
Q Consensus 141 Kp~NILl~~~-------------------g~lkl~DFGla~~~~~~~~~--------------~~~~~~~gt~~y~APE~ 187 (450)
||+||||+.. +.+|++|||+++........ ......+||+.|+|||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 9999999654 44566666666532110000 00112468999999999
Q ss_pred hccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCC-CCCCCCHHHHHHHHHccccCcCCCCCHHHHH
Q 013081 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRKILEPNPVKRITIAGIK 266 (450)
Q Consensus 188 l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il 266 (450)
+.+..| +.++|||||||+||||++|.+|+..... ....+.....+ .+....+...+++.+||++||.+|||+.+++
T Consensus 187 ~~~~~~-~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil 263 (793)
T PLN00181 187 DNGSSS-NCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELL 263 (793)
T ss_pred hccCCC-CchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHh
Confidence 888777 6899999999999999999999764321 11122111111 1111245678999999999999999999999
Q ss_pred hccccccC
Q 013081 267 ADEWFEQD 274 (450)
Q Consensus 267 ~h~~~~~~ 274 (450)
+||||...
T Consensus 264 ~h~~~~~~ 271 (793)
T PLN00181 264 QSEFINEP 271 (793)
T ss_pred hchhhhhh
Confidence 99999753
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=242.05 Aligned_cols=251 Identities=20% Similarity=0.245 Sum_probs=208.2
Q ss_pred CCeEEeeeecccCceEEEEEEECC-----CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE-eCC
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA-SKS 87 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~~ 87 (450)
.|+++...+-+|+||.||.|.+.. +.+.|-+|.++.+. .+-....+..|...+..+.|||+..+.++.. +..
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~ 361 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA 361 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC
Confidence 467888899999999999997553 34567777764332 2334678889999999999999999999874 456
Q ss_pred EEEEEEccCCCCChHHHHHhc--------CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecC
Q 013081 88 KIYMVLEYVTGGELFDKIASK--------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFG 159 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~--------~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFG 159 (450)
..+.++.+..-|+|..++... +.++..+...++.|++.|++|||++||+|.||-..|.+||+.-++||+|=.
T Consensus 362 ~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsa 441 (563)
T KOG1024|consen 362 TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSA 441 (563)
T ss_pred cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccch
Confidence 778888999889999888621 236777888999999999999999999999999999999999999999999
Q ss_pred CCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCC
Q 013081 160 LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLP 237 (450)
Q Consensus 160 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p 237 (450)
+++..-................||+||.+.+..|. .++|+|||||+||||+| |+.|+..-++.++...+.+| +..-|
T Consensus 442 LSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~ys-sasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP 520 (563)
T KOG1024|consen 442 LSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYS-SASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQP 520 (563)
T ss_pred hccccCcccccccCCCCCCcccccCHHHHhhhhhc-chhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecCC
Confidence 99854322222222233345689999999988885 88999999999999999 99999999999999888887 67778
Q ss_pred CCCCHHHHHHHHHccccCcCCCCCHHHHHh
Q 013081 238 KWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 238 ~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
-.+|+++..++.-||..+|++||+.+|+..
T Consensus 521 ~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 521 FNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred CCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 889999999999999999999999999754
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-27 Score=232.30 Aligned_cols=256 Identities=38% Similarity=0.623 Sum_probs=213.3
Q ss_pred eEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCC-CcceEEEEEEeCCEEEEEEc
Q 013081 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP-NVVRLHEVLASKSKIYMVLE 94 (450)
Q Consensus 16 y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~lv~E 94 (450)
|.+.+.||.|+||.||.+.+. ..+|+|.+.............+.+|+.+++.+.|+ +|+++.+.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 889999999999999999986 78999999876655444578899999999999988 79999999988888899999
Q ss_pred cCCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCC-CeEEeecCCCCCCCcccCC
Q 013081 95 YVTGGELFDKIASKG---RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLSALPQHFRDD 170 (450)
Q Consensus 95 ~~~gg~L~~~i~~~~---~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g-~lkl~DFGla~~~~~~~~~ 170 (450)
|+.++++.+.+.... .+++..+..++.|++.++.|+|+.|++|||+||+||+++..+ .++++|||.+.........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999998777664 799999999999999999999999999999999999999998 6999999999754332211
Q ss_pred C----ccccccCCCCccchhhhccC--CCCCccchhhhHHHHHHHHHhCCCCCCCCcH----HHHHHHHHhCCCC-CCCC
Q 013081 171 G----LLHTTCGSPNYVAPEVLANR--GYDGATSDIWSCGVILYVILTGYLPFDDRNL----AVLYQKIFRGDFK-LPKW 239 (450)
Q Consensus 171 ~----~~~~~~gt~~y~APE~l~~~--~~~~~~~DiwSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~-~p~~ 239 (450)
. .....+||+.|+|||.+... .+.....|+||+|++++++++|..||..... ......+.....+ ....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 1 34677999999999998874 4556889999999999999999999987763 4444444444433 2222
Q ss_pred CC--------HHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 240 LS--------PGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 240 ~s--------~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
.. ..+.+++.+++..+|..|.+..+...++|....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 21 478999999999999999999999888766544
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=226.24 Aligned_cols=159 Identities=23% Similarity=0.275 Sum_probs=129.4
Q ss_pred CChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCcccccc
Q 013081 99 GELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC 177 (450)
Q Consensus 99 g~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~ 177 (450)
|+|.+++.. ..++++.+++.++.|++.||.|||+++ ||+|||++.++.+|+ ||++..... ....
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~-------~~~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTP-------EQSR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecc-------ccCC
Confidence 689999986 456999999999999999999999999 999999999999999 999875432 1236
Q ss_pred CCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHH-HHHHHHHhCCCCC-------CCCCCH--HHHHH
Q 013081 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKIFRGDFKL-------PKWLSP--GAQNL 247 (450)
Q Consensus 178 gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~-------p~~~s~--~~~~L 247 (450)
||+.|+|||++.+..+ +.++||||+||++|+|++|..||...... .....+....... +..++. .+.++
T Consensus 66 g~~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (176)
T smart00750 66 VDPYFMAPEVIQGQSY-TEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADF 144 (176)
T ss_pred CcccccChHHhcCCCC-cchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHH
Confidence 8999999999988777 58999999999999999999999765432 3333333322111 122343 69999
Q ss_pred HHHccccCcCCCCCHHHHHhcccccc
Q 013081 248 LRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 248 i~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
+.+||+.||.+|||+.++++|+|+..
T Consensus 145 i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 145 MRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHHhcccccccCHHHHHHHHHHHH
Confidence 99999999999999999999999753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-28 Score=241.62 Aligned_cols=173 Identities=21% Similarity=0.170 Sum_probs=136.0
Q ss_pred ccCCcccCCeEEeeeecccCceEEEEEEECC-CCceEEEEEeecccc--cchhHHHHHHHHHHHHHhCCCCCcce-EEEE
Q 013081 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLD-SGLPFAVKILEKNRI--IHLKITDQIKREIATLKLLKHPNVVR-LHEV 82 (450)
Q Consensus 7 ~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~-~~~~vAvK~i~~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~-l~~~ 82 (450)
.+.....++|++.+.||+|+||+||+|.+.. +++.||||.+..... ........+.+|+++|++++|+|++. +++.
T Consensus 11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~ 90 (365)
T PRK09188 11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT 90 (365)
T ss_pred cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc
Confidence 3445667899999999999999999999876 678889998753311 12234567999999999999999985 5442
Q ss_pred EEeCCEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccC-CCCcEEEccCCCeEEeecCCC
Q 013081 83 LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL-KLENILLDSKGNIKISDFGLS 161 (450)
Q Consensus 83 ~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDl-Kp~NILl~~~g~lkl~DFGla 161 (450)
+..|+||||++|++|.. +.. .. ...++.|+++||.|||++||+|||| ||+|||++.++++||+|||+|
T Consensus 91 ----~~~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 91 ----GKDGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred ----CCcEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 45899999999999963 211 11 2578899999999999999999999 999999999999999999999
Q ss_pred CCCCcccCCCc------cccccCCCCccchhhhcc
Q 013081 162 ALPQHFRDDGL------LHTTCGSPNYVAPEVLAN 190 (450)
Q Consensus 162 ~~~~~~~~~~~------~~~~~gt~~y~APE~l~~ 190 (450)
+.......... ..+.++++.|+|||.+..
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 86543221111 245678999999998754
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-29 Score=255.08 Aligned_cols=239 Identities=33% Similarity=0.630 Sum_probs=209.8
Q ss_pred eecccCceEEEEEEE---CCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEccC
Q 013081 21 TLGEGNFGKVKFAQD---LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMVLEYV 96 (450)
Q Consensus 21 ~LG~G~~g~Vy~a~~---~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv~E~~ 96 (450)
.+|+|+||.|++++. ...|..+|+|+..+......... ....|-.++..++ ||.+++++..+.+++..|++++|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 479999999998753 34688899999887655433322 5667888888887 999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccccc
Q 013081 97 TGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT 176 (450)
Q Consensus 97 ~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~ 176 (450)
.||+|+..+.....+.+...+.+...++-|++++|+.||+|||+|++||+++.+|++++.|||+++..-. ....
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~------~~~~ 153 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVK------EKIA 153 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHh------hhhc
Confidence 9999999998888899999999999999999999999999999999999999999999999999985322 1122
Q ss_pred cCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccccCc
Q 013081 177 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNP 256 (450)
Q Consensus 177 ~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP 256 (450)
|||..|||||++. +. ...+|.||+|+++|+|+||..||.. +....|.+..+.+|..++..+++++..++..+|
T Consensus 154 cgt~eymApEI~~--gh-~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p 226 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN--GH-LSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQLFKRNP 226 (612)
T ss_pred ccchhhhhhHhhh--cc-CCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCH
Confidence 9999999999987 44 3679999999999999999999988 677888888999999999999999999999999
Q ss_pred CCCCC-----HHHHHhcccccc
Q 013081 257 VKRIT-----IAGIKADEWFEQ 273 (450)
Q Consensus 257 ~~R~t-----~~~il~h~~~~~ 273 (450)
.+|.- ..++++|++|+.
T Consensus 227 ~nrLg~~~~~~~eik~h~f~~~ 248 (612)
T KOG0603|consen 227 ENRLGAGPDGVDEIKQHEFFQS 248 (612)
T ss_pred HHHhccCcchhHHHhccchhee
Confidence 99975 578999999974
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.5e-26 Score=225.13 Aligned_cols=249 Identities=23% Similarity=0.288 Sum_probs=195.0
Q ss_pred CeEEeeeecccCceEEEEEEECCCC-ceEEEEEeecccccchhHHHHHHHHHHHHHhCCC----CCcceEEEEE-EeCCE
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSG-LPFAVKILEKNRIIHLKITDQIKREIATLKLLKH----PNVVRLHEVL-ASKSK 88 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~-~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~h----pnIv~l~~~~-~~~~~ 88 (450)
+|.+.+.||+|+||.||.+.+..++ ..+|+|+......... ..+..|+.++..+.. +++..+++.+ .....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999987764 6899998765432221 267889999998873 6999999999 58889
Q ss_pred EEEEEccCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccC-----CCeEEeecCCC
Q 013081 89 IYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-----GNIKISDFGLS 161 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~~i~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~-----g~lkl~DFGla 161 (450)
.|+||+.+ |.+|.++.... +.++...+.+++.|++.+|+++|+.|++||||||+|+++... ..+.|.|||+|
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999998 89999987543 579999999999999999999999999999999999999865 35999999999
Q ss_pred CCCCcccCC-------Cc-cccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHH---HHH
Q 013081 162 ALPQHFRDD-------GL-LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQ---KIF 230 (450)
Q Consensus 162 ~~~~~~~~~-------~~-~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~---~i~ 230 (450)
+........ .. .....||..|+++....+... +.+.|+||++.++.+++.|.+||.+........ +..
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~-~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQ-GRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCcc-CCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 832211111 11 223459999999999877766 699999999999999999999997755322222 222
Q ss_pred hCC-CC-CCCCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 231 RGD-FK-LPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 231 ~~~-~~-~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
... .. .....+..+..+...+-..+...+|....+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 254 RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 221 11 223355677777777777899999998877654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-25 Score=201.21 Aligned_cols=250 Identities=21% Similarity=0.299 Sum_probs=197.1
Q ss_pred cccCCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCC-CCcceEEEEEE
Q 013081 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH-PNVVRLHEVLA 84 (450)
Q Consensus 6 ~~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~ 84 (450)
+.++-...|+|.+++.||.|+||.+|+|....+|+.||||+=... ..+ .++..|..+.+.|++ .+|..+..++.
T Consensus 7 s~~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~ 81 (341)
T KOG1163|consen 7 SLEELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK-AKH----PQLLYESKVYRILQGGVGIPHIRHYGT 81 (341)
T ss_pred chhhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc-CCC----cchhHHHHHHHHhccCCCCchhhhhcc
Confidence 344556779999999999999999999999999999999986432 222 467789999999974 78888888888
Q ss_pred eCCEEEEEEccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccC---CCeEEeecCC
Q 013081 85 SKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK---GNIKISDFGL 160 (450)
Q Consensus 85 ~~~~~~lv~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~---g~lkl~DFGl 160 (450)
+.....+||+.. |.+|.+++.- ...++...+.-++-|++.-++|+|.++++||||||+|.|..-+ ..+.++|||+
T Consensus 82 e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGL 160 (341)
T KOG1163|consen 82 EKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGL 160 (341)
T ss_pred ccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccc
Confidence 999999999998 8899888763 3569999999999999999999999999999999999999644 4689999999
Q ss_pred CCCCCcccCCC-----ccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcH---HHHHHHHHhC
Q 013081 161 SALPQHFRDDG-----LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL---AVLYQKIFRG 232 (450)
Q Consensus 161 a~~~~~~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~---~~~~~~i~~~ 232 (450)
|+.+....... .-....||..|.+--...+... +..-|+=|+|.+|..+..|.+||++-.. ..-+.+|...
T Consensus 161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eq-SRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~Ek 239 (341)
T KOG1163|consen 161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQ-SRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEK 239 (341)
T ss_pred hhhhccccccccCccccCCccceeeeehhhhhhhhhhh-hhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHh
Confidence 98654322211 1233468999988666554443 4678999999999999999999998544 3455666665
Q ss_pred CCCCC-----CCCCHHHHHHHHHccccCcCCCCCH
Q 013081 233 DFKLP-----KWLSPGAQNLLRKILEPNPVKRITI 262 (450)
Q Consensus 233 ~~~~p-----~~~s~~~~~Li~~~L~~dP~~R~t~ 262 (450)
....| ..+|.++...+.-|-..--++-|..
T Consensus 240 K~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy 274 (341)
T KOG1163|consen 240 KMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDY 274 (341)
T ss_pred hcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcH
Confidence 55554 3478888888877766555555653
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.2e-26 Score=241.04 Aligned_cols=219 Identities=33% Similarity=0.610 Sum_probs=176.9
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
.+|+.+++|..|+||.||+++|+.+.+.+|+|+ +++.. +.|- ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l--------ilRn--ilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL--------ILRN--ILTFAGNPFVV---------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcc-cccch--------hhhc--cccccCCccee----------------
Confidence 579999999999999999999999999999954 44322 1111 33333444444
Q ss_pred ccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc-----
Q 013081 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR----- 168 (450)
Q Consensus 94 E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~----- 168 (450)
|+-...+..-++++... +.+++|||+.||+|||+||+|+||+.-|++|++|||++..--...
T Consensus 136 -----gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~ 202 (1205)
T KOG0606|consen 136 -----GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK 202 (1205)
T ss_pred -----chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence 45556666666776655 778999999999999999999999999999999999987421100
Q ss_pred --------CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCC-
Q 013081 169 --------DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKW- 239 (450)
Q Consensus 169 --------~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~- 239 (450)
..-.....||||.|.|||++...+| |..+|+|++|+|+|+.+.|..||.+.+.++++.+........|+.
T Consensus 203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgy-gkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~d 281 (1205)
T KOG0606|consen 203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEED 281 (1205)
T ss_pred hcchHHHHHHhhhccccCCccccChhhhhhhcc-CCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccC
Confidence 0001223599999999999998888 689999999999999999999999999999999998887777754
Q ss_pred --CCHHHHHHHHHccccCcCCCC---CHHHHHhcccccc
Q 013081 240 --LSPGAQNLLRKILEPNPVKRI---TIAGIKADEWFEQ 273 (450)
Q Consensus 240 --~s~~~~~Li~~~L~~dP~~R~---t~~~il~h~~~~~ 273 (450)
.+++++++|.++|+.+|..|. .+-++.+|+||+.
T Consensus 282 ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~ 320 (1205)
T KOG0606|consen 282 EALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQL 320 (1205)
T ss_pred cCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceee
Confidence 789999999999999999996 5778999999964
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-26 Score=244.87 Aligned_cols=260 Identities=33% Similarity=0.540 Sum_probs=220.9
Q ss_pred cCCeEEeeeecccCceEEEEEEECC-CCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLD-SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIY 90 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 90 (450)
...|.+.+.||+|+|+.|-++.+.. +...+|.|.+.... .......++..|..+-+.+. |+|++.+++........+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 6789999999999999999888754 45567777765443 23344577888999999997 999999999999999999
Q ss_pred EEEccCCCCChHHHH-HhcC-CCCHHHHHHHHHHHHHHHhhhh-hcCeeeccCCCCcEEEccCC-CeEEeecCCCCCCCc
Q 013081 91 MVLEYVTGGELFDKI-ASKG-RLQEAEGRKLFQQLIDGVSYCH-NKGVFHRDLKLENILLDSKG-NIKISDFGLSALPQH 166 (450)
Q Consensus 91 lv~E~~~gg~L~~~i-~~~~-~l~~~~~~~i~~ql~~aL~~LH-~~givHrDlKp~NILl~~~g-~lkl~DFGla~~~~~ 166 (450)
++++|..|+++++.+ .... ..+...+..++.|+..++.|+| ..++.||||||+|.+++..+ ++|++|||+|+....
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999999999 6665 7889999999999999999999 99999999999999999999 999999999997765
Q ss_pred -ccCCCccccccC-CCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHH-HHHHHhC--C--CCCCCC
Q 013081 167 -FRDDGLLHTTCG-SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVL-YQKIFRG--D--FKLPKW 239 (450)
Q Consensus 167 -~~~~~~~~~~~g-t~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~-~~~i~~~--~--~~~p~~ 239 (450)
..........|| ++.|+|||...+..|.++..|+||+|+++..+++|..||+....... +..+... . ......
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS 257 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence 444556777899 99999999998888889999999999999999999999987654332 1122211 1 223344
Q ss_pred CCHHHHHHHHHccccCcCCCCCHHHHHhcccccc
Q 013081 240 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 240 ~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
++..+.+++.++|..+|..|.+.+++..++|+..
T Consensus 258 ~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 258 ISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred CChhhhhcccccccCCchhccccccccccccccc
Confidence 8899999999999999999999999999999987
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.9e-25 Score=202.80 Aligned_cols=141 Identities=21% Similarity=0.281 Sum_probs=113.7
Q ss_pred eeeecccCceEEEEEEECCCCceEEEEEeecccccchh-----------------------HHHHHHHHHHHHHhCCCCC
Q 013081 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-----------------------ITDQIKREIATLKLLKHPN 75 (450)
Q Consensus 19 ~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~-----------------------~~~~~~~Ei~il~~l~hpn 75 (450)
.+.||+|+||.||+|.+. +|+.||||+++........ ......+|++++.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999986 8999999999765321111 0123456999999998888
Q ss_pred cceEEEEEEeCCEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhh-hhcCeeeccCCCCcEEEccCCCeE
Q 013081 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC-HNKGVFHRDLKLENILLDSKGNIK 154 (450)
Q Consensus 76 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~L-H~~givHrDlKp~NILl~~~g~lk 154 (450)
+.....+... ..|+||||++|+++.......+++++..+..++.|++.+|.++ |+.||+||||||+|||++ ++.++
T Consensus 81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 7544433222 2389999999988776655567899999999999999999999 799999999999999998 57899
Q ss_pred EeecCCCCC
Q 013081 155 ISDFGLSAL 163 (450)
Q Consensus 155 l~DFGla~~ 163 (450)
|+|||+|..
T Consensus 158 LiDFG~a~~ 166 (190)
T cd05147 158 IIDVSQSVE 166 (190)
T ss_pred EEEcccccc
Confidence 999999974
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.2e-25 Score=204.09 Aligned_cols=173 Identities=14% Similarity=0.200 Sum_probs=136.3
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHH------HHHHHHHHHhCCCCCcceEEEEEEeC
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ------IKREIATLKLLKHPNVVRLHEVLASK 86 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~------~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (450)
-++|++.+.||.|+||.||++.+ ++..+|+|+++......+..... +.+|+..+.++.||+|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 47999999999999999999765 46689999997665545444444 68999999999999999999886533
Q ss_pred --------CEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeec
Q 013081 87 --------SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDF 158 (450)
Q Consensus 87 --------~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DF 158 (450)
+..+++|||++|.+|.+... +++ ....|++.+|..||+.|++|||+||.||+++++| ++|+||
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 35899999999999987632 333 2456999999999999999999999999999999 999999
Q ss_pred CCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHH
Q 013081 159 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 211 (450)
Q Consensus 159 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ell 211 (450)
|.+........ ..-++....|. .++|+||||+++..+.
T Consensus 179 g~~~~~~e~~a--------------~d~~vler~y~-~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 179 SGKRCTAQRKA--------------KDRIDLERHYG-IKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCcccccchhh--------------HHHHHHHhHhc-ccccccceeEeehHHH
Confidence 98764321100 01134455565 7899999999877654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.7e-24 Score=195.77 Aligned_cols=143 Identities=22% Similarity=0.268 Sum_probs=116.1
Q ss_pred EeeeecccCceEEEEEEECCCCceEEEEEeecccccch-----------------------hHHHHHHHHHHHHHhCCCC
Q 013081 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL-----------------------KITDQIKREIATLKLLKHP 74 (450)
Q Consensus 18 i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~-----------------------~~~~~~~~Ei~il~~l~hp 74 (450)
+.+.||+|+||.||+|.+. +|+.||||+++....... .....+.+|.+.+.++.|+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999987 899999999986532100 0123456899999999999
Q ss_pred CcceEEEEEEeCCEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhh-cCeeeccCCCCcEEEccCCCe
Q 013081 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNI 153 (450)
Q Consensus 75 nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~-~givHrDlKp~NILl~~~g~l 153 (450)
++.....+.... .|+||||++|+++........++++.++..++.|++.++.++|+ +||+||||||+|||++ ++.+
T Consensus 80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~ 156 (190)
T cd05145 80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP 156 (190)
T ss_pred CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence 986555444332 48999999988665543345678999999999999999999999 9999999999999998 8999
Q ss_pred EEeecCCCCCC
Q 013081 154 KISDFGLSALP 164 (450)
Q Consensus 154 kl~DFGla~~~ 164 (450)
+|+|||+|...
T Consensus 157 ~liDFG~a~~~ 167 (190)
T cd05145 157 YIIDVSQAVEL 167 (190)
T ss_pred EEEEcccceec
Confidence 99999999854
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=198.45 Aligned_cols=212 Identities=24% Similarity=0.365 Sum_probs=176.2
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv 92 (450)
-.|.++++||+|+||..+.|.+.-++++||||.=.... ...+++.|.+..+.|. .++|...|-+..++....+|
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV 102 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV 102 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence 38999999999999999999999999999999754321 1467889999999995 79999999999999899999
Q ss_pred EccCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCC-----CeEEeecCCCCCCCc
Q 013081 93 LEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-----NIKISDFGLSALPQH 166 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g-----~lkl~DFGla~~~~~ 166 (450)
+|++ |.+|.|++.=+ ..|+...+..++.|++.-++|+|++.+|+|||||+|.||..-+ .+.++|||+|+....
T Consensus 103 idLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 103 IDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred hhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 9999 88998888754 4699999999999999999999999999999999999997543 489999999986432
Q ss_pred ccC-----CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCC---cHHHHHHHHHhC
Q 013081 167 FRD-----DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR---NLAVLYQKIFRG 232 (450)
Q Consensus 167 ~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~---~~~~~~~~i~~~ 232 (450)
... .+......||..||+--...++.. +..-|+=|||-+++..|-|.+||++. +...-|++|-..
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQ-SRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~ 254 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGET 254 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchh-hhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccc
Confidence 111 112234579999999877777665 47889999999999999999999874 455566666443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.2e-24 Score=203.92 Aligned_cols=234 Identities=26% Similarity=0.355 Sum_probs=153.5
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCC----------CCcceEEEEEE
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH----------PNVVRLHEVLA 84 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~h----------pnIv~l~~~~~ 84 (450)
.+..++.||.|+++.||.++|..||+.+|+|++...........+++++|.-....+.+ -.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 45778999999999999999999999999999876554444456788888766655432 12333333321
Q ss_pred ---------eC---CE-----EEEEEccCCCCChHHHHH---hcCCC---CHHHH-HHHHHHHHHHHhhhhhcCeeeccC
Q 013081 85 ---------SK---SK-----IYMVLEYVTGGELFDKIA---SKGRL---QEAEG-RKLFQQLIDGVSYCHNKGVFHRDL 140 (450)
Q Consensus 85 ---------~~---~~-----~~lv~E~~~gg~L~~~i~---~~~~l---~~~~~-~~i~~ql~~aL~~LH~~givHrDl 140 (450)
.. .. .+++|+-+ -++|.+.+. ..... ....| ..+..|++..+++||+.|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 11 12 35677777 458877653 22222 11223 444589999999999999999999
Q ss_pred CCCcEEEccCCCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCC-------CCCccchhhhHHHHHHHHHhC
Q 013081 141 KLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG-------YDGATSDIWSCGVILYVILTG 213 (450)
Q Consensus 141 Kp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-------~~~~~~DiwSlGvil~elltG 213 (450)
+|+|++++.+|.++|+||+...... ........+..|.+||...... ..+.+.|.|+||+++|.|+||
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g-----~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAG-----TRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETT-----EEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecC-----ceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 9999999999999999998776322 1122244567899999864421 225788999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHccccCcCCC
Q 013081 214 YLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKR 259 (450)
Q Consensus 214 ~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~~L~~dP~~R 259 (450)
..||+.......... .+ .+. .+|..++.||+++|++||.+|
T Consensus 247 ~lPf~~~~~~~~~~~----~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEW----DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGG----GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccccc----cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999987654322111 11 223 678999999999999999988
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=202.83 Aligned_cols=253 Identities=26% Similarity=0.453 Sum_probs=177.4
Q ss_pred cCCcccCCeEEeeeecccCceEEEEEEECCCCc-----------------------------------eEEEEEeecccc
Q 013081 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGL-----------------------------------PFAVKILEKNRI 52 (450)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~-----------------------------------~vAvK~i~~~~~ 52 (450)
..+.++++|++++.||+|.-+.||.|.-...|. +.|||.+-.-..
T Consensus 151 dskFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~ 230 (598)
T KOG4158|consen 151 DSKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEH 230 (598)
T ss_pred hcccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhccccc
Confidence 345677899999999999999999987443211 256665432111
Q ss_pred c--chhHHHHHHHHHH------HH--------H--------hCCCCCcceEEEEEEe-----------------------
Q 013081 53 I--HLKITDQIKREIA------TL--------K--------LLKHPNVVRLHEVLAS----------------------- 85 (450)
Q Consensus 53 ~--~~~~~~~~~~Ei~------il--------~--------~l~hpnIv~l~~~~~~----------------------- 85 (450)
. +....+.+-+|.- .+ + .-+|||||++...|.+
T Consensus 231 ~s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~ 310 (598)
T KOG4158|consen 231 DSGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPS 310 (598)
T ss_pred CCchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceeccc
Confidence 1 1222233333321 00 1 1259999999876522
Q ss_pred ----CCEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEc--cCC--CeEEee
Q 013081 86 ----KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD--SKG--NIKISD 157 (450)
Q Consensus 86 ----~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~--~~g--~lkl~D 157 (450)
....|+||...+ .+|..++-.+ ..+....+-++.|+++|+.|||++||.|||+|.+|||+. +|+ .+.|+|
T Consensus 311 g~g~~~tlylvMkrY~-~tLr~yl~~~-~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaD 388 (598)
T KOG4158|consen 311 GAGEPKTLYLVMKRYR-QTLREYLWTR-HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVAD 388 (598)
T ss_pred ccCCCceEEEehhcch-hhHHHHHhcC-CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcc
Confidence 345899998774 5899988763 467888899999999999999999999999999999994 343 489999
Q ss_pred cCCCCCCCcc--c--CCCccccccCCCCccchhhhccCC-----CCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHH
Q 013081 158 FGLSALPQHF--R--DDGLLHTTCGSPNYVAPEVLANRG-----YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQK 228 (450)
Q Consensus 158 FGla~~~~~~--~--~~~~~~~~~gt~~y~APE~l~~~~-----~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~ 228 (450)
||.+-.-+.. . -.+..-..-|.-.-||||+....+ .+-.++|.|++|.+.||++....||.+.....+-..
T Consensus 389 FGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r 468 (598)
T KOG4158|consen 389 FGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTR 468 (598)
T ss_pred cceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechh
Confidence 9987532210 0 001111235777899999975432 123589999999999999999999987544322222
Q ss_pred HHh--CCCCCCCCCCHHHHHHHHHccccCcCCCCCH
Q 013081 229 IFR--GDFKLPKWLSPGAQNLLRKILEPNPVKRITI 262 (450)
Q Consensus 229 i~~--~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~ 262 (450)
-++ ..+.+|+.+++.+++|+..+|++||++|++.
T Consensus 469 ~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp 504 (598)
T KOG4158|consen 469 TYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSP 504 (598)
T ss_pred hhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCc
Confidence 122 2456788899999999999999999999984
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.3e-25 Score=232.26 Aligned_cols=246 Identities=28% Similarity=0.408 Sum_probs=188.1
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeeccc-ccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNR-IIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 92 (450)
+.|...+.||.+.|=+|.+|++. .|. |+||++-+.. .....-..+..+|++ ...++|||.+.+..+...+...|+|
T Consensus 23 ~e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylv 99 (1431)
T KOG1240|consen 23 VECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLV 99 (1431)
T ss_pred cceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHH
Confidence 37889999999999999999974 344 9999987654 222222344445666 6677999999999998888889999
Q ss_pred EccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCC-
Q 013081 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG- 171 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~- 171 (450)
-+|+.. +|+|++..+.-+...+.+.|+.||+.||.-||..||+|||||.|||||+..+-+.|+||.--+. .....+.
T Consensus 100 Rqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKP-tYLPeDNP 177 (1431)
T KOG1240|consen 100 RQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKP-TYLPEDNP 177 (1431)
T ss_pred HHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCC-ccCCCCCc
Confidence 999965 9999999888889999999999999999999999999999999999999999999999975432 1111111
Q ss_pred -----ccccccCCCCccchhhhccCC----------CCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCC
Q 013081 172 -----LLHTTCGSPNYVAPEVLANRG----------YDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFK 235 (450)
Q Consensus 172 -----~~~~~~gt~~y~APE~l~~~~----------~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~ 235 (450)
...+...-.+|.|||.+.... .-+++.||||+||+++||++ |++||.-... -.+..+...
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL----~aYr~~~~~ 253 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL----LAYRSGNAD 253 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH----HhHhccCcc
Confidence 222334456899999875422 12478899999999999999 8999963211 111122111
Q ss_pred CC-----CCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 236 LP-----KWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 236 ~p-----~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
.| .--+..+++||..|++.||++|.++++.|+.
T Consensus 254 ~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 254 DPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred CHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 11 1135689999999999999999999999886
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-22 Score=184.03 Aligned_cols=190 Identities=18% Similarity=0.195 Sum_probs=142.2
Q ss_pred EEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhH-HHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEc
Q 013081 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKI-TDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMVLE 94 (450)
Q Consensus 17 ~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~-~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv~E 94 (450)
.+...|++|+||+||++.. .+..++.+.+.......... ...+.+|+++|++|. |+++.+++++ ...|++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 4678999999999998775 67778877665443322111 235889999999995 5889999886 34799999
Q ss_pred cCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccC-CCCcEEEccCCCeEEeecCCCCCCCcccCC---
Q 013081 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL-KLENILLDSKGNIKISDFGLSALPQHFRDD--- 170 (450)
Q Consensus 95 ~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDl-Kp~NILl~~~g~lkl~DFGla~~~~~~~~~--- 170 (450)
|+.|.+|...+.. . ...++.|++.+|.++|++||+|||| ||+|||++.+|.++|+|||+|........-
T Consensus 79 yI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~ 151 (218)
T PRK12274 79 YLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRL 151 (218)
T ss_pred eecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHH
Confidence 9999998754321 1 2457899999999999999999999 799999999999999999999854321100
Q ss_pred -C-------ccccccCCCCccchhhhccC-CCCCccchhhhHHHHHHHHHhCCCCCCC
Q 013081 171 -G-------LLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILTGYLPFDD 219 (450)
Q Consensus 171 -~-------~~~~~~gt~~y~APE~l~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~ 219 (450)
. ...-...++.|++|+.-.-- ...-...+.++.|+-+|.++|+..|+-+
T Consensus 152 L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 152 LAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 01123478899999874322 1212567999999999999999888644
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.6e-23 Score=189.65 Aligned_cols=247 Identities=20% Similarity=0.348 Sum_probs=200.3
Q ss_pred cCCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013081 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (450)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (450)
..+..++...+..+|.+...|+.|+|++ .|..++.|++..... .......|..|.-.|+-..||||+.+++.+....
T Consensus 184 ~~gid~~~lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~-t~risrdfneefp~lrifshpnilpvlgacnspp 260 (448)
T KOG0195|consen 184 YTGIDVSSLNLITKLAESHSGELWRGRW--QGNDIVAKILNVREV-TARISRDFNEEFPALRIFSHPNILPVLGACNSPP 260 (448)
T ss_pred ccCcchhhhhhhhhhccCCCcccccccc--cCcchhhhhhhhhhc-chhhcchhhhhCcceeeecCCchhhhhhhccCCC
Confidence 4456677778889999999999999998 455678888865443 3334577888999999999999999999999999
Q ss_pred EEEEEEccCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhhcC--eeeccCCCCcEEEccCCCeEEe--ecCCC
Q 013081 88 KIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLDSKGNIKIS--DFGLS 161 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~~--~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlKp~NILl~~~g~lkl~--DFGla 161 (450)
...++..|++-|+|+..+.... -.+..++.+++..++.|++|||+.. |.---|....+++|++-+.+|+ |--++
T Consensus 261 nlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfs 340 (448)
T KOG0195|consen 261 NLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFS 340 (448)
T ss_pred CceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceee
Confidence 9999999999999999997644 3678899999999999999999974 3344688889999998766553 43332
Q ss_pred CCCCcccCCCccccccCCCCccchhhhccCCCC--CccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC--CCCCC
Q 013081 162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD--GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLP 237 (450)
Q Consensus 162 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~--~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p 237 (450)
. .. ....-.|.|++||.++..+-+ -.++|+|||.+++|||.|...||.+-.+.+.-.++.-. ...+|
T Consensus 341 f-----qe----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ip 411 (448)
T KOG0195|consen 341 F-----QE----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIP 411 (448)
T ss_pred e-----ec----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCC
Confidence 2 11 123347899999999876654 34699999999999999999999998887766666543 56789
Q ss_pred CCCCHHHHHHHHHccccCcCCCCCHHHHH
Q 013081 238 KWLSPGAQNLLRKILEPNPVKRITIAGIK 266 (450)
Q Consensus 238 ~~~s~~~~~Li~~~L~~dP~~R~t~~~il 266 (450)
+.+++....|++-|++.||.+||.++.|.
T Consensus 412 pgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 412 PGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred CCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 99999999999999999999999987764
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=181.43 Aligned_cols=135 Identities=18% Similarity=0.205 Sum_probs=108.7
Q ss_pred eeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-----CCCCcceEEEEEEeCC---EEE
Q 013081 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-----KHPNVVRLHEVLASKS---KIY 90 (450)
Q Consensus 19 ~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-----~hpnIv~l~~~~~~~~---~~~ 90 (450)
.+.||+|+||.||. ++.++.. +||++...... ..+.+.+|+.+++.+ +||||++++++++++. .++
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~---~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDG---GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccccc---hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 57899999999995 7777666 69998764322 246799999999999 5799999999998874 434
Q ss_pred -EEEcc--CCCCChHHHHHhcCCCCHHHHHHHHHHHHHHH-hhhhhcCeeeccCCCCcEEEccC----CCeEEeecCCCC
Q 013081 91 -MVLEY--VTGGELFDKIASKGRLQEAEGRKLFQQLIDGV-SYCHNKGVFHRDLKLENILLDSK----GNIKISDFGLSA 162 (450)
Q Consensus 91 -lv~E~--~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL-~~LH~~givHrDlKp~NILl~~~----g~lkl~DFGla~ 162 (450)
+|+|| +.+++|.+++.+ +.+++. ..++.|++.++ +|||+++|+||||||+|||++.+ ++++|+||+-+.
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred EEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence 78999 557999999976 456666 35678888777 99999999999999999999743 379999955443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-21 Score=185.14 Aligned_cols=144 Identities=22% Similarity=0.251 Sum_probs=116.6
Q ss_pred CeEEeeeecccCceEEEEEE-ECCCCceEEEEEeecccccc---------------------hhHHHHHHHHHHHHHhCC
Q 013081 15 RYELGRTLGEGNFGKVKFAQ-DLDSGLPFAVKILEKNRIIH---------------------LKITDQIKREIATLKLLK 72 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~-~~~~~~~vAvK~i~~~~~~~---------------------~~~~~~~~~Ei~il~~l~ 72 (450)
-|++.+.||+|+||.||+|. +..+|+.||+|+++...... ......+.+|+.+++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999999 67799999999997543210 001234678999999997
Q ss_pred CCC--cceEEEEEEeCCEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcC-eeeccCCCCcEEEcc
Q 013081 73 HPN--VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG-VFHRDLKLENILLDS 149 (450)
Q Consensus 73 hpn--Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~g-ivHrDlKp~NILl~~ 149 (450)
+.+ +.++++. ...|+||||+.|.+|........++...++..++.|++.+|.+||++| ++||||||+||+++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 633 3444443 235899999999888776545566777788999999999999999999 99999999999999
Q ss_pred CCCeEEeecCCCCC
Q 013081 150 KGNIKISDFGLSAL 163 (450)
Q Consensus 150 ~g~lkl~DFGla~~ 163 (450)
+++++|+|||.|..
T Consensus 184 ~~~i~LiDFg~a~~ 197 (237)
T smart00090 184 DGKVVIIDVSQSVE 197 (237)
T ss_pred CCCEEEEEChhhhc
Confidence 88999999999874
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.8e-21 Score=206.39 Aligned_cols=195 Identities=23% Similarity=0.305 Sum_probs=163.2
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK---HPNVVRLHEVLASKSKI 89 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~ 89 (450)
..+|.|-+.||+|+||+||.|.+.+ |+.||+|+=.....+.--...+ ++.+|+ -+.|..+...+.-.+.-
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q------~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQ------VMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHH------HHHhhchhhhcchHHHHHHHccCCcc
Confidence 4589999999999999999999876 9999999977665544322233 333443 34566666665666778
Q ss_pred EEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEcc-------CCCeEEeecCCCC
Q 013081 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-------KGNIKISDFGLSA 162 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~-------~g~lkl~DFGla~ 162 (450)
++|+||.+-|+|.+++...+.+++..+..+..|++..|++||..+|||+||||+|.||.. +--++|+|||.|-
T Consensus 770 ~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si 849 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI 849 (974)
T ss_pred eeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence 899999999999999998899999999999999999999999999999999999999942 2358999999998
Q ss_pred CCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCC
Q 013081 163 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYL 215 (450)
Q Consensus 163 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~ 215 (450)
-+.-..+.......++|-.+-.+|+..++++. ..+|.|.+..+++.||.|+.
T Consensus 850 Dm~lfp~~~~F~~~~~td~f~C~EM~~grpWt-Yq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 850 DMKLFPDGTKFKAVWHTDLFDCIEMREGRPWT-YQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeeEcCCCcEEeeeeccccchhHHHhcCCCCc-hhhhhHHHHHHHHHHHHHHH
Confidence 66665566567788999999999999999984 89999999999999999964
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.8e-20 Score=170.03 Aligned_cols=138 Identities=24% Similarity=0.354 Sum_probs=116.6
Q ss_pred eeeecccCceEEEEEEECCCCceEEEEEeecccccchh-----HHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-----ITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 19 ~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~-----~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
++.||+|++|.||+|.+ .|..|++|+.......... ...++.+|+.++..+.|+|+.....++......+++|
T Consensus 1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence 36799999999999987 7788999986543322211 1246788999999999999988777777778889999
Q ss_pred ccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCC
Q 013081 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL 163 (450)
Q Consensus 94 E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~ 163 (450)
||++|++|.+.+..... ....++.+++.+|.++|+.|++|||++|.|||++ ++.++|+|||.+..
T Consensus 79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999998865332 8889999999999999999999999999999999 88999999999874
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.6e-19 Score=165.04 Aligned_cols=133 Identities=21% Similarity=0.277 Sum_probs=108.6
Q ss_pred eecccCceEEEEEEECCCCceEEEEEeecccccch-----hHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEcc
Q 013081 21 TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL-----KITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY 95 (450)
Q Consensus 21 ~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~-----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 95 (450)
.||+|+||.||+|.. +|..|++|.......... ....++.+|+.+++.+.|+++....-++......+++|||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999984 678899998654322211 1236778999999999988766555555566677999999
Q ss_pred CCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCC
Q 013081 96 VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL 163 (450)
Q Consensus 96 ~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~ 163 (450)
++|++|.+.+..... .++.|++.+|.+||+.|++|||++|.||+++ ++.+++.|||++..
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999988765321 8899999999999999999999999999999 88999999999874
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.8e-19 Score=166.37 Aligned_cols=138 Identities=25% Similarity=0.349 Sum_probs=110.1
Q ss_pred eEEeeeecccCceEEEEEEECCCCceEEEEEeecccccch-------------------hHHHHHHHHHHHHHhCCCCC-
Q 013081 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL-------------------KITDQIKREIATLKLLKHPN- 75 (450)
Q Consensus 16 y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~-------------------~~~~~~~~Ei~il~~l~hpn- 75 (450)
|.+.+.||+|+||.||+|.+. +|+.||||+++.....-. .......+|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 888999999999999999874 799999999865431100 01124678999999998874
Q ss_pred -cceEEEEEEeCCEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeE
Q 013081 76 -VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIK 154 (450)
Q Consensus 76 -Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lk 154 (450)
+...++ ....+++|||++|++|.+.... .....++.|++.++.++|+.|++||||||+||++++++.++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~ 165 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY 165 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence 444443 2456899999999998765321 45678899999999999999999999999999999999999
Q ss_pred EeecCCCCCC
Q 013081 155 ISDFGLSALP 164 (450)
Q Consensus 155 l~DFGla~~~ 164 (450)
|+|||++...
T Consensus 166 liDfg~~~~~ 175 (198)
T cd05144 166 IIDWPQMVST 175 (198)
T ss_pred EEECCccccC
Confidence 9999999743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.1e-19 Score=179.76 Aligned_cols=200 Identities=28% Similarity=0.412 Sum_probs=157.7
Q ss_pred HHhCCCCCcceEEEEEEeCCEEEEEEccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCe-eeccCCCCcE
Q 013081 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGV-FHRDLKLENI 145 (450)
Q Consensus 68 l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~gi-vHrDlKp~NI 145 (450)
|+.+.|.|+.++++.+.++...++|.+||..|+|.|.+.. ...++.--...+++.|+.||.|+|+..| +|+.+++.|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 4678999999999999999999999999999999999987 4567777788889999999999998865 9999999999
Q ss_pred EEccCCCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCC------CCccchhhhHHHHHHHHHhCCCCCCC
Q 013081 146 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY------DGATSDIWSCGVILYVILTGYLPFDD 219 (450)
Q Consensus 146 Ll~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~------~~~~~DiwSlGvil~elltG~~Pf~~ 219 (450)
++|....+||+|||+.................-...|.|||.+..... .+.++||||+|++++|+++...||+.
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 999999999999999886532111111122223457999999876422 24679999999999999999999976
Q ss_pred Cc----HHHHHHHHHh-CCC-CCCC-----CCCHHHHHHHHHccccCcCCCCCHHHHHh
Q 013081 220 RN----LAVLYQKIFR-GDF-KLPK-----WLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 220 ~~----~~~~~~~i~~-~~~-~~p~-----~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
.. ..++..++.+ +.. ..|. .+.+.+..+++.||..+|..||+++++..
T Consensus 161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 32 2345555555 322 2222 24557999999999999999999999754
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.79 E-value=1e-18 Score=185.18 Aligned_cols=138 Identities=21% Similarity=0.268 Sum_probs=112.4
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccc-----hhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH-----LKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~-----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (450)
.|...+.||+|+||.||++.+.. ..+++|......... ....+++.+|+++++.++|++++....+.......
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 44568899999999999998743 345555432221111 11235788999999999999999887777777778
Q ss_pred EEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCC
Q 013081 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL 163 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~ 163 (450)
++||||++|++|.+.+. ....++.|++.+|.+||+.|++||||||+|||+ .++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999998875 457899999999999999999999999999999 678999999999984
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.78 E-value=8.4e-20 Score=183.05 Aligned_cols=250 Identities=22% Similarity=0.295 Sum_probs=171.1
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCC---CceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEE-------
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE------- 81 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~------- 81 (450)
..+.+.+.+..+..+++.+....-..+ .+.++-+..+.+. ........+++-.+....|-+..-+.+
T Consensus 242 ~~~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~---~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~ 318 (516)
T KOG1033|consen 242 ESGSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDS---LCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFE 318 (516)
T ss_pred ccccccccccccccccCCchhhhhcccchhhhhccchhhhccc---hhhhhhhhhhhhheeccccCCcccccCCCCchhh
Confidence 345566777777777777765553333 3334444332222 122344556666665555444333333
Q ss_pred EE-----EeCCEEEEEEccCCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCe
Q 013081 82 VL-----ASKSKIYMVLEYVTGGELFDKIASKG---RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNI 153 (450)
Q Consensus 82 ~~-----~~~~~~~lv~E~~~gg~L~~~i~~~~---~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~l 153 (450)
.. ......||.|++|.-.+|.+.+.++. ..+......++.|++.|++| +|.+|||+||.||+...++.+
T Consensus 319 ~~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~ 395 (516)
T KOG1033|consen 319 SSKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQL 395 (516)
T ss_pred hccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhh
Confidence 11 11235789999999999999997543 35677889999999999999 999999999999999999999
Q ss_pred EEeecCCCCCCCccc----CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHH
Q 013081 154 KISDFGLSALPQHFR----DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQK 228 (450)
Q Consensus 154 kl~DFGla~~~~~~~----~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~ 228 (450)
||.|||+.+...... .........||..||+||++.+..| +.++||||||+||+||+. =..+|. .......
T Consensus 396 kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y-~~kvdIyaLGlil~EL~~~f~T~~e---r~~t~~d 471 (516)
T KOG1033|consen 396 KIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQY-SEKVDIYALGLILAELLIQFSTQFE---RIATLTD 471 (516)
T ss_pred hhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhh-hhhcchhhHHHHHHHHHHHhccHHH---HHHhhhh
Confidence 999999988544322 1113345689999999999998888 599999999999999997 222221 1222333
Q ss_pred HHhCCCCCCCC-CCHHHHHHHHHccccCcCCCCCHHHHHhcccc
Q 013081 229 IFRGDFKLPKW-LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 229 i~~~~~~~p~~-~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~ 271 (450)
+..+.++.--+ -.|.-..|+.++|.+.|.+||++.+.--|+|.
T Consensus 472 ~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 472 IRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 33344331112 23566799999999999999987777666664
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.1e-18 Score=157.31 Aligned_cols=138 Identities=27% Similarity=0.402 Sum_probs=101.1
Q ss_pred EeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHH---------------------HHHHHHHHHHhCCCCC-
Q 013081 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD---------------------QIKREIATLKLLKHPN- 75 (450)
Q Consensus 18 i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~---------------------~~~~Ei~il~~l~hpn- 75 (450)
+++.||+|+||.||+|.+. +|+.||||+++........... ....|...+..+.+.+
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 3578999999999999976 8999999998754322111111 1245667776665443
Q ss_pred -cceEEEEEEeCCEEEEEEccCCCCChHH-HHHhcCCCCHHHHHHHHHHHHHHHhhhhh-cCeeeccCCCCcEEEccCCC
Q 013081 76 -VVRLHEVLASKSKIYMVLEYVTGGELFD-KIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGN 152 (450)
Q Consensus 76 -Iv~l~~~~~~~~~~~lv~E~~~gg~L~~-~i~~~~~l~~~~~~~i~~ql~~aL~~LH~-~givHrDlKp~NILl~~~g~ 152 (450)
+.+.+.. ...+++|||++|+.+.. .+... ... .+++.++.|++.++.++|+ +||+||||||+||+++ ++.
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~ 152 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK 152 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc
Confidence 4455543 23589999999854322 12111 111 6789999999999999999 9999999999999999 899
Q ss_pred eEEeecCCCCC
Q 013081 153 IKISDFGLSAL 163 (450)
Q Consensus 153 lkl~DFGla~~ 163 (450)
++|+|||.+..
T Consensus 153 ~~liDfg~a~~ 163 (187)
T cd05119 153 VYIIDVPQAVE 163 (187)
T ss_pred EEEEECccccc
Confidence 99999999874
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.5e-17 Score=156.49 Aligned_cols=138 Identities=23% Similarity=0.375 Sum_probs=106.3
Q ss_pred eeeec-ccCceEEEEEEECCCCceEEEEEeeccccc----------chhHHHHHHHHHHHHHhCCCCCc--ceEEEEEEe
Q 013081 19 GRTLG-EGNFGKVKFAQDLDSGLPFAVKILEKNRII----------HLKITDQIKREIATLKLLKHPNV--VRLHEVLAS 85 (450)
Q Consensus 19 ~~~LG-~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~----------~~~~~~~~~~Ei~il~~l~hpnI--v~l~~~~~~ 85 (450)
...|| .|+.|+||.+.. .+..++||.+...... ......++.+|+.++..|.|++| +..+++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 34677 788888888876 4778999988643210 11223578899999999998885 667766433
Q ss_pred C-C---EEEEEEccCCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCC
Q 013081 86 K-S---KIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGL 160 (450)
Q Consensus 86 ~-~---~~~lv~E~~~g-g~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGl 160 (450)
. . ..++||||++| .+|.+++.. .++++.. +.||+.+|.+||++||+||||||+|||++.++.++|+|||.
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence 2 2 23599999997 688888764 4566543 57899999999999999999999999999999999999998
Q ss_pred CCC
Q 013081 161 SAL 163 (450)
Q Consensus 161 a~~ 163 (450)
+..
T Consensus 189 ~~~ 191 (239)
T PRK01723 189 GEL 191 (239)
T ss_pred ccc
Confidence 874
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.4e-17 Score=143.32 Aligned_cols=132 Identities=24% Similarity=0.292 Sum_probs=113.1
Q ss_pred EeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCC--CCcceEEEEEEeCCEEEEEEcc
Q 013081 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH--PNVVRLHEVLASKSKIYMVLEY 95 (450)
Q Consensus 18 i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~lv~E~ 95 (450)
+++.||+|.++.||++.+.. ..+++|....... ...+.+|+.+++.++| +++.+++.+....+..|++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 46789999999999999743 7899999865432 3578899999999976 5899999988888889999999
Q ss_pred CCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhc---CeeeccCCCCcEEEccCCCeEEeecCCCCC
Q 013081 96 VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK---GVFHRDLKLENILLDSKGNIKISDFGLSAL 163 (450)
Q Consensus 96 ~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlKp~NILl~~~g~lkl~DFGla~~ 163 (450)
+.|+++... +......++.+++.+++++|.. +++|||++|.||++++.+.+++.|||.+..
T Consensus 75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 998877543 5566778899999999999985 799999999999999989999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.5e-18 Score=182.52 Aligned_cols=264 Identities=26% Similarity=0.418 Sum_probs=212.7
Q ss_pred CcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (450)
......+.+.+-+-.|+++.+..+.-..+|...+.|+..+.........+.+.++-.++-..++|-++...-.+......
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 35667888999999999999999998888888888876554333222233344444433334456666554445567788
Q ss_pred EEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcc--
Q 013081 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF-- 167 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~-- 167 (450)
+++++|+.|++|...+.+.+..+++-++.+...+..+++|||+..+.|||++|.|+|...+|..+++|||........
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p 959 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPP 959 (1205)
T ss_pred chhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccC
Confidence 999999999999999999888999999999999999999999999999999999999999999999999843221000
Q ss_pred --------------------c-------CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCC
Q 013081 168 --------------------R-------DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR 220 (450)
Q Consensus 168 --------------------~-------~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~ 220 (450)
. +........||+.|.|||.+.+... +..+|+|+.|+++++.++|.+||...
T Consensus 960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~h-gs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRH-GSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred cCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccC-CCcchhhhhhhhhhhhhcCCCCCCCc
Confidence 0 0011234579999999999888776 58899999999999999999999999
Q ss_pred cHHHHHHHHHhCCCCCCC---CCCHHHHHHHHHccccCcCCCCCHH---HHHhccccccC
Q 013081 221 NLAVLYQKIFRGDFKLPK---WLSPGAQNLLRKILEPNPVKRITIA---GIKADEWFEQD 274 (450)
Q Consensus 221 ~~~~~~~~i~~~~~~~p~---~~s~~~~~Li~~~L~~dP~~R~t~~---~il~h~~~~~~ 274 (450)
.....++++.++..+.|. ..++.+++++.++|..+|.+|..+. +...|++|+..
T Consensus 1039 tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1039 TPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDV 1098 (1205)
T ss_pred chhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCC
Confidence 999999999998877764 3789999999999999999999987 89999999754
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.61 E-value=8.2e-16 Score=160.52 Aligned_cols=146 Identities=24% Similarity=0.378 Sum_probs=103.5
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeeccccc--------------------------c-----hhHHHH
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII--------------------------H-----LKITDQ 60 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~--------------------------~-----~~~~~~ 60 (450)
.+..|+. +.||.|++|.||.|+.+.+|+.||||+.++.... + .++.+.
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 3566887 8999999999999999888999999999754210 0 012223
Q ss_pred ------HHHHHHHHHhCC----CCCcceEEEEEEe-CCEEEEEEccCCCCChHHH--HHhcC----CCCHHHHHHHHHHH
Q 013081 61 ------IKREIATLKLLK----HPNVVRLHEVLAS-KSKIYMVLEYVTGGELFDK--IASKG----RLQEAEGRKLFQQL 123 (450)
Q Consensus 61 ------~~~Ei~il~~l~----hpnIv~l~~~~~~-~~~~~lv~E~~~gg~L~~~--i~~~~----~l~~~~~~~i~~ql 123 (450)
+.+|+..+.+++ +.+.+.+-.++.+ .+..++||||+.|+.+.+. +...+ .+.+..+..++.|+
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 334444444442 3444444444432 4567899999999999774 33333 35555666677776
Q ss_pred HHHHhhhhhcCeeeccCCCCcEEEccCC----CeEEeecCCCCCCC
Q 013081 124 IDGVSYCHNKGVFHRDLKLENILLDSKG----NIKISDFGLSALPQ 165 (450)
Q Consensus 124 ~~aL~~LH~~givHrDlKp~NILl~~~g----~lkl~DFGla~~~~ 165 (450)
+ ..|++|+|+||.||+++.+| .+++.|||++...+
T Consensus 277 f-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 F-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred H-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 5 48999999999999999988 99999999987543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.5e-14 Score=149.04 Aligned_cols=143 Identities=25% Similarity=0.318 Sum_probs=98.9
Q ss_pred eeeecccCceEEEEEEECCCCceEEEEEeecccccch-------------------------------hHHH------HH
Q 013081 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL-------------------------------KITD------QI 61 (450)
Q Consensus 19 ~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~-------------------------------~~~~------~~ 61 (450)
.+.||.|++|.||+|+. .+|+.||||+.+......- ++.. .+
T Consensus 122 ~~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 36799999999999986 4799999999865321000 0001 24
Q ss_pred HHHHHHHHhCC----CCCcceEEEEE-EeCCEEEEEEccCCCCChHHHHHhc-CCCCHHHHHHHHHHHHH-HHhhhhhcC
Q 013081 62 KREIATLKLLK----HPNVVRLHEVL-ASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLID-GVSYCHNKG 134 (450)
Q Consensus 62 ~~Ei~il~~l~----hpnIv~l~~~~-~~~~~~~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~-aL~~LH~~g 134 (450)
.+|.+.+.++. |.+-+.+-.++ ...+..++||||++|++|.+..... ... ....++.+++. .+..+|..|
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCC
Confidence 45666665553 32223333333 2234578999999999998876432 122 23445566655 467889999
Q ss_pred eeeccCCCCcEEEccCCCeEEeecCCCCCCC
Q 013081 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (450)
Q Consensus 135 ivHrDlKp~NILl~~~g~lkl~DFGla~~~~ 165 (450)
++|+|+||.||+++.+|.++++|||++...+
T Consensus 278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999987543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.7e-15 Score=151.59 Aligned_cols=253 Identities=21% Similarity=0.211 Sum_probs=190.6
Q ss_pred CeEEeeeecc--cCceEEEEEEE--CCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEE
Q 013081 15 RYELGRTLGE--GNFGKVKFAQD--LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKI 89 (450)
Q Consensus 15 ~y~i~~~LG~--G~~g~Vy~a~~--~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 89 (450)
.+.+...+|. |.+|.||.+.. ..++..+|+|.-+... .......+=.+|+...+.++ |+|.++.+..+++.+..
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~-s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPF-SPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCC-CCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 5667888999 99999999998 7889999999632211 11111234446777777774 99999999999999999
Q ss_pred EEEEccCCCCChHHHHHhcCC-CCHHHHHHHHHHHHH----HHhhhhhcCeeeccCCCCcEEEccC-CCeEEeecCCCCC
Q 013081 90 YMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLID----GVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGLSAL 163 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~~-l~~~~~~~i~~ql~~----aL~~LH~~givHrDlKp~NILl~~~-g~lkl~DFGla~~ 163 (450)
|+-+|+| |.+|.++...... +++..++.++.+..+ ||.++|+.+++|-|+||+||+...+ ...+++|||+...
T Consensus 194 fiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~ 272 (524)
T KOG0601|consen 194 FIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSK 272 (524)
T ss_pred eeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEE
Confidence 9999999 5788888876554 899999999999999 9999999999999999999999999 7899999999876
Q ss_pred CCcccCCC---ccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCC-cHHHH-HHHHHhCCCCCCC
Q 013081 164 PQHFRDDG---LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR-NLAVL-YQKIFRGDFKLPK 238 (450)
Q Consensus 164 ~~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~-~~~~~-~~~i~~~~~~~p~ 238 (450)
.....-.. ......|...|++||...+ ..+...|+||+|.+..+-.+|..++... +.... ..+.+ -..++-.
T Consensus 273 i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-ip~e~~~ 349 (524)
T KOG0601|consen 273 ISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-IPLEFCE 349 (524)
T ss_pred ccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-Cchhhhc
Confidence 54322111 1122267788999998654 3468899999999999998886655432 11110 00000 0111112
Q ss_pred CCCHHHHHHHHHccccCcCCCCCHHHHHhccccc
Q 013081 239 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 272 (450)
Q Consensus 239 ~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~ 272 (450)
..+.++...+..|++.+|-.|++.+.+++|++..
T Consensus 350 ~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~ 383 (524)
T KOG0601|consen 350 GGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIH 383 (524)
T ss_pred CcchhhhhHHHHhcCcchhhhhHHHHHhcccccc
Confidence 2456677799999999999999999999998876
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.55 E-value=8.8e-14 Score=143.68 Aligned_cols=234 Identities=18% Similarity=0.285 Sum_probs=162.6
Q ss_pred CeEEeeeecccCceEEE-EEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 15 RYELGRTLGEGNFGKVK-FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy-~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
-|++ ...+-++.+ +| .|..+.++.+|.|...+.... +....+.+-+.-|+.++||||+++++.++.++..|+|+
T Consensus 14 pY~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvT 88 (690)
T KOG1243|consen 14 PYDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVT 88 (690)
T ss_pred Cccc-ccccCCCcc-cccccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEe
Confidence 3665 333334444 44 466678899999999876543 44567888899999999999999999999999999999
Q ss_pred ccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhh-hcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCc
Q 013081 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH-NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (450)
Q Consensus 94 E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH-~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 172 (450)
|.+. .|..++.+.+ ......-+.||+.||.||| +.+++|++|.-..|+|+..|..||++|.++...+.... .
T Consensus 89 ErV~--Pl~~~lk~l~---~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~ 161 (690)
T KOG1243|consen 89 ERVR--PLETVLKELG---KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--P 161 (690)
T ss_pred eccc--cHHHHHHHhH---HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--c
Confidence 9984 6777776643 6677778899999999998 56899999999999999999999999998864433221 1
Q ss_pred cccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcc
Q 013081 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKIL 252 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L 252 (450)
.....---.|..|+.+.... -..|.|.|||++++++.|..+=. .....+..++.....+-.+-+
T Consensus 162 ~~~~~~~~s~~~P~~~~~s~---~s~D~~~Lg~li~el~ng~~~~~-------------~~~~~~~~ipk~~~~~~~k~~ 225 (690)
T KOG1243|consen 162 AKSLYLIESFDDPEEIDPSE---WSIDSWGLGCLIEELFNGSLLTK-------------TDLSNTGKIPKALIELYCKKL 225 (690)
T ss_pred cccchhhhcccChhhcCccc---cchhhhhHHHHHHHHhCcccCcc-------------hhhhccCccchhHHHHHHHHh
Confidence 12222233466777644332 23699999999999999943311 112223334444444554555
Q ss_pred ccCcCCCCCHHH-----HHhccccccCCC
Q 013081 253 EPNPVKRITIAG-----IKADEWFEQDYT 276 (450)
Q Consensus 253 ~~dP~~R~t~~~-----il~h~~~~~~~~ 276 (450)
--.+..||.... .+-|.||++.+.
T Consensus 226 ~~~~~~r~n~~~~~~~~~~~~gff~n~fv 254 (690)
T KOG1243|consen 226 GATELKRPNKLRFILECRLLGGFFRNDFV 254 (690)
T ss_pred ccccccccchhhHHHHHHhccccccchHH
Confidence 555556655322 344788876543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.55 E-value=6.4e-14 Score=128.13 Aligned_cols=142 Identities=16% Similarity=0.212 Sum_probs=105.7
Q ss_pred eeeecccCceEEEEEEECC------CCceEEEEEeeccccc-------------------chhHHH----HHHHHHHHHH
Q 013081 19 GRTLGEGNFGKVKFAQDLD------SGLPFAVKILEKNRII-------------------HLKITD----QIKREIATLK 69 (450)
Q Consensus 19 ~~~LG~G~~g~Vy~a~~~~------~~~~vAvK~i~~~~~~-------------------~~~~~~----~~~~Ei~il~ 69 (450)
...||.|.-+.||.|.... .+..+|||+.+..... ...... ..++|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4679999999999998643 3579999987542210 001122 3448999999
Q ss_pred hCCC--CCcceEEEEEEeCCEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhh-hhcCeeeccCCCCcEE
Q 013081 70 LLKH--PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC-HNKGVFHRDLKLENIL 146 (450)
Q Consensus 70 ~l~h--pnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~L-H~~givHrDlKp~NIL 146 (450)
++.. -++.+++++ ...++||||+.+..+.....++..+++.++..++.|++.+|..| |+.|++||||+|.|||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 9963 466677765 45789999997654533222334566777888899999999999 8999999999999999
Q ss_pred EccCCCeEEeecCCCCCCC
Q 013081 147 LDSKGNIKISDFGLSALPQ 165 (450)
Q Consensus 147 l~~~g~lkl~DFGla~~~~ 165 (450)
++ ++.+.|+|||.|...+
T Consensus 158 ~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 158 WH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EE-CCcEEEEECCCceeCC
Confidence 96 5789999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PF03822 NAF: NAF domain; InterPro: IPR004041 The NAF domain is a 24 amino acid domain that is found in a plant-specific subgroup of serine-threonine protein kinases (CIPKs), that interact with calcineurin B-like calcium sensor proteins (CBLs) | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.9e-14 Score=104.93 Aligned_cols=60 Identities=47% Similarity=0.866 Sum_probs=48.5
Q ss_pred CCcchhhhhhhccccccCCCCcccccc--cccccceecccCHHHHHHHHHHHHHhcCcEEEE
Q 013081 310 PPLINAFQLIGMSSCLDLSGFFEKEDV--SERKIRFTSNHSAKDLLERIEDIVTEMGFRVQK 369 (450)
Q Consensus 310 ~~~~~~~~~i~~s~~~~~~~~~~~~~~--~~~~~rf~s~~~~~~~~~~l~~~~~~~~~~~~~ 369 (450)
|..+|||++|++|+|+|||+||+.... .++.+||+|..+|+.|+++||++|+.+|++|+|
T Consensus 2 p~~lNAFdiIS~S~G~DLSgLFe~~~~~~~~~~~RF~S~~~~~~Ii~klEe~a~~~~~~V~K 63 (63)
T PF03822_consen 2 PKSLNAFDIISLSSGFDLSGLFEEKDKSSVKRETRFTSKEPASEIIEKLEEIAKKLGFRVKK 63 (63)
T ss_dssp -EE--HHHHHCTSTTTSCGGGGGCG-S-SS---EEEEESS-HHHHHHHHHHHHHHTTEEEEE
T ss_pred CccccHHHHHHhccCCChHHhcCccccccccccceEecCCCHHHHHHHHHHHHHhcCceeeC
Confidence 567899999999999999999987643 357899999999999999999999999999975
|
Whereas the N-terminal part of CIPKs comprises a conserved catalytic domain typical of Ser-Thr kinases, the much less conserved C-terminal domain appears to be unique to this subgroup of kinases. The only exception is the NAF domain that forms an 'island of conservation' in this otherwise variable region. The NAF domain has been named after the prominent conserved amino acids Asn-Ala-Phe. It represents a minimum protein interaction module that is both necessary and sufficient to mediate the interaction with the CBL calcium sensor proteins []. The secondary structure of the NAF domain is currently not known, but secondary structure computation of the C-terminal region of Arabidopsis thaliana CBL-interacting protein kinase 1 revealed a long helical structure [].; GO: 0007165 signal transduction; PDB: 2ZFD_B 2EHB_D. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.4e-13 Score=123.11 Aligned_cols=127 Identities=18% Similarity=0.228 Sum_probs=97.3
Q ss_pred eeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcc-eEEEEEEeCCEEEEEEccCC
Q 013081 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV-RLHEVLASKSKIYMVLEYVT 97 (450)
Q Consensus 19 ~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv-~l~~~~~~~~~~~lv~E~~~ 97 (450)
++.|+.|.++.||++.. .+..|++|+...... ....+.+|+.+++.+.+.+++ +++.... ...++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 46789999999999986 477899998754321 123467899999998765544 4555432 34579999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCe-----eeccCCCCcEEEccCCCeEEeecCCCC
Q 013081 98 GGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV-----FHRDLKLENILLDSKGNIKISDFGLSA 162 (450)
Q Consensus 98 gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~gi-----vHrDlKp~NILl~~~g~lkl~DFGla~ 162 (450)
|.++.+. ......++.+++.+|+.||+.++ +|+|++|.||+++ ++.++++|||.+.
T Consensus 75 G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 75 GSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 9887643 11124467899999999999885 9999999999999 6789999999886
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.46 E-value=5e-14 Score=144.11 Aligned_cols=254 Identities=20% Similarity=0.180 Sum_probs=191.1
Q ss_pred CcccCCeEEeeeecccCceEEEEEEEC-CCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDL-DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKS 87 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 87 (450)
....++|..+..||.|.|+.|+..... .++..+++|...+........ ..-..|+.+...+ .|.++++.+..+....
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~d-i~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASD-IFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhh-hcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 345688999999999999999987654 678899999876554433322 2233567666666 4999999988888888
Q ss_pred EEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccC-CCeEEeecCCCCCCCc
Q 013081 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGLSALPQH 166 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~-g~lkl~DFGla~~~~~ 166 (450)
..|+-.|||+|+++...+.-...+.+...+++..|++.++.++|+..++|+|+||.||++..+ +..++.|||.++...-
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~ 419 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF 419 (524)
T ss_pred cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce
Confidence 888999999999987776555668899999999999999999999999999999999999886 7889999999863111
Q ss_pred ccCCCccccccCCCCcc-chhhhccCCCCCccchhhhHHHHHHHHHhCCCC-CCCCcHHHHHHHHHhCCCCCCCCCCHHH
Q 013081 167 FRDDGLLHTTCGSPNYV-APEVLANRGYDGATSDIWSCGVILYVILTGYLP-FDDRNLAVLYQKIFRGDFKLPKWLSPGA 244 (450)
Q Consensus 167 ~~~~~~~~~~~gt~~y~-APE~l~~~~~~~~~~DiwSlGvil~elltG~~P-f~~~~~~~~~~~i~~~~~~~p~~~s~~~ 244 (450)
.......+..+. .+|++........++|++|||.-+.+.++|..- +.+. ....+..+..+........+
T Consensus 420 -----~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----~~~~i~~~~~p~~~~~~~~~ 490 (524)
T KOG0601|consen 420 -----SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV----QSLTIRSGDTPNLPGLKLQL 490 (524)
T ss_pred -----ecccccccccccccchhhccccccccccccccccccccccccCcccCcccc----cceeeecccccCCCchHHhh
Confidence 011112233444 355544444446899999999999999998653 2221 22334455555555556888
Q ss_pred HHHHHHccccCcCCCCCHHHHHhcccccc
Q 013081 245 QNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
..+.+.+..+++..|+.+.++..|.-|..
T Consensus 491 q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 491 QVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred hhhhhhhcCCccccchhhhhhcccchhhh
Confidence 99999999999999999999888876544
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.5e-14 Score=137.60 Aligned_cols=203 Identities=19% Similarity=0.260 Sum_probs=142.3
Q ss_pred HHHhCCCCCcceEEEEEEe-----CCEEEEEEccCCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHhhhhhcC--e
Q 013081 67 TLKLLKHPNVVRLHEVLAS-----KSKIYMVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYCHNKG--V 135 (450)
Q Consensus 67 il~~l~hpnIv~l~~~~~~-----~~~~~lv~E~~~gg~L~~~i~~~----~~l~~~~~~~i~~ql~~aL~~LH~~g--i 135 (450)
-+-.+.|-||++++.++.+ .....++.||++.|++..++++. ..+.....++|.-||++||.|||+.. |
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 3445569999999998754 45688999999999999998753 35888999999999999999999984 9
Q ss_pred eeccCCCCcEEEccCCCeEEeecCCCCCCCcccCC--CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhC
Q 013081 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD--GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 213 (450)
Q Consensus 136 vHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG 213 (450)
+|+++.-.-|++..+|-+|+.---........... .......+-++|.|||.=..... ..++|||++|....+|..|
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~-~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNT-TGASDIYKFGMCALEMAIL 278 (458)
T ss_pred ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccccc-ccchhhhhhhHHHHHHHHh
Confidence 99999999999999998887532211111111110 11122346789999996332333 3579999999999999887
Q ss_pred CCCC-CCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhcccccc
Q 013081 214 YLPF-DDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 214 ~~Pf-~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
..-- .+.+.......+.+.-+-. -.+.-+.++.+||+..|..||++.+++.||.+..
T Consensus 279 Eiq~tnseS~~~~ee~ia~~i~~l---en~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 279 EIQSTNSESKVEVEENIANVIIGL---ENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred eeccCCCcceeehhhhhhhheeec---cCccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence 6542 2222222222222211111 1233457899999999999999999999998653
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.7e-11 Score=109.02 Aligned_cols=134 Identities=25% Similarity=0.329 Sum_probs=100.4
Q ss_pred eeecccCceEEEEEEECCCCceEEEEEeecccccchhHH-----HHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEc
Q 013081 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT-----DQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (450)
Q Consensus 20 ~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~-----~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 94 (450)
..+++|+-+.+|.+.. -|..+++|.=.+....+++.. .+..+|.+++++++--+|.-..=+..+.....|+||
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 4678999999999865 455577776444333344332 456789999999876555544444445667789999
Q ss_pred cCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCC
Q 013081 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL 163 (450)
Q Consensus 95 ~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~ 163 (450)
|++|..|.+.+... . ..+++.+=.-+.-||..||+|+||.++||++..++ +.++||||+..
T Consensus 80 ~I~G~~lkd~l~~~---~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA---R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc---c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999888764 2 34555566667789999999999999999997665 99999999984
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.27 E-value=2.3e-11 Score=113.32 Aligned_cols=140 Identities=22% Similarity=0.337 Sum_probs=107.3
Q ss_pred eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCC--CCcceEEEEEEeC---CEEEEEEc
Q 013081 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH--PNVVRLHEVLASK---SKIYMVLE 94 (450)
Q Consensus 20 ~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~---~~~~lv~E 94 (450)
+.||.|..+.||++... +|+.+++|+....... .....+.+|..+++.+.+ .++.+++.+.... +..|++||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 67899999999999864 3688999997654321 124578899999999975 4467777776553 36789999
Q ss_pred cCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhh------------------------------------------
Q 013081 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN------------------------------------------ 132 (450)
Q Consensus 95 ~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~------------------------------------------ 132 (450)
|++|.++.+.+.. ..+++.+...++.+++.+|..||+
T Consensus 81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9999888765432 456777777778888888877773
Q ss_pred --------------cCeeeccCCCCcEEEcc--CCCeEEeecCCCCC
Q 013081 133 --------------KGVFHRDLKLENILLDS--KGNIKISDFGLSAL 163 (450)
Q Consensus 133 --------------~givHrDlKp~NILl~~--~g~lkl~DFGla~~ 163 (450)
..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23699999999999998 56689999998874
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.27 E-value=9.3e-11 Score=104.01 Aligned_cols=144 Identities=24% Similarity=0.253 Sum_probs=109.1
Q ss_pred EeeeecccCceEEEEEEECCCCceEEEEEeecccccchh-----HHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013081 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-----ITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 18 i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~-----~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 92 (450)
.+..|-+|+-+.|+.+.+ .|+...||.-......++. ...+.++|++++.++.--+|.-..-++.+...-.++
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 678899999999999987 7888888854333333332 236788999999999766665555555566667788
Q ss_pred EccCCC-CChHHHHHhc-CCCCHHH-HHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCC---eEEeecCCCCC
Q 013081 93 LEYVTG-GELFDKIASK-GRLQEAE-GRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSAL 163 (450)
Q Consensus 93 ~E~~~g-g~L~~~i~~~-~~l~~~~-~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~---lkl~DFGla~~ 163 (450)
|||++| .++.+++... ..-.++. ...++++|-+.+.-||.++|+|+||..+||++..+|+ +.+.|||++..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 999987 4677777542 2223333 3788899999999999999999999999999987763 58999999874
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.1e-11 Score=126.70 Aligned_cols=155 Identities=22% Similarity=0.337 Sum_probs=115.9
Q ss_pred HHHHHHhhhhhc-CeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC-------CCccccccCCCCccchhhhccCCC
Q 013081 122 QLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-------DGLLHTTCGSPNYVAPEVLANRGY 193 (450)
Q Consensus 122 ql~~aL~~LH~~-givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~-------~~~~~~~~gt~~y~APE~l~~~~~ 193 (450)
+.+.|+.|+|+. +++|++|.|++|.++.+|.+||+.|+.+........ ....-...-...|.|||++.. ..
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~~ 185 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-TT 185 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-cc
Confidence 344899999987 899999999999999999999999998764332110 011111124567999999877 45
Q ss_pred CCccchhhhHHHHHHHHH-hCCCCCCCCcHHHHHHHHHh----CCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 194 DGATSDIWSCGVILYVIL-TGYLPFDDRNLAVLYQKIFR----GDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 194 ~~~~~DiwSlGvil~ell-tG~~Pf~~~~~~~~~~~i~~----~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
.++++|+||+||++|.+. .|+.-+...+....+..-.. +....+..+++++++=+.++|..++..||++..++..
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSI 265 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhcc
Confidence 578999999999999999 57766655433322221111 1234456789999999999999999999999999999
Q ss_pred cccccCCCC
Q 013081 269 EWFEQDYTP 277 (450)
Q Consensus 269 ~~~~~~~~~ 277 (450)
+||.+....
T Consensus 266 ~ff~D~~~~ 274 (700)
T KOG2137|consen 266 PFFSDPGLK 274 (700)
T ss_pred cccCCchhh
Confidence 999876543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.6e-09 Score=109.46 Aligned_cols=212 Identities=21% Similarity=0.217 Sum_probs=156.2
Q ss_pred CceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE----eCCEEEEEEccCCC-CC
Q 013081 26 NFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA----SKSKIYMVLEYVTG-GE 100 (450)
Q Consensus 26 ~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~----~~~~~~lv~E~~~g-g~ 100 (450)
--.+.|+|....+|..|++|.++-.+.... .....-+++++++.|+|+|++.+++. .+..+++|++|.++ ++
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 346789999999999999999855444332 22334578899999999999999986 45678999999875 57
Q ss_pred hHHHHHh---------------cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCC
Q 013081 101 LFDKIAS---------------KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (450)
Q Consensus 101 L~~~i~~---------------~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 165 (450)
|.++--. ....+|...|.|+.||..||.++|+.|+..+-|.|.+||++.+-+++|+..|+..+..
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 7765421 2247889999999999999999999999999999999999999899999888766432
Q ss_pred cccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCC-CCCCcHHHH-HHHHHhCCCCCCCCCCHH
Q 013081 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP-FDDRNLAVL-YQKIFRGDFKLPKWLSPG 243 (450)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~P-f~~~~~~~~-~~~i~~~~~~~p~~~s~~ 243 (450)
... . |-+... .+-|.=.||.++..|.||..- +........ ...+ -..++.+
T Consensus 445 ~d~--------------~--~~le~~----Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I-------~~~yS~D 497 (655)
T KOG3741|consen 445 EDP--------------T--EPLESQ----QQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI-------TTTYSTD 497 (655)
T ss_pred CCC--------------C--cchhHH----hhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh-------hhhhhHH
Confidence 210 1 112221 346999999999999999543 222222221 1111 2346889
Q ss_pred HHHHHHHccccCcCCCCCHHHHHhc
Q 013081 244 AQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 244 ~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
++++|.-+...++.. -++.+++.+
T Consensus 498 ~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 498 LRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHHHHHhcCccc-ccHHHHHHH
Confidence 999999999888886 677887765
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.11 E-value=4.7e-10 Score=102.25 Aligned_cols=127 Identities=29% Similarity=0.383 Sum_probs=85.3
Q ss_pred EEEEEEECCCCceEEEEEeeccccc-----------------------chhHHHHHHHHHHHHHhCCCC--CcceEEEEE
Q 013081 29 KVKFAQDLDSGLPFAVKILEKNRII-----------------------HLKITDQIKREIATLKLLKHP--NVVRLHEVL 83 (450)
Q Consensus 29 ~Vy~a~~~~~~~~vAvK~i~~~~~~-----------------------~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~~ 83 (450)
.||.|.. ..|..+|+|+.+..... ........++|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 4899986 56779999987642110 011235678899999999865 466777553
Q ss_pred EeCCEEEEEEccCC--CCChHHHHHhcCCCCHHHHHHHHHHHHHHHhh-hhhcCeeeccCCCCcEEEccCCCeEEeecCC
Q 013081 84 ASKSKIYMVLEYVT--GGELFDKIASKGRLQEAEGRKLFQQLIDGVSY-CHNKGVFHRDLKLENILLDSKGNIKISDFGL 160 (450)
Q Consensus 84 ~~~~~~~lv~E~~~--gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~-LH~~givHrDlKp~NILl~~~g~lkl~DFGl 160 (450)
..++||||++ |..+..+... .++......++.+++..+.. +|+.||+|+||.+.|||++++ .+.++|||.
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred ----CCEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 3479999998 6555443322 22255677788888886555 579999999999999999887 899999998
Q ss_pred CCC
Q 013081 161 SAL 163 (450)
Q Consensus 161 a~~ 163 (450)
+..
T Consensus 153 av~ 155 (188)
T PF01163_consen 153 AVD 155 (188)
T ss_dssp EEE
T ss_pred cee
Confidence 874
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=7.9e-10 Score=104.07 Aligned_cols=138 Identities=26% Similarity=0.372 Sum_probs=105.0
Q ss_pred eEEeeeecccCceEEEEEEECCCCceEEEEEeeccccc---------------c----hhHHHHHHHHHHHHHhCCCC--
Q 013081 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---------------H----LKITDQIKREIATLKLLKHP-- 74 (450)
Q Consensus 16 y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~---------------~----~~~~~~~~~Ei~il~~l~hp-- 74 (450)
+.++..||-|.-|.||.|.+. .|.++|||.-+..... + .-.....++|..+|.+|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 357789999999999999975 7889999975431110 0 11134678999999999754
Q ss_pred CcceEEEEEEeCCEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeE
Q 013081 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIK 154 (450)
Q Consensus 75 nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lk 154 (450)
.+.+.+++ +...+||||++|-.|... +++.+.+..++..|+.-+.-+-..|++|+|+++-||++++||.+.
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~ 242 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV 242 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence 77777765 567899999999877543 223455566666666666666689999999999999999999999
Q ss_pred EeecCCCCC
Q 013081 155 ISDFGLSAL 163 (450)
Q Consensus 155 l~DFGla~~ 163 (450)
++||-.+..
T Consensus 243 vIDwPQ~v~ 251 (304)
T COG0478 243 VIDWPQAVP 251 (304)
T ss_pred EEeCccccc
Confidence 999987763
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.07 E-value=3.3e-09 Score=102.21 Aligned_cols=131 Identities=17% Similarity=0.126 Sum_probs=95.3
Q ss_pred eEEEEEEECCCCceEEEEEeecccccchhHH----------HHHHHHHHHHHhCCCCCc--ceEEEEEEe-----CCEEE
Q 013081 28 GKVKFAQDLDSGLPFAVKILEKNRIIHLKIT----------DQIKREIATLKLLKHPNV--VRLHEVLAS-----KSKIY 90 (450)
Q Consensus 28 g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~----------~~~~~Ei~il~~l~hpnI--v~l~~~~~~-----~~~~~ 90 (450)
..|..... .|+.|.||........ +.. ..+.+|...+.+|..-+| ..++.+++. ...-+
T Consensus 36 rrvvr~~~--~g~~~~vKr~~~~~~~--~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~ 111 (268)
T PRK15123 36 RRTLRFEL--AGKSYFLKWHRGTGWG--EIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSF 111 (268)
T ss_pred ceEEEEEE--CCEEEEEEEecCCcHH--HHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeE
Confidence 34555543 6778999966332211 011 147799999988864443 334444432 23578
Q ss_pred EEEccCCCC-ChHHHHHh--cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEcc-------CCCeEEeecCC
Q 013081 91 MVLEYVTGG-ELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-------KGNIKISDFGL 160 (450)
Q Consensus 91 lv~E~~~gg-~L~~~i~~--~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~-------~g~lkl~DFGl 160 (450)
+|||+++|. +|.+++.. ..+.++.....++.+++..+.-||+.||+|+|++|.|||++. ++.+.++||+.
T Consensus 112 LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r 191 (268)
T PRK15123 112 IITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHR 191 (268)
T ss_pred EEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCc
Confidence 999999886 78888764 345677888899999999999999999999999999999985 45789999998
Q ss_pred CC
Q 013081 161 SA 162 (450)
Q Consensus 161 a~ 162 (450)
+.
T Consensus 192 ~~ 193 (268)
T PRK15123 192 AQ 193 (268)
T ss_pred cc
Confidence 86
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.06 E-value=3.4e-09 Score=104.66 Aligned_cols=236 Identities=18% Similarity=0.227 Sum_probs=152.8
Q ss_pred EEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHh-CCCCCcceEEEE------EEeC-CE
Q 013081 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL-LKHPNVVRLHEV------LASK-SK 88 (450)
Q Consensus 17 ~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~------~~~~-~~ 88 (450)
..++.||+|+-+.+|-.-. -+..|| |+......... . +.+..|.. -.||-+-.=+.| ...+ ..
T Consensus 14 ~~gr~LgqGgea~ly~l~e--~~d~VA-KIYh~Pppa~~-----a-qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~ 84 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE--VRDQVA-KIYHAPPPAAQ-----A-QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKV 84 (637)
T ss_pred CCCccccCCccceeeecch--hhchhh-eeecCCCchHH-----H-HHHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence 4578899999999996543 222344 88876543221 1 11222322 346654331211 1122 23
Q ss_pred EEEEEccCCCCChHHHH-H---hcC---CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCC
Q 013081 89 IYMVLEYVTGGELFDKI-A---SKG---RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS 161 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~~i-~---~~~---~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla 161 (450)
+.+.|..++|..--..+ . +++ ...+.-+.+..+.|+.|.+.||..|-.-+|+.++|+|+++++.+.|.|=..-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 77889999876432222 1 122 3567888999999999999999999999999999999999999999975533
Q ss_pred CCCCcccCCCccccccCCCCccchhhhccCCC----CCccchhhhHHHHHHHHHhC-CCCCCCC-------cHHH--H--
Q 013081 162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY----DGATSDIWSCGVILYVILTG-YLPFDDR-------NLAV--L-- 225 (450)
Q Consensus 162 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~----~~~~~DiwSlGvil~elltG-~~Pf~~~-------~~~~--~-- 225 (450)
.+. .++......+|.+.|.+||.-.-..+ .++..|.|.||+++|++|.| +.||.+- +..+ +
T Consensus 165 qi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 165 QIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred eec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 321 23444556789999999997431111 14678999999999999996 9999751 1111 1
Q ss_pred ----H-HHHHhCCCCCC---CC--CCHHHHHHHHHcccc--CcCCCCCHHH
Q 013081 226 ----Y-QKIFRGDFKLP---KW--LSPGAQNLLRKILEP--NPVKRITIAG 264 (450)
Q Consensus 226 ----~-~~i~~~~~~~p---~~--~s~~~~~Li~~~L~~--dP~~R~t~~~ 264 (450)
+ .+-..+..+-| +| +++++..|..+|+.. +|.-|||++.
T Consensus 242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 0 01111112222 22 789999999999875 4678999753
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.6e-08 Score=93.91 Aligned_cols=105 Identities=23% Similarity=0.388 Sum_probs=85.5
Q ss_pred HHHHHHHHHHHhCCCCCc--ceEEEEEEeC----CEEEEEEccCCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhh
Q 013081 59 DQIKREIATLKLLKHPNV--VRLHEVLASK----SKIYMVLEYVTGG-ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131 (450)
Q Consensus 59 ~~~~~Ei~il~~l~hpnI--v~l~~~~~~~----~~~~lv~E~~~gg-~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH 131 (450)
.+..+|...+.+|..-+| .+.+.+.+.. ...++|+|+++|. +|.+.+.....++......++.+++..++-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 567889998888864333 4555555432 2458999999884 79998887555778888999999999999999
Q ss_pred hcCeeeccCCCCcEEEccCC---CeEEeecCCCCC
Q 013081 132 NKGVFHRDLKLENILLDSKG---NIKISDFGLSAL 163 (450)
Q Consensus 132 ~~givHrDlKp~NILl~~~g---~lkl~DFGla~~ 163 (450)
++||+|+|++|.|||++.++ .+.++||+-+..
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999999999999887 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.77 E-value=6.7e-08 Score=90.30 Aligned_cols=141 Identities=21% Similarity=0.241 Sum_probs=101.2
Q ss_pred EeeeecccCceEEEEEEECCCCceEEEEEeecccccchh---------------------HHHHHHHHHHHHHhCC--CC
Q 013081 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---------------------ITDQIKREIATLKLLK--HP 74 (450)
Q Consensus 18 i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~---------------------~~~~~~~Ei~il~~l~--hp 74 (450)
+...|+.|.-+.||+|.. .++..+|+|+.......-.. ......+|...|+++. +-
T Consensus 52 ~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV 130 (268)
T COG1718 52 LVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV 130 (268)
T ss_pred eEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 345788899999999985 57889999998654321111 1124567888888885 44
Q ss_pred CcceEEEEEEeCCEEEEEEccCCCCChH-HHHHhcCCCCHHHHHHHHHHHHHHHhhhhh-cCeeeccCCCCcEEEccCCC
Q 013081 75 NVVRLHEVLASKSKIYMVLEYVTGGELF-DKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGN 152 (450)
Q Consensus 75 nIv~l~~~~~~~~~~~lv~E~~~gg~L~-~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~-~givHrDlKp~NILl~~~g~ 152 (450)
.+.+.+.+. ...+||||+.....- -.+ +..++...++..+..+++..+.-|-. .|++|+||+.-|||+. +|.
T Consensus 131 rvP~Pi~~~----~nVLvMEfIg~~g~pAP~L-kDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~ 204 (268)
T COG1718 131 RVPEPIAFR----NNVLVMEFIGDDGLPAPRL-KDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGE 204 (268)
T ss_pred CCCCceeec----CCeEEEEeccCCCCCCCCc-ccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCe
Confidence 455556553 357899999543111 111 22345555899999999999998876 8999999999999999 889
Q ss_pred eEEeecCCCCCCC
Q 013081 153 IKISDFGLSALPQ 165 (450)
Q Consensus 153 lkl~DFGla~~~~ 165 (450)
+.++|||.|....
T Consensus 205 p~iID~~QaV~~~ 217 (268)
T COG1718 205 PYIIDVSQAVTID 217 (268)
T ss_pred EEEEECccccccC
Confidence 9999999988544
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.7e-07 Score=86.63 Aligned_cols=139 Identities=18% Similarity=0.257 Sum_probs=90.9
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHH------HHHHHHHHHHhCCCC---CcceEEEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD------QIKREIATLKLLKHP---NVVRLHEVL 83 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~------~~~~Ei~il~~l~hp---nIv~l~~~~ 83 (450)
-++|.+.+.+-......|.+..- +|+.+++|..+......+.... ...+++..+.++... ....++-+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 36788888888877777766553 6788999987654322221111 123444444444332 222322222
Q ss_pred E-----eCCEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeec
Q 013081 84 A-----SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDF 158 (450)
Q Consensus 84 ~-----~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DF 158 (450)
. -....+++|||++|.+|.+... +++ .+...+.+++.-+|+.|++|+|.+|.|+++++++ +++.||
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~ 178 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDT 178 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEEC
Confidence 1 1234568999999988876532 333 2445677789999999999999999999998655 999999
Q ss_pred CCCC
Q 013081 159 GLSA 162 (450)
Q Consensus 159 Gla~ 162 (450)
+..+
T Consensus 179 ~~k~ 182 (229)
T PF06176_consen 179 QGKR 182 (229)
T ss_pred cccc
Confidence 8665
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.67 E-value=7.7e-08 Score=100.37 Aligned_cols=136 Identities=25% Similarity=0.353 Sum_probs=91.7
Q ss_pred eeecccCceEEEEEEECCCCceEEEEEeecccccc-------------------------------hhHH------HHHH
Q 013081 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH-------------------------------LKIT------DQIK 62 (450)
Q Consensus 20 ~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~-------------------------------~~~~------~~~~ 62 (450)
+.|+.++-|.||.|+-. +|+.||||+.+..-... .++. -.+.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 67899999999999964 59999999986532100 0011 1344
Q ss_pred HHHHHHHhCC-----CCCcceEEEEE-EeCCEEEEEEccCCCCChHHHH--HhcCCCCHHH-----HHHHHHHHHHHHhh
Q 013081 63 REIATLKLLK-----HPNVVRLHEVL-ASKSKIYMVLEYVTGGELFDKI--ASKGRLQEAE-----GRKLFQQLIDGVSY 129 (450)
Q Consensus 63 ~Ei~il~~l~-----hpnIv~l~~~~-~~~~~~~lv~E~~~gg~L~~~i--~~~~~l~~~~-----~~~i~~ql~~aL~~ 129 (450)
+|...+.+++ .|++ .+=.++ +-.+.-.++|||+.|-.+.+.. .. .+++... +..++.|+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~~q~------ 281 (517)
T COG0661 210 REAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFLRQL------ 281 (517)
T ss_pred HHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHHHHH------
Confidence 5666665553 2333 222333 3345678999999999888773 44 4455332 23333333
Q ss_pred hhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCC
Q 013081 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (450)
Q Consensus 130 LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 165 (450)
=..|++|.|.+|.||+++.+|++.+.|||+....+
T Consensus 282 -~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 282 -LRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred -HhcCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 23899999999999999999999999999987543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.65 E-value=3.9e-07 Score=85.87 Aligned_cols=134 Identities=15% Similarity=0.225 Sum_probs=85.4
Q ss_pred eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--cceEEEEEEeCCEEEEEEccCC
Q 013081 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN--VVRLHEVLASKSKIYMVLEYVT 97 (450)
Q Consensus 20 ~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~~~~~~~~~lv~E~~~ 97 (450)
..||+|..+.||+. .|..+++|...... ....+.+|.++++.+..-+ +.+.+++.+..+..+++||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 57899999999973 25568889875422 1345789999999986443 4678888888888899999999
Q ss_pred CCC-hH--------------HHHHh------c---CCCCHHH-HHHHHHHH----------HH-HHhhhh----hcCeee
Q 013081 98 GGE-LF--------------DKIAS------K---GRLQEAE-GRKLFQQL----------ID-GVSYCH----NKGVFH 137 (450)
Q Consensus 98 gg~-L~--------------~~i~~------~---~~l~~~~-~~~i~~ql----------~~-aL~~LH----~~givH 137 (450)
|.+ +. ..+.. . ...+... ...+..++ .. ...+|. ...++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 863 11 11110 0 0111111 11111111 00 111111 124789
Q ss_pred ccCCCCcEEEccCCCeEEeecCCCCC
Q 013081 138 RDLKLENILLDSKGNIKISDFGLSAL 163 (450)
Q Consensus 138 rDlKp~NILl~~~g~lkl~DFGla~~ 163 (450)
+|+.|.||++++++ +.++||+.+..
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcCc
Confidence 99999999999888 99999998863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.57 E-value=8.3e-07 Score=81.79 Aligned_cols=138 Identities=17% Similarity=0.156 Sum_probs=97.8
Q ss_pred cccCceEEEEEEECCCCceEEEEEeecccccc---hhHHHHHHHHHHHHHhCCCCC--cceEEEEEE--e--CCEEEEEE
Q 013081 23 GEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH---LKITDQIKREIATLKLLKHPN--VVRLHEVLA--S--KSKIYMVL 93 (450)
Q Consensus 23 G~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~---~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~~~--~--~~~~~lv~ 93 (450)
|+||-+-|+.... .|+.+=+|.-....... .--...+.+|+..+++|..-+ +.++..... . .-.-+||+
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 5588888888764 34457777543111000 112467899999999996433 444441111 1 12367899
Q ss_pred ccCCC-CChHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCC--eEEeecCCCC
Q 013081 94 EYVTG-GELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN--IKISDFGLSA 162 (450)
Q Consensus 94 E~~~g-g~L~~~i~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~--lkl~DFGla~ 162 (450)
|-+.| .+|.+.+... .+.++.....++.+++.+++-||+.|+.|+|+-+.|||++.+|. ++++||.-++
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 97754 5888877652 35677888899999999999999999999999999999987777 9999998665
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.56 E-value=5.1e-09 Score=108.20 Aligned_cols=242 Identities=19% Similarity=0.174 Sum_probs=165.5
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN-VVRLHEVLASKSKIYMV 92 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~lv 92 (450)
..|....-+++|+++++++.+...+...+ .+.+... ....-++++|.+++||| .+..++-++.+...++.
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~ 312 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIP 312 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchh
Confidence 35667788999999999999976665544 5655322 34556889999999999 66667777778889999
Q ss_pred EccCCCC-ChHHHHH-hcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCC
Q 013081 93 LEYVTGG-ELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (450)
Q Consensus 93 ~E~~~gg-~L~~~i~-~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 170 (450)
++++.++ +-...+. ..-.+.+-+.....+.-+.+++++|+.--+||| |||..+ +..|..||+........
T Consensus 313 ~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~--- 384 (829)
T KOG0576|consen 313 MRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRT--- 384 (829)
T ss_pred hhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcc---
Confidence 9999887 2221110 111122333344455667889999998778998 887765 67899999988754321
Q ss_pred CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCC------CCCCHHH
Q 013081 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP------KWLSPGA 244 (450)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p------~~~s~~~ 244 (450)
....+..+++.++|||+.....+. ...|.|++|+--.++--|.+|-..+-.. ...+-.+ ...| .|-+..-
T Consensus 385 ~~~~t~~~~~~~~~pev~~~~~~~-~~p~~~~~~~~~~~~ap~~pPr~~P~~~--~~~~g~~-p~s~~L~~~~aw~~~~~ 460 (829)
T KOG0576|consen 385 MKPRTAIGTPEPLAPEVIQENTID-GCPDSGSLAVSAIQMAPGLPPRSSPPAV--LPMIGNG-PNSPMLTDKSAWSPVFH 460 (829)
T ss_pred cccccCCCCCCCCCchhhcccccc-cCCCccCCCcchhhcCCCCCCCCCCccc--cCCCCCC-CCccccchhhhcCcccc
Confidence 134567899999999998888776 6789999998777777787776441110 0000000 0001 1111122
Q ss_pred HHHHHHccccCcCCCCCHHHHHhccccccCCC
Q 013081 245 QNLLRKILEPNPVKRITIAGIKADEWFEQDYT 276 (450)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~~ 276 (450)
.++...|+..-|..|+....++.|.+|+....
T Consensus 461 ~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl 492 (829)
T KOG0576|consen 461 RDFPAPCLNGLPPTPKVHMGACFSKVFNGCPL 492 (829)
T ss_pred cCCcccccCCCCCCCcchhhHHHHHHhccCcc
Confidence 24778899999999999999999999986544
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.9e-06 Score=80.44 Aligned_cols=137 Identities=26% Similarity=0.334 Sum_probs=83.0
Q ss_pred eeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--cceEEEEE---EeCCEEEEEE
Q 013081 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN--VVRLHEVL---ASKSKIYMVL 93 (450)
Q Consensus 19 ~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~~---~~~~~~~lv~ 93 (450)
++.|+.|..+.||.+.... ..+++|..... .....+.+|..+++.+...+ +.+++... ......+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 5789999999999999754 48999986543 23567889999998886333 45666543 3344679999
Q ss_pred ccCCCCChHH----------------HHH---hc----CCCCHHH---H---HHH---------------HHHHHH-HHh
Q 013081 94 EYVTGGELFD----------------KIA---SK----GRLQEAE---G---RKL---------------FQQLID-GVS 128 (450)
Q Consensus 94 E~~~gg~L~~----------------~i~---~~----~~l~~~~---~---~~i---------------~~ql~~-aL~ 128 (450)
++++|..+.. .+. .. .++.... . ... ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999987776 111 11 1111100 0 000 111222 233
Q ss_pred hhh-------hcCeeeccCCCCcEEEc-cCCCeEEeecCCCC
Q 013081 129 YCH-------NKGVFHRDLKLENILLD-SKGNIKISDFGLSA 162 (450)
Q Consensus 129 ~LH-------~~givHrDlKp~NILl~-~~g~lkl~DFGla~ 162 (450)
.++ ...++|+|+.|.|||++ +++.+-|.||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 333 24699999999999999 66667899999775
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.42 E-value=3e-06 Score=93.46 Aligned_cols=205 Identities=19% Similarity=0.209 Sum_probs=146.3
Q ss_pred HHHHHHHHHHHhCCCCCcceEEEEEEeCCEE----EEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcC
Q 013081 59 DQIKREIATLKLLKHPNVVRLHEVLASKSKI----YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134 (450)
Q Consensus 59 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~----~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~g 134 (450)
....-|...+....|+|++.++.+...+... .+..++|+..++.+.++.-+..+...++.+..++..||+|+|+..
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 3344566777888999999999987554333 344689999999999999999999999999999999999999996
Q ss_pred eeeccCCCC---cEEEccCCCeEEe--ecCCCCCCCcccCCCccccccCCCCccchhhhccCCCC-CccchhhhHHHHHH
Q 013081 135 VFHRDLKLE---NILLDSKGNIKIS--DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD-GATSDIWSCGVILY 208 (450)
Q Consensus 135 ivHrDlKp~---NILl~~~g~lkl~--DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~~~DiwSlGvil~ 208 (450)
..|.-+... +-..+.++.+..+ ||+.+.... +........-+..+.|||....+.+. +...|+|++|..+.
T Consensus 307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~---d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~ 383 (1351)
T KOG1035|consen 307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLP---DNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL 383 (1351)
T ss_pred cceeEEecccccccccCccceeecchhhhcccccCC---CcccchhhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence 666555444 4444556666666 888776432 22223334456678888887665543 22369999999999
Q ss_pred HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCC
Q 013081 209 VILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 209 elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
.+..|..+-..... .... .+........+++.+|+.-++++|+++.+++.|++.....
T Consensus 384 ~~~~~~~i~~~~~~---~~~~------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~ 441 (1351)
T KOG1035|consen 384 QLSQGEDISEKSAV---PVSL------LDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPT 441 (1351)
T ss_pred hhhhcCcccccccc---hhhh------hccccchhhhhhhhhhcchhhhhccchhhhhhchhccccc
Confidence 99988665322111 0011 1111222678899999999999999999999999986543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.40 E-value=3e-06 Score=80.61 Aligned_cols=135 Identities=19% Similarity=0.171 Sum_probs=84.2
Q ss_pred eecccCc-eEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEccCCC
Q 013081 21 TLGEGNF-GKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMVLEYVTG 98 (450)
Q Consensus 21 ~LG~G~~-g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv~E~~~g 98 (450)
.|-.|.. +.||+... .+..+.+|+..... ...+.+|+.+++.+. +--+.+++++....+..++|||+++|
T Consensus 5 ~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 5 RVTEGQSGATVYRLDG--KNPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred ecCCCCCcCeEEEEcC--CCCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 3444555 78998875 34678889875432 245678999998884 44466788877766778999999999
Q ss_pred CChHHHH----------------HhcC-------CCCHH------HHHHH-------------------HHHHHHHHhh-
Q 013081 99 GELFDKI----------------ASKG-------RLQEA------EGRKL-------------------FQQLIDGVSY- 129 (450)
Q Consensus 99 g~L~~~i----------------~~~~-------~l~~~------~~~~i-------------------~~ql~~aL~~- 129 (450)
.+|.... ..-. ++... ..... ..++...|..
T Consensus 77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 156 (244)
T cd05150 77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT 156 (244)
T ss_pred ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence 7765331 0000 11100 00000 0111111111
Q ss_pred ---hhhcCeeeccCCCCcEEEccCCCeEEeecCCCCC
Q 013081 130 ---CHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL 163 (450)
Q Consensus 130 ---LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~ 163 (450)
.....++|+|+.|.|||+++++.+.|+||+.|..
T Consensus 157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 1123589999999999999987788999998763
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.30 E-value=7.8e-06 Score=91.27 Aligned_cols=145 Identities=19% Similarity=0.384 Sum_probs=91.8
Q ss_pred EeeeecccCceEEEEEEECCCC--ceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCc--ceEEEEEEeC---CEE
Q 013081 18 LGRTLGEGNFGKVKFAQDLDSG--LPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNV--VRLHEVLASK---SKI 89 (450)
Q Consensus 18 i~~~LG~G~~g~Vy~a~~~~~~--~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnI--v~l~~~~~~~---~~~ 89 (450)
-++.|+.|.+..+|+......+ ..+++|......... ....+.+|+++++.+. |+++ .+++.++.+. +..
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 3677899999999998764432 467788754332111 1356889999999995 6665 7778777654 467
Q ss_pred EEEEccCCCCChHH--------------------HHH---hcC----CC---------CHHHHHHHHHH-----------
Q 013081 90 YMVLEYVTGGELFD--------------------KIA---SKG----RL---------QEAEGRKLFQQ----------- 122 (450)
Q Consensus 90 ~lv~E~~~gg~L~~--------------------~i~---~~~----~l---------~~~~~~~i~~q----------- 122 (450)
|+||||++|..+.+ .+. .-. .+ ...++..|..|
T Consensus 120 flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~ 199 (822)
T PLN02876 120 FYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPP 199 (822)
T ss_pred eEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCC
Confidence 99999998864321 111 100 01 01123222222
Q ss_pred ----HHHHHhhhhh-----------cCeeeccCCCCcEEEccC-CC-eEEeecCCCCCC
Q 013081 123 ----LIDGVSYCHN-----------KGVFHRDLKLENILLDSK-GN-IKISDFGLSALP 164 (450)
Q Consensus 123 ----l~~aL~~LH~-----------~givHrDlKp~NILl~~~-g~-lkl~DFGla~~~ 164 (450)
+...+++|.. ..++|+|++|.|||++.+ +. .-|.||+++..-
T Consensus 200 ~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 200 RNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred CChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 2233455532 259999999999999853 34 579999998863
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.9e-05 Score=72.32 Aligned_cols=128 Identities=24% Similarity=0.284 Sum_probs=91.7
Q ss_pred CCeEEeeeecccCc-eEEEEEEECCCCceEEEEEeeccc----------ccc-h-------hHHHHHHHHHHHHHhCC--
Q 013081 14 GRYELGRTLGEGNF-GKVKFAQDLDSGLPFAVKILEKNR----------IIH-L-------KITDQIKREIATLKLLK-- 72 (450)
Q Consensus 14 ~~y~i~~~LG~G~~-g~Vy~a~~~~~~~~vAvK~i~~~~----------~~~-~-------~~~~~~~~Ei~il~~l~-- 72 (450)
..++.++.||.|+- |.||++.- .|+.+|+|++..-. ... . .....+..|.++..+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 67899999999999 99999986 78899999932200 000 0 22346788998888775
Q ss_pred -CCCc--ceEEEEEEeC------------------CEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhh
Q 013081 73 -HPNV--VRLHEVLASK------------------SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131 (450)
Q Consensus 73 -hpnI--v~l~~~~~~~------------------~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH 131 (450)
+.++ ++.+++..-. ....||.||++... .+.. .-+.+|.+-+..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~----~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQI----RDIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccch----hHHHHHHHHHHHHH
Confidence 4455 8999987211 12457888876543 2233 33456777788899
Q ss_pred hcCeeeccCCCCcEEEccCCCeEEeecCCC
Q 013081 132 NKGVFHRDLKLENILLDSKGNIKISDFGLS 161 (450)
Q Consensus 132 ~~givHrDlKp~NILl~~~g~lkl~DFGla 161 (450)
..||+-+|+++.|.. +-||+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc-----CCEEEecccC
Confidence 999999999999975 3489999864
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.17 E-value=1.2e-05 Score=83.99 Aligned_cols=141 Identities=21% Similarity=0.214 Sum_probs=89.7
Q ss_pred eeeecccCceEEEEEEECCCCceEEEEEeecccccc----------------------------hhHHH------HHHHH
Q 013081 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH----------------------------LKITD------QIKRE 64 (450)
Q Consensus 19 ~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~----------------------------~~~~~------~~~~E 64 (450)
-+.||.-+.|.|++|+-+. |+.||||+-+..-... .+..+ .+.+|
T Consensus 166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 3689999999999999655 9999999865421100 01111 23445
Q ss_pred HHHHHhC----CCCC------cceEEEEEEeCCEEEEEEccCCCCChHHH--HHhcCCCCHHHHHHHHHHHHHHHhhhhh
Q 013081 65 IATLKLL----KHPN------VVRLHEVLASKSKIYMVLEYVTGGELFDK--IASKGRLQEAEGRKLFQQLIDGVSYCHN 132 (450)
Q Consensus 65 i~il~~l----~hpn------Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~--i~~~~~l~~~~~~~i~~ql~~aL~~LH~ 132 (450)
.+...+. .|-+ |.++|-- -.+...++||||+|..+.|. |.+ ..++...+...+.+...-. +=.
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i~~~l~~~~~~q--If~ 319 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDK-RGISPHDILNKLVEAYLEQ--IFK 319 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHH-cCCCHHHHHHHHHHHHHHH--HHh
Confidence 4444333 3555 3333322 23467899999999887654 444 3456554433333322211 224
Q ss_pred cCeeeccCCCCcEEEcc----CCCeEEeecCCCCCCC
Q 013081 133 KGVFHRDLKLENILLDS----KGNIKISDFGLSALPQ 165 (450)
Q Consensus 133 ~givHrDlKp~NILl~~----~g~lkl~DFGla~~~~ 165 (450)
.|++|+|=+|.||+++. ++.+.+-|||+.....
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 68999999999999984 5679999999988543
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=98.14 E-value=2e-07 Score=104.21 Aligned_cols=211 Identities=18% Similarity=0.079 Sum_probs=149.7
Q ss_pred HHHHHHHHHHHhCCCCCcceEEEEEE--eCCEEEEEEccCCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHhhhhh
Q 013081 59 DQIKREIATLKLLKHPNVVRLHEVLA--SKSKIYMVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYCHN 132 (450)
Q Consensus 59 ~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~~~~lv~E~~~gg~L~~~i~~~----~~l~~~~~~~i~~ql~~aL~~LH~ 132 (450)
+....|..-++...|+++.....-.. +....|..++|+.+|.+++.|-+. .++.+.-+....++.+.+..-+|+
T Consensus 1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence 33444555666778999887766553 344578999999999999998642 345555566666666888888886
Q ss_pred c-C----eeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHH
Q 013081 133 K-G----VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 207 (450)
Q Consensus 133 ~-g----ivHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil 207 (450)
+ + .+|+++|+-|.+|..+.++|+.++|+.++..+ .........+++.|++|++...-.+. .++|+|..|+-+
T Consensus 1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t-~rsdilr~s~~l 1430 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFT-KRSDILRRSLSL 1430 (2724)
T ss_pred cccCCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhh-hHHHHHHHHHHH
Confidence 5 2 78999999999999999999999999984322 22345566788999999998777764 569999999999
Q ss_pred HHHHhCCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccc
Q 013081 208 YVILTGYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 272 (450)
Q Consensus 208 ~elltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~ 272 (450)
|.+..|..+|-......+...+..+ ..+++...|.++-.....+|-+.-..||.-..++.-+.+.
T Consensus 1431 y~rs~~n~~fi~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1431 YLRSDGNAYFIFFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred HHHhcccHHHHHHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 9999998887432222222222222 2334444455666666666667777888887777777664
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.14 E-value=2e-05 Score=70.17 Aligned_cols=129 Identities=18% Similarity=0.248 Sum_probs=91.6
Q ss_pred EEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcc-eEEEEEEeCCEEEEEEcc
Q 013081 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV-RLHEVLASKSKIYMVLEY 95 (450)
Q Consensus 17 ~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv-~l~~~~~~~~~~~lv~E~ 95 (450)
+..+.||+|++|.||++.+ .|..+|+|+-+.+.. ...+..|+++|..+.-.++. +++.+.. ..+.|||
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~-----r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~ 93 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSP-----RRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEY 93 (201)
T ss_pred hhhhhhhcccccEEEEeec--cCceEEEEEecCCcc-----hhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhh
Confidence 3467899999999999997 566899998654432 57899999999999876664 4555543 3355999
Q ss_pred CCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCC-CCcEEEccCCCeEEeecCCCCC
Q 013081 96 VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK-LENILLDSKGNIKISDFGLSAL 163 (450)
Q Consensus 96 ~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlK-p~NILl~~~g~lkl~DFGla~~ 163 (450)
+.|.+|.+.-... + ++-...++++---|-..||-|+.|. |...++..++.+.|+||.-|+.
T Consensus 94 i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 94 IDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 9998886653321 2 2223344555334566799999886 5555565666999999998874
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.13 E-value=1.3e-05 Score=75.86 Aligned_cols=73 Identities=12% Similarity=0.048 Sum_probs=46.6
Q ss_pred eeeecccCceE-EEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCC---CcceEEEEEEeC---CEEEE
Q 013081 19 GRTLGEGNFGK-VKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP---NVVRLHEVLASK---SKIYM 91 (450)
Q Consensus 19 ~~~LG~G~~g~-Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp---nIv~l~~~~~~~---~~~~l 91 (450)
++.|+.|+... ||... ..+++|+.+... ....+.+|..+++.+... .+.++++..... ...|+
T Consensus 2 ~~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~ 71 (235)
T cd05155 2 IEPVDSGGTDNATFRLG-----DDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS 71 (235)
T ss_pred ceeccCCCcccceEEcC-----CceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence 35677777764 88752 247788754321 135788999999888632 344455443322 24588
Q ss_pred EEccCCCCCh
Q 013081 92 VLEYVTGGEL 101 (450)
Q Consensus 92 v~E~~~gg~L 101 (450)
+|++++|.++
T Consensus 72 l~~~i~G~~l 81 (235)
T cd05155 72 VYRWLEGETA 81 (235)
T ss_pred EEEeecCCCC
Confidence 9999998766
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.00 E-value=0.00015 Score=66.80 Aligned_cols=134 Identities=20% Similarity=0.248 Sum_probs=95.0
Q ss_pred eeeecccCceEEEEEEECCCCceEEEEEeeccccc-------------chhHHHHHHHHHHHHHhCC------CCCcceE
Q 013081 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-------------HLKITDQIKREIATLKLLK------HPNVVRL 79 (450)
Q Consensus 19 ~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~-------------~~~~~~~~~~Ei~il~~l~------hpnIv~l 79 (450)
...||+|+.=.||. |+ ......||++...... .....++..+|+.-...+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~--HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEE--CC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 35789999999984 33 3344788998766500 0112356677777776666 7889999
Q ss_pred EEEEEeCCEEEEEEccCC------CCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCC--
Q 013081 80 HEVLASKSKIYMVLEYVT------GGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-- 151 (450)
Q Consensus 80 ~~~~~~~~~~~lv~E~~~------gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g-- 151 (450)
+++.+++....+|+|.+. +.+|.+++.+ +.+++ .. ...+-+-..||-+++|+.+|++|.||++..++
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 999999999999999763 2467888854 45666 33 34444556778889999999999999996543
Q ss_pred --CeEEee-cCC
Q 013081 152 --NIKISD-FGL 160 (450)
Q Consensus 152 --~lkl~D-FGl 160 (450)
.+.|+| ||-
T Consensus 158 ~~~lvlIDG~G~ 169 (199)
T PF10707_consen 158 EFRLVLIDGLGE 169 (199)
T ss_pred ceEEEEEeCCCC
Confidence 466776 453
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.93 E-value=9.4e-05 Score=72.97 Aligned_cols=145 Identities=21% Similarity=0.322 Sum_probs=101.6
Q ss_pred EeeeecccCceEEEEEEECCCCceEEEEEeeccccc----------------------chhHH-HHHHHHHHHHHhCCCC
Q 013081 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII----------------------HLKIT-DQIKREIATLKLLKHP 74 (450)
Q Consensus 18 i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~----------------------~~~~~-~~~~~Ei~il~~l~hp 74 (450)
+-..|..|.-+.||.|.. .+|..+|||+.+.+-.. ...++ -...+|++.|.+|+..
T Consensus 148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 556788999999999984 67888999987542110 11111 2456799999999766
Q ss_pred CcceEEEEEEeCCEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhh-hhcCeeeccCCCCcEEEccCCCe
Q 013081 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC-HNKGVFHRDLKLENILLDSKGNI 153 (450)
Q Consensus 75 nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~L-H~~givHrDlKp~NILl~~~g~l 153 (450)
+|.-.--+.- ....+||+|+.+..-..-.-++..++...+..+.+|++.-+.-| |.+++||.||.--|+|+ .+|.+
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~l 303 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGKL 303 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCEE
Confidence 5432211111 23568999994322111112345688899999999999888887 56799999999999999 66789
Q ss_pred EEeecCCCCCCCc
Q 013081 154 KISDFGLSALPQH 166 (450)
Q Consensus 154 kl~DFGla~~~~~ 166 (450)
.++|.+.+...++
T Consensus 304 yiIDVSQSVE~DH 316 (520)
T KOG2270|consen 304 YIIDVSQSVEHDH 316 (520)
T ss_pred EEEEccccccCCC
Confidence 9999998875443
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00031 Score=71.44 Aligned_cols=80 Identities=20% Similarity=0.211 Sum_probs=55.7
Q ss_pred eeeecccCceEEEEEEECCCCceEEEEEeeccccc--c--hhHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEE
Q 013081 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII--H--LKITDQIKREIATLKLLK---HPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 19 ~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~--~--~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~l 91 (450)
.+.||.|.+..||++.+...++.|+||.-...... . .-..++...|.+.|+.+. ..++.+++.+ +....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 46899999999999998644468999975321110 0 112467788888888873 3467777777 3455789
Q ss_pred EEccCCCCC
Q 013081 92 VLEYVTGGE 100 (450)
Q Consensus 92 v~E~~~gg~ 100 (450)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998643
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.89 E-value=5.1e-05 Score=69.36 Aligned_cols=98 Identities=19% Similarity=0.239 Sum_probs=78.5
Q ss_pred HHHHHHHhCCC-CCcceEEEEEEeCCEEEEEEccCCCCChHHH---HHhcCCCCHHHHHHHHHHHHHHHhhhhh---cCe
Q 013081 63 REIATLKLLKH-PNVVRLHEVLASKSKIYMVLEYVTGGELFDK---IASKGRLQEAEGRKLFQQLIDGVSYCHN---KGV 135 (450)
Q Consensus 63 ~Ei~il~~l~h-pnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~---i~~~~~l~~~~~~~i~~ql~~aL~~LH~---~gi 135 (450)
.|.-+++.+.+ +++.+++|.|- .+++.||...+++... +..-..-++....+++.|+++.+.+++. ..+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 58888999975 69999999872 2567899987766421 1122335889999999999999999987 347
Q ss_pred eeccCCCCcEEEccCCCeEEeecCCCCCC
Q 013081 136 FHRDLKLENILLDSKGNIKISDFGLSALP 164 (450)
Q Consensus 136 vHrDlKp~NILl~~~g~lkl~DFGla~~~ 164 (450)
.-.|++|+|+-++++|++|++|...+...
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcchh
Confidence 88999999999999999999999977643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF02149 KA1: Kinase associated domain 1; InterPro: IPR001772 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.86 E-value=2.2e-05 Score=54.38 Aligned_cols=43 Identities=28% Similarity=0.554 Sum_probs=38.4
Q ss_pred CceEEEEEEEEEc-CCeEEEEEEeccCCcceeeeccchhhHHHHHHHHhhhcC
Q 013081 387 GSLSVAAEVFEIS-PSLYVVELRKSYGDPTVYRQIKTSIVFVQLCNKLSSDLG 438 (450)
Q Consensus 387 ~~l~~~~~i~~~~-~~~~~v~~~~~~Gd~le~~~~~~~~~~~~~~~~~~~~l~ 438 (450)
..+.|.+||+.+. ++++.|+|+|.+||.+.|++ +|+++...|+
T Consensus 3 ~~v~fEieV~kl~~~~l~Gv~~kRi~Gd~~~yk~---------lc~~il~~l~ 46 (47)
T PF02149_consen 3 EVVKFEIEVCKLPRLGLYGVDFKRISGDSWQYKD---------LCSKILNELR 46 (47)
T ss_dssp C-EEEEEEEEEECCCTCEEEEEEEEES-HHHHHH---------HHHHHHHHTT
T ss_pred cceEEEEEEEEecCCCeeEEEEEEeeCCHHHHHH---------HHHHHHHHcc
Confidence 6789999999998 89999999999999999999 9999888775
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. Members of the KIN2/PAR-1/MARK kinase subfamily are conserved from yeast to human and share the same domain organisation: an N-terminal kinase domain (IPR000719 from INTERPRO) and a C-terminal kinase associated domain 1 (KA1). Some members of the KIN1/PAR-1/MARK family also contain an UBA domain (IPR000449 from INTERPRO). Members of this kinase subfamily are involved in various biological processes such as cell polarity, cell cycle control, intracellular signalling, microtubule stability and protein stability []. The function of the KA1 domain is not yet known. Some proteins known to contain a KA1 domain are listed below: Mammalian MAP/microtubule affinity-regulating kinases (MARK 1,2,3). They regulate polarity in neuronal cell models and appear to function redundantly in phosphorylating MT-associated proteins and in regulating MT stability []. Mammalian maternal embryonic leucine zipper kinase (MELK). It phosphorylates ZNF622 and may contribute to its redirection to the nucleus. It may be involved in the inhibition of spliceosome assembly during mitosis. Caenorhabditis elegans and drosophila PAR-1 protein. It is required for establishing polarity in embryos where it is asymmetrically distributed []. Fungal Kin1 and Kin2 protein kinases involved in regulation of exocytosis. They localise to the cytoplasmic face of the plasma membrane []. Plant KIN10 and KIN11 proteins, catalytic subunits of the putative trimeric SNF1-related protein kinase (SnRK) complex. This entry represents the KA1 domain.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3OSE_A 1V5S_A 1UL7_A. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00034 Score=68.74 Aligned_cols=78 Identities=13% Similarity=0.095 Sum_probs=56.0
Q ss_pred EEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCC---CCcceEEEEEEe---CCEEE
Q 013081 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH---PNVVRLHEVLAS---KSKIY 90 (450)
Q Consensus 17 ~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~h---pnIv~l~~~~~~---~~~~~ 90 (450)
.-.+.||.|..+.||..... ++ .+.+|..+ ... . ...+.+|...|+.|.- -.+.++++++.. .+..+
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~-~~~-~---~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~ 89 (297)
T PRK10593 17 SRVECISEQPYAALWALYDS-QG-NPMPLMAR-SFS-T---PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV 89 (297)
T ss_pred heeeecCCccceeEEEEEcC-CC-CEEEEEec-ccc-c---chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence 34678999999999988642 23 57778743 211 1 2578899999998853 357788877754 46689
Q ss_pred EEEccCCCCCh
Q 013081 91 MVLEYVTGGEL 101 (450)
Q Consensus 91 lv~E~~~gg~L 101 (450)
+|||+++|+++
T Consensus 90 LVmE~i~G~~~ 100 (297)
T PRK10593 90 LLLERLRGVSV 100 (297)
T ss_pred EEEeccCCEec
Confidence 99999998754
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.82 E-value=1.2e-05 Score=77.83 Aligned_cols=136 Identities=21% Similarity=0.288 Sum_probs=98.5
Q ss_pred eEEeeeecccCceEEEEEEECCCCceEEEEEeecccccc-----------------hhH--HHHHHHHHHHHHhCCC--C
Q 013081 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH-----------------LKI--TDQIKREIATLKLLKH--P 74 (450)
Q Consensus 16 y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~-----------------~~~--~~~~~~Ei~il~~l~h--p 74 (450)
|.+++.||-|.-+.+|.+.+ ..|++.++|+-+..+..- .-. .-...+|...|+.|.. -
T Consensus 94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 67899999999999999986 568889999654322110 000 1235578888888852 3
Q ss_pred CcceEEEEEEeCCEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeE
Q 013081 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIK 154 (450)
Q Consensus 75 nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lk 154 (450)
-+.+.+++ ++.++|||++.|-.|...-. ...+..+...++.-+--|-.+|+||+|..--||++++++.++
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~ 242 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV 242 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence 35555554 56789999999987755321 122344555666667778899999999999999999999999
Q ss_pred EeecCCCC
Q 013081 155 ISDFGLSA 162 (450)
Q Consensus 155 l~DFGla~ 162 (450)
++||-...
T Consensus 243 vIDFPQmv 250 (465)
T KOG2268|consen 243 VIDFPQMV 250 (465)
T ss_pred EeechHhh
Confidence 99998654
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00018 Score=70.44 Aligned_cols=137 Identities=19% Similarity=0.191 Sum_probs=83.7
Q ss_pred EeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--cceEEEE------EEeCCEE
Q 013081 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN--VVRLHEV------LASKSKI 89 (450)
Q Consensus 18 i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~------~~~~~~~ 89 (450)
-.+.|..|....+|+... .+..+++|+.... . ...+..|+.+++.+.+.+ +.+++.. ....+..
T Consensus 18 ~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~---~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~ 89 (296)
T cd05153 18 SFEGISAGIENTNYFVTT--DSGRYVLTLFEKV---S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKP 89 (296)
T ss_pred heecccCccccceEEEEe--CCCcEEEEEcCCC---C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCce
Confidence 366788888889998864 3457899987531 1 356777888888885332 4444431 2334567
Q ss_pred EEEEccCCCCChHH-----------HH---Hh-cCCCCH--------HHH----H--------HHHHHHHHHHhhhhh--
Q 013081 90 YMVLEYVTGGELFD-----------KI---AS-KGRLQE--------AEG----R--------KLFQQLIDGVSYCHN-- 132 (450)
Q Consensus 90 ~lv~E~~~gg~L~~-----------~i---~~-~~~l~~--------~~~----~--------~i~~ql~~aL~~LH~-- 132 (450)
+++++|++|..+.. .+ .. ...+.. .-. . .....+..++.++.+
T Consensus 90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~ 169 (296)
T cd05153 90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD 169 (296)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence 89999999876421 01 10 000000 000 0 011112233444432
Q ss_pred -----cCeeeccCCCCcEEEccCCCeEEeecCCCC
Q 013081 133 -----KGVFHRDLKLENILLDSKGNIKISDFGLSA 162 (450)
Q Consensus 133 -----~givHrDlKp~NILl~~~g~lkl~DFGla~ 162 (450)
.+++|+|+.|.|||+++++...|.||+.+.
T Consensus 170 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 170 PSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999988777899999876
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00038 Score=65.58 Aligned_cols=137 Identities=18% Similarity=0.191 Sum_probs=81.4
Q ss_pred eeeecccCceEEEEEEECC-CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEccC
Q 013081 19 GRTLGEGNFGKVKFAQDLD-SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-VRLHEVLASKSKIYMVLEYV 96 (450)
Q Consensus 19 ~~~LG~G~~g~Vy~a~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lv~E~~ 96 (450)
++.|..|-...+|++.... .++.|++|+....... .-...+|+.+++.+...++ .+++.... + .++|||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~----~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL----IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc----eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEee
Confidence 4677888888999987543 3568999976543211 1234579999998864333 44544332 2 4799999
Q ss_pred CCCChHHH----------H----H---hcC-CC----------C-HHHHHHHHHHH----------------------H-
Q 013081 97 TGGELFDK----------I----A---SKG-RL----------Q-EAEGRKLFQQL----------------------I- 124 (450)
Q Consensus 97 ~gg~L~~~----------i----~---~~~-~l----------~-~~~~~~i~~ql----------------------~- 124 (450)
+|.++... + . ... .. . ......+...+ .
T Consensus 75 ~G~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 154 (235)
T cd05157 75 PGRTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRD 154 (235)
T ss_pred CCCcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHH
Confidence 98765211 1 1 000 11 1 11222222111 1
Q ss_pred --HHHhh-h----hhcCeeeccCCCCcEEEcc-CCCeEEeecCCCCC
Q 013081 125 --DGVSY-C----HNKGVFHRDLKLENILLDS-KGNIKISDFGLSAL 163 (450)
Q Consensus 125 --~aL~~-L----H~~givHrDlKp~NILl~~-~g~lkl~DFGla~~ 163 (450)
..|.. + ...+++|+|+.|.|||+++ ++.+.+.||..|..
T Consensus 155 ~~~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 155 EISWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 11111 1 1236999999999999998 57899999998863
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00011 Score=70.36 Aligned_cols=133 Identities=17% Similarity=0.169 Sum_probs=78.7
Q ss_pred eecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEccCCCC
Q 013081 21 TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-VRLHEVLASKSKIYMVLEYVTGG 99 (450)
Q Consensus 21 ~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lv~E~~~gg 99 (450)
.+..|-.+.+|+.. .+++.+++|+...... ...-...+|..+++.+...++ .+++.... -++||||++|.
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~ 73 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCK---ALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGE 73 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccc---cccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCc
Confidence 45668888999887 3567888997543211 110135679999998864333 34444332 36899999986
Q ss_pred ChHH--------------HHH---hc----CCCCH-HHHHHHHHHHH---------HHHhhhh--------hcCeeeccC
Q 013081 100 ELFD--------------KIA---SK----GRLQE-AEGRKLFQQLI---------DGVSYCH--------NKGVFHRDL 140 (450)
Q Consensus 100 ~L~~--------------~i~---~~----~~l~~-~~~~~i~~ql~---------~aL~~LH--------~~givHrDl 140 (450)
.+.. .+. .. .+++. .....+..++. ..+..+- ...++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 6531 111 10 11221 12223322221 1111111 125899999
Q ss_pred CCCcEEEccCCCeEEeecCCCCC
Q 013081 141 KLENILLDSKGNIKISDFGLSAL 163 (450)
Q Consensus 141 Kp~NILl~~~g~lkl~DFGla~~ 163 (450)
.|.||++++++ +.|.||..|..
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCc
Confidence 99999999877 78999998874
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00041 Score=68.35 Aligned_cols=140 Identities=17% Similarity=0.220 Sum_probs=82.9
Q ss_pred eEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--cceEEEEE------EeCC
Q 013081 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN--VVRLHEVL------ASKS 87 (450)
Q Consensus 16 y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~~------~~~~ 87 (450)
..-++.++.|....+|++.. .+| .+++|+.+... . ...+..|+++++.|...+ +.+++... ...+
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~--~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g 96 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV--K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAG 96 (307)
T ss_pred ceeccccCCccccceEEEEe-CCC-cEEEEEecCCC--C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCC
Confidence 34467788888889998864 334 57889875422 1 234556777777774322 34443321 2245
Q ss_pred EEEEEEccCCCCChH-----------HHH---Hh-cCCCC--------HHH-----HH----------HHHHHHHHHHhh
Q 013081 88 KIYMVLEYVTGGELF-----------DKI---AS-KGRLQ--------EAE-----GR----------KLFQQLIDGVSY 129 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~-----------~~i---~~-~~~l~--------~~~-----~~----------~i~~ql~~aL~~ 129 (450)
..+++++|++|.++. ..+ .. ...++ ... .. .....+...+++
T Consensus 97 ~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 176 (307)
T TIGR00938 97 KPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDY 176 (307)
T ss_pred eEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHH
Confidence 678999999986531 111 10 00110 000 00 001122334544
Q ss_pred hh-------hcCeeeccCCCCcEEEccCCCeEEeecCCCC
Q 013081 130 CH-------NKGVFHRDLKLENILLDSKGNIKISDFGLSA 162 (450)
Q Consensus 130 LH-------~~givHrDlKp~NILl~~~g~lkl~DFGla~ 162 (450)
+. ..+++|+|+++.||++++++.+.|.||+.+.
T Consensus 177 l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 177 LDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 43 2589999999999999998877899999876
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00073 Score=66.31 Aligned_cols=76 Identities=13% Similarity=0.130 Sum_probs=49.1
Q ss_pred eeeecccCceEEEEEEECC------CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEE
Q 013081 19 GRTLGEGNFGKVKFAQDLD------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-VRLHEVLASKSKIYM 91 (450)
Q Consensus 19 ~~~LG~G~~g~Vy~a~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~l 91 (450)
++.|..|-...||++.... +++.+++|+...... ......+|..+++.+...++ .+++..+. + ..
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE----LLIDRERELVVFARLSERNLGPKLYGIFP-N---GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc----ceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cc
Confidence 3556667777899887533 267899999754321 12356788888888864333 35555543 2 35
Q ss_pred EEccCCCCChH
Q 013081 92 VLEYVTGGELF 102 (450)
Q Consensus 92 v~E~~~gg~L~ 102 (450)
|+||++|..+.
T Consensus 75 v~e~i~G~~l~ 85 (302)
T cd05156 75 IEEFIPSRTLT 85 (302)
T ss_pred hhheeCCCcCC
Confidence 89999887653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.002 Score=64.40 Aligned_cols=77 Identities=19% Similarity=0.142 Sum_probs=50.3
Q ss_pred eeecccCceEEEEEEECCCCceEEEEEeecccc----cchhHHHHHHHHHHHHHhCC--CC-CcceEEEEEEeCCEEEEE
Q 013081 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI----IHLKITDQIKREIATLKLLK--HP-NVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 20 ~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~~~~~Ei~il~~l~--hp-nIv~l~~~~~~~~~~~lv 92 (450)
+.||.|...-||++.+...++.|+||.-...-. .-.-..++..-|...|+... .| .+.+++.+ ++....+|
T Consensus 1 ~EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~v 78 (370)
T TIGR01767 1 QEVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTV 78 (370)
T ss_pred CcCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceeh
Confidence 357999999999999854446899996431110 00112466778888888764 34 45555554 44556689
Q ss_pred EccCCC
Q 013081 93 LEYVTG 98 (450)
Q Consensus 93 ~E~~~g 98 (450)
||+++.
T Consensus 79 MEdL~~ 84 (370)
T TIGR01767 79 MEDLSH 84 (370)
T ss_pred HhhCcc
Confidence 999854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0065 Score=60.08 Aligned_cols=136 Identities=15% Similarity=0.220 Sum_probs=75.6
Q ss_pred eeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--cceEEE------EEEeCCEEE
Q 013081 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN--VVRLHE------VLASKSKIY 90 (450)
Q Consensus 19 ~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~------~~~~~~~~~ 90 (450)
.+.|+.|....+|.... .+| .+++|++.. . . ...+..|+.+++.|...+ +.+.+. +....+..+
T Consensus 27 ~~~l~~G~~n~~y~v~t-~~g-~~vLK~~~~--~-~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~ 98 (319)
T PRK05231 27 LKGIAEGIENSNFFLTT-TQG-EYVLTLFER--L-T---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPA 98 (319)
T ss_pred cchhccccccceEEEEe-CCC-cEEEEEecc--C-C---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEE
Confidence 45677788889998874 233 689998751 1 1 233445666666653222 333332 123356789
Q ss_pred EEEccCCCCChH-----------HHHH---h-cCCC--------C--H--HHHH-----------HHHHH-HHHHHhhhh
Q 013081 91 MVLEYVTGGELF-----------DKIA---S-KGRL--------Q--E--AEGR-----------KLFQQ-LIDGVSYCH 131 (450)
Q Consensus 91 lv~E~~~gg~L~-----------~~i~---~-~~~l--------~--~--~~~~-----------~i~~q-l~~aL~~LH 131 (450)
++++|++|..+. ..+. . ...+ . . .... ..+.+ +...++.+.
T Consensus 99 ~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 178 (319)
T PRK05231 99 AIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLA 178 (319)
T ss_pred EEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhh
Confidence 999999987431 1111 0 0001 0 0 0000 11111 111122222
Q ss_pred -------hcCeeeccCCCCcEEEccCCCeEEeecCCCC
Q 013081 132 -------NKGVFHRDLKLENILLDSKGNIKISDFGLSA 162 (450)
Q Consensus 132 -------~~givHrDlKp~NILl~~~g~lkl~DFGla~ 162 (450)
..|+||+|++|.|||++.+...-|.||+.+.
T Consensus 179 ~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 179 SAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 2489999999999999866556899999876
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0023 Score=63.10 Aligned_cols=145 Identities=16% Similarity=0.197 Sum_probs=84.2
Q ss_pred EEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCC--CCcceEEEEEEeCC--EEEEE
Q 013081 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH--PNVVRLHEVLASKS--KIYMV 92 (450)
Q Consensus 17 ~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~--~~~lv 92 (450)
.+++.+-.|..-.+|...+. ++.+++. ... ............+|..+++.+.- .-+...++++.++. ..|.|
T Consensus 28 ~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v 103 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGDT--GQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV 103 (321)
T ss_pred ceeeeccCCcccceEEEecC--CceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence 34455544555556666653 7888888 321 22233345778889999988753 23344555555444 77999
Q ss_pred EccCCCCChHHH------------------HHhc-----------C---CCCHHHHHHHHHHH--------------HHH
Q 013081 93 LEYVTGGELFDK------------------IASK-----------G---RLQEAEGRKLFQQL--------------IDG 126 (450)
Q Consensus 93 ~E~~~gg~L~~~------------------i~~~-----------~---~l~~~~~~~i~~ql--------------~~a 126 (450)
|+|++|..+.+. +..- + .....+..++..+. ..-
T Consensus 104 ~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~ 183 (321)
T COG3173 104 MEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRL 183 (321)
T ss_pred EEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHH
Confidence 999998433211 1100 0 00111111111111 112
Q ss_pred Hhhhhh--------cCeeeccCCCCcEEEccCCCeEEeecCCCCCCC
Q 013081 127 VSYCHN--------KGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (450)
Q Consensus 127 L~~LH~--------~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 165 (450)
..|++. ..++|+|+++.||++++++-+-|.||+++..-+
T Consensus 184 ~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 184 IKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred HHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 233322 247999999999999999989999999998643
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0013 Score=67.73 Aligned_cols=161 Identities=24% Similarity=0.268 Sum_probs=103.4
Q ss_pred HHHHHHHHHHHhCCCCCcceEEEEEEeC-CEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeee
Q 013081 59 DQIKREIATLKLLKHPNVVRLHEVLASK-SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137 (450)
Q Consensus 59 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~-~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givH 137 (450)
.++.-...+++.+.|+|....+++.... .+..+|||++ +.+|.+.+..+. +-..... .+|+.|
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~--------------~~~~~~ 90 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL--------------AHGVLH 90 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc--------------ccccce
Confidence 4566678899999999999999987543 3478899999 679999876543 2111111 122222
Q ss_pred ccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCC
Q 013081 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 217 (450)
Q Consensus 138 rDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf 217 (450)
-|+ .+.+| -+++ . | ....++++||||+|.++.++.-|..-|
T Consensus 91 -----~~~-------~~~td-~~~t-------~-----------~--------~~~~~pKsdVwsl~~i~~el~L~~~l~ 131 (725)
T KOG1093|consen 91 -----LNI-------IYITD-HFLT-------K-----------Y--------PSPIGPKSDVWSLGFIILELYLGISLE 131 (725)
T ss_pred -----ehh-------hhccc-cccc-------c-----------C--------CCCCCcchhhhhHHHHHHHHHHhhHHH
Confidence 122 22333 0111 0 0 111235899999999999999998877
Q ss_pred CCCcHHHHHHHHHhCCC---CC---------CCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 218 DDRNLAVLYQKIFRGDF---KL---------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 218 ~~~~~~~~~~~i~~~~~---~~---------p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
......+....+.+-.. .. --.++.....+..+|+-..|..||...++++++-|...
T Consensus 132 ~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 132 AELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred HHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 65444333333322111 10 01146677899999999999999999999999988754
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0026 Score=61.81 Aligned_cols=30 Identities=23% Similarity=0.422 Sum_probs=25.8
Q ss_pred CeeeccCCCCcEEEccCCCe-EEeecCCCCC
Q 013081 134 GVFHRDLKLENILLDSKGNI-KISDFGLSAL 163 (450)
Q Consensus 134 givHrDlKp~NILl~~~g~l-kl~DFGla~~ 163 (450)
.++|+|++|.|||+++++++ -|.||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 48999999999999976664 6999998874
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0069 Score=61.66 Aligned_cols=77 Identities=16% Similarity=0.109 Sum_probs=52.8
Q ss_pred EeeeecccCceEEEEEEECCCCceEEEEEeecccc-cch---hHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEE
Q 013081 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI-IHL---KITDQIKREIATLKLLK---HPNVVRLHEVLASKSKIY 90 (450)
Q Consensus 18 i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~-~~~---~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~ 90 (450)
-.+.||.|....||+..+ .+..++||.-..... ... ....+...|...|+.+. ..++.+++.++. +..+
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 477899999999999887 345699997542111 011 12455666788887764 247888888876 4467
Q ss_pred EEEccCCC
Q 013081 91 MVLEYVTG 98 (450)
Q Consensus 91 lv~E~~~g 98 (450)
++|||+++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88999977
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.013 Score=57.56 Aligned_cols=29 Identities=31% Similarity=0.618 Sum_probs=25.8
Q ss_pred cCeeeccCCCCcEEEccCCCeEEeecCCCC
Q 013081 133 KGVFHRDLKLENILLDSKGNIKISDFGLSA 162 (450)
Q Consensus 133 ~givHrDlKp~NILl~~~g~lkl~DFGla~ 162 (450)
.+++|+|+.+.||+++. +.+.|.||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 57999999999999987 678999999765
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.0085 Score=60.14 Aligned_cols=137 Identities=21% Similarity=0.208 Sum_probs=81.4
Q ss_pred eeeecccCceEEEEEEECC----CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEE
Q 013081 19 GRTLGEGNFGKVKFAQDLD----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-VRLHEVLASKSKIYMVL 93 (450)
Q Consensus 19 ~~~LG~G~~g~Vy~a~~~~----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lv~ 93 (450)
++.|-.|-...+|++.... +++.|++|+..... ....++ .+|..+++.+..-++ .++++.+... .|.
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~ 112 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVE 112 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEE
Confidence 4455558888999986432 34689999875432 122233 679999998864444 3556655332 478
Q ss_pred ccCCCCChHHH----------H----H---hcC------CCCHHHHHHHHHHHH-----------------HHHhh----
Q 013081 94 EYVTGGELFDK----------I----A---SKG------RLQEAEGRKLFQQLI-----------------DGVSY---- 129 (450)
Q Consensus 94 E~~~gg~L~~~----------i----~---~~~------~l~~~~~~~i~~ql~-----------------~aL~~---- 129 (450)
+|++|.+|... + . ... +........+..++. ..+..
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 88887665311 1 1 100 011223333332221 11111
Q ss_pred ----hhhcCeeeccCCCCcEEEcc-CCCeEEeecCCCCC
Q 013081 130 ----CHNKGVFHRDLKLENILLDS-KGNIKISDFGLSAL 163 (450)
Q Consensus 130 ----LH~~givHrDlKp~NILl~~-~g~lkl~DFGla~~ 163 (450)
.+...++|+|+++.|||+++ ++.+.++||..|..
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 22336899999999999986 46899999998863
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.0098 Score=60.28 Aligned_cols=78 Identities=22% Similarity=0.221 Sum_probs=52.8
Q ss_pred eeeecccCceEEEEEEECCCCceEEEEEeecccccc---hhHHHHHHHHHHHHHhCC--CC-CcceEEEEEEeCCEEEEE
Q 013081 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH---LKITDQIKREIATLKLLK--HP-NVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 19 ~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~---~~~~~~~~~Ei~il~~l~--hp-nIv~l~~~~~~~~~~~lv 92 (450)
.+.||.|...-||++.+...++.|+||.-..--... .-..++..-|..+|+... .| .+.+++.+ ++....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 678999999999999985446789999632111111 112577788899998774 34 45556654 44556789
Q ss_pred EccCCC
Q 013081 93 LEYVTG 98 (450)
Q Consensus 93 ~E~~~g 98 (450)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999864
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.017 Score=57.61 Aligned_cols=137 Identities=16% Similarity=0.226 Sum_probs=79.3
Q ss_pred eeeecccCceEEEEEEECCC---CceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEc
Q 013081 19 GRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-VRLHEVLASKSKIYMVLE 94 (450)
Q Consensus 19 ~~~LG~G~~g~Vy~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lv~E 94 (450)
++.|..|-...+|+...... +..|.+|+...... . .-.-.+|..+++.+..-++ .+++.++. .+ +|.+
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~ 90 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---Y-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQS 90 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC---e-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeeh
Confidence 34454477778998865432 34799998754321 1 1223578899998875555 35565553 22 4889
Q ss_pred cCCCCChHH----------HH----Hh--cCC------C-CHHHHHHHHHHHH----------------------HHHh-
Q 013081 95 YVTGGELFD----------KI----AS--KGR------L-QEAEGRKLFQQLI----------------------DGVS- 128 (450)
Q Consensus 95 ~~~gg~L~~----------~i----~~--~~~------l-~~~~~~~i~~ql~----------------------~aL~- 128 (450)
|++|..|.. .+ .+ ..+ . ....+..|+.++- .-+.
T Consensus 91 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (330)
T PLN02421 91 FINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVE 170 (330)
T ss_pred hhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHH
Confidence 998765521 11 11 011 1 1223333333321 1111
Q ss_pred ---hhhhc----CeeeccCCCCcEEEcc-CCCeEEeecCCCCC
Q 013081 129 ---YCHNK----GVFHRDLKLENILLDS-KGNIKISDFGLSAL 163 (450)
Q Consensus 129 ---~LH~~----givHrDlKp~NILl~~-~g~lkl~DFGla~~ 163 (450)
.+... -++|+|+.|.|||+++ ++.++++||..|..
T Consensus 171 l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 171 LKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11112 2799999999999975 47899999998874
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.023 Score=55.44 Aligned_cols=76 Identities=17% Similarity=0.220 Sum_probs=48.7
Q ss_pred eEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEEE
Q 013081 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK---HPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 16 y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~lv 92 (450)
-+-.+.+|.|....+|... .+++.+-||+-.... ...+..|..-|+.|. .-.+.+++.+....+..|++
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLl 90 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESG------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLL 90 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEE
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecChhh------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEE
Confidence 3446788989999999887 578889999875221 246778888888884 34567889888877778999
Q ss_pred EccCCCC
Q 013081 93 LEYVTGG 99 (450)
Q Consensus 93 ~E~~~gg 99 (450)
|||++.+
T Consensus 91 le~l~~~ 97 (288)
T PF03881_consen 91 LEFLEMG 97 (288)
T ss_dssp EE-----
T ss_pred EEeecCC
Confidence 9999766
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.0095 Score=59.12 Aligned_cols=86 Identities=28% Similarity=0.352 Sum_probs=63.0
Q ss_pred CCCCcceEEEEE-EeCCEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhc-CeeeccCCCCcEEEcc
Q 013081 72 KHPNVVRLHEVL-ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDS 149 (450)
Q Consensus 72 ~hpnIv~l~~~~-~~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~-givHrDlKp~NILl~~ 149 (450)
-.++..+.+-+- .+....|++|++- |+.|. .+. --..+++..++.+.+.-++-+... ..-|||+.-.||||+
T Consensus 283 g~~~~e~~~vv~~de~~y~yl~~kdh-gt~is-~ik---~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId- 356 (488)
T COG5072 283 GSVFLETLKVVSLDETLYLYLHFKDH-GTPIS-IIK---ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID- 356 (488)
T ss_pred cchhhhcceEEecCCceEEEEEEecC-Cceee-eee---cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-
Confidence 344444544444 3344567888886 55553 222 234678888999998888877765 789999999999999
Q ss_pred CCCeEEeecCCCCC
Q 013081 150 KGNIKISDFGLSAL 163 (450)
Q Consensus 150 ~g~lkl~DFGla~~ 163 (450)
+|++.|+||-+++.
T Consensus 357 ~GnvtLIDfklsRl 370 (488)
T COG5072 357 EGNVTLIDFKLSRL 370 (488)
T ss_pred cCceEEEEeeeeec
Confidence 99999999999984
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.029 Score=55.27 Aligned_cols=29 Identities=21% Similarity=0.279 Sum_probs=27.4
Q ss_pred CeeeccCCCCcEEEccCCCeEEeecCCCC
Q 013081 134 GVFHRDLKLENILLDSKGNIKISDFGLSA 162 (450)
Q Consensus 134 givHrDlKp~NILl~~~g~lkl~DFGla~ 162 (450)
++||+|+.+.|+|+++++.+.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 79999999999999999999999999876
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.08 E-value=0.042 Score=55.91 Aligned_cols=75 Identities=16% Similarity=0.152 Sum_probs=45.3
Q ss_pred eeeecccCceEEEEEEECCC-Cce-----EEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEE
Q 013081 19 GRTLGEGNFGKVKFAQDLDS-GLP-----FAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-VRLHEVLASKSKIYM 91 (450)
Q Consensus 19 ~~~LG~G~~g~Vy~a~~~~~-~~~-----vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~l 91 (450)
++.|..|-...+|++..... +.. |.+++... ..+..-.-.+|+.+++.+...++ .++++.+. -++
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~----~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~ 126 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST----YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFT 126 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEeccC----CCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEE
Confidence 44565588889999875432 222 44443211 11111234578999999975544 56666654 268
Q ss_pred EEccCCCCCh
Q 013081 92 VLEYVTGGEL 101 (450)
Q Consensus 92 v~E~~~gg~L 101 (450)
+.||++|.+|
T Consensus 127 l~efIeGr~l 136 (383)
T PTZ00384 127 IQEWVEGNTM 136 (383)
T ss_pred EEEEeccccC
Confidence 9999998766
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.69 E-value=0.03 Score=56.49 Aligned_cols=63 Identities=19% Similarity=0.197 Sum_probs=44.6
Q ss_pred EEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhh-hhcCeeeccCCCCcEEEccCC
Q 013081 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC-HNKGVFHRDLKLENILLDSKG 151 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~L-H~~givHrDlKp~NILl~~~g 151 (450)
...++-+|..|-++...+.... .+++..+.++.-...|+--+ --.+++|.|++|.||++..+.
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~~-~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~~ 382 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWKS-QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFNK 382 (565)
T ss_pred cceeeeeccccccHHhhhhccc-ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEecC
Confidence 3456777888988888876533 45666666666566665543 345899999999999996543
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.48 E-value=0.28 Score=48.74 Aligned_cols=71 Identities=18% Similarity=0.114 Sum_probs=42.8
Q ss_pred cCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--cceEE---E--EEEeCCEEEEEEccCC
Q 013081 25 GNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN--VVRLH---E--VLASKSKIYMVLEYVT 97 (450)
Q Consensus 25 G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~---~--~~~~~~~~~lv~E~~~ 97 (450)
+.-..||.... .+|..+++|+.+.... . ...+..|+..+..|.... ++... + +...++..+.++++++
T Consensus 36 s~eN~vy~v~~-~~~~~~vlKv~r~~~~-~---~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~ 110 (325)
T PRK11768 36 SYENRVYQFGD-EDGRRVVAKFYRPERW-S---DAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRG 110 (325)
T ss_pred cccceEEEEec-CCCCEEEEEEcCcccC-C---HHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeC
Confidence 44556888874 4567799998754331 1 355677888877774211 22211 1 1233567888999998
Q ss_pred CCC
Q 013081 98 GGE 100 (450)
Q Consensus 98 gg~ 100 (450)
|..
T Consensus 111 G~~ 113 (325)
T PRK11768 111 GRA 113 (325)
T ss_pred CCC
Confidence 764
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.37 E-value=0.058 Score=50.19 Aligned_cols=99 Identities=16% Similarity=0.167 Sum_probs=64.6
Q ss_pred EEEEEeeccccc-chhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHH
Q 013081 42 FAVKILEKNRII-HLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120 (450)
Q Consensus 42 vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~ 120 (450)
..+|.++...+. + ...+..+.+++.++. +|+++.. ...-.+.++.|+|--... + -..++
T Consensus 88 L~lKKi~slp~~~~---~~~y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~~~i---------~----~~N~i 147 (308)
T PF07387_consen 88 LFLKKIRSLPCCIN---DALYFNKYRVFARMH--GILRLKN--DNNYKYGVILERCYKIKI---------N----FSNFI 147 (308)
T ss_pred hhhhhccCCCcccc---hhhhhhhhhHHHHhh--heeEeec--CCCceeEEEEeeccCccc---------c----hhHHH
Confidence 445555443333 2 245678888888774 6777763 234456789999843111 0 01112
Q ss_pred HHHHHHHhhhhh--cCeeeccCCCCcEEEccCCCeEEeecCC
Q 013081 121 QQLIDGVSYCHN--KGVFHRDLKLENILLDSKGNIKISDFGL 160 (450)
Q Consensus 121 ~ql~~aL~~LH~--~givHrDlKp~NILl~~~g~lkl~DFGl 160 (450)
..=+.+|.-.|+ .+.+|+|-.|+||+-|..|.+||.|=+.
T Consensus 148 ~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 148 TAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred HHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 222466777884 3799999999999999999999998764
|
The function of this family is unknown. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.21 E-value=0.97 Score=52.02 Aligned_cols=31 Identities=35% Similarity=0.494 Sum_probs=26.6
Q ss_pred cCeeeccCCCCcEEEccCC--CeE-EeecCCCCC
Q 013081 133 KGVFHRDLKLENILLDSKG--NIK-ISDFGLSAL 163 (450)
Q Consensus 133 ~givHrDlKp~NILl~~~g--~lk-l~DFGla~~ 163 (450)
.++||+|+.+.|||++.++ ++. |.|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999999876 565 999998863
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.55 E-value=0.06 Score=48.99 Aligned_cols=29 Identities=17% Similarity=0.421 Sum_probs=26.0
Q ss_pred CeeeccCCCCcEEEccCCCeEEeecCCCCC
Q 013081 134 GVFHRDLKLENILLDSKGNIKISDFGLSAL 163 (450)
Q Consensus 134 givHrDlKp~NILl~~~g~lkl~DFGla~~ 163 (450)
-.+|+|+.|.|++++++| ++|+||+.|..
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 469999999999998877 99999999874
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 450 | ||||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-75 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-74 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-73 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 8e-72 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-71 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-71 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-71 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-67 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-66 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-66 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-65 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-65 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-64 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-64 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-64 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-64 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-63 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-62 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-61 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-58 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 7e-58 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-57 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-57 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-56 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-53 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-48 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-48 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-48 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-48 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-48 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-48 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-48 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-47 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-47 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-47 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-47 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-47 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 8e-47 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-46 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-46 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-46 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-46 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-46 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-46 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-46 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-46 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-46 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-46 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-46 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-46 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-46 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-46 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-46 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-46 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-46 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-46 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-46 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-46 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-45 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-45 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-45 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-45 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-45 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-45 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-45 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-45 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 9e-45 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-45 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-44 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-44 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-44 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-44 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-44 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-44 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-44 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-44 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-44 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-44 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-44 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-44 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-44 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-44 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-44 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-44 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-44 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-44 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-44 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-44 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-43 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-43 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-43 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-43 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-43 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-43 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-43 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-43 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-43 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-43 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-43 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-43 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-43 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-43 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-43 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-43 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-43 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-43 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-43 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-43 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-43 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-43 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-43 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-43 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-43 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 8e-43 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-43 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-43 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-43 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-43 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 9e-43 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 9e-43 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-42 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-42 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-42 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-42 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-42 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-42 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-42 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-42 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-42 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-42 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-42 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-42 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-42 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-42 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-42 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-42 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-42 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-42 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-42 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-42 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-42 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-42 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-42 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-42 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-42 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-42 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-42 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-42 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-42 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-42 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-42 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-42 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-42 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-42 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-42 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-42 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-42 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-42 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-42 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-42 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-42 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-42 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-42 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-41 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-41 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-41 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-41 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-41 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-41 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-41 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-41 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-40 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-40 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-40 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-40 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-40 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 8e-40 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-39 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-39 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-39 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-39 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-39 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-39 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-39 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-39 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-39 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-39 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 8e-39 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 8e-39 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 9e-39 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-38 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-38 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-38 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-38 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-38 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-38 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-38 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-38 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-38 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-38 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-38 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-38 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-38 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-37 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-37 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-37 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-37 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-37 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-37 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-37 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-37 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-37 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-37 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-37 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-37 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-37 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-37 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-37 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-37 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-37 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-37 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-37 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-37 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-37 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-37 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-37 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-37 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-37 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-37 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-37 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-37 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-37 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-37 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-36 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-36 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-36 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-36 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-36 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-36 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-36 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-36 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-36 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-36 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-36 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-36 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-36 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-36 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-36 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-36 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-36 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-36 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-36 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-36 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-36 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-36 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 5e-36 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-36 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-36 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-36 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-35 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-35 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-35 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-35 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 8e-35 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-34 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-34 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-34 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-34 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-34 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-34 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-33 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-32 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-31 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-31 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-31 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-31 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-31 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-30 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-30 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-30 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-30 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-30 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-30 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-30 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-30 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-30 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-30 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-30 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-30 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-30 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 5e-30 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-30 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 6e-30 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 6e-30 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 6e-30 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-30 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 7e-30 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-29 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-29 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-29 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-29 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-29 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-29 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-29 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-29 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-29 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-29 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 6e-29 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-28 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-28 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 5e-27 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-27 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 5e-27 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 5e-27 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-27 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 5e-27 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 6e-27 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 6e-27 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 6e-27 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-27 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 7e-27 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 7e-27 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-27 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 8e-27 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 9e-27 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 9e-27 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-26 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-26 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-26 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-25 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-25 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-25 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 8e-25 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-24 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-24 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-24 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-24 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-24 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-24 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-24 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-24 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-24 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-24 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-24 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-24 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 9e-24 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 9e-24 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 9e-24 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-23 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-23 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-23 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-23 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-23 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-23 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-23 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-23 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 8e-23 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-23 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-23 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-22 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-22 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-22 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-22 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-22 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-22 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-22 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-22 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-22 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-22 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-22 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-22 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-22 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-22 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-22 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-22 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-22 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-22 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-22 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-22 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-22 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-22 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-22 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-22 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-22 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-22 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-22 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-22 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-22 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-22 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-22 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-22 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-22 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-22 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-22 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-22 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-22 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-22 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-22 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-22 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-22 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-22 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-22 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 7e-22 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 8e-22 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-22 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-21 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-21 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-21 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-21 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-21 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-21 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-21 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-21 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-21 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-21 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-21 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-21 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-21 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-21 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-21 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-21 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-21 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-21 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-21 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-21 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-21 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-21 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-21 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-21 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-21 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-21 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-21 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-21 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-21 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-21 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-21 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-21 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-21 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-21 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-21 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-21 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-21 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-21 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-21 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-21 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-21 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-21 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-21 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-21 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-21 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-21 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-21 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-21 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-21 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-21 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-21 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-21 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-21 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-21 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-21 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-21 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 8e-21 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-21 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-21 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-20 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-20 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-20 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-20 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-20 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-20 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-20 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-20 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-20 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-20 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-20 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-20 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-20 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-20 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-20 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-20 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-20 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-20 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-20 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-20 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-20 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-20 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-20 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-20 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-20 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-20 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-20 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-20 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-20 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-20 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-20 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-20 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-20 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-20 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-20 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-20 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-20 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-19 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-19 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-19 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-19 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-19 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-19 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-19 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-19 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-19 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-19 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-19 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-19 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-19 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-19 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-19 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-19 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-19 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-19 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 7e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 7e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-19 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-19 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 9e-19 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-19 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 9e-19 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-18 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-18 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-18 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-18 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-18 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-18 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-18 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-18 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-18 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-18 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-18 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-18 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-18 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-18 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-18 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-18 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-18 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-18 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-18 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-18 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-18 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 8e-18 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 8e-18 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 9e-18 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-18 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-18 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 9e-18 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-18 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-17 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-17 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-17 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-17 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-17 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-17 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-17 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-17 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-17 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-17 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-17 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-17 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-17 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-17 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-17 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-17 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-17 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-17 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-17 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-17 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-17 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-17 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-17 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-17 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-17 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-17 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-17 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-17 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-17 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-17 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-17 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-17 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-17 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-17 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-17 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-17 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-17 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-17 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-17 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-17 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-17 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 8e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 9e-17 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 9e-17 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 9e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-16 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-16 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-16 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-16 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-16 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-16 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-16 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-16 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-16 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-16 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-16 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-16 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-16 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-16 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-16 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-16 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 7e-16 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 7e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 7e-16 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-16 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-16 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-16 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 8e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 8e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 9e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 9e-16 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 9e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-15 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-15 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-15 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-15 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-15 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-15 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-15 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-15 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 7e-15 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 7e-15 | ||
| 2ehb_D | 143 | The Structure Of The C-Terminal Domain Of The Prote | 7e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 7e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 8e-15 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 8e-15 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 9e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 9e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 9e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-14 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-14 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-14 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-14 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-14 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-14 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-14 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-14 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-14 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-14 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-14 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-14 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-14 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-14 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-14 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-14 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-14 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-14 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-14 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-14 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-14 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-14 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-14 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-14 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-14 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-14 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-14 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-14 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-14 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-14 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-14 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-14 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-14 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 8e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 8e-14 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 8e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-14 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 8e-14 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 9e-14 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 9e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-13 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-13 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-13 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-13 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-13 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-13 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-13 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-13 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-13 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-13 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-13 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-13 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-13 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-13 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-13 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-13 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-13 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-13 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-13 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-13 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 7e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-13 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 8e-13 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 8e-13 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 8e-13 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 8e-13 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 8e-13 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 8e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 8e-13 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 9e-13 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 9e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 9e-13 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 9e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 9e-13 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-12 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-12 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-12 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-12 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-12 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-12 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-12 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-12 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-12 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-12 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-12 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-12 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-12 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-12 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-12 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-12 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-12 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-12 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-12 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-12 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-12 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-12 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-12 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-12 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 7e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-11 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-11 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-11 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-11 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 4e-11 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 5e-11 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 6e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 9e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-10 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 1e-10 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 1e-10 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 1e-10 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-10 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-10 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-10 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 3e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 7e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 9e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 9e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-09 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-09 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 2e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-09 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-09 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-09 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 5e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-09 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 6e-09 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 6e-09 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 6e-09 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 6e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-09 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 7e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 7e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 7e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 7e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 7e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-09 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 8e-09 |
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2EHB|D Chain D, The Structure Of The C-Terminal Domain Of The Protein Kinase Atsos2 Bound To The Calcium Sensor Atsos3 Length = 143 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 486 bits (1253), Expect = e-170
Identities = 152/474 (32%), Positives = 234/474 (49%), Gaps = 66/474 (13%)
Query: 1 MVIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ 60
M +K +++G Y LG TLG G FGKVK + +G AVKIL + +I L + +
Sbjct: 3 MAEKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGK 62
Query: 61 IKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
I+REI LKL +HP++++L++V+++ S I+MV+EYV+GGELFD I GRL E E R+LF
Sbjct: 63 IRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLF 122
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
QQ++ GV YCH V HRDLK EN+LLD+ N KI+DFGLS + D L T+CGSP
Sbjct: 123 QQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRTSCGSP 179
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWL 240
NY APEV++ R Y G DIWS GVILY +L G LPFDD ++ L++KI G F P++L
Sbjct: 180 NYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYL 239
Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWF-----------EQDYTPANPDDD------ 283
+P +LL+ +L+ +P+KR TI I+ EWF + Y+ DD+
Sbjct: 240 NPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVC 299
Query: 284 ------EEDI----------------------------------FVDNEAFSMHEVPSDG 303
EE++ + S +
Sbjct: 300 EKFECSEEEVLSCLYNRNHQDPLAVAYHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLT 359
Query: 304 GRTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIR---FTSNHSAKDLLERIEDIV 360
P P + A + +L+ K + S D++ + +
Sbjct: 360 RPHPERVPFLVAETPRARHTLDELNPQKSKHQGVRKAKWHLGIRSQSRPNDIMAEVCRAI 419
Query: 361 TEMGFRVQKKNG-KLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGD 413
++ + + N L+ K + ++ +++++ Y+++ R +
Sbjct: 420 KQLDYEWKVVNPYYLRV--RRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDE 471
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 477 bits (1229), Expect = e-168
Identities = 117/345 (33%), Positives = 174/345 (50%), Gaps = 18/345 (5%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
RY+ + +G GNFG + +D + AVK +E+ I + ++REI + L
Sbjct: 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSL 73
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
+HPN+VR EV+ + + + +++EY +GGEL+++I + GR E E R FQQL+ GVSYCH
Sbjct: 74 RHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCH 133
Query: 132 NKGVFHRDLKLENILLDSK--GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
+ + HRDLKLEN LLD +KI DFG S +T G+P Y+APEVL
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLHSQPKSTVGTPAYIAPEVLL 190
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQK----IFRGDFKLPK--WLSPG 243
+ YDG +D+WSCGV LYV+L G PF+D Y+K I + +P +SP
Sbjct: 191 RQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPE 250
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP--ANPDDDEEDIFVDNEAFSMHEVPS 301
+L+ +I +P RI+I IK WF ++ N + + +
Sbjct: 251 CCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIM 310
Query: 302 DGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSN 346
P + N M+ LDL + D SE +I S+
Sbjct: 311 QIISEATIPAVRNRCLDDFMTDNLDLDDDMDDFD-SESEIDIDSS 354
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 473 bits (1219), Expect = e-168
Identities = 132/274 (48%), Positives = 182/274 (66%), Gaps = 3/274 (1%)
Query: 4 AEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR 63
K +++G Y LG TLG G FGKVK + +G AVKIL + +I L + +IKR
Sbjct: 1 GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR 60
Query: 64 EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL 123
EI LKL +HP++++L++V+++ + +MV+EYV+GGELFD I GR++E E R+LFQQ+
Sbjct: 61 EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQI 120
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
+ V YCH V HRDLK EN+LLD+ N KI+DFGLS + D L T+CGSPNY
Sbjct: 121 LSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRTSCGSPNYA 177
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPG 243
APEV++ R Y G DIWSCGVILY +L G LPFDD ++ L++KI G F +P++L+
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRS 237
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277
LL +L+ +P+KR TI I+ EWF+QD
Sbjct: 238 VATLLMHMLQVDPLKRATIKDIREHEWFKQDLPS 271
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 467 bits (1204), Expect = e-165
Identities = 122/290 (42%), Positives = 184/290 (63%), Gaps = 5/290 (1%)
Query: 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
+G Y + TLGEG+FGKVK A + A+K + + + + +++REI+
Sbjct: 2 AISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREIS 61
Query: 67 TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
LKLL+HP++++L++V+ + + I MV+EY GGELFD I K R+ E EGR+ FQQ+I
Sbjct: 62 YLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICA 120
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
+ YCH + HRDLK EN+LLD N+KI+DFGLS + D L T+CGSPNY APE
Sbjct: 121 IEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNI---MTDGNFLKTSCGSPNYAAPE 177
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN 246
V+ + Y G D+WSCG++LYV+L G LPFDD + L++K+ + +P +LSPGAQ+
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQS 237
Query: 247 LLRKILEPNPVKRITIAGIKADEWFEQDYT-PANPDDDEEDIFVDNEAFS 295
L+R+++ +P++RITI I+ D WF + P ++ + + D+ S
Sbjct: 238 LIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVS 287
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 465 bits (1198), Expect = e-165
Identities = 101/266 (37%), Positives = 150/266 (56%), Gaps = 5/266 (1%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ ++L +TLGEG +G+V+ A + + AVKI++ R + + IK+EI K+L
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
H NVV+ + + Y+ LEY +GGELFD+I + E + ++ F QL+ GV Y H
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
G+ HRD+K EN+LLD + N+KISDFGL+ + ++ + LL+ CG+ YVAPE+L R
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGDFKLPKW--LSPGAQNLLR 249
+ D+WSCG++L +L G LP+D + Y L W + LL
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243
Query: 250 KILEPNPVKRITIAGIKADEWFEQDY 275
KIL NP RITI IK D W+ +
Sbjct: 244 KILVENPSARITIPDIKKDRWYNKPL 269
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 466 bits (1202), Expect = e-165
Identities = 108/309 (34%), Positives = 163/309 (52%), Gaps = 14/309 (4%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ ++L +TLGEG +G+V+ A + + AVKI++ R + + IK+EI K+L
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
H NVV+ + + Y+ LEY +GGELFD+I + E + ++ F QL+ GV Y H
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
G+ HRD+K EN+LLD + N+KISDFGL+ + ++ + LL+ CG+ YVAPE+L R
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGDFKLPKW--LSPGAQNLLR 249
+ D+WSCG++L +L G LP+D + Y L W + LL
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243
Query: 250 KILEPNPVKRITIAGIKADEWFEQDYTP--------ANPDDDEEDIFVDNEAFSMHEVPS 301
KIL NP RITI IK D W+ + + + F + ++ P
Sbjct: 244 KILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSPV 303
Query: 302 DGG-RTPGS 309
+ RTPGS
Sbjct: 304 NSASRTPGS 312
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 464 bits (1196), Expect = e-164
Identities = 104/289 (35%), Positives = 159/289 (55%), Gaps = 13/289 (4%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-ITDQIKREIATLKL 70
+G+Y +G LGEG++GKVK D ++ AVKIL+K ++ + +K+EI L+
Sbjct: 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRR 62
Query: 71 LKHPNVVRLHEVL--ASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDG 126
L+H NV++L +VL K K+YMV+EY G E+ D + + R + F QLIDG
Sbjct: 63 LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP-EKRFPVCQAHGYFCQLIDG 121
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
+ Y H++G+ H+D+K N+LL + G +KIS G++ F D T+ GSP + PE
Sbjct: 122 LEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181
Query: 187 VLAN-RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQ 245
+ + G DIWS GV LY I TG PF+ N+ L++ I +G + +P P
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLS 241
Query: 246 NLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN------PDDDEEDIF 288
+LL+ +LE P KR +I I+ WF + + PA P D +D +
Sbjct: 242 DLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKDRW 290
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 450 bits (1161), Expect = e-159
Identities = 94/276 (34%), Positives = 145/276 (52%), Gaps = 3/276 (1%)
Query: 3 IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
I E + RY GR LG+G F K D D+ FA KI+ K+ ++ +++
Sbjct: 4 IPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS 63
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
EI+ + L H +VV H +++VLE L + + L E E R +Q
Sbjct: 64 MEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ 123
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
++ G Y H V HRDLKL N+ L+ +KI DFGL+ ++ D CG+PNY
Sbjct: 124 IVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DGERKKVLCGTPNY 181
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSP 242
+APEVL+ +G+ D+WS G I+Y +L G PF+ L Y +I + ++ +PK ++P
Sbjct: 182 IAPEVLSKKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINP 240
Query: 243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA 278
A +L++K+L+ +P R TI + DE+F Y PA
Sbjct: 241 VAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA 276
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 449 bits (1156), Expect = e-158
Identities = 94/276 (34%), Positives = 145/276 (52%), Gaps = 3/276 (1%)
Query: 3 IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
I E + RY GR LG+G F K D D+ FA KI+ K+ ++ +++
Sbjct: 30 IPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS 89
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
EI+ + L H +VV H +++VLE L + + L E E R +Q
Sbjct: 90 MEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ 149
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
++ G Y H V HRDLKL N+ L+ +KI DFGL+ ++ D CG+PNY
Sbjct: 150 IVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DGERKKVLCGTPNY 207
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSP 242
+APEVL+ +G+ D+WS G I+Y +L G PF+ L Y +I + ++ +PK ++P
Sbjct: 208 IAPEVLSKKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINP 266
Query: 243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA 278
A +L++K+L+ +P R TI + DE+F Y PA
Sbjct: 267 VAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA 302
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 443 bits (1141), Expect = e-155
Identities = 115/283 (40%), Positives = 177/283 (62%), Gaps = 4/283 (1%)
Query: 3 IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
IA E +G Y L +T+G+GNF KVK A+ + +G A+KI++K ++ + ++
Sbjct: 4 IASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSL-QKLF 62
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
RE+ +K+L HPN+V+L EV+ ++ +Y+++EY +GGE+FD + + GR++E E R F+Q
Sbjct: 63 REVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQ 122
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
++ V YCH K + HRDLK EN+LLD+ NIKI+DFG S F G L CG+P Y
Sbjct: 123 IVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNE---FTVGGKLDAFCGAPPY 179
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSP 242
APE+ + YDG D+WS GVILY +++G LPFD +NL L +++ RG +++P ++S
Sbjct: 180 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMST 239
Query: 243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 285
+NLL++ L NP+KR T+ I D W + E
Sbjct: 240 DCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVE 282
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 438 bits (1128), Expect = e-154
Identities = 82/274 (29%), Positives = 152/274 (55%), Gaps = 4/274 (1%)
Query: 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
G ++ +++G LG+G+F V A+ + +GL A+K+++K + + +++ E+
Sbjct: 7 GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHC 66
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVS 128
LKHP+++ L+ + +Y+VLE GE+ + ++ E E R Q+I G+
Sbjct: 67 QLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML 126
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
Y H+ G+ HRDL L N+LL NIKI+DFGL+ + +T CG+PNY++PE+
Sbjct: 127 YLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM--PHEKHYTLCGTPNYISPEIA 184
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL 248
+ G SD+WS G + Y +L G PFD + K+ D+++P +LS A++L+
Sbjct: 185 TRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLI 243
Query: 249 RKILEPNPVKRITIAGIKADEWFEQDYTPANPDD 282
++L NP R++++ + + ++ + + D+
Sbjct: 244 HQLLRRNPADRLSLSSVLDHPFMSRNSSTKSKDE 277
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 430 bits (1109), Expect = e-151
Identities = 94/298 (31%), Positives = 153/298 (51%), Gaps = 32/298 (10%)
Query: 5 EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT------ 58
+ ++L +Y L +G+G++G VK A + + +A+K+L K ++I
Sbjct: 4 GSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPP 63
Query: 59 -----------------DQIKREIATLKLLKHPNVVRLHEVL--ASKSKIYMVLEYVTGG 99
+Q+ +EIA LK L HPNVV+L EVL ++ +YMV E V G
Sbjct: 64 RGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQG 123
Query: 100 ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFG 159
+ + + + L E + R FQ LI G+ Y H + + HRD+K N+L+ G+IKI+DFG
Sbjct: 124 PVME-VPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFG 182
Query: 160 LSALPQHFRDDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPF 217
+S + D LL T G+P ++APE L+ + + G D+W+ GV LY + G PF
Sbjct: 183 VSNEFK--GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240
Query: 218 DDRNLAVLYQKIFRGDFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273
D + L+ KI + P ++ ++L+ ++L+ NP RI + IK W +
Sbjct: 241 MDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 428 bits (1102), Expect = e-150
Identities = 88/278 (31%), Positives = 154/278 (55%), Gaps = 5/278 (1%)
Query: 3 IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
+AE + + +++GR LG+G FG V A++ + A+K+L K+++ + Q++
Sbjct: 3 LAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLR 62
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
REI L+HPN++R++ + +IY++LE+ GEL+ ++ GR E ++
Sbjct: 63 REIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE 122
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
L D + YCH + V HRD+K EN+L+ KG +KI+DFG S R T CG+ +Y
Sbjct: 123 LADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTLDY 178
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSP 242
+ PE++ + +D D+W GV+ Y L G PFD + +++I D K P +LS
Sbjct: 179 LPPEMIEGKTHDEK-VDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSD 237
Query: 243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
G+++L+ K+L +P +R+ + G+ W + + P
Sbjct: 238 GSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLP 275
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 418 bits (1078), Expect = e-147
Identities = 87/281 (30%), Positives = 152/281 (54%), Gaps = 5/281 (1%)
Query: 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
K+ L +E+GR LG+G FG V A++ S A+K+L K ++ + Q++RE+
Sbjct: 2 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 67 TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
L+HPN++RL+ +++Y++LEY G ++ ++ + E +L +
Sbjct: 62 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
+SYCH+K V HRD+K EN+LL S G +KI+DFG S R CG+ +Y+ PE
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPPE 177
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN 246
++ R +D D+WS GV+ Y L G PF+ Y++I R +F P +++ GA++
Sbjct: 178 MIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 236
Query: 247 LLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDI 287
L+ ++L+ NP +R + + W + + + ++E
Sbjct: 237 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESA 277
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 420 bits (1082), Expect = e-146
Identities = 84/312 (26%), Positives = 140/312 (44%), Gaps = 15/312 (4%)
Query: 4 AEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD---- 59
EG +Y LG G FG V A D + VK ++K +++ +
Sbjct: 14 GLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKL 73
Query: 60 -QIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE-YVTGGELFDKIASKGRLQEAEGR 117
++ EIA L ++H N++++ ++ ++ +V+E + +G +LF I RL E
Sbjct: 74 GKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLAS 133
Query: 118 KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC 177
+F+QL+ V Y K + HRD+K ENI++ IK+ DFG +A L +T C
Sbjct: 134 YIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY---LERGKLFYTFC 190
Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP 237
G+ Y APEVL Y G ++WS GV LY ++ PF + ++ P
Sbjct: 191 GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEAAIHPP 244
Query: 238 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMH 297
+S +L+ +L+P P +R T+ + D W Q A+ +E E+ +
Sbjct: 245 YLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESGVLS 304
Query: 298 EVPSDGGRTPGS 309
+ G S
Sbjct: 305 AASLEMGNRSLS 316
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 412 bits (1062), Expect = e-144
Identities = 86/292 (29%), Positives = 133/292 (45%), Gaps = 19/292 (6%)
Query: 4 AEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ--- 60
K Y LG LG+G FG V L L A+K++ +NR++
Sbjct: 21 PGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVT 80
Query: 61 IKREIATLKLL----KHPNVVRLHEVLASKSKIYMVLEY-VTGGELFDKIASKGRLQEAE 115
E+A L + HP V+RL + ++ +VLE + +LFD I KG L E
Sbjct: 81 CPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGP 140
Query: 116 GRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGLSALPQHFRDDGLLH 174
R F Q++ + +CH++GV HRD+K ENIL+D + G K+ DFG AL D
Sbjct: 141 SRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH----DEPYT 196
Query: 175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF 234
G+ Y PE ++ Y + +WS G++LY ++ G +PF+ Q+I +
Sbjct: 197 DFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------QEILEAEL 250
Query: 235 KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEED 286
P +SP L+R+ L P P R ++ I D W + + +
Sbjct: 251 HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGG 302
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 410 bits (1056), Expect = e-143
Identities = 89/291 (30%), Positives = 140/291 (48%), Gaps = 17/291 (5%)
Query: 3 IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI---IHLKITD 59
+A K++ +Y++G LG G FG V + LP A+K +EK+RI L
Sbjct: 32 LAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGT 91
Query: 60 QIKREIATLKLLKH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEG 116
++ E+ LK + V+RL + ++LE +LFD I +G LQE
Sbjct: 92 RVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 151
Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-KGNIKISDFGLSALPQHFRDDGLLHT 175
R F Q+++ V +CHN GV HRD+K ENIL+D +G +K+ DFG AL + D +
Sbjct: 152 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTD 207
Query: 176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK 235
G+ Y PE + Y G ++ +WS G++LY ++ G +PF+ ++I RG
Sbjct: 208 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVF 261
Query: 236 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEED 286
+ +S Q+L+R L P R T I+ W + P +
Sbjct: 262 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLH 312
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 390 bits (1003), Expect = e-134
Identities = 74/324 (22%), Positives = 132/324 (40%), Gaps = 50/324 (15%)
Query: 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK--------- 56
K++ + Y + RTL +G F K+ + +A+K EK+ + +
Sbjct: 23 VKEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDK 80
Query: 57 -----ITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRL 111
D K E+ + +K+ + ++ + ++Y++ EY+ + L
Sbjct: 81 ISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVL 140
Query: 112 Q--------EAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSA 162
+ + + +++ SY HN K + HRD+K NIL+D G +K+SDFG S
Sbjct: 141 DKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESE 200
Query: 163 LPQHFRDDGLLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYVILTGYLPFDD-R 220
+ D + + G+ ++ PE +N Y+GA DIWS G+ LYV+ +PF
Sbjct: 201 ----YMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256
Query: 221 NLAVLYQKIFRGDFKLP-------------------KWLSPGAQNLLRKILEPNPVKRIT 261
+L L+ I + + P +LS + L+ L NP +RIT
Sbjct: 257 SLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERIT 316
Query: 262 IAGIKADEWFEQDYTPANPDDDEE 285
EW + +E
Sbjct: 317 SEDALKHEWLADTNIEDLREFSKE 340
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 332 bits (853), Expect = e-112
Identities = 98/283 (34%), Positives = 145/283 (51%), Gaps = 19/283 (6%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-----HLKITDQIKREIATLK 69
Y + +TLG G G+VK A + + A+KI+ K + ++ EI LK
Sbjct: 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
L HP ++++ ++ Y+VLE + GGELFDK+ RL+EA + F Q++ V Y
Sbjct: 71 KLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 130 CHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
H G+ HRDLK EN+LL S+ IKI+DFG S + + L+ T CG+P Y+APE
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS---KILGETSLMRTLCGTPTYLAPE 186
Query: 187 VLANRGYDGATS--DIWSCGVILYVILTGYLPFDDRNL-AVLYQKIFRG--DFKLPKW-- 239
VL + G G D WS GVIL++ L+GY PF + L +I G +F W
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 246
Query: 240 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDD 282
+S A +L++K+L +P R T W + + D
Sbjct: 247 VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQD 289
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 325 bits (835), Expect = e-110
Identities = 97/275 (35%), Positives = 154/275 (56%), Gaps = 16/275 (5%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y L T+G G++G+VK A + + A K + K ++ D+ K+EI +K L HP
Sbjct: 10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF---VEDVDRFKQEIEIMKSLDHP 66
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N++RL+E + IY+V+E TGGELF+++ K +E++ ++ + ++ V+YCH
Sbjct: 67 NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN 126
Query: 135 VFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
V HRDLK EN L + +K+ DFGL+A F+ ++ T G+P YV+P+VL
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAA---RFKPGKMMRTKVGTPYYVSPQVL-EG 182
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNL 247
Y G D WS GV++YV+L GY PF + + KI G F W +SP A++L
Sbjct: 183 LY-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESL 241
Query: 248 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPDD 282
+R++L +P +RIT EWF + ++P +
Sbjct: 242 IRRLLTKSPKQRITSLQALEHEWF-EKQLSSSPRN 275
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 324 bits (832), Expect = e-109
Identities = 100/280 (35%), Positives = 156/280 (55%), Gaps = 12/280 (4%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y++ LG+G F V+ +GL FA KI+ ++ +++RE + L+HP
Sbjct: 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF-QKLEREARICRKLQHP 65
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N+VRLH+ + +S Y+V + VTGGELF+ I ++ EA+ QQ+++ ++YCH+ G
Sbjct: 66 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 125
Query: 135 VFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
+ HR+LK EN+LL SK +K++DFGL+ D H G+P Y++PEVL
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTPGYLSPEVLKKD 182
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNL 247
Y DIW+CGVILY++L GY PF D + LY +I G D+ P+W ++P A++L
Sbjct: 183 PY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 241
Query: 248 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDI 287
+ +L NP KRIT W A+ ++ +
Sbjct: 242 IDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTV 281
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 326 bits (838), Expect = e-108
Identities = 98/283 (34%), Positives = 146/283 (51%), Gaps = 19/283 (6%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-----HLKITDQIKREIATLK 69
Y + +TLG G G+VK A + + A++I+ K + ++ EI LK
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
L HP ++++ ++ Y+VLE + GGELFDK+ RL+EA + F Q++ V Y
Sbjct: 196 KLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 254
Query: 130 CHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
H G+ HRDLK EN+LL S+ IKI+DFG S + + L+ T CG+P Y+APE
Sbjct: 255 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS---KILGETSLMRTLCGTPTYLAPE 311
Query: 187 VLANRGYDGATS--DIWSCGVILYVILTGYLPF-DDRNLAVLYQKIFRG--DFKLPKW-- 239
VL + G G D WS GVIL++ L+GY PF + R L +I G +F W
Sbjct: 312 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 371
Query: 240 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDD 282
+S A +L++K+L +P R T W + + D
Sbjct: 372 VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQD 414
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 322 bits (827), Expect = e-108
Identities = 89/275 (32%), Positives = 141/275 (51%), Gaps = 20/275 (7%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI-----IHLKITDQIKREIATLK 69
+Y+ +G G V+ +G FAVKI+E ++ + +RE L+
Sbjct: 95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154
Query: 70 LLK-HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
+ HP+++ L + S S +++V + + GELFD + K L E E R + + L++ VS
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVS 214
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
+ H + HRDLK ENILLD I++SDFG S H L CG+P Y+APE+L
Sbjct: 215 FLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC---HLEPGEKLRELCGTPGYLAPEIL 271
Query: 189 ------ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW- 239
+ GY G D+W+CGVIL+ +L G PF R ++ + I G F P+W
Sbjct: 272 KCSMDETHPGY-GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWD 330
Query: 240 -LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273
S ++L+ ++L+ +P R+T +FE+
Sbjct: 331 DRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 318 bits (818), Expect = e-107
Identities = 86/283 (30%), Positives = 134/283 (47%), Gaps = 21/283 (7%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD------QIKREIATL 68
YE LG G V+ + +AVKI++ + +E+ L
Sbjct: 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 69 KLLK-HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
+ + HPN+++L + + + ++V + + GELFD + K L E E RK+ + L++ +
Sbjct: 78 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 137
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
H + HRDLK ENILLD NIK++DFG S L CG+P+Y+APE+
Sbjct: 138 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS---CQLDPGEKLREVCGTPSYLAPEI 194
Query: 188 LA------NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW 239
+ + GY G D+WS GVI+Y +L G PF R ++ + I G F P+W
Sbjct: 195 IECSMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 253
Query: 240 --LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
S ++L+ + L P KR T A +F+Q
Sbjct: 254 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVR 296
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 317 bits (814), Expect = e-106
Identities = 95/277 (34%), Positives = 147/277 (53%), Gaps = 15/277 (5%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+ LG G F +V + +G FA+K ++K+ ++ EIA LK +KH
Sbjct: 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEIAVLKKIKHE 66
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N+V L ++ S + Y+V++ V+GGELFD+I +G E + + QQ++ V Y H G
Sbjct: 67 NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG 126
Query: 135 VFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
+ HRDLK EN+L + I I+DFGLS +G++ T CG+P YVAPEVLA +
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLS----KMEQNGIMSTACGTPGYVAPEVLAQK 182
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNL 247
Y D WS GVI Y++L GY PF + + L++KI G +F+ P W +S A++
Sbjct: 183 PY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDF 241
Query: 248 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDE 284
+ +LE +P +R T + W + +
Sbjct: 242 ICHLLEKDPNERYTCEKALSHPWIDGNTALHRDIYPS 278
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 319 bits (819), Expect = e-106
Identities = 100/278 (35%), Positives = 154/278 (55%), Gaps = 12/278 (4%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y++ LG+G F V+ +GL FA KI+ ++ ++RE + L+HP
Sbjct: 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-LEREARICRKLQHP 88
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N+VRLH+ + +S Y+V + VTGGELF+ I ++ EA+ QQ+++ ++YCH+ G
Sbjct: 89 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 148
Query: 135 VFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
+ HR+LK EN+LL SK +K++DFGL+ D H G+P Y++PEVL
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPEVLKKD 205
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNL 247
Y DIW+CGVILY++L GY PF D + LY +I G D+ P+W ++P A++L
Sbjct: 206 PY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 264
Query: 248 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 285
+ +L NP KRIT W A+ ++
Sbjct: 265 IDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQD 302
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 314 bits (806), Expect = e-105
Identities = 94/269 (34%), Positives = 142/269 (52%), Gaps = 17/269 (6%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+ R LG G FG V ++ SGL +K + K+R +QI+ EI LK L HP
Sbjct: 23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPM--EQIEAEIEVLKSLDHP 80
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYC 130
N++++ EV +Y+V+E GGEL ++I S L E +L +Q+++ ++Y
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 131 HNKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
H++ V H+DLK ENIL IKI DFGL+ F+ D G+ Y+APEV
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE---LFKSDEHSTNAAGTALYMAPEV 197
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL---PKWLSPGA 244
R DIWS GV++Y +LTG LPF +L + QK + + L+P A
Sbjct: 198 F-KRDVTFKC-DIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQA 255
Query: 245 QNLLRKILEPNPVKRITIAGIKADEWFEQ 273
+LL+++L +P +R + A + EWF+Q
Sbjct: 256 VDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 314 bits (806), Expect = e-105
Identities = 72/290 (24%), Positives = 124/290 (42%), Gaps = 36/290 (12%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E LG+G FG+V A++ +A+K + + I E+ L L H
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASLNHQY 63
Query: 76 VVRLHEV-------------LASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQ 121
VVR + + KS +++ +EY G L+D I S+ Q E +LF+
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH------------FRD 169
Q+++ +SY H++G+ HRDLK NI +D N+KI DFGL+
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI 229
L + G+ YVA EVL G+ D++S G+I + ++ Y + +K+
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNILKKL 241
Query: 230 FRGDFKLPKWL----SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
+ P + ++R +++ +P KR + W +
Sbjct: 242 RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH 291
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 311 bits (800), Expect = e-104
Identities = 104/267 (38%), Positives = 155/267 (58%), Gaps = 13/267 (4%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
RY + LG+G+FG+V +D + +AVK++ K + K T I RE+ LK L HP
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHP 81
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N+++L E+L S Y+V E TGGELFD+I + R E + ++ +Q+ G++Y H
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 135 VFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
+ HRDLK ENILL+SK +IKI DFGLS F+ + + G+ Y+APEVL
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLST---CFQQNTKMKDRIGTAYYIAPEVL-RG 197
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNL 247
YD D+WS GVILY++L+G PF +N + +++ G F LP+W +S A++L
Sbjct: 198 TYDEK-CDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256
Query: 248 LRKILEPNPVKRITIAGIKADEWFEQD 274
+RK+L +P RIT W ++
Sbjct: 257 IRKMLTFHPSLRITATQCLEHPWIQKY 283
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 312 bits (802), Expect = e-103
Identities = 103/279 (36%), Positives = 156/279 (55%), Gaps = 13/279 (4%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y+L LG+G F V+ + +G +A I+ ++ ++RE +LLKHP
Sbjct: 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQK-LEREARICRLLKHP 70
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N+VRLH+ ++ + Y++ + VTGGELF+ I ++ EA+ QQ+++ V +CH G
Sbjct: 71 NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 130
Query: 135 VFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDG-LLHTTCGSPNYVAPEVLAN 190
V HR+LK EN+LL SK +K++DFGL+ + G+P Y++PEVL
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAI---EVEGEQQAWFGFAGTPGYLSPEVLRK 187
Query: 191 RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQN 246
Y G D+W+CGVILY++L GY PF D + LYQ+I G DF P+W ++P A++
Sbjct: 188 DPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKD 246
Query: 247 LLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 285
L+ K+L NP KRIT A W T A+ +E
Sbjct: 247 LINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQE 285
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 306 bits (787), Expect = e-102
Identities = 67/280 (23%), Positives = 124/280 (44%), Gaps = 19/280 (6%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y + + +G G KV + + +A+K + + + D + EIA L L+
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQH 86
Query: 75 N--VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
+ ++RL++ + IYMV+E +L + K + E + ++ +++ V H
Sbjct: 87 SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
G+ H DLK N L+ G +K+ DFG++ Q + + G+ NY+ PE + +
Sbjct: 146 HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204
Query: 193 YD----------GATSDIWSCGVILYVILTGYLPFDDR--NLAVLYQKI-FRGDFKLPKW 239
SD+WS G ILY + G PF ++ L+ I + + P
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 264
Query: 240 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN 279
Q++L+ L+ +P +RI+I + A + + P N
Sbjct: 265 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 304
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 302 bits (777), Expect = e-101
Identities = 88/271 (32%), Positives = 142/271 (52%), Gaps = 15/271 (5%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLL 71
YE+G LG G F V+ + +G +A K ++K R+ ++I+RE+ L+ +
Sbjct: 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
+HPN++ LH++ +K+ + ++LE V+GGELFD +A K L E E + +Q++DGV Y H
Sbjct: 66 RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 125
Query: 132 NKGVFHRDLKLENILLDSK----GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
+K + H DLK ENI+L K IK+ DFG++ G+P +VAPE+
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA---HKIEAGNEFKNIFGTPEFVAPEI 182
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPG 243
+ D+WS GVI Y++L+G PF I DF + S
Sbjct: 183 VNYEPLGLEA-DMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL 241
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQD 274
A++ +R++L +P +R+TIA W +
Sbjct: 242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 309 bits (794), Expect = e-101
Identities = 104/276 (37%), Positives = 156/276 (56%), Gaps = 13/276 (4%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
RY + LG+G+FG+V +D + +AVK++ K + K T I RE+ LK L HP
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHP 81
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N+++L E+L S Y+V E TGGELFD+I + R E + ++ +Q+ G++Y H
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 135 VFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
+ HRDLK ENILL+SK +IKI DFGLS F+ + + G+ Y+APEVL
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLS---TCFQQNTKMKDRIGTAYYIAPEVL-RG 197
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNL 247
Y D+WS GVILY++L+G PF +N + +++ G F LP+W +S A++L
Sbjct: 198 TY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256
Query: 248 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDD 283
+RK+L +P RIT W ++ + D
Sbjct: 257 IRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISD 292
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 303 bits (779), Expect = e-101
Identities = 92/288 (31%), Positives = 145/288 (50%), Gaps = 15/288 (5%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT---DQIKREIATLKLL 71
Y++G LG G F VK ++ +GL +A K ++K + + ++I+RE++ L+ +
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV 72
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
H NV+ LH+V +++ + ++LE V+GGELFD +A K L E E +Q++DGV+Y H
Sbjct: 73 LHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 132 NKGVFHRDLKLENILLDSK----GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
K + H DLK ENI+L K +IK+ DFGL+ D G+P +VAPE+
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA---HEIEDGVEFKNIFGTPEFVAPEI 189
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPG 243
+ D+WS GVI Y++L+G PF I DF + S
Sbjct: 190 VNYEPLGLEA-DMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSEL 248
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDN 291
A++ +RK+L KR+TI W E + ++N
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLEN 296
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 304 bits (779), Expect = e-101
Identities = 90/312 (28%), Positives = 138/312 (44%), Gaps = 53/312 (16%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ--IKREIATLKLLK 72
+Y L +G+G++G V+ A + + A+KI+ KN+I + D IK E+ +K L
Sbjct: 27 KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH 86
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQ-------------------- 112
HPN+ RL+EV + I +V+E GG L DK+
Sbjct: 87 HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 113 --------------------EAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN 152
E + +Q+ + Y HN+G+ HRD+K EN L + +
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKS 206
Query: 153 --IKISDFGLSAL--PQHFRDDGLLHTTCGSPNYVAPEVL--ANRGYDGATSDIWSCGVI 206
IK+ DFGLS + + + T G+P +VAPEVL N Y D WS GV+
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC-DAWSAGVL 265
Query: 207 LYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITI 262
L+++L G +PF N A ++ F+ P + LSP A++LL +L N +R
Sbjct: 266 LHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDA 325
Query: 263 AGIKADEWFEQD 274
W Q
Sbjct: 326 MRALQHPWISQF 337
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 304 bits (781), Expect = e-101
Identities = 93/288 (32%), Positives = 146/288 (50%), Gaps = 15/288 (5%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLL 71
Y++G LG G F VK ++ +GL +A K ++K + ++I+RE++ L+ +
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV 72
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
HPN++ LH+V +++ + ++LE V+GGELFD +A K L E E +Q++DGV+Y H
Sbjct: 73 LHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 132 NKGVFHRDLKLENILLDSK----GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
K + H DLK ENI+L K +IK+ DFGL+ D G+P +VAPE+
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA---HEIEDGVEFKNIFGTPEFVAPEI 189
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPG 243
+ D+WS GVI Y++L+G PF I DF + S
Sbjct: 190 VNYEPLGLEA-DMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSEL 248
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDN 291
A++ +RK+L KR+TI W T E + ++N
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLEN 296
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 302 bits (775), Expect = e-100
Identities = 72/309 (23%), Positives = 116/309 (37%), Gaps = 50/309 (16%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
+ L LG+G V + +G FA+K+ L+ D RE LK L H
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNH 66
Query: 74 PNVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVS 128
N+V+L + + +++E+ G L+ + L E+E + + ++ G++
Sbjct: 67 KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 129 YCHNKGVFHRDLKLENILL----DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
+ G+ HR++K NI+ D + K++DFG + DD + G+ Y+
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---ELEDDEQFVSLYGTEEYLH 183
Query: 185 PEVLANRGYD-------GATSDIWSCGVILYVILTGYLPFDD----RNLAVLYQKIFRG- 232
P++ GAT D+WS GV Y TG LPF R + KI G
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243
Query: 233 ------------------DFKLPKW--LSPGAQN----LLRKILEPNPVKRITIAGIKAD 268
+P LS G Q +L ILE + K A+
Sbjct: 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
Query: 269 EWFEQDYTP 277
Sbjct: 304 TSDILHRGN 312
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 308 bits (790), Expect = e-100
Identities = 94/292 (32%), Positives = 152/292 (52%), Gaps = 22/292 (7%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT----------DQIKRE 64
Y R LG G +G+V ++ + A+K+++K++ + + ++I E
Sbjct: 37 SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE 96
Query: 65 IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
I+ LK L HPN+++L +V K Y+V E+ GGELF++I ++ + E + + +Q++
Sbjct: 97 ISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQIL 156
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
G+ Y H + HRD+K ENILL++K NIKI DFGLS F D L G+
Sbjct: 157 SGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLS---SFFSKDYKLRDRLGTAY 213
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW 239
Y+APEVL + Y D+WSCGVI+Y++L GY PF +N + +K+ +G F W
Sbjct: 214 YIAPEVL-KKKY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDW 271
Query: 240 --LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFV 289
+S A+ L++ +L + KR T W ++ N D +
Sbjct: 272 KNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGA 323
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 303 bits (777), Expect = e-100
Identities = 94/278 (33%), Positives = 146/278 (52%), Gaps = 18/278 (6%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+E+ LG G V + + P+A+K+L+K ++ EI L L HP
Sbjct: 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT-----VDKKIVRTEIGVLLRLSHP 108
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N+++L E+ + ++I +VLE VTGGELFD+I KG E + +Q+++ V+Y H G
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG 168
Query: 135 VFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
+ HRDLK EN+L + +KI+DFGLS + L+ T CG+P Y APE+L
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLS---KIVEHQVLMKTVCGTPGYCAPEILRGC 225
Query: 192 GYDGATSDIWSCGVILYVILTGYLPF-DDRNLAVLYQKIFRG--DFKLPKW--LSPGAQN 246
Y G D+WS G+I Y++L G+ PF D+R ++++I F P W +S A++
Sbjct: 226 AY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKD 284
Query: 247 LLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDE 284
L+RK++ +P KR+T W D
Sbjct: 285 LVRKLIVLDPKKRLTTFQALQHPWV-TGKAANFVHMDT 321
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 307 bits (788), Expect = e-100
Identities = 104/282 (36%), Positives = 158/282 (56%), Gaps = 12/282 (4%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
RY+ R LG+G+FG+V +D +G AVK++ K ++ + + RE+ LK L HP
Sbjct: 27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N+++L+E K Y+V E TGGELFD+I S+ R E + ++ +Q++ G++Y H
Sbjct: 87 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146
Query: 135 VFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
+ HRDLK EN+LL+SK NI+I DFGLS HF + G+ Y+APEVL +
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKMKDKIGTAYYIAPEVL-HG 202
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNL 247
Y D+WS GVILY++L+G PF+ N + +K+ +G F+LP+W +S A++L
Sbjct: 203 TY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDL 261
Query: 248 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFV 289
+RK+L P RI+ EW + D
Sbjct: 262 IRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNA 303
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 302 bits (775), Expect = e-100
Identities = 87/284 (30%), Positives = 146/284 (51%), Gaps = 18/284 (6%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ--IKREIATLKLLK 72
YEL +G+G F V+ + ++G FAVKI++ + +KRE + +LK
Sbjct: 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQ----EAEGRKLFQQLIDGVS 128
HP++V L E +S +YMV E++ G +L +I + EA +Q+++ +
Sbjct: 85 HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144
Query: 129 YCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 185
YCH+ + HRD+K +LL SK N +K+ FG++ Q + G+P+++AP
Sbjct: 145 YCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI--QLGESGLVAGGRVGTPHFMAP 202
Query: 186 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LS 241
EV+ Y G D+W CGVIL+++L+G LPF L++ I +G +W +S
Sbjct: 203 EVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKER-LFEGIIKGKYKMNPRQWSHIS 260
Query: 242 PGAQNLLRKILEPNPVKRITIAGIKADEWF-EQDYTPANPDDDE 284
A++L+R++L +P +RIT+ W E+D E
Sbjct: 261 ESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPE 304
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 299 bits (767), Expect = 4e-99
Identities = 91/288 (31%), Positives = 145/288 (50%), Gaps = 15/288 (5%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT---DQIKREIATLKLL 71
Y+ G LG G F VK ++ +GL +A K ++K R + + I+RE++ LK +
Sbjct: 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
+HPNV+ LHEV +K+ + ++LE V GGELFD +A K L E E + +Q+++GV Y H
Sbjct: 72 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 132 NKGVFHRDLKLENILLDSK----GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
+ + H DLK ENI+L + IKI DFGL+ G+P +VAPE+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA---HKIDFGNEFKNIFGTPEFVAPEI 188
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPG 243
+ D+WS GVI Y++L+G PF + +F+ + S
Sbjct: 189 VNYEPLGLEA-DMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDN 291
A++ +R++L +P KR+TI W + T + ++
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNMEK 295
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 308 bits (791), Expect = 1e-98
Identities = 85/441 (19%), Positives = 143/441 (32%), Gaps = 58/441 (13%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
G +E+ LG G FG V D+G A+K + K ++ EI +K L
Sbjct: 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSP--KNRERWCLEIQIMKKL 69
Query: 72 KHPNVVRLHEVLASKSKI------YMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQ 122
HPNVV EV K+ + +EY GG+L + L+E R L
Sbjct: 70 NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD 129
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGS 179
+ + Y H + HRDLK ENI+L KI D G + + L G+
Sbjct: 130 ISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA---KELDQGELCTEFVGT 186
Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI---------- 229
Y+APE+L + Y T D WS G + + +TG+ PF V +
Sbjct: 187 LQYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 245
Query: 230 ----------FRGDFKLPKWLSPGAQNL----LRKILEPNPVKRITIAGIKADEWFEQDY 275
F P LS L+ +L + +R T F+
Sbjct: 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA-- 303
Query: 276 TPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQ-LIGMSSCLDLSG--FFE 332
+ + +H P + + + + + +
Sbjct: 304 LDSILSLKLLSVMNMVS-GRVHTYPVTENEN------LQNLKSWLQQDTGIPEEEQELLQ 356
Query: 333 KEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLGSLSVA 392
++ + + + + ++ F + + SV+
Sbjct: 357 ASGLALNSAQPLTQYVIDCTVIDGRQGEGDLIFLFDNRKTVYEPQISLPAH----PESVS 412
Query: 393 AEVFEISPSLYVVELRKSYGD 413
+ + L LR+ +G
Sbjct: 413 IVLQDPKRPLTYTHLRRVWGQ 433
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 298 bits (764), Expect = 1e-98
Identities = 67/285 (23%), Positives = 124/285 (43%), Gaps = 19/285 (6%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y + + +G G KV + + +A+K + + + D + EIA L L+
Sbjct: 10 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQH 67
Query: 75 N--VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
+ ++RL++ + IYMV+E +L + K + E + ++ +++ V H
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
G+ H DLK N L+ G +K+ DFG++ Q + + G+ NY+ PE + +
Sbjct: 127 HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 193 YD----------GATSDIWSCGVILYVILTGYLPFDDR--NLAVLYQKI-FRGDFKLPKW 239
SD+WS G ILY + G PF ++ L+ I + + P
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 245
Query: 240 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDE 284
Q++L+ L+ +P +RI+I + A + + P N
Sbjct: 246 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKG 290
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 303 bits (777), Expect = 2e-98
Identities = 91/276 (32%), Positives = 153/276 (55%), Gaps = 13/276 (4%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y+ + LG G +G+V +D + + A+KI+ K + + + E+A LKLL HP
Sbjct: 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSK-LLEEVAVLKLLDHP 96
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N+++L++ K Y+V+E GGELFD+I + + E + + +Q++ GV+Y H
Sbjct: 97 NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN 156
Query: 135 VFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
+ HRDLK EN+LL+SK IKI DFGLS F + + G+ Y+APEVL +
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLS---AVFENQKKMKERLGTAYYIAPEVL-RK 212
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNL 247
Y D+WS GVIL+++L GY PF + + +K+ +G F P+W +S GA++L
Sbjct: 213 KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDL 271
Query: 248 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDD 283
++++L+ + +RI+ W ++ + +
Sbjct: 272 IKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIE 307
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 299 bits (767), Expect = 2e-98
Identities = 67/286 (23%), Positives = 124/286 (43%), Gaps = 19/286 (6%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
Y + + +G G KV + + +A+K + + + D + EIA L L+
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQ 113
Query: 74 PN--VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
+ ++RL++ + IYMV+E +L + K + E + ++ +++ V H
Sbjct: 114 HSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 172
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
G+ H DLK N L+ G +K+ DFG++ Q + + G+ NY+ PE + +
Sbjct: 173 QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 192 GYD----------GATSDIWSCGVILYVILTGYLPFDDR--NLAVLYQKIFRG-DFKLPK 238
SD+WS G ILY + G PF ++ L+ I + + P
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 291
Query: 239 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDE 284
Q++L+ L+ +P +RI+I + A + + P N
Sbjct: 292 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKG 337
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 296 bits (761), Expect = 4e-98
Identities = 95/284 (33%), Positives = 141/284 (49%), Gaps = 22/284 (7%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKH 73
YE+ +G G++ K + + FAVKI++K++ EI L + +H
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQH 75
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
PN++ L +V +Y+V E + GGEL DKI + E E + + V Y H +
Sbjct: 76 PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ 135
Query: 134 GVFHRDLKLENILLDSKG----NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
GV HRDLK NIL + +I+I DFG + Q ++GLL T C + N+VAPEVL
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAK--QLRAENGLLMTPCYTANFVAPEVLE 193
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFD---DRNLAVLYQKIFRG--DFKLPKW--LSP 242
+GYD A DIWS GV+LY +LTGY PF D + +I G W +S
Sbjct: 194 RQGYDAA-CDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSD 252
Query: 243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEED 286
A++L+ K+L +P +R+T A + W + +D
Sbjct: 253 TAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQD 296
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 298 bits (765), Expect = 4e-98
Identities = 70/312 (22%), Positives = 117/312 (37%), Gaps = 55/312 (17%)
Query: 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
+ + L LG+G V + +G FA+K+ L+ D RE
Sbjct: 2 GSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFE 59
Query: 67 TLKLLKHPNVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQ 121
LK L H N+V+L + + +++E+ G L+ + L E+E + +
Sbjct: 60 VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILL----DSKGNIKISDFGLSALPQHFRDDGLLHTTC 177
++ G+++ G+ HR++K NI+ D + K++DFG + DD +
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---ELEDDEQFVSLY 176
Query: 178 GSPNYVAPEVLANRGYD-------GATSDIWSCGVILYVILTGYLPFDD----RNLAVLY 226
G+ Y+ P++ GAT D+WS GV Y TG LPF R +
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236
Query: 227 QKIFRGDF-------------------------KLPKWLSPGAQNLLRKILEPNPVKRIT 261
KI G L + L +L ILE + K
Sbjct: 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG 296
Query: 262 IAGIKADEWFEQ 273
D++F +
Sbjct: 297 F-----DQFFAE 303
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 292 bits (749), Expect = 1e-96
Identities = 66/274 (24%), Positives = 125/274 (45%), Gaps = 15/274 (5%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+Y + LG G FG V + S + K ++ +K+EI+ L + +H
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIARHR 61
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNK 133
N++ LHE S ++ M+ E+++G ++F++I + L E E Q+ + + + H+
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 134 GVFHRDLKLENILLDSKGN--IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
+ H D++ ENI+ ++ + IKI +FG + + + +P Y APEV +
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQA---RQLKPGDNFRLLFTAPEYYAPEVHQHD 178
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNL 247
AT D+WS G ++YV+L+G PF + + I F + +S A +
Sbjct: 179 VVSTAT-DMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237
Query: 248 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPD 281
+ ++L R+T + W +Q +
Sbjct: 238 VDRLLVKERKSRMTASEALQHPWLKQKIERVSTK 271
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 290 bits (745), Expect = 7e-96
Identities = 101/298 (33%), Positives = 158/298 (53%), Gaps = 28/298 (9%)
Query: 15 RYELG---RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
Y+L + LGEG+F + S FAVKI+ K ++EI LKL
Sbjct: 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME------ANTQKEITALKLC 62
Query: 72 K-HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
+ HPN+V+LHEV + ++V+E + GGELF++I K E E + ++L+ VS+
Sbjct: 63 EGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHM 122
Query: 131 HNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
H+ GV HRDLK EN+L + IKI DFG + L D+ L T C + +Y APE+
Sbjct: 123 HDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP--DNQPLKTPCFTLHYAAPEL 180
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-------LAVLYQKIFRG--DFKLPK 238
L GYD + D+WS GVILY +L+G +PF + + +KI +G F+
Sbjct: 181 LNQNGYDES-CDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA 239
Query: 239 W--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD-YTPANPDDDEEDIFVDNEA 293
W +S A++L++ +L +P KR+ ++G++ +EW + +NP + + A
Sbjct: 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAA 297
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 286 bits (735), Expect = 2e-94
Identities = 94/282 (33%), Positives = 139/282 (49%), Gaps = 17/282 (6%)
Query: 15 RYEL-GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
Y L + LG G F V+ +G +A K L+K R + I EIA L+L K
Sbjct: 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAE-ILHEIAVLELAKS 87
Query: 74 -PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYC 130
P V+ LHEV + S+I ++LEY GGE+F + + E + +L +Q+++GV Y
Sbjct: 88 CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147
Query: 131 HNKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
H + H DLK +NILL S G+IKI DFG+S + L G+P Y+APE+
Sbjct: 148 HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS---RKIGHACELREIMGTPEYLAPEI 204
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPG 243
L AT D+W+ G+I Y++LT PF + Y I + D+ + +S
Sbjct: 205 LNYDPITTAT-DMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQL 263
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 285
A + ++ +L NP KR T + W Q + N EE
Sbjct: 264 ATDFIQSLLVKNPEKRPTAEICLSHSWL-QQWDFENLFHPEE 304
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 285 bits (732), Expect = 5e-94
Identities = 92/300 (30%), Positives = 138/300 (46%), Gaps = 39/300 (13%)
Query: 15 RYELGR-TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK- 72
Y+L LGEG +V+ +L + +AVKI+EK I ++ RE+ L +
Sbjct: 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQG 69
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
H NV+ L E + + Y+V E + GG + I + E E + Q + + + HN
Sbjct: 70 HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN 129
Query: 133 KGVFHRDLKLENILLDSKGN---IKISDFGLSAL-----PQHFRDDGLLHTTCGSPNYVA 184
KG+ HRDLK ENIL + +KI DF L + L T CGS Y+A
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 185 PEVL-----ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV--------------- 224
PEV+ YD D+WS GVILY++L+GY PF R +
Sbjct: 190 PEVVEAFSEEASIYDKR-CDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM 248
Query: 225 LYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
L++ I G +F W +S A++L+ K+L + +R++ A + W Q P N
Sbjct: 249 LFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV-QGCAPENT 307
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 287 bits (737), Expect = 7e-94
Identities = 77/278 (27%), Positives = 138/278 (49%), Gaps = 14/278 (5%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y++ LG G FG V + +G F K + +K EI+ + L HP
Sbjct: 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHP 108
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNK 133
++ LH+ K ++ ++LE+++GGELFD+IA++ ++ EAE +Q +G+ + H
Sbjct: 109 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 168
Query: 134 GVFHRDLKLENILLDSKGN--IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
+ H D+K ENI+ ++K +KI DFGL+ D ++ T + + APE++
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLA---TKLNPDEIVKVTTATAEFAAPEIVDRE 225
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNL 247
T D+W+ GV+ YV+L+G PF + Q + R +F + +SP A++
Sbjct: 226 PVGFYT-DMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 284
Query: 248 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 285
++ +L+ P KR+T+ W + D++
Sbjct: 285 IKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSS 322
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 283 bits (727), Expect = 1e-92
Identities = 85/269 (31%), Positives = 139/269 (51%), Gaps = 16/269 (5%)
Query: 15 RYELGRT--LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
Y + +T LG G FG+V ++ +GL A KI++ +K +++K EI+ + L
Sbjct: 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLD 144
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCH 131
H N+++L++ SK+ I +V+EYV GGELFD+I + L E + +Q+ +G+ + H
Sbjct: 145 HANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH 204
Query: 132 NKGVFHRDLKLENILLDSKGN--IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
+ H DLK ENIL ++ IKI DFGL+ + ++ L G+P ++APEV+
Sbjct: 205 QMYILHLDLKPENILCVNRDAKQIKIIDFGLA---RRYKPREKLKVNFGTPEFLAPEVVN 261
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQ 245
T D+WS GVI Y++L+G PF N A I D + ++ +S A+
Sbjct: 262 YDFVSFPT-DMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAK 320
Query: 246 NLLRKILEPNPVKRITIAGIKADEWFEQD 274
+ K+L RI+ + W
Sbjct: 321 EFISKLLIKEKSWRISASEALKHPWLSDH 349
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 281 bits (721), Expect = 3e-92
Identities = 84/301 (27%), Positives = 142/301 (47%), Gaps = 33/301 (10%)
Query: 15 RYELGR-TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLK 72
Y+L + LG G GKV +G A+K+L + + ++E+ +
Sbjct: 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------KARQEVDHHWQASG 80
Query: 73 HPNVVRLHEV----LASKSKIYMVLEYVTGGELFDKIASKGRLQ--EAEGRKLFQQLIDG 126
P++V + +V K + +++E + GGELF +I +G E E ++ + +
Sbjct: 81 GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 140
Query: 127 VSYCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
+ + H+ + HRD+K EN+L SK +K++DFG + L T C +P YV
Sbjct: 141 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK----ETTQNALQTPCYTPYYV 196
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN----LAVLYQKIFRG--DFKLP 237
APEVL YD + D+WS GVI+Y++L G+ PF + ++I G F P
Sbjct: 197 APEVLGPEKYDKS-CDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 255
Query: 238 KW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD-YTPANPDDDEEDIFVDNEAF 294
+W +S A+ L+R +L+ +P +R+TI W Q P P + D + +
Sbjct: 256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDKDHW 315
Query: 295 S 295
Sbjct: 316 D 316
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 289 bits (740), Expect = 4e-92
Identities = 76/272 (27%), Positives = 132/272 (48%), Gaps = 14/272 (5%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y++ LG G FG V + +G FA K + + +++EI T+ +L+HP
Sbjct: 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHP 214
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNK 133
+V LH+ +++ M+ E+++GGELF+K+A + ++ E E + +Q+ G+ + H
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 274
Query: 134 GVFHRDLKLENILLDSKG--NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
H DLK ENI+ +K +K+ DFGL+ H + T G+ + APEV +
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLT---AHLDPKQSVKVTTGTAEFAAPEVAEGK 331
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNL 247
T D+WS GV+ Y++L+G PF N + + + + +S ++
Sbjct: 332 PVGYYT-DMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 390
Query: 248 LRKILEPNPVKRITIAGIKADEWFEQDYTPAN 279
+RK+L +P R+TI W P
Sbjct: 391 IRKLLLADPNTRMTIHQALEHPWLTPGNAPGR 422
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 282 bits (723), Expect = 1e-91
Identities = 83/300 (27%), Positives = 141/300 (47%), Gaps = 30/300 (10%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK-LLKHP 74
+ LG G GKV + + FA+K+L+ + +RE+ + P
Sbjct: 64 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCP 115
Query: 75 NVVRLHEV----LASKSKIYMVLEYVTGGELFDKIASKGRLQ--EAEGRKLFQQLIDGVS 128
++VR+ +V A + + +V+E + GGELF +I +G E E ++ + + + +
Sbjct: 116 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 175
Query: 129 YCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 185
Y H+ + HRD+K EN+L SK +K++DFG + + L T C +P YVAP
Sbjct: 176 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAP 232
Query: 186 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV----LYQKIFRG--DFKLPKW 239
EVL YD + D+WS GVI+Y++L GY PF + + +I G +F P+W
Sbjct: 233 EVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 291
Query: 240 --LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMH 297
+S + L+R +L+ P +R+TI W Q + +++
Sbjct: 292 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWED 351
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 270 bits (692), Expect = 4e-88
Identities = 86/272 (31%), Positives = 139/272 (51%), Gaps = 7/272 (2%)
Query: 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
+ R ++ G+ LGEG+F V A++L + +A+KILEK II + RE
Sbjct: 23 QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD 82
Query: 67 TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
+ L HP V+L+ K+Y L Y GEL I G E R +++
Sbjct: 83 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 142
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
+ Y H KG+ HRDLK ENILL+ +I+I+DFG + + ++ G+ YV+PE
Sbjct: 143 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 202
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN 246
+L + +SD+W+ G I+Y ++ G PF N +++QKI + ++ P+ P A++
Sbjct: 203 LLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 261
Query: 247 LLRKILEPNPVKRITI------AGIKADEWFE 272
L+ K+L + KR+ +KA +FE
Sbjct: 262 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 293
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 269 bits (689), Expect = 7e-87
Identities = 57/311 (18%), Positives = 100/311 (32%), Gaps = 53/311 (17%)
Query: 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
+ + G R G LG+ + A D ++G F V + Q+K E+
Sbjct: 65 ESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEV 124
Query: 66 ATLKLLK-------------------------HPNVVRLHEVLASKSKIYMVLEY----- 95
L+LL+ ++R+ + Y
Sbjct: 125 LRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQS 184
Query: 96 ---VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN 152
G L ++ L +L Q+I ++ H+ G+ H L+ +I+LD +G
Sbjct: 185 NLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG 244
Query: 153 IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG----------YDGATSDIWS 202
+ ++ F DG + S + PE+ A R + D W+
Sbjct: 245 VFLTGFEHL------VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298
Query: 203 CGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITI 262
G+++Y I LP + IFR K + + LL L R+
Sbjct: 299 LGLVIYWIWCADLPITKDAALGGSEWIFRS----CKNIPQPVRALLEGFLRYPKEDRLLP 354
Query: 263 AGIKADEWFEQ 273
+EQ
Sbjct: 355 LQAMETPEYEQ 365
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 259 bits (663), Expect = 3e-82
Identities = 79/295 (26%), Positives = 119/295 (40%), Gaps = 49/295 (16%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKH 73
+ LG G+ G V F G P AVK + + D EI L + H
Sbjct: 16 LVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFC------DIALMEIKLLTESDDH 68
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-------RLQEAEGRKLFQQLIDG 126
PNV+R + + +Y+ LE L D + SK +E L +Q+ G
Sbjct: 69 PNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 127 VSYCHNKGVFHRDLKLENILLDSKG-------------NIKISDFGLSAL--PQHFRDDG 171
V++ H+ + HRDLK +NIL+ + I ISDFGL
Sbjct: 128 VAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 172 LLHTTCGSPNYVAPEVL-------ANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLA 223
L+ G+ + APE+L R + DI+S G + Y IL+ G PF D+
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRS-IDIFSMGCVFYYILSKGKHPFGDKYSR 246
Query: 224 VLYQKIFRGDFKLP-------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271
I RG F L + L A +L+ ++++ +P+KR T + F
Sbjct: 247 E--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 254 bits (652), Expect = 4e-82
Identities = 65/286 (22%), Positives = 112/286 (39%), Gaps = 23/286 (8%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y + LGEG F V + L G +A+K + + + + +RE +L HP
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDRE---EAQREADMHRLFNHP 86
Query: 75 NVVRLHEV----LASKSKIYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDG 126
N++RL +K + +++L + G L+++I L E + L + G
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH-------FRDDGLLHTTCGS 179
+ H KG HRDLK NILL +G + D G +
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 180 PNYVAPEVLANRGYDGAT--SDIWSCGVILYVILTGYLPFDDRNLAV-LYQKIFRGDFKL 236
+Y APE+ + + + +D+WS G +LY ++ G P+D + +
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266
Query: 237 PKW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
P+ S LL ++ +P +R I + + Q P
Sbjct: 267 PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQH 312
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 255 bits (653), Expect = 6e-82
Identities = 84/308 (27%), Positives = 135/308 (43%), Gaps = 34/308 (11%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-H 73
R + R L EG F V AQD+ SG +A+K L N + I +E+ +K L H
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNR---AIIQEVCFMKKLSGH 85
Query: 74 PNVVRLH-------EVLASKSKIYMVLEYVTGGELFDKI---ASKGRLQEAEGRKLFQQL 123
PN+V+ E + +++L + G+L + + S+G L K+F Q
Sbjct: 86 PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145
Query: 124 IDGVSYCHNKG--VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH------- 174
V + H + + HRDLK+EN+LL ++G IK+ DFG + H+ D
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 175 ---TTCGSPNYVAPEV--LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI 229
T +P Y PE+ L + G DIW+ G ILY++ PF+D +I
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK----LRI 261
Query: 230 FRGDFKLPKWL--SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDI 287
G + +P +L+R +L+ NP +R++IA + NP ++
Sbjct: 262 VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITEL 321
Query: 288 FVDNEAFS 295
N +
Sbjct: 322 LEQNGGYG 329
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 2e-80
Identities = 78/274 (28%), Positives = 128/274 (46%), Gaps = 16/274 (5%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
R YE+ T+G G++G+ + + G K L+ + + E+ L+ L
Sbjct: 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLREL 62
Query: 72 KHPNVVRLHE--VLASKSKIYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLID 125
KHPN+VR ++ + + + +Y+V+EY GG+L I + L E ++ QL
Sbjct: 63 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 126 GVSYCHNKG-----VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
+ CH + V HRDLK N+ LD K N+K+ DFGL+ + H D T G+P
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKTFVGTP 180
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKW 239
Y++PE + Y+ SDIWS G +LY + PF + L KI G F ++P
Sbjct: 181 YYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 239
Query: 240 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273
S ++ ++L R ++ I + +
Sbjct: 240 YSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 247 bits (633), Expect = 2e-79
Identities = 78/298 (26%), Positives = 132/298 (44%), Gaps = 52/298 (17%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHP 74
+ LG G GKV + + FA+K+L+ + +RE+ + + P
Sbjct: 20 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCP 71
Query: 75 NVVRLHEV----LASKSKIYMVLEYVTGGELFDKIASKGRLQ--EAEGRKLFQQLIDGVS 128
++VR+ +V A + + +V+E + GGELF +I +G E E ++ + + + +
Sbjct: 72 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 131
Query: 129 YCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 185
Y H+ + HRD+K EN+L SK +K++DFG A
Sbjct: 132 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-----------------------AK 168
Query: 186 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV----LYQKIFRG--DFKLPKW 239
E YD + D+WS GVI+Y++L GY PF + + +I G +F P+W
Sbjct: 169 ETTG-EKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 226
Query: 240 --LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD-YTPANPDDDEEDIFVDNEAF 294
+S + L+R +L+ P +R+TI W Q P P + D E +
Sbjct: 227 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERW 284
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 248 bits (635), Expect = 4e-79
Identities = 73/264 (27%), Positives = 136/264 (51%), Gaps = 7/264 (2%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ +Y + +GEG+FGK + + G + +K + +R+ K ++ +RE+A L +K
Sbjct: 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMK 81
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI--ASKGRLQEAEGRKLFQQLIDGVSYC 130
HPN+V+ E +Y+V++Y GG+LF +I QE + F Q+ + +
Sbjct: 82 HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
H++ + HRD+K +NI L G +++ DFG++ + L G+P Y++PE+ N
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--TVELARACIGTPYYLSPEICEN 199
Query: 191 RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLR 249
+ Y+ SDIW+ G +LY + T F+ ++ L KI G F + S ++L+
Sbjct: 200 KPYN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVS 258
Query: 250 KILEPNPVKRITIAGIKADEWFEQ 273
++ + NP R ++ I + +
Sbjct: 259 QLFKRNPRDRPSVNSILEKGFIAK 282
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 250 bits (641), Expect = 5e-79
Identities = 61/272 (22%), Positives = 98/272 (36%), Gaps = 24/272 (8%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK-LLKH 73
+ LG G G + + D AVK + RE+ L+ +H
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFD-NRDVAVKRILPECF------SFADREVQLLRESDEH 77
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHN 132
PNV+R + Y+ +E L + + K E L QQ G+++ H+
Sbjct: 78 PNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS 136
Query: 133 KGVFHRDLKLENILLDSKGN-----IKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPE 186
+ HRDLK NIL+ ISDFGL L G+ ++APE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
Query: 187 VL---ANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKW--- 239
+L DI+S G + Y +++ G PF +
Sbjct: 197 MLSEDCKENPTYT-VDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKH 255
Query: 240 LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271
A+ L+ K++ +P KR + + +F
Sbjct: 256 EDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 247 bits (634), Expect = 5e-79
Identities = 91/272 (33%), Positives = 148/272 (54%), Gaps = 11/272 (4%)
Query: 5 EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE 64
Q +L +++ +TLG G+FG+V + +SG +A+KIL+K +++ LK + E
Sbjct: 32 TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 65 IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
L+ + P +V+L S +YMV+EYV GGE+F + GR E R Q++
Sbjct: 92 KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
Y H+ + +RDLK EN+L+D +G I+++DFG + R G T CG+P +A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALA 206
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244
PE++ ++GY+ A D W+ GV++Y + GY PF +Y+KI G + P S
Sbjct: 207 PEIILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 245 QNLLRKILEPNPVKRI-----TIAGIKADEWF 271
++LLR +L+ + KR + IK +WF
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 3e-78
Identities = 81/262 (30%), Positives = 145/262 (55%), Gaps = 11/262 (4%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+++ RTLG G+FG+V + +G +A+K+L+K ++ LK + E L ++ HP
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
++R+ +I+M+++Y+ GGELF + R + ++ + Y H+K +
Sbjct: 68 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 127
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
+RDLK ENILLD G+IKI+DFG + + +T CG+P+Y+APEV++ + Y
Sbjct: 128 IYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEVVSTKPY-N 181
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
+ D WS G+++Y +L GY PF D N Y+KI + + P + + ++LL +++ +
Sbjct: 182 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRD 241
Query: 256 PVKRI-----TIAGIKADEWFE 272
+R+ +K WF+
Sbjct: 242 LSQRLGNLQNGTEDVKNHPWFK 263
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 239 bits (613), Expect = 1e-76
Identities = 62/277 (22%), Positives = 117/277 (42%), Gaps = 33/277 (11%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
++ +G G FG+V A+ G + +K ++ N ++ +RE+ L L H
Sbjct: 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHV 64
Query: 75 NVVRLHE----------------VLASKSKIYMVLEYVTGGELFDKI--ASKGRLQEAEG 116
N+V + + +++ +E+ G L I +L +
Sbjct: 65 NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124
Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT 176
+LF+Q+ GV Y H+K + +RDLK NI L +KI DFGL ++DG +
Sbjct: 125 LELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS---LKNDGKRTRS 181
Query: 177 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL 236
G+ Y++PE ++++ Y D+++ G+IL +L + + + + G +
Sbjct: 182 KGTLRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFETS--KFFTDLRDG--II 236
Query: 237 PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273
+ LL+K+L P R + I +
Sbjct: 237 SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 9e-75
Identities = 66/261 (25%), Positives = 110/261 (42%), Gaps = 10/261 (3%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
++ LG G++G+V + + G +AVK ++ + K+ +HP
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNK 133
VRL + +Y+ E G L + G L EA+ + + +++ H++
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 193
G+ H D+K NI L +G K+ DFGL G G P Y+APE+L Y
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLV---ELGTAGAGEVQEGDPRYMAPELLQG-SY 232
Query: 194 DGATSDIWSCGVILYVILTGY-LPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKIL 252
A +D++S G+ + + LP L Q +F LS +++L +L
Sbjct: 233 GTA-ADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEF--TAGLSSELRSVLVMML 289
Query: 253 EPNPVKRITIAGIKADEWFEQ 273
EP+P R T + A Q
Sbjct: 290 EPDPKLRATAEALLALPVLRQ 310
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 2e-73
Identities = 78/262 (29%), Positives = 126/262 (48%), Gaps = 11/262 (4%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
L + + + +G G F +V A L G+P A+K ++ ++ K +EI LK L
Sbjct: 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL 89
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGV 127
HPNV++ + +++ +VLE G+L I K + E K F QL +
Sbjct: 90 NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
+ H++ V HRD+K N+ + + G +K+ D GL H+ G+P Y++PE
Sbjct: 150 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPER 207
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPF--DDRNLAVLYQKIFRGDFK-LPKW-LSPG 243
+ GY+ SDIWS G +LY + PF D NL L +KI + D+ LP S
Sbjct: 208 IHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE 266
Query: 244 AQNLLRKILEPNPVKRITIAGI 265
+ L+ + P+P KR + +
Sbjct: 267 LRQLVNMCINPDPEKRPDVTYV 288
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 2e-72
Identities = 37/301 (12%), Positives = 82/301 (27%), Gaps = 47/301 (15%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+ +L L G+ V +D++ FA+K+ +++ L
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 75 NVVRLHEVL--------------------------ASKSKIYMVLEYVTG------GELF 102
+ + + + +++ + L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 103 DKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA 162
+G L QLI + +KG+ H +N+ + G + + D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW 242
Query: 163 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD-GATSDIWSCGVILYVILTGYLPFDDRN 221
+ + Y E L + W G+ +Y + +LPF
Sbjct: 243 -----KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297
Query: 222 LAV--LYQKIFRG-------DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 272
+ +++ F L + L+ + L + +R+ F
Sbjct: 298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL 357
Query: 273 Q 273
Q
Sbjct: 358 Q 358
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 232 bits (592), Expect = 5e-72
Identities = 61/346 (17%), Positives = 105/346 (30%), Gaps = 49/346 (14%)
Query: 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
G R G LG+ + A D ++G F V + Q+K E+ L+
Sbjct: 74 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLR 133
Query: 70 LL----------------------KHPNVVRLHEVLASKSKIYMVLEYVT---------- 97
LL K P ++ V + ++++ +
Sbjct: 134 LLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQT 193
Query: 98 -GGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKIS 156
G L ++ L +L Q+I ++ H+ G+ H L+ +I+LD +G + ++
Sbjct: 194 FGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLT 253
Query: 157 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT----SDIWSCGVILYVILT 212
F + P A +L + D W+ G+ +Y I
Sbjct: 254 GFEHLVRDGASAVS-PIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312
Query: 213 GYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 272
LP D + IFR +P + LL L R+ +E
Sbjct: 313 ADLPNTDDAALGGSEWIFRSCKNIP----QPVRALLEGFLRYPKEDRLLPLQAMETPEYE 368
Query: 273 Q------DYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPL 312
Q P D E S P + G +
Sbjct: 369 QLRTELSAALPLYQTDGEPTREGGAPP-SGTSQPDEAGAAEAVTAI 413
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 1e-71
Identities = 68/293 (23%), Positives = 117/293 (39%), Gaps = 33/293 (11%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
L +E + LG G FG V A++ +A+K + + +++ RE+ L L+
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR--EKVMREVKALAKLE 61
Query: 73 HPNVVRLHEV------------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR--- 117
HP +VR + K +Y+ ++ L D + + ++E E
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 118 KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL----------PQHF 167
+F Q+ + V + H+KG+ HRDLK NI +K+ DFGL
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLY 226
G+ Y++PE + Y DI+S G+IL+ +L PF +
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELLY---PFSTQMERVRTL 237
Query: 227 QKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA 278
+ F L P +++ +L P+P++R I + FE P
Sbjct: 238 TDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPG 290
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 227 bits (582), Expect = 2e-71
Identities = 91/259 (35%), Positives = 146/259 (56%), Gaps = 7/259 (2%)
Query: 5 EKKQEGMRLGRYELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRII-HLKITDQ 60
+ E +R +EL R LG+G +GKV + ++G FA+K+L+K I+ + K T
Sbjct: 8 NRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAH 67
Query: 61 IKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
K E L+ +KHP +V L + K+Y++LEY++GGELF ++ +G E
Sbjct: 68 TKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYL 127
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
++ + + H KG+ +RDLK ENI+L+ +G++K++DFGL + D + HT CG+
Sbjct: 128 AEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTFCGTI 185
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWL 240
Y+APE+L G+ D WS G ++Y +LTG PF N KI + LP +L
Sbjct: 186 EYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYL 244
Query: 241 SPGAQNLLRKILEPNPVKR 259
+ A++LL+K+L+ N R
Sbjct: 245 TQEARDLLKKLLKRNAASR 263
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 3e-71
Identities = 72/262 (27%), Positives = 131/262 (50%), Gaps = 11/262 (4%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
E+ R +G+G+FGKV Q D+ +A+K + K + + + +E+ ++ L+HP +
Sbjct: 18 EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFL 77
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVF 136
V L + ++MV++ + GG+L + +E + +L+ + Y N+ +
Sbjct: 78 VNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRII 137
Query: 137 HRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR---GY 193
HRD+K +NILLD G++ I+DF ++A + + T G+ Y+APE+ ++R GY
Sbjct: 138 HRDMKPDNILLDEHGHVHITDFNIAA---MLPRETQITTMAGTKPYMAPEMFSSRKGAGY 194
Query: 194 DGATSDIWSCGVILYVILTGYLPFDDR---NLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 250
D WS GV Y +L G P+ R + + P S +LL+K
Sbjct: 195 -SFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKK 253
Query: 251 ILEPNPVKRI-TIAGIKADEWF 271
+LEPNP +R ++ ++ +
Sbjct: 254 LLEPNPDQRFSQLSDVQNFPYM 275
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 3e-70
Identities = 88/268 (32%), Positives = 147/268 (54%), Gaps = 5/268 (1%)
Query: 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
Q +++ + L + LG+G+FGKV A+ + FA+K L+K+ ++ + E
Sbjct: 9 SLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEK 68
Query: 66 ATLKL-LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
L L +HP + + +K ++ V+EY+ GG+L I S + + ++I
Sbjct: 69 RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEII 128
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
G+ + H+KG+ +RDLKL+NILLD G+IKI+DFG+ ++ D +T CG+P+Y+A
Sbjct: 129 LGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNTFCGTPDYIA 186
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244
PE+L + Y + D WS GV+LY +L G PF ++ L+ I + P+WL A
Sbjct: 187 PEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEA 245
Query: 245 QNLLRKILEPNPVKRITIAG-IKADEWF 271
++LL K+ P KR+ + G I+ F
Sbjct: 246 KDLLVKLFVREPEKRLGVRGDIRQHPLF 273
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 4e-70
Identities = 83/244 (34%), Positives = 137/244 (56%), Gaps = 3/244 (1%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
++ + LG+G FGKV ++ +G +A+KIL K II E L+ +HP
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
+ L + ++ V+EY GGELF ++ + E R +++ + Y H++ V
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
+RD+KLEN++LD G+IKI+DFGL + D + T CG+P Y+APEVL + Y G
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDY-G 183
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
D W GV++Y ++ G LPF +++ L++ I + + P+ LSP A++LL +L+ +
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKD 243
Query: 256 PVKR 259
P +R
Sbjct: 244 PKQR 247
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 225 bits (574), Expect = 6e-70
Identities = 52/298 (17%), Positives = 104/298 (34%), Gaps = 36/298 (12%)
Query: 6 KKQEGMRLG--RYELGRTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKIT 58
K + +LG + LGEG F +V A D + F +K+ + I
Sbjct: 55 KPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIG 114
Query: 59 DQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-----ASKGRLQE 113
Q+ LK ++ + ++ +V E + G L + I + + +
Sbjct: 115 TQLMER---LKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQ 171
Query: 114 AEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL-----------DSKGNIKISDFGLSA 162
+++ + H+ + H D+K +N +L D + + D G S
Sbjct: 172 GLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
Query: 163 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG-YLPFDDRN 221
+ F + C + + E+L+N+ ++ D + +Y +L G Y+ +
Sbjct: 232 DMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQI-DYFGVAATVYCMLFGTYMKVKNEG 290
Query: 222 LAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI---KADEWFEQDYT 276
+ +FR L W +L + + K + F+Q YT
Sbjct: 291 GECKPEGLFRRLPHLDMW-----NEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYT 343
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 6e-70
Identities = 91/274 (33%), Positives = 142/274 (51%), Gaps = 8/274 (2%)
Query: 3 IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
+ + + + +G+G+FGKV A+ + +AVK+L+K I+ K I
Sbjct: 27 LGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIM 86
Query: 63 REIATL-KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ 121
E L K +KHP +V LH + K+Y VL+Y+ GGELF + + E R
Sbjct: 87 SERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA 146
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
++ + Y H+ + +RDLK ENILLDS+G+I ++DFGL ++ + T CG+P
Sbjct: 147 EIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPE 204
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLS 241
Y+APEVL + Y T D W G +LY +L G PF RN A +Y I +L ++
Sbjct: 205 YLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNIT 263
Query: 242 PGAQNLLRKILEPNPVKRITIAG----IKADEWF 271
A++LL +L+ + KR+ IK+ +F
Sbjct: 264 NSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFF 297
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 1e-69
Identities = 86/259 (33%), Positives = 152/259 (58%), Gaps = 7/259 (2%)
Query: 4 AEKKQEGMRLGRYELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQ 60
++ E ++EL + LG+G+FGKV K D+ +A+K+L+K + + +
Sbjct: 14 VKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV-RDRVR 72
Query: 61 IKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
K E L + HP +V+LH ++ K+Y++L+++ GG+LF +++ + E + +
Sbjct: 73 TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL 132
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
+L + + H+ G+ +RDLK ENILLD +G+IK++DFGLS + + ++ CG+
Sbjct: 133 AELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTV 190
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWL 240
Y+APEV+ RG+ ++D WS GV+++ +LTG LPF ++ I + +P++L
Sbjct: 191 EYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFL 249
Query: 241 SPGAQNLLRKILEPNPVKR 259
SP AQ+LLR + + NP R
Sbjct: 250 SPEAQSLLRMLFKRNPANR 268
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 5e-69
Identities = 88/286 (30%), Positives = 144/286 (50%), Gaps = 20/286 (6%)
Query: 3 IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
I + + +E R LG+G+FGKV A+ ++G +AVK+L+K+ I+ +
Sbjct: 12 IGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTM 71
Query: 63 REIATLKL-LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ 121
E L L HP + +L + +++ V+E+V GG+L I R EA R
Sbjct: 72 TEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAA 131
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
++I + + H+KG+ +RDLKL+N+LLD +G+ K++DFG+ + + T CG+P+
Sbjct: 132 EIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPD 189
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLS 241
Y+APE+L Y G D W+ GV+LY +L G+ PF+ N L++ I + P WL
Sbjct: 190 YIAPEILQEMLY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLH 248
Query: 242 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDI 287
A +L+ + NP R+ G + E I
Sbjct: 249 EDATGILKSFMTKNPTMRL---G-------------SLTQGGEHAI 278
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 9e-69
Identities = 86/255 (33%), Positives = 144/255 (56%), Gaps = 4/255 (1%)
Query: 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
++ M+L + LG+G+FGKV ++ + +AVKIL+K+ +I + E
Sbjct: 12 GNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEK 71
Query: 66 ATLKL-LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
L L K P + +LH + ++Y V+EYV GG+L I GR +E ++
Sbjct: 72 RVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIA 131
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
G+ + +KG+ +RDLKL+N++LDS+G+IKI+DFG+ ++ D T CG+P+Y+A
Sbjct: 132 IGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIA 189
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244
PE++A + Y G + D W+ GV+LY +L G PF+ + L+Q I + PK +S A
Sbjct: 190 PEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEA 248
Query: 245 QNLLRKILEPNPVKR 259
+ + ++ +P KR
Sbjct: 249 VAICKGLMTKHPGKR 263
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 1e-67
Identities = 85/257 (33%), Positives = 142/257 (55%), Gaps = 4/257 (1%)
Query: 4 AEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR 63
K + + + +E + LG+G FGKV ++ +G +A+KIL+K I+
Sbjct: 138 LAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT 197
Query: 64 EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL 123
E L+ +HP + L + ++ V+EY GGELF ++ + E R ++
Sbjct: 198 ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI 257
Query: 124 IDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
+ + Y H+ K V +RDLKLEN++LD G+IKI+DFGL + +D + T CG+P Y
Sbjct: 258 VSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEY 315
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSP 242
+APEVL + Y G D W GV++Y ++ G LPF +++ L++ I + + P+ L P
Sbjct: 316 LAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGP 374
Query: 243 GAQNLLRKILEPNPVKR 259
A++LL +L+ +P +R
Sbjct: 375 EAKSLLSGLLKKDPKQR 391
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 3e-67
Identities = 82/290 (28%), Positives = 149/290 (51%), Gaps = 29/290 (10%)
Query: 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
+ + L ++L R +G G++ KV + + +A+K+++K + + D ++ E
Sbjct: 3 MDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHV 62
Query: 68 LKL-LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
+ HP +V LH ++S+++ V+EYV GG+L + + +L E R ++
Sbjct: 63 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 122
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
++Y H +G+ +RDLKL+N+LLDS+G+IK++D+G+ + R T CG+PNY+APE
Sbjct: 123 LNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPE 180
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF---------DDRNLAVLYQKIFRGDFKLP 237
+L Y G + D W+ GV+++ ++ G PF D L+Q I ++P
Sbjct: 181 ILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP 239
Query: 238 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDI 287
+ LS A ++L+ L +P +R+ G +P DI
Sbjct: 240 RSLSVKAASVLKSFLNKDPKERL---G-------------CHPQTGFADI 273
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 1e-66
Identities = 82/292 (28%), Positives = 149/292 (51%), Gaps = 29/292 (9%)
Query: 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
K + L ++L R +G G++ KV + + +A+++++K + + D ++ E
Sbjct: 44 KASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEK 103
Query: 66 ATLKL-LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
+ HP +V LH ++S+++ V+EYV GG+L + + +L E R ++
Sbjct: 104 HVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS 163
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
++Y H +G+ +RDLKL+N+LLDS+G+IK++D+G+ + R T CG+PNY+A
Sbjct: 164 LALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIA 221
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPF---------DDRNLAVLYQKIFRGDFK 235
PE+L Y G + D W+ GV+++ ++ G PF D L+Q I +
Sbjct: 222 PEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR 280
Query: 236 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDI 287
+P+ LS A ++L+ L +P +R+ G +P DI
Sbjct: 281 IPRSLSVKAASVLKSFLNKDPKERL---G-------------CHPQTGFADI 316
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 224 bits (571), Expect = 2e-66
Identities = 86/255 (33%), Positives = 144/255 (56%), Gaps = 4/255 (1%)
Query: 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
++ M+L + LG+G+FGKV ++ + +AVKIL+K+ +I + E
Sbjct: 333 GNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEK 392
Query: 66 ATLKL-LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
L L K P + +LH + ++Y V+EYV GG+L I GR +E ++
Sbjct: 393 RVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIA 452
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
G+ + +KG+ +RDLKL+N++LDS+G+IKI+DFG+ ++ D T CG+P+Y+A
Sbjct: 453 IGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIA 510
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244
PE++A + Y G + D W+ GV+LY +L G PF+ + L+Q I + PK +S A
Sbjct: 511 PEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEA 569
Query: 245 QNLLRKILEPNPVKR 259
+ + ++ +P KR
Sbjct: 570 VAICKGLMTKHPGKR 584
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 5e-66
Identities = 80/267 (29%), Positives = 128/267 (47%), Gaps = 15/267 (5%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+ R LG+G FG+V Q +G +A K LEK RI K E L+ +
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGVSYCHNK 133
VV L +K + +VL + GG+L I G+ E R +F ++ G+ H +
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 193
+ +RDLK ENILLD G+I+ISD GL+ H + + G+ Y+APEV+ N Y
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLA---VHVPEGQTIKGRVGTVGYMAPEVVKNERY 362
Query: 194 DGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG----DFKLPKWLSPGAQNLLR 249
+ D W+ G +LY ++ G PF R + +++ R + + SP A++L
Sbjct: 363 TFSP-DWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCS 421
Query: 250 KILEPNPVKRI-----TIAGIKADEWF 271
++L +P +R+ + +K F
Sbjct: 422 QLLCKDPAERLGCRGGSAREVKEHPLF 448
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 2e-65
Identities = 81/347 (23%), Positives = 140/347 (40%), Gaps = 42/347 (12%)
Query: 6 KKQEGMRLGR--YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR 63
K E +G + R LG G FG+V Q +G +A K L K R+ K
Sbjct: 175 KWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMV 234
Query: 64 EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQE--AEGRKLF- 120
E L + +V L +K+ + +V+ + GG++ I + E R +F
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 121 -QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179
Q++ G+ + H + + +RDLK EN+LLD GN++ISD GL+ + G+
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV--ELKAGQTKTKGYAGT 352
Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV----LYQKIFRGDFK 235
P ++APE+L YD + D ++ GV LY ++ PF R V L Q++
Sbjct: 353 PGFMAPELLLGEEYDFSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVT 411
Query: 236 LPKWLSPGAQNLLRKILEPNPVKRITIAG-----IKADEWFEQDYTPANPDDDEEDIFVD 290
P SP +++ +L+ +P KR+ ++ F +
Sbjct: 412 YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD---------------IS 456
Query: 291 NEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVS 337
+ PP + + + + D+ F + V+
Sbjct: 457 WRQLEAGMLT---------PPFVPDSRTVYAKNIQDVGAFSTVKGVA 494
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 2e-65
Identities = 83/283 (29%), Positives = 137/283 (48%), Gaps = 17/283 (6%)
Query: 2 VIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI 61
I + + M+ YE+ + +G G FG+V+ + + +A+K+L K +I +
Sbjct: 57 TINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFF 116
Query: 62 KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ 121
E + P VV+L +YMV+EY+ GG+L + S + E R
Sbjct: 117 WEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTA 175
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL--HTTCGS 179
+++ + H+ G HRD+K +N+LLD G++K++DFG +G++ T G+
Sbjct: 176 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM---KMNKEGMVRCDTAVGT 232
Query: 180 PNYVAPEVLANRGYD---GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI--FRGDF 234
P+Y++PEVL ++G D G D WS GV LY +L G PF +L Y KI +
Sbjct: 233 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL 292
Query: 235 KLPK--WLSPGAQNLLRKILEPNPVKRITIAG---IKADEWFE 272
P +S A+NL+ L + R+ G IK +F+
Sbjct: 293 TFPDDNDISKEAKNLICAFLT-DREVRLGRNGVEEIKRHLFFK 334
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 4e-65
Identities = 86/283 (30%), Positives = 159/283 (56%), Gaps = 18/283 (6%)
Query: 5 EKKQEGMRLGRYELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRII-HLKITDQ 60
E + + +EL + LG G +GKV + D+G +A+K+L+K I+ K T+
Sbjct: 45 TGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEH 104
Query: 61 IKREIATLKLLKH-PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL 119
+ E L+ ++ P +V LH +++K++++L+Y+ GGELF ++ + R E E +
Sbjct: 105 TRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY 164
Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179
+++ + + H G+ +RD+KLENILLDS G++ ++DFGLS + + CG+
Sbjct: 165 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGT 223
Query: 180 PNYVAPEVL--ANRGYDGATSDIWSCGVILYVILTGYLPF----DDRNLAVLYQKIFRGD 233
Y+AP+++ + G+D A D WS GV++Y +LTG PF + + A + ++I + +
Sbjct: 224 IEYMAPDIVRGGDSGHDKAV-DWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 282
Query: 234 FKLPKWLSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWF 271
P+ +S A++L++++L +P KR+ IK +F
Sbjct: 283 PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 2e-63
Identities = 90/395 (22%), Positives = 164/395 (41%), Gaps = 51/395 (12%)
Query: 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE- 64
+ + + + + R +G G FG+V + D+G +A+K L+K RI + E
Sbjct: 181 ELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNER 240
Query: 65 --IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
++ + P +V + + K+ +L+ + GG+L ++ G EA+ R +
Sbjct: 241 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE 300
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
+I G+ + HN+ V +RDLK NILLD G+++ISD GL+ H + G+ Y
Sbjct: 301 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD----FSKKKPHASVGTHGY 356
Query: 183 VAPEVLA-NRGYDGATSDIWSCGVILYVILTGYLPFDDRN---LAVLYQKIFRGDFKLPK 238
+APEVL YD + D +S G +L+ +L G+ PF + + +LP
Sbjct: 357 MAPEVLQKGVAYDSSA-DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD 415
Query: 239 WLSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWFEQDYTPANPDDDEEDIFVDNEA 293
SP ++LL +L+ + +R+ +K +F +D +
Sbjct: 416 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS---------------LDWQM 460
Query: 294 FSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKI---------RFT 344
+ + P PPLI + + D+ F++ED K+ F
Sbjct: 461 VFLQKYP---------PPLIPPRGEVNAADAFDIG-SFDEEDTKGIKLLDSDQELYRNFP 510
Query: 345 SNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQE 379
S + E E + + + + K +
Sbjct: 511 LTISERWQQEVAETVFDTINAETDRLEARKKTKNK 545
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 3e-63
Identities = 77/287 (26%), Positives = 134/287 (46%), Gaps = 21/287 (7%)
Query: 2 VIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI 61
++ KQ + +E+ + +G G FG+V + ++ FA+KIL K ++ T
Sbjct: 62 FTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACF 121
Query: 62 KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIA-SKGRLQEAEGRKLF 120
+ E L + LH + +Y+V++Y GG+L ++ + RL E R
Sbjct: 122 REERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYL 181
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL--HTTCG 178
+++ + H HRD+K +NIL+D G+I+++DFG +DG + G
Sbjct: 182 AEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCL---KLMEDGTVQSSVAVG 238
Query: 179 SPNYVAPEVL-----ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI--FR 231
+P+Y++PE+L Y G D WS GV +Y +L G PF +L Y KI +
Sbjct: 239 TPDYISPEILQAMEGGKGRY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK 297
Query: 232 GDFKLPKW---LSPGAQNLLRKILEPNPVKRITIAG---IKADEWFE 272
F+ P +S A++L+R+++ R+ G K +F
Sbjct: 298 ERFQFPTQVTDVSENAKDLIRRLICSRE-HRLGQNGIEDFKKHPFFS 343
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 1e-62
Identities = 71/288 (24%), Positives = 130/288 (45%), Gaps = 21/288 (7%)
Query: 2 VIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI 61
++ K+ ++ +E+ + +G G F +V + +G +A+KI+ K ++
Sbjct: 49 IVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCF 108
Query: 62 KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLF 120
+ E L + +LH ++ +Y+V+EY GG+L ++ G R+ R
Sbjct: 109 REERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYL 168
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL--HTTCG 178
+++ + H G HRD+K +NILLD G+I+++DFG R DG + G
Sbjct: 169 AEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCL---KLRADGTVRSLVAVG 225
Query: 179 SPNYVAPEVLANRGYD------GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG 232
+P+Y++PE+L G G D W+ GV Y + G PF + A Y KI
Sbjct: 226 TPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHY 285
Query: 233 DFKLP-----KWLSPGAQNLLRKILEPNPVKRITIAG---IKADEWFE 272
L + + A++ ++++L P R+ G + +F
Sbjct: 286 KEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFF 332
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 2e-59
Identities = 58/274 (21%), Positives = 101/274 (36%), Gaps = 35/274 (12%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+ +G G FG V G +A+K +K + + ++ A L +H
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGVSYC 130
+VVR A + + EY GG L D I +EAE + L Q+ G+ Y
Sbjct: 72 HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 131 HNKGVFHRDLKLENILLDSKGNI-------------------KISDFGLSALPQHFRDDG 171
H+ + H D+K NI + KI D G
Sbjct: 132 HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR------IS 185
Query: 172 LLHTTCGSPNYVAPEVLA-NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF 230
G ++A EVL N + +DI++ + + + + + +I
Sbjct: 186 SPQVEEGDSRFLANEVLQENYTHLPK-ADIFALALTVVCAAGAEPLPRNGD---QWHEIR 241
Query: 231 RGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIA 263
+G ++P+ LS LL+ ++ P+P +R +
Sbjct: 242 QGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAM 275
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 7e-58
Identities = 77/259 (29%), Positives = 128/259 (49%), Gaps = 17/259 (6%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
LG+G +G V +DL + + A+K + + + + + EIA K LK
Sbjct: 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQ---PLHEEIALHKHLK 77
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEG--RKLFQQLIDGVSY 129
H N+V+ + I + +E V GG L + SK G L++ E +Q+++G+ Y
Sbjct: 78 HKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKY 137
Query: 130 CHNKGVFHRDLKLENILLDSK-GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
H+ + HRD+K +N+L+++ G +KISDFG S T G+ Y+APE++
Sbjct: 138 LHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTETFTGTLQYMAPEII 195
Query: 189 --ANRGYDGATSDIWSCGVILYVILTGYLPFDD--RNLAVLYQKIFRGDF--KLPKWLSP 242
RGY A +DIWS G + + TG PF + A ++ K+ ++P+ +S
Sbjct: 196 DKGPRGYGKA-ADIWSLGCTIIEMATGKPPFYELGEPQAAMF-KVGMFKVHPEIPESMSA 253
Query: 243 GAQNLLRKILEPNPVKRIT 261
A+ + K EP+P KR
Sbjct: 254 EAKAFILKCFEPDPDKRAC 272
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 8e-58
Identities = 59/255 (23%), Positives = 103/255 (40%), Gaps = 18/255 (7%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+G G+FG+V +D +G AVK + + E+ L P
Sbjct: 59 WMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR--------LEVFRVEELVACAGLSSP 110
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
+V L+ + + + +E + GG L I G L E Q ++G+ Y H +
Sbjct: 111 RIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR 170
Query: 135 VFHRDLKLENILLDSKGN-IKISDFGLSA---LPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
+ H D+K +N+LL S G+ + DFG + + G+ ++APEV+
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 191 RGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGD---FKLPKWLSPGAQN 246
+ D DIWS ++ +L G P+ + KI ++P +P
Sbjct: 231 KPCDAK-VDIWSSCCMMLHMLNGCHPWTQYFRGPLCL-KIASEPPPIREIPPSCAPLTAQ 288
Query: 247 LLRKILEPNPVKRIT 261
+++ L PV R +
Sbjct: 289 AIQEGLRKEPVHRAS 303
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 9e-53
Identities = 65/272 (23%), Positives = 127/272 (46%), Gaps = 18/272 (6%)
Query: 14 GRYE-LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
GR+ +G G+F V D ++ + A L+ ++ + + K E LK L+
Sbjct: 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER-QRFKEEAEMLKGLQ 83
Query: 73 HPNVVRLH----EVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
HPN+VR + + K I +V E +T G L + ++ R +Q++ G+
Sbjct: 84 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ 143
Query: 129 YCHNKG--VFHRDLKLENILLDSK-GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 185
+ H + + HRDLK +NI + G++KI D GL+ L + G+P ++AP
Sbjct: 144 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR----ASFAKAVIGTPEFMAP 199
Query: 186 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGD--FKLPKWLSP 242
E+ YD + D+++ G+ + + T P+ + +N A +Y+++ G K P
Sbjct: 200 EMY-EEKYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 257
Query: 243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274
+ ++ + N +R +I + +F+++
Sbjct: 258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 3e-51
Identities = 51/246 (20%), Positives = 93/246 (37%), Gaps = 17/246 (6%)
Query: 41 PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGE 100
+ + D +I + N V + + K +Y+ ++
Sbjct: 88 IWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKEN 147
Query: 101 LFDKIASKGRLQEAEG---RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISD 157
L D + + L++ E +F Q+ + V + H+KG+ HRDLK NI +K+ D
Sbjct: 148 LKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD 207
Query: 158 FGLSA----------LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 207
FGL + G+ Y++PE + Y DI+S G+IL
Sbjct: 208 FGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHK-VDIFSLGLIL 266
Query: 208 YVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIK 266
+ +L + +R + + F L P +++ +L P+P +R I
Sbjct: 267 FELLYSFSTQMER--VRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDII 324
Query: 267 ADEWFE 272
+ FE
Sbjct: 325 ENAIFE 330
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 4e-08
Identities = 17/66 (25%), Positives = 32/66 (48%), Gaps = 2/66 (3%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E + +G G FG V A++ +A+K + + +++ RE+ L L+HP
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR--EKVMREVKALAKLEHPG 65
Query: 76 VVRLHE 81
+VR
Sbjct: 66 IVRYFN 71
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 3e-50
Identities = 84/323 (26%), Positives = 123/323 (38%), Gaps = 76/323 (23%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--------R 63
R RYE LGEG F V A+D ++ A+K K I L + K R
Sbjct: 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIK---K---IKLGHRSEAKDGINRTALR 61
Query: 64 EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQ 121
EI L+ L HPN++ L + KS I +V +++ + + L + +
Sbjct: 62 EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYML 119
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
+ G+ Y H + HRDLK N+LLD G +K++DFGL+ + GSPN
Sbjct: 120 MTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLA-------------KSFGSPN 166
Query: 182 -----------YVAPEVL-ANRGYDGATSDIWSCGVILYVILTG--YLPFDDRNLAVLYQ 227
Y APE+L R Y D+W+ G IL +L +LP D +L L
Sbjct: 167 RAYTHQVVTRWYRAPELLFGARMYGVGV-DMWAVGCILAELLLRVPFLPGDS-DLDQLT- 223
Query: 228 KIFR-----------GDFKLP-----------------KWLSPGAQNLLRKILEPNPVKR 259
+IF LP +L++ + NP R
Sbjct: 224 RIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCAR 283
Query: 260 ITIAGIKADEWFEQDYTPANPDD 282
IT ++F P
Sbjct: 284 ITATQALKMKYFSNRPGPTPGCQ 306
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 1e-48
Identities = 79/314 (25%), Positives = 126/314 (40%), Gaps = 68/314 (21%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKH 73
+YE +GEG++G V ++ D+G A+K LE +K REI LK LKH
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIAL--REIRMLKQLKH 61
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
PN+V L EV K ++++V EY D+ + + E + + Q + V++CH
Sbjct: 62 PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-----NYV--- 183
HRD+K ENIL+ IK+ DFG + R P + V
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFA------R-------LLTGPSDYYDDEVATR 166
Query: 184 ---APEVL-ANRGYDGATSDIWSCGVILYVILTG--YLPFDDRNLAVLYQKIFR------ 231
+PE+L + Y D+W+ G + +L+G P ++ LY I +
Sbjct: 167 WYRSPELLVGDTQYGPPV-DVWAIGCVFAELLSGVPLWPGKS-DVDQLY-LIRKTLGDLI 223
Query: 232 -------------GDFKLPKW------------LSPGAQNLLRKILEPNPVKRITIAGIK 266
K+P +S A LL+ L +P +R+T +
Sbjct: 224 PRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLL 283
Query: 267 ADEWFEQDYTPANP 280
+FE +
Sbjct: 284 HHPYFENIREIEDL 297
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 7e-48
Identities = 81/312 (25%), Positives = 133/312 (42%), Gaps = 58/312 (18%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKH 73
+YE +GEG++G V ++ D+G A+K LE + +K REI LK L+H
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKI--AMREIKLLKQLRH 83
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
N+V L EV K + Y+V E+V + + L +K Q+I+G+ +CH
Sbjct: 84 ENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELF--PNGLDYQVVQKYLFQIINGIGFCH 141
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV------AP 185
+ + HRD+K ENIL+ G +K+ DFG + + G ++ + V AP
Sbjct: 142 SHNIIHRDIKPENILVSQSGVVKLCDFGFA---RTLAAPGEVYD-----DEVATRWYRAP 193
Query: 186 EVL-ANRGYDGATSDIWSCGVILYVILTG--YLPFDDRNLAVLYQKIFR----------- 231
E+L + Y A D+W+ G ++ + G P D ++ LY I
Sbjct: 194 ELLVGDVKYGKAV-DVWAIGCLVTEMFMGEPLFPGDS-DIDQLY-HIMMCLGNLIPRHQE 250
Query: 232 --------GDFKLPKW------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271
+LP+ LS +L +K L +P KR A + ++F
Sbjct: 251 LFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310
Query: 272 EQDYTPANPDDD 283
+ D +
Sbjct: 311 QMDGFAERFSQE 322
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 1e-47
Identities = 82/296 (27%), Positives = 130/296 (43%), Gaps = 71/296 (23%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK----ITDQIKREIATLKL 70
+YE +GEG +G V A++ ++ A+K + R+ + REI LK
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALK---RVRLDDDDEGVPSS--ALREICLLKE 57
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
LKH N+VRLH+VL S K+ +V E+ + FD G L + QL+ G+
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLG 115
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN------- 181
+CH++ V HRDLK +N+L++ G +K+++FGL+ R G P
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLA------R-------AFGIPVRCYSAEV 162
Query: 182 ----YVAPEVL-ANRGYDGATSDIWSCGVILYVILTGYLPF--DDRNLAVLYQKIFR--- 231
Y P+VL + Y + D+WS G I + P + L +IFR
Sbjct: 163 VTLWYRPPDVLFGAKLYSTSI-DMWSAGCIFAELANAGRPLFPGNDVDDQLK-RIFRLLG 220
Query: 232 --------GDFKLPKW------------------LSPGAQNLLRKILEPNPVKRIT 261
KLP + L+ ++LL+ +L+ NPV+RI+
Sbjct: 221 TPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS 276
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 4e-47
Identities = 76/324 (23%), Positives = 124/324 (38%), Gaps = 74/324 (22%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIATLKL 70
Y LGEG + V + + A+K + I L+ + RE++ LK
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALK---E---IRLEHEEGAPCTAIREVSLLKD 56
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
LKH N+V LH+++ ++ + +V EY+ + D + + QL+ G++
Sbjct: 57 LKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFLFQLLRGLA 114
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN------- 181
YCH + V HRDLK +N+L++ +G +K++DFGL+ R P
Sbjct: 115 YCHRQKVLHRDLKPQNLLINERGELKLADFGLA------R-------AKSIPTKTYDNEV 161
Query: 182 ----YVAPEVL-ANRGYDGATSDIWSCGVILYVILTG--YLPFDDRNLAVLYQKIFR--- 231
Y P++L + Y D+W G I Y + TG P L+ IFR
Sbjct: 162 VTLWYRPPDILLGSTDYSTQI-DMWGVGCIFYEMATGRPLFPGST-VEEQLH-FIFRILG 218
Query: 232 ----------------GDFKLPKW-----------LSPGAQNLLRKILEPNPVKRITIAG 264
+ PK+ L +LL K+L+ RI+
Sbjct: 219 TPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAED 278
Query: 265 IKADEWFEQDYTPANPDDDEEDIF 288
+F + D IF
Sbjct: 279 AMKHPFFLSLGERIHKLPDTTSIF 302
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 6e-47
Identities = 80/323 (24%), Positives = 135/323 (41%), Gaps = 79/323 (24%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIATLKL 70
+++ LG G + V + +G+ A+K + L + REI+ +K
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKE------VKLDSEEGTPSTAIREISLMKE 59
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGG-----ELFDKIASKGRLQEAEGRKLFQQLID 125
LKH N+VRL++V+ +++K+ +V E++ + + L+ + QL+
Sbjct: 60 LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN---- 181
G+++CH + HRDLK +N+L++ +G +K+ DFGL+ R G P
Sbjct: 120 GLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA------R-------AFGIPVNTFS 166
Query: 182 -------YVAPEVL-ANRGYDGATSDIWSCGVILYVILTG--YLPFDDRNLAVLYQKIFR 231
Y AP+VL +R Y + DIWSCG IL ++TG P + + L IF
Sbjct: 167 SEVVTLWYRAPDVLMGSRTYSTSI-DIWSCGCILAEMITGKPLFPGTN-DEEQLK-LIFD 223
Query: 232 -----------GDFKLPKW-----------------------LSPGAQNLLRKILEPNPV 257
KLPK+ L + L +L+ NP
Sbjct: 224 IMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPD 283
Query: 258 KRITIAGIKADEWFEQDYTPANP 280
R++ WF + Y A+
Sbjct: 284 MRLSAKQALHHPWFAEYYHHASM 306
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 8e-47
Identities = 74/250 (29%), Positives = 126/250 (50%), Gaps = 13/250 (5%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+ +G G+FG V A+ G AVKIL + H + ++ RE+A +K L+HPN+
Sbjct: 40 NIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNI 96
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---GVSYCHNK 133
V + + +V EY++ G L+ + G ++ + R+ D G++Y HN+
Sbjct: 97 VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 134 G--VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
+ HR+LK N+L+D K +K+ DFGLS L + G+P ++APEVL +
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS--TFLSSKSAAGTPEWMAPEVLRDE 214
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGD-FKLPKWLSPGAQNLLR 249
+ SD++S GVIL+ + T P+ + N V+ F+ ++P+ L+P ++
Sbjct: 215 PSNEK-SDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIE 273
Query: 250 KILEPNPVKR 259
P KR
Sbjct: 274 GCWTNEPWKR 283
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-46
Identities = 85/318 (26%), Positives = 138/318 (43%), Gaps = 91/318 (28%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK------------ 62
+Y +GEG +G V AQ+ LK +I+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN------------NYGETFALK---KIRLEKEDEGIPSTT 47
Query: 63 -REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKL 119
REI+ LK LKH N+V+L++V+ +K ++ +V E++ +L D +G L+ +
Sbjct: 48 IREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSF 105
Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179
QL++G++YCH++ V HRDLK +N+L++ +G +KI+DFGL+ R G
Sbjct: 106 LLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLA------R-------AFGI 152
Query: 180 PN-----------YVAPEVL-ANRGYDGATSDIWSCGVILYVILTG--YLPFDDRNLAVL 225
P Y AP+VL ++ Y DIWS G I ++ G P L
Sbjct: 153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTI-DIWSVGCIFAEMVNGTPLFPGVS-EADQL 210
Query: 226 YQKIFR-----------GDFKLPKW------------------LSPGAQNLLRKILEPNP 256
+IFR +LPK+ L +LL K+L+ +P
Sbjct: 211 M-RIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDP 269
Query: 257 VKRITIAGIKADEWFEQD 274
+RIT +F+++
Sbjct: 270 NQRITAKQALEHAYFKEN 287
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 4e-46
Identities = 83/306 (27%), Positives = 132/306 (43%), Gaps = 92/306 (30%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK------------ 62
+Y+ +GEG +G V A+D + RI+ LK +I+
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKD------------SQGRIVALK---RIRLDAEDEGIPSTA 66
Query: 63 -REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKL 119
REI+ LK L HPN+V L +V+ S+ + +V E++ ++ D+ K LQ+++ +
Sbjct: 67 IREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDEN--KTGLQDSQIKIY 124
Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179
QL+ GV++CH + HRDLK +N+L++S G +K++DFGL+ R G
Sbjct: 125 LYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLA------R-------AFGI 171
Query: 180 PN-----------YVAPEVL-ANRGYDGATSDIWSCGVILYVILTG--YLPFDDRNLAVL 225
P Y AP+VL ++ Y + DIWS G I ++TG P + L
Sbjct: 172 PVRSYTHEVVTLWYRAPDVLMGSKKYSTSV-DIWSIGCIFAEMITGKPLFPGVT-DDDQL 229
Query: 226 YQKIFR-----------GDFKLP-------------------KWLSPGAQNLLRKILEPN 255
KIF +LP +LL +L +
Sbjct: 230 P-KIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFD 288
Query: 256 PVKRIT 261
P KRI+
Sbjct: 289 PNKRIS 294
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 8e-46
Identities = 62/255 (24%), Positives = 119/255 (46%), Gaps = 20/255 (7%)
Query: 17 ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
+G+ +G G+FG V K+ D+ AVK+L + K E+ L+ +H
Sbjct: 27 TVGQRIGSGSFGTVYKGKWHGDV------AVKMLNVTAP-TPQQLQAFKNEVGVLRKTRH 79
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHN 132
N++ ++ ++ +V ++ G L+ + AS+ + + + + +Q G+ Y H
Sbjct: 80 VNILLFMGY-STAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA 138
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
K + HRDLK NI L +KI DFGL+ + GS ++APEV+ +
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 193 YDGAT--SDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGDFK-----LPKWLSPGA 244
+ + SD+++ G++LY ++TG LP+ + N + + + RG +
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRM 258
Query: 245 QNLLRKILEPNPVKR 259
+ L+ + L+ +R
Sbjct: 259 KRLMAECLKKKRDER 273
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-45
Identities = 87/320 (27%), Positives = 132/320 (41%), Gaps = 76/320 (23%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK----ITDQIKREIAT 67
+ RY LGEG +G+V A D + A+K + R+ H + T I RE++
Sbjct: 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIK---RIRLEHEEEGVPGT-AI-REVSL 86
Query: 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
LK L+H N++ L V+ +++++ EY +L + + + QLI+GV
Sbjct: 87 LKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGV 145
Query: 128 SYCHNKGVFHRDLKLENILLDS-----KGNIKISDFGLSALPQHFRDDGLLHTTCGSPN- 181
++CH++ HRDLK +N+LL +KI DFGL+ R G P
Sbjct: 146 NFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA------R-------AFGIPIR 192
Query: 182 ----------YVAPEVL-ANRGYDGATSDIWSCGVILYVILTG--YLPFDDRNLAVLYQK 228
Y PE+L +R Y + DIWS I +L P D + L+ K
Sbjct: 193 QFTHEIITLWYRPPEILLGSRHYSTSV-DIWSIACIWAEMLMKTPLFPGDS-EIDQLF-K 249
Query: 229 IFR--G--------------DFK--------------LPKWLSPGAQNLLRKILEPNPVK 258
IF G D+K L L +LL +LE +PVK
Sbjct: 250 IFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVK 309
Query: 259 RITIAGIKADEWF-EQDYTP 277
RI+ +F D+ P
Sbjct: 310 RISAKNALEHPYFSHNDFDP 329
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-45
Identities = 73/305 (23%), Positives = 121/305 (39%), Gaps = 45/305 (14%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
E+ +G G FG V A+ A+K +E E+ L + HPN+
Sbjct: 11 EVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNI 63
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---GVSYCHN- 132
V+L A + + +V+EY GG L++ + L + GV+Y H+
Sbjct: 64 VKL--YGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 133 --KGVFHRDLKLENILLDSKGN-IKISDFGLSALPQHFRD-DGLLHTTCGSPNYVAPEVL 188
K + HRDLK N+LL + G +KI DFG + D + GS ++APEV
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTA------CDIQTHMTNNKGSAAWMAPEVF 175
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-----LPKWLSPG 243
Y D++S G+IL+ ++T PFD+ + +I L K L
Sbjct: 176 EGSNYSEK-CDVFSWGIILWEVITRRKPFDE--IGGPAFRIMWAVHNGTRPPLIKNLPKP 232
Query: 244 AQNLLRKILEPNPVKR--------------ITIAGIKADEWFEQDYTPANPDDDEEDIFV 289
++L+ + +P +R G + ++ +D + +V
Sbjct: 233 IESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRVEPYV 292
Query: 290 DNEAF 294
D F
Sbjct: 293 DFAEF 297
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 7e-45
Identities = 86/313 (27%), Positives = 121/313 (38%), Gaps = 72/313 (23%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL----EKNRIIHLKITDQIKREIATLKL 70
RYE +G G +G V A+D SG A+K + L I+ RE+A L+
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPIS--TVREVALLRR 67
Query: 71 LK---HPNVVRLHEVLASKS-----KIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLF 120
L+ HPNVVRL +V A+ K+ +V E+V DK G L + L
Sbjct: 68 LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLM 126
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
+Q + G+ + H + HRDLK ENIL+ S G +K++DFGL+ R
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA------R-------IYSYQ 173
Query: 181 N----------YVAPEVLANRGYDGATSDIWSCGVILYVILTG--YLPFDDRNLAVLYQK 228
Y APEVL Y D+WS G I + + L K
Sbjct: 174 MALTPVVVTLWYRAPEVLLQSTYATPV-DMWSVGCIFAEMFRRKPLFCGNS-EADQLG-K 230
Query: 229 IFR-----------GDFKLPKW----------------LSPGAQNLLRKILEPNPVKRIT 261
IF D LP+ + LL ++L NP KRI+
Sbjct: 231 IFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRIS 290
Query: 262 IAGIKADEWFEQD 274
+ +D
Sbjct: 291 AFRALQHSYLHKD 303
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-44
Identities = 69/255 (27%), Positives = 119/255 (46%), Gaps = 15/255 (5%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
RY++ LG G V A+D + A+K + + + +RE+ L H
Sbjct: 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
N+V + +V Y+V+EY+ G L + I S G L Q++DG+ + H+
Sbjct: 71 QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM 130
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTC--GSPNYVAPEVLAN 190
+ HRD+K +NIL+DS +KI DFG++ AL + L T G+ Y +PE A
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKAL----SETSLTQTNHVLGTVQYFSPE-QAK 185
Query: 191 RGYDGATSDIWSCGVILYVILTGYLPFD-DRNLAVLYQKIFRGDF-----KLPKWLSPGA 244
+DI+S G++LY +L G PF+ + +++ + I + + K +
Sbjct: 186 GEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHI-QDSVPNVTTDVRKDIPQSL 244
Query: 245 QNLLRKILEPNPVKR 259
N++ + E + R
Sbjct: 245 SNVILRATEKDKANR 259
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 1e-43
Identities = 78/281 (27%), Positives = 120/281 (42%), Gaps = 18/281 (6%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD----QIKREIATLKLL 71
+E LG GN G V SGL A K+ IHL+I QI RE+ L
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKL------IHLEIKPAIRNQIIRELQVLHEC 88
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
P +V + S +I + +E++ GG L + GR+ E K+ +I G++Y
Sbjct: 89 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 148
Query: 132 NKG-VFHRDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVLA 189
K + HRD+K NIL++S+G IK+ DFG+S L D + ++ G+ +Y++PE L
Sbjct: 149 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-----IDSMANSFVGTRSYMSPERLQ 203
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLR 249
Y SDIWS G+ L + G P + L P + R
Sbjct: 204 GTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262
Query: 250 KILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVD 290
+ + R +A + ++ + P P F D
Sbjct: 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQD 303
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 2e-43
Identities = 66/263 (25%), Positives = 115/263 (43%), Gaps = 21/263 (7%)
Query: 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI-----K 62
+EG + G Y L R +G G G V A+D A+K++ + L +D + +
Sbjct: 28 REGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSE----TLS-SDPVFRTRMQ 82
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
RE T L+ P+VV +H+ ++Y+ + + G +L + +G L + +Q
Sbjct: 83 REARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQ 142
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHT--TCGSP 180
+ + H G HRD+K ENIL+ + + DFG++ D+ L T G+
Sbjct: 143 IGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIA---SATTDEKLTQLGNTVGTL 199
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK-- 238
Y+APE + +DI++ +LY LTG P+ L+V+ I P
Sbjct: 200 YYMAPERFSESHATYR-ADIYALTCVLYECLTGSPPYQGDQLSVMGAHI-NQAIPRPSTV 257
Query: 239 --WLSPGAQNLLRKILEPNPVKR 259
+ ++ + + NP R
Sbjct: 258 RPGIPVAFDAVIARGMAKNPEDR 280
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-43
Identities = 81/331 (24%), Positives = 134/331 (40%), Gaps = 79/331 (23%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK----ITDQIKREIAT 67
+ +YE +G+G FG+V A+ +G A+K K + + K IT REI
Sbjct: 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK---KVLMENEKEGFPITAL--REIKI 69
Query: 68 LKLLKHPNVVRLHEVLASKS--------KIYMVLEYV----TGGELFDKIASKGRLQEAE 115
L+LLKH NVV L E+ +K+ IY+V ++ G L + + +E
Sbjct: 70 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNV--LVKFTLSE 125
Query: 116 GRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLH 174
+++ Q L++G+ Y H + HRD+K N+L+ G +K++DFGL+ A +
Sbjct: 126 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185
Query: 175 TTCGSPN------YVAPEVL-ANRGYDGATSDIWSCGVILYVILTG--YLPFDDRNLAVL 225
T N Y PE+L R Y D+W G I+ + T + +
Sbjct: 186 T-----NRVVTLWYRPPELLLGERDYGPPI-DLWGAGCIMAEMWTRSPIMQGNT----EQ 235
Query: 226 YQ--KIFR-------------------GDFKLPKW-------------LSPGAQNLLRKI 251
+Q I + +L K P A +L+ K+
Sbjct: 236 HQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKL 295
Query: 252 LEPNPVKRITIAGIKADEWFEQDYTPANPDD 282
L +P +RI ++F D P++
Sbjct: 296 LVLDPAQRIDSDDALNHDFFWSDPMPSDLKG 326
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 3e-43
Identities = 63/262 (24%), Positives = 108/262 (41%), Gaps = 26/262 (9%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
G LG+G FG+ ++G +K L + + +E+ ++ L+HPNV
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLEHPNV 69
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLID---GVSYCHN 132
++ VL ++ + EY+ GG L I S + D G++Y H+
Sbjct: 70 LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPW---SQRVSFAKDIASGMAYLHS 126
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQH------------FRDDGLLHTTCGSP 180
+ HRDL N L+ N+ ++DFGL+ L D +T G+P
Sbjct: 127 MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGDFKL--P 237
++APE++ R YD D++S G++L I+ D + + RG P
Sbjct: 187 YWMAPEMINGRSYDEK-VDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCP 245
Query: 238 KWLSPGAQNLLRKILEPNPVKR 259
P + + + +P KR
Sbjct: 246 PNCPPSFFPITVRCCDLDPEKR 267
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 3e-43
Identities = 84/309 (27%), Positives = 124/309 (40%), Gaps = 92/309 (29%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK------------ 62
+YE +GEG +GKV A+DL +G R + LK +++
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNG----------GRFVALK---RVRVQTGEEGMPLST 58
Query: 63 -REIATLKLLK---HPNVVRLHEVL-----ASKSKIYMVLEYVTG--GELFDKIASKGRL 111
RE+A L+ L+ HPNVVRL +V ++K+ +V E+V DK+ G +
Sbjct: 59 IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG-V 117
Query: 112 QEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171
+ + QL+ G+ + H+ V HRDLK +NIL+ S G IK++DFGL+ R
Sbjct: 118 PTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA------R--- 168
Query: 172 LLHTTCGSPN----------YVAPEVLANRGYDGATSDIWSCGVILYVILTG--YLPFDD 219
Y APEVL Y D+WS G I +
Sbjct: 169 ----IYSFQMALTSVVVTLWYRAPEVLLQSSYATPV-DLWSVGCIFAEMFRRKPLFRGSS 223
Query: 220 RNLAVLYQKIFR-----------GDFKLPKW----------------LSPGAQNLLRKIL 252
++ L KI D LP+ + ++LL K L
Sbjct: 224 -DVDQLG-KILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCL 281
Query: 253 EPNPVKRIT 261
NP KRI+
Sbjct: 282 TFNPAKRIS 290
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 5e-43
Identities = 52/259 (20%), Positives = 99/259 (38%), Gaps = 32/259 (12%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
L E + G++ G VK+L K R + + E L++ HPNV
Sbjct: 13 NFLTKLNENHSGELWKG--RWQGNDIVVKVL-KVRDWSTRKSRDFNEECPRLRIFSHPNV 69
Query: 77 VRLHEVLAS--KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------G 126
+ + S ++ ++ G L++ L E + Q + G
Sbjct: 70 LPVLGACQSPPAPHPTLITHWMPYGSLYN------VLHEGTNFVVDQSQAVKFALDMARG 123
Query: 127 VSYCHNKG--VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
+++ H + L ++++D +IS + +P +VA
Sbjct: 124 MAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK----FSFQSP---GRMYAPAWVA 176
Query: 185 PEVLANRGYDGAT--SDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGD-FKLPKWL 240
PE L + D +D+WS V+L+ ++T +PF D N+ + + G +P +
Sbjct: 177 PEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGI 236
Query: 241 SPGAQNLLRKILEPNPVKR 259
SP L++ + +P KR
Sbjct: 237 SPHVSKLMKICMNEDPAKR 255
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 7e-43
Identities = 67/248 (27%), Positives = 118/248 (47%), Gaps = 11/248 (4%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLKLLK 72
+ +G+G+FG+V D + A+KI LE+ +I D I++EI L
Sbjct: 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA---EDEIED-IQQEITVLSQCD 78
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
P V + + +K+++++EY+ GG D + G L E + + ++++ G+ Y H+
Sbjct: 79 SPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHS 137
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
+ HRD+K N+LL G +K++DFG++ Q +T G+P ++APEV+
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVIKQSA 195
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 251
YD +DIWS G+ + G P + + + VL+ L S + +
Sbjct: 196 YDSK-ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEAC 254
Query: 252 LEPNPVKR 259
L P R
Sbjct: 255 LNKEPSFR 262
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 8e-43
Identities = 66/263 (25%), Positives = 116/263 (44%), Gaps = 30/263 (11%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL----EKNRIIHLKITDQIKREIATLKLLK 72
E + +G+G FG V + + A+K L + ++ + +RE+ + L
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---GVSY 129
HPN+V+L + MV+E+V G+L+ ++ K + + ++D G+ Y
Sbjct: 82 HPNIVKL--YGLMHNPPRMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEY 137
Query: 130 CHNKG--VFHRDLKLENILLDSKG-----NIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
N+ + HRDL+ NI L S K++DFGLS + G+ +
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGLLGNFQW 192
Query: 183 VAPEVLANRG--YDGATSDIWSCGVILYVILTGYLPFDDRN---LAVLYQKIFRGD-FKL 236
+APE + Y +D +S +ILY ILTG PFD+ + + + G +
Sbjct: 193 MAPETIGAEEESYTEK-ADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTI 251
Query: 237 PKWLSPGAQNLLRKILEPNPVKR 259
P+ P +N++ +P KR
Sbjct: 252 PEDCPPRLRNVIELCWSGDPKKR 274
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 1e-42
Identities = 79/269 (29%), Positives = 121/269 (44%), Gaps = 25/269 (9%)
Query: 8 QEGMRL-GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI----- 61
L RYELG LG G +V A+DL AVK+L L D
Sbjct: 5 TTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRA----DLA-RDPSFYLRF 59
Query: 62 KREIATLKLLKHPNVVRLHEV----LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR 117
+RE L HP +V +++ + Y+V+EYV G L D + ++G +
Sbjct: 60 RREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI 119
Query: 118 KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC 177
++ +++ H G+ HRD+K NI++ + +K+ DFG+ A + + T
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGI-ARAIADSGNSVTQTAA 178
Query: 178 --GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD-DRNLAVLYQKIFRGDF 234
G+ Y++PE A A SD++S G +LY +LTG PF D ++V YQ + R D
Sbjct: 179 VIGTAQYLSPE-QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV-REDP 236
Query: 235 KLPK----WLSPGAQNLLRKILEPNPVKR 259
P LS ++ K L NP R
Sbjct: 237 IPPSARHEGLSADLDAVVLKALAKNPENR 265
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-42
Identities = 72/257 (28%), Positives = 115/257 (44%), Gaps = 22/257 (8%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL-KITDQIKREIATLKLLKHPN 75
L +G G FGKV A G AVK + + + + +++E +LKHPN
Sbjct: 10 TLEEIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG- 134
++ L V + + +V+E+ GG L ++ K R+ Q+ G++Y H++
Sbjct: 68 IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 135 --VFHRDLKLENILLDSKG--------NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
+ HRDLK NIL+ K +KI+DFGL+ + G+ ++A
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA----REWHRTTKMSAAGAYAWMA 182
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGD-FKLPKWLSP 242
PEV+ + SD+WS GV+L+ +LTG +PF LAV Y +P
Sbjct: 183 PEVIRASMFSKG-SDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPE 241
Query: 243 GAQNLLRKILEPNPVKR 259
L+ P+P R
Sbjct: 242 PFAKLMEDCWNPDPHSR 258
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 3e-42
Identities = 58/260 (22%), Positives = 110/260 (42%), Gaps = 25/260 (9%)
Query: 17 ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
E+G +G+G FG+V ++ ++ A+++++ R KRE+ + +H
Sbjct: 36 EIGELIGKGRFGQVYHGRWHGEV------AIRLIDIERDNE-DQLKAFKREVMAYRQTRH 88
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHN 132
NVV S + ++ G L+ + K L + R++ Q+++ G+ Y H
Sbjct: 89 ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA 148
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
KG+ H+DLK +N+ D G + I+DFGL + Q R + L G ++APE++
Sbjct: 149 KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207
Query: 190 NRGYDGAT--------SDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL--PKW 239
D SD+++ G I Y + PF + + ++ G
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIG 267
Query: 240 LSPGAQNLLRKILEPNPVKR 259
+ ++L +R
Sbjct: 268 MGKEISDILLFCWAFEQEER 287
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-40
Identities = 72/255 (28%), Positives = 131/255 (51%), Gaps = 17/255 (6%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+E+ LG+G FGKV A++ ++G A K++E ++ D EI L HP
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELED-YIVEIEILATCDHP 76
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
+V+L K+++++E+ GG + + L E + + + +Q+++ +++ H+K
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR-- 191
+ HRDLK N+L+ +G+I+++DFG+SA ++ + + G+P ++APEV+
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSA--KNLKTLQKRDSFIGTPYWMAPEVVMCETM 194
Query: 192 ---GYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGD---FKLPKWLSPGA 244
YD +DIWS G+ L + P + N + VL KI + D P S
Sbjct: 195 KDTPYDYK-ADIWSLGITLIEMAQIEPPHHELNPMRVLL-KIAKSDPPTLLTPSKWSVEF 252
Query: 245 QNLLRKILEPNPVKR 259
++ L+ L+ NP R
Sbjct: 253 RDFLKIALDKNPETR 267
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 4e-40
Identities = 68/252 (26%), Positives = 126/252 (50%), Gaps = 14/252 (5%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+++ LGEG++G V A ++G A+K + + +I +EI+ ++ P
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL-----QEIIKEISIMQQCDSP 84
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
+VV+ + + +++V+EY G + D I L E E + Q + G+ Y H
Sbjct: 85 HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM 144
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 193
HRD+K NILL+++G+ K++DFG++ Q +T G+P ++APEV+ GY
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAG--QLTDTMAKRNTVIGTPFWMAPEVIQEIGY 202
Query: 194 DGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGD---FKLPKWLSPGAQNLLR 249
+ +DIWS G+ + G P+ D + + ++ I F+ P+ S + ++
Sbjct: 203 NCV-ADIWSLGITAIEMAEGKPPYADIHPMRAIF-MIPTNPPPTFRKPELWSDNFTDFVK 260
Query: 250 KILEPNPVKRIT 261
+ L +P +R T
Sbjct: 261 QCLVKSPEQRAT 272
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 4e-40
Identities = 71/252 (28%), Positives = 129/252 (51%), Gaps = 14/252 (5%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLKLLK 72
+Y +G+G G V A D+ +G A++ L++ L I EI ++ K
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-----IINEILVMRENK 75
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
+PN+V + ++++V+EY+ GG L D + ++ + E + + ++ + + + H+
Sbjct: 76 NPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHS 134
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
V HRD+K +NILL G++K++DFG A Q + T G+P ++APEV+ +
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRG--DFKLPKWLSPGAQNLLR 249
Y DIWS G++ ++ G P+ + N L LY G + + P+ LS ++ L
Sbjct: 193 YGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251
Query: 250 KILEPNPVKRIT 261
+ LE + KR +
Sbjct: 252 RCLEMDVEKRGS 263
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 6e-40
Identities = 71/253 (28%), Positives = 133/253 (52%), Gaps = 16/253 (6%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLKLLK 72
+ +GEG+ G V A++ SG AVK+ L K + L + E+ ++ +
Sbjct: 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRREL-----LFNEVVIMRDYQ 100
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
H NVV +++ ++++++E++ GG L D I S+ RL E + + + ++ ++Y H
Sbjct: 101 HFNVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHA 159
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
+GV HRD+K ++ILL G +K+SDFG A Q +D + G+P ++APEV++
Sbjct: 160 QGVIHRDIKSDSILLTLDGRVKLSDFGFCA--QISKDVPKRKSLVGTPYWMAPEVISRSL 217
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGD---FKLPKWLSPGAQNLL 248
Y DIWS G+++ ++ G P+ + + + ++ K +SP ++ L
Sbjct: 218 YA-TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK-RLRDSPPPKLKNSHKVSPVLRDFL 275
Query: 249 RKILEPNPVKRIT 261
++L +P +R T
Sbjct: 276 ERMLVRDPQERAT 288
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-39
Identities = 61/255 (23%), Positives = 109/255 (42%), Gaps = 17/255 (6%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHP 74
E +G G G+V + +G AVK + ++ + + +I ++ + K P
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS--GNKEENKRILMDLDVVLKSHDCP 84
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK- 133
+V+ + + +++ +E + K +G + E K+ ++ + Y K
Sbjct: 85 YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH 144
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 193
GV HRD+K NILLD +G IK+ DFG+S DD + G Y+APE +
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGISG---RLVDDKAKDRSAGCAAYMAPERIDPPDP 201
Query: 194 DGAT----SDIWSCGVILYVILTGYLPFDDRN--LAVLYQKIFRGD---FKLPKWLSPGA 244
+D+WS G+ L + TG P+ + VL K+ + + S
Sbjct: 202 TKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVL-TKVLQEEPPLLPGHMGFSGDF 260
Query: 245 QNLLRKILEPNPVKR 259
Q+ ++ L + KR
Sbjct: 261 QSFVKDCLTKDHRKR 275
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-39
Identities = 75/270 (27%), Positives = 121/270 (44%), Gaps = 31/270 (11%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLKLLK 72
YEL +G G V+ A A+K LEK + D++ +EI +
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ----TSMDELLKEIQAMSQCH 71
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI-------- 124
HPN+V + K ++++V++ ++GG + D I E + L + I
Sbjct: 72 HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL---HTTCGSPN 181
+G+ Y H G HRD+K NILL G+++I+DFG+SA D T G+P
Sbjct: 132 EGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 182 YVAPEVLA-NRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLY----------QKI 229
++APEV+ RGYD +DIWS G+ + TG P+ + VL +
Sbjct: 192 WMAPEVMEQVRGYD-FKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETG 250
Query: 230 FRGDFKLPKWLSPGAQNLLRKILEPNPVKR 259
+ L K+ + ++ L+ +P KR
Sbjct: 251 VQDKEMLKKY-GKSFRKMISLCLQKDPEKR 279
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 4e-39
Identities = 94/371 (25%), Positives = 136/371 (36%), Gaps = 98/371 (26%)
Query: 15 RYE-LGRTLGEGNFGKVKFAQDLD--SGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
+E G +G G +G V A+ D +A+K +E I REIA L+ L
Sbjct: 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC-----REIALLREL 75
Query: 72 KHPNVVRLHEVLASKS--KIYMVLEYV--------TGGELFDKIASKGRLQEAEGRKLFQ 121
KHPNV+ L +V S + K++++ +Y +L + L
Sbjct: 76 KHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLY 135
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDS----KGNIKISDFGLSALPQHFRDDGLLHTTC 177
Q++DG+ Y H V HRDLK NIL+ +G +KI+D G + R
Sbjct: 136 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA------R-------LF 182
Query: 178 GSPN--------------YVAPEVL-ANRGYDGATSDIWSCGVILYVILTGYLPF----D 218
SP Y APE+L R Y A DIW+ G I +LT F +
Sbjct: 183 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAI-DIWAIGCIFAELLTSEPIFHCRQE 241
Query: 219 DRNLAVLYQ-----KIFR-----------GDFKLPKW----------------------- 239
D + Y +IF K+P+
Sbjct: 242 DIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEK 301
Query: 240 ----LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFS 295
A +LL+K+L +P+KRIT D +F +D P + I F
Sbjct: 302 HKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFAGCQIPYPKREFL 361
Query: 296 MHEVPSDGGRT 306
E P D G
Sbjct: 362 TEEEPDDKGDK 372
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-38
Identities = 54/230 (23%), Positives = 101/230 (43%), Gaps = 18/230 (7%)
Query: 14 GRYELGRTLGEG--NFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLK 69
G YEL +G+G + V A+ +G V+ LE + ++ E+ K
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMV---TFLQGELHVSK 81
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGV 127
L HPN+V + +++++V ++ G D + E + Q ++ +
Sbjct: 82 LFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKAL 141
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTC----GSPNY 182
Y H+ G HR +K +IL+ G + +S + + H + ++H +
Sbjct: 142 DYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201
Query: 183 VAPEVLA--NRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKI 229
++PEVL +GYD SDI+S G+ + G++PF D +L +K+
Sbjct: 202 LSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKDMPATQMLLEKL 250
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-38
Identities = 67/253 (26%), Positives = 117/253 (46%), Gaps = 18/253 (7%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+ R +G G+FG V FA+D+ + A+K + + + I +E+ L+ L+HP
Sbjct: 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 114
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N ++ + ++V+EY G K LQE E + + G++Y H+
Sbjct: 115 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 174
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVLANR-- 191
+ HRD+K NILL G +K+ DFG ++ + ++ G+P ++APEV+
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-------NSFVGTPYWMAPEVILAMDE 227
Query: 192 -GYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGD---FKLPKWLSPGAQN 246
YDG D+WS G+ + P + N ++ LY I + + + W S +N
Sbjct: 228 GQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNESPALQSGHW-SEYFRN 284
Query: 247 LLRKILEPNPVKR 259
+ L+ P R
Sbjct: 285 FVDSCLQKIPQDR 297
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-37
Identities = 74/264 (28%), Positives = 126/264 (47%), Gaps = 27/264 (10%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK-LLK 72
G +EL +G G +G+V + + +G A+K+++ + + + IK+EI LK
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEE-IKQEINMLKKYSH 79
Query: 73 HPNVVRLHE------VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLI 124
H N+ + ++++V+E+ G + D K L+E + ++++
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
G+S+ H V HRD+K +N+LL +K+ DFG+SA Q R G +T G+P ++A
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMA 197
Query: 185 PEVLANR-----GYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGD---FK 235
PEV+A YD SD+WS G+ + G P D + + L+ I R K
Sbjct: 198 PEVIACDENPDATYDFK-SDLWSLGITAIEMAEGAPPLCDMHPMRALF-LIPRNPAPRLK 255
Query: 236 LPKWLSPGAQNLLRKILEPNPVKR 259
KW S Q+ + L N +R
Sbjct: 256 SKKW-SKKFQSFIESCLVKNHSQR 278
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-37
Identities = 67/268 (25%), Positives = 111/268 (41%), Gaps = 38/268 (14%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD----QIKREIAT-LKL 70
+ +G G +G V SG AVK I + + Q+ ++ ++
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKR------IRSTVDEKEQKQLLMDLDVVMRS 77
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI------ASKGRLQEAEGRKLFQQLI 124
P +V+ + L + ++ +E ++ FDK + E K+ +
Sbjct: 78 SDCPYIVQFYGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATV 135
Query: 125 DGVSYCHNKG-VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
+++ + HRD+K NILLD GNIK+ DFG+S D G Y+
Sbjct: 136 KALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSIAKTRDAGCRPYM 192
Query: 184 APEVLA----NRGYDGATSDIWSCGVILYVILTGYLPFDDRN--LAVLYQKIFRGD-FKL 236
APE + +GYD SD+WS G+ LY + TG P+ N L ++ +GD +L
Sbjct: 193 APERIDPSASRQGYD-VRSDVWSLGITLYELATGRFPYPKWNSVFDQL-TQVVKGDPPQL 250
Query: 237 P-----KWLSPGAQNLLRKILEPNPVKR 259
++ SP N + L + KR
Sbjct: 251 SNSEEREF-SPSFINFVNLCLTKDESKR 277
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 8e-37
Identities = 63/277 (22%), Positives = 114/277 (41%), Gaps = 32/277 (11%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD----QIKREIA-TLKL 70
E LG G +G V+ + + SG AVK I + ++ ++ +++
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKR------IRATVNSQEQKRLLMDLDISMRT 62
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-----ASKGRLQEAEGRKLFQQLID 125
+ P V + L + +++ +E + DK + E K+ ++
Sbjct: 63 VDCPFTVTFYGALFREGDVWICMELMDTS--LDKFYKQVIDKGQTIPEDILGKIAVSIVK 120
Query: 126 GVSYCHNKG-VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
+ + H+K V HRD+K N+L+++ G +K+ DFG+S + DD G Y+A
Sbjct: 121 ALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISG---YLVDDVAKDIDAGCKPYMA 177
Query: 185 PEVLANR----GYDGATSDIWSCGVILYVILTGYLPFDDRN--LAVLYQKIFRGDFKLP- 237
PE + GY SDIWS G+ + + P+D L Q + +LP
Sbjct: 178 PERINPELNQKGYS-VKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPA 236
Query: 238 -KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273
K+ S + + L+ N +R T + +F
Sbjct: 237 DKF-SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 2e-36
Identities = 63/265 (23%), Positives = 108/265 (40%), Gaps = 38/265 (14%)
Query: 8 QEGMRL-GRYELGRTLGEGNFGKVKFAQDLD-SGLPFAVKILEKNRIIHLKITDQI---- 61
G + G+YE+ + G G + A D + +G P +K L + D
Sbjct: 73 NPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-------DAEAQAM 125
Query: 62 -KREIATLKLLKHPNVVRLHEV-----LASKSKIYMVLEYVTGGELFDKIASKGRLQEAE 115
E L + HP++V++ Y+V+EYV G L +L AE
Sbjct: 126 AMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAE 183
Query: 116 GRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGL-SALPQHFRDDGLLH 174
+++ +SY H+ G+ + DLK ENI+L + +K+ D G S + G L
Sbjct: 184 AIAYLLEILPALSYLHSIGLVYNDLKPENIMLT-EEQLKLIDLGAVSRINS----FGYL- 237
Query: 175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF 234
G+P + APE++ R +DI++ G L + + R + L +
Sbjct: 238 --YGTPGFQAPEIV--RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDD----- 288
Query: 235 KLPKWLSPGAQNLLRKILEPNPVKR 259
LLR+ ++P+P +R
Sbjct: 289 -PVLKTYDSYGRLLRRAIDPDPRQR 312
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 84/353 (23%), Positives = 131/353 (37%), Gaps = 100/353 (28%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKH 73
Y + +G G+FG V A+ DSG A+K +L+ R + RE+ ++ L H
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDH 106
Query: 74 PNVVRLHEVLASKS------KIYMVLEYVTG---GELFDKIASKGRLQEAEGRKLFQQLI 124
N+VRL S + +VL+YV +K L + QL
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGLSALPQHFRDDGLLHTTCGSPN-- 181
++Y H+ G+ HRD+K +N+LLD +K+ DFG + G PN
Sbjct: 167 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA-----------KQLVRGEPNVS 215
Query: 182 YV------APEVLAN-RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD- 233
Y+ APE++ Y + D+WS G +L +L G Q IF GD
Sbjct: 216 YICSRYYRAPELIFGATDYTSSI-DVWSAGCVLAELLLG-------------QPIFPGDS 261
Query: 234 -----------------------------FKLPKW------------LSPGAQNLLRKIL 252
FK P+ P A L ++L
Sbjct: 262 GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLL 321
Query: 253 EPNPVKRITIAGIKADEWFEQDYTPAN--PDDDEEDIFVDNEAFSMHEVPSDG 303
E P R+T A +F++ P P+ + + F+ E+ S+
Sbjct: 322 EYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFN---FTTQELSSNP 371
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 7e-35
Identities = 72/237 (30%), Positives = 106/237 (44%), Gaps = 26/237 (10%)
Query: 17 ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
L LG+G+FG V ++ + AVK L+ + + + D RE+ + L H
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------G 126
N++RL+ V + MV E G L D RL++ +G L L G
Sbjct: 81 RNLIRLYGV-VLTPPMKMVTELAPLGSLLD------RLRKHQGHFLLGTLSRYAVQVAEG 133
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYV-- 183
+ Y +K HRDL N+LL ++ +KI DFGL ALPQ +D
Sbjct: 134 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ---NDDHYVMQEHRKVPFAW 190
Query: 184 -APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
APE L R + A SD W GV L+ + T G P+ N + + KI + +LP+
Sbjct: 191 CAPESLKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR 246
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-34
Identities = 73/310 (23%), Positives = 126/310 (40%), Gaps = 74/310 (23%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVK--ILEKNRIIHLKITDQIKREIATLKLLK 72
Y + +G G+FG V A+ ++S A+K + +K RE+ ++++K
Sbjct: 41 AYTNCKVIGNGSFGVVFQAKLVESD-EVAIKKVLQDKRFKN---------RELQIMRIVK 90
Query: 73 HPNVVRLHEVLASKS------KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ----Q 122
HPNVV L S + +VLEYV ++ +L++ L + Q
Sbjct: 91 HPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQ 149
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDS-KGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
L+ ++Y H+ G+ HRD+K +N+LLD G +K+ DFG + G PN
Sbjct: 150 LLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSA-----------KILIAGEPN 198
Query: 182 --YV------APEVLAN-RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR- 231
Y+ APE++ Y DIWS G ++ ++ G F + +I +
Sbjct: 199 VSYICSRYYRAPELIFGATNYTTNI-DIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKV 257
Query: 232 ----------------GDFKLPKW------------LSPGAQNLLRKILEPNPVKRITIA 263
+ K P+ P A +L+ ++LE P R+T
Sbjct: 258 LGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAI 317
Query: 264 GIKADEWFEQ 273
+F++
Sbjct: 318 EALCHPFFDE 327
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-34
Identities = 38/260 (14%), Positives = 75/260 (28%), Gaps = 43/260 (16%)
Query: 10 GMRL--GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
G R+ GRY L G + A D A+ ++ ++ + +
Sbjct: 25 GARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLR 84
Query: 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
L + P V R+ +V+ +++ +V E++ GG L + + Q L
Sbjct: 85 LSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVAD--TSPSPVGAIRAMQSLAAAA 142
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
H GV + + G++ ++ +
Sbjct: 143 DAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPDA- 179
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN----LAVLYQKIFRGDFKLPKWLSPG 243
DI G LY +L P + LA + G P +
Sbjct: 180 -------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDT-AGQPIEPADIDRD 231
Query: 244 A----QNLLRKILEPNPVKR 259
+ + ++ + R
Sbjct: 232 IPFQISAVAARSVQGDGGIR 251
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-33
Identities = 80/344 (23%), Positives = 130/344 (37%), Gaps = 75/344 (21%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
RY+ + +G G G V A D A+K L + H K + RE+ +K +
Sbjct: 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK---RAYRELVLMKCVN 82
Query: 73 HPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
H N++ L V + +Y+V+E + L I + L L Q++ G
Sbjct: 83 HKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVI--QMELDHERMSYLLYQMLCG 139
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV--- 183
+ + H+ G+ HRDLK NI++ S +KI DFGL+ R G YV
Sbjct: 140 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTP---YVVTR 190
Query: 184 ---APEVLANRGYDGATSDIWSCGVILYVILTG--------------------------- 213
APEV+ GY DIWS G I+ ++ G
Sbjct: 191 YYRAPEVILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 249
Query: 214 ----------YL----PFDDRNLAVLYQK-IFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258
Y+ + + L+ +F D + K + A++LL K+L + K
Sbjct: 250 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASK 309
Query: 259 RITIAGIKADEWFEQDYTPANPDDDEEDIF---VDNEAFSMHEV 299
RI++ + Y P+ + I +D ++ E
Sbjct: 310 RISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEW 353
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-33
Identities = 63/293 (21%), Positives = 112/293 (38%), Gaps = 52/293 (17%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
L +G+G +G+V G AVKI + + + E+ +L+H N+
Sbjct: 11 TLLECVGKGRYGEVWRGSW--QGENVAVKIFSS----RDEKSWFRETELYNTVMLRHENI 64
Query: 77 VRL----HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
+ S ++++++ Y G L+D + L ++ + G+++ H
Sbjct: 65 LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHI 123
Query: 133 K--------GVFHRDLKLENILLDSKGNIKISDFGLSAL--PQHFRDDGLLHTTCGSPNY 182
+ + HRDLK +NIL+ G I+D GL+ + + D + G+ Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 183 VAPEVLANRGYDGAT-----SDIWSCGVILYVILTGY----------LPFDDRN------ 221
+APEVL DIW+ G++L+ + PF D
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243
Query: 222 ----LAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE----PNPVKRITIAGIK 266
V + R + +W S L K+++ NP R+T IK
Sbjct: 244 EDMRKVVCVDQQ-RPNIP-NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294
|
| >2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} Length = 143 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-33
Identities = 40/132 (30%), Positives = 69/132 (52%), Gaps = 12/132 (9%)
Query: 308 GSPPLINAFQLIGMSSCLDLSGFFEKE-DVSERKIRFTSNHSAKDLLERIEDIVTEMGFR 366
P ++NAF++I +S L+LS F++ D +R+ RF S +++ IE + MGF+
Sbjct: 2 EGPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFK 61
Query: 367 VQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQIKTSIVF 426
+N K + E G L+V E++E++PSL++V++RK+ G+ Y
Sbjct: 62 SHTRNFKTR--LEGLSSIKAGQLAVVIEIYEVAPSLFMVDVRKAAGETLEYH-------- 111
Query: 427 VQLCNKLSSDLG 438
+ KL S L
Sbjct: 112 -KFYKKLCSKLE 122
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-33
Identities = 82/344 (23%), Positives = 132/344 (38%), Gaps = 75/344 (21%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
RY+ + +G G G V A D A+K L + H K + RE+ +K +
Sbjct: 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---RAYRELVLMKCVN 119
Query: 73 HPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
H N++ L V + +Y+V+E + L I + L L Q++ G
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI--QMELDHERMSYLLYQMLCG 176
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV--- 183
+ + H+ G+ HRDLK NI++ S +KI DFGL+ R G T+ YV
Sbjct: 177 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAG---TSFMMTPYVVTR 227
Query: 184 ---APEVLANRGYDGATSDIWSCGVILYVILTG--------------------------- 213
APEV+ GY DIWS G I+ ++
Sbjct: 228 YYRAPEVILGMGYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 286
Query: 214 ----------YL----PFDDRNLAVLYQK-IFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258
Y+ + L+ +F D + K + A++LL K+L +P K
Sbjct: 287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 346
Query: 259 RITIAGIKADEWFEQDYTPANPDDDEEDIF---VDNEAFSMHEV 299
RI++ + Y PA + I+ +D ++ E
Sbjct: 347 RISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEW 390
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 8e-33
Identities = 66/291 (22%), Positives = 120/291 (41%), Gaps = 58/291 (19%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-H 73
Y+L R LG G + +V A ++ + VKI + +IKREI L+ L+
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKI------LKPVKKKKIKREIKILENLRGG 90
Query: 74 PNVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
PN++ L +++ +V E+V + + L + + R +++ + YCH
Sbjct: 91 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCH 147
Query: 132 NKGVFHRDLKLENILLDSK-GNIKISDFGLSALPQHFRDDGLLHTT-CGSPNYVAPEVLA 189
+ G+ HRD+K N+++D + +++ D+GL+ F G + S + PE+L
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA----EFYHPGQEYNVRVASRYFKGPELLV 203
Query: 190 N-RGYDGATSDIWSCGVILYVILTGYLPF--------------------DDRNLAVLYQK 228
+ + YD + D+WS G +L ++ PF D + Y
Sbjct: 204 DYQMYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262
Query: 229 IFRGDFK--LPKW----------------LSPGAQNLLRKILEPNPVKRIT 261
F L + +SP A + L K+L + R+T
Sbjct: 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT 313
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 8e-33
Identities = 79/340 (23%), Positives = 127/340 (37%), Gaps = 63/340 (18%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD--QIKREIATLKLLK 72
++L LGEG +G V A +G A+K K K + REI LK K
Sbjct: 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIK---KIEPFD-KPLFALRTLREIKILKHFK 67
Query: 73 HPNVVRLHEVLASKSK-----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
H N++ + + S +Y++ E + +L ++ S L + + Q + V
Sbjct: 68 HENIITIFNIQRPDSFENFNEVYIIQELM-QTDL-HRVISTQMLSDDHIQYFIYQTLRAV 125
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGL--SALPQHFRDDGLLHTTCGSPNYV-- 183
H V HRDLK N+L++S ++K+ DFGL + G +V
Sbjct: 126 KVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185
Query: 184 ----APEV-LANRGYDGATSDIWSCGVILYVILTG--------YL------------PFD 218
APEV L + Y A D+WSCG IL + Y P
Sbjct: 186 RWYRAPEVMLTSAKYSRAM-DVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244
Query: 219 DRNLAVL-----------YQKIFRGDFK--LPKWLSPGAQNLLRKILEPNPVKRITIAGI 265
D +L + + P+ ++P +LL+++L +P KRIT
Sbjct: 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPR-VNPKGIDLLQRMLVFDPAKRITAKEA 303
Query: 266 KADEWFEQDYTP-----ANPDDDEEDIF-VDNEAFSMHEV 299
+ + + P P F EA + ++
Sbjct: 304 LEHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDL 343
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 9e-33
Identities = 73/260 (28%), Positives = 113/260 (43%), Gaps = 20/260 (7%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
LG +G GNFG+V + AVK + LK + +E LK HPN+
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKA--KFLQEARILKQYSHPNI 174
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF-QQLIDGVSYCHNKGV 135
VRL V K IY+V+E V GG+ + ++G + G+ Y +K
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC 234
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGSPNY----VAPEVLA 189
HRDL N L+ K +KISDFG+S R+ DG+ + G APE L
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMS------REEADGVYAASGGLRQVPVKWTAPEALN 288
Query: 190 NRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGAQN 246
Y SD+WS G++L+ + G P+ + + + + +G +L P+
Sbjct: 289 YGRYSSE-SDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG-GRLPCPELCPDAVFR 346
Query: 247 LLRKILEPNPVKRITIAGIK 266
L+ + P +R + + I
Sbjct: 347 LMEQCWAYEPGQRPSFSTIY 366
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 60/233 (25%), Positives = 107/233 (45%), Gaps = 26/233 (11%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+ LG G +G+V L AVK L+++ + ++ +E A +K +KHPN+
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV----EEFLKEAAVMKEIKHPNL 278
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVS 128
V+L V + Y++ E++T G L D L+E +++ L+ +
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLD------YLRECNRQEVSAVVLLYMATQISSAME 332
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY--VAPE 186
Y K HR+L N L+ +K++DFGLS + D APE
Sbjct: 333 YLEKKNFIHRNLAARNCLVGENHLVKVADFGLS---RLMTGDTYTAHAGAKFPIKWTAPE 389
Query: 187 VLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
LA + SD+W+ GV+L+ I T G P+ +L+ +Y+ + + +++ +
Sbjct: 390 SLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRMER 440
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-32
Identities = 58/237 (24%), Positives = 110/237 (46%), Gaps = 29/237 (12%)
Query: 17 ELGRTLGEGNFGKVK----FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ + LG G FG V + +P A+K L + +I E + +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVD 75
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID------- 125
+P+V RL + S + ++ + + G L D ++E + Q L++
Sbjct: 76 NPHVCRLLGIC-LTSTVQLITQLMPFGCLLD------YVREHKDNIGSQYLLNWCVQIAK 128
Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGS-P-NY 182
G++Y ++ + HRDL N+L+ + ++KI+DFGL+ L ++ H G P +
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA---EEKEYHAEGGKVPIKW 185
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
+A E + +R Y SD+WS GV ++ ++T G P+D + + + +G +LP+
Sbjct: 186 MALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERLPQ 240
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-32
Identities = 63/235 (26%), Positives = 108/235 (45%), Gaps = 30/235 (12%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLLKHP 74
+ LG G +G+V L AVK L+++ + + +E A +K +KHP
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT------MEVEEFLKEAAVMKEIKHP 69
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------G 126
N+V+L V + Y++ E++T G L D L+E +++ L+
Sbjct: 70 NLVQLLGVCTREPPFYIITEFMTYGNLLD------YLRECNRQEVSAVVLLYMATQISSA 123
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS-P-NYVA 184
+ Y K HRDL N L+ +K++DFGLS L D P + A
Sbjct: 124 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWTA 180
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
PE LA + SD+W+ GV+L+ I T G P+ +L+ +Y+ + + +++ +
Sbjct: 181 PESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRMER 233
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-32
Identities = 70/285 (24%), Positives = 122/285 (42%), Gaps = 32/285 (11%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
L LG+G FG+V + A+K L+ + + +E +K L+H +
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKL 241
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVS 128
V+L+ V S+ IY+V EY++ G L D L+ G+ L QL+D G++
Sbjct: 242 VQLYAV-VSEEPIYIVTEYMSKGSLLD------FLKGETGKYLRLPQLVDMAAQIASGMA 294
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS-P-NYVAPE 186
Y HRDL+ NIL+ K++DFGL+ + D+ P + APE
Sbjct: 295 YVERMNYVHRDLRAANILVGENLVCKVADFGLA---RLIEDNEYTARQGAKFPIKWTAPE 351
Query: 187 VLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPG 243
+ SD+WS G++L + T G +P+ + ++ RG +++ P
Sbjct: 352 AALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPES 409
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIF 288
+L+ + P +R T ++ + E +T P +
Sbjct: 410 LHDLMCQCWRKEPEERPTFEYLQ--AFLEDYFTSTEPQYQPGENL 452
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 9e-32
Identities = 70/285 (24%), Positives = 122/285 (42%), Gaps = 32/285 (11%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
L LG+G FG+V + A+K L+ + + +E +K L+H +
Sbjct: 270 RLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKL 324
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVS 128
V+L+ V S+ IY+V EY++ G L D L+ G+ L QL+D G++
Sbjct: 325 VQLYAV-VSEEPIYIVTEYMSKGSLLD------FLKGETGKYLRLPQLVDMAAQIASGMA 377
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS-P-NYVAPE 186
Y HRDL+ NIL+ K++DFGL+ + D+ P + APE
Sbjct: 378 YVERMNYVHRDLRAANILVGENLVCKVADFGLA---RLIEDNEYTARQGAKFPIKWTAPE 434
Query: 187 VLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPG 243
+ SD+WS G++L + T G +P+ + ++ RG +++ P
Sbjct: 435 AALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPES 492
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIF 288
+L+ + P +R T ++ + E +T P +
Sbjct: 493 LHDLMCQCWRKEPEERPTFEYLQ--AFLEDYFTSTEPQYQPGENL 535
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 9e-32
Identities = 64/236 (27%), Positives = 107/236 (45%), Gaps = 26/236 (11%)
Query: 17 ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
+ + +G G+ G+V + +P A+K L+ + E + + H
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR--RDFLSEASIMGQFDH 109
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------G 126
PN++RL V+ +V EY+ G L L+ +G+ QL+ G
Sbjct: 110 PNIIRLEGVVTRGRLAMIVTEYMENGSLDT------FLRTHDGQFTIMQLVGMLRGVGAG 163
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV--- 183
+ Y + G HRDL N+L+DS K+SDFGLS + + D +TT G +
Sbjct: 164 MRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE--DDPDAAYTTTGGKIPIRWT 221
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
APE +A R + A SD+WS GV+++ +L G P+ + + + G ++LP
Sbjct: 222 APEAIAFRTFSSA-SDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG-YRLPA 275
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 9e-32
Identities = 61/228 (26%), Positives = 99/228 (43%), Gaps = 14/228 (6%)
Query: 18 LGRTLGEGNFGKVKFA--QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+ LG GNFG VK Q AVKIL KN + D++ E ++ L +P
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPY 79
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
+VR+ + +V+E G L + +++ +L Q+ G+ Y
Sbjct: 80 IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 138
Query: 136 FHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGS--P-NYVAPEVLANR 191
HRDL N+LL ++ KISDFGLS AL D+ P + APE +
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRA---DENYYKAQTHGKWPVKWYAPECINYY 195
Query: 192 GYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
+ SD+WS GV+++ + G P+ + + + +G ++
Sbjct: 196 KFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-ERMGC 241
|
| >2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} Length = 123 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-31
Identities = 30/112 (26%), Positives = 53/112 (47%), Gaps = 5/112 (4%)
Query: 309 SPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQ 368
+NAF +I S +LSG F +R RF S +A+ ++ER+E+IV+ V
Sbjct: 2 GARRMNAFDIISGSPGFNLSGLFGDARKYDRVERFVSAWTAERVVERLEEIVSAENLTVA 61
Query: 369 KKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQI 420
KK + K G+ ++ E+ +++ L ++E+RK R +
Sbjct: 62 KKETWGMKIEGQK-----GNFAMVVEINQLTDELVMIEVRKRQRAAASGRDL 108
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 89/332 (26%), Positives = 138/332 (41%), Gaps = 64/332 (19%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
RY+ +G G +G V A D +GL AVK L + IIH K + RE+ LK +K
Sbjct: 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 86
Query: 73 HPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
H NV+ L +V +Y+V + G +L + + + +L + + L Q++ G
Sbjct: 87 HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRG 144
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV--- 183
+ Y H+ + HRDLK N+ ++ +KI DFGL+ YV
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG-----------YVATR 193
Query: 184 ---APEV-LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR------GD 233
APE+ L Y+ DIWS G I+ +LTG F + + I R +
Sbjct: 194 WYRAPEIMLNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 252
Query: 234 F--------------KLPKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKAD 268
L + +P A +LL K+L + KRIT A A
Sbjct: 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312
Query: 269 EWFEQDYTPAN-PDDDEEDIFVDNEAFSMHEV 299
+F Q + P + P D D +++ + E
Sbjct: 313 AYFAQYHDPDDEPVADPYDQSLESRDLLIDEW 344
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-31
Identities = 91/360 (25%), Positives = 137/360 (38%), Gaps = 80/360 (22%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
Y + +G G +G V A D +G A+K L + + K + RE+ LK ++
Sbjct: 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK---RAYRELRLLKHMR 82
Query: 73 HPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
H NV+ L +V Y+V+ ++ G +L K+ +L E + L Q++ G
Sbjct: 83 HENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDL-GKLMKHEKLGEDRIQFLVYQMLKG 140
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV--- 183
+ Y H G+ HRDLK N+ ++ +KI DFGL+ R T YV
Sbjct: 141 LRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA------RQADSEMT-----GYVVTR 189
Query: 184 ---APEV-LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF--------- 230
APEV L Y DIWS G I+ ++TG F + ++I
Sbjct: 190 WYRAPEVILNWMRYTQTV-DIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 248
Query: 231 ---------------------RGDFK--LPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267
+ DF L SP A NLL K+L + +R+T A
Sbjct: 249 FVQRLQSDEAKNYMKGLPELEKKDFASILTN-ASPLAVNLLEKMLVLDAEQRVTAGEALA 307
Query: 268 DEWFEQDYTPA--------NPDDDEEDIFVD-------NEAFSMHEVPSDGGRTPGSPPL 312
+FE + + D+ D +D E S G R PL
Sbjct: 308 HPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGARVSKETPL 367
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-31
Identities = 77/325 (23%), Positives = 122/325 (37%), Gaps = 73/325 (22%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD--QIKREIATLKLLK 72
RY + LG G G V A D D A+K +I+ REI ++ L
Sbjct: 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK-----KIVLTDPQSVKHALREIKIIRRLD 66
Query: 73 HPNVVRLHEVLASKSK--------------IYMVLEYVTGGELFDKIASKGRLQEAEGRK 118
H N+V++ E+L +Y+V EY+ +L + +G L E R
Sbjct: 67 HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDL-ANVLEQGPLLEEHARL 124
Query: 119 LFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLS-ALPQHFRDDGLLHTT 176
QL+ G+ Y H+ V HRDLK N+ ++++ +KI DFGL+ + H+ G L
Sbjct: 125 FMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHL--- 181
Query: 177 CGSPNYV------APEV-LANRGYDGATSDIWSCGVILYVILTGYLPF------------ 217
+ +P + L+ Y A D+W+ G I +LTG F
Sbjct: 182 ---SEGLVTKWYRSPRLLLSPNNYTKAI-DMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237
Query: 218 -------DDRNLAVLYQKIFRGDFKLPKW-----------LSPGAQNLLRKILEPNPVKR 259
+ + L I +S A + L +IL +P+ R
Sbjct: 238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDR 297
Query: 260 ITIAGIKADEWFEQDYTPANPDDDE 284
+T + + P DE
Sbjct: 298 LTAEEALSHPYMSIYSFP----MDE 318
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-31
Identities = 65/238 (27%), Positives = 109/238 (45%), Gaps = 33/238 (13%)
Query: 17 ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
ELGR +GEG FG V + + L A+K + ++ ++ +E T++ H
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR--EKFLQEALTMRQFDH 75
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------G 126
P++V+L V+ +++ +++++E T GEL LQ + LI
Sbjct: 76 PHIVKLIGVI-TENPVWIIMELCTLGELRS------FLQVRKYSLDLASLILYAYQLSTA 128
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGS--P-N 181
++Y +K HRD+ N+L+ S +K+ DFGLS R D + P
Sbjct: 129 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS------RYMEDSTYYKASKGKLPIK 182
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
++APE + R + A SD+W GV ++ IL G PF + +I G +LP
Sbjct: 183 WMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-ERLPM 238
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 7e-31
Identities = 64/236 (27%), Positives = 107/236 (45%), Gaps = 27/236 (11%)
Query: 18 LGRTLGEGNFGKVKFA----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
+ +G G FG+V +P A+K L+ + E + H
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR--VDFLGEAGIMGQFSH 105
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------G 126
N++RL V++ + ++ EY+ G L L+E +G QL+ G
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENGALDK------FLREKDGEFSVLQLVGMLRGIAAG 159
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV--- 183
+ Y N HRDL NIL++S K+SDFGLS + + D +TT G +
Sbjct: 160 MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE--DDPEATYTTSGGKIPIRWT 217
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
APE ++ R + A SD+WS G++++ ++T G P+ + + + + I G F+LP
Sbjct: 218 APEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-FRLPT 271
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 9e-31
Identities = 58/237 (24%), Positives = 106/237 (44%), Gaps = 29/237 (12%)
Query: 17 ELGRTLGEGNFGKVKFA----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ LG G FG V + +P +K++E + + + + L
Sbjct: 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSLD 73
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID------- 125
H ++VRL + S + +V +Y+ G L D +++ G Q L++
Sbjct: 74 HAHIVRLLGLC-PGSSLQLVTQYLPLGSLLD------HVRQHRGALGPQLLLNWGVQIAK 126
Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCG-SP-NY 182
G+ Y G+ HR+L N+LL S ++++DFG++ LP DD L + +P +
Sbjct: 127 GMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP---DDKQLLYSEAKTPIKW 183
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
+A E + Y SD+WS GV ++ ++T G P+ LA + + +G +L +
Sbjct: 184 MALESIHFGKYTHQ-SDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG-ERLAQ 238
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 80/332 (24%), Positives = 140/332 (42%), Gaps = 59/332 (17%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKH 73
RY +GEG +G V A D + + A+K I + + + REI L +H
Sbjct: 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ---RTLREIKILLRFRH 84
Query: 74 PNVVRLHEVLASKSK-----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
N++ +++++ + + +Y+V + + +L+ + ++ L Q++ G+
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQ-HLSNDHICYFLYQILRGLK 142
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV----- 183
Y H+ V HRDLK N+LL++ ++KI DFGL+ + D T YV
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT-----EYVATRWY 197
Query: 184 -APEV-LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN--------LAVL-------Y 226
APE+ L ++GY + DIWS G IL +L+ F ++ L +L
Sbjct: 198 RAPEIMLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256
Query: 227 QKIF---------------RGDFK--LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADE 269
I + + P A +LL K+L NP KRI + A
Sbjct: 257 NCIINLKARNYLLSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKRIEVEQALAHP 315
Query: 270 WFEQDYTPANPDDDEE--DIFVDNEAFSMHEV 299
+ EQ Y P++ E ++ + ++
Sbjct: 316 YLEQYYDPSDEPIAEAPFKFDMELDDLPKEKL 347
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-30
Identities = 60/237 (25%), Positives = 106/237 (44%), Gaps = 36/237 (15%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLLKHP 74
+ +G G FG V + A+K + + + E + L HP
Sbjct: 11 TFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGA------MSEEDFIEEAEVMMKLSHP 63
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------GV 127
+V+L+ V ++ I +V E++ G L D L+ G + L+ G+
Sbjct: 64 KLVQLYGVCLEQAPICLVTEFMEHGCLSD------YLRTQRGLFAAETLLGMCLDVCEGM 117
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGS--P-NY 182
+Y V HRDL N L+ IK+SDFG++ R D ++ G+ P +
Sbjct: 118 AYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT------RFVLDDQYTSSTGTKFPVKW 171
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
+PEV + Y SD+WS GV+++ + + G +P+++R+ + + + I G F+L K
Sbjct: 172 ASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-FRLYK 226
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 90/334 (26%), Positives = 139/334 (41%), Gaps = 68/334 (20%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
Y +G G +G V A D SG A+K L + I K + RE+ LK ++
Sbjct: 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK---RAYRELLLLKHMQ 81
Query: 73 HPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
H NV+ L +V S Y+V+ ++ +L + + E + + L Q++ G
Sbjct: 82 HENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM--GLKFSEEKIQYLVYQMLKG 138
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV--- 183
+ Y H+ GV HRDLK N+ ++ +KI DFGL+ R T YV
Sbjct: 139 LKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA------RHADAEMT-----GYVVTR 187
Query: 184 ---APEV-LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF--------- 230
APEV L+ Y+ DIWS G I+ +LTG F ++ +I
Sbjct: 188 WYRAPEVILSWMHYNQTV-DIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 246
Query: 231 ---------------------RGDFK--LPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267
R DF P+ SP A +LL K+LE + KR+T A
Sbjct: 247 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPR-ASPQAADLLEKMLELDVDKRLTAAQALT 305
Query: 268 DEWFEQDYTPANPDDDEE--DIFVDNEAFSMHEV 299
+FE P + ++ D +++E ++ E
Sbjct: 306 HPFFEPFRDPEEETEAQQPFDDSLEHEKLTVDEW 339
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 76/348 (21%), Positives = 135/348 (38%), Gaps = 90/348 (25%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILE----KNRIIHLKITDQIKREIATLK 69
R+++ R G+G FG V+ ++ +G+ A+K +++ +NR + + + L
Sbjct: 24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNREL---------QIMQDLA 74
Query: 70 LLKHPNVVRLHEVLASKSK-------IYMVLEYV--TGGELFDKIASKGRLQEAEGRKLF 120
+L HPN+V+L + + + +V+EYV T + K+F
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVF 134
Query: 121 Q-QLIDGVSYCHNK--GVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTT 176
QLI + H V HRD+K N+L++ + G +K+ DFG + + + +
Sbjct: 135 LFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK--KLSPSEPNVAYI 192
Query: 177 CGSPNYVAPEVLAN-RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-- 233
C S Y APE++ + Y A DIWS G I ++ G + IFRGD
Sbjct: 193 C-SRYYRAPELIFGNQHYTTAV-DIWSVGCIFAEMMLG-------------EPIFRGDNS 237
Query: 234 ----------------------------FKLPKW---------------LSPGAQNLLRK 250
L + A +LL
Sbjct: 238 AGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSA 297
Query: 251 ILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHE 298
+L+ P +R+ +F++ + PA + +D+ D F +E
Sbjct: 298 LLQYLPEERMKPYEALCHPYFDELHDPATKLPNNKDLPEDLFRFLPNE 345
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 58/237 (24%), Positives = 110/237 (46%), Gaps = 29/237 (12%)
Query: 17 ELGRTLGEGNFGKVK----FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ + LG G FG V + +P A+K L + +I E + +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVD 75
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID------- 125
+P+V RL + S + ++ + + G L D ++E + Q L++
Sbjct: 76 NPHVCRLLGIC-LTSTVQLITQLMPFGCLLD------YVREHKDNIGSQYLLNWCVQIAK 128
Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGS-P-NY 182
G++Y ++ + HRDL N+L+ + ++KI+DFGL+ L ++ H G P +
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA---EEKEYHAEGGKVPIKW 185
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
+A E + +R Y SD+WS GV ++ ++T G P+D + + + +G +LP+
Sbjct: 186 MALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERLPQ 240
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 64/240 (26%), Positives = 111/240 (46%), Gaps = 36/240 (15%)
Query: 18 LGRTLGEGNFGKV---KFAQDLDSGLPFAVKIL-----EKNRIIHLKITDQIKREIATLK 69
+ + +G G FG+V + + A+K L EK R L E + +
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-------GEASIMG 101
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---- 125
HPN++RL V+ + +V EY+ G L L++ + + QL+
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF------LRKHDAQFTVIQLVGMLRG 155
Query: 126 ---GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
G+ Y + G HRDL NIL++S K+SDFGL + + D +TT G
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE--DDPEAAYTTRGGKIP 213
Query: 183 V---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
+ +PE +A R + A SD+WS G++L+ +++ G P+ + + + + + G ++LP
Sbjct: 214 IRWTSPEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLPP 271
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 69/293 (23%), Positives = 118/293 (40%), Gaps = 52/293 (17%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
L ++G+G FG+V + G AVKI + + + EI +L+H N+
Sbjct: 45 VLQESIGKGRFGEVWRGKW--RGEEVAVKIFSS----REERSWFREAEIYQTVMLRHENI 98
Query: 77 VRL----HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH- 131
+ ++ + +++++V +Y G LFD + + KL G+++ H
Sbjct: 99 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHM 157
Query: 132 -------NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGSPNY 182
+ HRDLK +NIL+ G I+D GL+ D D + G+ Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 183 VAPEVLANRGYDGAT-----SDIWSCGVILYVILTGY----------LPFDDRN------ 221
+APEVL + +DI++ G++ + I LP+ D
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 277
Query: 222 ----LAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE----PNPVKRITIAGIK 266
V QK+ R + +W S A ++ KI+ N R+T IK
Sbjct: 278 EEMRKVVCEQKL-RPNIP-NRWQSCEALRVMAKIMRECWYANGAARLTALRIK 328
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 63/237 (26%), Positives = 110/237 (46%), Gaps = 36/237 (15%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLLKHP 74
+ LG G FG VK+ + A+K++++ + + E + L H
Sbjct: 27 TFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEG------SMSEDEFIEEAKVMMNLSHE 79
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------GV 127
+V+L+ V + I+++ EY+ G L + L+E R QQL++ +
Sbjct: 80 KLVQLYGVCTKQRPIFIITEYMANGCLLN------YLREMRHRFQTQQLLEMCKDVCEAM 133
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGS--P-NY 182
Y +K HRDL N L++ +G +K+SDFGLS R D ++ GS P +
Sbjct: 134 EYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLS------RYVLDDEYTSSVGSKFPVRW 187
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
PEVL + SDIW+ GV+++ I + G +P++ + + I +G +L +
Sbjct: 188 SPPEVLMYSKFSSK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-LRLYR 242
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 64/248 (25%), Positives = 101/248 (40%), Gaps = 32/248 (12%)
Query: 5 EKKQEGMRLGRYELGRTLGEGNFGKVKFAQ--DLDSGLPFAVKILEKNRIIHLKITDQIK 62
K++ + + ELG GNFG V+ + A+K+L++ +++
Sbjct: 5 FLKRDNLLIADIELG----CGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT--EEMM 58
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
RE + L +P +VRL V + +V+E GG L L
Sbjct: 59 REAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHK------FLVGKREEIPVSN 111
Query: 123 LID-------GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLH 174
+ + G+ Y K HRDL N+LL ++ KISDFGLS AL DD
Sbjct: 112 VAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA---DDSYYT 168
Query: 175 TTCGS--P-NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIF 230
P + APE + R + SD+WS GV ++ L+ G P+ + I
Sbjct: 169 ARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 227
Query: 231 RGDFKLPK 238
+G ++
Sbjct: 228 QG-KRMEC 234
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-30
Identities = 57/299 (19%), Positives = 110/299 (36%), Gaps = 54/299 (18%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
+ +L G FG V AQ AVKI K + Q + E+ +L +
Sbjct: 22 QSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQD----KQSWQNEYEVYSLPGM 75
Query: 72 KHPNVVRL----HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
KH N+++ + ++++ + G L D + + E + + + G+
Sbjct: 76 KHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-KANVVSWNELCHIAETMARGL 134
Query: 128 SYCHNK----------GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC 177
+Y H + HRD+K +N+LL + I+DFGL+ + + G H
Sbjct: 135 AYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQV 194
Query: 178 GSPNYVAPEVLANRGYDGAT----SDIWSCGVILYVILTGYLP----------------- 216
G+ Y+APEVL D+++ G++L+ + +
Sbjct: 195 GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254
Query: 217 ----FDDRNLAVLYQKIFRGDFKLPK-WLSPGAQNLLRKILE----PNPVKRITIAGIK 266
+D V+++K L W +L + +E + R++ +
Sbjct: 255 QHPSLEDMQEVVVHKKK---RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVG 310
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-30
Identities = 61/240 (25%), Positives = 105/240 (43%), Gaps = 37/240 (15%)
Query: 17 ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
L R LGEG FG+V + + AVK +K+ + K ++ E +K L H
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIMKNLDH 72
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------G 126
P++V+L ++ + ++++E GEL L+ + L+
Sbjct: 73 PHIVKLIGII-EEEPTWIIMELYPYGELGH------YLERNKNSLKVLTLVLYSLQICKA 125
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGS--PNY 182
++Y + HRD+ + NIL+ S +K+ DFGLS R D + + P
Sbjct: 126 MAYLESINCVHRDIAVRNILVASPECVKLGDFGLS------RYIEDEDYYKASVTRLP-- 177
Query: 183 V---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
+ +PE + R + A SD+W V ++ IL+ G PF + + +G +LPK
Sbjct: 178 IKWMSPESINFRRFTTA-SDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG-DRLPK 235
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-30
Identities = 65/243 (26%), Positives = 108/243 (44%), Gaps = 48/243 (19%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+L LG G FG+V + AVK L++ + D E +K L+H +
Sbjct: 16 KLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQHQRL 70
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVS 128
VRL+ V ++ IY++ EY+ G L D L+ G KL +L+D G++
Sbjct: 71 VRLYAV-VTQEPIYIITEYMENGSLVD------FLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV----- 183
+ + HRDL+ NIL+ + KI+DFGL+ + D+ Y
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFGLA---RLIEDN----------EYTAREGA 170
Query: 184 -------APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFK 235
APE + + SD+WS G++L I+T G +P+ + Q + RG ++
Sbjct: 171 KFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-YR 228
Query: 236 LPK 238
+ +
Sbjct: 229 MVR 231
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-30
Identities = 68/279 (24%), Positives = 127/279 (45%), Gaps = 44/279 (15%)
Query: 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLLKHPN 75
L + LG G FG VK + AVK++++ + + +E T+ L HP
Sbjct: 12 LLKELGSGQFGVVKLGK-WKGQYDVAVKMIKEG------SMSEDEFFQEAQTMMKLSHPK 64
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------GVS 128
+V+ + V + + IY+V EY++ G L + L+ QL++ G++
Sbjct: 65 LVKFYGVCSKEYPIYIVTEYISNGCLLN------YLRSHGKGLEPSQLLEMCYDVCEGMA 118
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGS--P-NYV 183
+ + HRDL N L+D +K+SDFG++ R D ++ G+ P +
Sbjct: 119 FLESHQFIHRDLAARNCLVDRDLCVKVSDFGMT------RYVLDDQYVSSVGTKFPVKWS 172
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKWLSP 242
APEV Y SD+W+ G++++ + + G +P+D + + K+ +G +L +
Sbjct: 173 APEVFHYFKYSSK-SDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG-HRLYR--PH 228
Query: 243 GAQNLLRKIL----EPNPVKRITIAGIKA--DEWFEQDY 275
A + + +I+ P KR T + + + E+D
Sbjct: 229 LASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKDK 267
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 5e-30
Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 24/210 (11%)
Query: 17 ELGRTLGEGNFGKVKFA----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ + LG+GNFG V+ ++G AVK L+ + + +REI LK L+
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ 69
Query: 73 HPNVVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID----- 125
H N+V+ V S + + +++EY+ G L D LQ+ + R +L+
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD------YLQKHKERIDHIKLLQYTSQI 123
Query: 126 --GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NY 182
G+ Y K HRDL NIL++++ +KI DFGL+ + ++ + SP +
Sbjct: 124 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFW 183
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILT 212
APE L + A SD+WS GV+LY + T
Sbjct: 184 YAPESLTESKFSVA-SDVWSFGVVLYELFT 212
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-30
Identities = 66/233 (28%), Positives = 98/233 (42%), Gaps = 52/233 (22%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD---------QIKREI 65
RYE+ +G G++G V A D A+K KI +I REI
Sbjct: 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIK----------KILRVFEDLIDCKRILREI 103
Query: 66 ATLKLLKHPNVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
A L L H +VV++ +++ K ++Y+VLE + + L E + L
Sbjct: 104 AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLL 162
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-----------ALPQHFRD 169
L+ GV Y H+ G+ HRDLK N L++ ++K+ DFGL+ LP R+
Sbjct: 163 YNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRE 222
Query: 170 DGLLHTTCGSPN--------YV------APEV-LANRGYDGATSDIWSCGVIL 207
D + T +V APE+ L Y A D+WS G I
Sbjct: 223 DDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI-DVWSIGCIF 274
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 6e-30
Identities = 70/339 (20%), Positives = 123/339 (36%), Gaps = 66/339 (19%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL------KITD--QIKREIA 66
Y + R + G++G V D G+P A+K + ++ REI
Sbjct: 23 PYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR 81
Query: 67 TLKLLKHPNVVRLHEVLASKSK-----IYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLF 120
L HPN++ L ++ + +Y+V E + +L I + + +
Sbjct: 82 LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFM 140
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
++ G+ H GV HRDL NILL +I I DF L+ + D
Sbjct: 141 YHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA---REDTADANK------T 191
Query: 181 NYV------APEV-LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN--------LAVL 225
+YV APE+ + +G+ D+WS G ++ + F + V+
Sbjct: 192 HYVTHRWYRAPELVMQFKGFTKLV-DMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVV 250
Query: 226 ------------------YQKIFRGDFKLPKW------LSPGAQNLLRKILEPNPVKRIT 261
Y + + W P A +L+ K+LE NP +RI+
Sbjct: 251 GTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIS 310
Query: 262 IAGIKADEWFEQDYTPAN-PDDDEEDIFVDNEAFSMHEV 299
+FE + P + + E D ++++
Sbjct: 311 TEQALRHPYFESLFDPLDLTEGLSERFHFDESVTDVYDM 349
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-30
Identities = 67/221 (30%), Positives = 102/221 (46%), Gaps = 35/221 (15%)
Query: 17 ELGRTLGEGNFGKVKFA----QDLDSGLPFAVKILEKNRIIHLKITDQIK---REIATLK 69
+ LG+GNFG V+ ++G AVK L+ + DQ + REI LK
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG------PDQQRDFQREIQILK 79
Query: 70 LLKHPNVVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-- 125
L +V+ V + + +V+EY+ G L D LQ R +L+
Sbjct: 80 ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRD------FLQRHRARLDASRLLLYS 133
Query: 126 -----GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCG- 178
G+ Y ++ HRDL NIL++S+ ++KI+DFGL+ LP D + G
Sbjct: 134 SQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD--KDYYVVREPGQ 191
Query: 179 SP-NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 217
SP + APE L++ + SD+WS GV+LY + T
Sbjct: 192 SPIFWYAPESLSDNIFSRQ-SDVWSFGVVLYELFTYCDKSC 231
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 8e-30
Identities = 59/236 (25%), Positives = 101/236 (42%), Gaps = 38/236 (16%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+L +T+G+G FG V G AVK ++ + E + + L+H N+
Sbjct: 24 KLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNL 76
Query: 77 VRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GV 127
V+L V + K +Y+V EY+ G L D L+ L L+ +
Sbjct: 77 VQLLGVIVEEKGGLYIVTEYMAKGSLVD------YLRSRGRSVLGGDCLLKFSLDVCEAM 130
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY----V 183
Y HRDL N+L+ K+SDFGL+ ++ +T +
Sbjct: 131 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT------KEA---SSTQDTGKLPVKWT 181
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
APE L + + SD+WS G++L+ I + G +P+ L + ++ +G +K+
Sbjct: 182 APEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDA 235
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 65/233 (27%), Positives = 111/233 (47%), Gaps = 28/233 (12%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+L + LG G FG+V A AVK ++ + + E +K L+H +
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHT-KVAVKTMKPGSMSV----EAFLAEANVMKTLQHDKL 245
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVS 128
V+LH V +K IY++ E++ G L D L+ EG K +LID G++
Sbjct: 246 VKLHAV-VTKEPIYIITEFMAKGSLLD------FLKSDEGSKQPLPKLIDFSAQIAEGMA 298
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS-P-NYVAPE 186
+ + HRDL+ NIL+ + KI+DFGL+ + D+ P + APE
Sbjct: 299 FIEQRNYIHRDLRAANILVSASLVCKIADFGLA---RVIEDNEYTAREGAKFPIKWTAPE 355
Query: 187 VLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
+ + SD+WS G++L I+T G +P+ + + + + RG +++P+
Sbjct: 356 AINFGSFTIK-SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMPR 406
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-29
Identities = 64/293 (21%), Positives = 118/293 (40%), Gaps = 52/293 (17%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
++ + +G+G +G+V + G AVK+ + + + EI L++H N+
Sbjct: 40 QMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFT----TEEASWFRETEIYQTVLMRHENI 93
Query: 77 VRL----HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
+ + S +++Y++ +Y G L+D + S L KL + G+ + H
Sbjct: 94 LGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHT 152
Query: 133 K--------GVFHRDLKLENILLDSKGNIKISDFGLSAL--PQHFRDDGLLHTTCGSPNY 182
+ + HRDLK +NIL+ G I+D GL+ D +T G+ Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 183 VAPEVLANRGYDGAT-----SDIWSCGVILYVILTGYLP--------------------F 217
+ PEVL +D++S G+IL+ + + +
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY 272
Query: 218 DDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE----PNPVKRITIAGIK 266
+D V +K+ R F +W S + K++ NP R+T +K
Sbjct: 273 EDMREIVCIKKL-RPSFP-NRWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 63/275 (22%), Positives = 107/275 (38%), Gaps = 43/275 (15%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
Y + +G G++G V A D ++ A+K + + +I K +I REI L LK
Sbjct: 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCK---RILREITILNRLK 83
Query: 73 HPNVVRLHEVLASKSK-----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
++RL++++ +Y+VLE +L + L E + + L+ G
Sbjct: 84 SDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLGE 142
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-----------ALPQHFRDDGLLHTT 176
++ H G+ HRDLK N LL+ ++K+ DFGL+ ++ H
Sbjct: 143 NFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202
Query: 177 CGSP---NYV------APEV-LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY 226
++V APE+ L Y + DIWS G I +L +
Sbjct: 203 NLKKQLTSHVVTRWYRAPELILLQENYTKSI-DIWSTGCIFAELLNMLQSHINDPTN--R 259
Query: 227 QKIFRGDFKLPKWLSPGAQNL--------LRKILE 253
+F G P ++ + L I
Sbjct: 260 FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFN 294
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 24/210 (11%)
Query: 17 ELGRTLGEGNFGKVKFA----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ + LG+GNFG V+ ++G AVK L+ + + +REI LK L+
Sbjct: 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ 100
Query: 73 HPNVVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID----- 125
H N+V+ V S + + +++EY+ G L D LQ+ + R +L+
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD------YLQKHKERIDHIKLLQYTSQI 154
Query: 126 --GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NY 182
G+ Y K HRDL NIL++++ +KI DFGL+ + ++ + SP +
Sbjct: 155 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFW 214
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILT 212
APE L + A SD+WS GV+LY + T
Sbjct: 215 YAPESLTESKFSVA-SDVWSFGVVLYELFT 243
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 6e-29
Identities = 64/235 (27%), Positives = 109/235 (46%), Gaps = 27/235 (11%)
Query: 17 ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
ELGR +GEG FG V + + + A+K + ++ ++ +E T++ H
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR--EKFLQEALTMRQFDH 450
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------G 126
P++V+L V+ +++ +++++E T GEL LQ + LI
Sbjct: 451 PHIVKLIGVI-TENPVWIIMELCTLGELRS------FLQVRKFSLDLASLILYAYQLSTA 503
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG-SP-NYVA 184
++Y +K HRD+ N+L+ S +K+ DFGLS D + G P ++A
Sbjct: 504 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY---MEDSTYYKASKGKLPIKWMA 560
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
PE + R + A SD+W GV ++ IL G PF + +I G +LP
Sbjct: 561 PESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-ERLPM 613
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-29
Identities = 62/210 (29%), Positives = 103/210 (49%), Gaps = 23/210 (10%)
Query: 17 ELGRTLGEGNFGKVKFA----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ R LGEG+FGKV+ + ++G AVK L K I D +K+EI L+ L
Sbjct: 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIAD-LKKEIEILRNLY 81
Query: 73 HPNVVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID----- 125
H N+V+ + I +++E++ G L + L + + + +Q +
Sbjct: 82 HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKE------YLPKNKNKINLKQQLKYAVQI 135
Query: 126 --GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NY 182
G+ Y ++ HRDL N+L++S+ +KI DFGL+ + ++ + SP +
Sbjct: 136 CKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFW 195
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILT 212
APE L + A SD+WS GV L+ +LT
Sbjct: 196 YAPECLMQSKFYIA-SDVWSFGVTLHELLT 224
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 7e-29
Identities = 53/293 (18%), Positives = 97/293 (33%), Gaps = 55/293 (18%)
Query: 17 ELGRTLGEGNFGKV-------KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
+LG+G F K+ +K+L+K H ++ + +
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA---HRNYSESFFEAASMMS 67
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---- 125
L H ++V + V + +V E+V G L L++ + ++
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTY------LKKNKNCINILWKLEVAKQ 121
Query: 126 ---GVSYCHNKGVFHRDLKLENILLDSKGN--------IKISDFGLSALPQHFRDDGLLH 174
+ + + H ++ +NILL + + IK+SD G+S
Sbjct: 122 LAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS------IT----- 170
Query: 175 TTCGSPNY-------VAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLY 226
+ V PE + N +D WS G L+ I + G P +
Sbjct: 171 --VLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL 228
Query: 227 QKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA--DEWFEQDYTP 277
Q +LP + NL+ ++ P R + I + F D P
Sbjct: 229 QFYEDR-HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVP 280
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 8e-29
Identities = 62/234 (26%), Positives = 103/234 (44%), Gaps = 34/234 (14%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ-IKREIATLKLLKHPN 75
+L +T+G+G FG V G AVK ++ + T Q E + + L+H N
Sbjct: 196 KLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKND------ATAQAFLAEASVMTQLRHSN 247
Query: 76 VVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------G 126
+V+L V + K +Y+V EY+ G L D L+ L L+
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVD------YLRSRGRSVLGGDCLLKFSLDVCEA 301
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAP 185
+ Y HRDL N+L+ K+SDFGL+ ++ T P + AP
Sbjct: 302 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT------KEASSTQDTGKLPVKWTAP 355
Query: 186 EVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
E L + + SD+WS G++L+ I + G +P+ L + ++ +G +K+
Sbjct: 356 EALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDA 407
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 83/360 (23%), Positives = 135/360 (37%), Gaps = 81/360 (22%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
+YEL + LG+G +G V + D +G AVK + + + REI L L
Sbjct: 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQ---RTFREIMILTELS 66
Query: 73 -HPNVVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
H N+V L VL + + +Y+V +Y+ +L I + L+ + + QLI + Y
Sbjct: 67 GHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRAN-ILEPVHKQYVVYQLIKVIKY 124
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPN------- 181
H+ G+ HRD+K NILL+++ ++K++DFGLS + R + +
Sbjct: 125 LHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 182 -----YV------APEV-LANRGYDGATSDIWSCGVILYVILTG---------------- 213
YV APE+ L + Y D+WS G IL IL G
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGI-DMWSLGCILGEILCGKPIFPGSSTMNQLERI 243
Query: 214 ----------------------YL---------PFDDRNLAVLYQKIFRGDFKLPKWLSP 242
+ ++ K +
Sbjct: 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNE 303
Query: 243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDI---FVDNEAFSMHEV 299
A +LL K+L+ NP KRI+ + + P + + I DN S+ +
Sbjct: 304 EALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHSIDDY 363
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-28
Identities = 65/251 (25%), Positives = 101/251 (40%), Gaps = 31/251 (12%)
Query: 5 EKKQEGMRLGRYEL---GRTLGEGNFGKVKFAQ--DLDSGLPFAVKILEKNRIIHLKITD 59
E K + + L R L LG GNFG V+ + A+K+L++ +
Sbjct: 324 ELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT--E 381
Query: 60 QIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL 119
++ RE + L +P +VRL V + +V+E GG L L
Sbjct: 382 EMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHK------FLVGKREEIP 434
Query: 120 FQQLID-------GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDG 171
+ + G+ Y K HR+L N+LL ++ KISDFGLS AL DD
Sbjct: 435 VSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA---DDS 491
Query: 172 LLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQ 227
+ APE + R + SD+WS GV ++ L+ G P+ +
Sbjct: 492 YYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMA 550
Query: 228 KIFRGDFKLPK 238
I +G ++
Sbjct: 551 FIEQG-KRMEC 560
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 69/211 (32%), Positives = 104/211 (49%), Gaps = 27/211 (12%)
Query: 17 ELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ R LGEG+FGKV + +G AVK L+ + + K+EI L+ L
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLY 91
Query: 73 HPNVVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
H ++++ + +V+EYV G L D + + + A+ QQ+ +G++Y
Sbjct: 92 HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMAYL 150
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQ-----HFRDDGLLHTTCGSPNYV- 183
H + HRDL N+LLD+ +KI DFGL+ A+P+ R+DG P V
Sbjct: 151 HAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS------P--VF 202
Query: 184 --APEVLANRGYDGATSDIWSCGVILYVILT 212
APE L + A SD+WS GV LY +LT
Sbjct: 203 WYAPECLKEYKFYYA-SDVWSFGVTLYELLT 232
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-28
Identities = 73/314 (23%), Positives = 130/314 (41%), Gaps = 50/314 (15%)
Query: 17 ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
LGR LG+G FG V + Q+ S + AVK+L+ + I I + RE A +K H
Sbjct: 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEE-FLREAACMKEFDH 84
Query: 74 PNVVRL------HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI--- 124
P+V +L ++L ++ G+L + + R+ E Q L+
Sbjct: 85 PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLAS-RIGENPFNLPLQTLVRFM 143
Query: 125 ----DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
G+ Y ++ HRDL N +L + ++DFGLS R +++
Sbjct: 144 VDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS------RK---IYSG---- 190
Query: 181 NY-------------VAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLY 226
+Y +A E LA+ Y SD+W+ GV ++ I+T G P+ A +Y
Sbjct: 191 DYYRQGCASKLPVKWLALESLADNLYTVH-SDVWAFGVTMWEIMTRGQTPYAGIENAEIY 249
Query: 227 QKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 285
+ G+ K P +L+ + +P +R + ++ + E + +
Sbjct: 250 NYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRME--LENILGHLSVLSTSQ 307
Query: 286 D-IFVDNEAFSMHE 298
D ++++ E H
Sbjct: 308 DPLYINIERAHHHH 321
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 4e-28
Identities = 54/225 (24%), Positives = 86/225 (38%), Gaps = 37/225 (16%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE--IATLKLLKHP 74
+L +G G +G V LD P AVK+ E I + L++H
Sbjct: 16 KLLELIGRGRYGAVYKGS-LD-ERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHD 67
Query: 75 NVVRL-----HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
N+ R + + +V+EY G L + S +L + G++Y
Sbjct: 68 NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-SLHTSDWVSSCRLAHSVTRGLAY 126
Query: 130 CH---------NKGVFHRDLKLENILLDSKGNIKISDFGLS------ALPQHFRDDGLLH 174
H + HRDL N+L+ + G ISDFGLS L + +D
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAI 186
Query: 175 TTCGSPNYVAPEVL------ANRGYDGATSDIWSCGVILYVILTG 213
+ G+ Y+APEVL + D+++ G+I + I
Sbjct: 187 SEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 70/343 (20%), Positives = 120/343 (34%), Gaps = 107/343 (31%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK---REIATLKLL 71
+Y LG+TLG G+FG V D++SG FA+K K+ + RE+ +K+L
Sbjct: 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALK----------KVLQDPRYKNRELDIMKVL 57
Query: 72 KHPNVVRLHEVLASKSK--------------------------------------IYMVL 93
H N+++L + + + +++
Sbjct: 58 DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 94 EYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 149
EYV L + S + QL V + H+ G+ HRD+K +N+L++S
Sbjct: 118 EYV-PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS 176
Query: 150 K-GNIKISDFGLSALPQHFRDDGLLHTTCGSPN--YV------APEVLAN-RGYDGATSD 199
K +K+ DFG + + P+ Y+ APE++ Y + D
Sbjct: 177 KDNTLKLCDFGSA------K-----KLIPSEPSVAYICSRFYRAPELMLGATEYTPSI-D 224
Query: 200 IWSCGVILYVILTGYLPFDDRNLAVLYQKIF-----------------RGDFKLPKW--- 239
+WS G + ++ G F +I + + P
Sbjct: 225 LWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAK 284
Query: 240 ---------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273
A +LL +IL P RI A +F+
Sbjct: 285 DWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH 327
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 63/246 (25%), Positives = 102/246 (41%), Gaps = 44/246 (17%)
Query: 17 ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLL 71
+G G+FG V + + AVK L + I + + E +K
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----TDIGEVSQFLTEGIIMKDF 83
Query: 72 KHPNVVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI------ 124
HPNV+ L + L S+ +VL Y+ G+L + ++ + LI
Sbjct: 84 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNPTVKDLIGFGLQV 137
Query: 125 -DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL-------PQHFRDDGLLHTT 176
G+ Y +K HRDL N +LD K +K++DFGL+ H + L
Sbjct: 138 AKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL--- 194
Query: 177 CGSPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG 232
P V A E L + + SD+WS GV+L+ ++T G P+ D N + + +G
Sbjct: 195 ---P--VKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 248
Query: 233 DFKLPK 238
+L +
Sbjct: 249 -RRLLQ 253
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 6e-27
Identities = 63/249 (25%), Positives = 103/249 (41%), Gaps = 50/249 (20%)
Query: 17 ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
+G G+FG V + + AVK L NRI + Q E +K H
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSH 149
Query: 74 PNVVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI-------D 125
PNV+ L + L S+ +VL Y+ G+L + ++ + LI
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNPTVKDLIGFGLQVAK 203
Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV-- 183
G+ + +K HRDL N +LD K +K++DFGL+ RD ++ +
Sbjct: 204 GMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA------RD---MYDK----EFDSV 250
Query: 184 -------------APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKI 229
A E L + + SD+WS GV+L+ ++T G P+ D N + +
Sbjct: 251 HNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 309
Query: 230 FRGDFKLPK 238
+G +L +
Sbjct: 310 LQG-RRLLQ 317
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 70/314 (22%), Positives = 126/314 (40%), Gaps = 56/314 (17%)
Query: 17 ELGRTLGEGNFGKV--KFAQDLDSGLPF---AVKILEKNRIIHLKITDQIKREIATLKLL 71
+ R LG+G+FG V A+ + P A+K + + + +I + E + +K
Sbjct: 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMKEF 85
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGEL--FDKIASKGRLQEAEGRKL-FQQLI---- 124
+VVRL V++ +++E +T G+L + + ++I
Sbjct: 86 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145
Query: 125 ---DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-----------D 170
DG++Y + HRDL N ++ +KI DFG++ RD
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT------RDIYETDYYRKGGK 199
Query: 171 GLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLY 226
GLL P V +PE L + + SD+WS GV+L+ I T P+ + +
Sbjct: 200 GLL------P--VRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGLSNEQVL 250
Query: 227 QKIFRGDFKLPKWLSPGAQNLLRKIL----EPNPVKRITIAGIKA--DEWFEQDYTPANP 280
+ + G L K ++L +++ + NP R + I + E E + +
Sbjct: 251 RFVMEG-GLLDK--PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSF 307
Query: 281 DDDEEDIFVDNEAF 294
EE+ + E
Sbjct: 308 YYSEENKLPEPEEL 321
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 3e-26
Identities = 65/222 (29%), Positives = 99/222 (44%), Gaps = 29/222 (13%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
RYE+ + +G+G+FG+V A D A+K++ +N + Q EI L+ L+
Sbjct: 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMV-RN---EKRFHRQAAEEIRILEHLRK 152
Query: 74 ------PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEG------RKLFQ 121
NV+ + E ++ I M E + L++ I K + Q G RK
Sbjct: 153 QDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELI-KKNKFQ---GFSLPLVRKFAH 207
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILL--DSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179
++ + H + H DLK ENILL + IK+ DFG S + ++T S
Sbjct: 208 SILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS-----CYEHQRVYTYIQS 262
Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN 221
Y APEV+ Y D+WS G IL +LTGY +
Sbjct: 263 RFYRAPEVILGARYGMP-IDMWSLGCILAELLTGYPLLPGED 303
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-26
Identities = 61/244 (25%), Positives = 105/244 (43%), Gaps = 40/244 (16%)
Query: 17 ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
R +G+G+FG V ++ + + A+K L +RI ++ + RE ++ L H
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL--SRITEMQQVEAFLREGLLMRGLNH 81
Query: 74 PNVVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID------- 125
PNV+ L + L + +++L Y+ G+L ++ + + LI
Sbjct: 82 PNVLALIGIMLPPEGLPHVLLPYMCHGDL------LQFIRSPQRNPTVKDLISFGLQVAR 135
Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL-------PQHFRDDGLLHTTCG 178
G+ Y + HRDL N +LD +K++DFGL+ L
Sbjct: 136 GMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL----- 190
Query: 179 SPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDF 234
P V A E L + SD+WS GV+L+ +LT G P+ + L + +G
Sbjct: 191 -P--VKWTALESLQTYRFTTK-SDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG-R 245
Query: 235 KLPK 238
+LP+
Sbjct: 246 RLPQ 249
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 7e-26
Identities = 68/250 (27%), Positives = 103/250 (41%), Gaps = 45/250 (18%)
Query: 18 LGRTLGEGNFGKVKFAQ--DLDSGLPFAVKILEKNRIIHLKITDQIK----REIATLK-L 70
+GEGNFG+V A+ + A+K +++ + E+ L L
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY------ASKDDHRDFAGELEVLCKL 82
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFD--------KIASKGRLQEAEGRKL-FQ 121
HPN++ L + +Y+ +EY G L D + + + L Q
Sbjct: 83 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142
Query: 122 QLID-------GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH 174
QL+ G+ Y K HRDL NIL+ KI+DFGLS R +
Sbjct: 143 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS------RGQEVYV 196
Query: 175 TTCGS--PNYV---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQK 228
P V A E L Y SD+WS GV+L+ I++ G P+ A LY+K
Sbjct: 197 KKTMGRLP--VRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 253
Query: 229 IFRGDFKLPK 238
+ +G ++L K
Sbjct: 254 LPQG-YRLEK 262
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 9e-26
Identities = 65/246 (26%), Positives = 98/246 (39%), Gaps = 47/246 (19%)
Query: 17 ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
LG+ LGEG FG V Q+ + L AVK + K + ++ E A +K H
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKDFSH 95
Query: 74 PNVVRL-----HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI---- 124
PNV+RL K ++L ++ G+L + RL+ Q L+
Sbjct: 96 PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS-RLETGPKHIPLQTLLKFMV 154
Query: 125 ---DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-----------D 170
G+ Y N+ HRDL N +L + ++DFGLS +
Sbjct: 155 DIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLS------KKIYSGDYYRQGRI 208
Query: 171 GLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLY 226
+ P V A E LA+R Y SD+W+ GV ++ I T G P+ +Y
Sbjct: 209 AKM------P--VKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGMTPYPGVQNHEMY 259
Query: 227 QKIFRG 232
+ G
Sbjct: 260 DYLLHG 265
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 9e-26
Identities = 67/313 (21%), Positives = 113/313 (36%), Gaps = 64/313 (20%)
Query: 17 ELGRTLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
L R LG G FG+V + S L AVK L + ++ E +
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL--DFLMEALIISKF 90
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLI------ 124
H N+VR V ++++E + GG+L + R + ++ L L+
Sbjct: 91 NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRET-RPRPSQPSSLAMLDLLHVARDI 149
Query: 125 -DGVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRD----------- 169
G Y HRD+ N LL G KI DFG++ RD
Sbjct: 150 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA------RDIYRASYYRKGG 203
Query: 170 DGLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVL 225
+L P V PE + +D WS GV+L+ I + GY+P+ ++ +
Sbjct: 204 CAML------P--VKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEV 254
Query: 226 YQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGIKA------------DEWF 271
+ + G ++ PK ++ + + P R A I +
Sbjct: 255 LEFVTSG-GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTAL 313
Query: 272 EQDYTPANPDDDE 284
+Y P ++++
Sbjct: 314 PIEYGPLVEEEEK 326
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 1e-25
Identities = 60/262 (22%), Positives = 95/262 (36%), Gaps = 62/262 (23%)
Query: 17 ELGRTLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIAT 67
LGE FGKV + A+K L+ ++ E
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK------AEGPLREEFRHEAML 65
Query: 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFD---------KIASKGRLQEAEGRK 118
L+HPNVV L V+ + M+ Y + G+L + + S + +
Sbjct: 66 RARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125
Query: 119 LFQQLI-------DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-- 169
+ G+ Y + V H+DL N+L+ K N+KISD GL R+
Sbjct: 126 EPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF------REVY 179
Query: 170 ---------DGLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-GYLP 216
+ LL P + APE + + SDIWS GV+L+ + + G P
Sbjct: 180 AADYYKLLGNSLL------P--IRWMAPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQP 230
Query: 217 FDDRNLAVLYQKIFRGDFKLPK 238
+ + + + I LP
Sbjct: 231 YCGYSNQDVVEMIRNR-QVLPC 251
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 69/317 (21%), Positives = 115/317 (36%), Gaps = 72/317 (22%)
Query: 17 ELGRTLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIAT 67
L R LG G FG+V + S L AVK L + ++Q + E
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV------CSEQDELDFLMEALI 127
Query: 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLI-- 124
+ H N+VR V +++LE + GG+L + R + ++ L L+
Sbjct: 128 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRET-RPRPSQPSSLAMLDLLHV 186
Query: 125 -----DGVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRD------- 169
G Y HRD+ N LL G KI DFG++ RD
Sbjct: 187 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA------RDIYRAGYY 240
Query: 170 ----DGLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRN 221
+L P V PE + +D WS GV+L+ I + GY+P+ ++
Sbjct: 241 RKGGCAML------P--VKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKS 291
Query: 222 LAVLYQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGIKA------------ 267
+ + + G ++ PK ++ + + P R A I
Sbjct: 292 NQEVLEFVTSG-GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVI 350
Query: 268 DEWFEQDYTPANPDDDE 284
+ +Y P ++++
Sbjct: 351 NTALPIEYGPLVEEEEK 367
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 64/216 (29%), Positives = 97/216 (44%), Gaps = 23/216 (10%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
RYE+ +G+G+FG+V A D A+KI+ KN +Q + E+ L+L+
Sbjct: 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-KN---KKAFLNQAQIEVRLLELMNK 109
Query: 74 P------NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLID 125
+V L ++ + +V E + L+D + + + RK QQ+
Sbjct: 110 HDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCT 168
Query: 126 GVSYCHNK--GVFHRDLKLENILL--DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
+ + + H DLK ENILL + IKI DFG S+ R ++ S
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG-SSCQLGQR----IYQYIQSRF 223
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 217
Y +PEVL YD A D+WS G IL + TG F
Sbjct: 224 YRSPEVLLGMPYDLA-IDMWSLGCILVEMHTGEPLF 258
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 73/368 (19%), Positives = 131/368 (35%), Gaps = 95/368 (25%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK- 72
RY L R LG G+F V A+D+ + A+KI+ ++ T+ + EI L+ +
Sbjct: 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVND 74
Query: 73 ----------HPNVVRLHEVLASKSKIY----MVLEYVTGGELFD--KIASKGRLQEAEG 116
++++L + K MV E V G L K +
Sbjct: 75 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYV 133
Query: 117 RKLFQQLIDGVSYCHNK-GVFHRDLKLENILLD------SKGNIKISDFGLSALPQHFRD 169
+++ +QL+ G+ Y H + G+ H D+K EN+L++ + IKI+D G +
Sbjct: 134 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW-----Y 188
Query: 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY--- 226
D + + Y +PEVL + DIWS +++ ++TG F+
Sbjct: 189 DEHYTNSIQTREYRSPEVLLGAPWGCGA-DIWSTACLIFELITGDFLFEPDEGHSYTKDD 247
Query: 227 ------------------------QKIF--RGDFK---------LPKWLSPGAQ------ 245
+ F RG + L L+ +
Sbjct: 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 307
Query: 246 ----NLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPS 301
+ L +L+ +P KR G+ W ++ + ++ E+
Sbjct: 308 KEISDFLSPMLQLDPRKRADAGGLVNHPWL------------KDTLGMEEIRVPDRELYG 355
Query: 302 DGGRTPGS 309
G PG
Sbjct: 356 SGSDIPGW 363
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 76/331 (22%), Positives = 134/331 (40%), Gaps = 72/331 (21%)
Query: 17 ELGRTLGEGNFGKVKFA-------QDLDSGLPFAVKILEKNRIIHLKITDQIK----REI 65
LG+ LGEG FG+V A + AVK+L+ + T++ E+
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD------ATEKDLSDLISEM 125
Query: 66 ATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFD--------KIASKGRLQEAEG 116
+K++ KH N++ L +Y+++EY + G L + +
Sbjct: 126 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 185
Query: 117 RKL-FQQLID-------GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168
+L + L+ G+ Y +K HRDL N+L+ +KI+DFGL+ R
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA------R 239
Query: 169 D-----------DGLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-G 213
D +G L P V APE L +R Y SD+WS GV+L+ I T G
Sbjct: 240 DIHHIDYYKKTTNGRL------P--VKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLG 290
Query: 214 YLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271
P+ + L++ + G ++ P + ++R P +R T + E
Sbjct: 291 GSPYPGVPVEELFKLLKEG-HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV--EDL 347
Query: 272 EQDYTPANPDDDEEDIFVDNEAFSMHEVPSD 302
++ ++E + + +++P+
Sbjct: 348 DRIVALT---SNQEMGYYHHHHHHDYDIPTT 375
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-24
Identities = 72/262 (27%), Positives = 105/262 (40%), Gaps = 65/262 (24%)
Query: 17 ELGRTLGEGNFGKVK--FAQDLDSGLPF---AVKILEKNRIIHLKITDQIK----REIAT 67
LG+TLGEG FGKV A L + AVK+L++N + E
Sbjct: 26 VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN------ASPSELRDLLSEFNV 79
Query: 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL----------------FDKIASKGRL 111
LK + HP+V++L+ + + +++EY G L + L
Sbjct: 80 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 112 QEAEGRKL-FQQLI-------DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL 163
+ R L LI G+ Y + HRDL NIL+ +KISDFGLS
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLS-- 197
Query: 164 PQHFRDDGLLHTTCGSPNYV------------APEVLANRGYDGATSDIWSCGVILYVIL 211
RD ++ +YV A E L + Y SD+WS GV+L+ I+
Sbjct: 198 ----RD---VYEE---DSYVKRSQGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIV 246
Query: 212 T-GYLPFDDRNLAVLYQKIFRG 232
T G P+ L+ + G
Sbjct: 247 TLGGNPYPGIPPERLFNLLKTG 268
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 67/265 (25%), Positives = 114/265 (43%), Gaps = 65/265 (24%)
Query: 17 ELGRTLGEGNFGKVKFA-------QDLDSGLPFAVKILEKNRIIHLKITDQIK----REI 65
LG+ LGEG FG+V A + AVK+L+ + T++ E+
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD------ATEKDLSDLVSEM 91
Query: 66 ATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFD--------KIASKGRLQEAEG 116
+K++ KH N++ L +Y+++EY + G L + + +
Sbjct: 92 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 117 RKL-FQQLI-------DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168
++ F+ L+ G+ Y ++ HRDL N+L+ +KI+DFGL+ R
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA------R 205
Query: 169 D-----------DGLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-G 213
D +G L P V APE L +R Y SD+WS GV+++ I T G
Sbjct: 206 DINNIDYYKKTTNGRL------P--VKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLG 256
Query: 214 YLPFDDRNLAVLYQKIFRGDFKLPK 238
P+ + L++ + G ++ K
Sbjct: 257 GSPYPGIPVEELFKLLKEG-HRMDK 280
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 59/233 (25%), Positives = 96/233 (41%), Gaps = 48/233 (20%)
Query: 17 ELGRTLGEGNFGKVKFAQ-----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
+ G+TLG G FGKV A D+ L AVK+L+ H + + E+ + L
Sbjct: 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST--AHADEKEALMSELKIMSHL 106
Query: 72 -KHPNVVRLHEVLASKSKIYMVLEYVTGGELFD------KIASKGRLQEAEGRKL-FQQL 123
+H N+V L + ++ EY G+L + ++ + L
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDL 166
Query: 124 ID-------GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT 176
+ G+++ +K HRD+ N+LL + KI DFGL+ RD +
Sbjct: 167 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA------RD---IMND 217
Query: 177 CGSPNYV------------APEVLANRGYDGATSDIWSCGVILYVILT-GYLP 216
NY+ APE + + Y SD+WS G++L+ I + G P
Sbjct: 218 ---SNYIVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNP 266
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 65/237 (27%), Positives = 95/237 (40%), Gaps = 52/237 (21%)
Query: 17 ELGRTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
G+TLG G FGKV A D+ + AVK+L+ + HL + + E+ L L
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTEREALMSELKVLSYL 83
Query: 72 -KHPNVVRLHEVLASKSKIYMVLEYVTGGEL-----------FDKIASKGRLQEAEGRKL 119
H N+V L ++ EY G+L S +++ E
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 120 FQQLID-------GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172
+ L+ G+++ +K HRDL NILL KI DFGL+ RD
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA------RD--- 194
Query: 173 LHTTCGSPNYV------------APEVLANRGYDGATSDIWSCGVILYVILT-GYLP 216
+ NYV APE + N Y SD+WS G+ L+ + + G P
Sbjct: 195 IKND---SNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSP 247
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-24
Identities = 69/262 (26%), Positives = 105/262 (40%), Gaps = 63/262 (24%)
Query: 17 ELGRTLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIAT 67
L R LGEG FGKV + AVK L+ T + RE
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-------TLAARKDFQREAEL 70
Query: 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFD---------KIASKGRLQEAEGRK 118
L L+H ++V+ + V + MV EY+ G+L I G+ ++A+G
Sbjct: 71 LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130
Query: 119 LFQQLI-------DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-- 169
Q++ G+ Y ++ HRDL N L+ + +KI DFG+S RD
Sbjct: 131 GLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS------RDVY 184
Query: 170 ---------DGLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-GYLP 216
+L P + PE + R + SD+WS GVIL+ I T G P
Sbjct: 185 STDYYRVGGHTML------P--IRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQP 235
Query: 217 FDDRNLAVLYQKIFRGDFKLPK 238
+ + + + I +G L +
Sbjct: 236 WFQLSNTEVIECITQG-RVLER 256
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 67/265 (25%), Positives = 114/265 (43%), Gaps = 65/265 (24%)
Query: 17 ELGRTLGEGNFGKVKFA-------QDLDSGLPFAVKILEKNRIIHLKITDQIK----REI 65
LG+ LGEG FG+V A + AVK+L+ + T++ E+
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD------ATEKDLSDLVSEM 137
Query: 66 ATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFD--------KIASKGRLQEAEG 116
+K++ KH N++ L +Y+++EY + G L + + +
Sbjct: 138 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197
Query: 117 RKL-FQQLID-------GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168
++ F+ L+ G+ Y ++ HRDL N+L+ +KI+DFGL+ R
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA------R 251
Query: 169 D-----------DGLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-G 213
D +G L P V APE L +R Y SD+WS GV+++ I T G
Sbjct: 252 DINNIDYYKKTTNGRL------P--VKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLG 302
Query: 214 YLPFDDRNLAVLYQKIFRGDFKLPK 238
P+ + L++ + G ++ K
Sbjct: 303 GSPYPGIPVEELFKLLKEG-HRMDK 326
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 61/264 (23%), Positives = 104/264 (39%), Gaps = 69/264 (26%)
Query: 17 ELGRTLGEGNFGKV--KFAQDLDSGLPF---AVKILEKNRIIHLKITDQIK----REIAT 67
E R +GEG FG+V A L PF AVK+L++ + ++ RE A
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE------ASADMQADFQREAAL 103
Query: 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL----------------FDKIASKGRL 111
+ +PN+V+L V A + ++ EY+ G+L ++++ R+
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 112 QEAEGRKL-FQQLI-------DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL 163
L + + G++Y + HRDL N L+ +KI+DFGLS
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS-- 221
Query: 164 PQHFRD-----------DGLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILYV 209
R+ + + P + PE + Y SD+W+ GV+L+
Sbjct: 222 ----RNIYSADYYKADGNDAI------P--IRWMPPESIFYNRYTTE-SDVWAYGVVLWE 268
Query: 210 ILT-GYLPFDDRNLAVLYQKIFRG 232
I + G P+ + + G
Sbjct: 269 IFSYGLQPYYGMAHEEVIYYVRDG 292
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 7e-24
Identities = 68/261 (26%), Positives = 98/261 (37%), Gaps = 62/261 (23%)
Query: 17 ELGRTLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIAT 67
L LGEG FGKV + AVK L++ ++ + RE
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-------SESARQDFQREAEL 96
Query: 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL--------FDKIASKGRLQEAEGRKL 119
L +L+H ++VR V + MV EY+ G+L D G A G
Sbjct: 97 LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156
Query: 120 FQQLI-------DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--- 169
QL+ G+ Y HRDL N L+ +KI DFG+S RD
Sbjct: 157 LGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS------RDIYS 210
Query: 170 --------DGLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 217
+L P + PE + R + SD+WS GV+L+ I T G P+
Sbjct: 211 TDYYRVGGRTML------P--IRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPW 261
Query: 218 DDRNLAVLYQKIFRGDFKLPK 238
+ I +G +L +
Sbjct: 262 YQLSNTEAIDCITQG-RELER 281
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 60/236 (25%), Positives = 99/236 (41%), Gaps = 43/236 (18%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
+ + R +G+G FG+V Q +D+ +AVK++ +N K T K E LK +++
Sbjct: 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV-RN---IKKYTRSAKIEADILKKIQN 90
Query: 74 -----PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDG 126
N+V+ H + ++ E G L++ I + + +++
Sbjct: 91 DDINNNNIVKYHGKFMYYDHMCLIFE-PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKA 149
Query: 127 VSYCHNKGVFHRDLKLENILLDS-------------------------KGNIKISDFGLS 161
++Y + H DLK ENILLD IK+ DFG
Sbjct: 150 LNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG-C 208
Query: 162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 217
A + + + Y APEV+ N G+D + SD+WS G +L + TG L F
Sbjct: 209 ATFKSDY----HGSIINTRQYRAPEVILNLGWDVS-SDMWSFGCVLAELYTGSLLF 259
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 5e-23
Identities = 61/223 (27%), Positives = 98/223 (43%), Gaps = 37/223 (16%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
+G G FGKV + L G A+K ++ + + EI TL +HP++V L
Sbjct: 47 IGHGVFGKV-YKGVLRDGAKVALKRRTPESSQGIE---EFETEIETLSFCRHPHLVSLIG 102
Query: 82 VLASKSKIYMVLEYVTGGE----LFDKIASKG------RLQEAEG--RKLFQQLIDGVSY 129
++++ ++ +Y+ G L+ RL+ G R G+ Y
Sbjct: 103 FCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR--------GLHY 154
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT---CGSPNYVAPE 186
H + + HRD+K NILLD KI+DFG+S + H + G+ Y+ PE
Sbjct: 155 LHTRAIIHRDVKSINILLDENFVPKITDFGISKK---GTELDQTHLSTVVKGTLGYIDPE 211
Query: 187 VLANRGYDGATSDIWSCGVILYVILTG------YLPFDDRNLA 223
+G SD++S GV+L+ +L LP + NLA
Sbjct: 212 -YFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA 253
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 5e-23
Identities = 64/225 (28%), Positives = 91/225 (40%), Gaps = 52/225 (23%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR----EIATLKLLKHPNVV 77
+GEG FG V + ++ AVK L I + ++K+ EI + +H N+V
Sbjct: 39 MGEGGFGVV-YKGYVN-NTTVAVKKLAAMVDITTE---ELKQQFDQEIKVMAKCQHENLV 93
Query: 78 RL--------HEVLASKSKIYMVLEYVTGG----ELFDKIASKG-----RLQEAEG--RK 118
L L +Y Y+ G L + R + A+G
Sbjct: 94 ELLGFSSDGDDLCL-----VY---VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN- 144
Query: 119 LFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT-- 176
G+++ H HRD+K NILLD KISDFGL+ T
Sbjct: 145 -------GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARA---SEKFAQTVMTSR 194
Query: 177 -CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR 220
G+ Y+APE L RG SDI+S GV+L I+TG D+
Sbjct: 195 IVGTTAYMAPEAL--RGEITPKSDIYSFGVVLLEIITGLPAVDEH 237
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 6e-23
Identities = 65/241 (26%), Positives = 99/241 (41%), Gaps = 59/241 (24%)
Query: 17 ELGRTLGEGNFGKVK--FAQDLDSGLPF---AVKILEKNRIIHLKITDQIK----REIAT 67
+LG+ LG G FG+V A +D AVK+L++ T E+
Sbjct: 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG------ATHSEHRALMSELKI 83
Query: 68 LKLL-KHPNVVRLHEV-LASKSKIYMVLEYVTGGELFD--------KIASKGRLQEAEGR 117
L + H NVV L + +++E+ G L + K ++
Sbjct: 84 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143
Query: 118 KL-FQQLID-------GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169
L + LI G+ + ++ HRDL NILL K +KI DFGL+ RD
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA------RD 197
Query: 170 DGLLHTTCGSPNYV------------APEVLANRGYDGATSDIWSCGVILYVILT-GYLP 216
++ P+YV APE + +R Y SD+WS GV+L+ I + G P
Sbjct: 198 ---IYKD---PDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASP 250
Query: 217 F 217
+
Sbjct: 251 Y 251
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 64/242 (26%), Positives = 95/242 (39%), Gaps = 57/242 (23%)
Query: 17 ELGRTLGEGNFGKVKFAQ-----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
E G+ LG G FGKV A + AVK+L++ + + E+ + L
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK--ADSSEREALMSELKMMTQL 105
Query: 72 -KHPNVVRLHEVLASKSKIYMVLEYVTGGEL---------------FDKIASKGRLQEAE 115
H N+V L IY++ EY G+L + K +E +
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 116 GRKL-FQQLI-------DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167
L F+ L+ G+ + K HRDL N+L+ +KI DFGL+
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA------ 219
Query: 168 RDDGLLHTTCGSPNYV------------APEVLANRGYDGATSDIWSCGVILYVILT-GY 214
RD + + NYV APE L Y SD+WS G++L+ I + G
Sbjct: 220 RD---IMSD---SNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGV 272
Query: 215 LP 216
P
Sbjct: 273 NP 274
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 69/238 (28%), Positives = 94/238 (39%), Gaps = 51/238 (21%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPF-AVKILEKNRIIHLKITDQIKREIATLKLLK 72
RYE+ TLGEG FGKV D +G AVKI+ KN + + + EI L+ L
Sbjct: 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV-KN---VDRYCEAARSEIQVLEHLN 69
Query: 73 HP------NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLI 124
V++ E I +V E + G +D I G + RK+ Q+
Sbjct: 70 TTDPNSTFRCVQMLEWFEHHGHICIVFE-LLGLSTYDFIKENGFLPFRLDHIRKMAYQIC 128
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGN-------------------IKISDFGLSALPQ 165
V++ H+ + H DLK ENIL IK+ DFG SA
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG-SATYD 187
Query: 166 HFRDDGLLHTTCGSPNYV------APEVLANRGYDGATSDIWSCGVILYVILTGYLPF 217
H+T V APEV+ G+ D+WS G IL G+ F
Sbjct: 188 DEH-----HST-----LVSTRHYRAPEVILALGWSQP-CDVWSIGCILIEYYLGFTVF 234
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 63/238 (26%), Positives = 91/238 (38%), Gaps = 51/238 (21%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSG-LPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
RYE+ LGEG FGKV D G A+KI+ +N K + + EI LK +K
Sbjct: 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKII-RN---VGKYREAARLEINVLKKIK 74
Query: 73 HP------NVVRLHEVLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLI 124
V + + + + E + G F+ K + R + QL
Sbjct: 75 EKDKENKFLCVLMSDWFNFHGHMCIAFE-LLGKNTFEFLKENNFQPYPLPHVRHMAYQLC 133
Query: 125 DGVSYCHNKGVFHRDLKLENILLDS-------------------KGNIKISDFGLSALPQ 165
+ + H + H DLK ENIL + +I+++DFG SA
Sbjct: 134 HALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG-SATFD 192
Query: 166 HFRDDGLLHTTCGSPNYV------APEVLANRGYDGATSDIWSCGVILYVILTGYLPF 217
H HTT V PEV+ G+ D+WS G IL+ G+ F
Sbjct: 193 HEH-----HTT-----IVATRHYRPPEVILELGWAQP-CDVWSIGCILFEYYRGFTLF 239
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 4e-21
Identities = 64/220 (29%), Positives = 100/220 (45%), Gaps = 34/220 (15%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
LG G FGKV + L G AVK L++ R Q + E+ + + H N++RL
Sbjct: 38 LGRGGFGKVYKGR-LADGTLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRG 94
Query: 82 VLASKSKIYMVLEYVTGG----ELFDKIASKG------RLQEAEG--RKLFQQLIDGVSY 129
+ ++ +V Y+ G L ++ S+ R + A G R G++Y
Sbjct: 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSAR--------GLAY 146
Query: 130 CH---NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT---CGSPNYV 183
H + + HRD+K NILLD + + DFGL+ L D H T G+ ++
Sbjct: 147 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL----MDYKDTHVTTAVRGTIGHI 202
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA 223
APE + G +D++ GV+L ++TG FD LA
Sbjct: 203 APE-YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA 241
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 86.9 bits (215), Expect = 9e-19
Identities = 81/371 (21%), Positives = 117/371 (31%), Gaps = 125/371 (33%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK- 72
GRY + R LG G+F V + D+ A+K+++ T+ EI LK ++
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRN 92
Query: 73 ----HPN---VVRLHEVLASKSK----IYMVLEYVTGGELFDKIAS--KGRLQEAEGRKL 119
PN VV+L + I MV E V G L I L +K+
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCVKKI 151
Query: 120 FQQLIDGVSYCHNK-GVFHRDLKLENILL------------------------------- 147
QQ++ G+ Y H K + H D+K ENILL
Sbjct: 152 IQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211
Query: 148 ------------------DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN-YVAPEVL 188
K +KI+D G + T Y + EVL
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQTRQYRSLEVL 265
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY---------------------- 226
GY+ +DIWS + + + TG F+ +
Sbjct: 266 IGSGYN-TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIV 324
Query: 227 -----QKIF--RGDFKLPKWLSP-------------------GAQNLLRKILEPNPVKRI 260
++ F +GD K L P G + L +LE P KR
Sbjct: 325 AGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRA 384
Query: 261 TIAGIKADEWF 271
T A W
Sbjct: 385 TAAECLRHPWL 395
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 82.4 bits (203), Expect = 4e-17
Identities = 52/223 (23%), Positives = 93/223 (41%), Gaps = 37/223 (16%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK- 72
++ LGR +G G+FG++ ++ + A+K+ E + H Q+ E ++L+
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKH----PQLLYESKIYRILQG 61
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-------LQEAEGRKLFQQLID 125
+ + +V++ + G L D R L A+ Q+I+
Sbjct: 62 GTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLAD------QMIN 114
Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSAL------PQH--FRDDGLLH 174
V + H+K HRD+K +N L+ + I DFGL+ QH +R++
Sbjct: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN---K 171
Query: 175 TTCGSPNYVAPEVLANRGYD-GATSDIWSCGVILYVILTGYLP 216
G+ Y + V + G + D+ S G +L L G LP
Sbjct: 172 NLTGTARYAS--VNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-16
Identities = 60/242 (24%), Positives = 98/242 (40%), Gaps = 44/242 (18%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
+ +G+ +G GNFG+++ ++L + A+K LE + Q+ E K L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRA----PQLHLEYRFYKQLGS 63
Query: 74 -PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRK--------LFQQLI 124
+ +++ MVLE G L D L + R + QLI
Sbjct: 64 GDGIPQVYYFGPCGKYNAMVLEL-LGPSLED-------LFDLCDRTFSLKTVLMIAIQLI 115
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGN-----IKISDFGLS------ALPQH--FRDDG 171
+ Y H+K + +RD+K EN L+ GN I I DF L+ +H +R+
Sbjct: 116 SRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHK 175
Query: 172 LLHTTCGSPNYVAPEVLANRGYD-GATSDIWSCGVILYVILTGYLP---FDDRNLAVLYQ 227
L G+ Y++ + + G + D+ + G + L G LP L YQ
Sbjct: 176 SL---TGTARYMS--INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQ 230
Query: 228 KI 229
KI
Sbjct: 231 KI 232
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 9e-16
Identities = 59/239 (24%), Positives = 95/239 (39%), Gaps = 40/239 (16%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
RY LGR +G G+FG + D+ +G A+K+ E + H Q+ E K+++
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKH----PQLHIESKIYKMMQG 63
Query: 74 -PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-------LQEAEGRKLFQQLID 125
+ + A MV+E + G L D R L A+ Q+I
Sbjct: 64 GVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLAD------QMIS 116
Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDD-GLLHTT----- 176
+ Y H+K HRD+K +N L+ + I DFGL+ + +RD H
Sbjct: 117 RIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA---KKYRDARTHQHIPYRENK 173
Query: 177 --CGSPNYVAPEVLANRGYD-GATSDIWSCGVILYVILTGYLP---FDDRNLAVLYQKI 229
G+ Y + + + G + D+ S G +L G LP Y++I
Sbjct: 174 NLTGTARYAS--INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 230
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 55/242 (22%), Positives = 95/242 (39%), Gaps = 44/242 (18%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
Y++GR +GEG+FG + +L + A+K E R Q++ E T KLL
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDA----PQLRDEYRTYKLLAG 64
Query: 74 -PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRK--------LFQQLI 124
+ ++ +V++ G L D L + GRK +Q++
Sbjct: 65 CTGIPNVYYFGQEGLHNVLVIDL-LGPSLED-------LLDLCGRKFSVKTVAMAAKQML 116
Query: 125 DGVSYCHNKGVFHRDLKLENILL----DSKGN-IKISDFGLS------ALPQH--FRDDG 171
V H K + +RD+K +N L+ N I + DFG+ QH +R+
Sbjct: 117 ARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK- 175
Query: 172 LLHTTCGSPNYVAPEVLANRGYD-GATSDIWSCGVILYVILTGYLP---FDDRNLAVLYQ 227
G+ Y++ + + G + D+ + G + L G LP Y+
Sbjct: 176 --KNLSGTARYMS--INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE 231
Query: 228 KI 229
+I
Sbjct: 232 RI 233
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 69.9 bits (170), Expect = 2e-13
Identities = 38/192 (19%), Positives = 66/192 (34%), Gaps = 48/192 (25%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL-----EKNRIIHLKITDQIKREIATLK 69
+ + +GEG FG+V F Q + P A+KI+ + H K ++I EI K
Sbjct: 21 KLQRCEKIGEGVFGEV-F-QTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78
Query: 70 LL---------KHPNVVRLHEV------------------------------LASKSKIY 90
L + + L+ V +++
Sbjct: 79 ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138
Query: 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDS 149
+VLE+ GG +++ +K A + + QL ++ HRDL N+LL
Sbjct: 139 IVLEFEFGGIDLEQMRTK-LSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKK 197
Query: 150 KGNIKISDFGLS 161
K+
Sbjct: 198 TSLKKLHYTLNG 209
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 31/179 (17%), Positives = 69/179 (38%), Gaps = 29/179 (16%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
++ LG+ +G G FG + A + A +++ + + E+ + +
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN----GPLFSELKFYQRVAK 92
Query: 74 PNVVRLHEVLASKSKI-------------------YMVLEYVTGGELFDKIASKGRLQEA 114
+ ++ + +MV+E + G +L G +++
Sbjct: 93 KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKS 151
Query: 115 EGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK--GNIKISDFGLSALPQHFRDDG 171
+L +++D + Y H H D+K N+LL K + ++D+GLS + +G
Sbjct: 152 TVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLS---YRYCPNG 207
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 8e-12
Identities = 34/207 (16%), Positives = 74/207 (35%), Gaps = 55/207 (26%)
Query: 3 IAEKKQEGMRL-----GRYELGRTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRI 52
+AE+ G + +++G +G+G FG + A + + S P VK+ +
Sbjct: 19 LAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSD-- 76
Query: 53 IHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI-------------------YMVL 93
+ E+ + P ++ + +M++
Sbjct: 77 -----NGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIM 131
Query: 94 EYVTGGELFDKIASKGR-------LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENIL 146
+ G +L + + LQ + +++D + Y H H D+K N+L
Sbjct: 132 DRF-GSDLQKIYEANAKRFSRKTVLQLSL------RILDILEYIHEHEYVHGDIKASNLL 184
Query: 147 LDSK--GNIKISDFGLSALPQHFRDDG 171
L+ K + + D+GL+ + +G
Sbjct: 185 LNYKNPDQVYLVDYGLA---YRYCPEG 208
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 36/258 (13%), Positives = 84/258 (32%), Gaps = 58/258 (22%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGL--------PFAVKILEKNRIIHLKI-------- 57
+++L N G + A + F++K+ K+ + +
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 58 TDQIKREIATLKLLKHPNVVRLHEVLASKSKI-YMVLEYVTGGELFDKIASKGRLQEAEG 116
Q+ + L + + K ++VL + G L +
Sbjct: 102 PLQVNKWK-KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQS-------ALDVSP 152
Query: 117 RKLF---------QQLIDGVSYCHNKGVFHRDLKLENILL--DSKGNIKISDFGLSALPQ 165
+ + +L+D + + H H ++ ENI + + + + ++ +G +
Sbjct: 153 KHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFA---F 209
Query: 166 HFRDDG----------LLHTTCGSPNYVAPEVLANRGYDGA-TSDIWSCGVILYVILTGY 214
+ G H G +++ + ++G + SD+ S G + L G+
Sbjct: 210 RYCPSGKHVAYVEGSRSPHE--GDLEFIS--MDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265
Query: 215 LP---FDDRNLAVLYQKI 229
LP ++ QK
Sbjct: 266 LPWTNCLPNTEDIMKQKQ 283
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 37/108 (34%), Positives = 51/108 (47%), Gaps = 26/108 (24%)
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
Q+ G+ + ++ HRDL NILL K +KI DFGL+ RD P+
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA------RD------IYKDPD 248
Query: 182 YV------------APEVLANRGYDGATSDIWSCGVILYVILT-GYLP 216
YV APE + +R Y SD+WS GV+L+ I + G P
Sbjct: 249 YVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASP 295
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 4e-07
Identities = 32/171 (18%), Positives = 52/171 (30%), Gaps = 13/171 (7%)
Query: 17 ELGRTLGEGNFGKVKFAQ-----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
+LG+ LG G FG+V A + AVK+L + E+ L +
Sbjct: 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHI 82
Query: 72 -KHPNVVRLH-EVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
H NVV L + +++E+ G L + R + E +
Sbjct: 83 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----RSKRNEFVPYKTKGARFRQG 138
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
G DLK + S + S F ++
Sbjct: 139 KDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDF 189
|
| >3ose_A Serine/threonine-protein kinase MARK1; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.70A {Homo sapiens} PDB: 1ul7_A Length = 120 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 2e-06
Identities = 21/115 (18%), Positives = 44/115 (38%), Gaps = 17/115 (14%)
Query: 332 EKEDVSERKIRF------TSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKS 385
E +D R +RF TS+ D++ I ++ ++K L ++
Sbjct: 16 EGKDSKPRSLRFTWSMKTTSSMDPNDMMREIRKVLDANNCDYEQKERFLLFCVHGDARQD 75
Query: 386 LGSLSVAAEVFEIS-PSLYVVELRKSYGDPTVYRQIKTSIVFVQLCNKLSSDLGL 439
+ EV ++ SL V ++ G ++ I +K++++L L
Sbjct: 76 -SLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNI---------ASKIANELKL 120
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.0 bits (108), Expect = 2e-05
Identities = 64/415 (15%), Positives = 117/415 (28%), Gaps = 152/415 (36%)
Query: 2 VIAEKKQEGMRLGRYELGRTLGEGN--FGKV--KFAQDL----DSGLPFAVKILEKNRII 53
++ + L + + T E K QDL + P + I
Sbjct: 280 FLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSI------- 332
Query: 54 HLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQE 113
I + I+ +AT KH N +L ++ S L L+
Sbjct: 333 ---IAESIRDGLATWDNWKHVNCDKLTTIIESS------LNV---------------LEP 368
Query: 114 AEGRKLFQQL--------I------------------DGVSYCHNKGVFHRDLK-----L 142
AE RK+F +L I V+ H + + K +
Sbjct: 369 AEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISI 428
Query: 143 ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG-ATSDIW 201
+I L+ K ++ LH + +Y P + +D +
Sbjct: 429 PSIYLELK--------------VKLENEYALHRSIVD-HYNIP-----KTFDSDDLIPPY 468
Query: 202 SCGVILYVILTGY-LPFDDR-NLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 259
I G+ L + L++ +F DF ++L +KI
Sbjct: 469 LDQYFYSHI--GHHLKNIEHPERMTLFRMVFL-DF---RFLE-------QKI-------- 507
Query: 260 ITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLI 319
D T N + + + + +D +L+
Sbjct: 508 ------------RHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYE----------RLV 545
Query: 320 GMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERI----EDIVTEMGFR-VQK 369
+ F K + E I S ++ DLL ++ + E + VQ+
Sbjct: 546 N-----AILDFLPK--IEENLIC--SKYT--DLLRIALMAEDEAIFEEAHKQVQR 589
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 8e-05
Identities = 79/500 (15%), Positives = 153/500 (30%), Gaps = 122/500 (24%)
Query: 2 VIAEKKQEGMRLGRYEL----GRTL-GEGNFGK------VKFAQDLDSGLPFAV------ 44
V + +R EL + G GK V + + + F +
Sbjct: 131 VSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLK 190
Query: 45 ------KILEKNRIIHLKIT---DQIKREIATLKLLKHPNVVRLHEVLASKS--KIYMVL 93
+LE + + +I + +KL H L +L SK +VL
Sbjct: 191 NCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVL 250
Query: 94 EYVTGGEL---FD---KIASKGRLQEAEGRKLFQQLIDG----VSYCHNKGVFHRDLKLE 143
V + F+ KI L +++ L +S H+ D
Sbjct: 251 LNVQNAKAWNAFNLSCKI-----LLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKS 305
Query: 144 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC-GSPNYVAPEVLANRGYDG-ATSDIW 201
LL + + D LP +P ++ ++A DG AT D W
Sbjct: 306 --LLLKYLDCRPQD-----LP---------REVLTTNPRRLS--IIAESIRDGLATWDNW 347
Query: 202 ---SCGVILYVILTGYLPFDDRNLAVLYQK--IFRGDFKLPK------WLSPGAQ----- 245
+C + +I + + ++ + +F +P W
Sbjct: 348 KHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVV 407
Query: 246 -NLLRK--ILEPNPVK-RITIAGIKADEWFEQDYTPANPDDDE-EDIFVDNEAFSMHEVP 300
N L K ++E P + I+I I + ++ VD +++ +
Sbjct: 408 VNKLHKYSLVEKQPKESTISIPSI------YLELKVKLENEYALHRSIVD--HYNIPKTF 459
Query: 301 SDGGRTPGSPPLIN-AFQLIG--MSSC--LDLSGFFEKE--DVS--ERKIRFTSNHSAKD 351
P P L + IG + + + F D E+KIR S +A +
Sbjct: 460 DSDDLIP--PYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDS--TAWN 515
Query: 352 LLERIEDIVTEMGFRVQKKNGKLKATQEHKPQ-----KSLGS-LSVAAEVFEISPSLYVV 405
I + + + + K ++ P+ ++ L E S ++
Sbjct: 516 ASGSILNTLQQ--LKFYKPY-----ICDNDPKYERLVNAILDFLPKIEENLICSKYTDLL 568
Query: 406 ELRKSYGDPTVY----RQIK 421
+ D ++ +Q++
Sbjct: 569 RIALMAEDEAIFEEAHKQVQ 588
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 40.3 bits (94), Expect = 7e-04
Identities = 28/166 (16%), Positives = 63/166 (37%), Gaps = 28/166 (16%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI-------------- 61
+G+ +GEG V + VK + K+ ++
Sbjct: 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 150
Query: 62 -KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
+ E L+ L+ V +++ +++E + EL+ R++ + ++
Sbjct: 151 ARNEFRALQKLQGLAVPKVYAW----EGNAVLMELIDAKELYRV-----RVENPD--EVL 199
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166
+++ V+ +++G+ H DL N+L+ + I I DF S
Sbjct: 200 DMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGE 244
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 450 | |||
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 2ehb_D | 143 | CBL-interacting serine/threonine-protein kinase 2; | 99.97 | |
| 2zfd_B | 123 | Putative uncharacterized protein T20L15_90; calciu | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.94 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.88 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.8 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.48 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.35 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.25 | |
| 3ose_A | 120 | Serine/threonine-protein kinase MARK1; kinase asso | 99.19 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.18 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.91 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.75 | |
| 1v5s_A | 126 | MAP/microtubule affinity-regulating kinase 3; Ka1 | 98.72 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.67 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.58 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.45 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.43 | |
| 4eai_A | 106 | 5'-AMP-activated protein kinase catalytic subunit | 98.38 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.33 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.26 | |
| 2v8q_A | 157 | 5'-AMP-activated protein kinase catalytic subunit; | 98.1 | |
| 2y8l_A | 173 | 5'-AMP-activated protein kinase catalytic subunit; | 98.06 | |
| 4eag_A | 130 | EG:132E8.2 protein; AMPK, transferase; HET: ATP TA | 98.05 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.94 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.87 | |
| 2qrd_A | 137 | SNF1-like protein kinase SSP2; AMPK, ADP, ATP-bind | 97.84 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.83 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.76 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.58 | |
| 3t4n_A | 179 | Carbon catabolite-derepressing protein kinase; CBS | 97.53 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.52 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.51 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.44 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.42 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.25 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.22 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.16 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.02 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.41 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.63 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.72 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 89.17 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 85.01 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 84.7 |
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-69 Score=518.91 Aligned_cols=265 Identities=48% Similarity=0.909 Sum_probs=225.1
Q ss_pred cccCCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 013081 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (450)
Q Consensus 6 ~~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 85 (450)
.-..|..+|+|++++.||+|+||+||+|+++.+|+.||||++++..........++.+|+.+|++++||||+++++++.+
T Consensus 5 ~l~~G~~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~ 84 (275)
T 3hyh_A 5 SLADGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS 84 (275)
T ss_dssp ---------CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCCCCEeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 34456788999999999999999999999999999999999988766655567789999999999999999999999999
Q ss_pred CCEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCC
Q 013081 86 KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (450)
Q Consensus 86 ~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 165 (450)
++.+|+||||| +|+|.+++.+++++++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+...
T Consensus 85 ~~~~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 85 KDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT 163 (275)
T ss_dssp SSEEEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred CCEEEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecC
Confidence 99999999999 78999999999999999999999999999999999999999999999999999999999999998543
Q ss_pred cccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHH
Q 013081 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQ 245 (450)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 245 (450)
......+.+||+.|+|||++.+..|++.++||||+||++|+|+||+.||.+.+...+++++..+.+++|+++|++++
T Consensus 164 ---~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 240 (275)
T 3hyh_A 164 ---DGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAA 240 (275)
T ss_dssp --------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHH
T ss_pred ---CCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 23345678999999999999998888889999999999999999999999999999999999999999999999999
Q ss_pred HHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 246 NLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 246 ~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
+||.+||++||++|||++|+++||||+.+
T Consensus 241 ~li~~~L~~dP~~R~s~~eil~hpw~k~~ 269 (275)
T 3hyh_A 241 GLIKRMLIVNPLNRISIHEIMQDDWFKVD 269 (275)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHHCHHHHTT
T ss_pred HHHHHHccCChhHCcCHHHHHcCcccccC
Confidence 99999999999999999999999999854
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-69 Score=525.80 Aligned_cols=263 Identities=32% Similarity=0.591 Sum_probs=244.0
Q ss_pred CcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (450)
....++|++++.||+|+||+||+|+++.+|+.||||++++....+....+.+.+|+++|++++|||||++++++.+++.+
T Consensus 28 ~~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 107 (311)
T 4aw0_A 28 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 107 (311)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 34567899999999999999999999999999999999876655445568899999999999999999999999999999
Q ss_pred EEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC
Q 013081 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 169 (450)
|+|||||+||+|++++.+.+++++.+++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.......
T Consensus 108 yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 108 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999986544334
Q ss_pred CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q 013081 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLR 249 (450)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~ 249 (450)
.....+.||||.|+|||++.+.+| +.++|||||||++|+|++|++||.+.+...++.++.++.+.+|+.+|+++++||.
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~ 266 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVE 266 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCB-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHH
T ss_pred cccccCcccCcccCCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHH
Confidence 445678899999999999998877 5899999999999999999999999999999999999999999999999999999
Q ss_pred HccccCcCCCCCHHH------HHhcccccc
Q 013081 250 KILEPNPVKRITIAG------IKADEWFEQ 273 (450)
Q Consensus 250 ~~L~~dP~~R~t~~~------il~h~~~~~ 273 (450)
+||++||++|||++| |++||||+.
T Consensus 267 ~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~ 296 (311)
T 4aw0_A 267 KLLVLDATKRLGCEEMEGYGPLKAHPFFES 296 (311)
T ss_dssp HHSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred HHccCCHhHCcChHHHcCCHHHHCCCCcCC
Confidence 999999999999987 589999974
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-66 Score=515.30 Aligned_cols=260 Identities=28% Similarity=0.561 Sum_probs=230.1
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
.+++|++++.||+|+||+||+|+++.+|+.||||++++.... ....+.+.+|+.+|++|+|||||++++++.+++.+|+
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi 100 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS-SKEREESRREVAVLANMKHPNIVQYRESFEENGSLYI 100 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCC-HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 467999999999999999999999999999999999876543 3446789999999999999999999999999999999
Q ss_pred EEccCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC
Q 013081 92 VLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 169 (450)
|||||+||+|+++|... ..+++.+++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... .
T Consensus 101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~ 178 (350)
T 4b9d_A 101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--T 178 (350)
T ss_dssp EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH--H
T ss_pred EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecC--C
Confidence 99999999999999754 3579999999999999999999999999999999999999999999999999986532 1
Q ss_pred CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCC-CCCCCCCHHHHHHH
Q 013081 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLL 248 (450)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li 248 (450)
.....+.|||+.|+|||++.+.+| +.++|||||||++|+|+||+.||.+.+...++.++..+.+ +.+..+|+++.+||
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y-~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li 257 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPY-NNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLV 257 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHH
T ss_pred cccccccCCCccccCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHH
Confidence 123456789999999999988877 5899999999999999999999999999999999998865 46677999999999
Q ss_pred HHccccCcCCCCCHHHHHhccccccCC
Q 013081 249 RKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 249 ~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
.+||++||++|||++|+|+||||.+..
T Consensus 258 ~~~L~~dP~~R~s~~e~l~hp~~~~~~ 284 (350)
T 4b9d_A 258 SQLFKRNPRDRPSVNSILEKGFIAKRI 284 (350)
T ss_dssp HHHTCSSGGGSCCHHHHHTSHHHHTTG
T ss_pred HHHccCChhHCcCHHHHhcCHHhhcCC
Confidence 999999999999999999999998643
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-65 Score=507.27 Aligned_cols=256 Identities=26% Similarity=0.425 Sum_probs=231.4
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 92 (450)
-..|++++.||+|+||+||+|+++.+|+.||||++++..... .+.+.+|+.+|+.++|||||++++++.+++.+|+|
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv 149 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 149 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 457999999999999999999999999999999998665433 35688999999999999999999999999999999
Q ss_pred EccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCc
Q 013081 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 172 (450)
||||+||+|.+++.+ +++++.+++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... ....
T Consensus 150 mEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~~~~ 226 (346)
T 4fih_A 150 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPR 226 (346)
T ss_dssp ECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--SSCC
T ss_pred EeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCC--CCCc
Confidence 999999999998875 6799999999999999999999999999999999999999999999999999985432 2334
Q ss_pred cccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCC---CCCCCCCHHHHHHHH
Q 013081 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---KLPKWLSPGAQNLLR 249 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~Li~ 249 (450)
..+.|||+.|+|||++.+.+| +.++|||||||++|+|++|++||.+.+....+..+..... +.+..+|+++.+||.
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~ 305 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD 305 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHH
T ss_pred ccccccCcCcCCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHH
Confidence 567899999999999988887 5899999999999999999999999999888888877633 233458999999999
Q ss_pred HccccCcCCCCCHHHHHhccccccCC
Q 013081 250 KILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 250 ~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
+||++||++|||++|+|+||||++..
T Consensus 306 ~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 306 RLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp HHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 99999999999999999999998754
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-66 Score=503.97 Aligned_cols=257 Identities=34% Similarity=0.641 Sum_probs=228.3
Q ss_pred cCCeEEeeeecccCceEEEEEEEC---CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (450)
.++|++++.||+|+||+||+|++. .+++.||||++++....... ..++.+|+.+|++++|||||++++++.+++.+
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIVKLHYAFQTEGKL 101 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-CC------CCCCCCCCTTEECEEEEEEETTEE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-HHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 468999999999999999999984 46889999999875543222 34688999999999999999999999999999
Q ss_pred EEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC
Q 013081 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 169 (450)
|+|||||+||+|++++.+.+++++.+++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... .
T Consensus 102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~ 179 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID--H 179 (304)
T ss_dssp EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC------
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC--C
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999985322 2
Q ss_pred CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q 013081 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLR 249 (450)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~ 249 (450)
.....+.|||+.|+|||++.+.+|+ .++||||+||++|+|+||++||.+.+..+++.++.++.+++|+.+|+++.+||.
T Consensus 180 ~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 258 (304)
T 3ubd_A 180 EKKAYSFCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLR 258 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred CccccccccCcccCCHHHhccCCCC-CCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHHH
Confidence 3345678999999999999888775 899999999999999999999999999999999999999999999999999999
Q ss_pred HccccCcCCCCC-----HHHHHhcccccc
Q 013081 250 KILEPNPVKRIT-----IAGIKADEWFEQ 273 (450)
Q Consensus 250 ~~L~~dP~~R~t-----~~~il~h~~~~~ 273 (450)
+||++||++||| ++|+++||||+.
T Consensus 259 ~~L~~dP~~R~ta~~~~~~eil~Hp~f~~ 287 (304)
T 3ubd_A 259 MLFKRNPANRLGAGPDGVEEIKRHSFFST 287 (304)
T ss_dssp HHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred HHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence 999999999998 589999999974
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-63 Score=507.90 Aligned_cols=257 Identities=26% Similarity=0.429 Sum_probs=232.3
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
.-++|++++.||+|+||.||+|+++.+|+.||||+++...... .+.+.+|+.+|+.++|||||++++++.+.+.+||
T Consensus 149 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~i 225 (423)
T 4fie_A 149 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV 225 (423)
T ss_dssp GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEE
Confidence 3467999999999999999999999999999999998664433 3568899999999999999999999999999999
Q ss_pred EEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCC
Q 013081 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 171 (450)
|||||+||+|.+++.. +++++.+++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.... ...
T Consensus 226 VmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~--~~~ 302 (423)
T 4fie_A 226 VMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVP 302 (423)
T ss_dssp EEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCS--SCC
T ss_pred EEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCC--CCc
Confidence 9999999999998865 6799999999999999999999999999999999999999999999999999985432 233
Q ss_pred ccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC---CCCCCCCCHHHHHHH
Q 013081 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGAQNLL 248 (450)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~Li 248 (450)
...+.|||+.|||||++.+..| +.++|||||||++|+|++|++||.+.+....+..+.... ...+..+|+++++||
T Consensus 303 ~~~~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli 381 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFL 381 (423)
T ss_dssp CBCCCEECTTTCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHH
T ss_pred cccccccCcCcCCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHH
Confidence 4567899999999999988887 589999999999999999999999999988888887763 334456899999999
Q ss_pred HHccccCcCCCCCHHHHHhccccccCC
Q 013081 249 RKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 249 ~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
.+||++||++|||+.|+|+||||++..
T Consensus 382 ~~~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 382 DRLLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp HHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence 999999999999999999999998754
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-63 Score=485.76 Aligned_cols=255 Identities=25% Similarity=0.477 Sum_probs=222.8
Q ss_pred cCCe-EEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe----CC
Q 013081 13 LGRY-ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS----KS 87 (450)
Q Consensus 13 ~~~y-~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~ 87 (450)
-|+| ++.+.||+|+||+||+|.+..+++.||+|.+.+.... ....+.+.+|+.+|++|+|||||++++++.+ +.
T Consensus 24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~ 102 (290)
T 3fpq_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEE
T ss_pred CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCc
Confidence 4677 7888999999999999999999999999999865543 3346789999999999999999999999865 35
Q ss_pred EEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcC--eeeccCCCCcEEEcc-CCCeEEeecCCCCCC
Q 013081 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLDS-KGNIKISDFGLSALP 164 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlKp~NILl~~-~g~lkl~DFGla~~~ 164 (450)
.+|+|||||+||+|.+++.+.+++++..++.|+.||+.||+|||++| |+||||||+|||++. +|++||+|||+|+..
T Consensus 103 ~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 68999999999999999999899999999999999999999999998 999999999999984 799999999999853
Q ss_pred CcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCC-cHHHHHHHHHhCCC--CCCCCCC
Q 013081 165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR-NLAVLYQKIFRGDF--KLPKWLS 241 (450)
Q Consensus 165 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~-~~~~~~~~i~~~~~--~~p~~~s 241 (450)
......+.||||.|||||++.+ +| +.++|||||||++|+|+||+.||.+. +...++..+..+.. .++..++
T Consensus 183 ----~~~~~~~~~GTp~YmAPE~~~~-~y-~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~ 256 (290)
T 3fpq_A 183 ----RASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 256 (290)
T ss_dssp ----CTTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCC
T ss_pred ----CCCccCCcccCccccCHHHcCC-CC-CcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCC
Confidence 3345667899999999999864 56 58999999999999999999999765 45566666666543 3456689
Q ss_pred HHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 242 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 242 ~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
+++.+||.+||++||++|||++|+++||||++.
T Consensus 257 ~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~~ 289 (290)
T 3fpq_A 257 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 999999999999999999999999999999863
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-61 Score=503.34 Aligned_cols=406 Identities=37% Similarity=0.654 Sum_probs=313.4
Q ss_pred cccCCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 013081 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (450)
Q Consensus 6 ~~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 85 (450)
.......+++|.+++.||+|+||.||+|.+..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+
T Consensus 8 ~~~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~ 87 (476)
T 2y94_A 8 KHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST 87 (476)
T ss_dssp -CCSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccCCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 44566788999999999999999999999999999999999986544333446789999999999999999999999999
Q ss_pred CCEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCC
Q 013081 86 KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (450)
Q Consensus 86 ~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 165 (450)
....|+||||++||+|.+++...+++++.+++.++.||+.||+|||++||+||||||+|||++.++++||+|||++....
T Consensus 88 ~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 88 PSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp SSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 99999999999999999999988899999999999999999999999999999999999999999999999999998543
Q ss_pred cccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHH
Q 013081 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQ 245 (450)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 245 (450)
......+.+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+....+.++..+.+..|..+++++.
T Consensus 168 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 244 (476)
T 2y94_A 168 ---DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVI 244 (476)
T ss_dssp ---TTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHH
T ss_pred ---ccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHH
Confidence 23345677999999999999888887889999999999999999999999999999999999999999999999999
Q ss_pred HHHHHccccCcCCCCCHHHHHhccccccCCCCCC----CCCCcc--cc-----ccccccccccc--------CCCC----
Q 013081 246 NLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN----PDDDEE--DI-----FVDNEAFSMHE--------VPSD---- 302 (450)
Q Consensus 246 ~Li~~~L~~dP~~R~t~~~il~h~~~~~~~~~~~----~~~~~~--~~-----~~~~~~~~~~~--------~~~~---- 302 (450)
+||++||+.||.+|||+.++++||||.+...... +..... +. ..........+ .+.+
T Consensus 245 ~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 324 (476)
T 2y94_A 245 SLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLYNRNHQDPLAV 324 (476)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTCHHHHTTCCTTTTTSSSCSSCSHHHHHHHHSCCCC-----------------------
T ss_pred HHHHHHcCCCchhCcCHHHHHhCHHhhhcCccccCCCCcccccccCCHHHHHHHHHHcCCCHHHHHHHHhCCCCCCHHHH
Confidence 9999999999999999999999999986532211 100000 00 00000000000 0000
Q ss_pred -------CCCC------------------------CCCCCcchhhhh-hhccccccCCCCc----c--ccccccccccee
Q 013081 303 -------GGRT------------------------PGSPPLINAFQL-IGMSSCLDLSGFF----E--KEDVSERKIRFT 344 (450)
Q Consensus 303 -------~~~~------------------------~~~~~~~~~~~~-i~~s~~~~~~~~~----~--~~~~~~~~~rf~ 344 (450)
.... ...|... .+.. .+.+....+..+. . .....++.+++.
T Consensus 325 ~y~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~lgi~ 403 (476)
T 2y94_A 325 AYHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERV-PFLVAETPRARHTLDELNPQKSKHQGVRKAKWHLGIR 403 (476)
T ss_dssp --------CCTTCCSSHHHHHHHHHHSCGGGTSCCCCSSCTT-TTCSCCCCCCSTTCTTTSSSTTTCSCCCCCCEEESEE
T ss_pred HHHHHHhchhhhhhhhccccccCCccccccccccccCCcccC-CcccccCCcccccccccccccccccccccceeeecCc
Confidence 0000 0000000 0000 0000000000000 0 012246788999
Q ss_pred cccCHHHHHHHHHHHHHhcCcEEEEe-CCeEEEEeecCCCCcCCceEEEEEEEEEcCCeEEEEEEeccCCccee
Q 013081 345 SNHSAKDLLERIEDIVTEMGFRVQKK-NGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVY 417 (450)
Q Consensus 345 s~~~~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~~~~~~Gd~le~ 417 (450)
|+..|.+|+..+..+++.+|+.|++. .+.|++........ ..+.|.+++|+++++.+||||++..|+.++|
T Consensus 404 s~~~p~~im~ev~~al~~lg~~Wk~~~~~~i~~r~~~~~~~--~~~k~~lqly~~~~~~~llDf~~~~~~~~~~ 475 (476)
T 2y94_A 404 SQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTS--TFSKMSLQLYQVDSRTYLLDFRSIDDEILEV 475 (476)
T ss_dssp ECSCHHHHHHHHHHHHHTTTCBCCEEETTEEEEEEECTTTC--CEEEEEEEEEECSSSCEEEEEEEECCC----
T ss_pred cCCCHHHHHHHHHHHHHHcCCeeccCCCEEEEEEECCCCCC--ceEEEEEEEEEecCCcEEEEeeecCCCcccc
Confidence 99999999999999999999999875 68888854433222 5678999999999999999999999999887
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-63 Score=489.49 Aligned_cols=255 Identities=24% Similarity=0.356 Sum_probs=224.5
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
.++.|++.+.||+|+||+||+|+++.+|+.||||+++++.. ..+|+.+|+.++|||||++++++.+++.+||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~i 127 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNI 127 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45679999999999999999999999999999999986543 2469999999999999999999999999999
Q ss_pred EEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCC-CeEEeecCCCCCCCcccCC
Q 013081 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLSALPQHFRDD 170 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g-~lkl~DFGla~~~~~~~~~ 170 (450)
|||||+||+|.+++.+.+++++.+++.|+.||+.||+|||++||+||||||+||||+.+| .+||+|||+|+........
T Consensus 128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 999999999999999999999999999999999999999999999999999999999998 5999999999865332111
Q ss_pred ---CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCC---CCCCCCCHHH
Q 013081 171 ---GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---KLPKWLSPGA 244 (450)
Q Consensus 171 ---~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~ 244 (450)
......|||+.|||||++.+.+| +.++|||||||++|+|+||++||.+.+...+..++..... .+|+.+|+.+
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~ 286 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPC-DAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLT 286 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHH
T ss_pred cceecCCccccCccccCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHH
Confidence 12234689999999999998877 4899999999999999999999998887777788877754 3577899999
Q ss_pred HHHHHHccccCcCCCCCHHHH-------------HhccccccCC
Q 013081 245 QNLLRKILEPNPVKRITIAGI-------------KADEWFEQDY 275 (450)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~~i-------------l~h~~~~~~~ 275 (450)
.+||.+||++||.+|||+.|+ ++|||+.+..
T Consensus 287 ~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~ 330 (336)
T 4g3f_A 287 AQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK 330 (336)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred HHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence 999999999999999999997 5688886543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-61 Score=488.23 Aligned_cols=260 Identities=26% Similarity=0.356 Sum_probs=226.3
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe------CC
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS------KS 87 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------~~ 87 (450)
++|++++.||+|+||+||+|+++.+|+.||||++++... .....+++.+|+.+|+.++|||||++++++.. .+
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 479999999999999999999999999999999976543 33446788899999999999999999999754 36
Q ss_pred EEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcc
Q 013081 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 167 (450)
.+|+|||||. |+|++++.+.+++++.+++.|++||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~ 211 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS 211 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence 7899999995 689999999899999999999999999999999999999999999999999999999999999864321
Q ss_pred --cCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCC---------
Q 013081 168 --RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL--------- 236 (450)
Q Consensus 168 --~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~--------- 236 (450)
.......+.|||+.|+|||++.+..+++.++||||+||++|+|++|++||.+.+....+..+.......
T Consensus 212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~ 291 (398)
T 4b99_A 212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVG 291 (398)
T ss_dssp ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC---
T ss_pred ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhh
Confidence 123345678999999999999887777899999999999999999999999999888887775431111
Q ss_pred ----------------------CCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCC
Q 013081 237 ----------------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 237 ----------------------p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
.+.+|+++.+||.+||++||.+|||+.|+|+||||++..
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 292 AERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp --CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred hhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 123689999999999999999999999999999998643
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-60 Score=504.49 Aligned_cols=261 Identities=27% Similarity=0.445 Sum_probs=232.1
Q ss_pred CCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHH---HHHHHHHHHHHhCCCCCcceEEEEEEe
Q 013081 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT---DQIKREIATLKLLKHPNVVRLHEVLAS 85 (450)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~---~~~~~Ei~il~~l~hpnIv~l~~~~~~ 85 (450)
....+++|++++.||+|+||+||+|+++.+|+.||||++++......... ...++++.+++.++|||||++++++.+
T Consensus 184 ~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~ 263 (689)
T 3v5w_A 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT 263 (689)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred CCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE
Confidence 45778999999999999999999999999999999999987654322222 333445677788899999999999999
Q ss_pred CCEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCC
Q 013081 86 KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (450)
Q Consensus 86 ~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 165 (450)
.+.+|+|||||+||+|+++|.+.+.+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+...
T Consensus 264 ~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 264 PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999998543
Q ss_pred cccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCC---cHHHHHHHHHhCCCCCCCCCCH
Q 013081 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR---NLAVLYQKIFRGDFKLPKWLSP 242 (450)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~---~~~~~~~~i~~~~~~~p~~~s~ 242 (450)
.....+.||||.|+|||++.+...++.++|||||||++|+|++|++||.+. +...+...+......+|..+|+
T Consensus 344 ----~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~ 419 (689)
T 3v5w_A 344 ----KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 419 (689)
T ss_dssp ----SCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred ----CCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCH
Confidence 234567899999999999976544469999999999999999999999764 3456777888889999999999
Q ss_pred HHHHHHHHccccCcCCCCC-----HHHHHhcccccc
Q 013081 243 GAQNLLRKILEPNPVKRIT-----IAGIKADEWFEQ 273 (450)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t-----~~~il~h~~~~~ 273 (450)
++++||.+||++||.+|++ ++||++||||+.
T Consensus 420 ~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~ 455 (689)
T 3v5w_A 420 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455 (689)
T ss_dssp HHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred HHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence 9999999999999999998 799999999974
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-60 Score=463.35 Aligned_cols=256 Identities=25% Similarity=0.428 Sum_probs=204.1
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS----- 87 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----- 87 (450)
+++|++++.||+|+||+||+|+++.+|+.||||+++... .....+++.+|+.+|++|+|||||++++++.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 81 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL 81 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence 567999999999999999999999999999999997654 3334578999999999999999999999986544
Q ss_pred -------EEEEEEccCCCCChHHHHHhcCCC---CHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEee
Q 013081 88 -------KIYMVLEYVTGGELFDKIASKGRL---QEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISD 157 (450)
Q Consensus 88 -------~~~lv~E~~~gg~L~~~i~~~~~l---~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~D 157 (450)
.+|+|||||+||+|.+++...+.+ ++..++.|+.||++||+|||++||+||||||+|||++.+|.+||+|
T Consensus 82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEcc
Confidence 379999999999999999876653 4567899999999999999999999999999999999999999999
Q ss_pred cCCCCCCCcccCC----------CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHH-HHH
Q 013081 158 FGLSALPQHFRDD----------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLY 226 (450)
Q Consensus 158 FGla~~~~~~~~~----------~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-~~~ 226 (450)
||+|+........ ....+.|||+.|||||++.+.+| +.++|||||||++|||++ ||...... ...
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y-~~~~DiwSlGvilyell~---Pf~~~~~~~~~~ 237 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSY-SHKVDIFSLGLILFELLY---PFSTQMERVRTL 237 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCC-CTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCC-CCHHHHHHHHHHHHHHcc---CCCCccHHHHHH
Confidence 9999865432111 12345689999999999988777 589999999999999996 88754322 233
Q ss_pred HHHHhCCCC-CCCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 227 QKIFRGDFK-LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 227 ~~i~~~~~~-~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
..+....++ .+...++.+.+||.+||++||.+|||+.|+++||||++-
T Consensus 238 ~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~ 286 (299)
T 4g31_A 238 TDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286 (299)
T ss_dssp HHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred HHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence 333333322 112356788999999999999999999999999999753
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-60 Score=461.82 Aligned_cols=257 Identities=27% Similarity=0.394 Sum_probs=223.3
Q ss_pred cccCCeEEeeeecccCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 85 (450)
..-.+|.+.+.||+|+||+||+|++. .+++.||||+++.. .....+.+.+|+++|++++|||||++++++.+
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 86 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVE 86 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence 34468999999999999999999875 35789999999754 33446789999999999999999999999999
Q ss_pred CCEEEEEEccCCCCChHHHHHhc-------------CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCC
Q 013081 86 KSKIYMVLEYVTGGELFDKIASK-------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN 152 (450)
Q Consensus 86 ~~~~~lv~E~~~gg~L~~~i~~~-------------~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~ 152 (450)
.+.+|+|||||+||+|.+++... ..+++.++..++.||++||+|||+++|+||||||+|||++.+++
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL 166 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc
Confidence 99999999999999999999764 36999999999999999999999999999999999999999999
Q ss_pred eEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHh
Q 013081 153 IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFR 231 (450)
Q Consensus 153 lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~ 231 (450)
+||+|||+|+..............+||+.|+|||++.+..| +.++|||||||++|||+| |+.||.+.+..++...+..
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~-~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~ 245 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 245 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 99999999985433222222334679999999999988877 599999999999999999 9999999999888888888
Q ss_pred CC-CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhcccccc
Q 013081 232 GD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 232 ~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
+. .+.|..+|+++.+|+.+||+.||++|||+.++ ++|+++
T Consensus 246 ~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~ 286 (299)
T 4asz_A 246 GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQN 286 (299)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHH
T ss_pred CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHH
Confidence 74 57788899999999999999999999999999 457653
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-59 Score=465.76 Aligned_cols=253 Identities=25% Similarity=0.401 Sum_probs=209.1
Q ss_pred cCCeEEeeeecccCceEEEEEEEC---CCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSK 88 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 88 (450)
-++|++++.||+|+||+||+|+++ .+++.||+|.+.+.. ...++.+|+++|+.+ +||||+++++++.+.+.
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 368999999999999999999875 467899999986543 135688999999998 69999999999999999
Q ss_pred EEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccC-CCeEEeecCCCCCCCcc
Q 013081 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGLSALPQHF 167 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~-g~lkl~DFGla~~~~~~ 167 (450)
+|+|||||+||+|.+++. .+++.+++.|++||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 95 ~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~ 171 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT 171 (361)
T ss_dssp EEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred EEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence 999999999999999984 59999999999999999999999999999999999999877 79999999999743211
Q ss_pred c--------------------------CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCC-
Q 013081 168 R--------------------------DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR- 220 (450)
Q Consensus 168 ~--------------------------~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~- 220 (450)
. ......+.|||+.|+|||++.+.++++.++||||+||++|+|++|+.||...
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~ 251 (361)
T 4f9c_A 172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS 251 (361)
T ss_dssp SCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence 0 1112345689999999999988776679999999999999999999999543
Q ss_pred cHHHHHHHHHh--------------------------------------CC----------------CCCCCCCCHHHHH
Q 013081 221 NLAVLYQKIFR--------------------------------------GD----------------FKLPKWLSPGAQN 246 (450)
Q Consensus 221 ~~~~~~~~i~~--------------------------------------~~----------------~~~p~~~s~~~~~ 246 (450)
+......++.. .. ......+|+++.+
T Consensus 252 ~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~D 331 (361)
T 4f9c_A 252 DDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYD 331 (361)
T ss_dssp SHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHH
T ss_pred CHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHH
Confidence 33333322211 00 0112347899999
Q ss_pred HHHHccccCcCCCCCHHHHHhcccccc
Q 013081 247 LLRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 247 Li~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
||++||++||++|||++|+|+||||++
T Consensus 332 Ll~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 332 LLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp HHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 999999999999999999999999975
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-58 Score=459.23 Aligned_cols=254 Identities=28% Similarity=0.400 Sum_probs=216.5
Q ss_pred cccCCeEEeeeecccCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 85 (450)
....+|.+.+.||+|+||+||+|++. .+++.||||+++.. .....+.+.+|+++|++++|||||++++++.+
T Consensus 38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 114 (329)
T 4aoj_A 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCTE 114 (329)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 34467899999999999999999865 36889999999654 33446789999999999999999999999999
Q ss_pred CCEEEEEEccCCCCChHHHHHhc---------------CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccC
Q 013081 86 KSKIYMVLEYVTGGELFDKIASK---------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 150 (450)
Q Consensus 86 ~~~~~lv~E~~~gg~L~~~i~~~---------------~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~ 150 (450)
...+|+|||||+||+|.+++... +++++.++..|+.||+.||+|||+++|+||||||+||||+++
T Consensus 115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~ 194 (329)
T 4aoj_A 115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG 194 (329)
T ss_dssp SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCC
Confidence 99999999999999999999753 459999999999999999999999999999999999999999
Q ss_pred CCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHH
Q 013081 151 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKI 229 (450)
Q Consensus 151 g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i 229 (450)
+++||+|||+|+..............+||+.|||||++.+..| +.++|||||||+||||+| |+.||.+.+..+....+
T Consensus 195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~-~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i 273 (329)
T 4aoj_A 195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF-TTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI 273 (329)
T ss_dssp TEEEECCCC----------------CCCCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH
T ss_pred CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCC-CccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999986543222333456789999999999988877 599999999999999999 99999999888888888
Q ss_pred HhC-CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 230 FRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 230 ~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
..+ .++.|+.+|+++.+|+.+||+.||++|||+.||+++
T Consensus 274 ~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 274 TQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 876 577888999999999999999999999999999875
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-58 Score=488.74 Aligned_cols=261 Identities=30% Similarity=0.590 Sum_probs=236.5
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (450)
..+++|++++.||+|+||.||+|+++.+|+.||+|++.+.. ....+.+.+|+.+|+.|+|||||++++++.+...+|
T Consensus 154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 230 (573)
T 3uto_A 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 230 (573)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEE
T ss_pred cCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 45789999999999999999999999999999999997653 233577899999999999999999999999999999
Q ss_pred EEEccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccC--CCeEEeecCCCCCCCcc
Q 013081 91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK--GNIKISDFGLSALPQHF 167 (450)
Q Consensus 91 lv~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~--g~lkl~DFGla~~~~~~ 167 (450)
+|||||+||+|++++.. .+.+++.+++.|++||+.||.|||++||+||||||+|||++.+ |.+||+|||+|+...
T Consensus 231 iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~-- 308 (573)
T 3uto_A 231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD-- 308 (573)
T ss_dssp EEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC--
T ss_pred EEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEcc--
Confidence 99999999999999964 4689999999999999999999999999999999999999854 899999999998543
Q ss_pred cCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHH
Q 013081 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPG 243 (450)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~ 243 (450)
......+.|||+.|+|||++.+.+| +.++|||||||++|+|++|++||.+.+....+.++....+.++ ..+|++
T Consensus 309 -~~~~~~~~~GT~~y~APEv~~~~~y-~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 386 (573)
T 3uto_A 309 -PKQSVKVTTGTAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED 386 (573)
T ss_dssp -TTSEEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHH
T ss_pred -CCCceeeeEECccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 3345667899999999999998887 5899999999999999999999999999999999998876655 458999
Q ss_pred HHHHHHHccccCcCCCCCHHHHHhccccccCCCCC
Q 013081 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA 278 (450)
Q Consensus 244 ~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~~~~ 278 (450)
+++||++||++||.+|||+.|+|+||||+....+.
T Consensus 387 ~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~ 421 (573)
T 3uto_A 387 GKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG 421 (573)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTT
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCC
Confidence 99999999999999999999999999998765543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-58 Score=454.56 Aligned_cols=256 Identities=25% Similarity=0.375 Sum_probs=225.1
Q ss_pred CcccCCeEEeeeecccCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA 84 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 84 (450)
....+.+++++.||+|+||+||+|... .+++.||||.++... .....+.+.+|+.+|++++|||||++++++.
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~ 99 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVT 99 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence 356678999999999999999999853 467899999996543 2233578999999999999999999999999
Q ss_pred eCCEEEEEEccCCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEc
Q 013081 85 SKSKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 148 (450)
Q Consensus 85 ~~~~~~lv~E~~~gg~L~~~i~~~----------------~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~ 148 (450)
+++.+|+|||||++|+|.+++... ..+++.++.+++.||+.||+|||+++|+||||||+||||+
T Consensus 100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY 179 (308)
T ss_dssp SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence 999999999999999999999643 3589999999999999999999999999999999999999
Q ss_pred cCCCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHH
Q 013081 149 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQ 227 (450)
Q Consensus 149 ~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~ 227 (450)
+++++||+|||+|+..............+||+.|+|||++.+..| +.++|||||||+||||+| |..||.+.+..++..
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~-s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~ 258 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 258 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCC-CccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999986543333334556789999999999988877 599999999999999999 999999999888888
Q ss_pred HHHhCC-CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 228 KIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 228 ~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
.+..+. .+.|+.+|+.+.+|+.+||+.||++|||+.||+++
T Consensus 259 ~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 259 MIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 888764 57788899999999999999999999999999875
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-58 Score=450.28 Aligned_cols=253 Identities=25% Similarity=0.365 Sum_probs=207.1
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
..+++++++.||+|+||+||+|++. ..||||+++.... ..+..+.+.+|+.+|++++|||||++++++.. +.+|+
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i 108 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI 108 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence 4568899999999999999999853 3599999875433 34456889999999999999999999998854 56899
Q ss_pred EEccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCC
Q 013081 92 VLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 170 (450)
|||||+||+|.+++.. .+++++.++..++.||+.||+|||++||+||||||+||||++++++||+|||+|+........
T Consensus 109 VmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp EEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 9999999999999975 457999999999999999999999999999999999999999999999999999875543333
Q ss_pred CccccccCCCCccchhhhccC--CCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHH-HhCCC-----CCCCCCCH
Q 013081 171 GLLHTTCGSPNYVAPEVLANR--GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI-FRGDF-----KLPKWLSP 242 (450)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~--~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i-~~~~~-----~~p~~~s~ 242 (450)
....+.+||+.|||||++... ..++.++|||||||+||||+||+.||.+.+.......+ ..+.. ..+..+|+
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 268 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPK 268 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCH
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchH
Confidence 445677999999999998643 23468999999999999999999999886655444433 33321 23456899
Q ss_pred HHHHHHHHccccCcCCCCCHHHHHhcc
Q 013081 243 GAQNLLRKILEPNPVKRITIAGIKADE 269 (450)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t~~~il~h~ 269 (450)
.+.+|+.+||+.||++|||+.|++++-
T Consensus 269 ~l~~li~~cl~~dP~~RPs~~ei~~~L 295 (307)
T 3omv_A 269 AMKRLVADCVKKVKEERPLFPQILSSI 295 (307)
T ss_dssp HHHHHHHHHTCSSSTTSCCHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 999999999999999999999987654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-57 Score=447.12 Aligned_cols=265 Identities=42% Similarity=0.828 Sum_probs=243.8
Q ss_pred ccCCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013081 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (450)
Q Consensus 7 ~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (450)
......+++|++++.||+|+||.||+|.+..+|+.||||++.+... +....+.+.+|+.+++.++||||+++++++.+.
T Consensus 8 ~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 86 (328)
T 3fe3_A 8 ADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETE 86 (328)
T ss_dssp ---CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred cccCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 4456678999999999999999999999999999999999977544 334467889999999999999999999999999
Q ss_pred CEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCc
Q 013081 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (450)
Q Consensus 87 ~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 166 (450)
+..|+||||++||+|.+++...+++++.+++.++.||+.||+|||++||+||||||+|||++.++++||+|||++....
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~- 165 (328)
T 3fe3_A 87 KTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT- 165 (328)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS-
T ss_pred CEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecC-
Confidence 9999999999999999999988999999999999999999999999999999999999999999999999999997532
Q ss_pred ccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHH
Q 013081 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN 246 (450)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 246 (450)
........+||+.|+|||++.+..+++.++||||+||++|+|++|+.||.+.+......++..+....|..+++++.+
T Consensus 166 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 243 (328)
T 3fe3_A 166 --VGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCEN 243 (328)
T ss_dssp --SSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred --CCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 234456789999999999999888878899999999999999999999999999999999999999999999999999
Q ss_pred HHHHccccCcCCCCCHHHHHhccccccCC
Q 013081 247 LLRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 247 Li~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
||++||+.||.+|||++|+++||||+...
T Consensus 244 li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 244 LLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp HHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred HHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 99999999999999999999999998654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-56 Score=446.03 Aligned_cols=254 Identities=26% Similarity=0.384 Sum_probs=217.5
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCC-----CceEEEEEeecccccchhHHHHHHHHHHHHHhCCC-CCcceEEEEEEe
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDS-----GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH-PNVVRLHEVLAS 85 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~ 85 (450)
..++|++++.||+|+||+||+|.+..+ ++.||||.+..... ....+.+.+|+.+|++++| ||||++++++..
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~--~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~ 139 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTK 139 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--hHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence 346899999999999999999997654 46899999975432 3335779999999999975 999999999865
Q ss_pred -CCEEEEEEccCCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEc
Q 013081 86 -KSKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 148 (450)
Q Consensus 86 -~~~~~lv~E~~~gg~L~~~i~~~----------------~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~ 148 (450)
...+|+|||||+||+|.++|... ..+++.++..|+.||+.||+|||+++|+||||||+|||++
T Consensus 140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~ 219 (353)
T 4ase_A 140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 219 (353)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeC
Confidence 45789999999999999999752 3489999999999999999999999999999999999999
Q ss_pred cCCCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcH-HHHH
Q 013081 149 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNL-AVLY 226 (450)
Q Consensus 149 ~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~-~~~~ 226 (450)
+++.+||+|||+|+............+.+||+.|||||++.+..| +.++|||||||+||||+| |..||.+.+. ....
T Consensus 220 ~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y-~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~ 298 (353)
T 4ase_A 220 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 298 (353)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH
T ss_pred CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCC-CCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999986543222223445789999999999988877 599999999999999998 9999988654 4444
Q ss_pred HHHHhC-CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 227 QKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 227 ~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
..+..+ .++.|+.+++++.+|+.+||+.||++|||+.+|++|
T Consensus 299 ~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 299 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 555554 567888999999999999999999999999999988
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-55 Score=442.40 Aligned_cols=262 Identities=33% Similarity=0.633 Sum_probs=233.0
Q ss_pred CCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 013081 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKS 87 (450)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 87 (450)
....+++|++++.||+|+||.||+|++..+|+.||||++.+...........+.+|..+++.+ +||||+++++++.+..
T Consensus 18 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 97 (353)
T 3txo_A 18 NRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD 97 (353)
T ss_dssp -----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Confidence 346678999999999999999999999999999999999876544444567788999999998 6999999999999999
Q ss_pred EEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcc
Q 013081 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 167 (450)
..|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 98 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~- 176 (353)
T 3txo_A 98 RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC- 176 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc-
Confidence 9999999999999999999889999999999999999999999999999999999999999999999999999984322
Q ss_pred cCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 013081 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247 (450)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~L 247 (450)
......+.|||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+...++.++..+...+|.++++.+.+|
T Consensus 177 -~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l 254 (353)
T 3txo_A 177 -NGVTTATFCGTPDYIAPEILQEMLY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGI 254 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHC-TTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred -CCccccccCCCcCeEChhhcCCCCc-CCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 2234556799999999999987776 58999999999999999999999999999999999999999999999999999
Q ss_pred HHHccccCcCCCCCH------HHHHhcccccc
Q 013081 248 LRKILEPNPVKRITI------AGIKADEWFEQ 273 (450)
Q Consensus 248 i~~~L~~dP~~R~t~------~~il~h~~~~~ 273 (450)
|++||++||.+||++ .++++||||+.
T Consensus 255 i~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~ 286 (353)
T 3txo_A 255 LKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286 (353)
T ss_dssp HHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred HHHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence 999999999999998 89999999975
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-55 Score=435.91 Aligned_cols=260 Identities=32% Similarity=0.630 Sum_probs=238.8
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (450)
+.+++|++++.||+|+||.||+|++..+|+.||+|++++...........+.+|+.+++.++||||+++++++.+....|
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 45789999999999999999999999999999999998754433334678889999999999999999999999999999
Q ss_pred EEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCC
Q 013081 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (450)
Q Consensus 91 lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 170 (450)
+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++..... ..
T Consensus 82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~--~~ 159 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DG 159 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--TT
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhccc--CC
Confidence 9999999999999999888999999999999999999999999999999999999999999999999999975322 22
Q ss_pred CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 013081 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 250 (450)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~ 250 (450)
....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+......+|..+++++.+||.+
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 238 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 238 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred CcccccccChhhCChhhhcCCCC-CchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 34567799999999999987776 58999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCcCCCC-----CHHHHHhcccccc
Q 013081 251 ILEPNPVKRI-----TIAGIKADEWFEQ 273 (450)
Q Consensus 251 ~L~~dP~~R~-----t~~~il~h~~~~~ 273 (450)
||+.||.+|| ++.++++||||..
T Consensus 239 lL~~dP~~R~g~~~~~~~ei~~h~~f~~ 266 (337)
T 1o6l_A 239 LLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence 9999999999 9999999999964
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-56 Score=442.58 Aligned_cols=262 Identities=45% Similarity=0.870 Sum_probs=236.5
Q ss_pred CcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (450)
...+|+|++++.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+....
T Consensus 5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 84 (336)
T 3h4j_B 5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDI 84 (336)
T ss_dssp CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 45689999999999999999999999999999999999765443333346789999999999999999999999999999
Q ss_pred EEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC
Q 013081 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 169 (450)
|+||||+ +|+|.+++...+++++.+++.++.||+.||.|||++||+||||||+|||++.++++||+|||++.....
T Consensus 85 ~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~--- 160 (336)
T 3h4j_B 85 VMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD--- 160 (336)
T ss_dssp EEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT---
T ss_pred EEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccC---
Confidence 9999999 789999999889999999999999999999999999999999999999999999999999999986432
Q ss_pred CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q 013081 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLR 249 (450)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~ 249 (450)
.......+||+.|+|||++.+..+.++++|||||||++|+|++|..||.+.+......++..+....|..+++.+.+||+
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 240 (336)
T 3h4j_B 161 GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIR 240 (336)
T ss_dssp SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHH
T ss_pred CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence 33456779999999999998888777899999999999999999999998776666666666677888999999999999
Q ss_pred HccccCcCCCCCHHHHHhccccccCC
Q 013081 250 KILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 250 ~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
+||++||.+|||++|+++||||+...
T Consensus 241 ~~L~~dP~~Rpt~~eil~hp~~~~~~ 266 (336)
T 3h4j_B 241 RMIVADPMQRITIQEIRRDPWFNVNL 266 (336)
T ss_dssp TTSCSSGGGSCCHHHHTTCHHHHTTC
T ss_pred HHcCCChhHCcCHHHHHhChhhccCC
Confidence 99999999999999999999998653
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-54 Score=428.31 Aligned_cols=257 Identities=32% Similarity=0.690 Sum_probs=237.7
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (450)
..+++|++++.||+|+||.||+|++..+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+....|
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 46789999999999999999999999999999999998754433334577889999999999999999999999999999
Q ss_pred EEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCC
Q 013081 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (450)
Q Consensus 91 lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 170 (450)
+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~----- 157 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP----- 157 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS-----
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecC-----
Confidence 999999999999999988899999999999999999999999999999999999999999999999999998532
Q ss_pred CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 013081 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 250 (450)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~ 250 (450)
....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+.++......+|..+++++.+||.+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 236 (318)
T 1fot_A 158 DVTYTLCGTPDYIAPEVVSTKPY-NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSR 236 (318)
T ss_dssp SCBCCCCSCTTTCCHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred CccccccCCccccCHhHhcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 23456789999999999988777 58999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCcCCCC-----CHHHHHhcccccc
Q 013081 251 ILEPNPVKRI-----TIAGIKADEWFEQ 273 (450)
Q Consensus 251 ~L~~dP~~R~-----t~~~il~h~~~~~ 273 (450)
||+.||.+|| +++++++||||+.
T Consensus 237 lL~~dp~~R~~~~~~~~~~i~~hp~f~~ 264 (318)
T 1fot_A 237 LITRDLSQRLGNLQNGTEDVKNHPWFKE 264 (318)
T ss_dssp HTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred HhccCHHHcCCCcCCCHHHHhcCccccC
Confidence 9999999999 9999999999974
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-55 Score=435.25 Aligned_cols=263 Identities=33% Similarity=0.600 Sum_probs=236.8
Q ss_pred cCCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 013081 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK 86 (450)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 86 (450)
.....+++|++++.||+|+||.||+|+++.+|+.||+|++++...........+.+|..+++.+ +||||+++++++.+.
T Consensus 11 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~ 90 (345)
T 1xjd_A 11 QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK 90 (345)
T ss_dssp -----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred cCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC
Confidence 3456789999999999999999999999999999999999875433333356788899999877 899999999999999
Q ss_pred CEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCc
Q 013081 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (450)
Q Consensus 87 ~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 166 (450)
...|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 91 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 91 ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 99999999999999999999888999999999999999999999999999999999999999999999999999975322
Q ss_pred ccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHH
Q 013081 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN 246 (450)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 246 (450)
......+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+...++.++..+...+|.++++++.+
T Consensus 171 --~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 247 (345)
T 1xjd_A 171 --GDAKTNTFCGTPDYIAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKD 247 (345)
T ss_dssp --TTCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred --CCCcccCCCCCcccCChhhhcCCCC-CChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHH
Confidence 2234567799999999999988776 5899999999999999999999999999999999999999999999999999
Q ss_pred HHHHccccCcCCCCCHH-HHHhcccccc
Q 013081 247 LLRKILEPNPVKRITIA-GIKADEWFEQ 273 (450)
Q Consensus 247 Li~~~L~~dP~~R~t~~-~il~h~~~~~ 273 (450)
||.+||+.||.+||++. ++++||||..
T Consensus 248 li~~lL~~dp~~R~~~~~~i~~hp~f~~ 275 (345)
T 1xjd_A 248 LLVKLFVREPEKRLGVRGDIRQHPLFRE 275 (345)
T ss_dssp HHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred HHHHHhcCCHhHcCCChHHHHcCccccC
Confidence 99999999999999998 9999999975
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-54 Score=432.44 Aligned_cols=263 Identities=34% Similarity=0.614 Sum_probs=237.0
Q ss_pred cCCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 013081 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK 86 (450)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 86 (450)
.....+++|++++.||+|+||.||+|++..+|+.||+|++.+.........+.+.+|..++..+ +||||+++++++.+.
T Consensus 14 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~ 93 (353)
T 2i0e_A 14 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 93 (353)
T ss_dssp -----CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS
T ss_pred cCCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC
Confidence 4456789999999999999999999999999999999999876443334457788999999988 799999999999999
Q ss_pred CEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCc
Q 013081 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (450)
Q Consensus 87 ~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 166 (450)
...|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|.....
T Consensus 94 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 94 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 99999999999999999999888999999999999999999999999999999999999999999999999999985322
Q ss_pred ccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHH
Q 013081 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN 246 (450)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 246 (450)
........+||+.|+|||++.+.++ +.++|||||||++|+|++|+.||.+.+...++.++......+|..+++++.+
T Consensus 174 --~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 250 (353)
T 2i0e_A 174 --DGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVA 250 (353)
T ss_dssp --TTCCBCCCCSCGGGCCHHHHTTCCB-STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred --CCcccccccCCccccChhhhcCCCc-CCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 2234567799999999999988777 5899999999999999999999999999999999999999999999999999
Q ss_pred HHHHccccCcCCCCC-----HHHHHhcccccc
Q 013081 247 LLRKILEPNPVKRIT-----IAGIKADEWFEQ 273 (450)
Q Consensus 247 Li~~~L~~dP~~R~t-----~~~il~h~~~~~ 273 (450)
||.+||++||.+||+ +.++++||||+.
T Consensus 251 li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 251 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp HHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred HHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence 999999999999994 699999999974
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-54 Score=437.78 Aligned_cols=263 Identities=30% Similarity=0.600 Sum_probs=233.0
Q ss_pred cCCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 013081 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK 86 (450)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 86 (450)
.....+++|++++.||+|+||+||+|++..+++.||+|++++...........+.+|..+++++ +||||+++++++.+.
T Consensus 46 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~ 125 (396)
T 4dc2_A 46 SSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE 125 (396)
T ss_dssp ---CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC
Confidence 3456678999999999999999999999999999999999877655555556788999999887 899999999999999
Q ss_pred CEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCc
Q 013081 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (450)
Q Consensus 87 ~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 166 (450)
...|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 126 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 126 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred CEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 99999999999999999999889999999999999999999999999999999999999999999999999999984221
Q ss_pred ccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCC---------cHHHHHHHHHhCCCCCC
Q 013081 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR---------NLAVLYQKIFRGDFKLP 237 (450)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~---------~~~~~~~~i~~~~~~~p 237 (450)
......+.|||+.|+|||++.+..+ +.++|||||||++|+|++|+.||... ....+++.+......+|
T Consensus 206 --~~~~~~~~~gt~~Y~aPE~l~~~~~-~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p 282 (396)
T 4dc2_A 206 --PGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP 282 (396)
T ss_dssp --TTCCBCCCCBCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCC
T ss_pred --CCCccccccCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCC
Confidence 2334567899999999999988777 58999999999999999999999632 34457788888899999
Q ss_pred CCCCHHHHHHHHHccccCcCCCCCH------HHHHhcccccc
Q 013081 238 KWLSPGAQNLLRKILEPNPVKRITI------AGIKADEWFEQ 273 (450)
Q Consensus 238 ~~~s~~~~~Li~~~L~~dP~~R~t~------~~il~h~~~~~ 273 (450)
..+++++.+||++||++||.+||++ +++++||||+.
T Consensus 283 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~ 324 (396)
T 4dc2_A 283 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324 (396)
T ss_dssp TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence 9999999999999999999999984 89999999974
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=426.79 Aligned_cols=261 Identities=31% Similarity=0.605 Sum_probs=236.3
Q ss_pred CcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSK 88 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 88 (450)
...+++|++++.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+++++ +||||+++++++.+...
T Consensus 5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 84 (345)
T 3a8x_A 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 84 (345)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence 45678999999999999999999999999999999999887666666678899999999988 89999999999999999
Q ss_pred EEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc
Q 013081 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 168 (450)
.|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~-- 162 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-- 162 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC--
Confidence 999999999999999999888999999999999999999999999999999999999999999999999999975322
Q ss_pred CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCC---------CcHHHHHHHHHhCCCCCCCC
Q 013081 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD---------RNLAVLYQKIFRGDFKLPKW 239 (450)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~---------~~~~~~~~~i~~~~~~~p~~ 239 (450)
......+.+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.. ......++.+......+|..
T Consensus 163 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~ 241 (345)
T 3a8x_A 163 PGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 241 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTT
T ss_pred CCCcccccCCCccccCccccCCCCC-ChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCC
Confidence 2234566799999999999988777 5899999999999999999999975 34456777888888899999
Q ss_pred CCHHHHHHHHHccccCcCCCCCH------HHHHhcccccc
Q 013081 240 LSPGAQNLLRKILEPNPVKRITI------AGIKADEWFEQ 273 (450)
Q Consensus 240 ~s~~~~~Li~~~L~~dP~~R~t~------~~il~h~~~~~ 273 (450)
+++.+.+||.+||+.||.+||++ .++++||||..
T Consensus 242 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~ 281 (345)
T 3a8x_A 242 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281 (345)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence 99999999999999999999995 89999999974
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-54 Score=430.60 Aligned_cols=260 Identities=34% Similarity=0.666 Sum_probs=239.8
Q ss_pred cCCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013081 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (450)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (450)
.....+++|++++.||+|+||.||+|++..+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+..
T Consensus 35 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 114 (350)
T 1rdq_E 35 QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114 (350)
T ss_dssp CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccCCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34467899999999999999999999999999999999998765443344678899999999999999999999999999
Q ss_pred EEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcc
Q 013081 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 167 (450)
..|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 115 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~- 193 (350)
T 1rdq_E 115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG- 193 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS-
T ss_pred EEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC-
Confidence 9999999999999999999888999999999999999999999999999999999999999999999999999985322
Q ss_pred cCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 013081 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247 (450)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~L 247 (450)
...+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+.++..+...+|..+++.+.+|
T Consensus 194 ----~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l 268 (350)
T 1rdq_E 194 ----RTWTLCGTPEALAPEIILSKGY-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268 (350)
T ss_dssp ----CBCCCEECGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHH
T ss_pred ----CcccccCCccccCHHHhcCCCC-CCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 2346789999999999988776 58999999999999999999999999999999999999999999999999999
Q ss_pred HHHccccCcCCCCC-----HHHHHhcccccc
Q 013081 248 LRKILEPNPVKRIT-----IAGIKADEWFEQ 273 (450)
Q Consensus 248 i~~~L~~dP~~R~t-----~~~il~h~~~~~ 273 (450)
|.+||+.||.+||+ ++++++||||..
T Consensus 269 i~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HHHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence 99999999999998 999999999974
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-53 Score=427.79 Aligned_cols=260 Identities=34% Similarity=0.590 Sum_probs=234.3
Q ss_pred CcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccch---hHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---KITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (450)
...-++|++++.||+|+||.||+|.+..+|+.||+|++.+...... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 87 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR 87 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC
Confidence 4455789999999999999999999999999999999987543221 1246789999999999999999999999999
Q ss_pred CEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCC----CeEEeecCCCC
Q 013081 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG----NIKISDFGLSA 162 (450)
Q Consensus 87 ~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g----~lkl~DFGla~ 162 (450)
...|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp SEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 99999999999999999999888999999999999999999999999999999999999998877 79999999998
Q ss_pred CCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCC----C
Q 013081 163 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----K 238 (450)
Q Consensus 163 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~ 238 (450)
.... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+.++..+...++ .
T Consensus 168 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (361)
T 2yab_A 168 EIED---GVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFS 243 (361)
T ss_dssp ECCT---TCCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred EcCC---CCccccCCCCccEECchHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhcc
Confidence 5432 233456789999999999987766 5899999999999999999999999999999999988877765 4
Q ss_pred CCCHHHHHHHHHccccCcCCCCCHHHHHhcccccc
Q 013081 239 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 239 ~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
.+++.+.+||.+||.+||.+|||+.|+++||||..
T Consensus 244 ~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 244 QTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred CCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 58999999999999999999999999999999974
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-53 Score=409.13 Aligned_cols=265 Identities=32% Similarity=0.652 Sum_probs=237.5
Q ss_pred ccCCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013081 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (450)
Q Consensus 7 ~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (450)
++....+++|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.++++++||||+++++++.+.
T Consensus 2 k~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 81 (279)
T 3fdn_A 2 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA 81 (279)
T ss_dssp --CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred CcceeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC
Confidence 34567889999999999999999999999999999999999765544444467899999999999999999999999999
Q ss_pred CEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCc
Q 013081 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (450)
Q Consensus 87 ~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 166 (450)
...|+||||+++++|.+.+....++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 82 TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 99999999999999999999888999999999999999999999999999999999999999999999999999864322
Q ss_pred ccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHH
Q 013081 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN 246 (450)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 246 (450)
......+||+.|+|||++.+..+ +.++||||+|+++|+|++|..||...+.......+......+|..+++.+.+
T Consensus 162 ----~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (279)
T 3fdn_A 162 ----SRRTDLCGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 236 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHH
T ss_pred ----ccccccCCCCCccCHhHhccCCC-CccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHH
Confidence 23345689999999999877655 5899999999999999999999999999999999999999999999999999
Q ss_pred HHHHccccCcCCCCCHHHHHhccccccCCC
Q 013081 247 LLRKILEPNPVKRITIAGIKADEWFEQDYT 276 (450)
Q Consensus 247 Li~~~L~~dP~~R~t~~~il~h~~~~~~~~ 276 (450)
||.+||++||.+|||+.++++||||+....
T Consensus 237 li~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 237 LISRLLKHNPSQRPMLREVLEHPWITANSS 266 (279)
T ss_dssp HHHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred HHHHHhccChhhCCCHHHHhhCccccCCcc
Confidence 999999999999999999999999987654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-53 Score=428.66 Aligned_cols=262 Identities=35% Similarity=0.599 Sum_probs=229.6
Q ss_pred CCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHH-HHhCCCCCcceEEEEEEeCC
Q 013081 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT-LKLLKHPNVVRLHEVLASKS 87 (450)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~i-l~~l~hpnIv~l~~~~~~~~ 87 (450)
.....++|++++.||+|+||.||+|+++.+++.||+|++.+...........+.+|..+ ++.++||||+++++++.+.+
T Consensus 33 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~ 112 (373)
T 2r5t_A 33 PHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD 112 (373)
T ss_dssp TTCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred CCCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence 45667899999999999999999999999999999999988765554445677778777 57789999999999999999
Q ss_pred EEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcc
Q 013081 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 167 (450)
..|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~- 191 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE- 191 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC-
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc-
Confidence 9999999999999999999888999999999999999999999999999999999999999999999999999974221
Q ss_pred cCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 013081 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247 (450)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~L 247 (450)
......+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+...++.++......+|..+++.+.+|
T Consensus 192 -~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l 269 (373)
T 2r5t_A 192 -HNSTTSTFCGTPEYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHL 269 (373)
T ss_dssp -CCCCCCSBSCCCCCCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHH
T ss_pred -CCCccccccCCccccCHHHhCCCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Confidence 2334567899999999999988776 58999999999999999999999999999999999999999999999999999
Q ss_pred HHHccccCcCCCCCH----HHHHhcccccc
Q 013081 248 LRKILEPNPVKRITI----AGIKADEWFEQ 273 (450)
Q Consensus 248 i~~~L~~dP~~R~t~----~~il~h~~~~~ 273 (450)
|.+||+.||.+||++ .++++||||..
T Consensus 270 i~~lL~~dp~~R~~~~~~~~~i~~h~~f~~ 299 (373)
T 2r5t_A 270 LEGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299 (373)
T ss_dssp HHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred HHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence 999999999999986 69999999974
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-53 Score=428.27 Aligned_cols=263 Identities=27% Similarity=0.505 Sum_probs=236.2
Q ss_pred cCCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013081 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (450)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (450)
...+.+++|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+..
T Consensus 9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 88 (384)
T 4fr4_A 9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE 88 (384)
T ss_dssp CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 45567899999999999999999999999999999999998765444444678899999999999999999999999999
Q ss_pred EEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcc
Q 013081 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 167 (450)
..|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|....
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~-- 166 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP-- 166 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeecc--
Confidence 999999999999999999988899999999999999999999999999999999999999999999999999998543
Q ss_pred cCCCccccccCCCCccchhhhccC--CCCCccchhhhHHHHHHHHHhCCCCCCC---CcHHHHHHHHHhCCCCCCCCCCH
Q 013081 168 RDDGLLHTTCGSPNYVAPEVLANR--GYDGATSDIWSCGVILYVILTGYLPFDD---RNLAVLYQKIFRGDFKLPKWLSP 242 (450)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~--~~~~~~~DiwSlGvil~elltG~~Pf~~---~~~~~~~~~i~~~~~~~p~~~s~ 242 (450)
......+.+||+.|+|||++... ..++.++|||||||++|+|++|..||.. .........+......+|..+++
T Consensus 167 -~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~ 245 (384)
T 4fr4_A 167 -RETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQ 245 (384)
T ss_dssp -TTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCH
T ss_pred -CCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCH
Confidence 23345678999999999998642 2236899999999999999999999974 34556677777888889999999
Q ss_pred HHHHHHHHccccCcCCCCC-HHHHHhcccccc
Q 013081 243 GAQNLLRKILEPNPVKRIT-IAGIKADEWFEQ 273 (450)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t-~~~il~h~~~~~ 273 (450)
.+.+||.+||++||.+||+ ++++++||||..
T Consensus 246 ~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~ 277 (384)
T 4fr4_A 246 EMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277 (384)
T ss_dssp HHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred HHHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence 9999999999999999998 999999999975
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-53 Score=411.00 Aligned_cols=260 Identities=26% Similarity=0.458 Sum_probs=229.6
Q ss_pred cCCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013081 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (450)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (450)
..+...++|++++.||+|+||.||+|.+..+|+.||+|++....... .+.+.+|+.+++.++||||+++++++...+
T Consensus 14 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 90 (297)
T 3fxz_A 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGD 90 (297)
T ss_dssp BSSCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred CcCChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECC
Confidence 34556789999999999999999999999999999999997654333 467889999999999999999999999999
Q ss_pred EEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcc
Q 013081 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 167 (450)
..|+||||++||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 91 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~- 168 (297)
T 3fxz_A 91 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP- 168 (297)
T ss_dssp EEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS-
T ss_pred EEEEEEECCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCC-
Confidence 99999999999999999876 4699999999999999999999999999999999999999999999999999875432
Q ss_pred cCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC---CCCCCCCCCHHH
Q 013081 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---DFKLPKWLSPGA 244 (450)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~ 244 (450)
........+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.......+... ....|..+++.+
T Consensus 169 -~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (297)
T 3fxz_A 169 -EQSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246 (297)
T ss_dssp -TTCCBCCCCSCGGGCCHHHHHCSCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHH
T ss_pred -cccccCCccCCcCccChhhhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHH
Confidence 2223456789999999999988777 58999999999999999999999988876665555443 344566789999
Q ss_pred HHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 245 QNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
.+||.+||++||.+|||+.++++||||+..
T Consensus 247 ~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 247 RDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 999999999999999999999999999864
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-53 Score=420.09 Aligned_cols=262 Identities=39% Similarity=0.674 Sum_probs=226.0
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
.+++|++++.||+|+||.||+|.+..+++.||+|++....... ..+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 82 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc--hHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 4689999999999999999999999999999999997554322 24678899999999999999999999999999999
Q ss_pred EEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCC
Q 013081 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 171 (450)
||||++||+|.+++.....+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999998544322333
Q ss_pred ccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHH-HHHHHHHhCCCCCC--CCCCHHHHHHH
Q 013081 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKIFRGDFKLP--KWLSPGAQNLL 248 (450)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~p--~~~s~~~~~Li 248 (450)
.....+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+.. ..+..+.......+ ..+++.+.+||
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHH
Confidence 4456789999999999988887778999999999999999999999876543 33334444333333 44899999999
Q ss_pred HHccccCcCCCCCHHHHHhccccccCC
Q 013081 249 RKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 249 ~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
.+||+.||.+|||+.|+++||||++..
T Consensus 243 ~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 243 HKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp HHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHccCChhhCcCHHHHhhChhhcccc
Confidence 999999999999999999999998654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-53 Score=433.93 Aligned_cols=259 Identities=37% Similarity=0.701 Sum_probs=231.7
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
..++|++++.||+|+||.||+|.+..+|+.||+|++.+.... ....+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCH-HHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 347899999999999999999999999999999999876543 3335778999999999999999999999999999999
Q ss_pred EEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEc---cCCCeEEeecCCCCCCCccc
Q 013081 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD---SKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~---~~g~lkl~DFGla~~~~~~~ 168 (450)
||||+.||+|.+.+...+.+++.+++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|.....
T Consensus 88 v~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~-- 165 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG-- 165 (444)
T ss_dssp EECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT--
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC--
Confidence 999999999999999989999999999999999999999999999999999999998 457899999999975433
Q ss_pred CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCC----CCCHHH
Q 013081 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK----WLSPGA 244 (450)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~ 244 (450)
........+||+.|+|||++.+..+ +.++|||||||++|+|++|.+||.+.+....+.++..+...+|. .+++++
T Consensus 166 ~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 244 (444)
T 3soa_A 166 EQQAWFGFAGTPGYLSPEVLRKDPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA 244 (444)
T ss_dssp TCCBCCCSCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred CCceeecccCCcccCCHHHhcCCCC-CCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHH
Confidence 2233456789999999999987777 58999999999999999999999999999999999888766553 489999
Q ss_pred HHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 245 QNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
.+||.+||++||.+|||+.|+++||||...
T Consensus 245 ~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 245 KDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred HHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 999999999999999999999999999754
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-53 Score=436.69 Aligned_cols=261 Identities=33% Similarity=0.629 Sum_probs=228.2
Q ss_pred CcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (450)
...+++|++++.||+|+||.||+|.+..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+.+.+
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 223 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL 223 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence 34578999999999999999999999999999999999876544444456788999999999999999999999999999
Q ss_pred EEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhh-cCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc
Q 013081 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~-~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 168 (450)
|+||||++||+|.+++...+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+|+....
T Consensus 224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~-- 301 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK-- 301 (446)
T ss_dssp EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC--
Confidence 9999999999999999988899999999999999999999998 8999999999999999999999999999985322
Q ss_pred CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 013081 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL 248 (450)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li 248 (450)
........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......+|..+++.+.+||
T Consensus 302 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 380 (446)
T 4ejn_A 302 DGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLL 380 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCcccccccCCccccCHhhcCCCCC-CCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence 2234556799999999999987776 589999999999999999999999999999999999999999999999999999
Q ss_pred HHccccCcCCCC-----CHHHHHhcccccc
Q 013081 249 RKILEPNPVKRI-----TIAGIKADEWFEQ 273 (450)
Q Consensus 249 ~~~L~~dP~~R~-----t~~~il~h~~~~~ 273 (450)
.+||++||.+|| |+.++++||||..
T Consensus 381 ~~~L~~dP~~R~~~~~~t~~ell~hp~f~~ 410 (446)
T 4ejn_A 381 SGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410 (446)
T ss_dssp HHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence 999999999999 9999999999975
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=415.95 Aligned_cols=263 Identities=36% Similarity=0.634 Sum_probs=225.9
Q ss_pred cCCcccCCeEEeeeecccCceEEEEEEEC---CCCceEEEEEeeccccc-chhHHHHHHHHHHHHHhCCCCCcceEEEEE
Q 013081 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRII-HLKITDQIKREIATLKLLKHPNVVRLHEVL 83 (450)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 83 (450)
+.....++|++++.||+|+||.||+|++. .+|+.||+|++++.... .......+.+|+.+++.++||||+++++++
T Consensus 11 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 90 (327)
T 3a62_A 11 PEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF 90 (327)
T ss_dssp --CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE
T ss_pred CCCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE
Confidence 44566789999999999999999999985 68999999999765432 222346688999999999999999999999
Q ss_pred EeCCEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCC
Q 013081 84 ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL 163 (450)
Q Consensus 84 ~~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~ 163 (450)
...+..|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 91 QTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp ECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 99999999999999999999999888999999999999999999999999999999999999999999999999999874
Q ss_pred CCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHH
Q 013081 164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPG 243 (450)
Q Consensus 164 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 243 (450)
... ........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+......++......+|..+++.
T Consensus 171 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 247 (327)
T 3a62_A 171 SIH--DGTVTHTFCGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQE 247 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHH
T ss_pred ccc--CCccccccCCCcCccCHhhCcCCCC-CCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHH
Confidence 322 2233456789999999999987766 5899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHccccCcCCCC-----CHHHHHhcccccc
Q 013081 244 AQNLLRKILEPNPVKRI-----TIAGIKADEWFEQ 273 (450)
Q Consensus 244 ~~~Li~~~L~~dP~~R~-----t~~~il~h~~~~~ 273 (450)
+.+||.+||+.||.+|| ++.++++||||+.
T Consensus 248 ~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~ 282 (327)
T 3a62_A 248 ARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282 (327)
T ss_dssp HHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred HHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence 99999999999999999 8999999999974
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=406.82 Aligned_cols=259 Identities=29% Similarity=0.476 Sum_probs=220.1
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 92 (450)
+++|++++.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.++++++||||+++++++.+....|+|
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence 5789999999999999999999999999999999976543 334457888999999999999999999999999999999
Q ss_pred EccCCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCC
Q 013081 93 LEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (450)
Q Consensus 93 ~E~~~gg~L~~~i~-~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 171 (450)
|||+.| +|.+.+. ..+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~ 156 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVR 156 (292)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCS--CCS
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCC--ccc
Confidence 999976 5555554 467899999999999999999999999999999999999999999999999999975432 223
Q ss_pred ccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCC-CCCCcHHHHHHHHHhC--C---------------
Q 013081 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP-FDDRNLAVLYQKIFRG--D--------------- 233 (450)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~P-f~~~~~~~~~~~i~~~--~--------------- 233 (450)
.....+||+.|+|||++.+....+.++||||+||++|+|++|..| |.+.+.......+... .
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence 345568999999999998777567999999999999999987776 6666666666655431 0
Q ss_pred ------------CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCC
Q 013081 234 ------------FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 234 ------------~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
...++.+++.+.+||.+||++||++|||++|+++||||++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 011234788999999999999999999999999999998643
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=420.71 Aligned_cols=256 Identities=38% Similarity=0.716 Sum_probs=231.0
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 92 (450)
.++|++++.||+|+||.||+|.+..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.+....|+|
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 35899999999999999999999999999999999865543 33457899999999999999999999999999999999
Q ss_pred EccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCC---CeEEeecCCCCCCCcccC
Q 013081 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRD 169 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g---~lkl~DFGla~~~~~~~~ 169 (450)
|||+.||+|.+.+...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~--- 183 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--- 183 (362)
T ss_dssp ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT---
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC---
Confidence 99999999999999888999999999999999999999999999999999999998654 599999999985432
Q ss_pred CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCC----CCCHHHH
Q 013081 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK----WLSPGAQ 245 (450)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~ 245 (450)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+..+...+|. .+++++.
T Consensus 184 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 262 (362)
T 2bdw_A 184 SEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 262 (362)
T ss_dssp CCSCCCSCSCTTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHH
T ss_pred CcccccCCCCccccCHHHHccCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 233456789999999999987766 58999999999999999999999999988899998888766653 3799999
Q ss_pred HHHHHccccCcCCCCCHHHHHhcccccc
Q 013081 246 NLLRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 246 ~Li~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
+||.+||++||.+|||+.++++||||..
T Consensus 263 ~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 263 SLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp HHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred HHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 9999999999999999999999999974
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=414.19 Aligned_cols=256 Identities=25% Similarity=0.477 Sum_probs=230.9
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
..++|++++.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 78 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEE
Confidence 4589999999999999999999999999999999986432 234678899999999999999999999999999999
Q ss_pred EEccCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEcc--CCCeEEeecCCCCCCCccc
Q 013081 92 VLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS--KGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~--~g~lkl~DFGla~~~~~~~ 168 (450)
||||++||+|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~--- 155 (321)
T 1tki_A 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK--- 155 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC---
T ss_pred EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC---
Confidence 99999999999999765 47999999999999999999999999999999999999987 7899999999998543
Q ss_pred CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHH
Q 013081 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGA 244 (450)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~ 244 (450)
........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+..+...++ ..+|+++
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 234 (321)
T 1tki_A 156 PGDNFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234 (321)
T ss_dssp TTCEEEEEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred CCCccccccCChhhcCcHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHH
Confidence 2234456789999999999877655 5899999999999999999999999999999999988877766 3589999
Q ss_pred HHHHHHccccCcCCCCCHHHHHhccccccCC
Q 013081 245 QNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
.+||.+||++||.+|||+.|+++||||++..
T Consensus 235 ~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 235 MDFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred HHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence 9999999999999999999999999998653
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=420.15 Aligned_cols=259 Identities=40% Similarity=0.773 Sum_probs=219.1
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (450)
...++|++++.||+|+||.||+|++..+++.||+|++.+..... +.+.+|+.+++.++||||+++++++.+....|
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence 44689999999999999999999999999999999997654332 56889999999999999999999999999999
Q ss_pred EEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCC--eEEeecCCCCCCCccc
Q 013081 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN--IKISDFGLSALPQHFR 168 (450)
Q Consensus 91 lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~--lkl~DFGla~~~~~~~ 168 (450)
+||||++||+|.+++...+++++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+...
T Consensus 93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~--- 169 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV--- 169 (361)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccc---
Confidence 99999999999999988889999999999999999999999999999999999999988775 9999999997422
Q ss_pred CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCc----HHHHHHHHHhCCCCCCC--CCCH
Q 013081 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN----LAVLYQKIFRGDFKLPK--WLSP 242 (450)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~----~~~~~~~i~~~~~~~p~--~~s~ 242 (450)
........+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.+.+ .......+......+|. .+++
T Consensus 170 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 249 (361)
T 3uc3_A 170 LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISP 249 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCH
T ss_pred ccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCH
Confidence 22234556899999999999888887666999999999999999999998743 34555666666666665 4899
Q ss_pred HHHHHHHHccccCcCCCCCHHHHHhccccccCCC
Q 013081 243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 276 (450)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~~ 276 (450)
.+.+||.+||++||.+|||+.++++||||.....
T Consensus 250 ~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 283 (361)
T 3uc3_A 250 ECCHLISRIFVADPATRISIPEIKTHSWFLKNLP 283 (361)
T ss_dssp HHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCC
T ss_pred HHHHHHHHHccCChhHCcCHHHHHhCcchhcCCc
Confidence 9999999999999999999999999999976543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=404.63 Aligned_cols=268 Identities=32% Similarity=0.674 Sum_probs=238.9
Q ss_pred cccccCCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEE
Q 013081 4 AEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVL 83 (450)
Q Consensus 4 ~~~~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 83 (450)
++-......+++|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++
T Consensus 4 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 83 (284)
T 2vgo_A 4 AEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF 83 (284)
T ss_dssp ------CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhCCccchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEE
Confidence 44556677889999999999999999999999999999999999765433333457889999999999999999999999
Q ss_pred EeCCEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCC
Q 013081 84 ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL 163 (450)
Q Consensus 84 ~~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~ 163 (450)
.+....|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 84 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~ 163 (284)
T 2vgo_A 84 HDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVH 163 (284)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EcCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEeccccccc
Confidence 99999999999999999999999888999999999999999999999999999999999999999999999999999864
Q ss_pred CCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHH
Q 013081 164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPG 243 (450)
Q Consensus 164 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 243 (450)
... ......+||+.|+|||++.+..+ +.++||||+|+++|+|++|..||...+.......+......+|..+++.
T Consensus 164 ~~~----~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T 2vgo_A 164 APS----LRRRTMCGTLDYLPPEMIEGKTH-DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDG 238 (284)
T ss_dssp CSS----SCBCCCCSCGGGCCHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHH
T ss_pred Ccc----cccccccCCCCcCCHHHhccCCC-CcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHH
Confidence 322 22345689999999999887766 5899999999999999999999999988888888888888899999999
Q ss_pred HHHHHHHccccCcCCCCCHHHHHhccccccCCC
Q 013081 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 276 (450)
Q Consensus 244 ~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~~ 276 (450)
+.+||.+||+.||.+|||+.++++||||+....
T Consensus 239 ~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 239 SKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR 271 (284)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred HHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence 999999999999999999999999999986543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=403.65 Aligned_cols=266 Identities=49% Similarity=0.906 Sum_probs=231.4
Q ss_pred ccCCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013081 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (450)
Q Consensus 7 ~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (450)
.......++|++++.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 83 (276)
T 2h6d_A 4 HDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP 83 (276)
T ss_dssp ---CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred ccCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 35567789999999999999999999999999999999999765433334457899999999999999999999999999
Q ss_pred CEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCc
Q 013081 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (450)
Q Consensus 87 ~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 166 (450)
...|+||||++|++|.+++...+++++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++.....
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 84 TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 99999999999999999999888999999999999999999999999999999999999999999999999999985432
Q ss_pred ccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHH
Q 013081 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN 246 (450)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 246 (450)
.......+||+.|+|||++.+..+.+.++||||+|+++|+|++|..||...+.......+..+....|..+++.+.+
T Consensus 164 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 240 (276)
T 2h6d_A 164 ---GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVAT 240 (276)
T ss_dssp ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred ---CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHH
Confidence 22344568999999999998777666899999999999999999999999988888888888888889999999999
Q ss_pred HHHHccccCcCCCCCHHHHHhccccccCC
Q 013081 247 LLRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 247 Li~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
||.+||+.||.+|||+.++++||||++..
T Consensus 241 li~~~l~~~p~~Rps~~~~l~h~~~~~~~ 269 (276)
T 2h6d_A 241 LLMHMLQVDPLKRATIKDIREHEWFKQDL 269 (276)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred HHHHHccCChhhCCCHHHHHhChhhccCc
Confidence 99999999999999999999999998754
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=409.92 Aligned_cols=263 Identities=36% Similarity=0.644 Sum_probs=222.2
Q ss_pred ccCCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccc-----------------------hhHHHHHHH
Q 013081 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH-----------------------LKITDQIKR 63 (450)
Q Consensus 7 ~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~-----------------------~~~~~~~~~ 63 (450)
......+++|++.+.||+|+||.||+|.+..+++.||||++.+..... ....+.+.+
T Consensus 6 ~~~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 85 (298)
T 2zv2_A 6 SGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQ 85 (298)
T ss_dssp ----CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHH
T ss_pred CCCceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHH
Confidence 344567899999999999999999999999999999999997654221 112356889
Q ss_pred HHHHHHhCCCCCcceEEEEEEe--CCEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCC
Q 013081 64 EIATLKLLKHPNVVRLHEVLAS--KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141 (450)
Q Consensus 64 Ei~il~~l~hpnIv~l~~~~~~--~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlK 141 (450)
|+.++++++||||+++++++.+ ....|+||||+++++|.+++. .+++++.+++.++.||+.||+|||++||+|||||
T Consensus 86 E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk 164 (298)
T 2zv2_A 86 EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIK 164 (298)
T ss_dssp HHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred HHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC
Confidence 9999999999999999999986 678999999999999988643 4679999999999999999999999999999999
Q ss_pred CCcEEEccCCCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCC--CCccchhhhHHHHHHHHHhCCCCCCC
Q 013081 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY--DGATSDIWSCGVILYVILTGYLPFDD 219 (450)
Q Consensus 142 p~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~--~~~~~DiwSlGvil~elltG~~Pf~~ 219 (450)
|+|||++.++.+||+|||++..... ........+||+.|+|||++.+... .+.++|||||||++|+|++|..||.+
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKG--SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSS--SSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHEEECCCCCEEEecCCCcccccc--ccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999975432 2223455689999999999876542 36789999999999999999999999
Q ss_pred CcHHHHHHHHHhCCCCCC--CCCCHHHHHHHHHccccCcCCCCCHHHHHhccccc
Q 013081 220 RNLAVLYQKIFRGDFKLP--KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 272 (450)
Q Consensus 220 ~~~~~~~~~i~~~~~~~p--~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~ 272 (450)
.+.......+.......| ..+++.+.+||.+||++||.+|||+.|+++||||+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 243 ERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp SSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred ccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 888888888777766555 45899999999999999999999999999999996
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=430.84 Aligned_cols=262 Identities=27% Similarity=0.504 Sum_probs=228.2
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (450)
...++|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+....|
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 150 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLY 150 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEE
Confidence 44679999999999999999999999999999999997644332222345889999999999999999999999999999
Q ss_pred EEEccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC
Q 013081 91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (450)
Q Consensus 91 lv~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 169 (450)
+||||++||+|.+++.+ .+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+..... .
T Consensus 151 lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~-~ 229 (437)
T 4aw2_A 151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-G 229 (437)
T ss_dssp EEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-S
T ss_pred EEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccC-C
Confidence 99999999999999987 578999999999999999999999999999999999999999999999999999753221 1
Q ss_pred CCccccccCCCCccchhhhcc----CCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC--CCCCCCC---C
Q 013081 170 DGLLHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW---L 240 (450)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~----~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~---~ 240 (450)
.......+||+.|+|||++.. ...++.++|||||||++|+|++|+.||.+.+....+.++... .+.+|.. +
T Consensus 230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 309 (437)
T 4aw2_A 230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDV 309 (437)
T ss_dssp CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCS
T ss_pred CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccC
Confidence 112334689999999999862 333468999999999999999999999999999888888753 3555544 8
Q ss_pred CHHHHHHHHHccccCcCC--CCCHHHHHhcccccc
Q 013081 241 SPGAQNLLRKILEPNPVK--RITIAGIKADEWFEQ 273 (450)
Q Consensus 241 s~~~~~Li~~~L~~dP~~--R~t~~~il~h~~~~~ 273 (450)
++++.+||++||..+|++ |++++++++||||+.
T Consensus 310 s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~ 344 (437)
T 4aw2_A 310 SENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG 344 (437)
T ss_dssp CHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred CHHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence 999999999999998888 999999999999974
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-53 Score=416.03 Aligned_cols=248 Identities=24% Similarity=0.311 Sum_probs=194.6
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----EE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS----KI 89 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~~ 89 (450)
.+|.+.+.||+|+||+||+|++ +|+.||||+++.... ......+|+..+.+++|||||++++++..++ .+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~----~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 4689999999999999999997 689999999965421 1223445777778899999999999997653 68
Q ss_pred EEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhc--------CeeeccCCCCcEEEccCCCeEEeecCCC
Q 013081 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK--------GVFHRDLKLENILLDSKGNIKISDFGLS 161 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~--------givHrDlKp~NILl~~~g~lkl~DFGla 161 (450)
|+|||||+||+|.+++.+ .+++++.+.+++.|++.||+|||++ +|+||||||+|||++.++++||+|||+|
T Consensus 77 ~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 999999999999999976 5799999999999999999999987 9999999999999999999999999999
Q ss_pred CCCCcccC--CCccccccCCCCccchhhhccCC-----CCCccchhhhHHHHHHHHHhCCCCCCC---------------
Q 013081 162 ALPQHFRD--DGLLHTTCGSPNYVAPEVLANRG-----YDGATSDIWSCGVILYVILTGYLPFDD--------------- 219 (450)
Q Consensus 162 ~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~-----~~~~~~DiwSlGvil~elltG~~Pf~~--------------- 219 (450)
+....... .......+||+.|+|||++.+.. .++.++|||||||+||||+||.+||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 85433211 11234568999999999987542 124789999999999999999776632
Q ss_pred CcHHHHHHHHHhCC--CCCCCC-----CCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 220 RNLAVLYQKIFRGD--FKLPKW-----LSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 220 ~~~~~~~~~i~~~~--~~~p~~-----~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
.....+...+.... +++|.. .++.+.+|+.+||+.||++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 12233444443332 334432 22467899999999999999999999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-52 Score=411.28 Aligned_cols=259 Identities=35% Similarity=0.610 Sum_probs=231.1
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccch---hHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---KITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (450)
.-++|++++.||+|+||.||+|.+..+|+.||+|++.+...... ...+.+.+|+.+++.++||||+++++++.+...
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 34689999999999999999999999999999999976543221 125678999999999999999999999999999
Q ss_pred EEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCC----CeEEeecCCCCCC
Q 013081 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG----NIKISDFGLSALP 164 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g----~lkl~DFGla~~~ 164 (450)
.|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 999999999999999998888999999999999999999999999999999999999999888 7999999999854
Q ss_pred CcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCC----CCC
Q 013081 165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWL 240 (450)
Q Consensus 165 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~ 240 (450)
.. .......+||+.|+|||++....+ +.++|||||||++|+|++|..||.+.+.......+......++ ..+
T Consensus 169 ~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (326)
T 2y0a_A 169 DF---GNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT 244 (326)
T ss_dssp CT---TSCCCCCCSCTTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTS
T ss_pred CC---CCccccccCCcCcCCceeecCCCC-CcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccC
Confidence 32 223455689999999999877666 5899999999999999999999999888888888877766655 458
Q ss_pred CHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 241 s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
++.+.+||.+||++||.+|||+.++++||||...
T Consensus 245 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 9999999999999999999999999999999753
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-53 Score=429.67 Aligned_cols=262 Identities=31% Similarity=0.529 Sum_probs=229.3
Q ss_pred CcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (450)
....++|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+...+
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 144 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 144 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 45568999999999999999999999999999999999764332222234588999999999999999999999999999
Q ss_pred EEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC
Q 013081 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 169 (450)
|+||||++||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|...... .
T Consensus 145 ~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~-~ 222 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE-G 222 (410)
T ss_dssp EEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-S
T ss_pred EEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccC-C
Confidence 999999999999999875 57999999999999999999999999999999999999999999999999999754321 1
Q ss_pred CCccccccCCCCccchhhhccCC---CCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC--CCCCC--CCCCH
Q 013081 170 DGLLHTTCGSPNYVAPEVLANRG---YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLP--KWLSP 242 (450)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~---~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p--~~~s~ 242 (450)
.....+.+||+.|+|||++.+.+ +++.++|||||||++|+|++|+.||.+.+....+.++..+ ...+| ..+|+
T Consensus 223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~ 302 (410)
T 3v8s_A 223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISK 302 (410)
T ss_dssp EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCH
T ss_pred cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccH
Confidence 11234679999999999987654 2358999999999999999999999999999999888765 24445 46999
Q ss_pred HHHHHHHHccccCcCC--CCCHHHHHhcccccc
Q 013081 243 GAQNLLRKILEPNPVK--RITIAGIKADEWFEQ 273 (450)
Q Consensus 243 ~~~~Li~~~L~~dP~~--R~t~~~il~h~~~~~ 273 (450)
++.+||++||+.+|.+ |+++++|++||||+.
T Consensus 303 ~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~ 335 (410)
T 3v8s_A 303 EAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 335 (410)
T ss_dssp HHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred HHHHHHHHHccChhhhCCCCCHHHHhcCccccC
Confidence 9999999999999998 999999999999975
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-51 Score=398.96 Aligned_cols=265 Identities=35% Similarity=0.612 Sum_probs=241.6
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (450)
...++|++++.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 45679999999999999999999999999999999998776555666788999999999999999999999999999999
Q ss_pred EEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCC
Q 013081 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (450)
Q Consensus 91 lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 170 (450)
+||||++|++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~--~~ 169 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DG 169 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS--TT
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceeccc--Cc
Confidence 9999999999999998888999999999999999999999999999999999999999999999999999975432 12
Q ss_pred CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 013081 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 250 (450)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~ 250 (450)
......+||+.|+|||++.+..+ +.++||||+|+++|+|++|..||...+.......+.......|..+++.+.+||.+
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 248 (294)
T 2rku_A 170 ERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 248 (294)
T ss_dssp CCBCCCCSCCSSCCHHHHTTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH
T ss_pred cccccccCCCCcCCcchhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHH
Confidence 23445689999999999887666 58999999999999999999999999888888888888888999999999999999
Q ss_pred ccccCcCCCCCHHHHHhccccccCCCCC
Q 013081 251 ILEPNPVKRITIAGIKADEWFEQDYTPA 278 (450)
Q Consensus 251 ~L~~dP~~R~t~~~il~h~~~~~~~~~~ 278 (450)
||+.||.+|||+.++++||||.....+.
T Consensus 249 ~l~~~p~~Rps~~~ll~~~~~~~~~~~~ 276 (294)
T 2rku_A 249 MLQTDPTARPTINELLNDEFFTSGYIPA 276 (294)
T ss_dssp HTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred HcccChhhCcCHHHHhhChheecCCcCC
Confidence 9999999999999999999998776543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-52 Score=414.95 Aligned_cols=256 Identities=33% Similarity=0.661 Sum_probs=223.0
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccc--hhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH--LKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
++|++++.||+|+||.||+|.+..+|+.||||+++...... ....+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 68999999999999999999999999999999997543221 1124678999999999999999999999999999999
Q ss_pred EEccCCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCC---eEEeecCCCCCC
Q 013081 92 VLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSALP 164 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~----~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~---lkl~DFGla~~~ 164 (450)
||||++|++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++...
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 183 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence 99999999999887543 35899999999999999999999999999999999999987665 999999999754
Q ss_pred CcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCC----CCC
Q 013081 165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWL 240 (450)
Q Consensus 165 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~ 240 (450)
.. ........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.. ...+..+..+....+ ..+
T Consensus 184 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~~ 259 (351)
T 3c0i_A 184 GE--SGLVAGGRVGTPHFMAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHI 259 (351)
T ss_dssp CT--TSCBCCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTTS
T ss_pred cC--CCeeecCCcCCcCccCHHHHcCCCC-CchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccccC
Confidence 32 1223456789999999999987776 589999999999999999999998854 456677777766554 458
Q ss_pred CHHHHHHHHHccccCcCCCCCHHHHHhcccccc
Q 013081 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 241 s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
++.+.+||.+||++||.+|||+.++++||||+.
T Consensus 260 s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 260 SESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 999999999999999999999999999999975
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-52 Score=408.36 Aligned_cols=262 Identities=27% Similarity=0.441 Sum_probs=209.1
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
..++|++++.||+|+||.||+|.+..+|+.||+|++...... .....+.+|+.++++++||||+++++++.+.+..|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 80 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE--GTPSTAIREISLMKELKHENIVRLYDVIHTENKLTL 80 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCSTT--CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc--ccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEE
Confidence 357899999999999999999999999999999999765422 224678899999999999999999999999999999
Q ss_pred EEccCCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCC
Q 013081 92 VLEYVTGGELFDKIASK------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~------~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 165 (450)
||||++ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 81 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 81 VFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp EEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred EEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 999997 5999988753 359999999999999999999999999999999999999999999999999997543
Q ss_pred cccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC--CC---------
Q 013081 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DF--------- 234 (450)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~--------- 234 (450)
. ........+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+... ..
T Consensus 160 ~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 160 I--PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp S--CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred C--CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 2 1223445689999999999877555578999999999999999999999998877766665431 00
Q ss_pred -----------------------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCCCCC
Q 013081 235 -----------------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA 278 (450)
Q Consensus 235 -----------------------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~~~~ 278 (450)
..+..+++.+.+||.+||++||.+|||+.|+++||||.+.+.++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~ 304 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHA 304 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC--
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchh
Confidence 01224788999999999999999999999999999999866543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-51 Score=406.39 Aligned_cols=264 Identities=35% Similarity=0.616 Sum_probs=241.5
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
..++|.+++.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 45789999999999999999999999999999999987766566667889999999999999999999999999999999
Q ss_pred EEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCC
Q 013081 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 171 (450)
||||+.|++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 119 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~--~~~ 196 (335)
T 2owb_A 119 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DGE 196 (335)
T ss_dssp EECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCS--TTC
T ss_pred EEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceeccc--Ccc
Confidence 999999999999998888999999999999999999999999999999999999999999999999999975432 122
Q ss_pred ccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q 013081 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 251 (450)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~ 251 (450)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+....+..+......+|..+++.+.+||.+|
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 275 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKM 275 (335)
T ss_dssp CBCCCCSCCSSCCHHHHHTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHH
T ss_pred cccccCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHH
Confidence 3445689999999999987766 589999999999999999999999998888888888888889999999999999999
Q ss_pred cccCcCCCCCHHHHHhccccccCCCCC
Q 013081 252 LEPNPVKRITIAGIKADEWFEQDYTPA 278 (450)
Q Consensus 252 L~~dP~~R~t~~~il~h~~~~~~~~~~ 278 (450)
|+.||.+|||+.++++||||...+.+.
T Consensus 276 l~~dp~~Rps~~ell~~~~~~~~~~~~ 302 (335)
T 2owb_A 276 LQTDPTARPTINELLNDEFFTSGYIPA 302 (335)
T ss_dssp TCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred ccCChhHCcCHHHHhcCccccCCCccc
Confidence 999999999999999999999876543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-52 Score=448.11 Aligned_cols=262 Identities=34% Similarity=0.617 Sum_probs=237.8
Q ss_pred CCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 013081 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKS 87 (450)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 87 (450)
....+++|++++.||+|+||.||+|++..+++.||||++.+.........+.+.+|..++..+ +||||+++++++.+..
T Consensus 336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~ 415 (674)
T 3pfq_A 336 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 415 (674)
T ss_dssp ----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS
T ss_pred ccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC
Confidence 345678999999999999999999999999999999999875443333457788999999988 6999999999999999
Q ss_pred EEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcc
Q 013081 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 167 (450)
.+|+||||++||+|.+++...+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 416 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~- 494 (674)
T 3pfq_A 416 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW- 494 (674)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC-
T ss_pred EEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc-
Confidence 9999999999999999999989999999999999999999999999999999999999999999999999999984322
Q ss_pred cCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 013081 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247 (450)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~L 247 (450)
......+.+||+.|+|||++.+..| +.++|||||||++|+|++|.+||.+.+...++.++......+|..+++++.+|
T Consensus 495 -~~~~~~~~~GT~~Y~APE~l~~~~~-~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 572 (674)
T 3pfq_A 495 -DGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAI 572 (674)
T ss_dssp -TTCCBCCCCSCSSSCCHHHHTCCCB-STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHH
T ss_pred -CCcccccccCCCcccCHhhhcCCCC-CccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHH
Confidence 2334567899999999999988777 58999999999999999999999999999999999999999999999999999
Q ss_pred HHHccccCcCCCCCH-----HHHHhcccccc
Q 013081 248 LRKILEPNPVKRITI-----AGIKADEWFEQ 273 (450)
Q Consensus 248 i~~~L~~dP~~R~t~-----~~il~h~~~~~ 273 (450)
|++||++||.+||++ ++|++||||+.
T Consensus 573 i~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~ 603 (674)
T 3pfq_A 573 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603 (674)
T ss_dssp HHHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred HHHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence 999999999999997 99999999974
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-52 Score=424.83 Aligned_cols=262 Identities=26% Similarity=0.465 Sum_probs=227.0
Q ss_pred CcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (450)
....++|++++.||+|+||+||+|+++.+|+.||+|++++...........+.+|..++..++||||+++++++.+....
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 136 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL 136 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 34568999999999999999999999999999999999865433333345688999999999999999999999999999
Q ss_pred EEEEccCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc
Q 013081 90 YMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~-~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 168 (450)
|+||||++||+|.+++.+.+ .+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||++......
T Consensus 137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~- 215 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD- 215 (412)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCC-
Confidence 99999999999999998754 7999999999999999999999999999999999999999999999999999754321
Q ss_pred CCCccccccCCCCccchhhhcc------CCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC--CCCCC---
Q 013081 169 DDGLLHTTCGSPNYVAPEVLAN------RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLP--- 237 (450)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~------~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p--- 237 (450)
........+||+.|+|||++.. ...++.++|||||||++|+|++|+.||.+.+....+.++... ...+|
T Consensus 216 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 295 (412)
T 2vd5_A 216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVD 295 (412)
T ss_dssp SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC---
T ss_pred CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccc
Confidence 1112235689999999999873 223368999999999999999999999999998888888753 23444
Q ss_pred CCCCHHHHHHHHHccccCcCCC---CCHHHHHhcccccc
Q 013081 238 KWLSPGAQNLLRKILEPNPVKR---ITIAGIKADEWFEQ 273 (450)
Q Consensus 238 ~~~s~~~~~Li~~~L~~dP~~R---~t~~~il~h~~~~~ 273 (450)
..+|+++++||++||. +|.+| ++++++++||||..
T Consensus 296 ~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~ 333 (412)
T 2vd5_A 296 EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG 333 (412)
T ss_dssp -CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTT
T ss_pred cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCC
Confidence 5699999999999999 99998 59999999999975
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-52 Score=406.69 Aligned_cols=262 Identities=29% Similarity=0.399 Sum_probs=217.4
Q ss_pred cCCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013081 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (450)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (450)
......++|++++.||+|+||.||+|.+. +|+.||+|++..... .......+.+|+.+++.++||||+++++++.+..
T Consensus 15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 92 (311)
T 3niz_A 15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSER 92 (311)
T ss_dssp CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS
T ss_pred eecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC
Confidence 44456799999999999999999999985 589999999975432 3334577889999999999999999999999999
Q ss_pred EEEEEEccCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCc
Q 013081 88 KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 166 (450)
..|+||||++| +|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 93 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 93 CLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp CEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred EEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 99999999975 888877654 4699999999999999999999999999999999999999999999999999985432
Q ss_pred ccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC--CCC---------
Q 013081 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFK--------- 235 (450)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~--------- 235 (450)
........+||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+......++... ...
T Consensus 172 --~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 249 (311)
T 3niz_A 172 --PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQE 249 (311)
T ss_dssp --CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTT
T ss_pred --CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhc
Confidence 2223445689999999999877555579999999999999999999999887665555444321 000
Q ss_pred -------------------CCCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 236 -------------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 236 -------------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
..+.+++++.+||.+||++||.+|||+.|+++||||++-
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 112367899999999999999999999999999999863
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-52 Score=401.18 Aligned_cols=264 Identities=31% Similarity=0.632 Sum_probs=209.4
Q ss_pred CCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013081 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (450)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (450)
.+..+++|++++.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++.+.+.
T Consensus 6 ~g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 85 (278)
T 3cok_A 6 IGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNY 85 (278)
T ss_dssp HCSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSE
T ss_pred cccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCe
Confidence 35567899999999999999999999999999999999976543333445789999999999999999999999999999
Q ss_pred EEEEEccCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcc
Q 013081 89 IYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 167 (450)
.|+||||+++++|.+++... .++++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 86 VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 99999999999999999865 67999999999999999999999999999999999999999999999999999754321
Q ss_pred cCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 013081 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247 (450)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~L 247 (450)
.......+||+.|+|||++.+..+ +.++||||+|+++|+|++|+.||...+......++.......|..+++.+.+|
T Consensus 166 --~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 242 (278)
T 3cok_A 166 --HEKHYTLCGTPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDL 242 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHH
T ss_pred --CCcceeccCCCCcCCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHH
Confidence 122345689999999999877655 58999999999999999999999887766666666666777888899999999
Q ss_pred HHHccccCcCCCCCHHHHHhccccccCC
Q 013081 248 LRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 248 i~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
|.+||+.||.+|||+.++++||||....
T Consensus 243 i~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 243 IHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp HHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred HHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 9999999999999999999999998643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-52 Score=401.60 Aligned_cols=257 Identities=32% Similarity=0.496 Sum_probs=215.7
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 92 (450)
+++|++++.||+|+||.||+|.+ .+|+.||+|.+..... .......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence 57899999999999999999998 6789999999975542 222346788999999999999999999999999999999
Q ss_pred EccCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCC
Q 013081 93 LEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 171 (450)
|||+.+ +|.+.+... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~ 155 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI--PVR 155 (288)
T ss_dssp EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCc--ccc
Confidence 999975 999988764 6799999999999999999999999999999999999999999999999999874321 112
Q ss_pred ccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC--CC---------------
Q 013081 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DF--------------- 234 (450)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~--------------- 234 (450)
.....+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+......++.+. ..
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence 2345689999999999877655579999999999999999999999988877666655431 00
Q ss_pred ------------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 235 ------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 235 ------------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
..+..+++++.+||.+||++||++|||+.|+++||||++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 0123478999999999999999999999999999999853
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-51 Score=394.80 Aligned_cols=258 Identities=37% Similarity=0.685 Sum_probs=232.6
Q ss_pred CcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (450)
+...++|++.+.||+|+||.||+|.+..++..||+|.+.+..... .+.+.+|+.+++.++||||+++++++.+....
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (277)
T 3f3z_A 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDI 81 (277)
T ss_dssp -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeE
Confidence 345678999999999999999999999999999999997654333 56789999999999999999999999999999
Q ss_pred EEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEE---ccCCCeEEeecCCCCCCCc
Q 013081 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL---DSKGNIKISDFGLSALPQH 166 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl---~~~g~lkl~DFGla~~~~~ 166 (450)
|+||||++|++|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~- 160 (277)
T 3f3z_A 82 YLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK- 160 (277)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred EEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc-
Confidence 9999999999999999988899999999999999999999999999999999999999 788899999999997543
Q ss_pred ccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCC----CCCH
Q 013081 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK----WLSP 242 (450)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~ 242 (450)
........+||+.|+|||++.+. .+.++||||+|+++|+|++|..||...+......++..+....|. .+++
T Consensus 161 --~~~~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (277)
T 3f3z_A 161 --PGKMMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSP 236 (277)
T ss_dssp --TTSCBCCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCH
T ss_pred --CccchhccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCH
Confidence 22344567899999999998654 468999999999999999999999999988888888888877774 5899
Q ss_pred HHHHHHHHccccCcCCCCCHHHHHhccccccCC
Q 013081 243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
.+.+||.+||++||.+|||+.++++||||++..
T Consensus 237 ~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~ 269 (277)
T 3f3z_A 237 QAESLIRRLLTKSPKQRITSLQALEHEWFEKQL 269 (277)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence 999999999999999999999999999998643
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=415.94 Aligned_cols=265 Identities=21% Similarity=0.343 Sum_probs=220.6
Q ss_pred CcccCCeEEeeeeccc--CceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013081 10 GMRLGRYELGRTLGEG--NFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G--~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (450)
-...++|++++.||+| +||.||+|++..+|+.||||++..... .......+.+|+.+++.++||||+++++++.+.+
T Consensus 21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 99 (389)
T 3gni_B 21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN 99 (389)
T ss_dssp CCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC
Confidence 3456899999999999 999999999999999999999986544 3445688999999999999999999999999999
Q ss_pred EEEEEEccCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCC
Q 013081 88 KIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 165 (450)
..|+||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||.+....
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 999999999999999999875 679999999999999999999999999999999999999999999999999886432
Q ss_pred ccc-----CCCccccccCCCCccchhhhccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC------
Q 013081 166 HFR-----DDGLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD------ 233 (450)
Q Consensus 166 ~~~-----~~~~~~~~~gt~~y~APE~l~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------ 233 (450)
... ........+||+.|+|||++.+. ...+.++|||||||++|+|++|+.||.+.+.......+..+.
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence 110 11223345899999999998773 233689999999999999999999998755443333222111
Q ss_pred ----------------------------------------CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhcccccc
Q 013081 234 ----------------------------------------FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 234 ----------------------------------------~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
.+.+..+++.+.+||.+||++||.+|||+.|+++||||+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~ 339 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 339 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGG
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHH
Confidence 1234557899999999999999999999999999999986
Q ss_pred CC
Q 013081 274 DY 275 (450)
Q Consensus 274 ~~ 275 (450)
..
T Consensus 340 ~~ 341 (389)
T 3gni_B 340 IK 341 (389)
T ss_dssp C-
T ss_pred Hh
Confidence 53
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-51 Score=414.53 Aligned_cols=261 Identities=30% Similarity=0.578 Sum_probs=231.1
Q ss_pred CCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013081 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (450)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (450)
.+...++|++++.||+|+||.||+|.+..+|+.||+|++..... .....+.+|+.+++.++||||+++++++.+...
T Consensus 46 ~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 122 (387)
T 1kob_A 46 QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE 122 (387)
T ss_dssp CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred CCccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch---hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCE
Confidence 34566899999999999999999999999999999999976532 224678899999999999999999999999999
Q ss_pred EEEEEccCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEcc--CCCeEEeecCCCCCCC
Q 013081 89 IYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS--KGNIKISDFGLSALPQ 165 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~~i~~~~-~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~--~g~lkl~DFGla~~~~ 165 (450)
.|+||||++||+|.+++.... .+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 123 ~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 123 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecC
Confidence 999999999999999987644 7999999999999999999999999999999999999974 4679999999998543
Q ss_pred cccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCC----CCCC
Q 013081 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLS 241 (450)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s 241 (450)
........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+......++......++ ..++
T Consensus 203 ---~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 278 (387)
T 1kob_A 203 ---PDEIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVS 278 (387)
T ss_dssp ---TTSCEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSC
T ss_pred ---CCcceeeeccCCCccCchhccCCCC-CCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCC
Confidence 2234456789999999999987766 5899999999999999999999999988888888887765544 3589
Q ss_pred HHHHHHHHHccccCcCCCCCHHHHHhccccccCCC
Q 013081 242 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 276 (450)
Q Consensus 242 ~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~~ 276 (450)
+++.+||.+||+.||.+|||+.++++||||+....
T Consensus 279 ~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 279 PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 313 (387)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence 99999999999999999999999999999987543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-51 Score=392.97 Aligned_cols=259 Identities=37% Similarity=0.704 Sum_probs=231.9
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
..++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.++++++||||+++++++......|+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 82 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence 35799999999999999999999999999999999976554 33345788999999999999999999999999999999
Q ss_pred EEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCC---eEEeecCCCCCCCccc
Q 013081 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHFR 168 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~---lkl~DFGla~~~~~~~ 168 (450)
||||++|++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.....
T Consensus 83 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~-- 160 (284)
T 3kk8_A 83 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND-- 160 (284)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS--
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc--
Confidence 9999999999999998889999999999999999999999999999999999999987765 99999999975432
Q ss_pred CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHH
Q 013081 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGA 244 (450)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~ 244 (450)
........||+.|+|||++.+..+ +.++||||+|+++|+|++|..||.+.+.......+..+....| ..+++.+
T Consensus 161 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T 3kk8_A 161 -SEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA 238 (284)
T ss_dssp -SCBCCCSCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred -CccccCCCCCcCCcCchhhcCCCC-CcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHH
Confidence 223345689999999999987766 5899999999999999999999999998888888887766554 3589999
Q ss_pred HHHHHHccccCcCCCCCHHHHHhccccccCC
Q 013081 245 QNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
.+||.+||++||.+|||+.|+++||||....
T Consensus 239 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 239 KSLIDSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred HHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence 9999999999999999999999999998643
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-51 Score=399.87 Aligned_cols=259 Identities=28% Similarity=0.419 Sum_probs=217.8
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 92 (450)
+++|++++.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.++++++||||+++++++...+..|+|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 6899999999999999999999999999999999865432 334467788999999999999999999999999999999
Q ss_pred EccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCc
Q 013081 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 172 (450)
|||+++++|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... ....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~ 158 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG--PSDY 158 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccC--cccc
Confidence 99999999999988888899999999999999999999999999999999999999999999999999975432 2223
Q ss_pred cccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC--------------------
Q 013081 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-------------------- 232 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-------------------- 232 (450)
....+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 456689999999999887555579999999999999999999999988766554443321
Q ss_pred -CCCCC----------CCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 233 -DFKLP----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 233 -~~~~p----------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
..+.+ +.+++.+.+||.+||++||.+|||++|+++||||++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 291 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI 291 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTC
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhc
Confidence 11111 3478899999999999999999999999999999864
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-51 Score=426.96 Aligned_cols=263 Identities=35% Similarity=0.650 Sum_probs=231.1
Q ss_pred CCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccch----------hHHHHHHHHHHHHHhCCCCCcce
Q 013081 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL----------KITDQIKREIATLKLLKHPNVVR 78 (450)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~----------~~~~~~~~Ei~il~~l~hpnIv~ 78 (450)
.+...++|++++.||+|+||.||+|.+..+++.||+|++.+...... ...+.+.+|+.+++.++||||++
T Consensus 31 ~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~ 110 (504)
T 3q5i_A 31 EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIK 110 (504)
T ss_dssp CSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCC
T ss_pred CCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCe
Confidence 34456799999999999999999999999999999999986543221 23577899999999999999999
Q ss_pred EEEEEEeCCEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCC---CeEE
Q 013081 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---NIKI 155 (450)
Q Consensus 79 l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g---~lkl 155 (450)
+++++.+....|+|||||+||+|.+.+...+++++..++.++.||+.||.|||++||+||||||+|||++.++ .+||
T Consensus 111 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 111 LFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEE
Confidence 9999999999999999999999999999889999999999999999999999999999999999999999876 6999
Q ss_pred eecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCC
Q 013081 156 SDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK 235 (450)
Q Consensus 156 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~ 235 (450)
+|||+|..... .......+||+.|+|||++.+ .+ +.++||||+||++|+|++|.+||.+.+......++..+...
T Consensus 191 ~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 265 (504)
T 3q5i_A 191 VDFGLSSFFSK---DYKLRDRLGTAYYIAPEVLKK-KY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYY 265 (504)
T ss_dssp CCCTTCEECCT---TSCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred EECCCCEEcCC---CCccccccCCcCCCCHHHhcc-CC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Confidence 99999985432 234556789999999999864 45 68999999999999999999999999999999999988776
Q ss_pred CC----CCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCCC
Q 013081 236 LP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 276 (450)
Q Consensus 236 ~p----~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~~ 276 (450)
++ ..+|+.+.+||++||++||.+|||+.|+++||||+....
T Consensus 266 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 310 (504)
T 3q5i_A 266 FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN 310 (504)
T ss_dssp CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence 65 458999999999999999999999999999999987543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=433.81 Aligned_cols=260 Identities=30% Similarity=0.446 Sum_probs=232.9
Q ss_pred CcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (450)
....++|++++.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+|+.++||||+++++++.+....
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 259 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL 259 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEE
Confidence 45678999999999999999999999999999999999876543333456788999999999999999999999999999
Q ss_pred EEEEccCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcc
Q 013081 90 YMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~--~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 167 (450)
|+||||++||+|.+++...+ .+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|....
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~-- 337 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVP-- 337 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecc--
Confidence 99999999999999998754 49999999999999999999999999999999999999999999999999997543
Q ss_pred cCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCC----cHHHHHHHHHhCCCCCCCCCCHH
Q 013081 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR----NLAVLYQKIFRGDFKLPKWLSPG 243 (450)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s~~ 243 (450)
........+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+. ....+...+......+|..++++
T Consensus 338 -~~~~~~~~~GT~~Y~APEvl~~~~~-~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~ 415 (576)
T 2acx_A 338 -EGQTIKGRVGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQ 415 (576)
T ss_dssp -TTCCEECCCSCGGGCCHHHHTTCEE-SSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred -cCccccccCCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHH
Confidence 2233456799999999999988776 58999999999999999999999875 34567777777788888999999
Q ss_pred HHHHHHHccccCcCCCC-----CHHHHHhcccccc
Q 013081 244 AQNLLRKILEPNPVKRI-----TIAGIKADEWFEQ 273 (450)
Q Consensus 244 ~~~Li~~~L~~dP~~R~-----t~~~il~h~~~~~ 273 (450)
+.+||.+||++||.+|| +++++++||||+.
T Consensus 416 ~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 416 ARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp HHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred HHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence 99999999999999999 8999999999975
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-52 Score=412.36 Aligned_cols=251 Identities=37% Similarity=0.656 Sum_probs=222.3
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~l 91 (450)
.++|++++.||+|+||.||+|.+..+|+.||+|++.+... ...+|+.++.++ +||||+++++++.+....|+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 4689999999999999999999999999999999976542 234688888887 79999999999999999999
Q ss_pred EEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccC-C---CeEEeecCCCCCCCcc
Q 013081 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-G---NIKISDFGLSALPQHF 167 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~-g---~lkl~DFGla~~~~~~ 167 (450)
||||++||+|.+.+...+.+++.+++.++.||+.||+|||++||+||||||+|||+.++ + .+||+|||++.....
T Consensus 94 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~- 172 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA- 172 (342)
T ss_dssp EECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC-
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC-
Confidence 99999999999999988899999999999999999999999999999999999998543 3 499999999985432
Q ss_pred cCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCC---CcHHHHHHHHHhCCCCCC----CCC
Q 013081 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD---RNLAVLYQKIFRGDFKLP----KWL 240 (450)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~---~~~~~~~~~i~~~~~~~p----~~~ 240 (450)
......+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+ .+...+...+..+.+.++ ..+
T Consensus 173 -~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 250 (342)
T 2qr7_A 173 -ENGLLMTPCYTANFVAPEVLERQGY-DAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV 250 (342)
T ss_dssp -TTCCBCCSSCCSSCCCHHHHHHHHH-HHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTS
T ss_pred -CCCceeccCCCccccCHHHhcCCCC-CCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccC
Confidence 2334567799999999999987666 4899999999999999999999986 456677888888877655 458
Q ss_pred CHHHHHHHHHccccCcCCCCCHHHHHhcccccc
Q 013081 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 241 s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
++.+.+||++||++||.+|||+.++++||||..
T Consensus 251 s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 251 SDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 999999999999999999999999999999964
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-51 Score=430.89 Aligned_cols=262 Identities=27% Similarity=0.441 Sum_probs=234.1
Q ss_pred CCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013081 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (450)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (450)
.....++|++++.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+...
T Consensus 180 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 259 (543)
T 3c4z_A 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD 259 (543)
T ss_dssp SCCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ccCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCE
Confidence 45667899999999999999999999999999999999987654433445778899999999999999999999999999
Q ss_pred EEEEEccCCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCC
Q 013081 89 IYMVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP 164 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~~i~~~----~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~ 164 (450)
.|+||||++||+|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||++...
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 99999999999999999763 36999999999999999999999999999999999999999999999999999854
Q ss_pred CcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCC----cHHHHHHHHHhCCCCCCCCC
Q 013081 165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR----NLAVLYQKIFRGDFKLPKWL 240 (450)
Q Consensus 165 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~----~~~~~~~~i~~~~~~~p~~~ 240 (450)
.. ........+||+.|+|||++.+..| +.++|||||||++|+|++|+.||.+. ....+...+......+|..+
T Consensus 340 ~~--~~~~~~~~~GT~~Y~APE~l~~~~~-~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~ 416 (543)
T 3c4z_A 340 KA--GQTKTKGYAGTPGFMAPELLLGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKF 416 (543)
T ss_dssp CT--TCCCBCCCCSCTTTSCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTS
T ss_pred cC--CCcccccccCCccccChhhhcCCCC-ChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCccc
Confidence 32 1223345699999999999988777 58999999999999999999999875 45677888888888899999
Q ss_pred CHHHHHHHHHccccCcCCCCC-----HHHHHhcccccc
Q 013081 241 SPGAQNLLRKILEPNPVKRIT-----IAGIKADEWFEQ 273 (450)
Q Consensus 241 s~~~~~Li~~~L~~dP~~R~t-----~~~il~h~~~~~ 273 (450)
++.+.+||.+||++||.+||+ ++++++||||+.
T Consensus 417 s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 417 SPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred CHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence 999999999999999999996 589999999975
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-51 Score=415.43 Aligned_cols=261 Identities=31% Similarity=0.425 Sum_probs=211.4
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCC--
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKS-- 87 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~-- 87 (450)
..+++|++++.||+|+||.||+|.+..+|+.||||.+.+.. ........+.+|+.+++.+. ||||+++++++...+
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 34689999999999999999999999999999999986542 23444678889999999997 999999999997544
Q ss_pred EEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcc
Q 013081 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 167 (450)
.+|+||||+. ++|.+.+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred EEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 7899999997 589988876 67999999999999999999999999999999999999999999999999999754221
Q ss_pred -------------------cCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHH
Q 013081 168 -------------------RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQK 228 (450)
Q Consensus 168 -------------------~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~ 228 (450)
.........+||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+......+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 242 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 0112334568999999999998755557999999999999999999999999887776666
Q ss_pred HHhC-CC----------------------------------------------CCCCCCCHHHHHHHHHccccCcCCCCC
Q 013081 229 IFRG-DF----------------------------------------------KLPKWLSPGAQNLLRKILEPNPVKRIT 261 (450)
Q Consensus 229 i~~~-~~----------------------------------------------~~p~~~s~~~~~Li~~~L~~dP~~R~t 261 (450)
+... .. ..+..+++++.+||.+||+.||.+|||
T Consensus 243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t 322 (388)
T 3oz6_A 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322 (388)
T ss_dssp HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence 5421 00 011257899999999999999999999
Q ss_pred HHHHHhccccccC
Q 013081 262 IAGIKADEWFEQD 274 (450)
Q Consensus 262 ~~~il~h~~~~~~ 274 (450)
++|+++||||..-
T Consensus 323 ~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 323 ANDALKHPFVSIF 335 (388)
T ss_dssp HHHHTTSTTTTTT
T ss_pred HHHHhCCHHHHHh
Confidence 9999999999754
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=406.66 Aligned_cols=253 Identities=38% Similarity=0.730 Sum_probs=204.6
Q ss_pred cCCeEEe---eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCE
Q 013081 13 LGRYELG---RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSK 88 (450)
Q Consensus 13 ~~~y~i~---~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~ 88 (450)
+.+|++. +.||+|+||.||+|.+..+|+.||||++.+.. ...+.+|+.+++.+. ||||+++++++.+...
T Consensus 7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~ 80 (325)
T 3kn6_A 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLCEGHPNIVKLHEVFHDQLH 80 (325)
T ss_dssp HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCE
Confidence 4678885 78999999999999999999999999996532 467789999999997 9999999999999999
Q ss_pred EEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCC---CeEEeecCCCCCCC
Q 013081 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQ 165 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g---~lkl~DFGla~~~~ 165 (450)
.|+||||++||+|.+++...+++++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~ 160 (325)
T 3kn6_A 81 TFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP 160 (325)
T ss_dssp EEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECC
T ss_pred EEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecC
Confidence 999999999999999999988999999999999999999999999999999999999998766 79999999997543
Q ss_pred cccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCc-------HHHHHHHHHhCCCCCCC
Q 013081 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-------LAVLYQKIFRGDFKLPK 238 (450)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~-------~~~~~~~i~~~~~~~p~ 238 (450)
. ........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+ ......++..+.+.++.
T Consensus 161 ~--~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 237 (325)
T 3kn6_A 161 P--DNQPLKTPCFTLHYAAPELLNQNGY-DESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG 237 (325)
T ss_dssp C------------------------CCC-CHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCS
T ss_pred C--CCCcccccCCCcCccCHHHhcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCc
Confidence 2 2234456789999999999987776 589999999999999999999998643 34667777777766653
Q ss_pred ----CCCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 239 ----WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 239 ----~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
.+++++.+||.+||++||.+|||+.++++||||+..
T Consensus 238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 489999999999999999999999999999999864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=407.78 Aligned_cols=263 Identities=27% Similarity=0.405 Sum_probs=214.1
Q ss_pred cCCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013081 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (450)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (450)
+....+++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.++++++||||+++++++.+..
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (329)
T 3gbz_A 28 PSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH 106 (329)
T ss_dssp ----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETT
T ss_pred CcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence 455778999999999999999999999999999999999975543 2233567789999999999999999999999999
Q ss_pred EEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEc-----cCCCeEEeecCCCC
Q 013081 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-----SKGNIKISDFGLSA 162 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~-----~~g~lkl~DFGla~ 162 (450)
..|+||||+.| +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 107 ~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 107 RLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 99999999975 9999999988999999999999999999999999999999999999995 44559999999997
Q ss_pred CCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC--CCC-----
Q 013081 163 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFK----- 235 (450)
Q Consensus 163 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~----- 235 (450)
.... ........+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+......++... ...
T Consensus 186 ~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (329)
T 3gbz_A 186 AFGI--PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP 263 (329)
T ss_dssp HHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred ccCC--cccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhh
Confidence 5322 1223445678999999999987665579999999999999999999999998877766666532 110
Q ss_pred ----CCC-------------------CCCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 236 ----LPK-------------------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 236 ----~p~-------------------~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
.+. .+++++.+||.+||++||.+|||+.|+++||||+..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 011 167899999999999999999999999999999864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=400.33 Aligned_cols=260 Identities=34% Similarity=0.581 Sum_probs=231.9
Q ss_pred CcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccch---hHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---KITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (450)
....++|++++.||+|+||.||+|.+..+|+.||+|++........ ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 87 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR 87 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 3445789999999999999999999999999999999976543221 1256789999999999999999999999999
Q ss_pred CEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCC----CeEEeecCCCC
Q 013081 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG----NIKISDFGLSA 162 (450)
Q Consensus 87 ~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g----~lkl~DFGla~ 162 (450)
...|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 99999999999999999999888899999999999999999999999999999999999999888 79999999997
Q ss_pred CCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCC----C
Q 013081 163 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----K 238 (450)
Q Consensus 163 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~ 238 (450)
.... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.......+ .
T Consensus 168 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (321)
T 2a2a_A 168 EIED---GVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS 243 (321)
T ss_dssp ECCT---TCCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred ecCc---cccccccCCCCCccCcccccCCCC-CCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhc
Confidence 5432 223345679999999999887666 5899999999999999999999999988888888887766655 4
Q ss_pred CCCHHHHHHHHHccccCcCCCCCHHHHHhcccccc
Q 013081 239 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 239 ~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
.+++.+.+||.+||++||.+|||+.++++||||..
T Consensus 244 ~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~ 278 (321)
T 2a2a_A 244 HTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (321)
T ss_dssp TCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred ccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence 68999999999999999999999999999999974
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=429.28 Aligned_cols=259 Identities=37% Similarity=0.664 Sum_probs=232.9
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
..++|++++.||+|+||.||+|.+..+|+.||||++.+...........+.+|+.++++++||||+++++++.+....|+
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 34689999999999999999999999999999999987655444446789999999999999999999999999999999
Q ss_pred EEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEE---ccCCCeEEeecCCCCCCCccc
Q 013081 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL---DSKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl---~~~g~lkl~DFGla~~~~~~~ 168 (450)
||||+.||+|.+.+...+++++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|....
T Consensus 104 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~--- 180 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--- 180 (484)
T ss_dssp EECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC---
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc---
Confidence 99999999999999998999999999999999999999999999999999999999 567899999999997532
Q ss_pred CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCC--CC--CCCHHH
Q 013081 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL--PK--WLSPGA 244 (450)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~--p~--~~s~~~ 244 (450)
........+||+.|+|||++.+ .+ +.++||||+||++|+|++|.+||.+.+......++..+...+ |. .+|+.+
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 258 (484)
T 3nyv_A 181 ASKKMKDKIGTAYYIAPEVLHG-TY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESA 258 (484)
T ss_dssp CCCSHHHHTTGGGTCCHHHHHT-CC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHH
T ss_pred cccccccCCCCccccCceeecC-CC-CCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHH
Confidence 2334556789999999999865 45 589999999999999999999999999999999998886544 33 389999
Q ss_pred HHHHHHccccCcCCCCCHHHHHhccccccCC
Q 013081 245 QNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
.+||++||++||.+|||+.++++||||+...
T Consensus 259 ~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 259 KDLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred HHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 9999999999999999999999999998643
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-51 Score=393.39 Aligned_cols=262 Identities=39% Similarity=0.679 Sum_probs=227.2
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 92 (450)
+++|++++.||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch--hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence 57899999999999999999999999999999999765432 2357889999999999999999999999999999999
Q ss_pred EccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCc
Q 013081 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 172 (450)
|||++|++|.+++.....+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++...........
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 163 (276)
T 2yex_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (276)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhc
Confidence 99999999999998878899999999999999999999999999999999999999999999999999975433222233
Q ss_pred cccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHH-HHHHHHHhCCCCCC--CCCCHHHHHHHH
Q 013081 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKIFRGDFKLP--KWLSPGAQNLLR 249 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~p--~~~s~~~~~Li~ 249 (450)
....+||+.|+|||++.+..+.+.++||||+|+++|+|++|..||...+.. ..+..+.......+ ..+++.+.+||.
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 243 (276)
T 2yex_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243 (276)
T ss_dssp BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHH
T ss_pred ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHH
Confidence 456789999999999988777678899999999999999999999876543 23334443333233 458999999999
Q ss_pred HccccCcCCCCCHHHHHhccccccCCC
Q 013081 250 KILEPNPVKRITIAGIKADEWFEQDYT 276 (450)
Q Consensus 250 ~~L~~dP~~R~t~~~il~h~~~~~~~~ 276 (450)
+||+.||.+|||+.++++||||++...
T Consensus 244 ~~l~~~p~~Rps~~~il~~~~~~~~~~ 270 (276)
T 2yex_A 244 KILVENPSARITIPDIKKDRWYNKPLK 270 (276)
T ss_dssp HHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHCCCCchhCCCHHHHhcCccccChhh
Confidence 999999999999999999999986543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-51 Score=426.33 Aligned_cols=262 Identities=37% Similarity=0.655 Sum_probs=230.2
Q ss_pred CCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013081 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (450)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (450)
.+...++|++++.||+|+||.||+|.+..+++.||||++.+...... ....+.+|+.++++++||||+++++++.+...
T Consensus 17 ~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 95 (486)
T 3mwu_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDHPNIMKLFEILEDSSS 95 (486)
T ss_dssp CCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccch-HHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCE
Confidence 34556799999999999999999999999999999999976443222 25778999999999999999999999999999
Q ss_pred EEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEc---cCCCeEEeecCCCCCCC
Q 013081 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD---SKGNIKISDFGLSALPQ 165 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~---~~g~lkl~DFGla~~~~ 165 (450)
+|+||||+.||+|.+.+...+++++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 96 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 999999999999999998889999999999999999999999999999999999999995 45679999999998543
Q ss_pred cccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCC--CC--CCC
Q 013081 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL--PK--WLS 241 (450)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~--p~--~~s 241 (450)
. .......+||+.|+|||++.+ .| +.++||||+||++|+|++|.+||.+.+......++..+...+ |. .+|
T Consensus 176 ~---~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 250 (486)
T 3mwu_A 176 Q---NTKMKDRIGTAYYIAPEVLRG-TY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTIS 250 (486)
T ss_dssp C---C----CCTTGGGGCCGGGGGS-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSC
T ss_pred C---CCccCCCcCCCCCCCHHHhCC-CC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCC
Confidence 2 233456789999999999875 34 689999999999999999999999999999888888876544 33 389
Q ss_pred HHHHHHHHHccccCcCCCCCHHHHHhccccccCCC
Q 013081 242 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 276 (450)
Q Consensus 242 ~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~~ 276 (450)
+.+.+||.+||++||.+|||+.++++||||+....
T Consensus 251 ~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 251 DDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 99999999999999999999999999999987543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=391.41 Aligned_cols=259 Identities=36% Similarity=0.625 Sum_probs=222.1
Q ss_pred cCCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013081 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (450)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (450)
..+...++|++.+.||+|+||.||+|.+..++..||+|++....... ..+.+.+|+.+++.++||||+++++++.+..
T Consensus 16 ~~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 93 (285)
T 3is5_A 16 FQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV--PMEQIEAEIEVLKSLDHPNIIKIFEVFEDYH 93 (285)
T ss_dssp ESSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CCCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccch--hHHHHHHHHHHHHhCCCchHHhHHHheecCC
Confidence 34556689999999999999999999999999999999997654322 2578899999999999999999999999999
Q ss_pred EEEEEEccCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEE---ccCCCeEEeecCC
Q 013081 88 KIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL---DSKGNIKISDFGL 160 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~----~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl---~~~g~lkl~DFGl 160 (450)
..|+||||++||+|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~ 173 (285)
T 3is5_A 94 NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGL 173 (285)
T ss_dssp EEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCC
T ss_pred eEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeec
Confidence 99999999999999998854 3679999999999999999999999999999999999999 4567899999999
Q ss_pred CCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCC---
Q 013081 161 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP--- 237 (450)
Q Consensus 161 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p--- 237 (450)
+..... .......+||+.|+|||++.. .+ +.++|||||||++|+|++|..||.+.+...............+
T Consensus 174 a~~~~~---~~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (285)
T 3is5_A 174 AELFKS---DEHSTNAAGTALYMAPEVFKR-DV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVEC 248 (285)
T ss_dssp CCC-------------CTTGGGCCHHHHTT-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--
T ss_pred ceecCC---cccCcCcccccCcCChHHhcc-CC-CcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccccccc
Confidence 985432 223456689999999999753 44 5899999999999999999999999888887777766554443
Q ss_pred CCCCHHHHHHHHHccccCcCCCCCHHHHHhcccccc
Q 013081 238 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 238 ~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
..+++.+.+||.+||++||.+|||+.|+++||||++
T Consensus 249 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 249 RPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred CcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 237899999999999999999999999999999975
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-51 Score=424.78 Aligned_cols=256 Identities=35% Similarity=0.662 Sum_probs=223.8
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
..++|++++.||+|+||.||+|++..++..||+|++.+...... ....+.+|+.+++.++||||+++++++.+....|+
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 113 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS-SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL 113 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C-TTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch-HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34579999999999999999999999999999999986543222 24678899999999999999999999999999999
Q ss_pred EEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccC---CCeEEeecCCCCCCCccc
Q 013081 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHFR 168 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~---g~lkl~DFGla~~~~~~~ 168 (450)
|||||+||+|.+.+....++++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|.....
T Consensus 114 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~-- 191 (494)
T 3lij_A 114 VMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN-- 191 (494)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT--
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC--
Confidence 99999999999999988999999999999999999999999999999999999999764 4599999999985432
Q ss_pred CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHH
Q 013081 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGA 244 (450)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~ 244 (450)
.......+||+.|+|||++.. .| +.++||||+||++|+|++|.+||.+.+......++..+...++ ..+|+.+
T Consensus 192 -~~~~~~~~gt~~y~aPE~l~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 268 (494)
T 3lij_A 192 -QKKMKERLGTAYYIAPEVLRK-KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGA 268 (494)
T ss_dssp -TBCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHH
T ss_pred -CccccccCCCcCeeCHHHHcc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHH
Confidence 233456789999999999863 45 5899999999999999999999999999999999988876554 3489999
Q ss_pred HHHHHHccccCcCCCCCHHHHHhcccccc
Q 013081 245 QNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
.+||++||++||.+|||+.++++||||+.
T Consensus 269 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 269 KDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred HHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 99999999999999999999999999975
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=397.05 Aligned_cols=259 Identities=31% Similarity=0.410 Sum_probs=215.4
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeeccccc--chhHHHHHHHHHHHHHhCC---CCCcceEEEEEEe
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII--HLKITDQIKREIATLKLLK---HPNVVRLHEVLAS 85 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~ 85 (450)
...++|++++.||+|+||.||+|++..+|+.||+|++...... .......+.+|+.++++++ ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 4458999999999999999999999999999999999754321 1112345677888877775 9999999999977
Q ss_pred CC-----EEEEEEccCCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeec
Q 013081 86 KS-----KIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDF 158 (450)
Q Consensus 86 ~~-----~~~lv~E~~~gg~L~~~i~~~~~--l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DF 158 (450)
.. ..|++|||+. ++|.+++..... +++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence 55 5899999996 599999987654 999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC--CC-
Q 013081 159 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FK- 235 (450)
Q Consensus 159 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~- 235 (450)
|++..... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+......++.... .+
T Consensus 165 g~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (308)
T 3g33_A 165 GLARIYSY---QMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 240 (308)
T ss_dssp SCTTTSTT---CCCSGGGGCCCSSCCHHHHHTSCC-CSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred ccccccCC---CcccCCccccccccCchHHcCCCC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 99985432 233456789999999999987776 589999999999999999999999988877777665421 00
Q ss_pred ------------------------CCCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 236 ------------------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 236 ------------------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
..+.+++.+.+||.+||++||.+|||+.|+++||||++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 012468899999999999999999999999999999864
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=396.06 Aligned_cols=260 Identities=34% Similarity=0.587 Sum_probs=218.5
Q ss_pred cccCCeEEe-eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 013081 11 MRLGRYELG-RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSK 88 (450)
Q Consensus 11 ~~~~~y~i~-~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 88 (450)
..-++|++. +.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++++ +||||+++++++.+.+.
T Consensus 9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~ 85 (316)
T 2ac3_A 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDR 85 (316)
T ss_dssp CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS---CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 345689995 789999999999999999999999999976532 2256788999999985 79999999999999999
Q ss_pred EEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCC---eEEeecCCCCCCC
Q 013081 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQ 165 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~---lkl~DFGla~~~~ 165 (450)
.|+||||++|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 9999999999999999998889999999999999999999999999999999999999998876 9999999987543
Q ss_pred cccC-----CCccccccCCCCccchhhhcc-----CCCCCccchhhhHHHHHHHHHhCCCCCCCCc--------------
Q 013081 166 HFRD-----DGLLHTTCGSPNYVAPEVLAN-----RGYDGATSDIWSCGVILYVILTGYLPFDDRN-------------- 221 (450)
Q Consensus 166 ~~~~-----~~~~~~~~gt~~y~APE~l~~-----~~~~~~~~DiwSlGvil~elltG~~Pf~~~~-------------- 221 (450)
.... .......+||+.|+|||++.. ..+ +.++|||||||++|+|++|..||.+.+
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIY-DKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHH-TTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCC-CcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 2111 112335679999999999864 234 589999999999999999999998753
Q ss_pred -HHHHHHHHHhCCCCCC----CCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 222 -LAVLYQKIFRGDFKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 222 -~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
.......+..+...+| ..+++.+.+||.+||+.||.+|||+.++++||||+..
T Consensus 245 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 302 (316)
T 2ac3_A 245 CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302 (316)
T ss_dssp HHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred HHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence 2345667777777766 3589999999999999999999999999999999854
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-51 Score=423.46 Aligned_cols=256 Identities=28% Similarity=0.440 Sum_probs=212.8
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK----- 86 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 86 (450)
..++|++++.||+|+||.||+|.+..+|+.||||++.+.. .......++.+|+.+++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 3589999999999999999999999999999999997653 2344567899999999999999999999999654
Q ss_pred -CEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCC
Q 013081 87 -SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (450)
Q Consensus 87 -~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 165 (450)
..+|+||||+.+ +|.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+...
T Consensus 139 ~~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 139 FQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp CCEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred CCeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 468999999976 5767664 359999999999999999999999999999999999999999999999999998543
Q ss_pred cccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC-C----------
Q 013081 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-F---------- 234 (450)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~---------- 234 (450)
........+||+.|+|||++.+..| +.++|||||||++|+|++|++||.+.+....+.++.... .
T Consensus 216 ---~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 216 ---TSFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp ----CCCC----CCCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred ---CCcccCCCcccccccCHHHHcCCCC-CHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 2234566799999999999988877 489999999999999999999999988777666654320 0
Q ss_pred ----------------CCCCCC---------------CHHHHHHHHHccccCcCCCCCHHHHHhccccccCC
Q 013081 235 ----------------KLPKWL---------------SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 235 ----------------~~p~~~---------------s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
.+|..+ ++++.+||.+||++||.+|||++|+|+||||+...
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~ 363 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 363 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhcc
Confidence 000001 56799999999999999999999999999998644
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=403.51 Aligned_cols=255 Identities=35% Similarity=0.668 Sum_probs=209.9
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
.-++|++.+.||+|+||.||+|.+..+++.||||++.... ..+.+.+|+.++++++||||+++++++.+....|+
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 125 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL 125 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence 3468999999999999999999999999999999997543 13568899999999999999999999999999999
Q ss_pred EEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEcc---CCCeEEeecCCCCCCCccc
Q 013081 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS---KGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~---~g~lkl~DFGla~~~~~~~ 168 (450)
||||++|++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 126 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~-- 203 (349)
T 2w4o_A 126 VLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH-- 203 (349)
T ss_dssp EECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc--
Confidence 9999999999999998888999999999999999999999999999999999999975 88999999999985432
Q ss_pred CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHH-HHHHHHHhCCCCCC----CCCCHH
Q 013081 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKIFRGDFKLP----KWLSPG 243 (450)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~p----~~~s~~ 243 (450)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.... ..+..+.......+ ..+++.
T Consensus 204 -~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 281 (349)
T 2w4o_A 204 -QVLMKTVCGTPGYCAPEILRGCAY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLN 281 (349)
T ss_dssp ----------CGGGSCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHH
T ss_pred -ccccccccCCCCccCHHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHH
Confidence 223456789999999999987766 58999999999999999999999776544 46667776654433 348999
Q ss_pred HHHHHHHccccCcCCCCCHHHHHhccccccCC
Q 013081 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 244 ~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
+.+||.+||+.||++|||+.++++||||....
T Consensus 282 ~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 282 AKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 99999999999999999999999999998643
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-51 Score=403.77 Aligned_cols=259 Identities=25% Similarity=0.395 Sum_probs=213.4
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 92 (450)
+++|++++.||+|+||.||+|.+..+++.||+|++....... ....+.+|+.+++.++||||+++++++.+....|+|
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccc--cchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence 578999999999999999999999999999999996543211 122455799999999999999999999999999999
Q ss_pred EccCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCC
Q 013081 93 LEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~~~-~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 171 (450)
|||+. |+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~--~~~ 155 (324)
T 3mtl_A 79 FEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSI--PTK 155 (324)
T ss_dssp EECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred ecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccC--Ccc
Confidence 99997 58988887644 599999999999999999999999999999999999999999999999999975432 222
Q ss_pred ccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC--C---------------
Q 013081 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--F--------------- 234 (450)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~--------------- 234 (450)
.....+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+.+.. .
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence 34456889999999998875555789999999999999999999999988777666654421 0
Q ss_pred --C-----------CCCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCCC
Q 013081 235 --K-----------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 276 (450)
Q Consensus 235 --~-----------~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~~ 276 (450)
. .++.+++++.+||.+||++||.+|||++|+++||||.....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 0 01236889999999999999999999999999999986543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=403.96 Aligned_cols=267 Identities=26% Similarity=0.376 Sum_probs=222.9
Q ss_pred CCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe---
Q 013081 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--- 85 (450)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--- 85 (450)
....+++|++++.||+|+||.||+|++..+|+.||+|++....... .....+.+|+.+++.++||||+++++++..
T Consensus 12 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 90 (351)
T 3mi9_A 12 FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKAS 90 (351)
T ss_dssp TSCBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred ccccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhccCCCcccHhheeecccc
Confidence 3456799999999999999999999999999999999986654322 224567899999999999999999999876
Q ss_pred -----CCEEEEEEccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecC
Q 013081 86 -----KSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFG 159 (450)
Q Consensus 86 -----~~~~~lv~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFG 159 (450)
.+..|+||||+.| +|.+.+.. ...+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 91 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 91 PYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp ------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred ccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccch
Confidence 4568999999975 77777765 3579999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCccc--CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCC
Q 013081 160 LSALPQHFR--DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP 237 (450)
Q Consensus 160 la~~~~~~~--~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p 237 (450)
+|....... ........+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.......+
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 997543211 122344568999999999987766557999999999999999999999999888777666654321111
Q ss_pred CC--------------------------------CCHHHHHHHHHccccCcCCCCCHHHHHhccccccCCCC
Q 013081 238 KW--------------------------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277 (450)
Q Consensus 238 ~~--------------------------------~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~~~ 277 (450)
.. .++.+.+||.+||+.||.+|||++|+++||||.....+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 321 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP 321 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCC
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCc
Confidence 11 26789999999999999999999999999999875543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-50 Score=394.48 Aligned_cols=254 Identities=26% Similarity=0.452 Sum_probs=223.7
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEc
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 94 (450)
.|+..+.||+|+||.||+|.+..+|+.||||++....... .+.+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS---HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 4888999999999999999999999999999997654322 4678899999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccc
Q 013081 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH 174 (450)
Q Consensus 95 ~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 174 (450)
|++|++|.+++.. .++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ......
T Consensus 123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~ 199 (321)
T 2c30_A 123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK--DVPKRK 199 (321)
T ss_dssp CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--SSCCBC
T ss_pred cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeeccc--Cccccc
Confidence 9999999998864 5799999999999999999999999999999999999999999999999999875432 122334
Q ss_pred cccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCC---CCCCCCHHHHHHHHHc
Q 013081 175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK---LPKWLSPGAQNLLRKI 251 (450)
Q Consensus 175 ~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~~~Li~~~ 251 (450)
..+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.....+ .+..+++.+.+||.+|
T Consensus 200 ~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 278 (321)
T 2c30_A 200 SLVGTPYWMAPEVISRSLY-ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERM 278 (321)
T ss_dssp CCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHH
T ss_pred cccCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHH
Confidence 5689999999999987666 58999999999999999999999998887777777665332 2335889999999999
Q ss_pred cccCcCCCCCHHHHHhccccccCC
Q 013081 252 LEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 252 L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
|+.||.+|||+.++++||||.+..
T Consensus 279 l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 279 LVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp SCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred ccCChhhCcCHHHHhcChhhccCC
Confidence 999999999999999999998643
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=407.68 Aligned_cols=255 Identities=30% Similarity=0.508 Sum_probs=224.6
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccch-----hHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL-----KITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~-----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 85 (450)
...++|++++.||+|+||.||+|.+..+++.||||++.+...... .....+.+|+.+++.++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 345789999999999999999999999999999999987543221 123457789999999999999999999999
Q ss_pred CCEEEEEEccCCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCC
Q 013081 86 KSKIYMVLEYVTGG-ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP 164 (450)
Q Consensus 86 ~~~~~lv~E~~~gg-~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~ 164 (450)
.+..|+||||+.+| +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 99999999998766 99999998889999999999999999999999999999999999999999999999999999854
Q ss_pred CcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHH
Q 013081 165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244 (450)
Q Consensus 165 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~ 244 (450)
.. .......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||..... ........|..+++.+
T Consensus 181 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~~~~~~~~~~l 251 (335)
T 3dls_A 181 ER---GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAIHPPYLVSKEL 251 (335)
T ss_dssp CT---TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTCCCCSSCCCHHH
T ss_pred CC---CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhccCCCcccCHHH
Confidence 32 23445678999999999998888877899999999999999999999976332 2334456677799999
Q ss_pred HHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 245 QNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
.+||.+||++||.+|||+.++++||||.+.
T Consensus 252 ~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 252 MSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred HHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 999999999999999999999999999864
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=395.34 Aligned_cols=265 Identities=37% Similarity=0.676 Sum_probs=229.0
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccc-hhHHHHHHHHHHHHHhCCCCCcceEEEEE--EeCCE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH-LKITDQIKREIATLKLLKHPNVVRLHEVL--ASKSK 88 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~--~~~~~ 88 (450)
.+++|++++.||+|+||.||+|.+..+++.||+|++....... ......+.+|+.+++.++||||+++++++ .+...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 4689999999999999999999999999999999997643221 23357899999999999999999999998 44568
Q ss_pred EEEEEccCCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCc
Q 013081 89 IYMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~~i~~--~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 166 (450)
.|+||||+.++ |.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 89999999876 7777765 45799999999999999999999999999999999999999999999999999986543
Q ss_pred ccCCCccccccCCCCccchhhhccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHH
Q 013081 167 FRDDGLLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQ 245 (450)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 245 (450)
...........||+.|+|||++.+.. +.+.++||||||+++|+|++|..||.+.+.......+..+....|..+++.+.
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 241 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLS 241 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHHH
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHHH
Confidence 33333445667999999999987533 33578999999999999999999999999888889998998889999999999
Q ss_pred HHHHHccccCcCCCCCHHHHHhccccccCCCC
Q 013081 246 NLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277 (450)
Q Consensus 246 ~Li~~~L~~dP~~R~t~~~il~h~~~~~~~~~ 277 (450)
+||.+||+.||.+|||+.++++||||+....+
T Consensus 242 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 273 (305)
T 2wtk_C 242 DLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP 273 (305)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC
T ss_pred HHHHHHccCChhhCCCHHHHhcCcccccCCCC
Confidence 99999999999999999999999999876543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=418.68 Aligned_cols=261 Identities=30% Similarity=0.393 Sum_probs=201.0
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-----CC
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-----KS 87 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----~~ 87 (450)
-++|++++.||+|+||.||+|.+..+|+.||||++.+.. .+....+++.+|+.+|+.++||||+++++++.. ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 378999999999999999999999999999999996543 334446789999999999999999999999843 35
Q ss_pred EEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcc
Q 013081 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 167 (450)
.+|+||||+ +++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 209 (458)
T 3rp9_A 131 ELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209 (458)
T ss_dssp CEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred eEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence 799999998 5799999998889999999999999999999999999999999999999999999999999999865321
Q ss_pred cCC-------------------------CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh----------
Q 013081 168 RDD-------------------------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT---------- 212 (450)
Q Consensus 168 ~~~-------------------------~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt---------- 212 (450)
... ......+||+.|+|||++.....++.++|||||||++|+|++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~ 289 (458)
T 3rp9_A 210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA 289 (458)
T ss_dssp TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGG
T ss_pred cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccc
Confidence 110 123456899999999987555545799999999999999999
Q ss_pred -CCCCCCCCcH--------------------HHHHHHHHh--C--------------------CC---------CCCCCC
Q 013081 213 -GYLPFDDRNL--------------------AVLYQKIFR--G--------------------DF---------KLPKWL 240 (450)
Q Consensus 213 -G~~Pf~~~~~--------------------~~~~~~i~~--~--------------------~~---------~~p~~~ 240 (450)
|.+||.+.+. ......+.. + .+ ...+.+
T Consensus 290 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (458)
T 3rp9_A 290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPAS 369 (458)
T ss_dssp GCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTS
T ss_pred cccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCC
Confidence 7777766431 111111110 0 00 011336
Q ss_pred CHHHHHHHHHccccCcCCCCCHHHHHhccccccCC
Q 013081 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 241 s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
++++.+||++||++||.+|||++|+|+||||+...
T Consensus 370 s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~ 404 (458)
T 3rp9_A 370 SADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404 (458)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred CHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence 89999999999999999999999999999998643
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-50 Score=391.24 Aligned_cols=261 Identities=25% Similarity=0.389 Sum_probs=223.8
Q ss_pred CcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (450)
...-++|++++.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 86 (294)
T 4eqm_A 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY 86 (294)
T ss_dssp SCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEE
T ss_pred hHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeE
Confidence 34457899999999999999999999999999999999776666666678899999999999999999999999999999
Q ss_pred EEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC
Q 013081 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 169 (450)
|+||||++|++|.+++...+++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 87 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~ 165 (294)
T 4eqm_A 87 YLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET-S 165 (294)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc-c
Confidence 999999999999999998899999999999999999999999999999999999999999999999999999864321 1
Q ss_pred CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCC-----CCCCCCHHH
Q 013081 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-----LPKWLSPGA 244 (450)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-----~p~~~s~~~ 244 (450)
.......+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.+.+......+......+ .+..+++.+
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 244 (294)
T 4eqm_A 166 LTQTNHVLGTVQYFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSL 244 (294)
T ss_dssp ---------CCSSCCHHHHHTCCC-CTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHH
T ss_pred ccccCccccCccccCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHH
Confidence 122345679999999999987766 58999999999999999999999998877766666555432 345689999
Q ss_pred HHHHHHccccCcCCCCCHHHHHhccccc
Q 013081 245 QNLLRKILEPNPVKRITIAGIKADEWFE 272 (450)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~~il~h~~~~ 272 (450)
.++|.+||++||.+||+..+.+.+.|..
T Consensus 245 ~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 245 SNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp HHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred HHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 9999999999999999767777777754
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=411.32 Aligned_cols=255 Identities=31% Similarity=0.593 Sum_probs=211.7
Q ss_pred CCcccCCeEEe-eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHH-HhCCCCCcceEEEEEEe-
Q 013081 9 EGMRLGRYELG-RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVRLHEVLAS- 85 (450)
Q Consensus 9 ~~~~~~~y~i~-~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~~~- 85 (450)
.+..+++|.+. +.||+|+||+||+|.+..+|+.||||+++.. ..+.+|+.++ +..+||||+++++++..
T Consensus 56 ~~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~ 127 (400)
T 1nxk_A 56 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL 127 (400)
T ss_dssp CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred CCcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeec
Confidence 34567889987 7899999999999999999999999998642 3567888887 45589999999999875
Q ss_pred ---CCEEEEEEccCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEcc---CCCeEEee
Q 013081 86 ---KSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS---KGNIKISD 157 (450)
Q Consensus 86 ---~~~~~lv~E~~~gg~L~~~i~~~~--~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~---~g~lkl~D 157 (450)
...+|+||||++||+|.+++...+ .+++.+++.++.||+.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 128 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~D 207 (400)
T 1nxk_A 128 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 207 (400)
T ss_dssp ETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred ccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEe
Confidence 667899999999999999998654 5999999999999999999999999999999999999998 78899999
Q ss_pred cCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHH----HHHHHHHhCC
Q 013081 158 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA----VLYQKIFRGD 233 (450)
Q Consensus 158 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~----~~~~~i~~~~ 233 (450)
||++.... ......+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.. .....+..+.
T Consensus 208 FG~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~ 283 (400)
T 1nxk_A 208 FGFAKETT---SHNSLTTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 283 (400)
T ss_dssp CTTCEECC--------------CTTCCGGGSCCCCS-SSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTC
T ss_pred cccccccC---CCCccccCCCCCCccCHhhcCCCCC-CCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCc
Confidence 99998532 2233457799999999999877776 58999999999999999999999775432 2455566665
Q ss_pred CCCC----CCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCC
Q 013081 234 FKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 234 ~~~p----~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
+.+| ..+++++.+||++||+.||.+|||+.++++||||.+..
T Consensus 284 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 284 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred ccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 5554 34899999999999999999999999999999998643
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=393.27 Aligned_cols=256 Identities=36% Similarity=0.682 Sum_probs=227.3
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (450)
...++|++++.||+|+||.||+|.+..+|+.||+|++...... ....+.+|+.+++.++||||+++++++.+....|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF---RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYY 82 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc---chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEE
Confidence 3457899999999999999999999999999999999765322 2357889999999999999999999999999999
Q ss_pred EEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEE---ccCCCeEEeecCCCCCCCcc
Q 013081 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL---DSKGNIKISDFGLSALPQHF 167 (450)
Q Consensus 91 lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl---~~~g~lkl~DFGla~~~~~~ 167 (450)
+||||++|++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~-- 160 (304)
T 2jam_A 83 LVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ-- 160 (304)
T ss_dssp EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC--
T ss_pred EEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC--
Confidence 999999999999999888899999999999999999999999999999999999999 778899999999997532
Q ss_pred cCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHH
Q 013081 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPG 243 (450)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~ 243 (450)
.......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.......+..+...++ ..+++.
T Consensus 161 --~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 237 (304)
T 2jam_A 161 --NGIMSTACGTPGYVAPEVLAQKPY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISES 237 (304)
T ss_dssp --CBTTHHHHSCCCBCCTTTBSSCSC-CHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHH
T ss_pred --CCccccccCCCCccChHHhccCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHH
Confidence 223455689999999999877666 5899999999999999999999999888888888887755443 458999
Q ss_pred HHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 244 ~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
+.+||.+||++||.+|||+.++++||||...
T Consensus 238 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 238 AKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp HHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred HHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 9999999999999999999999999999864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-51 Score=401.01 Aligned_cols=265 Identities=26% Similarity=0.421 Sum_probs=224.5
Q ss_pred CCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-
Q 013081 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS- 87 (450)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~- 87 (450)
.....++|++++.||+|+||.||+|.+..+++.||||++.............+.+|+.++++++||||+++++++....
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 86 (311)
T 3ork_A 7 PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP 86 (311)
T ss_dssp CSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET
T ss_pred cceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC
Confidence 3455689999999999999999999999999999999998766656666788999999999999999999999986543
Q ss_pred ---EEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCC
Q 013081 88 ---KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP 164 (450)
Q Consensus 88 ---~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~ 164 (450)
..|+||||++|++|.+++...+++++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 87 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 87 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp TEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred CCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 35999999999999999998889999999999999999999999999999999999999999999999999999854
Q ss_pred CcccC-CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCC----CC
Q 013081 165 QHFRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KW 239 (450)
Q Consensus 165 ~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~ 239 (450)
..... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+......+........+ ..
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 245 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTT
T ss_pred cccccccccccccCcCcccCCHHHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCC
Confidence 33211 122334679999999999987766 5899999999999999999999999888777766666554332 45
Q ss_pred CCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 240 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 240 ~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
+++++.+||.+||++||.+||+..+++.|+|+...
T Consensus 246 ~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 246 LSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 89999999999999999999999999999999753
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-50 Score=402.05 Aligned_cols=258 Identities=32% Similarity=0.591 Sum_probs=227.8
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeeccccc-----chhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-----HLKITDQIKREIATLKLL-KHPNVVRLHEVLASK 86 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 86 (450)
.++|++.+.||+|+||.||+|.+..+|+.||||+++..... .....+.+.+|+.+++++ +||||+++++++...
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 36799999999999999999999999999999999765321 122356788999999999 799999999999999
Q ss_pred CEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCc
Q 013081 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (450)
Q Consensus 87 ~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 166 (450)
...|+||||++|++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++.....
T Consensus 173 ~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~ 252 (365)
T 2y7j_A 173 SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252 (365)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence 99999999999999999999888999999999999999999999999999999999999999999999999999875432
Q ss_pred ccCCCccccccCCCCccchhhhccC-----CCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCC----
Q 013081 167 FRDDGLLHTTCGSPNYVAPEVLANR-----GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP---- 237 (450)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~-----~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p---- 237 (450)
.......+||+.|+|||++.+. ...+.++|||||||++|+|++|..||.+.+.......+..+....+
T Consensus 253 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 329 (365)
T 2y7j_A 253 ---GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEW 329 (365)
T ss_dssp ---TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred ---CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCccc
Confidence 2334567899999999998632 2236899999999999999999999999888888888877766554
Q ss_pred CCCCHHHHHHHHHccccCcCCCCCHHHHHhcccccc
Q 013081 238 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 238 ~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
..+++.+.+||.+||+.||.+|||+.++++||||+.
T Consensus 330 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 330 DDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 358899999999999999999999999999999963
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=387.71 Aligned_cols=265 Identities=31% Similarity=0.519 Sum_probs=229.5
Q ss_pred ccCCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeeccccc------chhHHHHHHHHHHHHHhCC-CCCcceE
Q 013081 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII------HLKITDQIKREIATLKLLK-HPNVVRL 79 (450)
Q Consensus 7 ~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~------~~~~~~~~~~Ei~il~~l~-hpnIv~l 79 (450)
.......++|++.+.||+|+||.||+|.+..+|+.||||+++..... .....+.+.+|+.+++++. ||||+++
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~ 89 (298)
T 1phk_A 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQL 89 (298)
T ss_dssp -----CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred cCCcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeee
Confidence 33445678999999999999999999999999999999999765311 1233567889999999996 9999999
Q ss_pred EEEEEeCCEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecC
Q 013081 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFG 159 (450)
Q Consensus 80 ~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFG 159 (450)
++++......|+||||++|++|.+++.....+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 90 KDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred eeeeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEeccc
Confidence 99999999999999999999999999988899999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCcccCCCccccccCCCCccchhhhcc-----CCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCC
Q 013081 160 LSALPQHFRDDGLLHTTCGSPNYVAPEVLAN-----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF 234 (450)
Q Consensus 160 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~ 234 (450)
++..... .......+||+.|+|||++.. ....+.++||||||+++|+|++|..||.+.+.......+..+..
T Consensus 170 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 246 (298)
T 1phk_A 170 FSCQLDP---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 246 (298)
T ss_dssp TCEECCT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred chhhcCC---CcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCc
Confidence 9975432 233455689999999999852 23336899999999999999999999999888888888877765
Q ss_pred CCC----CCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 235 KLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 235 ~~p----~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
..+ ..+++.+.+||.+||+.||.+|||+.++++||||++.
T Consensus 247 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (298)
T 1phk_A 247 QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290 (298)
T ss_dssp CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence 544 2478999999999999999999999999999999864
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=399.84 Aligned_cols=261 Identities=29% Similarity=0.427 Sum_probs=220.9
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (450)
..+++|++++.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+....|
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 100 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWY 100 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEE
Confidence 467899999999999999999999999999999999865532 3344577889999999999999999999999999999
Q ss_pred EEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCC
Q 013081 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (450)
Q Consensus 91 lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 170 (450)
+||||+++++|.+++...+++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 101 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~ 178 (331)
T 4aaa_A 101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA--PG 178 (331)
T ss_dssp EEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred EEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecC--Cc
Confidence 9999999999998888778899999999999999999999999999999999999999999999999999975432 22
Q ss_pred CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC------------------
Q 013081 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------------ 232 (450)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------------ 232 (450)
......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+...
T Consensus 179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence 33455689999999999887655578999999999999999999999988766555444321
Q ss_pred -CCCCC------------CCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 233 -DFKLP------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 233 -~~~~p------------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
....| +.+++.+.+||.+||++||.+|||+.|+++||||+..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 01111 2468999999999999999999999999999999753
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-50 Score=410.17 Aligned_cols=261 Identities=28% Similarity=0.397 Sum_probs=211.6
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----C
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-----S 87 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~ 87 (450)
-++|++++.||+|+||.||+|.+..+|+.||||++.+.. ......+++.+|+.+++.++||||+++++++... .
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 479999999999999999999999999999999997542 3444467899999999999999999999999766 5
Q ss_pred EEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcc
Q 013081 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 167 (450)
..|+||||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 182 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred eEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence 7999999996 599999998888999999999999999999999999999999999999999999999999999864332
Q ss_pred cCC--------------------CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhC-----------CCC
Q 013081 168 RDD--------------------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG-----------YLP 216 (450)
Q Consensus 168 ~~~--------------------~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG-----------~~P 216 (450)
... ......+||+.|+|||++.....++.++||||+||++|+|++| .++
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~ 262 (432)
T 3n9x_A 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL 262 (432)
T ss_dssp ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCS
T ss_pred ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccccc
Confidence 111 1246678999999999976555557999999999999999984 444
Q ss_pred CCCCcH-----------------HHHHHHHH------------------------hCCCCCC-------CCCCHHHHHHH
Q 013081 217 FDDRNL-----------------AVLYQKIF------------------------RGDFKLP-------KWLSPGAQNLL 248 (450)
Q Consensus 217 f~~~~~-----------------~~~~~~i~------------------------~~~~~~p-------~~~s~~~~~Li 248 (450)
|.+.+. ......+. ......+ +.+++.+.+||
T Consensus 263 f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl 342 (432)
T 3n9x_A 263 FPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLL 342 (432)
T ss_dssp CCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHH
T ss_pred CCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHH
Confidence 444320 11111111 1111111 34799999999
Q ss_pred HHccccCcCCCCCHHHHHhccccccCC
Q 013081 249 RKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 249 ~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
.+||++||.+|||++|+|+||||+...
T Consensus 343 ~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 369 (432)
T 3n9x_A 343 ESMLKFNPNKRITIDQALDHPYLKDVR 369 (432)
T ss_dssp HHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred HHHhcCCcccCCCHHHHhcChhhhhcc
Confidence 999999999999999999999998653
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-50 Score=386.10 Aligned_cols=258 Identities=34% Similarity=0.627 Sum_probs=226.4
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccch---hHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---KITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (450)
-++|++++.||+|+||.||+|.+..+|+.||+|++........ ...+.+.+|+.++++++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 3689999999999999999999999999999999976543321 1257889999999999999999999999999999
Q ss_pred EEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCC----CeEEeecCCCCCCC
Q 013081 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG----NIKISDFGLSALPQ 165 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g----~lkl~DFGla~~~~ 165 (450)
|+||||++|++|.+++.....+++..++.++.||+.||.|||++|++||||||+||+++.++ .+||+|||++....
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~ 163 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence 99999999999999998888999999999999999999999999999999999999999887 89999999997543
Q ss_pred cccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCC----CCCC
Q 013081 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLS 241 (450)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s 241 (450)
. ........||+.|+|||++.+..+ +.++||||+|+++|+|++|..||.+.+.......+.......+ ..++
T Consensus 164 ~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T 3bhy_A 164 A---GNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTS 239 (283)
T ss_dssp -----------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred C---CCcccccCCCcCccCcceecCCCC-CcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCC
Confidence 2 222345679999999999877666 5899999999999999999999999888888888777665554 4589
Q ss_pred HHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 242 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 242 ~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
+.+.+||.+||+.||.+|||+.++++||||+..
T Consensus 240 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 240 ELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 999999999999999999999999999999753
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=402.28 Aligned_cols=262 Identities=33% Similarity=0.537 Sum_probs=221.6
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeeccccc--chhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII--HLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
++|++++.||+|+||.||+|.+..+++.||+|++.+.... .....+.+.+|+.++++++||||+++++++.+....|+
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 6899999999999999999999999999999999765322 23346789999999999999999999999999999999
Q ss_pred EEccCCCCChHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHHHhhhh
Q 013081 92 VLEYVTGGELFDKIAS----------------------------------------KGRLQEAEGRKLFQQLIDGVSYCH 131 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~----------------------------------------~~~l~~~~~~~i~~ql~~aL~~LH 131 (450)
||||++||+|.+++.. ...+++..++.++.||+.||+|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 9999999999998842 112467889999999999999999
Q ss_pred hcCeeeccCCCCcEEEccCC--CeEEeecCCCCCCCcccCCC--ccccccCCCCccchhhhccC-CCCCccchhhhHHHH
Q 013081 132 NKGVFHRDLKLENILLDSKG--NIKISDFGLSALPQHFRDDG--LLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVI 206 (450)
Q Consensus 132 ~~givHrDlKp~NILl~~~g--~lkl~DFGla~~~~~~~~~~--~~~~~~gt~~y~APE~l~~~-~~~~~~~DiwSlGvi 206 (450)
++||+||||||+|||++.++ .+||+|||++.......... .....+||+.|+|||++... ...+.++|||||||+
T Consensus 186 ~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~i 265 (345)
T 3hko_A 186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265 (345)
T ss_dssp HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHH
T ss_pred HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHH
Confidence 99999999999999998777 89999999997543221111 23466899999999998652 344689999999999
Q ss_pred HHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCC----CCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCC
Q 013081 207 LYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK----WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 207 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
+|+|++|..||.+.+......++......++. .+++.+.+||.+||++||.+|||+.++++||||++..
T Consensus 266 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 266 LHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred HHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 99999999999999888888888777654432 3799999999999999999999999999999998643
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-50 Score=404.90 Aligned_cols=254 Identities=33% Similarity=0.555 Sum_probs=219.4
Q ss_pred CCeEE--eeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 14 GRYEL--GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 14 ~~y~i--~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
+.|.+ .+.||+|+||.||+|.+..+|+.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..|+
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 163 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVL 163 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 45655 6789999999999999999999999999976532 335788999999999999999999999999999999
Q ss_pred EEccCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEE--ccCCCeEEeecCCCCCCCccc
Q 013081 92 VLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL--DSKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl--~~~g~lkl~DFGla~~~~~~~ 168 (450)
||||++|++|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 164 v~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~-- 241 (373)
T 2x4f_A 164 VMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP-- 241 (373)
T ss_dssp EEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT--
T ss_pred EEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCC--
Confidence 99999999999988654 469999999999999999999999999999999999999 5667899999999985432
Q ss_pred CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHH
Q 013081 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGA 244 (450)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~ 244 (450)
.......+||+.|+|||++....+ +.++|||||||++|+|++|..||.+.+......++......++ ..+++++
T Consensus 242 -~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 319 (373)
T 2x4f_A 242 -REKLKVNFGTPEFLAPEVVNYDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEA 319 (373)
T ss_dssp -TCBCCCCCSSCTTCCHHHHTTCBC-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHH
T ss_pred -ccccccccCCCcEeChhhccCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHH
Confidence 223445689999999999876655 5899999999999999999999999998888888888766554 3589999
Q ss_pred HHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 245 QNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
.+||.+||++||.+|||+.++++||||...
T Consensus 320 ~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 320 KEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred HHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 999999999999999999999999999753
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-50 Score=404.26 Aligned_cols=255 Identities=29% Similarity=0.404 Sum_probs=214.5
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC------
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK------ 86 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------ 86 (450)
.++|++++.||+|+||.||+|.+..+|+.||||.+.... ......+++.+|+.+++.++||||+++++++...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 478999999999999999999999999999999986543 2344567899999999999999999999999765
Q ss_pred CEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCc
Q 013081 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (450)
Q Consensus 87 ~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 166 (450)
..+|+||||+ |++|.+++.. +++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 180 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence 3469999999 8899998876 6799999999999999999999999999999999999999999999999999985322
Q ss_pred ccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCC------------
Q 013081 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF------------ 234 (450)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~------------ 234 (450)
.....+||+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+......++.....
T Consensus 181 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 255 (367)
T 1cm8_A 181 -----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255 (367)
T ss_dssp -----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred -----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 234568999999999988744457899999999999999999999999887666655543110
Q ss_pred -------------------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCC
Q 013081 235 -------------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 235 -------------------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
..+...++.+.+||.+||+.||.+|||+.++++||||+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 12234689999999999999999999999999999998643
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-50 Score=399.47 Aligned_cols=251 Identities=26% Similarity=0.415 Sum_probs=217.3
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-----CCCcceEEEEEEe
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-----HPNVVRLHEVLAS 85 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----hpnIv~l~~~~~~ 85 (450)
..-++|++++.||+|+||.||+|.+..+++.||||++... ........+|+.+++.+. ||||+++++++..
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~ 107 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY 107 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE
Confidence 4457999999999999999999999999999999998642 233567788999999997 9999999999999
Q ss_pred CCEEEEEEccCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEcc--------------
Q 013081 86 KSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-------------- 149 (450)
Q Consensus 86 ~~~~~lv~E~~~gg~L~~~i~~~~--~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~-------------- 149 (450)
.+..|+||||+ |++|.+++.... ++++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 108 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~ 186 (360)
T 3llt_A 108 YDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVT 186 (360)
T ss_dssp TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred CCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccc
Confidence 99999999999 999999998654 5999999999999999999999999999999999999975
Q ss_pred -----------CCCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCC
Q 013081 150 -----------KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD 218 (450)
Q Consensus 150 -----------~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~ 218 (450)
++.+||+|||+|..... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.
T Consensus 187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~ 260 (360)
T 3llt_A 187 DGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGW-DVSSDMWSFGCVLAELYTGSLLFR 260 (360)
T ss_dssp TCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCC-CCccchHHHHHHHHHHHHCCCCCC
Confidence 78999999999975322 2345689999999999988776 589999999999999999999999
Q ss_pred CCcHHHHHHHHHhCCCCCCC----------------------------------------------CCCHHHHHHHHHcc
Q 013081 219 DRNLAVLYQKIFRGDFKLPK----------------------------------------------WLSPGAQNLLRKIL 252 (450)
Q Consensus 219 ~~~~~~~~~~i~~~~~~~p~----------------------------------------------~~s~~~~~Li~~~L 252 (450)
..+.......+.....+.|. ..++.+.+||.+||
T Consensus 261 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 340 (360)
T 3llt_A 261 THEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSIL 340 (360)
T ss_dssp CSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHC
T ss_pred CCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHh
Confidence 88877666555443222221 12367889999999
Q ss_pred ccCcCCCCCHHHHHhccccc
Q 013081 253 EPNPVKRITIAGIKADEWFE 272 (450)
Q Consensus 253 ~~dP~~R~t~~~il~h~~~~ 272 (450)
++||.+|||+.|+++||||+
T Consensus 341 ~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 341 QIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp CSSGGGSCCHHHHTTSGGGC
T ss_pred cCChhhCCCHHHHhcCcccC
Confidence 99999999999999999995
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=401.53 Aligned_cols=265 Identities=27% Similarity=0.358 Sum_probs=217.1
Q ss_pred CcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccc--hhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH--LKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (450)
+...++|++++.||+|+||.||+|.+..+|+.||+|++....... ......+.+|+.+++.++||||+++++++.+..
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 456789999999999999999999999999999999997543221 112346889999999999999999999999999
Q ss_pred EEEEEEccCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCc
Q 013081 88 KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 166 (450)
..|+||||+.+ +|.+.+... ..+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence 99999999976 888888764 4699999999999999999999999999999999999999999999999999986432
Q ss_pred ccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC--CCC---C-----
Q 013081 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFK---L----- 236 (450)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~---~----- 236 (450)
........+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+......++... ... .
T Consensus 165 --~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 242 (346)
T 1ua2_A 165 --PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 242 (346)
T ss_dssp --CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred --CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhcc
Confidence 2233456789999999999876665578999999999999999999999998887777766542 100 0
Q ss_pred ------------------CCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCCCC
Q 013081 237 ------------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277 (450)
Q Consensus 237 ------------------p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~~~ 277 (450)
...+++.+.+||.+||+.||.+|||+.|+++||||.....+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~ 301 (346)
T 1ua2_A 243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 301 (346)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred CcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCC
Confidence 13357899999999999999999999999999999875443
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-50 Score=398.10 Aligned_cols=262 Identities=25% Similarity=0.418 Sum_probs=216.3
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCC--CCcceEEEEEEeCCEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH--PNVVRLHEVLASKSKI 89 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~~ 89 (450)
.-++|++++.||+|+||.||+|.+ .+++.||||++..... .....+.+.+|+.+++.++| |||+++++++.+....
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 345799999999999999999997 5688999999976543 33446789999999999986 9999999999999999
Q ss_pred EEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC
Q 013081 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 169 (450)
|+|||+ .+++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++........
T Consensus 85 ~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~ 162 (343)
T 3dbq_A 85 YMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 162 (343)
T ss_dssp EEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred EEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence 999995 5889999999989999999999999999999999999999999999999996 68899999999986543322
Q ss_pred CCccccccCCCCccchhhhcc----------CCCCCccchhhhHHHHHHHHHhCCCCCCCCc-HHHHHHHHHhC--CCCC
Q 013081 170 DGLLHTTCGSPNYVAPEVLAN----------RGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRG--DFKL 236 (450)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~----------~~~~~~~~DiwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~~--~~~~ 236 (450)
.......+||+.|+|||++.+ ....+.++|||||||++|+|++|..||.+.. .......+... ...+
T Consensus 163 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T 3dbq_A 163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 242 (343)
T ss_dssp -------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCC
T ss_pred cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCC
Confidence 223456789999999999864 1344689999999999999999999998743 33334444433 4567
Q ss_pred CCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCCCC
Q 013081 237 PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277 (450)
Q Consensus 237 p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~~~ 277 (450)
|...++.+.+||.+||+.||.+|||+.++++||||+....+
T Consensus 243 ~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~ 283 (343)
T 3dbq_A 243 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 283 (343)
T ss_dssp CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC-
T ss_pred cccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCCc
Confidence 77788999999999999999999999999999999865443
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-50 Score=384.65 Aligned_cols=253 Identities=23% Similarity=0.326 Sum_probs=216.1
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIY 90 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 90 (450)
..++|++++.||+|+||.||+|.+..+++.||+|++........ ....+.+|+..+..+ +||||+++++++.+.+..|
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~ 87 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSV-DEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML 87 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSH-HHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccH-HHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 34789999999999999999999999999999999986543332 356788999999999 8999999999999999999
Q ss_pred EEEccCCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCC---------------
Q 013081 91 MVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG--------------- 151 (450)
Q Consensus 91 lv~E~~~gg~L~~~i~~~----~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g--------------- 151 (450)
+||||++|++|.+++... +.+++.+++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 999999999999999764 6799999999999999999999999999999999999998544
Q ss_pred ----CeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHH
Q 013081 152 ----NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQ 227 (450)
Q Consensus 152 ----~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~ 227 (450)
.+||+|||++..... .....||+.|+|||++.+....+.++|||||||++|+|++|.+|+..... ..
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~ 238 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISS------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WH 238 (289)
T ss_dssp --CCCEEECCCTTCEETTC------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HH
T ss_pred CCceEEEEcccccccccCC------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HH
Confidence 799999999875432 23456999999999988765556899999999999999999988765533 33
Q ss_pred HHHhC-CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 228 KIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 228 ~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
.+..+ ....|..+++.+.+||.+||++||.+|||+.++++||||...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 239 EIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred HHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 34444 345677899999999999999999999999999999999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-50 Score=404.92 Aligned_cols=259 Identities=25% Similarity=0.401 Sum_probs=217.8
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC--CCCcceEEEEEEeCCEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK--HPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~~~l 91 (450)
.+|++++.||+|+||.||+|.+.. ++.||||++..... .....+.+.+|+.+++.++ ||||+++++++.....+|+
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 459999999999999999999865 89999999976543 3445678999999999996 5999999999999999999
Q ss_pred EEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCC
Q 013081 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 171 (450)
||| +.+++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..........
T Consensus 134 v~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~ 211 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 211 (390)
T ss_dssp EEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-------
T ss_pred EEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccc
Confidence 999 56889999999888999999999999999999999999999999999999995 6899999999998654322222
Q ss_pred ccccccCCCCccchhhhccC----------CCCCccchhhhHHHHHHHHHhCCCCCCCCc-HHHHHHHHHhC--CCCCCC
Q 013081 172 LLHTTCGSPNYVAPEVLANR----------GYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRG--DFKLPK 238 (450)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~----------~~~~~~~DiwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~~--~~~~p~ 238 (450)
.....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.. .......+... ...+|.
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 291 (390)
T 2zmd_A 212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 291 (390)
T ss_dssp --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCC
T ss_pred cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCc
Confidence 34567899999999998652 234689999999999999999999998753 33445555544 456678
Q ss_pred CCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCCC
Q 013081 239 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 276 (450)
Q Consensus 239 ~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~~ 276 (450)
+.++.+.+||.+||+.||.+|||+.++++||||+....
T Consensus 292 ~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~ 329 (390)
T 2zmd_A 292 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 329 (390)
T ss_dssp CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC-
T ss_pred cchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCc
Confidence 88999999999999999999999999999999986543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=384.81 Aligned_cols=254 Identities=24% Similarity=0.455 Sum_probs=218.8
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe----CCEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS----KSKI 89 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~~ 89 (450)
..|++.+.||+|+||.||+|.+..++..||+|++...... ....+.+.+|+.+++.++||||+++++++.. ...+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 3589999999999999999999999999999999765443 3446789999999999999999999999865 4568
Q ss_pred EEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcC--eeeccCCCCcEEEc-cCCCeEEeecCCCCCCCc
Q 013081 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLD-SKGNIKISDFGLSALPQH 166 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlKp~NILl~-~~g~lkl~DFGla~~~~~ 166 (450)
|+||||++|++|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++...
T Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~-- 182 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-- 182 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC--
T ss_pred EEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc--
Confidence 999999999999999998889999999999999999999999999 99999999999998 7899999999999743
Q ss_pred ccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCc-HHHHHHHHHhCC--CCCCCCCCHH
Q 013081 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGD--FKLPKWLSPG 243 (450)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~~~--~~~p~~~s~~ 243 (450)
........+||+.|+|||++.+ .+ +.++||||+||++|+|++|..||.+.. .......+..+. ..++...++.
T Consensus 183 --~~~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (290)
T 1t4h_A 183 --RASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 258 (290)
T ss_dssp --CTTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHH
T ss_pred --cccccccccCCcCcCCHHHHhc-cC-CCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHH
Confidence 2234456789999999998764 34 689999999999999999999998744 444555554442 2344567899
Q ss_pred HHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 244 ~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
+.+||.+||+.||.+|||+.++++||||++.
T Consensus 259 l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 259 VKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred HHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 9999999999999999999999999999863
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=396.96 Aligned_cols=255 Identities=25% Similarity=0.391 Sum_probs=223.3
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
++|++++.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.++||||+++++++......|+||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 46999999999999999999999999999999998665545555678999999999999999999999999999999999
Q ss_pred ccCCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCc
Q 013081 94 EYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (450)
Q Consensus 94 E~~~gg~L~~~i~-~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 172 (450)
||+. |+|.+.+. ...++++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~------ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ 206 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC------
Confidence 9997 58888775 456899999999999999999999999999999999999999999999999999985432
Q ss_pred cccccCCCCccchhhhcc--CCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCC--CCCCCCHHHHHHH
Q 013081 173 LHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK--LPKWLSPGAQNLL 248 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~~--~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~~~~~Li 248 (450)
....+||+.|+|||++.. ....+.++|||||||++|+|++|..||.+.+.......+.....+ .+..+++.+.+||
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 286 (348)
T 1u5q_A 207 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 286 (348)
T ss_dssp BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHH
T ss_pred CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence 235689999999999852 233358999999999999999999999988877666666665432 2456899999999
Q ss_pred HHccccCcCCCCCHHHHHhccccccCC
Q 013081 249 RKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 249 ~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
.+||+.||.+|||+.++++||||....
T Consensus 287 ~~~l~~dP~~Rps~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 287 DSCLQKIPQDRPTSEVLLKHRFVLRER 313 (348)
T ss_dssp HHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred HHHcccChhhCcCHHHHhhChhhhccC
Confidence 999999999999999999999997643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=398.59 Aligned_cols=259 Identities=29% Similarity=0.449 Sum_probs=219.7
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----CE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-----SK 88 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~~ 88 (450)
++|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.++++++||||+++++++... ..
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 59999999999999999999999999999999996432 334457889999999999999999999999654 46
Q ss_pred EEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc
Q 013081 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 168 (450)
.|+||||+. ++|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 105 ~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 899999997 599998875 579999999999999999999999999999999999999999999999999998654322
Q ss_pred C-CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC--C------------
Q 013081 169 D-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--D------------ 233 (450)
Q Consensus 169 ~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~------------ 233 (450)
. .......+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+... .
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 262 (364)
T 3qyz_A 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262 (364)
T ss_dssp CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 1 223455689999999999776665578999999999999999999999987765555544321 0
Q ss_pred --------C----C-----CCCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCCC
Q 013081 234 --------F----K-----LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 276 (450)
Q Consensus 234 --------~----~-----~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~~ 276 (450)
. . .++.+++++.+||.+||++||.+|||+.|+++||||++.+.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~ 322 (364)
T 3qyz_A 263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322 (364)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence 0 0 11347899999999999999999999999999999987543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-50 Score=400.54 Aligned_cols=262 Identities=31% Similarity=0.587 Sum_probs=225.8
Q ss_pred cccCCeEEeeeecccCceEEEEEEEC---CCCceEEEEEeeccccc-chhHHHHHHHHHHHHHhC-CCCCcceEEEEEEe
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRII-HLKITDQIKREIATLKLL-KHPNVVRLHEVLAS 85 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 85 (450)
..+++|++++.||+|+||.||+|++. .+|+.||||++++.... .....+.+.+|+.+++.+ .||||+++++++..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 130 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence 45689999999999999999999985 58999999999754321 112235677899999999 69999999999999
Q ss_pred CCEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCC
Q 013081 86 KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (450)
Q Consensus 86 ~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 165 (450)
....|+||||++|++|.+++...+++++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++...
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 99999999999999999999988899999999999999999999999999999999999999999999999999997543
Q ss_pred cccCCCccccccCCCCccchhhhccC-CCCCccchhhhHHHHHHHHHhCCCCCCCC----cHHHHHHHHHhCCCCCCCCC
Q 013081 166 HFRDDGLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILTGYLPFDDR----NLAVLYQKIFRGDFKLPKWL 240 (450)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~----~~~~~~~~i~~~~~~~p~~~ 240 (450)
.. ........+||+.|+|||++.+. ...+.++|||||||++|+|++|..||... ....+...+.....++|..+
T Consensus 211 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (355)
T 1vzo_A 211 AD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 289 (355)
T ss_dssp GG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred cC-CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCccc
Confidence 21 11233456899999999998753 33468899999999999999999999743 34556667777788888899
Q ss_pred CHHHHHHHHHccccCcCCCC-----CHHHHHhcccccc
Q 013081 241 SPGAQNLLRKILEPNPVKRI-----TIAGIKADEWFEQ 273 (450)
Q Consensus 241 s~~~~~Li~~~L~~dP~~R~-----t~~~il~h~~~~~ 273 (450)
++.+.+||.+||+.||.+|| |+.++++||||+.
T Consensus 290 ~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 290 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred CHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence 99999999999999999999 9999999999975
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=401.53 Aligned_cols=252 Identities=27% Similarity=0.401 Sum_probs=212.6
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe------
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS------ 85 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------ 85 (450)
..++|++++.||+|+||.||+|.+..+|+.||||++..+.. ...+|+.+++.++||||+++++++..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 45789999999999999999999999999999999865432 23379999999999999999999843
Q ss_pred --------------------------------CCEEEEEEccCCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHhh
Q 013081 86 --------------------------------KSKIYMVLEYVTGGELFDKIA----SKGRLQEAEGRKLFQQLIDGVSY 129 (450)
Q Consensus 86 --------------------------------~~~~~lv~E~~~gg~L~~~i~----~~~~l~~~~~~~i~~ql~~aL~~ 129 (450)
....|+||||++| +|.+.+. ..+.+++..++.++.||+.||+|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 3448999999975 7766654 45789999999999999999999
Q ss_pred hhhcCeeeccCCCCcEEEc-cCCCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHH
Q 013081 130 CHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 208 (450)
Q Consensus 130 LH~~givHrDlKp~NILl~-~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ 208 (450)
||++||+||||||+|||++ .++.+||+|||+|..... .......+||+.|+|||++.+....+.++||||+||++|
T Consensus 157 LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 233 (383)
T 3eb0_A 157 IHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP---SEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233 (383)
T ss_dssp HHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCT---TSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred HHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCC---CCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence 9999999999999999998 688999999999985422 223456688999999999887665579999999999999
Q ss_pred HHHhCCCCCCCCcHHHHHHHHHhC-----------------CCC------------CCCCCCHHHHHHHHHccccCcCCC
Q 013081 209 VILTGYLPFDDRNLAVLYQKIFRG-----------------DFK------------LPKWLSPGAQNLLRKILEPNPVKR 259 (450)
Q Consensus 209 elltG~~Pf~~~~~~~~~~~i~~~-----------------~~~------------~p~~~s~~~~~Li~~~L~~dP~~R 259 (450)
+|++|+.||.+.+......++... ... +|..+++.+.+||.+||+.||.+|
T Consensus 234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 313 (383)
T 3eb0_A 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR 313 (383)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence 999999999998877766665431 011 345578999999999999999999
Q ss_pred CCHHHHHhccccccC
Q 013081 260 ITIAGIKADEWFEQD 274 (450)
Q Consensus 260 ~t~~~il~h~~~~~~ 274 (450)
||+.|+++||||+..
T Consensus 314 ~t~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 314 INPYEAMAHPFFDHL 328 (383)
T ss_dssp CCHHHHHTSGGGHHH
T ss_pred CCHHHHhcCHHHHHH
Confidence 999999999999753
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-50 Score=409.77 Aligned_cols=257 Identities=36% Similarity=0.636 Sum_probs=210.6
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccc-----hhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH-----LKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~-----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (450)
.++|++.+.||+|+||.||+|.+..+++.||+|++.+..... ......+.+|+.++++++||||+++++++. ..
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AE 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SS
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 478999999999999999999999999999999998654321 112235789999999999999999999985 45
Q ss_pred EEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCC---CeEEeecCCCCCC
Q 013081 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALP 164 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g---~lkl~DFGla~~~ 164 (450)
..|+||||++||+|.+++...+++++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|...
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~ 292 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence 6899999999999999998888999999999999999999999999999999999999997654 5999999999864
Q ss_pred CcccCCCccccccCCCCccchhhhcc--CCCCCccchhhhHHHHHHHHHhCCCCCCCCcH-HHHHHHHHhCCCCCC----
Q 013081 165 QHFRDDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNL-AVLYQKIFRGDFKLP---- 237 (450)
Q Consensus 165 ~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~~~p---- 237 (450)
.. .......+||+.|+|||++.+ ....+.++|||||||++|+|++|..||.+... ......+..+....+
T Consensus 293 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~ 369 (419)
T 3i6u_A 293 GE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 369 (419)
T ss_dssp C--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHH
T ss_pred CC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhh
Confidence 32 334456789999999999853 23335799999999999999999999986543 234455555555443
Q ss_pred CCCCHHHHHHHHHccccCcCCCCCHHHHHhcccccc
Q 013081 238 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 238 ~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
..+++.+.+||.+||++||.+|||++++++||||+.
T Consensus 370 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 370 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 458999999999999999999999999999999974
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=389.95 Aligned_cols=258 Identities=29% Similarity=0.485 Sum_probs=216.4
Q ss_pred CcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (450)
....++|++.+.||+|+||.||+|.+ +|+.||+|++..... .....+.+.+|+.++++++||||+++++++......
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred cCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 35568999999999999999999987 688999999976543 334467889999999999999999999999999999
Q ss_pred EEEEccCCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHhhhhhcC--eeeccCCCCcEEEccCCCeEEeecCCCCCC
Q 013081 90 YMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLDSKGNIKISDFGLSALP 164 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~~---l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlKp~NILl~~~g~lkl~DFGla~~~ 164 (450)
|+||||++||+|.+++...+. +++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++...
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 999999999999999987553 999999999999999999999999 999999999999999999999999999753
Q ss_pred CcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHH--hCCCCCCCCCCH
Q 013081 165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF--RGDFKLPKWLSP 242 (450)
Q Consensus 165 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~ 242 (450)
.. ........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+. ......|..+++
T Consensus 190 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (309)
T 3p86_A 190 AS--TFLSSKSAAGTPEWMAPEVLRDEPS-NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNP 266 (309)
T ss_dssp --------------CCTTSCHHHHTTCCC-CTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCH
T ss_pred cc--cccccccCCCCccccChhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCH
Confidence 32 1122445689999999999987766 589999999999999999999999988877766664 335677888999
Q ss_pred HHHHHHHHccccCcCCCCCHHHHHh--cccccc
Q 013081 243 GAQNLLRKILEPNPVKRITIAGIKA--DEWFEQ 273 (450)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t~~~il~--h~~~~~ 273 (450)
.+.+||.+||+.||.+|||+.++++ ++|++.
T Consensus 267 ~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 267 QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 9999999999999999999999987 456554
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-50 Score=393.60 Aligned_cols=257 Identities=24% Similarity=0.402 Sum_probs=210.2
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS---- 87 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---- 87 (450)
.+++|++++.||+|+||.||+|++..+|+.||||++.... .....+.+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 81 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKW 81 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence 4578999999999999999999999999999999997654 2334678999999999999999999999985543
Q ss_pred -----------------------------------------------------EEEEEEccCCCCChHHHHHhcCC---C
Q 013081 88 -----------------------------------------------------KIYMVLEYVTGGELFDKIASKGR---L 111 (450)
Q Consensus 88 -----------------------------------------------------~~~lv~E~~~gg~L~~~i~~~~~---l 111 (450)
..|+||||++|++|.+++..... .
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~ 161 (332)
T 3qd2_B 82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161 (332)
T ss_dssp HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence 38999999999999999987553 5
Q ss_pred CHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC----------CCccccccCCCC
Q 013081 112 QEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD----------DGLLHTTCGSPN 181 (450)
Q Consensus 112 ~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~----------~~~~~~~~gt~~ 181 (450)
++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ .......+||+.
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred hhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 5667999999999999999999999999999999999999999999999986543211 112344679999
Q ss_pred ccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCC-CCCCCHHHHHHHHHccccCcCCCC
Q 013081 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL-PKWLSPGAQNLLRKILEPNPVKRI 260 (450)
Q Consensus 182 y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-p~~~s~~~~~Li~~~L~~dP~~R~ 260 (450)
|+|||++.+..+ +.++||||+||++|+|++|..|+.. .............+. +...++.+.+||.+||++||.+||
T Consensus 242 y~aPE~~~~~~~-~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 318 (332)
T 3qd2_B 242 YMSPEQIHGNNY-SHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERP 318 (332)
T ss_dssp GSCHHHHHCCCC-CTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSC
T ss_pred ccChHHhcCCCC-cchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCC
Confidence 999999987766 5899999999999999999877532 222233333332221 123578899999999999999999
Q ss_pred CHHHHHhcccccc
Q 013081 261 TIAGIKADEWFEQ 273 (450)
Q Consensus 261 t~~~il~h~~~~~ 273 (450)
|+.++++||||++
T Consensus 319 s~~~~l~~~~f~~ 331 (332)
T 3qd2_B 319 EATDIIENAIFEN 331 (332)
T ss_dssp CHHHHHHSTTCCC
T ss_pred CHHHHhhchhhhc
Confidence 9999999999974
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=391.76 Aligned_cols=256 Identities=35% Similarity=0.559 Sum_probs=221.2
Q ss_pred CCeEEe-eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEE
Q 013081 14 GRYELG-RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 14 ~~y~i~-~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~l 91 (450)
++|.+. +.||+|+||.||+|.+..+|+.||+|++.+..... .....+.+|+.+++.+. ||||+++++++......|+
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l 106 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL 106 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence 578887 89999999999999999999999999997654322 23567889999999995 6999999999999999999
Q ss_pred EEccCCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEcc---CCCeEEeecCCCCCCCc
Q 013081 92 VLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS---KGNIKISDFGLSALPQH 166 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~--~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~---~g~lkl~DFGla~~~~~ 166 (450)
||||+.||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 186 (327)
T 3lm5_A 107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186 (327)
T ss_dssp EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence 9999999999999854 367999999999999999999999999999999999999988 78999999999985432
Q ss_pred ccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCH
Q 013081 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSP 242 (450)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~ 242 (450)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.......+ ..+++
T Consensus 187 ---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 262 (327)
T 3lm5_A 187 ---ACELREIMGTPEYLAPEILNYDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQ 262 (327)
T ss_dssp ----------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred ---ccccccccCCcCccCCeeecCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCH
Confidence 223345689999999999987766 5899999999999999999999999988888877776654433 34889
Q ss_pred HHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
.+.+||.+||++||.+|||++++++||||+..
T Consensus 263 ~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~ 294 (327)
T 3lm5_A 263 LATDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294 (327)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence 99999999999999999999999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=390.42 Aligned_cols=250 Identities=25% Similarity=0.368 Sum_probs=206.2
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv 92 (450)
++|++++.||+|+||+||+|.+..+|+.||||++......... .....+|+..+..+ +||||+++++++.+.+..|+|
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKD-RARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHH-HHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 6799999999999999999999999999999998654433333 34445555555444 899999999999999999999
Q ss_pred EccCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCC
Q 013081 93 LEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 171 (450)
|||+ +++|.+.+... .++++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||++..... ..
T Consensus 136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~---~~ 211 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT---AG 211 (311)
T ss_dssp EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeeccc---CC
Confidence 9999 67998888764 4699999999999999999999999999999999999999999999999999875432 22
Q ss_pred ccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCC--CCCCCCCHHHHHHHH
Q 013081 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF--KLPKWLSPGAQNLLR 249 (450)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~~~Li~ 249 (450)
.....+||+.|+|||++.+ .+ +.++||||+||++|+|++|..||.+... ...+..+.. .++..+++.+.+||.
T Consensus 212 ~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~ 286 (311)
T 3p1a_A 212 AGEVQEGDPRYMAPELLQG-SY-GTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSSELRSVLV 286 (311)
T ss_dssp ---CCCCCGGGCCGGGGGT-CC-STHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCHHHHHHHH
T ss_pred CCcccCCCccccCHhHhcC-CC-CchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCHHHHHHHH
Confidence 3445679999999999875 44 6899999999999999999776654332 223333322 234568999999999
Q ss_pred HccccCcCCCCCHHHHHhcccccc
Q 013081 250 KILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 250 ~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
+||++||.+|||+.++++||||++
T Consensus 287 ~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 287 MMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHcCCChhhCcCHHHHHhCccccC
Confidence 999999999999999999999975
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=383.37 Aligned_cols=261 Identities=30% Similarity=0.519 Sum_probs=227.2
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE--eCCE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA--SKSK 88 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~~ 88 (450)
...++|++++.||+|+||.||+|.+..+|+.||+|.+...... ....+.+.+|+.++++++||||+++++++. ....
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (279)
T 2w5a_A 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT 81 (279)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTE
T ss_pred CchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCce
Confidence 3568999999999999999999999999999999999765432 334678999999999999999999999874 4678
Q ss_pred EEEEEccCCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHhhhhhcC-----eeeccCCCCcEEEccCCCeEEeecC
Q 013081 89 IYMVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYCHNKG-----VFHRDLKLENILLDSKGNIKISDFG 159 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~~i~~~----~~l~~~~~~~i~~ql~~aL~~LH~~g-----ivHrDlKp~NILl~~~g~lkl~DFG 159 (450)
.|+||||++|++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 99999999999999998753 34999999999999999999999999 9999999999999999999999999
Q ss_pred CCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCC-CCCC
Q 013081 160 LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPK 238 (450)
Q Consensus 160 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~ 238 (450)
++..... ........+||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+..+.. .+|.
T Consensus 162 ~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 238 (279)
T 2w5a_A 162 LARILNH--DTSFAKTFVGTPYYMSPEQMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY 238 (279)
T ss_dssp HHHHC-----CHHHHHHHSCCTTCCHHHHHCC-C-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCT
T ss_pred hheeecc--ccccccccCCCccccChHHhccCCC-CchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCc
Confidence 9875322 1122345689999999999887766 5899999999999999999999999888888888877754 5677
Q ss_pred CCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCC
Q 013081 239 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 239 ~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
.+++.+.+||.+||+.||.+|||+.++++|+|+....
T Consensus 239 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 239 RYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred ccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence 8999999999999999999999999999999997653
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=396.11 Aligned_cols=259 Identities=29% Similarity=0.441 Sum_probs=221.6
Q ss_pred CCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013081 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (450)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (450)
.....++|++++.||+|+||.||+|.+..+++.||+|++.... .....+.+.+|+.+++.++||||+++++++...+.
T Consensus 28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 105 (360)
T 3eqc_A 28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE 105 (360)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTE
T ss_pred cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCE
Confidence 3455689999999999999999999999999999999997653 34446789999999999999999999999999999
Q ss_pred EEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhc-CeeeccCCCCcEEEccCCCeEEeecCCCCCCCcc
Q 013081 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~-givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 167 (450)
.|+||||++|++|.+++...+.+++..++.++.|++.||.|||+. ||+||||||+|||++.++++||+|||++.....
T Consensus 106 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~- 184 (360)
T 3eqc_A 106 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 184 (360)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred EEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc-
Confidence 999999999999999999888999999999999999999999996 999999999999999999999999999864321
Q ss_pred cCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHH--------------------
Q 013081 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQ-------------------- 227 (450)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~-------------------- 227 (450)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+......
T Consensus 185 ---~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 185 ---SMANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp ---HC----CCCCTTCCHHHHTTCCC-SHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred ---ccccCCCCCCCeECHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence 12345689999999999987766 589999999999999999999998766543321
Q ss_pred ----------------------HHHhCC-CCCC-CCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 228 ----------------------KIFRGD-FKLP-KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 228 ----------------------~i~~~~-~~~p-~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
.+.... ...+ ..+++++.+||.+||++||.+|||+.++++||||+..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 222221 1222 3378999999999999999999999999999999864
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-50 Score=398.69 Aligned_cols=260 Identities=27% Similarity=0.513 Sum_probs=227.7
Q ss_pred CCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchh--------------HHHHHHHHHHHHHhCCCC
Q 013081 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK--------------ITDQIKREIATLKLLKHP 74 (450)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~--------------~~~~~~~Ei~il~~l~hp 74 (450)
.....++|++++.||+|+||.||+|.+ +|+.||+|++......... ..+.+.+|+.+++.++||
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 103 (348)
T 2pml_X 26 KDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNE 103 (348)
T ss_dssp SCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCT
T ss_pred cccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCC
Confidence 345568999999999999999999999 8999999999765432211 127889999999999999
Q ss_pred CcceEEEEEEeCCEEEEEEccCCCCChHHH------HHh--cCCCCHHHHHHHHHHHHHHHhhhhh-cCeeeccCCCCcE
Q 013081 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDK------IAS--KGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENI 145 (450)
Q Consensus 75 nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~------i~~--~~~l~~~~~~~i~~ql~~aL~~LH~-~givHrDlKp~NI 145 (450)
||+++++++.+.+..|+||||++|++|.++ +.. ...+++..++.++.||+.||.|||+ +||+||||||+||
T Consensus 104 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Ni 183 (348)
T 2pml_X 104 YCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNI 183 (348)
T ss_dssp TBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGE
T ss_pred CcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhE
Confidence 999999999999999999999999999998 665 5789999999999999999999999 9999999999999
Q ss_pred EEccCCCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCcH-H
Q 013081 146 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILTGYLPFDDRNL-A 223 (450)
Q Consensus 146 Ll~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-~ 223 (450)
|++.++.+||+|||++..... .......||+.|+|||++.+. .+.+.++||||+||++|+|++|..||...+. .
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 259 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVD----KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV 259 (348)
T ss_dssp EECTTSCEEECCCTTCEECBT----TEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred EEcCCCcEEEecccccccccc----ccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence 999999999999999975422 234556899999999998876 4443489999999999999999999998776 7
Q ss_pred HHHHHHHhCCCCCC-------------------CCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 224 VLYQKIFRGDFKLP-------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 224 ~~~~~i~~~~~~~p-------------------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
.....+..+....| ..+++.+.+||.+||+.||.+|||+.++++||||+..
T Consensus 260 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 260 ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 77778877777766 5689999999999999999999999999999999753
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=399.60 Aligned_cols=255 Identities=31% Similarity=0.446 Sum_probs=202.1
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC------
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK------ 86 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------ 86 (450)
.++|++++.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++||||+++++++...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 379999999999999999999999999999999986543 2334467888999999999999999999998654
Q ss_pred CEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCc
Q 013081 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (450)
Q Consensus 87 ~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 166 (450)
...|+++||+ |++|.+++.. +++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~ 184 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184 (367)
T ss_dssp CCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred CeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence 5689999999 7899988865 6799999999999999999999999999999999999999999999999999985322
Q ss_pred ccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC--C-----------
Q 013081 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--D----------- 233 (450)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~----------- 233 (450)
.....+||+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+.......+.+. .
T Consensus 185 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 259 (367)
T 2fst_X 185 -----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259 (367)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred -----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 2345689999999999887555578999999999999999999999998876666555431 0
Q ss_pred ----------CCCC--------CCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCC
Q 013081 234 ----------FKLP--------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 234 ----------~~~p--------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
...+ ...++.+.+||.+||++||.+|||+.++++||||....
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319 (367)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence 0111 23688999999999999999999999999999998643
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=398.52 Aligned_cols=255 Identities=27% Similarity=0.393 Sum_probs=209.0
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS---- 87 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---- 87 (450)
..++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC-ChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 46899999999999999999999999999999999976432 3444678889999999999999999999997654
Q ss_pred --EEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCC
Q 013081 88 --KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (450)
Q Consensus 88 --~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 165 (450)
..|+||||+.| +|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 102 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 102 FQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp CCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred ccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 78999999975 7888875 469999999999999999999999999999999999999999999999999998543
Q ss_pred cccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCC----------
Q 013081 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK---------- 235 (450)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------- 235 (450)
. .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+......++......
T Consensus 179 ~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 179 T---SFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp --------------CTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred c---ccccCCceecCCccCHHHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 2 223445789999999999988766 58999999999999999999999998877766666543110
Q ss_pred ------------C--------------CCC------CCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 236 ------------L--------------PKW------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 236 ------------~--------------p~~------~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
. |.. .++.+.+||++||+.||.+|||++|+++||||+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 325 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence 0 000 15678999999999999999999999999999754
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-49 Score=388.64 Aligned_cols=251 Identities=25% Similarity=0.426 Sum_probs=211.7
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEe--CCE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLAS--KSK 88 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~--~~~ 88 (450)
..++|++++.||+|+||.||+|.+..+++.||+|++.... .+.+.+|+.++++++ ||||+++++++.+ ...
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 107 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 107 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence 3478999999999999999999999999999999986432 467889999999997 9999999999987 678
Q ss_pred EEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCC-CeEEeecCCCCCCCcc
Q 013081 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLSALPQHF 167 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g-~lkl~DFGla~~~~~~ 167 (450)
.++||||+.+++|.+++.. +++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 108 ~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~- 183 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP- 183 (330)
T ss_dssp EEEEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT-
T ss_pred eEEEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC-
Confidence 9999999999999988753 89999999999999999999999999999999999999777 899999999975432
Q ss_pred cCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCC-cHHHHHHH-------------HHhCC
Q 013081 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR-NLAVLYQK-------------IFRGD 233 (450)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~-~~~~~~~~-------------i~~~~ 233 (450)
.......+||+.|+|||++.+....+.++|||||||++|+|++|..||... +....... +....
T Consensus 184 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 261 (330)
T 3nsz_A 184 --GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261 (330)
T ss_dssp --TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred --CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence 233456689999999999887555679999999999999999999999543 22221111 11111
Q ss_pred CCC------------------------CCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 234 FKL------------------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 234 ~~~------------------------p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
... +..+++.+.+||.+||++||.+|||++|+++||||+.-
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence 111 12278999999999999999999999999999999864
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=381.48 Aligned_cols=260 Identities=22% Similarity=0.321 Sum_probs=205.0
Q ss_pred CcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (450)
....++|++++.||+|+||.||+|.+..+|+.||+|++..... .......+.++...++.++||||+++++++.+.+..
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 3567899999999999999999999999999999999975432 222234455566668889999999999999999999
Q ss_pred EEEEccCCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHhhhhhc-CeeeccCCCCcEEEccCCCeEEeecCCCCCC
Q 013081 90 YMVLEYVTGGELFDKIA----SKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALP 164 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~----~~~~l~~~~~~~i~~ql~~aL~~LH~~-givHrDlKp~NILl~~~g~lkl~DFGla~~~ 164 (450)
|+||||++| +|.+.+. ....+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||++...
T Consensus 82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999999975 8877664 356899999999999999999999998 9999999999999999999999999999754
Q ss_pred CcccCCCccccccCCCCccchhhhc---cCCCCCccchhhhHHHHHHHHHhCCCCCCCC-cHHHHHHHHH-hCCCCCC-C
Q 013081 165 QHFRDDGLLHTTCGSPNYVAPEVLA---NRGYDGATSDIWSCGVILYVILTGYLPFDDR-NLAVLYQKIF-RGDFKLP-K 238 (450)
Q Consensus 165 ~~~~~~~~~~~~~gt~~y~APE~l~---~~~~~~~~~DiwSlGvil~elltG~~Pf~~~-~~~~~~~~i~-~~~~~~p-~ 238 (450)
.. .......+||+.|+|||++. .....+.++||||+||++|+|++|..||... .......... ......+ .
T Consensus 161 ~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (290)
T 3fme_A 161 VD---DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD 237 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTT
T ss_pred cc---cccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccc
Confidence 32 22334457999999999972 3334468999999999999999999999863 3333333333 3333333 4
Q ss_pred CCCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 239 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 239 ~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
.+++.+.+||.+||++||.+|||+.++++||||+..
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 238 KFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred cCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 589999999999999999999999999999999854
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-49 Score=380.90 Aligned_cols=259 Identities=39% Similarity=0.668 Sum_probs=228.2
Q ss_pred CcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (450)
+...++|++++.||+|+||.||+|.+..+++.||+|++....... .....+.+|+.++++++||||+++++++......
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch-HHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 445679999999999999999999999999999999997654332 2357889999999999999999999999999999
Q ss_pred EEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCC---CeEEeecCCCCCCCc
Q 013081 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQH 166 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g---~lkl~DFGla~~~~~ 166 (450)
|+||||++|++|.+.+...+++++..++.++.||+.||.|||++|++||||||+|||++.++ .+||+|||++.....
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence 99999999999999998888999999999999999999999999999999999999997644 699999999885432
Q ss_pred ccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCH
Q 013081 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSP 242 (450)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~ 242 (450)
........||+.|+|||++.+. + +.++||||||+++|+|++|..||.+.+.......+..+....+ ..+++
T Consensus 177 ---~~~~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (287)
T 2wei_A 177 ---NTKMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD 251 (287)
T ss_dssp ---CSSCSCHHHHHTTCCHHHHTTC-C-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCH
T ss_pred ---CCccccccCcccccChHHhcCC-C-CCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCH
Confidence 2223455789999999998653 4 6899999999999999999999999988888888877765443 45899
Q ss_pred HHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
.+.+||.+||++||.+|||+.++++||||++.
T Consensus 252 ~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred HHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 99999999999999999999999999999764
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-51 Score=410.49 Aligned_cols=249 Identities=19% Similarity=0.221 Sum_probs=206.9
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHH---HHHhCCCCCcceEE-------EE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA---TLKLLKHPNVVRLH-------EV 82 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~---il~~l~hpnIv~l~-------~~ 82 (450)
.++|++++.||+|+||.||+|.+..+|+.||||++.+.........+.+.+|+. +++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 478999999999999999999998999999999998765555556788999994 55555799999998 77
Q ss_pred EEeCCE-----------------EEEEEccCCCCChHHHHHhcCCCCH-------HHHHHHHHHHHHHHhhhhhcCeeec
Q 013081 83 LASKSK-----------------IYMVLEYVTGGELFDKIASKGRLQE-------AEGRKLFQQLIDGVSYCHNKGVFHR 138 (450)
Q Consensus 83 ~~~~~~-----------------~~lv~E~~~gg~L~~~i~~~~~l~~-------~~~~~i~~ql~~aL~~LH~~givHr 138 (450)
+.+.+. .|++|||+ +|+|.+++...+.+++ ..++.++.||+.||+|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 766543 89999999 6799999987665665 7888899999999999999999999
Q ss_pred cCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccC-----------CCCCccchhhhHHHHH
Q 013081 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR-----------GYDGATSDIWSCGVIL 207 (450)
Q Consensus 139 DlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-----------~~~~~~~DiwSlGvil 207 (450)
||||+|||++.+|.+||+|||+|+.. .......+| +.|+|||++.+. .+ +.++|||||||++
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~-----~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DvwSlG~il 303 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRD-----GARVVSSVS-RGFEPPELEARRATISYHRDRRTLM-TFSFDAWALGLVI 303 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEET-----TCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEEC-CHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheec-----CCcccCCCC-cCccChhhhcccccccccccccccC-ChhhhHHHHHHHH
Confidence 99999999999999999999999842 223456678 999999998876 55 6999999999999
Q ss_pred HHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhcccccc
Q 013081 208 YVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 208 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
|+|++|+.||.+.+.......+. ..+..+++.+.+||.+||+.||.+|||+.++++||||+.
T Consensus 304 ~elltg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 304 YWIWCADLPITKDAALGGSEWIF----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp HHHHHSSCCC------CCSGGGG----SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred HHHHHCCCCCcccccccchhhhh----hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 99999999998765443322222 234568999999999999999999999999999999975
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-49 Score=402.94 Aligned_cols=253 Identities=28% Similarity=0.407 Sum_probs=214.8
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC------CCCCcceEEEEEEe
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL------KHPNVVRLHEVLAS 85 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l------~hpnIv~l~~~~~~ 85 (450)
..++|++++.||+|+||.||+|.+..+++.||||++... ......+.+|+.+++.+ +|+||+++++++..
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~ 170 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF 170 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence 446899999999999999999999999999999999653 23346777888888887 57799999999999
Q ss_pred CCEEEEEEccCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCC--eEEeecCCC
Q 013081 86 KSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN--IKISDFGLS 161 (450)
Q Consensus 86 ~~~~~lv~E~~~gg~L~~~i~~~~--~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~--lkl~DFGla 161 (450)
....|+||||+. ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|
T Consensus 171 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 171 RNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp TTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred CCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 999999999995 69999987654 5999999999999999999999999999999999999999987 999999999
Q ss_pred CCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC-C------
Q 013081 162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-F------ 234 (450)
Q Consensus 162 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~------ 234 (450)
.... ....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|.+||.+.+.......+.... .
T Consensus 250 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~ 323 (429)
T 3kvw_A 250 CYEH-----QRVYTYIQSRFYRAPEVILGARY-GMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL 323 (429)
T ss_dssp EETT-----CCCCSSCSCGGGCCHHHHHTBCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred eecC-----CcccccCCCCCccChHHHhCCCC-CchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 7432 23456789999999999988776 589999999999999999999999988766655443210 0
Q ss_pred -------------C---------------------------------------CCCCCCHHHHHHHHHccccCcCCCCCH
Q 013081 235 -------------K---------------------------------------LPKWLSPGAQNLLRKILEPNPVKRITI 262 (450)
Q Consensus 235 -------------~---------------------------------------~p~~~s~~~~~Li~~~L~~dP~~R~t~ 262 (450)
. ++...++.+.+||++||++||++|||+
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta 403 (429)
T 3kvw_A 324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP 403 (429)
T ss_dssp HTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCH
Confidence 0 011237889999999999999999999
Q ss_pred HHHHhccccccCC
Q 013081 263 AGIKADEWFEQDY 275 (450)
Q Consensus 263 ~~il~h~~~~~~~ 275 (450)
.|+|+||||++..
T Consensus 404 ~e~L~Hpw~~~~~ 416 (429)
T 3kvw_A 404 GQALRHPWLRRRL 416 (429)
T ss_dssp HHHHTSTTTC---
T ss_pred HHHhCChhhccCC
Confidence 9999999998754
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=389.21 Aligned_cols=258 Identities=36% Similarity=0.643 Sum_probs=214.7
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeeccccc-----chhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-----HLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (450)
..++|++++.||+|+||.||+|.+..+++.||||++...... .......+.+|+.+++.++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 346899999999999999999999999999999999764321 112234688999999999999999999998766
Q ss_pred CEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCC---eEEeecCCCCC
Q 013081 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSAL 163 (450)
Q Consensus 87 ~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~---lkl~DFGla~~ 163 (450)
. .|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++..
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred c-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 5 8999999999999999988889999999999999999999999999999999999999987765 99999999975
Q ss_pred CCcccCCCccccccCCCCccchhhhcc--CCCCCccchhhhHHHHHHHHHhCCCCCCCCcHH-HHHHHHHhCCCCCC---
Q 013081 164 PQHFRDDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKIFRGDFKLP--- 237 (450)
Q Consensus 164 ~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~p--- 237 (450)
... .......+||+.|+|||++.. ....+.++|||||||++|+|++|..||...... .....+..+....+
T Consensus 167 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (322)
T 2ycf_A 167 LGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 243 (322)
T ss_dssp CCC---CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHH
T ss_pred ccc---ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchh
Confidence 422 223345689999999999742 333468999999999999999999999765432 33444555544432
Q ss_pred -CCCCHHHHHHHHHccccCcCCCCCHHHHHhcccccc
Q 013081 238 -KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 238 -~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
..+++.+.+||.+||+.||.+|||+.++++||||+.
T Consensus 244 ~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 457999999999999999999999999999999975
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-49 Score=395.72 Aligned_cols=256 Identities=26% Similarity=0.443 Sum_probs=221.7
Q ss_pred CcccCCeEEeeeecccCceEEEEEEEC-------CCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEE
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHE 81 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~ 81 (450)
....++|++++.||+|+||.||+|.+. .++..||+|+++... .......+.+|+.+++++ +||||+++++
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 154 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 154 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 345579999999999999999999874 345679999997543 334467899999999999 8999999999
Q ss_pred EEEeCCEEEEEEccCCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcE
Q 013081 82 VLASKSKIYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENI 145 (450)
Q Consensus 82 ~~~~~~~~~lv~E~~~gg~L~~~i~~~~----------------~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NI 145 (450)
++...+..|+||||++||+|.+++.... .+++.+++.++.||+.||+|||++||+||||||+||
T Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 234 (370)
T 2psq_A 155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 234 (370)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence 9999999999999999999999998643 479999999999999999999999999999999999
Q ss_pred EEccCCCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHH
Q 013081 146 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAV 224 (450)
Q Consensus 146 Ll~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~ 224 (450)
|++.+|.+||+|||++................+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+...
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~ellt~g~~p~~~~~~~~ 313 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 313 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCC-CcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 999999999999999985433222223344567889999999987766 589999999999999999 999999988777
Q ss_pred HHHHHHhC-CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 225 LYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 225 ~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
....+..+ ....|..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 314 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 77777666 456777899999999999999999999999999875
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=380.49 Aligned_cols=257 Identities=24% Similarity=0.423 Sum_probs=227.2
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 92 (450)
-.+|++++.||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++......|+|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS--TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 35799999999999999999999999999999999765432 2357899999999999999999999999999999999
Q ss_pred EccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCc
Q 013081 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 172 (450)
|||++|++|.+++.. +++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus 99 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~ 175 (303)
T 3a7i_A 99 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT--QIK 175 (303)
T ss_dssp EECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT--BCC
T ss_pred EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcc--ccc
Confidence 999999999998865 67999999999999999999999999999999999999999999999999999754321 122
Q ss_pred cccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHc
Q 013081 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKI 251 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~ 251 (450)
....+||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+.... ...+..+++.+.+||.+|
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 254 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEAC 254 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHHH
T ss_pred cCccCCCcCccCHHHHhcCCC-CchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHHH
Confidence 345679999999999987766 489999999999999999999999888777666665553 445667899999999999
Q ss_pred cccCcCCCCCHHHHHhccccccCC
Q 013081 252 LEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 252 L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
|++||.+|||+.++++||||....
T Consensus 255 l~~dp~~Rps~~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 255 LNKEPSFRPTAKELLKHKFILRNA 278 (303)
T ss_dssp CCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred cCCChhhCcCHHHHhhChhhhcCC
Confidence 999999999999999999997653
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=384.71 Aligned_cols=259 Identities=26% Similarity=0.408 Sum_probs=218.8
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (450)
...++|++++.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++...+..|
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 92 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE---EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLW 92 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH---HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEE
Confidence 345799999999999999999999999999999999865432 22578889999999999999999999999999999
Q ss_pred EEEccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC
Q 013081 91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (450)
Q Consensus 91 lv~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 169 (450)
+||||++|++|.+++.. ...+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++..... .
T Consensus 93 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~ 170 (302)
T 2j7t_A 93 IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK--T 170 (302)
T ss_dssp EEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH--H
T ss_pred EEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccc--c
Confidence 99999999999998875 56799999999999999999999999999999999999999999999999998753211 1
Q ss_pred CCccccccCCCCccchhhhc----cCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCC---CCCCCCH
Q 013081 170 DGLLHTTCGSPNYVAPEVLA----NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK---LPKWLSP 242 (450)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~----~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~ 242 (450)
.......+||+.|+|||++. .....+.++||||||+++|+|++|..||...+.......+.....+ .+..+++
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (302)
T 2j7t_A 171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSV 250 (302)
T ss_dssp HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCH
T ss_pred ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCH
Confidence 11223457999999999984 2333468999999999999999999999998887777777665432 3456899
Q ss_pred HHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
.+.+||.+||+.||.+|||+.++++||||...
T Consensus 251 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 282 (302)
T 2j7t_A 251 EFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282 (302)
T ss_dssp HHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred HHHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence 99999999999999999999999999999753
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=382.26 Aligned_cols=262 Identities=28% Similarity=0.388 Sum_probs=213.9
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE------
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA------ 84 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~------ 84 (450)
..-++|++++.||+|+||.||+|.+..+|+.||+|.+... +....+.+.+|+.+++.++||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (320)
T 2i6l_A 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQL 84 (320)
T ss_dssp EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBC
T ss_pred ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccc
Confidence 3457999999999999999999999999999999998754 3344678899999999999999999999873
Q ss_pred --------eCCEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEc-cCCCeEE
Q 013081 85 --------SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-SKGNIKI 155 (450)
Q Consensus 85 --------~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~-~~g~lkl 155 (450)
.....|+||||+. |+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++ +++.+||
T Consensus 85 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 85 TDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp CC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEE
T ss_pred ccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEE
Confidence 4468899999997 599998864 6799999999999999999999999999999999999997 5678999
Q ss_pred eecCCCCCCCccc-CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCC
Q 013081 156 SDFGLSALPQHFR-DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF 234 (450)
Q Consensus 156 ~DFGla~~~~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~ 234 (450)
+|||++....... .........+|+.|+|||++......+.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 242 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSC
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999998643211 122344567899999999987655557899999999999999999999999887666655543211
Q ss_pred C------------------------------CCCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCCCC
Q 013081 235 K------------------------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277 (450)
Q Consensus 235 ~------------------------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~~~ 277 (450)
. .++.+++.+.+||.+||+.||.+|||+.++++||||+....|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p 315 (320)
T 2i6l_A 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP 315 (320)
T ss_dssp CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence 0 124579999999999999999999999999999999865433
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=388.11 Aligned_cols=255 Identities=26% Similarity=0.412 Sum_probs=211.8
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--E
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS--K 88 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--~ 88 (450)
..-++|++++.||+|+||.||+|.+..+|+.||||++....... ..+.+.+|+.++++++||||+++++++.... .
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCce
Confidence 34578999999999999999999999999999999997544322 2567789999999999999999999997655 7
Q ss_pred EEEEEccCCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEE----ccCCCeEEeecCCC
Q 013081 89 IYMVLEYVTGGELFDKIASKG---RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL----DSKGNIKISDFGLS 161 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~~i~~~~---~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl----~~~g~lkl~DFGla 161 (450)
.|+||||++|++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 899999999999999997644 39999999999999999999999999999999999999 77788999999999
Q ss_pred CCCCcccCCCccccccCCCCccchhhhcc-------CCCCCccchhhhHHHHHHHHHhCCCCCCCC----cHHHHHHHHH
Q 013081 162 ALPQHFRDDGLLHTTCGSPNYVAPEVLAN-------RGYDGATSDIWSCGVILYVILTGYLPFDDR----NLAVLYQKIF 230 (450)
Q Consensus 162 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~-------~~~~~~~~DiwSlGvil~elltG~~Pf~~~----~~~~~~~~i~ 230 (450)
..... .......+||+.|+|||++.. ....+.++|||||||++|+|++|..||... .......++.
T Consensus 164 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 240 (319)
T 4euu_A 164 RELED---DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (319)
T ss_dssp EECCT---TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred eecCC---CCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence 85432 233445689999999999862 233468999999999999999999999642 2334455554
Q ss_pred hCCC-------------------CCC------CCCCHHHHHHHHHccccCcCCCCCHHHHHhccc
Q 013081 231 RGDF-------------------KLP------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 270 (450)
Q Consensus 231 ~~~~-------------------~~p------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~ 270 (450)
.+.. .+| ..+++.+.+||++||+.||++|||++|+++||-
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 4332 111 124567889999999999999999999999973
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=400.64 Aligned_cols=252 Identities=28% Similarity=0.386 Sum_probs=209.4
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC------
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK------ 86 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------ 86 (450)
..+|++++.||+|+||.||+|.+..+|+.||||.+..... ...+|+.+++.++||||+++++++...
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~ 125 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 125 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence 3479999999999999999999999999999999865431 234799999999999999999998432
Q ss_pred CEEEEEEccCCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccC-CCeEEeecCCC
Q 013081 87 SKIYMVLEYVTGGELFDKIA----SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGLS 161 (450)
Q Consensus 87 ~~~~lv~E~~~gg~L~~~i~----~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~-g~lkl~DFGla 161 (450)
..+++||||+++ +|.+.+. ....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++
T Consensus 126 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred eeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhh
Confidence 236799999975 6666554 35679999999999999999999999999999999999999966 56899999999
Q ss_pred CCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC---------
Q 013081 162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--------- 232 (450)
Q Consensus 162 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--------- 232 (450)
+.... .......+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+......++.+.
T Consensus 205 ~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 205 KQLVR---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 281 (420)
T ss_dssp EECCT---TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred hhccc---CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 85422 223345689999999999877655578999999999999999999999998776655555431
Q ss_pred --------CCC------------CCCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCC
Q 013081 233 --------DFK------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 233 --------~~~------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
.+. ++..+++++.+||.+||+.||.+|||+.|+++||||+...
T Consensus 282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 112 2234689999999999999999999999999999997643
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=386.47 Aligned_cols=261 Identities=26% Similarity=0.386 Sum_probs=217.2
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK---- 86 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 86 (450)
...++|++++.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 85 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFEN 85 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTT
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCc
Confidence 34579999999999999999999999999999999996432 334457788999999999999999999998654
Q ss_pred -CEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCC
Q 013081 87 -SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (450)
Q Consensus 87 -~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 165 (450)
...|+||||+. ++|.+.+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 86 ~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 86 FNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp CCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 67899999996 589998876 679999999999999999999999999999999999999999999999999998543
Q ss_pred cccCC--------CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC--C--
Q 013081 166 HFRDD--------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--D-- 233 (450)
Q Consensus 166 ~~~~~--------~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~-- 233 (450)
..... ......+||+.|+|||++......+.++|||||||++|+|++|..||.+.+.......+... .
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence 21111 01234578999999999876555578999999999999999999999988765544433220 0
Q ss_pred --------------------CC--------CCCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCC
Q 013081 234 --------------------FK--------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 234 --------------------~~--------~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
.. .++.+++.+.+||.+||+.||.+|||+.++++||||+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 00 1135789999999999999999999999999999998643
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=381.94 Aligned_cols=259 Identities=26% Similarity=0.390 Sum_probs=216.5
Q ss_pred CcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEe---
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS--- 85 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~--- 85 (450)
....++|++++.||+|+||.||+|.+..+|+.||+|++...... ...+.+|+.+++++ +||||+++++++..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST----THHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc----HHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 34568999999999999999999999999999999999754322 36788999999999 79999999999976
Q ss_pred ---CCEEEEEEccCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCC
Q 013081 86 ---KSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGL 160 (450)
Q Consensus 86 ---~~~~~lv~E~~~gg~L~~~i~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGl 160 (450)
....|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 175 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV 175 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTT
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcC
Confidence 56899999999999999999764 5799999999999999999999999999999999999999999999999999
Q ss_pred CCCCCcccCCCccccccCCCCccchhhhcc----CCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCC-
Q 013081 161 SALPQHFRDDGLLHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK- 235 (450)
Q Consensus 161 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~----~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~- 235 (450)
+..... ........+||+.|+|||++.. ....+.++|||||||++|+|++|..||.+.+.......+.....+
T Consensus 176 ~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 253 (326)
T 2x7f_A 176 SAQLDR--TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR 253 (326)
T ss_dssp TC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC
T ss_pred ceecCc--CccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccc
Confidence 885432 1122345689999999999862 233468999999999999999999999988877666666554332
Q ss_pred -CCCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 236 -LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 236 -~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
.+..+++.+.+||.+||+.||.+|||+.++++||||...
T Consensus 254 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 254 LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred CCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 245589999999999999999999999999999999864
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=380.71 Aligned_cols=256 Identities=26% Similarity=0.438 Sum_probs=217.9
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (450)
...++|++++.||+|+||.||+|.+..+|+.||+|.+..... ...+.+|+.+++.++||||+++++++......|
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW 100 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence 345689999999999999999999999999999999975431 356889999999999999999999999999999
Q ss_pred EEEccCCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC
Q 013081 91 MVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (450)
Q Consensus 91 lv~E~~~gg~L~~~i~-~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 169 (450)
+||||++|++|.+++. ....+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT-- 178 (314)
T ss_dssp EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT--
T ss_pred EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh--
Confidence 9999999999999987 4568999999999999999999999999999999999999999999999999999754321
Q ss_pred CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC---CCCCCCCCHHHHH
Q 013081 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGAQN 246 (450)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~ 246 (450)
........||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+.......+.... ...|..+++.+.+
T Consensus 179 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 257 (314)
T 3com_A 179 MAKRNTVIGTPFWMAPEVIQEIGY-NCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTD 257 (314)
T ss_dssp BSCBCCCCSCGGGCCHHHHSSSCB-CTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred ccccCccCCCCCccChhhcCCCCC-CccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHH
Confidence 122345679999999999987766 589999999999999999999999877665555544442 3335568999999
Q ss_pred HHHHccccCcCCCCCHHHHHhccccccC
Q 013081 247 LLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 247 Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
||.+||+.||.+|||+.++++||||...
T Consensus 258 li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 258 FVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp HHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred HHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 9999999999999999999999999864
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-49 Score=386.27 Aligned_cols=262 Identities=25% Similarity=0.363 Sum_probs=203.2
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCc---eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGL---PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (450)
...++|++++.||+|+||.||+|.+..++. .||+|++....... ...+.+.+|+.++++++||||+++++++....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 445789999999999999999999877665 89999997654333 33678999999999999999999999998766
Q ss_pred EE------EEEEccCCCCChHHHHHhcC------CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEE
Q 013081 88 KI------YMVLEYVTGGELFDKIASKG------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKI 155 (450)
Q Consensus 88 ~~------~lv~E~~~gg~L~~~i~~~~------~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl 155 (450)
.. |+||||+.||+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEE
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEE
Confidence 55 99999999999999986533 5999999999999999999999999999999999999999999999
Q ss_pred eecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-C
Q 013081 156 SDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-D 233 (450)
Q Consensus 156 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~ 233 (450)
+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+ .
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~ 257 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLY-TVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR 257 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCC-CCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC
Confidence 99999986433222222334457789999999987766 589999999999999999 99999998877777777665 4
Q ss_pred CCCCCCCCHHHHHHHHHccccCcCCCCC-------HHHHHhccccccC
Q 013081 234 FKLPKWLSPGAQNLLRKILEPNPVKRIT-------IAGIKADEWFEQD 274 (450)
Q Consensus 234 ~~~p~~~s~~~~~Li~~~L~~dP~~R~t-------~~~il~h~~~~~~ 274 (450)
...|..+++.+.+||.+||+.||.+||| +++++.|+|+...
T Consensus 258 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 258 LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 5677789999999999999999999999 7889999998764
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=386.63 Aligned_cols=265 Identities=26% Similarity=0.444 Sum_probs=199.2
Q ss_pred cCCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013081 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (450)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (450)
+.....++|++++.||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+.++++++||||+++++++...+
T Consensus 9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 86 (303)
T 2vwi_A 9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ--TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD 86 (303)
T ss_dssp ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSS
T ss_pred ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc--hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC
Confidence 3445678999999999999999999999889999999998654322 23567889999999999999999999999999
Q ss_pred EEEEEEccCCCCChHHHHHh--------cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecC
Q 013081 88 KIYMVLEYVTGGELFDKIAS--------KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFG 159 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~--------~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFG 159 (450)
..|+||||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEecc
Confidence 99999999999999999874 4569999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCccc---CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCC--
Q 013081 160 LSALPQHFR---DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-- 234 (450)
Q Consensus 160 la~~~~~~~---~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-- 234 (450)
++....... ........+||+.|+|||++......+.++|||||||++|+|++|..||.................
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 246 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS 246 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCC
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCc
Confidence 987443211 112234567999999999987633346899999999999999999999988766554444443322
Q ss_pred --------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 235 --------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 235 --------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
..+..+++.+.+||.+||+.||.+|||+.++++||||++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 1224578999999999999999999999999999999864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-49 Score=398.23 Aligned_cols=255 Identities=27% Similarity=0.399 Sum_probs=210.3
Q ss_pred CCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-
Q 013081 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS- 87 (450)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~- 87 (450)
.....++|++++.||+|+||.||+|.+..+++ ||+|.+..... ...+|+.+++.++||||+++++++....
T Consensus 35 ~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~-------~~~~E~~il~~l~h~niv~l~~~~~~~~~ 106 (394)
T 4e7w_A 35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR-------FKNRELQIMRIVKHPNVVDLKAFFYSNGD 106 (394)
T ss_dssp CCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEESS
T ss_pred CCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc-------hHHHHHHHHHhCCCCCcceEEEEEEecCC
Confidence 33445789999999999999999999987776 88887754432 1237999999999999999999985543
Q ss_pred -----EEEEEEccCCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEc-cCCCeEEee
Q 013081 88 -----KIYMVLEYVTGGELFDKIA----SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-SKGNIKISD 157 (450)
Q Consensus 88 -----~~~lv~E~~~gg~L~~~i~----~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~-~~g~lkl~D 157 (450)
..|+||||++++ +.+.+. ..+.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|
T Consensus 107 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~D 185 (394)
T 4e7w_A 107 KKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLID 185 (394)
T ss_dssp SSSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECC
T ss_pred CCCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEee
Confidence 388999999764 433332 356899999999999999999999999999999999999999 789999999
Q ss_pred cCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC-----
Q 013081 158 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG----- 232 (450)
Q Consensus 158 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~----- 232 (450)
||+|+.... .......+||+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+.......+.+.
T Consensus 186 FG~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~ 262 (394)
T 4e7w_A 186 FGSAKILIA---GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPS 262 (394)
T ss_dssp CTTCEECCT---TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred CCCcccccC---CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 999975422 223445688999999999877665579999999999999999999999998877666555431
Q ss_pred ------------CCC------------CCCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCC
Q 013081 233 ------------DFK------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 233 ------------~~~------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
... ++..+++++.+||.+||++||.+|||+.++++||||+.-.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 263 REQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp HHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred HHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 011 2334789999999999999999999999999999998643
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-49 Score=400.25 Aligned_cols=259 Identities=32% Similarity=0.442 Sum_probs=197.5
Q ss_pred cCCeEE-eeeecccCceEEEEEEEC--CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CC
Q 013081 13 LGRYEL-GRTLGEGNFGKVKFAQDL--DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--KS 87 (450)
Q Consensus 13 ~~~y~i-~~~LG~G~~g~Vy~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~ 87 (450)
-+.|++ +++||+|+||.||+|.+. .+++.||||++..... ...+.+|+.+|+.++||||+++++++.. ..
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADR 93 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence 356887 668999999999999976 5789999999975432 2467899999999999999999999954 77
Q ss_pred EEEEEEccCCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEE----ccCCCeE
Q 013081 88 KIYMVLEYVTGGELFDKIASK---------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL----DSKGNIK 154 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~---------~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl----~~~g~lk 154 (450)
..|+||||+. ++|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+|
T Consensus 94 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 94 KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred eEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEE
Confidence 8999999996 5888877532 249999999999999999999999999999999999999 6778999
Q ss_pred EeecCCCCCCCccc-CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHH---------H
Q 013081 155 ISDFGLSALPQHFR-DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA---------V 224 (450)
Q Consensus 155 l~DFGla~~~~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---------~ 224 (450)
|+|||+|+...... ........+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+.. .
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 99999998653321 1123456789999999999987665679999999999999999999999765432 2
Q ss_pred HHHHHHhC--CCCCC------------------------------------CCCCHHHHHHHHHccccCcCCCCCHHHHH
Q 013081 225 LYQKIFRG--DFKLP------------------------------------KWLSPGAQNLLRKILEPNPVKRITIAGIK 266 (450)
Q Consensus 225 ~~~~i~~~--~~~~p------------------------------------~~~s~~~~~Li~~~L~~dP~~R~t~~~il 266 (450)
....+... ..... ...++.+.+||.+||++||.+|||++|+|
T Consensus 253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 22333221 11000 11277899999999999999999999999
Q ss_pred hccccccCCCC
Q 013081 267 ADEWFEQDYTP 277 (450)
Q Consensus 267 ~h~~~~~~~~~ 277 (450)
+||||.....+
T Consensus 333 ~hp~f~~~~~~ 343 (405)
T 3rgf_A 333 QDPYFLEDPLP 343 (405)
T ss_dssp TSGGGTSSSCC
T ss_pred cChhhccCCCC
Confidence 99999876544
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=389.49 Aligned_cols=259 Identities=24% Similarity=0.364 Sum_probs=205.5
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE--
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK-- 88 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~-- 88 (450)
..+++|++.+.||+|+||.||+|.+..+|+.||||++...... .....+|+..++.++||||+++++++.....
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF----RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC----CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc----cHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 5678999999999999999999999999999999998654322 2356678888899999999999999865433
Q ss_pred -----EEEEEccCCCCChHHHH----HhcCCCCHHHHHHHHHHHHHHHhhhh--hcCeeeccCCCCcEEEcc-CCCeEEe
Q 013081 89 -----IYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGVSYCH--NKGVFHRDLKLENILLDS-KGNIKIS 156 (450)
Q Consensus 89 -----~~lv~E~~~gg~L~~~i----~~~~~l~~~~~~~i~~ql~~aL~~LH--~~givHrDlKp~NILl~~-~g~lkl~ 156 (450)
.|+||||+.+ +|.+.+ .....+++..++.++.||+.||.||| ++||+||||||+|||++. ++.+||+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~ 174 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLC 174 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEEC
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEe
Confidence 8899999986 544433 35667999999999999999999999 999999999999999997 8999999
Q ss_pred ecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC---
Q 013081 157 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--- 233 (450)
Q Consensus 157 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--- 233 (450)
|||++..... .......+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+.+..
T Consensus 175 Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 251 (360)
T 3e3p_A 175 DFGSAKKLSP---SEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCP 251 (360)
T ss_dssp CCTTCBCCCT---TSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred eCCCceecCC---CCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCC
Confidence 9999986432 2233456789999999998776656799999999999999999999999988777666654310
Q ss_pred -----------------------------CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCCCC
Q 013081 234 -----------------------------FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277 (450)
Q Consensus 234 -----------------------------~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~~~ 277 (450)
...+...++.+.+||.+||++||.+|||+.|+++||||++...+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 324 (360)
T 3e3p_A 252 SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDP 324 (360)
T ss_dssp CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCT
T ss_pred CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCc
Confidence 01112256789999999999999999999999999999875443
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-49 Score=396.28 Aligned_cols=261 Identities=23% Similarity=0.306 Sum_probs=224.5
Q ss_pred CcccCCeEEeeeecccCceEEEEEE-----ECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQ-----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA 84 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~-----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 84 (450)
....++|++++.||+|+||.||+|. +..+++.||||++.... .......+.+|+.++++++||||+++++++.
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 144 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSL 144 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 3456789999999999999999999 44578899999986432 2334567889999999999999999999999
Q ss_pred eCCEEEEEEccCCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCC---CeE
Q 013081 85 SKSKIYMVLEYVTGGELFDKIASKG-------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---NIK 154 (450)
Q Consensus 85 ~~~~~~lv~E~~~gg~L~~~i~~~~-------~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g---~lk 154 (450)
.....|+||||++||+|.+++.... .+++.+++.++.||+.||+|||++||+||||||+|||++.+| .+|
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence 9999999999999999999997643 489999999999999999999999999999999999999665 499
Q ss_pred EeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCC
Q 013081 155 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD 233 (450)
Q Consensus 155 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~ 233 (450)
|+|||+|+...............||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+.
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~ 303 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIF-TSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 303 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999974332222233445678999999999987776 589999999999999998 999999999888888887764
Q ss_pred -CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhcccccc
Q 013081 234 -FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 234 -~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
...|..+++.+.+|+.+||+.||.+|||+.+++++.|+..
T Consensus 304 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 304 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 5667789999999999999999999999999999988753
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=390.71 Aligned_cols=252 Identities=31% Similarity=0.428 Sum_probs=213.8
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE----
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI---- 89 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~---- 89 (450)
++|.+++.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++||||+++++++......
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 69999999999999999999999999999999997543 2344567889999999999999999999999876654
Q ss_pred --EEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcc
Q 013081 90 --YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (450)
Q Consensus 90 --~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 167 (450)
|+||||+. ++|.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 121 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~- 196 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA- 196 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC------
T ss_pred eEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc-
Confidence 99999997 58887763 4599999999999999999999999999999999999999999999999999985322
Q ss_pred cCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC--------------
Q 013081 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-------------- 233 (450)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-------------- 233 (450)
.....+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+......++....
T Consensus 197 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 272 (371)
T 4exu_A 197 ----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 272 (371)
T ss_dssp -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCH
T ss_pred ----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhh
Confidence 23456899999999998874555789999999999999999999999988766665554310
Q ss_pred ---------C--------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 234 ---------F--------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 234 ---------~--------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
. ..++.+++.+.+||.+||++||.+|||+.|+++||||+..
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 273 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp HHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 0 0123468999999999999999999999999999999854
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=383.17 Aligned_cols=256 Identities=24% Similarity=0.384 Sum_probs=220.3
Q ss_pred CcccCCeEEeeeecccCceEEEEEEECCCCc---eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGL---PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (450)
....++|++.+.||+|+||.||+|.+..+++ .||||++.... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 122 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG 122 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 3456899999999999999999999986655 49999997543 333457899999999999999999999999999
Q ss_pred CEEEEEEccCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCC
Q 013081 87 SKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (450)
Q Consensus 87 ~~~~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 165 (450)
...|+||||++|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999999999754 579999999999999999999999999999999999999999999999999998653
Q ss_pred cccCCC-ccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCH
Q 013081 166 HFRDDG-LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSP 242 (450)
Q Consensus 166 ~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~ 242 (450)
...... ......+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+ ..+.|..+++
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTF-SSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPH 281 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCC-CcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCH
Confidence 321111 1223456778999999987766 589999999999999999 99999998888888877766 5667778999
Q ss_pred HHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 243 GAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
.+.+||.+||+.||.+|||+.++++.
T Consensus 282 ~l~~li~~~l~~dp~~Rps~~eil~~ 307 (325)
T 3kul_A 282 ALHQLMLDCWHKDRAQRPRFSQIVSV 307 (325)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999999863
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=379.16 Aligned_cols=262 Identities=24% Similarity=0.382 Sum_probs=211.8
Q ss_pred cccccCCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEE
Q 013081 4 AEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVL 83 (450)
Q Consensus 4 ~~~~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 83 (450)
+.....+..+++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++
T Consensus 24 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 103 (309)
T 2h34_A 24 TAESREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFG 103 (309)
T ss_dssp ----------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccccCCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEE
Confidence 34556778899999999999999999999999999999999999876555555668899999999999999999999999
Q ss_pred EeCCEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCC
Q 013081 84 ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL 163 (450)
Q Consensus 84 ~~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~ 163 (450)
...+..|+||||++|++|.+++...+++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 104 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~ 183 (309)
T 2h34_A 104 EIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASA 183 (309)
T ss_dssp EETTEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC---
T ss_pred eeCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcc
Confidence 99999999999999999999999888999999999999999999999999999999999999999999999999999875
Q ss_pred CCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCC---CCCCCC
Q 013081 164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---KLPKWL 240 (450)
Q Consensus 164 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~ 240 (450)
.... ........+||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+.......+..... ..+..+
T Consensus 184 ~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (309)
T 2h34_A 184 TTDE-KLTQLGNTVGTLYYMAPERFSESHA-TYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGI 261 (309)
T ss_dssp --------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTC
T ss_pred cccc-ccccccccCCCcCccCHHHHcCCCC-CchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCC
Confidence 4321 1122345679999999999877665 5899999999999999999999998877655444443322 235668
Q ss_pred CHHHHHHHHHccccCcCCCC-CHHHHHh
Q 013081 241 SPGAQNLLRKILEPNPVKRI-TIAGIKA 267 (450)
Q Consensus 241 s~~~~~Li~~~L~~dP~~R~-t~~~il~ 267 (450)
++.+.+||.+||++||.+|| |++++++
T Consensus 262 ~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 262 PVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp CTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred CHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 99999999999999999999 7777765
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=383.62 Aligned_cols=255 Identities=30% Similarity=0.433 Sum_probs=214.9
Q ss_pred CCcccCCeEEeeeecccCceEEEEEEE-CCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC------cceEEE
Q 013081 9 EGMRLGRYELGRTLGEGNFGKVKFAQD-LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN------VVRLHE 81 (450)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~-~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn------Iv~l~~ 81 (450)
.....++|++++.||+|+||.||+|.+ ..+++.||+|++... ....+.+.+|+.+++.++|++ ++++++
T Consensus 9 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~ 84 (339)
T 1z57_A 9 GDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLE 84 (339)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEE
T ss_pred CCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeec
Confidence 334457999999999999999999998 568999999998643 233577889999999987654 999999
Q ss_pred EEEeCCEEEEEEccCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEcc----------
Q 013081 82 VLASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS---------- 149 (450)
Q Consensus 82 ~~~~~~~~~lv~E~~~gg~L~~~i~~~~--~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~---------- 149 (450)
++...+..|+||||+ +++|.+++...+ ++++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 85 ~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 85 WFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp EEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC--
T ss_pred ccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCc
Confidence 999999999999999 899999998765 6899999999999999999999999999999999999987
Q ss_pred ---------CCCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCC
Q 013081 150 ---------KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR 220 (450)
Q Consensus 150 ---------~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~ 220 (450)
++.+||+|||++.... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~ 237 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDD-----EHHSTLVSTRHYRAPEVILALGW-SQPCDVWSIGCILIEYYLGFTVFPTH 237 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETT-----SCCCSSCSCGGGCCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccCCCceEeeCcccccCc-----cccccccCCccccChHHhhCCCC-CcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 6789999999997532 22345689999999999987776 58999999999999999999999987
Q ss_pred cHHHHHHHHHhCCCCCC--------------------------------------------CCCCHHHHHHHHHccccCc
Q 013081 221 NLAVLYQKIFRGDFKLP--------------------------------------------KWLSPGAQNLLRKILEPNP 256 (450)
Q Consensus 221 ~~~~~~~~i~~~~~~~p--------------------------------------------~~~s~~~~~Li~~~L~~dP 256 (450)
+.......+.....+.| ...++.+.+||.+||++||
T Consensus 238 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 317 (339)
T 1z57_A 238 DSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP 317 (339)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred ChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence 76654443322111111 1134678899999999999
Q ss_pred CCCCCHHHHHhccccccC
Q 013081 257 VKRITIAGIKADEWFEQD 274 (450)
Q Consensus 257 ~~R~t~~~il~h~~~~~~ 274 (450)
.+|||+.|+++||||+.-
T Consensus 318 ~~Rpt~~ell~hp~f~~~ 335 (339)
T 1z57_A 318 AKRITLREALKHPFFDLL 335 (339)
T ss_dssp TTSCCHHHHTTSGGGGGG
T ss_pred ccccCHHHHhcCHHHHHH
Confidence 999999999999999853
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=388.05 Aligned_cols=257 Identities=33% Similarity=0.582 Sum_probs=224.0
Q ss_pred CCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccch---hHHHHHHHHHHHHHhCC--CCCcceEEEEE
Q 013081 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---KITDQIKREIATLKLLK--HPNVVRLHEVL 83 (450)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~Ei~il~~l~--hpnIv~l~~~~ 83 (450)
.....++|++++.||+|+||.||+|.+..+++.||||++........ .....+.+|+.++++++ ||||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 33456799999999999999999999999999999999976543321 11245678999999996 59999999999
Q ss_pred EeCCEEEEEEccCCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEc-cCCCeEEeecCCC
Q 013081 84 ASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLS 161 (450)
Q Consensus 84 ~~~~~~~lv~E~~~g-g~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~-~~g~lkl~DFGla 161 (450)
...+..++||||+.+ ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~ 197 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 197 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence 999999999999976 89999999889999999999999999999999999999999999999999 7889999999999
Q ss_pred CCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCC
Q 013081 162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLS 241 (450)
Q Consensus 162 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s 241 (450)
..... ......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.... .+.......+..++
T Consensus 198 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~ 267 (320)
T 3a99_A 198 ALLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVS 267 (320)
T ss_dssp EECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCC
T ss_pred ccccc----ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccccccccCC
Confidence 85432 234456799999999999887777788999999999999999999997643 34456667788899
Q ss_pred HHHHHHHHHccccCcCCCCCHHHHHhccccccCC
Q 013081 242 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 242 ~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
+.+.+||.+||+.||.+|||+.++++||||++..
T Consensus 268 ~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 268 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 9999999999999999999999999999998653
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=380.86 Aligned_cols=257 Identities=28% Similarity=0.377 Sum_probs=221.8
Q ss_pred CCcccCCeEEeeeecccCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEE
Q 013081 9 EGMRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVL 83 (450)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 83 (450)
.....++|++++.||+|+||.||+|.+. .+++.||+|++.... .....+.+.+|+.+++.++||||+++++++
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 95 (314)
T 2ivs_A 18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95 (314)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence 3445679999999999999999999983 456899999997543 334467899999999999999999999999
Q ss_pred EeCCEEEEEEccCCCCChHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHhhhhhcCeeecc
Q 013081 84 ASKSKIYMVLEYVTGGELFDKIASKGR------------------------LQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139 (450)
Q Consensus 84 ~~~~~~~lv~E~~~gg~L~~~i~~~~~------------------------l~~~~~~~i~~ql~~aL~~LH~~givHrD 139 (450)
.+.+..|+||||++|++|.+++..... +++.+++.++.||+.||.|||++||+|||
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d 175 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD 175 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccc
Confidence 999999999999999999999986543 89999999999999999999999999999
Q ss_pred CCCCcEEEccCCCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCC
Q 013081 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFD 218 (450)
Q Consensus 140 lKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~ 218 (450)
|||+|||++.++.+||+|||++................+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCc-CchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999975432211112234567889999999987666 589999999999999999 999999
Q ss_pred CCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 219 DRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 219 ~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
+.+.......+..+ ....|..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 255 GIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp TCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 88877777776665 456677899999999999999999999999999875
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=389.94 Aligned_cols=261 Identities=25% Similarity=0.377 Sum_probs=210.5
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccc--------cchhHHHHHHHHHHHHHhCCCCCcceEEEEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI--------IHLKITDQIKREIATLKLLKHPNVVRLHEVL 83 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~--------~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 83 (450)
..++|++++.||+|+||.||+|.+.. |+.||||.+..... .+....+.+.+|+.++++++||||+++++++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 45899999999999999999999855 99999999865332 1233457899999999999999999999998
Q ss_pred Ee-----CCEEEEEEccCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEee
Q 013081 84 AS-----KSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISD 157 (450)
Q Consensus 84 ~~-----~~~~~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~D 157 (450)
.. ....|+||||+. |+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp EECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred EeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEe
Confidence 43 347899999997 5888887654 4799999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC-----
Q 013081 158 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG----- 232 (450)
Q Consensus 158 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~----- 232 (450)
||++..... .......+||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+......++...
T Consensus 178 fg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 254 (362)
T 3pg1_A 178 FNLAREDTA---DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK 254 (362)
T ss_dssp TTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cCccccccc---ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 999974322 223445689999999999887555579999999999999999999999998876666555321
Q ss_pred -------------------CCC--------CCCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCCCC
Q 013081 233 -------------------DFK--------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277 (450)
Q Consensus 233 -------------------~~~--------~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~~~ 277 (450)
... .++..++.+.+||.+||++||.+|||+.++++||||+..+.+
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 326 (362)
T 3pg1_A 255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDP 326 (362)
T ss_dssp HHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred hHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCc
Confidence 001 123468899999999999999999999999999999876543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=390.42 Aligned_cols=255 Identities=26% Similarity=0.391 Sum_probs=216.1
Q ss_pred cccCCeEEeeeecccCceEEEEEE-----ECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQ-----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA 84 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~-----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 84 (450)
...++|++++.||+|+||.||+|. +..+++.||||++.... .....+.+.+|+.+++++ +||||+++++++.
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~ 96 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 96 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeeee
Confidence 456899999999999999999998 55677899999997543 233357899999999999 7999999999987
Q ss_pred eCC-EEEEEEccCCCCChHHHHHhcCC-----------------------------------------------------
Q 013081 85 SKS-KIYMVLEYVTGGELFDKIASKGR----------------------------------------------------- 110 (450)
Q Consensus 85 ~~~-~~~lv~E~~~gg~L~~~i~~~~~----------------------------------------------------- 110 (450)
..+ ..|+||||++||+|.+++.....
T Consensus 97 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (359)
T 3vhe_A 97 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV 176 (359)
T ss_dssp STTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred cCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence 754 48999999999999999976543
Q ss_pred -------------CCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCcccccc
Q 013081 111 -------------LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC 177 (450)
Q Consensus 111 -------------l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~ 177 (450)
+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++................
T Consensus 177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 256 (359)
T 3vhe_A 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256 (359)
T ss_dssp -------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CE
T ss_pred hhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccC
Confidence 8999999999999999999999999999999999999999999999999998653322222344567
Q ss_pred CCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHH-HHHHHHhC-CCCCCCCCCHHHHHHHHHcccc
Q 013081 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAV-LYQKIFRG-DFKLPKWLSPGAQNLLRKILEP 254 (450)
Q Consensus 178 gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~-~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~ 254 (450)
||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+... ....+..+ ....|..+++++.+++.+||++
T Consensus 257 ~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 335 (359)
T 3vhe_A 257 LPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHG 335 (359)
T ss_dssp ECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCceeEChhhhcCCCC-CchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccC
Confidence 8999999999987766 589999999999999998 999998866433 33333333 5667788999999999999999
Q ss_pred CcCCCCCHHHHHhc
Q 013081 255 NPVKRITIAGIKAD 268 (450)
Q Consensus 255 dP~~R~t~~~il~h 268 (450)
||.+|||+.++++|
T Consensus 336 dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 336 EPSQRPTFSELVEH 349 (359)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred ChhhCCCHHHHHHH
Confidence 99999999999987
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=371.28 Aligned_cols=252 Identities=23% Similarity=0.404 Sum_probs=220.4
Q ss_pred CcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (450)
....++|++++.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+.++++++||||+++++++.+....
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (269)
T 4hcu_A 6 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 80 (269)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred EeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCce
Confidence 345579999999999999999999986 5778999999765432 35688999999999999999999999999999
Q ss_pred EEEEccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc
Q 013081 90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 168 (450)
|+||||++|++|.+++.. .+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 160 (269)
T 4hcu_A 81 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 160 (269)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred EEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence 999999999999999965 4569999999999999999999999999999999999999999999999999997543211
Q ss_pred CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 013081 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 246 (450)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 246 (450)
........+|+.|+|||++.+..+ +.++||||+|+++|+|++ |..||.+.+.......+..+ ....|..+++.+.+
T Consensus 161 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T 4hcu_A 161 -YTSSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQ 238 (269)
T ss_dssp -HHSTTSTTCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred -cccccCcccccccCCHHHhcCCCC-CchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHH
Confidence 112234456788999999987776 589999999999999999 99999999888888888776 45567778999999
Q ss_pred HHHHccccCcCCCCCHHHHHhc
Q 013081 247 LLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 247 Li~~~L~~dP~~R~t~~~il~h 268 (450)
++.+||+.||.+|||+.+++++
T Consensus 239 li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 239 IMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHccCCcccCcCHHHHHHH
Confidence 9999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=392.76 Aligned_cols=251 Identities=29% Similarity=0.438 Sum_probs=207.6
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC--------CCCcceEEEEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK--------HPNVVRLHEVL 83 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~--------hpnIv~l~~~~ 83 (450)
..++|++++.||+|+||.||+|++..+++.||||++... ....+.+.+|+.+++.++ ||||+++++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~ 110 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF 110 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence 347999999999999999999999999999999999643 234577889999999996 78899999998
Q ss_pred E----eCCEEEEEEccCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhhc-CeeeccCCCCcEEEccCC-----
Q 013081 84 A----SKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKG----- 151 (450)
Q Consensus 84 ~----~~~~~~lv~E~~~gg~L~~~i~~~--~~l~~~~~~~i~~ql~~aL~~LH~~-givHrDlKp~NILl~~~g----- 151 (450)
. .....|+||||+ +++|.+.+... +++++..++.++.||+.||+|||++ ||+||||||+|||++.++
T Consensus 111 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 111 KISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp EEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHH
T ss_pred eecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhh
Confidence 7 556899999999 66777777654 5699999999999999999999998 999999999999999776
Q ss_pred --------------------------------------------CeEEeecCCCCCCCcccCCCccccccCCCCccchhh
Q 013081 152 --------------------------------------------NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187 (450)
Q Consensus 152 --------------------------------------------~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~ 187 (450)
.+||+|||+|..... .....+||+.|+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-----~~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----HFTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-----CSCSCCSCGGGCCHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-----cCccCCCCCcccCChh
Confidence 799999999975432 2345689999999999
Q ss_pred hccCCCCCccchhhhHHHHHHHHHhCCCCCCCCc------HHHHHHHHHh--C---------------------------
Q 013081 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN------LAVLYQKIFR--G--------------------------- 232 (450)
Q Consensus 188 l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~------~~~~~~~i~~--~--------------------------- 232 (450)
+.+..+ +.++|||||||++|+|++|..||...+ .......+.. +
T Consensus 265 ~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 343 (397)
T 1wak_A 265 LIGSGY-NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT 343 (397)
T ss_dssp HHTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred hcCCCC-CcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence 988776 589999999999999999999997643 1222222211 0
Q ss_pred -------------CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhcccccc
Q 013081 233 -------------DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 233 -------------~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
....+...++.+.+||.+||++||.+|||+.|+++||||++
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 01112223567889999999999999999999999999963
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=384.58 Aligned_cols=256 Identities=26% Similarity=0.363 Sum_probs=222.6
Q ss_pred CcccCCeEEeeeecccCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA 84 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 84 (450)
....++|++++.||+|+||.||+|.+. .+++.||+|++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 455689999999999999999999987 355899999997543 3344678999999999999999999999999
Q ss_pred eCCEEEEEEccCCCCChHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccC
Q 013081 85 SKSKIYMVLEYVTGGELFDKIASK------------------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL 140 (450)
Q Consensus 85 ~~~~~~lv~E~~~gg~L~~~i~~~------------------------~~l~~~~~~~i~~ql~~aL~~LH~~givHrDl 140 (450)
+....|+||||++||+|.+++... .++++.+++.++.||+.||.|||++||+||||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl 200 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 999999999999999999999763 57999999999999999999999999999999
Q ss_pred CCCcEEEccCCCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCC
Q 013081 141 KLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDD 219 (450)
Q Consensus 141 Kp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~ 219 (450)
||+|||++.++.+||+|||++................||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCc-CcccccHHHHHHHHHHHhcCCCcCCC
Confidence 99999999999999999999875432222223345678899999999887776 589999999999999999 9999999
Q ss_pred CcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 220 RNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 220 ~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
.+.......+..+. ...|..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 280 MAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp SCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 88888888777764 45678899999999999999999999999999864
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-48 Score=384.87 Aligned_cols=253 Identities=30% Similarity=0.425 Sum_probs=213.5
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE----
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK---- 88 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~---- 88 (450)
.++|.+.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 378999999999999999999999999999999997543 234456788999999999999999999999976653
Q ss_pred --EEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCc
Q 013081 89 --IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (450)
Q Consensus 89 --~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 166 (450)
.|+||||+. ++|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred eeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 599999997 58887764 3599999999999999999999999999999999999999999999999999985322
Q ss_pred ccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC--------------
Q 013081 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-------------- 232 (450)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-------------- 232 (450)
.....+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+.+.
T Consensus 179 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 253 (353)
T 3coi_A 179 -----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253 (353)
T ss_dssp ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred -----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhh
Confidence 2345688999999999887455578999999999999999999999988766555544321
Q ss_pred --------------C---CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 233 --------------D---FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 233 --------------~---~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
. ...+..+++.+.+||.+||+.||.+|||+.++++||||+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp HHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 0 11234578999999999999999999999999999999754
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-48 Score=373.54 Aligned_cols=255 Identities=29% Similarity=0.477 Sum_probs=209.1
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-------
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS------- 85 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------- 85 (450)
.++|++++.||+|+||.||+|.+..+|+.||+|++... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP 80 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence 36899999999999999999999999999999999643 2345788999999999999999999998754
Q ss_pred ------CCEEEEEEccCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeec
Q 013081 86 ------KSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDF 158 (450)
Q Consensus 86 ------~~~~~lv~E~~~gg~L~~~i~~~~-~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DF 158 (450)
....|+||||++|++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 81 MTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp -----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred hcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeC
Confidence 457899999999999999998544 6889999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCccc------------CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCC-cHHHH
Q 013081 159 GLSALPQHFR------------DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR-NLAVL 225 (450)
Q Consensus 159 Gla~~~~~~~------------~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~-~~~~~ 225 (450)
|++....... ........+||+.|+|||++.+.+..+.++||||+||++|+|++ ||... +....
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~ 237 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI 237 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH
Confidence 9998643211 01223456799999999998876555789999999999999998 66533 33455
Q ss_pred HHHHHhCCCCCCC----CCCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 226 YQKIFRGDFKLPK----WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 226 ~~~i~~~~~~~p~----~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
...+......+|+ ..++.+.+||.+||++||.+|||+.++++||||...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp HHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred HHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 5555555544443 456789999999999999999999999999999753
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=387.57 Aligned_cols=256 Identities=27% Similarity=0.451 Sum_probs=224.2
Q ss_pred CcccCCeEEeeeecccCceEEEEEEECC-------CCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEE
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDLD-------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHE 81 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~ 81 (450)
....++|++++.||+|+||.||+|.+.. .+..||+|++.... .......+.+|+.+++++ +||||+++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 142 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG 142 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhhee
Confidence 3455799999999999999999999754 33579999997553 334467899999999999 8999999999
Q ss_pred EEEeCCEEEEEEccCCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcE
Q 013081 82 VLASKSKIYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENI 145 (450)
Q Consensus 82 ~~~~~~~~~lv~E~~~gg~L~~~i~~~~----------------~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NI 145 (450)
++...+..|+||||++||+|.+++.... .+++.+++.++.||+.||+|||++||+||||||+||
T Consensus 143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 222 (382)
T 3tt0_A 143 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 222 (382)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred eeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceE
Confidence 9999999999999999999999998654 499999999999999999999999999999999999
Q ss_pred EEccCCCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHH
Q 013081 146 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAV 224 (450)
Q Consensus 146 Ll~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~ 224 (450)
|++.++.+||+|||+|................+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+...
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~ellt~g~~p~~~~~~~~ 301 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999986544322233445567889999999987666 589999999999999999 999999998888
Q ss_pred HHHHHHhC-CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 225 LYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 225 ~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
....+..+ ....|..+++++.+||.+||++||.+|||+.+++++
T Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 302 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 88877766 456677899999999999999999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=382.29 Aligned_cols=256 Identities=32% Similarity=0.602 Sum_probs=214.2
Q ss_pred CcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccch---hHHHHHHHHHHHHHhC----CCCCcceEEEE
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---KITDQIKREIATLKLL----KHPNVVRLHEV 82 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~Ei~il~~l----~hpnIv~l~~~ 82 (450)
....++|++++.||+|+||.||+|.+..+++.||+|++........ .....+.+|+.+++++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 4456799999999999999999999999999999999976543221 1224466799999998 89999999999
Q ss_pred EEeCCEEEEEEcc-CCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEc-cCCCeEEeecCC
Q 013081 83 LASKSKIYMVLEY-VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-SKGNIKISDFGL 160 (450)
Q Consensus 83 ~~~~~~~~lv~E~-~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~-~~g~lkl~DFGl 160 (450)
+...+..++|||| +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~ 186 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS 186 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence 9999999999999 78999999999888999999999999999999999999999999999999999 889999999999
Q ss_pred CCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCC
Q 013081 161 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWL 240 (450)
Q Consensus 161 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~ 240 (450)
+..... .......||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.... .+......++..+
T Consensus 187 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~~~~ 256 (312)
T 2iwi_A 187 GALLHD----EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFPAHV 256 (312)
T ss_dssp CEECCS----SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCCCTTS
T ss_pred hhhccc----CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCCcccC
Confidence 985432 234456799999999999887776678999999999999999999997642 3445667788889
Q ss_pred CHHHHHHHHHccccCcCCCCCHHHHHhccccccCC
Q 013081 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 241 s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
++.+.+||.+||+.||.+|||+.++++||||+...
T Consensus 257 ~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 257 SPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 99999999999999999999999999999998643
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=368.18 Aligned_cols=252 Identities=25% Similarity=0.420 Sum_probs=218.9
Q ss_pred CcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (450)
....++|++++.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.++++++||||+++++++.+....
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence 345689999999999999999999875 5678999999765432 35688999999999999999999999999999
Q ss_pred EEEEccCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc
Q 013081 90 YMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~-~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 168 (450)
|+||||++|++|.+++...+ .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 99999999999999997754 59999999999999999999999999999999999999999999999999997543211
Q ss_pred CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHH
Q 013081 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQN 246 (450)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ 246 (450)
........+|+.|+|||++.+..+ +.++||||+|+++|+|++ |..||...+.......+..+. ...|...++.+.+
T Consensus 159 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 236 (268)
T 3sxs_A 159 -YVSSVGTKFPVKWSAPEVFHYFKY-SSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQ 236 (268)
T ss_dssp -EEECCSCCCCGGGCCHHHHHHSEE-ETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred -hhcccCCCcCcccCCHHHHhccCC-chhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHH
Confidence 111223456778999999987766 589999999999999999 999999988888777777664 4556778999999
Q ss_pred HHHHccccCcCCCCCHHHHHhc
Q 013081 247 LLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 247 Li~~~L~~dP~~R~t~~~il~h 268 (450)
|+.+||+.||.+|||+.+++++
T Consensus 237 li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 237 IMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999987
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=396.42 Aligned_cols=253 Identities=15% Similarity=0.183 Sum_probs=195.6
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC--CCCCcceEE-------EEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL--KHPNVVRLH-------EVLA 84 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l--~hpnIv~l~-------~~~~ 84 (450)
.+|++++.||+|+||.||+|.+..+|+.||||++.............+.+|+.+++.| +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 3599999999999999999999999999999999886654555567888886555554 699988755 5554
Q ss_pred eC-----------------CEEEEEEccCCCCChHHHHHhcC-CCCHHHH------HHHHHHHHHHHhhhhhcCeeeccC
Q 013081 85 SK-----------------SKIYMVLEYVTGGELFDKIASKG-RLQEAEG------RKLFQQLIDGVSYCHNKGVFHRDL 140 (450)
Q Consensus 85 ~~-----------------~~~~lv~E~~~gg~L~~~i~~~~-~l~~~~~------~~i~~ql~~aL~~LH~~givHrDl 140 (450)
.. ..+|+||||++ |+|.+++...+ .+++... ..++.||+.||+|||++||+||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi 220 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF 220 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence 43 34899999998 89999998643 3444444 566799999999999999999999
Q ss_pred CCCcEEEccCCCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhcc--CCCCCccchhhhHHHHHHHHHhCCCCCC
Q 013081 141 KLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFD 218 (450)
Q Consensus 141 Kp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~~DiwSlGvil~elltG~~Pf~ 218 (450)
||+|||++.+|.+||+|||+|+... .......+|+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||.
T Consensus 221 kp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~ 294 (371)
T 3q60_A 221 TPDNLFIMPDGRLMLGDVSALWKVG-----TRGPASSVPVTYAPREFLNASTATF-THALNAWQLGLSIYRVWCLFLPFG 294 (371)
T ss_dssp SGGGEEECTTSCEEECCGGGEEETT-----CEEEGGGSCGGGCCHHHHTCSEEEC-CHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred CHHHEEECCCCCEEEEecceeeecC-----CCccCccCCcCCcChhhccCCCCCc-CccccHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999998532 22225667799999999876 445 699999999999999999999998
Q ss_pred CCcHHH--HHHH-----HHhCCCCCC--CCCCHHHHHHHHHccccCcCCCCCHHHHHhcccccc
Q 013081 219 DRNLAV--LYQK-----IFRGDFKLP--KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 219 ~~~~~~--~~~~-----i~~~~~~~p--~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
+..... .+.. .......+| ..+++.+.+||.+||++||++|||+.++++||||++
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp BCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred CcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 764321 0000 001122223 468999999999999999999999999999999975
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-48 Score=377.60 Aligned_cols=251 Identities=24% Similarity=0.390 Sum_probs=212.5
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (450)
...++|++++.||+|+||.||+|.+..+++.||+|.+... .....+.+.+|+.++++++||||+++++++.+....|
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN 83 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence 4568999999999999999999999999999999988543 3445678999999999999999999999999999999
Q ss_pred EEEccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC
Q 013081 91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (450)
Q Consensus 91 lv~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 169 (450)
+||||++|++|.+++.. ...+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp EEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred EEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 99999999999999987 56799999999999999999999999999999999999999999999999999975432111
Q ss_pred C------------CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHH-----HHHHHHhC
Q 013081 170 D------------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV-----LYQKIFRG 232 (450)
Q Consensus 170 ~------------~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~-----~~~~i~~~ 232 (450)
. ......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||....... .......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~- 241 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSY-DEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD- 241 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH-
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCC-CcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc-
Confidence 1 01125689999999999987766 589999999999999999999987532110 0111111
Q ss_pred CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHh
Q 013081 233 DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 233 ~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
...|..+++.+.+|+.+||+.||.+|||+.++++
T Consensus 242 -~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 242 -RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp -HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 2346778999999999999999999999999986
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=371.32 Aligned_cols=258 Identities=28% Similarity=0.462 Sum_probs=213.8
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 92 (450)
+++|.....||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus 21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 97 (295)
T 2clq_A 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIF 97 (295)
T ss_dssp BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEE
Confidence 344444559999999999999999999999999997653 23357789999999999999999999999999999999
Q ss_pred EccCCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEcc-CCCeEEeecCCCCCCCccc
Q 013081 93 LEYVTGGELFDKIASKG---RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-KGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~~~---~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~-~g~lkl~DFGla~~~~~~~ 168 (450)
|||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~- 176 (295)
T 2clq_A 98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI- 176 (295)
T ss_dssp EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCC-
Confidence 99999999999997642 4678999999999999999999999999999999999988 899999999999754321
Q ss_pred CCCccccccCCCCccchhhhccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCcHH--HHHH-HHHhCCCCCCCCCCHHH
Q 013081 169 DDGLLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYVILTGYLPFDDRNLA--VLYQ-KIFRGDFKLPKWLSPGA 244 (450)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--~~~~-~i~~~~~~~p~~~s~~~ 244 (450)
........||+.|+|||++.+.. ..+.++||||||+++|+|++|..||...... .... .........|..+++.+
T Consensus 177 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (295)
T 2clq_A 177 -NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEA 255 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHH
T ss_pred -CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHH
Confidence 12234567999999999987543 2368999999999999999999999754322 2222 22334556778899999
Q ss_pred HHHHHHccccCcCCCCCHHHHHhccccccCC
Q 013081 245 QNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
.+||.+||++||.+|||+.++++||||+...
T Consensus 256 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 256 KAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp HHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred HHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 9999999999999999999999999998643
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=374.19 Aligned_cols=248 Identities=21% Similarity=0.286 Sum_probs=214.1
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCC-------ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSG-------LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVL 83 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~-------~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 83 (450)
...++|++.+.||+|+||.||+|.+..++ ..||+|++.... ....+.+.+|+.+++.++||||+++++++
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGVC 81 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 45679999999999999999999998777 469999986543 23357899999999999999999999999
Q ss_pred EeCCEEEEEEccCCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCC--------eE
Q 013081 84 ASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN--------IK 154 (450)
Q Consensus 84 ~~~~~~~lv~E~~~gg~L~~~i~~~~~-l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~--------lk 154 (450)
.+.+..|+||||++|++|.+++...+. +++..++.++.||+.||.|||++||+||||||+|||++.++. +|
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence 999999999999999999999987554 999999999999999999999999999999999999999887 99
Q ss_pred EeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhC-CCCCCCCcHHHHHHHHHhCC
Q 013081 155 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG-YLPFDDRNLAVLYQKIFRGD 233 (450)
Q Consensus 155 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG-~~Pf~~~~~~~~~~~i~~~~ 233 (450)
|+|||++.... ......||+.|+|||++.+....+.++|||||||++|+|++| .+||...+... ........
T Consensus 162 l~Dfg~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-~~~~~~~~ 234 (289)
T 4fvq_A 162 LSDPGISITVL------PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-KLQFYEDR 234 (289)
T ss_dssp ECCCCSCTTTS------CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-HHHHHHTT
T ss_pred eccCccccccc------CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-HHHHhhcc
Confidence 99999987432 224457899999999998745557999999999999999995 55665555443 34445556
Q ss_pred CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 234 FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 234 ~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
...|...++.+.+|+.+||+.||.+|||+.+++++
T Consensus 235 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 235 HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 66777789999999999999999999999999986
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=392.00 Aligned_cols=254 Identities=27% Similarity=0.402 Sum_probs=219.1
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
..++|++++.||+|+||.||+|.+..+++.||||+++... .......+.+|+.+++.++||||+++++++......|+
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence 3468999999999999999999999999999999986542 23345678899999999999999999999999999999
Q ss_pred EEccCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCC
Q 013081 92 VLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~~-~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 170 (450)
||||++||+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 190 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 999999999999997654 6999999999999999999999999999999999999999999999999999743221101
Q ss_pred CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHH
Q 013081 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLL 248 (450)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li 248 (450)
.......+++.|+|||++....+ +.++|||||||++|+|++ |..||.+.+.......+..+ ..+.|..+++.+.+||
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 348 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGRY-SSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLM 348 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred ecCCCCCCCcCcCCHhHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 11112235678999999987766 589999999999999998 99999998877777666655 5677888999999999
Q ss_pred HHccccCcCCCCCHHHHHhc
Q 013081 249 RKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 249 ~~~L~~dP~~R~t~~~il~h 268 (450)
.+||+.||.+|||+.++++.
T Consensus 349 ~~cl~~dP~~Rps~~~i~~~ 368 (377)
T 3cbl_A 349 EQCWAYEPGQRPSFSTIYQE 368 (377)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCchhCcCHHHHHHH
Confidence 99999999999999999763
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=376.33 Aligned_cols=257 Identities=31% Similarity=0.423 Sum_probs=216.0
Q ss_pred ccCCeEEeeeecccCceEEEEEEEC-CCCceEEEEEeecccccchhHHHHHHHHHHHHHhC---CCCCcceEEEEEE---
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDL-DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL---KHPNVVRLHEVLA--- 84 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~--- 84 (450)
..++|++++.||+|+||.||+|.+. .+|+.||+|++....... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 3489999999999999999999995 678999999997543221 1123466777777766 8999999999987
Q ss_pred --eCCEEEEEEccCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCC
Q 013081 85 --SKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGL 160 (450)
Q Consensus 85 --~~~~~~lv~E~~~gg~L~~~i~~~~--~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGl 160 (450)
.....|+||||+. |+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcc
Confidence 5677899999997 59999997643 499999999999999999999999999999999999999999999999999
Q ss_pred CCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC-------
Q 013081 161 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD------- 233 (450)
Q Consensus 161 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------- 233 (450)
+...... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+......++....
T Consensus 167 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 167 ARIYSFQ---MALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242 (326)
T ss_dssp CCCCCGG---GGGCCCCCCCTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred cccccCC---CCccccccccceeCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence 9864321 23345689999999999887766 589999999999999999999999988777666665310
Q ss_pred --------------------CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 234 --------------------FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 234 --------------------~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
..++..+++.+.+||.+||+.||.+|||+.++++||||++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 303 (326)
T 1blx_A 243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303 (326)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence 01234578999999999999999999999999999999754
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=374.60 Aligned_cols=261 Identities=25% Similarity=0.402 Sum_probs=213.3
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC--CCCcceEEEEEEeCCEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK--HPNVVRLHEVLASKSKIY 90 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~~~ 90 (450)
-++|++++.||+|+||.||+|.+. +++.||+|++..... .....+.+.+|+.++++++ ||||+++++++.+....|
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 104 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred cceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence 457999999999999999999985 588999999976543 3344678999999999997 599999999999999999
Q ss_pred EEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCC
Q 013081 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (450)
Q Consensus 91 lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 170 (450)
+||| +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.........
T Consensus 105 lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~ 182 (313)
T 3cek_A 105 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 182 (313)
T ss_dssp EEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC-------
T ss_pred EEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCcccc
Confidence 9999 55889999999888999999999999999999999999999999999999996 589999999999865432222
Q ss_pred CccccccCCCCccchhhhccC----------CCCCccchhhhHHHHHHHHHhCCCCCCCCc-HHHHHHHHHhC--CCCCC
Q 013081 171 GLLHTTCGSPNYVAPEVLANR----------GYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRG--DFKLP 237 (450)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~----------~~~~~~~DiwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~~--~~~~p 237 (450)
......+||+.|+|||++.+. ...+.++|||||||++|+|++|..||.... .......+... ...+|
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 262 (313)
T 3cek_A 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 262 (313)
T ss_dssp -------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCC
T ss_pred ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCc
Confidence 233456899999999998651 234689999999999999999999998753 33334444433 34567
Q ss_pred CCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCCCC
Q 013081 238 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277 (450)
Q Consensus 238 ~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~~~ 277 (450)
...++.+.+||.+||+.||.+|||+.++++||||+....+
T Consensus 263 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~ 302 (313)
T 3cek_A 263 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 302 (313)
T ss_dssp CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC---
T ss_pred ccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCc
Confidence 7789999999999999999999999999999999876544
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=369.48 Aligned_cols=252 Identities=23% Similarity=0.394 Sum_probs=217.5
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (450)
...++|++++.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.+++.++||||+++++++.+....|
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF 95 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeE
Confidence 44569999999999999999999875 6778999999765432 356889999999999999999999999999999
Q ss_pred EEEccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC
Q 013081 91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (450)
Q Consensus 91 lv~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 169 (450)
+||||++|++|.+++.. ..++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 174 (283)
T 3gen_A 96 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE- 174 (283)
T ss_dssp EEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccc-
Confidence 99999999999999976 5679999999999999999999999999999999999999999999999999997543211
Q ss_pred CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 013081 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 247 (450)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 247 (450)
........+|+.|+|||++.+..+ +.++||||+|+++|+|++ |..||...+.......+..+ ....|...++.+.+|
T Consensus 175 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 253 (283)
T 3gen_A 175 YTSSVGSKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTI 253 (283)
T ss_dssp HHSTTSTTSCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred cccccCCccCcccCCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHHH
Confidence 111233456788999999987776 589999999999999998 99999998888888888776 455667789999999
Q ss_pred HHHccccCcCCCCCHHHHHhcc
Q 013081 248 LRKILEPNPVKRITIAGIKADE 269 (450)
Q Consensus 248 i~~~L~~dP~~R~t~~~il~h~ 269 (450)
|.+||+.||.+|||+.++++|-
T Consensus 254 i~~~l~~~p~~Rps~~~ll~~L 275 (283)
T 3gen_A 254 MYSCWHEKADERPTFKILLSNI 275 (283)
T ss_dssp HHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHHccCChhHCcCHHHHHHHH
Confidence 9999999999999999999873
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=370.28 Aligned_cols=255 Identities=27% Similarity=0.426 Sum_probs=208.8
Q ss_pred CCcccCCeEEeeeecccCceEEEEEEECCC---CceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 013081 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (450)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 85 (450)
.....++|++++.||+|+||.||+|.+..+ +..||+|.+.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 86 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 86 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-
Confidence 345568999999999999999999998654 4579999986432 3344678999999999999999999999984
Q ss_pred CCEEEEEEccCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCC
Q 013081 86 KSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP 164 (450)
Q Consensus 86 ~~~~~lv~E~~~gg~L~~~i~~~~-~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~ 164 (450)
++..|+||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccccc
Confidence 567899999999999999997654 6999999999999999999999999999999999999999999999999999864
Q ss_pred CcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCH
Q 013081 165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSP 242 (450)
Q Consensus 165 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~ 242 (450)
.... ........+|+.|+|||++....+ +.++|||||||++|+|++ |..||.+.+.......+..+ ..+.|..+++
T Consensus 167 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (281)
T 1mp8_A 167 EDST-YYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 244 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred Cccc-ccccccCCCcccccChhhcccCCC-CCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCH
Confidence 3211 112234457789999999987766 589999999999999997 99999988777777777665 4567788999
Q ss_pred HHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 243 GAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
.+.+|+.+||+.||.+|||+.+++++
T Consensus 245 ~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 245 TLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999999875
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=386.11 Aligned_cols=253 Identities=28% Similarity=0.358 Sum_probs=213.0
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CC-----CcceEEEEEE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HP-----NVVRLHEVLA 84 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hp-----nIv~l~~~~~ 84 (450)
...++|++.+.||+|+||.||+|.+..+++.||||++... ......+.+|+.+++.++ |+ +|+++++++.
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 4468999999999999999999999999999999999643 234567888999998885 55 4999999999
Q ss_pred eCCEEEEEEccCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhh--hcCeeeccCCCCcEEEc--cCCCeEEeec
Q 013081 85 SKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCH--NKGVFHRDLKLENILLD--SKGNIKISDF 158 (450)
Q Consensus 85 ~~~~~~lv~E~~~gg~L~~~i~~~--~~l~~~~~~~i~~ql~~aL~~LH--~~givHrDlKp~NILl~--~~g~lkl~DF 158 (450)
..+..|+||||+. ++|.+++... +++++..++.++.||+.||.||| +.||+||||||+|||++ .++.+||+||
T Consensus 127 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 127 FRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp ETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred cCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 9999999999996 5999999765 46999999999999999999999 47999999999999995 4778999999
Q ss_pred CCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCC--
Q 013081 159 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL-- 236 (450)
Q Consensus 159 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-- 236 (450)
|+|.... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+......++.......
T Consensus 206 G~a~~~~-----~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 279 (382)
T 2vx3_A 206 GSSCQLG-----QRIYQYIQSRFYRSPEVLLGMPY-DLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPA 279 (382)
T ss_dssp TTCEETT-----CCCCSSCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred cCceecc-----cccccccCCccccChHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 9997542 22346789999999999988776 589999999999999999999999988777666654321000
Q ss_pred -----------------------------------CCC---------------------------CCHHHHHHHHHcccc
Q 013081 237 -----------------------------------PKW---------------------------LSPGAQNLLRKILEP 254 (450)
Q Consensus 237 -----------------------------------p~~---------------------------~s~~~~~Li~~~L~~ 254 (450)
|.. .++.+.+||.+||++
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~ 359 (382)
T 2vx3_A 280 HILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDY 359 (382)
T ss_dssp HHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCS
T ss_pred HHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCC
Confidence 000 013789999999999
Q ss_pred CcCCCCCHHHHHhccccccC
Q 013081 255 NPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 255 dP~~R~t~~~il~h~~~~~~ 274 (450)
||++|||+.|+|+||||++.
T Consensus 360 dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 360 DPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp CTTTSCCHHHHTTSGGGCC-
T ss_pred ChhhCCCHHHHhcCcccccC
Confidence 99999999999999999864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=372.63 Aligned_cols=259 Identities=25% Similarity=0.384 Sum_probs=210.5
Q ss_pred cccCCcccCCeEEeeeecccCceEEEEEE----ECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEE
Q 013081 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81 (450)
Q Consensus 6 ~~~~~~~~~~y~i~~~LG~G~~g~Vy~a~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~ 81 (450)
+.+.....++|++++.||+|+||.||+|+ +..+++.||+|++... .....+.+.+|+.++++++||||+++++
T Consensus 2 s~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 78 (295)
T 3ugc_A 2 SDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKG 78 (295)
T ss_dssp ----CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred CCcCcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 34556677899999999999999999998 5678999999998654 3344578999999999999999999999
Q ss_pred EEEe--CCEEEEEEccCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeec
Q 013081 82 VLAS--KSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDF 158 (450)
Q Consensus 82 ~~~~--~~~~~lv~E~~~gg~L~~~i~~~~-~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DF 158 (450)
++.. ....|+||||++||+|.+++.... ++++..+..++.||+.||+|||++||+||||||+|||++.++++||+||
T Consensus 79 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Df 158 (295)
T 3ugc_A 79 VCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDF 158 (295)
T ss_dssp EECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCC
T ss_pred EEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccC
Confidence 9854 456899999999999999997644 5999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCcccCC-CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHH--------------
Q 013081 159 GLSALPQHFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-------------- 223 (450)
Q Consensus 159 Gla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-------------- 223 (450)
|++......... .......+++.|+|||++.+..+ +.++||||+|+++|+|++|..||......
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~ 237 (295)
T 3ugc_A 159 GLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 237 (295)
T ss_dssp CSCC-------------CTTCGGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHH
T ss_pred cccccccCCcceeeeccCCCCccceeCcHHhcCCCC-ChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchh
Confidence 999865332111 12233457778999999988776 58999999999999999999998754322
Q ss_pred --HHHHHHHh-CCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 224 --VLYQKIFR-GDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 224 --~~~~~i~~-~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
.....+.. ...+.|..+++.+.+||.+||+.||.+|||+.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~ 285 (295)
T 3ugc_A 238 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 285 (295)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 11222222 2556678899999999999999999999999999763
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=365.62 Aligned_cols=250 Identities=27% Similarity=0.440 Sum_probs=206.5
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccc-hhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH-LKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (450)
...++|++.+.||+|+||.||+|.+ +|+.||+|++....... ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred cchhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 4578999999999999999999998 48899999987643322 22357789999999999999999999999999999
Q ss_pred EEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcC---eeeccCCCCcEEEcc--------CCCeEEeec
Q 013081 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG---VFHRDLKLENILLDS--------KGNIKISDF 158 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlKp~NILl~~--------~g~lkl~DF 158 (450)
|+||||++|++|.+++. .+++++..++.++.|++.||.|||++| |+||||||+|||++. ++.+||+||
T Consensus 82 ~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999998885 468999999999999999999999999 999999999999986 678999999
Q ss_pred CCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC--CCC
Q 013081 159 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKL 236 (450)
Q Consensus 159 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~ 236 (450)
|++..... .......||+.|+|||++.+..+ +.++||||+|+++|+|++|+.||.+.+............ .+.
T Consensus 161 g~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 235 (271)
T 3dtc_A 161 GLAREWHR----TTKMSAAGAYAWMAPEVIRASMF-SKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI 235 (271)
T ss_dssp CC-----------------CCGGGSCHHHHHHCCC-SHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCC
T ss_pred Cccccccc----ccccCCCCccceeCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCC
Confidence 99975432 22335679999999999887766 589999999999999999999999988777666666553 456
Q ss_pred CCCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 237 PKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 237 p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
|..+++.+.+|+.+||+.||.+|||+.+++++
T Consensus 236 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 236 PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 67799999999999999999999999999875
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=381.79 Aligned_cols=255 Identities=30% Similarity=0.562 Sum_probs=186.0
Q ss_pred CCcccCCeEEee-eecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--
Q 013081 9 EGMRLGRYELGR-TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-- 85 (450)
Q Consensus 9 ~~~~~~~y~i~~-~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-- 85 (450)
.....++|++.+ .||+|+||.||+|.+..+|+.||||++.... ....+....++.+.||||+++++++..
T Consensus 23 ~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~ 95 (336)
T 3fhr_A 23 KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQASGGPHIVCILDVYENMH 95 (336)
T ss_dssp CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-------HHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred CccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-------HHHHHHHHHHHhcCCCChHHHHHHHhhcc
Confidence 345568999965 6999999999999999999999999986532 122223344677799999999999876
Q ss_pred --CCEEEEEEccCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccC---CCeEEeec
Q 013081 86 --KSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK---GNIKISDF 158 (450)
Q Consensus 86 --~~~~~lv~E~~~gg~L~~~i~~~~--~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~---g~lkl~DF 158 (450)
....|+||||++||+|.+++...+ .+++.+++.++.||+.||.|||++||+||||||+|||++.+ +.+||+||
T Consensus 96 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Df 175 (336)
T 3fhr_A 96 HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDF 175 (336)
T ss_dssp TTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred CCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecc
Confidence 456899999999999999998754 69999999999999999999999999999999999999864 45999999
Q ss_pred CCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHH----HHHHHhCCC
Q 013081 159 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVL----YQKIFRGDF 234 (450)
Q Consensus 159 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~----~~~i~~~~~ 234 (450)
|++.... .......+||+.|+|||++....+ +.++|||||||++|+|++|..||........ ...+.....
T Consensus 176 g~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 250 (336)
T 3fhr_A 176 GFAKETT----QNALQTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQY 250 (336)
T ss_dssp TTCEEC--------------------------CHH-HHHHHHHHHHHHHHHHHHSSCCC---------------------
T ss_pred ccceecc----ccccccCCCCcCccChhhhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccc
Confidence 9997432 223456789999999999876666 5899999999999999999999987654433 222333333
Q ss_pred CCC----CCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCC
Q 013081 235 KLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 235 ~~p----~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
..| ..+++.+.+||.+||+.||.+|||+.++++||||++..
T Consensus 251 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 251 GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 222 45899999999999999999999999999999998643
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=379.71 Aligned_cols=253 Identities=26% Similarity=0.411 Sum_probs=212.2
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCC-ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC------cceEEEEE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSG-LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN------VVRLHEVL 83 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~-~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn------Iv~l~~~~ 83 (450)
..-++|++++.||+|+||.||+|.+..++ +.||+|+++.. ....+.+.+|+.+++.++|++ ++.+++++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 91 (355)
T 2eu9_A 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF 91 (355)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE
T ss_pred eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee
Confidence 34579999999999999999999998776 79999999643 233567889999999998766 89999999
Q ss_pred EeCCEEEEEEccCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEE--------------
Q 013081 84 ASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL-------------- 147 (450)
Q Consensus 84 ~~~~~~~lv~E~~~gg~L~~~i~~~~--~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl-------------- 147 (450)
...+..|+||||+ +++|.+.+.... ++++.+++.++.||+.||+|||++||+||||||+|||+
T Consensus 92 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 92 NFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred eeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccc
Confidence 9999999999999 678878776543 79999999999999999999999999999999999999
Q ss_pred -----ccCCCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcH
Q 013081 148 -----DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL 222 (450)
Q Consensus 148 -----~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~ 222 (450)
+.++.+||+|||++.... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDH-----EHHTTIVATRHYRPPEVILELGW-AQPCDVWSIGCILFEYYRGFTLFQTHEN 244 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETT-----SCCCSSCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccCCCcEEEeecCcccccc-----ccccCCcCCCcccCCeeeecCCC-CCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 667899999999997532 22345689999999999987776 5899999999999999999999998776
Q ss_pred HHHHHHHHhCCCCCC--------------------------------------------CCCCHHHHHHHHHccccCcCC
Q 013081 223 AVLYQKIFRGDFKLP--------------------------------------------KWLSPGAQNLLRKILEPNPVK 258 (450)
Q Consensus 223 ~~~~~~i~~~~~~~p--------------------------------------------~~~s~~~~~Li~~~L~~dP~~ 258 (450)
......+.....+.| ...++.+.+||.+||++||.+
T Consensus 245 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 324 (355)
T 2eu9_A 245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324 (355)
T ss_dssp HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence 654444332211111 112457889999999999999
Q ss_pred CCCHHHHHhccccccC
Q 013081 259 RITIAGIKADEWFEQD 274 (450)
Q Consensus 259 R~t~~~il~h~~~~~~ 274 (450)
|||+.|+++||||+..
T Consensus 325 Rpt~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 325 RITLAEALLHPFFAGL 340 (355)
T ss_dssp SCCHHHHTTSGGGGGC
T ss_pred CcCHHHHhcChhhcCC
Confidence 9999999999999863
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=364.85 Aligned_cols=251 Identities=20% Similarity=0.327 Sum_probs=219.1
Q ss_pred cCCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-
Q 013081 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK- 86 (450)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~- 86 (450)
..+..+++|++.+.||+|+||.||+|.+ +++.||+|++..... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 80 (271)
T 3kmu_A 4 HSGIDFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP 80 (271)
T ss_dssp CCCCCGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT
T ss_pred cCCCCHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC
Confidence 3567789999999999999999999998 488999999976543 333457899999999999999999999999876
Q ss_pred -CEEEEEEccCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhhcC--eeeccCCCCcEEEccCCCeEEeecCCC
Q 013081 87 -SKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLDSKGNIKISDFGLS 161 (450)
Q Consensus 87 -~~~~lv~E~~~gg~L~~~i~~~~--~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlKp~NILl~~~g~lkl~DFGla 161 (450)
...|+||||++||+|.+++.... .+++..++.++.||+.||+|||++| ++||||||+|||++.++.++|+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~ 160 (271)
T 3kmu_A 81 APHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK 160 (271)
T ss_dssp SSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred CCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccce
Confidence 78899999999999999998755 4899999999999999999999999 999999999999999999999999987
Q ss_pred CCCCcccCCCccccccCCCCccchhhhccCCCCC--ccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC--CCCCC
Q 013081 162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG--ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLP 237 (450)
Q Consensus 162 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~--~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p 237 (450)
.... .....||+.|+|||++.+..+.. .++|||||||++|+|++|..||.+.+.......+... ....|
T Consensus 161 ~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (271)
T 3kmu_A 161 FSFQ-------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIP 233 (271)
T ss_dssp CTTS-------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCC
T ss_pred eeec-------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCC
Confidence 6321 23457899999999988765542 3799999999999999999999998887776666554 45667
Q ss_pred CCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 238 KWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 238 ~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
..+++.+.+||.+||+.||.+|||+.++++.
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 264 (271)
T 3kmu_A 234 PGISPHVSKLMKICMNEDPAKRPKFDMIVPI 264 (271)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7899999999999999999999999999863
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-48 Score=380.98 Aligned_cols=255 Identities=22% Similarity=0.342 Sum_probs=216.0
Q ss_pred CcccCCeEEeeeecccCceEEEEEEECCCCce----EEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLP----FAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~----vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 85 (450)
....++|++++.||+|+||.||+|.+..+++. ||+|.+..... ......+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 85 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP- 85 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS--CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-
Confidence 34567999999999999999999999888887 66676643321 112345778999999999999999999986
Q ss_pred CCEEEEEEccCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCC
Q 013081 86 KSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP 164 (450)
Q Consensus 86 ~~~~~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~ 164 (450)
....|+||||+.+|+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++..
T Consensus 86 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 86 GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccccc
Confidence 45689999999999999999764 57999999999999999999999999999999999999999999999999999865
Q ss_pred CcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCH
Q 013081 165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSP 242 (450)
Q Consensus 165 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~ 242 (450)
.............||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+ ....|..+++
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKY-THQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTI 244 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCT
T ss_pred CcccccccccCCCCcccccChHHhccCCC-ChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcH
Confidence 44333334455678889999999987776 589999999999999999 99999998877777777665 4566777899
Q ss_pred HHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 243 GAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
.+.+|+.+||+.||.+|||+.+++++
T Consensus 245 ~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 245 DVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp TTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999999987
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=380.07 Aligned_cols=254 Identities=22% Similarity=0.334 Sum_probs=209.5
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceE----EEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPF----AVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~v----AvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (450)
...++|++++.||+|+||.||+|.+..+++.+ |+|.+.... .......+.+|+.++++++||||+++++++.+.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 44578999999999999999999998887765 667664332 223357899999999999999999999999875
Q ss_pred CEEEEEEccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCC
Q 013081 87 SKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (450)
Q Consensus 87 ~~~~lv~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 165 (450)
. .++++||+.+|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+|+...
T Consensus 90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 5 7889999999999999976 4579999999999999999999999999999999999999999999999999997543
Q ss_pred cccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHH
Q 013081 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPG 243 (450)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 243 (450)
............||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+ ..+.|..++..
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID 247 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHH
T ss_pred CCcccccccCCCccccccChHHhccCCC-CchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence 3222222334567889999999988766 589999999999999999 99999988777766666655 45677789999
Q ss_pred HHHHHHHccccCcCCCCCHHHHHhc
Q 013081 244 AQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 244 ~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
+.+|+.+||+.||.+|||+.+++++
T Consensus 248 ~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 248 VYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCCCHHHHHHH
Confidence 9999999999999999999999876
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=381.61 Aligned_cols=257 Identities=24% Similarity=0.369 Sum_probs=216.3
Q ss_pred cccCCeEEeeeecccCceEEEEEEE-----CCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQD-----LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA 84 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 84 (450)
...++|++++.||+|+||.||+|.+ ..++..||+|++.... .....+.+.+|+.+++++ +||||+++++++.
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 3457899999999999999999997 3467789999997543 222347899999999999 8999999999999
Q ss_pred eCCEEEEEEccCCCCChHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCC
Q 013081 85 SKSKIYMVLEYVTGGELFDKIASKG-----------------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141 (450)
Q Consensus 85 ~~~~~~lv~E~~~gg~L~~~i~~~~-----------------------~l~~~~~~~i~~ql~~aL~~LH~~givHrDlK 141 (450)
..+..|+||||++||+|.+++.... .+++..++.++.||+.||.|||++||+|||||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik 199 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA 199 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 9999999999999999999997643 37999999999999999999999999999999
Q ss_pred CCcEEEccCCCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCC
Q 013081 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDR 220 (450)
Q Consensus 142 p~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~ 220 (450)
|+|||++.++.+||+|||++................||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY-TIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCC-ChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 9999999999999999999986543222223345568889999999887766 589999999999999998 99999887
Q ss_pred cHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhccc
Q 013081 221 NLAVLYQKIFRG--DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 270 (450)
Q Consensus 221 ~~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~ 270 (450)
............ ....|..+++.+.+||.+||+.||.+|||+.+++++-.
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 279 PVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp CCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 654444444433 45567789999999999999999999999999998754
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=376.67 Aligned_cols=257 Identities=26% Similarity=0.437 Sum_probs=220.5
Q ss_pred CCcccCCeEEeeeecccCceEEEEEEEC-------CCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEE
Q 013081 9 EGMRLGRYELGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLH 80 (450)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~ 80 (450)
-....++|++++.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+++++ +||||++++
T Consensus 30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 107 (334)
T 2pvf_A 30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL 107 (334)
T ss_dssp TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEE
Confidence 3445589999999999999999999986 457789999997543 334467899999999999 899999999
Q ss_pred EEEEeCCEEEEEEccCCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCc
Q 013081 81 EVLASKSKIYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLEN 144 (450)
Q Consensus 81 ~~~~~~~~~~lv~E~~~gg~L~~~i~~~~----------------~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~N 144 (450)
+++...+..|+||||++||+|.+++.... .+++.+++.++.||+.||.|||++||+||||||+|
T Consensus 108 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 187 (334)
T 2pvf_A 108 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 187 (334)
T ss_dssp EEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred EEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccce
Confidence 99999999999999999999999998654 38999999999999999999999999999999999
Q ss_pred EEEccCCCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHH
Q 013081 145 ILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLA 223 (450)
Q Consensus 145 ILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~ 223 (450)
||++.++.+||+|||++................+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~ 266 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCc-ChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence 9999999999999999975433211112233467889999999887666 589999999999999999 99999998888
Q ss_pred HHHHHHHhC-CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 224 VLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 224 ~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
.....+..+ ....|..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 267 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 877777666 356677899999999999999999999999999876
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=374.36 Aligned_cols=255 Identities=27% Similarity=0.418 Sum_probs=217.4
Q ss_pred cccCCeEEeeeecccCceEEEEEEE-----CCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQD-----LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA 84 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 84 (450)
...++|++++.||+|+||.||+|.+ ..+++.||+|++.... .....+.+.+|+.+++++ +||||+++++++.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 4457999999999999999999985 4578899999997543 233457899999999999 8999999999999
Q ss_pred eCCEEEEEEccCCCCChHHHHHhcC------------------CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEE
Q 013081 85 SKSKIYMVLEYVTGGELFDKIASKG------------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENIL 146 (450)
Q Consensus 85 ~~~~~~lv~E~~~gg~L~~~i~~~~------------------~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NIL 146 (450)
..+..|+||||++||+|.+++.... ++++..++.++.||+.||.|||++||+||||||+|||
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil 177 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL 177 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEE
Confidence 9999999999999999999997654 4899999999999999999999999999999999999
Q ss_pred EccCCCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHH
Q 013081 147 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVL 225 (450)
Q Consensus 147 l~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~ 225 (450)
++.++.+||+|||++................||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+......
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 256 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence 99999999999999986543322222344567889999999887766 589999999999999999 9999988665444
Q ss_pred HHHHHhC--CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 226 YQKIFRG--DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 226 ~~~i~~~--~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
....... ....+..+++.+.+||.+||++||.+|||+.+++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 257 FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 4333332 344567789999999999999999999999999875
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=383.14 Aligned_cols=253 Identities=26% Similarity=0.464 Sum_probs=208.4
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-----------CCCcceEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-----------HPNVVRLH 80 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----------hpnIv~l~ 80 (450)
..++|++++.||+|+||.||+|.+..+++.||||++.... .....+.+|+.++++++ ||||++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~ 92 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 92 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence 4579999999999999999999999999999999997532 23467889999999886 89999999
Q ss_pred EEEEeCC----EEEEEEccCCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHhhhhhc-CeeeccCCCCcEEEccC---
Q 013081 81 EVLASKS----KIYMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSK--- 150 (450)
Q Consensus 81 ~~~~~~~----~~~lv~E~~~gg~L~~~i~~--~~~l~~~~~~~i~~ql~~aL~~LH~~-givHrDlKp~NILl~~~--- 150 (450)
+++...+ ..+++|||+ |++|.+++.. ..++++..++.++.||+.||+|||++ ||+||||||+|||++.+
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 93 DHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred HHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCC
Confidence 9987654 789999999 8999999976 34699999999999999999999998 99999999999999543
Q ss_pred ---CCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcH-----
Q 013081 151 ---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL----- 222 (450)
Q Consensus 151 ---g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~----- 222 (450)
+.+||+|||++..... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 245 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245 (373)
T ss_dssp TTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCC-CTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred cCcceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence 4799999999975432 2344689999999999988776 5899999999999999999999986542
Q ss_pred -HHHHHHHH------------------------------------------hCCCCCCCCCCHHHHHHHHHccccCcCCC
Q 013081 223 -AVLYQKIF------------------------------------------RGDFKLPKWLSPGAQNLLRKILEPNPVKR 259 (450)
Q Consensus 223 -~~~~~~i~------------------------------------------~~~~~~p~~~s~~~~~Li~~~L~~dP~~R 259 (450)
......+. .....++..+++.+.+||.+||++||.+|
T Consensus 246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence 11111211 11223344456788999999999999999
Q ss_pred CCHHHHHhccccccCC
Q 013081 260 ITIAGIKADEWFEQDY 275 (450)
Q Consensus 260 ~t~~~il~h~~~~~~~ 275 (450)
||+.|+++||||++..
T Consensus 326 pt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 326 ADAGGLVNHPWLKDTL 341 (373)
T ss_dssp BCHHHHHTCGGGTTCT
T ss_pred CCHHHHhhChhhhccc
Confidence 9999999999998754
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-47 Score=366.58 Aligned_cols=253 Identities=19% Similarity=0.229 Sum_probs=213.3
Q ss_pred CCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 013081 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKS 87 (450)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 87 (450)
....-++|++++.||+|+||.||+|.+..+|+.||+|++..... ...+.+|+.+++.+ +|||++++++++....
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 79 (298)
T 1csn_A 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGL 79 (298)
T ss_dssp -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCc
Confidence 34556789999999999999999999999999999999865432 24578899999999 7999999999999999
Q ss_pred EEEEEEccCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCC-----eEEeecCCC
Q 013081 88 KIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN-----IKISDFGLS 161 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~~-~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~-----lkl~DFGla 161 (450)
..|+||||+ |++|.+++...+ ++++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++
T Consensus 80 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 80 HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred eeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 999999999 999999998654 6999999999999999999999999999999999999988776 999999999
Q ss_pred CCCCcccCC-----CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCC---cHHHHHHHHHhCC
Q 013081 162 ALPQHFRDD-----GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR---NLAVLYQKIFRGD 233 (450)
Q Consensus 162 ~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~---~~~~~~~~i~~~~ 233 (450)
......... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+. .....+..+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK 237 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc
Confidence 864432111 12345689999999999887766 68999999999999999999999873 3344444443322
Q ss_pred C-----CCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 234 F-----KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 234 ~-----~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
. ..+..+++.+.+|+.+||+.||.+|||+.++++.
T Consensus 238 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 238 QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 1 1234689999999999999999999999998764
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=373.60 Aligned_cols=255 Identities=22% Similarity=0.313 Sum_probs=221.1
Q ss_pred cccCCeEEeeeecccCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 85 (450)
...++|++.+.||+|+||.||+|.+. .+++.||+|.+.... .......+.+|+.+++.++||||+++++++.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 99 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 99 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence 44578999999999999999999876 357899999997543 23335678899999999999999999999999
Q ss_pred CCEEEEEEccCCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEE
Q 013081 86 KSKIYMVLEYVTGGELFDKIASK----------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKI 155 (450)
Q Consensus 86 ~~~~~lv~E~~~gg~L~~~i~~~----------~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl 155 (450)
....|+||||++||+|.+++... .++++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl 179 (322)
T 1p4o_A 100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 179 (322)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEE
T ss_pred CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEE
Confidence 99999999999999999998753 45799999999999999999999999999999999999999999999
Q ss_pred eecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCC-
Q 013081 156 SDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD- 233 (450)
Q Consensus 156 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~- 233 (450)
+|||++................||+.|+|||++.+..+ +.++||||+||++|+|++ |..||.+.+.......+..+.
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 258 (322)
T 1p4o_A 180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 258 (322)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred CcCccccccccccccccccCCCCCCCccChhhhccCCC-CchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCc
Confidence 99999985433221122334567899999999887766 589999999999999999 999999988888887777664
Q ss_pred CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 234 FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 234 ~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
...|..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 259 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 259 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 45677899999999999999999999999999987
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=365.88 Aligned_cols=257 Identities=29% Similarity=0.479 Sum_probs=209.5
Q ss_pred CCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013081 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (450)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (450)
....+++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++...+.
T Consensus 27 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 106 (310)
T 2wqm_A 27 GYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE 106 (310)
T ss_dssp TTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred ccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCc
Confidence 34567899999999999999999999999999999999986555555667889999999999999999999999999999
Q ss_pred EEEEEccCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCC
Q 013081 89 IYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP 164 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~~i~~----~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~ 164 (450)
.|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++...
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 9999999999999998864 456999999999999999999999999999999999999999999999999998754
Q ss_pred CcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCC--cHHHHHHHHHhCCCCC--CCCC
Q 013081 165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR--NLAVLYQKIFRGDFKL--PKWL 240 (450)
Q Consensus 165 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~--~~~~~~~~i~~~~~~~--p~~~ 240 (450)
.. .........||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+. +.......+.....+. +..+
T Consensus 187 ~~--~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (310)
T 2wqm_A 187 SS--KTTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHY 263 (310)
T ss_dssp --------------CCSSCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTS
T ss_pred cC--CCccccccCCCeeEeChHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCccccc
Confidence 32 1222345679999999999887666 58999999999999999999999764 3344555555554332 2558
Q ss_pred CHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 241 SPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 241 s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
++.+.+||.+||+.||.+|||+.+++++
T Consensus 264 ~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 264 SEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 9999999999999999999999999874
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=374.78 Aligned_cols=254 Identities=22% Similarity=0.343 Sum_probs=210.4
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceE----EEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPF----AVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~v----AvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (450)
...++|++++.||+|+||.||+|.+..+++.| |+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 44589999999999999999999999888876 555553322 222357889999999999999999999999876
Q ss_pred CEEEEEEccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCC
Q 013081 87 SKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (450)
Q Consensus 87 ~~~~lv~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 165 (450)
. .++++||+.+|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 5 7889999999999999976 4579999999999999999999999999999999999999999999999999998654
Q ss_pred cccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHH
Q 013081 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPG 243 (450)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 243 (450)
............+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........+..+ ..+.|..+++.
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID 247 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHH
T ss_pred CccccccccCCCccccccCHHHHcCCCC-ChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence 3222223334567889999999987776 589999999999999999 99999998877777666665 46677789999
Q ss_pred HHHHHHHccccCcCCCCCHHHHHhc
Q 013081 244 AQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 244 ~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
+.+||.+||+.||.+|||+.++++.
T Consensus 248 l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 248 VYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999999999999999999999874
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=368.99 Aligned_cols=260 Identities=23% Similarity=0.354 Sum_probs=201.5
Q ss_pred CcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (450)
...+++|++++.||+|+||.||+|.+..+|+.||||++...... ......+.++..+++.++||||+++++++...+..
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~ 99 (318)
T 2dyl_A 21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDV 99 (318)
T ss_dssp ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Confidence 35678999999999999999999999999999999999765432 22234455556678888999999999999999999
Q ss_pred EEEEccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhc-CeeeccCCCCcEEEccCCCeEEeecCCCCCCCcc
Q 013081 90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~-givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 167 (450)
|+||||+ ++.+..+... .+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++.....
T Consensus 100 ~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~- 177 (318)
T 2dyl_A 100 FIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD- 177 (318)
T ss_dssp EEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred EEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC-
Confidence 9999999 5555555543 56899999999999999999999995 999999999999999999999999999975432
Q ss_pred cCCCccccccCCCCccchhhhcc----CCCCCccchhhhHHHHHHHHHhCCCCCCC-CcHHHHHHHHHhCCCC-CC--CC
Q 013081 168 RDDGLLHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGDFK-LP--KW 239 (450)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~----~~~~~~~~DiwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~-~p--~~ 239 (450)
.......+||+.|+|||++.. ....+.++||||+||++|+|++|..||.. .........+.....+ .| ..
T Consensus 178 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (318)
T 2dyl_A 178 --DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMG 255 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSC
T ss_pred --CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCC
Confidence 223345679999999999852 23346899999999999999999999987 3445555666655432 33 34
Q ss_pred CCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 240 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 240 ~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
+++.+.+||.+||+.||.+|||+.++++||||+..
T Consensus 256 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 256 FSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp CCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 89999999999999999999999999999999753
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=374.66 Aligned_cols=252 Identities=27% Similarity=0.425 Sum_probs=217.4
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceE--EEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPF--AVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKS 87 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~v--AvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 87 (450)
..+++|++.+.||+|+||.||+|.+..++..+ |+|.+.... .......+.+|+.+++++ +||||+++++++.+.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 55689999999999999999999998888865 999886432 223356789999999999 8999999999999999
Q ss_pred EEEEEEccCCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCC
Q 013081 88 KIYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG 151 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~~----------------~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g 151 (450)
..|+||||++|++|.+++...+ ++++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 9999999999999999997654 799999999999999999999999999999999999999999
Q ss_pred CeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHH
Q 013081 152 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIF 230 (450)
Q Consensus 152 ~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~ 230 (450)
.+||+|||++...... .......+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+.
T Consensus 180 ~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~ 255 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 255 (327)
T ss_dssp CEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred eEEEcccCcCcccccc---ccccCCCCCccccChhhhccccC-CchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh
Confidence 9999999998743221 12234567889999999887666 589999999999999998 999999998888887776
Q ss_pred hC-CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 231 RG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 231 ~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
.+ ....|..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 256 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 256 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 66 456677799999999999999999999999999986
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=377.28 Aligned_cols=248 Identities=22% Similarity=0.281 Sum_probs=210.6
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIY 90 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 90 (450)
.-++|++++.||+|+||.||+|.+..+|+.||||++..... ...+.+|+.+++.+ +||||+++++++......|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 81 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA 81 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence 34689999999999999999999999999999999875432 23578999999999 8999999999999999999
Q ss_pred EEEccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCC-----eEEeecCCCCCC
Q 013081 91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN-----IKISDFGLSALP 164 (450)
Q Consensus 91 lv~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~-----lkl~DFGla~~~ 164 (450)
+||||+ |++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++...
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 999999 9999999986 468999999999999999999999999999999999999999887 999999999854
Q ss_pred CcccCCC-----ccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCC---CcHHHHHHHHHhCCCCC
Q 013081 165 QHFRDDG-----LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD---RNLAVLYQKIFRGDFKL 236 (450)
Q Consensus 165 ~~~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~---~~~~~~~~~i~~~~~~~ 236 (450)
....... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+ ......+.++.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQ-SRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCC-CchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 3221111 1346789999999999988776 5899999999999999999999987 34445555554443332
Q ss_pred C-----CCCCHHHHHHHHHccccCcCCCCCHHHHHh
Q 013081 237 P-----KWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 237 p-----~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
| ..++ ++.+|+.+||+.||.+||++.++++
T Consensus 240 ~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 240 PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 2 2244 9999999999999999999998866
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=376.30 Aligned_cols=261 Identities=22% Similarity=0.295 Sum_probs=218.6
Q ss_pred CcccCCeEEeeeecccCceEEEEEE-----ECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQ-----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA 84 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~-----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 84 (450)
....++|++++.||+|+||.||+|. +..+++.||+|.+.... .......+.+|+.++++++||||+++++++.
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSL 103 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence 4556899999999999999999999 55688899999996432 2334567899999999999999999999999
Q ss_pred eCCEEEEEEccCCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccC---CCeE
Q 013081 85 SKSKIYMVLEYVTGGELFDKIASKG-------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK---GNIK 154 (450)
Q Consensus 85 ~~~~~~lv~E~~~gg~L~~~i~~~~-------~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~---g~lk 154 (450)
.....|+||||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+|
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence 9999999999999999999998653 48999999999999999999999999999999999999954 4699
Q ss_pred EeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-
Q 013081 155 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG- 232 (450)
Q Consensus 155 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~- 232 (450)
|+|||++................||+.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+..+
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 262 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF-TSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 262 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC
Confidence 999999874322212223345678999999999887766 589999999999999998 99999998888777777765
Q ss_pred CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhcccccc
Q 013081 233 DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 233 ~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
....+..+++.+.+||.+||+.||.+|||+.+++++.|+..
T Consensus 263 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 263 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 45567779999999999999999999999999999998753
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=363.13 Aligned_cols=252 Identities=26% Similarity=0.409 Sum_probs=211.7
Q ss_pred CcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhH----HHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKI----TDQIKREIATLKLLKHPNVVRLHEVLAS 85 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~----~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 85 (450)
....++|++.+.||+|+||.||+|.+..+++.||+|++.......... .+.+.+|+.+++.++||||+++++++.+
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN 94 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence 355689999999999999999999999999999999987654332221 1678999999999999999999999876
Q ss_pred CCEEEEEEccCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcC--eeeccCCCCcEEEccCCC-----eEEee
Q 013081 86 KSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLDSKGN-----IKISD 157 (450)
Q Consensus 86 ~~~~~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlKp~NILl~~~g~-----lkl~D 157 (450)
.. ++||||++|++|.+.+... .++++..++.++.|++.||+|||++| |+||||||+|||++.++. +||+|
T Consensus 95 ~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 95 PP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp TT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred CC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 65 7999999999999988654 47999999999999999999999999 999999999999998886 99999
Q ss_pred cCCCCCCCcccCCCccccccCCCCccchhhhcc-CCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHH--HHHHHHhC--
Q 013081 158 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN-RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV--LYQKIFRG-- 232 (450)
Q Consensus 158 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~--~~~~i~~~-- 232 (450)
||++.... ......+||+.|+|||++.. ....+.++||||+||++|+|++|..||...+... ....+...
T Consensus 173 fg~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 247 (287)
T 4f0f_A 173 FGLSQQSV-----HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL 247 (287)
T ss_dssp CTTCBCCS-----SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC
T ss_pred CCcccccc-----ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC
Confidence 99997432 23455789999999999843 2233689999999999999999999998754332 23333333
Q ss_pred CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 233 DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 233 ~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
....|..+++.+.+||.+||+.||.+|||+.++++.
T Consensus 248 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 283 (287)
T 4f0f_A 248 RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283 (287)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 445677899999999999999999999999999863
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=365.47 Aligned_cols=253 Identities=23% Similarity=0.325 Sum_probs=215.0
Q ss_pred ccCCeEEee-eecccCceEEEEEEE--CCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013081 12 RLGRYELGR-TLGEGNFGKVKFAQD--LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (450)
Q Consensus 12 ~~~~y~i~~-~LG~G~~g~Vy~a~~--~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (450)
..++|++.+ .||+|+||.||+|.+ ..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++ ....
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~ 91 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC-EAES 91 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence 346899998 999999999999954 56788999999976532 333467899999999999999999999999 5677
Q ss_pred EEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc
Q 013081 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 168 (450)
.|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171 (291)
T ss_dssp EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred cEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCC
Confidence 89999999999999999988889999999999999999999999999999999999999999999999999997543211
Q ss_pred CC-CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHH
Q 013081 169 DD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQ 245 (450)
Q Consensus 169 ~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 245 (450)
.. .......+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+.......+..+ ....|..+++.+.
T Consensus 172 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 250 (291)
T 1xbb_A 172 NYYKAQTHGKWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMY 250 (291)
T ss_dssp SEEEC----CCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred CcccccccCCCCceeeChHHhccCCC-ChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 10 11223456788999999987766 589999999999999999 99999998888777777665 4566788999999
Q ss_pred HHHHHccccCcCCCCCHHHHHh
Q 013081 246 NLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 246 ~Li~~~L~~dP~~R~t~~~il~ 267 (450)
++|.+||+.||.+|||+.++++
T Consensus 251 ~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 251 DLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999876
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=366.97 Aligned_cols=254 Identities=27% Similarity=0.394 Sum_probs=222.5
Q ss_pred CCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013081 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (450)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (450)
.....++|++.+.||+|+||.||+|.+..++..||+|++.... ...+.+.+|+.+++.++||||+++++++.+...
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 83 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 83 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3456689999999999999999999999999999999996543 235778899999999999999999999999999
Q ss_pred EEEEEccCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCc
Q 013081 89 IYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~~i~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 166 (450)
.|+||||++|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 99999999999999999863 4599999999999999999999999999999999999999999999999999986432
Q ss_pred ccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHH
Q 013081 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGA 244 (450)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~ 244 (450)
. .........+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+.......+... ....|..+++.+
T Consensus 164 ~-~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (288)
T 3kfa_A 164 D-TYTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV 241 (288)
T ss_dssp S-SSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHH
T ss_pred C-ccccccCCccccCcCChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHH
Confidence 1 1122334567889999999987766 589999999999999999 99999988877777666655 556677899999
Q ss_pred HHHHHHccccCcCCCCCHHHHHhc
Q 013081 245 QNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
.+|+.+||+.||.+|||+.++++.
T Consensus 242 ~~li~~~l~~dp~~Rps~~~~~~~ 265 (288)
T 3kfa_A 242 YELMRACWQWNPSDRPSFAEIHQA 265 (288)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhCCChhhCcCHHHHHHH
Confidence 999999999999999999999763
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=373.03 Aligned_cols=255 Identities=26% Similarity=0.390 Sum_probs=216.2
Q ss_pred cccCCeEEeeeecccCceEEEEEEE-----CCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQD-----LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA 84 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 84 (450)
...++|++++.||+|+||.||+|.+ ..+++.||+|++.... .......+.+|+.+++++ +||||+++++++.
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 101 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 101 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEe
Confidence 4457999999999999999999985 3577899999997543 233456889999999999 6999999999987
Q ss_pred eCC-EEEEEEccCCCCChHHHHHhcCC----------------CCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEE
Q 013081 85 SKS-KIYMVLEYVTGGELFDKIASKGR----------------LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL 147 (450)
Q Consensus 85 ~~~-~~~lv~E~~~gg~L~~~i~~~~~----------------l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl 147 (450)
..+ ..|+||||++|++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~ 181 (316)
T 2xir_A 102 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 181 (316)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE
Confidence 654 58999999999999999987554 8999999999999999999999999999999999999
Q ss_pred ccCCCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHH-HH
Q 013081 148 DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLA-VL 225 (450)
Q Consensus 148 ~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~-~~ 225 (450)
+.++.+||+|||++................||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.... ..
T Consensus 182 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~ 260 (316)
T 2xir_A 182 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 260 (316)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccc-cchhHHHHHHHHHHHHHhCCCCCCcccchhHHH
Confidence 9999999999999986533222223345678899999999987766 589999999999999998 99999876543 33
Q ss_pred HHHHHhC-CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 226 YQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 226 ~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
...+..+ ....|..+++.+.++|.+||+.||.+|||+.++++|
T Consensus 261 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 261 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3444443 456678899999999999999999999999999987
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=360.19 Aligned_cols=251 Identities=23% Similarity=0.404 Sum_probs=219.1
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (450)
...++|++.+.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (267)
T 3t9t_A 5 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 79 (267)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred EchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE
Confidence 34578999999999999999999986 6778999999765432 357889999999999999999999999999999
Q ss_pred EEEccCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC
Q 013081 91 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (450)
Q Consensus 91 lv~E~~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 169 (450)
+||||++|++|.+++... +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~- 158 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ- 158 (267)
T ss_dssp EEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-
T ss_pred EEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc-
Confidence 999999999999999764 568999999999999999999999999999999999999999999999999987542211
Q ss_pred CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 013081 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 247 (450)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 247 (450)
........+|+.|+|||++.+..+ +.++||||+|+++|+|++ |..||.+.+.......+..+ ....|..+++.+.+|
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 237 (267)
T 3t9t_A 159 YTSSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQI 237 (267)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred ccccccccccccccChhhhcCCCc-cchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHH
Confidence 111233467789999999987766 589999999999999999 99999998888888777776 445567789999999
Q ss_pred HHHccccCcCCCCCHHHHHhc
Q 013081 248 LRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 248 i~~~L~~dP~~R~t~~~il~h 268 (450)
+.+||+.||.+|||+.+++++
T Consensus 238 i~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 238 MNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999875
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=369.78 Aligned_cols=256 Identities=25% Similarity=0.378 Sum_probs=208.7
Q ss_pred cccCCeEEeeeecccCceEEEEEEECC---CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLD---SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (450)
...++|.+++.||+|+||.||+|.+.. +++.||+|++..... .....+.+.+|+.++++++||||+++++++....
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 445799999999999999999998765 556899999975543 3334578999999999999999999999987654
Q ss_pred -----EEEEEEccCCCCChHHHHH------hcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEe
Q 013081 88 -----KIYMVLEYVTGGELFDKIA------SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKIS 156 (450)
Q Consensus 88 -----~~~lv~E~~~gg~L~~~i~------~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~ 156 (450)
..|+||||+++++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~ 189 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVA 189 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEEC
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEe
Confidence 3599999999999999984 33569999999999999999999999999999999999999999999999
Q ss_pred ecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CC
Q 013081 157 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DF 234 (450)
Q Consensus 157 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~ 234 (450)
|||++................+++.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+.......+..+ ..
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 268 (313)
T 3brb_A 190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRL 268 (313)
T ss_dssp SCSCC----------------CCGGGSCHHHHHSSCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC
T ss_pred ecCcceecccccccCcccccCCCccccCchhhcCCCc-cchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCC
Confidence 9999985433221122334567889999999987666 589999999999999999 99999988877777777666 45
Q ss_pred CCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 235 KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 235 ~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
..|..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 269 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 269 KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 6677899999999999999999999999999875
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=373.89 Aligned_cols=261 Identities=23% Similarity=0.353 Sum_probs=195.8
Q ss_pred ccCCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHH-HHHhCCCCCcceEEEEEEe
Q 013081 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA-TLKLLKHPNVVRLHEVLAS 85 (450)
Q Consensus 7 ~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~ 85 (450)
.......++|++++.||+|+||.||+|.+..+|+.||||++..... ......+.+|+. +++.++||||+++++++..
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~ 92 (327)
T 3aln_A 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD--EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR 92 (327)
T ss_dssp EEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC--HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC
T ss_pred HhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC--chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe
Confidence 3445667899999999999999999999999999999999976532 223455566665 7788899999999999999
Q ss_pred CCEEEEEEccCCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHhhhhhc-CeeeccCCCCcEEEccCCCeEEeecC
Q 013081 86 KSKIYMVLEYVTGGELFDKIAS-----KGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFG 159 (450)
Q Consensus 86 ~~~~~lv~E~~~gg~L~~~i~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~-givHrDlKp~NILl~~~g~lkl~DFG 159 (450)
.+..|+||||+.| +|.+++.. ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 171 (327)
T 3aln_A 93 EGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFG 171 (327)
T ss_dssp SSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCS
T ss_pred CCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCC
Confidence 9999999999975 88777763 56799999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCCcccCCCccccccCCCCccchhhhc----cCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHH-HHHHHHHhCCC
Q 013081 160 LSALPQHFRDDGLLHTTCGSPNYVAPEVLA----NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKIFRGDF 234 (450)
Q Consensus 160 la~~~~~~~~~~~~~~~~gt~~y~APE~l~----~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~ 234 (450)
++..... ........||+.|+|||++. +..+ +.++|||||||++|+|++|..||.+.+.. .....+..+..
T Consensus 172 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 247 (327)
T 3aln_A 172 ISGQLVD---SIAKTRDAGCRPYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDP 247 (327)
T ss_dssp SSCC---------------------------------C-CSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCC
T ss_pred Cceeccc---ccccccCCCCccccCceeeccccCcCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCC
Confidence 9975432 12233457999999999983 3334 68999999999999999999999875432 22222222221
Q ss_pred -CCC----CCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 235 -KLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 235 -~~p----~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
.++ ..+++.+.+||.+||+.||.+|||+.++++||||...
T Consensus 248 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 248 PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 122 3489999999999999999999999999999999754
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=374.39 Aligned_cols=255 Identities=24% Similarity=0.397 Sum_probs=216.7
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCc-----eEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGL-----PFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA 84 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~-----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 84 (450)
...++|++++.||+|+||.||+|.+..+++ .||+|++.... .....+.+.+|+.+++.+ +||||+++++++.
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 445789999999999999999999977665 79999997543 333467899999999999 8999999999999
Q ss_pred eCCEEEEEEccCCCCChHHHHHhc--------------CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccC
Q 013081 85 SKSKIYMVLEYVTGGELFDKIASK--------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 150 (450)
Q Consensus 85 ~~~~~~lv~E~~~gg~L~~~i~~~--------------~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~ 150 (450)
..+..|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGG
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCC
Confidence 999999999999999999998753 458999999999999999999999999999999999999999
Q ss_pred CCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHH
Q 013081 151 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKI 229 (450)
Q Consensus 151 g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i 229 (450)
+.+||+|||++................||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+..........
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 279 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL 279 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHH
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCC-ChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHH
Confidence 9999999999985433222222334567889999999887766 589999999999999999 99999886654444444
Q ss_pred HhC--CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 230 FRG--DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 230 ~~~--~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
... ....|...++.+.+||.+||+.||.+|||+.+++++
T Consensus 280 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 280 VKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 433 345567789999999999999999999999999874
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=362.81 Aligned_cols=256 Identities=25% Similarity=0.361 Sum_probs=219.0
Q ss_pred cccCCeEEee-eecccCceEEEEEEEC--CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013081 11 MRLGRYELGR-TLGEGNFGKVKFAQDL--DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (450)
Q Consensus 11 ~~~~~y~i~~-~LG~G~~g~Vy~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (450)
...++|.+.+ .||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++.++||||+++++++ ..+
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~ 82 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE 82 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC
Confidence 4457888887 9999999999999864 468889999997643 334467899999999999999999999999 456
Q ss_pred EEEEEEccCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCc
Q 013081 88 KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 166 (450)
..|+||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 689999999999999998653 5699999999999999999999999999999999999999999999999999985432
Q ss_pred ccC-CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHH
Q 013081 167 FRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPG 243 (450)
Q Consensus 167 ~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 243 (450)
... ........||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+ ....|..+++.
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 241 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPE 241 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHH
T ss_pred CcceeeccccccccccccCHHHhccCCC-CchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHH
Confidence 111 111233457889999999887666 589999999999999998 99999988877777777766 35677889999
Q ss_pred HHHHHHHccccCcCCCCCHHHHHhccc
Q 013081 244 AQNLLRKILEPNPVKRITIAGIKADEW 270 (450)
Q Consensus 244 ~~~Li~~~L~~dP~~R~t~~~il~h~~ 270 (450)
+.+||.+||+.||.+|||+.+++++.|
T Consensus 242 l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 242 LYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 999999999999999999999998865
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=365.97 Aligned_cols=254 Identities=26% Similarity=0.386 Sum_probs=209.7
Q ss_pred cccCCeEEeeeecccCceEEEEEE----ECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (450)
....+|++++.||+|+||.||+|. +..+++.||+|++..... ......+.+|+.+++.++||||+++++++...
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGICTED 95 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 445679999999999999999999 567899999999975532 22357889999999999999999999999876
Q ss_pred --CEEEEEEccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCC
Q 013081 87 --SKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL 163 (450)
Q Consensus 87 --~~~~lv~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~ 163 (450)
...|+||||++|++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccc
Confidence 678999999999999999954 46799999999999999999999999999999999999999999999999999985
Q ss_pred CCcccCC-CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCc---------------HHHHHH
Q 013081 164 PQHFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN---------------LAVLYQ 227 (450)
Q Consensus 164 ~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~---------------~~~~~~ 227 (450)
....... .......||+.|+|||++.+..+ +.++||||+||++|+|++|..|+.... ......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKF-YIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCC-CcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence 4332110 12344578889999999987776 489999999999999999999864321 112223
Q ss_pred HHHhC-CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHh
Q 013081 228 KIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 228 ~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
.+..+ ..+.|..+++.+.+||.+||+.||.+|||+.++++
T Consensus 255 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 255 TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 33332 45667889999999999999999999999999986
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=380.12 Aligned_cols=255 Identities=22% Similarity=0.370 Sum_probs=208.5
Q ss_pred CcccCCeEEeeeecccCceEEEEEEEC---CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (450)
....++|++.+.||+|+||.||+|++. .++..||||.++... .....+.+.+|+.++++++||||+++++++...
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 118 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS 118 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 344568999999999999999999976 467789999986543 334467899999999999999999999999999
Q ss_pred CEEEEEEccCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCC
Q 013081 87 SKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (450)
Q Consensus 87 ~~~~lv~E~~~gg~L~~~i~~~~-~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 165 (450)
...|+||||++||+|.+++...+ .+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 99999999999999999998654 69999999999999999999999999999999999999999999999999998653
Q ss_pred cccCCC-ccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCH
Q 013081 166 HFRDDG-LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSP 242 (450)
Q Consensus 166 ~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~ 242 (450)
...... ......+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+ ..+.|..+++
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~ 277 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKF-TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPA 277 (373)
T ss_dssp ---------------CTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBH
T ss_pred cCCccceeccCCCcCCCccChhhhccCCc-CchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccH
Confidence 321111 1122345788999999987776 589999999999999998 99999998888777777665 4555677899
Q ss_pred HHHHHHHHccccCcCCCCCHHHHHh
Q 013081 243 GAQNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
.+.+|+.+||+.||.+|||+.++++
T Consensus 278 ~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 278 ALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhCcChhhCcCHHHHHH
Confidence 9999999999999999999999876
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=374.13 Aligned_cols=250 Identities=22% Similarity=0.275 Sum_probs=202.4
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS---- 87 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---- 87 (450)
..++|++++.||+|+||.||+|.+. ++.||||++.... .......+|+.++++++||||+++++++....
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDV 95 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred chhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCc
Confidence 4579999999999999999999984 7899999996542 22355667999999999999999999997743
Q ss_pred EEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhc----------CeeeccCCCCcEEEccCCCeEEee
Q 013081 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK----------GVFHRDLKLENILLDSKGNIKISD 157 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~----------givHrDlKp~NILl~~~g~lkl~D 157 (450)
.+|+||||+++|+|.+++.. .++++..++.++.|++.||+|||+. ||+||||||+|||++.++.+||+|
T Consensus 96 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 96 DLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp EEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred eEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence 47999999999999999976 5699999999999999999999999 999999999999999999999999
Q ss_pred cCCCCCCCcccCCCccccccCCCCccchhhhccCC----CCCccchhhhHHHHHHHHHhCCCCCCCCc------------
Q 013081 158 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG----YDGATSDIWSCGVILYVILTGYLPFDDRN------------ 221 (450)
Q Consensus 158 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~----~~~~~~DiwSlGvil~elltG~~Pf~~~~------------ 221 (450)
||+|...............+||+.|+|||++.+.. ..+.++|||||||++|+|++|+.||.+..
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 99997544332333344568999999999987632 22467899999999999999999997532
Q ss_pred ----HHHHHHHHHhCCC--CCCCC-----CCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 222 ----LAVLYQKIFRGDF--KLPKW-----LSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 222 ----~~~~~~~i~~~~~--~~p~~-----~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
............. ..+.. .++.+.+||.+||+.||++|||+.++++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 312 (322)
T 3soc_A 255 QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312 (322)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2222222222221 11211 23459999999999999999999999864
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=360.54 Aligned_cols=256 Identities=24% Similarity=0.347 Sum_probs=214.9
Q ss_pred cCCcccCCeEEeeeecccCceEEEEEEECC---CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 013081 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLD---SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA 84 (450)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 84 (450)
..+...++|++.+.||+|+||.||+|.+.. ++..||+|++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 6 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 83 (281)
T 3cc6_A 6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE 83 (281)
T ss_dssp CCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC
T ss_pred cceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEc
Confidence 345667899999999999999999998654 34569999987653 2334678999999999999999999999986
Q ss_pred eCCEEEEEEccCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCC
Q 013081 85 SKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL 163 (450)
Q Consensus 85 ~~~~~~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~ 163 (450)
+ ...|+||||++|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 84 ~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 84 E-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred C-CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 5 4568999999999999999765 4599999999999999999999999999999999999999999999999999985
Q ss_pred CCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCC
Q 013081 164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLS 241 (450)
Q Consensus 164 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s 241 (450)
..... ........+|+.|+|||++.+..+ +.++||||||+++|+|++ |+.||...........+..+ ..+.|..++
T Consensus 163 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (281)
T 3cc6_A 163 IEDED-YYKASVTRLPIKWMSPESINFRRF-TTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCP 240 (281)
T ss_dssp C----------CCCCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCC
T ss_pred ccccc-ccccccCCCCcceeCchhhccCCC-CchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCC
Confidence 43211 112234567889999999877766 589999999999999998 99999877666666655554 456677899
Q ss_pred HHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 242 PGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 242 ~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
+.+.+||.+||+.||.+|||+.+++++
T Consensus 241 ~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 241 PVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 999999999999999999999999875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=385.49 Aligned_cols=244 Identities=26% Similarity=0.482 Sum_probs=213.5
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-EE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-KI 89 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-~~ 89 (450)
...++|++++.||+|+||.||+|.+ +|+.||||+++... ..+.+.+|+.+|++++||||+++++++.... ..
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 262 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 262 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCce
Confidence 4567999999999999999999998 47899999997543 2467889999999999999999999987655 79
Q ss_pred EEEEccCCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcc
Q 013081 90 YMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~~--l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 167 (450)
|+||||+++|+|.+++...+. +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 263 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~- 341 (450)
T 1k9a_A 263 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS- 341 (450)
T ss_dssp EEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc-
Confidence 999999999999999987654 79999999999999999999999999999999999999999999999999974321
Q ss_pred cCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHH
Q 013081 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQ 245 (450)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 245 (450)
......+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+ ..+.|..+++.+.
T Consensus 342 ----~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~ 416 (450)
T 1k9a_A 342 ----TQDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY 416 (450)
T ss_dssp ---------CCCTTTSCHHHHHSSCC-CHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHH
T ss_pred ----cccCCCCCcceeCHHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHH
Confidence 1233467899999999987776 589999999999999998 99999988777777777666 5677888999999
Q ss_pred HHHHHccccCcCCCCCHHHHHh
Q 013081 246 NLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 246 ~Li~~~L~~dP~~R~t~~~il~ 267 (450)
+||.+||+.||.+|||+.++++
T Consensus 417 ~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 417 DVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999999999875
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=362.91 Aligned_cols=255 Identities=24% Similarity=0.429 Sum_probs=199.6
Q ss_pred cCCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013081 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (450)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (450)
.....-++|++++.||+|+||.||+|.+. ..||+|++..... .....+.+.+|+.+++.++||||++++++. ...
T Consensus 18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~ 92 (289)
T 3og7_A 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAP 92 (289)
T ss_dssp CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSS
T ss_pred CCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCC
Confidence 34456689999999999999999999863 3599999975543 344467899999999999999999999965 556
Q ss_pred EEEEEEccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCc
Q 013081 88 KIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 166 (450)
..++||||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 93 QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp SCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred ccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccc
Confidence 68999999999999999964 45799999999999999999999999999999999999999999999999999986543
Q ss_pred ccCCCccccccCCCCccchhhhc---cCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHH-HHHHHHHhCCCC-----CC
Q 013081 167 FRDDGLLHTTCGSPNYVAPEVLA---NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKIFRGDFK-----LP 237 (450)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~---~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~-----~p 237 (450)
..........+||+.|+|||++. ...+ +.++||||||+++|+|++|..||.+.+.. .....+..+... .+
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPY-SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVR 251 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCS-CHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSC
T ss_pred ccccccccccCCCccccCchhhcccCCCCC-CcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhcc
Confidence 33333445568999999999986 3333 57999999999999999999999875544 344444443322 23
Q ss_pred CCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 238 KWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 238 ~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
..+++.+.+||.+||+.||.+|||+.++++.
T Consensus 252 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 282 (289)
T 3og7_A 252 SNCPKRMKRLMAECLKKKRDERPSFPRILAE 282 (289)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 4588999999999999999999999999863
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-46 Score=367.47 Aligned_cols=255 Identities=24% Similarity=0.363 Sum_probs=213.0
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCC----ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (450)
..-++|++.+.||+|+||.||+|.+..++ ..||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 118 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 118 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence 34578999999999999999999986553 359999997543 333456789999999999999999999999999
Q ss_pred CEEEEEEccCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCC
Q 013081 87 SKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (450)
Q Consensus 87 ~~~~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 165 (450)
...|+||||++|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 9999999999999999999764 679999999999999999999999999999999999999999999999999998643
Q ss_pred cccCCC-ccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCH
Q 013081 166 HFRDDG-LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSP 242 (450)
Q Consensus 166 ~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~ 242 (450)
...... ......+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+ ..+.|..+++
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKF-TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS 277 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBH
T ss_pred cccccccccCCCCccccccCchhcccCCC-CchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCH
Confidence 321111 1223356788999999887666 589999999999999999 99999988888877777766 4566777999
Q ss_pred HHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 243 GAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
.+.+|+.+||+.||.+|||+.+++++
T Consensus 278 ~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 278 AIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999999875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=359.64 Aligned_cols=246 Identities=26% Similarity=0.435 Sum_probs=211.8
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--------
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-------- 85 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-------- 85 (450)
++|++++.||+|+||.||+|.+..+|+.||+|.+.... ..+.+|+.+++.++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 68999999999999999999999999999999997543 346789999999999999999998854
Q ss_pred --------CCEEEEEEccCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEE
Q 013081 86 --------KSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKI 155 (450)
Q Consensus 86 --------~~~~~lv~E~~~gg~L~~~i~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl 155 (450)
....|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEE
Confidence 45589999999999999999754 57999999999999999999999999999999999999999999999
Q ss_pred eecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCC
Q 013081 156 SDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK 235 (450)
Q Consensus 156 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~ 235 (450)
+|||++..... ........||+.|+|||++.+..+ +.++||||||+++|+|++|..||... ......+..+ .
T Consensus 164 ~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~--~ 235 (284)
T 2a19_B 164 GDFGLVTSLKN---DGKRTRSKGTLRYMSPEQISSQDY-GKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDG--I 235 (284)
T ss_dssp CCCTTCEESSC---CSCCCCCCSCCTTSCHHHHHCSCC-CTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTT--C
T ss_pred Ccchhheeccc---cccccccCCcccccChhhhccCCC-cchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhcc--c
Confidence 99999875432 223345679999999999887766 58999999999999999999987532 2233333332 3
Q ss_pred CCCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 236 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 236 ~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
.+..+++.+.+||.+||+.||.+|||+.+++++.|.-..
T Consensus 236 ~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 236 ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 466789999999999999999999999999999887543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=358.49 Aligned_cols=251 Identities=24% Similarity=0.369 Sum_probs=212.7
Q ss_pred CeEEeeeecccCceEEEEEEECCCCc---eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE-E
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGL---PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI-Y 90 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~-~ 90 (450)
.|++.+.||+|+||.||+|.+..+++ .||+|.+.... .....+.+.+|+.+++.++||||+++++++.+.+.. |
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 57788999999999999999765544 79999986432 334467889999999999999999999999766555 9
Q ss_pred EEEccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc-
Q 013081 91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR- 168 (450)
Q Consensus 91 lv~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~- 168 (450)
++|||+.+++|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 99999999999999976 4578999999999999999999999999999999999999999999999999997543211
Q ss_pred -CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHH
Q 013081 169 -DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQ 245 (450)
Q Consensus 169 -~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 245 (450)
.........+|+.|+|||++.+..+ +.++||||+||++|+|++ |.+||...+.......+..+ ..+.|..+++.+.
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 258 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTYRF-TTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLY 258 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred cccccCcCCCCCccccChhhhccCCC-ChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHH
Confidence 1223344578899999999987766 589999999999999999 66667777766666666655 4566778999999
Q ss_pred HHHHHccccCcCCCCCHHHHHhc
Q 013081 246 NLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 246 ~Li~~~L~~dP~~R~t~~~il~h 268 (450)
+|+.+||+.||.+|||+.++++.
T Consensus 259 ~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 259 QVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999998864
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=359.36 Aligned_cols=245 Identities=26% Similarity=0.478 Sum_probs=207.2
Q ss_pred CcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCE
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-KSK 88 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~ 88 (450)
....++|++++.||+|+||.||+|.+ +|+.||+|+++... ..+.+.+|+.++++++||||+++++++.. .+.
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 89 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred cCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCc
Confidence 35568999999999999999999987 58899999986542 24678999999999999999999999754 457
Q ss_pred EEEEEccCCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCc
Q 013081 89 IYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~~i~~~~~--l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 166 (450)
.|+||||++|++|.+++...+. +++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++.....
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 8999999999999999976543 89999999999999999999999999999999999999999999999999874322
Q ss_pred ccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHH
Q 013081 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGA 244 (450)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~ 244 (450)
......+++.|+|||++.+..+ +.++||||||+++|+|++ |..||...+.......+..+ ....|..+++.+
T Consensus 170 -----~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 243 (278)
T 1byg_A 170 -----TQDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAV 243 (278)
T ss_dssp -----------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHH
T ss_pred -----cccCCCccccccCHHHhCCCCC-CchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHH
Confidence 2234568899999999887766 589999999999999998 99999988777777666655 456677899999
Q ss_pred HHHHHHccccCcCCCCCHHHHHh
Q 013081 245 QNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
.++|.+||+.||.+|||+.++++
T Consensus 244 ~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 244 YEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcCChhhCCCHHHHHH
Confidence 99999999999999999999876
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=374.81 Aligned_cols=255 Identities=22% Similarity=0.304 Sum_probs=210.1
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (450)
...++|++.+.||+|+||.||+|.+ .+|+.||+|.+..... ...+.+.+|+.+++.++||||+++++++...+..|
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 111 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESS---QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI 111 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCS---SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred HHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccCh---HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 3458999999999999999999996 4689999998865432 23578899999999999999999999999999999
Q ss_pred EEEccCCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCc
Q 013081 91 MVLEYVTGGELFDKIASKG----RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (450)
Q Consensus 91 lv~E~~~gg~L~~~i~~~~----~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 166 (450)
+||||++||+|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTE 191 (321)
T ss_dssp EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9999999999999986543 589999999999999999999999999999999999999999999999999975433
Q ss_pred ccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHH-------HHHHHhCCC-----
Q 013081 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVL-------YQKIFRGDF----- 234 (450)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~-------~~~i~~~~~----- 234 (450)
..........+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+...... ......+..
T Consensus 192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (321)
T 2qkw_B 192 LDQTHLSTVVKGTLGYIDPEYFIKGRL-TEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270 (321)
T ss_dssp SSCCCCBCCCEEETTTCCHHHHHHCBC-CTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSS
T ss_pred ccccccccccCCCccccCHHHhcCCCC-CcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcC
Confidence 223333445679999999999887766 5899999999999999999999976432211 111111111
Q ss_pred -CC----CCCCCHHHHHHHHHccccCcCCCCCHHHHHhccc
Q 013081 235 -KL----PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 270 (450)
Q Consensus 235 -~~----p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~ 270 (450)
.. +...++.+.+++.+||+.||++|||+.+++++..
T Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 311 (321)
T 2qkw_B 271 PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311 (321)
T ss_dssp SSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 11 1223567899999999999999999999998743
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=358.03 Aligned_cols=250 Identities=22% Similarity=0.254 Sum_probs=206.7
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEE-EEeCCEEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEV-LASKSKIY 90 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~-~~~~~~~~ 90 (450)
.-++|++++.||+|+||.||+|++..+|+.||+|++..... ...+.+|+.+++.++|++++..+.. .......|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceE
Confidence 34799999999999999999999999999999999875432 2358899999999998876665554 46778899
Q ss_pred EEEccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEE---ccCCCeEEeecCCCCCCCc
Q 013081 91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL---DSKGNIKISDFGLSALPQH 166 (450)
Q Consensus 91 lv~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl---~~~g~lkl~DFGla~~~~~ 166 (450)
+||||+ +++|.+++.. ..++++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 999999 9999999974 5679999999999999999999999999999999999999 5889999999999985443
Q ss_pred ccCC-----CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCc---HHHHHHHHHhCCCCC--
Q 013081 167 FRDD-----GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN---LAVLYQKIFRGDFKL-- 236 (450)
Q Consensus 167 ~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~~-- 236 (450)
.... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+ ....+..+.......
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred cccccccccccccccccccccCChhhhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence 2111 12345689999999999887766 589999999999999999999998632 222333333322222
Q ss_pred ---CCCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 237 ---PKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 237 ---p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
+..+|+.+.+|+.+||+.||.+|||+.++++.
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 274 (296)
T 3uzp_A 240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL 274 (296)
T ss_dssp HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHH
Confidence 36689999999999999999999999998763
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=390.68 Aligned_cols=250 Identities=26% Similarity=0.403 Sum_probs=218.8
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
...+|++.+.||+|+||.||+|.+..++..||||++..... ..+.+.+|+.+|++++||||+++++++......|+
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 293 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence 34679999999999999999999998899999999975432 24678999999999999999999999999999999
Q ss_pred EEccCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC
Q 013081 92 VLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 169 (450)
||||++||+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 372 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT- 372 (495)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-
T ss_pred EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCc-
Confidence 99999999999999863 458999999999999999999999999999999999999999999999999998643211
Q ss_pred CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 013081 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 247 (450)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 247 (450)
........+++.|+|||++....+ +.++|||||||++|+|++ |..||.+.+.......+..+ ....|..+++.+.+|
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 451 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL 451 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred eeecCCCcCCcceeCHhHHhcCCC-CcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 111223456788999999987766 589999999999999999 99999988877777666655 456788899999999
Q ss_pred HHHccccCcCCCCCHHHHHh
Q 013081 248 LRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 248 i~~~L~~dP~~R~t~~~il~ 267 (450)
|.+||+.||.+|||+.++++
T Consensus 452 i~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 452 MRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCcChhHCcCHHHHHH
Confidence 99999999999999999976
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=359.37 Aligned_cols=256 Identities=25% Similarity=0.338 Sum_probs=212.9
Q ss_pred CcccCCeEEeeeecccCceEEEEEEECCC---CceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEE-Ee
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVL-AS 85 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-~~ 85 (450)
+....+|++.+.||+|+||.||+|.+..+ +..||+|.+.... .....+.+.+|+.++++++||||+++++++ ..
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 98 (298)
T 3f66_A 21 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 98 (298)
T ss_dssp CGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred CccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC
Confidence 34456899999999999999999997543 3468999886532 344467899999999999999999999985 55
Q ss_pred CCEEEEEEccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCC
Q 013081 86 KSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP 164 (450)
Q Consensus 86 ~~~~~lv~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~ 164 (450)
++..|+||||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 99 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 99 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred CCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccc
Confidence 6788999999999999999976 446899999999999999999999999999999999999999999999999999864
Q ss_pred CcccC--CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCC-CCCCCCC
Q 013081 165 QHFRD--DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWL 240 (450)
Q Consensus 165 ~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~ 240 (450)
..... ........||+.|+|||++.+..+ +.++||||+|+++|+|++ |.+||.+.+.......+..+. ...|..+
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 257 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTC
T ss_pred cccchhccccccCCCCCccccChHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccC
Confidence 33211 122334567889999999987766 589999999999999999 788888877766666666664 4456778
Q ss_pred CHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 241 SPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 241 s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
++.+.+++.+||++||.+|||+.++++.
T Consensus 258 ~~~l~~li~~~l~~~p~~Rps~~ell~~ 285 (298)
T 3f66_A 258 PDPLYEVMLKCWHPKAEMRPSFSELVSR 285 (298)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999999863
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=356.20 Aligned_cols=249 Identities=27% Similarity=0.414 Sum_probs=214.2
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (450)
...++|++++.||+|+||.||+|.+. ++..||+|.+...... .+.+.+|+.+++.++||||+++++++. .+..|
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 83 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIY 83 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc----HHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcE
Confidence 44578999999999999999999975 5678999998754321 467889999999999999999999986 45689
Q ss_pred EEEccCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc
Q 013081 91 MVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 91 lv~E~~~gg~L~~~i~~~~--~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 168 (450)
+||||++|++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (279)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred EEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence 9999999999999987543 79999999999999999999999999999999999999999999999999998543211
Q ss_pred CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 013081 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 246 (450)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 246 (450)
........+++.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+.......+..+ ....|..+++.+.+
T Consensus 164 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 241 (279)
T 1qpc_A 164 -YTAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ 241 (279)
T ss_dssp -EECCTTCCCCTTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred -cccccCCCCccCccChhhhccCCC-CchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHH
Confidence 111233457889999999877666 589999999999999999 99999998888777777665 45566779999999
Q ss_pred HHHHccccCcCCCCCHHHHHh
Q 013081 247 LLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 247 Li~~~L~~dP~~R~t~~~il~ 267 (450)
|+.+||+.||.+|||+.++++
T Consensus 242 li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 242 LMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhccChhhCCCHHHHHH
Confidence 999999999999999999876
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=366.22 Aligned_cols=254 Identities=26% Similarity=0.405 Sum_probs=213.4
Q ss_pred cccCCeEEeeeecccCceEEEEEE----ECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE--
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA-- 84 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-- 84 (450)
..-++|++++.||+|+||.||+|+ +..+++.||+|++.... ....+.+.+|+.++++++||||+++++++.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 96 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVSYGP 96 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence 344799999999999999999999 56789999999997542 344577999999999999999999999886
Q ss_pred eCCEEEEEEccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCC
Q 013081 85 SKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL 163 (450)
Q Consensus 85 ~~~~~~lv~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~ 163 (450)
+....|+||||++|++|.+++.. ..++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccccee
Confidence 55679999999999999999976 45699999999999999999999999999999999999999999999999999985
Q ss_pred CCcccCC-CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHH---------------HHHH
Q 013081 164 PQHFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA---------------VLYQ 227 (450)
Q Consensus 164 ~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---------------~~~~ 227 (450)
....... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... ....
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIF-SRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE 255 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCC-ChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence 4322111 12234568888999999887766 58999999999999999999999654332 2222
Q ss_pred HHHhC-CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 228 KIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 228 ~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
.+..+ ..+.|..+++.+.+||.+||++||.+|||+.+++++
T Consensus 256 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 256 LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 23332 456677899999999999999999999999999765
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=383.66 Aligned_cols=249 Identities=25% Similarity=0.421 Sum_probs=215.3
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (450)
...++|++.+.||+|+||.||+|.+. ++..||||+++.... ..+.+.+|+.+|+.++||||+++++++. ....|
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~ 258 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY 258 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred echHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence 34568999999999999999999985 467899999975432 2568899999999999999999999986 56789
Q ss_pred EEEccCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc
Q 013081 91 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 91 lv~E~~~gg~L~~~i~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 168 (450)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence 999999999999999754 368999999999999999999999999999999999999999999999999998543211
Q ss_pred CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 013081 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 246 (450)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 246 (450)
........+|+.|+|||++....+ +.++|||||||++|+|++ |..||.+.+.......+..+ ..+.|..+++.+.+
T Consensus 339 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 416 (454)
T 1qcf_A 339 -YTAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYN 416 (454)
T ss_dssp -HHTTCSSSSCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHH
T ss_pred -eeccCCCcccccccCHHHhccCCC-CcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 011123456788999999987766 589999999999999999 99999998888877777765 56677889999999
Q ss_pred HHHHccccCcCCCCCHHHHHh
Q 013081 247 LLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 247 Li~~~L~~dP~~R~t~~~il~ 267 (450)
||.+||+.||.+|||+.+++.
T Consensus 417 li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 417 IMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHccCChhHCcCHHHHHH
Confidence 999999999999999999875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=370.97 Aligned_cols=254 Identities=18% Similarity=0.197 Sum_probs=201.9
Q ss_pred cCCeEEeeeecccCceEEEEEEECC---CCceEEEEEeecccccchh--------HHHHHHHHHHHHHhCCCCCcceEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLD---SGLPFAVKILEKNRIIHLK--------ITDQIKREIATLKLLKHPNVVRLHE 81 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~--------~~~~~~~Ei~il~~l~hpnIv~l~~ 81 (450)
-++|++++.||+|+||.||+|.+.. ++..||+|++......... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 3589999999999999999999987 8889999998765321110 1134668899999999999999999
Q ss_pred EEEe----CCEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCC--CeEE
Q 013081 82 VLAS----KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG--NIKI 155 (450)
Q Consensus 82 ~~~~----~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g--~lkl 155 (450)
++.. ....|+||||+ |++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL 194 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYL 194 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEE
Confidence 9987 78899999999 999999998877999999999999999999999999999999999999999887 9999
Q ss_pred eecCCCCCCCcccC-----CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCC--cHHHHHHH
Q 013081 156 SDFGLSALPQHFRD-----DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR--NLAVLYQK 228 (450)
Q Consensus 156 ~DFGla~~~~~~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~--~~~~~~~~ 228 (450)
+|||+++....... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+. +.......
T Consensus 195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~ 273 (345)
T 2v62_A 195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVAL-SRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA 273 (345)
T ss_dssp CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH
T ss_pred EeCCCceecccccccccchhccccccCCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCccccccccHHHHHH
Confidence 99999975432211 112245689999999999887665 58999999999999999999999652 22222221
Q ss_pred HHhCCCCCC---------CCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 229 IFRGDFKLP---------KWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 229 i~~~~~~~p---------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
........| ..+++.+.+||.+||+.||.+|||+.++++.
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 274 KTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 111111222 2688999999999999999999999999874
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=365.51 Aligned_cols=254 Identities=24% Similarity=0.358 Sum_probs=206.3
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE----eCCE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA----SKSK 88 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~----~~~~ 88 (450)
-++|++++.||+|+||.||+|.+..+|+.||+|++... .....+.+.+|+.+++.++||||+++++++. ....
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 46899999999999999999999999999999998654 2344678899999999999999999999986 2347
Q ss_pred EEEEEccCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCC
Q 013081 89 IYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP 164 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~~i~~----~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~ 164 (450)
.|+||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 8999999999999999875 467999999999999999999999999999999999999999999999999998753
Q ss_pred CcccCCC-------ccccccCCCCccchhhhccCCC--CCccchhhhHHHHHHHHHhCCCCCCCCcHH--HHHHHHHh-C
Q 013081 165 QHFRDDG-------LLHTTCGSPNYVAPEVLANRGY--DGATSDIWSCGVILYVILTGYLPFDDRNLA--VLYQKIFR-G 232 (450)
Q Consensus 165 ~~~~~~~-------~~~~~~gt~~y~APE~l~~~~~--~~~~~DiwSlGvil~elltG~~Pf~~~~~~--~~~~~i~~-~ 232 (450)
....... ......||+.|+|||++..... .+.++|||||||++|+|++|..||...... .....+.. .
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 264 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL 264 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC-
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccC
Confidence 2211110 1123468999999999865432 358999999999999999999999642110 11111121 1
Q ss_pred CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhcc
Q 013081 233 DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADE 269 (450)
Q Consensus 233 ~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~ 269 (450)
..+.+..+++.+.+||.+||+.||.+|||+.+++++-
T Consensus 265 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 265 SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 3344456899999999999999999999999999873
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=360.93 Aligned_cols=255 Identities=27% Similarity=0.394 Sum_probs=207.2
Q ss_pred ccCCeEEeeeecccCceEEEEEEECC-CCc--eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLD-SGL--PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~-~~~--~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (450)
..++|++++.||+|+||.||+|.+.. +++ .||+|+++..........+.+.+|+.+++.++||||+++++++.+..
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence 34689999999999999999998643 333 69999997665444455788999999999999999999999998765
Q ss_pred EEEEEccCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcc
Q 013081 89 IYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 167 (450)
.++||||+++++|.+++... +.+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 174 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccccc
Confidence 88999999999999998764 57999999999999999999999999999999999999999999999999999754322
Q ss_pred cCC-CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCC--CCCCCCCCHH
Q 013081 168 RDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD--FKLPKWLSPG 243 (450)
Q Consensus 168 ~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~ 243 (450)
... .......+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+.......+.... .+.+..+++.
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (291)
T 1u46_A 175 DDHYVMQEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 253 (291)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHH
T ss_pred ccchhhhccCCCCceeeCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCHH
Confidence 111 12234567889999999887766 589999999999999999 999999988888887777653 4455679999
Q ss_pred HHHHHHHccccCcCCCCCHHHHHhc
Q 013081 244 AQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 244 ~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
+.++|.+||+.||.+|||+.+++++
T Consensus 254 l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 254 IYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCCcccCcCHHHHHHH
Confidence 9999999999999999999999874
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=381.32 Aligned_cols=253 Identities=26% Similarity=0.426 Sum_probs=208.2
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--E
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS--K 88 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--~ 88 (450)
..-++|++.+.||+|+||.||+|.+..+|+.||||++....... ..+.+.+|+.++++++||||+++++++.... .
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 83 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCe
Confidence 34578999999999999999999999999999999997544322 2467789999999999999999999998655 7
Q ss_pred EEEEEccCCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEE----ccCCCeEEeecCCC
Q 013081 89 IYMVLEYVTGGELFDKIASKG---RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL----DSKGNIKISDFGLS 161 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~~i~~~~---~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl----~~~g~lkl~DFGla 161 (450)
.|+||||++||+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 899999999999999997543 39999999999999999999999999999999999999 77778999999999
Q ss_pred CCCCcccCCCccccccCCCCccchhhhccC-------CCCCccchhhhHHHHHHHHHhCCCCCCC----CcHHHHHHHHH
Q 013081 162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANR-------GYDGATSDIWSCGVILYVILTGYLPFDD----RNLAVLYQKIF 230 (450)
Q Consensus 162 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-------~~~~~~~DiwSlGvil~elltG~~Pf~~----~~~~~~~~~i~ 230 (450)
..... .......+||+.|+|||++... ...+.++|||||||++|+|++|+.||.. ........++.
T Consensus 164 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 240 (396)
T 4eut_A 164 RELED---DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (396)
T ss_dssp EECCC---GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred eEccC---CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence 85432 2233456899999999998641 2235789999999999999999999964 22334455555
Q ss_pred hCCCC-------------------CC------CCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 231 RGDFK-------------------LP------KWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 231 ~~~~~-------------------~p------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
.+..+ .| ..+++.+.+||++||++||++|||+.+++++
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 44321 11 1235678899999999999999999998654
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=357.40 Aligned_cols=248 Identities=22% Similarity=0.279 Sum_probs=202.6
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEE-EEeCCEEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEV-LASKSKIYM 91 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~-~~~~~~~~l 91 (450)
-++|++++.||+|+||.||+|.+..+++.||+|++..... ...+.+|+.+++.++|++++..+.. +......|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 3789999999999999999999999999999998765432 2357889999999998877666555 477888999
Q ss_pred EEccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEE---ccCCCeEEeecCCCCCCCcc
Q 013081 92 VLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL---DSKGNIKISDFGLSALPQHF 167 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl---~~~g~lkl~DFGla~~~~~~ 167 (450)
||||+ +++|.+++.. .+++++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 99999 9999999974 4679999999999999999999999999999999999999 78999999999999864432
Q ss_pred cCC-----CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcH---HHHHHHHHhCCCCCC--
Q 013081 168 RDD-----GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL---AVLYQKIFRGDFKLP-- 237 (450)
Q Consensus 168 ~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~p-- 237 (450)
... ......+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.+.+. ......+.......|
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 4hgt_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred ccCccCCCCcccccCCCccccchHHhcCCCC-CchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhh
Confidence 211 12345689999999999987766 5899999999999999999999976432 122233332222222
Q ss_pred ---CCCCHHHHHHHHHccccCcCCCCCHHHHHh
Q 013081 238 ---KWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 238 ---~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
..+++.+.+||.+||+.||++|||+.++++
T Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 241 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 567999999999999999999999999876
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=370.85 Aligned_cols=252 Identities=17% Similarity=0.209 Sum_probs=200.2
Q ss_pred CCeEEeeeecccCceEEEEEEECCC-----CceEEEEEeecccccchhH--------HHHHHHHHHHHHhCCCCCcceEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDS-----GLPFAVKILEKNRIIHLKI--------TDQIKREIATLKLLKHPNVVRLH 80 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~-----~~~vAvK~i~~~~~~~~~~--------~~~~~~Ei~il~~l~hpnIv~l~ 80 (450)
++|++++.||+|+||.||+|.+..+ ++.||||++.......... .....+|+..++.++||||++++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~ 114 (364)
T 3op5_A 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114 (364)
T ss_dssp CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence 4899999999999999999998764 5899999987653211100 12344567778888999999999
Q ss_pred EEEEeC----CEEEEEEccCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEc--cCCCe
Q 013081 81 EVLASK----SKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD--SKGNI 153 (450)
Q Consensus 81 ~~~~~~----~~~~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~--~~g~l 153 (450)
+++... ...|+||||+ |++|.+++... +++++..++.++.||+.||+|||++||+||||||+|||++ .++.+
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~ 193 (364)
T 3op5_A 115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQV 193 (364)
T ss_dssp EEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCE
T ss_pred eeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeE
Confidence 998764 5689999999 99999999875 6799999999999999999999999999999999999999 88999
Q ss_pred EEeecCCCCCCCcccCC-----CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHH
Q 013081 154 KISDFGLSALPQHFRDD-----GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQK 228 (450)
Q Consensus 154 kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~ 228 (450)
||+|||+|+........ ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.........
T Consensus 194 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~ 272 (364)
T 3op5_A 194 YLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAP-SRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVR 272 (364)
T ss_dssp EECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHH
T ss_pred EEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCccccccCHHHHH
Confidence 99999999754332111 12234569999999999987766 6999999999999999999999986322211111
Q ss_pred HH----hCCC-------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHHh
Q 013081 229 IF----RGDF-------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 229 i~----~~~~-------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
.. .... -.+..+++++.+|+..||+.||.+|||+.++++
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 273 DSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 10 0010 012557899999999999999999999999876
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=379.47 Aligned_cols=248 Identities=25% Similarity=0.383 Sum_probs=210.8
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
..++|++.+.||+|+||.||+|.+.. +..||||+++..... .+.+.+|+.+|++++||||+++++++.+ ...|+
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~i 255 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 255 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEE
Confidence 34689999999999999999999864 467999999754321 3678999999999999999999999866 67899
Q ss_pred EEccCCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC
Q 013081 92 VLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~--~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 169 (450)
||||+++|+|.+++.. ...+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... .
T Consensus 256 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~ 334 (452)
T 1fmk_A 256 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-E 334 (452)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred EehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCC-c
Confidence 9999999999999974 356999999999999999999999999999999999999999999999999999864321 1
Q ss_pred CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 013081 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 247 (450)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 247 (450)
........+++.|+|||++....+ +.++|||||||++|+|++ |..||.+.+.......+..+ ..+.|..+++.+.+|
T Consensus 335 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 413 (452)
T 1fmk_A 335 YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL 413 (452)
T ss_dssp --------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred eecccCCcccccccCHhHHhcCCC-CccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 112233457789999999887766 589999999999999999 99999998888887777766 566788899999999
Q ss_pred HHHccccCcCCCCCHHHHHh
Q 013081 248 LRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 248 i~~~L~~dP~~R~t~~~il~ 267 (450)
|.+||+.||++|||+.++++
T Consensus 414 i~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 414 MCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHH
Confidence 99999999999999999876
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=357.63 Aligned_cols=235 Identities=29% Similarity=0.571 Sum_probs=196.7
Q ss_pred cCCcccCCeEEe-eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHH-HhCCCCCcceEEEEEEe
Q 013081 8 QEGMRLGRYELG-RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVRLHEVLAS 85 (450)
Q Consensus 8 ~~~~~~~~y~i~-~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~~~ 85 (450)
..+..+++|.+. +.||+|+||.||+|.+..+++.||+|++... ..+.+|+.++ +.++||||+++++++..
T Consensus 11 ~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~ 82 (299)
T 3m2w_A 11 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYEN 82 (299)
T ss_dssp BCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhh
Confidence 456778999998 7899999999999999999999999998642 4567888888 66689999999999977
Q ss_pred ----CCEEEEEEccCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEcc---CCCeEEe
Q 013081 86 ----KSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS---KGNIKIS 156 (450)
Q Consensus 86 ----~~~~~lv~E~~~gg~L~~~i~~~~--~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~---~g~lkl~ 156 (450)
....|+||||++||+|.+++.... ++++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~ 162 (299)
T 3m2w_A 83 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT 162 (299)
T ss_dssp EETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred hcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEe
Confidence 678999999999999999998754 6999999999999999999999999999999999999998 7889999
Q ss_pred ecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHH----HHhC
Q 013081 157 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQK----IFRG 232 (450)
Q Consensus 157 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~----i~~~ 232 (450)
|||++.... +..+ +.++||||+||++|+|++|..||.+.+....... +...
T Consensus 163 Dfg~a~~~~------------------------~~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 217 (299)
T 3m2w_A 163 DFGFAKETT------------------------GEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 217 (299)
T ss_dssp CCTTCEECT------------------------TCGG-GGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTT
T ss_pred ccccccccc------------------------cccC-CchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhc
Confidence 999986321 1223 5789999999999999999999987654433211 1122
Q ss_pred CCCCC----CCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCC
Q 013081 233 DFKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 233 ~~~~p----~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
....| ..+++++.+||.+||+.||.+|||+.++++||||.+..
T Consensus 218 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 218 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 23333 45899999999999999999999999999999998654
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=367.04 Aligned_cols=245 Identities=16% Similarity=0.215 Sum_probs=203.7
Q ss_pred CCeEEeeeecccCceEEEEEEECC--------CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcce-------
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLD--------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVR------- 78 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~--------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~------- 78 (450)
++|++++.||+|+||.||+|.+.. .++.||+|++... ..+.+|+.++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 799999999999999999999987 4889999998754 35778999999999999987
Q ss_pred --------EEEEEEe-CCEEEEEEccCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEE
Q 013081 79 --------LHEVLAS-KSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL 147 (450)
Q Consensus 79 --------l~~~~~~-~~~~~lv~E~~~gg~L~~~i~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl 147 (450)
+++++.. ....|+||||+ |++|.+++... +.+++.+++.++.||+.||.|||++||+||||||+|||+
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV 192 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence 6777766 78899999999 99999999875 789999999999999999999999999999999999999
Q ss_pred ccCC--CeEEeecCCCCCCCcccCC-----CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCC
Q 013081 148 DSKG--NIKISDFGLSALPQHFRDD-----GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR 220 (450)
Q Consensus 148 ~~~g--~lkl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~ 220 (450)
+.++ .+||+|||++......... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGP-SRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCcccC
Confidence 9998 8999999999865432211 12234589999999999887666 58999999999999999999999875
Q ss_pred c--HHHHHHH---HHhCCCCCCC------CCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 221 N--LAVLYQK---IFRGDFKLPK------WLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 221 ~--~~~~~~~---i~~~~~~~p~------~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
. ....... +......++. .+++.+.+||.+||+.||.+|||+.++++.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 330 (352)
T 2jii_A 272 LPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN 330 (352)
T ss_dssp TTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred CcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence 3 3322222 2222222222 368999999999999999999999999764
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=370.99 Aligned_cols=244 Identities=15% Similarity=0.187 Sum_probs=201.0
Q ss_pred cCCeEEeeeecccCceEEEEE-----EECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC---CCCcceEEEEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK---HPNVVRLHEVLA 84 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a-----~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~ 84 (450)
-++|++.+.||+|+||.||+| .+..+++.||+|++.... ...+.+|+.++++++ |+||+++++++.
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 467999999999999999999 467789999999996542 356778888888887 999999999999
Q ss_pred eCCEEEEEEccCCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEcc----------
Q 013081 85 SKSKIYMVLEYVTGGELFDKIAS-----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS---------- 149 (450)
Q Consensus 85 ~~~~~~lv~E~~~gg~L~~~i~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~---------- 149 (450)
..+..|+||||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-----
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccccc
Confidence 99999999999999999999973 467999999999999999999999999999999999999998
Q ss_pred -CCCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHH
Q 013081 150 -KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQK 228 (450)
Q Consensus 150 -~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~ 228 (450)
++.+||+|||+|+..............+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.......
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~---- 292 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPW-NYQIDYFGVAATVYCMLFGTYMKVKNEGGE---- 292 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCB-STHHHHHHHHHHHHHHHHSSCCCEEEETTE----
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCC-CccccHHHHHHHHHHHHhCCCccccCCCCc----
Confidence 89999999999975433333344566789999999999988776 589999999999999999999996533210
Q ss_pred HHhCCCCC-CCCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 229 IFRGDFKL-PKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 229 i~~~~~~~-p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
......+ ..+.++.+.+++.+||+.+|.+|++..+.+.+
T Consensus 293 -~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 293 -CKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp -EEECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred -eeechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 0001111 12357789999999999999999765554444
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=362.26 Aligned_cols=252 Identities=30% Similarity=0.436 Sum_probs=189.5
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEE--------
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLA-------- 84 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~-------- 84 (450)
.+|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++++. ||||+++++++.
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 38999999999999999999999999999999986542 334577899999999996 999999999983
Q ss_pred eCCEEEEEEccCCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHhhhhhcC--eeeccCCCCcEEEccCCCeEEeecC
Q 013081 85 SKSKIYMVLEYVTGGELFDKIAS---KGRLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLDSKGNIKISDFG 159 (450)
Q Consensus 85 ~~~~~~lv~E~~~gg~L~~~i~~---~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlKp~NILl~~~g~lkl~DFG 159 (450)
....+|++|||+. |+|.+++.. .+++++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCc
Confidence 3456899999995 699888864 567999999999999999999999999 9999999999999999999999999
Q ss_pred CCCCCCcccCC----------CccccccCCCCccchhhhc--cCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHH
Q 013081 160 LSALPQHFRDD----------GLLHTTCGSPNYVAPEVLA--NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQ 227 (450)
Q Consensus 160 la~~~~~~~~~----------~~~~~~~gt~~y~APE~l~--~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~ 227 (450)
++......... ......+||+.|+|||++. .....+.++|||||||++|+|++|..||.+........
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~ 263 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN 263 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhc
Confidence 99865432111 0112457999999999983 22333689999999999999999999998755443322
Q ss_pred HHHhCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhcccc
Q 013081 228 KIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 228 ~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~ 271 (450)
.. ...+.+...++.+.+||.+||+.||.+|||+.+++++-+-
T Consensus 264 ~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 305 (337)
T 3ll6_A 264 GK--YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQE 305 (337)
T ss_dssp ----CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred Cc--ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 21 1233445678899999999999999999999999998653
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=361.00 Aligned_cols=252 Identities=28% Similarity=0.380 Sum_probs=208.0
Q ss_pred ccCCe-EEeeeecccCceEEEEEE----ECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-
Q 013081 12 RLGRY-ELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS- 85 (450)
Q Consensus 12 ~~~~y-~i~~~LG~G~~g~Vy~a~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~- 85 (450)
.-++| ++++.||+|+||.||++. +..+++.||||++.... .......+.+|+.++++++||||+++++++.+
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA 105 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence 34566 999999999999998875 34578999999997653 33446789999999999999999999999987
Q ss_pred -CCEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCC
Q 013081 86 -KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP 164 (450)
Q Consensus 86 -~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~ 164 (450)
...+|+||||+++++|.+++.. .++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 106 GAASLQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp TTTEEEEEECCCTTCBHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred CCceEEEEEecccCCcHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccc
Confidence 4689999999999999999876 45999999999999999999999999999999999999999999999999999854
Q ss_pred CcccCC-CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHH---------------HHHHH
Q 013081 165 QHFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA---------------VLYQK 228 (450)
Q Consensus 165 ~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---------------~~~~~ 228 (450)
...... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... .....
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKF-YYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 263 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH
Confidence 331110 12334568889999999987776 48999999999999999999999764322 11222
Q ss_pred HHhC-CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHh
Q 013081 229 IFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 229 i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
+..+ ..+.|..+++.+.+||.+||+.||.+|||+.++++
T Consensus 264 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 264 LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 2222 45667789999999999999999999999999985
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=356.94 Aligned_cols=243 Identities=28% Similarity=0.455 Sum_probs=201.0
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (450)
...++|++.+.||+|+||.||+|.+ .++.||+|.+... ...+.+.+|+.++++++||||+++++++.+ ..|
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 75 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVC 75 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcE
Confidence 4567999999999999999999998 4788999998643 235678999999999999999999998763 478
Q ss_pred EEEccCCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHhhhhh---cCeeeccCCCCcEEEccCCC-eEEeecCCCCC
Q 013081 91 MVLEYVTGGELFDKIASKG---RLQEAEGRKLFQQLIDGVSYCHN---KGVFHRDLKLENILLDSKGN-IKISDFGLSAL 163 (450)
Q Consensus 91 lv~E~~~gg~L~~~i~~~~---~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlKp~NILl~~~g~-lkl~DFGla~~ 163 (450)
+||||++|++|.+++.... .+++..+..++.|++.||+|||+ +||+||||||+|||++.++. +||+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 9999999999999998655 37899999999999999999999 89999999999999999887 79999999974
Q ss_pred CCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCc--HHHHHHHHHhC-CCCCCCCC
Q 013081 164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN--LAVLYQKIFRG-DFKLPKWL 240 (450)
Q Consensus 164 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~--~~~~~~~i~~~-~~~~p~~~ 240 (450)
... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.... ..........+ ..+.+..+
T Consensus 156 ~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (307)
T 2eva_A 156 IQT-----HMTNNKGSAAWMAPEVFEGSNY-SEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNL 229 (307)
T ss_dssp --------------CCTTSSCHHHHTCCCC-CTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTC
T ss_pred ccc-----ccccCCCCCceEChhhhCCCCC-CcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCccccc
Confidence 322 2334579999999999987666 589999999999999999999998543 22333333333 45566779
Q ss_pred CHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 241 SPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 241 s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
++.+.+|+.+||+.||.+|||+.+++++
T Consensus 230 ~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 230 PKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 9999999999999999999999999874
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=353.40 Aligned_cols=250 Identities=24% Similarity=0.349 Sum_probs=198.4
Q ss_pred CcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHh--CCCCCcceEEEEEEe--
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL--LKHPNVVRLHEVLAS-- 85 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~-- 85 (450)
....++|++++.||+|+||.||+|.+ +|+.||||++.... ...+.+|.+++.. ++||||+++++++..
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~ 75 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSR 75 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence 34567999999999999999999998 78999999986532 3455667777766 789999999998643
Q ss_pred --CCEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhh--------hcCeeeccCCCCcEEEccCCCeEE
Q 013081 86 --KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH--------NKGVFHRDLKLENILLDSKGNIKI 155 (450)
Q Consensus 86 --~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH--------~~givHrDlKp~NILl~~~g~lkl 155 (450)
....|+||||+++|+|.+++.. ..+++..++.++.||+.||+||| ++||+||||||+|||++.++.+||
T Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 76 HSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp TTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred CCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence 3568999999999999999954 67999999999999999999999 999999999999999999999999
Q ss_pred eecCCCCCCCcccCC--CccccccCCCCccchhhhccCCCC-----CccchhhhHHHHHHHHHhC----------CCCCC
Q 013081 156 SDFGLSALPQHFRDD--GLLHTTCGSPNYVAPEVLANRGYD-----GATSDIWSCGVILYVILTG----------YLPFD 218 (450)
Q Consensus 156 ~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~-----~~~~DiwSlGvil~elltG----------~~Pf~ 218 (450)
+|||+|......... ......+||+.|+|||++.+.... +.++||||+||++|+|++| ..||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 999999743221110 112345899999999998765322 3689999999999999999 88986
Q ss_pred CCc----HHHHHHHHHhC---CCCCCCC-----CCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 219 DRN----LAVLYQKIFRG---DFKLPKW-----LSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 219 ~~~----~~~~~~~i~~~---~~~~p~~-----~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
... ......+.... ....|.. .++.+.+|+.+||+.||.+|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~ 296 (301)
T 3q4u_A 235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT 296 (301)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred ccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 532 12222333222 2222221 44679999999999999999999999863
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=374.55 Aligned_cols=250 Identities=31% Similarity=0.418 Sum_probs=195.4
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv 92 (450)
+.|.+.+.||+|+||+||.+. ..+|+.||||.+..+. .+.+.+|+.+++++ +||||+++++++.+....|+|
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv 87 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA 87 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred heeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence 456778999999999998764 4679999999986532 35678999999876 899999999999999999999
Q ss_pred EccCCCCChHHHHHhcCCCC-------HHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccC-------------CC
Q 013081 93 LEYVTGGELFDKIASKGRLQ-------EAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-------------GN 152 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~~~~l~-------~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~-------------g~ 152 (450)
||||. |+|.+++....... +..++.++.||+.||+|||++||+||||||+|||++.+ +.
T Consensus 88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceE
Confidence 99995 59999998754332 33457899999999999999999999999999999764 47
Q ss_pred eEEeecCCCCCCCcccCC--CccccccCCCCccchhhhcc------CCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHH
Q 013081 153 IKISDFGLSALPQHFRDD--GLLHTTCGSPNYVAPEVLAN------RGYDGATSDIWSCGVILYVILT-GYLPFDDRNLA 223 (450)
Q Consensus 153 lkl~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~l~~------~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~ 223 (450)
+||+|||++......... ......+||+.|+|||++.+ ....+.++|||||||++|+|++ |..||.+....
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 999999999865332111 12345689999999999865 2344689999999999999999 99999876543
Q ss_pred HHHHHHHhCCCCCCC-------CCCHHHHHHHHHccccCcCCCCCHHHHHhcccccc
Q 013081 224 VLYQKIFRGDFKLPK-------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 224 ~~~~~i~~~~~~~p~-------~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
. ..+..+....+. .+++++.+||.+||+.||.+|||+.++++||||..
T Consensus 247 ~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 247 E--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp H--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred H--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 3 334444433332 14578999999999999999999999999999964
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=360.05 Aligned_cols=250 Identities=27% Similarity=0.360 Sum_probs=204.8
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccc-cchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI-IHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
.|..++.||+|+||.||+|.+ +++.||+|.+..... ......+.+.+|+.+++.++||||+++++++.+....|+||
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 109 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVY 109 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEE
Confidence 355569999999999999986 688999999875432 23345678999999999999999999999999999999999
Q ss_pred ccCCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCC
Q 013081 94 EYVTGGELFDKIAS---KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (450)
Q Consensus 94 E~~~gg~L~~~i~~---~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 170 (450)
||++|++|.+++.. ..++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 189 (307)
T 2nru_A 110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189 (307)
T ss_dssp ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSC
T ss_pred EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccc
Confidence 99999999999874 346999999999999999999999999999999999999999999999999999754432222
Q ss_pred CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHH----HHHHHHHhCCC-----------C
Q 013081 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA----VLYQKIFRGDF-----------K 235 (450)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~----~~~~~i~~~~~-----------~ 235 (450)
......+||+.|+|||++.+ .+ +.++||||||+++|+|++|..||.+.... .....+..... .
T Consensus 190 ~~~~~~~g~~~y~aPE~~~~-~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (307)
T 2nru_A 190 VMTSRIVGTTAYMAPEALRG-EI-TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMND 267 (307)
T ss_dssp EECSSCCSCGGGCCHHHHTT-EE-CTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSC
T ss_pred ccccccCCCcCcCChHHhcC-CC-CccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccc
Confidence 23345679999999999765 34 58999999999999999999999875432 22222222111 1
Q ss_pred CCCCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 236 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 236 ~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
.+...++.+.+++.+||+.||.+|||+.+++++
T Consensus 268 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 268 ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 122245678999999999999999999999875
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=370.83 Aligned_cols=252 Identities=25% Similarity=0.346 Sum_probs=203.6
Q ss_pred CCeEEeeeecccCceEEEEEEECCC---CceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE-eCCEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA-SKSKI 89 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~~~~ 89 (450)
.+|++.+.||+|+||.||+|.+..+ +..||+|.++... .....+.+.+|+.++++++||||+++++++. .++..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS--CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 3588999999999999999987543 3468999886432 3344678999999999999999999999864 45688
Q ss_pred EEEEccCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc
Q 013081 90 YMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 168 (450)
|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 9999999999999999764 458999999999999999999999999999999999999999999999999998543211
Q ss_pred CC--CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHH
Q 013081 169 DD--GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGA 244 (450)
Q Consensus 169 ~~--~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~ 244 (450)
.. .......+|+.|+|||++.+..+ +.++|||||||++|+|++ |.+||.+.+.......+..+ ....|..+++.+
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l 325 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL 325 (373)
T ss_dssp -----------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHH
T ss_pred cccccccCCCCCcccccChHHhcCCCC-CcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 11 11233467889999999987766 589999999999999999 89999887766666666655 345577799999
Q ss_pred HHHHHHccccCcCCCCCHHHHHhc
Q 013081 245 QNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
.+++.+||+.||.+|||+.+++++
T Consensus 326 ~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 326 YEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999875
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=364.25 Aligned_cols=255 Identities=23% Similarity=0.328 Sum_probs=206.0
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (450)
...++|++.+.||+|+||.||+|.+ .+|+.||+|++........ ...+.+|+.+++.++||||+++++++.+....|
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGG--ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 103 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----C--CCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCE
T ss_pred HHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchH--HHHHHHHHHHHHhccCCCccceEEEEecCCceE
Confidence 3457999999999999999999985 4689999999976543221 236889999999999999999999999999999
Q ss_pred EEEccCCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHhhhhhc---CeeeccCCCCcEEEccCCCeEEeecCCCCC
Q 013081 91 MVLEYVTGGELFDKIASKG----RLQEAEGRKLFQQLIDGVSYCHNK---GVFHRDLKLENILLDSKGNIKISDFGLSAL 163 (450)
Q Consensus 91 lv~E~~~gg~L~~~i~~~~----~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlKp~NILl~~~g~lkl~DFGla~~ 163 (450)
+||||+.||+|.+++.... ++++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||+|||++..
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 183 (326)
T 3uim_A 104 LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 183 (326)
T ss_dssp EEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccc
Confidence 9999999999999997643 499999999999999999999999 999999999999999999999999999985
Q ss_pred CCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCc----HHHHHHHHHhCCC-----
Q 013081 164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN----LAVLYQKIFRGDF----- 234 (450)
Q Consensus 164 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~----~~~~~~~i~~~~~----- 234 (450)
.... ........+||+.|+|||++.+..+ +.++||||+||++|+|++|..||+... .............
T Consensus 184 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (326)
T 3uim_A 184 MDYK-DTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 261 (326)
T ss_dssp CCSS-SSCEECCCCSCGGGCCHHHHHHSEE-CHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCS
T ss_pred cCcc-cccccccccCCcCccCHHHhccCCC-CccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhh
Confidence 4321 2223445579999999999887766 589999999999999999999996211 0011111111110
Q ss_pred ----------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhccc
Q 013081 235 ----------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 270 (450)
Q Consensus 235 ----------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~ 270 (450)
..+...++.+.+|+.+||+.||.+|||+.++++|-+
T Consensus 262 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 262 EALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp TTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred hhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 011113467899999999999999999999999865
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=376.29 Aligned_cols=255 Identities=25% Similarity=0.348 Sum_probs=198.0
Q ss_pred cccC--CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 013081 11 MRLG--RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKS 87 (450)
Q Consensus 11 ~~~~--~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 87 (450)
..++ +|++.+.||+|+||+||.. ...+|+.||||.+..... ..+.+|+.+++.+ +||||+++++++.+..
T Consensus 19 ~~i~~~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 91 (432)
T 3p23_A 19 VIVGKISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQ 91 (432)
T ss_dssp EEETTEEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETT
T ss_pred EEEccEEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence 3444 4999999999999997643 346889999999965433 2356899999999 7999999999999999
Q ss_pred EEEEEEccCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEcc---CC--CeEEeecCCC
Q 013081 88 KIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS---KG--NIKISDFGLS 161 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~~-~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~---~g--~lkl~DFGla 161 (450)
..|+|||||. |+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++ .+||+|||+|
T Consensus 92 ~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 92 FQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp EEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred EEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 9999999996 59999997654 4666778899999999999999999999999999999953 33 5789999999
Q ss_pred CCCCcccC-CCccccccCCCCccchhhhcc--CCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCC-
Q 013081 162 ALPQHFRD-DGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL- 236 (450)
Q Consensus 162 ~~~~~~~~-~~~~~~~~gt~~y~APE~l~~--~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~- 236 (450)
........ .......+||+.|+|||++.+ ....+.++||||+||++|+|++ |..||...................
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~ 250 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCL 250 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTS
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCcccc
Confidence 86432211 123345689999999999874 2233578999999999999999 999997665444332222222211
Q ss_pred --CCCCCHHHHHHHHHccccCcCCCCCHHHHHhcccccc
Q 013081 237 --PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 237 --p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
+...++.+.+||.+||+.||.+|||+.++++||||..
T Consensus 251 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 251 HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 1224567899999999999999999999999999964
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=358.76 Aligned_cols=258 Identities=25% Similarity=0.389 Sum_probs=210.4
Q ss_pred cccCCcccCCeEEeeeecccCceEEEEEE----ECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEE
Q 013081 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81 (450)
Q Consensus 6 ~~~~~~~~~~y~i~~~LG~G~~g~Vy~a~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~ 81 (450)
..+.....++|++++.||+|+||.||+|. +..+|+.||+|++... .....+.+.+|+.++++++||||+++++
T Consensus 33 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 109 (326)
T 2w1i_A 33 RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKG 109 (326)
T ss_dssp ----CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cCccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEE
Confidence 34455666789999999999999999998 4568999999998754 2334578999999999999999999999
Q ss_pred EEEeCC--EEEEEEccCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeec
Q 013081 82 VLASKS--KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDF 158 (450)
Q Consensus 82 ~~~~~~--~~~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DF 158 (450)
++...+ ..|+||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 110 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Df 189 (326)
T 2w1i_A 110 VCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDF 189 (326)
T ss_dssp EECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCC
T ss_pred EEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecC
Confidence 986543 789999999999999999875 46999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCcccCC-CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHH--------------
Q 013081 159 GLSALPQHFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-------------- 223 (450)
Q Consensus 159 Gla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-------------- 223 (450)
|++......... .......+++.|+|||++.+..+ +.++|||||||++|+|++|..||......
T Consensus 190 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 268 (326)
T 2w1i_A 190 GLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 268 (326)
T ss_dssp TTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHH
T ss_pred cchhhccccccccccccCCCCceeEECchhhcCCCC-CchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhh
Confidence 999864332111 11223457788999999887766 58999999999999999999998653211
Q ss_pred --HHHHHHHh-CCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHh
Q 013081 224 --VLYQKIFR-GDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 224 --~~~~~i~~-~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
.....+.. ...+.|..+++.+.+||.+||+.||.+|||+.++++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 269 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11122222 245667789999999999999999999999999976
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=389.13 Aligned_cols=245 Identities=24% Similarity=0.345 Sum_probs=209.4
Q ss_pred eeecccCceEEEEEEE--CCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEccCC
Q 013081 20 RTLGEGNFGKVKFAQD--LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT 97 (450)
Q Consensus 20 ~~LG~G~~g~Vy~a~~--~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 97 (450)
+.||+|+||.||+|.+ ..+++.||||+++.... .....+.+.+|+.+|++++||||+++++++.. ...|+||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG-CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence 4899999999999954 45678999999975432 33446789999999999999999999999965 45889999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC-CCccccc
Q 013081 98 GGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-DGLLHTT 176 (450)
Q Consensus 98 gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~-~~~~~~~ 176 (450)
||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....... .......
T Consensus 453 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 532 (635)
T 4fl3_A 453 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 532 (635)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----------
T ss_pred CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCC
Confidence 999999999888999999999999999999999999999999999999999999999999999975432211 1122334
Q ss_pred cCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHcccc
Q 013081 177 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEP 254 (450)
Q Consensus 177 ~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~ 254 (450)
.+|+.|+|||++....+ +.++|||||||++|+|++ |..||.+.+.......+..+ ....|..+++++.+||.+||+.
T Consensus 533 ~~t~~y~APE~~~~~~~-~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~ 611 (635)
T 4fl3_A 533 KWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 611 (635)
T ss_dssp --CGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCceeeeChhhhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 57789999999987776 589999999999999998 99999999888888888776 4667888999999999999999
Q ss_pred CcCCCCCHHHHHh
Q 013081 255 NPVKRITIAGIKA 267 (450)
Q Consensus 255 dP~~R~t~~~il~ 267 (450)
||++|||+.++++
T Consensus 612 dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 612 DVENRPGFAAVEL 624 (635)
T ss_dssp STTTSCCHHHHHH
T ss_pred CHhHCcCHHHHHH
Confidence 9999999999875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=385.96 Aligned_cols=255 Identities=25% Similarity=0.365 Sum_probs=211.9
Q ss_pred CCeEEee-eecccCceEEEEEEEC--CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013081 14 GRYELGR-TLGEGNFGKVKFAQDL--DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (450)
Q Consensus 14 ~~y~i~~-~LG~G~~g~Vy~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (450)
++|.+.+ .||+|+||.||+|.+. .++..||||+++.... ....+.+.+|+.+|+.++||||+++++++.. ...|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~ 411 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 411 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS--STTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeE
Confidence 4566666 8999999999999875 3567899999976432 2235789999999999999999999999976 5689
Q ss_pred EEEccCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC
Q 013081 91 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (450)
Q Consensus 91 lv~E~~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 169 (450)
+||||+.||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 412 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~ 491 (613)
T 2ozo_A 412 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491 (613)
T ss_dssp EEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred EEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence 999999999999999754 4699999999999999999999999999999999999999999999999999986432111
Q ss_pred C-CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 013081 170 D-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 246 (450)
Q Consensus 170 ~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 246 (450)
. .......+|+.|+|||++....+ +.++|||||||++|+|++ |..||.+.+..+....+..+ ....|..+++.+.+
T Consensus 492 ~~~~~~~~~~~~~y~APE~~~~~~~-~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~ 570 (613)
T 2ozo_A 492 YYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA 570 (613)
T ss_dssp ----------CCTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred eeeeccCCCCccceeCHhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 1 11223346789999999987776 589999999999999998 99999998888888888776 46778889999999
Q ss_pred HHHHccccCcCCCCCHHHHH---hccccc
Q 013081 247 LLRKILEPNPVKRITIAGIK---ADEWFE 272 (450)
Q Consensus 247 Li~~~L~~dP~~R~t~~~il---~h~~~~ 272 (450)
||.+||+.||.+|||+.+++ ++.|+.
T Consensus 571 li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 571 LMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp HHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 99999999999999999974 444443
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=356.39 Aligned_cols=259 Identities=22% Similarity=0.339 Sum_probs=194.7
Q ss_pred ccCCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHH--HHHHHHhCCCCCcceEEEEEE
Q 013081 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR--EIATLKLLKHPNVVRLHEVLA 84 (450)
Q Consensus 7 ~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~--Ei~il~~l~hpnIv~l~~~~~ 84 (450)
......+++|++++.||+|+||.||+|.+ +++.||||++.... ...+.. |+..++.++||||+++++.+.
T Consensus 6 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~ 77 (336)
T 3g2f_A 6 SEPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDE 77 (336)
T ss_dssp ---CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred cCCCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheeccc
Confidence 34567889999999999999999999987 78999999997543 223333 444455689999999998654
Q ss_pred e-----CCEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhc---------CeeeccCCCCcEEEccC
Q 013081 85 S-----KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK---------GVFHRDLKLENILLDSK 150 (450)
Q Consensus 85 ~-----~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~---------givHrDlKp~NILl~~~ 150 (450)
. ...+|+||||++||+|.+++.. ...++..+..++.||+.||.|||++ ||+||||||+|||++.+
T Consensus 78 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~ 156 (336)
T 3g2f_A 78 RVTADGRMEYLLVMEYYPNGSLXKYLSL-HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND 156 (336)
T ss_dssp EECTTSCEEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTT
T ss_pred ccccCCCceEEEEEecCCCCcHHHHHhh-cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCC
Confidence 2 3367899999999999999976 4469999999999999999999999 99999999999999999
Q ss_pred CCeEEeecCCCCCCCccc------CCCccccccCCCCccchhhhccC------CCCCccchhhhHHHHHHHHHhCCCCCC
Q 013081 151 GNIKISDFGLSALPQHFR------DDGLLHTTCGSPNYVAPEVLANR------GYDGATSDIWSCGVILYVILTGYLPFD 218 (450)
Q Consensus 151 g~lkl~DFGla~~~~~~~------~~~~~~~~~gt~~y~APE~l~~~------~~~~~~~DiwSlGvil~elltG~~Pf~ 218 (450)
+.+||+|||++....... ........+||+.|+|||++.+. ...+.++|||||||++|+|++|..||.
T Consensus 157 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 236 (336)
T 3g2f_A 157 GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236 (336)
T ss_dssp SCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred CcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence 999999999997543211 11223355799999999998752 222468999999999999999977653
Q ss_pred C-Cc-----------------HHHHHHHHHhC--CCCCCCC------CCHHHHHHHHHccccCcCCCCCHHHH------H
Q 013081 219 D-RN-----------------LAVLYQKIFRG--DFKLPKW------LSPGAQNLLRKILEPNPVKRITIAGI------K 266 (450)
Q Consensus 219 ~-~~-----------------~~~~~~~i~~~--~~~~p~~------~s~~~~~Li~~~L~~dP~~R~t~~~i------l 266 (450)
. .. ........... ...+|.. +++.+.+||.+||+.||++|||+.++ +
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l 316 (336)
T 3g2f_A 237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316 (336)
T ss_dssp TTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred CccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence 2 11 11111111111 2333333 33479999999999999999999999 4
Q ss_pred hccccccC
Q 013081 267 ADEWFEQD 274 (450)
Q Consensus 267 ~h~~~~~~ 274 (450)
.++|-++.
T Consensus 317 l~~~~~~~ 324 (336)
T 3g2f_A 317 MMIWERNK 324 (336)
T ss_dssp HHCCCC--
T ss_pred HHHHHhcc
Confidence 46666544
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=356.60 Aligned_cols=248 Identities=23% Similarity=0.368 Sum_probs=196.9
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC--CCCCcceEEEEEEeC---
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL--KHPNVVRLHEVLASK--- 86 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l--~hpnIv~l~~~~~~~--- 86 (450)
..++|++++.||+|+||.||+|.+ +|+.||||++.... .....+|..++..+ +||||+++++++...
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred cccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 347899999999999999999998 48999999986432 23445566666554 899999999999877
Q ss_pred -CEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhc--------CeeeccCCCCcEEEccCCCeEEee
Q 013081 87 -SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK--------GVFHRDLKLENILLDSKGNIKISD 157 (450)
Q Consensus 87 -~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~--------givHrDlKp~NILl~~~g~lkl~D 157 (450)
...|+||||++||+|.+++.. .++++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D 185 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred CCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence 789999999999999999965 5799999999999999999999998 999999999999999999999999
Q ss_pred cCCCCCCCcccCC--CccccccCCCCccchhhhccCCCCCc-----cchhhhHHHHHHHHHhC----------CCCCCCC
Q 013081 158 FGLSALPQHFRDD--GLLHTTCGSPNYVAPEVLANRGYDGA-----TSDIWSCGVILYVILTG----------YLPFDDR 220 (450)
Q Consensus 158 FGla~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~-----~~DiwSlGvil~elltG----------~~Pf~~~ 220 (450)
||++......... ......+||+.|+|||++.+..+... ++|||||||++|+|++| ..||...
T Consensus 186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp CTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 9999754322111 11235689999999999877655422 38999999999999999 7777543
Q ss_pred c-----HHHHHHHHHhC--CCCCCC-----CCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 221 N-----LAVLYQKIFRG--DFKLPK-----WLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 221 ~-----~~~~~~~i~~~--~~~~p~-----~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
. ........... ...+|. .+++.+.+||.+||+.||.+|||+.+++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 266 VPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 1 22222222222 223332 245679999999999999999999999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=381.54 Aligned_cols=250 Identities=25% Similarity=0.374 Sum_probs=215.4
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (450)
...++|++.+.||+|+||.||+|.+.. +..||||+++..... .+.+.+|+.+|++++||||+++++++.. ...|
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~ 337 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 337 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence 345689999999999999999999864 467999999764321 3678999999999999999999999866 6789
Q ss_pred EEEccCCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc
Q 013081 91 MVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 91 lv~E~~~gg~L~~~i~~--~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 168 (450)
+||||+.+|+|.+++.. ...+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 99999999999999974 3569999999999999999999999999999999999999999999999999998643211
Q ss_pred CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 013081 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 246 (450)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 246 (450)
........+++.|+|||++....+ +.++|||||||++|+|++ |..||.+....+....+..+ ..+.|..+++.+.+
T Consensus 418 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 495 (535)
T 2h8h_A 418 -YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 495 (535)
T ss_dssp -HHTTCSTTSCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred -eecccCCcCcccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 011223456788999999887766 589999999999999999 99999998888887777766 46677889999999
Q ss_pred HHHHccccCcCCCCCHHHHHhc
Q 013081 247 LLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 247 Li~~~L~~dP~~R~t~~~il~h 268 (450)
||.+||+.||++|||+.++++.
T Consensus 496 li~~cl~~dP~~RPt~~~l~~~ 517 (535)
T 2h8h_A 496 LMCQCWRKEPEERPTFEYLQAF 517 (535)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHHH
Confidence 9999999999999999999763
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=358.21 Aligned_cols=256 Identities=21% Similarity=0.360 Sum_probs=211.9
Q ss_pred cCCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013081 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (450)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (450)
......++|++++.||+|+||.||+|.+.. .||+|++....... ...+.+.+|+.++++++||||+++++++.+..
T Consensus 27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNE-DQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCC-CCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCH-HHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 344567899999999999999999999854 49999987543222 22356778999999999999999999999999
Q ss_pred EEEEEEccCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCc
Q 013081 88 KIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~~-~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 166 (450)
..|++|||++|++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||++.....
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 9999999999999999997654 699999999999999999999999999999999999998 78999999999875432
Q ss_pred cc---CCCccccccCCCCccchhhhcc--------CCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCC
Q 013081 167 FR---DDGLLHTTCGSPNYVAPEVLAN--------RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK 235 (450)
Q Consensus 167 ~~---~~~~~~~~~gt~~y~APE~l~~--------~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~ 235 (450)
.. .........||+.|+|||++.. ....+.++|||||||++|+|++|..||...+.......+..+..+
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 261 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP 261 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCC
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCC
Confidence 11 1223345579999999999864 223468999999999999999999999998888777777666433
Q ss_pred C--CCCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 236 L--PKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 236 ~--p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
. +..+++.+.+|+.+||+.||.+|||+.++++.
T Consensus 262 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 262 NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 2 23478999999999999999999999999874
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=384.53 Aligned_cols=253 Identities=26% Similarity=0.432 Sum_probs=215.0
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCC---CceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (450)
...++|++++.||+|+||.||+|.+..+ +..||+|.+.... .....+.+.+|+.++++++||||+++++++. ++
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 463 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 463 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence 3457899999999999999999998654 4579999886432 3344578999999999999999999999985 46
Q ss_pred EEEEEEccCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCc
Q 013081 88 KIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~~-~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 166 (450)
..|+||||++||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence 6899999999999999998644 699999999999999999999999999999999999999999999999999986432
Q ss_pred ccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHH
Q 013081 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGA 244 (450)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~ 244 (450)
.. ........+|+.|+|||++.+..+ +.++||||+||++|+|++ |..||.+.+.......+..+ ..+.|..+++.+
T Consensus 544 ~~-~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l 621 (656)
T 2j0j_A 544 ST-YYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 621 (656)
T ss_dssp -----------CCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHH
T ss_pred Cc-ceeccCCCCCcceeCHHHhcCCCC-CchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHH
Confidence 11 112233467789999999987766 589999999999999997 99999998888888777766 466788899999
Q ss_pred HHHHHHccccCcCCCCCHHHHHhc
Q 013081 245 QNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
.+||.+||+.||.+|||+.++++.
T Consensus 622 ~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 622 YSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHHH
Confidence 999999999999999999999864
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=393.26 Aligned_cols=260 Identities=28% Similarity=0.400 Sum_probs=207.5
Q ss_pred cCCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--
Q 013081 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-- 85 (450)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-- 85 (450)
..+..+++|++++.||+|+||.||+|.+..+|+.||||++.... .....+.+.+|+.++++++||||+++++++..
T Consensus 8 ~pg~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~ 85 (676)
T 3qa8_A 8 LPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQ 85 (676)
T ss_dssp ---------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTC
T ss_pred CCCCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccc
Confidence 34566799999999999999999999999999999999986542 34446789999999999999999999999755
Q ss_pred ----CCEEEEEEccCCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCC---eEE
Q 013081 86 ----KSKIYMVLEYVTGGELFDKIASKG---RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN---IKI 155 (450)
Q Consensus 86 ----~~~~~lv~E~~~gg~L~~~i~~~~---~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~---lkl 155 (450)
.+..|+||||++||+|.+++.... ++++..++.++.||+.||+|||++||+||||||+|||++.++. +||
T Consensus 86 ~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL 165 (676)
T 3qa8_A 86 KLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKI 165 (676)
T ss_dssp CCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEE
T ss_pred cccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEE
Confidence 677899999999999999998644 6999999999999999999999999999999999999998775 899
Q ss_pred eecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHH-------
Q 013081 156 SDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQK------- 228 (450)
Q Consensus 156 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~------- 228 (450)
+|||++..... .......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...........
T Consensus 166 ~DFG~a~~~~~---~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~ 241 (676)
T 3qa8_A 166 IDLGYAKELDQ---GELCTEFVGTLQYLAPELLEQKKY-TVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSN 241 (676)
T ss_dssp CSCCCCCBTTS---CCCCCCCCSCCTTCSSCSSCCSCC-STTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC----
T ss_pred ccccccccccc---ccccccccCCcccCChHHhccCCC-CchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccc
Confidence 99999986432 233455789999999999887766 5899999999999999999999976533221100
Q ss_pred -------HHhCCC------CCC----CCCCHHHHHHHHHccccCcCCCCCHHHHHhcccccc
Q 013081 229 -------IFRGDF------KLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 229 -------i~~~~~------~~p----~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
...+.. +.| ..+++.+.+||.+||++||.+|||+.++++||||+.
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 001111 112 225678999999999999999999999999999963
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=351.66 Aligned_cols=246 Identities=25% Similarity=0.359 Sum_probs=202.1
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHh--CCCCCcceEEEEEEeCC----
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL--LKHPNVVRLHEVLASKS---- 87 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~~~---- 87 (450)
++|++.+.||+|+||.||+|.+ +|+.||||++.... ...+.+|+++++. ++||||+++++++....
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 6899999999999999999998 58999999986432 3567789999988 78999999999998776
Q ss_pred EEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhh--------hcCeeeccCCCCcEEEccCCCeEEeecC
Q 013081 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH--------NKGVFHRDLKLENILLDSKGNIKISDFG 159 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH--------~~givHrDlKp~NILl~~~g~lkl~DFG 159 (450)
..|+||||+++|+|.+++.+ .++++..++.++.||+.||.||| ++||+||||||+|||++.++++||+|||
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 192 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 192 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCT
T ss_pred eeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECC
Confidence 89999999999999999976 57999999999999999999999 8999999999999999999999999999
Q ss_pred CCCCCCcccCC--CccccccCCCCccchhhhccCCCC-----CccchhhhHHHHHHHHHhC----------CCCCCCC--
Q 013081 160 LSALPQHFRDD--GLLHTTCGSPNYVAPEVLANRGYD-----GATSDIWSCGVILYVILTG----------YLPFDDR-- 220 (450)
Q Consensus 160 la~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~-----~~~~DiwSlGvil~elltG----------~~Pf~~~-- 220 (450)
++......... ......+||+.|+|||++.+.... +.++|||||||++|+|++| ..||...
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~ 272 (342)
T 1b6c_B 193 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 272 (342)
T ss_dssp TCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCc
Confidence 99754321110 023455799999999998765322 2679999999999999999 8899764
Q ss_pred ---cHHHHHHHHHhCC--CCCCCC-----CCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 221 ---NLAVLYQKIFRGD--FKLPKW-----LSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 221 ---~~~~~~~~i~~~~--~~~p~~-----~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
........+.... ..+|.. .++.+.+|+.+||+.||.+|||+.+++++
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred CcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 2334444443332 223321 23578999999999999999999999886
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=365.62 Aligned_cols=249 Identities=20% Similarity=0.275 Sum_probs=207.4
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCC-CCcceEEEEEEeCCEEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH-PNVVRLHEVLASKSKIY 90 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~ 90 (450)
..++|++++.||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.++| ++|..+..++......|
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~ 79 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV 79 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence 457999999999999999999999999999999998754332 347789999999986 56666777778889999
Q ss_pred EEEccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEE---ccCCCeEEeecCCCCCCCc
Q 013081 91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL---DSKGNIKISDFGLSALPQH 166 (450)
Q Consensus 91 lv~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl---~~~g~lkl~DFGla~~~~~ 166 (450)
+||||+ |++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 80 lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 999999 9999999975 5679999999999999999999999999999999999999 6889999999999986443
Q ss_pred ccCC-----CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCc---HHHHHHHHHhCCC----
Q 013081 167 FRDD-----GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN---LAVLYQKIFRGDF---- 234 (450)
Q Consensus 167 ~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~---- 234 (450)
.... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.. ....+.++.....
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CccccccccccccccCCCccccCHHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 2111 12236789999999999987776 589999999999999999999998743 3333433333221
Q ss_pred -CCCCCCCHHHHHHHHHccccCcCCCCCHHHHHh
Q 013081 235 -KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 235 -~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
.++..+++++.+||.+||+.||.+||++.++++
T Consensus 238 ~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 223568999999999999999999999998754
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=371.08 Aligned_cols=250 Identities=21% Similarity=0.218 Sum_probs=195.8
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCC-CCc---------c-----
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH-PNV---------V----- 77 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnI---------v----- 77 (450)
...|.+++.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.++| +|. +
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 3458899999999999999999999999999999875444343345789999999999987 322 1
Q ss_pred -------eEEEEEEe-----CCEEEEEEccCCCCChHHHHHh-------cCCCCHHHHHHHHHHHHHHHhhhhhcCeeec
Q 013081 78 -------RLHEVLAS-----KSKIYMVLEYVTGGELFDKIAS-------KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138 (450)
Q Consensus 78 -------~l~~~~~~-----~~~~~lv~E~~~gg~L~~~i~~-------~~~l~~~~~~~i~~ql~~aL~~LH~~givHr 138 (450)
.+..++.. ...++++|+++ +++|.+++.. ..++++..+..++.||+.||+|||++||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr 235 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 235 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 11111111 22467777776 6799988841 2347788899999999999999999999999
Q ss_pred cCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhc---------cCCCCCccchhhhHHHHHHH
Q 013081 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA---------NRGYDGATSDIWSCGVILYV 209 (450)
Q Consensus 139 DlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~---------~~~~~~~~~DiwSlGvil~e 209 (450)
||||+|||++.++.+||+|||+++.... .....+| +.|+|||++. .....+.++|||||||++|+
T Consensus 236 DiKp~NILl~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e 309 (413)
T 3dzo_A 236 YLRPVDIVLDQRGGVFLTGFEHLVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309 (413)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred CcccceEEEecCCeEEEEeccceeecCC-----ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence 9999999999999999999999875332 2456688 9999999983 22223579999999999999
Q ss_pred HHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhcccccc
Q 013081 210 ILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 210 lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
|++|+.||.+.+.......+.. ....+|+.+.+||.+||++||.+|||+.++++||||+.
T Consensus 310 lltg~~Pf~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 310 IWCADLPNTDDAALGGSEWIFR----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp HHHSSCCCCTTGGGSCSGGGGS----SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHHCCCCCCCcchhhhHHHHHh----hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 9999999988765443333322 22357899999999999999999999999999999975
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=366.87 Aligned_cols=244 Identities=22% Similarity=0.302 Sum_probs=197.8
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeeccccc-----chhHHHHHHHHHHHHHhCC---------CCCcc
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-----HLKITDQIKREIATLKLLK---------HPNVV 77 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~---------hpnIv 77 (450)
..++|++++.||+|+||.||+|++ +|+.||||++...... .....+.+.+|+.+++.++ ||||+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 357899999999999999999998 7899999999876432 2223477889999999886 88888
Q ss_pred eEEEEEE------------------------------eCCEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 013081 78 RLHEVLA------------------------------SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127 (450)
Q Consensus 78 ~l~~~~~------------------------------~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL 127 (450)
++.+++. +....|+||||+++|++.+.+.+ +.+++.+++.++.||+.||
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHH
Confidence 8887753 26789999999999988777754 6789999999999999999
Q ss_pred hhhh-hcCeeeccCCCCcEEEccCC--------------------CeEEeecCCCCCCCcccCCCccccccCCCCccchh
Q 013081 128 SYCH-NKGVFHRDLKLENILLDSKG--------------------NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186 (450)
Q Consensus 128 ~~LH-~~givHrDlKp~NILl~~~g--------------------~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE 186 (450)
+||| ++||+||||||+|||++.++ .+||+|||+|+.... ...+||+.|+|||
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aPE 247 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDED 247 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCSG
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccChh
Confidence 9999 99999999999999999987 899999999985321 2458999999999
Q ss_pred hhccCCCCCccchhhhHHHH-HHHHHhCCCCCCCCcH-HHHHHHHHhC-CCC--C----CCCCCHHHHHHHHHccccCcC
Q 013081 187 VLANRGYDGATSDIWSCGVI-LYVILTGYLPFDDRNL-AVLYQKIFRG-DFK--L----PKWLSPGAQNLLRKILEPNPV 257 (450)
Q Consensus 187 ~l~~~~~~~~~~DiwSlGvi-l~elltG~~Pf~~~~~-~~~~~~i~~~-~~~--~----p~~~s~~~~~Li~~~L~~dP~ 257 (450)
++.+.. +.++||||+|++ .+++++|..||.+... ......+... ... . +..+++++.+||++||++|
T Consensus 248 ~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-- 323 (336)
T 2vuw_A 248 LFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-- 323 (336)
T ss_dssp GGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS--
T ss_pred hhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC--
Confidence 988655 689999998777 7889999999965321 1223333321 111 1 1236889999999999987
Q ss_pred CCCCHHHHH-hccccc
Q 013081 258 KRITIAGIK-ADEWFE 272 (450)
Q Consensus 258 ~R~t~~~il-~h~~~~ 272 (450)
|+.|+| +||||+
T Consensus 324 ---sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 324 ---SATDLLCQHSLFK 336 (336)
T ss_dssp ---SHHHHHHHCGGGC
T ss_pred ---CHHHHHhcCCCcC
Confidence 999999 999995
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=340.99 Aligned_cols=224 Identities=15% Similarity=0.172 Sum_probs=191.0
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
.-|+|++.+.||+|+||.||+|.+..+|+.||||++.............+.+|+.+++.++||||+++++++...+..|+
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 33789999999999999999999999999999999987766556667889999999999999999999999999999999
Q ss_pred EEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCC
Q 013081 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 171 (450)
||||++|++|.+++.. + ..+.++..++.||+.||+|||++||+||||||+|||++.+|.+||+++|
T Consensus 109 v~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~------------ 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------------ 174 (286)
T ss_dssp EEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC------------
T ss_pred EEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc------------
Confidence 9999999999999854 3 4667889999999999999999999999999999999999999998544
Q ss_pred ccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHH---HHHHhCCCC----CCCCCCHHH
Q 013081 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY---QKIFRGDFK----LPKWLSPGA 244 (450)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~---~~i~~~~~~----~p~~~s~~~ 244 (450)
|++| .+.++|||||||++|+|++|+.||.+.+..... .+...+... .+..+++.+
T Consensus 175 ----------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (286)
T 3uqc_A 175 ----------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQI 236 (286)
T ss_dssp ----------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHH
T ss_pred ----------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHH
Confidence 2222 368999999999999999999999876542211 011122221 235689999
Q ss_pred HHHHHHccccCcCCCCCHHHHHhc
Q 013081 245 QNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
.+||.+||++||.+| |+.++++.
T Consensus 237 ~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 237 SAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp HHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred HHHHHHHcccCCccC-CHHHHHHH
Confidence 999999999999999 99999874
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=376.67 Aligned_cols=237 Identities=25% Similarity=0.412 Sum_probs=201.1
Q ss_pred ccCCeEEeeeecccCceEEEEEEECC-CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE--
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLD-SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK-- 88 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~-- 88 (450)
..++|++++.||+|+||.||+|.+.. +|+.||||++.... .......+.+|+.++++++||||+++++++...+.
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 155 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG 155 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence 34899999999999999999999976 78999999986532 33445778999999999999999999999987655
Q ss_pred ---EEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCC
Q 013081 89 ---IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (450)
Q Consensus 89 ---~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 165 (450)
.|+||||++|++|.+.+.. ++++.+++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||++....
T Consensus 156 ~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~ 232 (681)
T 2pzi_A 156 DPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN 232 (681)
T ss_dssp CEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred CceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence 7999999999999987754 79999999999999999999999999999999999999875 89999999998543
Q ss_pred cccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCC-----CC
Q 013081 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK-----WL 240 (450)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~-----~~ 240 (450)
. ....+||+.|+|||++.+. + +.++|||||||++|+|++|..||.+.... ..+. ..
T Consensus 233 ~------~~~~~gt~~y~aPE~~~~~-~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~-----------~~~~~~~~~~~ 293 (681)
T 2pzi_A 233 S------FGYLYGTPGFQAPEIVRTG-P-TVATDIYTVGRTLAALTLDLPTRNGRYVD-----------GLPEDDPVLKT 293 (681)
T ss_dssp C------CSCCCCCTTTSCTTHHHHC-S-CHHHHHHHHHHHHHHHHSCCCEETTEECS-----------SCCTTCHHHHH
T ss_pred c------CCccCCCccccCHHHHcCC-C-CCceehhhhHHHHHHHHhCCCCCcccccc-----------ccccccccccc
Confidence 2 2456899999999998764 3 68999999999999999999998763211 1111 14
Q ss_pred CHHHHHHHHHccccCcCCCCCHHHHHhccccc
Q 013081 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFE 272 (450)
Q Consensus 241 s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~ 272 (450)
++.+.+||.+||++||.+||+..+.+.|+|+.
T Consensus 294 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 294 YDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 67899999999999999999999999999974
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=323.40 Aligned_cols=233 Identities=14% Similarity=0.116 Sum_probs=162.2
Q ss_pred eeecccCceEEEEEEECCCCceEEEEEeecccccc-------hhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEE
Q 013081 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH-------LKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 20 ~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~-------~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~l 91 (450)
..++.|+.|.++.++....|+.||+|++.+..... ....+.+.+|+.+|+++ .|+||++++++++++...||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 34678888888888877789999999998653221 22346799999999999 69999999999999999999
Q ss_pred EEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCC
Q 013081 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 171 (450)
||||++|++|.++|.+.+++++. +|+.||++||+|||++||+||||||+|||++.+|++||+|||+|+.... ...
T Consensus 320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~--~~~ 394 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ--DCS 394 (569)
T ss_dssp EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----C
T ss_pred EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCC--CCc
Confidence 99999999999999998888765 5899999999999999999999999999999999999999999986543 233
Q ss_pred ccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q 013081 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 251 (450)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~ 251 (450)
...+.+||+.|+|||++.+. + ..++|+||+|++++.|.+|..||. ..... .|.. ...+..+...+
T Consensus 395 ~~~t~vGTp~YmAPE~l~g~-~-~~~~d~~s~g~~~~~l~~~~~~~~--------~~l~~----~~~~-~~~~~~l~~~l 459 (569)
T 4azs_A 395 WPTNLVQSFFVFVNELFAEN-K-SWNGFWRSAPVHPFNLPQPWSNWL--------YAVWQ----EPVE-RWNFVLLLALF 459 (569)
T ss_dssp CSHHHHHHHHHHHHHHC-------------------CCCCTTHHHHH--------HHHHT----SCGG-GCSHHHHHHHH
T ss_pred cccCceechhhccHHHhCCC-C-CCcccccccccchhhhccccchhH--------HHhhc----CCCC-CCcHHHHHHHH
Confidence 45678999999999998754 3 467999999999998877654431 11111 1111 11245666677
Q ss_pred cccCcCCCCCHHHHHhccccc
Q 013081 252 LEPNPVKRITIAGIKADEWFE 272 (450)
Q Consensus 252 L~~dP~~R~t~~~il~h~~~~ 272 (450)
+..+|..|+.......++|..
T Consensus 460 ~~~~~~~~~~~~~~~~~~~~~ 480 (569)
T 4azs_A 460 EKKAKLPSAEQQRGATEQWII 480 (569)
T ss_dssp HTGGGSCCGGGSSCCHHHHHH
T ss_pred hCCCCCCCCChhhhccchhHH
Confidence 777777777766666666653
|
| >2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.1e-31 Score=225.65 Aligned_cols=124 Identities=31% Similarity=0.572 Sum_probs=116.1
Q ss_pred CCCcchhhhhhhccccccCCCCcccccc-cccccceecccCHHHHHHHHHHHHHhcCcEEEEeCCeEEEEeecCCCCcCC
Q 013081 309 SPPLINAFQLIGMSSCLDLSGFFEKEDV-SERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLG 387 (450)
Q Consensus 309 ~~~~~~~~~~i~~s~~~~~~~~~~~~~~-~~~~~rf~s~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (450)
.|..+|||++|++|+|+|||+||+.... .++++||+|..+|++|+++||++|+.+||+|++++++|++++..+|+| |
T Consensus 3 ~p~~lNAFdiIs~S~g~dLSgLFe~~~~~~~r~tRF~s~~~a~~ii~klEe~a~~lg~~V~kk~~~vkl~~~~~grk--G 80 (143)
T 2ehb_D 3 GPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFKSHTRNFKTRLEGLSSIKA--G 80 (143)
T ss_dssp CCEECCHHHHHTTCTTTCGGGGGCSCCCSCCCCCEEEECSCHHHHHHHHHHHHHHTTEEEEESSSEEEEEECCSSGG--G
T ss_pred CccccCHHHHHHHCcCCCchhhhccccccccccceEEeCCCHHHHHHHHHHHHHhcCcEEEEcCcEEEEEEecCCCc--c
Confidence 4667999999999999999999976532 467899999999999999999999999999999989999999999999 9
Q ss_pred ceEEEEEEEEEcCCeEEEEEEeccCCcceeeeccchhhHHHHHHHHhhhcCCCCcc
Q 013081 388 SLSVAAEVFEISPSLYVVELRKSYGDPTVYRQIKTSIVFVQLCNKLSSDLGLPPSQ 443 (450)
Q Consensus 388 ~l~~~~~i~~~~~~~~~v~~~~~~Gd~le~~~~~~~~~~~~~~~~~~~~l~~~~~~ 443 (450)
.|++.||||||+|+++||||+|++||++||++ ||++|+|+|++++.+
T Consensus 81 ~l~v~~EVfevapsl~vVEvrks~GD~lEy~k---------~~~~Lr~~L~diV~~ 127 (143)
T 2ehb_D 81 QLAVVIEIYEVAPSLFMVDVRKAAGETLEYHK---------FYKKLCSKLENIIWR 127 (143)
T ss_dssp CCEEEEEEEEEETTEEEEEEEEEESCHHHHHH---------HHHHHHHHSTTTBCC
T ss_pred eEEEEEEEEEecCCEEEEEEEecCCChHHHHH---------HHHHHHHHhhcceec
Confidence 99999999999999999999999999999999 999999999998854
|
| >2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-30 Score=217.41 Aligned_cols=120 Identities=28% Similarity=0.376 Sum_probs=105.0
Q ss_pred CCCcchhhhhhhccccccCCCCcccccccccccceecccCHHHHHHHHHHHHHhcCcEEEEeCCeEEEEeecCCCCcCCc
Q 013081 309 SPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLGS 388 (450)
Q Consensus 309 ~~~~~~~~~~i~~s~~~~~~~~~~~~~~~~~~~rf~s~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (450)
.|..+|||++|++|+|+|||+||+.+...++++||+|..+|++|+++||++|+++||+|++++++ ++..+|+| |.
T Consensus 2 ~~~~lNAFdiIs~S~g~dLSgLFe~~~~~~r~tRF~S~~~a~~ii~klEe~a~~lg~~v~kk~~~---~~~~~g~k--G~ 76 (123)
T 2zfd_B 2 GARRMNAFDIISGSPGFNLSGLFGDARKYDRVERFVSAWTAERVVERLEEIVSAENLTVAKKETW---GMKIEGQK--GN 76 (123)
T ss_dssp --CCCCHHHHHHTSTTSSSGGGGGGGCSSCCCEEEEESSCHHHHHHHHHHHHHHTTCEEEEEETT---EEEEEEGG--GT
T ss_pred CcccccHHHHHHHCcCCCchHhcCcccccccceEEEeCCCHHHHHHHHHHHHHHCCCEEEEcCCc---cccccCCC--cc
Confidence 35679999999999999999999764323678999999999999999999999999999988775 66667888 99
Q ss_pred eEEEEEEEEEcCCeEEEEEEeccCCcceeeeccchhhHHHHHH-HHhhhcCCCCc
Q 013081 389 LSVAAEVFEISPSLYVVELRKSYGDPTVYRQIKTSIVFVQLCN-KLSSDLGLPPS 442 (450)
Q Consensus 389 l~~~~~i~~~~~~~~~v~~~~~~Gd~le~~~~~~~~~~~~~~~-~~~~~l~~~~~ 442 (450)
|++.||||||+|+++||||+|++||++||++ ||. +|+|+|++++.
T Consensus 77 l~v~~EVfev~p~l~vVEvrks~GD~lEy~~---------~~~~~L~~~L~diV~ 122 (123)
T 2zfd_B 77 FAMVVEINQLTDELVMIEVRKRQRAAASGRD---------LWTDTLRPFFVELVH 122 (123)
T ss_dssp EEEEEEEEECSSSCEEEEEEEEESCC---CC---------HHHHTHHHHHHHTBC
T ss_pred EEEEEEEEEecCCEEEEEEEecCCChHHHHH---------HHHHHHHHHHhhhhc
Confidence 9999999999999999999999999999999 997 89999998873
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.8e-30 Score=269.73 Aligned_cols=189 Identities=18% Similarity=0.208 Sum_probs=145.0
Q ss_pred EEeeeecccCceEEEEEEECCCCceEEEEEeecccccchh-----HHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-----ITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 17 ~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~-----~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
...+.||+|+||.||+|. ..++.+|+|........... ..+++.+|+.++++++||||+++..+.......|+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 346789999999999994 46788999987553332222 24568999999999999999955545456677799
Q ss_pred EEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCC
Q 013081 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 171 (450)
||||++|++|.+++.. +..++.|+++||.|||++||+||||||+|||++. ++||+|||+|+.........
T Consensus 417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~ 486 (540)
T 3en9_A 417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA 486 (540)
T ss_dssp EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence 9999999999999875 6789999999999999999999999999999998 99999999998653321111
Q ss_pred -----ccccccCCCCccchhhhcc--CCCCCccchhhhHHHHHHHHHhCCCCCC
Q 013081 172 -----LLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFD 218 (450)
Q Consensus 172 -----~~~~~~gt~~y~APE~l~~--~~~~~~~~DiwSlGvil~elltG~~Pf~ 218 (450)
...+.+||+.|+|||++.. .+| +..+|+||..+-..+...++-+|.
T Consensus 487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y-~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 487 VDLIVFKKAVLSTHHEKFDEIWERFLEGY-KSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHCGGGHHHHHHHHHHHH-HHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cchhhhhhhhcCCCCcCCHHHHHHHHHHH-HHHHhHHHHHHHHHHHHHhccccC
Confidence 1246789999999999876 555 367899999988888877776653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.1e-27 Score=228.04 Aligned_cols=144 Identities=20% Similarity=0.261 Sum_probs=116.4
Q ss_pred EeeeecccCceEEEEEEECCCCceEEEEEeecccccch---------------hHHHHHHHHHHHHHhCCCCCcceEEEE
Q 013081 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---------------KITDQIKREIATLKLLKHPNVVRLHEV 82 (450)
Q Consensus 18 i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~---------------~~~~~~~~Ei~il~~l~hpnIv~l~~~ 82 (450)
+++.||+|+||.||+|.+ .+|+.||+|+++....... .....+.+|+.++++++| +++.++
T Consensus 94 ~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~~~ 169 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVPKV 169 (282)
T ss_dssp EEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSCCE
T ss_pred ecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcCeE
Confidence 339999999999999999 8899999999965332110 134678999999999994 555555
Q ss_pred EEeCCEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCC
Q 013081 83 LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA 162 (450)
Q Consensus 83 ~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~ 162 (450)
+.. +..|+||||++|++|.+ +. ...+..++.|++.||.|||++||+||||||+|||++ +|.+||+|||+|+
T Consensus 170 ~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~ 240 (282)
T 1zar_A 170 YAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 240 (282)
T ss_dssp EEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCE
T ss_pred Eec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCe
Confidence 443 45699999999999987 42 234567999999999999999999999999999999 9999999999986
Q ss_pred CCCcccCCCccccccCCCCccchhhhc
Q 013081 163 LPQHFRDDGLLHTTCGSPNYVAPEVLA 189 (450)
Q Consensus 163 ~~~~~~~~~~~~~~~gt~~y~APE~l~ 189 (450)
.+..|.|||++.
T Consensus 241 ---------------~~~~~~a~e~l~ 252 (282)
T 1zar_A 241 ---------------EVGEEGWREILE 252 (282)
T ss_dssp ---------------ETTSTTHHHHHH
T ss_pred ---------------ECCCCCHHHHHH
Confidence 245689999875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=7.8e-23 Score=195.28 Aligned_cols=139 Identities=21% Similarity=0.280 Sum_probs=110.0
Q ss_pred eEEeeeecccCceEEEEEEECCCCce--EEEEEeecccccc---------------------hhHHHHHHHHHHHHHhCC
Q 013081 16 YELGRTLGEGNFGKVKFAQDLDSGLP--FAVKILEKNRIIH---------------------LKITDQIKREIATLKLLK 72 (450)
Q Consensus 16 y~i~~~LG~G~~g~Vy~a~~~~~~~~--vAvK~i~~~~~~~---------------------~~~~~~~~~Ei~il~~l~ 72 (450)
|++.+.||+|+||.||+|.+..+|+. ||||+++...... ......+.+|+.+++++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78999999999999999998778989 9999975432110 011246889999999998
Q ss_pred CCCc--ceEEEEEEeCCEEEEEEccCCC-C----ChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhh-hcCeeeccCCCCc
Q 013081 73 HPNV--VRLHEVLASKSKIYMVLEYVTG-G----ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH-NKGVFHRDLKLEN 144 (450)
Q Consensus 73 hpnI--v~l~~~~~~~~~~~lv~E~~~g-g----~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH-~~givHrDlKp~N 144 (450)
|+|+ ..+++. ...|+||||+.+ | +|.+.... .++..+..++.||+.||.||| ++||+||||||+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N 201 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN 201 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence 8864 444443 246899999942 3 66665432 345678899999999999999 9999999999999
Q ss_pred EEEccCCCeEEeecCCCCC
Q 013081 145 ILLDSKGNIKISDFGLSAL 163 (450)
Q Consensus 145 ILl~~~g~lkl~DFGla~~ 163 (450)
||++. .++|+|||+|..
T Consensus 202 ILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 202 IMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp EEESS--SEEECCCTTCEE
T ss_pred EEEcC--cEEEEECccccc
Confidence 99988 999999999974
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.80 E-value=9e-20 Score=182.56 Aligned_cols=137 Identities=20% Similarity=0.212 Sum_probs=103.5
Q ss_pred eEEeeeecccCceEEEEEEECCCCceEEEEEeeccccc---------------chhH----HHHHHHHHHHHHhCCCCCc
Q 013081 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---------------HLKI----TDQIKREIATLKLLKHPNV 76 (450)
Q Consensus 16 y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~---------------~~~~----~~~~~~Ei~il~~l~hpnI 76 (450)
|++++.||+|+||.||+|.+. +|+.||||+++..... .... .-...+|...|.++.++++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 899999999999999999974 6999999998643211 0000 1123467888888865554
Q ss_pred c--eEEEEEEeCCEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCC--
Q 013081 77 V--RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN-- 152 (450)
Q Consensus 77 v--~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~-- 152 (450)
. ..++. . ..++||||++|++|.+.. ..+.+..++.||+.+|.+||++||+||||||.|||++++|.
T Consensus 176 ~vp~p~~~--~--~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 176 PVPEPIAQ--S--RHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp SCCCEEEE--E--TTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred CCCeeeec--c--CceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence 3 23332 2 237999999998886542 22356788999999999999999999999999999998873
Q ss_pred --------eEEeecCCCCC
Q 013081 153 --------IKISDFGLSAL 163 (450)
Q Consensus 153 --------lkl~DFGla~~ 163 (450)
+.|+||+.+..
T Consensus 246 d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CTTSEEEEEEECCCTTCEE
T ss_pred cccccccceEEEEeCCccc
Confidence 89999998763
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=1.1e-13 Score=131.25 Aligned_cols=142 Identities=15% Similarity=0.108 Sum_probs=114.9
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKI 89 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 89 (450)
..++.|++...+|.|+.+.||++.. .++.+++|+........ ...+.+|+.+++.+. +..+.++++++.+.+..
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~ 85 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHhccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCce
Confidence 3567899999999999999999975 36889999986532111 245889999999985 67788999999999999
Q ss_pred EEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhh-------------------------------------
Q 013081 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN------------------------------------- 132 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~------------------------------------- 132 (450)
|+||||++|.+|.+.+. +......++.+++.+|..||+
T Consensus 86 ~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 86 NLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 99999999999876521 223345788999999999998
Q ss_pred ----------------------cCeeeccCCCCcEEEccCCCeEEeecCCCC
Q 013081 133 ----------------------KGVFHRDLKLENILLDSKGNIKISDFGLSA 162 (450)
Q Consensus 133 ----------------------~givHrDlKp~NILl~~~g~lkl~DFGla~ 162 (450)
..++|+|++|.|||+++++.+.|+||+.+.
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999876556799999775
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.35 E-value=1.8e-12 Score=122.14 Aligned_cols=137 Identities=19% Similarity=0.187 Sum_probs=102.9
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--cceEEEEEEeCCE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN--VVRLHEVLASKSK 88 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~~~~~~~ 88 (450)
..+..|.+....+.|..+.||++.. .+|..+++|+..... ...+.+|+.+++.+.+.+ +.+++.+....+.
T Consensus 17 ~~~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~ 89 (264)
T 1nd4_A 17 ERLFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGR 89 (264)
T ss_dssp TTTTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSC
T ss_pred HhcCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCC
Confidence 3456788765555677799999964 567889999975431 245778999999986544 5668898888888
Q ss_pred EEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcC----------------------------------
Q 013081 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG---------------------------------- 134 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---------------------------------- 134 (450)
.|+||||++|.+|. . ...+ ...++.+++..|..||+..
T Consensus 90 ~~~v~e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (264)
T 1nd4_A 90 DWLLLGEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE 161 (264)
T ss_dssp EEEEEECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred CEEEEEecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence 99999999998883 1 1122 2356677777777777643
Q ss_pred ------------------------eeeccCCCCcEEEccCCCeEEeecCCCC
Q 013081 135 ------------------------VFHRDLKLENILLDSKGNIKISDFGLSA 162 (450)
Q Consensus 135 ------------------------ivHrDlKp~NILl~~~g~lkl~DFGla~ 162 (450)
++|+|++|.|||+++++.+.|+|||.+.
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999877666799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.25 E-value=1.5e-11 Score=122.22 Aligned_cols=142 Identities=17% Similarity=0.342 Sum_probs=107.9
Q ss_pred eEEeeeecccCceEEEEEEECCCCceEEEEEee--cccccchhHHHHHHHHHHHHHhCC--CCCcceEEEEEEeC---CE
Q 013081 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILE--KNRIIHLKITDQIKREIATLKLLK--HPNVVRLHEVLASK---SK 88 (450)
Q Consensus 16 y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~--~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~---~~ 88 (450)
..-++.|+.|.++.||++.. .+..+++|... ..... .....+.+|+.+++.|. +..+.+++.++.+. +.
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~ 115 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGR 115 (359)
T ss_dssp CCEEEECCC-CCSCEEEEEC--SSCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSS
T ss_pred CceEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCC
Confidence 34477899999999999875 34678899765 32211 11357889999999997 45678899888766 45
Q ss_pred EEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhh------------------------------------
Q 013081 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN------------------------------------ 132 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~------------------------------------ 132 (450)
.|+||||++|..+.+.. ...+++.+...++.+++.+|..||+
T Consensus 116 ~~~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 116 AFYIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp CEEEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred eEEEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 89999999998875421 2347888889999999999999997
Q ss_pred ----------------------cCeeeccCCCCcEEEccCCC--eEEeecCCCCC
Q 013081 133 ----------------------KGVFHRDLKLENILLDSKGN--IKISDFGLSAL 163 (450)
Q Consensus 133 ----------------------~givHrDlKp~NILl~~~g~--lkl~DFGla~~ 163 (450)
.+++|||++|.|||++.++. +.|.||+.+..
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36999999999999998764 68999998874
|
| >3ose_A Serine/threonine-protein kinase MARK1; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.70A {Homo sapiens} SCOP: d.129.6.1 PDB: 1ul7_A | Back alignment and structure |
|---|
Probab=99.19 E-value=8e-11 Score=97.91 Aligned_cols=86 Identities=17% Similarity=0.290 Sum_probs=77.3
Q ss_pred ceecccCHHHHHHHHHHHHHhcCcEEEEeC-CeEEEEeecCCCCcCCceEEEEEEEEEc-CCeEEEEEEeccCCcceeee
Q 013081 342 RFTSNHSAKDLLERIEDIVTEMGFRVQKKN-GKLKATQEHKPQKSLGSLSVAAEVFEIS-PSLYVVELRKSYGDPTVYRQ 419 (450)
Q Consensus 342 rf~s~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~i~~~~-~~~~~v~~~~~~Gd~le~~~ 419 (450)
..+|..+|++|+..|++++..+|+.+++++ |.+++...+...+ +.+.+.+||+++. +++++|+|+|.+||.+.|++
T Consensus 32 ~tTS~~~P~eIm~eI~rvL~~~gi~~~~~g~y~l~C~~~~~~~~--~~v~fElEVckl~~~~l~gV~~kRi~Gd~~~yk~ 109 (120)
T 3ose_A 32 KTTSSMDPNDMMREIRKVLDANNCDYEQKERFLLFCVHGDARQD--SLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKN 109 (120)
T ss_dssp CCEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEESCTTTT--CCEEEEEEEEEEGGGTEEEEEEEEEESCHHHHHH
T ss_pred cCcccCCHHHHHHHHHHHHHHCCCEEEEcCCEEEEEEecCCCCC--ccEEEEEEEEEecCCCceeEEEEecCCCHHHHHH
Confidence 457899999999999999999999998875 8889977654444 7899999999996 89999999999999999999
Q ss_pred ccchhhHHHHHHHHhhhcC
Q 013081 420 IKTSIVFVQLCNKLSSDLG 438 (450)
Q Consensus 420 ~~~~~~~~~~~~~~~~~l~ 438 (450)
+|++|..+|+
T Consensus 110 ---------lc~~il~~L~ 119 (120)
T 3ose_A 110 ---------IASKIANELK 119 (120)
T ss_dssp ---------HHHHHHHHCC
T ss_pred ---------HHHHHHHHhc
Confidence 9999998886
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.18 E-value=2.4e-11 Score=118.02 Aligned_cols=182 Identities=18% Similarity=0.187 Sum_probs=123.0
Q ss_pred eeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCC--cceEEEEEEeCC---EEEEE
Q 013081 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPN--VVRLHEVLASKS---KIYMV 92 (450)
Q Consensus 19 ~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpn--Iv~l~~~~~~~~---~~~lv 92 (450)
++.++.|....||++. ..+++|+.... .....+.+|..+++.+. +.. +.+++....... ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 4568999999999763 46899986432 23577899999998884 333 345555443333 35899
Q ss_pred EccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhh----------------------------------------
Q 013081 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN---------------------------------------- 132 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~---------------------------------------- 132 (450)
|++++|.+|.+... ..++..+...++.|++..|..||+
T Consensus 95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 99999988875433 347788888888899888888885
Q ss_pred ------------------cCeeeccCCCCcEEEcc--CCCeEEeecCCCCCCCcccCCCccccccCCCCc---cchhhhc
Q 013081 133 ------------------KGVFHRDLKLENILLDS--KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY---VAPEVLA 189 (450)
Q Consensus 133 ------------------~givHrDlKp~NILl~~--~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y---~APE~l~ 189 (450)
..++|+|++|.||++++ .+.+.|+||+.+..-+...+ ......+ ..|+...
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D------l~~~~~~~~~~~~~~~~ 246 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND------FISLMEDDEEYGMEFVS 246 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH------HHTTCCTTTSCCHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH------HHHHHhhccccCHHHHH
Confidence 13799999999999998 45578999998864221100 0011111 2233211
Q ss_pred ----cCCCCC---------ccchhhhHHHHHHHHHhCCCCCC
Q 013081 190 ----NRGYDG---------ATSDIWSCGVILYVILTGYLPFD 218 (450)
Q Consensus 190 ----~~~~~~---------~~~DiwSlGvil~elltG~~Pf~ 218 (450)
..+... .-.+.|++|.++|.+.+|..+|-
T Consensus 247 ~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 247 KILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 111100 12589999999999999988763
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.75 E-value=1.4e-07 Score=91.55 Aligned_cols=133 Identities=21% Similarity=0.224 Sum_probs=95.7
Q ss_pred eeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCC---CcceEEEEEE-eCCEEEEEEc
Q 013081 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP---NVVRLHEVLA-SKSKIYMVLE 94 (450)
Q Consensus 19 ~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp---nIv~l~~~~~-~~~~~~lv~E 94 (450)
++.++.|....||+. |..+++|+... ......+.+|..+|+.+.+. .+.+++.+.. ..+..|++||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 456888999999988 56789998532 23357899999999999752 3556666664 4566789999
Q ss_pred cCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhc-----------------------------------------
Q 013081 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK----------------------------------------- 133 (450)
Q Consensus 95 ~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~----------------------------------------- 133 (450)
|++|..+.+..- ..++..+...+..|+...|..||+.
T Consensus 94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 999988866321 2345555555555555555555532
Q ss_pred -------------------CeeeccCCCCcEEEcc---CCCe-EEeecCCCCC
Q 013081 134 -------------------GVFHRDLKLENILLDS---KGNI-KISDFGLSAL 163 (450)
Q Consensus 134 -------------------givHrDlKp~NILl~~---~g~l-kl~DFGla~~ 163 (450)
.++|+|++|.|||++. ++.+ .|.||+.+..
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 4599999999999987 4665 8999998874
|
| >1v5s_A MAP/microtubule affinity-regulating kinase 3; Ka1 domain, ELKL motif, MARK3, phosphorylation, structural genomics, NPPSFA; NMR {Mus musculus} SCOP: d.129.6.1 | Back alignment and structure |
|---|
Probab=98.72 E-value=1.6e-08 Score=84.00 Aligned_cols=86 Identities=16% Similarity=0.261 Sum_probs=74.4
Q ss_pred eecccCHHHHHHHHHHHHHhcCcEEEEe-CCeEEEEeecCCCCcCCceEEEEEEEEEc-CCeEEEEEEeccCCcceeeec
Q 013081 343 FTSNHSAKDLLERIEDIVTEMGFRVQKK-NGKLKATQEHKPQKSLGSLSVAAEVFEIS-PSLYVVELRKSYGDPTVYRQI 420 (450)
Q Consensus 343 f~s~~~~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~~~i~~~~-~~~~~v~~~~~~Gd~le~~~~ 420 (450)
.+|..+|++|+..|..+++.+|+.|+++ .|.+++...+...+ ..+.|.+||+++. .+++.|+|+|.+||.+.|++
T Consensus 33 tTSsk~P~eIm~EI~rvL~~~~i~~k~~~~y~L~C~~~~~~~~--~~vkfEiEVcKvp~l~l~GI~fKRisGd~w~YK~- 109 (126)
T 1v5s_A 33 QGSSGSSGDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAE--NLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKN- 109 (126)
T ss_dssp CCCCSSHHHHHHHHHHHHHHTTEEEEEEETTEEEEEECSSSTT--TCEEEEEECCCCTTTCSCCCEEEEEESCHHHHHH-
T ss_pred eecCCCHHHHHHHHHHHHHHcCCcEEEECCEEEEEEECCCCCC--ceEEEEEEEEEecCCCceeEEEeeccCchhHHHH-
Confidence 4678899999999999999999999874 58788866443333 7899999999995 78999999999999999999
Q ss_pred cchhhHHHHHHHHhhhcCC
Q 013081 421 KTSIVFVQLCNKLSSDLGL 439 (450)
Q Consensus 421 ~~~~~~~~~~~~~~~~l~~ 439 (450)
+|++|-.+|+.
T Consensus 110 --------lc~~IL~eLkL 120 (126)
T 1v5s_A 110 --------IASKIANELKL 120 (126)
T ss_dssp --------HHHHHHHHTTC
T ss_pred --------HHHHHHHHHhc
Confidence 99988888774
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.67 E-value=2.7e-07 Score=87.24 Aligned_cols=137 Identities=15% Similarity=0.229 Sum_probs=97.5
Q ss_pred CeEEeeeecccCce-EEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEE
Q 013081 15 RYELGRTLGEGNFG-KVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 15 ~y~i~~~LG~G~~g-~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv 92 (450)
.|+. +.+..|..+ .||+......+..+.+|+-... ....+.+|..+|+.+. +--+.+++.++.+.+..|+|
T Consensus 26 g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lv 98 (272)
T 4gkh_A 26 GYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLL 98 (272)
T ss_dssp TCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred CCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEE
Confidence 3443 234445444 6998887777788999986432 2456889999999885 33467889999999999999
Q ss_pred EccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhc---------------------------------------
Q 013081 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK--------------------------------------- 133 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~--------------------------------------- 133 (450)
||+++|.++.+..... ......+..++...|.-||+.
T Consensus 99 me~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (272)
T 4gkh_A 99 TTAIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGW 174 (272)
T ss_dssp EECCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTC
T ss_pred EEeeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccch
Confidence 9999998877654321 122334455555555555531
Q ss_pred -------------------CeeeccCCCCcEEEccCCCeEEeecCCCC
Q 013081 134 -------------------GVFHRDLKLENILLDSKGNIKISDFGLSA 162 (450)
Q Consensus 134 -------------------givHrDlKp~NILl~~~g~lkl~DFGla~ 162 (450)
.++|+|+.|.|||+++++.+-|.||+.+.
T Consensus 175 ~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 175 PVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp CHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 26899999999999987767799999876
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.45 E-value=4e-07 Score=91.44 Aligned_cols=80 Identities=18% Similarity=0.155 Sum_probs=51.1
Q ss_pred EeeeecccCceEEEEEEECCCCceEEEEEeecccc-cch---hHHHHHHHHHHHHHhCCC--CC-cceEEEEEEeCCEEE
Q 013081 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI-IHL---KITDQIKREIATLKLLKH--PN-VVRLHEVLASKSKIY 90 (450)
Q Consensus 18 i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~-~~~---~~~~~~~~Ei~il~~l~h--pn-Iv~l~~~~~~~~~~~ 90 (450)
-.+.||.|.++.||++.+..+++.+++|....... ... ....++.+|..+++.+.. |. +.+++.+ +....+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 36789999999999997655678899998653211 000 113456789999988742 33 4456644 344568
Q ss_pred EEEccCCCC
Q 013081 91 MVLEYVTGG 99 (450)
Q Consensus 91 lv~E~~~gg 99 (450)
+||||++|.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999874
|
| >4eai_A 5'-AMP-activated protein kinase catalytic subunit linker, 5'-AMP-activated protein...; AMPK, transferase; HET: AMP; 2.29A {Rattus norvegicus} PDB: 4eaj_A* 4eak_A* 4eal_A* | Back alignment and structure |
|---|
Probab=98.38 E-value=1.9e-06 Score=69.09 Aligned_cols=90 Identities=9% Similarity=0.261 Sum_probs=73.7
Q ss_pred ccccceecccCHHHHHHHHHHHHHhcCcEEEEe-CCeEEEEeecCCCCcCCceEEEEEEEEEcCCeEEEEEEeccCC---
Q 013081 338 ERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKK-NGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGD--- 413 (450)
Q Consensus 338 ~~~~rf~s~~~~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~~~~~~Gd--- 413 (450)
+......|...|.+|+..|..+++.+|+.|++. .|.|++.-...... ..+.+.+++|++.++.+|+||++..||
T Consensus 7 kW~LGIrS~~~P~eiM~eIyraLk~lg~~Wk~~~~Y~lkcR~~~~~~~--~~vK~~lQLYkv~~~~YLLDfq~i~g~~~~ 84 (106)
T 4eai_A 7 KWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTS--TFSKMSLQLYQVDSRTYLLDFRSIDDGGGG 84 (106)
T ss_dssp EEEESEEECSCHHHHHHHHHHHHHHHTCEEEEEETTEEEEEEECTTTC--CEEEEEEEEEECSSSCEEEEEEECCSSCCC
T ss_pred cceEcceeCCCHHHHHHHHHHHHHHcCCEEeeCCceEEEEEEcCCCCC--ceeEEEEEEEEecCCcEEEEEEeccCCCCC
Confidence 345567788999999999999999999999876 68888865432222 679999999999999999999999995
Q ss_pred -----cceeeeccchhhHHHHHHHHhhhcC
Q 013081 414 -----PTVYRQIKTSIVFVQLCNKLSSDLG 438 (450)
Q Consensus 414 -----~le~~~~~~~~~~~~~~~~~~~~l~ 438 (450)
+++|-+ +|..+...|.
T Consensus 85 ~~~~~~~~F~d---------~ca~li~~la 105 (106)
T 4eai_A 85 GGGSHTIEFFE---------MCANLIKILA 105 (106)
T ss_dssp SSSCHHHHHHH---------HHHHHHHHCC
T ss_pred CCCcCcEeHHH---------HHHHHHHHHh
Confidence 566666 9998877664
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=4.2e-07 Score=89.75 Aligned_cols=83 Identities=10% Similarity=0.172 Sum_probs=56.9
Q ss_pred EEeeee-cccCceEEEEEEEC--C----CCceEEEEEeeccc---ccchhHHHHHHHHHHHHHhCC-C--CCcceEEEEE
Q 013081 17 ELGRTL-GEGNFGKVKFAQDL--D----SGLPFAVKILEKNR---IIHLKITDQIKREIATLKLLK-H--PNVVRLHEVL 83 (450)
Q Consensus 17 ~i~~~L-G~G~~g~Vy~a~~~--~----~~~~vAvK~i~~~~---~~~~~~~~~~~~Ei~il~~l~-h--pnIv~l~~~~ 83 (450)
...+.| +.|....+|+.... . ++..+++|+..... ... ...+.+|+.+++.|. + -.+.+++.+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~~ 99 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWIE 99 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEEE
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEEc
Confidence 345778 88999999988653 0 26689999865432 101 135678899888885 3 3567788877
Q ss_pred EeC---CEEEEEEccCCCCChH
Q 013081 84 ASK---SKIYMVLEYVTGGELF 102 (450)
Q Consensus 84 ~~~---~~~~lv~E~~~gg~L~ 102 (450)
.+. +..|+||||++|..+.
T Consensus 100 ~~~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 100 TTGDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp CSSTTTSSCEEEEECCCCBCCC
T ss_pred cCCCccCCceEEEEecCCCChh
Confidence 654 3578999999986653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.26 E-value=6.1e-06 Score=80.35 Aligned_cols=135 Identities=11% Similarity=0.090 Sum_probs=78.5
Q ss_pred eeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-----CCCcceEE-E--EEEeCCEEE
Q 013081 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-----HPNVVRLH-E--VLASKSKIY 90 (450)
Q Consensus 19 ~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----hpnIv~l~-~--~~~~~~~~~ 90 (450)
.+.|+.|..+.||++... +..+++|+.... ...+..|..+++.|. .|.++... + +....+..|
T Consensus 37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~-------~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~ 107 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRP-------EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLF 107 (346)
T ss_dssp EEECC----CEEEEEEET--TEEEEEEEECSC-------HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEE
T ss_pred eeeccccccCcEEEEEeC--CCCEEEEecCCC-------HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEE
Confidence 455677788999998752 335899998642 123445555555553 34444310 0 123467889
Q ss_pred EEEccCCCCChH--------------HHHHh-cCCC--C-----------HH--------H-------------------
Q 013081 91 MVLEYVTGGELF--------------DKIAS-KGRL--Q-----------EA--------E------------------- 115 (450)
Q Consensus 91 lv~E~~~gg~L~--------------~~i~~-~~~l--~-----------~~--------~------------------- 115 (450)
++|+|++|.++. ..+.. ...+ + .. .
T Consensus 108 ~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 187 (346)
T 2q83_A 108 VVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQL 187 (346)
T ss_dssp EEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHH
T ss_pred EEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHH
Confidence 999999986542 11111 0111 1 10 0
Q ss_pred ----HHHHHHHHHHHHhhhh-------------hcCeeeccCCCCcEEEccCCCeEEeecCCCC
Q 013081 116 ----GRKLFQQLIDGVSYCH-------------NKGVFHRDLKLENILLDSKGNIKISDFGLSA 162 (450)
Q Consensus 116 ----~~~i~~ql~~aL~~LH-------------~~givHrDlKp~NILl~~~g~lkl~DFGla~ 162 (450)
...+..++..++.+|+ ..+++|+|++|.|||++.++.+.|+||+.+.
T Consensus 188 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 188 YLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1112223344566665 2579999999999999888899999999875
|
| >2v8q_A 5'-AMP-activated protein kinase catalytic subunit; phosphorylation, nucleotide-binding, serine/threonine-protei kinase, magnesium, CBS domain; HET: AMP; 2.10A {Rattus norvegicus} SCOP: d.129.6.2 PDB: 2v92_A* 2v9j_A* 2y94_C* | Back alignment and structure |
|---|
Probab=98.10 E-value=1.8e-05 Score=67.21 Aligned_cols=77 Identities=8% Similarity=0.220 Sum_probs=61.7
Q ss_pred ccccceecccCHHHHHHHHHHHHHhcCcEEEEe-CCeEEEEeecCCCCcCCceEEEEEEEEEcCCeEEEEEEeccCCcce
Q 013081 338 ERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKK-NGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTV 416 (450)
Q Consensus 338 ~~~~rf~s~~~~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~~~~~~Gd~le 416 (450)
+......|+..|.+|+..|..+++.+|+.|++. .|.|++.-...... ..+.|.+++|++.++.+||||++..||+.|
T Consensus 4 kWhLGIrSrs~P~eIM~EVyRALk~Lg~eWK~~~pY~IkcRw~~~~~~--~~vKm~LQLYkv~~~~YLLDFk~l~g~~~e 81 (157)
T 2v8q_A 4 AWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTS--TFSKMSLQLYQVDSRTYLLDFRSIDDEITE 81 (157)
T ss_dssp EEEESEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTC--CEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred cceeecccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCC--ceEEEEEEEEEecCCCEEEEEEecCCCccc
Confidence 345566788899999999999999999999987 58888854422111 468999999999999999999999999866
|
| >2y8l_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, serine/threonine-protein KI; HET: ADP AMP; 2.50A {Rattus norvegicus} PDB: 2y8q_A* 2ya3_A* | Back alignment and structure |
|---|
Probab=98.06 E-value=2.5e-05 Score=67.22 Aligned_cols=78 Identities=8% Similarity=0.211 Sum_probs=63.2
Q ss_pred cccccceecccCHHHHHHHHHHHHHhcCcEEEEe-CCeEEEEeecCCCCcCCceEEEEEEEEEcCCeEEEEEEeccCCcc
Q 013081 337 SERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKK-NGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPT 415 (450)
Q Consensus 337 ~~~~~rf~s~~~~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~~~~~~Gd~l 415 (450)
.+......|+..|.+|+..|..+++.+|+.|++. .|.|++.-...... ..+.|.+++|++.++.|||||++..||+.
T Consensus 17 ~kWhLGIrSrs~P~eIM~EVyRALk~Lg~eWK~i~pY~IkcRw~~~~~~--~~vKmeLQLYKv~~~~YLLDFk~l~Gd~~ 94 (173)
T 2y8l_A 17 MAWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTS--TFSKMSLQLYQVDSRTYLLDFRSIDDEIT 94 (173)
T ss_dssp CEEEESEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTC--CEEEEEEEEEECSSSCEEEEEEEECCC--
T ss_pred ceeeeecccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCC--eeEEEEEEEEEEcCCCEEEEEEecCCCcc
Confidence 3566778899999999999999999999999987 58888864422111 46899999999999999999999999986
Q ss_pred e
Q 013081 416 V 416 (450)
Q Consensus 416 e 416 (450)
|
T Consensus 95 e 95 (173)
T 2y8l_A 95 E 95 (173)
T ss_dssp -
T ss_pred c
Confidence 6
|
| >4eag_A EG:132E8.2 protein; AMPK, transferase; HET: ATP TAM; 2.70A {Drosophila melanogaster} | Back alignment and structure |
|---|
Probab=98.05 E-value=4.9e-05 Score=62.48 Aligned_cols=80 Identities=5% Similarity=0.184 Sum_probs=60.4
Q ss_pred ccccceecccCHHHHHHHHHHHHHhcCcEEEEe-CCeEEEEeecCCCCcCCceEEEEEEEEEcCCeEEEEEEeccCCcce
Q 013081 338 ERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKK-NGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTV 416 (450)
Q Consensus 338 ~~~~rf~s~~~~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~~~~~~Gd~le 416 (450)
+......|+..|.+|+..|..+++.+|+.|++. .|.|++.-...... ....+.+++|++.++.+|+||++..||-.|
T Consensus 7 kW~LGIrS~~~P~eIM~EVyrALk~Lg~eWK~~~pY~vkcR~~n~~~~--~~vKm~LQLYqv~~~~YLLDfk~~~~~~~~ 84 (130)
T 4eag_A 7 KWHLGIRSQSKPNDIMLEVYRAMKALSYEWKIINPYHVRVRRQNVKTG--KFSKMSLQLYQVDAKSYLLDFKSLTNDEVE 84 (130)
T ss_dssp CEEESBCCCSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTC--CEEEEEEEEEESSSSCEEEEEEECC-----
T ss_pred ceeeeeecCCCHHHHHHHHHHHHHHCCCEEeeCCCEEEEEEecCCCCC--ceeEEEEEEEEecCCcEEEEeccCCcchhh
Confidence 344556688889999999999999999999887 58888865443333 578899999999999999999999999766
Q ss_pred eee
Q 013081 417 YRQ 419 (450)
Q Consensus 417 ~~~ 419 (450)
+..
T Consensus 85 ~~~ 87 (130)
T 4eag_A 85 QGD 87 (130)
T ss_dssp ---
T ss_pred ccC
Confidence 654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.94 E-value=5.4e-05 Score=73.53 Aligned_cols=76 Identities=21% Similarity=0.236 Sum_probs=61.0
Q ss_pred EeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEEEEc
Q 013081 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK---HPNVVRLHEVLASKSKIYMVLE 94 (450)
Q Consensus 18 i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~lv~E 94 (450)
-.+.|+.|.+..+|+... .+..+++|+.... ....+.+|...|+.|. ...+.+++.+....+..|+|||
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme 111 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE 111 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence 357789999999999874 4678899987542 1467889999998884 3567888988888889999999
Q ss_pred cCCCCCh
Q 013081 95 YVTGGEL 101 (450)
Q Consensus 95 ~~~gg~L 101 (450)
|++|..+
T Consensus 112 ~l~G~~~ 118 (312)
T 3jr1_A 112 ALNKSKN 118 (312)
T ss_dssp CCCCCCC
T ss_pred eccCCCC
Confidence 9998764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.87 E-value=5.8e-05 Score=76.23 Aligned_cols=32 Identities=16% Similarity=0.326 Sum_probs=28.3
Q ss_pred hhcCeeeccCCCCcEEEccCCCeEEeecCCCCC
Q 013081 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSAL 163 (450)
Q Consensus 131 H~~givHrDlKp~NILl~~~g~lkl~DFGla~~ 163 (450)
+...++|+|++|.|||++.++ +.+.||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 456899999999999998877 99999998873
|
| >2qrd_A SNF1-like protein kinase SSP2; AMPK, ADP, ATP-binding, kinase, nucleotide-binding, serine/T protein kinase, transferase, CBS domain; HET: ADP ATP; 2.41A {Schizosaccharomyces pombe} SCOP: d.129.6.2 PDB: 2ooy_A* 2qr1_A* 2qrc_A* 2oox_A* 2qre_A* | Back alignment and structure |
|---|
Probab=97.84 E-value=2.2e-05 Score=66.00 Aligned_cols=101 Identities=14% Similarity=0.214 Sum_probs=71.5
Q ss_pred ccccceecccCHHHHHHHHHHHHHhcCcEEEEe---------C-CeEEEEeecCCC---CcCCceEEEEEEEEEcCCeEE
Q 013081 338 ERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKK---------N-GKLKATQEHKPQ---KSLGSLSVAAEVFEISPSLYV 404 (450)
Q Consensus 338 ~~~~rf~s~~~~~~~~~~l~~~~~~~~~~~~~~---------~-~~~~~~~~~~~~---~~~~~l~~~~~i~~~~~~~~~ 404 (450)
+.....-|+..|.+|+..|..+++.+|+.|++. + |.|++.-..... .....+.|.+++|++.++.+|
T Consensus 12 kWhlGIRSrs~P~eIM~EVyrALk~Lg~eWk~~~~~~~~~~~~~y~Ik~R~~~~~~~~~~~~~~vkm~iQLYqv~~~~YL 91 (137)
T 2qrd_A 12 KWHFGVRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKNTYAYIELQLYEVMPGCFM 91 (137)
T ss_dssp CCEESEEEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCCEEEEEEEEEEEEETTEEE
T ss_pred ccccccccCCCHHHHHHHHHHHHHHCCCEEEeccccccccCCCceEEEEEEecCCCccccCCceEEEEEEEEEecCCcEE
Confidence 456667789999999999999999999999876 4 667764321100 001368899999999999999
Q ss_pred EEEEeccCCccee----------eeccchhhHHHHHHHHhhhcC
Q 013081 405 VELRKSYGDPTVY----------RQIKTSIVFVQLCNKLSSDLG 438 (450)
Q Consensus 405 v~~~~~~Gd~le~----------~~~~~~~~~~~~~~~~~~~l~ 438 (450)
|||++..|+..+- ...-....|..+|.+|...|.
T Consensus 92 lDFk~~~~~~~~~~~~~~~~~~~~~~~s~~~Fldlca~Li~eLa 135 (137)
T 2qrd_A 92 LDVKSNGYKDIYSHPERTADHGMDDLKSSFPFLDLCAMLVCKLF 135 (137)
T ss_dssp EEEEEEEEEESCC-------------CCCTTHHHHHHHHHHHHH
T ss_pred EEEEecCCccccccCccccccCCccccccccHHHHHHHHHHHHh
Confidence 9999999983211 011112456669988876653
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.83 E-value=0.00014 Score=66.22 Aligned_cols=123 Identities=19% Similarity=0.148 Sum_probs=82.3
Q ss_pred CChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhh-hhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccccc
Q 013081 99 GELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYC-HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT 176 (450)
Q Consensus 99 g~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~L-H~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~ 176 (450)
.+|.+.+.. +.+++|+++|.++.|.+.+|.-+ +.+.-..+=+.|..|++..+|+|.+.+ +.+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------- 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------
Confidence 378888875 56899999999999999998776 211222344567999999999988763 2111
Q ss_pred cCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccccC
Q 013081 177 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255 (450)
Q Consensus 177 ~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~d 255 (450)
.....+.|||... ...+.+.=|||||+++|.-+-=.+| ..-+..+|+.+.+||..|..-.
T Consensus 98 ~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~-----------------e~eE~eLS~~LE~LL~~Mt~~~ 157 (229)
T 2yle_A 98 AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLK-----------------ENEERELSPPLEQLIDHMANTV 157 (229)
T ss_dssp ---------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCC-----------------TTEEECCCHHHHHHHHHHTTCC
T ss_pred ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCC-----------------cccchhhCHHHHHHHHHHHhcc
Confidence 1234677888753 2335788999999999998853332 1223458999999999998663
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.76 E-value=6.1e-05 Score=72.36 Aligned_cols=135 Identities=17% Similarity=0.093 Sum_probs=77.1
Q ss_pred eEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEc
Q 013081 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-VRLHEVLASKSKIYMVLE 94 (450)
Q Consensus 16 y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lv~E 94 (450)
+.-++.|+.|....+|++ ..+++|+....... .-...+|..+++.+...++ .+++.+ ....-++++|
T Consensus 20 ~~~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e 87 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA------GDLCLRIPGKGTEE----YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTR 87 (301)
T ss_dssp CCSCEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEE
T ss_pred ccceeEcCCcccccccee------eeEEEECCCCCccc----eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEe
Confidence 333788999999999998 56899987542110 1123568888877753333 455554 3334578999
Q ss_pred cC-CCCChHHH---------------H---HhcC-CC----C-HHHHHHHHHH--------------HHHHHhhh-----
Q 013081 95 YV-TGGELFDK---------------I---ASKG-RL----Q-EAEGRKLFQQ--------------LIDGVSYC----- 130 (450)
Q Consensus 95 ~~-~gg~L~~~---------------i---~~~~-~l----~-~~~~~~i~~q--------------l~~aL~~L----- 130 (450)
|+ +|.++... + .... .+ + ......+..+ +...+..+
T Consensus 88 ~i~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~ 167 (301)
T 3dxq_A 88 YIAGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALA 167 (301)
T ss_dssp CCTTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHH
T ss_pred ecCCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHH
Confidence 99 66544210 0 1111 01 1 1111111111 11111111
Q ss_pred ---hhcCeeeccCCCCcEEEccCCCeEEeecCCCCC
Q 013081 131 ---HNKGVFHRDLKLENILLDSKGNIKISDFGLSAL 163 (450)
Q Consensus 131 ---H~~givHrDlKp~NILl~~~g~lkl~DFGla~~ 163 (450)
....++|+|+.|.||+ ..++.+.++||..+..
T Consensus 168 ~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 168 AHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp SSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred hcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 1124899999999999 6677899999998863
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00011 Score=70.93 Aligned_cols=141 Identities=13% Similarity=0.149 Sum_probs=78.7
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--cceEEEE------EEeC
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN--VVRLHEV------LASK 86 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~------~~~~ 86 (450)
...-.+.|+.|....+|+.... +| .+++|+..... . ...+..|+.+++.|...+ +.+++.. ....
T Consensus 23 ~~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~--~---~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~ 95 (322)
T 2ppq_A 23 SLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV--E---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELS 95 (322)
T ss_dssp CEEEEEEECC---EEEEEEEES-SC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEET
T ss_pred cceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC--C---HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEEC
Confidence 3344667888998999998753 33 68899886521 1 234566777777764212 2222211 1234
Q ss_pred CEEEEEEccCCCCChHH--------------HHHhc-CCC--------CHHHHHHHH---------------HHHHHHHh
Q 013081 87 SKIYMVLEYVTGGELFD--------------KIASK-GRL--------QEAEGRKLF---------------QQLIDGVS 128 (450)
Q Consensus 87 ~~~~lv~E~~~gg~L~~--------------~i~~~-~~l--------~~~~~~~i~---------------~ql~~aL~ 128 (450)
+..+++++|++|..+.. .+... ..+ ........+ ..+...++
T Consensus 96 g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~ 175 (322)
T 2ppq_A 96 GRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEID 175 (322)
T ss_dssp TEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHH
T ss_pred CEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHH
Confidence 67899999999865310 11110 011 111000000 01233344
Q ss_pred hhh-------hcCeeeccCCCCcEEEccCCCeEEeecCCCC
Q 013081 129 YCH-------NKGVFHRDLKLENILLDSKGNIKISDFGLSA 162 (450)
Q Consensus 129 ~LH-------~~givHrDlKp~NILl~~~g~lkl~DFGla~ 162 (450)
+++ ..+++|+|++|.|||+++++.+.|.||+.+.
T Consensus 176 ~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 176 YLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 443 2479999999999999887656899999775
|
| >3t4n_A Carbon catabolite-derepressing protein kinase; CBS domain, nucleotide binding, cytosol, protein binding; HET: ADP; 2.30A {Saccharomyces cerevisiae} SCOP: d.129.6.2 PDB: 3tdh_A* 3te5_A* 2qlv_A | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00049 Score=59.76 Aligned_cols=99 Identities=18% Similarity=0.231 Sum_probs=68.9
Q ss_pred ccccceecccCHHHHHHHHHHHHHhcCcEEEEe----CCeEEEEeecCC--C-----CcCCceEEEEEEEEEcCCeEEEE
Q 013081 338 ERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKK----NGKLKATQEHKP--Q-----KSLGSLSVAAEVFEISPSLYVVE 406 (450)
Q Consensus 338 ~~~~rf~s~~~~~~~~~~l~~~~~~~~~~~~~~----~~~~~~~~~~~~--~-----~~~~~l~~~~~i~~~~~~~~~v~ 406 (450)
+......|+..|.+|+..|..+++.+|+.|++. .|.|++.-.... . +....+.|.+++|++.++.+|||
T Consensus 50 kW~LGIrS~~~P~eIM~EVyrALk~Lg~~WKk~~~~~pY~IkcRw~~~~~~~~~~~~~~p~~vKmeLQLYkv~~~~YLLD 129 (179)
T 3t4n_A 50 RWHFGIRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLVD 129 (179)
T ss_dssp CCEESEEECSCHHHHHHHHHHHHHHHTCEEECCCGGGTTEEEEEECC-----------CCCEEEEEEEEEEEETTEEEEE
T ss_pred eeeeccccCCCHHHHHHHHHHHHHHcCCEEeeCCCCCceEEEEEEeCCCCcccccccCCCceeEEEEEEEEecCCceEEE
Confidence 455567789999999999999999999999875 477887532110 0 10145899999999999999999
Q ss_pred EEeccCCcceeeecc-------------chhhHHHHHHHHhhhc
Q 013081 407 LRKSYGDPTVYRQIK-------------TSIVFVQLCNKLSSDL 437 (450)
Q Consensus 407 ~~~~~Gd~le~~~~~-------------~~~~~~~~~~~~~~~l 437 (450)
|+ ..|--.++-+.- ...-|..+|.+|.-.|
T Consensus 130 fk-~~G~e~~~~~~~~~~~~~~~e~~~~s~~pFLdlca~LI~eL 172 (179)
T 3t4n_A 130 FK-FDGWESSYGDDTTVSNISEDEMSTFSAYPFLHLTTKLIMEL 172 (179)
T ss_dssp EE-EEEEECC----------------CCCCHHHHHHHHHHHHHH
T ss_pred EE-eccccccccccccccccccccccccCCccHHHHHHHHHHHH
Confidence 99 777221221110 2355777998776555
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00018 Score=69.95 Aligned_cols=136 Identities=11% Similarity=0.130 Sum_probs=71.9
Q ss_pred eeeecccCceE-EEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCC--CcceEEEEEEeCCEEEEEEcc
Q 013081 19 GRTLGEGNFGK-VKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP--NVVRLHEVLASKSKIYMVLEY 95 (450)
Q Consensus 19 ~~~LG~G~~g~-Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~~~~~~~~~lv~E~ 95 (450)
.+.|+.|+... +|+... .+|..+++|....... ..+..|+.+++.+... .+.+++.+....+ +++||+
T Consensus 23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~ 93 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEG------GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIED 93 (333)
T ss_dssp ECC--------CCEEEEC-TTCCEEEEEECCTTTT------CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECC
T ss_pred eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCCC------ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEee
Confidence 45676665555 556652 2366788876543210 2345677777777422 3456666533333 789999
Q ss_pred CCCCChHHHHHhc--------------------------CCCCHHHHH-------H-HH------------HHHHHHHhh
Q 013081 96 VTGGELFDKIASK--------------------------GRLQEAEGR-------K-LF------------QQLIDGVSY 129 (450)
Q Consensus 96 ~~gg~L~~~i~~~--------------------------~~l~~~~~~-------~-i~------------~ql~~aL~~ 129 (450)
+.|..+.+.+... ..++..... . +. ..+...++.
T Consensus 94 l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~ 173 (333)
T 3csv_A 94 LGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQ 173 (333)
T ss_dssp CCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHH
T ss_pred CCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence 9776665433210 012221110 0 00 011111222
Q ss_pred h------hhcCeeeccCCCCcEEEccC----CCeEEeecCCCCC
Q 013081 130 C------HNKGVFHRDLKLENILLDSK----GNIKISDFGLSAL 163 (450)
Q Consensus 130 L------H~~givHrDlKp~NILl~~~----g~lkl~DFGla~~ 163 (450)
+ +...++|||+.|.||+++.+ +.+.|.||+.+..
T Consensus 174 l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 174 ILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred HHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 2 23479999999999999875 6799999998873
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00036 Score=67.56 Aligned_cols=135 Identities=22% Similarity=0.171 Sum_probs=78.8
Q ss_pred eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--cceEEEE-----EEeCCEEEEE
Q 013081 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN--VVRLHEV-----LASKSKIYMV 92 (450)
Q Consensus 20 ~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~-----~~~~~~~~lv 92 (450)
..|+ |....||++.. .+|+.+++|+.+.... . ...+..|..+++.|...+ +.+++.. ....+..+++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~-~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW-T---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS-C---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC-C---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 4566 88889998763 4566899999864321 1 345667888887774222 3333332 2235677899
Q ss_pred EccCCCCChH-----------HH---HHh---cC------CCCHHHH----------------------HHHHHHHHHHH
Q 013081 93 LEYVTGGELF-----------DK---IAS---KG------RLQEAEG----------------------RKLFQQLIDGV 127 (450)
Q Consensus 93 ~E~~~gg~L~-----------~~---i~~---~~------~l~~~~~----------------------~~i~~ql~~aL 127 (450)
|+|++|..+. .. +.. .. ..+.... ...+.+++..+
T Consensus 106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l 185 (328)
T 1zyl_A 106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV 185 (328)
T ss_dssp EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence 9999885431 01 110 00 1111110 11112222222
Q ss_pred hhh----hhcCeeeccCCCCcEEEccCCCeEEeecCCCC
Q 013081 128 SYC----HNKGVFHRDLKLENILLDSKGNIKISDFGLSA 162 (450)
Q Consensus 128 ~~L----H~~givHrDlKp~NILl~~~g~lkl~DFGla~ 162 (450)
.-+ +...++|+|++|.|||++ + .+.|.||+.+.
T Consensus 186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 221 234689999999999998 4 89999999776
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.44 E-value=0.00096 Score=63.43 Aligned_cols=79 Identities=15% Similarity=0.091 Sum_probs=55.8
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCC---CCcceEEEEEEeCCEEEE
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH---PNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~h---pnIv~l~~~~~~~~~~~l 91 (450)
+..-++.+|.|..+.||+... .+|+.|.+|+-....... ...+.+|...|+.|.- --+.+++.+. . -++
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~~l 87 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--RTL 87 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--TEE
T ss_pred CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEecc--C--ceE
Confidence 456688899999999999984 578999999865432221 2457889999998852 2345555542 2 378
Q ss_pred EEccCCCCCh
Q 013081 92 VLEYVTGGEL 101 (450)
Q Consensus 92 v~E~~~gg~L 101 (450)
+|||+.++..
T Consensus 88 v~e~l~~~~~ 97 (288)
T 3f7w_A 88 AMEWVDERPP 97 (288)
T ss_dssp EEECCCCCCC
T ss_pred EEEeecccCC
Confidence 9999987653
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00036 Score=70.78 Aligned_cols=74 Identities=11% Similarity=0.131 Sum_probs=50.3
Q ss_pred eeeecccCceEEEEEEECC-------CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEE
Q 013081 19 GRTLGEGNFGKVKFAQDLD-------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-VRLHEVLASKSKIY 90 (450)
Q Consensus 19 ~~~LG~G~~g~Vy~a~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~ 90 (450)
++.|+.|....||++.... .+..+.+|+..... . ...+.+|..+++.|...++ .++++.+. + .
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~---~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g 148 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFS--G--G 148 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--E
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--c---HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--C
Confidence 5678889899999998643 25789999874321 1 1345579999988853334 56776553 2 3
Q ss_pred EEEccCCCCCh
Q 013081 91 MVLEYVTGGEL 101 (450)
Q Consensus 91 lv~E~~~gg~L 101 (450)
+|+||++|.+|
T Consensus 149 ~v~e~l~G~~l 159 (429)
T 1nw1_A 149 RLEEYIPSRPL 159 (429)
T ss_dssp EEECCCCEEEC
T ss_pred EEEEEeCCccc
Confidence 89999987443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.25 E-value=0.00045 Score=68.82 Aligned_cols=136 Identities=17% Similarity=0.137 Sum_probs=82.6
Q ss_pred eeeecccCceEEEEEEECC-------CCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEE
Q 013081 19 GRTLGEGNFGKVKFAQDLD-------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIY 90 (450)
Q Consensus 19 ~~~LG~G~~g~Vy~a~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 90 (450)
++.|..|-...+|++.... +++.+.+|+.-.. . .....+.+|..+++.|. +.-..+++..+.+ .
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g 126 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-L---QGVDSLVLESVMFAILAERSLGPQLYGVFPE----G 126 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----E
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-c---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----c
Confidence 4567678888899988642 3578999985321 1 11355668999998885 3333566666543 2
Q ss_pred EEEccCCCCChHH--------------HHH---hc----C-CCC--HHHHHHHHHHHHHH-------------------H
Q 013081 91 MVLEYVTGGELFD--------------KIA---SK----G-RLQ--EAEGRKLFQQLIDG-------------------V 127 (450)
Q Consensus 91 lv~E~~~gg~L~~--------------~i~---~~----~-~l~--~~~~~~i~~ql~~a-------------------L 127 (450)
+||||++|..|.. .+. .. + +.. ..++.+|..|+... +
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 8999999865421 111 11 1 111 35566666555321 2
Q ss_pred hhhh--------hcCeeeccCCCCcEEEccC----CCeEEeecCCCC
Q 013081 128 SYCH--------NKGVFHRDLKLENILLDSK----GNIKISDFGLSA 162 (450)
Q Consensus 128 ~~LH--------~~givHrDlKp~NILl~~~----g~lkl~DFGla~ 162 (450)
..|. ...++|+|+.+.|||++.+ +.+.++||..|.
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2222 1359999999999999877 789999999886
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.22 E-value=0.00047 Score=68.14 Aligned_cols=75 Identities=12% Similarity=0.052 Sum_probs=45.2
Q ss_pred eeeecccCceEEEEEEECC--------CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCEE
Q 013081 19 GRTLGEGNFGKVKFAQDLD--------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN-VVRLHEVLASKSKI 89 (450)
Q Consensus 19 ~~~LG~G~~g~Vy~a~~~~--------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~ 89 (450)
.+.|+.|....+|++.... .+..+++|+...... . .....+|..+++.+...+ +.+++... .+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~---~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~-- 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD---E-LYNTISEFEVYKTMSKYKIAPQLLNTF--NG-- 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG---G-TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc---c-eecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence 5677888889999998643 136899998754211 1 112467888888885334 34666544 22
Q ss_pred EEEEccCCCCCh
Q 013081 90 YMVLEYVTGGEL 101 (450)
Q Consensus 90 ~lv~E~~~gg~L 101 (450)
++||||++|..+
T Consensus 110 ~~v~e~i~G~~l 121 (369)
T 3c5i_A 110 GRIEEWLYGDPL 121 (369)
T ss_dssp EEEEECCCSEEC
T ss_pred cEEEEEecCCcC
Confidence 689999988543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0018 Score=63.30 Aligned_cols=31 Identities=26% Similarity=0.387 Sum_probs=27.7
Q ss_pred cCeeeccCCCCcEEEccCCCeEEeecCCCCC
Q 013081 133 KGVFHRDLKLENILLDSKGNIKISDFGLSAL 163 (450)
Q Consensus 133 ~givHrDlKp~NILl~~~g~lkl~DFGla~~ 163 (450)
..++|+|+.|.||++++++.+.|.||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3699999999999999888999999988763
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.02 E-value=0.0068 Score=61.83 Aligned_cols=75 Identities=13% Similarity=0.179 Sum_probs=49.0
Q ss_pred eeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEccCC
Q 013081 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-VRLHEVLASKSKIYMVLEYVT 97 (450)
Q Consensus 19 ~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lv~E~~~ 97 (450)
++.|+.|-...+|++.....+..+++|+..... .. .. ...+|..+++.|...++ .++++++. + ..||||++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~--~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~ 184 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DE--II-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMD 184 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CS--CS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hh--hc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeC
Confidence 567888999999999875445789999874321 11 11 12579999999975554 56777663 2 24999998
Q ss_pred CCCh
Q 013081 98 GGEL 101 (450)
Q Consensus 98 gg~L 101 (450)
|..|
T Consensus 185 G~~l 188 (458)
T 2qg7_A 185 GYAL 188 (458)
T ss_dssp SEEC
T ss_pred CccC
Confidence 7543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.63 E-value=0.059 Score=54.23 Aligned_cols=75 Identities=13% Similarity=0.092 Sum_probs=48.3
Q ss_pred eeeecccCceEEEEEEECCC-------CceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEE
Q 013081 19 GRTLGEGNFGKVKFAQDLDS-------GLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIY 90 (450)
Q Consensus 19 ~~~LG~G~~g~Vy~a~~~~~-------~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 90 (450)
++.|..|-...+|+...... +..+++|+..... .. .-...+|..+++.+. +.-..++++.+ .+ +
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~ 146 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GK-FYDSKVELDVFRYLSNINIAPNIIADF--PE--G 146 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--E
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---ch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--C
Confidence 55677788889999986521 5789999864321 11 112457888888885 32234566543 22 6
Q ss_pred EEEccCCCCCh
Q 013081 91 MVLEYVTGGEL 101 (450)
Q Consensus 91 lv~E~~~gg~L 101 (450)
.||||++|..|
T Consensus 147 ~I~efI~G~~l 157 (424)
T 3mes_A 147 RIEEFIDGEPL 157 (424)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEeCCccC
Confidence 88999998653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.72 E-value=0.25 Score=49.12 Aligned_cols=30 Identities=33% Similarity=0.440 Sum_probs=25.5
Q ss_pred CeeeccCCCCcEEE------ccCCCeEEeecCCCCC
Q 013081 134 GVFHRDLKLENILL------DSKGNIKISDFGLSAL 163 (450)
Q Consensus 134 givHrDlKp~NILl------~~~g~lkl~DFGla~~ 163 (450)
.++|+|+.+.|||+ ++++.+.++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 37899999999999 3456799999999874
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=89.17 E-value=1.5 Score=39.54 Aligned_cols=83 Identities=12% Similarity=0.101 Sum_probs=64.3
Q ss_pred CCCCcceEEEEEEeCCEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHh-hhhhcCeeeccCCCCcEEEccC
Q 013081 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS-YCHNKGVFHRDLKLENILLDSK 150 (450)
Q Consensus 72 ~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~-~LH~~givHrDlKp~NILl~~~ 150 (450)
.||++ -..+-.+++.+.+.++.-+++.=+..++. ++..+.++++.+|+.... ++++ -+|=-|+|+||+++.+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~---~~~~eKlrll~nl~~L~~~~~~~--r~tf~l~P~NL~f~~~ 120 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK---TTLLSRIRAAIHLVSKVKHHSAR--RLIFIVCPENLMFNRA 120 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT---SCHHHHHHHHHHHHHHHSSCCSS--SEECCCCGGGEEECTT
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh---cCHHHHHHHHHHHHHHHHHhhhC--ceeEEEeCceEEEeCC
Confidence 58888 55555778888888887766665666643 789999999999998877 5544 4566789999999999
Q ss_pred CCeEEeecCCC
Q 013081 151 GNIKISDFGLS 161 (450)
Q Consensus 151 g~lkl~DFGla 161 (450)
+.+++.=.|+-
T Consensus 121 ~~p~i~hRGi~ 131 (219)
T 4ano_A 121 LEPFFLHVGVK 131 (219)
T ss_dssp CCEEESCCEET
T ss_pred CcEEEEEcCCc
Confidence 99999877653
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=85.01 E-value=0.06 Score=54.86 Aligned_cols=64 Identities=9% Similarity=0.153 Sum_probs=18.7
Q ss_pred EEeeeecccCceEEEEEEECCCCceEEE------EEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 013081 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAV------KILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA 84 (450)
Q Consensus 17 ~i~~~LG~G~~g~Vy~a~~~~~~~~vAv------K~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 84 (450)
.+.+.|| ||.||.+.......+||+ |....... ..+....+.+|..+++.++|||+++.+.+..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~-~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGV-SEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC------------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccc-cccccccccccccccccccccccCCCcceEE
Confidence 4456676 999999987665668999 65543222 2222456778999999999999999988754
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=84.70 E-value=1.9 Score=38.78 Aligned_cols=84 Identities=12% Similarity=0.169 Sum_probs=63.0
Q ss_pred CCCCcceEEEEEEeCCEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCC
Q 013081 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG 151 (450)
Q Consensus 72 ~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g 151 (450)
.||+.+.. .+-.+++.+.+.++.-+.+.=+..+. .++..+.++++.+|+....++++ =+|=-|+|+||+++.++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik---~~~~~eKlr~l~ni~~l~~~~~~--r~tf~L~P~NL~f~~~~ 116 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK---SFTKNEKLRYLLNIKNLEEVNRT--RYTFVLAPDELFFTRDG 116 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG---GSCHHHHHHHHHHGGGGGGGGGS--SEECCCSGGGEEECTTS
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH---hcCHHHHHHHHHHHHHHHHHhcC--ceEEEEecceEEEcCCC
Confidence 58999877 67677787777777665443344443 37889999999999888755543 35667999999999999
Q ss_pred CeEEeecCCC
Q 013081 152 NIKISDFGLS 161 (450)
Q Consensus 152 ~lkl~DFGla 161 (450)
.+++.=-|+-
T Consensus 117 ~p~i~~RGik 126 (215)
T 4ann_A 117 LPIAKTRGLQ 126 (215)
T ss_dssp CEEESCCEET
T ss_pred CEEEEEccCc
Confidence 9998866653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 450 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-90 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-86 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-85 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-83 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-82 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-80 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-80 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-79 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-79 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-79 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-77 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-76 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-76 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-75 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-75 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 9e-75 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-74 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-74 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-74 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-71 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-70 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-70 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-69 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-68 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-65 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-65 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-65 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-65 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-63 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-63 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-62 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-62 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-62 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-62 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 8e-62 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-61 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-61 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-61 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-61 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-61 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-61 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-60 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-60 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-60 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-59 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-59 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-59 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-58 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-57 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-57 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-57 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-56 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-55 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-55 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-54 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-53 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-53 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-53 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-51 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-49 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-48 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 9e-42 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-23 | |
| d1ul7a_ | 102 | d.129.6.1 (A:) Map/microtubule affinity-regulating | 8e-13 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 271 bits (695), Expect = 8e-90
Identities = 85/262 (32%), Positives = 145/262 (55%), Gaps = 5/262 (1%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
L +E+GR LG+G FG V A++ S A+K+L K ++ + Q++RE+ L+
Sbjct: 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
HPN++RL+ +++Y++LEY G ++ ++ + E +L + +SYCH+
Sbjct: 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 124
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
K V HRD+K EN+LL S G +KI+DFG S T CG+ +Y+ PE++ R
Sbjct: 125 KRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEMIEGRM 180
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKIL 252
+D D+WS GV+ Y L G PF+ Y++I R +F P +++ GA++L+ ++L
Sbjct: 181 HDEK-VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 239
Query: 253 EPNPVKRITIAGIKADEWFEQD 274
+ NP +R + + W +
Sbjct: 240 KHNPSQRPMLREVLEHPWITAN 261
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 263 bits (674), Expect = 1e-86
Identities = 101/266 (37%), Positives = 150/266 (56%), Gaps = 5/266 (1%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ ++L +TLGEG +G+V+ A + + AVKI++ R + + IK+EI K+L
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 61
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
H NVV+ + + Y+ LEY +GGELFD+I + E + ++ F QL+ GV Y H
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
G+ HRD+K EN+LLD + N+KISDFGL+ + ++ + LL+ CG+ YVAPE+L R
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 193 YDGATSDIWSCGVILYVILTGYLPFD-DRNLAVLYQKIFRGDFKLPKW--LSPGAQNLLR 249
+ D+WSCG++L +L G LP+D + Y L W + LL
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 241
Query: 250 KILEPNPVKRITIAGIKADEWFEQDY 275
KIL NP RITI IK D W+ +
Sbjct: 242 KILVENPSARITIPDIKKDRWYNKPL 267
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 261 bits (668), Expect = 2e-85
Identities = 82/263 (31%), Positives = 135/263 (51%), Gaps = 1/263 (0%)
Query: 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
R ++ G+ LGEG+F V A++L + +A+KILEK II + RE +
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
L HP V+L+ K+Y L Y GEL I G E R +++ + Y
Sbjct: 65 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 124
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
H KG+ HRDLK ENILL+ +I+I+DFG + + ++ G+ YV+PE+L
Sbjct: 125 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 191 RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 250
+ + SD+W+ G I+Y ++ G PF N +++QKI + ++ P+ P A++L+ K
Sbjct: 185 KSACKS-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 243
Query: 251 ILEPNPVKRITIAGIKADEWFEQ 273
+L + KR+ ++ +
Sbjct: 244 LLVLDATKRLGCEEMEGYGPLKA 266
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 256 bits (656), Expect = 9e-83
Identities = 77/275 (28%), Positives = 143/275 (52%), Gaps = 14/275 (5%)
Query: 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
++G Y++ LG G FG V + +G F K + + +K EI+
Sbjct: 23 KQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY---TVKNEISI 79
Query: 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDG 126
+ L HP ++ LH+ K ++ ++LE+++GGELFD+IA++ ++ EAE +Q +G
Sbjct: 80 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEG 139
Query: 127 VSYCHNKGVFHRDLKLENILLDSK--GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
+ + H + H D+K ENI+ ++K ++KI DFGL+ D ++ T + + A
Sbjct: 140 LKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLA---TKLNPDEIVKVTTATAEFAA 196
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK----WL 240
PE++ +D+W+ GV+ YV+L+G PF + Q + R D++ + +
Sbjct: 197 PEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV 255
Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
SP A++ ++ +L+ P KR+T+ W + D+
Sbjct: 256 SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 255 bits (653), Expect = 2e-82
Identities = 79/280 (28%), Positives = 137/280 (48%), Gaps = 14/280 (5%)
Query: 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
+ L Y++ LG G FG V + +G FA K + H + +++EI T
Sbjct: 20 KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQT 76
Query: 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDG 126
+ +L+HP +V LH+ +++ M+ E+++GGELF+K+A + ++ E E + +Q+ G
Sbjct: 77 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 136
Query: 127 VSYCHNKGVFHRDLKLENILLDSK--GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
+ + H H DLK ENI+ +K +K+ DFGL+A H + T G+ + A
Sbjct: 137 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTGTAEFAA 193
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWL 240
PEV + +D+WS GV+ Y++L+G PF N + + D+ + +
Sbjct: 194 PEVAEGKPVGYY-TDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI 252
Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
S ++ +RK+L +P R+TI W P
Sbjct: 253 SEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRD 292
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 248 bits (635), Expect = 2e-80
Identities = 73/269 (27%), Positives = 132/269 (49%), Gaps = 13/269 (4%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+E+ LG+G FGKV AQ+ ++ + A K+++ L+ EI L HP
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE---DYMVEIDILASCDHP 69
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNK 133
N+V+L + ++ +++++E+ GG + + R L E++ + + +Q +D ++Y H+
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 129
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 193
+ HRDLK NIL G+IK++DFG+SA ++ R + G+P ++APEV+
Sbjct: 130 KIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCETS 187
Query: 194 D----GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGAQN 246
+D+WS G+ L + P + N + KI + + P S ++
Sbjct: 188 KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKD 247
Query: 247 LLRKILEPNPVKRITIAGIKADEWFEQDY 275
L+K LE N R T + + + D
Sbjct: 248 FLKKCLEKNVDARWTTSQLLQHPFVTVDS 276
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 247 bits (633), Expect = 7e-80
Identities = 64/272 (23%), Positives = 114/272 (41%), Gaps = 10/272 (3%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+ R +G G+FG V FA+D+ + A+K + + + I +E+ L+ L+HP
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N ++ + ++V+EY G K LQE E + + G++Y H+
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 135
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
+ HRD+K NILL G +K+ DFG + ++ G+P ++APEV+
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANSFVGTPYWMAPEVILAMDEG 189
Query: 195 GAT--SDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKW--LSPGAQNLLRK 250
D+WS G+ + P + N I + + + S +N +
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 249
Query: 251 ILEPNPVKRITIAGIKADEWFEQDYTPANPDD 282
L+ P R T + + ++ P D
Sbjct: 250 CLQKIPQDRPTSEVLLKHRFVLRERPPTVIMD 281
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 244 bits (625), Expect = 3e-79
Identities = 84/275 (30%), Positives = 136/275 (49%), Gaps = 19/275 (6%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL------KITDQIKREIATL 68
YE LG G V+ + +AVKI++ ++ + +E+ L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 69 KLLK-HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
+ + HPN+++L + + + ++V + + GELFD + K L E E RK+ + L++ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
H + HRDLK ENILLD NIK++DFG S L CG+P+Y+APE+
Sbjct: 124 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLREVCGTPSYLAPEI 180
Query: 188 LA-----NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL--PKW- 239
+ N G D+WS GVI+Y +L G PF R ++ + I G+++ P+W
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240
Query: 240 -LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273
S ++L+ + L P KR T A +F+Q
Sbjct: 241 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 245 bits (626), Expect = 6e-79
Identities = 100/273 (36%), Positives = 147/273 (53%), Gaps = 13/273 (4%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y+ LG G F +V A+D + A+K + K + ++ EIA L +KHP
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIKHP 67
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N+V L ++ S +Y++++ V+GGELFD+I KG E + +L Q++D V Y H+ G
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127
Query: 135 VFHRDLKLENILL---DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
+ HRDLK EN+L D I ISDFGLS + +L T CG+P YVAPEVLA +
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQK 184
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGAQNL 247
Y A D WS GVI Y++L GY PF D N A L+++I + +++ +S A++
Sbjct: 185 PYSKA-VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 243
Query: 248 LRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
+R ++E +P KR T W D
Sbjct: 244 IRHLMEKDPEKRFTCEQALQHPWIAGDTALDKN 276
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 244 bits (624), Expect = 9e-79
Identities = 64/261 (24%), Positives = 127/261 (48%), Gaps = 10/261 (3%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
+Y +G+G G V A D+ +G A++ + + + I EI ++ K+
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE---LIINEILVMRENKN 76
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
PN+V + ++++V+EY+ GG L D + ++ + E + + ++ + + + H+
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 193
V HRD+K +NILL G++K++DFG A + T G+P ++APEV+ + Y
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 194 DGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---DFKLPKWLSPGAQNLLRK 250
DIWS G++ ++ G P+ + N I + + P+ LS ++ L +
Sbjct: 194 GPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252
Query: 251 ILEPNPVKRITIAGIKADEWF 271
L+ + KR + + ++
Sbjct: 253 CLDMDVEKRGSAKELLQHQFL 273
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 241 bits (615), Expect = 5e-77
Identities = 65/274 (23%), Positives = 126/274 (45%), Gaps = 15/274 (5%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+Y + LG G FG V + S + K ++ +K+EI+ L + +H
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIARHR 61
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNK 133
N++ LHE S ++ M+ E+++G ++F++I + L E E Q+ + + + H+
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 134 GVFHRDLKLENILLDSKGN--IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
+ H D++ ENI+ ++ + IKI +FG + + + +P Y APEV +
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQA---RQLKPGDNFRLLFTAPEYYAPEVHQHD 178
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGAQNL 247
A +D+WS G ++YV+L+G PF + + I ++ K +S A +
Sbjct: 179 VVSTA-TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237
Query: 248 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPD 281
+ ++L R+T + W +Q +
Sbjct: 238 VDRLLVKERKSRMTASEALQHPWLKQKIERVSTK 271
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 240 bits (612), Expect = 1e-76
Identities = 87/261 (33%), Positives = 145/261 (55%), Gaps = 5/261 (1%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL-LKH 73
+ L + LG+G+FGKV A+ + FA+K L+K+ ++ + E L L +H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
P + + +K ++ V+EY+ GG+L I S + + ++I G+ + H+K
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 122
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 193
G+ +RDLKL+NILLD G+IKI+DFG+ ++ D +T CG+P+Y+APE+L + Y
Sbjct: 123 GIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNTFCGTPDYIAPEILLGQKY 180
Query: 194 DGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE 253
+ + D WS GV+LY +L G PF ++ L+ I + P+WL A++LL K+
Sbjct: 181 NHS-VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFV 239
Query: 254 PNPVKRITIAG-IKADEWFEQ 273
P KR+ + G I+ F +
Sbjct: 240 REPEKRLGVRGDIRQHPLFRE 260
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 237 bits (605), Expect = 3e-76
Identities = 77/271 (28%), Positives = 127/271 (46%), Gaps = 16/271 (5%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
R YE+ T+G G++G+ + + G K L+ + + + E+ L+ L
Sbjct: 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLREL 60
Query: 72 KHPNVVRLHEVLASKS--KIYMVLEYVTGGELFDKIA----SKGRLQEAEGRKLFQQLID 125
KHPN+VR ++ + ++ +Y+V+EY GG+L I + L E ++ QL
Sbjct: 61 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120
Query: 126 GVSYCHNKG-----VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
+ CH + V HRDLK N+ LD K N+K+ DFGL+ + H D G+P
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKAFVGTP 178
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKW 239
Y++PE + Y+ SDIWS G +LY + PF + L KI G F ++P
Sbjct: 179 YYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 237
Query: 240 LSPGAQNLLRKILEPNPVKRITIAGIKADEW 270
S ++ ++L R ++ I +
Sbjct: 238 YSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (599), Expect = 3e-75
Identities = 85/274 (31%), Positives = 131/274 (47%), Gaps = 17/274 (6%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKL 70
+Y++G LG G FG V + LP A+K +EK+RI L ++ E+ LK
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 71 LK--HPNVVRLHEVLASKSKIYMVLEYVTGG-ELFDKIASKGRLQEAEGRKLFQQLIDGV 127
+ V+RL + ++LE +LFD I +G LQE R F Q+++ V
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 128 SYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
+CHN GV HRD+K ENIL+D ++G +K+ DFG D + G+ Y PE
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG----ALLKDTVYTDFDGTRVYSPPE 179
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN 246
+ Y G ++ +WS G++LY ++ G +PF+ +I RG + +S Q+
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQH 233
Query: 247 LLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
L+R L P R T I+ W + P
Sbjct: 234 LIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQET 267
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 235 bits (601), Expect = 5e-75
Identities = 81/263 (30%), Positives = 147/263 (55%), Gaps = 11/263 (4%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+++ RTLG G+FG+V + +G +A+K+L+K ++ LK + E L ++ HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
++R+ +I+M+++Y+ GGELF + R + ++ + Y H+K +
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 125
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
+RDLK ENILLD G+IKI+DFG + + +T CG+P+Y+APEV++ + Y+
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEVVSTKPYNK 180
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
+ D WS G+++Y +L GY PF D N Y+KI + + P + + ++LL +++ +
Sbjct: 181 S-IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRD 239
Query: 256 PVKRI-----TIAGIKADEWFEQ 273
+R+ +K WF++
Sbjct: 240 LSQRLGNLQNGTEDVKNHPWFKE 262
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 236 bits (603), Expect = 9e-75
Identities = 95/392 (24%), Positives = 170/392 (43%), Gaps = 44/392 (11%)
Query: 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
+ + + + R +G G FG+V + D+G +A+K L+K RI + E L L
Sbjct: 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 60
Query: 71 LK---HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
+ P +V + + K+ +L+ + GG+L ++ G EA+ R ++I G+
Sbjct: 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 120
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
+ HN+ V +RDLK NILLD G+++ISD GL+ H + G+ Y+APEV
Sbjct: 121 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC----DFSKKKPHASVGTHGYMAPEV 176
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDD---RNLAVLYQKIFRGDFKLPKWLSPGA 244
L +++D +S G +L+ +L G+ PF ++ + + +LP SP
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 236
Query: 245 QNLLRKILEPNPVKRITIAGIKADE-----WFEQDYTPANPDDDEEDIFVDNEAFSMHEV 299
++LL +L+ + +R+ G A E +F +D + + +
Sbjct: 237 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS---------------LDWQMVFLQKY 281
Query: 300 PSDGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKD----LLER 355
P PPLI + + D+ F++ED K+ + ++ + ER
Sbjct: 282 P---------PPLIPPRGEVNAADAFDIG-SFDEEDTKGIKLLDSDQELYRNFPLTISER 331
Query: 356 IEDIVTEMGFRVQKKNGKLKATQEHKPQKSLG 387
+ V E F ++ K LG
Sbjct: 332 WQQEVAETVFDTINAETDRLEARKKTKNKQLG 363
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (592), Expect = 2e-74
Identities = 65/270 (24%), Positives = 125/270 (46%), Gaps = 18/270 (6%)
Query: 14 GRY-ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
GR+ + +G G+F V D ++ + A L+ ++ + K E LK L+
Sbjct: 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQ 66
Query: 73 HPNVVRLHEVLASKSK----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
HPN+VR ++ S K I +V E +T G L + ++ R +Q++ G+
Sbjct: 67 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ 126
Query: 129 YCHNKG--VFHRDLKLENILLDSK-GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 185
+ H + + HRDLK +NI + G++KI D GL+ + G+P ++AP
Sbjct: 127 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFAKAVIGTPEFMAP 182
Query: 186 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRG--DFKLPKWLSP 242
E+ YD + D+++ G+ + + T P+ + +N A +Y+++ G K P
Sbjct: 183 EMY-EEKYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 240
Query: 243 GAQNLLRKILEPNPVKRITIAGIKADEWFE 272
+ ++ + N +R +I + +F+
Sbjct: 241 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (596), Expect = 3e-74
Identities = 77/308 (25%), Positives = 125/308 (40%), Gaps = 52/308 (16%)
Query: 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
++ +E LG GN G V SGL A K++ I I +QI RE+ L
Sbjct: 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHE 60
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
P +V + S +I + +E++ GG L + GR+ E K+ +I G++Y
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 131 HNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
K + HRD+K NIL++S+G IK+ DFG+S D + ++ G+ +Y++PE L
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG----QLIDSMANSFVGTRSYMSPERLQ 176
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPF---DDRNLAVLYQKIFRGDFKL---------- 236
Y SDIWS G+ L + G P D + L +++ GD
Sbjct: 177 GTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235
Query: 237 -------------------------------PKWLSPGAQNLLRKILEPNPVKRITIAGI 265
S Q+ + K L NP +R + +
Sbjct: 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
Query: 266 KADEWFEQ 273
+ ++
Sbjct: 296 MVHAFIKR 303
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (591), Expect = 7e-74
Identities = 89/270 (32%), Positives = 141/270 (52%), Gaps = 15/270 (5%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---ITDQIKREIATLKLL 71
Y+ G LG G F VK ++ +GL +A K ++K R + + I+RE++ LK +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
+HPNV+ LHEV +K+ + ++LE V GGELFD +A K L E E + +Q+++GV Y H
Sbjct: 71 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 132 NKGVFHRDLKLENILLDSKG----NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
+ + H DLK ENI+L + IKI DFGL+ G+P +VAPE+
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA---HKIDFGNEFKNIFGTPEFVAPEI 187
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPG 243
+ +D+WS GVI Y++L+G PF + +++ S
Sbjct: 188 VNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQ 273
A++ +R++L +P KR+TI W +
Sbjct: 247 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (579), Expect = 2e-71
Identities = 86/264 (32%), Positives = 142/264 (53%), Gaps = 8/264 (3%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ ++ + LG+G FGKV ++ +G +A+KIL K II E L+ +
Sbjct: 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
HP + L + ++ V+EY GGELF ++ + E R +++ + Y H+
Sbjct: 64 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
+ V +RD+KLEN++LD G+IKI+DFGL D + T CG+P Y+APEVL +
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGTPEYLAPEVLEDND 181
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKIL 252
Y A D W GV++Y ++ G LPF +++ L++ I + + P+ LSP A++LL +L
Sbjct: 182 YGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL 240
Query: 253 EPNPVKRITIAGIKADE-----WF 271
+ +P +R+ A E +F
Sbjct: 241 KKDPKQRLGGGPSDAKEVMEHRFF 264
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (568), Expect = 1e-70
Identities = 59/261 (22%), Positives = 116/261 (44%), Gaps = 14/261 (5%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
G+ +G+ +G G+FG V + AVK+L + K E+ L+ +H
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRH 63
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHN 132
N++ ++ ++ +V ++ G L+ + + + + + + +Q G+ Y H
Sbjct: 64 VNILLFMGY-STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
K + HRDLK NI L +KI DFGL+ + + GS ++APEV+ +
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 193 YDGAT--SDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF------KLPKWLSPGA 244
+ + SD+++ G++LY ++TG LP+ + N + + K+
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 242
Query: 245 QNLLRKILEPNPVKRITIAGI 265
+ L+ + L+ +R I
Sbjct: 243 KRLMAECLKKKRDERPLFPQI 263
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 222 bits (567), Expect = 1e-70
Identities = 70/266 (26%), Positives = 118/266 (44%), Gaps = 10/266 (3%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
RYELG LG G +V A+DL AVK+L + + +RE L H
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 74 PNVVRLHEVLASKSK----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
P +V +++ +++ Y+V+EYV G L D + ++G + ++ +++
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVL 188
H G+ HRD+K NI++ + +K+ DFG++ + G+ Y++PE
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGA 244
D SD++S G +LY +LTG PF + + + R D P + LS
Sbjct: 187 RGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADL 245
Query: 245 QNLLRKILEPNPVKRITIAGIKADEW 270
++ K L NP R A +
Sbjct: 246 DAVVLKALAKNPENRYQTAAEMRADL 271
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 222 bits (566), Expect = 2e-69
Identities = 89/272 (32%), Positives = 147/272 (54%), Gaps = 11/272 (4%)
Query: 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
Q +L +++ +TLG G+FG+V + +SG +A+KIL+K +++ LK + E
Sbjct: 33 PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 66 ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID 125
L+ + P +V+L S +YMV+EYV GGE+F + GR E R Q++
Sbjct: 93 RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 185
Y H+ + +RDLK EN+L+D +G I+++DFG + + T CG+P +AP
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WTLCGTPEALAP 207
Query: 186 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQ 245
E++ ++GY+ A D W+ GV++Y + GY PF +Y+KI G + P S +
Sbjct: 208 EIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 246 NLLRKILEPNPVKRI-----TIAGIKADEWFE 272
+LLR +L+ + KR + IK +WF
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (554), Expect = 8e-68
Identities = 79/301 (26%), Positives = 138/301 (45%), Gaps = 25/301 (8%)
Query: 8 QEGMRLGRYE-LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
++ + Y+ + LG G GKV + + FA+K+L+ + +RE+
Sbjct: 5 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVE 56
Query: 67 TL-KLLKHPNVVRLHEVL----ASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKL 119
+ + P++VR+ +V A + + +V+E + GGELF +I +G E E ++
Sbjct: 57 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 116
Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179
+ + + + Y H+ + HRD+K EN+L SK I + L T C +
Sbjct: 117 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 176
Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN----LAVLYQKIFRGDFK 235
P YVAPEVL YD + D+WS GVI+Y++L GY PF + + +I G ++
Sbjct: 177 PYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 235
Query: 236 LP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDN 291
P +S + L+R +L+ P +R+TI W Q + ++
Sbjct: 236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKED 295
Query: 292 E 292
+
Sbjct: 296 K 296
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 1e-65
Identities = 68/311 (21%), Positives = 115/311 (36%), Gaps = 43/311 (13%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
+ +YE +G+G FG+V A+ +G A+K + REI L+LL
Sbjct: 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLL 66
Query: 72 KHPNVVRLHEVLAS--------KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL 123
KH NVV L E+ + K IY+V ++ + +E +++ Q L
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 126
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL--PQHFRDDGLLHTTCGSPN 181
++G+ Y H + HRD+K N+L+ G +K++DFGL+ +
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK--- 238
Y PE+L G D+W G I+ + T I + +
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246
Query: 239 -----------------------------WLSPGAQNLLRKILEPNPVKRITIAGIKADE 269
P A +L+ K+L +P +RI +
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306
Query: 270 WFEQDYTPANP 280
+F D P++
Sbjct: 307 FFWSDPMPSDL 317
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 6e-65
Identities = 77/315 (24%), Positives = 127/315 (40%), Gaps = 39/315 (12%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
RY +GEG +G V A D + + A+K + H + REI L +H
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRH 65
Query: 74 PNVVRLHEVLASKS----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
N++ +++++ + + K ++ ++ G +L+ + L Q++ G+ Y
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLKY 124
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT-CGSPNYVAPEVL 188
H+ V HRDLK N+LL++ ++KI DFGL+ + D T + Y APE++
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-------------- 234
N + DIWS G IL +L+ F ++ I
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244
Query: 235 -----------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277
+L A +LL K+L NP KRI + A + EQ Y P
Sbjct: 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304
Query: 278 ANPDDDEEDIFVDNE 292
++ E D E
Sbjct: 305 SDEPIAEAPFKFDME 319
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 8e-65
Identities = 69/294 (23%), Positives = 109/294 (37%), Gaps = 32/294 (10%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK--ITDQIKREIATLKLLKHP 74
E LGEG F V A+D ++ A+K ++ K I REI L+ L HP
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N++ L + KS I +V +++ + L + + + G+ Y H
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
+ HRDLK N+LLD G +K++DFGL+ + + Y APE+L
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAK--SFGSPNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 195 GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR--GDFKLPKW------------- 239
G D+W+ G IL +L + +IF G +W
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 240 -------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
+L++ + NP RIT ++F P
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPG 292
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 9e-65
Identities = 64/257 (24%), Positives = 111/257 (43%), Gaps = 18/257 (7%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+L +T+G+G FG V G AVK ++ + E + + L+H
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHS 60
Query: 75 NVVRLHEVLA-SKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCH 131
N+V+L V+ K +Y+V EY+ G L D + S+GR L K + + + Y
Sbjct: 61 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
HRDL N+L+ K+SDFGL+ +D T + APE L +
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEALREK 175
Query: 192 GYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLR 249
+ SD+WS G++L+ I + G +P+ L + ++ +G P P +++
Sbjct: 176 KFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMK 234
Query: 250 KILEPNPVKRITIAGIK 266
+ R + ++
Sbjct: 235 NCWHLDAAMRPSFLQLR 251
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 204 bits (520), Expect = 2e-63
Identities = 80/288 (27%), Positives = 131/288 (45%), Gaps = 33/288 (11%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+Y +GEG +G V AQ+ + G FA+K + + I REI+ LK LKH
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDE-GIPSTTIREISILKELKHS 60
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N+V+L++V+ +K ++ +V E++ +G L+ + QL++G++YCH++
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
V HRDLK +N+L++ +G +KI+DFGL+ + Y AP+VL
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGI--PVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 195 GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-------------------- 234
T DIWS G I ++ G F + A +IFR
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 235 ---------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273
K L +LL K+L+ +P +RIT +F++
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 2e-63
Identities = 64/259 (24%), Positives = 107/259 (41%), Gaps = 8/259 (3%)
Query: 15 RYELGRTLGEGNFGKVKFAQ---DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
L LG+G+FG V+ + + AVK L+ + + + D RE+ + L
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYC 130
H N++RL+ V+ + + MV E G L D++ G + Q+ +G+ Y
Sbjct: 69 DHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
+K HRDL N+LL ++ +KI DFGL D ++ P
Sbjct: 128 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 191 RGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKW--LSPGAQNL 247
SD W GV L+ + T G P+ N + + KI + +LP+ N+
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNV 247
Query: 248 LRKILEPNPVKRITIAGIK 266
+ + P R T ++
Sbjct: 248 MVQCWAHKPEDRPTFVALR 266
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 1e-62
Identities = 63/261 (24%), Positives = 106/261 (40%), Gaps = 10/261 (3%)
Query: 20 RTLGEGNFGKVKFA--QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
+ LG GNFG VK Q AVKIL KN + D++ E ++ L +P +V
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 78 RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
R+ + +V+E G L + +++ +L Q+ G+ Y H
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130
Query: 138 RDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 196
RDL N+LL ++ KISDFGLS AL + APE + +
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK 190
Query: 197 TSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEP 254
SD+WS GV+++ + G P+ + + + +G+ P +L+
Sbjct: 191 -SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 249
Query: 255 NPVKRITIAGIKA--DEWFEQ 273
+ R A ++ ++
Sbjct: 250 DVENRPGFAAVELRLRNYYYD 270
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 2e-62
Identities = 60/253 (23%), Positives = 114/253 (45%), Gaps = 14/253 (5%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+ LG G FG VK+ + A+K++++ + D+ E + L H
Sbjct: 6 LTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEK 60
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
+V+L+ V + I+++ EY+ G L + + + R Q + ++ + + + + Y +K
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT--CGSPNYVAPEVLANRG 192
HRDL N L++ +G +K+SDFGLS ++ DD + + PEVL
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLS---RYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 193 YDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRK 250
+ SDIW+ GV+++ I + G +P++ + + I +G P S ++
Sbjct: 178 FSSK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS 236
Query: 251 ILEPNPVKRITIA 263
+R T
Sbjct: 237 CWHEKADERPTFK 249
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 5e-62
Identities = 77/293 (26%), Positives = 133/293 (45%), Gaps = 33/293 (11%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
++ +GEG +G V A++ +G A+K + + + REI+ LK L HP
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHP 61
Query: 75 NVVRLHEVLASKSKIYMVLEYV-TGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
N+V+L +V+ +++K+Y+V E++ + F ++ + + QL+ G+++CH+
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 193
V HRDLK +N+L++++G IK++DFGL+ + Y APE+L Y
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLA--RAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 194 DGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------------DFK 235
DIWS G I ++T F + +IFR
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 236 LPKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277
PKW L ++LL ++L +P KRI+ A +F+ P
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 6e-62
Identities = 80/282 (28%), Positives = 146/282 (51%), Gaps = 14/282 (4%)
Query: 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIH-LKITDQI 61
E + + +EL + LG G +GKV + + D+G +A+K+L+K I+ K T+
Sbjct: 16 GHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHT 75
Query: 62 KREIATLKLLKH-PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
+ E L+ ++ P +V LH +++K++++L+Y+ GGELF ++ + R E E +
Sbjct: 76 RTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV 135
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
+++ + + H G+ +RD+KLENILLDS G++ ++DFGLS +
Sbjct: 136 GEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 195
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN----LAVLYQKIFRGDFKL 236
V D WS GV++Y +LTG PF A + ++I + +
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY 255
Query: 237 PKWLSPGAQNLLRKILEPNPVKRITIAGIKADE-----WFEQ 273
P+ +S A++L++++L +P KR+ ADE +F++
Sbjct: 256 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 8e-62
Identities = 72/302 (23%), Positives = 121/302 (40%), Gaps = 49/302 (16%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y + +G G+FG V A+ DSG A+K + +++ RE+ ++ L H
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHC 73
Query: 75 NVVRLHEVLASKSK------IYMVLEYVTGG---ELFDKIASKGRLQEAEGRKLFQQLID 125
N+VRL S + + +VL+YV +K L + QL
Sbjct: 74 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
++Y H+ G+ HRD+K +N+LLD + K+ DFG + + + S Y A
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA---KQLVRGEPNVSYICSRYYRA 190
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR------------- 231
PE++ ++ D+WS G +L +L G F + +I +
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250
Query: 232 ----GDFKLPKW------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
+FK P+ P A L ++LE P R+T A +F++
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310
Query: 276 TP 277
P
Sbjct: 311 DP 312
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 1e-61
Identities = 73/296 (24%), Positives = 114/296 (38%), Gaps = 25/296 (8%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKH 73
+ +GEGNFG+V A+ GL I E+ L KL H
Sbjct: 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKI----------------ASKGRLQEAEGR 117
PN++ L + +Y+ +EY G L D + ++ L +
Sbjct: 71 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130
Query: 118 KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC 177
+ G+ Y K HRDL NIL+ KI+DFGLS +
Sbjct: 131 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS---RGQEVYVKKTMGR 187
Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFK 235
++A E L N SD+WS GV+L+ I++ G P+ A LY+K+ +G +
Sbjct: 188 LPVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 246
Query: 236 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKA--DEWFEQDYTPANPDDDEEDIFV 289
P +L+R+ P +R + A I + E+ T N E+ +
Sbjct: 247 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYA 302
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 2e-61
Identities = 64/283 (22%), Positives = 111/283 (39%), Gaps = 35/283 (12%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSG-----LPFAVKILEKNRIIHLKITDQIKREIATL- 68
E G+ LG G FGKV A + AVK+L++ + + E+ +
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMT 95
Query: 69 KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-------------------- 108
+L H N+V L IY++ EY G+L + + SK
Sbjct: 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 109 ---GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165
L + Q+ G+ + K HRDL N+L+ +KI DFGL+
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215
Query: 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAV 224
+ + ++APE L Y SD+WS G++L+ I + G P+ +
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPGIPVDA 274
Query: 225 LYQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGI 265
+ K+ + FK+ P + + +++ + KR + +
Sbjct: 275 NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL 317
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 2e-61
Identities = 75/295 (25%), Positives = 128/295 (43%), Gaps = 34/295 (11%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ +YE +GEG +G V A++ ++ A+K + + + REI LK LK
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELK 59
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
H N+VRLH+VL S K+ +V E+ + G L + QL+ G+ +CH+
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
+ V HRDLK +N+L++ G +K+++FGL+ + Y P+VL
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 193 YDGATSDIWSCGVILYVILTGYLP-FDDRNLAVLYQKIFRGDF----------------- 234
+ D+WS G I + P F ++ ++IFR
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237
Query: 235 ------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277
+ L+ ++LL+ +L+ NPV+RI+ +F D+ P
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF-SDFCP 291
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 199 bits (507), Expect = 2e-61
Identities = 72/275 (26%), Positives = 123/275 (44%), Gaps = 12/275 (4%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+ LG G +G+V L AVK L+++ + ++ +E A +K +KHP
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHP 73
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHN 132
N+V+L V + Y++ E++T G L D + R + + Q+ + Y
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
K HRDL N L+ +K++DFGLS L + APE LA
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNK 192
Query: 193 YDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRK 250
+ SD+W+ GV+L+ I T G P+ +L+ +Y+ + + + P+ L+R
Sbjct: 193 FSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA 251
Query: 251 ILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 285
+ NP R + A I + FE + ++ D+ E
Sbjct: 252 CWQWNPSDRPSFAEIH--QAFETMFQESSISDEVE 284
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 3e-61
Identities = 77/303 (25%), Positives = 123/303 (40%), Gaps = 45/303 (14%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y + +G G +G V A D +G A+K L + + RE+ LK ++H
Sbjct: 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE-LFAKRAYRELRLLKHMRHE 77
Query: 75 NVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
NV+ L +V L + Y+V+ ++ G K+ +L E + L Q++ G+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 135
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
Y H G+ HRDLK N+ ++ +KI DFGL+ D + + Y APEV+
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA-----DSEMTGYVVTRWYRAPEVI 190
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKW--------- 239
N T DIWS G I+ ++TG F + ++I + P
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250
Query: 240 ----------------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277
SP A NLL K+L + +R+T A +FE +
Sbjct: 251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 310
Query: 278 ANP 280
+
Sbjct: 311 EDE 313
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 9e-61
Identities = 69/263 (26%), Positives = 120/263 (45%), Gaps = 14/263 (5%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+L LG G FG+V + AVK L++ + D E +K L+H
Sbjct: 14 TLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQHQ 68
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHN 132
+VRL+ V+ ++ IY++ EY+ G L D + + +L + + Q+ +G+++
Sbjct: 69 RLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
+ HRDL+ NIL+ + KI+DFGL+ L + + APE + N G
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARL-IEDNEYTAREGAKFPIKWTAPEAI-NYG 185
Query: 193 YDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRK 250
SD+WS G++L I+T G +P+ + Q + RG P L+R
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRL 245
Query: 251 ILEPNPVKRITIAGIKA--DEWF 271
+ P R T +++ +++F
Sbjct: 246 CWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 1e-60
Identities = 65/275 (23%), Positives = 120/275 (43%), Gaps = 14/275 (5%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
L LG+G FG+V + A+K L+ + + +E +K L+H
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSP----EAFLQEAQVMKKLRHE 72
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHN 132
+V+L+ V+ S+ IY+V EY++ G L D + + L+ + + Q+ G++Y
Sbjct: 73 KLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
HRDL+ NIL+ K++DFGL+ L + + + APE
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGR 190
Query: 193 YDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRK 250
+ SD+WS G++L + T G +P+ + ++ RG P +L+ +
Sbjct: 191 FTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 249
Query: 251 ILEPNPVKRITIAGIKA--DEWFEQDYTPANPDDD 283
P +R T ++A +++F P ++
Sbjct: 250 CWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 284
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 1e-60
Identities = 66/250 (26%), Positives = 103/250 (41%), Gaps = 10/250 (4%)
Query: 22 LGEGNFGKVKFAQD--LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
LG GNFG V+ + A+K+L++ T+++ RE + L +P +VRL
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRL 74
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
V + +V+E GG L + K + + +L Q+ G+ Y K HR
Sbjct: 75 IGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 133
Query: 139 DLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT 197
DL N+LL ++ KISDFGLS AL + APE + R +
Sbjct: 134 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR- 192
Query: 198 SDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPN 255
SD+WS GV ++ L+ G P+ + I +G + P P L+
Sbjct: 193 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYK 252
Query: 256 PVKRITIAGI 265
R +
Sbjct: 253 WEDRPDFLTV 262
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 5e-60
Identities = 71/260 (27%), Positives = 120/260 (46%), Gaps = 11/260 (4%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLP-FAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
R ELGR +GEG FG V + P AV I + ++ +E T++ H
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHN 132
P++V+L V+ +++ +++++E T GEL + + L A QL ++Y +
Sbjct: 68 PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 126
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC--GSPNYVAPEVLAN 190
K HRD+ N+L+ S +K+ DFGLS ++ D + ++APE +
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLS---RYMEDSTYYKASKGKLPIKWMAPESINF 183
Query: 191 RGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLL 248
R + A SD+W GV ++ IL G PF + +I G+ +P P +L+
Sbjct: 184 RRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM 242
Query: 249 RKILEPNPVKRITIAGIKAD 268
K +P +R +KA
Sbjct: 243 TKCWAYDPSRRPRFTELKAQ 262
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 1e-59
Identities = 57/252 (22%), Positives = 108/252 (42%), Gaps = 10/252 (3%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+ +G G FG V L+ A+K + + + + E + L HP
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHP 60
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQ-EAEGRKLFQQLIDGVSYCHNK 133
+V+L+ V ++ I +V E++ G L D + ++ L + + +G++Y
Sbjct: 61 KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 193
V HRDL N L+ IK+SDFG++ T + +PEV + Y
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRY 179
Query: 194 DGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKI 251
SD+WS GV+++ + + G +P+++R+ + + + I G P+ S ++
Sbjct: 180 SSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC 238
Query: 252 LEPNPVKRITIA 263
+ P R +
Sbjct: 239 WKERPEDRPAFS 250
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (495), Expect = 1e-59
Identities = 78/295 (26%), Positives = 124/295 (42%), Gaps = 42/295 (14%)
Query: 15 RYELGRTLGEGNFGKVKFAQDL-DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK- 72
+YE +GEG +GKV A+DL + G A+K + + + + RE+A L+ L+
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLET 66
Query: 73 --HPNVVRLHEVLAS-----KSKIYMVLEYVTGGEL-FDKIASKGRLQEAEGRKLFQQLI 124
HPNVVRL +V ++K+ +V E+V + + + + + QL+
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
G+ + H+ V HRDLK +NIL+ S G IK++DFGL+ + + + Y A
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVTLWYRA 183
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------ 232
PEVL Y D+WS G I + F + KI
Sbjct: 184 PEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242
Query: 233 ---------------DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 272
K + ++LL K L NP KRI+ + +F+
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (495), Expect = 5e-59
Identities = 80/321 (24%), Positives = 128/321 (39%), Gaps = 51/321 (15%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
RY+ +G G +G V A D +GL AVK L + + + RE+ LK +KH
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHE 77
Query: 75 NVVRLHEVLASKSKI-----YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
NV+ L +V + ++ ++ G + I +L + + L Q++ G+ Y
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
H+ + HRDLK N+ ++ +KI DFGL+ + Y APE++
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIML 191
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWL--------- 240
N + T DIWS G I+ +LTG F + + I R L
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251
Query: 241 ----------------------SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA 278
+P A +LL K+L + KRIT A A +F Q + P
Sbjct: 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311
Query: 279 --------NPDDDEEDIFVDN 291
+ + D+ +D
Sbjct: 312 DEPVADPYDQSFESRDLLIDE 332
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 191 bits (486), Expect = 3e-58
Identities = 57/262 (21%), Positives = 106/262 (40%), Gaps = 12/262 (4%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLK 69
+ ++ + +G G FG+V G + A+K L+ K E + +
Sbjct: 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASIMG 82
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVS 128
HPNV+ L V+ + + ++ E++ G L + G+ + + + + G+
Sbjct: 83 QFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMK 142
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT---CGSPNYVAP 185
Y + HRDL NIL++S K+SDFGLS + D + + AP
Sbjct: 143 YLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 202
Query: 186 EVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPG 243
E + R + A SD+WS G++++ +++ G P+ D + I + P
Sbjct: 203 EAIQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSA 261
Query: 244 AQNLLRKILEPNPVKRITIAGI 265
L+ + + R I
Sbjct: 262 LHQLMLDCWQKDRNHRPKFGQI 283
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 1e-57
Identities = 55/285 (19%), Positives = 111/285 (38%), Gaps = 6/285 (2%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLKH 73
++ + LG G FG V + G + + K K +I E + + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
P+V RL + + + + G L K + Q+ G++Y ++
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 193
+ HRDL N+L+ + ++KI+DFGL+ L + ++A E + +R Y
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 190
Query: 194 DGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKI 251
SD+WS GV ++ ++T G P+D + + + +G+ P + ++ K
Sbjct: 191 THQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 249
Query: 252 LEPNPVKRITIAGIKAD-EWFEQDYTPANPDDDEEDIFVDNEAFS 295
+ R + + +D +E + + + S
Sbjct: 250 WMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDS 294
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 190 bits (482), Expect = 1e-57
Identities = 59/293 (20%), Positives = 100/293 (34%), Gaps = 27/293 (9%)
Query: 11 MRLG-RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
+R+G RY LGR +G G+FG + D+ +G A+K+ Q+ E K
Sbjct: 3 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK-----TKHPQLHIESKIYK 57
Query: 70 LLKHPN-VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
+++ + + A MV+E + + L Q+I +
Sbjct: 58 MMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIE 117
Query: 129 YCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLH-----TTCGSP 180
Y H+K HRD+K +N L+ + I DFGL+ + R + G+
Sbjct: 118 YIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK----- 235
Y + D+ S G +L G LP+ A QK R K
Sbjct: 178 RYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236
Query: 236 ---LPKWLSPGAQNLLRKILEPNPVKRITIAGIKA---DEWFEQDYTPANPDD 282
L K L + + ++ + + Q ++ D
Sbjct: 237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFD 289
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 188 bits (479), Expect = 3e-57
Identities = 65/282 (23%), Positives = 109/282 (38%), Gaps = 34/282 (12%)
Query: 15 RYELGRTLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
E R +GEG FG+V + AVK+L++ ++ +RE A +
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ--ADFQREAALMA 71
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR------------------- 110
+PN+V+L V A + ++ EY+ G+L + + S
Sbjct: 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 111 -----LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165
L AE + +Q+ G++Y + HRDL N L+ +KI+DFGLS
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191
Query: 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYL-PFDDRNLAV 224
++ PE + Y SD+W+ GV+L+ I + L P+
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPYYGMAHEE 250
Query: 225 LYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGI 265
+ + G+ P+ NL+R P R + I
Sbjct: 251 VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSI 292
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 187 bits (476), Expect = 2e-56
Identities = 64/299 (21%), Positives = 122/299 (40%), Gaps = 54/299 (18%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-H 73
Y+L R LG G + +V A ++ + VKIL+ + +IKREI L+ L+
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK------KKIKREIKILENLRGG 89
Query: 74 PNVVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
PN++ L +++ +V E+V + L + + R +++ + YCH
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCH 146
Query: 132 NKGVFHRDLKLENILLDSKGN-IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
+ G+ HRD+K N+++D + +++ D+GL+ + + + S + PE+L +
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA---EFYHPGQEYNVRVASRYFKGPELLVD 203
Query: 191 RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV--------------LYQKIFRGDFKL 236
+ D+WS G +L ++ PF + LY I + + +L
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263
Query: 237 PKW------------------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271
+SP A + L K+L + R+T +F
Sbjct: 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 1e-55
Identities = 68/278 (24%), Positives = 117/278 (42%), Gaps = 30/278 (10%)
Query: 15 RYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
R G+TLG G FGKV A D+ + AVK+L+ + HL + + E+ L
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLS 81
Query: 70 LLK-HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG------------------R 110
L H N+V L ++ EY G+L + + K
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 111 LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170
L + Q+ G+++ +K HRDL NILL KI DFGL+ ++ +
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKI 229
+ ++APE + N SD+WS G+ L+ + + G P+ + + K+
Sbjct: 202 VVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260
Query: 230 FRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGI 265
+ F++ P+ ++++ + +P+KR T I
Sbjct: 261 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 298
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 8e-55
Identities = 70/280 (25%), Positives = 118/280 (42%), Gaps = 29/280 (10%)
Query: 15 RYELGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
R LG+ LGEG FG+V A+ + + AVK+L+ + K + E+
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEM 71
Query: 68 LK-LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI----------------ASKGR 110
+K + KH N++ L +Y+++EY + G L + + + +
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 111 LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170
L + Q+ G+ Y +K HRDL N+L+ +KI+DFGL+ H
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKI 229
++APE L +R Y SD+WS GV+L+ I T G P+ + L++ +
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250
Query: 230 FRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268
G P + ++R P +R T + D
Sbjct: 251 KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 181 bits (460), Expect = 2e-54
Identities = 50/290 (17%), Positives = 93/290 (32%), Gaps = 27/290 (9%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
Y++GR +GEG+FG + +L + A+K + Q++ E T KLL
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-----SDAPQLRDEYRTYKLLAG 59
Query: 74 -PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
+ ++ +V++ + + +Q++ V H
Sbjct: 60 CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 119
Query: 133 KGVFHRDLKLENILLDSK-----GNIKISDFGLSALPQHFRDDGLLH-----TTCGSPNY 182
K + +RD+K +N L+ I + DFG+ + + G+ Y
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK------- 235
++ R D+ + G + L G LP+ A QK R K
Sbjct: 180 MSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238
Query: 236 -LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDE 284
L + ++ F + N +DE
Sbjct: 239 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ--GLFSKVLERLNTTEDE 286
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 1e-53
Identities = 61/259 (23%), Positives = 107/259 (41%), Gaps = 11/259 (4%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKL 70
+ +G G FG+V S +P A+K L+ ++ E +
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV--DFLGEAGIMGQ 65
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSY 129
H N++RL V++ + ++ EY+ G L + K G + + + + G+ Y
Sbjct: 66 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 125
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVL 188
N HRDL NIL++S K+SDFGLS L + APE +
Sbjct: 126 LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185
Query: 189 ANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 246
+ R + A SD+WS G++++ ++T G P+ + + + + I G P
Sbjct: 186 SYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQ 244
Query: 247 LLRKILEPNPVKRITIAGI 265
L+ + + +R A I
Sbjct: 245 LMMQCWQQERARRPKFADI 263
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 1e-53
Identities = 69/281 (24%), Positives = 117/281 (41%), Gaps = 18/281 (6%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
+G G+FG V LD+ + AVK L NRI + Q E +K
Sbjct: 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDF 85
Query: 72 KHPNVVRLHEV-LASKSKIYMVLEYVTGGELFD-KIASKGRLQEAEGRKLFQQLIDGVSY 129
HPNV+ L + L S+ +VL Y+ G+L + + Q+ G+ +
Sbjct: 86 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKF 145
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT--CGSPNYVAPEV 187
+K HRDL N +LD K +K++DFGL+ D + + T ++A E
Sbjct: 146 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205
Query: 188 LANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQ 245
L + + SD+WS GV+L+ ++T G P+ D N + + +G P++
Sbjct: 206 LQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 264
Query: 246 NLLRKILEPNPVKRITIAGIKA------DEWFEQDYTPANP 280
++ K P R + + + + + + Y N
Sbjct: 265 EVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNA 305
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 5e-53
Identities = 75/338 (22%), Positives = 129/338 (38%), Gaps = 59/338 (17%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
L RY+ + +G G G V A D A+K L + + + RE+ +K +
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 74
Query: 73 HPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
H N++ L V + +Y+V+E + + L L Q++ G
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCG 131
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
+ + H+ G+ HRDLK NI++ S +KI DFGL+ + ++ + Y APE
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRYYRAPE 188
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-------------- 232
V+ GY DIWS G I+ ++ + F R+ + K+
Sbjct: 189 VILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247
Query: 233 ----------------------------DFKLPKWLSPGAQNLLRKILEPNPVKRITIAG 264
D + K + A++LL K+L +P KRI++
Sbjct: 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 307
Query: 265 IKADEWFEQDYTPANPDDDEEDIF---VDNEAFSMHEV 299
+ Y PA + I+ +D ++ E
Sbjct: 308 ALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEW 345
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 6e-51
Identities = 59/291 (20%), Positives = 116/291 (39%), Gaps = 22/291 (7%)
Query: 15 RYELGRTLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
+ + R LG+G+FG V K + A+K + + ++ + E + +K
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMK 78
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR----------LQEAEGRKL 119
+VVRL V++ +++E +T G+L + S ++ ++
Sbjct: 79 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138
Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179
++ DG++Y + HRDL N ++ +KI DFG++
Sbjct: 139 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTG-YLPFDDRNLAVLYQKIFRGD-FKLP 237
+++PE L + + + D+WS GV+L+ I T P+ + + + + G P
Sbjct: 199 VRWMSPESLKDGVFTTYS-DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP 257
Query: 238 KWLSPGAQNLLRKILEPNPVKRITIAGIKA--DEWFEQDYTPANPDDDEED 286
L+R + NP R + I + E E + + EE+
Sbjct: 258 DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEEN 308
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 2e-49
Identities = 62/294 (21%), Positives = 111/294 (37%), Gaps = 48/294 (16%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
L ++G+G FG+V + G AVKI + EI +L+H
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSW----FREAEIYQTVMLRH 56
Query: 74 PNVVRLHEVL----ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
N++ + +++++V +Y G LFD + ++ + KL G+++
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAH 115
Query: 130 CH--------NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGS 179
H + HRDLK +NIL+ G I+D GL+ D D + G+
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175
Query: 180 PNYVAPEVL-----ANRGYDGATSDIWSCGVILYVILTGYLPFD---------------D 219
Y+APEVL +DI++ G++ + I D
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235
Query: 220 RNLAVLYQKIFRGDFKLP---KWLSPGA----QNLLRKILEPNPVKRITIAGIK 266
++ + + + + +W S A ++R+ N R+T IK
Sbjct: 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 1e-48
Identities = 63/276 (22%), Positives = 107/276 (38%), Gaps = 27/276 (9%)
Query: 15 RYELGRTLGEGNFGKVKFAQD-----LDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
R +LG+ LG G FG+V A + AVK+L++ H + + +
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIH 72
Query: 70 LLKHPNVVRLHEVLASK-SKIYMVLEYVTGGELFDKIASKGR----------------LQ 112
+ H NVV L + +++E+ G L + SK L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 113 EAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172
Q+ G+ + ++ HRDL NILL K +KI DFGL+ D
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192
Query: 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY-LPFDDRNLAVLYQKIFR 231
++APE + +R Y SD+WS GV+L+ I + P+ + + + +
Sbjct: 193 KGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251
Query: 232 GD--FKLPKWLSPGAQNLLRKILEPNPVKRITIAGI 265
+ P + +P + P +R T + +
Sbjct: 252 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL 287
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 149 bits (377), Expect = 9e-42
Identities = 58/333 (17%), Positives = 117/333 (35%), Gaps = 72/333 (21%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
RY L R LG G+F V A+D+ + A+KI+ +++ T+ + EI L+ +
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVND 68
Query: 74 PNVVRL-------------HEVLASKSKIYMVLEYVTGG---ELFDKIASKGRLQEAEGR 117
+ + H + +++V+ + G K + +
Sbjct: 69 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK 128
Query: 118 KLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHT 175
++ +QL+ G+ Y H + G+ H D+K EN+L++ + + ++ L D
Sbjct: 129 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN 188
Query: 176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY--------- 226
+ + Y +PEVL + +DIWS +++ ++TG F+
Sbjct: 189 SIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247
Query: 227 ---------------------------------------QKIFRGDFKLPKWLSPGAQNL 247
+ + +K K + +
Sbjct: 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 307
Query: 248 LRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
L +L+ +P KR G+ W +D
Sbjct: 308 LSPMLQLDPRKRADAGGLVNHPWL-KDTLGMEE 339
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 94.5 bits (234), Expect = 3e-23
Identities = 35/210 (16%), Positives = 71/210 (33%), Gaps = 36/210 (17%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD---------------Q 60
+G+ +GEG V VK + K+ +
Sbjct: 2 DAIGKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 61 IKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
+ E L+ L+ V +++ +++E + EL+ + ++
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAW----EGNAVLMELIDAKELYRV-------RVENPDEVL 109
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
+++ V+ +++G+ H DL N+L+ +G I I DF S +L +
Sbjct: 110 DMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDVRNI 168
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVI 210
+R Y DI S I ++
Sbjct: 169 IT-----YFSRTY-RTEKDINS--AIDRIL 190
|
| >d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]} Length = 102 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Kinase associated domain 1, KA1 domain: Map/microtubule affinity-regulating kinase 3 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 62.1 bits (151), Expect = 8e-13
Identities = 16/108 (14%), Positives = 38/108 (35%), Gaps = 17/108 (15%)
Query: 339 RKIRF------TSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLGSLSVA 392
RF TS+ D++ I ++ ++ + H + +
Sbjct: 5 SSGRFTWSMKTTSSMDPSDMMREIRKVLGANNCDY-EQRERFLLFCVHGDGHAENLVQWE 63
Query: 393 AEVFEI-SPSLYVVELRKSYGDPTVYRQIKTSIVFVQLCNKLSSDLGL 439
EV ++ SL V ++ G ++ + +K++++L L
Sbjct: 64 MEVCKLPRLSLNGVRFKRISGTSIAFK---------NIASKIANELKL 102
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 450 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1ul7a_ | 102 | Map/microtubule affinity-regulating kinase 3 {Mous | 99.42 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.59 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.29 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.15 | |
| d2v8qa1 | 153 | 5'-AMP-activated protein kinase catalytic subunit | 98.0 | |
| d2qrda1 | 127 | Snf1-like protein kinase ssp2 {Schizosaccharomyces | 97.47 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.3 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.08 | |
| d2qlva1 | 171 | Carbon catabolite-derepressing protein kinase SNF1 | 97.03 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.78 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-65 Score=491.53 Aligned_cols=258 Identities=33% Similarity=0.670 Sum_probs=240.5
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
.+++|++++.||+|+||+||+|+++.+|+.||+|++.+....+....+.+.+|+.++++++||||+++++++.+++.+|+
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 83 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 83 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEE
Confidence 47899999999999999999999999999999999987655444556789999999999999999999999999999999
Q ss_pred EEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCC
Q 013081 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 171 (450)
|||||+||+|.+++.+.+++++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|.... ..
T Consensus 84 vmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~----~~ 159 (263)
T d2j4za1 84 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SS 159 (263)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC----CC
T ss_pred EEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecC----CC
Confidence 99999999999999998999999999999999999999999999999999999999999999999999998543 23
Q ss_pred ccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q 013081 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 251 (450)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~ 251 (450)
.....+||+.|+|||++.+.+| +.++|||||||++|+|++|+.||.+.+....+.++.+..+.+|+.+|+++.+||.+|
T Consensus 160 ~~~~~~Gt~~Y~APE~~~~~~~-~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 238 (263)
T d2j4za1 160 RRTTLCGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL 238 (263)
T ss_dssp CCEETTEEGGGCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHH
T ss_pred cccccCCCCcccCHHHHcCCCC-CchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHH
Confidence 3456789999999999988777 589999999999999999999999999999999999999999999999999999999
Q ss_pred cccCcCCCCCHHHHHhccccccC
Q 013081 252 LEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 252 L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
|++||++|||++|+++||||..+
T Consensus 239 L~~dp~~R~t~~eil~hp~~~~~ 261 (263)
T d2j4za1 239 LKHNPSQRPMLREVLEHPWITAN 261 (263)
T ss_dssp TCSSGGGSCCHHHHHTCHHHHHH
T ss_pred ccCCHhHCcCHHHHHcCcCcCCc
Confidence 99999999999999999999754
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-65 Score=489.46 Aligned_cols=261 Identities=39% Similarity=0.681 Sum_probs=226.8
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 92 (450)
+++|++++.||+|+||+||+|+++.+|+.||||++++.... +..+.+.+|+.+|++++||||+++++++.+++..|+|
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence 57899999999999999999999999999999999865432 2346789999999999999999999999999999999
Q ss_pred EccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCc
Q 013081 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 172 (450)
||||+||+|++++.+.+++++.+++.++.||++||+|||++||+||||||+|||++++|++||+|||+|+..........
T Consensus 82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~ 161 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 161 (271)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred EeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence 99999999999998888999999999999999999999999999999999999999999999999999986544333344
Q ss_pred cccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHH-HHHHHHHhCCCCCC--CCCCHHHHHHHH
Q 013081 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKIFRGDFKLP--KWLSPGAQNLLR 249 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~p--~~~s~~~~~Li~ 249 (450)
..+.+||+.|+|||++.+.++++.++||||+||++|+|++|++||...+.. ..+..+.......+ ..+|+++.+||.
T Consensus 162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 241 (271)
T d1nvra_ 162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 241 (271)
T ss_dssp BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHH
T ss_pred ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHH
Confidence 567799999999999998888778899999999999999999999876543 33333433333333 348999999999
Q ss_pred HccccCcCCCCCHHHHHhccccccCC
Q 013081 250 KILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 250 ~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
+||++||++|||++|+++||||++..
T Consensus 242 ~~L~~dP~~R~t~~eil~hpwf~~~l 267 (271)
T d1nvra_ 242 KILVENPSARITIPDIKKDRWYNKPL 267 (271)
T ss_dssp HHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHcCCChhHCcCHHHHhcCHhhCcCC
Confidence 99999999999999999999998643
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-64 Score=490.90 Aligned_cols=264 Identities=33% Similarity=0.589 Sum_probs=236.8
Q ss_pred CCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013081 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (450)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (450)
....-++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+|++++||||+++++++.+++.
T Consensus 3 ~~~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 82 (288)
T d1uu3a_ 3 RKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK 82 (288)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSE
T ss_pred CCCCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCE
Confidence 33455789999999999999999999999999999999987654444456789999999999999999999999999999
Q ss_pred EEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc
Q 013081 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 168 (450)
+|+|||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++++|++||+|||+|+......
T Consensus 83 ~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999998665433
Q ss_pred CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 013081 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL 248 (450)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li 248 (450)
......+.+||+.|+|||++.+..| +.++||||+||++|+|++|+.||.+.+...++.++.++.+.+|+.+++++.+||
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 241 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLV 241 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHH
T ss_pred cccccccccCCccccCceeeccCCC-CcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence 3445566789999999999988777 589999999999999999999999999999999999999999999999999999
Q ss_pred HHccccCcCCCCCHHH------HHhcccccc
Q 013081 249 RKILEPNPVKRITIAG------IKADEWFEQ 273 (450)
Q Consensus 249 ~~~L~~dP~~R~t~~~------il~h~~~~~ 273 (450)
.+||++||++|||++| +++||||+.
T Consensus 242 ~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~ 272 (288)
T d1uu3a_ 242 EKLLVLDATKRLGCEEMEGYGPLKAHPFFES 272 (288)
T ss_dssp HTTSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred HHHccCCHhHCcCHHHHcCCHHHHcCCccCC
Confidence 9999999999999988 578888864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-63 Score=490.86 Aligned_cols=260 Identities=32% Similarity=0.628 Sum_probs=242.2
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (450)
+.+++|++++.||+|+||.||+|+++.+|+.||||++++.........+++.+|+.+|++++||||+++++++.+...+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 46889999999999999999999999999999999998765544445688999999999999999999999999999999
Q ss_pred EEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCC
Q 013081 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (450)
Q Consensus 91 lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 170 (450)
+|||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... ..
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~--~~ 159 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DG 159 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--TT
T ss_pred cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccccccc--CC
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999985432 23
Q ss_pred CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 013081 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 250 (450)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~ 250 (450)
....+.|||+.|+|||++.+.+| +.++|||||||++|+|++|++||.+.+...++.++..+.+.+|+.+|+++++||++
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~~~y-~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~ 238 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 238 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred cccccceeCHHHhhhhhccCCCC-ChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHh
Confidence 34567899999999999998888 58999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCcCCCCC-----HHHHHhcccccc
Q 013081 251 ILEPNPVKRIT-----IAGIKADEWFEQ 273 (450)
Q Consensus 251 ~L~~dP~~R~t-----~~~il~h~~~~~ 273 (450)
||++||.+|++ ++|+++||||..
T Consensus 239 ~L~~dP~~R~~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 239 LLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred hccCCchhhcccccccHHHHHcCccccc
Confidence 99999999994 999999999965
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-62 Score=477.23 Aligned_cols=254 Identities=26% Similarity=0.467 Sum_probs=227.6
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 92 (450)
-++|++++.||+|+||+||+|++..+|+.||||+++...... .+.+.+|+.+|++++||||+++++++.+.+.+|+|
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 95 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence 458999999999999999999999999999999998654333 46789999999999999999999999999999999
Q ss_pred EccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCc
Q 013081 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 172 (450)
||||+||+|.+++.+ +++++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... ....
T Consensus 96 mEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~--~~~~ 172 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSK 172 (293)
T ss_dssp EECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--TTCC
T ss_pred EEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecc--cccc
Confidence 999999999998765 6799999999999999999999999999999999999999999999999999985432 2234
Q ss_pred cccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC---CCCCCCCCCHHHHHHHH
Q 013081 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---DFKLPKWLSPGAQNLLR 249 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~Li~ 249 (450)
....+||+.|+|||++.+..| +.++||||+||++|+|++|+.||.+.+.......+... ..+.|..+|+.+++||.
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 251 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHH
T ss_pred ccccccCCCccChhhhcCCCC-CchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHH
Confidence 566789999999999988777 58999999999999999999999998877666666544 34456779999999999
Q ss_pred HccccCcCCCCCHHHHHhcccccc
Q 013081 250 KILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 250 ~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
+||++||.+|||+.|+++||||+.
T Consensus 252 ~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 252 RCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp HHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred HHccCChhHCcCHHHHhcCHhhCC
Confidence 999999999999999999999974
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5e-62 Score=478.83 Aligned_cols=256 Identities=32% Similarity=0.696 Sum_probs=238.6
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
.+++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+|++++||||+++++++.+.+.+|+
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence 36789999999999999999999999999999999987655444456789999999999999999999999999999999
Q ss_pred EEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCC
Q 013081 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 171 (450)
|||||+||+|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~----- 156 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----- 156 (316)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-----
T ss_pred EeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc-----
Confidence 999999999999999999999999999999999999999999999999999999999999999999999985432
Q ss_pred ccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q 013081 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 251 (450)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~ 251 (450)
...+.+||+.|+|||++.+.+|+ .++||||+||++|+|++|+.||.+.+......++..+...+|+.+|+++.++|.+|
T Consensus 157 ~~~~~~Gt~~Y~APE~l~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 235 (316)
T d1fota_ 157 VTYTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRL 235 (316)
T ss_dssp CBCCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred ccccccCcccccCHHHHcCCCCC-chhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence 34567999999999999888774 89999999999999999999999999999999999999999999999999999999
Q ss_pred cccCcCCCC-----CHHHHHhcccccc
Q 013081 252 LEPNPVKRI-----TIAGIKADEWFEQ 273 (450)
Q Consensus 252 L~~dP~~R~-----t~~~il~h~~~~~ 273 (450)
|++||.+|+ |++++++||||++
T Consensus 236 L~~dp~~R~~~~r~t~~~il~Hp~f~~ 262 (316)
T d1fota_ 236 ITRDLSQRLGNLQNGTEDVKNHPWFKE 262 (316)
T ss_dssp TCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred hhhCHHhccccchhhHHHHHcCccccc
Confidence 999999996 9999999999975
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.7e-62 Score=476.04 Aligned_cols=256 Identities=38% Similarity=0.710 Sum_probs=215.3
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 92 (450)
-++|++++.||+|+||+||+|+++.+|+.||||++.+...... ...+.+|+.+|+.++||||+++++++.+++.+|+|
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK--EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4679999999999999999999999999999999987654332 46788999999999999999999999999999999
Q ss_pred EccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEc---cCCCeEEeecCCCCCCCcccC
Q 013081 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD---SKGNIKISDFGLSALPQHFRD 169 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~---~~g~lkl~DFGla~~~~~~~~ 169 (450)
||||+||+|.+++...+++++.+++.++.||+.||+|||++||+||||||+|||+. ++|.+||+|||+|+... .
T Consensus 86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~---~ 162 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED---P 162 (307)
T ss_dssp ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred EeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEcc---C
Confidence 99999999999999989999999999999999999999999999999999999995 57899999999998543 2
Q ss_pred CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHH
Q 013081 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGAQ 245 (450)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~ 245 (450)
.....+.+||+.|+|||++.+.+| +.++|||||||++|+|++|+.||.+.+......++.++...++ +.+|+++.
T Consensus 163 ~~~~~~~~GT~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 241 (307)
T d1a06a_ 163 GSVLSTACGTPGYVAPEVLAQKPY-SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 241 (307)
T ss_dssp ----------CTTSCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred CCeeeeeeeCccccCcHHHcCCCC-CcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHH
Confidence 334567899999999999988777 5899999999999999999999999999999999988765543 45899999
Q ss_pred HHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 246 NLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 246 ~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
+||.+||++||++|||++|+++||||+..
T Consensus 242 ~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 242 DFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred HHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 99999999999999999999999999754
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-62 Score=472.52 Aligned_cols=256 Identities=27% Similarity=0.432 Sum_probs=226.2
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
+.|++++.||+|+||+||+|+++.+|+.||+|++++... ...+.+.+|+++|++++|||||++++++.+++.+|+||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE---EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS---GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 469999999999999999999999999999999976532 23467889999999999999999999999999999999
Q ss_pred ccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCc
Q 013081 94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (450)
Q Consensus 94 E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 172 (450)
|||+||+|.+++.+ .+++++.+++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.... ....
T Consensus 89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~--~~~~ 166 (288)
T d2jfla1 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TIQR 166 (288)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH--HHHH
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCC--Cccc
Confidence 99999999998765 45799999999999999999999999999999999999999999999999999975322 1123
Q ss_pred cccccCCCCccchhhhcc----CCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCC---CCCCCCCHHHH
Q 013081 173 LHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---KLPKWLSPGAQ 245 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~~----~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~ 245 (450)
..+.+||+.|+|||++.. ...++.++|||||||++|+|++|+.||.+.+......++.++.. ..|..+|+++.
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~ 246 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFK 246 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHH
Confidence 346789999999999842 22336899999999999999999999999888888888887753 33556899999
Q ss_pred HHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 246 NLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 246 ~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
+||.+||++||++|||++|+++||||+..
T Consensus 247 ~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 247 DFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred HHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 99999999999999999999999999753
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-62 Score=467.65 Aligned_cols=256 Identities=30% Similarity=0.536 Sum_probs=218.0
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--KSKI 89 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~ 89 (450)
+.++|++++.||+|+||+||+|+++.+|+.||+|++++.... ....+.+.+|+++|++++||||+++++++.+ .+.+
T Consensus 2 r~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 80 (269)
T d2java1 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 80 (269)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CE
T ss_pred CchhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEE
Confidence 457899999999999999999999999999999999876543 3346789999999999999999999999854 5668
Q ss_pred EEEEccCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHhhhhhcC-----eeeccCCCCcEEEccCCCeEEeecCC
Q 013081 90 YMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKG-----VFHRDLKLENILLDSKGNIKISDFGL 160 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~----~~~l~~~~~~~i~~ql~~aL~~LH~~g-----ivHrDlKp~NILl~~~g~lkl~DFGl 160 (450)
|+|||||+||+|.+++.+ .+.+++..++.++.||+.||.|||++| |+||||||+|||++.+|++||+|||+
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~ 160 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 160 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence 999999999999998863 467999999999999999999999976 99999999999999999999999999
Q ss_pred CCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCC-CCCCC
Q 013081 161 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKW 239 (450)
Q Consensus 161 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~ 239 (450)
|+.... ........+||+.|+|||++.+..| +.++|||||||++|+|+||+.||.+.+..++..++..+.. ..|..
T Consensus 161 a~~~~~--~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 237 (269)
T d2java1 161 ARILNH--DTSFAKAFVGTPYYMSPEQMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 237 (269)
T ss_dssp HHHC-------------CCCSCCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTT
T ss_pred eeeccc--CCCccccCCCCcccCCHHHHcCCCC-ChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 986433 2234556899999999999988777 5899999999999999999999999999999999888765 46778
Q ss_pred CCHHHHHHHHHccccCcCCCCCHHHHHhcccc
Q 013081 240 LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (450)
Q Consensus 240 ~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~ 271 (450)
+|+++.+||.+||++||.+|||++|+++|||+
T Consensus 238 ~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 238 YSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred cCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 99999999999999999999999999999995
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-61 Score=472.53 Aligned_cols=255 Identities=25% Similarity=0.369 Sum_probs=229.8
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEc
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 94 (450)
+|++++.||+|+||+||+|++..+|+.||||++++.........+.+.+|+.+|++++|||||++++++.+++..|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 59999999999999999999999999999999987766566667889999999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCccc
Q 013081 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH 174 (450)
Q Consensus 95 ~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 174 (450)
||.||+|..++...+++++.+++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|..... ..
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~------~~ 169 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------AN 169 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------BC
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC------CC
Confidence 999999988888888999999999999999999999999999999999999999999999999999985432 34
Q ss_pred cccCCCCccchhhhccC--CCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCC--CCCCCHHHHHHHHH
Q 013081 175 TTCGSPNYVAPEVLANR--GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGAQNLLRK 250 (450)
Q Consensus 175 ~~~gt~~y~APE~l~~~--~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~~~Li~~ 250 (450)
..+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+......++..+..+. +..+|+.+.+||.+
T Consensus 170 ~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~ 249 (309)
T d1u5ra_ 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 249 (309)
T ss_dssp CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHH
T ss_pred ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Confidence 57899999999998642 223589999999999999999999999988888887777765433 34589999999999
Q ss_pred ccccCcCCCCCHHHHHhccccccCC
Q 013081 251 ILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 251 ~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
||++||.+|||++|+++||||....
T Consensus 250 ~L~~dP~~Rpt~~ell~Hp~~~~~~ 274 (309)
T d1u5ra_ 250 CLQKIPQDRPTSEVLLKHRFVLRER 274 (309)
T ss_dssp HTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred HCcCChhHCcCHHHHHhCHHhcCCC
Confidence 9999999999999999999997643
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.1e-61 Score=479.55 Aligned_cols=257 Identities=34% Similarity=0.671 Sum_probs=239.3
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (450)
..+++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++||||+++++++.+....|
T Consensus 38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 117 (350)
T d1rdqe_ 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccc
Confidence 45789999999999999999999999999999999998765544445678999999999999999999999999999999
Q ss_pred EEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCC
Q 013081 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (450)
Q Consensus 91 lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 170 (450)
+||||+.||+|.+.+.+.+.+++.+++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 118 ~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~---- 193 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---- 193 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS----
T ss_pred cccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc----
Confidence 9999999999999999989999999999999999999999999999999999999999999999999999985432
Q ss_pred CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 013081 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 250 (450)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~ 250 (450)
...+.+||+.|+|||++.+.+| +.++|||||||++|+|+||+.||.+.+....+.++..+.+..|..+|+++.+||++
T Consensus 194 -~~~~~~Gt~~Y~APE~~~~~~~-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 271 (350)
T d1rdqe_ 194 -RTWTLCGTPEALAPEIILSKGY-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271 (350)
T ss_dssp -CBCCCEECGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHH
T ss_pred -ccccccCccccCCHHHHcCCCC-CccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHH
Confidence 3456789999999999988877 58999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCcCCCC-----CHHHHHhcccccc
Q 013081 251 ILEPNPVKRI-----TIAGIKADEWFEQ 273 (450)
Q Consensus 251 ~L~~dP~~R~-----t~~~il~h~~~~~ 273 (450)
||++||.+|+ |++++++||||+.
T Consensus 272 ~L~~dP~kR~~~~r~t~~ell~Hp~f~~ 299 (350)
T d1rdqe_ 272 LLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HhhhCHHhccccccccHHHHHcCccccC
Confidence 9999999995 9999999999975
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-61 Score=460.36 Aligned_cols=253 Identities=26% Similarity=0.475 Sum_probs=220.9
Q ss_pred cCCe-EEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe----CC
Q 013081 13 LGRY-ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS----KS 87 (450)
Q Consensus 13 ~~~y-~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~ 87 (450)
-||| ++.+.||+|+||+||+|++..+++.||+|.+...... ....+.+.+|+++|++++||||+++++++.+ ..
T Consensus 7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 85 (270)
T d1t4ha_ 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 85 (270)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCC
Confidence 3567 6888999999999999999999999999999765443 3346789999999999999999999999865 45
Q ss_pred EEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcC--eeeccCCCCcEEEc-cCCCeEEeecCCCCCC
Q 013081 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLD-SKGNIKISDFGLSALP 164 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlKp~NILl~-~~g~lkl~DFGla~~~ 164 (450)
.+|+|||||+||+|.+++.+.+.+++.+++.++.||+.||+|||++| |+||||||+|||++ +++.+||+|||+|+..
T Consensus 86 ~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 86 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 68999999999999999999899999999999999999999999998 99999999999996 5789999999999853
Q ss_pred CcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCC-cHHHHHHHHHhCCC--CCCCCCC
Q 013081 165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR-NLAVLYQKIFRGDF--KLPKWLS 241 (450)
Q Consensus 165 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~-~~~~~~~~i~~~~~--~~p~~~s 241 (450)
......+.+||+.|+|||++.+ +| +.++||||+||++|+|++|+.||.+. +...+++++..+.. .++...+
T Consensus 166 ----~~~~~~~~~GT~~Y~aPE~~~~-~~-~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~ 239 (270)
T d1t4ha_ 166 ----RASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 239 (270)
T ss_dssp ----CTTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCC
T ss_pred ----cCCccCCcccCccccCHHHhCC-CC-CCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCC
Confidence 2334567899999999999865 45 68999999999999999999999765 45556666665533 3445689
Q ss_pred HHHHHHHHHccccCcCCCCCHHHHHhccccc
Q 013081 242 PGAQNLLRKILEPNPVKRITIAGIKADEWFE 272 (450)
Q Consensus 242 ~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~ 272 (450)
+++.+||.+||++||++|||++|+++||||+
T Consensus 240 ~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 240 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 9999999999999999999999999999995
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.9e-61 Score=476.52 Aligned_cols=261 Identities=30% Similarity=0.585 Sum_probs=234.6
Q ss_pred CcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (450)
+..+++|++++.||+|+||.||+|+++.+|+.||||++.+.. ....+.+.+|+.+|++++||||+++++++.+++.+
T Consensus 22 ~~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 98 (350)
T d1koaa2 22 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM 98 (350)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEE
T ss_pred CCCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 346789999999999999999999999999999999997653 23357889999999999999999999999999999
Q ss_pred EEEEccCCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEcc--CCCeEEeecCCCCCCCc
Q 013081 90 YMVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS--KGNIKISDFGLSALPQH 166 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~-~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~--~g~lkl~DFGla~~~~~ 166 (450)
|+|||||+||+|.+++. ..+++++.+++.++.||+.||+|||++||+||||||+|||++. +|.+||+|||+|+...
T Consensus 99 ~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~- 177 (350)
T d1koaa2 99 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD- 177 (350)
T ss_dssp EEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC-
T ss_pred EEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecc-
Confidence 99999999999999995 4567999999999999999999999999999999999999964 5789999999998543
Q ss_pred ccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCC----CCCH
Q 013081 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK----WLSP 242 (450)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~ 242 (450)
......+.+||+.|+|||++.+.+| +.++|||||||++|+|++|+.||.+.+..+.+.++.......+. .+|+
T Consensus 178 --~~~~~~~~~gT~~Y~aPEv~~~~~~-~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 254 (350)
T d1koaa2 178 --PKQSVKVTTGTAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 254 (350)
T ss_dssp --TTSCEEEECSCTTTCCHHHHHTCCB-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCH
T ss_pred --cccccceecCcccccCHHHHcCCCC-ChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 2344567899999999999988877 58999999999999999999999999999999999888766553 4899
Q ss_pred HHHHHHHHccccCcCCCCCHHHHHhccccccCCCC
Q 013081 243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277 (450)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~~~ 277 (450)
++++||.+||++||++|||++|+++||||+....+
T Consensus 255 ~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~ 289 (350)
T d1koaa2 255 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 289 (350)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence 99999999999999999999999999999876543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=7.3e-61 Score=477.10 Aligned_cols=261 Identities=30% Similarity=0.576 Sum_probs=235.2
Q ss_pred CCcccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013081 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (450)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (450)
.+..+++|++++.||+|+||.||+|++..+|+.||||++++... .....+.+|+.+|++++||||+++++++.+++.
T Consensus 24 ~~~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~ 100 (352)
T d1koba_ 24 QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE 100 (352)
T ss_dssp CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred CCCcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 34567899999999999999999999999999999999976542 224678899999999999999999999999999
Q ss_pred EEEEEccCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEc--cCCCeEEeecCCCCCCC
Q 013081 89 IYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD--SKGNIKISDFGLSALPQ 165 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~~i~~~~-~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~--~~g~lkl~DFGla~~~~ 165 (450)
+|+|||||+||+|++.+...+ ++++.+++.++.||+.||+|||++||+||||||+|||++ .+|.+||+|||+|....
T Consensus 101 ~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~ 180 (352)
T d1koba_ 101 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180 (352)
T ss_dssp EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecC
Confidence 999999999999999876544 799999999999999999999999999999999999998 57899999999998543
Q ss_pred cccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCC----CCCC
Q 013081 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLS 241 (450)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s 241 (450)
......+.+||+.|+|||++.+..| +.++|||||||++|+|+||+.||.+.+....+.++..+...+| ..+|
T Consensus 181 ---~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 256 (352)
T d1koba_ 181 ---PDEIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVS 256 (352)
T ss_dssp ---TTSCEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSC
T ss_pred ---CCCceeeccCcccccCHHHHcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCC
Confidence 3345667899999999999988777 5899999999999999999999999999999999988876655 4589
Q ss_pred HHHHHHHHHccccCcCCCCCHHHHHhccccccCCC
Q 013081 242 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 276 (450)
Q Consensus 242 ~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~~ 276 (450)
+++.+||.+||++||.+|||+.|+|+||||+....
T Consensus 257 ~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~~ 291 (352)
T d1koba_ 257 PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 291 (352)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCcc
Confidence 99999999999999999999999999999987543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-60 Score=464.18 Aligned_cols=257 Identities=35% Similarity=0.611 Sum_probs=233.1
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccch---hHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---KITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (450)
-++|++++.||+|+||+||+|+++.+|+.||||++++...... ...+.+.+|+.+|++++||||+++++++.+.+.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 3689999999999999999999999999999999986544321 2357899999999999999999999999999999
Q ss_pred EEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCC----CeEEeecCCCCCCC
Q 013081 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG----NIKISDFGLSALPQ 165 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g----~lkl~DFGla~~~~ 165 (450)
|+|||||+||+|.+++...+++++..++.++.||+.||+|||++||+||||||+|||++.+| .+|++|||+|....
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence 99999999999999999889999999999999999999999999999999999999998877 49999999998543
Q ss_pred cccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCC----CCCC
Q 013081 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLS 241 (450)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s 241 (450)
......+.+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.+.+......++......++ +.+|
T Consensus 169 ---~~~~~~~~~~t~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 244 (293)
T d1jksa_ 169 ---FGNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 244 (293)
T ss_dssp ---TSCBCSCCCCCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred ---CCccccccCCCCcccCHHHHcCCCC-CCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCC
Confidence 2334556789999999999987766 6899999999999999999999999999999999988877655 5689
Q ss_pred HHHHHHHHHccccCcCCCCCHHHHHhcccccc
Q 013081 242 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 242 ~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
+.+.+||++||++||++|||++|+++||||+.
T Consensus 245 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 276 (293)
T d1jksa_ 245 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276 (293)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 99999999999999999999999999999975
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-61 Score=470.81 Aligned_cols=258 Identities=33% Similarity=0.603 Sum_probs=234.7
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHH-hCCCCCcceEEEEEEeCCEEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK-LLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~-~l~hpnIv~l~~~~~~~~~~~l 91 (450)
+++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.++. .++||||+++++++.+++..|+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 478999999999999999999999999999999998754433333556667777664 6899999999999999999999
Q ss_pred EEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCC
Q 013081 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 171 (450)
|||||+||+|.+++...+++++.+++.++.||+.||+|||++||+||||||+|||++++|++||+|||+|+.... ...
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~--~~~ 158 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML--GDA 158 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--TTC
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccc--ccc
Confidence 999999999999999999999999999999999999999999999999999999999999999999999985432 233
Q ss_pred ccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q 013081 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 251 (450)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~ 251 (450)
.....+||+.|+|||++.+.+|+ .++||||+||++|+|++|+.||.+.+...++.++..+.+.+|+.+|+++.+||++|
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~ 237 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKL 237 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred cccccCCCCCcCCHHHHcCCCCC-chhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHh
Confidence 44567899999999999988875 89999999999999999999999999999999999999999999999999999999
Q ss_pred cccCcCCCCCHH-HHHhcccccc
Q 013081 252 LEPNPVKRITIA-GIKADEWFEQ 273 (450)
Q Consensus 252 L~~dP~~R~t~~-~il~h~~~~~ 273 (450)
|++||.+|||+. ++++||||++
T Consensus 238 L~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 238 FVREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp SCSSGGGSBTTBSCGGGSGGGTT
T ss_pred cccCCCCCcCHHHHHHhCchhcc
Confidence 999999999995 8999999975
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.4e-60 Score=454.94 Aligned_cols=258 Identities=31% Similarity=0.548 Sum_probs=231.6
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccc------hhHHHHHHHHHHHHHhCC-CCCcceEEEEEEe
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH------LKITDQIKREIATLKLLK-HPNVVRLHEVLAS 85 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~------~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~ 85 (450)
.++|++++.||+|+||+||+|++..+|+.||||++++..... ....+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 478999999999999999999999999999999998764332 223467889999999997 9999999999999
Q ss_pred CCEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCC
Q 013081 86 KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (450)
Q Consensus 86 ~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 165 (450)
++.+|+|||||+||+|.+++...+++++.+++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999998543
Q ss_pred cccCCCccccccCCCCccchhhhcc-----CCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCC--
Q 013081 166 HFRDDGLLHTTCGSPNYVAPEVLAN-----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK-- 238 (450)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~-----~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~-- 238 (450)
. .......+||+.|+|||++.+ ....+.++||||+||++|+|++|+.||.+.+......++..+....+.
T Consensus 162 ~---~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (277)
T d1phka_ 162 P---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 238 (277)
T ss_dssp T---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred C---CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 2 233456789999999999863 233468999999999999999999999999999999988888665443
Q ss_pred --CCCHHHHHHHHHccccCcCCCCCHHHHHhcccccc
Q 013081 239 --WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 239 --~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
.+|+++++||.+||++||.+|||++|+++||||++
T Consensus 239 ~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 239 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 58999999999999999999999999999999975
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.1e-60 Score=474.75 Aligned_cols=258 Identities=28% Similarity=0.456 Sum_probs=226.0
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHH---HHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI---KREIATLKLLKHPNVVRLHEVLASKSK 88 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~---~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (450)
.+++|++++.||+|+||.||+|+++.+|+.||||++.+...........+ .+|+++++.++||||+++++++.+.+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 57899999999999999999999999999999999976544332222333 345777888889999999999999999
Q ss_pred EEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc
Q 013081 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 168 (450)
+|+|||||+||+|.+++.+.+.+++.+++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~-- 159 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-- 159 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS--
T ss_pred EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999985432
Q ss_pred CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcH---HHHHHHHHhCCCCCCCCCCHHHH
Q 013081 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL---AVLYQKIFRGDFKLPKWLSPGAQ 245 (450)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~p~~~s~~~~ 245 (450)
......+||+.|+|||++.....++.++|||||||++|+|+||+.||.+.+. ......+......+|..+|+++.
T Consensus 160 --~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 237 (364)
T d1omwa3 160 --KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 237 (364)
T ss_dssp --SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHH
T ss_pred --CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHH
Confidence 2345678999999999997665557999999999999999999999987543 34444555566778888999999
Q ss_pred HHHHHccccCcCCCCC-----HHHHHhcccccc
Q 013081 246 NLLRKILEPNPVKRIT-----IAGIKADEWFEQ 273 (450)
Q Consensus 246 ~Li~~~L~~dP~~R~t-----~~~il~h~~~~~ 273 (450)
+||.+||++||.+||| ++++++||||+.
T Consensus 238 ~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~ 270 (364)
T d1omwa3 238 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270 (364)
T ss_dssp HHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred HHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence 9999999999999999 799999999975
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-60 Score=471.01 Aligned_cols=256 Identities=29% Similarity=0.446 Sum_probs=218.7
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
.-++|++++.||+|+||+||+|+++.+|+.||+|++++.. ......++.+|+.+|+.++|||||++++++.+.+.+|+
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i 81 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 81 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 3468999999999999999999999999999999997653 23445789999999999999999999999999999999
Q ss_pred EEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhh-cCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCC
Q 013081 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~-~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 170 (450)
||||++||+|.+++.+.+++++..++.++.||+.||.|||+ +||+||||||+|||++.+|++||+|||+|+....
T Consensus 82 VmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~---- 157 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---- 157 (322)
T ss_dssp EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH----
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC----
Confidence 99999999999999988999999999999999999999997 5999999999999999999999999999985322
Q ss_pred CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHH------------------------
Q 013081 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY------------------------ 226 (450)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~------------------------ 226 (450)
....+.+||+.|+|||++.+..| +.++||||+||++|+|++|+.||.+.+.....
T Consensus 158 ~~~~~~~GT~~Y~APEvl~~~~y-~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 158 SMANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp HTC---CCSSCCCCHHHHHCSCC-CTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred CccccccCCccccCchHHcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 23456799999999999998777 58999999999999999999999765432110
Q ss_pred ------------------HHHHhC-CCCCCC-CCCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 227 ------------------QKIFRG-DFKLPK-WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 227 ------------------~~i~~~-~~~~p~-~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
..+... ....|. .+|+++.+||.+||++||.+|||++|+|+||||++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 011111 111221 268899999999999999999999999999999753
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-60 Score=464.88 Aligned_cols=255 Identities=25% Similarity=0.487 Sum_probs=231.9
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
.+++|++++.||+|+||+||+|.++.+|+.||||++++... ....+.+|+.+|++++||||+++++++.+.+.+|+
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~----~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l 78 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH----HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc----cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 47899999999999999999999999999999999976532 23568899999999999999999999999999999
Q ss_pred EEccCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccC--CCeEEeecCCCCCCCccc
Q 013081 92 VLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK--GNIKISDFGLSALPQHFR 168 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~~-~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~--g~lkl~DFGla~~~~~~~ 168 (450)
|||||+||+|++++...+ ++++.+++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~--- 155 (321)
T d1tkia_ 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK--- 155 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC---
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccc---
Confidence 999999999999998655 79999999999999999999999999999999999999854 479999999998532
Q ss_pred CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCC----CCCHHH
Q 013081 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK----WLSPGA 244 (450)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~ 244 (450)
......+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+....+.++.++.+.+|. .+|+++
T Consensus 156 ~~~~~~~~~~t~~y~ape~~~~~~~-~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 234 (321)
T d1tkia_ 156 PGDNFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234 (321)
T ss_dssp TTCEEEEEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred cCCcccccccccccccchhccCCCC-CchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHH
Confidence 2344567789999999999887776 58999999999999999999999999999999999998877764 589999
Q ss_pred HHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 245 QNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
.+||.+||++||.+|||++|+++||||++.
T Consensus 235 ~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 235 MDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 999999999999999999999999999764
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-60 Score=454.35 Aligned_cols=252 Identities=34% Similarity=0.597 Sum_probs=224.5
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchh---HHHHHHHHHHHHHhCC--CCCcceEEEEEEeCC
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---ITDQIKREIATLKLLK--HPNVVRLHEVLASKS 87 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~---~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~ 87 (450)
-++|++++.||+|+||.||+|++..+|+.||||++++....... ...++.+|+.+|++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 37899999999999999999999999999999999875443211 1234678999999997 899999999999999
Q ss_pred EEEEEEccCCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccC-CCeEEeecCCCCCCC
Q 013081 88 KIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGLSALPQ 165 (450)
Q Consensus 88 ~~~lv~E~~~g-g~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~-g~lkl~DFGla~~~~ 165 (450)
..|+||||+.+ +++.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~ 162 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence 99999999976 6888999888999999999999999999999999999999999999999855 789999999998532
Q ss_pred cccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHH
Q 013081 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQ 245 (450)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 245 (450)
.....+.+||+.|+|||++.+..+++.++||||+||++|+|++|+.||.+.+ .+.++...+++.+|+++.
T Consensus 163 ----~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~~~~~s~~~~ 232 (273)
T d1xwsa_ 163 ----DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQ 232 (273)
T ss_dssp ----SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCCHHHH
T ss_pred ----cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCCCCCCCHHHH
Confidence 2345567899999999999888887788999999999999999999998643 466778888999999999
Q ss_pred HHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 246 NLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 246 ~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
+||++||++||++|||++|+++||||++.
T Consensus 233 ~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 233 HLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred HHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 99999999999999999999999999864
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-59 Score=454.84 Aligned_cols=258 Identities=25% Similarity=0.324 Sum_probs=219.0
Q ss_pred EeeeecccCceEEEEEEECCCCceEEEEEeecccccc--hhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEcc
Q 013081 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH--LKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY 95 (450)
Q Consensus 18 i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 95 (450)
.++.||+|+||+||+|+++.+|+.||||+++...... ......+.+|+.+|++++||||+++++++.+++.+|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 5789999999999999999999999999997654322 12235788999999999999999999999999999999999
Q ss_pred CCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCcccc
Q 013081 96 VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHT 175 (450)
Q Consensus 96 ~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~ 175 (450)
+.|+++..+......+++.+++.+++||+.||+|||++||+||||||+|||++.++++||+|||+|+.... .......
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~--~~~~~~~ 159 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS--PNRAYTH 159 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS--CCCCCCC
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCC--Ccccccc
Confidence 99988887777777899999999999999999999999999999999999999999999999999985433 2234456
Q ss_pred ccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCC--------------------C
Q 013081 176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF--------------------K 235 (450)
Q Consensus 176 ~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--------------------~ 235 (450)
.+||+.|+|||++.....++.++||||+||++|+|++|.+||.+.+..+...++.+... .
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ua2a_ 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239 (299)
T ss_dssp SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCC
T ss_pred eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhcc
Confidence 78999999999988776667999999999999999999999999888877777654200 0
Q ss_pred C--------CCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCCCC
Q 013081 236 L--------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277 (450)
Q Consensus 236 ~--------p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~~~ 277 (450)
. .+.+++++.+||.+||++||++|||++|+|+||||++...|
T Consensus 240 ~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p 289 (299)
T d1ua2a_ 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 289 (299)
T ss_dssp CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred CCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCC
Confidence 0 12368899999999999999999999999999999865443
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-58 Score=445.40 Aligned_cols=261 Identities=29% Similarity=0.454 Sum_probs=220.2
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 92 (450)
+++|++++.||+|+||+||+|.+..+|+.||||+++.... .....+++.+|+++|++++||||+++++++.+.+.+|+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 5789999999999999999999999999999999975532 223357889999999999999999999999999999999
Q ss_pred EccCCCCChHHHHH--hcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCC
Q 013081 93 LEYVTGGELFDKIA--SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (450)
Q Consensus 93 ~E~~~gg~L~~~i~--~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 170 (450)
|||+.|+ +.+.+. ...++++.+++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+.... ..
T Consensus 80 ~e~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~--~~ 156 (298)
T d1gz8a_ 80 FEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PV 156 (298)
T ss_dssp EECCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC--CS
T ss_pred EeecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccC--Cc
Confidence 9999764 444443 345799999999999999999999999999999999999999999999999999975322 22
Q ss_pred CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCC----------------
Q 013081 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---------------- 234 (450)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---------------- 234 (450)
......+||+.|+|||++....+.+.++||||+||++|+|++|+.||.+.+......++.+...
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence 3455668999999999998888888999999999999999999999999887766655543100
Q ss_pred --CCC-----------CCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCCCC
Q 013081 235 --KLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277 (450)
Q Consensus 235 --~~p-----------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~~~ 277 (450)
..+ ..+|+++.+||++||++||.+|||+.|+++||||++-..|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 011 1357899999999999999999999999999999865544
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-58 Score=455.67 Aligned_cols=256 Identities=30% Similarity=0.575 Sum_probs=217.0
Q ss_pred cCCcccCCeEEee-eecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHh-CCCCCcceEEEEEEe
Q 013081 8 QEGMRLGRYELGR-TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL-LKHPNVVRLHEVLAS 85 (450)
Q Consensus 8 ~~~~~~~~y~i~~-~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~ 85 (450)
+....+++|++++ .||+|+||.||+|++..+|+.||||++++. ..+.+|+.++.+ ++||||+++++++.+
T Consensus 5 ~~~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~ 76 (335)
T d2ozaa1 5 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYEN 76 (335)
T ss_dssp BCSCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred CCCCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence 3455689999875 699999999999999999999999999643 457789998654 589999999999875
Q ss_pred ----CCEEEEEEccCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEcc---CCCeEEe
Q 013081 86 ----KSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS---KGNIKIS 156 (450)
Q Consensus 86 ----~~~~~lv~E~~~gg~L~~~i~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~---~g~lkl~ 156 (450)
+..+|+|||||+||+|++++.+. .++++.+++.|+.||+.||+|||++||+||||||+|||++. ++.+||+
T Consensus 77 ~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~ 156 (335)
T d2ozaa1 77 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT 156 (335)
T ss_dssp EETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred cccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccc
Confidence 46789999999999999999874 36999999999999999999999999999999999999986 4579999
Q ss_pred ecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHH----HHHHHhC
Q 013081 157 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVL----YQKIFRG 232 (450)
Q Consensus 157 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~----~~~i~~~ 232 (450)
|||+|+.... .......+||+.|+|||++.+..| +.++|||||||++|+|+||++||.+.+.... ..++..+
T Consensus 157 DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~y-~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~ 232 (335)
T d2ozaa1 157 DFGFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 232 (335)
T ss_dssp CCTTCEECCC---CCCCCCCSCCCSSCCCCCCCGGGG-SHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSC
T ss_pred ccceeeeccC---CCccccccCCcccCCcHHHcCCCC-CHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcC
Confidence 9999985432 334567799999999999988777 5899999999999999999999987654333 3334444
Q ss_pred CCCCCC----CCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCC
Q 013081 233 DFKLPK----WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 233 ~~~~p~----~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
...+|. .+|+++.+||++||++||++|||+.|+++||||.+..
T Consensus 233 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 279 (335)
T d2ozaa1 233 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279 (335)
T ss_dssp SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence 555553 3899999999999999999999999999999997543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.5e-57 Score=437.24 Aligned_cols=260 Identities=27% Similarity=0.427 Sum_probs=220.6
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS---- 87 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---- 87 (450)
.-++|++++.||+|+||.||+|++..+|+.||||+++++...+......+.+|+.+++.++||||+++++++...+
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 3478999999999999999999999999999999998877766777788999999999999999999999987654
Q ss_pred EEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcc
Q 013081 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 167 (450)
.+|+||||++|++|.+++...+++++.+++.++.||+.||+|||++||+||||||+|||++.++..+++|||.+......
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccc
Confidence 48999999999999999999999999999999999999999999999999999999999999999999999998754322
Q ss_pred c-CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCH
Q 013081 168 R-DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSP 242 (450)
Q Consensus 168 ~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~ 242 (450)
. ........+||+.|+|||++.+..+ ++++||||+||++|+|+||++||.+.+......++.......| +.+|+
T Consensus 165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 243 (277)
T d1o6ya_ 165 GNSVTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA 243 (277)
T ss_dssp --------------TTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCH
T ss_pred cccccccccccCcccccCHHHHcCCCC-CcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCH
Confidence 1 2224456789999999999987776 5899999999999999999999999998888888877655433 45899
Q ss_pred HHHHHHHHccccCcCCCCCHHHHHhccccc
Q 013081 243 GAQNLLRKILEPNPVKRITIAGIKADEWFE 272 (450)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t~~~il~h~~~~ 272 (450)
++.+||.+||++||.+||+..+.+.|+|.+
T Consensus 244 ~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 244 DLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 999999999999999999555555677764
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2e-57 Score=439.81 Aligned_cols=257 Identities=31% Similarity=0.465 Sum_probs=220.3
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 92 (450)
+++|++++.||+|+||+||+|+++ +|+.||||+++.... .....+++.+|+.+|++++||||+++++++.+.+..|++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence 579999999999999999999985 789999999976543 233357899999999999999999999999999999999
Q ss_pred EccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCc
Q 013081 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 172 (450)
|||+.++.+..+....+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..... ....
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~--~~~~ 156 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI--PVRK 156 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceeccc--Cccc
Confidence 99998888877777788999999999999999999999999999999999999999999999999999875322 2223
Q ss_pred cccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC--CC----------------
Q 013081 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DF---------------- 234 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~---------------- 234 (450)
.....|++.|+|||++.+..+.+.++||||+||++|+|++|+.||.+.+......++... ..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence 445679999999999988777789999999999999999999999998877766665431 00
Q ss_pred -----------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhcccccc
Q 013081 235 -----------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 235 -----------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
..++.+++.+.+||++||++||++|||++|+++||||++
T Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 112346889999999999999999999999999999974
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-56 Score=437.50 Aligned_cols=265 Identities=25% Similarity=0.343 Sum_probs=219.1
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-----
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS----- 85 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----- 85 (450)
..+++|++++.||+|+||+||+|++..+|+.||||++.+.... .....++.+|+.+|+.++||||+++++++..
T Consensus 7 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~ 85 (318)
T d3blha1 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPY 85 (318)
T ss_dssp CBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred CccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHhcCCCccceEeeeecccccc
Confidence 3479999999999999999999999999999999998765432 2335778899999999999999999999854
Q ss_pred ---CCEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCC
Q 013081 86 ---KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA 162 (450)
Q Consensus 86 ---~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~ 162 (450)
....|++|||+.++.+.........+++..++.+++||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 86 ~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 86 NRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp -----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceee
Confidence 34689999999887776666667789999999999999999999999999999999999999999999999999997
Q ss_pred CCCccc--CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCC--
Q 013081 163 LPQHFR--DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK-- 238 (450)
Q Consensus 163 ~~~~~~--~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~-- 238 (450)
...... ......+.+||+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+.......+.......+.
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 245 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 543211 1223455689999999999887666679999999999999999999999988877766665442111110
Q ss_pred ------------------------------CCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCCC
Q 013081 239 ------------------------------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 276 (450)
Q Consensus 239 ------------------------------~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~~ 276 (450)
..++.+.+||.+||++||++|||+.|+|+||||+..+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~ 313 (318)
T d3blha1 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM 313 (318)
T ss_dssp STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSC
T ss_pred ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCC
Confidence 02678899999999999999999999999999986544
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-56 Score=431.53 Aligned_cols=254 Identities=24% Similarity=0.388 Sum_probs=208.2
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (450)
...++|++++.||+|+||+||+|+.. ..||||+++..... ....+.+.+|+.+|++++||||+++++++. .+.+|
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~ 79 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLA 79 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCC-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEE
Confidence 34688999999999999999999743 35999999765433 334678999999999999999999999875 45689
Q ss_pred EEEccCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC
Q 013081 91 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (450)
Q Consensus 91 lv~E~~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 169 (450)
+|||||+||+|.+++... +++++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+|+.......
T Consensus 80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 999999999999999754 5799999999999999999999999999999999999999999999999999987654333
Q ss_pred CCccccccCCCCccchhhhccC--CCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHH-HHHHHhCCC-----CCCCCCC
Q 013081 170 DGLLHTTCGSPNYVAPEVLANR--GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVL-YQKIFRGDF-----KLPKWLS 241 (450)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~--~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~-~~~i~~~~~-----~~p~~~s 241 (450)
.....+.+||+.|+|||++... ..++.++|||||||++|||+||+.||.+.+.... ...+.++.. ..+..+|
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 239 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCC
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccch
Confidence 3445667899999999998643 2236899999999999999999999988665443 333433321 2355689
Q ss_pred HHHHHHHHHccccCcCCCCCHHHHHhcc
Q 013081 242 PGAQNLLRKILEPNPVKRITIAGIKADE 269 (450)
Q Consensus 242 ~~~~~Li~~~L~~dP~~R~t~~~il~h~ 269 (450)
+++.+|+.+||+.||++|||+.+++++-
T Consensus 240 ~~l~~li~~cl~~dp~~RPt~~~il~~L 267 (276)
T d1uwha_ 240 KAMKRLMAECLKKKRDERPLFPQILASI 267 (276)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 9999999999999999999999999873
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-56 Score=440.75 Aligned_cols=253 Identities=25% Similarity=0.374 Sum_probs=216.1
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCc-----eEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGL-----PFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK 86 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~-----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 86 (450)
.++|++++.||+|+||+||+|++..+++ .||+|.+..... ......+.+|+.+|+++ +|||||++++++.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC--HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 3689999999999999999999876544 699999865432 22346788999999998 899999999999999
Q ss_pred CEEEEEEccCCCCChHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCC
Q 013081 87 SKIYMVLEYVTGGELFDKIASK-----------------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLE 143 (450)
Q Consensus 87 ~~~~lv~E~~~gg~L~~~i~~~-----------------------~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~ 143 (450)
+..|+|||||+||+|.+++... +.+++.+++.++.||+.||+|||++||+||||||+
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~ 193 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 193 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchh
Confidence 9999999999999999999754 24899999999999999999999999999999999
Q ss_pred cEEEccCCCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcH
Q 013081 144 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNL 222 (450)
Q Consensus 144 NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~ 222 (450)
|||++.++++||+|||+|+............+.+||+.|+|||++.+..| +.++|||||||++|||+| |.+||.+.+.
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY-TIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCC-CcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999986544333333446778999999999988777 589999999999999998 9999998766
Q ss_pred HHHHHHHHhC--CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 223 AVLYQKIFRG--DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 223 ~~~~~~i~~~--~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
.....++... .++.|..+|+++.+||.+||+.||++|||++||++|
T Consensus 273 ~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 273 DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp SHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 5555555544 456778899999999999999999999999999986
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-56 Score=424.36 Aligned_cols=248 Identities=23% Similarity=0.415 Sum_probs=210.3
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
++|++++.||+|+||.||+|.+. +++.||||++++.... .+.+.+|+.++++++||||+++++++...+..|+||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~ 79 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 79 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEE
Confidence 58999999999999999999985 5678999999764432 357899999999999999999999999999999999
Q ss_pred ccCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCc
Q 013081 94 EYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (450)
Q Consensus 94 E~~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 172 (450)
||+++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++++||+|||+|+...... ...
T Consensus 80 E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~-~~~ 158 (263)
T d1sm2a_ 80 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTS 158 (263)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred EecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCC-cee
Confidence 999999999998754 568999999999999999999999999999999999999999999999999998653321 122
Q ss_pred cccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHH
Q 013081 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRK 250 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~ 250 (450)
.....||+.|+|||++.+..| +.++||||+||++|||+| |.+||...+...+...+..+ ....|..+++++.+|+.+
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~-~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 237 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH 237 (263)
T ss_dssp ------CTTSCCHHHHTTCCC-CHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHH
T ss_pred ecceecCcccCChHHhcCCCC-CchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence 345679999999999988777 589999999999999999 68888888888888888776 456678899999999999
Q ss_pred ccccCcCCCCCHHHHHhc
Q 013081 251 ILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 251 ~L~~dP~~R~t~~~il~h 268 (450)
||++||++|||++++++|
T Consensus 238 cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 238 CWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HccCCHhHCcCHHHHHHH
Confidence 999999999999999986
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.9e-56 Score=431.39 Aligned_cols=255 Identities=22% Similarity=0.355 Sum_probs=211.0
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCc---eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGL---PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (450)
...++|++.+.||+|+||+||+|.++.+++ .||||.+.... .....+.+.+|+.+|++++|||||++++++.+.+
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST 100 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 446789999999999999999999987665 58888876543 3344578999999999999999999999999999
Q ss_pred EEEEEEccCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCc
Q 013081 88 KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 166 (450)
..|+|||||+||+|.+++... +.+++.++..++.||++||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999999999988764 5799999999999999999999999999999999999999999999999999986543
Q ss_pred ccCCC---ccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCC
Q 013081 167 FRDDG---LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLS 241 (450)
Q Consensus 167 ~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s 241 (450)
..... ......||+.|+|||++.+..+ +.++|||||||++|||+| |..||.+.+...+...+..+ ..+.|..++
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 259 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCP 259 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCC-CcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccch
Confidence 22111 1122467899999999987776 589999999999999998 89999999888888888776 466777899
Q ss_pred HHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 242 PGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 242 ~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
+.+.+|+.+||+.||++|||+.|++++
T Consensus 260 ~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 260 SALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999999998875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.5e-56 Score=431.45 Aligned_cols=250 Identities=26% Similarity=0.388 Sum_probs=218.0
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
..++|++++.||+|+||+||+|.+..+|+.||||+++.+... .+++.+|+++|++++||||+++++++.+.+..|+
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch----HHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence 446899999999999999999999999999999999765322 4678999999999999999999999999999999
Q ss_pred EEccCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC
Q 013081 92 VLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 169 (450)
|||||++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+..... .
T Consensus 91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~-~ 169 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-T 169 (287)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS-S
T ss_pred EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCC-C
Confidence 99999999999999754 57899999999999999999999999999999999999999999999999999864331 1
Q ss_pred CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCC-CCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 013081 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY-LPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 247 (450)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~-~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 247 (450)
........||+.|+|||++.+..| +.++||||+||++|||++|. +||.+.+...++..+..+ ..+.|..+|+.+.+|
T Consensus 170 ~~~~~~~~g~~~y~aPE~~~~~~~-~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 248 (287)
T d1opja_ 170 YTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL 248 (287)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ceeeccccccccccChHHHcCCCC-CchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHH
Confidence 112233468999999999988877 59999999999999999954 556666666666666555 567788899999999
Q ss_pred HHHccccCcCCCCCHHHHHh
Q 013081 248 LRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 248 i~~~L~~dP~~R~t~~~il~ 267 (450)
|.+||+.||++|||++++++
T Consensus 249 i~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 249 MRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHH
Confidence 99999999999999999976
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-56 Score=429.31 Aligned_cols=249 Identities=23% Similarity=0.350 Sum_probs=212.6
Q ss_pred eeecccCceEEEEEEEC--CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEccCC
Q 013081 20 RTLGEGNFGKVKFAQDL--DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT 97 (450)
Q Consensus 20 ~~LG~G~~g~Vy~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 97 (450)
+.||+|+||+||+|.+. .+++.||||+++.... +....+.+.+|+.+|++++||||+++++++.++ ..|+|||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence 47999999999999864 4567899999965433 344567899999999999999999999999654 5789999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCC-Cccccc
Q 013081 98 GGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD-GLLHTT 176 (450)
Q Consensus 98 gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~-~~~~~~ 176 (450)
||+|.+++.+..++++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+........ ......
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 170 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccccc
Confidence 9999999999899999999999999999999999999999999999999999999999999999854332111 122345
Q ss_pred cCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHcccc
Q 013081 177 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEP 254 (450)
Q Consensus 177 ~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~ 254 (450)
.||+.|+|||++.+..+ +.++|||||||++|||+| |..||.+.+..++...+.++ .++.|..+|+++.+||.+||+.
T Consensus 171 ~gt~~y~APE~l~~~~~-~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~ 249 (277)
T d1xbba_ 171 KWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 249 (277)
T ss_dssp CCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCCceecCchhhcCCCC-CchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCC
Confidence 78999999999988776 589999999999999998 99999998888888888776 4677888999999999999999
Q ss_pred CcCCCCCHHHH---Hhcccc
Q 013081 255 NPVKRITIAGI---KADEWF 271 (450)
Q Consensus 255 dP~~R~t~~~i---l~h~~~ 271 (450)
||++|||+++| |+|+|+
T Consensus 250 dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 250 DVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp STTTSCCHHHHHHHHHHHHH
T ss_pred CHhHCcCHHHHHHHhhCHHh
Confidence 99999999998 456554
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-55 Score=424.52 Aligned_cols=259 Identities=28% Similarity=0.440 Sum_probs=225.0
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 92 (450)
++||++++.||+|+||+||+|++..+|+.||||+++.... ......++.+|+.+|+.++||||+++++++.+....+++
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence 5799999999999999999999999999999999976543 344578899999999999999999999999999999999
Q ss_pred EccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCc
Q 013081 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 172 (450)
+|++.|++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++++||+|||.|..... ....
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~--~~~~ 157 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVRC 157 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--CCSC
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccC--CCcc
Confidence 99999999999998888999999999999999999999999999999999999999999999999999986433 2223
Q ss_pred cccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCC-CCCcHHHHHHHHHhC-------------------
Q 013081 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAVLYQKIFRG------------------- 232 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf-~~~~~~~~~~~i~~~------------------- 232 (450)
.....+++.|+|||++....+.+.++||||+||++|+|++|..|| .+.+......++...
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence 344567889999999988777789999999999999999999885 555555555554321
Q ss_pred ----------CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 233 ----------DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 233 ----------~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
....+..+++.+.+||++||++||.+|||++|+|+||||++-
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 011223468899999999999999999999999999999753
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-56 Score=432.76 Aligned_cols=256 Identities=31% Similarity=0.410 Sum_probs=214.4
Q ss_pred cCCeEEeeeecccCceEEEEEEECCC-CceEEEEEeecccccchhHHHHHHHHHHHHHhC---CCCCcceEEEEEEe---
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDS-GLPFAVKILEKNRIIHLKITDQIKREIATLKLL---KHPNVVRLHEVLAS--- 85 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~-~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~--- 85 (450)
-++|++++.||+|+||+||+|++..+ ++.||||+++...... .....+.+|+.+|+.| +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 47999999999999999999999765 6789999997654322 1233566788887766 79999999999853
Q ss_pred --CCEEEEEEccCCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCC
Q 013081 86 --KSKIYMVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA 162 (450)
Q Consensus 86 --~~~~~lv~E~~~gg~L~~~i~-~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~ 162 (450)
....|++|||+.++.+..... ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 357899999998877654443 34579999999999999999999999999999999999999999999999999998
Q ss_pred CCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC---------
Q 013081 163 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--------- 233 (450)
Q Consensus 163 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--------- 233 (450)
.... .......+||+.|+|||++.+.+| +.++||||+||++|+|++|++||.+.+......++....
T Consensus 165 ~~~~---~~~~~~~~gT~~Y~APE~~~~~~y-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (305)
T d1blxa_ 165 IYSF---QMALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240 (305)
T ss_dssp CCCG---GGGGCCCCCCCTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred hhcc---cccCCCcccChhhcCcchhcCCCC-ChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence 5432 234567789999999999988877 589999999999999999999999998887776664310
Q ss_pred ------------------CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhcccccc
Q 013081 234 ------------------FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 234 ------------------~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
..++..+++.+.+||++||++||++|||++|+|+||||++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~ 298 (305)
T d1blxa_ 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298 (305)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcC
Confidence 0123457899999999999999999999999999999975
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-55 Score=427.00 Aligned_cols=255 Identities=25% Similarity=0.363 Sum_probs=220.2
Q ss_pred CCeEEeee-ecccCceEEEEEEECC--CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013081 14 GRYELGRT-LGEGNFGKVKFAQDLD--SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (450)
Q Consensus 14 ~~y~i~~~-LG~G~~g~Vy~a~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (450)
++|.+.+. ||+|+||.||+|.+.. ++..||||++++.. .....+.+.+|+++|++++|||||++++++.+ +.+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~ 84 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 84 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEE
Confidence 56888885 9999999999998764 45589999997543 33446789999999999999999999999865 4589
Q ss_pred EEEccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC
Q 013081 91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (450)
Q Consensus 91 lv~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 169 (450)
+|||||+||+|.+++.. ++.+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 85 lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 164 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 164 (285)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccccc
Confidence 99999999999998765 46799999999999999999999999999999999999999999999999999986543211
Q ss_pred -CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 013081 170 -DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 246 (450)
Q Consensus 170 -~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 246 (450)
.......+||+.|+|||++....+ +.++|||||||++|||+| |..||.+.+..++...+..+ ..+.|+.+|+++.+
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~ 243 (285)
T d1u59a_ 165 YYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA 243 (285)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred ccccccccccCccccChHHHhCCCC-CccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 122335578999999999988776 589999999999999998 99999998888888888776 46788899999999
Q ss_pred HHHHccccCcCCCCCHHHH---Hhccccc
Q 013081 247 LLRKILEPNPVKRITIAGI---KADEWFE 272 (450)
Q Consensus 247 Li~~~L~~dP~~R~t~~~i---l~h~~~~ 272 (450)
||.+||+.||++|||+.+| |+|+|+.
T Consensus 244 li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 244 LMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 9999999999999999887 6778774
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-56 Score=425.15 Aligned_cols=254 Identities=26% Similarity=0.419 Sum_probs=219.3
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (450)
..++|++++.||+|+||.||+|.+. +++.||||+++..... .+.+.+|+.++++++|||||++++++.+ +..|+
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~i 84 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred CHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEE
Confidence 4578999999999999999999975 5788999999754322 3678999999999999999999998754 56799
Q ss_pred EEccCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC
Q 013081 92 VLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 169 (450)
||||+++|+|.+++... .++++.++..++.||+.||.|||++||+||||||+||||++++.+||+|||+|+..... .
T Consensus 85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~-~ 163 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-E 163 (272)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS-C
T ss_pred EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCC-c
Confidence 99999999999977543 36999999999999999999999999999999999999999999999999999865321 1
Q ss_pred CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 013081 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 247 (450)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 247 (450)
........||+.|+|||++.+..+ +.++|||||||++|||+| |.+||...+.....+.+..+ ....|..+++++.+|
T Consensus 164 ~~~~~~~~gt~~y~APE~~~~~~~-~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~l 242 (272)
T d1qpca_ 164 YTAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 242 (272)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred cccccccCCcccccChHHHhCCCC-CchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHH
Confidence 122345679999999999987776 589999999999999999 56777777888888888776 566788899999999
Q ss_pred HHHccccCcCCCCCHHHHHh--cccccc
Q 013081 248 LRKILEPNPVKRITIAGIKA--DEWFEQ 273 (450)
Q Consensus 248 i~~~L~~dP~~R~t~~~il~--h~~~~~ 273 (450)
+.+||+.||++|||++++++ |+||..
T Consensus 243 i~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 243 MRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 99999999999999999988 788753
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-55 Score=417.81 Aligned_cols=248 Identities=23% Similarity=0.407 Sum_probs=222.4
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (450)
++|++++.||+|+||+||+|+++ +++.||||++++.... .+.+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~ 78 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 78 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence 67999999999999999999984 7889999999875432 357899999999999999999999999999999999
Q ss_pred ccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCCCc
Q 013081 94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (450)
Q Consensus 94 E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 172 (450)
||+++|+|.+++.. ...+++..+++++.|+++||+|||++||+||||||+|||++.++.+||+|||+|+..... ....
T Consensus 79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~-~~~~ 157 (258)
T d1k2pa_ 79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTS 157 (258)
T ss_dssp ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS-SCCC
T ss_pred EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCC-Ccee
Confidence 99999999998754 457999999999999999999999999999999999999999999999999999865432 2223
Q ss_pred cccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHH
Q 013081 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRK 250 (450)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~ 250 (450)
....+||+.|+|||++.+..+ +.++|||||||++|||+| |+.||.+.+..++..++..+ ....|..+++.+.+||.+
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~-~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 236 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS 236 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred ecccCCCCCcCCcHHhcCCCC-CcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHH
Confidence 345679999999999988877 489999999999999998 89999999999888888886 566778899999999999
Q ss_pred ccccCcCCCCCHHHHHhc
Q 013081 251 ILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 251 ~L~~dP~~R~t~~~il~h 268 (450)
||+.||++|||+++|++|
T Consensus 237 cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 237 CWHEKADERPTFKILLSN 254 (258)
T ss_dssp TTCSSGGGSCCHHHHHHH
T ss_pred HccCCHhHCcCHHHHHHH
Confidence 999999999999999987
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-55 Score=435.87 Aligned_cols=254 Identities=29% Similarity=0.408 Sum_probs=213.4
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS----- 87 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----- 87 (450)
-++|++++.||+|+||+||+|.+..+|+.||||++++... .....+.+.+|+.+|+.++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 3799999999999999999999999999999999976533 4455688999999999999999999999997654
Q ss_pred -EEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCc
Q 013081 88 -KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (450)
Q Consensus 88 -~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 166 (450)
.+|+||||+ |.+|...+. .+++++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+|+...
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~- 172 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD- 172 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC-
Confidence 579999999 667766654 5789999999999999999999999999999999999999999999999999998543
Q ss_pred ccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCC------------
Q 013081 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF------------ 234 (450)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~------------ 234 (450)
......+||+.|+|||++.+..+.+.++||||+||++|+|++|++||.+.+.......+.....
T Consensus 173 ----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (346)
T d1cm8a_ 173 ----SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248 (346)
T ss_dssp ----SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred ----CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcc
Confidence 2345678999999999998877778999999999999999999999998876655444332110
Q ss_pred -------------------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccC
Q 013081 235 -------------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (450)
Q Consensus 235 -------------------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~ 274 (450)
..+..+++.+.+||++||++||.+|||+.|+|+||||+.-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 1224578999999999999999999999999999999853
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-55 Score=432.58 Aligned_cols=263 Identities=31% Similarity=0.584 Sum_probs=227.7
Q ss_pred CcccCCeEEeeeecccCceEEEEEEEC---CCCceEEEEEeeccccc-chhHHHHHHHHHHHHHhCCC-CCcceEEEEEE
Q 013081 10 GMRLGRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRII-HLKITDQIKREIATLKLLKH-PNVVRLHEVLA 84 (450)
Q Consensus 10 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~ 84 (450)
...+++|++++.||+|+||+||+|.+. .+|+.||||++++.... +....+.+.+|+.++++++| |||+++++++.
T Consensus 20 ~~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~ 99 (322)
T d1vzoa_ 20 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 99 (322)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred ccchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeec
Confidence 355789999999999999999999974 47899999999765432 22234678899999999976 89999999999
Q ss_pred eCCEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCC
Q 013081 85 SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP 164 (450)
Q Consensus 85 ~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~ 164 (450)
+....|++|||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 100 ~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 100 TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred cCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999754
Q ss_pred CcccCCCccccccCCCCccchhhhccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCcH----HHHHHHHHhCCCCCCCC
Q 013081 165 QHFRDDGLLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYVILTGYLPFDDRNL----AVLYQKIFRGDFKLPKW 239 (450)
Q Consensus 165 ~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~~p~~ 239 (450)
... ......+.+|++.|+|||.+.... +.+.++|||||||+||+|++|+.||.+.+. ..+.........++|..
T Consensus 180 ~~~-~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (322)
T d1vzoa_ 180 VAD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 258 (322)
T ss_dssp CGG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred ccc-ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCccc
Confidence 332 223455678999999999987644 446889999999999999999999977543 34455555667888888
Q ss_pred CCHHHHHHHHHccccCcCCCC-----CHHHHHhcccccc
Q 013081 240 LSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWFEQ 273 (450)
Q Consensus 240 ~s~~~~~Li~~~L~~dP~~R~-----t~~~il~h~~~~~ 273 (450)
+|+++.+||.+||++||.+|| |++|+++||||++
T Consensus 259 ~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 259 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred CCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 999999999999999999999 5899999999974
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-55 Score=432.16 Aligned_cols=260 Identities=28% Similarity=0.435 Sum_probs=214.9
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----EE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS----KI 89 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~~ 89 (450)
.||++++.||+|+||+||+|++..+|+.||||++++.. .....+++.+|+.+|+.++||||+++++++.... ..
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 57999999999999999999999999999999997543 3445678899999999999999999999986543 23
Q ss_pred EEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccC
Q 013081 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 169 (450)
+++++|+.||+|++++.. +++++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|........
T Consensus 86 ~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp EEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EEEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 444556679999999975 5799999999999999999999999999999999999999999999999999985433222
Q ss_pred -CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC--C-------------
Q 013081 170 -DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--D------------- 233 (450)
Q Consensus 170 -~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~------------- 233 (450)
.......+||+.|+|||++.....++.++||||+||++|+|++|+.||.+.+........... .
T Consensus 165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T d1pmea_ 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244 (345)
T ss_dssp BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhh
Confidence 234566789999999999877666679999999999999999999999987765544433211 0
Q ss_pred -------C---------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCCC
Q 013081 234 -------F---------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 276 (450)
Q Consensus 234 -------~---------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~~ 276 (450)
. ...+.+|+++.+||.+||++||.+|||+.|+|+||||++...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~ 303 (345)
T d1pmea_ 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303 (345)
T ss_dssp HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence 0 012347889999999999999999999999999999986543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-54 Score=431.44 Aligned_cols=251 Identities=28% Similarity=0.373 Sum_probs=211.5
Q ss_pred CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe------CCE
Q 013081 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS------KSK 88 (450)
Q Consensus 15 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------~~~ 88 (450)
+|+.+++||+|+||+||+|++..+|+.||||++.+... ...+|+.+|++++||||+++++++.. ...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 79999999999999999999999999999999976532 23479999999999999999999853 335
Q ss_pred EEEEEccCCCCChHH---HHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCC-CeEEeecCCCCCC
Q 013081 89 IYMVLEYVTGGELFD---KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLSALP 164 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~---~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g-~lkl~DFGla~~~ 164 (450)
+|+|||||+++.+.. ......++++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|...
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 899999997664333 234466899999999999999999999999999999999999999876 8999999999754
Q ss_pred CcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC------------
Q 013081 165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------ 232 (450)
Q Consensus 165 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------ 232 (450)
.. .....+.+||+.|+|||++.+...++.++||||+||++|+|++|+.||...+......++.+.
T Consensus 174 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 174 VR---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CT---TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred cC---CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 32 334556789999999999887666679999999999999999999999988877666555421
Q ss_pred -----CCCC------------CCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCC
Q 013081 233 -----DFKL------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 233 -----~~~~------------p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
...+ ...+++++.+||.+||++||.+|||+.|+|+||||++-.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 1111 234789999999999999999999999999999998653
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-54 Score=416.14 Aligned_cols=256 Identities=25% Similarity=0.399 Sum_probs=215.7
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (450)
...++|++++.||+|+||+||+|++..+ +.||||+++..... .+.+.+|+.+|++++|||||++++++.+ +..|
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~ 87 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 87 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEEec-CCeE
Confidence 4568999999999999999999998655 56999999755332 3678999999999999999999999854 5679
Q ss_pred EEEccCCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc
Q 013081 91 MVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 91 lv~E~~~gg~L~~~i~~--~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 168 (450)
+||||+++|+|.+++.. .+.+++.+++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+.....
T Consensus 88 lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~- 166 (285)
T d1fmka3 88 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN- 166 (285)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred EEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCC-
Confidence 99999999999988754 457999999999999999999999999999999999999999999999999999864321
Q ss_pred CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 013081 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 246 (450)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 246 (450)
........+||+.|+|||++.+..+ +.++||||+||++|||++ |.+||.+.+.......+.++ ..+.|..+++++.+
T Consensus 167 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 245 (285)
T d1fmka3 167 EYTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 245 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred CceeeccccccccccChHHHhCCCC-CcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHH
Confidence 1122344679999999999988777 589999999999999999 56667777777788777766 56788889999999
Q ss_pred HHHHccccCcCCCCCHHHHHh--ccccccC
Q 013081 247 LLRKILEPNPVKRITIAGIKA--DEWFEQD 274 (450)
Q Consensus 247 Li~~~L~~dP~~R~t~~~il~--h~~~~~~ 274 (450)
||.+||+.||++|||++++++ ++||...
T Consensus 246 li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 246 LMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 999999999999999999987 7888654
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-54 Score=416.50 Aligned_cols=251 Identities=27% Similarity=0.429 Sum_probs=208.9
Q ss_pred cCCeEEeeeecccCceEEEEEEECCC---CceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (450)
-++|++++.||+|+||.||+|++..+ +..||||.++... .....+.+.+|+.+|++++||||+++++++. ++..
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 46899999999999999999998754 3468888875432 3444678999999999999999999999985 5678
Q ss_pred EEEEccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc
Q 013081 90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 168 (450)
|+||||+++|+|.+++.. .+++++..++.++.||++||.|||++||+||||||+|||++.++++||+|||+|+.....
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~- 161 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS- 161 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCC-
Confidence 999999999999998765 457999999999999999999999999999999999999999999999999999864432
Q ss_pred CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 013081 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 246 (450)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 246 (450)
........+||+.|+|||++.+..| +.++|||||||++|||+| |.+||.+.+...+..++..+ ..+.|+.+|+.+.+
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~~~~-~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 240 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 240 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred cceeccceecCcccchhhHhccCCC-CCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 1223345678999999999988777 589999999999999998 99999999888888888877 46788889999999
Q ss_pred HHHHccccCcCCCCCHHHHHhc
Q 013081 247 LLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 247 Li~~~L~~dP~~R~t~~~il~h 268 (450)
||.+||+.||++|||+.||++|
T Consensus 241 li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 241 LMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999886
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=431.23 Aligned_cols=255 Identities=30% Similarity=0.394 Sum_probs=216.5
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----CE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-----SK 88 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~~ 88 (450)
+||++++.||+|+||+||+|++..+|+.||||++++... +....+++.+|+.+|+.++||||+++++++... ..
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 689999999999999999999999999999999976543 334457889999999999999999999998532 33
Q ss_pred EEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc
Q 013081 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 168 (450)
.+++|+|+.||+|.+++.. +++++.+++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||+|....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~--- 172 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--- 172 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT---
T ss_pred eEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC---
Confidence 4666777889999998854 679999999999999999999999999999999999999999999999999997533
Q ss_pred CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCC-------------
Q 013081 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK------------- 235 (450)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~------------- 235 (450)
....+.+||+.|+|||++.+..+.+.++||||+||++|+|++|++||.+.+.......+......
T Consensus 173 --~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 250 (348)
T d2gfsa1 173 --DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250 (348)
T ss_dssp --GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHH
T ss_pred --cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchh
Confidence 23456789999999999888878789999999999999999999999998877666665432111
Q ss_pred ----------C--------CCCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCC
Q 013081 236 ----------L--------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 236 ----------~--------p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
. ...+++++.+||++||++||.+|||+.|+|+||||++..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp HHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 1 124789999999999999999999999999999998654
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-53 Score=411.62 Aligned_cols=253 Identities=24% Similarity=0.364 Sum_probs=210.2
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCC----ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (450)
.-+.|++.+.||+|+||.||+|.+..++ ..||||.++... .......+.+|+.++++++|||||++++++.+..
T Consensus 5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~ 82 (283)
T d1mqba_ 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 82 (283)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC
Confidence 3467999999999999999999977654 479999996543 2334567899999999999999999999999999
Q ss_pred EEEEEEccCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCc
Q 013081 88 KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 166 (450)
..|+||||+.++++.+.+... +.+++.++..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+....
T Consensus 83 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 83 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 999999999999999987654 5799999999999999999999999999999999999999999999999999986543
Q ss_pred ccCC-CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHH
Q 013081 167 FRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPG 243 (450)
Q Consensus 167 ~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 243 (450)
.... .......||+.|+|||++.+..+ +.++|||||||++|||++ |.+||.+.+...+...+..+ ..+.|..+++.
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~-~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 241 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKF-TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSA 241 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHH
T ss_pred CCccceEeccCCCCccccCHHHHccCCC-CCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHH
Confidence 2211 12334578999999999988776 589999999999999999 56667777777777777766 56677889999
Q ss_pred HHHHHHHccccCcCCCCCHHHHHh
Q 013081 244 AQNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 244 ~~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
+.+||.+||+.||++|||+.+|++
T Consensus 242 l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 242 IYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHCcCCHhHCcCHHHHHH
Confidence 999999999999999999999987
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-54 Score=421.41 Aligned_cols=252 Identities=22% Similarity=0.337 Sum_probs=211.9
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCc----eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGL----PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (450)
.+|++++.||+|+||+||+|.+..+|+ .||+|.++... .....+.+.+|+.++++++|||||++++++.++ ..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 579999999999999999999988876 57778775432 223357899999999999999999999999765 56
Q ss_pred EEEEccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc
Q 013081 90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 168 (450)
++++||+.+|+|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+......
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 788899999999988765 4579999999999999999999999999999999999999999999999999998654332
Q ss_pred CCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 013081 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 246 (450)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 246 (450)
.........||+.|+|||++.+..| +.++|||||||++|||+| |.+||.+.+...+...+..+ ..+.|+.+++.+.+
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~ 244 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 244 (317)
T ss_dssp C--------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHH
T ss_pred ccccccccccCccccChHHHhcCCC-ChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHH
Confidence 2333344578999999999988776 589999999999999998 89999998877777777776 46778889999999
Q ss_pred HHHHccccCcCCCCCHHHHHhcc
Q 013081 247 LLRKILEPNPVKRITIAGIKADE 269 (450)
Q Consensus 247 Li~~~L~~dP~~R~t~~~il~h~ 269 (450)
|+.+||+.||.+|||+.|+++|.
T Consensus 245 li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 245 IMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHhCCCChhhCcCHHHHHHHH
Confidence 99999999999999999999884
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.1e-53 Score=421.49 Aligned_cols=250 Identities=24% Similarity=0.422 Sum_probs=209.8
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEe--CCE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLAS--KSK 88 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~--~~~ 88 (450)
..++|++++.||+|+||+||+|+++.+|+.||||++++.. .+++.+|+.+|+.++ ||||+++++++.. ...
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~ 106 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 106 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence 3468999999999999999999999999999999996542 467889999999995 9999999999974 456
Q ss_pred EEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCC-CeEEeecCCCCCCCcc
Q 013081 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLSALPQHF 167 (450)
Q Consensus 89 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g-~lkl~DFGla~~~~~~ 167 (450)
+|+|||||.+++|.... +.+++.+++.+++||+.||+|||++||+||||||+|||++.++ .+||+|||+|+....
T Consensus 107 ~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~- 182 (328)
T d3bqca1 107 PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP- 182 (328)
T ss_dssp EEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT-
T ss_pred eeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccC-
Confidence 99999999999997753 5699999999999999999999999999999999999999766 599999999985432
Q ss_pred cCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHH-HHHHHHH-------------hCC
Q 013081 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKIF-------------RGD 233 (450)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-~~~~~i~-------------~~~ 233 (450)
.......+||+.|+|||++.+...++.++||||+||++|+|++|..||...... .....+. ...
T Consensus 183 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 183 --GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp --TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred --CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 234566789999999999887776679999999999999999999999764322 1111111 000
Q ss_pred C------------------------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhcccccc
Q 013081 234 F------------------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (450)
Q Consensus 234 ~------------------------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~ 273 (450)
. .....+++++.+||++||++||.+|||++|+|+||||+.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~ 324 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 0 011226889999999999999999999999999999975
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-53 Score=415.06 Aligned_cols=252 Identities=26% Similarity=0.365 Sum_probs=220.0
Q ss_pred cCCeEEeeeecccCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (450)
-++|++++.||+|+||+||+|+++ .+++.||||+++... .....+++.+|+.+|+.++||||+++++++....
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 89 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence 468999999999999999999875 356789999987543 3344678999999999999999999999999999
Q ss_pred EEEEEEccCCCCChHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCC
Q 013081 88 KIYMVLEYVTGGELFDKIASKG------------------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLE 143 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~~------------------------~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~ 143 (450)
..+++|||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~ 169 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 169 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEccc
Confidence 9999999999999999986432 3889999999999999999999999999999999
Q ss_pred cEEEccCCCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhC-CCCCCCCcH
Q 013081 144 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG-YLPFDDRNL 222 (450)
Q Consensus 144 NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG-~~Pf~~~~~ 222 (450)
|||++.++++||+|||+|+............+.+||+.|+|||++.+..| +.++|||||||++|||++| .+||.+.+.
T Consensus 170 NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-t~ksDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 170 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred ceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCC-ChhhhhccchhhHHHHHccCCCCCCCCCH
Confidence 99999999999999999975443333334456789999999999988877 4899999999999999998 578999999
Q ss_pred HHHHHHHHhCC-CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHh
Q 013081 223 AVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 223 ~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
.+....+..+. .+.|..+++++.+||.+||+.||++|||+.||++
T Consensus 249 ~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 249 EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 88888888775 4567889999999999999999999999999965
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-53 Score=411.67 Aligned_cols=254 Identities=27% Similarity=0.451 Sum_probs=219.1
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCC-------ceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSG-------LPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEV 82 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~-------~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~ 82 (450)
...++|++++.||+|+||.||+|++..++ ..||||+++++.. ......+.+|...+.++ +||||++++++
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC--hHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 34589999999999999999999976544 4799999976542 33357788899888888 79999999999
Q ss_pred EEeCCEEEEEEccCCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEE
Q 013081 83 LASKSKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENIL 146 (450)
Q Consensus 83 ~~~~~~~~lv~E~~~gg~L~~~i~~~----------------~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NIL 146 (450)
+.+++..|+||||+++|+|.+++... ..+++.+++.++.||+.||+|||++||+||||||+|||
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiL 167 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 167 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccccee
Confidence 99999999999999999999999754 35899999999999999999999999999999999999
Q ss_pred EccCCCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHH
Q 013081 147 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVL 225 (450)
Q Consensus 147 l~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~ 225 (450)
++.++.+||+|||+++..............+||+.|+|||.+.+..| +.++|||||||++|+|++ |.+||.+.+...+
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y-~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~ 246 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCC-CchhhhHHhHHHHHHhccCCCCCCCCCCHHHH
Confidence 99999999999999997655444444566789999999999988777 599999999999999998 7999999998888
Q ss_pred HHHHHhC-CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHh
Q 013081 226 YQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 226 ~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
+..+..+ .++.|.++++++.+||.+||++||++|||+.|+++
T Consensus 247 ~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 247 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 8887766 56778889999999999999999999999999987
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-53 Score=423.26 Aligned_cols=256 Identities=29% Similarity=0.434 Sum_probs=206.0
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe------
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS------ 85 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------ 85 (450)
.+.+|++++.||+|+||+||+|+++.+|+.||||++.+... +.....++.+|+.++++++||||+++++++..
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence 34799999999999999999999999999999999976543 34456789999999999999999999999953
Q ss_pred CCEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCC
Q 013081 86 KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (450)
Q Consensus 86 ~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 165 (450)
...+|+|||||.|+ +.+.+ ...+++..++.+++||+.||+|||++||+||||||+|||++.++.+|++|||+++...
T Consensus 94 ~~~~~iv~Ey~~~~-l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 94 FQDVYLVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp CCEEEEEEECCSEE-HHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CceeEEEEeccchH-HHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccc
Confidence 46899999999764 55544 3569999999999999999999999999999999999999999999999999988543
Q ss_pred cccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC-------------
Q 013081 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------- 232 (450)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------- 232 (450)
. .......+||+.|+|||++.+..+ ++++||||+||++|+|++|++||.+.+......++...
T Consensus 171 ~---~~~~~~~~~t~~y~aPE~l~~~~~-~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 171 T---SFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp -------------CCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred c---ccccccccccccccChhhhcCCCC-CCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 2 234456689999999999988766 58999999999999999999999988776655554321
Q ss_pred ---------CCCC--------------C------CCCCHHHHHHHHHccccCcCCCCCHHHHHhccccccCC
Q 013081 233 ---------DFKL--------------P------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (450)
Q Consensus 233 ---------~~~~--------------p------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~~~~~~~ 275 (450)
.... + ..+++++.+||++||++||++|||++|+|+||||+...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~ 318 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 318 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 1000 0 01356889999999999999999999999999998643
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-53 Score=413.25 Aligned_cols=255 Identities=25% Similarity=0.371 Sum_probs=205.3
Q ss_pred cccCCeEEeeeecccCceEEEEEEECC-----CCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA 84 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 84 (450)
...++|++++.||+|+||.||+|.+.. +++.||||+++.... ....+.+.+|..++.++ +||||+.+++++.
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~ 87 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACT 87 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--cHHHHHHHHHHHHHHhhcCCCeEEEeeeeec
Confidence 334789999999999999999999754 456899999865432 23356677888877776 6899999999876
Q ss_pred eC-CEEEEEEccCCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEE
Q 013081 85 SK-SKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL 147 (450)
Q Consensus 85 ~~-~~~~lv~E~~~gg~L~~~i~~~----------------~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl 147 (450)
.. ..+|+|||||+||+|.+++... ..+++.+++.++.||++||.|||++||+||||||+|||+
T Consensus 88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl 167 (299)
T d1ywna1 88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 167 (299)
T ss_dssp STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE
Confidence 54 5689999999999999999653 248999999999999999999999999999999999999
Q ss_pred ccCCCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhC-CCCCCCCcHHHH-
Q 013081 148 DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG-YLPFDDRNLAVL- 225 (450)
Q Consensus 148 ~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG-~~Pf~~~~~~~~- 225 (450)
+.++++||+|||+|+..............+||+.|+|||++.+..+ +.++||||+||++|||+|| .+||.+.+....
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~ 246 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 246 (299)
T ss_dssp CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCC-CcccceeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999986544333334456789999999999988776 5999999999999999986 678987654433
Q ss_pred HHHHHhC-CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 226 YQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 226 ~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
...+..+ .++.|..+++++.+||.+||+.||++|||++|+++|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 247 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3444444 567788899999999999999999999999999987
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-53 Score=405.91 Aligned_cols=245 Identities=25% Similarity=0.470 Sum_probs=209.9
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE-eCCEE
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA-SKSKI 89 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~~~~ 89 (450)
..+++|++++.||+|+||.||+|.+ +|+.||||+++++. ..+.+.+|+.++++++||||+++++++. +.+.+
T Consensus 4 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 76 (262)
T d1byga_ 4 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 76 (262)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred cCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence 3467899999999999999999998 57899999996543 2467899999999999999999999885 45668
Q ss_pred EEEEccCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcc
Q 013081 90 YMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~--~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 167 (450)
|+||||+++|+|.+++...+ .+++..++.++.||+.||.|||+++|+||||||+|||++.+|++||+|||+++...
T Consensus 77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~-- 154 (262)
T d1byga_ 77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-- 154 (262)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecC--
Confidence 99999999999999996543 58999999999999999999999999999999999999999999999999998532
Q ss_pred cCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHH
Q 013081 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQ 245 (450)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 245 (450)
......++|+.|+|||++.+..+ +.++|||||||++|||+| |++||...+......++..+ ..++|..+++.+.
T Consensus 155 ---~~~~~~~~~~~y~aPE~l~~~~~-t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (262)
T d1byga_ 155 ---STQDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY 230 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHH
T ss_pred ---CCCccccccccCCChHHHhCCCC-ChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHH
Confidence 23345678999999999988776 599999999999999998 89999998888888888765 6778888999999
Q ss_pred HHHHHccccCcCCCCCHHHHHhc
Q 013081 246 NLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 246 ~Li~~~L~~dP~~R~t~~~il~h 268 (450)
+||.+||+.||.+|||+.+++++
T Consensus 231 ~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 231 EVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcccCHhHCcCHHHHHHH
Confidence 99999999999999999999874
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-53 Score=413.91 Aligned_cols=252 Identities=27% Similarity=0.407 Sum_probs=217.7
Q ss_pred cccCCeEEeeeecccCceEEEEEEECCCCce--EEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLP--FAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKS 87 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~--vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 87 (450)
..+++|++.+.||+|+||+||+|+++.+|.. ||||.++... ..+..+.+.+|+.+|+++ +||||+++++++.+.+
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 4568999999999999999999999888774 6677765332 223356799999999999 7999999999999999
Q ss_pred EEEEEEccCCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCC
Q 013081 88 KIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG 151 (450)
Q Consensus 88 ~~~lv~E~~~gg~L~~~i~~~----------------~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g 151 (450)
..|+||||++||+|.+++... ..+++..+.+++.||+.||.|||++||+||||||+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 999999999999999999654 5699999999999999999999999999999999999999999
Q ss_pred CeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhC-CCCCCCCcHHHHHHHHH
Q 013081 152 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG-YLPFDDRNLAVLYQKIF 230 (450)
Q Consensus 152 ~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG-~~Pf~~~~~~~~~~~i~ 230 (450)
.+||+|||+|+..... ......+||+.|+|||.+.+..| +.++|||||||++|||++| .+||.+.+...+...+.
T Consensus 165 ~~kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~-~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~ 240 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 240 (309)
T ss_dssp CEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred ceEEcccccccccccc---ccccceecCCcccchHHhccCCC-CccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 9999999999854332 22345679999999999988877 5899999999999999996 57899999999888887
Q ss_pred hC-CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 231 RG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 231 ~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
.+ .++.|..+++++.+||.+||+.||++|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 241 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 76 567788899999999999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-53 Score=408.67 Aligned_cols=253 Identities=27% Similarity=0.410 Sum_probs=207.0
Q ss_pred cCCeEEeeeecccCceEEEEEEECC-CC--ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLD-SG--LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~-~~--~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (450)
-++|++++.||+|+||.||+|+... ++ ..||||++.+......+..+.+.+|+.+|++++||||+++++++.+ ...
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 3679999999999999999998643 33 4789999987666555667889999999999999999999999965 467
Q ss_pred EEEEccCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCccc
Q 013081 90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 168 (450)
|+||||+++|++.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence 899999999999988765 4579999999999999999999999999999999999999999999999999998654322
Q ss_pred CCC-ccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCC--CCCCCCCCHHH
Q 013081 169 DDG-LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD--FKLPKWLSPGA 244 (450)
Q Consensus 169 ~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~ 244 (450)
... .....+|++.|+|||++.+..+ +.++|||||||++|||+| |..||.+.+..+...++.+.. ++.|+.+|+.+
T Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l 244 (273)
T d1u46a_ 166 DHYVMQEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 244 (273)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHH
T ss_pred CcceecCccccCcccCCHHHHhCCCC-CcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHH
Confidence 211 2334567889999999988766 589999999999999998 899999999999888887764 45567799999
Q ss_pred HHHHHHccccCcCCCCCHHHHHh
Q 013081 245 QNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
.+||.+||++||++|||+++|++
T Consensus 245 ~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 245 YNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999863
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-52 Score=407.49 Aligned_cols=254 Identities=22% Similarity=0.304 Sum_probs=222.2
Q ss_pred cccCCeEEeeeecccCceEEEEEEECC-----CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 013081 11 MRLGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (450)
Q Consensus 11 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 85 (450)
...++|++++.||+|+||+||+|.+.. +++.||||++++.. .......+.+|+.++++++||||+++++++..
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 344899999999999999999998752 46789999997543 33345678999999999999999999999999
Q ss_pred CCEEEEEEccCCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEE
Q 013081 86 KSKIYMVLEYVTGGELFDKIASK----------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKI 155 (450)
Q Consensus 86 ~~~~~lv~E~~~gg~L~~~i~~~----------~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl 155 (450)
+...++||||+++|+|.+++... ..+++..+..++.|+++||.|||+++|+||||||+|||++.++++||
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEE
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEE
Confidence 99999999999999999988642 24789999999999999999999999999999999999999999999
Q ss_pred eecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhC-CCCCCCCcHHHHHHHHHhCC-
Q 013081 156 SDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG-YLPFDDRNLAVLYQKIFRGD- 233 (450)
Q Consensus 156 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG-~~Pf~~~~~~~~~~~i~~~~- 233 (450)
+|||+|+..............+||+.|+|||.+.+..+ +.++|||||||++|||+|| .+||.+.+....+..+.++.
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~-~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~ 253 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 253 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred eecccceeccCCcceeeccceecccccCCHHHHccCCC-CcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCC
Confidence 99999986544333333445579999999999988777 4899999999999999998 68999999988888888764
Q ss_pred CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHh
Q 013081 234 FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 234 ~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
.+.|+.+++.+.+||.+||+.||++|||+.++++
T Consensus 254 ~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 254 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 5677889999999999999999999999999988
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-52 Score=405.91 Aligned_cols=252 Identities=27% Similarity=0.430 Sum_probs=217.2
Q ss_pred cCCeEEeeeecccCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK 86 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 86 (450)
-++|++++.||+|+||.||+|++. .+++.||||++++.. .......+.+|+.+++.+ +|||||++++++.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 478999999999999999999863 467899999997654 333456789999999999 699999999999999
Q ss_pred CEEEEEEccCCCCChHHHHHhcC------------------CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEc
Q 013081 87 SKIYMVLEYVTGGELFDKIASKG------------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 148 (450)
Q Consensus 87 ~~~~lv~E~~~gg~L~~~i~~~~------------------~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~ 148 (450)
...|+|||||+||+|.+++.... .+++..++.++.||+.||+|||++|++||||||+|||++
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccc
Confidence 99999999999999999987543 589999999999999999999999999999999999999
Q ss_pred cCCCeEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCcHHHHHH
Q 013081 149 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQ 227 (450)
Q Consensus 149 ~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~ 227 (450)
.++++|++|||+++..............+||+.|+|||++.+..+ +.++|||||||++|+|+| |.+||.+.+....+.
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCC-CCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999987654333334445689999999999987666 689999999999999998 777787766655555
Q ss_pred HHHhC--CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHHh
Q 013081 228 KIFRG--DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 228 ~i~~~--~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
++... ....|..+|+.+.+||.+||++||.+|||+++|++
T Consensus 259 ~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 259 KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 54433 45566779999999999999999999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-50 Score=390.79 Aligned_cols=249 Identities=24% Similarity=0.326 Sum_probs=206.2
Q ss_pred EEeeeecccCceEEEEEEECCCC---ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCEEEEE
Q 013081 17 ELGRTLGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-KSKIYMV 92 (450)
Q Consensus 17 ~i~~~LG~G~~g~Vy~a~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~lv 92 (450)
.+.++||+|+||+||+|++..++ ..||||.+++. .+....+++.+|+.+|++++||||+++++++.. +...|+|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 34689999999999999986643 36899998643 244556889999999999999999999999765 5689999
Q ss_pred EccCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCCCCCCCcccCC-
Q 013081 93 LEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD- 170 (450)
Q Consensus 93 ~E~~~gg~L~~~i~~~~-~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~- 170 (450)
||||++|+|.+++.... .+++..+.+++.|++.||.|||+.||+||||||+|||+++++.+||+|||+++........
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 99999999999887543 5788899999999999999999999999999999999999999999999999865432111
Q ss_pred -CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCC-CcHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 013081 171 -GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRG-DFKLPKWLSPGAQNL 247 (450)
Q Consensus 171 -~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 247 (450)
.......||+.|+|||.+....+ +.++||||||+++|||+||..||.. .+.......+..+ ....|+.+++.+.+|
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~l 266 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEV 266 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ceecccccccccccChHHHhcCCC-CChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHH
Confidence 12234578999999999888776 5999999999999999997666654 4444555666665 456778899999999
Q ss_pred HHHccccCcCCCCCHHHHHhc
Q 013081 248 LRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 248 i~~~L~~dP~~R~t~~~il~h 268 (450)
|.+||+.||++|||+.||++|
T Consensus 267 i~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 267 MLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999988
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-49 Score=387.27 Aligned_cols=257 Identities=22% Similarity=0.265 Sum_probs=204.8
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCEEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN-VVRLHEVLASKSKIYMV 92 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~lv 92 (450)
++|++++.||+|+||.||+|++..+|+.||||++..... ...+.+|+++++.++|+| |+.+..++.+.+..++|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 479999999999999999999999999999999876432 235778999999998766 55566667888999999
Q ss_pred EccCCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEcc---CCCeEEeecCCCCCCCccc
Q 013081 93 LEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS---KGNIKISDFGLSALPQHFR 168 (450)
Q Consensus 93 ~E~~~gg~L~~~i~-~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~---~g~lkl~DFGla~~~~~~~ 168 (450)
|||+ +++|.+.+. ..+.+++..+..++.|++.||+|||++||+||||||+|||++. +..+||+|||+|+......
T Consensus 82 me~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 82 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 9999 556666554 4568999999999999999999999999999999999999864 4579999999998654322
Q ss_pred CC-----CccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHH---HhCC-----CC
Q 013081 169 DD-----GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI---FRGD-----FK 235 (450)
Q Consensus 169 ~~-----~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i---~~~~-----~~ 235 (450)
.. ....+.+||+.|+|||++.+.++ +.++|||||||++|+|++|..||...........+ .... ..
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCC-CHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHH
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCC-CChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhH
Confidence 11 22345689999999999988776 58999999999999999999999875544332222 1111 11
Q ss_pred CCCCCCHHHHHHHHHccccCcCCCCCHH---HHHhccccccCCCC
Q 013081 236 LPKWLSPGAQNLLRKILEPNPVKRITIA---GIKADEWFEQDYTP 277 (450)
Q Consensus 236 ~p~~~s~~~~~Li~~~L~~dP~~R~t~~---~il~h~~~~~~~~~ 277 (450)
.+..+|+++.+|+.+||+.||++||+++ ++|+|+|.+.....
T Consensus 240 ~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~ 284 (299)
T d1ckia_ 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 284 (299)
T ss_dssp HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCC
T ss_pred hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCC
Confidence 2456899999999999999999999987 45788887665544
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.5e-48 Score=377.17 Aligned_cols=248 Identities=19% Similarity=0.221 Sum_probs=206.8
Q ss_pred cCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCC-CCcceEEEEEEeCCEEEE
Q 013081 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH-PNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 13 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~l 91 (450)
-++|++++.||+|+||+||+|++..+|+.||||++..... ...+.+|++.++.++| +|++.+++++......|+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 3699999999999999999999999999999999865432 2357789999999975 899999999999999999
Q ss_pred EEccCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEcc-----CCCeEEeecCCCCCCC
Q 013081 92 VLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-----KGNIKISDFGLSALPQ 165 (450)
Q Consensus 92 v~E~~~gg~L~~~i~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~-----~g~lkl~DFGla~~~~ 165 (450)
||||+ |++|.+.+... ..+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|+...
T Consensus 79 vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99999 78999988764 47999999999999999999999999999999999999974 5789999999998653
Q ss_pred cccC-----CCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCc---HHHHHHHHHhCCC---
Q 013081 166 HFRD-----DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN---LAVLYQKIFRGDF--- 234 (450)
Q Consensus 166 ~~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~--- 234 (450)
.... .....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.. ....+.++.....
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~-~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCC-ChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence 3211 123445689999999999988776 589999999999999999999997543 3333333332211
Q ss_pred --CCCCCCCHHHHHHHHHccccCcCCCCCHHHHHh
Q 013081 235 --KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (450)
Q Consensus 235 --~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 267 (450)
..+..+|+++.+++..|+..+|++||+.+.+.+
T Consensus 237 ~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 237 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 123568899999999999999999999877644
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-48 Score=377.90 Aligned_cols=248 Identities=24% Similarity=0.318 Sum_probs=193.1
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----EE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS----KI 89 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~~ 89 (450)
.+|.+.+.||+|+||.||+|++ +|+.||||+++.... ......+|+..+..++||||+++++++.+.+ .+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~----~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence 4689999999999999999987 689999999864321 1122334556667789999999999997654 68
Q ss_pred EEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhh--------cCeeeccCCCCcEEEccCCCeEEeecCCC
Q 013081 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN--------KGVFHRDLKLENILLDSKGNIKISDFGLS 161 (450)
Q Consensus 90 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~--------~givHrDlKp~NILl~~~g~lkl~DFGla 161 (450)
|+||||+++|+|.+++.+ .++++.....++.|++.||+|||+ +||+||||||+||||+.++++||+|||++
T Consensus 77 ~lv~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 999999999999999976 469999999999999999999996 59999999999999999999999999999
Q ss_pred CCCCcccC--CCccccccCCCCccchhhhccCCC-----CCccchhhhHHHHHHHHHhCCCCCCC---------------
Q 013081 162 ALPQHFRD--DGLLHTTCGSPNYVAPEVLANRGY-----DGATSDIWSCGVILYVILTGYLPFDD--------------- 219 (450)
Q Consensus 162 ~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~-----~~~~~DiwSlGvil~elltG~~Pf~~--------------- 219 (450)
+....... .......+||+.|+|||++.+... .+.++|||||||+||||+||..||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 85432211 123345789999999999875431 24689999999999999999888742
Q ss_pred CcHHHHHHHHHhCCC--CCCCC-----CCHHHHHHHHHccccCcCCCCCHHHHHhc
Q 013081 220 RNLAVLYQKIFRGDF--KLPKW-----LSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (450)
Q Consensus 220 ~~~~~~~~~i~~~~~--~~p~~-----~s~~~~~Li~~~L~~dP~~R~t~~~il~h 268 (450)
............... .+|.. .+..+.+|+.+||+.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 122333333333322 23322 12358899999999999999999999774
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.5e-47 Score=377.60 Aligned_cols=251 Identities=25% Similarity=0.436 Sum_probs=197.0
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-----------CCCcceEEEE
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-----------HPNVVRLHEV 82 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----------hpnIv~l~~~ 82 (450)
|||++++.||+|+||+||+|+++.+|+.||||+++++. ...+.+.+|+.+++.++ ||||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 57999999999999999999999999999999997643 23467788999988875 4789999988
Q ss_pred EEe--CCEEEEEEccCCCCChHHHH---HhcCCCCHHHHHHHHHHHHHHHhhhhh-cCeeeccCCCCcEEEccCCC----
Q 013081 83 LAS--KSKIYMVLEYVTGGELFDKI---ASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGN---- 152 (450)
Q Consensus 83 ~~~--~~~~~lv~E~~~gg~L~~~i---~~~~~l~~~~~~~i~~ql~~aL~~LH~-~givHrDlKp~NILl~~~g~---- 152 (450)
+.. ....+++++++..+...... .....+++..++.++.||+.||+|||+ +||+||||||+|||++.++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence 754 45667777776555443332 234579999999999999999999998 89999999999999987764
Q ss_pred --eEEeecCCCCCCCcccCCCccccccCCCCccchhhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCcHH------H
Q 013081 153 --IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA------V 224 (450)
Q Consensus 153 --lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~------~ 224 (450)
+|++|||.|.... ......+||+.|+|||++....+ +.++||||+||++++|++|+.||...+.. .
T Consensus 169 ~~~kl~dfg~s~~~~-----~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 169 IQIKIADLGNACWYD-----EHYTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp EEEEECCCTTCEETT-----BCCCSCCSCGGGCCHHHHHTCCC-CTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred ceeeEeecccccccc-----cccccccccccccChhhccccCC-CccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 9999999987432 23356789999999999988877 48999999999999999999999754321 1
Q ss_pred HHHHHHh------------------------------------------CCCCCCCCCCHHHHHHHHHccccCcCCCCCH
Q 013081 225 LYQKIFR------------------------------------------GDFKLPKWLSPGAQNLLRKILEPNPVKRITI 262 (450)
Q Consensus 225 ~~~~i~~------------------------------------------~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~ 262 (450)
....... .....+...++.+.+||.+||++||.+|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 1111100 0111112246789999999999999999999
Q ss_pred HHHHhccccccC
Q 013081 263 AGIKADEWFEQD 274 (450)
Q Consensus 263 ~~il~h~~~~~~ 274 (450)
+|+|+||||++.
T Consensus 323 ~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 323 GGLVNHPWLKDT 334 (362)
T ss_dssp HHHHTCGGGTTC
T ss_pred HHHhcCcccCCC
Confidence 999999999844
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=1.3e-26 Score=209.30 Aligned_cols=136 Identities=20% Similarity=0.259 Sum_probs=109.5
Q ss_pred eEEeeeecccCceEEEEEEECCCCceEEEEEeeccccc---------------chhHHHHHHHHHHHHHhCCCCCcceEE
Q 013081 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---------------HLKITDQIKREIATLKLLKHPNVVRLH 80 (450)
Q Consensus 16 y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~---------------~~~~~~~~~~Ei~il~~l~hpnIv~l~ 80 (450)
|.+++.||+|+||+||+|++. +|+.||||+++..... .........+|...+.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 568999999999999999984 7899999987642211 011124456789999999999999988
Q ss_pred EEEEeCCEEEEEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhhcCeeeccCCCCcEEEccCCCeEEeecCC
Q 013081 81 EVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGL 160 (450)
Q Consensus 81 ~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlKp~NILl~~~g~lkl~DFGl 160 (450)
++.. .+++|||+++..+.+ ++...+..++.||+.+|.|||++||+||||||+|||+++++ ++|+|||+
T Consensus 81 ~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDFG~ 148 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQ 148 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCCTT
T ss_pred EecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEECCC
Confidence 7632 379999998865532 56677889999999999999999999999999999998654 99999999
Q ss_pred CCCC
Q 013081 161 SALP 164 (450)
Q Consensus 161 a~~~ 164 (450)
|...
T Consensus 149 a~~~ 152 (191)
T d1zara2 149 SVEV 152 (191)
T ss_dssp CEET
T ss_pred cccC
Confidence 9743
|
| >d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Kinase associated domain 1, KA1 domain: Map/microtubule affinity-regulating kinase 3 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.42 E-value=2.6e-13 Score=107.41 Aligned_cols=88 Identities=15% Similarity=0.270 Sum_probs=80.9
Q ss_pred ccceecccCHHHHHHHHHHHHHhcCcEEEEe-CCeEEEEeecCCCCcCCceEEEEEEEEEc-CCeEEEEEEeccCCccee
Q 013081 340 KIRFTSNHSAKDLLERIEDIVTEMGFRVQKK-NGKLKATQEHKPQKSLGSLSVAAEVFEIS-PSLYVVELRKSYGDPTVY 417 (450)
Q Consensus 340 ~~rf~s~~~~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~~~i~~~~-~~~~~v~~~~~~Gd~le~ 417 (450)
....||..+|++|+.+|+++++.+|+.|+++ +|.+++...+.+++ +.++|.+||+++. +++++|+|+|.+||+++|
T Consensus 12 sv~tTS~~~P~eIm~eI~rvL~~lgv~~~~~g~y~l~c~~~~~~~~--~~v~fEieV~kv~~~~l~gv~~kR~~Gd~~~y 89 (102)
T d1ul7a_ 12 SMKTTSSMDPSDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAE--NLVQWEMEVCKLPRLSLNGVRFKRISGTSIAF 89 (102)
T ss_dssp CCCCCBCSCHHHHHHHHHHHHHHTTCEEEECSTTCEEEEECSSCGG--GCEEEEEEEEECSSSSSEEEEEEEEESCHHHH
T ss_pred eeecCcCCCHHHHHHHHHHHHHHcCcEEEEcCCEEEEEEecCCCCC--ceEEEEEEEEEcCCCceEEEEEEEccCCHHHH
Confidence 3456799999999999999999999999876 58999999988888 9999999999996 799999999999999999
Q ss_pred eeccchhhHHHHHHHHhhhcC
Q 013081 418 RQIKTSIVFVQLCNKLSSDLG 438 (450)
Q Consensus 418 ~~~~~~~~~~~~~~~~~~~l~ 438 (450)
++ ||+++...|+
T Consensus 90 k~---------l~~~il~~l~ 101 (102)
T d1ul7a_ 90 KN---------IASKIANELK 101 (102)
T ss_dssp HH---------HHHHHHHHCC
T ss_pred HH---------HHHHHHHhcc
Confidence 99 9999988876
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.59 E-value=9e-08 Score=87.87 Aligned_cols=141 Identities=14% Similarity=0.106 Sum_probs=95.7
Q ss_pred ccCCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEE
Q 013081 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIY 90 (450)
Q Consensus 12 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 90 (450)
.+..|+..+..+.++.+.||+.. ..++.+.+|......... ...+.+|...++.+. +--+.+++.+...++..|
T Consensus 12 ~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 12 LIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred hhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 35788888876666678999876 356678889875443222 245778888888774 434678888888899999
Q ss_pred EEEccCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhh--------------------------------------
Q 013081 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-------------------------------------- 132 (450)
Q Consensus 91 lv~E~~~gg~L~~~i~~~~~l~~~~~~~i~~ql~~aL~~LH~-------------------------------------- 132 (450)
+||++++|..+.+..... .....+..++...++.||+
T Consensus 87 lv~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EEEECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTT
T ss_pred EEEEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccc
Confidence 999999998775433211 1112223333333333331
Q ss_pred ---------------------cCeeeccCCCCcEEEccCCCeEEeecCCCC
Q 013081 133 ---------------------KGVFHRDLKLENILLDSKGNIKISDFGLSA 162 (450)
Q Consensus 133 ---------------------~givHrDlKp~NILl~~~g~lkl~DFGla~ 162 (450)
..++|+|+.|.|||+++++..-|.||+.+.
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 136899999999999877666799999876
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.29 E-value=1.2e-06 Score=85.64 Aligned_cols=81 Identities=17% Similarity=0.144 Sum_probs=51.2
Q ss_pred eeeecccCceEEEEEEECCCCceEEEEEeecccccc----hhHHHHHHHHHHHHHhCC-C--CCcceEEEEEEeCCEEEE
Q 013081 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH----LKITDQIKREIATLKLLK-H--PNVVRLHEVLASKSKIYM 91 (450)
Q Consensus 19 ~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~----~~~~~~~~~Ei~il~~l~-h--pnIv~l~~~~~~~~~~~l 91 (450)
.+.||.|....||++.+..+++.|++|.-....... .....+..+|...|+.+. + ..+.+++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 567899999999999987778899999653211000 011345677888888773 2 345566654 4455678
Q ss_pred EEccCCCCCh
Q 013081 92 VLEYVTGGEL 101 (450)
Q Consensus 92 v~E~~~gg~L 101 (450)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987554
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.15 E-value=3.9e-06 Score=76.16 Aligned_cols=81 Identities=19% Similarity=0.172 Sum_probs=56.0
Q ss_pred cCCeEEeeeecccC-ceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCC--CCcceEEEEEEeCCEE
Q 013081 13 LGRYELGRTLGEGN-FGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH--PNVVRLHEVLASKSKI 89 (450)
Q Consensus 13 ~~~y~i~~~LG~G~-~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~~ 89 (450)
+..++.. .+..|. -+.||+... ..+..+.+|...... ...+.+|...++.+.. -.+.+++.+..+.+..
T Consensus 10 l~g~~~~-~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~ 81 (255)
T d1nd4a_ 10 LFGYDWA-QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRD 81 (255)
T ss_dssp TTTCEEE-ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCE
T ss_pred ccCCceE-EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccce
Confidence 3445553 344444 478998874 557778999865432 2346778888887753 3356788888888899
Q ss_pred EEEEccCCCCCh
Q 013081 90 YMVLEYVTGGEL 101 (450)
Q Consensus 90 ~lv~E~~~gg~L 101 (450)
|++|++++|.++
T Consensus 82 ~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 82 WLLLGEVPGQDL 93 (255)
T ss_dssp EEEEECCSSEET
T ss_pred EEEEEeeecccc
Confidence 999999988665
|
| >d2v8qa1 d.129.6.2 (A:396-548) 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.00 E-value=1.8e-05 Score=64.66 Aligned_cols=73 Identities=8% Similarity=0.224 Sum_probs=60.8
Q ss_pred ceecccCHHHHHHHHHHHHHhcCcEEEEe-CCeEEEEeecCCCCcCCceEEEEEEEEEcCCeEEEEEEeccCCcce
Q 013081 342 RFTSNHSAKDLLERIEDIVTEMGFRVQKK-NGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTV 416 (450)
Q Consensus 342 rf~s~~~~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~~~~~~Gd~le 416 (450)
.+.|+..|.+|+..+..+++.+|+.|++. .|.|++.-...... ..+.+.+++|++.++.|||||+...|+-.|
T Consensus 4 GIrS~s~P~dIM~eVyrALk~L~~eWk~~~~y~ir~R~~~~~~~--~~~Km~lQLYqv~~~~YLLDfk~i~~~~~e 77 (153)
T d2v8qa1 4 GIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTS--TFSKMSLQLYQVDSRTYLLDFRSIDDEITE 77 (153)
T ss_dssp SEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTC--CEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred ccccCCCHHHHHHHHHHHHHHcCCeEEecCceEEEEEEECCCCC--ceeEEEEEEEEEcCCceEEEeeecCcchhc
Confidence 45678899999999999999999999886 58888866543333 788999999999999999999999998655
|
| >d2qrda1 d.129.6.2 (A:450-576) Snf1-like protein kinase ssp2 {Schizosaccharomyces pombe [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: Snf1-like protein kinase ssp2 species: Schizosaccharomyces pombe [TaxId: 4896]
Probab=97.47 E-value=0.00016 Score=57.70 Aligned_cols=68 Identities=10% Similarity=0.246 Sum_probs=53.7
Q ss_pred cccceecccCHHHHHHHHHHHHHhcCcEEEEeC----------CeEEEEee-----cCCCCcCCceEEEEEEEEEcCCeE
Q 013081 339 RKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKN----------GKLKATQE-----HKPQKSLGSLSVAAEVFEISPSLY 403 (450)
Q Consensus 339 ~~~rf~s~~~~~~~~~~l~~~~~~~~~~~~~~~----------~~~~~~~~-----~~~~~~~~~l~~~~~i~~~~~~~~ 403 (450)
.....-|+..|-+|+-.|..+++.+|+.|++.+ |.|++.-. ..... ..+.+.+++|++.++.+
T Consensus 3 WhfGIRSrs~P~eiM~eVYrALk~Lg~eWk~~~~~~~~~~~d~y~Ir~R~~~~~~~~~~~~--~~vkm~iQLYqve~~~Y 80 (127)
T d2qrda1 3 WHFGVRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKN--TYAYIELQLYEVMPGCF 80 (127)
T ss_dssp CEESEEEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCC--EEEEEEEEEEEEETTEE
T ss_pred ceeccccCCChHHHHHHHHHHHHHcCCEEeecCcccccccCCceEEEEEeecCCccccCCC--ceEEEEEEEEEEcCCcE
Confidence 344567899999999999999999999997653 56777532 12122 45788999999999999
Q ss_pred EEEEE
Q 013081 404 VVELR 408 (450)
Q Consensus 404 ~v~~~ 408 (450)
||||+
T Consensus 81 LlDFK 85 (127)
T d2qrda1 81 MLDVK 85 (127)
T ss_dssp EEEEE
T ss_pred EEEEc
Confidence 99997
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.30 E-value=0.00039 Score=65.31 Aligned_cols=69 Identities=25% Similarity=0.227 Sum_probs=45.7
Q ss_pred ceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc--ceEE-----EEEEeCCEEEEEEccCCCC
Q 013081 27 FGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV--VRLH-----EVLASKSKIYMVLEYVTGG 99 (450)
Q Consensus 27 ~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI--v~l~-----~~~~~~~~~~lv~E~~~gg 99 (450)
--.||++.. .+|+.|++|+.+..... .+++..|...+..|...++ +... ..+...+..+.+++++.|.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~~s----~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCCCC----HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 357999984 67889999998654322 3567788888877753222 1111 1234577889999999874
Q ss_pred C
Q 013081 100 E 100 (450)
Q Consensus 100 ~ 100 (450)
.
T Consensus 110 ~ 110 (325)
T d1zyla1 110 Q 110 (325)
T ss_dssp E
T ss_pred C
Confidence 3
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.08 E-value=0.0016 Score=62.70 Aligned_cols=74 Identities=11% Similarity=0.117 Sum_probs=50.6
Q ss_pred eeeecccCceEEEEEEECC-------CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEE
Q 013081 19 GRTLGEGNFGKVKFAQDLD-------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-VRLHEVLASKSKIY 90 (450)
Q Consensus 19 ~~~LG~G~~g~Vy~a~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~ 90 (450)
++.|+.|-.-.+|++.... .++.|.+++.-.. .. .-...+|..+++.+.-.++ .+++.++.+ .
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g 117 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----G 117 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--ch---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence 4678889999999998653 3456888876421 11 2345689999998863344 577777643 5
Q ss_pred EEEccCCCCCh
Q 013081 91 MVLEYVTGGEL 101 (450)
Q Consensus 91 lv~E~~~gg~L 101 (450)
+|+||++|..|
T Consensus 118 ~I~efi~g~~l 128 (395)
T d1nw1a_ 118 RLEEYIPSRPL 128 (395)
T ss_dssp EEECCCCEEEC
T ss_pred eEEEEeccccC
Confidence 78999987544
|
| >d2qlva1 d.129.6.2 (A:460-630) Carbon catabolite-derepressing protein kinase SNF1 {Saccharomyces cerevisiae [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: Carbon catabolite-derepressing protein kinase SNF1 species: Saccharomyces cerevisiae [TaxId: 4932]
Probab=97.03 E-value=0.00058 Score=57.16 Aligned_cols=72 Identities=15% Similarity=0.215 Sum_probs=52.0
Q ss_pred ccccceecccCHHHHHHHHHHHHHhcCcEEEEeC----CeEEEEeecC-------CCCcCCceEEEEEEEEEcCCeEEEE
Q 013081 338 ERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKN----GKLKATQEHK-------PQKSLGSLSVAAEVFEISPSLYVVE 406 (450)
Q Consensus 338 ~~~~rf~s~~~~~~~~~~l~~~~~~~~~~~~~~~----~~~~~~~~~~-------~~~~~~~l~~~~~i~~~~~~~~~v~ 406 (450)
+.....-|+..|-+|+-.|..+++.+|+.|++.+ |.+++.-.-. .......+.+.+++|+|.++.+|||
T Consensus 45 kWhfGIRSrs~P~eiM~evykALk~Lg~eWk~~~~~~~~~ir~Rwk~~~~~~~~~~~~~~~~vk~~iQLYqv~~~~YLlD 124 (171)
T d2qlva1 45 RWHFGIRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLVD 124 (171)
T ss_dssp CCEESEEECSCHHHHHHHHHHHHHHHTCEECCCC---CCEEEEEEC--------------CEEEEEEEEEC---CCEEEE
T ss_pred eeeeecccCCCHHHHHHHHHHHHHHcCCEEeecCCCCceEEEEEeecCCCcccccCCCCCceEEEEEEEEEEcCCceEEE
Confidence 4566778999999999999999999999997653 6677753200 0111245889999999999999999
Q ss_pred EEe
Q 013081 407 LRK 409 (450)
Q Consensus 407 ~~~ 409 (450)
|+-
T Consensus 125 FK~ 127 (171)
T d2qlva1 125 FKF 127 (171)
T ss_dssp EEE
T ss_pred Eec
Confidence 974
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.78 E-value=0.0014 Score=60.80 Aligned_cols=142 Identities=15% Similarity=0.158 Sum_probs=75.2
Q ss_pred CCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC-----cceEE---EEEEe
Q 013081 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN-----VVRLH---EVLAS 85 (450)
Q Consensus 14 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-----Iv~l~---~~~~~ 85 (450)
|+..-.+.|..|---+.|+... .+| .+++|+...... .+.+..|+.++..|...+ .+... .+..-
T Consensus 18 g~~~~~~~i~~G~~N~ny~v~t-~~g-~yVLri~~~~~~-----~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~ 90 (316)
T d2ppqa1 18 GSLTSYKGIAEGVENSNFLLHT-TKD-PLILTLYEKRVE-----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGEL 90 (316)
T ss_dssp CCEEEEEEECC---EEEEEEEE-SSC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEE
T ss_pred CCceEeecCCCCcccCeEEEEE-CCC-cEEEEEcCCCCC-----HHHHHHHHHHHHhhhhccccccccceecCCCcceee
Confidence 4444445566777788898875 334 589999864321 234556777777765322 22110 01223
Q ss_pred CCEEEEEEccCCCCChHH--------------HHHh---c------CCC------------------CHHHHHHHHHHHH
Q 013081 86 KSKIYMVLEYVTGGELFD--------------KIAS---K------GRL------------------QEAEGRKLFQQLI 124 (450)
Q Consensus 86 ~~~~~lv~E~~~gg~L~~--------------~i~~---~------~~l------------------~~~~~~~i~~ql~ 124 (450)
....+.++.+..|..... .+.. . ... ........+..+.
T Consensus 91 ~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 170 (316)
T d2ppqa1 91 SGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEI 170 (316)
T ss_dssp TTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHH
T ss_pred ecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHH
Confidence 455666777776643310 0000 0 000 0111122222333
Q ss_pred HHHhhhh----hcCeeeccCCCCcEEEccCCCeEEeecCCCC
Q 013081 125 DGVSYCH----NKGVFHRDLKLENILLDSKGNIKISDFGLSA 162 (450)
Q Consensus 125 ~aL~~LH----~~givHrDlKp~NILl~~~g~lkl~DFGla~ 162 (450)
..+.-.+ ..|++|+|+.++||+++.+...-|.||+.+.
T Consensus 171 ~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 171 DYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 3333332 2579999999999999988777899999875
|